chemical_name	cas_no	Drug Name	CAS Number	UNII	Pharmacology Classification	Pharmacology Description	Indication
((1-ethylpyrrolidin-2-yl) methyl)-4-hydroxy-7-methoxy-quinoline-3-carboxamide		((1-ethylpyrrolidin-2-yl) methyl)-4-hydroxy-7-methoxy-quinoline-3-carboxamide					
((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester		((1S)-1-((((1S)-1-Benzyl-3-(cyclopropylamino)-2,3-dioxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester	854402-59-8				
((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy)acetic acid	106105-17-3	((2-n-Butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy)acetic acid	106105-17-3				
((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine		((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine					
((3,4-(methylenedioxy)benzyl)amino)-6-chloroquinazoline		((3,4-(methylenedioxy)benzyl)amino)-6-chloroquinazoline					
((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide)		((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide)					
((5Z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4H-imidazol-4-one)		((5Z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4H-imidazol-4-one)					
((dihydroindenyl)oxy)alkanoic acid		((dihydroindenyl)oxy)alkanoic acid					
((E)-N-4-(1,2,3,4-tetrahydroisoquinolin-2-yl)butyl)-3-phenylacrylamide		(E)-N-[4-(3,4-Dihydro-1H-isoquinolin-2-YL)-butyl]-3-phenyl-acrylamide					
((Py-3')TPP-Ru(phen)2Cl)Cl		((Py-3')TPP-Ru(phen)2Cl)Cl					
((Z)-1-thiophen-2-ylethylideneamino)thiourea		((Z)-1-thiophen-2-ylethylideneamino)thiourea					
(+)-(S)-5,5-dimethylmorpholinyl-2-acetic acid		(+)-(S)-5,5-dimethylmorpholinyl-2-acetic acid					
(+)-JQ1 compound		(+)-JQ1 compound					
(1-(2-(bis(4-fluorophenyl)methoxy)ethyl)-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate)		(1-(2-(bis(4-fluorophenyl)methoxy)ethyl)-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate)					
(1-(2-morpholin-4-yl-ethyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone		(1-(2-morpholinoethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone	895155-26-7	5N69DXA53Z			
(1-(2,2-diphenyl-(1,3)dioxolan-4-yl)-ethyl)-dimethyl-amine		(1-(2,2-diphenyl-(1,3)dioxolan-4-yl)-ethyl)-dimethyl-amine					
(1-(4-fluorophenyl)-4a-methyl-5,6,7,8-tetrahydro-4H-benzo(f)indazol-5-yl)-(4-(trifluoromethyl)phenyl)methanol		(1-(4-fluorophenyl)-4a-methyl-5,6,7,8-tetrahydro-4H-benzo(f)indazol-5-yl)-(4-(trifluoromethyl)phenyl)methanol					
(1-hexyl-1H-indol-3-yl)-1-naphthalenylmethanone		(1-hexyl-1H-indol-3-yl)(naphthalen-1-yl)methanone	209414-08-4	0Z73828O4J			
(1-hydroxy-2-oxo-3-(N-methyl-3-aminopropyl)-3-methyl-3-aminopropyl)-3-methyl-1-triazene		(1-hydroxy-2-oxo-3-(N-methyl-3-aminopropyl)-3-methyl-3-aminopropyl)-3-methyl-1-triazene					
(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone		(1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone	1199943-44-6	1TYA7HVP1B			
(1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane		Ethaselen	217798-39-5	4Q2EZS1IWG			
(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid		Tpmpa	182485-36-5	TR7I0800L2			
(1'S, 2S)-4-amino-N-(1'-carbamoyl-2'-phenylethyl)-2-(4''-methyl-1''-naphthalenesulfonylamino)butanamide		(2S)-4-amino-N-[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]-2-[(4-methylnaphthalen-1-yl)sulfonylamino]butanamide	848647-56-3	H35JAI9M2X			
(19Z)-halichondramide		(19Z)-Halichondramide					
(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one		(1E,4E)-1,5-Bis(2-methoxyphenyl)penta-1,4-dien-3-one	41973-42-6				
(1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester	50370-56-4	methyl (1R,2S,3S,5S)-3-(4-fluorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate	50370-56-4	8ZT6KJ947T	Dopamine Uptake Inhibitors	Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. (See all compounds classified as Dopamine Uptake Inhibitors.)	
(1R,3S,3aR,8bS)-3a-(4-Bromophenyl)-6,8-dimethoxy-3-phenyl-2,3,3a,8b-tetrahydro-1H-cyclopenta(b)benzofuran-1,8b-diol		(1R,3S,3aR,8bS)-3a-(4-Bromophenyl)-6,8-dimethoxy-3-phenyl-2,3,3a,8b-tetrahydro-1H-cyclopenta(b)benzofuran-1,8b-diol					
(2-(2',3'-dihydrobenzo(1,4)dioxin-6'-yl)-2-hydroxy-1-pyrrolidin-1-ylmethylethyl)nonanoic acid amide		(2-(2',3'-dihydrobenzo(1,4)dioxin-6'-yl)-2-hydroxy-1-pyrrolidin-1-ylmethylethyl)nonanoic acid amide					
(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane		(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane	613-67-2	E9H51OIT2B	Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	
(2-(4-(4-isopropoxybenzyl)-phenylamino) imidazoline)		(2-(4-(4-isopropoxybenzyl)-phenylamino) imidazoline)					
(2-(5-amino-2-(4-fluorophenyl)-1,6-dihydro-6-oxo-1-pyrimidinyl)-N-(1-((5-methoxycarbonyl-2-benzoxazolyl)carbonyl)-2-phenylethyl)acetamide)		(2-(5-amino-2-(4-fluorophenyl)-1,6-dihydro-6-oxo-1-pyrimidinyl)-N-(1-((5-methoxycarbonyl-2-benzoxazolyl)carbonyl)-2-phenylethyl)acetamide)					
(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine		(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine					
(2-(trimethylammonium)ethyl)methanethiosulfonate	155450-08-1	Mtset	155450-08-1		Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
(2-boronoethyl)-cysteine		(2-boronoethyl)-cysteine					
(2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide		(2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide					
(2-hydroxy-4-(octyloxy)phenyl)phenylmethanone	1843-05-6	Octabenzone	1843-05-6	73P3618V2E			
(2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide		(2-isopropyl-5-methylcyclohexyl) diphenylphosphine oxide					
(2,3,5,6-tetrafluoro-4-methoxymethylphenyl)methyl-2,2-dimethyl-3-(1-propenyl)cyclopropanecarboxylate		Metofluthrin	240494-70-6				
(2,4-dihydroxy-5-isopropylphenyl)-(5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl)methanone		Onalespib	912999-49-6	Q7Y33N57ZZ			Investigated for use/treatment in cancer/tumors (unspecified).
(2)-5,6,7,8,4'-pentamethoxyflavanone		(2)-5,6,7,8,4'-pentamethoxyflavanone					
(22R, 25R)-20alpha-spirost-5-en-3beta-yl hexanoate		Caprospinol	4952-56-1	9BU4T267E4			Alzheimer's Disease
(25S)-26-adamantyl-25-hydroxy-2-methylene-22,23-didehydro-19,27-dinor-20-epi-vitamin D3		(25S)-26-adamantyl-25-hydroxy-2-methylene-22,23-didehydro-19,27-dinor-20-epi-vitamin D3					
(2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid		Peretinoin	81485-25-8	11ALM7A4RV			
(2E)-decenal		2-Decenal	3913-81-3	E93S23U2BU			
(2E)-N,N-dibutyl-3-(4-hydroxy-3-methoxyphenyl)acrylamide		(2E)-N,N-dibutyl-3-(4-hydroxy-3-methoxyphenyl)acrylamide					
(2R, 3S)-2-(((4-(2-butynyloxy)phenyl)sulfonyl)amino)-N,3-dihydroxybutanamide		(2R, 3S)-2-(((4-(2-butynyloxy)phenyl)sulfonyl)amino)-N,3-dihydroxybutanamide					
(2S,4R)-methyl-1-acetyl-4-(N-(4-bromophenyl)sulfamoyloxy)pyrrolidine-2-carboxylate		(2S,4R)-methyl-1-acetyl-4-(N-(4-bromophenyl)sulfamoyloxy)pyrrolidine-2-carboxylate					
(2S)-2-(4-(((3S)-1-acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphtyl)propanoic acid		2-(4-((1-Acetimidoyl-3-pyrrolidinyl)oxy)phenyl)-3-(7-amidino-2-naphthyl)propanoic acid hydrocloride pentahydrate	155204-81-2	QXQVEPEVI2	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
(2S*,3R*)-1-(biphenyl-4-carbonyl)piperazine-2,3-dicarboxylic acid		(2S*,3R*)-1-(biphenyl-4-carbonyl)piperazine-2,3-dicarboxylic acid					
(3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid	153994-81-1	(3-(1-((3-(Cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid	153994-81-1				
(3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester		(3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester					
(3-aminopropyl)(n-butyl)phosphinic acid	145537-81-1	(3-Aminopropyl)(n-butyl)phosphinic acid	123690-78-8	GBZ5UC0RME	GABA Antagonists	Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS. (See all compounds classified as GABA Antagonists.)	Investigated for use/treatment in alzheimer's disease, attention deficit/hyperactivity disorder (ADHD), memory loss, and schizophrenia and schizoaffective disorders.
(3-chloro-4-fluoro-phenyl)-(6-(4-diethylaminomethyl-piperidin-1yl)-pyrimido(5,4-d)pyrimidin-4-yl)amine		(3-chloro-4-fluoro-phenyl)-(6-(4-diethylaminomethyl-piperidin-1yl)-pyrimido(5,4-d)pyrimidin-4-yl)amine					
(3-ethyl-2-methyl-quinolin-6-yl)-(4-methoxycyclohexyl)methanone methanesulfonate		(3-ethyl-2-methyl-quinolin-6-yl)-(4-methoxycyclohexyl)methanone methanesulfonate					
(3-exo)-8-benzoyl-N-(((2S)7-chloro-2,3-dihydro-1,4-benzodioxin-1-yl)methyl)-8-azabicyclo(3.2.1)octane-3-methanamine monohydrochloride		(3-exo)-8-benzoyl-N-(((2S)7-chloro-2,3-dihydro-1,4-benzodioxin-1-yl)methyl)-8-azabicyclo(3.2.1)octane-3-methanamine monohydrochloride					
(3,3-dibenzylimidazo(1,2-a)pyridin-2-(3H)-one)		Imidazo[1,2-a]pyridin-2(3H)-one, 3,3-bis(phenylmethyl)-	324077-62-5				
(3,4-dihydroxyphenylamino)-2-imidazoline	57101-49-2	(3,4-Dihydroxyphenylamino)-2-imidazoline	57101-49-2	DEA5VW1N6R	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
(3,4,5-trimethoxy-N-(2-methoxyethyl)-N-(4-phenyl-2-thiazolyl)benzamide		(3,4,5-trimethoxy-N-(2-methoxyethyl)-N-(4-phenyl-2-thiazolyl)benzamide					
(3,6-dimethyl-2-(2,4,6-trimethylphenoxy)pyridin-4-yl)(1-ethylpropyl)amine		(3,6-dimethyl-2-(2,4,6-trimethylphenoxy)pyridin-4-yl)(1-ethylpropyl)amine					
(3b,5b,7a,12a)-7,12-dihydroxy-3-(2-((4-((11b,17b)-17-hydroxy-3-oxo-17-prop-1-ynylestra-4,9-dien-11-yl) phenyl)(methyl)amino)ethoxy)cholan-24-oic acid		(3b,5b,7a,12a)-7,12-dihydroxy-3-(2-((4-((11b,17b)-17-hydroxy-3-oxo-17-prop-1-ynylestra-4,9-dien-11-yl) phenyl)(methyl)amino)ethoxy)cholan-24-oic acid					
(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone		(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone					
(3Z)-3-(1H-pyrrol-2-yl)-methyllidene)-1-(1-(piperidylmethyl)-1,3-dihydro-2H-indol-2-one mesylate		(3Z)-3-(1H-pyrrol-2-yl)-methyllidene)-1-(1-(piperidylmethyl)-1,3-dihydro-2H-indol-2-one mesylate					
(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid		{4-[({2-[3-Fluoro-4-(Trifluoromethyl)phenyl]-4-Methyl-1,3-Thiazol-5-Yl}methyl)sulfanyl]-2-Methylphenoxy}acetic Acid	317318-84-6	4PZK9FJC4Z			
(4-(4-hydroxy-3-isopropyl-5-(4-nitrophenylethynyl)benzyl)-3,5-dimethylphenoxy)acetic acid		(4-(4-hydroxy-3-isopropyl-5-(4-nitrophenylethynyl)benzyl)-3,5-dimethylphenoxy)acetic acid					
(4-(4'-chloro-2'-fluoro)phenylamino)-6,7-dimethylquinazoline		(4-(4'-chloro-2'-fluoro)phenylamino)-6,7-dimethylquinazoline					
(4-(5-(4-fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl)pyridin-2-yl)-(1-phenylethyl)amine		(4-(5-(4-fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl)pyridin-2-yl)-(1-phenylethyl)amine					
(4-(7-chloroquinolin-4-yl)piperazino)(1-phenyl-5-(trifluoromethyl)-1H-pyrazol-4-yl)methanone		(4-(7-chloroquinolin-4-yl)piperazino)(1-phenyl-5-(trifluoromethyl)-1H-pyrazol-4-yl)methanone					
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride	55-45-8	(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride	55-45-8	CW55R761RE	Ganglionic Stimulants	Agents that mimic neural transmission by stimulation of the nicotinic receptors on postganglionic autonomic neurons. Drugs that indirectly augment ganglionic transmission by increasing the release or slowing the breakdown of acetylcholine or by non-nicotinic effects on postganglionic neurons are not included here nor are the nonspecific cholinergic agonists. (See all compounds classified as Ganglionic Stimulants.)	
(4-amidinophenyl)methanesulfonyl fluoride	71933-13-6	(4-Carbamimidoylphenyl)methanesulfonyl fluoride	71933-13-6				
(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)		(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)					
(4-benzylpiperazin-1-yl)acetic acid (3-allyl-2-hydroxybenzylidene)hydrazine		(4-benzylpiperazin-1-yl)acetic acid (3-allyl-2-hydroxybenzylidene)hydrazine					
(4-chloro-2-((2-fluoro-5-(propylsulfonyl)phenyl)ethynyl)phenoxy)acetic acid		(4-chloro-2-((2-fluoro-5-(propylsulfonyl)phenyl)ethynyl)phenoxy)acetic acid					
(4-chloro-2-((2-methyl-5-(propylsulfonyl)phenyl)ethynyl)phenoxy)acetic acid		(4-chloro-2-((2-methyl-5-(propylsulfonyl)phenyl)ethynyl)phenoxy)acetic acid					
(4-ethyl-1-naphthalenyl)(1-(5-fluoropentyl)-1H-indol-3-yl)methanone		(4-ethyl-1-naphthalenyl)(1-(5-fluoropentyl)-1H-indol-3-yl)methanone					
(4-formyl-9-methoxy-5-methyl-naphtho(2,3-b)furan-3-yl)methyl acetate		(4-formyl-9-methoxy-5-methyl-naphtho(2,3-b)furan-3-yl)methyl acetate					
(4-methoxy-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)methanone		(4-Methoxy-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)methanone					
(4-methyl-1-naphthyl)-(1-pentylindol-3-yl)methanone		(4-Methyl-1-naphthyl)-(1-pentylindol-3-yl)methanone	619294-47-2	44147RI31X			
(4,4-dimethyl-2,2-bipyridine)(acetylacetonate)copper(II)		(4,4-dimethyl-2,2-bipyridine)(acetylacetonate)copper(II)					
(4S,5S)-4,5-dihydroxy-1,2-dithiane		(4S,5S)-1,2-Dithiane-4,5-diol	14193-38-5	8T052MD8AP			
(5-(2,4-bis((3S)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol		[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol	1009298-09-2	970JJ37FPW			
(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid		(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid					
(5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride		(5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride					
(5-formylfuran-2-yl)methyl 4-hydroxy-2-methylenebutanoate		(5-Formylfuran-2-yl)methyl 4-hydroxy-2-methylenebutanoate					
(5,6-dimethoxyindan-2-yl)dipropylamine	153570-58-2	(5,6-Dimethoxyindan-2-yl)dipropylamine	83598-46-3	E5A8B0V7P3	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	
(5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid		(5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid					
(6,7-dimethoxyquinolin-4-yl)(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)methyl acetate		(6,7-dimethoxyquinolin-4-yl)(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)methyl acetate					
(7-(2-(4-difluorophenyl)-1-piperazinyl)ethyl)-2-(2-furanyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-5-amine		(7-(2-(4-difluorophenyl)-1-piperazinyl)ethyl)-2-(2-furanyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-5-amine					
(9H-fluoren-9-yl)methyl(1-((6-(tert-butoxycarbonyl)amino-1-((4-methyl-2-oxo-1,2-dihydroquinolin-7-yl)amino)-1-oxohexan-2-yl)amino)-3-cyclohexyl-1-oxopropan-2-yl)carbamate		(9H-fluoren-9-yl)methyl(1-((6-(tert-butoxycarbonyl)amino-1-((4-methyl-2-oxo-1,2-dihydroquinolin-7-yl)amino)-1-oxohexan-2-yl)amino)-3-cyclohexyl-1-oxopropan-2-yl)carbamate					
(all-E) phytoene	540-04-5	Phytoene	540-04-5	87E4NJ6N51			
(arginine)9-cysteinyl-glutaminyl-cysteinyl-arginyl-arginyl-lysyl-asparagine		(arginine)9-cysteinyl-glutaminyl-cysteinyl-arginyl-arginyl-lysyl-asparagine					
(Cr(salprn)(H2O)2)ClO4		(Cr(salprn)(H2O)2)ClO4					
(dichloro)tetraammineruthenium(III)		(dichloro)tetraammineruthenium(III)					
(E)-2-((2-(benzo(d)thiazol-2-yl)hydrazono)methyl)-4-nitrophenol		(E)-2-((2-(benzo(d)thiazol-2-yl)hydrazono)methyl)-4-nitrophenol					
(E)-3-((((6-(2-carboxyethenyl)-5-((8-(4-methoxyphenyl)octyl)oxy)-2-pyridinyl)methyl)thio)methyl)benzoic acid	150399-22-7	(E)-3-((((6-(2-Carboxyethenyl)-5-((8-(4-methoxyphenyl)octyl)oxy)-2-pyridinyl)methyl)thio)methyl)benzoic acid	150399-22-7	4TWC061LPM			
(E)-3-(2,3,4,5-tetrabromophenyl)acrylic acid		(E)-3-(2,3,4,5-Tetrabromophenyl)acrylic acid					
(E)-4-((2-N-(4-methoxybenzenesulfonyl)amino)stilbazole)1-oxide		(E)-4-(2-(2-(N-((p-Methoxyphenyl)sulfonyl)amino)phenyl)ethenyl)pyridine 1-oxide	173529-10-7				
(E)-4-(ethoxymethylene)-2-phenyloxazol-5(4H)-one		4-Ethoxymethylene-2-phenyl-2-oxazolin-5-one	15646-46-5	40RAK33386	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
(E)-N1-((6-chloro-3-pyridyl)methyl)-N2-cyano-N1-methylacetamidine		(E)-N1-((6-chloro-3-pyridyl)methyl)-N2-cyano-N1-methylacetamidine					
(endo-N-8-methyl-8-azabicyclo-(3.2.1)oct-3-yl)-2,3-dihydro-3-isopropyl-2-oxo-1H-benzimidazol-1-carboxamide	134296-40-5	Bimu 8	134296-40-5				
(endo-N-8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-2,3-dihydro-3-ethyl-2-oxo-1H-benzimidazol-1-carboxamide	127595-43-1	(endo-N-8-Methyl-8-azabicyclo(3.2.1)oct-3-yl)-2,3-dihydro-3-ethyl-2-oxo-1H-benzimidazol-1-carboxamide	127595-43-1				
(gamma-CyD)2 C60		(gamma-CyD)2 C60					
(glycyl-glycyl)GLP-2		(glycyl-glycyl)GLP-2					
(N-(1-(((cyanoimino)(5-quinolinylamino) methyl) amino)-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide)		(N-(1-(((cyanoimino)(5-quinolinylamino) methyl) amino)-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide)					
(N-5-(4-nitrobenzofurazan-7-yl)lysyl(8))cyclosporine		(N-5-(4-nitrobenzofurazan-7-yl)lysyl(8))cyclosporine					
(N-N'-bis-(2-(1H-indol-3-yl)-ethyl)-N,N'-bis-(3-thiomorpholin-4-yl-propyl)-phthalamide)		(N-N'-bis-(2-(1H-indol-3-yl)-ethyl)-N,N'-bis-(3-thiomorpholin-4-yl-propyl)-phthalamide)					
(N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamate		Ladostigil	209394-27-4	SW3H1USR4Q			
(N)-methanocarba-2MeSADP		(N)-methanocarba-2MeSADP					
(N)1-acetylisoniazid	1078-38-2	Acetylisoniazid	1078-38-2	J42942UVUN			
(Nphe(1),Arg(14),Lys(15))N-OFQ NH(2)		(Nphe(1),Arg(14),Lys(15))N-OFQ NH(2)					
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid		(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid					
(R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide		(2R)-N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-1-(4-methylphenyl)sulfonylpiperidine-2-carboxamide					
(R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine		1H-Benzimidazol-2-amine, N-((1R)-1,2,3,4-tetrahydro-1-naphthalenyl)-	875755-39-8	STF2BZ33XF			
(R)-N-cycloheptyl-6-((((tetrahydro-2-furyl)methyl)amino)methyl)thieno(2,3-d)pyrimidin-4-ylamine		N-cycloheptyl-6-[[[(2R)-oxolan-2-yl]methylamino]methyl]thieno[2,3-d]pyrimidin-4-amine					
(S)-2-methylbutyronitrile		(S)-(+)-2-Methylbutyronitrile	25570-03-0	GV2WA95CCL			
1 alpha-hydroxyergocalciferol		1 alpha-hydroxyergocalciferol					
1 alpha,24-dihydroxyvitamin D3	60965-80-2	1alpha,24-Dihydroxycholecalciferol	60965-80-2		Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol		1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol					
1-((2-methylbenzofuran-3-yl)methyl)-3-(thiophen-2-ylmethyl)urea		1-[(2-Methyl-1-benzofuran-3-yl)methyl]-3-(thiophen-2-ylmethyl)urea					
1-((3-benzyl-3-methyl-2,3-dihydro-1-benzofuran-6-yl)carbonyl)piperidine		1-((3-benzyl-3-methyl-2,3-dihydro-1-benzofuran-6-yl)carbonyl)piperidine					
1-((4-(aminocarbonyl)pyridinio)trimethylene)-2-((hydroxyimino)methyl)pyridinium		1-((4-(aminocarbonyl)pyridinio)trimethylene)-2-((hydroxyimino)methyl)pyridinium					
1-((4-cyano-4-pyridin-2-ylpiperidin-1-yl)methyl)-4-oxo-4H-quinolizine-3-carboxylic acid		1-((4-cyano-4-pyridin-2-ylpiperidin-1-yl)methyl)-4-oxo-4H-quinolizine-3-carboxylic acid					
1-((4-fluorobenzoylamino)ethyl)-4-(7-methoxy-1-naphthyl)piperazine hydrochloride	135721-98-1	S 14506 hydrochloride	135721-98-1	098102RI3W			
1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole	162054-19-5	1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole	162054-19-5	SVT5HFY7J5	Cyclooxygenase Inhibitors	Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)	
1-((4,5-bis(4-methoxyphenyl)-2-thiazoyl)carbonyl)-4-methylpiperazine	130717-51-0	FR 122047 hydrochloride	130717-51-0		Cyclooxygenase Inhibitors	Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)	
1-((5-(1-aminoethyl)-2-(8-methoxy-2-(triflurormethyl)-5-quinolinyl)-4-oxazolyl) carbonyl)-4-((cyclopropylcarbonyl)amino)proline ethyl ester		1-((5-(1-aminoethyl)-2-(8-methoxy-2-(triflurormethyl)-5-quinolinyl)-4-oxazolyl) carbonyl)-4-((cyclopropylcarbonyl)amino)proline ethyl ester					
1-((5-chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazine		1-[(5-chloro-1H-indol-2-yl)carbonyl]-4-methylpiperazine	459168-41-3	4H1AU2V37X			
1-((fluoro(methyl)phosphoryl)oxy)-3-isopropoxypropan-2-yl oleate		1-((fluoro(methyl)phosphoryl)oxy)-3-isopropoxypropan-2-yl oleate					
1-(1- pentyl-1H-indol-3-yl)-2-(2-methoxyphenyl)ethanone		1-(1- pentyl-1H-indol-3-yl)-2-(2-methoxyphenyl)ethanone					
1-(1-(4-fluorophenyl)ethyl)-3-((3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)methylene)-2-piperidinone		1-(1-(4-fluorophenyl)ethyl)-3-((3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)methylene)-2-piperidinone					
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine		1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine					
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea		1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea					
1-(1-dimethylaminomethyl-5-methoxybenzocyclobutan-1-yl)cyclohexanol		1-(1-dimethylaminomethyl-5-methoxybenzocyclobutan-1-yl)cyclohexanol					
1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea		1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea					
1-(1-methylethyl)-4-((1-(6-(trifluoromethyl)-3-pyridinyl)-4-piperidinyl)carbonyl)hexahydro-1H-1,4-diazepine		1-(1-methylethyl)-4-((1-(6-(trifluoromethyl)-3-pyridinyl)-4-piperidinyl)carbonyl)hexahydro-1H-1,4-diazepine					
1-(1-naphthyl)piperazine	57536-86-4	1-(1-Naphthyl)piperazine	57536-86-4	FJ7MR37A24			
1-(1-pentyl-1H-indol-3-yl)-2-o-tolylethanone		1-Pentyl-3-(2-methylphenylacetyl)indole	864445-39-6	55H9NDH32M			
1-(1-propynyl)pyrene		1-(1-propynyl)pyrene					
1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane		1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane					
1-(1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl)-1H-benzo(d)imidazol-2-(3H)-one		1-(1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl)-1H-benzo(d)imidazol-2-(3H)-one					
1-(1H-indol-3-yl)-3-(3H-indol-3-ylidene)propan-2-one		1-(1H-indol-3-yl)-3-(3H-indol-3-ylidene)propan-2-one					
1-(1H-indol-3-yl)-9H-pyrido(3,4-b)indole		1-(1h-Indol-3-yl)-9h-pyrido[3,4-b]indole					
1-(2 (diphenylmethoxy)ethyl)-4-(3-phenylpropyl)piperazine		1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine	76778-22-8	9J9974WIBA	Dopamine Uptake Inhibitors	Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. (See all compounds classified as Dopamine Uptake Inhibitors.)	
1-(2-((1-ethoxycarbonyloxyethoxycarbonylmethyl)carbamoyl)-3-phenylpropyldisulfanylmethyl)-3-methylsulfanylpropylamine		1-(2-((1-ethoxycarbonyloxyethoxycarbonylmethyl)carbamoyl)-3-phenylpropyldisulfanylmethyl)-3-methylsulfanylpropylamine					
1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea		1-(2-(1-Adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea	379262-36-9				
1-(2-(2-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzoyl)morpholin-2-yl)ethyl)spiro(benzo(c)thiophene-1(3H),4'-piperidine)-2-oxide		1-(2-(2-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzoyl)morpholin-2-yl)ethyl)spiro(benzo(c)thiophene-1(3H),4'-piperidine)-2-oxide					
1-(2-(2-thienyl)-2-adamantyl) morpholine		1-(2-(2-thienyl)-2-adamantyl) morpholine					
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole	130495-35-1	1-(2-(3-(4-Methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole hydrochloride	130495-35-1	33BI32858P	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
1-(2-(3-methoxyphenyl)ethyl)phenoxy-3-(dimethylamino)-2-propanol	127003-40-1	1-(Dimethylamino)-3-[2-[2-(4-methoxyphenyl)ethyl]phenoxy]propan-2-ol	127003-40-1				
1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine		1-[2-(3,4-Dichlorophenyl)ethyl]-4-methylpiperazine	150208-28-9				
1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine	67469-57-2	1-(2-(Diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine	67469-57-2	96Y892TJ2A	Dopamine Uptake Inhibitors	Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. (See all compounds classified as Dopamine Uptake Inhibitors.)	
1-(2-amino-3-methyl-butyryl)-azetidine-2-carbonitrile		1-(2-amino-3-methyl-butyryl)-azetidine-2-carbonitrile					
1-(2-bromophenyl)-3-(7-cyano-3H-benzotriazol-4-yl)urea		1-(2-bromophenyl)-3-(7-cyano-3H-benzotriazol-4-yl)urea					
1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one		1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one					
1-(2-chloroethyl)-1-nitrosourea	2365-30-2	1-(2-Chloroethyl)-1-nitrosourea	2365-30-2	HP3XC9MWW5			
1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole		1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole					
1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole		1-(2-Cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole	1345970-42-4	11030I5W3R			
1-(2-fluorophenyl)-3-(2-(morpholin-2-yl)ethyl)-1,3-dihydro-2,1,3-benzothiadiazole 2,2-dioxide		1-(2-fluorophenyl)-3-(2-(morpholin-2-yl)ethyl)-1,3-dihydro-2,1,3-benzothiadiazole 2,2-dioxide					
1-(2-hydroxyethyl)-1-nitrosourea	13743-07-2	1-(2-Hydroxyethyl)-1-nitrosourea	13743-07-2	AFH8YZH5PM			
1-(2-methoxy-phenyl)-4-(4-(4-(6-imidazol(2,1-b) thiazolyl)-phenoxy)-butyl-4-(14)C)-piperazine dimethane		Imidazo(2,1-b)thiazole, 6-(4-(4-(4-(2-methoxyphenyl)-1-piperazinyl)butoxy)phenyl)-	207277-37-0				
1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine	115338-32-4	2-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)isoindoline-1,3-dione hydrobromide	115338-32-4	919U0E9M3P	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
1-(2-methoxyphenyl)piperazine	35386-24-4	1-(2-Methoxyphenyl)piperazine	35386-24-4	81NJO1330A			
1-(2-methyl-4-methoxyphenyl)-4-((2-hydroxyethyl)amino)-6-trifluoromethoxy-2,3-dihydropyrrolo(3,2-c)quinoline		1-(2-Methyl-4-methoxyphenyl)-4-((2-hydroxyethyl)amino)-6-trifluoromethoxy-2,3-dihydropyrrolo(3,2-c)quinoline	220853-65-6	V5N6VD2H8S	Proton Pump Inhibitors	Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)	
1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea		1-(2-Methylbenzo[d]oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea	249889-64-3				
1-(2-thienyl)-2-(methylamino)propane		1-(2-thienyl)-2-(methylamino)propane					
1-(2-trifluoromethoxyphenyl)-2-nitroethanone		1-(2-trifluoromethoxyphenyl)-2-nitroethanone					
1-(2-trifluoromethylphenyl)imidazole	25371-96-4	1-(2-Trifluoromethylphenyl)imidazole	25371-96-4				
1-(2,3-dichlorobenzoyl)-5-methoxy-2-methyl-(2-(mopholin-4-yl)ethyl)-1H-indole		1-(2,3-dichlorobenzoyl)-5-methoxy-2-methyl-(2-(mopholin-4-yl)ethyl)-1H-indole					
1-(2,3-dihydro-1,4-benzodioxin-5-yl)-4-((5-(4-fluorophenyl)-3-pyridinyl)methyl)piperazine		Adoprazine	222551-17-9	7SNB18Q89D			
1-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)-4-((6-fluoropyridin-3-yl)methyl)piperazine		1-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)-4-((6-fluoropyridin-3-yl)methyl)piperazine					
1-(2,4-dichlorobenzyl)indazole-3-carbohydrazide		1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide	252025-52-8	VZT8V72829			
1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane	113346-50-2	1-(2,6-Dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane	113346-50-2				
1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea		1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea					
1-(3-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido(3,4-b)indole-3-carboxylic acid		1-(3-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido(3,4-b)indole-3-carboxylic acid					
1-(3-(2-(1-benzothiophen-5-yl) ethoxy) propyl)-3-azetidinol maleate		1-(3-(2-(1-benzothiophen-5-yl) ethoxy) propyl)-3-azetidinol maleate					
1-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-3,4-dihydro-5-methoxy-2(1H)-quinolinone		1-(3-(4-(3-Chlorophenyl)-1-piperazinyl)propyl)-5-methoxy-3,4-dihydro-2-quinolinone	145969-30-8	1981OTB4DS			Investigated for use/treatment in bulimia, depression, and obsessive-compulsive disorders.
1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid		1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid					
1-(3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl)-4-(2-(3-fluorophenyl)ethyl)piperazine		1-(3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl)-4-(2-(3-fluorophenyl)ethyl)piperazine	188400-51-3	HY4LUL3MKS	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	
1-(3-(trifluoromethyl)pyridin-2-yl)-N-(4-(trifluoromethylsulfonyl)phenyl)-1,2,3,6-tetrahydropyridine-4-carboxamide		3'-(Trifluoromethyl)-N-(4-((trifluoromethyl)sulfonyl)phenyl)-3,6-dihydro-2H-[1,2'-bipyridine]-4-carboxamide	824982-41-4	LB160J37HD			
1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo(d)imidazol-1-yl)-3-(p-tolyloxy)propan-2-ol		1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo(d)imidazol-1-yl)-3-(p-tolyloxy)propan-2-ol					
1-(3-chlorophenyl)biguanide	48144-44-1	m-Chlorophenylbiguanide	48144-44-1	910A4X901V	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	
1-(3-chlorophenyl)piperazine	6640-24-0	1-(3-Chlorophenyl)piperazine	6640-24-0	REY0CNO998	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	
1-(3-trifluoromethylphenyl)piperazine	15532-75-9	1-[3-(Trifluoromethyl)phenyl]piperazine	15532-75-9	25R3ONU51C	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	
1-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-((4-pyridinylmethyl)amino)-1-butanone		1-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-((4-pyridinylmethyl)amino)-1-butanone					
1-(3,4-dihydroxyphenyl)-2-thiocyanate-ethanone		2-(3,4-Dihydroxyphenyl)-2-oxoethyl thiocyanate	101714-41-4				
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one		1-(3,4-Dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one					
1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid		1-(3',4'-Dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid	749269-83-8	C35RF1MWQZ	Gamma Secretase Inhibitors and Modulators	Agents that suppress GAMMA-SECRETASE by inhibiting or modulating its activities. Targeted enzymatic activities include its involvement in accumulation of toxic AMYLOID BETA-PEPTIDES (e.g., A&#x3B2;42) in ALZHEIMER DISEASE and activation of NOTCH RECEPTOR mediated SIGNAL PATHWAYS in certain cancer types. (See all compounds classified as Gamma Secretase Inhibitors and Modulators.)	
1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane		1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane					
1-(3',5'-dihydroxyphenoxy)-7-(2'',4'',6''-trihydroxyphenoxy)-2,4,9-trihydroxydibenzo-1,4,-dioxin		1-(3',5'-dihydroxyphenoxy)-7-(2'',4'',6''-trihydroxyphenoxy)-2,4,9-trihydroxydibenzo-1,4,-dioxin					
1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one		1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one					
1-(4-((4-phenyl-5-trifluoromethyl-2-thienyl)methoxy)benzyl)azetidine-3-carboxylic acid		1-(4-((4-phenyl-5-trifluoromethyl-2-thienyl)methoxy)benzyl)azetidine-3-carboxylic acid					
1-(4-(1,1-dimethylheptyl)-2,6-dimethoxyphenyl)-3-methylcyclohexanol		1-(4-(1,1-dimethylheptyl)-2,6-dimethoxyphenyl)-3-methylcyclohexanol					
1-(4-(2-(bis(4-fluorophenyl)methoxy)ethyl)piperazinyl)-3-phenylpropan-2-ol		1-(4-(2-(bis(4-fluorophenyl)methoxy)ethyl)piperazinyl)-3-phenylpropan-2-ol					
1-(4-(2-(diphenylmethoxy)ethyl)piperazinyl)-3-phenylpropan-2-ol		1-(4-(2-(diphenylmethoxy)ethyl)piperazinyl)-3-phenylpropan-2-ol					
1-(4-(4-(3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl)phenoxy)butyl)-4-aza-1-azoniabicyclo(2.2.2)octane		1-(4-(4-(3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl)phenoxy)butyl)-4-aza-1-azoniabicyclo(2.2.2)octane					
1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one		1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one					
1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone		1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone					
1-(4-(benzothiazol-2-yloxy)benzyl)piperidine-4-carboxylic acid		1-(4-(Benzothiazol-2-yloxy)benzyl)piperidine-4-carboxylic acid	841202-16-2	7W7511NPF8			
1-(4-(furo(2,3-b)quinolin-4-ylamino)phenyl)ethanone		1-(4-(furo(2,3-b)quinolin-4-ylamino)phenyl)ethanone					
1-(4-(octahydropyrido(1,2-a)pyrazin-2-yl)phenyl)-2-phenyl-1,2,3,4-tetrahydroisoquinolin-6-ol		1-(4-(octahydropyrido(1,2-a)pyrazin-2-yl)phenyl)-2-phenyl-1,2,3,4-tetrahydroisoquinolin-6-ol					
1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone	138932-35-1	1-(4-Bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone	138932-35-1				
1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)but-2-ene		1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)but-2-ene					
1-(4-chlorobenzoyl)-5-methoxy-1H-indole-3-acetic acid morpholineamide		1-(4-chlorobenzoyl)-5-methoxy-1H-indole-3-acetic acid morpholineamide					
1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester		1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester					
1-(4-chlorophenyl)-3-(3-(4-chlorophenyl)-5,5-dimethyl-1-(3-(5-nitrofuran-2-yl)allyldienehydrazinocarbonylmethyl)-2-oxoimidazolidin-4-yl)-1-hydroxyurea		1-(4-chlorophenyl)-3-(3-(4-chlorophenyl)-5,5-dimethyl-1-(3-(5-nitrofuran-2-yl)allyldienehydrazinocarbonylmethyl)-2-oxoimidazolidin-4-yl)-1-hydroxyurea					
1-(4-chlorophenyl)-3-(3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl)urea		Psncbam-1	877202-74-9	P34SC5V6W2			
1-(4-chlorophenyl)-benzo-2,5-quinone		1-(4-chlorophenyl)-benzo-2,5-quinone					
1-(4-chlorophenyl)piperazine	38212-33-8	1-(4-Chlorophenyl)piperazine	38212-33-8	FMD47JE5C3			
1-(4-dimethylaminomethylphenyl)-8,9-dihydro-7H-2,7,9a-benzo(cd)azulen-6-one		1-(4-dimethylaminomethylphenyl)-8,9-dihydro-7H-2,7,9a-benzo(cd)azulen-6-one					
1-(4-ethoxyphenyl)-3-(4-nitrophenyl)-prop-2-en-1-one		1-(4-ethoxyphenyl)-3-(4-nitrophenyl)-prop-2-en-1-one					
1-(4-ethylphenyl-)-N-((2-methoxyphenyl)methyl) propane-2-amine		1-(4-ethylphenyl-)-N-((2-methoxyphenyl)methyl) propane-2-amine					
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane	108614-26-2	1-(4-Ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane	108614-26-2	VGI6L0G4CG	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
1-(4-fluorobenzoyl)-3-(((6-methoxy-2-naphthyl)oxy)methyl)azetidine-3-carboxylic acid		1-(4-Fluorobenzoyl)-3-[(6-methoxynaphthalen-2-yl)oxymethyl]azetidine-3-carboxylic acid	1078166-57-0	I7Z38E70VF			
1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium) propane dibromide		1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium) propane dibromide					
1-(4-hydroxyiminomethylpyridinium)-3-pyridiniumpropane		1-(4-hydroxyiminomethylpyridinium)-3-pyridiniumpropane					
1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane		1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane					
1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene	68684-63-9	1,2-Diphenyl-1-(4-hydroxyphenyl)but-1-ene	68684-63-9				
1-(4-methoxyphenyl)piperazine		1-(4-Methoxyphenyl)piperazine	38212-30-5	P385M92GYG			
1-(4-methylphenyl)propane-2-amine		1-(4-methylphenyl)propane-2-amine					
1-(4-nitro-2-(trifluoromethyl)phenyl)-4-(3-(trifluoromethyl)phenyl)piperazine		1-(4-nitro-2-(trifluoromethyl)phenyl)-4-(3-(trifluoromethyl)phenyl)piperazine					
1-(5-(2-thenyloxy)-1H-indol-3-yl)propan-2-amine		BW 723C86 hydrochloride	160521-72-2	8JMH6M2ELN			
1-(5-(4-chlorophenyl)-4-(4-pyridinyl)-1H-pyrazol-3-yl)-4-methylpiperazine		1-(5-(4-chlorophenyl)-4-(4-pyridinyl)-1H-pyrazol-3-yl)-4-methylpiperazine					
1-(5-azido-6-chloropyridin-3-ylmethyl)-2-nitroiminoimidazolidine		1-(5-azido-6-chloropyridin-3-ylmethyl)-2-nitroiminoimidazolidine					
1-(5-chloro-1-((2,4-dimethoxyphenyl)sulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl)-4-hydroxy-N,N-dimethyl-2-pyrrolidinecarboxamide		Nelivaptan	439687-69-1	3TY57MQ4OA			
1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)urea		1-(5-Chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)urea	501925-31-1	9EZT3PTH2J			
1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid		Jnj-42041935	1193383-09-3	T4PPL01131			
1-(5-fluoropentyl)-3-(1-naphthoyl)indole		(1-(5-Fluoropentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone	335161-24-5	TBJ0966F1O			
1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole		1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole					
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine	84477-87-2	1-(5-Isoquinolinesulfonyl)-2-methylpiperazine	84477-87-2	487H9Q0F9N	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
1-(5-isoquinolinylsulfonyl)-3-methylpiperazine	84477-73-6	1-(5-Isoquinolinylsulfonyl)-3-methylpiperazine	84477-73-6		Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
1-(6-((2-(dimethylamino)ethyl)(methyl)amino)-1,3-dimethyl-1H-pyrazolo(3,4-b)pyridine-5-carbonyl)-3-(3-isopropoxyphenyl)urea		1-(6-((2-(dimethylamino)ethyl)(methyl)amino)-1,3-dimethyl-1H-pyrazolo(3,4-b)pyridine-5-carbonyl)-3-(3-isopropoxyphenyl)urea					
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione	112648-68-7	1-(6-((3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione	112648-68-7		Phosphodiesterase Inhibitors	Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)	
1-(7-(2-chlorophenyl)-8-(4-chlorophenyl)-2-methylpyrazolo(1,5-a)-(1,3,5)triazin-4-yl)-3-ethylaminoazetidine-3-carboxylic acid amide		1-(7-(2-chlorophenyl)-8-(4-chlorophenyl)-2-methylpyrazolo(1,5-a)-(1,3,5)triazin-4-yl)-3-ethylaminoazetidine-3-carboxylic acid amide					
1-(8-bromobenzo(1,2-b;4,5-b')difuran-4-yl)-2-aminopropane		1-(8-bromobenzo(1,2-b;4,5-b')difuran-4-yl)-2-aminopropane					
1-(acetyloxy)-3,5,6,6a,7,8,9,10-octahydro-10-hydroxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)naphtho(1,8a-c)furan-3,5-diyl dibutanoate		1-(acetyloxy)-3,5,6,6a,7,8,9,10-octahydro-10-hydroxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)naphtho(1,8a-c)furan-3,5-diyl dibutanoate					
1-(alpha,apha-dimethylbenzyl)-3-(4-methylphenyl)urea		Daimuron	42609-52-9	D9676S9U11			
1-(beta-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetra-hydroisoquinoline		1-(beta-Naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline	213179-96-5				
1-(carboxymethyl)-3,5-diphenyl-2-methylbenzene		1-(Carboxymethyl)-3,5-diphenyl-2-methylbenzene					
1-(carboxymethylthio)tetradecane		Tetradecylthioacetic acid	2921-20-2	7ZU5I25S2O	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester		Quinolin-8-yl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate	1400742-42-8	EUD4ZLB25R			
1-(isopropylamino)-3-((4-propenyl-2-methoxy)phenoxy)-2-propanol		1-(isopropylamino)-3-((4-propenyl-2-methoxy)phenoxy)-2-propanol					
1-(methanesulfonamido-1-naphthyloxy)-2-(N-(4-methane sulfonamidophenethyl)-N-acetamido)ethane		1-(methanesulfonamido-1-naphthyloxy)-2-(N-(4-methane sulfonamidophenethyl)-N-acetamido)ethane					
1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester		1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester					
1-(N-(3-ammoniopropyl)-N-(n-propyl)amino)diazen-1-ium-1,2-diolate		1-(N-(3-ammoniopropyl)-N-(n-propyl)amino)diazen-1-ium-1,2-diolate					
1-(propoxymethyl)maleimide		1-(propoxymethyl)maleimide					
1-(quinoxalin-6-ylcarbonyl)piperidine		Ampalex	154235-83-3	Z5QU38B4V9			Investigated for use/treatment in alzheimer's disease, memory loss, autism, neurologic disorders, dementia, schizophrenia and schizoaffective disorders, attention deficit/hyperactivity disorder (ADHD), and sleep disorders.
1-(saligenin cyclic phospho)-9-biotinyldiaminononane	158040-84-7	1-(Saligenin cyclic phospho)-9-biotinyldiaminononane	158040-84-7				
1-3-methylbutyryl-N4-6-aminohexanoyl-piperazine		1-3-methylbutyryl-N4-6-aminohexanoyl-piperazine					
1-acetonaphthone		1'-Acetonaphthone	1333-52-4	U44R403XVS			
1-acyl-2-(12-((7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)dodecanoyl)phosphatidylcholine		1-acyl-2-(12-((7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)dodecanoyl)phosphatidylcholine					
1-amino-1,3-dicarboxycyclopentane	111900-32-4	(1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid	111900-32-4		Neuroprotective Agents	Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)	
1-amino-2-phosphonomethylcyclopropanecarboxylic acid		1-amino-2-phosphonomethylcyclopropanecarboxylic acid					
1-amino-2,4-dibromoanthraquinone	81-49-2	1-Amino-2,4-dibromoanthraquinone	81-49-2	RF75O3IKOZ			
1-amino-4-(3-(4,6-dichloro(1,3,5)triazine-2-ylamino)phenylamino)-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate		1-amino-4-(3-(4,6-dichloro(1,3,5)triazine-2-ylamino)phenylamino)-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate					
1-amino-4-hydroxyanthraquinone	116-85-8	1-Amino-4-hydroxyanthraquinone	116-85-8	15FG1M8OP9			
1-amino-8-nitropyrene	30269-02-4	1-Amino-8-nitropyrene	30269-02-4				
1-aminoanthracene	610-49-1	1-Aminoanthracene	610-49-1	8H6056DWN2			
1-aminoanthraquinone	82-45-1	1-Aminoanthraquinone	82-45-1	N5YYY1NEUI			
1-aminobenzotriazole	1614-12-6	1-Aminobenzotriazole	1614-12-6	9EFF75BJ1O			
1-aminocyclopentane-1,2,4-tricarboxylic acid		1-Aminocyclopentane-1,2,4-tricarboxylic acid					
1-aminocyclopropanol	54376-44-2	1-Aminocyclopropanol	54376-44-2	066FI25KXX			
1-aminoindan-1,5-dicarboxylic acid		Aida	168560-79-0		Excitatory Amino Acid Antagonists	Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)	
1-aminomethylphosphonic acid	1066-51-9	(Aminomethyl)phosphonic acid	1066-51-9	90825O5C1U			
1-aminopyrene	1606-67-3	1-Aminopyrene	1606-67-3	LUW9EO1681			
1-anilino-8-naphthalenesulfonate		8-Anilino-1-naphthalenesulfonic acid	82-76-8	630I4V6051			
1-benzyl-1,4-dihydronicotinamide		1-Benzyl-1,4-dihydronicotinamide	952-92-1	HSU8JA8RMP			
1-benzylimidazole	4238-71-5	1-Benzylimidazole	4238-71-5	W4C9Z5BCV7	Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	
1-benzylpiperazine	2759-28-6	1-Benzylpiperazine	2759-28-6	3UG152ZU0E			
1-benzylpiperidine	2905-56-8	1-Benzylpiperidine	2905-56-8	7HZE16210B			
1-bromo-2,4-dinitrobenzene	584-48-5	1-Bromo-2,4-dinitrobenzene	584-48-5	4MS3FTW380			
1-bromo-2,5-bis(4-hydroxystyryl)benzene		1-bromo-2,5-bis(4-hydroxystyryl)benzene					
1-bromohexane	111-25-1	1-Bromohexane	111-25-1	WVA0FAX7GA			
1-bromopropane	106-94-5	1-Bromopropane	106-94-5	Y9746DNE68			
1-Butanol	71-36-3	1-Butanol	71-36-3	8PJ61P6TS3			
1-butyl-3-methylimidazolium nitrate		1-Butyl-3-methylimidazolium nitrate	179075-88-8				
1-butyl-8-(3-noradamantyl)-3-(3-hydroxypropyl)xanthine		1-Butyl-8-(hexahydro-2,5-methanopentalen-3a(1H)-yl)-3,7-dihydro-3-(3-hydroxypropyl)-1H-purine-2,6-dione	524944-72-7				
1-butyrylglycerol	26999-06-4	Butanoic acid, 2,3-dihydroxypropyl ester	557-25-5	0YT8423E8U			
1-carboxyheptylimidazole	68887-68-3	1-(7-Carboxyheptyl)imidazole	68887-68-3				
1-carboxysalsoline	88598-26-9	1-Carboxysalsoline	88598-26-9	FD00LE5635	Catechol O-Methyltransferase Inhibitors	Compounds and drugs that inhibit or block the activity of CATECHOL O-METHYLTRANSFERASE enzymes. Drugs in this class are used in management of central nervous system disorders such as PARKINSON DISEASE. (See all compounds classified as Catechol O-Methyltransferase Inhibitors.)	
1-carboxysalsolinol	57256-34-5	Salsolinol-1-carboxylic acid	57256-34-5				
1-chloro-2,4-dinitrobenzene-glutathione conjugate		1-chloro-2,4-dinitrobenzene-glutathione conjugate					
1-chloro-4-(2,2-dichloro-1-(4-chlorophenyl)ethenyl)-3-(methylsulfonyl)benzene	62938-14-1	1-Chloro-4-(2,2-dichloro-1-(4-chlorophenyl)ethenyl)-3-(methylsulfonyl)benzene	62938-14-1				
1-chloro-4-(trifluoromethyl)benzene		4-Chlorobenzotrifluoride	98-56-6	694YO34JHC			
1-chloronaphthalene	90-13-1	1-Chloronaphthalene	90-13-1	K4OIF2EC56			
1-chloropyrene	34244-14-9	1-Chloropyrene	34244-14-9	ECZ7RUY70M			
1-chlorosucrose	64644-62-8	1-Chlorosucrose	64644-62-8	0X5NXD3E1H			
1-cyano-2-hydroxy-3-butene	27451-36-1	1-Cyano-2-hydroxy-3-butene	27451-36-1				
1-cyclohexyl-4-(3-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl)-piperazine		1-cyclohexyl-4-(3-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl)-piperazine					
1-cyclohexyl-4-(3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-n-propyl)piperazine		1-cyclohexyl-4-(3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-n-propyl)piperazine					
1-cyclohexylethylamine	4352-49-2	1-Cyclohexylethanamine	4352-49-2				
1-cyclopropyl-3-(3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl)urea		1-cyclopropyl-3-(3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl)urea					
1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine		1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine					
1-deazaadenosine	14432-09-8	1-Deaza-adenosine	14432-09-8				
1-decyl-3-methylimidazolium bromide		1-Decyl-3-methylimidazolium bromide	188589-32-4		Environmental Pollutants	Substances or energies, for example heat or light, which when introduced into the air, water, or land threaten life or health of individuals or ECOSYSTEMS. (See all compounds classified as Environmental Pollutants.)	
1-Deoxynojirimycin	19130-96-2	1-Deoxynojirimycin	19130-96-2	FZ56898FLE	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
1-dodecylsulfonyl-5N,6O-oxomethylidenenojirimycin		1-dodecylsulfonyl-5N,6O-oxomethylidenenojirimycin					
1-ethyl-2-benzimidazolinone		1-Ethyl-2-benzimidazolinone	10045-45-1	M82W79SS4W	Calcium Channel Agonists	Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in VASCULAR SMOOTH MUSCLE and/or CARDIAC MUSCLE cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture. (See all compounds classified as Calcium Channel Agonists.)	
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride		1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride	25952-53-8	19W5TL0WJ4			
1-ethylpyrene	17088-22-1	1-Ethylpyrene	17088-22-1	982JRB827L			
1-ethynylpyrene	34993-56-1	1-Ethynylpyrene	34993-56-1				
1-hexacosanol	506-52-5	1-Hexacosanol	506-52-5	M7SD300NNB			
1-hexadecyl-3-methylimidazolium chloride		1-Hexadecyl-3-methylimidazolium chloride	61546-01-8	EQ4UWS7WUN			
1-hexanol	111-27-3	1-Hexanol	111-27-3	6CP2QER8GS	Nicotinic Antagonists	Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)	
1-hydroxy-1-hydroperoxynonane		1-hydroxy-1-hydroperoxynonane					
1-hydroxy-1-norresistomycin		1-Hydroxy-1-norresistomycin					
1-hydroxy-2-naphthoic acid	86-48-6	1-Hydroxy-2-naphthoic acid	86-48-6	U8LZ3R07L8			
1-hydroxy-2-oxo-3-(3-aminopropyl)-3-isopropyl-1-triazene		1-Hydroxy-2-oxo-3-(3-aminopropyl)-3-isopropyl-1-triazene	146724-82-5				
1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene		1,1-Bis(2-aminoethyl)-2-hydroxy-3-oxotriazane	146724-94-9	LDS7ZYG72J	Nitric Oxide Donors	A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)	
1-hydroxy-2,3,5-trimethoxyxanthone		1-Hydroxy-2,3,5-trimethoxyxanthen-9-one	22804-49-5				
1-hydroxy-3-amino-2-pyrrolidone		3-Amino-1-hydroxypyrrolidin-2-one	1003-51-6	F2JLV9220T	Excitatory Amino Acid Agonists	Drugs that bind to and activate excitatory amino acid receptors. (See all compounds classified as Excitatory Amino Acid Agonists.)	
1-hydroxyanthraquinone		1-Hydroxyanthraquinone	129-43-1	LFU129OE9H	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
1-hydroxybenzo(a)pyrene	13345-23-8	1-Hydroxybenzo(a)pyrene	13345-23-8	TG2AP6R64H			
1-hydroxyethyl radical	16331-64-9	Ethoxide	16331-64-9				
1-hydroxymethylmidazolam	59468-90-5	1-Hydroxymidazolam	59468-90-5	E5142BN92Z			
1-hydroxymethylmidazolam glucuronide	81256-81-7	Mdz-glucuronide	81256-81-7				
1-hydroxymethylpyrene		1-Pyrenemethanol	24463-15-8	C76UX3EH8M			
1-hydroxyphenanthrene	2433-56-9	1-Hydroxyphenanthrene	2433-56-9	Y1FTF7MUY7			
1-hydroxypyrene	5315-79-7	1-Hydroxypyrene	5315-79-7	N2H6O5V707	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
1-hydroxyvitamin D5		1alpha-Hydroxyvitamin D5	187935-17-7	XY02042OD4			
1-indanol	6351-10-6	1-Indanol	6351-10-6	LHG5BD7LOR			
1-iodo-2,4-dinitrobenzene	709-49-9	1-Iodo-2,4-dinitrobenzene	709-49-9	NOT697X2XM			
1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea		1-(4-(Trifluoromethyl)benzyl)-3-(isoquinolin-5-yl)urea	581809-67-8	N2NOA4CE04			
1-menaphthyl sulfate	26489-16-7	1-Menaphthyl sulfate	26489-16-7	II2K3JD06R			
1-methoxy-3-indolylmethylglucosinolate	5187-84-8	Neoglucobrassicin	5187-84-8				
1-methyl-2-phenylindole		1-Methyl-2-phenylindole	3558-24-5	IE3UB978IA			
1-Methyl-3-isobutylxanthine	28822-58-4	3-Isobutyl-1-methylxanthine	28822-58-4	TBT296U68M	Phosphodiesterase Inhibitors	Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)	
1-methyl-4-(2-chloro-4-hydroxyphenylthio)piperidine		1-methyl-4-(2-chloro-4-hydroxyphenylthio)piperidine					
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	28289-54-5	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	28289-54-5	9P21XSP91P	Neurotoxins	Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept. (See all compounds classified as Neurotoxins.)	
1-methyl-4-phenyl-2,3-dihydropyridinium	94613-45-3	1-Methyl-4-phenyl-2,3-dihydropyridinium	94613-45-3				
1-Methyl-4-phenylpyridinium	48134-75-4	Cyperquat	48134-75-4	R865A5OY8J	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
1-methylanthracene	610-48-0	1-Methylanthracene	610-48-0	3T2PP79W0O			
1-methylbenz(a)anthracene	2498-77-3	1-Methylbenz(A)anthracene	2498-77-3	4K7797O3V4			
1-methylfluorene	1730-37-6	1-Methylfluorene	1730-37-6	5DR03K3111			
1-methylimidazole	616-47-7	1-Methylimidazole	616-47-7	P4617QS63Y			
1-methylindole	603-76-9	1-Methylindole	603-76-9	8H698ROJ5F			
1-methylnaphthalene	90-12-0	1-Methylnaphthalene	90-12-0	E7SK1Y1311			
1-methylphenanthrene	832-69-9	1-Methylphenanthrene	832-69-9	44IY90KLCE			
1-methylpropyl-2-imidazolyl disulfide		2-(Sec-butyldisulfanyl)-1h-imidazole	141400-58-0	8PQ9CZ8BTJ			Investigated for use/treatment in cancer/tumors (unspecified), gastric cancer, and pancreatic cancer.
1-methylpyrene	2381-21-7	1-Methylpyrene	2381-21-7	AB8420OXQA			
1-methyltryptophan		1-Methyl-DL-tryptophan	26988-72-7				
1-methyluric acid	708-79-2	1-Methyluric acid	708-79-2	2WS4HQ639J			
1-methylxanthine	6136-37-4	1-Methylxanthine	6136-37-4	7EE8WCA32U			
1-monomyristin	142-18-7	2,3-Dihydroxypropyl dodecanoate	142-18-7	WR963Y5QYW	Cariostatic Agents	Substances that inhibit or arrest DENTAL CARIES formation. (Boucher&apos;s Clinical Dental Terminology, 4th ed) (See all compounds classified as Cariostatic Agents.)	
1-N-methyl-5-thiotetrazole	13183-79-4	5-Mercapto-1-methyltetrazole	13183-79-4	ZRB9LL6WTB			
1-naphthaldehyde	66-77-3	1-Naphthaldehyde	66-77-3	H3I0B5F8SX			
1-naphthaleneacetic acid	86-87-3	1-Naphthaleneacetic acid	86-87-3	33T7G7757C			
1-naphthol	90-15-3	1-Naphthol	90-15-3	2A71EAQ389			
1-naphthylacetylspermine	122306-11-0	1-Naphthylacetylspermine	122306-11-0				
1-Naphthylamine	134-32-7	1-Naphthylamine	134-32-7	9753I242R5	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
1-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline		1-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline					
1-Naphthylisothiocyanate	551-06-4	1-Naphthyl isothiocyanate	551-06-4	HG44814A3V			
1-nitrobenzo(a)pyrene	70021-99-7	1-Nitrobenzo(a)pyrene	70021-99-7	7LW05PHL0K	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
1-nitronaphthalene	86-57-7	1-Nitronaphthalene	86-57-7	A51NP1DL2T	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
1-nitropropane	108-03-2	1-Nitropropane	108-03-2	39W305OW99			
1-nitropyrene	5522-43-0	1-Nitropyrene	5522-43-0	TD1665I8Q4	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
1-nitropyrene-4,5-oxide	105596-42-7	1-Nitropyrene-4,5-oxide	105596-42-7	EA18JIE48O			
1-nitropyrene-9,10-oxide	105596-43-8	1-Nitropyrene-9,10-oxide	105596-43-8				
1-nitrosocyclohexyl acetate		1-Nitrosocyclohexyl Acetate	10259-08-2				
1-nitrosopyrene	86674-51-3	1-Nitrosopyrene	86674-51-3	5XC7ZE327A			
1-nonanol	143-08-8	Nonan-1-ol	143-08-8	NGK73Q6XMC			
1-O-(2-((2',6'-dichlorophenyl)amino)phenylacetyl)glucopyranuronic acid		Diclofenac acyl glucuronide	64118-81-6	C8BEZ13XEN			
1-O-(2-(2,3-dimethylphenyl)aminobenzoyl)glucopyranuronic acid	102623-18-7	Mefenamic acid glucuronide	102623-18-7	OX5H10G1RG			
1-O-hexadecyl-2-arachidonyl-sn-glycero-3-phosphocholine	6931-56-2	1-Palmitoyl-2-arachidonyl-gpc	6931-56-2				
1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine	111057-91-1	N-Carbamyl-paf	111057-91-1				
1-O-hexyl-2,3,5-trimethylhydroquinone	148081-72-5	1-O-Hexyl-2,3,5-trimethylhydroquinone	148081-72-5	70BK60I8RP			
1-Octanol	111-87-5	1-Octanol	111-87-5	NV1779205D	Solvents	Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant and Hackh&apos;s Chemical Dictionary, 5th ed) (See all compounds classified as Solvents.)	
1-octen-3-ol	3391-86-4	1-Octen-3-OL	3391-86-4	WXB511GE38			
1-oleoyl lysophosphatidylcholine	3542-29-8	3-Oleoyl-rac-glycerol-1-phosphorylcholine	3542-29-8				
1-oleoyl-2-acetoyl-sn-glycerol		1-Oleoyl-2-acetoyl-sn-glycerol	92282-11-6				
1-oleoyl-2-acetylglycerol	86390-77-4	1-Oleoyl-2-acetyl-sn-glycerol	86390-77-4				
1-oxo-1-(5-(2-pyridyl)-2-yl)-7-phenylheptane		7-Phenyl-1-[5-(pyridin-2-yl)-1,3-oxazol-2-yl]heptan-1-one	681135-77-3	NC2J8K4ARH			
1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine		Povpc	121324-31-0				
1-palmitoyl-2-(5-oxovaleroyl)phosphatidylcholine		1-palmitoyl-2-(5-oxovaleroyl)phosphatidylcholine					
1-palmitoyl-2-(epoxycyclopentenone)-sn-glycero-3-phosphocholine		1-palmitoyl-2-(epoxycyclopentenone)-sn-glycero-3-phosphocholine					
1-palmitoyl-2-(epoxyisoprostane-E2)-sn-glycero-3-phosphocholine		1-palmitoyl-2-(epoxyisoprostane-E2)-sn-glycero-3-phosphocholine					
1-palmitoyl-2-arachidonyl-3-phosphorylcholine		1-palmitoyl-2-arachidonyl-3-phosphorylcholine					
1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine	59403-54-2	1-Palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine	59403-54-2				
1-palmitoyl-2-linoleoylphosphatidylcholine	6931-84-6	1-Palmitoyl-2-linoleoylphosphatidylcholine	8002-43-5				
1-palmitoyl-2-lysophosphatidylcholine		1-Palmitoyl-sn-glycero-3-phosphocholine	17364-16-8	JD6PYE3XUX			
1-palmitoyl-2-oleoyl-sn-glycerol	3123-73-7	1-Palmitoyl-2-oleoylglycerol	3123-73-7	TX2844DJ8C			
1-pentene-3-one	1629-58-9	Ethyl vinyl ketone	1629-58-9	R0053Y1AZ7			
1-pentyfluoro-1H-indole-3-carboxylic acid 8-quinolinyl ester		1-pentyfluoro-1H-indole-3-carboxylic acid 8-quinolinyl ester					
1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester		Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate	1400742-17-7	QM6J8F29FE			
1-pentyl-3-(1-naphthoyl)indole		1-Pentyl-3-(1-naphthoyl)indole	209414-07-3	G391998J57			
1-phenazinecarboxylic acid	2538-68-3	Phenazine-1-carboxylic acid	2538-68-3				
1-phenyl-1,2-propanedione	579-07-7	1-Phenyl-1,2-propanedione	579-07-7	ZB5XA3GD0I			
1-phenyl-2-(1-pyrrolidinyl)-1-pentanone		1-phenyl-2-(1-pyrrolidinyl)-1-pentanone					
1-phenyl-2-hexadecanoylamino-3-pyrrolidino-1-propanol		1-Phenyl-2-hexadecanoylamino-3-pyrrolidino-1-propanol					
1-phenyl-3-dimethylamino-1,2,3,4-tetrahydronaphthalene	152786-06-6	1-Phenyl-3-dimethylamino-1,2,3,4-tetrahydronaphthalene	152786-06-6				
1-phenyl-6,7-dihydroxy-isochroman		1-Phenyl-6,7-dihydroxy-isochroman					
1-phenylazo-2-naphthol	842-07-9	Sudan I	842-07-9	48I7IBB68J	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
1-phenylimidazole	7164-98-9	1-Phenylimidazole	7164-98-9				
1-piperonylpiperazine	32231-06-4	1-Piperonylpiperazine	32231-06-4	512G6R381X			
1-Propanol	71-23-8	1-Propanol	71-23-8	96F264O9SV			
1-propyl-5-(3-p-tolylisoxazol-5-yl)-1,2,3,6-tetrahydropyridine		1-propyl-5-(3-p-tolylisoxazol-5-yl)-1,2,3,6-tetrahydropyridine					
1-propyl-8-(4-sulfophenyl)xanthine		1-Propyl-8-(4-sulfophenyl)xanthine potassium salt hydrate			Adenosine A2 Receptor Antagonists	Compounds that selectively bind to and block the activation of ADENOSINE A2 RECEPTORS. (See all compounds classified as Adenosine A2 Receptor Antagonists.)	
1-pyrenebutanol		1-Pyrenebutanol	67000-89-9				
1-Sarcosine-8-Isoleucine Angiotensin II	9088-01-1	1-Sarcosine-8-Isoleucine Angiotensin II					
1-stearoyl-2-arachidonoylglycerol	65914-84-3	1-Stearoyl-2-arachidonoyl-SN-glycerol	65914-84-3				
1-stearoyl-2-arachidonoylphosphatidic acid	119904-30-2	(1-octadecanoyloxy-3-phosphonooxypropan-2-yl) (5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoate	119904-30-2				
1-stearoyl-2-docosahexaenoylglycerol		1-stearoyl-2-docosahexaenoylglycerol					
1-stearoyl-2-linoleoyl-sn-glycerol	34487-26-8	1-Stearoyl-2-linoleoyl-sn-glycerol	34487-26-8				
1-stearoyl-2-oleoyl-sn-glycerol	53702-48-0	1-Stearoyl-2-oleoyl-sn-glycerol	53702-48-0				
1-sulfooxymethylpyrene	130965-73-0	1-Sulfooxymethylpyrene	130965-73-0	UYC2177X5N			
1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline	131384-80-0	1-(trichloromethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole	6649-90-7				
1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea		1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea					
1-UFT protocol		Tegafur-Uracil	74578-38-4				Tegafur-uracil is indicated for the first line treatment of metastatic colorectal cancer with concomitant administration of calcium folinate. Colorectal cancer is the third most diagnosed cancer and 30% of the cases can present the metastatic state.
1-vinylpyrene	17088-21-0	1-Vinylpyrene	17088-21-0	B8HS8V7NH6			
1, 3-di-(N-carboxybenzoyl-leucyl-leucyl)amino acetone		(Z-LL)2 ketone	313664-40-3				
1,1-bis(3'-indolyl)-1-(4-chlorophenyl)methane		1,1-bis(3'-indolyl)-1-(4-chlorophenyl)methane					
1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane		4-(Di(1H-indol-3-yl)methyl)phenol					
1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane		1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane					
1,1-bis(3'-indolyl)-1-(p-anisyl)methane		1,1-Bis(3'-indolyl)-1-(p-anisyl)methane					
1,1-bis(4-hydroxyphenyl)-2-phenylbut-1-ene	91221-46-4	1,1-Bis(4-hydroxyphenyl)-2-phenylbut-1-ene	91221-46-4	K46GRM9275			
1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene		1,1-Dichloro-2,2-bis(4-hydroxyphenyl)ethylene	14868-03-2	U4668GRX7T			
1,1-bis(4-hydroxyphenyl)cyclohexane		1,1-Bis(4-hydroxyphenyl)cyclohexane	843-55-0	64ZF6464QY			
1,1-dichloro-1-fluoroethane		1,1-Dichloro-1-fluoroethane	1717-00-6	O1A3ASY5PW			
1,1-dichloro-2,2-difluoroethylene	79-35-6	1,1-Dichloro-2,2-difluoroethylene	79-35-6	WC503FP86Y			
1,1-dichloroethane	75-34-3	1,1-Dichloroethane	75-34-3	0S989LNA44			
1,1-diethyl-2-hydroxy-2-nitrosohydrazine	86831-65-4	1,1-Diethyl-2-hydroxy-2-nitrosohydrazine	86831-65-4		Nitric Oxide Donors	A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)	
1,1-dimethylbutyl-1-deoxy-Delta(9)-THC		(6AR,10AR)-3-(1,1-Dimethylbutyl)-6A,7,10,10A-tetrahydro-6,6,9-trimethyl-6H-dibenzo[B,D]pyran	259869-55-1	TDG8048RDA			
1,1-diphenyl-2-picrylhydrazyl	1898-66-4	1,1-Diphenyl-2-picrylhydrazyl					
1,1-diphenylhydrazine	530-50-7	1,1-Diphenylhydrazine	530-50-7	D133SQ5HMA			
1,1-ethanediol	4433-56-1	1,1-Ethanediol	4433-56-1				
1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane		Monodemethylmethoxychlor	28463-03-8	Y8I9CWQ645			
1,1,1-trichloroethane	71-55-6	1,1,1-Trichloroethane	71-55-6	113C650IR1			
1,1,1,2-tetrafluoro-2-chloroethane	2837-89-0	2-Chloro-1,1,1,2-tetrafluoroethane	2837-89-0	N00845EG42			
1,1,1,2,2-pentafluoro-7-phenylheptan-3-one		1,1,1,2,2-Pentafluoro-7-phenylheptan-3-one	1071000-98-0				
1,1,2-trichloroethane	79-00-5	1,1,2-Trichloroethane	79-00-5	28E9ERN9WU			
1,1,2,2-tetrabromoethane	79-27-6	1,1,2,2-Tetrabromoethane	79-27-6	V00GKC584O			
1,1,4-tris(acetyloxy)-2-nonene		1,1,4-tris(acetyloxy)-2-nonene					
1,10-phenanthroline	66-71-7	1,10-Phenanthroline	66-71-7	W4X6ZO7939	Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	
1,12-benzoperylene	191-24-2	Benzo[ghi]perylene	191-24-2	5ZME2E2Q9L			
1,2-benzisothiazol-3(2H)-one, 2-(4-(4-(7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-1-piperazinyl)butyl)-, 1,1-dioxide		1,2-Benzisothiazol-3(2H)-one, 2-(4-(4-(7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-1-piperazinyl)butyl)-, 1,1-dioxide	161611-99-0	ZB05V621UD			
1,2-benzisothiazoline-3-one	2634-33-5	1,2-Benzisothiazol-3(2H)-one	2634-33-5	HRA0F1A4R3	Disinfectants	Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley&apos;s Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Disinfectants.)	
1,2-bis-N-cytisinylethane		1,2-bis-N-cytisinylethane					
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester	139890-68-9	1,2-Bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester	139890-68-9		Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid	85233-19-8	Bapta	85233-19-8	K22DDW77C0	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
1,2-bis(2,4,6-tribromophenoxy)ethane		1,2-Bis(2,4,6-tribromophenoxy)ethane	37853-59-1	34I00D6RNM	Flame Retardants	Materials applied to fabrics, bedding, furniture, plastics, etc. to retard their burning; many may leach out and cause allergies or other harm. (See all compounds classified as Flame Retardants.)	
1,2-bis(isothiazol-5-yl)disulfane		5-(1,2-Thiazol-5-yldisulfanyl)-1,2-thiazole					
1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine		1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine	127792-84-1	6ZE344986H			
1,2-cyclohexanediamine		1,2-Cyclohexanediamine	694-83-7				
1,2-diacetylbenzene	704-00-7	1,2-Diacetylbenzene	704-00-7				
1,2-diacylglycerol		1,2,3-Propanetriol, diacetate	25395-31-7	9W955270ZW			
1,2-diamino-4-nitrobenzene	99-56-9	4-Nitro-o-phenylenediamine	99-56-9	5A9AX7Y0TT	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
1,2-diaminobenzene	95-54-5	o-PHENYLENEDIAMINE	95-54-5	8B713N8Q0F			
1,2-dibromo-2,4-dicyanobutane	35691-65-7	1,2-Dibromo-2,4-dicyanobutane	35691-65-7	YX089CPS05	Preservatives, Pharmaceutical	Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include ANTI-BACTERIAL AGENTS and antioxidants. (See all compounds classified as Preservatives, Pharmaceutical.)	Bromothalonil is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.
1,2-dibromo-3-chloropropane	96-12-8	1,2-Dibromo-3-chloropropane	96-12-8	96K0FD4803	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	
1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane		1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane	3322-93-8	502D5Q149T			
1,2-dichloro-4-nitrobenzene	99-54-7	3,4-Dichloronitrobenzene	99-54-7	IJT74JI7FS			
1,2-dichloroethylene	540-59-0	1,2-Dichloroethylene	540-59-0				
1,2-didecanoylglycerol	17863-69-3	1,2-Didecanoylglycerol	17863-69-3	D5K11SW7QP			
1,2-dielaidoylphosphatidylethanolamine	76391-83-8	Lipofectin	76391-83-8				
1,2-diethyl-3-hydroxypyridin-4-one	115900-75-9	1,2-Diethyl-3-hydroxypyridin-4-one	115900-75-9	G3PX21X7IU	Iron Chelating Agents	Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. (See all compounds classified as Iron Chelating Agents.)	
1,2-dihydro-1,2-dihydroxy-5-methylchrysene	67411-81-8	1,2-Dihydro-1,2-dihydroxy-5-methylchrysene	67411-81-8				
1,2-dihydrostilbene	103-29-7	1,2-Diphenylethane	103-29-7	007C07V77Z			
1,2-dihydroxy-1,2-dihydronaphthalene	7234-04-0	1,2-Dihydronaphthalene-1,2-diol	7234-04-0				
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt	149-45-1	Tiron	149-45-1	4X87R5T106	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
1,2-dihydroxynaphthalene	574-00-5	Naphthalene-1,2-diol	574-00-5	2R5017T335			
1,2-dilauroylphosphatidylcholine	18285-71-7	Dilaurylphosphatidylcholine	18656-40-1				
1,2-dilinolenoyl-3-(4-aminobutyryl)propane-1,2,3-triol	93349-26-9	[3-(4-aminobutanoyloxy)-2-[(9Z,12E,15E)-octadeca-9,12,15-trienoyl]oxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate	93349-26-9				
1,2-dimethyl-4-nitrobenzene	99-51-4	1,2-Dimethyl-4-nitrobenzene	99-51-4	FI6475010K			
1,2-Dimethylhydrazine	540-73-8	1,2-Dimethylhydrazine	540-73-8	IX068S9745	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
1,2-dimethylnaphthalene	573-98-8	1,2-Dimethylnaphthalene	28804-88-8	23T7O135BD			
1,2-dinitrobenzene	528-29-0	1,2-Dinitrobenzene	528-29-0	35XUO924Y0			
1,2-dioctanoylglycerol	1069-87-0	1,2-Dioctanoylglycerol	36354-80-0	SA9937IP23			
1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide		1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide					
1,2-dioleoyl-sn-glycero-3-phosphoglycerol	66322-31-4	1,2-Dioleoyl-sn-glycero-3-phosphoglycerol	66322-31-4				
1,2-dioleoyloxy-3-(trimethylammonium)propane	113669-21-9	Dotap	113669-21-9	MR86K0XRQP	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
1,2-Dipalmitoylphosphatidylcholine	2644-64-6	1,2-Dipalmitoylphosphatidylcholine	2644-64-6	2W15RT5V7V			
1,2-dipalmitoylphosphatidylglycerol	4537-77-3	Dipalmitoylphosphatidylglycerol	4537-77-3	VA9U6BR3SB			
1,2-diphenoxyethane		1,2-Diphenoxyethane	104-66-5	V9W31HX4AW			
1,2-diphenylhydrazine		1,2-Diphenylhydrazine	122-66-7	1G3CS09TUK			
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)		1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)					
1,2-distearoyllecithin	4539-70-2	1,2-Distearoyllecithin	4539-70-2	EAG959U971			
1,2-dithiol-3-thione		3H-1,2-Dithiole-3-thione	534-25-8	WT2QF220RR	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
1,2-epoxy-3-(p-nitrophenoxy)propane		1,2-Epoxy-3-(p-nitrophenoxy)propane	5255-75-4	96071991U0	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
1,2-epoxy-3,4-dihydroxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene	111001-48-0	1,2-Epoxy-3,4-dihydroxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene	111001-48-0		Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
1,2-epoxy-4-vinylcyclohexane	11094-48-7	Epoxy-4-vinylcyclohexene	11094-48-7				
1,2-linoleoylphosphatidylcholine	6542-05-8	Dilinoleoylphosphatidylcholine	6542-05-8				
1,2-naphthoquinone	524-42-5	1,2-Naphthoquinone	524-42-5	804K62F61Q			
1,2-oleoylphosphatidylcholine	10015-85-7	Dioleoyl phosphatidylcholine	68737-67-7	EDS2L3ODLV			
1,2,3-trichloropropane	96-18-4	1,2,3-Trichloropropane	96-18-4	3MJ7QCK0Z0			
1,2,3,4-tetrachlorodibenzodioxin	30746-58-8	1,2,3,4-Tetrachlorodibenzo-P-dioxin	30746-58-8	HF5S8P28CC			
1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline		1-Benzyl-1,2,3,4-tetrahydroisoquinoline	19716-56-4	X4S06GK4KN	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	
1,2,3,4-tetrahydroisoquinoline		1,2,3,4-Tetrahydroisoquinoline	91-21-4	56W89FBX3E			
1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid	35186-99-3	1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid	67123-97-1	C0KDL86B2L			
1,2,3,4,4a,5,10,10a-octahydro-6-methoxy-1-methylbenz(g)quinoline-3-carboxylic acid 4-(4-nitrophenyl)piperazine amide		[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(4-nitrophenyl)piperazin-1-yl]methanone					
1,2,3,4,5,6-hexabromocyclohexane		1,2,3,4,5,6-Hexabromocyclohexane	1837-91-8				
1,2,3,4,6,7-hexachlorinated naphthalene		1,2,3,4,6,7-hexachlorinated naphthalene					
1,2,3,4,6,7,8-heptachlorodibenzodioxin	35822-46-9	1,2,3,4,6,7,8-Heptachlorodibenzo-P-dioxin	35822-46-9	MM6333103R			
1,2,3,4,6,7,8-heptachlorodibenzofuran		1,2,3,4,6,7,8-Heptachlorodibenzofuran	67562-39-4	58J222A38N			
1,2,3,4,7,8-hexachlorodibenzodioxin	39227-28-6	1,2,3,4,7,8-Hexachlorodibenzo-P-dioxin	39227-28-6	5R0UY33JFS			
1,2,3,4,7,8-hexachlorodibenzofuran	70648-26-9	1,2,3,4,7,8-Hexachlorodibenzofuran	70648-26-9	BP4Q20NZGY			
1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta(b)(1,4)diazepino(6,7,1hj)indole		(7bR,10aR)-2,3,4,7b,8,9,10,10a-Octahydro-1H-cyclopenta[b][1,4]diazepino[6,7,1-hi]indole	428868-32-0	MN9LW8268N	Serotonin 5-HT2 Receptor Agonists	Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT2 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT2 receptor subtypes. (See all compounds classified as Serotonin 5-HT2 Receptor Agonists.)	
1,2,3,5-tetrachlorobenzene	634-90-2	1,2,3,5-Tetrachlorobenzene	634-90-2	I27N186CIN			
1,2,3,5,6,7-hexachloronaphthalene		1,2,3,5,6,7-Hexachloronaphthalene	103426-97-7	N12KLT51QK			
1,2,3,6,7,8-hexachlorodibenzodioxin	57653-85-7	1,2,3,6,7,8-Hexachlorodibenzo-P-dioxin	57653-85-7	B94L7A4G3D			
1,2,3,7,8-pentachlorodibenzo-p-dioxin	40321-76-4	1,2,3,7,8-Pentachlorodibenzo-P-dioxin	40321-76-4	2NE6H0QPCH			
1,2,3,7,8-pentachlorodibenzofuran	57117-41-6	1,2,3,7,8-Pentachlorodibenzofuran	57117-41-6	QNE7ZLB7SS			
1,2,4-triazole	288-88-0	1,2,4-Triazole	288-88-0	10MS0Y1RDI			
1,2,4-triazolo(1,5-c)pyrimidine		[1,2,4]Triazolo[1,5-c]pyrimidine	274-86-2				
1,2,4-trichlorobenzene	120-82-1	1,2,4-Trichlorobenzene	120-82-1	05IQ959M1N			
1,2,4-trimethylcyclohexane	2234-75-5	1,2,4-Trimethylcyclohexane	2234-75-5				
1,2,4,5-benzenetetraamine		1,2,4,5-benzenetetraamine					
1,2,4,5-tetrabromobenzene	636-28-2	1,2,4,5-Tetrabromobenzene	636-28-2	M25DK66LCZ			
1,2,4,5-tetrachlorobenzene	95-94-3	1,2,4,5-Tetrachlorobenzene	95-94-3	5N27529KGH			
1,2,5,6-dibenzanthracene	53-70-3	Dibenz[a,h]anthracene	53-70-3	T30ELH3D5X	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
1,2,5,6-tetrabromocyclooctane		1,2,5,6-Tetrabromocyclooctane	3194-57-8				
1,2,5,8-tetrahydroxy anthraquinone		Quinalizarin	81-61-8	6D43C3LYSG			
1,2,7,8-tetrachlorodibenzo-p-dioxin		1,2,7,8-Tetrachlorodibenzo-P-dioxin	34816-53-0	61CLS478M1			
1,2,7,8-tetrachlorodibenzofuran	58802-20-3	1,2,7,8-Tetrachlorodibenzofuran	58802-20-3	93O23N0574			
1,24-dihydroxyvitamin D2	124043-51-2	1alpha,24-Dihydroxy vitamin D2					
1,24,25-trihydroxyvitamin D3	50648-94-7	1,24,25-trihydroxyvitamin D3	50648-94-7				
1,25-dihydroxy-16-ene-vitamin D3	124409-58-1	1,25-Dihydroxy-16-ene-vitamin D3	124409-58-1				
1,25-dihydroxy-19-norvitamin D3	130447-37-9	1,25-Dihydroxy-19-norvitamin D3	130447-37-9	K5ZM856PSA			
1,25-dihydroxy-26,27-dimethylcholecalciferol	97473-92-2	26,27-Dimethylcalcitriol	97473-92-2				
1,25-dihydroxyergocalciferol	55248-15-2	(1R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol	55248-15-2				
1,25-dihydroxyvitamin D	66772-14-3	Calcitriol	32222-06-3	FXC9231JVH	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis.
1,25(OH)2-16-ene-23-yne-26,27-hexafluoro-19-nor-D3		(OH)2-ene-yne-(F)6-D3	195527-19-6				
1,3-benzothiazol-2-yl(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)acetonitrile		1,3-Benzothiazol-2-yl(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)acetonitrile	345987-15-7	Y9A2N9O85G			
1,3-bis(2-hydroxyiminomethylpyridinium)propane		1,3-bis(2-hydroxyiminomethylpyridinium)propane					
1,3-bis(4-(phthalimidomethoxyiminomethyl)pyridinium-1-yl)propane		1,3-bis(4-(phthalimidomethoxyiminomethyl)pyridinium-1-yl)propane					
1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole		1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole					
1,3-butadiene	106-99-0	1,3-Butadiene	106-99-0	JSD5FGP5VD	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
1,3-butylene glycol	107-88-0	Butylene Glycol	107-88-0	3XUS85K0RA			
1,3-di(1H-indol-3-yl)propan-2-one		1,3-di(1H-indol-3-yl)propan-2-one					
1,3-diacetoxytetradeca-6,12-dien-8,10-diyne		1,3-diacetoxytetradeca-6,12-dien-8,10-diyne					
1,3-dichloro-1-propene	542-75-6	1,3-Dichloropropene	542-75-6		Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
1,3-dichloro-2-propanol	96-23-1	1,3-Dichloro-2-propanol	96-23-1	0F4P2VQC07	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
1,3-dichlorobenzene	541-73-1	1,3-Dichlorobenzene	541-73-1	75W0WNE5FP			
1,3-dicyclohexylurea	2387-23-7	1,3-Dicyclohexylurea	2387-23-7	ZV7823VVIM			
1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one		Akt inhibitor VIII	612847-09-3	YX4CPQ6V6X			
1,3-dihydroxy-2-hydroxymethylpropyl-2-ammonium 2-((R)-3-cyclo-hexyl-1-phenylpropyl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylate monohydrate		1,3-dihydroxy-2-hydroxymethylpropyl-2-ammonium 2-((R)-3-cyclo-hexyl-1-phenylpropyl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylate monohydrate					
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole	145757-47-7	Carboxy-ptio	145757-47-7				
1,3-dihydroxypropan-2-yl 11-(2-hexyl-5-hydroxyphenoxy)undecanoate		1,3-dihydroxypropan-2-yl 11-(2-hexyl-5-hydroxyphenoxy)undecanoate					
1,3-dihydroxypropan-2-yl 11-(3-hydroxy-5-(2-methyloctan-2-yl)phenoxy)undecanoate		1,3-dihydroxypropan-2-yl 11-(3-hydroxy-5-(2-methyloctan-2-yl)phenoxy)undecanoate					
1,3-dimethoxy-5-methyl-2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)benzene		1,3-dimethoxy-5-methyl-2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)benzene					
1,3-dimethylthiourea	61805-96-7	N,N'-Dimethylthiourea	534-13-4	8P30PMD17W	Free Radical Scavengers	Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. (See all compounds classified as Free Radical Scavengers.)	
1,3-dinitropyrene		1,3-Dinitropyrene	75321-20-9	D09D9L0924	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
1,3-diphenylpropane	1335-47-3	Di-p-tolylmethane	4957-14-6				
1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine		Adentri	166374-48-7		Adenosine A1 Receptor Antagonists	Compounds that bind to and block the stimulation of ADENOSINE A1 RECEPTORS. (See all compounds classified as Adenosine A1 Receptor Antagonists.)	
1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine	85872-51-1	1,3-Dipropyl-8-(2-amino-4-chlorophenyl)xanthine	85872-51-1	ET7OKC2MCY	Adenosine A1 Receptor Antagonists	Compounds that bind to and block the stimulation of ADENOSINE A1 RECEPTORS. (See all compounds classified as Adenosine A1 Receptor Antagonists.)	
1,3-dipropyl-8-(4-sulfophenyl)xanthine	89073-57-4	1,3-Dipropyl-8-p-sulfophenylxanthine	89073-57-4		Purinergic P1 Receptor Antagonists	Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS. (See all compounds classified as Purinergic P1 Receptor Antagonists.)	
1,3-dipropyl-8-cyclopentylxanthine		8-Cyclopentyl-1,3-dipropylxanthine	102146-07-6	9PTP4FOI9E	Adenosine A1 Receptor Antagonists	Compounds that bind to and block the stimulation of ADENOSINE A1 RECEPTORS. (See all compounds classified as Adenosine A1 Receptor Antagonists.)	
1,3-ditolylguanidine	97-39-2	1,3-Di-o-tolylguanidine	97-39-2	LL2P01I17O	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
1,3-propane sultone	1120-71-4	1,3-Propane sultone	1120-71-4	L6NTK7VJX9			
1,3,4-oxadiazole		1,3,4-Oxadiazole	288-99-3	20O2F20OUR			
1,3,4,14b-tetrahydro-2,10-dimethyl-2H,10H-pyrazino(2,1-d)pyrrolo(1,2-b) (1,2,5)benzotriazepine		1,3,4,14b-tetrahydro-2,10-dimethyl-2H,10H-pyrazino(2,1-d)pyrrolo(1,2-b) (1,2,5)benzotriazepine					
1,3,5-triallyl isocyanurate	1025-15-6	Triallyl isocyanurate	1025-15-6	P48OBJ1G11			
1,3,5-tribromobenzene	626-39-1	1,3,5-Tribromobenzene	626-39-1	O3TD0U1OAQ			
1,3,5,6-tetrahydroxyxanthone		1,3,5,6-Tetrahydroxyxanthone	5084-31-1				
1,3,6-trinitropyrene	75321-19-6	1,3,6-Trinitropyrene	75321-19-6	49M5YJ3MLV			
1,3,7-trimethyluric acid	5415-44-1	1,3,7-Trimethyluric acid	5415-44-1	Z61UN6MHB7			
1,3,7,8-tetrachlorodibenzo-4-dioxin	50585-46-1	1,3,7,8-Tetrachlorodibenzo-P-dioxin	50585-46-1	85WEE3RG9K			
1,3,7,9-tetramethyluric acid		1,3,7,9-Tetramethyluric acid	2309-49-1	EJ939L81MY			
1,3,8-trihydroxy-6-hydroxymethylanthraquinone	481-73-2	Citreorosein	481-73-2	O2H2Z421AP			
1,4-androstadiene-3,17-dione	897-06-3	Androsta-1,4-diene-3,17-dione	897-06-3	2166Q8568W			
1,4-anthraquinone	635-12-1	1,4-Anthraquinone	635-12-1				
1,4-benzenedimethanethiol		1,4-Benzenedimethanethiol	105-09-9	K48UBZ9IMD			
1,4-bis(2-(3,5-dichloropyridyloxy))benzene	76150-91-9	Tcpobop	76150-91-9	P4R368GDD7			
1,4-bis(2-hydroxyiminomethylpyridinium)butane		1,4-bis(2-hydroxyiminomethylpyridinium)butane					
1,4-bis(2,3-epoxypropoxy)butane	2425-79-8	1,4-Butanediol diglycidyl ether	29611-97-0	E9MU425FIB			
1,4-bis(4-hydroxyiminomethylpyridinium)butane dibromide		1,4-bis(4-hydroxyiminomethylpyridinium)butane dibromide					
1,4-bisdesoxyquinocetone		1,4-bisdesoxyquinocetone					
1,4-cineole	470-67-7	1,4-Cineole	470-67-7	B55JTU839B			
1,4-cyclohexanedimethanol	105-08-8	1,4-Cyclohexanedimethanol	105-08-8	47A69Y3G5M			
1,4-diaminoanthraquinone	128-95-0	1,4-Diaminoanthraquinone	128-95-0	N21HDQ0TKN			
1,4-diaminocyclohexane	3114-70-3	Cyclohexane-1,4-diamine	3114-70-3	LWV4M8KF2B			
1,4-dibromobenzene	106-37-6	1,4-Dibromobenzene	106-37-6	9991W3M5HZ			
1,4-dideoxy-1,4-iminoarabinitol	100937-53-9	1,4-Dideoxy-1,4-imino-L-arabinitol	100937-53-9	Z330X18GMD			
1,4-dihydro-N-methylnicotinamide		1,4-dihydro-N-methylnicotinamide					
1,4-dihydropyridine	3337-17-5	1,4-Dihydropyridine	3337-17-5	7M8K3P6I89	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
1,4-dihydroquinone		1,4-dihydroquinone					
1,4-dihydroxy-2-naphthoic acid	31519-22-9	1,4-Dihydroxy-2-naphthoic acid	31519-22-9	1U77MR5Q7O			
1,4-dihydroxy-2-nonene		1,4-Dihydroxy-2-nonene					
1,4-dihydroxyanthraquinone	81-64-1	Quinizarin	81-64-1	8S496ZV3CS			
1,4-dimethoxy-2-naphthoic acid		1,4-Dimethoxy-2-naphthoic acid	78265-13-1				
1,4-dimethylnaphthalene	571-58-4	1,4-Dimethylnaphthalene	571-58-4	BQH3S1I0SO			
1,4-dinitrobenzene	100-25-4	1,4-Dinitrobenzene	100-25-4	784Q9O56S9			
1,4-dioxane	123-91-1	1,4-Dioxane	123-91-1	J8A3S10O7S			
1,4-dithiane	505-29-3	1,4-Dithiane	505-29-3	3274B1T5A0			
1,4-naphthoquinone	130-15-4	1,4-Naphthoquinone	130-15-4	RBF5ZU7R7K			
1,4-phenanthrenequinone	569-15-3	1,4-Phenanthrenedione	569-15-3	IU5XP36K84			
1,4-phenylenebis(methylene)selenocyanate	85539-83-9	1,4-Phenylenebis(methylene)selenocyanate	85539-83-9	Q22S9Y993E	Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	
1,4-phenylenebis(methylene)selenocyanate, glutathione conjugate		1,4-phenylenebis(methylene)selenocyanate, glutathione conjugate					
1,4,5,8-naphthalenetetracarboxylic diimide		1,4,5,8-naphthalenetetracarboxylic diimide					
1,4,7-triazacyclononane	4730-54-5	1,4,7-Triazacyclononane	4730-54-5	2UIF93C5H3			
1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane		1,4,7-Tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane	114873-37-9	A6DV6KJV7Z			
1,5-anhydrofructose	75414-43-6	1,5-Anhydro-D-fructose	75414-43-6				
1,5-benzothiazepine		1,5-Benzothiazepine	265-13-4				
1,5-bis(2-bromophenyl)penta-1,4-dien-3-one		1,5-Bis(2-bromophenyl)penta-1,4-dien-3-one					
1,5-bis(2,3-dimethoxyphenyl)penta-1,4-dien-3-one		1,4-Pentadien-3-one, 1,5-bis(2,3-dimethoxyphenyl)-, (1E,4E)-	170950-29-5				
1,5-diaminoanthraquinone		1,5-Diaminoanthraquinone	129-44-2	3ZXX3HK358			
1,5-diaminonaphthalene		1,5-Naphthalenediamine	2243-62-1	13PD3J52LK			
1,5-dihydroxyisoquinoline	5154-02-9	1,5-Isoquinolinediol	5154-02-9		Poly(ADP-ribose) Polymerase Inhibitors	Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. (See all compounds classified as Poly(ADP-ribose) Polymerase Inhibitors.)	
1,5-dihydroxynaphthalene	83-56-7	1,5-Dihydroxynaphthalene	83-56-7	P25HC23VH6			
1,5-naphthalenediamine	2243-62-1	1,5-Naphthalenediamine	2243-62-1	13PD3J52LK			
1,5(10)-estradiene-3,4,17-trione	40551-34-6	Estra-1,5(10)-diene-3,4,17-trione	40551-34-6	3U2V78OM3M			
1,6-Bis(4-(4-amino-3-hydroxyphenoxy)phenyl)diamantane		1,6-Bis(4-(4-amino-3-hydroxyphenoxy)phenyl)diamantane					
1,6-bis(cyclohexyloximinocarbonyl)hexane	83654-05-1	1,6-Bis(cyclohexyloximinocarbonyl)hexane	83654-05-1	9VB68H5WIT	Protease Inhibitors	Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)	
1,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamido)hexane		1,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamido)hexane					
1,6-diaminohexane	124-09-4	Hexamethylenediamine	124-09-4	ZRA5J5B2QW			
1,6-dichlorosucrose	61854-83-9	1,6-Dichlorosucrose	61854-83-9	CMY61A7Z2L			
1,6-dimethylnaphthalene		1,6-Dimethylnaphthalene	575-43-9	DXN13WI5EY			
1,6-dinitropyrene	42397-64-8	1,6-Dinitropyrene	42397-64-8	66Q2ZUF83N	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
1,6-hexamethylene diisocyanate	822-06-0	Hexamethylene diisocyanate	822-06-0	0I70A3I1UF	Air Pollutants	Any substance in the air which could, if present in high enough concentration, harm humans, animals, vegetation or materials. Substances include GASES; PARTICULATE MATTER; and volatile ORGANIC CHEMICALS. (See all compounds classified as Air Pollutants.)	
1,7-bis(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one		1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one					
1,7-dimethyluric acid	33868-03-0	1,7-Dimethyluric acid	33868-03-0	Z633Z7KAJU			
1,7-dimethylxanthine	611-59-6	Paraxanthine	611-59-6	Q3565Y41V7			
1,7-diphenyl-4,6-heptadien-3-ol		1,7-diphenyl-4,6-heptadien-3-ol					
1,7-diphenyl-5-heptene-3-one		1,7-Diphenyl-5-heptene-3-one					
1,7-N-heptylene-bis-9,9'-amino-1,2,3,4-tetrahydroacridine		N,N'-Di-1,2,3,4-Tetrahydroacridin-9-Ylheptane-1,7-Diamine	181865-13-4				
1,7-phenanthroline	230-46-6	1,7-Phenanthroline	230-46-6	5Y778HQU2S			
1,8-diaminonaphthalene		1,8-Diaminonaphthalene	479-27-6	IKA7029YH9			
1,8-diazafluoren-one		1,8-diazafluoren-one					
1,8-dinitro-4,5-dihydroxyanthraquinone		1,8-Dihydroxy-4,5-dinitroanthraquinone	81-55-0	HEO6302D6D			
1,8-dinitropyrene	42397-65-9	1,8-Dinitropyrene	42397-65-9	51U7E9MW6I	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
1,9-dideoxyforskolin	64657-18-7	1,9-Dideoxyforskolin	64657-18-7	OAW710HWIX			
1,N(2)-propanodeoxyguanosine	120667-07-4	1,N(2)-Propanodeoxyguanosine	120667-07-4	2L6Y9J6X5R			
1,N(6)-ethenoadenine	13875-63-3	1,N6-Ethenoadenine	13875-63-3	SIN7411HG7	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
1'-(hydroxymethyl)eugenol		1'-Hydroxymethyleugenol	31706-95-3	DA6575YC8S			
1'-acetoxychavicol acetate		1'-Acetoxychavicol acetate	52946-22-2	SQV3080A20			
1'-hydroxyestragole	51410-44-7	1'-Hydroxyestragole	51410-44-7				
1'-hydroxysafrole	5208-87-7	1'-Hydroxysafrole	5208-87-7	C9B19855E2			
1',2'-dihydrorotenone	6659-45-6	Dihydrorotenone	6659-45-6	538CX0LPPO			
1',3'-dihydro-1'-ethanol-3',3'-dimethyl-8-methoxy-6-nitro-spiro(2H-1-benzopyran-2,2'-(2H)-indole)		1',3'-dihydro-1'-ethanol-3',3'-dimethyl-8-methoxy-6-nitro-spiro(2H-1-benzopyran-2,2'-(2H)-indole)					
10-(2-pyrazolylethoxy)camptothecin		10-(2-pyrazolylethoxy)camptothecin					
10-(4'-(N-diethylamino)butyl)-2-chlorophenoxazine		10-[4'-(N-diethylamino)butyl]-2-chlorophenoxazine					
10-(alpha-diethylaminopropionyl)phenothiazine	63834-04-8	Dimethylaminopropionylphenothiazine	63834-04-8	00435Z54H1			
10-(fluoroethoxyphosphinyl)-N-(biotinamidopentyl)decanamide		10-(fluoroethoxyphosphinyl)-N-(biotinamidopentyl)decanamide					
10-(octyloxy)decyl-2-(trimethylammonium)ethyl phosphate		10-(octyloxy)decyl-2-(trimethylammonium)ethyl phosphate					
10-carboxymethyl-9-acridanone	38609-97-1	Cridanimod	38609-97-1	X91E9EME19	Interferon Inducers	Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons. (See all compounds classified as Interferon Inducers.)	
10-deacetylpaclitaxel		10-Deacetyltaxol	78432-77-6	B77R96LJLK			
10-decarbamoylmitomycin C	26909-37-5	Decarbamoylmitomycin C	26909-37-5				
10-formyltetrahydropteroylglutamic acid	2800-34-2	10-Formyltetrahydropteroylglutamic acid	2800-34-2	43SUG29HQR			
10-hydroxycamptothecin	67656-30-8	9-Hydroxycamptothecin	67656-30-8				
10-hydroxynortriptyline	1156-99-6	10-Hydroxynortriptyline	1156-99-6	7A43OTR1B8			
10-hydroxywarfarin	83219-99-2	10-Hydroxywarfarin	83219-99-2				
10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one		10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one					
10-methoxy-5-(2-propenyl)-2,5-dihydro-2,2,4-trimethyl-1H-(1)benzopyrano(3,4-f)quinoline		5-allyl-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-f]quinoline					
10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-(1,4)diazepino(5',6'-4,5)thieno(3,2-f)quinolin-8-one		10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-(1,4)diazepino(5',6'-4,5)thieno(3,2-f)quinolin-8-one					
10-nitro-oleic acid		10-Nitrooleic acid	875685-46-4	1N19AGY57Y	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
10-propargyl-10-deazaaminopterin		Pralatrexate	146464-95-1	A8Q8I19Q20			Pralatrexate is indicated for the treatment of relapsed or refractory peripheral T-cell lymphoma.
10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone		10,10-Bis(pyridin-4-ylmethyl)anthracen-9-one	122955-42-4				
10,11-dihydro-10-hydroxycarbamazepine		Licarbazepine	29331-92-8	XFX1A5KJ3V			
10,11-dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide	35079-97-1	Dihydroxycarbazepine	35079-97-1				
10,11-dihydro-5H-dibenzo(a,d)cycloheptene		10,11-Dihydro-5H-dibenzo[a,d]cycloheptene	833-48-7	GU7KLN5ED5			
10,12-octadecadienoic acid		10,12-Octadecadienoic acid	1072-36-2				
10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone		10'(Z),13'(E),15'(E)-Heptadecatrienylhydroquinone					
10074-G5		4-nitro-N-(2-phenylphenyl)-2,1,3-benzoxadiazol-7-amine	413611-93-5				
103D5R		1-(1-(5-Methoxy-2,2-dimethyl-2H-chromen-6-yl)ethyl)-1H-imidazo[4,5-b]pyridine	773852-25-8				
10H-3,6-diazaphenothiazine		10H-3,6-diazaphenothiazine					
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene		11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene					
11-(dansylamino)undecanoic acid	73025-02-2	11-(Dansylamino)undecanoic acid	73025-02-2		Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
11-dehydro-thromboxane B2	67910-12-7	11-Dehydro-thromboxane B2	67910-12-7	CJ6ST9UG7C			
11-dehydrocorticosterone	72-23-1	11-Dehydrocorticosterone	72-23-1	FO4V44A3G3			
11-deoxy-16-phenoxy-17,18,19,20-tetranorprostaglandin E1	80558-61-8	Dpt-prostaglandin E1	80558-61-8	70K4BF31QF	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	
11-deoxyprostaglandin E1	37786-00-8	11-Deoxy-PGE1	37786-00-8	UG6237D2HO	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	
11-fluoro-7-(14,14,15,15-pentafluoro-6-methyl-10-thia-6-azapentadecyl)estra-1,3-5(10)-triene-3,17-diol		11-fluoro-7-(14,14,15,15-pentafluoro-6-methyl-10-thia-6-azapentadecyl)estra-1,3-5(10)-triene-3,17-diol					
11-hexadecenal	53939-28-9	(Z)-11-Hexadecenal	53939-28-9	733PD1I6EI			
11-hydroxy-5,8,12,14-eicosatetraenoic acid	73151-66-3	11-Hydroxy-5,8,12,14-eicosatetraenoic acid	73151-66-3				
11-hydroxy-delta(9)-tetrahydrocannabinol	26108-40-7	6a,7,8,10a-Tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl-6H-dibenzo(b,d)pyran-9-methanol	26108-40-7				
11-hydroxyandrostenedione	564-32-9	11-Hydroxyandrostenedione	564-32-9				
11-hydroxytestosterone	1816-85-9	11beta-Hydroxytestosterone	1816-85-9	BEF7K94MWQ			
11-keto-boswellic acid		Holothurin A	38-26-6	1EV65QT62C			
11-ketotestosterone	53187-98-7	17-Hydroxyandrost-4-ene-3,11-dione	53187-98-7				
11-methylbenzanthracene		11-Methylbenz[a]anthracene	6111-78-0	B98QX69WD3			
11-Mrp-14-Nal-18-Cys-22-Asp-beta-MSH(11-22)NH2		11-Mrp-14-Nal-18-Cys-22-Asp-beta-MSH(11-22)NH2					
11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid	64280-14-4	11-Nor-9-carboxy-thc	64280-14-4				
11-oxo-delta(8)-tetrahydrocannabinol	53865-18-2	11-Oxo-thc	53865-18-2				
11-oxoeicosatetraenoic acid		11-oxoeicosatetraenoic acid					
11,11'-dideoxyverticilin		11,11'-dideoxyverticilin					
11,12-dihydroxyeicosatrienoic acid		11,12-dihydroxy-5Z,8Z,14Z-eicosatrienoic acid	192461-95-3				
11,12-epoxy-5,8,14-eicosatrienoic acid		11,12-Epoxy-5,8,14-eicosatrienoic acid	81276-02-0		Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
11,12,15-trihydroxyeicosatrienoic acid	82144-59-0	11,12,15-Trihydroxyeicosatrienoic acid	82144-59-0				
11,14,15-trihydroxyeicosa-5,8,12-trienoic acid	79595-81-6	11,14,15-Trihydroxyeicosa-5,8,12-trienoic acid	79595-81-6				
11,15-dioxo-9-hydroxy-2,3,4,5-tetranorprostan-1,20-dioic acid		11,15-dioxo-9-hydroxy-2,3,4,5-tetranorprostan-1,20-dioic acid					
11,17-dihydroxy-6-methyl-17-(1-propynyl)androsta-1,4,6-triene-3-one	74915-64-3	11,17-Dihydroxy-6-methyl-17-(1-propynyl)androsta-1,4,6-triene-3-one	74915-64-3	VH397CN9SV			
111In-DOTA-TOC		111In-DOTA-TOC					
12-(3-adamantan-1-ylureido)dodecanoic acid		12-(3-adamantan-1-ylureido)dodecanoic acid					
12-acetoxyhawtriwaic acid lactone		12-acetoxyhawtriwaic acid lactone					
12-dehydrogingerdione		12-Dehydrogingerdione					
12-deoxyphorbolphenylacetate-20-acetate	54662-30-5	12-Deoxyphorbol 13-phenylacetate 20-acetate	54662-30-5				
12-HPETE	67675-13-2	Arachidonic acid omega-9 hydroperoxide	67675-13-2		Vasoconstrictor Agents	Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)	
12-hydroxy-5,8,10-heptadecatrienoic acid	50683-78-8	12-Hydroxy-5,8,10-heptadecatrienoic acid	50683-78-8				
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid	59985-28-3	12-Hydroxy-5,8,10,14-eicosatetraenoic acid	59985-28-3				
12-hydroxydodecanoic acid	505-95-3	12-Hydroxydodecanoic acid	505-95-3	SUH3LR2K9D			
12-hydroxyellipticine		12-hydroxyellipticine					
12-ketoendrin	28548-08-5	12-Ketoendrin	28548-08-5				
12-mesyloxynevirapine		12-mesyloxynevirapine					
12-methylbenzanthracene	2422-79-9	12-Methylbenz(a)anthracene	2422-79-9	8F95087GC8			
12-O-tetradecanoylphorbol-1,3-acetate		12-O-tetradecanoylphorbol-1,3-acetate					
12-tungstophosphoric acid		12-Wolframophosphoric acid	1343-93-7				
13-cis-12-(3'-carboxyphenyl)retinoic acid	141948-79-0	13-cis-12-(3'-Carboxyphenyl)retinoic acid	141948-79-0	Y8U3B6ZM8D			
13-cis-retinal	472-86-6	13-cis-Retinal	472-86-6	IBP64540CD			
13-desmethylspirolide C		13-desmethyl spirolide C	334974-07-1				
13-hydroperoxy-9,11-octadecadienoic acid	23017-93-8	13-Hpode	23017-93-8	DPF3WUY4S4			
13-hydroxy-10-oxo-11-octadecenoic acid	28979-44-4	10-Oxo-13-hydroxy-11-octadecenoic acid	28979-44-4				
13-hydroxy-9,11-octadecadienoic acid	5204-88-6	13-Hydroxy-9,11-octadecadienoic acid	5204-88-6				
13-hydroxyellipticine		13-hydroxyellipticine					
13-methylarachidonic acid		13-methylarachidonic acid					
13-oxo-9,11-octadecadienoic acid	31385-09-8	13-Oxo-9,11-octadecadienoic acid	31385-09-8				
13,14-dihydro-15-ketoprostaglandin D2	59894-07-4	13,14-Dihydro-15-keto-pgd2	59894-07-4				
13,14-dihydro-15-ketoprostaglandin E1	5094-14-4	13,14-Dihydro-15-keto-PGE1	5094-14-4	M3I99MYM0V			
13,17,21-trimethyldocosa-12,16,20-trien-11-one		13,17,21-Trimethyldocosa-12,16,20-trien-11-one					
13,19-didesmethyl spirolide C		13,19-didesmethyl spirolide C					
13beta-methyl 19-nor-steroid		13beta-methyl 19-nor-steroid					
14-benzyloxy-4,5-epoxy-3-hydroxy-17-methylmorphinan-6-one		14-benzyloxy-4,5-epoxy-3-hydroxy-17-methylmorphinan-6-one					
14-deoxy-11,12-didehydroandrographolide		14-Deoxy-11,12-didehydroandrographolide	42895-58-9	5S0X4YZJ0E			
14-hydroxy-4,14-retro-retinol	139257-77-5	14(R)-Hydroxy-retro-vitamin A	139257-77-5	W4B62B4I6M			
14-hydroxydocosahexaenoic acid	86360-66-9	14-Hydroxydocosahexaenoic acid	86360-66-9				
14-methoxymetopon	131575-03-6	14-Methoxymetopon	131575-03-6				
14-methylergosta-8,24(28)-dien-3,6-diol	120523-06-0	14-Methylergosta-8,24(28)-dien-3,6-diol	120523-06-0				
14-O-methyloxymorphone		14-O-methyloxymorphone					
14-phenylpropoxymetopon		14-Phenylpropoxymetopon					
14,15-dihydroxyeicosatrienoic acid		14,15-dihydroxy-5Z,8Z,11Z-eicosatrienoic acid	77667-09-5				
14,15-eicosa-5-enoic acid		14,15-eicosa-5-enoic acid					
14,15-epoxy-5,8,11-eicosatrienoic acid	81276-03-1	14,15-Epoxy-5,8,11-eicosatrienoic acid	81276-03-1		Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
15-acetyldeoxynivalenol	88337-96-6	15-Acetyldeoxynivalenol	88337-96-6	0430X4R3Z1			
15-deoxy-delta(12,14)-prostaglandin J2		15-Deoxy-delta-12,14-prostaglandin J2	87893-55-8	ALI977775J	Immunologic Factors	Biologically active substances whose activities affect or play a role in the functioning of the immune system. (See all compounds classified as Immunologic Factors.)	
15-deoxyprostaglandin J2		15-deoxyprostaglandin J2	64222-94-2				
15-hydroperoxy-5,8,11,13-eicosatetraenoic acid	67675-14-3	15-Hpete	69371-38-6	33R5U5V88C	Lipoxygenase Inhibitors	Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)	
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid	76898-47-0	15-Hydroxy-11alpha,9alpha-(epoxymethano)prosta-5,13-dienoic acid	76898-47-0		Vasoconstrictor Agents	Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)	
15-hydroxy-11,12-epoxyeicosatrienoic acid		15H-11,12-Eeta	877878-78-9				
15-hydroxy-5,8,11,13-eicosatetraenoic acid	73945-47-8	15-Hydroxy-5,8,11,13-eicosatetraenoic acid	73945-47-8				
15-hydroxy-5,8,11,13,17-eicosapentaenoic acid	97850-14-1	15-Hydroxy-5,8,11,13,17-eicosapentaenoic acid	97850-14-1				
15-hydroxytestosterone	2226-70-2	15-Hydroxytestosterone	2226-70-2	T193O3374B			
15-keto-13,14-dihydroprostaglandin E2	363-23-5	13,14-Dihydro-15-keto-PGE2	363-23-5				
15-keto-13,14-dihydroprostaglandin F2alpha	27376-76-7	13,14-Dihydro-15-keto-pgf2alpha	27376-76-7				
15-keto-5,8,11,13-eicosatetraenoic acid	81416-72-0	15-Oxo-ETE	81416-72-0				
15-ketoprostaglandin E	22973-19-9	15-Oxoprostaglandin E1	22973-19-9	63FR527UJ6			
15-ketoprostaglandin E2	26441-05-4	15-keto-prostaglandin E2	26441-05-4	2S0F1FTK13			
15-ketoprostaglandin F2alpha	35850-13-6	15-Keto-PGF2alpha	35850-13-6				
15R-methyl prostaglandin D2		15R-methyl prostaglandin D2					
16 alpha-bromo-17 beta-estradiol	54982-79-5	16alpha-Bromo-17beta-estradiol	54982-79-5				
16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione	24320-06-7	(8R,9S,10R,13S,14S,16R,17S)-16-ethyl-17-(2-hydroxyacetyl)-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one	24320-06-7				
16 alpha-iodoestradiol	71765-94-1	Estra-1,3,5(10)-triene-3,17-diol, 16-iodo-, (16alpha,17beta)-	71765-94-1	45FQ48B1OQ			
16 alpha,17-epoxyprogesterone	1097-51-4	16alpha,17-Epoxyprogesterone	1097-51-4	F2DR02G069			
16-(4-fluorophenoxy)lipoxin A4		16-(4-fluorophenoxy)lipoxin A4					
16-hydroxycleroda-3,13(14)-dien-15,16-olide	92593-91-4	(5r)-5-Hydroxy-4-{2-[(2r,4ar,8ar)-1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]ethyl}furan-2(5h)-one	92593-91-4				
16-hydroxyestrone	18186-49-7	16-Hydroxyestrone	18186-49-7				
16-hydroxyprogesterone	14264-44-9	16-Hydroxyprogesterone	14264-44-9				
16-hydroxytestosterone	63-01-4	16alpha-Hydroxytestosterone	63-01-4	76E963P1A9			
16-ketoestrone	1228-73-5	16-Ketoestrone	1228-73-5	113V416QTU			
16-O-demethylaconitine		16-O-demethylaconitine					
16,16-Dimethylprostaglandin E2	39746-25-3	16,16-dimethylprostaglandin E2	39746-25-3	M790V82VAC	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	
17 alpha-hydroperoxypregnenolone	34069-59-5	(3beta)-17-Hydroperoxy-3-hydroxypregn-5-en-20-one	34069-59-5				
17 alpha-Hydroxyprogesterone Caproate		Hydroxyprogesterone Caproate	630-56-8	276F2O42F5	Progestins	Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. (See all compounds classified as Progestins.)	Hydroxyprogesterone caproate was previously indicated in the US for the prevention of spontaneous preterm births in singleton pregnancies in women with a history of spontaneous preterm birth. This indication was revoked by the FDA in April 2023.  Hydroxyprogesterone caproate remains indicated in other jurisdictions for the management of primary and secondary amenorrhea, corpus luteum insufficiency, and for the prevention of preterm birth.
17 alpha-iodoethynylestradiol	70761-64-7	17alpha-Iodoethynylestradiol	70761-64-7				
17 alpha,20 beta-dihydroxypregn-4-en-3-one	1662-06-2	(20R)-17,20-Dihydroxypregn-4-en-3-one	1662-06-2				
17-(4'-ethynyldimethylbenzylamine)-17-testosterone		17-(4'-ethynyldimethylbenzylamine)-17-testosterone					
17-(5'-isoxazolyl)androsta-4,16-dien-3-one		17-(5'-Isoxazolyl)androsta-4,16-dien-3-one					
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin		Alvespimycin	467214-20-6	001L2FE0M3			Investigated for use as an antineoplastic agent for solid tumors, advanced solid tumours or acute myeloid leukaemia.
17-alpha-Hydroxypregnenolone	387-79-1	17alpha-Hydroxypregnenolone	387-79-1	77ME40334S			
17-alpha-Hydroxyprogesterone	68-96-2	Hydroxyprogesterone	68-96-2	21807M87J2			
17-amino-17-demethoxygeldanamycin -C2-galactose		17-amino-17-demethoxygeldanamycin -C2-galactose					
17-benzyl-5-androstane-3,17-diol		17-benzyl-5-androstane-3,17-diol					
17-desoxyestradiol	53-63-4	17-Deoxyestradiol	53-63-4	73A01W88SP			
17-dihydroequilenin	1423-97-8	Estra-1,3,5,7,9-pentaene-3,17beta-diol	1423-97-8	ET2MK3VGB4			
17-ethynyl-5-androstene-3, 7, 17-triol		Triolex	1001100-69-1	PH8858757I			For the treatment of rheumatoid arthritis and type 2 diabetes.
17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid	90780-52-2	17-HDoHE	90780-52-2				
17-hydroxyjolkinolide B	116360-82-8	Bisoxireno(1,10a:3,4)phenanthro(3,2-b)furan-9-ol, 1,2,3,4,4a,5,6,7a,9,11a,11b,11c-dodecahydro-4,4,8,11c-tetramethyl-	116360-82-8				
17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one	73671-86-0	17-N,N-Diethylcarbamoyl-4-methyl-4-azaandrostane-3-one	73671-86-0		5-alpha Reductase Inhibitors	Drugs that inhibit 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE. They are commonly used to reduce the production of DIHYDROTESTOSTERONE. (See all compounds classified as 5-alpha Reductase Inhibitors.)	
17-phenyltrinorprostaglandin E2		17-phenyl-omega-trinor-PGE2	38315-43-4				
17,17'-bis(cyclopropylmethyl)-6,6',7,7'-tetrahydro-4,5-4',5'-diepoxy-6,6'-(benzylimino)(7,7'-bimorphinan)-3,3',14,14'-tetrol		17,17'-bis(cyclopropylmethyl)-6,6',7,7'-tetrahydro-4,5-4',5'-diepoxy-6,6'-(benzylimino)(7,7'-bimorphinan)-3,3',14,14'-tetrol					
17,20-dihydroxy-4-pregnen-3-one	10456-50-5	17,21-Dihydroxypregn-4-en-3-one	10456-50-5				
17,20-dihydroxyvitamin D2		17,20-dihydroxyvitamin D2					
17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol	21466-08-0	3alpha-Hydroxynorethynodrel	21466-08-0	21T2V97Q32			
18-hydroxycortisol		18-Hydroxycortisol	86002-90-6				
18-hydroxydeoxycorticosterone	379-68-0	18,21-Dihydroxypregn-4-ene-3,20-dione	379-68-0				
18-methoxycoronaridine		18-Methoxycoronaridine	308123-60-6	KX8NQX91Z8			
18-oxocortisol	2410-60-8	11b,17,21-Trihydroxy-3,20-dioxo-pregn-4-en-18-al	2410-60-8				
18(R)-hydroxyeicosapentaenoic acid		18(R)-hydroxyeicosapentaenoic acid					
18alpha-glycyrrhetinic acid	1449-05-4	18alpha-Glycyrrhetinic acid	1449-05-4	X6NYL2CP2E			
18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate		18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate					
19-epi-okadaic acid		19-epi-okadaic acid					
19-hydroxy-1alpha,6-diacetoxy-6,7-seco-ent-kaur-16-en-15-one-7,20-olide		19-hydroxy-1alpha,6-diacetoxy-6,7-seco-ent-kaur-16-en-15-one-7,20-olide					
19-hydroxy-5,8,11,14-eicosatetraenoic acid	79551-85-2	19-Hydroxy-5,8,11,14-eicosatetraenoic acid	79551-85-2				
19-oxo-11-deoxycorticosterone acetate	88378-35-2	19-Oxo-11-deoxycorticosterone acetate	88378-35-2				
19,20-dihydroxydocosapentaenoic acid		19,20-DiHDPA					
1alpha,20-dihydroxyvitamin D3		1alpha,20-dihydroxyvitamin D3					
1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one		1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one					
1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one		1h-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one	41443-28-1	S57V2NMV38	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
1H-3-benzazepin-7-ol, 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-		8-Bromo-3-methyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ol	99295-33-7	D203LR7XUS	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	
1H-benzotriazole-5-carboxylic acid	23814-12-2	1H-Benzotriazole-5-carboxylic acid	60932-58-3				
1H-Indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1S,2R,3S)-		1H-Indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2-(carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1S,2R,3S)-	157659-79-5	0I32BCL40Z			
1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate		1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate					
1NMPP1 compound		1NMPP1 compound					
2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide	92891-93-5	Propanamide, 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-	92891-93-5		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
2-(((3-(morpholinylmethyl)-2H-chromen-8-yl)oxy)methyl)morpholine		2-(((3-(morpholinylmethyl)-2H-chromen-8-yl)oxy)methyl)morpholine					
2-(((3,5-dichlorophenyl)carbamoyl)oxy)-2-methyl-3-butenoic acid	119209-27-7	2-(((3,5-Dichlorophenyl)carbamoyl)oxy)-2-methyl-3-butenoic acid	119209-27-7				
2-((2-(dimethylamino)ethyl)thio)-3-phenylquinoline	85273-95-6	2-((2-(Dimethylamino)ethyl)thio)-3-phenylquinoline	85273-95-6	4CT4CS5BA7	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one		2-((2-piperidin-1-ylethyl)thio)quinazolin-4(3H)-one	684276-17-3	AH677T32NW	Poly(ADP-ribose) Polymerase Inhibitors	Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. (See all compounds classified as Poly(ADP-ribose) Polymerase Inhibitors.)	
2-((2,4-dichlorphenyl)amino)-N-((tetrahydro-2H-pyran-4-yl)methyl)-4-(trifluoromethyl)-5-pyrimidinecarboxamide		2-((2,4-dichlorphenyl)amino)-N-((tetrahydro-2H-pyran-4-yl)methyl)-4-(trifluoromethyl)-5-pyrimidinecarboxamide					
2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester		S-diclofenac	912758-00-0				
2-((2'-quinolinyl)-1,3-indandione)	8003-22-3	Quinoline Yellow	8003-22-3	44F3HYL954			
2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid		2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid					
2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate		2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate					
2-((3-acrylamido-4-methylphenyl)amino)-N-(2-methyl-5-(3,4,5-trimethoxybenzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide		Chmfl-bmx-078			Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
2-((4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy)methyl)quinoline		2-((4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy)methyl)quinoline					
2-((6-chloro-1,1,2,2,3,3,4,4,5,5,6,6-dodecafluorohexyl)oxy)-1,1,2,2-tetrafluoroethanesulfonic acid		2-((6-chloro-1,1,2,2,3,3,4,4,5,5,6,6-dodecafluorohexyl)oxy)-1,1,2,2-tetrafluoroethanesulfonic acid					
2-((7-nitrobenzo(c)(1,2,5)oxadiazol-4-yl)thio)pyridine 1-oxide		2-((7-nitrobenzo(c)(1,2,5)oxadiazol-4-yl)thio)pyridine 1-oxide					
2-((8-chlorodibenzo(b,f)thiepin-10-yl)oxy)-N-methylethan-1-amine		2-((8-chlorodibenzo(b,f)thiepin-10-yl)oxy)-N-methylethan-1-amine					
2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide		5-(4-Fluorophenyl)-2-ureidothiophene-3-carboxamide	507475-17-4	9M632G86CC	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
2-((dimethylamino)methyl)-9-hydroxythieno(2,3-c)isoquinolin-5(4H)-one		2-((dimethylamino)methyl)-9-hydroxythieno(2,3-c)isoquinolin-5(4H)-one					
2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide		3-[1-[3-(Dimethylamino)propyl]-5-methoxy-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione	133053-19-7		Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
2-(1-(4-piperonyl)piperazinyl)benzothiazole	155106-73-3	2-[1-(4-Piperonyl)piperazinyl]benzothiazole	155106-73-3				
2-(1-adamantyl)-4-methylphenol		2-(1-Adamantyl)-4-methylphenol	41031-50-9				
2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid		(S,S)-2-{1-Carboxy-2-[3-(3,5-dichloro-benzyl)-3H-imidazol-4-YL]-ethylamino}-4-methyl-pentanoic acid	305335-31-3	4LD0ZHV25K			
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a	149402-51-7	2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a	149402-51-7	DOB7Y3RSX0			
2-(1-hydroxy-4-oxocyclohexa-2,5-dienyl)pyran-4-one		2-(1-hydroxy-4-oxocyclohexa-2,5-dienyl)pyran-4-one					
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide		2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide					
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide		2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide	349085-38-7	MU78VFH9C7			
2-(1'-methyl-2'-pyrrolidinyl)-7-hydroxy-1,4-benzodioxane		2-(1'-methyl-2'-pyrrolidinyl)-7-hydroxy-1,4-benzodioxane					
2-(1',2',3',4'-tetrahydroxybutyl)thiazolidine-4-carboxylic acid	17087-36-4	2-(1,2,3,4-Tetrahydroxybutyl)thiazolidine-4-carboxylic acid	17087-36-4				
2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester		2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester					
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine		2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine					
2-(2-((13-amino-2-(4-hydroxybenzyl)-3,14-dioxo-1,4-diazacyclotetradec-7-ene-5-carboxamido)methyl)phenyl)acetic acid		2-(2-((13-amino-2-(4-hydroxybenzyl)-3,14-dioxo-1,4-diazacyclotetradec-7-ene-5-carboxamido)methyl)phenyl)acetic acid					
2-(2-((1H-indole-2-carbonyl)amino)benzoylamino)-4-phenylbutyric acid		2-(2-((1H-indole-2-carbonyl)amino)benzoylamino)-4-phenylbutyric acid					
2-(2-((3-(4-chlorophenyl)-1-methyl-1H-pyrazol-5-yloxy)methyl)phenyl)-3-methoxyacrylate		Pyraoxystrobin	862588-11-2	SZ7U7R7ZC8			
2-(2-(2-dimethylaminothiazol-5-yl)ethenyl)-6-(2-(fluoro)ethoxy)benzoxazole		2-(2-(2-Dimethylaminothiazol-5-yl)ethenyl)-6-(2-(fluoro)ethoxy)benzoxazole	845647-80-5				
2-(2-(3,4-dichlorophenyl)-2,3-dihydro-1H-isoindol-5-ylamino)nicotinic acid		2-(2-(3,4-dichlorophenyl)-2,3-dihydro-1H-isoindol-5-ylamino)nicotinic acid					
2-(2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-(3-methyl-4-oxo-4,5-dihydro-3H-benzo(d)(1,2)diazepin-5-yl)propanamide		Benzeneacetamide, N-((1S)-2-(((5S)-4,5-dihydro-3-methyl-4-oxo-3H-2,3-benzodiazepin-5-yl)amino)-1-methyl-2-oxoethyl)-3,5-difluoro-alpha-hydroxy-, (alphaS)-	935525-13-6	R1E8M783K2	Gamma Secretase Inhibitors and Modulators	Agents that suppress GAMMA-SECRETASE by inhibiting or modulating its activities. Targeted enzymatic activities include its involvement in accumulation of toxic AMYLOID BETA-PEPTIDES (e.g., A&#x3B2;42) in ALZHEIMER DISEASE and activation of NOTCH RECEPTOR mediated SIGNAL PATHWAYS in certain cancer types. (See all compounds classified as Gamma Secretase Inhibitors and Modulators.)	
2-(2-(3,5-difluorophenyl)-acetylamino)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo(e)(1,4)diazepin-3-yl)propionamide		2-(2-(3,5-difluorophenyl)-acetylamino)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo(e)(1,4)diazepin-3-yl)propionamide					
2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate		2-[2-[4-(4-Nitrobenzyloxy)phenyl]ethyl]isothiourea mesylate	182004-65-5		Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
2-(2-(4-chlorophenyl)ethoxy)adenosine		Sonedenoson	131865-88-8	2OT4KAG5JL			
2-(2-(4-heptylphenyl)ethyl)-6-hydroxy-benzoic acid		2-(2-(4-heptylphenyl)ethyl)-6-hydroxy-benzoic acid					
2-(2-(4-phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid		2-(2-(4-Phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid	209808-51-5				
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one		2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	167869-21-8	SJE1IO5E3I	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
2-(2-aminoethyl)pyridine	2706-56-1	2-(2-Aminoethyl)pyridine	2706-56-1	ATW1AH7OJ5	Histamine Agonists	Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. (See all compounds classified as Histamine Agonists.)	
2-(2-aminoethyl)thiazole	18453-07-1	2-(2-Aminoethyl)thiazole	18453-07-1		Histamine Agonists	Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. (See all compounds classified as Histamine Agonists.)	
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide		2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide	212631-67-9				
2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide		2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide	212631-79-3	R3K9Y00J04			
2-(2-chlorophenyl)-4-methyl-5-(pyridin-2-ylmethyl)-1H-pyrazolo(4,3-c)pyridine-3,6(2H,5H)-dione		2-(2-chlorophenyl)-4-methyl-5-(pyridin-2-ylmethyl)-1H-pyrazolo(4,3-c)pyridine-3,6(2H,5H)-dione					
2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide	1222-87-3	4H-1,3,2-Benzodioxaphosphorin, 2-(2-methylphenoxy)-, 2-oxide	1222-87-3				
2-(2-fluorobenzamido)benzoate ethyl ester		2-(2-fluorobenzamido)benzoate ethyl ester					
2-(2-furanyl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)-1-piperazinyl)ethyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidine-5-amine		2-(2-furanyl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)-1-piperazinyl)ethyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidine-5-amine					
2-(2-hydroxybiphenyl-3-yl)-1H-indole-5-carboxamidine		2-(2-hydroxybiphenyl-3-yl)-1H-indole-5-carboxamidine					
2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone		2-((2-Hydroxyethyl)thio)-3-methylnaphthalene-1,4-dione	59147-84-1				
2-(2-imidazolin-2-yl)-1-phenyl-1H-indole		2-(2-imidazolin-2-yl)-1-phenyl-1H-indole	142872-83-1				
2-(2-oxo-2-((3,7,11-trimethyl-2,6,10-dodecatrienyl)oxy)aminoethyl)phosphonic acid, (2,2-dimethyl-1-oxopropoxy)methyl ester sodium		2-(2-oxo-2-((3,7,11-trimethyl-2,6,10-dodecatrienyl)oxy)aminoethyl)phosphonic acid, (2,2-dimethyl-1-oxopropoxy)methyl ester sodium					
2-(2,3-dicarboxycyclopropyl)glycine	147782-19-2	Dcg-IV	147782-19-2		Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)-2,6-dihydropyrrolo(3,4-c)pyrazol-5(4H)-yl)tetrahydro-2H-pyran-3-amine		2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)-2,6-dihydropyrrolo(3,4-c)pyrazol-5(4H)-yl)tetrahydro-2H-pyran-3-amine					
2-(2,6-diisopropylphenyl)-5-hydroxy-1H-isoindole-1,3-dione		2-(2,6-Diisopropylphenyl)-5-hydroxyisoindoline-1,3-dione	105624-86-0	5SZ69PBV5B			
2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid		2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid					
2-(2,6-dimethylmorpholin-4-yl)-N-(5-(6-morpholin-4-yl-4-oxo-4H-pyran-2-yl)-9H-thioxanthen-2-yl)acetamide		2-(2,6-dimethylmorpholin-4-yl)-N-(5-(6-morpholin-4-yl-4-oxo-4H-pyran-2-yl)-9H-thioxanthen-2-yl)acetamide					
2-(2,6-dioxopiperidin-3-yl)phthalimidine	26581-81-7	3-(1,3-Dihydro-1-oxo-2h-isoindol-2-yl)-2,6-piperidinedione	26581-81-7				
2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole	3846-71-7	2-(2H-Benzo[d][1,2,3]triazol-2-yl)-4,6-di-tert-butylphenol	3846-71-7	US7KL87A2P			
2-(2'-thienyl)-5-(4''-(2''-aminopyrimidyl)thiophene		2-(2'-thienyl)-5-(4''-(2''-aminopyrimidyl)thiophene					
2-(2',4'-dibromophenoxy)-3,5-dibromoanisole		2-(2',4'-dibromophenoxy)-3,5-dibromoanisole					
2-(3-((4-aminobutyl )amino)propyl )-7-(3-((2-methoxybenzyl)amino)propyl)benzo(lmn)(3,8)phenanthroline-1,3,6,8(2H,7H)-tetraone		2-(3-((4-aminobutyl )amino)propyl )-7-(3-((2-methoxybenzyl)amino)propyl)benzo(lmn)(3,8)phenanthroline-1,3,6,8(2H,7H)-tetraone					
2-(3-(1,3-dicarboxypropyl)ureido)pentanedioic acid		2-[3-(1,3-Dicarboxypropyl)ureido]pentanedioic acid					
2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone		2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone					
2-(3-bromo-2-hydroxy-5-methylphenyl)-1H-indole-5-carboxamidine		2-(3-bromo-2-hydroxy-5-methylphenyl)-1H-indole-5-carboxamidine					
2-(3-chloro-4-hydroxyphenyl)-2-(4-hydroxyphenyl)propane		2-(3-chloro-4-hydroxyphenyl)-2-(4-hydroxyphenyl)propane					
2-(3-cyano-5-(3,4-dichlorophenyl)-4,5-dimethylfuran-2(5H)-ylidene)malononitrile		2-(3-cyano-5-(3,4-dichlorophenyl)-4,5-dimethylfuran-2(5H)-ylidene)malononitrile					
2-(3-estrone-N-ethyl-piperazine-methyl)tetracycline		2-(3-estrone-N-ethyl-piperazine-methyl)tetracycline					
2-(3-mercaptopropyl)pentanedioic acid		2-(3-Mercaptopropyl)pentanedioic acid	254737-29-6	TV8F3S5KLG			
2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone		Methoxetamine	1239943-76-0	ZO5ZCE6E12	Anesthetics, Dissociative	Intravenous anesthetics that induce a state of sedation, immobility, amnesia, and marked analgesia. Subjects may experience a strong feeling of dissociation from the environment. The condition produced is similar to NEUROLEPTANALGESIA, but is brought about by the administration of a single drug. (From Gilman et al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) (See all compounds classified as Anesthetics, Dissociative.)	
2-(3-pyridinyl)-1-hydroxyethylidene-1,1-phosphonocarboxylic acid		2-(3-pyridinyl)-1-hydroxyethylidene-1,1-phosphonocarboxylic acid					
2-(3-trifluoromethylphenyl)histamine		2-(3-Trifluoromethylphenyl)histamine					
2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one		2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one					
2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole		Benzothiazole, 2-(3,4-dimethoxyphenyl)-5-fluoro-	872726-44-8	X3XWA9LQ3Q			
2-(3'-methoxyphenyl)-6-pyrrolidinyl-4-quinazolinone		2-(3'-methoxyphenyl)-6-pyrrolidinyl-4-quinazolinone					
2-(4-((4-(6-methoxy-3-pyridinyl)-5-(4-(trifluoromethoxy)phenyl)-2-thiazolyl)methoxy)-2-methylphenoxy)acetic acid		2-(4-((4-(6-methoxy-3-pyridinyl)-5-(4-(trifluoromethoxy)phenyl)-2-thiazolyl)methoxy)-2-methylphenoxy)acetic acid					
2-(4-((dimethylamino)carbonyl)-3-fluorophenyl)-alpha,alpha-dimethyl-N-1,3,4-thiadiazol-2-yl-5H-(1)benzopyrano(2,3-b)pyridin-5-acetamide		2-(4-((dimethylamino)carbonyl)-3-fluorophenyl)-alpha,alpha-dimethyl-N-1,3,4-thiadiazol-2-yl-5H-(1)benzopyrano(2,3-b)pyridin-5-acetamide					
2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one		2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one					
2-(4-(1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl)-3-(pyridin-4-yl)-1H-pyrazol-1-yl)ethan-1-ol		GDC-0879 Hydrochloride	905281-76-7				
2-(4-(2-(((1,2)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)phenoxy)-2-methylpropionic acid		2-(4-(2-(((1,2)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)phenoxy)-2-methylpropionic acid					
2-(4-(2-(3,4-dichlorophenyl)ethyl)phenylamino)benzoic acid		2-(4-(2-(3,4-dichlorophenyl)ethyl)phenylamino)benzoic acid					
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine	120225-54-9	2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine	120225-54-9	T5HB1E831H	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
2-(4-(3-(1-(4-(2-aminopyrimidin-5-yl)phenyl)-1-cyclopropylethyl)-(1,2,4)oxadiazol-5-yl)pyrazol-1-yl)-N,N-dimethylacetamide		2-(4-(3-(1-(4-(2-aminopyrimidin-5-yl)phenyl)-1-cyclopropylethyl)-(1,2,4)oxadiazol-5-yl)pyrazol-1-yl)-N,N-dimethylacetamide					
2-(4-(3-quinolin-6-ylmethyl-3H-(1,2,3)triazolo(4,5-b)pyrazin-5-yl)pyrazol-1-yl)ethanol		2-(4-(3-quinolin-6-ylmethyl-3H-(1,2,3)triazolo(4,5-b)pyrazin-5-yl)pyrazol-1-yl)ethanol					
2-(4-(4-chlorophenyl)piperazin-1-ylmethyl)pyrazolo(1,5-a)-pyridine		2-(4-(4-chlorophenyl)piperazin-1-ylmethyl)pyrazolo(1,5-a)-pyridine					
2-(4-(4-hydroxy-3-isopropyl-5-((4-nitrophenyl)ethynyl)benzyl)-3,5-dimethylphenoxy)acetic acid		Acetic acid, (4-((4-hydroxy-3-(1-methylethyl)-5-((4-nitrophenyl)ethynyl)phenyl)methyl)-3,5-dimethylphenoxy)-	447415-26-1	54KY638G8W			
2-(4-(5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl amino)ethanol		2-(4-(5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl amino)ethanol					
2-(4-(6-chloro-1,3-benzoxazol-2-yloxy)phenoxy)-2'-fluoro-N-methylpropionanilide		Metamifop [ISO]					
2-(4-(biphenyl-4-sulfonyl)-piperazin-1-yl)-6,7-dipropoxyquinazolin-4-yl-amine		2-(4-(biphenyl-4-sulfonyl)-piperazin-1-yl)-6,7-dipropoxyquinazolin-4-yl-amine					
2-(4-(nitrophenyl)butan-2-ylamino)-1-(4-methoxyphenyl)ethanol		2-(4-(nitrophenyl)butan-2-ylamino)-1-(4-methoxyphenyl)ethanol					
2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid	128253-31-6	Veliflapon	128253-31-6	JXH6X663L0	Lipoxygenase Inhibitors	Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)	
2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine		2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine					
2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole		4-(5-Fluoro-1,3-benzothiazol-2-yl)-2-methylaniline	260443-89-8	3J3GHW53E4			
2-(4-aminophenyl)-1,3,2-dithiarsinane		2-(4-Aminophenyl)-1,3,2-dithiarsinane					
2-(4-amylcinnamoyl)amino-4-chlorobenzoic acid	99754-06-0	2-(4-Amylcinnamoyl)amino-4-chlorobenzoic acid	99754-06-0				
2-(4-benzylpiperidin-1-yl)-1-(6-hydroxy-1H-indol-3-yl)ethanone		2-(4-benzylpiperidin-1-yl)-1-(6-hydroxy-1H-indol-3-yl)ethanone					
2-(4-bromo-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine		25B-NBOMe	1026511-90-9	S6NAA81PHK			
2-(4-bromo-2,5-dimethoxyphenyl)ethylamine		4-Bromo-2,5-dimethoxyphenethylamine	66142-81-2	V77772N32H	Adrenergic alpha-1 Receptor Agonists	Compounds that bind to and activate ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Agonists.)	
2-(4-chloro-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine		N-(2-methoxybenzyl)-2-(4-chloro-2,5-dimethoxyphenyl)ethanamine	1227608-02-7	9FGW3C260N			
2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid		2-({4-Chloro-6-[(2,3-dimethylphenyl)amino]pyrimidin-2-yl}sulfanyl)octanoic acid	916482-17-2				
2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide		2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide					
2-(4-chlorophenoxy)propionic acid	3307-39-9	2-(4-Chlorophenoxy)propionic acid	3307-39-9				
2-(4-chlorophenyl)-5-(4-methoxybenzylidene)-5H-thiazol-4-one		2-(4-chlorophenyl)-5-(4-methoxybenzylidene)-5H-thiazol-4-one					
2-(4-fluorophenylsulfonyl)-3-(1-(3-nitrophenylsulfonyl)-1H-pyrrol-2-yl)acrylonitrile		2-(4-fluorophenylsulfonyl)-3-(1-(3-nitrophenylsulfonyl)-1H-pyrrol-2-yl)acrylonitrile					
2-(4-hydroxy-3,5-dimethylphenyl)-5-methoxy-3-methylindole	104007-80-9	2-(4-Hydroxy-3,5-dimethylphenyl)-5-methoxy-3-methylindole	104007-80-9	GH878F6QQL			
2-(4-hydroxyphenyl)-3-methyl-1-(4-(2-piperidin-1-yl-ethoxy)-benzyl)-1H-indol-5-ol		Pipendoxifene	198480-55-6	TPC5Q8496G			Investigated for use/treatment in breast cancer.
2-(4-hydroxyphenyl)-3-phenylpent-2-enoic acid (4-(2-dimethylaminoethoxy)phenyl)amide		2-(4-hydroxyphenyl)-3-phenylpent-2-enoic acid (4-(2-dimethylaminoethoxy)phenyl)amide					
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine		25I-NBOMe	919797-19-6	547KGL06IP			
2-(4-isobutylphenyl)propionic acid 4-(diethoxyphosphoryloxy)butyl ester		2-(4-isobutylphenyl)propionic acid 4-(diethoxyphosphoryloxy)butyl ester					
2-(4-methoxyphenyl)-1-(1-pentyl-indol-3-yl)methanone		2-(4-methoxyphenyl)-1-(1-pentyl-indol-3-yl)methanone					
2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside		2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside					
2-(4-morpholino)ethyl-1-phenylcyclohexane-1-carboxylate	138847-85-5	2-(4-Morpholino)ethyl-1-phenylcyclohexane-1-carboxylate	138847-85-5	74BW8WG2MQ			
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	154447-36-6	2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	154447-36-6	31M2U1DVID	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole		4-(4-Fluorophenyl)-2-(4-nitrophenyl)-5-(4-pyridyl)-1H-imidazole	152121-53-4	GX3Y2V80CV	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
2-(4-toluidino)-6-naphthalenesulfonic acid	7724-15-4	2-Naphthalenesulfonic acid, 6-[(4-methylphenyl)amino]-	7724-15-4	95ZZA2FN7X	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
2-(4,5-dihydro-1,3-thiazol-2-ylthio)-1-(3,4-dihydroxyphenyl)ethanone		2-(4,5-dihydro-1,3-thiazol-2-ylthio)-1-(3,4-dihydroxyphenyl)ethanone					
2-(4'-chlorophenyl)benzothiazole	6265-91-4	2-(4-Chlorophenyl)benzothiazole	6265-91-4				
2-(4'-maleimidylanilino)naphthalene-6-sulfonic acid	71936-81-7	Mians	71936-81-7				
2-(4'-methoxybenzenesulfonyl)-2,3,4,9-tetrahydro-1H-pyrido(3,4-b)indole-3-carboxylic acid amide		2-(4'-methoxybenzenesulfonyl)-2,3,4,9-tetrahydro-1H-pyrido(3,4-b)indole-3-carboxylic acid amide					
2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid		2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid					
2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride		2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride					
2-(6-((3-(4-(diphenylmethoxy)piperidino)propyl)amino)imidazo(1,2-b)pyridazin-2-yl)-2-methylpropionic acid		Bamirastine	215529-47-8	SIG10953FN			
2-(6-((3,4-dihydro-2H-chromen-2-ylmethyl)amino)hexyl)tetrahydro-1H-pyrrolo(1,2-c)imidazole-1,3(2H)-dione		2-(6-((3,4-dihydro-2H-chromen-2-ylmethyl)amino)hexyl)tetrahydro-1H-pyrrolo(1,2-c)imidazole-1,3(2H)-dione					
2-(7-(3,4-dimethoxyphenyl)imidazo(1,2-c)pyrimidin-5-ylamino)nicotinamide		2-(7-(3,4-dimethoxyphenyl)imidazo(1,2-c)pyrimidin-5-ylamino)nicotinamide					
2-(8-quinolinoxy)propionic acid		2-(8-quinolinoxy)propionic acid					
2-(acetoxyamino)-1-methyl-6-phenylimidazo(4,5-b)pyridine		N-Acetoxy-phip	142784-27-8	B7449XS5RK			
2-(acetyloxy)benzoic acid 6-(nitrooxymethyl)-2-phenylmethyl ester		2-(acetyloxy)benzoic acid 6-(nitrooxymethyl)-2-phenylmethyl ester					
2-(allylthio)pyrazine		2-(Allylthio)pyrazine	164352-89-0	UXC2RYG7XE	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
2-(benzylaminocarbonyl)-3-(3,4-dihydroxystyryl)acrylonitrile		2,4-Pentadienamide, 2-cyano-5-(3,4-dihydroxyphenyl)-N-(phenylmethyl)-, (2E,4E)-	368836-72-0	T669M1395I			
2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone	95034-25-6	2-(beta-(3-Iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone	95034-25-6	3EGK3ZND2L	Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	
2-(bromoacetylamino)fluorene	41098-69-5	N-bromo-N-(9H-fluoren-2-yl)acetamide	41098-69-5				
2-(hydroxyimino)-N,N-dimethyl-N'-propylacetimidamide		2-(hydroxyimino)-N,N-dimethyl-N'-propylacetimidamide					
2-(methylamino)isobutyric acid	2566-34-9	2-(Methylamino)isobutyric acid	2566-34-9	26F96C8MBJ			
2-(morpholin-4-yl)benzo(h)chromen-4-one		2-(Morpholin-4-yl)-benzo[h]chromen-4-one	154447-35-5	DJ7RQT66H6			
2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose		2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose					
2-(N-ethylperfluorooctanesulfonamido)ethyl alcohol		2-(N-ethylperfluorooctanesulfonamido)ethyl alcohol					
2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin	87857-27-0	2-(N-Propyl-N-phenethylamino)-5-hydroxytetralin	87857-27-0		Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
2-(oxalylamino)benzoic acid		2-(Oxalylamino)benzoic acid					
2-(phosphonomethyl)pentanedioic acid		2-(Phosphonomethyl)pentanedioic acid	173039-10-6	XH88WJG9LJ			
2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl)thiophene		2-(pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl)thiophene					
2-(S-glutathionyl)hydroquinone	76726-99-3	2-(S-Glutathionyl)hydroquinone	76726-99-3				
2-(sec-butyl)-4,5-dihydrothiazole	56367-27-2	2-(sec-Butyl)-4,5-dihydrothiazole	56367-27-2	LE756QG3F5			
2-(thiocyanomethylthio)benzothiazole	21564-17-0	2-(Thiocyanomethylthio)benzothiazole	21564-17-0	5GE166YVQV			
2-4-(3-(1H-1,2,3,4-tetraazol-5-yl)propoxy)phenethyl-1,3-isoindolinedione		2-4-(3-(1H-1,2,3,4-tetraazol-5-yl)propoxy)phenethyl-1,3-isoindolinedione					
2-acetamidoethanethiol	1190-73-4	N-Acetylcysteamine	1190-73-4	NSH3F3JX85			
2-acetoxy-5-(2-4-(trifluoromethyl)phenethylamino)benzoic acid		2-acetoxy-5-(2-4-(trifluoromethyl)phenethylamino)benzoic acid					
2-acetylamino-3-(4-(2-acetylamino-2-carboxyethylsulfanylthiocarbonylamino)phenylthiocarbamoylsulfanyl)propionic acid		2-acetylamino-3-(4-(2-acetylamino-2-carboxyethylsulfanylthiocarbonylamino)phenylthiocarbamoylsulfanyl)propionic acid					
2-Acetylaminofluorene	53-96-3	2-Acetylaminofluorene	53-96-3	9M98QLJ2DL	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
2-acetylbenzothiophene-S-oxide		2-acetylbenzothiophene-S-oxide					
2-acetylphenothiazine		1-(10H-Phenothiazin-2-yl)ethanone	6631-94-3	8DEE7H3XAB			
2-acetyltributylcitrate	77-90-7	Acetyl tributyl citrate	77-90-7	0ZBX0N59RZ			
2-allylphenol	1745-81-9	2-Allylphenol	1745-81-9	O04F145ZJZ			
2-amino-(1,6-dimethylfuro(3,2-e)imidazo(4,5-b))pyridine		1,6-Dimethyl-1H-furo[3,2-b]imidazo[4,5-e]pyridin-2-amine	357383-27-8	SVZ5X27Q2P			
2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine	126861-72-1	4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol	126861-72-1	YL9NJ9QS6V			
2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct		2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct					
2-amino-1-methyl-6-phenyl-1H-imidazo(4,5-b)pyridine		2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	105650-23-5	909C6UN66T	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	105650-23-5	2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	105650-23-5	909C6UN66T	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
2-amino-1-phenylethanol		2-Amino-1-phenylethanol	7568-93-6	2P4Y56479O			
2-amino-1,3',3'-trimethyl-7'-(pyrimidin-5-yl)-3',4'-dihydro-2'H-spiro(imidazole-4,1'-naphthalen)-5(1H)-one		2-amino-1,3',3'-trimethyl-7'-(pyrimidin-5-yl)-3',4'-dihydro-2'H-spiro(imidazole-4,1'-naphthalen)-5(1H)-one					
2-amino-1,7-dimethylimidazo(4,5-g)quinoxaline		2-amino-1,7-dimethylimidazo(4,5-g)quinoxaline					
2-amino-14,16-dimethyloctadecan-3-ol		2-Amino-14,16-dimethyloctadecan-3-ol	540770-33-0	C7267YCJ7Y			
2-amino-2-methyl-1-propanol	124-68-5	2-Amino-2-methyl-1-propanol	124-68-5	LU49E6626Q			
2-amino-3-(2-amino-2-carboxyethylsulfanyl-mercuricsulfanyl)-propionic acid		2-amino-3-(2-amino-2-carboxyethylsulfanyl-mercuricsulfanyl)-propionic acid					
2-amino-3-(3-hydrox-5(2-methyl-2H-tetrazol-5-yl)isoxazol-4-yl)propionic acid		2-amino-3-(3-hydrox-5(2-methyl-2H-tetrazol-5-yl)isoxazol-4-yl)propionic acid					
2-amino-3-(4-((5-amino-2-phenylbenzo(d)oxazol-7-yl)methoxy)-3,5-dichlorophenyl)propanoic acid		2-amino-3-(4-((5-amino-2-phenylbenzo(d)oxazol-7-yl)methoxy)-3,5-dichlorophenyl)propanoic acid					
2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid		2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid					
2-amino-3-(4'-N,N-bis(2-chloroethyl)amino)phenylpropionic acid N-oxide		PX-478 2HCl	685898-44-6	T23U22X160			Investigated for use/treatment in cancer/tumors (unspecified).
2-amino-3-(5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl)propionic acid		2-Amino-3-(5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl)propionic acid					
2-amino-3-chloro-1,4-naphthoquinone		2-Amino-3-chloro-1,4-naphthoquinone	2797-51-5	JN6NK7K14F			
2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate		Q2RA5BK4A7	745020-66-0	Q2RA5BK4A7			
2-amino-3-hydroxypyridine		2-Amino-3-hydroxypyridine	16867-03-1	P8740PEW4B			
2-amino-3-methyl-3H-imidazo(4,5-f)quinoline		2-Amino-3-methylimidazo(4,5-f)quinoline	76180-96-6	30GL3D3T0G			
2-amino-3-methyl-9H-pyrido(2,3-b)indole	68006-83-7	2-Amino-3-methyl-9H-pyrido[2,3-b]indole	68006-83-7	20AI638WCJ			
2-amino-3-methylimidazo(4,5-f)quinoline	76180-96-6	2-Amino-3-methylimidazo(4,5-f)quinoline	76180-96-6	30GL3D3T0G			
2-amino-3-methylimidazo(4,5-f)quinoxaline		2-amino-3-methylimidazo(4,5-f)quinoxaline					
2-amino-3,4-dimethylimidazo(4,5-f)quinoline	77094-11-2	2-Amino-3,4-dimethylimidazo(4,5-f)quinoline	77094-11-2	G2Q7M1P33X	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
2-amino-3,7,8-trimethylimidazo(4,5-f)quinoxaline	92180-79-5	7-Methyl meiqx	92180-79-5	691747VC8D			
2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline	77500-04-0	Meiqx	77500-04-0	5GYH6416ZG	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
2-amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)pyrimidine		N4-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)pyrimidine-2,4-diamine	853220-52-7				
2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile		2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile	1118460-77-7				
2-amino-4-chlorophenol	95-85-2	2-Amino-4-chlorophenol	95-85-2	2Z43LEA3DX			
2-amino-4-hydroxy-6-formylpteridine	712-30-1	6-Formylpterin	712-30-1				
2-amino-4-hydroxymethyl-3,8-dimethylimidazo(4,5-f)quinoxaline	153954-29-1	2-Amino-4-hydroxymethyl-3,8-dimethylimidazo(4,5-f)quinoxaline	153954-29-1				
2-amino-4-methylphenol	95-84-1	2-Amino-4-methylphenol	95-84-1	9ZV2574SER			
2-amino-4-methylthio-3-butenoic acid	143800-82-2	2-Amino-4-methylthio-3-butenoic acid	143800-82-2				
2-amino-4-phenyl-8-pyrrolidin-1-ylmethylindeno(1,2-d)pyrimidin-5-one		2-amino-4-phenyl-8-pyrrolidin-1-ylmethylindeno(1,2-d)pyrimidin-5-one					
2-amino-4-phenylbutyric acid	7636-28-4	L-Homophenylalanine	943-73-7	8JYL44CC06			
2-amino-4-phosphonobutyric acid	6323-99-5	2-Amino-4-phosphonobutyric acid	6323-99-5	H8B59H10OK	Excitatory Amino Acid Agonists	Drugs that bind to and activate excitatory amino acid receptors. (See all compounds classified as Excitatory Amino Acid Agonists.)	
2-amino-4-picoline	695-34-1	2-Amino-4-methylpyridine	695-34-1	394N1Z644H			
2-amino-4,6-dinitrotoluene	35572-78-2	2-Amino-4,6-dinitrotoluene	35572-78-2	189OOM840S			
2-amino-5-nitrophenol	121-88-0	2-Amino-5-nitrophenol	121-88-0	0149H05U82			
2-Amino-5-phosphonovalerate	76726-92-6	2-Amino-5-phosphonopentanoic acid	76326-31-3	39PJ29YY8Z			
2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine		6-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine	1121-91-1				
2-amino-6-(2-(cyclopropylmethoxy)-6-hydroxyphenyl)-4-piperidin-4-yl nicotinonitrile		2-amino-6-(2-(cyclopropylmethoxy)-6-hydroxyphenyl)-4-piperidin-4-yl nicotinonitrile					
2-amino-6-borono-2-(difluoromethyl)hexanoic acid		2-Amino-6-borono-2-(difluoromethyl)hexanoic acid					
2-amino-6-borono-2-methylhexanoic acid		2-Amino-6-borono-2-methylhexanoic acid					
2-amino-6-boronohexanoic acid		2-Amino-6-boronohexanoic acid					
2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole	67730-11-4	2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole	67730-11-4	RXM718XV6O	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
2-amino-7-(4-fluoro-2-(6-methoxypyridin-2-yl)phenyl)-4-methyl-7,8-dihydropyrido(4,3-d)pyrimidin-5(6H)-one		2-amino-7-(4-fluoro-2-(6-methoxypyridin-2-yl)phenyl)-4-methyl-7,8-dihydropyrido(4,3-d)pyrimidin-5(6H)-one					
2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one		2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one					
2-amino-9H-pyrido(2,3-b)indole	26148-68-5	2-Amino-9H-pyrido[2,3-b]indole	26148-68-5	P0GZ1ICS6X			
2-aminoacetophenone	551-93-9	2'-Aminoacetophenone	551-93-9	69Y77091BC			
2-aminoadamantane	13074-39-0	2-Aminoadamantane	13074-39-0				
2-Aminoadipic Acid	542-32-5	2-Aminohexanedioic acid	542-32-5	1K7B1OED4N	Excitatory Amino Acid Antagonists	Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)	
2-aminoanthraquinone	117-79-3	2-Aminoanthraquinone	117-79-3	65Z03V2Z09			
2-aminobenzimidazole	934-32-7	2-Aminobenzimidazole	934-32-7	E65DE7521V			
2-aminodiphenyl	90-41-5	2-Aminobiphenyl	90-41-5	8LQM58EBRY			
2-aminoethoxydiphenyl borate		2-Aminoethyl diphenylborinate	524-95-8	E4ES684O93			
2-aminoethoxydiphenylborane		2-Aminoethyl diphenylborinate	524-95-8	E4ES684O93			
2-aminoethyl diphenylborinate		2-Aminoethyl diphenylborinate	524-95-8	E4ES684O93			
2-aminofluorene	153-78-6	2-Aminofluorene	153-78-6	3A69OS195N	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
2-aminoindan	2975-41-9	2-Aminoindan	2975-41-9	1P810SQ3EY			
2-aminomethyl-2-tricyclo(3.3.1.1(1,7))decaneacetic acid hydrochloride		2-aminomethyl-2-tricyclo(3.3.1.1(1,7))decaneacetic acid hydrochloride					
2-aminophenol	95-55-6	2-Aminophenol	95-55-6	23RH73DZ65			
2-Aminopurine	452-06-2	2-Aminopurine	452-06-2	O14B3U97FW	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	
2-aminopyrimidine	109-12-6	2-Aminopyrimidine	109-12-6	OB8I17P2G4			
2-aminothiazole-methoxyimino acetic acid	65872-41-5	2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetic acid	65872-41-5	31Y5PR0Y6R			
2-aminothiophenol	137-07-5	2-Aminothiophenol	137-07-5	KIT82KOK2Z			
2-anisidine	90-04-0	O-Anisidine	90-04-0	NUX042F201			
2-anthramine	613-13-8	2-Aminoanthracene	613-13-8	8240818JGU	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
2-azido-3-iodo-7,8-dibromodibenzo-1,4-dioxin	106463-72-3	2-Azido-3-iodo-7,8-dibromodibenzo-1,4-dioxin	106463-72-3				
2-aziridin-1-yl-3-((2-((2-(3-aziridin-1-yl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio)ethoxy)ethyl)thio)naphthoquinone		2-aziridin-1-yl-3-((2-((2-(3-aziridin-1-yl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio)ethoxy)ethyl)thio)naphthoquinone					
2-benzoquinone	583-63-1	1,2-Benzoquinone	583-63-1	SVD1LJ47R7			
2-benzylidene-4-phenyl-1,3-diselenole		2-benzylidene-4-phenyl-1,3-diselenole					
2-bromo-12,13-dihydro-5-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione		2-bromo-12,13-dihydro-5-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione					
2-bromoethylamine	107-09-5	2-Bromoethylamine	107-09-5	UK8ZP6FC3A			
2-bromopalmitate	18263-25-7	2-Bromohexadecanoic acid	18263-25-7	7EI4G5X28Z	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	
2-bromophenol	95-56-7	2-Bromophenol	95-56-7	A0UB206YF0			
2-bromopropane		2-Bromopropane	75-26-3	R651XOV97Z	Solvents	Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant and Hackh&apos;s Chemical Dictionary, 5th ed) (See all compounds classified as Solvents.)	
2-butanol	78-92-2	2-Butanol	78-92-2	0TUL3ENK62			
2-butenal	4170-30-3	Crotonaldehyde	4170-30-3	9G72074TUW			
2-butylamino-2-demethoxy-hypocrellin B		2-butylamino-2-demethoxy-hypocrellin B					
2-chloro-1,4-benzoquinone	695-99-8	2-Chloro-1,4-benzoquinone	695-99-8	2M5BFC679H			
2-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine	1977-08-8	2-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine	1977-08-8	4Q6V732VRT			
2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine		2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine					
2-chloro-4-nitroaniline	121-87-9	2-Chloro-4-nitroaniline	121-87-9	XSA3ZX337B			
2-chloro-4-phenylphenol	92-04-6	2-Chloro-4-phenylphenol	92-04-6	229K1W6JFY			
2-chloro-4'-methoxychalcone		2-chloro-4'-methoxychalcone					
2-chloro-5-hydroxyphenylglycine		2-Chloro-5-hydroxyphenylglycine	170846-74-9	LSA5YS5PNZ	Excitatory Amino Acid Agonists	Drugs that bind to and activate excitatory amino acid receptors. (See all compounds classified as Excitatory Amino Acid Agonists.)	
2-chloro-5-nitrobenzanilide		2-Chloro-5-nitro-N-phenylbenzamide	22978-25-2	UM18UZV2YD			
2-chloro-N-(2,6-diethylphenyl)acetamide	6967-29-9	2-Chloro-N-(2,6-diethylphenyl)acetamide	6967-29-9				
2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide		2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide					
2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide	163042-96-4	Chloro-IB-MECA	163042-96-4	Z07JR07J6C	Purinergic P1 Receptor Agonists	Compounds that bind to and stimulate PURINERGIC P1 RECEPTORS. (See all compounds classified as Purinergic P1 Receptor Agonists.)	
2-chloro-N(6)cyclopentyladenosine	37739-05-2	2-Chloro-N6-cyclopentyladenosine	37739-05-2	JX2F2W6WSP			
2-chloro-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate		2-chloro-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate					
2-chloroacetanilide	587-65-5	2-Chloroacetanilide	587-65-5	2R6RM9R0W8			
2-Chloroadenosine	146-77-0	2-Chloroadenosine	146-77-0	7W7ZUG45G8			
2-chloroaniline	95-51-2	2-Chloroaniline	95-51-2	G14I494T2F			
2-chlorobenzaldehyde	89-98-5	2-Chlorobenzaldehyde	89-98-5	QHR24X1LXK			
2-chlorobiphenyl	2051-60-7	2-Chlorobiphenyl	2051-60-7	2E08SP4D3P			
2-chlorodibenzo-4-dioxin		2-Chlorodibenzo-P-dioxin	39227-54-8	N0SSV5YGWH			
2-chloroethyl butyl sulfide	4303-40-6	2-Chloroethyl butyl sulfide	4303-40-6				
2-chloroethyl ethyl sulfide	693-07-2	2-Chloroethyl ethyl sulfide	693-07-2	5MN267Q6RG			
2-chloroethyl isocyanate	1943-83-5	2-Chloroethyl isocyanate	1943-83-5	KJ4TMD25MS			
2-chloroethylamine	689-98-5	2-Chloroethylamine	689-98-5	P7YLY3O329			
2-chloromethylpyridine	4377-33-7	2-(Chloromethyl)pyridine	4377-33-7	59YW2EH117			
2-cresol	95-48-7	o-Cresol	95-48-7	YW84DH5I7U			
2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-hepten-6-ynamide	185915-33-7	Manitimus	185915-33-7	4B135RK2KL			Investigated for use/treatment in immunosuppressive and transplant (rejection).
2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid		2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid					
2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide		Cddo-EA	932730-51-3				
2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid methyl amide		2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid methyl amide					
2-cyano-N-((ethylamino)carbonyl)-2-(methoxyimino)acetamide	57966-95-7	Cymoxanil	57966-95-7	QJO7SS7R8U			
2-cyanoethylene oxide	4538-51-6	2-Cyanoethylene oxide	4538-51-6	0C17IZ13QV	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
2-cyclohexylselenazolidine-4-carboxylic acid		2-cyclohexylselenazolidine-4-carboxylic acid					
2-cyclopentyl-4-(5-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl)-benzoic acid		2-cyclopentyl-4-(5-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl)-benzoic acid					
2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole		2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole					
2-deoxyribose 1-phosphate	17210-42-3	Deoxyribose 1-phosphate	17210-42-3	RBH273D9YF			
2-desamino-2-methylaminopterin	118869-52-6	2-Desamino-2-methylaminopterin	118869-52-6				
2-dichlorobenzene	95-50-1	1,2-Dichlorobenzene	95-50-1	6PJ93I88XL	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole		4,5,6,7-Tetrabromo-N,N-dimethyl-1H-benzimidazol-2-amine	749234-11-5				
2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione		6-Dodecyl-2-methoxy-1,4-benzoquinone	4075-01-8				
2-ethoxy-3-(4-(2-(4-trifluoromethanesulfonyloxyphenyl)ethoxy)phenyl)propionic acid		2-ethoxy-3-(4-(2-(4-trifluoromethanesulfonyloxyphenyl)ethoxy)phenyl)propionic acid					
2-ethoxyethanol	110-80-5	2-Ethoxyethanol	110-80-5	IDK7C2HS09			
2-ethyl-4-(4-hydroxyphenyl)-5-(4-(2-piperidin-1-ylethoxy)phenyl)-2-imidazoline		2-ethyl-4-(4-hydroxyphenyl)-5-(4-(2-piperidin-1-ylethoxy)phenyl)-2-imidazoline					
2-ethyl-5-carboxypentyl phthalate	40809-41-4	2-Ethyl-5-carboxypentyl phthalate	40809-41-4				
2-ethyl-5-methoxy-N,N-dimethyltryptamine		2-(2-ethyl-5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine	263744-72-5	GWM65988LJ	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
2-ethylhexanoic acid	149-57-5	2-Ethylhexanoic acid	149-57-5	01MU2J7VVZ			
2-ethylhexanol	104-76-7	2-Ethylhexan-1-ol	104-76-7	XZV7TAA77P			
2-ethylhexyl 2,3,4,5-tetrabromobenzoate		2-Ethylhexyl 2,3,4,5-Tetrabromobenzoate	183658-27-7				
2-ethylhexyl acrylate	103-11-7	2-Ethylhexyl acrylate	9003-77-4	HR49R9S6XG			
2-ethylhexyl salicylate		2-Ethylhexyl salicylate	118-60-5	4X49Y0596W	Sunscreening Agents	Chemical or physical agents that protect the skin from sunburn and erythema by absorbing or blocking ultraviolet radiation. (See all compounds classified as Sunscreening Agents.)	Ingredient in sunscreens for protection against damage effects of sun light, provides protection from sunburns, aging and skin cancer.
2-ethylhexyldiphenylphosphate	1241-94-7	2-Ethylhexyl diphenyl phosphate	1241-94-7	4F53Z6NE1Y			
2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine	30223-73-5	Pyrrolidine, 1,5-dimethyl-3,3-diphenyl-2-ethylidene-	30223-73-5				
2-ethylphenol		2-Ethylphenol	90-00-6	355O0P4JU7			
2-ethynylnaphthalene	2949-26-0	2-Ethynylnaphthalene	2949-26-0	X4QQT78LBL			
2-ethynylpyrene		Pyrene, 2-ethynyl-	146445-96-7				
2-fluorobenzoic acid	445-29-4	2-Fluorobenzoic acid	445-29-4	64UZ32KOO4			
2-fluorohexadecanoic acid	16518-94-8	2-Fluoropalmitic acid	16518-94-8				
2-furan-2-yl-7-3-(4-(4-(4-methylpiperazine-1-sulfonyl)phenylethyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo-(1,5-c)pyrimdin-5-ylamine)		2-furan-2-yl-7-3-(4-(4-(4-methylpiperazine-1-sulfonyl)phenylethyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo-(1,5-c)pyrimdin-5-ylamine)					
2-furoyl-LIGRLO-amide		2-furoyl-LIGRLO-amide					
2-gluthionyl-3,5,6-trichloro-1,4-benzoquinone	117383-28-5	2,5,6-Trichloro-3-(glutathion-S-yl)-1,4-benzoquinone	117383-28-5				
2-heptanone	110-43-0	2-Heptanone	110-43-0	89VVP1B008			
2-heptenal	2463-63-0	2-Heptenal	18829-55-5	4NJZ8GMQ6F			
2-hexanol		2-Hexanol	626-93-7	9CDT0V6T4P			
2-hexenal	505-57-7	2-Hexenal	1335-39-3	69JX3AIR1I			
2-hexyl-1-cyclopentanone thiosemicarbazone		[(2-Hexylcyclopentylidene)amino]thiourea					
2-hexynyladenosine-5'-N-ethylcarboxamide	141018-30-6	2-Hexynyl-NECA	141018-30-6				
2-hydroxy-1-(2-((9-(4-methylcyclohexyl)-9H-pyrido(4',3'-4,5)pyrrolo(2,3-d)pyrimidin-2-yl)amino)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl)ethanone		2-hydroxy-1-(2-((9-(4-methylcyclohexyl)-9H-pyrido(4',3'-4,5)pyrrolo(2,3-d)pyrimidin-2-yl)amino)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl)ethanone					
2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone		N'-[(2-hydroxynaphthalen-1-yl)methylidene]pyridine-4-carbohydrazide					
2-hydroxy-3-(5-((morpholin-4-yl)methyl)pyridin-2-yl)-1H-indole-5-carbonitrile		2-hydroxy-3-(5-(morpholinomethyl)pyridin-2-yl)-1H-indole-5-carbonitrile	612487-72-6	0TII45R8IJ			
2-hydroxy-3-methoxyestradiol		2-Hydroxyestradiol-3-methyl ether	5976-65-8				
2-hydroxy-3,5,3',5'-tetramethoxystilbene		2-hydroxy-3,5,3',5'-tetramethoxystilbene					
2-hydroxy-3',5,5'-trimethoxychalcone		2-Hydroxy-3',5,5'-trimethoxychalcone					
2-hydroxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoic acid		2-hydroxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoic Acid	651331-92-9	NM6AF3AW9M			
2-hydroxy-4-(4-(5-(2-methyl-3-phenylprop-2-enylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)butanoylamino)benzoic acid		2-hydroxy-4-(4-(5-(2-methyl-3-phenylprop-2-enylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)butanoylamino)benzoic acid					
2-hydroxy-4-methoxy benzoic acid		2-hydroxy-4-methoxy benzoic acid					
2-hydroxy-4-methylselenobutanoic acid		2-Hydroxy-4-methylseleno-butanoic acid	873660-49-2				
2-hydroxy-9-cis-octadecenoic acid		2-Hydroxyoleic acid	56472-29-8	OSV3KVO1BT			
2-hydroxyacetanilide	614-80-2	2-Acetamidophenol	614-80-2	4AS8989RNI			
2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine	124489-20-9	2-Hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine	124489-20-9	JC2M95KK23	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
2-hydroxyamino-3-methylimidazolo(4,5-f)quinoline	77314-23-9	2-Hydroxyamino-3-methylimidazolo(4,5-f)quinoline	77314-23-9				
2-hydroxyatrazine	2163-68-0	2-Hydroxyatrazine	2163-68-0	D9Y04ELA63			
2-hydroxychavicol	1126-61-0	4-Allylbenzene-1,2-diol	1126-61-0	FG58C4J9BR			
2-hydroxychrysophanol	58322-78-4	2-Hydroxychrysophanol	58322-78-4				
2-hydroxyemodin	641-90-7	2-Hydroxyemodin	641-90-7	87C66SE4CP			
2-hydroxyestradiol	362-05-0	2-Hydroxyestradiol	362-05-0	AYU2L67YUU			
2-hydroxyestriol	1232-80-0	2-Hydroxyestriol	1232-80-0	XS3NDJ547R			
2-hydroxyestrone	362-06-1	2-Hydroxyestrone	362-06-1	UQS3A06ILY	Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	
2-hydroxyethidium		2-hydroxyethidium					
2-hydroxyethyl acrylate	818-61-1	2-Hydroxyethyl acrylate	26022-14-0	25GT92NY0C			
2-hydroxyethyl disulfide	1892-29-1	2-Hydroxyethyl disulfide	1892-29-1	45543L74BS			
2-hydroxyisobutyric acid	594-61-6	2-Hydroxyisobutyric acid	594-61-6	DMW250U2HF			
2-hydroxymenthofuran		2-hydroxymenthofuran					
2-hydroxymethyl-4,8-dihydrobenzo(1,2-b-5,4-b')dithiophene-48-dione		2-hydroxymethyl-4,8-dihydrobenzo(1,2-b-5,4-b')dithiophene-48-dione					
2-hydroxyphenylacetic acid	614-75-5	2-Hydroxyphenylacetic acid	614-75-5	UK3R9Q59AV			
2-hydroxyphytanic acid	14721-68-7	2-Hydroxyphytanic acid	14721-68-7				
2-hydroxypropyl methacrylate	923-26-2	2-Hydroxypropyl methacrylate	923-26-2	V9B8S034AW			
2-Hydroxypropyl-beta-cyclodextrin		2-Hydroxypropyl-beta-cyclodextrin	94035-02-6				
2-hydroxypyridine	142-08-5	2-Hydroxypyridine	142-08-5	6770O3A2I5			
2-hydroxypyrimidine	557-01-7	2-Hydroxypyrimidine	557-01-7	13K708ILY4			
2-hydroxyquinoline	59-31-4	2-Hydroxyquinoline	70254-42-1	803BHY7QWU			
2-iodo-7,8-dibromodibenzo-1,4-dioxin	117333-18-3	7-Iodo-2,3-dibromodibenzo-p-dioxin	117333-18-3				
2-iodobenzenamine		2-Iodoaniline	615-43-0				
2-iodohexadecanal	130770-02-4	2-Iodohexadecanal	130770-02-4				
2-iodomelatonin	93515-00-5	2-Iodomelatonin	93515-00-5	2Q5TZ5754A			
2-iodophenyl-(1-(1-methylpiperidin-2-ylmethyl)-1H-indol-3-yl)methanone		2-iodophenyl-(1-(1-methylpiperidin-2-ylmethyl)-1H-indol-3-yl)methanone	444912-55-4	160N27WT0S			
2-isobutyl-3-methoxypyrazine	24683-00-9	2-Isobutyl-3-methoxypyrazine	24683-00-9	S327O0T12O			
2-isopropyl-5-methylcyclohexanone		p-Menthan-3-one	491-07-6				
2-isopropyl-6-methyl-4-pyrimidinol		2-Isopropyl-6-methyl-4-pyrimidone	2814-20-2	0JET159MZQ			
2-isopropylphenol	88-69-7	2-Isopropylphenol	88-69-7	B2899Z0Q2U			
2-keto-4-methylthiobutyric acid	583-92-6	4-(Methylsulfanyl)-2-oxobutanoic acid	583-92-6	286060413U			
2-mercapto-1-methylimidazole		Methimazole	60-56-0	554Z48XN5E	Antithyroid Agents	Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones. (See all compounds classified as Antithyroid Agents.)	In the United States, methimazole is indicated for the treatment of hyperthyroidism in patients with Graves' disease or toxic multinodular goiter for whom thyroidectomy or radioactive iodine therapy are not appropriate treatment options. Methimazole is also indicated for the amelioration of hyperthyroid symptoms in preparation for thyroidectomy or radioactive iodine therapy.  In Canada, methimazole carries the above indications and is also indicated for the medical treatment of hyperthyroidism regardless of other available treatment options.
2-mercaptoacetate	68-11-1	Thioglycolic acid	68-11-1	7857H94KHM			
2-mercaptobenzimidazole	583-39-1	2-Mercaptobenzimidazole	583-39-1	619CVM6HOK			
2-mercaptomethyl-3-guanidinoethylthiopropionic acid	77102-28-4	Mergetpa	77102-28-4	X8EOD1X17Q	Protease Inhibitors	Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)	
2-mercaptomethylbenzimidazole	53988-10-6	2H-Benzimidazole-2-thione, 1,3-dihydro-4-methyl-	53988-10-6				
2-methoxy-1,4-naphthoquinone	2348-82-5	2-Methoxy-1,4-naphthoquinone	2348-82-5	39020BUT1D			
2-methoxy-3-O-sulfamoyl-17-cyanomethylestra-1,3,5(10)-triene		2-methoxy-3-O-sulfamoyl-17-cyanomethylestra-1,3,5(10)-triene					
2-methoxy-4-amino-5-chlorobenzoic acid 2-(diethylamino)ethyl ester	137196-67-9	2-(Diethylamino)ethyl 4-amino-5-chloro-2-methoxybenzoate	137196-67-9		Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
2-methoxy-4-aminoazobenzene	3544-23-8	3-Methoxy-4-aminoazobenzene	3544-23-8	69RJD2DP9F			
2-methoxy-5-((3,4,5-trimethosyphenyl)seleninyl)phenol		2-methoxy-5-((3,4,5-trimethosyphenyl)seleninyl)phenol					
2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone	60423-21-4	2-Methoxy-5-(2',3',4'-trimethoxyphenyl)tropone	60423-21-4	XLQ3SGL8DP	Tubulin Modulators	Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)	
2-methoxy-6-undecyl-1,4-benzoquinone		2-Methoxy-6-undecyl-1,4-benzoquinone					
2-methoxy-N-(3-(4-((3-methyl-4-((6-methyl-3-pyridinyl)oxy)phenyl)amino)-6-quinazolinyl)-2-propenyl)acetamide		2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide	845680-17-3	I05QZ0S4V3			
2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide		2-Methoxy-N-(3-Methyl-2-Oxo-1,2,3,4-Tetrahydroquinazolin-6-Yl)benzenesulfonamide	1403764-72-6				
2-methoxyacetaldehyde	10312-83-1	Methoxyacetaldehyde	10312-83-1	5G4O7K64WA			
2-methoxybenzoic acid	579-75-9	2-Methoxybenzoic acid	579-75-9	49WA6Z7GZA			
2-methoxycinnamaldehyde	1504-74-1	O-Methoxycinnamaldehyde, (E)-	1504-74-1	3GG2B2MUHB			
2-Methoxyestradiol	362-07-2	2-Methoxyestradiol	362-07-2	6I2QW73SR5	Tubulin Modulators	Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)	For the treatment of breast cancer and inflammatory diseases such as rheumatoid arthritis.
2-methoxyestradiol-3,17-bis-O,O-sulfamate		2-methoxyestradiol-3,17-bis-O,O-sulfamate					
2-methoxyestradiol-3,17-O,O-bis(sulfamate)		(9beta,13alpha,14beta,17alpha)-2-Methoxyestra-1,3,5(10)-Triene-3,17-Diyl Disulfamate	401600-86-0	S57SQE6LE5			
2-methoxyestrone	362-08-3	2-Methoxyestrone	362-08-3	SJ5857RRL3			
2-methoxyidazoxan	102575-24-6	2-Methoxyidazoxan	102575-24-6	E27LB7P0ET	Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	
2-methoxynaphthalene	93-04-9	2-Methoxynaphthalene	93-04-9	VX2T1Z50C4			
2-methoxyoestrone-3-O-sulphamate		2-methoxyoestrone-3-O-sulphamate					
2-methoxypropanol	1589-47-5	2-Methoxy-1-propanol	1589-47-5	18B570XOYF			
2-methyl-1-((4-methyl-5-isoquinolinyl)sulfonyl)homopiperazine		2-methyl-1-((4-methyl-5-isoquinolinyl)sulfonyl)homopiperazine					
2-methyl-1-propenylbenzoate		2-methyl-1-propenylbenzoate					
2-methyl-1,3,6-trihydroxy-9,10-anthraquinone-3-O-(6'-O-acetyl)-alpha-rhamnosyl(1-2)-beta-glucoside		2-methyl-1,3,6-trihydroxy-9,10-anthraquinone-3-O-(6'-O-acetyl)-alpha-rhamnosyl(1-2)-beta-glucoside					
2-methyl-1,4-benzoquinone	553-97-9	p-Toluquinone	553-97-9	VF06HB6AZN			
2-methyl-1,4-hydroquinone	95-71-6	Methylhydroquinone	95-71-6	332W51E0OC			
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide		2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide					
2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester		No-ursodeoxycholic acid	401519-96-8	V9G7HR5L1Q			
2-methyl-3-(4-(2-(5-methyl-2-thiophen-2-yloxazol-4-yl)ethoxy)phenyl)-2-phenoxypropionic acid		2-Methyl-3-(4-(2-(5-methyl-2-thiophen-2-yloxazol-4-yl)ethoxy)phenyl)-2-phenoxypropionic acid					
2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid	75987-08-5	2-Methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid	75987-08-5	BHN2L91IVP	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
2-methyl-4-(N-propyl-N-cycloproanemethylamino)-5-chloro-6-(2,4,6-trichloranilino)pyrimidine		5-chloro-4-N-(cyclopropylmethyl)-2-methyl-4-N-propyl-6-N-(2,4,6-trichlorophenyl)pyrimidine-4,6-diamine	184241-44-9				
2-methyl-4-chlorophenol		4-Chloro-2-methylphenol	1570-64-5	297V63W9RI			
2-methyl-4-chlorophenoxy gamma-butyric acid	94-81-5	4-(4-Chloro-2-methylphenoxy)butanoic acid	94-81-5	OA1Z4N1842	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
2-Methyl-4-chlorophenoxyacetic Acid	94-74-6	(4-Chloro-2-methylphenoxy)acetic acid	94-74-6	D888C394VO	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
2-methyl-4-isothiazolin-3-one	2682-20-4	2-Methyl-4-isothiazolin-3-one	2682-20-4	229D0E1QFA	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
2-methyl-5-(1-methylethenyl)cyclohexanol		Dihydrocarveol	38049-26-2				
2-methyl-5-HT	78263-90-8	2-Methyl-5-hydroxytryptamine	78263-90-8	D77Z9HJT2U			
2-methyl-5-isopropenylcyclohex-2-enone oxime		2-methyl-5-isopropenylcyclohex-2-enone oxime					
2-methyl-c-5-(4-(5-methyl-2-(4-methylphenyl)-4-oxazolyl)butyl)-1,3-dioxane-r-2-carboxylic acid		2-methyl-c-5-(4-(5-methyl-2-(4-methylphenyl)-4-oxazolyl)butyl)-1,3-dioxane-r-2-carboxylic acid					
2-methylacetoacetanilide		2-Methylacetoacetanilide					
2-methylamino-1,4-naphthoquinone		1,4-Naphthalenedione, 2-(methylamino)-	14423-00-8				
2-methylanthracene	613-12-7	2-Methylanthracene	613-12-7	6C868JOV4A			
2-methylanthraquinone	84-54-8	2-Methylanthraquinone	84-54-8	Q9P233HWAJ			
2-methylarachidonyl-2'-fluoroethylamide		2-methylarachidonyl-2'-fluoroethylamide					
2-methylbenz(a)anthracene	2498-76-2	2-Methylbenz[a]anthracene	2498-76-2	G9U5XDR8XU			
2-methylbutyric acid 4-((1,3)dioxan-5-ylmethoxyimino)-8-(2-(4-hydroxy-6-oxo-tetrahydropyran-2-yl)ethyl -7-methyl-6-oxo-1,2,3,4,6,7,8,8a-octahydronaphthyl)heptanoate		2-methylbutyric acid 4-((1,3)dioxan-5-ylmethoxyimino)-8-(2-(4-hydroxy-6-oxo-tetrahydropyran-2-yl)ethyl -7-methyl-6-oxo-1,2,3,4,6,7,8,8a-octahydronaphthyl)heptanoate					
2-methylcyclopentadienyl manganese tricarbonyl	12108-13-3	12108-13-3					
2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol		2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol					
2-methylestradiol	1818-12-8	2-Methyl estradiol	1818-12-8				
2-methylfuran	534-22-5	2-Methylfuran	534-22-5	51O3BGW3F2			
2-methylharmine	6519-18-2	N(2)-methylharmine	6519-18-2				
2-methylhistamine	34392-54-6	2-Methylhistamine	34392-54-6	H5DHG2WBHM			
2-methylimidazole	693-98-1	2-Methylimidazole	693-98-1	T0049Z45LZ			
2-methylindole	95-20-5	2-Methylindole	95-20-5	I7CN58827I			
2-methylnaphthalene	91-57-6	2-Methylnaphthalene	91-57-6	S8MCX3C16H			
2-methylphenanthrene	2531-84-2	2-Methylphenanthrene	2531-84-2	5IQJ3J6PN0			
2-methylpyrrolidine		2-Methylpyrrolidine	765-38-8				
2-methylquinoline	91-63-4	2-Methylquinoline	91-63-4	DVG30M0M87			
2-methylresorcinol	608-25-3	2-Methylresorcinol	608-25-3	32W7044A3T			
2-methylthio-ATP		2-Mesatp	43170-89-4		Purinergic Agonists	Compounds that bind to and activate PURINERGIC RECEPTORS. (See all compounds classified as Purinergic Agonists.)	
2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one		2-Morpholino-6-(thianthren-1-yl)-4H-pyran-4-one	587871-26-9	O549494L5D			
2-n-butyl-9-methyl-8-(1,2,3)triazol-2-yl-9H-purin-6-ylamine		2-n-butyl-9-methyl-8-(1,2,3)triazol-2-yl-9H-purin-6-ylamine					
2-n-octyl-4-isothiazolin-3-one	26530-20-1	Octhilinone	26530-20-1	4LFS24GD0V			
2-naphthalenethiol	91-60-1	2-Naphthalenethiol	91-60-1	SZ5U1S741V			
2-naphthol	135-19-3	2-Naphthol	135-19-3	P2Z71CIK5H			
2-naphthoylethyltrimethylammonium	31059-54-8	2-Naphthoylethyltrimethylammonium	31059-54-8				
2-Naphthylamine	91-59-8	2-Naphthylamine	91-59-8	CKR7XL41N4	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
2-nitro-4-phenylenediamine	5307-14-2	2-Nitro-P-phenylenediamine	5307-14-2	PV83F3C01Q			
2-nitroanisole	91-23-6	2-Nitroanisole	91-23-6	ZRE7HLZ17K			
2-nitroanthracene	3586-69-4	2-Nitroanthracene	3586-69-4				
2-nitrobenzaldehyde		2-Nitrobenzaldehyde	552-89-6	48B18Q9B8E			
2-nitrofluoranthene		2-Nitrofluoranthene	13177-29-2	S5CB71I99S	Air Pollutants	Any substance in the air which could, if present in high enough concentration, harm humans, animals, vegetation or materials. Substances include GASES; PARTICULATE MATTER; and volatile ORGANIC CHEMICALS. (See all compounds classified as Air Pollutants.)	
2-nitrofluorene	607-57-8	2-Nitrofluorene	607-57-8	191LL4U4GZ	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
2-nitronaphthalene	581-89-5	2-Nitronaphthalene	581-89-5	V5NB52B64Q			
2-nitrophenol	88-75-5	2-Nitrophenol	88-75-5	BD148E95KD			
2-nitrophenyl selenocyanic acid	51694-22-5	2-Nitrophenyl selenocyanate	51694-22-5				
2-nitrophenylacetic acid	3740-52-1	2-Nitrophenylacetic acid	3740-52-1	05TN0SUY38			
2-nitropropane	79-46-9	2-Nitropropane	79-46-9	GKV234L2QH			
2-nitrosofluorene	2508-20-5	2-Nitrosofluorene	2508-20-5	34E9V9B29K	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
2-nitrotoluene	88-72-2	2-Nitrotoluene	88-72-2	6Q9N88YIAY			
2-nonenal	2463-53-8	2-Nonenal	18829-56-6	8VEO649985			
2-nonynoic acid methyl ester	111-80-8	Methyl 2-nonynoate	111-80-8	8RN66UR57V			
2-O-(3-carboxyl-4-iodosobenzyl)-beta-cyclodextrin		2-O-(3-carboxyl-4-iodosobenzyl)-beta-cyclodextrin					
2-octanol	123-96-6	2-Octanol	123-96-6	66B0DD5E40			
2-octenal	2363-89-5	2-Octenal	2548-87-0	55N91D7775			
2-octyl-4H-1,3,2-benzodioxaphosphorin-2-oxide		2-Octyl-4H-1,3,2-benzodioxaphosphorin 2-oxide	142840-32-2				
2-octyl-gamma-bromoacetoacetate	40529-35-9	2-Octyl-gamma-bromoacetoacetate	40529-35-9				
2-oleoylglycerol		2-Monoolein	3443-84-3	9A2389K694			
2-oxindole	59-48-3	Oxindole	59-48-3	0S9338U62H			
2-oxo-clopidogrel		2-Oxoclopidogrel	1147350-75-1	0IX303KU54			
2-oxohexyl isothiocyanate		2-Oxohexyl isothiocyanate					
2-oxoselenazolidine-4-carboxylic acid		2-oxoselenazolidine-4-carboxylic acid					
2-oxothiazolidine-4-carboxylic acid		2-Oxothiazolidine-4-carboxylic acid	19750-45-9				
2-palmitoylglycerol		2-Palmitoylglycerol	23470-00-0	21I29V2935			
2-pentenal	764-39-6	2-Pentenal	764-39-6	7A4R3CQA2T			
2-phenyl-2-(1-piperidinyl)propane		1-(2-Phenylpropan-2-yl)piperidine	92321-29-4				
2-phenyl-2-propanol	617-94-7	2-Phenyl-2-propanol	617-94-7	JE030BGE05			
2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine		2-Phenyl-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridine	452342-37-9	273G6SN31H			
2-phenyl-4-oxohydroquinoline	14802-18-7	2-Phenylquinolin-4-ol	14802-18-7				
2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide	18390-00-6	2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide	18390-00-6	6E3YBW5333	Free Radical Scavengers	Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. (See all compounds classified as Free Radical Scavengers.)	
2-phenylacetylenesulfonamide		2-Phenylethynesulfonamide	64984-31-2				
2-phenylamino-1,4-naphthoquinone		2-phenylamino-1,4-naphthoquinone					
2-phenylaminoadenosine	53296-10-9	2-Phenylaminoadenosine	53296-10-9	K40I59G1EF	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
2-phenylcyclopropanecarboxylic acid	939-90-2	trans-2-Phenylcyclopropanecarboxylic acid	939-90-2	AJY6BGY81V			
2-phenylindole		2-Phenylindole	948-65-2	MQD44HV3P1			
2-phenylphenol	90-43-7	2-Phenylphenol	90-43-7	D343Z75HT8	Disinfectants	Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley&apos;s Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Disinfectants.)	
2-piperidinoethyl 4-amino-5-chloro-2-methoxybenzoate		2-Piperidinoethyl 4-amino-5-chloro-2-methoxybenzoate	148868-55-7				
2-piperidone	675-20-7	2-Piperidone	675-20-7	WLN0GQQ6EK			
2-Propanol	67-63-0	Isopropyl Alcohol	67-63-0	ND2M416302	Solvents	Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant and Hackh&apos;s Chemical Dictionary, 5th ed) (See all compounds classified as Solvents.)	
2-propenyl thiosulfate		2-propenyl thiosulfate					
2-propyl-4-pentenoic acid	1575-72-0	2-Propyl-4-pentenoic acid	1575-72-0	2GYI36I25W	Teratogens	An agent that causes the production of physical defects in the developing embryo. (See all compounds classified as Teratogens.)	
2-propylthio-D-beta,gamma-difluoromethylene ATP		[[[[(2R,3S,4R,5R)-5-(6-amino-2-propylsulfanylpurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]-difluoromethyl]phosphonic acid					
2-pyridine-3-yl-methylene-indan-1,3-dione		1,3-Indandione, 2-(3-pyridylmethylene)-	31083-55-3	J625FJL5DX			
2-pyridylcarboxaldehyde isonicotinoylhydrazone		N'-[(1E)-pyridin-2-ylmethylene]isonicotinohydrazide	15017-32-0				
2-pyrone		2H-Pyran-2-one	504-31-4	8WW45I202V			
2-quinoxaline-carboxamide-N-adamantan-1-yl		2-quinoxaline-carboxamide-N-adamantan-1-yl					
2-S-glutathionylcaffeic acid	100045-68-9	2-S-Glutathionylcaffeic acid	100045-68-9				
2-sec-butylphenol	89-72-5	2-sec-Butylphenol	89-72-5	025P24OTM5			
2-selenium-bridged beta-cyclodextrin		2-selenium-bridged beta-cyclodextrin					
2-sulfoxymethylfuran		2-Sulfoxymethylfuran					
2-tert-butyl-4-methylphenol	2409-55-4	2-tert-Butyl-4-methylphenol	2409-55-4	Y9VVU7G7J4			
2-tert-butyl-4-quinone		2-tert-Butyl-1,4-benzoquinone	3602-55-9	F18QT8490S			
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one		Pyridone 6	457081-03-7	LDX3F0CCST			
2-tert-butylhydroquinone	1948-33-0	Tert-Butylhydroquinone	1948-33-0	C12674942B	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
2-tert-butylphenol	88-18-6	2-Tert-butylphenol	88-18-6	NL2FPV3N0Z			
2-tetradecylglycidic acid	68170-97-8	Palmoxiric acid	68170-97-8	R326X4TRBY	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	
2-thio(3-iodobenzyl)-5-(1-pyridyl)-(1,3,4)oxadiazole		2-thio(3-iodobenzyl)-5-(1-pyridyl)-(1,3,4)oxadiazole					
2-thiomalic acid	70-49-5	Mercaptosuccinic acid	70-49-5	94239W5L4H			
2-tolidine	119-93-7	3,3'-Dimethylbenzidine	119-93-7	63HLO2IV6K			
2-toluic acid	118-90-1	o-Toluic Acid	118-90-1	9NR3033Y0U			
2-toluidine	95-53-4	o-Toluidine	95-53-4	B635MZ0ZLU	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
2-trifluoromethyl-2'-methoxychalone		2-trifluoromethyl-2'-methoxychalone					
2-vanillin		2-Hydroxy-3-methoxybenzaldehyde	148-53-8	008LR748FI			
2-xylene	95-47-6	O-Xylene	95-47-6	Z2474E14QP			
2,10,11-trihydroxy-N-n-propylnoraporphine	77761-73-0	2,10,11-Trihydroxy-N-n-propylnoraporphine	77761-73-0	X24JVA4SAX			
2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene		O,P'-Dde	3424-82-6	DM084YLQ1L			
2,2-(2-chlorophenyl-4'-chlorophenyl)acetic acid	34113-46-7	2-(o-Chlorophenyl)-2-(p-chlorophenyl)acetic acid	34113-46-7				
2,2-bis(3-chloro-4-hydroxyphenyl)propane		3,3'-Dichlorobisphenol A	79-98-1	WS963RA8KZ			
2,2-bis(4-(2,3-dihydroxypropoxy)phenyl)propane		2,2-bis(4-(2,3-dihydroxypropoxy)phenyl)propane					
2,2-bis(4-glycidyloxyphenyl)propane	1675-54-3	Bisphenol A diglycidyl ether	1675-54-3	F3XRM1NX4H	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane	2971-36-0	2,2-Bis(4-hydroxyphenyl)-1,1,1-trichloroethane	2971-36-0	H58165YO91			
2,2-bis(bromomethyl)-1,3-propanediol	3296-90-0	2,2-Bis(bromomethyl)-1,3-propanediol	3296-90-0	4ZHG182S25			
2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one		Prima-1	5608-24-2	GHC34M30BG			
2,2-di(4-methacryloxyphenyl)propane	3253-39-2	Bisphenol A dimethacrylate	3253-39-2	982O8255NE			
2,2-dichloro-1-(triphenylphosphonio)vinyl formamide perchlorate		2,2-dichloro-1-(triphenylphosphonio)vinyl formamide perchlorate					
2,2-dichloro-1,1,1-trifluoroethane	306-83-2	2,2-Dichloro-1,1,1-trifluoroethane	306-83-2	6S7C791U3V			
2,2-dichloro-12-(p-chlorophenyl)-dodecanoic acid		2,2-Dichloro-12-(4-chlorophenyl)dodecanoic acid	221564-97-2	TM9XQR923G			
2,2-dichloroacetyl chloride	79-36-7	Dichloroacetyl chloride	79-36-7	52O60099FY			
2,2-dimethyl-3-(4-(naphthalen-2-ylamino)phenyl)-3-(1,2,4)triazol-1-yl-propionic acid methyl ester		2,2-dimethyl-3-(4-(naphthalen-2-ylamino)phenyl)-3-(1,2,4)triazol-1-yl-propionic acid methyl ester					
2,2-dimethylsuccinic acid	597-43-3	2,2-Dimethylsuccinic acid	597-43-3	MX6TVR2107			
2,2-dithiobis(4,6-dichlorophenol)	57548-07-9	2,2-Dithiobis(4,6-dichlorophenol)	57548-07-9				
2,2,2-tribromoacetaldehyde	115-17-3	Tribromoacetaldehyde	115-17-3	W2WDI7648E			
2,2,2-trichloroethanol	115-20-8	2,2,2-Trichloroethanol	115-20-8	AW835AJ62N			
2,2,2,-trichloro-1-(3,4-dichlorophenyl)-ethylacetate		2,2,2,-trichloro-1-(3,4-dichlorophenyl)-ethylacetate					
2,2,4-trimethyl-1,3-pentanediol diisobutyrate	6846-50-0	2,2,4-Trimethyl-1,3-pentanediol diisobutyrate	6846-50-0	4KZA479DWQ			
2,2,5,7,8-pentamethyl-1-hydroxychroman	950-99-2	2,2,5,7,8-Pentamethyl-6-chromanol	950-99-2	7G73627R36	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
2,2'-(hydroxynitrosohydrazono)bis-ethanamine	146724-94-9	1,1-Bis(2-aminoethyl)-2-hydroxy-3-oxotriazane	146724-94-9	LDS7ZYG72J	Nitric Oxide Donors	A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)	
2,2'-azobis(2-amidinopropane)	13217-66-8	2,2'-Azobis(2-amidinopropane)	13217-66-8		Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
2,2'-biphenol	1806-29-7	2,2'-Biphenol	1806-29-7	PM2R53I3C9			
2,2'-bisphenol F	2467-02-9	2,2'-Methylenediphenol	2467-02-9	04D0A23747			
2,2'-cyclohexane-1,2-diylbis(azanediyl)bis(methylene)diphenoldichloroplatinum(II)		2,2'-cyclohexane-1,2-diylbis(azanediyl)bis(methylene)diphenoldichloroplatinum(II)					
2,2'-dichlorobiphenyl	13029-08-8	2,2'-Dichlorobiphenyl	13029-08-8	1433W7U14D			
2,2'-dihydroxy-6,6'-dinaphthyldisulfide	6088-51-3	6-Hydroxy-2-naphthyl disulfide	6088-51-3	Y4YW3C2D2S			
2,2'-dihydroxychalcone		2,2'-Dihydroxychalcone	34000-30-1				
2,2'-Dipyridyl	366-18-7	2,2'-Bipyridine	366-18-7	551W113ZEP	Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	
2,2'-dipyridyl disulfide	2127-03-9	2,2'-Dithiodipyridine	2127-03-9	L6X912UPBU	Oxidants	Electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION). (See all compounds classified as Oxidants.)	
2,2'-dithienyl diselenide		2,2'-dithienyl diselenide					
2,2'-methylenebis(4-methyl-6-tert-butylphenol)	119-47-1	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	119-47-1	KVM0X4X57B			
2,2'-methylenebis(ethyl-6-tert-butylphenol)	88-24-4	2,2'-Methylenebis(4-ethyl-6-tert-butylphenol)	88-24-4	RZW97F6CTS			
2,2'-thiodiethanol	111-48-8	Thiodiglycol	111-48-8	9BW5T43J04	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
2,2',2''-trichlorotriethylamine	555-77-1	Trichlormethine	555-77-1	66WBM7N0NM			
2,2',3,3',4,4',5-heptachlorobiphenyl		2,2',3,3',4,4',5-Heptachlorobiphenyl	35065-30-6	2I988FUS7H			
2,2',3,3',4,4',5,5',6-nonabromodiphenyl ether		Nonabromodiphenyl ether	63936-56-1	2O56GK0P1R			
2,2',3,3',4,4',6,6'-octabromodiphenyl ether		2,2',3,3',4,4',6,6'-Octabromodiphenyl ether	117964-21-3	1SD9VS79J1			
2,2',3,3',4,6'-hexachlorobiphenyl	38380-05-1	2,2',3,3',4,6'-Hexachlorobiphenyl	38380-05-1	814T8D9W95			
2,2',3,4,4',5',6-heptabromodiphenyl ether		2,2',3,4,4',5',6-Heptabromodiphenyl ether	207122-16-5	6M82N9DXAI	Flame Retardants	Materials applied to fabrics, bedding, furniture, plastics, etc. to retard their burning; many may leach out and cause allergies or other harm. (See all compounds classified as Flame Retardants.)	
2,2',3,4',5,5',6-heptachlorobiphenyl		2,2',3,4',5,5',6-Heptachlorobiphenyl	52663-68-0	CIP7BRA48E			
2,2',3,4',5',6-hexachlorobiphenyl		2,2',3,4',5',6-Hexachlorobiphenyl	38380-04-0	5JNS37UVGI			
2,2',3,4',6-pentachlorobiphenyl		2,2',3,4',6-Pentachlorobiphenyl	68194-05-8	VIU6O9X06D			
2,2',3,5,5',6-hexachlorobiphenyl	52663-63-5	2,2',3,5,5',6-Hexachlorobiphenyl	52663-63-5	R846435E65			
2,2',3,5',6-pentachlorobiphenyl	38379-99-6	2,2',3,5',6-Pentachlorobiphenyl	38379-99-6	0YO8J06WCR			
2,2',3',4,4',5-hexachlorobiphenyl	35065-28-2	2,2',3,4,4',5'-Hexachlorobiphenyl	35065-28-2	7Y6JIG1867			
2,2',4,4'-tetrabromodiphenyl ether		2,2',4,4'-Tetrabromodiphenyl ether	5436-43-1	0N97R5X10X			
2,2',4,4'-tetrahydroxybenzophenone	131-55-5	2,2',4,4'-Tetrahydroxybenzophenone	131-55-5	PRR8K3H9VN			
2,2',4,4',5-brominated diphenyl ether		2,2',4,4',5-brominated diphenyl ether					
2,2',4,4',5-pentachlorobiphenyl		2,2',4,4',5-Pentachlorobiphenyl	38380-01-7	3PY435PFIO			
2,2',4,4',5,5'-hexabrominated diphenyl ether		2,2',4,4',5,5'-hexabrominated diphenyl ether					
2,2',4,4',5,6'-hexabromodiphenyl ether		2,2',4,4',5,6'-Hexabromodiphenyl ether	207122-15-4	OGY508QK5U			
2,2',4,5'-tetrabromodiphenyl ether		2,2',4,5'-Tetrabromodiphenyl ether	243982-82-3	D24364111Z			
2,2',4,5'-tetrachlorobiphenyl	41464-40-8	2,2',4,5'-Tetrachlorobiphenyl	41464-40-8	BT5E4PD553			
2,2',4,6-tetrachlorobiphenyl		2,2',4,6-Tetrachlorobiphenyl	62796-65-0	PD736T0W8F			
2,2',4,6,6'-pentachlorobiphenyl		2,2',4,6,6'-Pentachlorobiphenyl	56558-16-8	Z4YYF101N3			
2,2',4,6'-tetramethoxystilbene		2,2',4,6'-Tetramethoxystilbene					
2,2',5-trichlorobiphenyl	37680-65-2	2,2',5-Trichlorobiphenyl	37680-65-2	6LEV53Y3OX			
2,2',5,5'-tetrachlorobenzidine	15721-02-5	2,2',5,5'-Tetrachlorobenzidine	15721-02-5	ICS5PD3141			
2,3-bis(2-hydroxyethylsulfanyl)-(1,4)naphthoquinone		2,3-Bis(2-hydroxyethylsulfanyl)-(1,4)naphthoquinone					
2,3-bis(3'-hydroxybenzyl)butane-1,4-diol	76543-16-3	2,3-Bis(3-hydroxybenzyl)butane-1,4-diol	76543-16-3		Phytoestrogens	Compounds derived from plants, primarily ISOFLAVONES that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS. (See all compounds classified as Phytoestrogens.)	
2,3-bis(3'-hydroxybenzyl)butyrolactone	76543-15-2	3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one	76543-15-2		Phytoestrogens	Compounds derived from plants, primarily ISOFLAVONES that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS. (See all compounds classified as Phytoestrogens.)	
2,3-bis(4-hydroxyphenyl)-propionitrile		2,3-Bis(4-hydroxyphenyl)propionitrile	1428-67-7	52XWB8Q4V8			
2,3-bis(4-nitrophenyl)acrylonitrile		2,3-Bis(4-nitrophenyl)acrylonitrile					
2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine	87420-41-5	N-Palmitoyl-2,3-bis(palmitoyloxy)-2-propylcysteine	87420-41-5	R3PDV16IN3			
2,3-bis(palmitoyloxy)-2-propyl-N-palmitoyl-cysteinyl-seryl-seryl-asparaginyl-alanine	87173-03-3	Tripalmitoyl pentapeptide	87173-03-3				
2,3-butylene glycol	513-85-9	2,3-Butanediol	513-85-9				
2,3-dialdehydocellulose	9032-52-4	2,3-Dialdehydocellulose					
2,3-diaminonaphthalene	771-97-1	2,3-Diaminonaphthalene	771-97-1	2BNZ6BRS87			
2,3-diaminotoluene	2687-25-4	2,3-Diaminotoluene	2687-25-4	SR8WC7LLQ2			
2,3-dibromopropyl-2,4,6-tribromophenyl ether		2,3-Dibromopropyl-2,4,6-tribromophenyl ether					
2,3-dichloro-1-propanol		2,3-Dichloro-1-propanol	616-23-9	88I7UKE7IM			
2,3-dichlorobiphenyl	16605-91-7	2,3-Dichlorobiphenyl	25512-42-9	S0B721XXDK			
2,3-dichlorodibenzo-4-dioxin		2,3-Dichlorodibenzo-P-dioxin	29446-15-9	2V27FP8LNQ			
2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate		Propyl 6-ethyl-5-ethylsulfanylcarbonyl-2-phenyl-4-propylpyridine-3-carboxylate	212329-37-8	6D9Q2QUU75	Purinergic P1 Receptor Antagonists	Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS. (See all compounds classified as Purinergic P1 Receptor Antagonists.)	
2,3-dihydroquinolin-4(1H)-one		2,3-dihydro-1H-quinolin-4-one	4295-36-7				
2,3-dihydroxybenzoic acid	303-38-8	2,3-Dihydroxybenzoic acid	303-38-8	70D5FBB392	Iron Chelating Agents	Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. (See all compounds classified as Iron Chelating Agents.)	
2,3-dihydroxynaphthalene	92-44-4	2,3-Dihydroxynaphthalene	92-44-4	O9U131030Z			
2,3-dihydroxypropyl dichloroacetate	93623-15-5	2,3-Dihydroxypropyl dichloroacetate	93623-15-5				
2,3-dihydroxypyridine	16867-04-2	2,3-Dihydroxypyridine	16867-04-2	7HY4BCJ130			
2,3-dimercaptosuccinic acid monocyclohexyl ester		2,3-dimercaptosuccinic acid monocyclohexyl ester					
2,3-dimethoxy-1,4-naphthoquinone	6956-96-3	2,3-Dimethoxy-1,4-naphthoquinone	6956-96-3	MFW94A3JEK			
2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone	55486-00-5	Decylubiquinone	55486-00-5	DP8EJ59CQN			
2,3-dimethoxy-6,6-dimethyl-5,6-dihydrobenzo(7,8)indolizino (2,3-b)quinoxaline		5,6-Dihydro-2,3-dimethoxy-6,6-dimethylbenz[7,8]indolizino[2,3-B]quinoxaline	163769-88-8	6U3RC7G5VT			
2,3-dimethylhydroquinone		2,3-Dimethylhydroquinone	1321-28-4	F0L7HG609J			
2,3-dimethylphenol	526-75-0	2,3-Dimethylphenol	526-75-0	RLF9YS3586			
2,3-dimethylsuccinic acid	13545-04-5	2,3-Dimethylsuccinic acid	13545-04-5				
2,3-dinitrophenol	66-56-8	2,3-Dinitrophenol	25550-58-7	735M30625H			
2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline	118876-58-7	2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline	118876-58-7	8LZ6Q43V2S	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	
2,3-Diphosphoglycerate	138-81-8	2,3-Diphosphoglyceric acid	138-81-8	TZ4454O4YZ			
2,3-hexanedione	3848-24-6	2,3-Hexanedione	3848-24-6	559ANR3NVS			
2,3-N-octanoylsphingosine		2,3-N-octanoylsphingosine					
2,3-pentanedione	600-14-6	2,3-Pentanedione	600-14-6	K4WBE45SCM			
2,3,2-tetramine	4741-99-5	N,N'-Bis(2-aminoethyl)-1,3-propanediamine	4741-99-5	3J941O9333			
2,3,3'-trichlorobiphenyl		2,3,3'-Trichlorobiphenyl	38444-84-7	3370393855			
2,3,3',4,4'-pentachlorobiphenyl		2,3,3',4,4'-Pentachlorobiphenyl	32598-14-4	0S596V3MLH	Environmental Pollutants	Substances or energies, for example heat or light, which when introduced into the air, water, or land threaten life or health of individuals or ECOSYSTEMS. (See all compounds classified as Environmental Pollutants.)	
2,3,3',4,4',5-hexachlorobiphenyl	38380-08-4	2,3,3',4,4',5-Hexachlorobiphenyl	38380-08-4	4D6049M2OC			
2,3,3',4',5-pentachloro-4-hydroxybiphenyl		4-Hydroxy-2,3,3',4',5-pentachlorobiphenyl	152969-11-4				
2,3,3',4',6-pentachlorobiphenyl	38380-03-9	2,3,3',4',6-Pentachlorobiphenyl	38380-03-9	97RWU5J04P			
2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate	62414-75-9	2,3,4-Tri-O-acetylarabinopyranosyl isothiocyanate	62414-75-9				
2,3,4,2',3',4'-hexachlorobiphenyl	38380-07-3	2,2',3,3',4,4'-Hexachlorobiphenyl	11096-82-5	PJ11O9J71Y			
2,3,4,4'5-pentachlorobiphenyl		2,3,4,4',5-Pentachlorobiphenyl	74472-37-0	86S23H0DSX			
2,3,4,5-tetrachlorobiphenyl		2,3,4,5-Tetrachlorobiphenyl	33284-53-6	392EXD3SC9			
2,3,4,5-tetrachlorophenate	4901-51-3	2,3,4,5-Tetrachlorophenol	4901-51-3	D2UW5NHW9J			
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine	67287-49-4	2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine	67287-49-4	R7TF327S2C	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
2,3,4,5,3',4',5'-heptachlorobiphenyl	39635-31-9	2,3,3',4,4',5,5'-Heptachlorobiphenyl	39635-31-9	BN8554XK23			
2,3,4,5,6-pentabromotoluene	87-83-2	2,3,4,5,6-Pentabromotoluene	87-83-2	87007N97G5			
2,3,4,5,6-pentachloroaniline	527-20-8	Pentachloroaniline	527-20-8	UW5QVL647I			
2,3,4,6-tetrachlorophenol	58-90-2	2,3,4,6-Tetrachlorophenol	58-90-2	2442S914FX			
2,3,4,7,8-pentachlorodibenzofuran	57117-31-4	2,3,4,7,8-Pentachlorodibenzofuran	57117-31-4	U4C2RV3124			
2,3,4',6-tetrachlorobiphenyl	52663-58-8	2,3,4',6-Tetrachlorobiphenyl	52663-58-8	K2Y92IEV5R			
2,3,5-(triglutathion-S-yl)hydroquinone	119212-33-8	2,3,5-(Triglutathion-S-yl)hydroquinone	119212-33-8	WZ24N9OOS1			
2,3,5-trichloro-6-phenyl-(1,4)benzoquinone		2,3,5-trichloro-6-phenyl-(1,4)benzoquinone					
2,3,5-trichlorophenol	933-78-8	2,3,5-Trichlorophenol	933-78-8	6T7DUC2C8B			
2,3,5-trichlorophenyl methyl sulfone	104380-10-1	2,3,5-Trichlorophenyl methyl sulfone	104380-10-1				
2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone	80809-81-0	Docebenone	80809-81-0	2XRX3BD53M	Lipoxygenase Inhibitors	Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)	
2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside	133186-49-9	4OH-Stil-2-O-glu	133186-49-9				
2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside		2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside	82373-94-2	54QRI6OKJ5			
2,3,5,6-tetrachlorobiphenyl	33284-54-7	2,3,5,6-Tetrachlorobiphenyl	33284-54-7	F7XE9G6462			
2,3,5,6-tetrachlorohydroquinone	87-87-6	Tetrachlorohydroquinone	87-87-6	5P245C48WP			
2,3,5,6-tetrachlorophenate		2,3,5,6-Tetrachlorophenol	935-95-5	SW5F2W8SDJ			
2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate		Force	79538-32-2	2HE8P42H2J			
2,3,6,2',3',6'-hexachlorobiphenyl	38411-22-2	2,2',3,3',6,6'-Hexachlorobiphenyl	38411-22-2	MOA04J1VTW			
2,3,6,7-tetrachlorobiphenylene		2,3,6,7-Tetrachlorobiphenylene	7090-41-7				
2,3,7,8-tetrabromodibenzo-4-dioxin	50585-41-6	2,3,7,8-Tetrabromodibenzo-P-dioxin	50585-41-6	04PL7F455E			
2,3,7,8-tetrachlorodibenzofuran	51207-31-9	2,3,7,8-Tetrachlorodibenzofuran	51207-31-9	XZJ41GQI5D	Environmental Pollutants	Substances or energies, for example heat or light, which when introduced into the air, water, or land threaten life or health of individuals or ECOSYSTEMS. (See all compounds classified as Environmental Pollutants.)	
2,3'-dichlorobiphenyl	25569-80-6	2,3'-Dichlorobiphenyl	25569-80-6	VZ4O46M8F5			
2,3',4,4'-tetrachlorobiphenyl	32598-10-0	2,3',4,4'-Tetrachlorobiphenyl	32598-10-0	K8L6S986MK			
2,3',4,4',5-pentachlorobiphenyl		2,3',4,4',5-Pentachlorobiphenyl	31508-00-6	2B2AQE8U50			
2,4-bis(4'-fluorophenethylamino)-6-(3'-(N,N-dimethylamino)propylamino)-1,3,5-triazine		2,4-bis(4'-fluorophenethylamino)-6-(3'-(N,N-dimethylamino)propylamino)-1,3,5-triazine					
2,4-bis(alpha,alpha-dimethylbenzyl)phenol		2,4-Bis(1-methyl-1-phenylethyl)phenol	2772-45-4	9U10Z6U3JP			
2,4-D n-butyl ester	94-80-4	Butyl 2,4-dichlorophenoxyacetate	94-80-4	6GO3LVR34R			
2,4-decadienal	2363-88-4	2,4-Decadienal	2363-88-4	3G88X2RK09			
2,4-di-tert-butylphenol		2,4-Di-tert-butylphenol	96-76-4	FOB94G6HZT			
2,4-diaminobutyric acid	305-62-4	2,4-Diaminobutyric acid	305-62-4	92V7KM11ZK			
2,4-diaminohypoxanthine	56-06-4	2,4-Diamino-6-hydroxypyrimidine	56-06-4	EDH7CNS75I	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
2,4-diaminopyridine	461-88-1	2,4-Diaminopyridine	461-88-1	96832TI6EN			
2,4-diaminopyrimidine	156-81-0	2,4-Diaminopyrimidine	156-81-0	L5ZY0JJP5J			
2,4-diaminotoluene	95-80-7	2,4-Diaminotoluene	95-80-7	IS1AKN4HYB	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
2,4-dibromo-17-ethynyl(6,7)estradiol	79769-52-1	3H-2,4-Dbee2	79769-52-1				
2,4-dibromophenol	615-58-7	2,4-Dibromophenol	615-58-7	IA75T5C9TG			
2,4-dichloroaniline	554-00-7	2,4-Dichloroaniline	554-00-7	19AE42M6WS			
2,4-dichlorophenol	120-83-2	2,4-Dichlorophenol	120-83-2	R669TG1950	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	
2,4-Dichlorophenoxyacetic Acid	94-75-7	2,4-Dichlorophenoxyacetic acid	94-75-7	2577AQ9262	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
2,4-dichlorophenoxyacetic acid isooctyl ester	25168-26-7	2,4-D Isooctyl ester	25168-26-7	M7GLT14C7B			
2,4-dichlorophenoxyacetyl-S-acyl-CoA thioester		2,4-dichlorophenoxyacetyl-S-acyl-CoA thioester					
2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one		Dimboa	15893-52-4	TI783RU0DR			
2,4-dihydroxy-N-(4-hydroxyphenyl)benzamide		2,4-dihydroxy-N-(4-hydroxyphenyl)benzamide					
2,4-dihydroxybenzophenone	131-56-6	2,4-Dihydroxybenzophenone	131-56-6	LJ54R4Z029			
2,4-dimethylphenol	105-67-9	2,4-Dimethylphenol	105-67-9	5OD803C081			
2,4-dinitrobenzene		1,3-Dinitrobenzene	99-65-0	DK8B627BU0			
2,4-dinitrobenzenesulfonic acid	89-02-1	2,4-Dinitrobenzenesulfonic acid	89-02-1	3WF0U675G6			
2,4-dinitrofluorobenzene sulfonic acid	143134-35-4	2,4-dinitrofluorobenzene Sulfonic Acid	143134-35-4				
2,4-dinitroimidazole-1-ethanol	69542-89-8	2,4-Dinitroimidazole-1-ethanol	69542-89-8				
2,4-Dinitrophenol	51-28-5	2,4-Dinitrophenol	51-28-5	Q13SKS21MN	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
2,4-dinitrophenyl-S-(N-acetylcysteine)		2,4-dinitrophenyl-S-(N-acetylcysteine)					
2,4-dinitrotoluene	121-14-2	2,4-Dinitrotoluene	121-14-2	6741D310ED	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
2,4-heptadienal		2,4-Heptadienal	4313-03-5	VY79R3SU8X			
2,4-hexadienal	80466-34-8	2,4-Hexadienal	142-83-6	878K4I6N7T			
2,4-nonadienal	6750-03-4	2,4-Nonadienal	30551-17-8	Y411G77SH7			
2,4-thiazolidinedione	2295-31-0	2,4-Thiazolidinedione	2295-31-0	AA68LXK93C	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	
2,4-xylidine	95-68-1	2,4-Dimethylaniline	95-68-1	367R1L22C9			
2,4,2'-trihydroxychalcone		2,2',4'-Trihydroxychalcone	26962-50-5				
2,4,2',4'-tetrachlorobiphenyl		2,2',4,4'-Tetrachlorobiphenyl	2437-79-8	4470AQR07D			
2,4,3',5'-tetramethoxystilbene		2,3',4,5'-Tetramethoxystilbene	24144-92-1				
2,4,4'-trichlorobiphenyl	7012-37-5	2,4,4'-Trichlorobiphenyl	7012-37-5	844ODP31Q0			
2,4,4',5-tetrachlorobiphenyl		2,4,4',5-Tetrachlorobiphenyl	32690-93-0	W0250484DW			
2,4,5 trimethylthiazoline		2,4,5 trimethylthiazoline					
2,4,5-trichlorophenol	95-95-4	2,4,5-Trichlorophenol	95-95-4	32526637PN			
2,4,5-Trichlorophenoxyacetic Acid	93-76-5	2,4,5-Trichlorophenoxyacetic acid	93-76-5	9Q963S4YMX	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
2,4,5-trihydroxyphenylalanine quinone		Topaquinone	64192-68-3	PAG3GKA51Y			
2,4,5,2',4',5'-hexabromobiphenyl	59080-40-9	2,2',4,4',5,5'-Hexabromobiphenyl	67774-32-7	9S2PWX7KBN			
2,4,5,2',4',5'-hexachlorobiphenyl	35065-27-1	2,2',4,4',5,5'-Hexachlorobiphenyl	35065-27-1	ZRU0C9E32O			
2,4,5,2',5'-pentachlorobiphenyl	37680-73-2	2,2',4,5,5'-Pentachlorobiphenyl	37680-73-2	803YVI5BNP			
2,4,5,3',4'-pentabromobiphenyl	67888-97-5	2,4,5,3',4'-Pentabromobiphenyl	67888-97-5	ZRP9G85IJI			
2,4,5,3',4',5'-hexachlorobiphenyl	52663-72-6	2,3',4,4',5,5'-Hexachlorobiphenyl	52663-72-6	HD4MZI40CH			
2,4,6-tribromoanisole		2,4,6-Tribromoanisole	607-99-8	DO7M3M4LX5			
2,4,6-tribromophenol	118-79-6	2,4,6-Tribromophenol	118-79-6	YS6K3EU393			
2,4,6-trichlorobiphenyl	35693-92-6	2,4,6-Trichlorobiphenyl	35693-92-6	0BYA65Q6C2			
2,4,6-trichlorophenol	88-06-2	2,4,6-Trichlorophenol	88-06-2	MHS8C5BAUZ	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
2,4,6-trichlorophenyl 4-nitrophenyl ether	1836-77-7	Chlornitrofen	1836-77-7	1NMN2MY1CW			
2,4,6-trichlorophenyl-4'-aminophenyl ether	26306-61-6	2,4,6-Trichlorophenyl-4'-aminophenyl ether	26306-61-6				
2,4,6-trichlorophenylhydrazine	5329-12-4	2,4,6-Trichlorophenylhydrazine	5329-12-4	3ARF2RVG9W			
2,4,6-trihydroxyacetophenone		2',4',6'-Trihydroxyacetophenone	480-66-0	8L7XD8830T			
2,4,6-triiodophenol	609-23-4	2,4,6-Triiodophenol	609-23-4	9RB2R81A7U			
2,4,6-trimethyl-N-((3'-(methylsulfonyl)-4-biphenylyl)methyl)-N-((5-(trifluoromethyl)-2-furanyl)methyl)benzenesulfonamide		2,4,6-trimethyl-N-((3'-(methylsulfonyl)-4-biphenylyl)methyl)-N-((5-(trifluoromethyl)-2-furanyl)methyl)benzenesulfonamide					
2,4,6-trimethyl-N-(meta-3-trifluoromethylphenyl)benzenesulfonamide		m-3M3FBS	9013-93-8				
2,4,6-trimethylbenzaldehyde		2,4,6-Trimethylbenzaldehyde	487-68-3	4W00MG84DR			
2,4,6-triphenyl-1-hexene		2,4,6-Triphenyl-1-hexene	18964-53-9	GH1VCQ7P6X			
2,4,6-triphenyl-1,3-dioxane	117525-88-9	2,4,6-Triphenyl-1,3-dioxane	117525-88-9				
2,4,6-tris(2,4,6-tribromophenoxy)-1,3,5-triazine		2,4,6-Tris(2,4,6-tribromophenoxy)-1,3,5-triazine	25713-60-4	QKS4PD9ZS8			
2,4,6-tris(dimethylaminomethyl)phenol	90-72-2	2,4,6-Tris(dimethylaminomethyl)phenol	90-72-2	2AGN35QF4W			
2,4,7-trimethyldibenzothiophene		2,4,7-Trimethyldibenzothiophene	216983-03-8				
2,4'-bisphenol F	2467-03-0	2,4'-Dihydroxydiphenylmethane	2467-03-0	LIX5YMK20B			
2,4'-dichlorobiphenyl	34883-43-7	2,4'-Dichlorobiphenyl	34883-43-7	TTP086070W			
2,4',5-trichlorobiphenyl	16606-02-3	2,4',5-Trichlorobiphenyl	16606-02-3	1ZNA5F571U			
2,5-anhydromannitol 1-phosphate	52011-52-6	2,5-Anhydromannitol 1-phosphate	52011-52-6				
2,5-di-(2-phenethyl)pyrrolidine		2,5-di-(2-phenethyl)pyrrolidine					
2,5-di-tert-butylhydroquinone		2,5-Di-tert-butylhydroquinone	88-58-4	26XK13B61B	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
2,5-diaminotoluene	95-70-5	2,5-Diaminotoluene	95-70-5	24JO8Z0RJU			
2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone		2,5-Diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone					
2,5-dichloro-3-(glutathionyl-S-yl)-1,4-benzoquinone	135608-87-6	(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(2,5-dichloro-3,6-dioxocyclohexa-1,4-dien-1-yl)sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid	135608-87-6				
2,5-dichlorobiphenyl	34883-39-1	2,5-Dichlorobiphenyl	34883-39-1	35R7J07E3D			
2,5-dihydro-2,4,5-trimethylthiazoline		2,5-dihydro-2,4,5-trimethylthiazoline					
2,5-dihydroxybenzaldehyde		2,5-Dihydroxybenzaldehyde	1194-98-5	0Q83HDS90W			
2,5-dihydroxybenzoic acid	490-79-9	2,5-Dihydroxybenzoic acid	490-79-9	VP36V95O3T			
2,5-dimethoxy-4-bromoamphetamine	32156-26-6	Brolamfetamine	64638-07-9	67WJC4Y2QY	Hallucinogens	Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. (See all compounds classified as Hallucinogens.)	
2,5-dimethoxy-N-benzylphenethylamine		2,5-dimethoxy-N-benzylphenethylamine					
2,5-dimethyl-1,4-benzoquinonediamine		2,5-Dimethylbenzene-1,4-diamine	6393-01-7	RE400VN2B4			
2,5-dimethyl-3,6-diaziridinyl-1,4-benzoquinone	18735-47-2	2,5-Dimethyl-3,6-diaziridinyl-1,4-benzoquinone	18735-47-2				
2,5-dimethyl-4-benzoquinone	137-18-8	2,5-Dimethyl-1,4-benzoquinone	137-18-8	18D1OR9CE1			
2,5-dimethylcelecoxib		2,5-Dimethylcelecoxib	457639-26-8	STL56MF6TH			
2,5-hexanedione		2,5-Hexanedione	110-13-4	C0Z8884J3P	Cross-Linking Reagents	Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)	
2,5-xylenol	95-87-4	2,5-Dimethylphenol	95-87-4	XH3E3564KX			
2,5-xylidene	95-78-3	2,5-Dimethylaniline	95-78-3	XWK0W8DA04			
2,5,2',5'-tetrachlorobiphenyl	35693-99-3	2,2',5,5'-Tetrachlorobiphenyl	35693-99-3	1EH557950R			
2,5,3'-trichlorobiphenyl	38444-81-4	2,3',5-Trichlorobiphenyl	38444-81-4	98H9867N6L			
2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid		alpha-Tocopheryloxyacetic acid	261929-52-6	JW7FJR3ZLY			
2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol		2,6-Ditert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol	57717-80-3	ZAM4WWA5Y4	GABA-B Receptor Agonists	Endogenous compounds and drugs that bind to and activate GABA-B RECEPTORS. (See all compounds classified as GABA-B Receptor Agonists.)	
2,6-di-tert-butyl-4-hydroperoxy-4-methyl-2,5-cyclohexadienone	6485-57-0	2,6-Di-tert-butyl-4-hydroperoxy-4-methyl-2,5-cyclohexadienone	6485-57-0	HK05U8X26D			
2,6-di-tert-butyl-4-hydroxy-4-methyl-2,5-cyclohexadien-1-one	10396-80-2	2,6-Di-tert-butyl-4-hydroxy-4-methyl-2,5-cyclohexadien-1-one	10396-80-2	RCK267MPS5			
2,6-di-tert-butyl-4-hydroxymethylphenol	88-26-6	3,5-Di-tert-butyl-4-hydroxybenzyl alcohol	88-26-6	46ND6GQI48			
2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone	2607-52-5	2,6-Di-tert-butyl-4-methylene-2,5-cyclohexadienone	2607-52-5	49860VI52B			
2,6-di-tert-butylphenol	128-39-2	2,6-DI-Tert-butylphenol	128-39-2	21294V58PF			
2,6-diamino-4-hydroxy-5-formamidopyrimidine	133310-38-0	2,6-Diamino-4-hydroxy-5-formamidopyrimidine	133310-38-0				
2,6-diaminohexanoic acid (4-(5-fluorobenzothiazol-2-yl)-2-methylphenyl)amide		2,6-diaminohexanoic acid (4-(5-fluorobenzothiazol-2-yl)-2-methylphenyl)amide					
2,6-diaminopyridine-3,5-bis(thiocyanate)		2,6-diaminopyridine-3,5-bis(thiocyanate)					
2,6-diaminotoluene	823-40-5	2,6-Diaminotoluene	823-40-5	H838Q10551	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
2,6-dibromobenzoquinone	19643-45-9	2,6-Dibromo-p-benzoquinone	19643-45-9	XJ6G477JMP			
2,6-dibromophenol	608-33-3	2,6-Dibromophenol	608-33-3	27MIP05EAV			
2,6-dichloro-(1,4)benzoquinone		2,6-dichloro-(1,4)benzoquinone					
2,6-dichloro-4-nitrophenol	618-80-4	2,6-Dichloro-4-nitrophenol	618-80-4	36WLM45T7L			
2,6-dichlorobiphenyl	33146-45-1	2,6-Dichlorobiphenyl	33146-45-1	0S2FWS766G			
2,6-Dichloroindophenol	956-48-9	2,6-Dichloroindophenol	537-14-4	C35QN2Z58B	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
2,6-difluoro-N-(1-(4-hydroxy-2-(trifluoromethyl)benzyl)-1H-pyrazol-3-yl)benzamide		2,6-difluoro-N-(1-(4-hydroxy-2-(trifluoromethyl)benzyl)-1H-pyrazol-3-yl)benzamide					
2,6-dihydroxyanthraquinone	84-60-6	2,6-Dihydroxyanthraquinone	84-60-6	W83883330W			
2,6-diisocyanatotoluene	91-08-7	2,6-Diisocyanatotoluene	91-08-7	78243HXH5O			
2,6-diisopropyl-4-(3-(3-methyl-3H-diazirin-3-yl)propyl)phenol		2,6-diisopropyl-4-(3-(3-methyl-3H-diazirin-3-yl)propyl)phenol					
2,6-diisopropylnaphthalene	24157-81-1	2,6-Diisopropylnaphthalene	24157-81-1	1X71YEU9QB			
2,6-dimethoxy-1,4-benzoquinone	530-55-2	2,6-Dimethoxyquinone	26547-64-8	1Z701W789S			
2,6-dimethyl-1,4-benzoquinone	527-61-7	2,6-Dimethylbenzoquinone	527-61-7	HET5TF8ZGO			
2,6-dimethyl-3,5-bis(2'-propoxyethoxycarbonyl)-4-(2''-difluoromethoxyphenyl)-1,4-dihydropyridine	118790-71-9	Cerebrocrast	118790-71-9				
2,6-dimethylnaphthalene	581-42-0	2,6-Dimethylnaphthalene	581-42-0	76U29QW3FM			
2,6-dimethylquinoline		2,6-Dimethylquinoline	877-43-0	KST0M1T4MB			
2,6-dinitrotoluene	606-20-2	2,6-Dinitrotoluene	606-20-2	GG7FAV92MK			
2,6-nonadienal	26370-28-5	2,6-Nonadienal	26370-28-5				
2,6-xylenol	576-26-1	2,6-Dimethylphenol	576-26-1	I8N0RO87OV			
2,6-xylidine	87-62-7	2,6-Dimethylaniline	87-62-7	4FT62OX08D			
2,7-diaminomitosene	78598-43-3	2,7-Diaminomitosene	78598-43-3				
2,7-dichlorodibenzo-4-dioxin	33857-26-0	2,7-Dichlorodibenzo-P-dioxin	33857-26-0	3KMT7J3HEQ			
2,7-dihydroxynaphthalene	582-17-2	2,7-Dihydroxynaphthalene	582-17-2	0TO8E448UD			
2,7-dinitrofluorene	5405-53-8	2,7-Dinitrofluorene	5405-53-8	D67MT7ZUY3			
2,7-dioxo-2,7-dihydro-3H-naphtho(1,2,3-de)quinoline-1-carboxylate		2,7-dioxo-2,7-dihydro-3H-naphtho(1,2,3-de)quinoline-1-carboxylate					
2,7-fluorenediamine	525-64-4	2,7-Diaminofluorene	525-64-4	U63328L315			
2,8-dichlorodibenzo-4-dioxin		2,8-Dichlorodibenzo-P-dioxin	38964-22-6	JPA391PZI1			
2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione		2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione					
2'-(4-fluorophenyl)-21-fluoro-20-oxo-11beta,17alpha-dihydroxy-pregn-4-eno(3,2-c)pyrazole		2'-(4-fluorophenyl)-21-fluoro-20-oxo-11beta,17alpha-dihydroxy-pregn-4-eno(3,2-c)pyrazole					
2'-(glutathion-S-yl)-deschlorodiclofenac		2'-(glutathion-S-yl)-deschlorodiclofenac					
2'-benzoyloxycinnamaldehyde		2-(3-Oxoprop-1-en-1-yl)phenyl benzoate	208118-56-3				
2'-C-methylcytidine		2'-C-methylcytidine	20724-73-6	27FS20C1D8			
2'-cyano-2'-deoxyarabinofuranosylcytosine	134665-72-8	2'-Cyano-2'-deoxyarabinofuranosylcytosine	134665-72-8	VSS4ZDZ2IE			
2'-deoxy-N4-(2-(4-nitrophenyl)ethoxycarbonyl)-5-azacytidine		2'-deoxy-N4-(2-(4-nitrophenyl)ethoxycarbonyl)-5-azacytidine					
2'-deoxyadenosine	958-09-8	2'-Deoxyadenosine	958-09-8	P582C98ULC	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
2'-deoxyadenosine triphosphate		2'-Deoxyadenosine 5'-triphosphate	1927-31-7	K8KCC8SH6N			
2'-deoxycytidine 5'-triphosphate	2056-98-6	2'-Deoxycytidine-5'-triphosphate	2056-98-6				
2'-deoxyguanosine 5'-phosphate	902-04-5	2'-Deoxyguanosine 5'-phosphate	902-04-5	7EAM4TG712			
2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine	19192-40-6	Adenosine, thymidylyl-(3'-5')-2'-deoxy-	19192-40-6				
2'-deoxyuridylic acid	964-26-1	2'-Deoxyuridine 5'-monophosphate	964-26-1	N9J10KFG94			
2'-epi-2'-O-acetylthevetin B		2'-epi-2'-O-acetylthevetin B					
2'-fluoro-6,7-methylenedioxy-2-phenyl-4-quinolone		2'-fluoro-6,7-methylenedioxy-2-phenyl-4-quinolone					
2'-hydroxy-2,3',4,5'-tetrabromodipheyl ether		2'-hydroxy-2,3',4,5'-tetrabromodipheyl ether					
2'-hydroxychalcone		2'-Hydroxychalcone	888-12-0	VY06DZ94OC			
2'-hydroxyflavanone		2'-Hydroxyflavanone	17348-76-4				
2'-O-methyl-8-(4-chlorophenylthio)cAMP		2'-O-methyl-8-(4-chlorophenylthio)cAMP					
2',3-dimethyl-4-aminobiphenyl	13394-86-0	2',3-Dimethyl-4-aminobiphenyl	13394-86-0		Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
2',3,3',4',5-pentachloro-4-hydroxybiphenyl		2',3,3',4',5-pentachloro-4-hydroxybiphenyl					
2',3'-dialdehyde ATP	54970-91-1	2',3'-dialdehyde ATP	54970-91-1		Affinity Labels	Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. (See all compounds classified as Affinity Labels.)	
2',3'-dideoxycytidine 5'-triphosphate	66004-77-1	2',3'-Dideoxycytidine 5'-triphosphate	66004-77-1				
2',3'-dideoxyguanosine 5'-triphosphate	68726-28-3	2'-3'-Dideoxyguanosine-5'-triphosphate					
2',3',4',5,5'-pentachloro-2-biphenylol	67651-36-9	2-Hydroxy-2',3',4',5,5'-pentachlorobiphenyl	67651-36-9				
2',3',4',5'-tetrachloro-4-biphenylol		2,3,4,5-Tetrachloro-4'-biphenylol	67651-34-7	LH750S39FX			
2',4'-dichlorobenzamil amiloride	90689-42-2	2',4'-Dichlorobenzamil amiloride	90689-42-2				
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone		2',4'-Dihydroxy-6'-methoxy-3',5'-dimethylchalcone	65349-31-7				
2',4'-dihydroxychalcone	25515-43-9	2',4'-Dihydroxychalcone	25515-43-9	M7LF69Z68L			
2',5'-dideoxyadenosine	6698-26-6	2',5'-Dideoxyadenosine	6698-26-6	988H339Z1L			
2',5'-dihydroxychalcone		2',5'-Dihydroxychalcone	19312-13-1				
2',5'-oligoadenylate	61172-40-5	Oligoadenylate	61172-40-5		Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein		Bcpcf	202872-98-8				
2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein	85138-49-4	2',7'-Bis(carboxyethyl)-5(6)-carboxyfluorescein	85138-49-4		Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
2',7'-dichlorofluorescein	76-54-0	2',7'-Dichlorofluorescein	76-54-0	56NQM5UZT1			
2''-galloylhyperin	53209-27-1	2'-O-galloylhyperin	53209-27-1				
2''-O-acetyl-polygalacin D2		2''-O-acetyl-polygalacin D2					
20-alpha-dihydrodydrogesterone		Pregna-4,6-dien-3-one, 20-hydroxy-, (9beta,10alpha,20S)-	4243-74-7	QPF25HV8PA			
20-alpha-Dihydroprogesterone	145-14-2	(20S)-20-Hydroxypregn-4-en-3-one	145-14-2	45630A64AC	Progestins	Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. (See all compounds classified as Progestins.)	
20-hydroximino-4,16-pregnadien-3-one		20-hydroximino-4,16-pregnadien-3-one					
20-hydroxy-5,8,11,14-eicosatetraenoic acid	79551-86-3	20-Hydroxyeicosatetraenoic acid	79551-86-3				
20-hydroxycholesterol	516-72-3	20-Hydroxycholesterol	516-72-3	30060WAL99			
20-hydroxyeicosa-5(Z),14(Z)-dienoic acid		20-hydroxyeicosa-5(Z),14(Z)-dienoic acid					
20-hydroxyeicosa-6(Z),15(Z)-dienoic acid		20-hydroxyeicosa-6(Z),15(Z)-dienoic acid					
20-hydroxylecdysone		20-hydroxylecdysone					
20-hydroxyvitamin D2		20-hydroxyvitamin D2					
20-O-(beta-D-glucopyranosyl)-20(S)-protopanaxadiol		ginsenoside C-K	39262-14-1	G8D4792Q7K			
20,21-epoxyresibufogenin-3-formate		20,21-epoxyresibufogenin-3-formate					
20(S)-ginsenoside-Rh1-6'-acetate		20(S)-ginsenoside-Rh1-6'-acetate					
21-dehydrocortisol	14760-49-7	21-Dehydrocortisol	14760-49-7	XT2H26EPI2			
22-hydroxycholesterol	17711-16-9	22-Hydroxycholesterol	17711-16-9	TJ9HV8VPD2			
22-thiocyanatosalvinorin A		22-Thiocyanatosalvinorin A	1174223-49-4	GH7ZNH3JMF			
22,23-dihydroavermectin B(1)a	71827-03-7	Ivermectin B1a	71827-03-7	91Y2202OUW	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	Administered topically, ivermectin cream is indicated for the treatment of inflammatory lesions associated with rosacea. An over-the-counter ivermection lotion is commercially available and indicated for the topical treatment of head lice infestations in patients 6 months of age.  Orally administered ivermectin is indicated as a broad-spectrum anti-parasitic for the treatment of intestinal strongyloidiasis caused by _Strongyloides stercoralis_ and onchocerciasis caused by _Onchocerca volvulus_. Systemic ivermectin therapy is used internationally for the treatment of various tropical diseases, including filariasis, cutaneous larva migrans, and _Loa loa_ infection, amongst others.
23-epi-26-deoxyactein		23-epi-26-Deoxyactein	501938-01-8	2A97XP2V7I			
24-diamino-5-phenylthiazole		24-diamino-5-phenylthiazole					
24-hydroxycholesterol	474-73-7	24(S)-hydroxycholesterol	474-73-7	47IMW63S3F			
24-norcholan-2,3,24-tryl-2,3,23-sulfuric acid		24-norcholan-2,3,24-tryl-2,3,23-sulfuric acid					
24-norursodeoxycholic acid	99697-24-2	Norursodeoxycholic Acid	99697-24-2	8A5G600D9V			Treatment of autoimmune sclerosing cholangitis, Treatment of primary sclerosing cholangitis
24,25-Dihydroxyvitamin D 3	40013-87-4	24,25-Dihydroxycholecalciferol	40013-87-4	0AXX2V8L5Z	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	
24,25-epoxycholesterol	68138-65-8	Cholestan-3-ol, 24,25-epoxy-, (3alpha,5beta)-	68138-65-8				
24a-homo-1,15-dihydroxyergocalciferol		24a-homo-1,15-dihydroxyergocalciferol					
25-hydroxycholesterol	2140-46-7	25-Hydroxycholesterol	2140-46-7	767JTD2N31			
25-hydroxyprotopanaxadiol		25(R)-Hydroxyprotopanaxadiol	83349-37-5				
25-hydroxyvitamin D		(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-5-hydroxy-1,5-dimethyl-hexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol					
25-methoxyldammarane-3,12,20-triol		25-methoxyldammarane-3,12,20-triol					
26-aminocholesterol	71472-94-1	26-Aminocholesterol	71472-94-1				
26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3	83805-11-2	Falecalcitriol	83805-11-2	G70A8514T8	Dermatologic Agents	Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)	
27-hydroxy-4-cholesten-3-one		27-hydroxy-4-cholesten-3-one					
27-hydroxycholesterol		27-Hydroxycholesterol	20380-11-4	6T2NA6P5SQ			
28-deoxonimbolide	126005-94-5	28-Deoxonimbolide	126005-94-5				
28-O-acetylbetulin-3-ylglucopyranoside		28-O-acetylbetulin-3-ylglucopyranoside					
28-O-caffeoyl betulin		28-O-caffeoyl betulin					
2beta-carbomethoxy-3beta-(4-iodophenyl)tropane		Iometopane	135416-43-2	4H1Z7121WS	Radiopharmaceuticals	Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)	
2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-	303-75-3	2H-Benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-	303-75-3	H2S3M5M720			
3-((2-fluorothiazol-4-yl)ethynyl)-5-fluorobenzonitrile		3-((2-Fluorothiazol-4-yl)ethynyl)-5-fluorobenzonitrile					
3-((2-fluorothiazol-4-yl)ethynyl)benzonitrile		3-((2-Fluorothiazol-4-yl)ethynyl)benzonitrile					
3-((2-iodothiazol)-4-ethynyl)-5-fluorobenzonitrile		3-((2-Iodothiazol)-4-ethynyl)-5-fluorobenzonitrile					
3-((2-methyl-1,3-thiazol-4-yl)ethynyl)piperidine		2-Methyl-4-(pyridin-3-ylethynyl)thiazole	329205-68-7	XDA7P9K5S6			
3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine		3-((2-Methyl-1,3-thiazol-4-yl)ethynyl)pyridine					
3-((2,4-dimethylpyrrol-5-yl)methylidenyl)-2-indolinone		3-((2,4-dimethylpyrrol-5-yl)methylidenyl)-2-indolinone					
3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone		CFTRinh-172	307510-92-5				
3-((3,5-bis(trifluoromethyl)phenyl)methyloxy)-2-phenylpiperidine	148700-85-0	(2S,3S)-3-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-2-phenylpiperidine	148700-85-0	PK8CG2B44U	Neurokinin-1 Receptor Antagonists	Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS. (See all compounds classified as Neurokinin-1 Receptor Antagonists.)	
3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine		3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo[2,3-b]pyridine	158985-00-3	J3OLN3XSX7	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	
3-((4-chlorobenzyl)oxy)-N-((1S)-1-phenylethyl)-2-thiophenecarboxamide		3-((4-chlorobenzyl)oxy)-N-((1S)-1-phenylethyl)-2-thiophenecarboxamide					
3-((4,6-diphenoxy-1,3,5-triazin-2-yl)amino)benzoic acid		3-((4,6-diphenoxy-1,3,5-triazin-2-yl)amino)benzoic acid					
3-((5-(6-((3-chlorophenyl)amino)pyrazinyl)-3-pyridinyl)amino)-1-propanol		3-((5-(6-((3-chlorophenyl)amino)pyrazinyl)-3-pyridinyl)amino)-1-propanol					
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide		3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide					
3-((adamantan-1-yl)carbonyl)-1-pentylindole		3-((adamantan-1-yl)carbonyl)-1-pentylindole					
3-((O-6-deoxymannopyranosyl-1-2-O-(xylopyranosyl-1-3)arabinopyranosyl)oxy)-21-glucopyranosyloxy-20-hydroxydammar-24-en-19-al		3-((O-6-deoxymannopyranosyl-1-2-O-(xylopyranosyl-1-3)arabinopyranosyl)oxy)-21-glucopyranosyloxy-20-hydroxydammar-24-en-19-al					
3-(1-azepanylsulfonyl)-N-(3-bromphenyl)benzamide		3-(azepan-1-ylsulfonyl)-N-(3-bromophenyl)benzamide	420831-40-9	308B6B695N			
3-(1-deoxyribofuranosyl)benzamide	138385-29-2	Benzamide riboside	138385-29-2		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
3-(1,1-dimethyl-heptyl)-1-9-dihydroxy-benzo(c)chromen-6-one		6H-Dibenzo(b,d)pyran-6-one, 3-(1,1-dimethylheptyl)-1,9-dihydroxy-	335371-37-4	E3OY6PCU04			
3-(1,1-dimethyl-heptyl)-1-hydroxy-9-methoxy-benzo(c)chromen-6-one		3-(1,1-dimethyl-heptyl)-1-hydroxy-9-methoxy-benzo(c)chromen-6-one					
3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one	127792-75-0	3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one	127792-75-0	Y4BW369LGS	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	
3-(1H-indazol-5-yl)-N-propylimidazo(1,2-b)pyridazin-6-amine		3-(1H-indazol-5-yl)-N-propylimidazo(1,2-b)pyridazin-6-amine					
3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid		3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid					
3-(2-(2,2-dimethylpropylsulfanyl)pyridin-3-yl)-N-(3-hydroxycyclohexyl)acrylamide		3-(2-(2,2-dimethylpropylsulfanyl)pyridin-3-yl)-N-(3-hydroxycyclohexyl)acrylamide					
3-(2-(3-(1-adamantyl)-4-hydroxyphenyl)-5-pyrimidinyl)-2-propenoic acid		3-(2-(3-(1-adamantyl)-4-hydroxyphenyl)-5-pyrimidinyl)-2-propenoic acid					
3-(2-(3-guanidino-2-methyl-3-oxo-propenyl)-5-methylphenyl)-N-isopropylidene-2-methyl-acrylamide dihydrochloride		3-(2-(3-guanidino-2-methyl-3-oxo-propenyl)-5-methylphenyl)-N-isopropylidene-2-methyl-acrylamide dihydrochloride	215183-03-2				
3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate		3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate					
3-(2-(4-chlorophenylsulfanyl)phenyl)-N-(4-dimethylaminobutyl)acrylamide		3-(2-(4-chlorophenylsulfanyl)phenyl)-N-(4-dimethylaminobutyl)acrylamide	538368-27-3	2W6T5I5964			
3-(2-(dimethylamino)isopropoxy)-1-hydroxybenzo(b)naphtho(2,3-d)furan-6,11-dione		3-(2-(dimethylamino)isopropoxy)-1-hydroxybenzo(b)naphtho(2,3-d)furan-6,11-dione					
3-(2-(N,N-diethyl-N-methylammonium)ethyl)-7-methoxy-4-methylcoumarin		3-(2-(N,N-diethyl-N-methylammonium)ethyl)-7-methoxy-4-methylcoumarin					
3-(2-(pyrrolidinyl)methoxy)pyridine		3-((S)-1-Methyl-pyrrolidin-2-ylmethoxy)-pyridine	161416-43-9	WSK2XM6RPF			
3-(2-benzyloxyphenyl)-5-chloromethylisoxazole		3-(2-Benzyloxyphenyl)-5-chloromethylisoxazole	601519-76-0				
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid	100828-16-8	4-(3-Phosphonopropyl)piperazine-2-carboxylic acid	100828-16-8	98Y1I8ZD4M			
3-(2-cyano-3-(trifluoromethyl)phenoxy)phenyl-4,4,4-trifluoro-1-butanesulfonate		3-(2-cyano-3-(trifluoromethyl)phenoxy)phenyl-4,4,4-trifluoro-1-butanesulfonate					
3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate		3-(2-Ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate	174689-39-5	Z4G2GB3YHU	Adrenergic beta-3 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC BETA-3 RECEPTORS. (See all compounds classified as Adrenergic beta-3 Receptor Antagonists.)	
3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole	69095-83-6	3-(2-Ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole	69095-83-6	5HK8O3MA34	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol	83003-12-7	2-[(1r,2r,5r)-5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol	83002-04-4	KFY70972J5	Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol		3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol					
3-(2-methoxybenzylamino)-2-phenylpiperidine	136982-36-0	(2S,3S)-3-(2-Methoxybenzylamino)-2-phenylpiperidine	136982-36-0	5KM4QA7RZC			
3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid	55701-05-8	3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid	55701-05-8				
3-(2,2,2-trimethylhydrazine)propionate	76144-81-5	Meldonium	76144-81-5	73H7UDN6EC	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
3-(2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl)phenol		6,7-Bis(3-hydroxyphenyl)pteridine-2,4-diamine	677297-51-7	7ACH1U1E2M			Investigated for use/treatment in angioedema and myocardial infarction.
3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone		3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	338967-87-6				
3-(2,4-dimethoxybenzylidene)anabaseine		3-(2,4-Dimethoxybenzylidene)anabaseine	148372-04-7	8S399XDN2K	Nicotinic Agonists	Drugs that bind to and activate nicotinic cholinergic receptors (RECEPTORS, NICOTINIC). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission. (See all compounds classified as Nicotinic Agonists.)	Investigated for use/treatment in alzheimer's disease and schizophrenia and schizoaffective disorders.
3-(2'-deoxy-beta-D-erythro-pentofuranosyl)pyrimido(1,2-alpha)purin-10(3H)-one		3-(2'-deoxy-beta-D-erythro-pentofuranosyl)pyrimido(1,2-alpha)purin-10(3H)-one					
3-(2'-phosphonomethyl(1,1'-biphenyl)-3-yl)alanine		3-(2'-phosphonomethyl(1,1'-biphenyl)-3-yl)alanine					
3-(3-(3-(4,5-dihydroimidazol-2-ylamino)propyloxylisoxazol-5-yl)carbonylamino)-2-(phenylsulfonylamino)propionic acid		3-(3-(3-(4,5-dihydroimidazol-2-ylamino)propyloxylisoxazol-5-yl)carbonylamino)-2-(phenylsulfonylamino)propionic acid					
3-(3-(dimethylamino)propyl)-4-hydroxy-N-(4-(4-pyridinyl)phenyl)benzamide	172854-55-6	3-(3-(Dimethylamino)propyl)-4-hydroxy-N-(4-(pyridin-4-yl)phenyl)benzamide dihydrochloride			Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
3-(3-(quinolin-2-ylamino)phenyl)acrylic Acid		3-(3-(quinolin-2-ylamino)phenyl)acrylic Acid					
3-(3-(quinoxalin-3-ylamino)phenyl)prop-2-en-1-ol		3-(3-(quinoxalin-3-ylamino)phenyl)prop-2-en-1-ol					
3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione		3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione	264218-23-7				
3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea		Metoxuron	19937-59-8	Y58EM37E76			
3-(3-cyanophenyl)-N-n-propylpiperidine	150336-90-6	3-(3-Cyanophenyl)-N-n-propylpiperidine	150336-90-6				
3-(3-cyclohexyl-1-(2-(dimethylamino)-2-oxoethyl)-6-(4-methyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indol-2-yl)-N,N-dimethylbenzamide		3-(3-cyclohexyl-1-(2-(dimethylamino)-2-oxoethyl)-6-(4-methyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indol-2-yl)-N,N-dimethylbenzamide					
3-(3-dimethylaminopropylamino)-8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carbonitrile		3-(3-dimethylaminopropylamino)-8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carbonitrile					
3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide		3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide					
3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one		3-(3-Pyridinyl)-1-(4-pyridinyl)-2-propen-1-one	18550-98-6				
3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5H)-furanone	162011-83-8	3-(3,4-Difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5H)-furanone	162011-83-8				
3-(3,4-dimethoxyphenyl)propenoic acid	2316-26-9	3,4-Dimethoxycinnamic acid	14737-89-4	BVZ841PVJL			
3-(3,4,5-trimethoxybenzylidene)-5-carboethoxyindolin-2-one		3-(3,4,5-trimethoxybenzylidene)-5-carboethoxyindolin-2-one					
3-(3,5-dichlorophenyl)-2,4-thiazolidinedione		3-(3,5-dichlorophenyl)-2,4-thiazolidinedione					
3-(4-((2,6-dichloropyridin-4-yl)ethynyl)phenyl)propanoic acid		3-(4-((2,6-dichloropyridin-4-yl)ethynyl)phenyl)propanoic acid					
3-(4-((2',6'-dimethylbiphenyl-3-yl)methoxy)-2-fluorophenyl)propanoic acid		3-(4-((2',6'-dimethylbiphenyl-3-yl)methoxy)-2-fluorophenyl)propanoic acid					
3-(4-(1,2-diphenylbut-1-enyl)phenyl)acrylic acid	155701-61-4	(2E)-3-{4-[(1E)-1,2-Diphenylbut-1-enyl]phenyl}acrylic acid	155701-61-4	WEM4BUT8FL			
3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid		3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid					
3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine		3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine					
3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole	81226-60-0	3-(4-(4-Chlorophenyl-4-hydroxypiperidino)methyl)indole	81226-60-0	WTW4A6SW92	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	
3-(4-(morpholin-4-yl)-7H-pyrrolo(2,3-d)pyrimidin-5-yl)benzonitrile		3-(4-(morpholin-4-yl)-7H-pyrrolo(2,3-d)pyrimidin-5-yl)benzonitrile					
3-(4-Amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo(3,4-b)pyridine		3-(4-Amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo(3,4-b)pyridine					
3-(4-azidobenzoyl)-6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thiophene	131589-60-1	3-(4-Azidobenzoyl)-6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thiophene	131589-60-1				
3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide		3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide					
3-(4-bromophenyl)-2-(ethylsulfonyl)-6-methylquinoxaline-1,4-dioxide		3-(4-bromophenyl)-2-(ethylsulfonyl)-6-methylquinoxaline-1,4-dioxide					
3-(4-chloro-3-nitrolphenyl)-1,2,3-oxadiazolium-5-olate		3-(4-chloro-3-nitrolphenyl)-1,2,3-oxadiazolium-5-olate					
3-(4-chlorophenyl)-3-(2-(dimethylamino)ethyl)isochroman-1-one		3-(4-Chlorophenyl)-3-(2-(dimethylamino)ethyl)isochroman-1-one					
3-(4-chlorophenyl)-3-(4-hydroxy-3,5-dimethoxybenzyloxy)-2-propyl-2,3-dihydroisoindol-1-one		3-(4-Chlorophenyl)-3-(4-hydroxy-3,5-dimethoxybenzyloxy)-2-propyl-2,3-dihydroisoindol-1-one					
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide		Tricyclo(3.3.1.13,7)decane-1-carboxamide, 3-(4-chlorophenyl)-N-(4-pyridinylmethyl)-	915385-81-8				
3-(4-chlorophenylselanyl)-1-methyl-1H-indole		3-(4-chlorophenylselanyl)-1-methyl-1H-indole					
3-(4-dimethylamino-benzylidenyl)-2-indolinone		3-(4-Dimethylamino-benzylidenyl)-2-indolinone	5812-07-7				
3-(4-dimethylaminobenzylidene)-1,3-dihydroindol-2-one		3-(4-dimethylaminobenzylidene)-1,3-dihydroindol-2-one					
3-(4-hydroxy-2-methoxybenzylidene)anabaseine		3-(4-hydroxy-2-methoxybenzylidene)anabaseine					
3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazoleacetic acid methyl ester		3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazoleacetic acid methyl ester					
3-(4-methylphenylsulfonyl)-2-propenenitrile		(E)-3-Tosylacrylonitrile	19542-67-7	4Y5G2A4F6O			
3-(4-methylpiperazin)-8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carbonitrile		3-(4-methylpiperazin)-8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carbonitrile					
3-(4-methylsulfonylphenyl)-4-phenyl-5-trifluoromethylisoxazole		3-(4-Methylsulfonylphenyl)-4-phenyl-5-trifluoromethylisoxazole	340267-36-9				
3-(4-pyridyl)-1H-indole		Rockout	7272-84-6				
3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide		(2E)-N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-3-[4-(1,1-dimethylethyl)phenyl]-2-propenamide	545395-94-6	182HIJ2D7F			
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid		Adarotene	496868-77-0	W6SU73VG8H			
3-(5-(-1-acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-(4-(5-methoxypyrimidin-2-yl)-benzyl)-1H-indol-2-yl)-2,2-dimethyl-propionic acid		3-(5-(-1-acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-(4-(5-methoxypyrimidin-2-yl)-benzyl)-1H-indol-2-yl)-2,2-dimethyl-propionic acid					
3-(5-(2-(1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-2-ethyl-5-isobutyl-7-methyl-3H-imidazo(4,5-b)pyridine		3-(5-(2-(1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-2-ethyl-5-isobutyl-7-methyl-3H-imidazo(4,5-b)pyridine					
3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl)methylpyridine		3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl)methylpyridine					
3-(5-(4-(2-hydroxy-2-methylpropionyl)piperazin-1-yl)-2-trifluoromethylphenyl)-4-(1H-indol-3-yl)pyrrole-2,5-dione		3-(5-(4-(2-hydroxy-2-methylpropionyl)piperazin-1-yl)-2-trifluoromethylphenyl)-4-(1H-indol-3-yl)pyrrole-2,5-dione					
3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid		3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxy-1,2-benzisoxazol-6-yl)methoxy)phenyl)propionic acid					
3-(5-methyl-2-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid		3-(5-methyl-2-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid					
3-(5-tert-butylisoxazol-3-yl)-2-((3-chlorophenyl)hydrazono)-3-oxopropionitrile		3-(5-tert-butylisoxazol-3-yl)-2-((3-chlorophenyl)hydrazono)-3-oxopropionitrile					
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole	154453-18-6	Lificiguat	170632-47-0	515CC1WPTE	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester		tert-Butyl 3-((3S,6S,12aS)-6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino[1',2':1,6]pyrido[3,4-b]indol-3-yl)propanoate	461054-93-3				
3-(6-methoxypyridin-3-yl)-3-(2-oxo-3-(3-(5,6,7,8-tetrahydro(1,8)naphthyridin-2-yl)propyl)imidazolidin-1-yl)propionic acid		(3S)-3-(6-Methoxy-3-pyridyl)-3-(2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)imidazolidin-1-yl)propanoic acid	227963-15-7	1JL033A2D0			
3-(7-trifluoromethyl-5-(2-trifluoromethylphenyl)-1H-benzimidazol-2-yl)-1-oxa-2-azaspiro(4.5)dec-2-ene		3-(7-trifluoromethyl-5-(2-trifluoromethylphenyl)-1H-benzimidazol-2-yl)-1-oxa-2-azaspiro(4.5)dec-2-ene					
3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol		3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol					
3-(alpha,alpha-dimethylallyl)psoralen	13164-03-9	Chalepensin	13164-03-9	TGU8MP93CA			
3-(carbamoylamino)-5-(3-fluorophenyl)-N-(3-piperidyl)thiophene-2-carboxamide		3-(carbamoylamino)-5-(3-fluorophenyl)-N-(3-piperidyl)thiophene-2-carboxamide					
3-(difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole	151506-44-4	3-(Difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole	151506-44-4	C7M22YQZ95			
3-(formylhydroxyamino)-2-(3-phenyl-1-propyl)butanoic acid (2,2-dimethyl-1-methylcarbamoyl-1-propyl)amide		3-(formylhydroxyamino)-2-(3-phenyl-1-propyl)butanoic acid (2,2-dimethyl-1-methylcarbamoyl-1-propyl)amide					
3-(glutathion-S-yl)acetaminophen	64889-81-2	3-(Glutathion-S-yl)acetaminophen	64889-81-2	T3YTW02XCU			
3-(hydroxymethyl)phenytoin	21616-46-6	3-(Hydroxymethyl)-5,5-diphenylimidazolidine-2,4-dione	21616-46-6	F71KON5KGN			
3-(indol-3-yl)propionic acid		3-Indolepropionic acid	830-96-6	JF49U1Q7KN			
3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol		3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol					
3-(N-phenylamino)-1,2-propanediol 1,2-dioleoyl ester	95416-26-5	3-(N-Phenylamino)-1,2-propanediol 1,2-dioleoyl ester	95416-26-5				
3-(pentadec-10-enyl)catechol	83532-37-0	3-(Pentadec-10-enyl)catechol	83532-37-0				
3-(phenylsulfonyl)-4-(2-(4-(2-(3,7,11-trimethyldodeca-2,6,10-trienylthio)benzoyl)piperazin-1-yl)ethoxy)-1,2,5-oxadiazole-2-oxide		3-(phenylsulfonyl)-4-(2-(4-(2-(3,7,11-trimethyldodeca-2,6,10-trienylthio)benzoyl)piperazin-1-yl)ethoxy)-1,2,5-oxadiazole-2-oxide					
3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one		3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one					
3-acetyl-4-oxo-6,7-dihydro-12H indolo(2,3-a)quinolizine		3-acetyl-4-oxo-6,7-dihydro-12H indolo(2,3-a)quinolizine					
3-acetyl-5-methyltetronic acid		3-acetyl-5-methyltetronic acid					
3-acetyl-7-(4-hydroxyphenyl)-2H-chromen-2-one		3-acetyl-7-(4-hydroxyphenyl)-2H-chromen-2-one					
3-acetyl-7-methoxycoumarin		3-acetyl-7-methoxy-2H-chromen-2-one	64267-19-2				
3-acetyldeoxynivalenol	50722-38-8	3-Acetyldeoxynivalenol	50722-38-8	838JJ2425Y			
3-acetylpyridine	350-03-8	3-Acetylpyridine	350-03-8	00QT8FX306	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
3-adenin-9-yl-2-hydroxypropanoic acid isobutyl ester	94458-82-9	Isobutyl 3-(6-amino-9H-purin-9-yl)-2-hydroxypropanoate					
3-amino-1-methyl-5H-pyrido(4,3-b)indole		3-Amino-1-methyl-5H-pyrido[4,3-b]indole	62450-07-1	775UJ9HCTR	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole		3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole	62450-06-0	LAH2R5Z22D	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
3-amino-2-quinoxalinecarbonitrile		3-Amino-2-quinoxalinecarbonitrile	23190-84-3				
3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid		3-Amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid					
3-amino-5-((2-((2-methoxyethyl)amino)-6-(4-(trifluoromethyl)phenyl)pyrimidin-4-yl)oxy)quinoxalin-2(1H)-one		3-amino-5-((2-((2-methoxyethyl)amino)-6-(4-(trifluoromethyl)phenyl)pyrimidin-4-yl)oxy)quinoxalin-2(1H)-one					
3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide		3-Amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide	1232410-49-9	BF884TQ935			
3-aminobenzamide		3-Aminobenzamide	3544-24-9	8J365YF1YH	Poly(ADP-ribose) Polymerase Inhibitors	Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. (See all compounds classified as Poly(ADP-ribose) Polymerase Inhibitors.)	
3-aminobenzanthrone		3-Aminobenzanthrone	13456-80-9				
3-aminobenzoic acid	99-05-8	3-Aminobenzoic acid	99-05-8	G2X3B3O37U			
3-aminofluoranthene	2693-46-1	3-Aminofluoranthene	2693-46-1	8UN5PRH090			
3-aminophenol	591-27-5	3-Aminophenol	591-27-5	L3WTS6QT82			
3-aminopropylphosphinic acid	103680-47-3	3-Aminopropylphosphinic acid	103680-47-3	QMT5SS3QRE	GABA Agonists	Endogenous compounds and drugs that bind to and activate GAMMA-AMINOBUTYRIC ACID receptors (RECEPTORS, GABA). (See all compounds classified as GABA Agonists.)	
3-aminopyridine-2-carboxaldehyde thiosemicarbazone	143621-35-6	Triapine	143621-35-6	U4XIL4091C			
3-aminothioacridone		3-amino-10H-acridine-9-thione	129821-08-5				
3-anisidine		m-Anisidine	536-90-3	JXA144KX2I			
3-azibutanol		2-(3-Methyl-3H-diazirin-3-yl)ethanol	25055-82-7	W3T6XGA58Y			
3-benzenesulfonyl-8-piperazin-1-ylquinoline		Intepirdine	607742-69-8	2IOB2M82HY			
3-benzoylpyridine	5424-19-1	3-Benzoylpyridine	5424-19-1	2A1326450X			
3-benzyl-5-((2-nitrophenoxy)methyl)dihydrofuran-2(3H)-one		3-benzyl-5-((2-nitrophenoxy)methyl)dihydrofuran-2(3H)-one					
3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo(4,5-d)pyrimidine		3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo(4,5-d)pyrimidine					
3-benzylidene camphor		3-Benzylidene camphor	36275-29-3	2F60H204CM	Sunscreening Agents	Chemical or physical agents that protect the skin from sunburn and erythema by absorbing or blocking ultraviolet radiation. (See all compounds classified as Sunscreening Agents.)	
3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one	3039-71-2	3beta-(2-Diethylaminoethoxy)androst-5-en-17-one hydrochloride	3039-71-2	V0DPR5J8ZJ	Anticholesteremic Agents	Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)	
3-biphenyl-4-yl-4-(2-fluorophenyl)-5-isopropyl-4H-1,2,4-triazole		3-biphenyl-4-yl-4-(2-fluorophenyl)-5-isopropyl-4H-1,2,4-triazole					
3-bromo-2-oxopropionic acid		Bromopyruvic acid	1113-59-3	63JMV04GRK	Affinity Labels	Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. (See all compounds classified as Affinity Labels.)	
3-bromo-7-nitroindazole		3-Bromo-7-nitroindazole	74209-34-0				
3-bromoacetylamino benzoic acid ethyl ester		3-bromoacetylamino benzoic acid ethyl ester					
3-bromomethcathinone		1-Propanone, 1-(3-bromophenyl)-2-(methylamino)-	486459-02-3	789QE5VA57			
3-bromopropylamine	18370-81-5	3-Bromopropylamine	18370-81-5	Z3NKY847J9			
3-buten-2-one	78-94-4	Methyl vinyl ketone	78-94-4	AR7642I1MP			
3-butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3H)-isobenzofuranone	153609-96-2	3-Butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3H)-isobenzofuranone	153609-96-2				
3-caffeoyl-4-dicaffeoylquinic acid		3-caffeoyl-4-dicaffeoylquinic acid					
3-caffeoyl-4-dihydrocaffeoylquinic acid		3-caffeoyl-4-dihydrocaffeoylquinic acid					
3-carboxy-2,2,5,5-tetramethylpyrrolidin-1-yloxyl		3-carboxy-2,2,5,5-tetramethylpyrrolidin-1-yloxyl					
3-chloro-1,2-propanediol 1-palmitate		3-Chloro-1,2-propanediol 1-Palmitate	30557-04-1	F94G01857T			
3-chloro-3'-((2-cyclopentyl-3-oxo-2,3-dihydrobenzo(d)isothiazol-6-yloxy)methyl)biphenyl-4-carboxylic acid		3-chloro-3'-((2-cyclopentyl-3-oxo-2,3-dihydrobenzo(d)isothiazol-6-yloxy)methyl)biphenyl-4-carboxylic acid					
3-chloro-4-(4-((2-(3-pyridyl)pyrrolidin-1-yl)methyl)phenoxy)benzamide		3-chloro-4-(4-((2-(3-pyridyl)pyrrolidin-1-yl)methyl)phenoxy)benzamide					
3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone	77439-76-0	3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone	77439-76-0	SSD7YR4366	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
3-chloroacetylindole	28755-03-5	2-Chloro-1-(1H-indol-3-yl)ethanone	28755-03-5				
3-chloroaniline	108-42-9	3-Chloroaniline	108-42-9	6GKR52SKIY			
3-chlorobiphenyl	2051-61-8	3-Chlorobiphenyl	11104-28-2	WLQ4633SJY			
3-chloroperbenzoic acid		3-Chloroperoxybenzoic acid	937-14-4	G203D4H1RB	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
3-chlorophenol	108-43-0	3-Chlorophenol	108-43-0	Z2Z7M2FTAD			
3-coumaric acid	588-30-7	3'-Hydroxycinnamic acid	14755-02-3	KWJ2DDJ34H			
3-cresol	108-39-4	m-Cresol	108-39-4	GGO4Y809LO			
3-cyano-7-ethoxycoumarin	117620-77-6	3-Cyano-7-ethoxycoumarin	117620-77-6	997LV3DUS7			
3-cyano-7-hydroxycoumarin	19088-73-4	3-Cyano-7-hydroxycoumarin	19088-73-4				
3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide		Cdppb	781652-57-1	Y4F3R8YW3G			
3-cyanoalanine	923-01-3	3-Cyanoalanine	923-01-3	NGZ6PU7PK7			
3-cyanocoumarin		3-Cyanocoumarin	15119-34-3				
3-deazaadenosine	6736-58-9	3-Deazaadenosine	6736-58-9	037V4520IY			
3-deazaguanine	41729-52-6	Dezaguanine	41729-52-6	9DRB973HUI	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	
3-deazaneplanocin	102052-95-9	3-Deazaneplanocin	102052-95-9	544SH4020S			
3-dehydrocarnitine		3-Dehydrocarnitine	10457-99-5	759KUA9C5Z			
3-demethylubiquinone Q2		3-demethylubiquinone Q2					
3-deoxyestrone	53-45-2	3-Deoxyestrone	53-45-2	M8WJ87C2AC			
3-deoxyglucosone		3-Deoxyglucosone	4084-27-9	EXV5374VEY			
3-dihydroxy-6-methyl-7-(phenylmethyl)-4-propylnaphthalene-1-carboxylic acid		7-benzyl-2,3-dihydroxy-6-methyl-4-propyl-naphthalene-1-carboxylic Acid	213971-34-7				
3-dimethylaminopropylamine	109-55-7	3-Dimethylaminopropylamine	109-55-7	I98I2UEC03			
3-dinitrobenzene	99-65-0	1,3-Dinitrobenzene	99-65-0	DK8B627BU0			
3-DOXYLANDROSTANOL	25521-33-9	3-Doxylandrostanol	25521-33-9				
3-ethoxycarbonyl-2-methyl-4-(2-nitrophenyl)-4,11-dihydro-1H-pyrido(2,3-b)(1,5)benzodiazepine		3-ethoxycarbonyl-2-methyl-4-(2-nitrophenyl)-4,11-dihydro-1H-pyrido(2,3-b)(1,5)benzodiazepine					
3-ethylaniline		3-Ethylaniline	587-02-0	W5U3OQY77O			
3-ethylphenol		3-Ethylphenol	620-17-7	0G9ZK222JX			
3-fluoro-3-(3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl)-N-(2-methylpropyl)cyclobutanecarboxamide		H3 receptor antagonist 1	935840-35-0	FPI2G03BJ1			
3-fluoro-4-(4-((2-(3-fluorophenyl)pyrrolidin-1-yl)methyl)phenoxy)benzamide		3-fluoro-4-(4-((2-(3-fluorophenyl)pyrrolidin-1-yl)methyl)phenoxy)benzamide					
3-fluoro-4-hydroxybenzoate	350-29-8	3-Fluoro-4-hydroxybenzoic acid	350-29-8				
3-fluoro-5-(2-(2-(fluoromethyl)thiazol-4-yl)ethynyl)benzonitrile		Benzonitrile, 3-fluoro-5-(2-(2-(fluoromethyl)-4-thiazolyl)ethynyl)-	945933-41-5	T35FOR92W2			
3-fluorobenzoic acid	455-38-9	3-Fluorobenzoic acid	455-38-9	ELG54JFF34			
3-hexen-1-ol	928-96-1	cis-3-Hexen-1-ol	928-96-1	V14F8G75P4			
3-hydro-2,2,5,6-tetramethylpyrazine		3-hydro-2,2,5,6-tetramethylpyrazine					
3-hydrogenkwadaphnin		3-hydrogenkwadaphnin					
3-hydroxy-17-(1H-1,2,3-triazol-1-yl)androsta-5,16-diene		3-hydroxy-17-(1H-1,2,3-triazol-1-yl)androsta-5,16-diene					
3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene		Galeterone	851983-85-2	WA33E149SW	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
3-hydroxy-17-(imidazol-1-yl)androsta-5,16-diene		3-hydroxy-17-(imidazol-1-yl)androsta-5,16-diene					
3-hydroxy-2-naphthoic acid	92-70-6	3-Hydroxy-2-naphthoic acid	92-70-6	C7S9D784HX			
3-hydroxy-2-naphthoic acid o-aniside	135-62-6	3-Hydroxy-2'-methoxy-2-naphthanilide	135-62-6	G9HI0D9DPC			
3-hydroxy-2,2',4,4',5,6'-hexabromodiphenyl ether		3-hydroxy-2,2',4,4',5,6'-hexabromodiphenyl ether					
3-hydroxy-3-methylglutaryl-coenzyme A	1553-55-5	3-Hydroxy-3-methylglutaryl-CoA	1553-55-5				
3-hydroxy-4-methoxyphenethylamine	3213-30-7	5-(2-Aminoethyl)-2-methoxyphenol	3213-30-7	62MI76A89G			
3-hydroxy-4-pentenoic acid	38996-03-1	3-Hydroxypent-4-enoic acid	38996-03-1				
3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid		2-Hydroxy-4-methoxy-3-(3-methyl-2-butenyl)-6-(2-phenylethenyl)benzoic acid	87402-84-4				
3-hydroxy-5-cholestenoic acid	6561-58-6	3-Hydroxy-5-cholestenoic acid	6561-58-6				
3-hydroxyacetanilide	621-42-1	Metacetamol	621-42-1	V942ZCN81H	Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
3-hydroxyanisole	150-19-6	3-Methoxyphenol	150-19-6	HXB7441U87			
3-hydroxybenz(a)anthracene	4834-35-9	3-Hydroxybenz[a]anthracene	4834-35-9				
3-hydroxybenzaldehyde	100-83-4	3-Hydroxybenzaldehyde	100-83-4	8Z2819J40E			
3-hydroxybenzeneacetic acid		3-Hydroxyphenylacetic acid	621-37-4	K59Z6Z8REF			
3-hydroxybenzo(a)pyrene	13345-21-6	3-Hydroxybenzo(a)pyrene	13345-21-6	672ICH1Q4L			
3-hydroxybenzoic acid	99-06-9	3-Hydroxybenzoic acid	99-06-9	2ZFW40OJ7U			
3-hydroxybenzyl alcohol	620-24-6	3-Hydroxybenzyl alcohol	620-24-6	H652F6XF7Y			
3-hydroxybenzylhydrazine	637-33-2	3-Hydroxybenzylhydrazine	637-33-2	A27K5Q85R2	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
3-hydroxybiphenyl	580-51-8	3-Phenylphenol	580-51-8	ZU11X47H4O			
3-hydroxybisphenol A		5-hydroxybisphenol A	79371-66-7				
3-Hydroxybutyric Acid	300-85-6	3-Hydroxybutyric acid	300-85-6	TZP1275679			
3-hydroxydesloratadine		3-Hydroxydesloratadine	119410-08-1	3H9FFN759V			
3-hydroxyflavanone		3'-Hydroxyflavanone	92496-65-6	5O4MY88W2V			
3-hydroxyflavone	577-85-5	3-Hydroxyflavone	577-85-5	ZTG9LSS5QH			
3-hydroxykynurenine	484-78-6	3-Hydroxykynurenine	484-78-6	27723548JL			
3-hydroxylup-20(29)-ene-27,28-dioic acid dimethyl ester		3-hydroxylup-20(29)-ene-27,28-dioic acid dimethyl ester					
3-hydroxypicolinic acid	874-24-8	3-Hydroxypicolinic acid	874-24-8	XV7XP64JR5			
3-hydroxypregn-4-en-20-one	25680-68-6	3alpha-Dihydroprogesterone	25680-68-6	6U8M6JFV3W			
3-hydroxyquinidine		3-Hydroxyquinidine	53467-23-5	00G939C83O			
3-hydroxystilbene		3-(2-Phenylethenyl)phenol	17861-18-6				
3-ingenyl angelate		Ingenol Mebutate	75567-37-2	7686S50JAH			For the topical treatment of actinic keratosis.
3-iodo-2-propynylbutylcarbamate	55406-53-6	3-Iodo-2-propynyl butylcarbamate	55406-53-6	603P14DHEB			
3-Iodobenzylguanidine	77679-27-7	Iobenguane I-131	77679-27-7	Q461L7AK4R	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
3-iodothyronamine		3-Iodothyronamine	712349-95-6	VMM45J7F4L			
3-iodotyrosine		3-Iodo-L-tyrosine	70-78-0	FRQ98U4U27			
3-isobutanoyl-1-(2-oxo-3-(4-phenoxyphenoxy)propyl)indole-5-carboxylic acid		3-isobutanoyl-1-(2-oxo-3-(4-phenoxyphenoxy)propyl)indole-5-carboxylic acid					
3-keto-N-aminoethylaminoethylcaproyldihydrocinnamoyl cyclopamine		N-[2-[(3'R,7'aR)-3',6',10,11b-tetramethyl-3-oxospiro[1,2,4,6,6a,6b,7,8,11,11a-decahydrobenzo[a]fluorene-9,2'-3,3a,5,6,7,7a-hexahydrofuro[3,2-b]pyridine]-4'-yl]ethyl]-6-(3-phenylpropanoylamino)hexanamide	306387-90-6				
3-ketocholanoic acid		3-ketocholanoic acid					
3-ketolithocholic acid		Dehydrolithocholic acid	1553-56-6	96JBM35FXF			
3-mercaptopicolinic acid	14623-54-2	3-Mercaptopicolinic acid	14623-54-2	7XW1R5R974	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
3-Mercaptopropionic Acid	107-96-0	3-Mercaptopropionic acid	107-96-0	B03TJ3QU9M	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
3-mercaptopyruvic acid	2464-23-5	3-Mercaptopyruvic acid	2464-23-5	5Z1F5OW4YB			
3-methoxy-4'-methylthiostilbene		3-methoxy-4'-methylthiostilbene					
3-methoxy-6-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)pyridin-2-amine		3-methoxy-6-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)pyridin-2-amine					
3-methoxycatechol	934-00-9	3-Methoxycatechol	934-00-9	IC13U5393C			
3-methoxymethyl-7-(4,4,4-trifluorobutoxy)-3,3a,4,5-tetrahydro-1,3-oxazolo(3,4-a)quinolin-1-one		3-methoxymethyl-7-(4,4,4-trifluorobutoxy)-3,3a,4,5-tetrahydro-1,3-oxazolo(3,4-a)quinolin-1-one					
3-methoxymorphinan	1531-25-5	Morphinan, 3-methoxy-	1531-25-5	497WV2EY4T			
3-methoxytyramine	554-52-9	4-(2-Aminoethyl)-2-methoxyphenol	554-52-9	JCH2767EDP			
3-methyl-1-phenyl-2-(phenylseleno)oct-2-en-1-one		3-Methyl-1-phenyl-2-(phenylseleno)oct-2-en-1-one					
3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole	147402-53-7	3-Methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole	147402-53-7	B9I6MZL7BW	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	
3-methyl-9-(2-oxa-2lambda(5)-2H-1,3,2-oxazaphosphorine-2-cyclohexyl)-3,6,9-triazaspiro(5.5)undecane		3-methyl-9-(2-oxa-2lambda(5)-2H-1,3,2-oxazaphosphorine-2-cyclohexyl)-3,6,9-triazaspiro(5.5)undecane					
3-methyl-N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamide		3-methyl-N-phenyl-N-(3-(piperidin-1-yl)propyl)benzo[b]furan-2-carboxamide					
3-methyladenine	5142-23-4	3-Methyladenine	5142-23-4	DR88TV7SNU			
3-methyladenosine	72055-62-0	3-Methyladenosine	72055-62-0				
3-methylbenzaldehyde	620-23-5	3-Methylbenzaldehyde	620-23-5	OWH6650C4Y			
3-methylbenzyl alcohol	587-03-1	3-Methylbenzyl alcohol	587-03-1	TTG38P37U6			
3-methylcatechol	488-17-5	3-Methylcatechol	488-17-5	0HUZ4Q9R8C			
3-methylcholanthrylene	3343-10-0	3-Methylcholanthrylene	3343-10-0	249VV7E1QH			
3-methylchrysene		3-Methylchrysene	3351-31-3	A1D0DVO36T			
3-methyleneindolenine	40642-83-9	3-Methyleneindolenine	40642-83-9	F4W4M3S5Z4			
3-methylglutaric acid	626-51-7	3-Methylglutaric acid	626-51-7	3Q0P190C7B			
3-methylpentyl(4-sulphamoylphenyl)carbamate		3-methylpentyl(4-sulphamoylphenyl)carbamate					
3-methylpyridine	108-99-6	beta-PICOLINE	108-99-6	B083J4KF7F			
3-methylquercetin	480-19-3	Isorhamnetin	480-19-3	07X3IB4R4Z			
3-methylquinoline	612-58-8	3-Methylquinoline	612-58-8	1YC9RBW2G0			
3-methylsulfonyl-4-piperidinobenzoyl guanidine	141923-47-9	3-Methylsulfonyl-4-piperidin-1-ylbenzoyl guanidine					
3-methylsydnone-5-nitrosimine		3-Methylsydnone-5-nitrosimine	17590-38-4				
3-morpholinopropyl isothiocyanate		3-Morpholinopropyl isothiocyanate	32813-50-6				
3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate		Trodusquemine	186139-09-3	KKC12PIF16			Investigated for use/treatment in obesity and diabetes mellitus type 2.
3-n-butylphthalide	6066-49-5	Butylphthalide	6066-49-5	822Q956KGM	Neuroprotective Agents	Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)	
3-N-methylspiperone	87539-19-3	3-N-Methylspiperone	87539-19-3	5U54JM2T8G	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
3-nitrobenzaldehyde	99-61-6	3-Nitrobenzaldehyde	99-61-6	G4O92KO71Z			
3-nitrobenzanthrone		3-Nitrobenzanthrone	17117-34-9	O4OJW7BC7W			
3-nitrobenzhydrazide	618-94-0	3-Nitrobenzhydrazide	618-94-0				
3-nitrobenzo(a)pyrene	70021-98-6	3-Nitrobenzo(a)pyrene	70021-98-6	R4GCL2XE8T	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
3-nitrodibenzofuran	5410-97-9	3-Nitrodibenzofuran	5410-97-9				
3-nitrofluoranthene	892-21-7	3-Nitrofluoranthene	892-21-7	R9796OQK2M	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
3-nitroperylene	20589-63-3	3-Nitroperylene	20589-63-3	DCG4K35YXW			
3-nitrophenol	554-84-7	3-Nitrophenol	554-84-7	T6P4T52V9W			
3-nitropropionic acid	504-88-1	3-Nitropropionic acid	504-88-1	QY4L0FOX0D	Convulsants	Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)	
3-nitrotyrosine	3604-79-3	3-Nitrotyrosine	3604-79-3				
3-O-(3,4,5-trimethoxybenzoyl)epicatechin		3-O-(3,4,5-trimethoxybenzoyl)epicatechin					
3-O-acetylspectaline		(-)-3-O-acetylspectaline	709046-67-3	N6XK6QHP8K			
3-O-caffeoyl-1-methylquinic acid		3-O-caffeoyl-1-methylquinic acid					
3-O-methylgallic acid	3934-84-7	3,4-Dihydroxy-5-methoxybenzoic acid	3934-84-7	8JA4OZ7166			
3-O-Methylglucose	146-72-5	3-O-Methyl-d-glucose	146-72-5	48DU64I6O5			
3-O-methylsphingomyelin		3-O-methylsphingomyelin					
3-O-tert-butoxycarbonylspectaline		3-O-tert-butoxycarbonylspectaline					
3-oxo-1,1-diphenyltetrahydrooxazolo(3,4-a)pyrazine-7-carboxylic acid 4-fluorobenzylamide		3-oxo-1,1-diphenyltetrahydrooxazolo(3,4-a)pyrazine-7-carboxylic acid 4-fluorobenzylamide					
3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile		3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile					
3-oxocholan-24-oic acid	1553-56-6	Dehydrolithocholic acid	1553-56-6	96JBM35FXF			
3-pentadecylphenol		3-Pentadecylphenol	501-24-6	J10ATZ45ZU			
3-phenoxybenzaldehyde		3-Phenoxybenzaldehyde	39515-51-0	2ZI2173196			
3-phenoxybenzoic acid		3-Phenoxybenzoic acid	3739-38-6	69DC2655VH	Metabolic Side Effects of Drugs and Substances	Specific effects of drugs and substances on metabolic pathways such as those occurring through the CYTOCHROME P-450 ENZYME SYSTEM. These include effects that often result in DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; and HERB-DRUG INTERACTIONS. (See all compounds classified as Metabolic Side Effects of Drugs and Substances.)	
3-phenoxybenzylalcohol		(3-Phenoxyphenyl)methanol	13826-35-2	04964J25DQ			
3-phenylpropanol-1	122-97-4	3-Phenyl-1-propanol	122-97-4	U04IC2765C			
3-phenylpropionic acid	501-52-0	3-Phenylpropionic acid	501-52-0	5Q445IN5CU			
3-phosphoglycerate	820-11-1	3-Phosphoglycerate	820-11-1				
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester	71145-03-4	Methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate	71145-03-4		Calcium Channel Agonists	Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in VASCULAR SMOOTH MUSCLE and/or CARDIAC MUSCLE cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture. (See all compounds classified as Calcium Channel Agonists.)	
3-tert-butyl-4-hydroxyanisole	121-00-6	2-tert-Butyl-4-methoxyphenol	25013-16-5	62RAC24292			
3-thiomethyl-5,6-(dimethoxyphenyl)-1,2,4-triazine		3-Thiomethyl-5,6-(dimethoxyphenyl)-1,2,4-triazine					
3-toluic acid	99-04-7	M-Toluic acid	99-04-7	1UA7K8EEXT			
3-toluidine	108-44-1	m-Toluidine	108-44-1	006FKQ96T3			
3-trifluoromethyl-4-nitrophenol	88-30-2	4-Nitro-3-(trifluoromethyl)phenol	88-30-2	96W52A3IFS			
3-tritylthio-L-alanine	2799-07-7	S-Trityl-L-cysteine	2799-07-7				
3-tyramine	588-05-6	m-Tyramine	588-05-6	K1OA38R0EZ			
3-xylene	108-38-3	m-Xylene	108-38-3	O9XS864HTE			
3,19-(2-bromobenzylidene)andrographolide		3,19-(2-bromobenzylidene)andrographolide					
3,3-bis(trifluoromethyl)bicyclo(2.2.1)heptane-2,2-dicarbonitrile	82947-63-5	3,3-Bis(trifluoromethyl)bicyclo(2.2.1)heptane-2,2-dicarbonitrile	82947-63-5				
3,3-dimethylallyl pyrophosphate	358-72-5	Dimethylallyl diphosphate	358-72-5				
3,3-diphenylpropanoate	606-83-7	3,3-Diphenylpropionic acid	606-83-7	8N5P6K2EGB			
3,3,5-trimethylcyclohexanone		3,3,5-Trimethylcyclohexanone	873-94-9	QXG9U7N202			
3,3'-Dichlorobenzidine	91-94-1	3,3'-Dichlorobenzidine	91-94-1	1SDI2328UX	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
3,3'-dichlorobiphenyl	2050-67-1	3,3'-Dichlorobiphenyl	2050-67-1	62U12S7CJZ			
3,3'-dichlorobisphenol A		3,3'-Dichlorobisphenol A	79-98-1	WS963RA8KZ			
3,3'-diethylthiacarbocyanine iodide	905-97-5	3,3'-Diethylthiacarbocyanine iodide	905-97-5				
3,3'-diindolylmethane	1968-05-4	3,3'-Diindolylmethane	1968-05-4	SSZ9HQT61Z	Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	
3,3'-diiodothyronine	70-40-6	3,3'-Diiodothyronine	70-40-6	GNC4MZ8B3Q			
3,3'-iminodipropionitrile		3,3'-Iminodipropionitrile	111-94-4	3XP1CVU865			
3,3',4,4'-tetrabromobiphenyl	77102-82-0	3,3',4,4'-Tetrabromobiphenyl	77102-82-0	O9I88185BK			
3,3',4,4',5,5'-hexabromobiphenyl	60044-26-0	3,3',4,4',5,5'-Hexabromobiphenyl	60044-26-0	O0S2JKE526			
3,3',4,4',5,5'-hexahydroxystilbene		5-[2-(3,4,5-Trihydroxyphenyl)ethenyl]benzene-1,2,3-triol					
3,3',4,5'-tetrahydroxystilbene	4339-71-3	Piceatannol	10083-24-6	6KS3LS0D4F			
3,3',4',5-tetrachloro-4-hydroxybiphenyl		3,3',4',5-tetrachloro-4-hydroxybiphenyl					
3,3',4',5-tetrachlorosalicylanilide	1154-59-2	3,3',4',5-Tetrachlorosalicylanilide	1154-59-2	HNE676755I	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
3,3',4',5,6,7,8-heptamethoxyflavone	1178-24-1	3,5,6,7,8,3',4'-Heptamethphoxyflavone	1178-24-1	288R4CAV1V			
3,3',4',5,7-pentamethylquercetin		3,3',4',5,7-pentamethylquercetin					
3,3',5-trichlorobenzidine	63390-12-5	3,3',5-Trichlorobenzidine	63390-12-5	FRN3U92NVJ			
3,3',5-triiodothyroacetic acid	51-24-1	Tiratricol	51-24-1	29OQ9EU4R1			
3,3',5,5'-tetrahydroxystilbene		3,3',5,5'-tetrahydroxystilbene					
3,3',5,5'-tetramethylbenzidine	54827-17-7	3,3',5,5'-Tetramethylbenzidine	54827-17-7	3B3T5CB8EO	Chromogenic Compounds	Colorless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into colored compounds; used in biochemical assays and in diagnosis as indicators, especially in the form of enzyme substrates. Synonym: chromogens (not to be confused with pigment-synthesizing bacteria also called chromogens). (See all compounds classified as Chromogenic Compounds.)	
3,3',5',5,7-pentahydroflavanone		3,3',5',5,7-pentahydroflavanone					
3,4-di-O-caffeoylquinic acid		4,5-Dicaffeoylquinic acid	89886-31-7	45777W94HK			
3,4-dicarboxyphenylglycine		(RS)-3,4-Dicarboxyphenylglycine	176796-64-8				
3,4-dichlorinated biphenyl		3,4-dichlorinated biphenyl					
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer	67198-13-4	trans-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzeneacetamide	67198-13-4		Analgesics, Non-Narcotic	A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)	
3,4-dichloroacetanilide	2150-93-8	N-(3,4-Dichlorophenyl)acetamide	2150-93-8	N6H98GF14R			
3,4-dichloroaniline	95-76-1	3,4-Dichloroaniline	95-76-1	20KR9WJ4NS			
3,4-dichloroisocoumarin	51050-59-0	3,4-Dichloroisocoumarin	51050-59-0	SD08W1HH6E	Serine Proteinase Inhibitors	Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)	
3,4-dichlorophenol	95-77-2	3,4-Dichlorophenol	95-77-2	070FTM6DVF			
3,4-dichloropropionanilide		Propanil	709-98-8	F57I4G0520	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
3,4-didehydroretinoic acid	4159-20-0	3,4-Didehydroretinoic acid	4159-20-0				
3,4-dideoxyglucosone-3-ene		(6R)-2-Hydroxy-6-(hydroxymethyl)-2H-pyran-3(6H)-one	252006-38-5				
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone		3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone	129075-73-6	5007H57E2L	Poly(ADP-ribose) Polymerase Inhibitors	Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. (See all compounds classified as Poly(ADP-ribose) Polymerase Inhibitors.)	
3,4-dihydro-5-methyl-1(2H)-isoquinolinone	129075-56-5	5-methyl-3,4-dihydroisoquinolin-1(2H)-one	129075-56-5	FI8AN8XP0W			
3,4-dihydrocoumarin	119-84-6	3,4-Dihydrocoumarin	119-84-6	NM5K1Y1BT2			
3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene	64551-89-9	3,4-Dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene	64551-89-9				
3,4-dihydroxyacetophenone	1197-09-7	3',4'-Dihydroxyacetophenone	1197-09-7	07OQ35LVBK	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
3,4-dihydroxybenzaldoxime	3343-59-7	3,4-Dihydroxybenzaldoxime	3343-59-7				
3,4-dihydroxybenzoate		3,4-Dihydroxybenzoate					
3,4-dihydroxybenzohydroxamic acid	69839-83-4	Didox	69839-83-4	L106XFV0RQ	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
3,4-dihydroxymandelic acid	775-01-9	3,4-Dihydroxymandelic acid	775-01-9	WDP6VCX5T6			
3,4-dihydroxyphenylacetaldehyde	5707-55-1	3,4-Dihydroxyphenylacetaldehyde	5707-55-1	F2E9Q24TSL			
3,4-Dihydroxyphenylacetic Acid	102-32-9	3,4-Dihydroxyphenylacetic acid	102-32-9	KEX5N0R4N5			
3,4-dihydroxyphenylethanol	10597-60-1	Hydroxytyrosol	10597-60-1	QEU0NE4O90	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
3,4-dihydroxyphenylglycol		3,4-Dihydroxyphenylglycol	28822-73-3	UEH9K539KJ			
3,4-dihydroxyphenyllactic acid	23028-17-3	3-(3,4-Dihydroxyphenyl)-2-hydroxypropanoic acid	23028-17-3	NA8H56YM3K			
3,4-dihydroxyphenylpropionic acid	1078-61-1	Dihydrocaffeic acid	1078-61-1	MSW0228VUB			
3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide		3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide	927823-01-6	MUA7QA3W73			
3,4-dimethylbenzaldehyde		3,4-Dimethylbenzaldehyde	5973-71-7	16G1J12ARB			
3,4-dimethylmethcathinone		3,4-Dimethylmethcathinone	1082110-00-6	C4EW58DTW5			
3,4-dimethylphenol	95-65-8	3,4-Dimethylphenol	95-65-8	4L479F5JU6			
3,4-epoxy-1-butene	930-22-3	Butadiene monoxide	930-22-3	478ERR5NKR	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
3,4-epoxybutane-1,2-diol	17177-50-3	(1,2-Dihydroxyethyl)oxirane	17177-50-3				
3,4-methylenedioxy-beta-nitrostyrene		3,4-Methylenedioxy-beta-nitrostyrene	22568-48-5	4C25J4B9PJ			
3,4-Methylenedioxyamphetamine	4764-17-4	Tenamfetamine	4764-17-4	XJZ28FJ27W	Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	
3,4-methylenedioxyethamphetamine		3,4-Methylenedioxy-N-ethylamphetamine	82801-81-8	ML1I4KK67B	Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	
3,4-xylidine	95-64-7	3,4-Dimethylaniline	95-64-7	R27I33AIDT			
3,4,3',4'-tetrachloroazobenzene	14047-09-7	3,3',4,4'-Tetrachloroazobenzene	14047-09-7	PGG7W94GS9			
3,4,3',4'-tetrachloroazoxybenzene	21232-47-3	3,3',4,4'-Tetrachloroazoxybenzene	21232-47-3				
3,4,3',4'-tetrachlorobiphenyl		3,3',4,4'-Tetrachlorobiphenyl	32598-13-3	Y2I6546TMI			
3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol	123594-64-9	(4aS,10bS)-4-propyl-3,4a,5,10b-tetrahydro-2H-chromeno[4,3-b][1,4]oxazin-9-ol	123594-64-9		Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
3,4,5-tri-O-(E)-caffeoylquinic acid		3,4,5-tri-O-(E)-caffeoylquinic acid					
3,4,5-trichlorophenol		3,4,5-Trichlorophenol	609-19-8	2JF54EGE7O			
3,4,5-trihydroxy-2--methoxy-8,8-dimethyl-N-(hexahydro-2-oxo-6-(cyclohexylcarbonyl)oxy-2H-azepin-3-yl)non-6-enamide		3,4,5-trihydroxy-2--methoxy-8,8-dimethyl-N-(hexahydro-2-oxo-6-(cyclohexylcarbonyl)oxy-2H-azepin-3-yl)non-6-enamide					
3,4,5-trihydroxy-N-(4-(thiazol-2-ylsulfamoyl)-phenyl)-benzamide		3,4,5-trihydroxy-N-(4-(thiazol-2-ylsulfamoyl)-phenyl)-benzamide					
3,4,5-trihydroxybenzamidoxime		Trimidox	95933-74-7	WRR9SR69TE	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
3,4,5-trimethoxybenzaldehyde		3,4,5-Trimethoxybenzaldehyde	86-81-7	WL86YD76N6			
3,4,5,3',4'-pentachlorobiphenyl	57465-28-8	3,3',4,4',5-Pentachlorobiphenyl	57465-28-8	TSH69IA9XF	Estrogen Antagonists	Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)	
3,4,5,3',4',5'-hexachlorobiphenyl		3,3',4,4',5,5'-Hexachlorobiphenyl	1336-36-3	T2P1WH546D			
3,4,5,4'-tetrahydroxystilbene		3,4,5,4'-tetrahydroxystilbene					
3,4,5,4'-tetramethoxystilbene		3,4,5,4'-Tetramethoxystilbene	134029-62-2				
3,4,5,6-tetrachlorocatechol	1198-55-6	Tetrachlorocatechol	1198-55-6	5REG09UJO0			
3,4,7,8-tetramethyl-1,10-phenanthroline	1660-93-1	3,4,7,8-Tetramethyl-1,10-phenanthroline	1660-93-1				
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine	95896-78-9	4-Methyl meiqx	95896-78-9	YRA7G7WU6P	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
3,4'-dihydroxystilbene		3-[2-(4-Hydroxyphenyl)ethenyl]phenol	62574-04-3				
3,4',5-trimethoxystilbene		(E)-3,5,4'-Trimethoxystilbene	22255-22-7				
3,5-bis((4-nitrophenyl)methylidene)-1-prop-2-enoylpiperidin-4-one		3,5-bis((4-nitrophenyl)methylidene)-1-prop-2-enoylpiperidin-4-one					
3,5-bis(2-fluorobenzylidene)piperidin-4-one		3,5-Bis(2-fluorobenzylidene)piperidin-4-one	917813-75-3	O5YT36MST0			
3,5-bis(trifluoromethyl)benzyl N-acetyltryptophan	148451-96-1	3,5-Bis(trifluoromethyl)benzyl N-acetyltryptophan	148451-96-1				
3,5-di-tert-butyl-4-hydroxybenzaldehyde		3,5-Di-tert-butyl-4-hydroxybenzaldehyde	1620-98-0	95VTI93VUL			
3,5-di-tert-butylchalcone 4'-carboxylic acid	95906-67-5	3,5-Di-tert-butylchalcone	95906-67-5				
3,5-di-tert-butylphenol		3,5-Di-tert-butylphenol	1138-52-9	F4SMH8G9W7			
3,5-diaminobenzoic acid	535-87-5	3,5-Diaminobenzoic acid	535-87-5	1609U1093N			
3,5-dibromo-2-(2,4-dibromophenoxy)phenol	79755-43-4	3,5-Dibromo-2-(2,4-dibromophenoxy)phenol	79755-43-4				
3,5-dibromo-4-(3,4-dimethoxyphenyl)-1H-pyrrole-2-carboxylic acid ethyl ester		3,5-Dibromo-4-(3,4-dimethoxyphenyl)-1H-pyrrole-2-carboxylic acid ethyl ester					
3,5-dibromosalicylic acid		3,5-Dibromosalicylic acid	3147-55-5	T5JO5UA21H			
3,5-dicaffeoylquinic acid		Isochlorogenic acid A	89919-62-0		HIV Integrase Inhibitors	Inhibitors of HIV INTEGRASE, an enzyme required for integration of viral DNA into cellular DNA. (See all compounds classified as HIV Integrase Inhibitors.)	
3,5-dicaffeoylquinic acid methyl ester		3,5-Di-O-caffeoylquinic acid methyl ester					
3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine	1153-66-8	3,5-Dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine	1153-66-8	ZR2P6EX7SX			
3,5-dichloro-N-(1-(2,2-dimethyltetrahydropyran-4-ylmethyl)-4-fluoropiperidin-4-ylmethyl)benzamide		3,5-dichloro-N-(1-(2,2-dimethyltetrahydropyran-4-ylmethyl)-4-fluoropiperidin-4-ylmethyl)benzamide					
3,5-dichlorobenzidine	63390-11-4	3,5-Dichlorobenzidine	63390-11-4				
3,5-dichlorobiphenyl	34883-41-5	3,5-Dichlorobiphenyl	34883-41-5	IXL47709VM			
3,5-diethoxycarbonyl-1,4-dihydrocollidine		3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,4,6-trimethyl-, diethyl ester	632-93-9				
3,5-dihydroxy-4'-methoxystilbene		(E)-5-(4-Methoxystyryl)benzene-1,3-diol	33626-08-3	RU7RRY3RUW			
3,5-dihydroxyphenylglycine	146255-66-5	3,5-Dihydroxyphenylglycine	146255-66-5	5YR2N37E6D	Excitatory Amino Acid Antagonists	Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)	
3,5-diiodosalicylic acid	133-91-5	3,5-Diiodosalicylic acid	133-91-5	1496OH15B6			
3,5-diiodothyronine	534-51-0	3,5-Diiodothyronine	534-51-0	U1Y9GN485M			
3,5-diiodothyropropionic acid		3,5-Diiodothyropropionic acid	1158-10-7	1HTO2X0SJ9	Hormones	Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. (See all compounds classified as Hormones.)	
3,5-dimethoxy-4'-hydroxystilbene		Pterostilbene	537-42-8	26R60S6A5I			
3,5-dimethoxy-4'-methylthiostilbene		3,5-dimethoxy-4'-methylthiostilbene					
3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one	130841-70-2	(2R,5S)-3,5-Dimethyl-2-pyridin-3-yl-1,3-thiazolidin-4-one;hydrochloride	158511-47-8				
3,5-dimethylaminophenol		3,5-dimethylaminophenol					
3,5-dimethylaniline		3,5-Dimethylaniline	108-69-0	1418BR6T2H			
3,5-xylenol	108-68-9	3,5-Dimethylphenol	108-68-9	ONA760G0WA			
3,5,2',4'-tetrahydroxychalcone		3,5,2',4'-tetrahydroxychalcone					
3,5,3',4',5'-pentahydroxy-stilbene		5-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2,3-triol	35154-48-4				
3,5,3',4',5'-pentamethoxystilbene		3,3',4,5,5'-Pentamethoxystilbene					
3,5,5-trimethylhexanoylferrocene	67527-18-8	3,5,5-Trimethylhexanoylferrocene					
3,5,6-trichloro-2-pyridinol	6515-38-4	3,5,6-Trichloro-2-pyridinol	6515-38-4	JS52YZJ84A	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
3,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamidopropyl)-2(1H)-pyrazinone		3,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamidopropyl)-2(1H)-pyrazinone					
3,6-dihydroxy-7-fluorocholanoic acid		3,6-dihydroxy-7-fluorocholanoic acid					
3,6-dihydroxychrysene		3,6-Dihydroxychrysene					
3,6-dinitrobenzopyrene	128714-76-1	3,6-Dinitrobenzo(a)pyrene	128714-76-1	0F54JZ113B			
3,7-bis(2-hydroxyethyl)icaritin		3,7-Bis(2-hydroxyethyl)icaritin	1067198-74-6	5U58D99D1L			
3,7-dihydroxy-7-methylcholanoic acid	91414-09-4	3,7-Dihydroxy-7-methylcholanoic acid	91414-09-4				
3,7-dihydroxyflavone		3,7-Dihydroxyflavone	492-00-2	O948D0K9BQ			
3,7-dimethoxyflavone		3,7-Dimethoxyflavone	20950-52-1				
3,7-dimethyl-1-propargylxanthine	14114-46-6	3,7-Dimethyl-1-propargylxanthine	14114-46-6	5YFR5SPS6T	Adenosine A2 Receptor Antagonists	Compounds that selectively bind to and block the activation of ADENOSINE A2 RECEPTORS. (See all compounds classified as Adenosine A2 Receptor Antagonists.)	
3,7-dioxolanosta-8,24-dien-26-oic acid		Gaderic acid DM					
3,7-O-dimethylquercetin		3,7-Di-O-methylquercetin	2068-02-2	V8R92XSR1M			
3,7,11-trimethyldodeca-2,6,10-trienoic acid hexadecylamide		3,7,11-Trimethyldodeca-2,6,10-trienoic acid hexadecylamide					
3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid	81485-25-8	Peretinoin	81485-25-8	11ALM7A4RV			
3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one	1143-70-0	urolithin A	1143-70-0	ILJ8NEF6DT			
3,9-bis((ethylthio)methyl)-K-252a	156177-65-0	3,9-Bis((ethylthio)methyl)-K-252a	156177-65-0	200HA2LIMK			Investigated for use/treatment in asthma and parkinson's disease.
3,N-dimethyl-N-(1-methyl-3-(4-methylpiperidin-1-yl)propyl)benzenesulfonamide		3,N-dimethyl-N-(1-methyl-3-(4-methylpiperidin-1-yl)propyl)benzenesulfonamide					
3,N(4)-ethenocytosine		imidazo[1,2-c]pyrimidin-5(6H)-one	55662-66-3				
3'-amino-2',3'-dideoxycytidine	84472-90-2	3'-Amino-2',3'-dideoxycytidine	84472-90-2				
3'-azido-3'-deoxythymidine 5'-diphosphate	106060-89-3	Zidovudine diphosphate	106060-89-3	K7ZG448V5M			
3'-azido-3'-deoxythymidine 5'phosphate	29706-85-2	Zidovudine monophosphate	29706-85-2	97YMU05VPJ			
3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin	88254-07-3	3'-Deamino-3'-(3-cyanomorpholin-4-yl)doxorubicin	88254-07-3		Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	
3'-dehydrolutein		3'-Dehydrolutein					
3'-dimethylaminoflavone		3'-dimethylaminoflavone					
3'-hydroxy-genistein		Orobol	480-23-9	LU8UZM1T51			
3'-hydroxyhexobarbital	427-29-2	3'-Hydroxyhexobarbital	427-29-2				
3'-methoxy-4'-nitroflavone		3'-Methoxy-4'-nitroflavone	145370-39-4				
3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate	81790-82-1	BzATP	81790-82-1	4P5DXU1F8Q	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
3'-oxomethylisoeugenol		3'-oxomethylisoeugenol					
3'-p-hydroxypaclitaxel	132160-32-8	3'-p-Hydroxypaclitaxel	132160-32-8				
3',3'',5',5''-tetrabromophenolphthalein	76-62-0	Tetrabromophenolphthalein	76-62-0	YZ4HT20I0V			
3',4'-dihydroxy-4-monochlorobiphenyl		3',4'-dihydroxy-4-monochlorobiphenyl					
3',4'-dihydroxyflavone	4143-64-0	3',4'-Dihydroxyflavone	4143-64-0	KOH101S66V			
3',4'-dimethoxy-alpha-naphthoflavone		3',4'-Dimethoxy-alpha-naphthoflavone	14756-24-2				
3',4'-dimethoxyflavone		3',4'-Dimethoxyflavone	4143-62-8				
3',4',5'-trimethoxyflavone		2-(3,4,5-Trimethoxyphenyl)-4H-chromen-4-one	67858-30-4	ZP0OD925FK			
3',4',7-trihydroxyisoflavone		3',4',7-Trihydroxyisoflavone	485-63-2	T08Y239E7Y			
3',5'-dichloro-2-hydroxy-2-methylbut-3-enanilide		3',5'-Dichloro-2-hydroxy-2-methylbut-3-enanilide	83792-61-4	U6Y06GAX2T			
3',5'-dimethoxyflavone		3',5'-Dimethoxyflavone					
3'(R)-O-beta-D-glucopyranosyl-3',4'-dihydroxanthyletin		3'(R)-O-beta-D-glucopyranosyl-3',4'-dihydroxanthyletin					
32-hydroxy-24,25-dihydrolanosterol	59200-39-4	32-Hydroxy-24,25-dihydrolanosterol	59200-39-4				
4-(((4-carboxybutyl) (2- (5-fluoro-2-((4'-(trifluoromethyl) biphenyl-4-yl)methoxy)phenyl)ethyl) amino)methyl)benzoic acid		4-(((4-carboxybutyl) (2- (5-fluoro-2-((4'-(trifluoromethyl) biphenyl-4-yl)methoxy)phenyl)ethyl) amino)methyl)benzoic acid					
4-(((6-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)-2-(trifluoromethyl)-3-pyridinyl)methylamino)methyl)benzoic acid		4-(((6-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)-2-(trifluoromethyl)-3-pyridinyl)methylamino)methyl)benzoic acid					
4-((1-butyl-3-phenylureido)methyl)-N-hydroxybenzamide		Nexturastat A	1403783-31-2				
4-((2-(1-methyl-2-pyrrolidinyl)ethyl)thio)phenol hydrochloride		4-[2-(1-Methylpyrrolidin-2-yl)ethylsulfanyl]phenol	191611-76-4	TF4A9P6T8R	Nicotinic Antagonists	Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)	
4-((2'-O-acetylrhamnosyloxy)benzyl)isothiocyanate		4-((2'-O-acetylrhamnosyloxy)benzyl)isothiocyanate					
4-((3-(5,6-dihydro-4H-(2,3')bipyridinyl-3-ylidene)propenyl)phenyl)dimethylamine		4-((3-(5,6-dihydro-4H-(2,3')bipyridinyl-3-ylidene)propenyl)phenyl)dimethylamine					
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline		N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine	153436-54-5	TC62B68RSL	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
4-((3,4-(methylenedioxy)benzyl)amino)-6-methoxyquinazoline		4-((3,4-(methylenedioxy)benzyl)amino)-6-methoxyquinazoline					
4-((4-(4-ethylphenyl)-2,2-dimethyl-(2H)-thiochromen-6-yl)ethynyl)benzoic acid		4-((4-(4-ethylphenyl)-2,2-dimethyl-2H-thiochromen-6-yl)ethynyl)benzoic acid	229961-45-9	V2W3I5K9O0			
4-((4-hydroxyphenylimino)methyl)benzene-1,2-diol		4-((4-hydroxyphenylimino)methyl)benzene-1,2-diol					
4-((alpha-L-rhamnosyloxy)benzyl)isothiocyanate		Moringin	73255-40-0				
4-((diethylamino)sulfonyl)benzoic acid	1213-06-5	Etebenecid	1213-06-5	4413I5098G			
4-((methylnitrosoamino)-1-(3-pyridyl)but-1-yl)beta-omega-glucosiduronic acid		4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronide	131119-04-5				
4-(1-(4-tert-butylphenyl)-2-oxo-4-pyrrolidinyl)methoxybenzoic acid		4-(1-(4-tert-butylphenyl)-2-oxo-4-pyrrolidinyl)methoxybenzoic acid					
4-(1-adamantyl)phenol		4-(1-Adamantyl)phenol	29799-07-3	T35W8S7C9P			
4-(1-benzenesulfonyl-1H-indol-2-yl)-4-hydroxycyclohexa-2,5-dienone		4-(1-benzenesulfonyl-1H-indol-2-yl)-4-hydroxycyclohexa-2,5-dienone					
4-(1-ethylpropoxy)-3,6-dimethyl-2-(2,4,6-trimethylphenoxy)pyridine		Pyridine, 4-(1-ethylpropoxy)-3,6-dimethyl-2-(2,4,6-trimethylphenoxy)-	175139-41-0	GNW87JO5PF			
4-(1-phenylethyl)-1,3-benzenediol		Phenylethyl resorcinol	85-27-8	G37UFG162O			
4-(1H-imidazol-1-yl)retinoic acid		4-(1H-imidazol-1-yl)retinoic acid					
4-(1H-imidazol-4-ylmethyl)piperidine	151070-83-6	Immepip	151070-83-6	PZS44KB9KC			
4-(2-(2-chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)phenyl)cyclopropyl)benzoic acid		4-(2-(2-Chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)phenyl)cyclopropyl)benzoic acid	1268244-85-4	378SU5NO8S			
4-(2-(3,5-dimethoxyphenyl)vinyl)pyridine		4-(2-(3,5-dimethoxyphenyl)vinyl)pyridine					
4-(2-(4-chlorophenyl)ethyl)-1-piperidinecarboxylic acid 2-(methylamino)-2-oxoethyl ester		4-(2-(4-chlorophenyl)ethyl)-1-piperidinecarboxylic acid 2-(methylamino)-2-oxoethyl ester					
4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid		4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid					
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid	71441-28-6	Ttnpb	71441-28-6	673M8C29UR	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
4-(2-adamantan-1-yl-2-oxoethoxymethyl)-N,N-dimethylbenzamide		4-(2-adamantan-1-yl-2-oxoethoxymethyl)-N,N-dimethylbenzamide					
4-(2-aminoethyl)benzenesulfonylfluoride	34284-75-8	4-(2-Aminoethyl)benzenesulfonyl fluoride	34284-75-8	F5D36L5354	Serine Proteinase Inhibitors	Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)	
4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine		4-(2-Bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine	231286-79-6				
4-(2-chloro-4-(2-piperidin-1-ylethoxy)phenyl)-5-(2,6-dichloro-4-hydroxyphenyl)-2-imidazoline		4-(2-chloro-4-(2-piperidin-1-ylethoxy)phenyl)-5-(2,6-dichloro-4-hydroxyphenyl)-2-imidazoline					
4-(2-chloro-4-methoxy-5-methylphenyl)-N(2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl)-5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine		Crinecerfont	752253-39-7	MFT24BX55I			Treatment of atypical haemolytic uremic syndrome, Treatment of paroxysmal nocturnal haemoglobinuria
4-(2-phenyl-5,7-bis(trifluoromethyl)pyrazolo(1,5-a)pyrimidin-3-yl)phenol		Phtpp	805239-56-9	NN82CVN36N			
4-(2-pyridylazo)resorcinol	1141-59-9	4-(2-Pyridylazo)resorcinol	16593-81-0	N68T40H95T	Chromogenic Compounds	Colorless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into colored compounds; used in biochemical assays and in diagnosis as indicators, especially in the form of enzyme substrates. Synonym: chromogens (not to be confused with pigment-synthesizing bacteria also called chromogens). (See all compounds classified as Chromogenic Compounds.)	
4-(2-thiazolylazo)resorcinol	2246-46-0	4-(2-Thiazolylazo)resorcinol	2246-46-0	XM6NV2GYM9			
4-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,4-dihydro-5-((5-nitro-2-thiazolyl)thio)-3H-1,2,4-triazol-3-one		4-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,4-dihydro-5-((5-nitro-2-thiazolyl)thio)-3H-1,2,4-triazol-3-one					
4-(2,5-difluorophenyl)-N-(3-fluoro-1-methylpiperidin-4-yl)-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide		4-(2,5-difluorophenyl)-N-(3-fluoro-1-methylpiperidin-4-yl)-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide					
4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide		4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide					
4-(2'-methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine	155204-23-2	p-MPPI	155204-23-2		Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
4-(3-(1-adamantyl)-4-hydroxyphenyl)-3-chlorocinnamic acid		4-(3-(1-adamantyl)-4-hydroxyphenyl)-3-chlorocinnamic acid					
4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid		2-(4-(3-(4-Acetyl-3-hydroxy-2-propylphenoxy)propoxy)phenoxy)acetic acid	79558-09-1	7RV682Z3FQ			
4-(3-(4-(1-methyl-1H-pyrazol-5-yl)phenylthio)phenyl)-tetrahydro-2H-pyran-4-carboxamide		4-(3-(4-(1-methyl-1H-pyrazol-5-yl)phenylthio)phenyl)-tetrahydro-2H-pyran-4-carboxamide	1029317-21-2	YX55DXP4T1			
4-(3-(4-(4-fluoro-phenyl)-3,6-dihydro-2H-pyridin-1-yl)-2-hydroxy-propoxy)-benzamide		4-(3-(4-(4-fluoro-phenyl)-3,6-dihydro-2H-pyridin-1-yl)-2-hydroxy-propoxy)-benzamide					
4-(3-(4-cyanophenoxy)propyl)-1H-imidazole		4-(3-(4-cyanophenoxy)propyl)-1H-imidazole					
4-(3-3,4-p-menthadien-(1,8)-yl)olivetol		Resorcinol, 4-p-mentha-1,8-dien-3-yl-5-pentyl-	78216-32-7				
4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone	29925-17-5	4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone	29925-17-5	DIW6F13QW2	Phosphodiesterase Inhibitors	Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)	
4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)pyrazolo(1,5-a)pyrimidine		3-(4-methoxy-2-methylphenyl)-2,5-dimethyl-N-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-amine	202579-74-6				
4-(3,5-dimethoxystyryl)phenyl acetate		4-(3,5-Dimethoxystyryl)phenyl acetate					
4-(3',5'-dimethyl 3'-heptyl)phenol		4-(3',5'-dimethyl 3'-heptyl)phenol					
4-(3',6'-dimethyl-3'-heptyl)phenol		4-(1-Ethyl-1,4-dimethylpentyl)phenol	142731-63-3	510794F9KY			
4-(4-((2',3',4',6'-tetra-O-acetylglucopyranosyl)thiomethyl)-5-iodo-1-H-1,2,3-triazol-1-yl)benzenesulfonamide		4-(4-((2',3',4',6'-tetra-O-acetylglucopyranosyl)thiomethyl)-5-iodo-1-H-1,2,3-triazol-1-yl)benzenesulfonamide					
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid		4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid					
4-(4-((glucopyranosyl)thiomethyl)-5-iodo-1-H-1,2,3-triazol-1-yl)benzenesulfonamide		4-(4-((glucopyranosyl)thiomethyl)-5-iodo-1-H-1,2,3-triazol-1-yl)benzenesulfonamide					
4-(4-(2-(n-butoxy)ethoxy)-5-methylthiazol-2-yl)-2-fluorobenzoic acid		4-(4-(2-(n-butoxy)ethoxy)-5-methylthiazol-2-yl)-2-fluorobenzoic acid					
4-(4-(2,3-dihydrobenzo(1,4)dioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl)benzamide		4-(4-(2,3-dihydrobenzo(1,4)dioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl)benzamide					
4-(4-(2,4-dioxothiazolidin-5-ylidenemethyl)-2-methoxyphenoxy)-3-trifluoromethylbenzonitrile		4-(4-(2,4-dioxothiazolidin-5-ylidenemethyl)-2-methoxyphenoxy)-3-trifluoromethylbenzonitrile					
4-(4-(3-(4-trifluoromethoxy-phenyl)ureido)cyclohexyloxy)benzoic acid		4-(4-(3-(4-trifluoromethoxy-phenyl)ureido)cyclohexyloxy)benzoic acid					
4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide		4-(4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide	452342-67-5	N14114957J			
4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid		4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid					
4-(4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-1H,4H,5H,6H-pyrrolo(3,4-c)pyrazol-5-yl)benzoic acid		4-(4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-1H,4H,5H,6H-pyrrolo(3,4-c)pyrazol-5-yl)benzoic acid					
4-(4-(3-methylmorpholin-4-yl)-6-(1-(methylsulfonyl)cyclopropyl)pyrimidin-2-yl)-1H-indole		4-(4-(3-methylmorpholin-4-yl)-6-(1-(methylsulfonyl)cyclopropyl)pyrimidin-2-yl)-1H-indole					
4-(4-(4-chloro-phenyl)thiazol-2-ylamino)phenol		4-(4-(4-chloro-phenyl)thiazol-2-ylamino)phenol					
4-(4-(4-fluorophenoxy)benzenesulfonylamino)tetrahydropyran-4-carboxylic acid hydroxyamide		2H-Pyran-4-carboxamide, 4-(((4-(4-fluorophenoxy)phenyl)sulfonyl)amino)tetrahydro-N-hydroxy-	230954-09-3	516DO4KL5R	Matrix Metalloproteinase Inhibitors	Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES. (See all compounds classified as Matrix Metalloproteinase Inhibitors.)	
4-(4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxalinyl)-1,3-thiazol-2-yl)benzoic acid		Benzoic acid, 4-(4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxalinyl)-2-thiazolyl)-	187400-31-3	44X4BU4PFM			
4-(4-(bis(4-fluorophenyl)methyl)piperazin-1-ylbut-2-enyloxy)acetic acid		{4-[4-[Bis-(4-fluorophenyl)methyl]piperazin-1-yl]-(E)-but-2-enyloxy}acetic acid dihydrochloride	607736-84-5	3QKT19VDE2			
4-(4-(dimethylamino)phenyl)-1-methylpyridinium		4-(4-(dimethylamino)phenyl)-1-methylpyridinium					
4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide		4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide					
4-(4-(N-benzoylamino)anilino)-6-methoxy-7-(3-(1-morpholino)propoxy)quinazoline		4-(4-(N-benzoylamino)anilino)-6-methoxy-7-(3-(1-morpholino)propoxy)quinazoline					
4-(4-bromophenyl)-2,3-dihydro-N,3-bis(3,4,5-trimethoxyphenyl)-2-oxoidmi-dazole-1-carboxamide		4-(4-bromophenyl)-2,3-dihydro-N,3-bis(3,4,5-trimethoxyphenyl)-2-oxoidmi-dazole-1-carboxamide					
4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide		Droxinostat	99873-43-5				
4-(4-chlorophenyl)-3-methylbut-3-en-2-oxime		4-(4-Chlorophenyl)-3-methylbut-3-EN-2-oxime	55224-94-7				
4-(4-cyano-2-(2-(4-fluoronaphthalen-1-yl)propionylamino)phenyl)butyric acid		4-(4-cyano-2-(2-(4-fluoronaphthalen-1-yl)propionylamino)phenyl)butyric acid					
4-(4-cyanophenyl)-2-(2-cyclopentylidenehydrazinyl)thiazole		4-(4-cyanophenyl)-2-(2-cyclopentylidenehydrazinyl)thiazole					
4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide		Tilmacoxib	180200-68-4	G6VI5P84SX			
4-(4-dimethylaminostyryl)-1-methylpyridinium		N,N-dimethyl-4-[2-(1-methylpyridin-1-ium-4-yl)ethenyl]aniline	48174-78-3				
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole		4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole	152121-30-7	PVX798P8GI	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
4-(4-fluorophenyl)sulfonyl-5-methylthio-2-phenyloxazole		4-(4-fluorophenyl)sulfonyl-5-methylthio-2-phenyloxazole					
4-(4-guanidinobenzoyloxy)phenylacetic acid	71079-09-9	4-(4-Guanidinobenzoyloxy)phenylacetic acid	71079-09-9				
4-(4,6-diphenyl-1,3-dioxan-2-yl)-N,N-dimethylaniline		4-(4,6-diphenyl-1,3-dioxan-2-yl)-N,N-dimethylaniline					
4-(4'-chlorobenzyloxy)benzyl nicotinate	63608-11-7	4-(4'-Chlorobenzyloxy)benzyl nicotinate	63608-11-7				
4-(5-(1-methylpiperidin-4-yloxy)-1H-benzo(d)imidazol-1-yl)-2-(1-(2-(trifluoromethyl)phenyl)ethoxy)benzamide		4-(5-(1-methylpiperidin-4-yloxy)-1H-benzo(d)imidazol-1-yl)-2-(1-(2-(trifluoromethyl)phenyl)ethoxy)benzamide					
4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide		4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide	170569-86-5	9HGW1H8S2M	Cyclooxygenase Inhibitors	Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)	
4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo(1,2-f)(1,2,4)triazine-6-carboxamide		4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo(1,2-f)(1,2,4)triazine-6-carboxamide					
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide		4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide	301836-41-9	E1557V1V0N			
4-(5,6-dihydro-5,5-dimethyl-8-(quinolin-3-yl)naphthalen-2-carboxamido)benzoic acid		4-(5,6-dihydro-5,5-dimethyl-8-(quinolin-3-yl)naphthalen-2-carboxamido)benzoic acid					
4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid	107430-51-3	4-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid	107430-51-3				
4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine		4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidine					
4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline		4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline					
4-(6-cyclohexylmethoxy-9H-purin-2-ylamino)-N,N-diethylbenzamide		4-(6-Cyclohexylmethoxy-9H-purin-2-ylamino)-N,N-diethylbenzamide	444723-13-1				
4-(6-hydroxy-2-naphthyl)-1,3-benzenediol		4-(6-Hydroxynaphthalen-2-yl)benzene-1,3-diol	927885-00-5	5YWK2UV4R5			
4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone	127686-49-1	4-(Acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone	127686-49-1				
4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide	156727-74-1	4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide	156727-74-1	L842QB22SW			
4-(aminocarbonyl)-1-(3-(4-((E)-(hydroxyimino)methyl)pyridinium-1-yl)propyl)pyridinium dibromide		4-(aminocarbonyl)-1-(3-(4-((E)-(hydroxyimino)methyl)pyridinium-1-yl)propyl)pyridinium dibromide					
4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one		4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one					
4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine	146998-34-7	4-(Benzodioxan-5-yl)-1-(indan-2-yl)piperazine	146998-34-7	XE6KA72FCB			
4-(benzothiazol-2-yl)-4-hydroxy-2,5-cyclohexadien-1-one		4-(Benzothiazol-2-yl)-4-hydroxy-2,5-cyclohexadien-1-one	485842-97-5	YJX11V636Q			
4-(benzylamino)-2-((2-(3-chloro-4-hydroxyphenyl)ethyl)amino)pyrimidine-5-carboxamide		4-(benzylamino)-2-((2-(3-chloro-4-hydroxyphenyl)ethyl)amino)pyrimidine-5-carboxamide					
4-(bis(2-methoxyethyl)amino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)pyrazolo(1,5-a)-1,3,5-triazine		4-(bis(2-methoxyethyl)amino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)pyrazolo(1,5-a)-1,3,5-triazine					
4-(diethylamino)benzaldehyde	120-21-8	4-(Diethylamino)benzaldehyde	120-21-8	S640XWL10H			
4-(E)-((p-tolylimino)-methylbenzene-1,2-diol)		4-(E)-((p-tolylimino)-methylbenzene-1,2-diol)					
4-(ethylcarboxyl)-2'-(hydroxyiminomethyl)-1,1'-(phenylene-1,3-diyl)-bispyridinium		4-(ethylcarboxyl)-2'-(hydroxyiminomethyl)-1,1'-(phenylene-1,3-diyl)-bispyridinium					
4-(heptyloxy)phenol		4-Heptyloxyphenol	13037-86-0	W9GSE02182			
4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide	38236-46-3	4-(Isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide	38236-46-3	T4H9FLX72T	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	
4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol		4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol	76014-81-8	EN7PIX794W			
4-(methylsulfinyl)phenol	14763-64-5	4-(Methylsulfinyl)phenol	14763-64-5				
4-(methylthio)-3-butenyl isothiocyanate		4-Isothiocyanato-1-(methylthio)-1-butene	51598-96-0				
4-(N-(4-chlorophenyl)carbamoyloxy)-4-pent-2-ammonium iodide		4-(N-(4-chlorophenyl)carbamoyloxy)-4-pent-2-ammonium iodide					
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone	64091-91-4	4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone	64091-91-4	7S395EDO61	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
4-(N-nitroso-N-methylamino)butyric acid	61445-55-4	N-Nitroso-N-methyl-4-aminobutyric acid	61445-55-4	7K7252TZ54			
4-(nitroxy)butanoic acid 4-acetylaminophenyl ester		Nitroparacetamol	326850-30-0	F8Y1ZV5V9P			Investigated for use/treatment in pain (acute or chronic).
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid	27816-59-7	4-Acetamido-4'-isothiocyanostilbene-2,2'-disulphonic acid	27816-59-7				
4-acetylaminofluorene	28322-02-3	4-Acetylaminofluorene	28322-02-3	U41BO8XU2Z	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
4-acetylanisole	100-06-1	4'-Methoxyacetophenone	100-06-1	0IRH2BR587			
4-acetylantroquinonol B		4-acetylantroquinonol B	1187652-02-3	72XZO87CZJ			
4-AcO-DET		3-(2-(Diethylamino)ethyl)-1H-indol-4-yl acetate	1135424-15-5	43U8799479			
4-allyl-8-ethyl-7,8-dihydro-2-(3-methoxy-1-methyl-1H-pyrazol-5-yl)-1H-imidazo(2,1-i)purin-5(4H)-one		4-allyl-8-ethyl-7,8-dihydro-2-(3-methoxy-1-methyl-1H-pyrazol-5-yl)-1H-imidazo(2,1-i)purin-5(4H)-one					
4-amidino-2-nitrophenyl 4'-anisate	105450-73-5	4-Amidino-2-nitrophenyl 4'-anisate	105450-73-5				
4-amino-1-(6-chloro-2-pyridyl)piperidine hydrochloride		4-Amino-1-(6-chloro-2-pyridyl)-piperidine hydrochloride	77145-61-0	OW45B79UZD			
4-amino-1,8-naphthalimide	1742-95-6	4-Amino-1,8-naphthalimide	1742-95-6	S529AR2S8B	Poly(ADP-ribose) Polymerase Inhibitors	Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. (See all compounds classified as Poly(ADP-ribose) Polymerase Inhibitors.)	
4-amino-2-((diethylamino)methyl)phenol		4-Amino-2-[(Diethylamino)Methyl]Phenol	51387-92-9				
4-amino-2-hydroxytoluene		5-Amino-2-methylphenol	2835-95-2	UBB8XEB10B			
4-amino-2-nitrophenol	119-34-6	4-Amino-2-nitrophenol	119-34-6	N3499RCQ6B			
4-amino-2-phenoxymethanesulfonanilide		4-amino-2-phenoxymethanesulfonanilide					
4-amino-2-trifluoromethyl-phenyl retinate		4-amino-2-trifluoromethyl-phenyl retinate					
4-amino-2,6-dinitrotoluene	19406-51-0	4-Amino-2,6-dinitrotoluene	19406-51-0	VGF967AJX2			
4-amino-4'-hydroxylaminodiphenylsulfone		Dapsone hydroxylamine	32695-27-5	GS5815Z51W			
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine		4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine					
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one		4-Amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one					
4-amino-5-hexynoic acid	57659-38-8	4-Aminohex-5-ynoic acid	57659-38-8	PG9G3XCD6P	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
4-amino-7-phenylpyrazol(3,4-d)pyrimidine		4-amino-7-phenylpyrazol(3,4-d)pyrimidine					
4-amino-TEMPO	14691-88-4	14691-88-4					
4-aminobenzamide	2835-68-9	4-Aminobenzamide	2835-68-9	77722I6PAC			
4-aminobenzamidine		4-Aminobenzamidine	3858-83-1	63GK9KT599	Trypsin Inhibitors	Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. (See all compounds classified as Trypsin Inhibitors.)	
4-aminobenzhydrazide	5351-17-7	4-Aminobenzohydrazide	5351-17-7				
4-Aminobenzoic Acid	150-13-0	4-Aminobenzoic acid	150-13-0	TL2TJE8QTX			
4-aminobenzonitrile	873-74-5	4-Aminobenzonitrile	873-74-5	PB8V69Y76T			
4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid		4-Aminobenzoyl-Gly-Pro-D-Leu-D-Ala hydroxamic acid	124168-73-6				
4-aminobutyraldehyde	4390-05-0	4-Aminobutanal	4390-05-0	VTX8N8R7G2			
4-aminocrotonic acid	25747-40-4	(E)-4-Amino-2-butenoic acid	25747-40-4	S2R6R1I2MP			
4-aminodiphenylamine	101-54-2	N-Phenyl-p-phenylenediamine	101-54-2	007X4XXS71			
4-aminoethylamino-emodin		4-aminoethylamino-emodin					
4-aminophenol	123-30-8	p-Aminophenol	123-30-8	R7P8FRP05V	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
4-aminophenylarsenoxide	1122-90-3	4-Aminophenylarsenoxide	1122-90-3	Q80F4IJC71			
4-aminophenylmercuriacetate	6283-24-5	p-Aminophenylmercuric acetate	6283-24-5				
4-Aminopyridine	504-24-5	Dalfampridine	504-24-5	BH3B64OKL9	Potassium Channel Blockers	A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS. (See all compounds classified as Potassium Channel Blockers.)	Dalfampridine is a neurofunctional modifier that helps improve walking speed in patients with multiple sclerosis (MS).
4-amylcinnamoylanthranilic acid	110683-10-8	N-(p-Amylcinnamoyl)anthranilic acid	99196-74-4	LCJ9M6AJ5F			
4-androstene-3,17-diol	1852-61-5	Androst-4-ene-3,17-diol	1156-92-9				
4-anisaldehyde	123-11-5	p-Anisaldehyde	123-11-5	9PA5V6656V			
4-anisidine	104-94-9	p-Anisidine	104-94-9	575917SNR4			
4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine		4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine					
4-benzoylbenzoic acid	611-95-0	4-Benzoylbenzoic acid	611-95-0	GWF8XRR32J			
4-benzoylpyridine		4-Benzoylpyridine	14548-46-0	524YQ3O21T			
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione		4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione	327036-89-5				
4-benzyloxy-3,5-dimethoxy-N-(1-(dimethylaminocyclopently)methyl)benzamide		4-benzyloxy-3,5-dimethoxy-N-(1-(dimethylaminocyclopently)methyl)benzamide					
4-benzylphenol	101-53-1	4-Benzylphenol	101-53-1	CS02509J25			
4-benzylpyridine	2116-65-6	4-Benzylpyridine	2116-65-6	1P29GQM0OH			
4-biphenylamine	92-67-1	4-Aminobiphenyl	92-67-1	16054949HJ	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
4-bis(2-chloroethyl)aminobenzaldehyde	1208-03-3	4-[Bis(2-chloroethyl)amino]benzaldehyde	1208-03-3	8KH2MH9UUB			
4-bromo-2-(4-chlorophenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile		Tralopyril	122454-29-9	MEC6MCY7QB			
4-bromo-2-chlorophenol	3964-56-5	4-Bromo-2-chlorophenol	3964-56-5	994SJ34D8P			
4-bromo-A-23187	76455-48-6	4-Bromo-A23187	76455-48-6				
4-bromoaniline	106-40-1	4-Bromoaniline	106-40-1	0RR61TC330			
4-bromodiphenyl ether		1-Bromo-4-phenoxybenzene	101-55-3	N19SE3QCFN			
4-bromohomoibotenic acid	121313-14-2	4-Bromohomoibotenic acid	121313-14-2				
4-bromophenacyl bromide	99-73-0	2,4'-Dibromoacetophenone	99-73-0	PN0FRW1G4Z	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
4-bromostyrene		4-Bromostyrene	2039-82-9	TVK4S80XLU			
4-carboxybenzaladehyde	619-66-9	4-Formylbenzoic acid	619-66-9	UES4QRK36E			
4-carboxyfluorescein	76823-03-5	5-Carboxyfluorescein	76823-03-5	AB2MM66GSF			
4-carboxyphenylglycine	7292-81-1	4-Carboxyphenylglycine	7292-81-1		Excitatory Amino Acid Antagonists	Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)	
4-chloro-1,2-diaminobenzene	95-83-0	4-Chloro-o-phenylenediamine	95-83-0	8E72QRZ33H			
4-chloro-2-(imidazolin-2-yl)isoindoline	170034-96-5	4-Chloro-2-(imidazolin-2-YL)isoindoline hydrochloride					
4-chloro-2-cresol	1570-64-5	4-Chloro-2-methylphenol	1570-64-5	297V63W9RI			
4-chloro-3-(4-cyclopropylbenzyl)-1-(xylopyranosyl)-1H-indole		4-chloro-3-(4-cyclopropylbenzyl)-1-(xylopyranosyl)-1H-indole					
4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide	119168-77-3	Tebufenpyrad	119168-77-3	IRU3P7ZB3F			
4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide		4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide					
4-chloro-N-(2-(2-thienyl)imidazo(1,2-a)pyridin-3-yl)benzamide		4-chloro-N-(2-(2-thienyl)imidazo(1,2-a)pyridin-3-yl)benzamide					
4-chloroaniline	106-47-8	4-Chloroaniline	106-47-8	Z553SGH315			
4-chlorobenzaldehyde	104-88-1	4-Chlorobenzaldehyde	104-88-1	E67727UP9Z			
4-chlorobenzo(f)isoquinoline		4-Chlorobenzo[f]isoquinoline	32081-28-0				
4-chlorobenzyltetrahydroberberine		4-chlorobenzyltetrahydroberberine					
4-chlorobiphenyl	2051-62-9	4-Chlorobiphenyl	2051-62-9	QA22Z3NGLU			
4-chlorocatechol		4-Chlorocatechol	2138-22-9	I01EXU3P3J			
4-chloroestradiol	88847-88-5	4-Chloroestradiol	88847-88-5	N59ZAM9VAA			
4-Chloromercuribenzenesulfonate	554-77-8	Pcmbs	554-77-8		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
4-chloronitrobenzene	100-00-5	1-Chloro-4-nitrobenzene	100-00-5	CVL66U249D			
4-chlorophenol	106-48-9	4-Chlorophenol	106-48-9	3DLC36A01X	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	Used as an intermediate in organic synthesis of dyes and drugs. Local antibacterial agent in root canal therapy, as topical antiseptic in ointments
4-chlorophenylbiguanide	5304-59-6	4-Chlorophenylbiguanide	5304-59-6	61UQ98597T			
4-chlorostyrene	1073-67-2	4-Chlorostyrene	1073-67-2	T0J05U220F			
4-chromone	491-38-3	Chromone	491-38-3	20C556MJ76			
4-cresol	106-44-5	P-Cresol	106-44-5	1MXY2UM8NV			
4-cresol sulfate		p-Cresol sulfate	3233-58-7	56M34ZQY1S			
4-cresylglucuronide		4-cresylglucuronide					
4-cumylphenol		4-Cumylphenol	599-64-4	2RLA3OL3QT			
4-cyano-4-(2,3-dihydro-8-methoxy-1,4-benzodioxin-5-yl)cyclohexanecarboxylic acid		4-cyano-4-(2,3-dihydro-8-methoxy-1,4-benzodioxin-5-yl)cyclohexanecarboxylic acid					
4-cyano-N-(2-(1-cyclohexen-1-yl)-4-(1-((dimethylamino)acetyl)-4-piperidinyl)phenyl)-1H-imidazole-2-carboxamide		5-Cyano-N-(5-(1-(2-(dimethylamino)acetyl)piperidin-4-yl)-2',3',4',5'-tetrahydro-[1,1'-biphenyl]-2-yl)-1H-imidazole-2-carboxamide hydrochloride	1149939-55-8	9M5069B3F8			
4-cyclododecyl-2,6-dimethylmorpholine acetate	31717-87-0	Dodemorph acetate	31717-87-0				
4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine		22103-14-6					
4-cyclohexyloxy-2-(1-(4-(4-methoxy-benzenesulfonyl)piperazin-1-yl)ethyl)quinazoline		4-cyclohexyloxy-2-(1-(4-(4-methoxy-benzenesulfonyl)piperazin-1-yl)ethyl)quinazoline					
4-cymene	99-87-6	p-CYMENE	99-87-6	1G1C8T1N7Q			
4-dichlorobenzene	106-46-7	1,4-Dichlorobenzene	106-46-7	D149TYB5MK	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide	133208-93-2	Ibrolipim	133208-93-2	07H1561618	Lipoprotein Lipase Activators	Compounds that increase the enzymatic activity of LIPOPROTEIN LIPASE. Lipoprotein lipase activators have a potential role in the treatment of OBESITY by increasing LIPID METABOLISM. Note that substances that increase the synthesis of lipoprotein lipase are not included here. (See all compounds classified as Lipoprotein Lipase Activators.)	
4-dimethylamino-3',4'-dimethoxychalcone		4-dimethylamino-3',4'-dimethoxychalcone					
4-dimethylaminobenzylamine	19293-58-4	4-Dimethylaminobenzylamine	6406-74-2	S273H97VEA			
4-dimethylaminochalcone		4-(Dimethylamino)chalcone	1030-27-9	LQL6UU7VC4			
4-dimethylaminocinnamaldehyde	6203-18-5	4-Dimethylaminocinnamaldehyde	20432-35-3	9RSI7WZ9F0	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
4-diphenylacetoxy-1,1-dimethylpiperidinium	81405-11-0	4-Diphenylacetoxy-1,1-dimethylpiperidinium	81405-11-0	T2C393VHB9	Muscarinic Antagonists	Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)	
4-diphenylacetoxy-N-methylpiperidine methobromide		4-diphenylacetoxy-N-methylpiperidine methobromide					
4-ethylaniline	589-16-2	4-Ethylaniline	589-16-2	MHX72W1ZQV			
4-ethylcatechol		4-Ethylcatechol	1124-39-6	574JV8BYR2			
4-ethylguaiacol	2785-89-9	4-Ethyl-2-methoxyphenol	2785-89-9	C9NFD83BJ5			
4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone		4-Ethylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone	824959-81-1	R18JYO04PY			
4-ethylphenol	123-07-9	4-Ethylphenol	123-07-9	AGG7E6G0ZC			
4-ethynylbiphenyl	29079-00-3	4-Ethynyl-1,1'-biphenyl	29079-00-3				
4-ethynylpyrene		4-Ethynylpyrene	185506-23-4				
4-fluoro-2-(4-(4-(2-hydroxypropan-2-yl)pyrrolidin-3-ylamino)-6,7-dimethoxyquinazolin-2-yl)phenol		4-fluoro-2-(4-(4-(2-hydroxypropan-2-yl)pyrrolidin-3-ylamino)-6,7-dimethoxyquinazolin-2-yl)phenol					
4-fluoro-N-methylaniline	459-59-6	4-Fluoro-N-methylaniline	459-59-6	88F75YIS0F			
4-fluoroamphetamine	459-02-9	4-Fluoroamphetamine	459-02-9	S5744XYR1Z	Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	
4-fluoroaniline	371-40-4	4-Fluoroaniline	371-40-4	60HI1G076Z			
4-fluorobenzoic acid	456-22-4	4-Fluorobenzoic acid	456-22-4	V5ROO2HOU4			
4-fluorobenzoyl-TN-14003		4-fluorobenzoyl-TN-14003					
4-fluorochalcone oxide	42846-54-8	4-Fluorochalcone oxide	42846-54-8				
4-fluorohexahydrosiladifenidol	116679-83-5	pFHHSiD	116679-83-5	XEO1GM7K2V	Muscarinic Antagonists	Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)	
4-fluoromethamphetamine		4-Fluoromethamphetamine	351-03-1	8LLF59DO7F			
4-hexyloxyaniline	39905-57-2	4-Hexyloxyaniline	39905-57-2	VMX449YP3L			
4-HO-MET		4-Hydroxy-N-methyl-N-ethyltryptamine	77872-41-4	6RN01B78NY			
4-hydroperoxy-2-nonenal	83920-83-6	4-Hydroperoxy-2-nonenal	83920-83-6				
4-hydroxy-1-(3-pyridyl)-1-butanone		4-Hydroxy-1-(3-pyridyl)-1-butanone	59578-62-0	Z79CGY64XC			
4-hydroxy-2-decenal	29389-17-1	4-Hydroxydecenal	29389-17-1				
4-hydroxy-2-hexenal	17427-08-6	4-Hydroxyhexenal	17427-21-3				
4-hydroxy-2-nonenal	29343-52-0	4-Hydroxynonenal	75899-68-2	K1CVM13F96	Cross-Linking Reagents	Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)	
4-hydroxy-2-nonenoic acid		4-Hydroxy-2-nonenoic acid	95087-42-6				
4-hydroxy-2-octenal	17449-15-9	4-Hydroxy-2-octenal	55-88-9				
4-hydroxy-2',3',4'-5'-tetrachlorobiphenyl	67651-34-7	2,3,4,5-Tetrachloro-4'-biphenylol	67651-34-7	LH750S39FX			
4-hydroxy-2',4',6'-trichlorobiphenyl		4-Hydroxy-2',4',6'-trichlorobiphenyl	14962-28-8	03KW6RT30C			
4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2,3-b)pyridine-5-carbonitrile		4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2,3-b)pyridine-5-carbonitrile					
4-hydroxy-4-(3-pyridyl)butanoic acid		4-Hydroxy-4-(3-pyridyl)-butanoic acid	15569-97-8	AP9AJ7AWV9			
4-hydroxy-7-oxo-5-heptenoic acid lactone		4-hydroxy-7-oxo-5-heptenoic acid lactone					
4-hydroxy-equilenin	81608-60-8	4-Hydroxyequilenin	81608-60-8				
4-hydroxy-N-desmethyltamoxifen		Endoxifen	112093-28-4	46AF8680RC			
4-hydroxyacetophenone	99-93-4	4'-Hydroxyacetophenone	99-93-4	G1L3HT4CMH			
4-hydroxyazobenzene		4-Hydroxyazobenzene	1689-82-3	VX4306NSH1			
4-hydroxybenzoic acid	99-96-7	4-Hydroxybenzoic acid	99-96-7	JG8Z55Y12H			
4-hydroxybenzophenone	1137-42-4	4-Hydroxybenzophenone	1137-42-4	04R2LWS0MS			
4-hydroxybenzyl alcohol	623-05-2	4-Hydroxybenzyl alcohol	623-05-2	1A3AH1FP1B			
4-hydroxybenzyl isothiocyanate	2086-86-4	4-Hydroxybenzyl isothiocyanate	2086-86-4	318HJ2034L			
4-hydroxybutyric acid	591-81-1	4-Hydroxybutanoic acid	591-81-1	30IW36W5B2			Used as a general anesthetic, to treat conditions such as insomnia, clinical depression, narcolepsy, and alcoholism, and to improve athletic performance.
4-hydroxychalcone	20426-12-4	4-Hydroxychalcone	38239-55-3	JO97Q47VBU			
4-hydroxyclomiphene	79838-51-0	Phenol, 4-(2-chloro-1-(4-(2-(diethylamino)ethoxy)phenyl)-2-phenylethenyl)-	79838-51-0				
4-hydroxyclonidine	57101-48-1	4-Hydroxyclonidine	57101-48-1	EQF32CAD7U			
4-hydroxycoumarin	1076-38-6	4-Hydroxycoumarin	1076-38-6	X954ZLL2RD			
4-hydroxycyclophosphamide	40277-05-2	4-Hydroxycyclophosphamide	40277-05-2	1XBF4E50HS			
4-hydroxyequilenin-o-quinone		4-hydroxyequilenin-o-quinone					
4-hydroxyestradiol	5976-61-4	4-Hydroxyestradiol	5976-61-4	C3ZO03450E			
4-hydroxyestrone	3131-23-5	4-Hydroxyestrone	3131-23-5	3MN57C55S2			
4-hydroxyestrone-4-methyl ether	58562-33-7	4-Methoxyestrone	58562-33-7	EX27GM9MHY			
4-hydroxyifosfamide		4-Hydroxyifosfamide	50892-10-9	ARX5AJ985I			
4-hydroxyiminomethyl-1-methylpyridinium iodide		4-hydroxyiminomethyl-1-methylpyridinium iodide					
4-hydroxyisoleucine		4-Hydroxyisoleucine	781658-23-9				
4-hydroxymephenytoin	61837-65-8	5-Ethyl-5-(4-hydroxyphenyl)-3-methylimidazolidine-2,4-dione	61837-65-8				
4-hydroxymercuribenzoate	138-85-2	Mercurate(1-), (4-carboxylatophenyl)hydroxy-, sodium	138-85-2		Protease Inhibitors	Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)	
4-hydroxymidazolam	59468-85-8	4-Hydroxymidazolam	59468-85-8	LIW2RH792R			
4-hydroxynonenoic acid		4-Hydroxy-2-nonenoic acid	95087-42-6				
4-hydroxyphenyl 4-isopropoxyphenylsulfone		4-hydroxyphenyl 4-isopropoxyphenylsulfone					
4-hydroxyphenylacetic acid		4-Hydroxyphenylacetic acid	156-38-7	3J9SHG0RCN	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
4-hydroxyphenylacetone		4-Hydroxyphenylacetone	770-39-8	7K79N2OO7F			
4-hydroxyphenylbutazone	16860-43-8	4-Hydroxyphenylbutazone	16860-43-8	R4ROQ243U3			
4-hydroxyphenylethanol	501-94-0	Tyrosol	501-94-0	1AK4MU3SNX	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
4-hydroxyphenylpyruvic acid	156-39-8	4-Hydroxyphenylpyruvic acid	156-39-8	0YP1694WNQ			
4-hydroxypropranolol	10476-53-6	4-Hydroxypropranolol	10476-53-6	2449QP4SVP			
4-hydroxypyrazole	4843-98-5	1H-Pyrazol-4-ol	4843-98-5				
4-hydroxyquinoline	611-36-9	4-Hydroxyquinoline	529-37-3	M1O131WXFO			
4-hydroxyretinal	18344-42-8	4-Hydroxyretinal					
4-hydroxyretinoic acid	66592-72-1	4-Hydroxyretinoic acid	66592-72-1	GT84HX78DR			
4-hydroxystilbene	3839-46-1	4-Hydroxystilbene	6554-98-9	S6E4ZX5JSS			
4-hydroxytoremifene		4-Hydroxytoremifene	110503-62-3	WTW99894I6			
4-hydroxyvalproate	60113-82-8	4-Hydroxyvalproic acid	60113-82-8				
4-iodine-benzo(b)thiophene-2-carboxamidine		4-iodo-1-benzothiophene-2-carboxiMidaMide hydrochloride	149732-36-5				
4-iodo-2,5-dimethoxyphenylisopropylamine	64584-34-5	1-(4-Iodo-2,5-dimethoxyphenyl)propan-2-amine	64584-34-5	OOM10GW9UE	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	
4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)cinnamoylamide		4-iodo-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)cinnamoylamide					
4-iodo-tamoxifen	116057-68-2	2-(4-(1-(4-Iodophenyl)-2-phenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine	116057-68-2				
4-iodoaniline	540-37-4	4-Iodoaniline	540-37-4	0BMK56397B			
4-ipomeanol		4-Ipomeanol	32954-58-8	URT1FLO407	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
4-isopropylcatechol	2138-43-4	4-Isopropylcatechol	2138-43-4	SE856V0X6N			
4-isopropylphenol	99-89-8	4-Isopropylphenol	99-89-8	9F59JOO816			
4-mercaptobenzoate	1074-36-8	4-Mercaptobenzoic acid	1074-36-8				
4-mercuribenzoate		p-Mercuribenzoate					
4-methoxy-2-naphthylamine	2764-95-6	4-Methoxy-2-naphthylamine	2764-95-6				
4-methoxy-2,2,6,6-tetramethylpiperidinyl-1-oxy	95407-69-5	4-Methoxy-2,2,6,6-tetramethyl-1-oxidopiperidine	95407-69-5				
4-methoxy-3-phenylenediamine	615-05-4	2,4-Diaminoanisole	615-05-4	86SSM2N1X7			
4-methoxyamphetamine	64-13-1	4-Methoxyamphetamine	64-13-1	OVB8F8P39Q	Hallucinogens	Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. (See all compounds classified as Hallucinogens.)	
4-methoxybenzohydrazide		4-Methoxybenzhydrazide	3290-99-1	33BK77102I			
4-methoxycinnamate methyl ester	832-01-9	Methyl 4-methoxycinnamate	3901-07-3	1F58T0S3Q7			
4-methoxycinnamic acid	830-09-1	trans-4-Methoxycinnamic acid	830-09-1				
4-methoxyestradiol	26788-23-8	4-Methoxyestradiol	26788-23-8	R6YV5Q2LKS			
4-methoxymethamphetamine	22331-70-0	p-Methoxymethamphetamine	22331-70-0	037U5SR9KL			
4-methoxytranylcypromine	19009-68-8	2-(4-Methoxyphenyl)Cyclopropanamine	19009-68-8				
4-methyl-2-((2-methylbenzyl) amino)-1,3-thiazole-5-carboxylic acid		4-methyl-2-((2-methylbenzyl) amino)-1,3-thiazole-5-carboxylic acid					
4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene		Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-	13464-24-9	TZ5YWX57VV			
4-methyl-4'-(3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl)-1,2,3-thiadiazole-5-carboxanilide		4-methyl-4'-(3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl)-1,2,3-thiadiazole-5-carboxanilide					
4-methyl-7-diethylaminocoumarin	91-44-1	7-Diethylamino-4-methylcoumarin	91-44-1	1SFJ7F6R2C			
4-methyl-7,8-dihydroxycoumarin		7,8-Dihydroxy-4-methylcoumarin	2107-77-9	5Z87S33XES			
4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine		4-Methyl-N1-(3-phenylpropyl)benzene-1,2-diamine	749886-87-1				
4-methylaminorex	3568-94-3	4-Methylaminorex	3568-94-3		Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	
4-methylbenz(a)anthracene	316-49-4	4-Methylbenz[a]anthracene	316-49-4				
4-methylbenzaldehyde	104-87-0	4-Methylbenzaldehyde	104-87-0	GAX22QZ28Q			
4-methylbenzenethiol		4-Methylbenzenethiol	106-45-6	6L2WW9XYZO			
4-methylcatechol	452-86-8	4-Methylcatechol	452-86-8	12GLI7JGB3	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
4-methylchrysene		4-Methylchrysene	3351-30-2	TWU6H5YT57			
4-methylcyclohexanol	589-91-3	4-Methylcyclohexanol	589-91-3	1UK9W4X7H9			
4-methylcyclohexyl-1,6-dicarboxylic acid anhydride	19438-60-9	Hexahydro-4-methylphthalic anhydride	19438-60-9				
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid		trans-4-Methylene-2-octyl-5-oxotetrahydrofuran-3-carboxylic acid	191282-48-1				
4-methylesculetin		4-Methylesculetin	529-84-0	132H8N0A91			
4-methylethcathinone		4-Methylethcathinone	1225617-18-4	9665W17SH3	Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	
4-methylhistamine	36507-31-0	4-Methylhistamine	36507-31-0	54ST71P9EE			
4-methylimidazole		4-Methylimidazole	822-36-6	Q64GF9FV4I			
4-methylquinoline	491-35-0	4-Methylquinoline	491-35-0	116169T3O8			
4-methylthioamphetamine		4-Methylthioamphetamine	14116-06-4	6JP2T8KXTR	Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	
4-methylumbelliferone 8-carbaldehyde		4-methylumbelliferone 8-carbaldehyde					
4-methylumbelliferyl acetate	2747-05-9	4-Methylumbelliferyl acetate	2747-05-9	ZD294D576M			
4-methylumbelliferyl beta-D-ribopyranoside	66912-32-1	2H-1-Benzopyran-2-one, 4-methyl-7-(beta-D-ribopyranosyloxy)-	66912-32-1				
4-methylumbelliferyl glucoside	18997-57-4	4-Methylumbelliferyl glucoside	18997-57-4				
4-methylumbelliferyl glucuronide	6160-80-1	4-Methylumbelliferyl glucuronide	6160-80-1		Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
4-methylumbelliferyl heptanoate	18319-92-1	4-Methylumbelliferyl heptanoate	18319-92-1				
4-methylumbelliferyl oleate	18323-58-5	4-Methylumbelliferyl oleate	18323-58-5				
4-methylumbelliferyl phosphate	3368-04-5	4-Methylumbelliferyl phosphate	3368-04-5		Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
4-methylumbelliferyl sulfate	25892-63-1	4-Methylumbelliferone sulfate	25892-63-1				
4-methylumbelliferyl-galactopyranoside	6160-78-7	4-Methylumbelliferyl-galactopyranoside	6160-78-7		Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
4-methylumbelliferylguanidinobenzoate		4-Methylumbelliferylguanidinobenzoate	57817-70-6				
4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl)-piperidine hydrogen chloride		4-(4-Butylpiperidin-1-yl)-1-(2-methylphenyl)butan-1-one	244291-63-2				
4-naphthalene-1-yl-3a,4,5,9b-tetrahydro-3-H-cyclopenta(c)quinoline-8-sulfonic acid amide		4-naphthalene-1-yl-3a,4,5,9b-tetrahydro-3-H-cyclopenta(c)quinoline-8-sulfonic acid amide					
4-nerolidylcatechol		4-Nerolidylcatechol	74683-11-7				
4-nitro-3-(octanoyloxy)benzoic acid		4-Nitro-3-(octanoyloxy)benzoic acid	55894-52-5				
4-nitro-3-cresol		3-Methyl-4-nitrophenol	2581-34-2	2CC94832EU			
4-nitro-3-phenylphenol		4-Nitro-3-phenylphenol	21419-75-0				
4-nitroacetophenone	100-19-6	4'-Nitroacetophenone	100-19-6	4FM2J8HQ27	Radiation-Sensitizing Agents	Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. (See all compounds classified as Radiation-Sensitizing Agents.)	
4-nitroaniline	100-01-6	4-Nitroaniline	100-01-6	1MRQ0QZG7G			
4-nitroanisole	100-17-4	4-Nitroanisole	100-17-4	G989Z7WOLH			
4-nitrobenzaldehyde	555-16-8	4-Nitrobenzaldehyde	555-16-8	NX859P8MB0			
4-nitrobenzenthiol		4-nitrobenzenthiol					
4-nitrobenzofurazan	16322-19-3	4-Nitrobenzofurazan	16322-19-3	L2GK95S4XU			
4-nitrobenzoic acid	62-23-7	4-Nitrobenzoic acid	62-23-7	G83NWR61OW			
4-nitrobenzyl bromide	100-11-8	4-Nitrobenzyl bromide	100-11-8	QCHRSPCHUE			
4-nitrobenzyl chloride	100-14-1	4-Nitrobenzyl chloride	100-14-1	3BLD9LVT3X			
4-nitrobenzylthioinosine	38048-32-7	4-Nitrobenzylthioinosine	38048-32-7	GV1L2DZM2Z	Affinity Labels	Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. (See all compounds classified as Affinity Labels.)	
4-nitrobiphenyl	92-93-3	4-Nitrobiphenyl	92-93-3	QM80NUW6WZ			
4-nitrocatechol	3316-09-4	4-Nitrocatechol	3316-09-4	SW60NG75EN			
4-nitrocatechol sulfate	10485-66-2	4-Nitrocatechol sulfate	10485-66-2	HD9MHQ536A			
4-nitrochalcone		4-Nitrochalcone	2960-55-6	YT67D88ODY			
4-nitrophenethyl bromide	5339-26-4	4-Nitrophenethyl bromide	5339-26-4				
4-nitrophenol	100-02-7	4-Nitrophenol	100-02-7	Y92ZL45L4R			
4-nitrophenyl 2-propylmethylphosphonate	3735-97-5	4-Nitrophenyl 2-propylmethylphosphonate	3735-97-5				
4-nitrophenyl acetate	830-03-5	4-Nitrophenyl acetate	830-03-5	I902J0QH9S			
4-nitrophenyl beta-D-xyloside	2001-96-9	4-Nitrophenyl beta-D-xyloside	2001-96-9				
4-nitrophenyl butyrate	2635-84-9	4-Nitrophenyl butyrate	2635-84-9	42RWS6BQC4			
4-nitrophenyl laurate	1956-11-2	4-Nitrophenyl laurate	1956-11-2				
4-nitrophenyl sulfate	1080-04-2	4-Nitrophenyl sulfate	1080-04-2				
4-nitrophenylacetic acid	104-03-0	4-Nitrophenylacetic acid	104-03-0	KLB4P626RE			
4-nitrophenylglucuronide	10344-94-2	4-Nitrophenyl beta-D-glucopyranosiduronic acid	10344-94-2				
4-nitrophenyloctanoate	1956-10-1	4-Nitrophenyl caprylate	1956-10-1				
4-nitropyrene		4-Nitropyrene	57835-92-4	XOT1408EDI			
4-Nitroquinoline-1-oxide	56-57-5	4-Nitroquinoline N-oxide	56-57-5	X5081510EV	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
4-nitroquinolone-1-oxide		4-nitroquinolone-1-oxide					
4-nitroso-N-phenylaniline	156-10-5	4-Nitroso-N-phenylaniline	156-10-5	F7052989CV			
4-nitrosobiphenyl	10125-76-5	4-Nitrosobiphenyl	10125-76-5	9U69963CQ2			
4-nitrosodimethylaniline	138-89-6	N,N-Dimethyl-4-nitrosoaniline	138-89-6	726V2ETM9E			
4-nitrososulfamethoxazole	131549-85-4	4-Nitrososulfamethoxazole	131549-85-4	KK4E4D7F9Y			
4-nitrotoluene	99-99-0	4-Nitrotoluene	99-99-0	E88IMG14EX			
4-nonylphenol	104-40-5	4-Nonylphenol	104-40-5				
4-O-decyl-gabosine D		4-O-decyl-gabosine D					
4-O-methyl-12-O-tetradecanoylphorbol 13-acetate	57716-89-9	4-O-Methyl-12-O-tetradecanoylphorbol 13-acetate	57716-89-9				
4-O-methylascochlorin	38561-40-9	4-O-Methylascochlorin	38561-40-9				
4-O-methylhonokiol		4-O-Methylhonokiol	68592-15-4	TUH6B83HJW			
4-octylphenol	1806-26-4	4-Octylphenol	1806-26-4	7DF2B8LH3P	Estrogens, Non-Steroidal	Non-steroidal compounds with estrogenic activity. (See all compounds classified as Estrogens, Non-Steroidal.)	
4-OH-2',3,3',4',5'-pentachlorobiphenyl		4-OH-2',3,3',4',5'-pentachlorobiphenyl					
4-oxo-2-nonenal		4-Oxo-2-nonenal	103560-62-9				
4-oxo-4-(3-pyridinebutanal)	76014-80-7	4-Oxo-4-(pyridin-3-yl)butanal	76014-80-7	82739XE26C			
4-oxo-4-(3-pyridyl)butanoic acid		4-Oxo-4-(pyridin-3-yl)butanoic acid	4192-31-8	8Y4EX5XJ5B			
4-oxofenretinide		4-Oxofenretinide	865536-65-8	HT9VGV5Y5X			
4-oxoretinaldehyde	33532-44-4	4-Oxoretinal	33532-44-4				
4-oxoretinoic acid	38030-57-8	All-trans-4-oxoretinoic acid	38030-57-8	CJN45G18UA			
4-oxoretinol	62702-55-0	4-Oxoretinol	62702-55-0	6FFM6M3NPT			
4-oxy-6-(4-oxybezoyloxy)dauc-8,9-en	41743-44-6	Ferutinine	41743-44-6				
4-p-hydroxyphenyl-2,2,4-trimethylchroman		Phenol, 4-(3,4-dihydro-2,2,4-trimethyl-2H-1-benzopyran-4-yl)-	472-41-3	90766708Z6			
4-pentenoic acid	591-80-0	4-Pentenoic acid	591-80-0	D4S77Y29FB			
4-pentylphenol		4-Pentylphenol	14938-35-3	40069Q368Q			
4-phenoxyphenol		4-Phenoxyphenol	831-82-3	D83R742GJR			
4-phenyl-1,2,3,4-tetrahydroisoquinoline	89160-45-2	Isoquinoline, 1,2,3,4-tetrahydro-4-phenyl-, (R)-	89160-45-2				
4-phenyl-2-propionamidotetraline		4-P-Pdot	134865-74-0				
4-phenyl-3-furoxancarbonitrile		4-Phenyl-3-furoxancarbonitrile					
4-phenylbenzoic acid	92-92-2	4-Biphenylcarboxylic acid	92-92-2	36J7VPO67K			
4-phenylbutylamine		4-Phenylbutylamine	13214-66-9	UG8K2LT79Y			
4-phenylbutyric acid	1821-12-1	Phenylbutyric acid	1821-12-1	7WY7YBI87E	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Phenylbutyric acid is used for the treatment of various conditions, including urea cycle disorders, neonatal-onset deficiency, late-onset deficiency disease in patients with a history of hyperammonemic encephalopathy. Phenylbutyric acid must be combined with dietary protein restriction and, in some cases, essential amino acid supplementation.  Phenylbutyric acid, as sodium phenylbutyrate, is used in combination with [tauroursodeoxycholic acid] to treat amyotrophic lateral sclerosis (ALS) in adults.
4-phenylcoumarin		4-Phenylcoumarin	15185-05-4	13O55K0UYE			
4-phenylenediamine	106-50-3	p-Phenylenediamine	106-50-3	U770QIT64J	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
4-phenylphenol	92-69-3	4-Phenylphenol	92-69-3	50LH4BZ6MD			
4-propylphenol	645-56-7	4-Propylphenol	645-56-7	H27VG833JY			
4-Quinolones		4-Quinolones					
4-styrylpyrimidin-2-ylamine		4-styrylpyrimidin-2-ylamine					
4-t-octylphenolmonoethoxylate		4-t-octylphenolmonoethoxylate					
4-tert-butylcyclohexanol		4-tert-Butylcyclohexanol	98-52-2	L5067JRJ73			
4-tert-butylcyclohexyl acetate		4-tert-Butylcyclohexyl acetate	1900-69-2	JN4PL52AKL			
4-tert-butylphenyl salicylate		4-tert-Butylphenyl salicylate	87-18-3	V0H9R55TGV			
4-tert-octylcatechol		1139-46-4					
4-tert-octylphenol	140-66-9	4-tert-Octylphenol	140-66-9	IOY9FVU3J3	Surface-Active Agents	Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)	
4-toluenesulfonyl fluoride	455-16-3	p-TOLUENESULFONYL FLUORIDE	455-16-3		Protease Inhibitors	Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)	
4-toluic acid	99-94-5	4-Methylbenzoic acid	99-94-5	A26GBX5SSV			
4-toluidine	106-49-0	p-Toluidine	106-49-0	I1D0KL7I4U			
4-tolyl isocyanate	622-58-2	p-Tolyl isocyanate	622-58-2	BTR9S4N53V			
4-tosylcyclonovobiocic acid		4-tosylcyclonovobiocic acid					
4-trifluoromethylsalicylic acid	328-90-5	4-Trifluoromethylsalicylic acid	328-90-5	UKY7YRE9E9			
4-trifluoromethylumbelliferyl iduronide	128095-54-5	(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[2-oxo-4-(trifluoromethyl)chromen-7-yl]oxyoxane-2-carboxylic acid	128095-54-5				
4-vinyl-1-cyclohexene dioxide		4-Vinylcyclohexene dioxide	106-87-6	596C064IG4	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
4-vinyl-2,6-dimethoxyphenol		2,6-Dimethoxy-4-vinylphenol	28343-22-8	ZB5OK5EX8B			
4-vinylcyclohexene	100-40-3	4-Vinylcyclohexene	100-40-3	212JQJ15PS			
4-vinylphenol	2628-17-3	4-Vinylphenol	2628-17-3	OA7V1SM8YL			
4-vinylpyridine	100-43-6	4-Vinylpyridine	100-43-6	I56G67XM8D	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
4-xylene	106-42-3	P-Xylene	106-42-3	6WAC1O477V			
4,16-androstadien-3-one	4075-07-4	Androsta-4,16-dien-3-one	4075-07-4	ZUZ4FHD36E			
4,17 beta-dihydroxy-4-androstene-3-one	2141-17-5	4-Hydroxytestosterone	2141-17-5	912GOZ167T			
4,4 -(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bis(phenol)		4,4 -(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bis(phenol)					
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene		Bodipy			Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
4,4-dimethyl-5-alpha-cholesta-(8,24)-dien-3-beta-ol	7448-02-4	14-Demethyllanosterol	7448-02-4				
4,4-dimethylcholesta-8,14,24-trienol	64284-64-6	4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol	64284-64-6				
4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate)		4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate)					
4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione	21416-68-2	4,4'-(1,2-Dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione	21416-68-2		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
4,4'-(carbonylbis(imino-3,1-phenylenecarbonylimino-3,1-(4-methylphenylene)carbonylimino))bis(1,3-xylene-alpha,alpha'-diphosphonic acid)		4,4'-(carbonylbis(imino-3,1-phenylenecarbonylimino-3,1-(4-methylphenylene)carbonylimino))bis(1,3-xylene-alpha,alpha'-diphosphonic acid)					
4,4'-bis(2-sulfostyryl)biphenyl		Disodium distyrylbiphenyl disulfonate, (Z,Z)-	27344-41-8	I25R28R1YG			
4,4'-bisphenol F	620-94-8	4,4'-Methylenediphenol	620-92-8	QD2C19044Z			
4,4'-butylidenebis(6-t-butyl-m-cresol)		Santowhite	85-60-9	IM86P8WF2S			
4,4'-cyclohexylidenebisphenol		1,1-Bis(4-hydroxyphenyl)cyclohexane	843-55-0	64ZF6464QY			
4,4'-diaminodiphenylmethane	101-77-9	4,4'-Methylenedianiline	101-77-9	GG5LL7OBZC	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
4,4'-dichlorobenzophenone	90-98-2	4,4'-Dichlorobenzophenone	90-98-2	3MTL0YC2Q5			
4,4'-dichlorobiphenyl	2050-68-2	4,4'-Dichlorobiphenyl	2050-68-2	DOF6S5DT2R			
4,4'-dichlorodiphenyl sulfone	80-07-9	4,4'-Dichlorodiphenyl sulfone	80-07-9	5U49794253			
4,4'-dihydroxybiphenyl	92-88-6	4,4'-Dihydroxybiphenyl	92-88-6	R8994A0904			
4,4'-dihydroxystilbene	659-22-3	4,4'-Dihydroxystilbene	15058-36-3	921UXX4IZL			
4,4'-diiodobiphenyl	3001-15-8	4,4'-Diiodobiphenyl	3001-15-8	LLR69F3JMZ			
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid	53005-05-3	4,4'-Diisothiocyanostilbene-2,2'-disulfonic acid	152216-76-7	Q1O6DSW23R			
4,4'-dimethylbiphenyl	613-33-2	4,4'-Dimethylbiphenyl	613-33-2	5J314QOJ2V			
4,4'-dinitro-2,2'-stilbenedisulfonic acid		4,4'-Dinitrostilbene-2,2'-disulfonic acid	128-42-7	6ND7PC82E2			
4,4'-diphenylmethane diisocyanate		4,4'-Diphenylmethane diisocyanate	26447-40-5	B0LO6BBS8C			
4,4'-dipyridyl disulfide	2645-22-9	4,4'-Dipyridyl disulfide	2645-22-9	EI4LXL5JH8			
4,4'-hexafluorisopropylidene diphenol		4,4'-hexafluorisopropylidene diphenol					
4,4'-methanol-bisbenzonitrile		Bis(4-cyanophenyl)methanol	134521-16-7	3WEU2JKQ13			
4,4'-thiobis(6-tert-butyl-3-cresol)	96-69-5	4,4'-Thiobis(6-tert-butyl-m-cresol)	96-69-5	3CA5G9822V			
4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol		4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol					
4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1H-pyrzolo(3,4-g)quinoline		Quinpirole hydrochloride	85798-08-9	T6I2W5V2K1	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
4,5-amino-3,5-dichloro-6-fluoro-2-pyridinyloxyacetic acid		Fluroxypyr	69377-81-7	8O40SHO197	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
4,5-dianilinophthalimide		4,5-Dianilinophthalimide	145915-58-8	Z13D008FZ2	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
4,5-dicaffeoyl quinic acid		4,5-Dicaffeoyl quinic acid					
4,5-dichloro-1,2-dithiol-3-one		4,5-Dichloro-3H-1,2-dithiol-3-one	1192-52-5	N864R2B87O			
4,5-dichlorocatechol		4,5-Dichlorocatechol	3428-24-8	ZGN07HXZ5R			
4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine	66000-40-6	4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine	66000-40-6	6V6JF56BXO	Lipoxygenase Inhibitors	Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)	
4,5-dihydroorotic acid	155-54-4	Dihydroorotic acid	155-54-4	39LRK7UX5B			
4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide		4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide					
4,5-dihydroxy-4,5-dihydrobenzo(a)pyrene	28622-84-6	4,5-Dihydro-4,5-dihydroxybenzo(a)pyrene	28622-84-6				
4,5-dimethoxy-2-nitrobenzyl-8-bromo-cAMP	177592-87-9	Caged 8-Br-camp	177592-87-9				
4,5-dimethyl-1,2-phenylenediamine	3171-45-7	4,5-Dimethyl-1,2-phenylenediamine	3171-45-7	1OJ9D3R6NH			
4,5-dimethyl-3-hydroxy-2(5H)-furanone	28664-35-9	3-Hydroxy-4,5-dimethylfuran-2(5H)-one	28664-35-9	T62RL2NEGW			
4,5-epoxy-2-decenal		trans-4,5-epoxy-2(E)-Decenal	188590-62-7				
4,5,6,7-tetrabromo-2-azabenzimidazole		4,5,6,7-Tetrabromobenzotriazole	17374-26-4				
4,5,6,7-tetrabromobenzotriazole		4,5,6,7-Tetrabromobenzotriazole	17374-26-4				
4,5,6,7-tetrachlorophthalide		Fthalide	27355-22-2	44IHE2M2T4			
4,5,7a,8,9,10,11,11a-octohydro-7H-10-methylindolol(1,7bc)(2,6)-napthyridine		4,5,7a,8,9,10,11,11a-octohydro-7H-10-methylindolol(1,7bc)(2,6)-napthyridine					
4,6-diamino-5-N-formamidopyrimidine	5122-36-1	N-(4,6-diaminopyrimidin-5-yl)formamide	5122-36-1				
4,6-dimorpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine		4,6-dimorpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine					
4,7-diphenylphenanthroline sulfonate	40795-59-3	4,7-Diphenyl-1,10-phenanthrolinesulphonic acid	40795-59-3				
4,7-phenanthroline	230-07-9	4,7-Phenanthroline	230-07-9	WQM4R8KEX6			
4,8-bis(4-hydroxy-3-methoxyphenyl)-3,7-dioxabicyclo(3.3.0)octane-2,6-dione		4,8-bis(4-hydroxy-3-methoxyphenyl)-3,7-dioxabicyclo(3.3.0)octane-2,6-dione					
4'-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol		4'-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol					
4'-bromoflavone		4'-Bromoflavone	20525-20-6	6TC8H54C8T			
4'-chlorodiazepam	14439-61-3	4'-Chlorodiazepam	14439-61-3	2QW0IK1742	Convulsants	Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)	
4'-chloroflavone	10420-75-4	4'-Chloroflavone	10420-75-4				
4'-cyanobiphenyl-4-sulfonic acid (6-aminopyridin-2-yl)amide		4'-cyanobiphenyl-4-sulfonic acid (6-aminopyridin-2-yl)amide					
4'-demethyldesoxypodophyllotoxin		4'-Demethyldeoxypodophyllotoxin	3590-93-0				
4'-hydroxychalcone	2657-25-2	4'-Hydroxychalcone	2657-25-2	2K338K8UOA			
4'-hydroxydiclofenac		4'-Hydroxydiclofenac	64118-84-9	NJF5O599EF			
4'-hydroxyflavanone		4'-Hydroxyflavanone	6515-37-3	5K6L8O868Y			
4'-hydroxytetramethoxyflavone		4'-hydroxytetramethoxyflavone					
4'-hydroxytolbutamide		4'-hydroxytolbutamide					
4'-hydroxywarfarin	24579-14-4	4'-Hydroxywarfarin	24579-14-4	3D8G6747YQ			
4'-hydroxywogonin		4'-Hydroxywogonin	57096-02-3				
4'-iodoflavone		4'-iodoflavone					
4'-methoxy licoflavanone		4'-methoxy licoflavanone					
4'-methoxy-1-naphthylfenoterol		4'-methoxy-1-naphthylfenoterol					
4'-methoxy-3',5,7-trihydroxyisoflavone		Pratensein	2284-31-3	D2CF8CJ6AP			
4'-methoxychalcone	959-23-9	4'-Methoxychalcone	22966-19-4	BM45N45FIZ			
4'-methoxyflavone		4'-Methoxyflavone	4143-74-2				
4'-O-glucosyl-5-O-methylvisamminol		4'-O-Glucosyl-5-O-methylvisamminol					
4'-O-methylalpinumisoflavone		4'-O-methylalpinumisoflavone	27762-87-4				
4',5'-bis(1,3,2-dithioarsolan-2-yl)fluorescein		4',5'-bis(1,3,2-dithioarsolan-2-yl)fluorescein					
4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline		BMS-345541 free base	445430-58-0	26SU0NEF5F			
4(4-(5-nitro-furan-2-ylmethylene)-3,5-dioxo-pyrazolidin-1-yl)-benzoic acid ethyl ester		4(4-(5-nitro-furan-2-ylmethylene)-3,5-dioxo-pyrazolidin-1-yl)-benzoic acid ethyl ester					
4(G)-alpha-glucopyranosyl-rutin	130603-71-3	4(G)-alpha-Glucopyranosyl-rutin	130603-71-3				
4557 W		4557 W					
4CP.P		4CP.P					
4H-thieno(3,2-b)pyrrole-5-carboxylic acid		4H-thieno[3,2-b]pyrrole-5-carboxylic acid	39793-31-2				
5-((1,5-bis(4-methoxyphenyl)pyrazol-3-yl)dimethoxymethyl)-2-chlorobenzamide		Benzamide, 5-((1,5-bis(4-methoxyphenyl)-1H-pyrazol-3-yl)dimethoxymethyl)-2-chloro-	179325-62-3	72Y1B3J8FS			
5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide	213252-19-8	5-((2,4-Dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide	213252-19-8				
5-((2,6-dichlorobenzyl)sulfonyl)-3-((3,5-dimethyl-4-((2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-1,3-dihydro-2H-indol-2-one		5-((2,6-dichlorobenzyl)sulfonyl)-3-((3,5-dimethyl-4-((2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-1,3-dihydro-2H-indol-2-one					
5-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-2-pyrazinecarboxamide		5-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-2-pyrazinecarboxamide					
5-((3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl)-N-(2,4,6-trimethoxyphenyl)-2-furamide		5-((3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl)-N-(2,4,6-trimethoxyphenyl)-2-furamide					
5-((4-(2-(1-indolyl)ethoxy)-phenyl)methyl)thiazolidine-2,4-dione		5-((4-(2-(1-indolyl)ethoxy)-phenyl)methyl)thiazolidine-2,4-dione					
5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone		5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone					
5-((5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-N-(2-hydroxy-3-morpholin-4-ylpropyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide		1H-Pyrrole-3-carboxamide, 5-((5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-N-((2S)-2-hydroxy-3-(4-morpholinyl)propyl)-2,4-dimethyl-	452105-23-6	ZZ6VH5MZ17			
5-(2-aminopropyl)benzofuran		5-(2-Aminopropyl)benzofuran	286834-81-9	2M3825704H			
5-(2-aminopropyl)indole		5-(2-Aminopropyl)indole	3784-30-3	W98BOE73HH			
5-(2-azetidinylmethoxy)-2-chloropyridine		Tebanicline tosylate	198283-74-8	CP1A26546Z			
5-(2,2-difluorobenzo(1,3)dioxol-5-ylmethylene)thiazolidine-2,4-dione		5-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethylene)-thiazolidine-2,4-dione	648449-76-7				
5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide		5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide					
5-(2,4-dihydroxybenzylidene)-2-(phenylimino)-1,3-thiazolidin		5-(2,4-Dihydroxybenzylidene)-2-(phenylimino)-1,3-thiazolidin					
5-(3-((3-(5-methoxybenzisoxazol-3-yl)benzimidazol-1-yl)methyl)phenyl)-5-methyloxazolidinedione		5-(3-((3-(5-methoxybenzisoxazol-3-yl)benzimidazol-1-yl)methyl)phenyl)-5-methyloxazolidinedione					
5-(3-(2-(3-hydroxy-4-(3-(trifluoromethyl)phenyl)butyl)-5-oxopyrrolidin-1-yl)propyl)thiophene-2-carboxylate		5-(3-(2-(3-hydroxy-4-(3-(trifluoromethyl)phenyl)butyl)-5-oxopyrrolidin-1-yl)propyl)thiophene-2-carboxylate					
5-(3-(3-hydroxyphenoxy)azetidin-1-yl)-5-methyl-2,2-diphenylhexanamide		1-Azetidinepentanamide, 3-(3-hydroxyphenoxy)-delta,delta-dimethyl-alpha,alpha-diphenyl-	931409-24-4	O0RG3QM34H			
5-(3-(4-(4-benzylpiperazin-1-yl)-N-(4-phenylthiazol-2-yl))propanamide		5-(3-(4-(4-benzylpiperazin-1-yl)-N-(4-phenylthiazol-2-yl))propanamide					
5-(3-(4-benzylpiperidin-1-yl)prop-1-ynyl)-1,3-dihydrobenzoimidazol-2-((11)C)one		5-(3-(4-benzylpiperidin-1-yl)prop-1-ynyl)-1,3-dihydrobenzoimidazol-2-((11)C)one					
5-(3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,4-imidazolidinedione		5-(3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)-2,4-imidazolidinedione					
5-(3-bromophenyl)-1,3-dihydro-2H-benzofuro(3,2-e)-1,4-diazepin-2-one		5-(3-bromophenyl)-1,3-dihydro-2H-benzofuro(3,2-e)-1,4-diazepin-2-one					
5-(3-methoxy-5-(4-methoxystyryl)phenoxy)-2,2-dimethylpentanoic acid		5-(3-methoxy-5-(4-methoxystyryl)phenoxy)-2,2-dimethylpentanoic acid					
5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-2-oxo-1,2-dihydro-1,6-naphthyridine		Radequinil	219846-31-8	2G222T03EY			
5-(3-methylphenoxy)-2(1H)-pyrimidinone		Tolimidone	41964-07-2	MU3JD8E9IS			
5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl)imidazole		5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl)imidazole					
5-(4-((6-(allyloxy)-2,5,7,8-tetramethylchroman-2-yl)methoxy)-3-methoxybenzylidene)thiazolidine-2,4-dione		5-(4-((6-(allyloxy)-2,5,7,8-tetramethylchroman-2-yl)methoxy)-3-methoxybenzylidene)thiazolidine-2,4-dione					
5-(4-(2-(2-ethyl-4-methyl-6-oxo-1,6-dihydro-1-pyrimidinyl)ethoxy)phenylmethyl)thiazolidine-2,4-dione		5-(4-(2-(2-ethyl-4-methyl-6-oxo-1,6-dihydro-1-pyrimidinyl)ethoxy)phenylmethyl)thiazolidine-2,4-dione					
5-(4-(3-(4-cyclohexyl-2-propylphenoxy)propoxy)phenyl)-1,3-oxazolidine-2,4-dione		5-(4-(3-(4-cyclohexyl-2-propylphenoxy)propoxy)phenyl)-1,3-oxazolidine-2,4-dione					
5-(4-benzyloxyphenyl)-4S-(7-phenylheptanoylamino)pentanoic acid		(S)-5-(4-Benzyloxy-phenyl)-4-(7-phenyl-heptanoylamino)-pentanoic acid	393569-31-8				
5-(4-bromobenzylidene)-alpha-isopropyl-4-oxo-2-thioxo-3-thazolidineacetic acid		5-(4-bromobenzylidene)-alpha-isopropyl-4-oxo-2-thioxo-3-thazolidineacetic acid					
5-(4-dimethylaminobenzoyl)-aminovaleric acid hydroxamate		5-(4-dimethylaminobenzoyl)-aminovaleric acid hydroxamate					
5-(4-ethylbenzylidene)-2-thioxothiazolidin-4-one		5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone	403811-55-2				
5-(5-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)-2-chlorobenzoic acid		5-(5-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)-2-chlorobenzoic acid					
5-(5-(4-fluoro-2-hydroxyphenyl)furan-2-ylmethylene)thiazolidine-2,4-dione		AS-252424	900515-16-4	63D4RUV1GN			
5-(5-amino-3-(4-fluorophenyl)pyrazin-2-yl)-1-isopropylprydine-2(1H)-one		2(1H)-Pyridinone, 5-(5-amino-3-(4-fluorophenyl)-2-pyrazinyl)-1-(1-methylethyl)-	851087-60-0	BJS8Y4IC5V	Adenosine A1 Receptor Antagonists	Compounds that bind to and block the stimulation of ADENOSINE A1 RECEPTORS. (See all compounds classified as Adenosine A1 Receptor Antagonists.)	
5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-((2-(trifluoromethyl)benzyl)oxy)thiophene-2-carboxamide		5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-((2-(trifluoromethyl)benzyl)oxy)thiophene-2-carboxamide					
5-(alpha-methyl-4-bromobenzylamino)phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione		5-(alpha-Methyl-4-bromobenzylamino)phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione	858131-65-4				
5-(cyclohexylmethoxy)-3-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one		5-(cyclohexylmethoxy)-3-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one					
5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide	153042-42-3	5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide	153042-42-3		Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid		5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid					
5-(N-benzyl-N-methylaminomethyl)-1--(2,6-difluorobenzyl)-6-(4-(3-methoxyureido)phenyl)-3-phenylthieno(2,3-d)pyrimidine-2,4(1H,3H)-dione		5-(N-benzyl-N-methylaminomethyl)-1--(2,6-difluorobenzyl)-6-(4-(3-methoxyureido)phenyl)-3-phenylthieno(2,3-d)pyrimidine-2,4(1H,3H)-dione					
5-(N-methyl-N-isobutyl)amiloride	96861-65-3	5-(N-Methyl-N-isobutyl)amiloride	96861-65-3				
5-(N-methyl-N-propargylaminomethyl)-8-hydroxyquinoline		5-(N-methyl-N-propargylaminomethyl)-8-hydroxyquinoline					
5-(N,N-dimethylaminomethyl)-3-(4-nitrophenyl)-4,5-dihydroisoxazole		5-(N,N-dimethylaminomethyl)-3-(4-nitrophenyl)-4,5-dihydroisoxazole					
5-(N,N-hexamethylene)amiloride	1428-95-1	5-(N,N-Hexamethylene)amiloride	1428-95-1		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
5-(tetradecyloxy)-2-furancarboxylic acid	54857-86-2	5-(Tetradecyloxy)-2-furoic acid	54857-86-2	BI12FRY055	Hypolipidemic Agents	Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)	
5-2-(4-((ethylmethylamino)carbonyl)-3-fluorophenyl)-alpha,alpha-dimethyl-N-1,3,4-thiadiazol-2-yl-5H-(1)benzopyrano(2,3-b)pyridin-5-acetamide		5-2-(4-((ethylmethylamino)carbonyl)-3-fluorophenyl)-alpha,alpha-dimethyl-N-1,3,4-thiadiazol-2-yl-5H-(1)benzopyrano(2,3-b)pyridin-5-acetamide					
5-acetyl-1,1,2,6-tetramethyl-3-isopropylindane		5-acetyl-1,1,2,6-tetramethyl-3-isopropylindane					
5-acetylamino-6-formylamino-3-methyluracil	85438-96-6	5-Acetylamino-6-formylamino-3-methyluracil	85438-96-6	LQW8YAU3VF			
5-alpha-Dihydroprogesterone	566-65-4	5alpha-Pregnane-3,20-dione	566-65-4	98G4S1OH0Z			
5-amino-1-naphthol	83-55-6	5-Amino-1-naphthol	83-55-6	AG7EQ6HH6B			
5-amino-2-ethoxy-N-(3-trifluoromethylphenyl)benzamide		5-amino-2-ethoxy-N-(3-trifluoromethylphenyl)benzamide					
5-amino-2-methylsulfanyl-4-(3-(2-morpholin-4-ylacetylamino)phenyl)thieno(2,3-d)pyrimidine-6-carboxylic acid tert-butylamide		5-amino-2-methylsulfanyl-4-(3-(2-morpholin-4-ylacetylamino)phenyl)thieno(2,3-d)pyrimidine-6-carboxylic acid tert-butylamide					
5-amino-2,4-dihydroxy-alpha-methylphenylethylamine	106868-44-4	5-Amino-2,4-dihydroxy-alpha-methylphenylethylamine	106868-44-4				
5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine		5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine					
5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid		5-Amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid					
5-amino-o-cresol		5-Amino-2-methylphenol	2835-95-2	UBB8XEB10B			
5-aminoindole		5-Aminoindole	5192-03-0	Q732PG0Y16			
5-aminoisoquinoline		1125-60-6					
5-aminoisoquinolinone		5-aminoisoquinolinone					
5-aminolevulinic acid hexyl ester		5-aminolevulinic acid hexyl ester					
5-androstene-16-fluoro-17-one	156680-74-9	5-androstene-16-fluoro-17-one					
5-androstene-3,17-dione	571-36-8	Androst-5-ene-3,17-dione	571-36-8	HEE11L5C3G			
5-androstene-3,7,17-triol		5-androstene-3,7,17-triol					
5-azidoepibatidine		5-azidoepibatidine					
5-aziridinyl-3-hydroxyl-1-methylindole-4,7-dione		5-aziridinyl-3-hydroxyl-1-methylindole-4,7-dione					
5-benzo(1,3)dioxol-5-yl-1-(2,5-dichloro-phenyl)-1H-pyrazole-3-carbaldehyde		5-benzo(1,3)dioxol-5-yl-1-(2,5-dichloro-phenyl)-1H-pyrazole-3-carbaldehyde					
5-benzylacyclouridine	82857-69-0	5-Benzylacyclouridine	82857-69-0	0H851I3O9D	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
5-bromotryptamine	3610-42-2	5-Bromotryptamine	3610-42-2				
5-butyl-6-hydroxy-10-chlorobenzo(c)quinolizinium chloride		5-butyl-6-hydroxy-10-chlorobenzo(c)quinolizinium chloride					
5-butyl-7-chloro-6-hydroxybenzo(c)quinolizinium		5-butyl-7-chloro-6-hydroxybenzo(c)quinolizinium					
5-carboxamidotryptamine	74885-09-9	3-(2-aminoethyl)-1H-indole-5-carboxamide					
5-carboxy-8-hydroxyquinoline		5-Carboxy-8-hydroxyquinoline					
5-carboxyfluorescein diacetate	79955-27-4	5-Carboxyfluorescein diacetate	79955-27-4				
5-chloro-1-(4-chlorobenzyl)-3-(phenylthio)indole-2-carboxylic acid		5-chloro-1-(4-chlorobenzyl)-3-(phenylthio)indole-2-carboxylic acid					
5-chloro-2-(3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl)-4(3H)-quinazolinone		5-chloro-2-(3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl)-4(3H)-quinazolinone					
5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide		Ataciguat	254877-67-3	QP166M390Q	Enzyme Activators	Compounds or factors that act on a specific enzyme to increase its activity. (See all compounds classified as Enzyme Activators.)	
5-chloro-2-mercaptobenzothiazole		2(3H)-Benzothiazolethione, 5-chloro-					
5-chloro-2-methyl-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole		5-chloro-2-methyl-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole					
5-chloro-2-methyl-4-isothiazolin-3-one	26172-55-4	5-Chloro-2-methyl-4-isothiazolin-3-one	26172-55-4	DEL7T5QRPN	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	Methylchloroisothiazolinone is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.
5-chloro-2'-deoxycytidine	32387-56-7	5-Chloro-2'-deoxycytidine					
5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride		5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride					
5-chloro-8-hydroxyquinoline	130-16-5	130-16-5					
5-chloro-N2-(1-(5-fluoropyridin-2-yl)ethyl)-N4-(5-isopropoxy-1H-pyrazol-3-yl)pyrimidine-2,4-diamine		5-chloro-N2-(1-(5-fluoropyridin-2-yl)ethyl)-N4-(5-isopropoxy-1H-pyrazol-3-yl)pyrimidine-2,4-diamine					
5-chlorobenzo(d)isoxazol-3-ol		5-chlorobenzo(d)isoxazol-3-ol					
5-chloromethylfluorescein	136832-63-8	5-Chloromethylfluorescein diacetate	136832-63-8	WG6H2YMA2X	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
5-chlorotryptamine		5-Chlorotryptamine					
5-chlorouracil	1820-81-1	1820-81-1					
5-cholesten-3,25-diol 3-sulfonate		5-cholesten-3,25-diol 3-sulfonate					
5-demethylnobiletin		5-demethylnobiletin					
5-dihydrocortisol	516-41-6	Hydrallostane	516-41-6	364XCM54BS			
5-dihydrocortisone	68-54-2	17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione					
5-dihydrodeoxycorticosterone		5-dihydrodeoxycorticosterone					
5-diisopropoxyphosphoryl-5-methyl-1-pyrroline-N-oxide		5-diisopropoxyphosphoryl-5-methyl-1-pyrroline-N-oxide					
5-dimethylamiloride	1214-79-5	5-dimethylamiloride					
5-diphosphomevalonic acid	4872-34-8	(3r)-3-Hydroxy-5-{[(R)-Hydroxy(Phosphonooxy)phosphoryl]oxy}-3-Methylpentanoic Acid	103025-21-4				
5-F-ADB-PINACA		5-F-ADB-PINACA					
5-fluoro-2'-deoxyuridine		2'-Deoxy-5-fluorouridine					
5-fluoro-alpha-methyltryptamine	712-08-3	5-Fluoro-alpha-methyltryptamine					
5-fluorocytidine	2341-22-2	2341-22-2					
5-fluoropyrimidin-2-one beta-ribofuranoside	64967-16-4	5-Fluoropyrimidin-2-one beta-ribofuranoside	64967-16-4				
5-fluoropyrimidine	675-21-8	5-fluoropyrimidine					
5-fluorotryptamine	576-16-9	576-16-9					
5-fluorouridine	316-46-1	5-Fluorouridine	316-46-1	4K0M952561			
5-fluorowillardiine	140187-23-1	(S)-F-Willardiine					
5-formyl-2'-deoxyuridine 5'-triphosphate		5-formyl-2'-deoxyuridine 5'-triphosphate					
5-formyldeoxycytosine-5'-triphosphate		5-formyldeoxycytosine-5'-triphosphate					
5-furan-2yl-isoxazole-3-carboxylic acid (3-imidazol-1yl-propyl)-amide		5-furan-2yl-isoxazole-3-carboxylic acid (3-imidazol-1yl-propyl)-amide					
5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate	111372-46-4	Hddfp	111372-46-4		Lipoxygenase Inhibitors	Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)	
5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone		5-Hydroxy-3,6,7,8,3',4'-hexamethoxyflavone	1176-88-1	07JTS22V9J			
5-hydroxy-6,7,8,3',4'-pentamethoxyflavone		Demethylnobiletin					
5-hydroxy-6,8,11,14-eicosatetraenoic acid	72255-35-7	(6E,8E,11E,14E)-5-hydroxyicosa-6,8,11,14-tetraenoic acid	72255-35-7				
5-hydroxy-6,8,11,14,17-eicosapentaenoic acid	83952-40-3	5-Hydroxy-6,8,11,14,17-eicosapentaenoic acid					
5-hydroxy-7-methoxyflavone		4H-1-Benzopyran-4-one, 5-hydroxy-7-methoxy-2-phenyl-					
5-hydroxydecanoic acid	624-00-0	5-hydroxydecanoic acid					
5-hydroxydiclofenac		(2-(2,6-Dichloroanilino)-5-hydroxyphenyl)acetic acid					
5-hydroxydopamine	1927-04-4	5-hydroxydopamine					
5-hydroxyeicosatetraenoic acid lactone	81517-87-5	5-hydroxyeicosatetraenoic acid lactone					
5-hydroxyflavone	491-78-1	491-78-1					
5-hydroxyindole	1953-54-4	1953-54-4					
5-hydroxyindomethacin	2504-32-7	5-Hydroxyindomethacin	2504-32-7	K89VS3UAD8			
5-hydroxymethylcytosine	1123-95-1	5-Hydroxymethylcytosine	1123-95-1	6CD2RLN1NK			
5-hydroxymethylflucloxacillin	75524-31-1	5-Hydroxymethylflucloxacillin	75524-31-1				
5-hydroxymethylfurfural	67-47-0	5-Hydroxymethylfurfural	67-47-0	70ETD81LF0			
5-hydroxymethylomeprazole	92340-57-3	5-Hydroxymethylomeprazole					
5-hydroxypropranolol		5-hydroxypropranolol					
5-hydroxypyrazinoic acid	34604-60-9	34604-60-9					
5-hydroxythalidomide		64567-60-8					
5-hydroxythienilic acid	90966-18-0	5-Hydroxythienilic acid					
5-Hydroxytryptophan	56-69-9	5-HTP					
5-hydroxyvalproate	53660-23-4	2-n-Propyl-5-hydroxypentanoic acid					
5-iodo-3-((3,5-dibromo-4-hydroxyphenyl)methylene)-2-indolinone		5-Iodo-3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-2-indolinone	220904-83-6	B7W8RS1GG2			
5-iodo-3-(2-azetidinylmethoxy)pyridine		5-iodo-3-(2-azetidinylmethoxy)pyridine					
5-iodosalicylic acid	119-30-2	119-30-2					
5-iodotubercidin	24386-93-4	(2R,3R,4S,5R)-2-(4-amino-5-iodo-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol					
5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo(2,3-b)pyridin-5-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-amine		5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo(2,3-b)pyridin-5-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-amine					
5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole		5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole					
5-methoxy-1-methyl-2-(n-propylamino)tetralin	85379-09-5	5-Methoxy-1-methyl-2-(n-propylamino)tetralin	85379-09-5		Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	
5-methoxy-1,2-dimethyl-3-((4-nitrophenoxy)methyl)indole-4,7-dione		5-methoxy-1,2-dimethyl-3-((4-nitrophenoxy)methyl)indole-4,7-dione					
5-methoxy-N,N-diisopropyltryptamine	4021-34-5	5-Methoxy-N,N-diisopropyltryptamine	4021-34-5	12D06G8W8E			
5-methoxyflavone		42079-78-7					
5-methoxyindole		1006-94-6					
5-methoxyindole-2-carboxylic acid	24610-33-1	7-Methoxy-1H-indole-2-carboxylic acid	24610-33-1				
5-methoxyindoleacetic acid	3471-31-6	5-Methoxyindole-3-acetic acid	3471-31-6	MSN7CK6ETH			
5-Methoxypsoralen	484-20-8	484-20-8					
5-Methoxytryptamine	608-07-1	5-Methoxytryptamine	608-07-1	3VMW6141KC			
5-methyl-1,10-phenanthroline	3002-78-6	5-Methyl-1,10-phenanthroline	3002-78-6				
5-methylbenzanthracene	2319-96-2	5-Methylbenz[a]anthracene	2319-96-2	HYA1M14J11			
5-methylchrysene	3697-24-3	5-Methylchrysene	3697-24-3	O66195MC8L	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
5-Methylcytosine	554-01-8	5-Methylcytosine					
5-methylfurtrethonium	14172-53-3	5-Methylfurmethide	14172-53-3	T1W11CO5XU	Parasympathomimetics	Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. (See all compounds classified as Parasympathomimetics.)	
5-methylindole	614-96-0	5-Methylindole	614-96-0	KT52363RI5			
5-methylpyrazole-3-carboxylic acid	402-61-9	5-Methyl-1H-pyrazole-3-carboxylic acid	402-61-9	U71778T48T			
5-methylselenylmethyl-2'-deoxyuridine		5-methylselenylmethyl-2'-deoxyuridine					
5-methyltetrahydrofolate	134-35-0	5-Methyltetrahydrofolic acid	134-35-0	TYK22LML8F			
5-methyltryptamine	1821-47-2	1821-47-2					
5-methylurapidil	34661-85-3	5-methylurapidil					
5-n-butyl-pyrazolo(1,5-a)pyrimidine		5-n-butyl-pyrazolo(1,5-a)pyrimidine					
5-nitro-2-(3-phenylpropylamino)benzoic acid	107254-86-4	107254-86-4					
5-nitro-2-mercaptobenzimidazole	6325-91-3	2-Benzimidazolethiol, 5-nitro-					
5-nitro-6,7,8,9-tetrahydrobenzo(G)indole-2,3-dione-3-oxime	136623-01-3	136623-01-3					
5-nitroacenaphthene	602-87-9	1,2-Dihydro-5-nitro-acenaphthylene					
5-nitroindazole		1H-Indazole, 5-nitro-					
5-nitroso-8-quinolinol		5-Nitroso-8-hydroxyquinoline	3565-26-2	P302KW5VDN	Histone Deacetylase Inhibitors	Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)	
5-O-methyl-(E)-resveratrol 3-O-beta-D-glucopyranoside		5-O-methyl-(E)-resveratrol 3-O-beta-D-glucopyranoside					
5-O-methyl-(E)-resveratrol-3-O-beta-D-apiofuranosyl-(1-6)-beta-D-glucopyranoside		5-O-methyl-(E)-resveratrol-3-O-beta-D-apiofuranosyl-(1-6)-beta-D-glucopyranoside					
5-octylphenol		5-octylphenol					
5-OH-BDE-47		5-OH-BDE-47					
5-OH,11-O-hydrophenanthrene		5-OH,11-O-hydrophenanthrene					
5-oxo-6,8,11,14-eicosatetraenoic acid	126432-17-5	5-Oxoete	126432-17-5				
5-oxo-hexahydroquinoline		5-oxo-hexahydroquinoline					
5-p-methylphenyl-5-phenylhydantoin	51169-17-6	5-(p-Methylphenyl)-5-phenylhydantoin	51169-17-6	8WSX411Z31			
5-phenyl-5-(4-hydroxyphenyl)hydantoin glucuronide	53819-79-7	4-Hydroxyphenytoin glucuronide	53819-79-7				
5-phenylpent-4-enyl-1-hydroperoxide	94242-71-4	5-Phenylpent-4-enyl-1-hydroperoxide	94242-71-4				
5-phenylpent-4-enyl-1-ol	13159-16-5	(E)-5-phenyl-pent-4-en-1-ol					
5-phenylselenylmethyl-2'-deoxyuridine		5-phenylselenylmethyl-2'-deoxyuridine					
5-pregnene-3,20-diol	901-56-4	901-56-4					
5-propylamino-5,6-dihydro-4H-imidazo(4,5,1-ij)quinolin-2(1H)-one	152886-85-6	5-propylamino-5,6-dihydro-4H-imidazo(4,5,1-ij)quinolin-2(1H)-one					
5-quinoxalin-6-ylmethylenethiazolidine-2,4-dione		648450-29-7					
5-S-glutathionyl-alpha-methyldopa		5-S-glutathionyl-alpha-methyldopa					
5-S-glutathionyldopamine		5-S-glutathionyldopamine					
5-thio-D-glucose	20408-97-3	5-Thio-D-Glucose	20408-97-3	3PRV1384UO	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	
5,10-methylenetetrahydrofolic acid		5,10-methylenetetrahydrofolic acid					
5,10,15,20-(tetra(N-methyl-3-pyridyl))-26,28-diselenasapphyrin chloride		5,10,15,20-(tetra(N-methyl-3-pyridyl))-26,28-diselenasapphyrin chloride					
5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron(III) chloride		5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron(III) chloride					
5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphyrinato-iron(III)		5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphyrinato-iron(III)					
5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol		5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol					
5,12-naphthacenequinone		1090-13-7					
5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid	79008-24-5	20-hydroxyleukotriene B4	79008-24-5				
5,15-diphenylporphine		22112-89-6					
5,15-diphenylporphyrin		22112-89-6					
5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate		5,21 - 12,17-dimetheneo-18H-dibenzo(i,o)pyrrolo(3,4-1)(1,8)diazacyclohexandecine-18,10(19H)dione,8((dimethylamino)methyl)-6,7,8,9,10,11-hexahydro,monomethanesulfonate					
5,3'-dihydroxy-3,6,7,4',5'-pentamethoxyflavone		5,3'-Dihydroxy-3,6,7,4',5'-pentamethoxyflavone					
5,3'-dihydroxy-3,6,7,8,4'-pentamethoxyflavone		5,3'-Dihydroxy-3,6,7,8,4'-pentamethoxyflavone					
5,4'-dihydroxy-3,6,7-trimethoxyflavone		Penduletin					
5,4'-dihydroxy-3,6,7,8,3'-pentamethoxyflavone	50439-47-9	5,4'-Dihydroxy-3,6,7,8,3'-pentamethoxyflavone	50439-47-9	PYF99PJ2WQ			
5,5-dimethyl-1-pyrroline-1-oxide	3317-61-1	3317-61-1					
5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulfonyl)phenyl-2(5H)-furanone		5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulfonyl)phenyl-2(5H)-furanone					
5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate)	63741-13-9	5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate)					
5,6-dehydrokawain	1952-41-6	5,6-Dehydrokawain					
5,6-dehydronorketamine	57683-62-2	57683-62-2					
5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole-3',5'-monophosphorothioate	120912-54-1	(7R,8R)-7-(5,6-dichlorobenzimidazol-1-yl)-5a,7,8,8a-tetrahydro-5H-furo[3,2-e][1,4,2,3]dioxathiaphosphepine-5,8-diol	120912-54-1				
5,6-dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-one		5,6-Dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-one					
5,6-dichloro-4-thia-5-hexenoyl-coenzyme A		5,6-dichloro-4-thia-5-hexenoyl-coenzyme A					
5,6-dichlorobenzimidazole		5,6-dichlorobenzimidazole					
5,6-dihydrocyclopenta-1,2-dithiole-3-thione		5,6-dihydrocyclopenta-1,2-dithiole-3-thione					
5,6-dihydroxy-1-(2-imidazolinyl)tetralin	100449-07-8	5,6-dihydroxy-1-(2-imidazolinyl)tetralin					
5,6-dihydroxy-2-indolylcarboxylic acid	4790-08-3	4790-08-3					
5,6-dimethoxy-3-methyl-N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamide		5,6-dimethoxy-3-methyl-N-phenyl-N-(3-(piperidin-1-yl)propyl)benzofuran-2-carboxamide					
5,6-epoxy-8,11,14-eicosatrienoic acid	81246-84-6	5,6-Epoxy-8,11,14-eicosatrienoic acid					
5,6,7-trimethoxyflavone		5,6,7-Trimethoxyflavone					
5,6,7,8-tetrahydro-2-naphthol	1125-78-6	1125-78-6					
5,6,7,8-tetrahydrofolic acid	29347-89-5	(6S)-tetrahydrofolate					
5,6,7,8-tetrahydroxy-4-oxooctanal		5,6,7,8-Tetrahydroxy-4-oxooctanal					
5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one		5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one					
5,7-dihydroxy-3-(3-hydroxy-4-methoxybenzyl)-6-methoxychroman-4-one		3-(3-hydroxy-4-methoxybenzyl)-5,7-dihydroxy-6-methoxychroman-4-one					
5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one		oroxylin A					
5,7-Dihydroxytryptamine	31363-74-3	5,7-Dihydroxytryptamine					
5,7-dimethoxyflavone	21392-57-4	5,7-Dimethoxyflavone	21392-57-4	J8HQQ4R4F2			
5,7,3'-trihydroxy-3,4'-dimethoxyflavone		Quercetin 3,4'-dimethyl ether					
5,7,3',4'-tetramethylluteolin	855-97-0	3',4',5,7-Tetramethoxyflavone	855-97-0				
5,7,4'-trimethylapigenin	5631-70-9	4',5,7-Trimethoxyflavone					
5,8-dihydroxy-3-methyl-4-(9H)-naphtho(2,3-c)furanone	150045-18-4	5,8-Dihydroxy-3-methyl-4-(9H)-naphtho(2,3-c)furanone					
5,8,11,14-Eicosatetraynoic Acid	1191-85-1	5,8,11,14-Eicosatetraynoic Acid					
5'-4-(fluorosulfonyl)benzoyl-8-azidoadenosine	125366-29-2	8-Azidoadenosine 5'-(4-(fluorosulfonyl)benzoate)	125366-29-2				
5'-adenylyl (beta,gamma-methylene)diphosphonate	3469-78-1	Phosphomethylphosphonic acid adenylate ester	3469-78-1				
5'-amino-5'-deoxyadenosine	14365-44-7	5'-Amino-5'-deoxyadenosine					
5'-bromo-5-phenyl-spiro(3H-1,3,4-thiadiazole-2,3'-indoline)-2'-one		5'-bromo-5-phenyl-spiro(3H-1,3,4-thiadiazole-2,3'-indoline)-2'-one					
5'-deoxy-5-fluorocytidine		5'-Deoxy-5-fluorocytidine					
5'-deoxy-5'-S-isobutylthioadenosine	35899-54-8	5'-deoxy-5'-S-isobutylthioadenosine					
5'-fluoro-5'-deoxyadenosine		5'-Fluoro-5'-deoxyadenosine	731-98-6	8LJ6NC6D44			
5'-hydroxythalidomide		5Hthalid					
5'-methylthioadenosine	2457-80-9	5'-Deoxy-5'-methylthioadenosine	2457-80-9	634Z2VK3UQ	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	
5(6)-carboxy-2',7'-dichlorofluorescein	111843-78-8	5(6)-Carboxy-2',7'-dichlorofluorescein	111843-78-8				
5(S),6(R)-7-trihydroxyheptanoic acid, methyl ester		5(S),6(R)-7-trihydroxyheptanoic acid, methyl ester					
5F-ADB cannabinoid		5F-ADB cannabinoid					
5F-APP-PICA		PX-1					
5F-CUMYL-PICA		5F-CUMYL-PICA					
5F-MDMB-PICA		5-Fluoro-MDMB-PICA	1971007-88-1	NG3U6O970A			
5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one		5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one					
5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid		5S,12R,18R-Trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid					
6 alpha-naloxol	20410-95-1	6-Alpha Naloxol	20410-95-1	FLW43Q2H9L			
6 beta-hydroxycortisol	53-35-0	6beta-Hydroxycortisol	53-35-0	J37WKJ5Y50			
6 beta-hydroxynaltrexone	49625-89-0	6 beta-hydroxynaltrexone					
6 beta-hydroxytestosterone	62-99-7	62-99-7					
6 beta-naloxol	53154-12-4	6 beta-naloxol					
6-((2-(4-imidazolyl)ethyl)amino)heptanoic acid 4-toluidide	103827-15-2	6-[2-(1H-imidazol-5-yl)ethylamino]-N-(4-methylphenyl)heptanamide	103827-15-2				
6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine		purvalanol A	212844-53-6	YP483E75C4			
6-(1-(4-fluoro-2-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl)-2H-1,4-benzoxazin-3(4H)-one		6-(1-(4-fluoro-2-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl)-2H-1,4-benzoxazin-3(4H)-one					
6-(1,1-dimethylallyl)naringenin		(2S)-5,7,4'-Trihydroxy-6-(1,1-dimethylallyl)flavanone					
6-(2-fluoroethoxy)-2-(2-(4-methylaminophenil)ethenyl)benzoxazole		6-(2-Fluoroethoxy)-2-(2-(4-methylaminophenil)ethenyl)benzoxazole	634911-47-0				
6-(3-(4-cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)pyridine-2-sulfonic acid amide		6-(3-(4-cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)pyridine-2-sulfonic acid amide					
6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid		6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid					
6-(3,4-dihydro-1H-isoquinolin-2-yl)-N-(6-methylpyridin-2-yl)nicotinamide		6-(3,4-dihydro-1H-isoquinolin-2-yl)-N-(6-methylpyridin-2-yl)nicotinamide					
6-(3'-(1-adamantyl)-4'-hydroxyphenyl)-5-chloronaphthalenecarboxylic acid		6-(3'-(1-adamantyl)-4'-hydroxyphenyl)-5-chloronaphthalenecarboxylic acid					
6-(4-(3-(2-methylpyrrolidin-1-yl)propoxy)phenyl)-2H-pyridazin-3-one		6-(4-(3-(2-methylpyrrolidin-1-yl)propoxy)phenyl)-2H-pyridazin-3-one					
6-(4-(3-(methylsulfonyl)benzylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-3,4-dihydroquinolin-2(1H)-one		6-(4-(3-(methylsulfonyl)benzylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-3,4-dihydroquinolin-2(1H)-one					
6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime		6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime					
6-(4-diethylamino)phenyl-7-chloro-5,8-quinolinedione		6-(4-diethylamino)phenyl-7-chloro-5,8-quinolinedione					
6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole		6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole	72873-74-6	9R6QDF1UO7	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
6-(4-hydroxy-3-(trifluoromethyl)phenyl)-1-naphthol		6-(4-hydroxy-3-(trifluoromethyl)phenyl)-1-naphthol					
6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylprpyl)-3-pyridinecarboxamide		6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylprpyl)-3-pyridinecarboxamide					
6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol		6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol					
6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one	88070-98-8	6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one					
6-(methylamino)pyrido(3,4-d)pyrimidine		6-(methylamino)pyrido(3,4-d)pyrimidine					
6-(N-(7-nitro-2,1,3-benzoxadiazol-4-yl)amino)hexanoyl-glucosylceramide		6-(N-(7-nitro-2,1,3-benzoxadiazol-4-yl)amino)hexanoyl-glucosylceramide					
6-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone		6-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone					
6-amino-N-(3-(4-(4-morpholinyl)pyrido(3',2'-4,5)furo(3,2-d)pyrimidin-2-yl)phenyl)-3-pyridinecarboxamide		371942-69-7					
6-amino-N-cyclohexyl-N,3-dimethylthiazolo(3,2-a)benzimidazole-2-carboxamide		6-amino-N-cyclohexyl-N,3-dimethylthiazolo(3,2-a)benzimidazole-2-carboxamide					
6-aminochrysene-1,2-dihydrodiol	117760-93-7	6-aminochrysene-1,2-dihydrodiol					
6-aminoindazole	6967-12-0	1H-Indazol-6-amine					
6-Aminonicotinamide	329-89-5	6-Aminonicotinamide	329-89-5	D6FNW67F2B	Teratogens	An agent that causes the production of physical defects in the developing embryo. (See all compounds classified as Teratogens.)	
6-anilino-5,8-quinolinedione	91300-60-6	6-Anilino-5,8-quinolinedione	91300-60-6	TD9FS56333	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
6-azacytidine	3131-60-0	3131-60-0					
6-bromo-3-methylthieno(3,2-b)thiophene-2-carboxylic acid		6-bromo-3-methylthieno(3,2-b)thiophene-2-carboxylic acid					
6-bromo-8-ethoxy-3-nitro-2H-chromene		6-bromo-8-ethoxy-3-nitro-2H-chromene					
6-bromoacetyl-2-dimethylaminonaphthalene		6-bromoacetyl-2-dimethylaminonaphthalene					
6-bromoindirubin-3'-oxime		6-BROMOINDIRUBIN-3'-OXIME					
6-carboxyfluorescein	3301-79-9	3',6'-dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-6-carboxylic acid					
6-chloro-2-(1-piperazinyl)pyrazine		2-Chloro-6-(1-piperazinyl)pyrazine					
6-chloro-2-(2-hydroxybiphenyl-3-yl)-1H-indole-5-carboxamidine		6-Chloro-2-(2-Hydroxybiphenyl-3-yl)-1H-Indole-5-Carboxamidine					
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide		(+/-)-6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide					
6-chloro-3,5-diaminopyrazine-3-carboxamide	1144-27-0	1144-27-0					
6-chloro-5-methyl-1-((2-(2-methylpyrid-3-yloxy)pyrid-5-yl)carbamoyl)indoline		6-chloro-5-methyl-1-((2-(2-methylpyrid-3-yloxy)pyrid-5-yl)carbamoyl)indoline					
6-chloroacetyl-2-dimethylaminonaphthalene		6-chloroacetyl-2-dimethylaminonaphthalene					
6-chrysenamine	2642-98-0	6-Chrysenamine	2642-98-0	I56L81BL2L	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
6-codeinone		(5alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-one					
6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane	163163-23-3	Chromanol 293B	163163-23-3		Potassium Channel Blockers	A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS. (See all compounds classified as Potassium Channel Blockers.)	
6-Cyano-7-nitroquinoxaline-2,3-dione	115066-14-3	115066-14-3					
6-deisopropylatrazine	1007-28-9	1007-28-9					
6-deoxy-6-bromoascorbic acid	62983-44-2	6-Deoxy-6-bromoascorbic acid	62983-44-2				
6-deoxypenciclovir		6-deoxypenciclovir					
6-diphenylmethyl-5-(5-isopropyl-2-methoxybenzylamino)-1-azabicyclo(2.2.2)octane-3-carboxylic acid		6-diphenylmethyl-5-(5-isopropyl-2-methoxybenzylamino)-1-azabicyclo(2.2.2)octane-3-carboxylic acid					
6-ethyl-6-(4-((phenylthio)methyl)phenyl)-6,7-dihydrobenzo(b)pyrrolo(1,2-d)(1,4)oxazepin-7-one		6-ethyl-6-(4-((phenylthio)methyl)phenyl)-6,7-dihydrobenzo(b)pyrrolo(1,2-d)(1,4)oxazepin-7-one					
6-fluorotestosterone		6-fluorotestosterone					
6-formylindolo(3,2-b)carbazole		6-formylindolo(3,2-b)carbazole					
6-hydroxy-10-chlorobenzo(c)quinolizinium		6-hydroxy-10-chlorobenzo(c)quinolizinium					
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid	56305-04-5	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid					
6-hydroxy-3-O-methylkaempferol 6-O-glucopyranoside		6-hydroxy-3-O-methylkaempferol 6-O-glucopyranoside					
6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt		6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt					
6-hydroxybenzbromarone		6-hydroxybenzbromarone					
6-hydroxychlorzoxazone	1750-45-4	1750-45-4					
6-hydroxychrysene	37515-51-8	6-hydroxychrysene					
6-hydroxyflavone		4H-1-Benzopyran-4-one, 6-hydroxy-2-phenyl-					
6-hydroxyluteolin	18003-33-3	6-Hydroxyluteolin	18003-33-3	T1XT53489D			
6-hydroxymelatonin		2208-41-5					
6-hydroxynorketamine	81395-70-2	Cyclohexanone, 2-amino-2-(2-chlorophenyl)-6-hydroxy-	81395-70-2	6VAD9SC8NW			
6-hydroxyquinoline	580-16-5	580-16-5					
6-hydroxytaxol	153212-75-0	6-hydroxytaxol					
6-hydroxywarfarin	17834-02-5	17834-02-5					
6-iodo-5-hydroxy-eicosatrienoic acid, delta-lactone		6-iodo-5-hydroxy-eicosatrienoic acid, delta-lactone					
6-iodouridine 5'-monophosphate		6-Iodouridine 5'-Monophosphate					
6-isopropoxy-9-oxoxanthene-2-carboxylic acid	33458-93-4	6-isopropoxy-9-oxoxanthene-2-carboxylic acid					
6-Ketoprostaglandin F1 alpha	58962-34-8	6-Keto-prostaglandin F1alpha	58962-34-8	8URB805JJJ			
6-methoxy-3-(4-methylphenyl)coumarin		6-methoxy-3-(4-methylphenyl)coumarin					
6-methoxy-8-((2-furanylmethyl)amino)-4-methyl-5-(3-trifluoromethylphenyloxy)quinoline		6-methoxy-8-((2-furanylmethyl)amino)-4-methyl-5-(3-trifluoromethylphenyloxy)quinoline					
6-methoxycomaparvin		6-Methoxycomaparvin					
6-methoxymianserin		6-methoxymianserin					
6-methoxytryptoline	20315-68-8	6-methoxy-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole	20315-68-8	BR3W85U4GS	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
6-methyl-1,3,8-trichlorodibenzofuran	115039-00-4	6-methyl-1,3,8-trichlorodibenzofuran					
6-methyl-2-(phenylethynyl)pyridine		6-methyl-2-(phenylethynyl)pyridine					
6-methyl-2-thiouracil		Methylthiouracil	56-04-2	QW24888U5F	Antithyroid Agents	Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones. (See all compounds classified as Antithyroid Agents.)	
6-methyl-3-(2-nitro-1-(thiophen-2-yl)propyl)-2-phenyl-1H-indole		6-methyl-3-(2-nitro-1-(thiophen-2-yl)propyl)-2-phenyl-1H-indole					
6-methyladenine		6-Methyladenine	443-72-1	W7IBY2BGAX			
6-methylbenz(a)anthracene	316-14-3	6-Methylbenz[a]anthracene	316-14-3	CAC9SJF3PP			
6-methylbenzo(a)pyrene	2381-39-7	6-Methylbenzo[a]pyrene	2381-39-7	3RZA2C33TG			
6-methylchrysene	1705-85-7	1705-85-7					
6-methylflavone		6-methylflavone					
6-methylquinoline	91-62-3	6-Methylquinoline					
6-methylsulfinylhexyl isothiocyanate		6-Methylsulfinylhexyl isothiocyanate	4430-35-7	8RUP6Q3JBB			
6-N,N-diethyl-beta,gamma-dibromomethylene-D-ATP		6-N,N-diethyl-beta,gamma-dibromomethylene-D-ATP					
6-nitrobenzo(a)pyrene	63041-90-7	6-Nitrobenzo[a]pyrene					
6-nitrochrysene	7496-02-8	6-Nitrochrysene	7496-02-8	82ZK83O33Y			
6-nitroquipazine	77372-73-7	6-Nitroquipazine	77372-73-7	28M0X094BH	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
6-O-angeloylenolin		6-O-angeloylenolin					
6-O-carboxypropyl-alpha-tocotrienol		6-O-carboxypropyl-alpha-tocotrienol					
6-O-monoacetylmorphine	2784-73-8	2784-73-8					
6-O-palmitoylascorbic acid	137-66-6	137-66-6					
6-OH-BDE-47		6-OH-BDE-47					
6-oxocampestanol		6-oxocampestanol					
6-phenylhexyl isothiocyanate	133920-06-6	(6-isothiocyanatohexyl)benzene					
6-phosphogluconic acid		6-PHOSPHOGLUCONIC ACID					
6-prenylchrysin		6-prenylchrysin					
6-prenylnaringenin		5,7,4'-Trihydroxy-6-prenylflavanone					
6-tert-butyl-2,3-epoxy-1,4-benzoquinone	158592-93-9	6-tert-Butyl-2,3-epoxy-1,4-benzoquinone	158592-93-9				
6-thio-2'-deoxyguanosine-5'-triphosphate		6-thio-2'-deoxyguanosine-5'-triphosphate					
6-thiouric acid	2002-60-0	6-Thiouric acid	2002-60-0	7F23ZQP3EM			
6-thioxanthine	2002-59-7	2002-59-7					
6,10-diaza-3(1,3),8(1,4)dibenzena-1,5(1,4)diquinolinacyclodecaphane		6,10-diaza-3(1,3),8(1,4)dibenzena-1,5(1,4)diquinolinacyclodecaphane					
6,11-dihydro-5-thia-11-aza-benzo(a)-fluorene		6,11-dihydro-5-thia-11-aza-benzo(a)-fluorene					
6,11-hexadecadienyl diazoacetate	114318-33-1	114318-33-1					
6,2',4'-trimethoxyflavone		6,2',4'-trimethoxyflavone					
6,6-dimethyl-2-phenylethynyl-7,8-dihydro-6H-quinolin-5-one		6,6-dimethyl-2-phenylethynyl-7,8-dihydro-6H-quinolin-5-one					
6,6'-bis(2,3-dimethoxybenzoyl)-alpha,alpha-trehalose		6,6'-bis(2,3-dimethoxybenzoyl)-alpha,alpha-trehalose					
6,7-dichloro-1H-indole-2,3-dione 3-oxime		(Z)-6,7-dichloro-3-(hydroxyimino)indolin-2-one	18711-16-5				
6,7-dihydro-1,1,2,3,3-pentamethyl-4-(5H)indanone		(+-)-Cashmeran					
6,7-dihydroxyflavone		6,7-Dihydroxyflavone	38183-04-9	P6R86H59XS			
6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine		UNC 0379					
6,7-dimethoxy-2-phenylquinoxaline		1489-12-9					
6,7-dimethoxy-3-phenylquinoxaline	146535-11-7	6,7-dimethoxy-3-phenylquinoxaline					
6,7-dimethyl-2-(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl-prop-2-enoyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride		6,7-dimethyl-2-(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl-prop-2-enoyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride					
6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one		6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one					
6,8-dichloro-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine		6,8-dichloro-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine					
6'-guanidinonaltrindole		6'-Guanidinonaltrindole					
6',7'-dihydroxybergamottin		6',7'-dihydroxybergamottin					
6(hydroxymethyl)-1,4-anthracenedione		6(hydroxymethyl)-1,4-anthracenedione					
64Cu-CB-TE2A-sst2-ANT		64Cu-CB-TE2A-sst2-ANT					
64Cu-CB-TE2A-Y3-TATE		64Cu-CB-TE2A-Y3-TATE					
64Cu-DOTA-cetuximab		64Cu-DOTA-cetuximab					
64Cu-DOTA-Y3-TATE		64Cu-DOTA-Y3-TATE					
666-15 compound		666-15 compound					
6alpha-ethyl-23(S)-methylcholic acid		INT 777					
6F peptide		6F peptide					
6R-2',5'-thienyl-5,10-dideazatetrahydrofolic acid		4HF					
7 alpha-hydroxy-4-cholesten-3-one	3862-25-7	3862-25-7					
7-((9-fluorenylmethoxycarbonyl)cyclohexylalanyllysyl)amino-4-methylcoumarin		7-((9-fluorenylmethoxycarbonyl)cyclohexylalanyllysyl)amino-4-methylcoumarin					
7-(2-(2-(dimethylamino)ethoxy)ethoxy)-6-methoxy-2-(4-methyl-1,4-diazepan-1-yl)-N-(1-methylpiperidin-4-yl)quinazolin-4-amine		7-(2-(2-(Dimethylamino)ethoxy)ethoxy)-6-methoxy-2-(4-methyl-1,4-diazepan-1-yl)-N-(1-methylpiperidin-4-yl)quinazolin-4-amine					
7-(2-(2,2-difluoroethoxy)-3,5-di-tert-butylbenzene)-3-methylocta-2,4,6-trienoic acid		7-(2-(2,2-difluoroethoxy)-3,5-di-tert-butylbenzene)-3-methylocta-2,4,6-trienoic acid					
7-(2-(4-(4-nitrobenzene)piperazinyl)ethyl)-1,3-dimethylxanthine		7-(2-(4-(4-nitrobenzene)piperazinyl)ethyl)-1,3-dimethylxanthine					
7-(2-(cyclopropylmethoxy)-6-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido(2,3-d)(1,3)oxazin-2-one		7-(2-(cyclopropylmethoxy)-6-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido(2,3-d)(1,3)oxazin-2-one					
7-(2-aminopyrimidin-5-yl)-1-((1-cyclopropyl-2,2,2-trifluoroethyl)amino)-5H-pyrido(4,3-b)indole-4-carboxamide		7-(2-aminopyrimidin-5-yl)-1-((1-cyclopropyl-2,2,2-trifluoroethyl)amino)-5H-pyrido(4,3-b)indole-4-carboxamide					
7-(3-(2-(cyclopropylmethyl)-3-methoxy-4-((methylamino)carbonyl)phenoxy)propoxy)-3,4-dihydro-8-propyl-2H-1-benzopyran-2-propanoic acid	141059-52-1	7-(3-(2-(Cyclopropylmethyl)-3-methoxy-4-((methylamino)carbonyl)phenoxy)propoxy)-3,4-dihydro-8-propyl-2H-1-benzopyran-2-propanoic acid	141059-52-1				
7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid	124924-85-2	7-(3-(3-Hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid	124924-85-2				
7-(3-(cyclohexylmethyl)ureido)-3-(1-methyl-1H-pyrrolo(2,3-b)pyridin-3-yl)quinoxalin-2(1H)-one		7-(3-(cyclohexylmethyl)ureido)-3-(1-methyl-1H-pyrrolo(2,3-b)pyridin-3-yl)quinoxalin-2(1H)-one					
7-(3,4 dihydroxyphenyl)-5-hydroxy-1-phenyl-1-heptene		7-(3,4 dihydroxyphenyl)-5-hydroxy-1-phenyl-1-heptene					
7-(3,4-difluorophenoxy)-4-(1H-imidazol-1-ylmethyl)-2H-chromen-2-one		7-(3,4-Difluorophenoxy)-4-(1H-imidazol-1-ylmethyl)-2H-chromen-2-one					
7-(4-fluorophenyl)-N2-(3-methoxy-4-(3-methyl-1H-1,2,4-triazol-1-yl)phenyl)-N4-methyl-6,7-dihydro-5H-cyclopenta(d)pyrimidine-2,4-diamine		7-(4-fluorophenyl)-N2-(3-methoxy-4-(3-methyl-1H-1,2,4-triazol-1-yl)phenyl)-N4-methyl-6,7-dihydro-5H-cyclopenta(d)pyrimidine-2,4-diamine					
7-(4,6-di-tert-butylpyrimidin-2-yl)-3-(4-trifluoromethoxyphenyl)-5,6,7,8-tetrahydro(1,2,4)triazolo(4,3-a)pyrazine		7-(4,6-di-tert-butylpyrimidin-2-yl)-3-(4-trifluoromethoxyphenyl)-5,6,7,8-tetrahydro(1,2,4)triazolo(4,3-a)pyrazine					
7-(7-amino-7-methyl-5-azaspiro(2.4)heptan-5-yl)-6-fluoro-1-(2-fluoro-1-cyclopropyl)-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid		7-(7-amino-7-methyl-5-azaspiro(2.4)heptan-5-yl)-6-fluoro-1-(2-fluoro-1-cyclopropyl)-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid					
7-(benzylamino)-1,3,4,8-tetrahydropyrrolo(4,3,2-de)quinolin-8(1H)-one		7-(benzylamino)-1,3,4,8-tetrahydropyrrolo(4,3,2-de)quinolin-8(1H)-one					
7-(deoxyadenosin-N(6)--yl)aristolactam II		7-(deoxyadenosin-N(6)--yl)aristolactam II					
7-(deoxyadenosin-N(6)-yl)aristolactam I	127191-86-0	dA-Aai	127191-86-0				
7-(deoxyguanosin-N(2)-yl)aristolactam I	127191-85-9	dG-Aai	127191-85-9				
7-(hydroxyimino)cyclopropan(b)chromen-1a-carbxoylic acid ethyl ester		ethyl (7Z)-7-hydroxyimino-1,7a-dihydrocyclopropa[b]chromene-1a-carboxylate					
7-(N,N-dipropylamino)-5,6,7,8-tetrahydronaphtho(2,3-b)dihydro-2,3-furan	157622-55-4	7-(N,N-Dipropylamino)-5,6,7,8-tetrahydronaphtho(2,3-b)dihydro-2,3-furan	121454-18-0				
7-acetoxy-6,7-dihydro-6-(4-methoxyphenyl)pyrrolo(2,1-d)(1,5)benzothiazepine	131403-76-4	5-(4-Methoxyphenyl)pyrrolo[2,1-d][1,5]benzothiazepin-4-ol acetate	131403-76-4				
7-Ala-angiotensin (1-7)		7-Ala-angiotensin (1-7)					
7-amino-4-chloromethylcoumarin		7-Amino-4-chloromethylcoumarin	147963-22-2				
7-amino-4-hydroxy-2-naphthalenesulfonic acid	87-02-5	2-Naphthalenesulfonic acid, 7-amino-4-hydroxy-					
7-aminocephalosporanic acid	957-68-6	(7R)-7-Aminocephalosporanate					
7-benzylamino-5-(2-(hydroxymethyl)propyl)amino-3-isopropyl-1(2)H-pyrazolo(4,3-d)pyrimidine		7-benzylamino-5-(2-(hydroxymethyl)propyl)amino-3-isopropyl-1(2)H-pyrazolo(4,3-d)pyrimidine					
7-benzylidenenaltrexone	129468-28-6	7-Benzylidenenaltrexone			Narcotic Antagonists	Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)	
7-benzyloxy-4-trifluoromethylcoumarin		7-(benzyloxy)-4-(trifluoromethyl)-2H-chromen-2-one					
7-benzyloxyquinoline	131802-60-3	7-Benzyloxyquinoline	131802-60-3				
7-bromoindirubin-3'-oxime		7-Bromoindirubin-3'-oxime					
7-chloro-3-(1-hydroxy-2-propyl)amino-4H-1,2,4-benzothiadiazine 1,1-dioxide		7-chloro-3-(1-hydroxy-2-propyl)amino-4H-1,2,4-benzothiadiazine 1,1-dioxide					
7-chloro-3-imino-5-methyl-2-azabicyclo(4.1.0)heptane		7-chloro-3-imino-5-methyl-2-azabicyclo(4.1.0)heptane					
7-chlorobenz(a)anthracene	20268-52-4	7-Chlorobenz(a)anthracene					
7-chlorokynurenic acid	18000-24-3	18000-24-3					
7-dehydrocholesterol	434-16-2	434-16-2					
7-diethylamino-4-methyl coumarin		7-diethylamino-4-methyl coumarin					
7-difluoromethyl-5,4'-dimethoxygenistein		7-difluoromethyl-5,4'-dimethoxygenistein					
7-dimethylamino-4-methylcoumarin	87-01-4	2H-1-Benzopyran-2-one, 7-(dimethylamino)-4-methyl-					
7-ethoxy-4-trifluoromethylcoumarin	115453-82-2	7-ethoxy-4-trifluoromethylcoumarin					
7-ethoxycoumarin	31005-02-4	31005-02-4					
7-ethyl-10-hydroxycamptothecin beta-glucuronide		7-ethyl-10-hydroxycamptothecin beta-glucuronide					
7-fluoro-1,3-diphenylisoquinoline-1-amine		7-fluoro-1,3-diphenylisoquinoline-1-amine					
7-fluoro-2-oxo-4-(2-(4-(thieno(3,2-c)pyridin-4-yl)piperazin-1-yl)ethyl)-1,2-dihydroquinoline-1-acetamide		Trelanserin	189003-92-7	QUD44MBL5S			
7-hydroxy-2-N,N-dipropylaminotetralin	74938-11-7	7-(Dipropylamino)-5,6,7,8-tetrahydronaphthalen-2-ol	74938-11-7	RR7D75YDF4	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
7-hydroxy-3-methylcoumarin		7-hydroxy-3-methylcoumarin					
7-hydroxy-4-(trifluoromethyl)coumarin		7-Hydroxy-4-(Trifluoromethyl)Coumarin					
7-hydroxy-4-trifluoromethylcoumarin	575-03-1	7-Hydroxy-4-(trifluoromethyl)coumarin	575-03-1				
7-hydroxy-7-methyl-3-methylene-1-octene		7-hydroxy-7-methyl-3-methylene-1-octene					
7-hydroxy-N-(1-((4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide		7-hydroxy-N-(1-((4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide					
7-hydroxy-N-(1-((4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-2-methylbutyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide dihydrochloride		7-hydroxy-N-(1-((4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-2-methylbutyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide dihydrochloride					
7-hydroxycoumarin	93-35-6	7-Hydroxycoumarin					
7-hydroxycoumarin glucuronide	66695-14-5	2-Oxo-2H-1-benzopyran-7-yl beta-D-glucopyranosiduronic acid					
7-hydroxyellipticine	67484-39-3	7-Hydroxyellipticine					
7-hydroxyflavanone	6515-36-2	7-Hydroxyflavanone	6515-36-2	CC64495H41			
7-hydroxyflavone		7-Hydroxyflavone	6665-86-7	ZE72458E4L			
7-hydroxyl-1-methylindole-3-acetonitrile		7-hydroxyl-1-methylindole-3-acetonitrile					
7-hydroxyloxapine	37081-75-7	7-Hydroxyloxapine					
7-hydroxymethotrexate	5939-37-7	7-hydroxymethotrexate					
7-hydroxymitragynine		7-Hydroxymitragynine	174418-82-7	2T3TWA75R0			
7-hydroxyprogesterone	27534-93-6	7-Hydroxyprogesterone					
7-hydroxystaurosporine	112953-11-4	(+)-UCN-01					
7-hydroxytheonellasterol		7-hydroxytheonellasterol					
7-hydroxywarfarin		7-Hydroxywarfarin	17834-03-6	B92SFW09LJ			
7-ketocholesterol	566-28-9	7-Ketocholesterol	566-28-9	O7676FE78M	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
7-ketodeoxycholic acid	911-40-0	7-Ketodeoxycholic acid	911-40-0	14DEP88BGS			
7-ketolithocholic acid	4651-67-6	3alpha-Hydroxy-7-keto-5beta-cholanic Acid					
7-methoxy-4-(aminomethyl)coumarin		7-methoxy-4-(aminomethyl)coumarin					
7-methoxy-4-trifluoromethylcoumarin		7-methoxy-4-(trifluoromethyl)-2H-chromen-2-one					
7-methoxy-N-((6-(3-methylisothiazol-5-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)methyl)-1,5-naphthyridin-4-amine		7-methoxy-N-((6-(3-methylisothiazol-5-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)methyl)-1,5-naphthyridin-4-amine					
7-methoxyresorufin	5725-89-3	7-Methoxy-3H-phenoxazin-3-one	5725-89-3				
7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine		7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine					
7-methyl-6,7,8,9,14,15-hexahydro-5H-benz(d)indolo(2,3-g)azecine		7-methyl-6,7,8,9,14,15-hexahydro-5H-benz(d)indolo(2,3-g)azecine					
7-methylbenzanthracene	2541-69-7	10-Methyl-1,2-benzanthracen					
7-methylbenzo(a)pyrene	63041-77-0	7-Methylbenzo(a)pyrene					
7-methylguanine	578-76-7	578-76-7					
7-methylguanosine 5'-diphosphate	104809-16-7	7-Methylguanosine 5'-diphosphate					
7-methylguanosine triphosphate		26554-26-7					
7-methylguanosine-5'-monophosphate	10162-58-0	7-methylguanosine-5'-monophosphate					
7-methylindole		1H-Indole, 7-methyl-					
7-methyljuglone		7-Methyljuglone	14787-38-3	ZS3RW9P6DY			
7-methyltryptamine	14490-05-2	7-Methyltryptamine	14490-05-2				
7-monohydroxyethylrutoside		7-monohydroxyethylrutoside					
7-nitro-1H-indole-2-carboxylic acid (4-(1-(guanidinohydrazone)ethyl)phenyl)amide		7-nitro-1H-indole-2-carboxylic acid (4-(1-(guanidinohydrazone)ethyl)phenyl)amide					
7-nitrobenzanthracene	20268-51-3	20268-51-3					
7-nitroindazole	2942-42-9	7-Nitroindazole	2942-42-9	UX0N37CMVH	Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
7-O-galloyltaxifolin		7-O-Galloyltaxifolin					
7-oxozeanol		7-oxozeanol					
7-propyl spirolactone	76676-33-0	7-Propyl spirolactone					
7-tosylcyclonovobiocic acid		7-tosylcyclonovobiocic acid					
7,12-benz(a)anthraquinone	2498-66-0	1,10-anthraquinone					
7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol	72617-60-8	7,12-Dimethylbenz(a)anthracene-3,4-dihydrodiol	72617-60-8				
7,12-dimethylbenz(a)anthracene-DNA adduct		7,12-dimethylbenz(a)anthracene-DNA adduct					
7,13-bis(4-nitrobenzyl)-1,4,10-trioxa-7,13-diazacyclopentadecane		7,13-Bis(4-nitrobenzyl)-1,4,10-trioxa-7,13-diazacyclopentadecane					
7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid		7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid					
7,3'-dihydroxy-4'-methoxyisoflavone		Calycosin	20575-57-9	09N3E8P7TA			
7,3',4'-trimethylquercetin		7,3',4'-trimethylquercetin					
7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one	135911-02-3	4H-Isoindol-4-one, octahydro-2-(1-imino-2-(2-methoxyphenyl)ethyl)-7,7-diphenyl-, (3aR,7aR)-	135911-02-3	49U9M41BGY	Neurokinin-1 Receptor Antagonists	Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS. (See all compounds classified as Neurokinin-1 Receptor Antagonists.)	
7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester	73536-69-3	Bifendate	73536-69-3	0G32E321W1	Cytochrome P-450 Enzyme Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES. (See all compounds classified as Cytochrome P-450 Enzyme Inhibitors.)	
7,8-benzoquinoline		Benzo[h]quinoline	230-27-3	8KWJ7WT6Y7			
7,8-diacetoxy-4-methylcoumarin		7,8-Diacetoxy-4-methylcoumarin	68454-15-9				
7,8-diacetoxy-4-methylthiocoumarin		7,8-Diacetoxy-4-methylthiocoumarin					
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	55097-80-8	Benzo(a)pyrene diol epoxide	55097-80-8		Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
7,8-dihydro-8-ethyl-2-(4-bicyclo(2.2.2)octan-1-ol)-4-propyl-1H-imidazo(2,1-i)purin-5(4H)-one		7,8-dihydro-8-ethyl-2-(4-bicyclo(2.2.2)octan-1-ol)-4-propyl-1H-imidazo(2,1-i)purin-5(4H)-one					
7,8-dihydro-8-oxoguanine		8-Hydroxyguanine	5614-64-2	V5WDN6HY4L			
7,8-dihydrobiopterin	6779-87-9	Dihydrobiopterin	6779-87-9				
7,8-dihydromethysticin		Dihydromethysticin	19902-91-1	FZ66MQ73GS			
7,8-dihydroneopterin	1218-98-0	7,8-Dihydroneopterin	1218-98-0				
7'-Isothiocyanato-11-hydroxy-1',1'-dimethylheptylhexahydrocannabinol		7'-Isothiocyanato-11-hydroxy-1',1'-dimethylheptylhexahydrocannabinol					
7alpha-methyl-17alpha-ethynylestradiol		7alpha-methyl-17alpha-ethynylestradiol					
7alpha,11beta-dimethyl-19-nortestosterone		7alpha,11beta-dimethyl-19-nortestosterone					
7alpha,8beta-dihydroxydeepoxysarcophine		7alpha,8beta-Dihydroxydeepoxysarcophine					
7H-dibenzo(c,g)carbazole	194-59-2	7H-Dibenzo[c,g]carbazole	194-59-2	SZF1OJI89D	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
8-((4-chlorophenyl)thio)cyclic-3',5'-AMP	41941-66-6	8-(4-Chlorophenylthio)-cAMP	41941-66-6		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
8-((4-chlorophenyl)thio)cyclic-3',5'-GMP	54364-02-2	8-Pcpt-cgmp	54364-02-2		Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
8-(2,6-dichlorophenyl)-10-methyl-3-((4-morpholin-4-ylphenyl)amino)-2,4,10-triazabicyclo(4.4.0)deca-1,3,5,7-tetraen-9-one		8-(2,6-dichlorophenyl)-10-methyl-3-((4-morpholin-4-ylphenyl)amino)-2,4,10-triazabicyclo(4.4.0)deca-1,3,5,7-tetraen-9-one					
8-(3-(2-chloro-10H-phenothiazin-10-yl)propyl)-1-thia-4,8-diazaspiro(4.5)decan-3-one		8-(3-(2-chloro-10H-phenothiazin-10-yl)propyl)-1-thia-4,8-diazaspiro(4.5)decan-3-one					
8-(3-chlorostyryl)caffeine	148589-13-3	8-(3-Chlorostyryl)caffeine	147700-11-6				
8-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphate		8-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphate					
8-(4-chlorophenylthio)-2'-O-methyladenosine-3',5'-monophosphate acetoxymethyl ester		8-(4-chlorophenylthio)-2'-O-methyladenosine-3',5'-monophosphate acetoxymethyl ester					
8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate		8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate					
8-(4-methoxyphenyl)-4-oxo-4,6,7,8-tetrahydroimidazo(2,1-c)(1,2,4)triazine-3-carbohydrazide		8-(4-methoxyphenyl)-4-oxo-4,6,7,8-tetrahydroimidazo(2,1-c)(1,2,4)triazine-3-carbohydrazide					
8-(4-sulfophenyl)theophylline	80206-91-3	8-(p-Sulfophenyl)theophylline	80206-91-3		Purinergic P1 Receptor Antagonists	Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS. (See all compounds classified as Purinergic P1 Receptor Antagonists.)	
8-(5-(5-amino-2,4-dimethoxyphenyl)-5-oxopentyl)-1,3,8-triazaspiro(4.5)decane-2,4-dione		8-(5-(5-amino-2,4-dimethoxyphenyl)-5-oxopentyl)-1,3,8-triazaspiro(4.5)decane-2,4-dione					
8-(bis(2-methylphenyl)methyl)-3-phenyl-8-azabicyclo(3.2.1)octan-3-ol		8-(bis(2-methylphenyl)methyl)-3-phenyl-8-azabicyclo(3.2.1)octan-3-ol					
8-(dicyclopropylmethyl)-1,3-dipropylxanthine	131080-42-7	8-(Dicyclopropylmethyl)-1,3-dipropylxanthine	131080-42-7				
8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate	57818-92-5	8-(Diethylamino)octyl 3,4,5-trimethoxybenzoate	57818-92-5	T9NF33OQ5T	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
8-acenaphthen-1-yl-1-phenyl-1,3,8-triazaspiro(4.5)decan-4-one		8-acenaphthen-1-yl-1-phenyl-1,3,8-triazaspiro(4.5)decan-4-one					
8-anilino-1-naphthalenesulfonic acid		8-Anilino-1-naphthalenesulfonic acid	82-76-8	630I4V6051			
8-azaadenine	1123-54-2	8-Azaadenine	1123-54-2	WPP3R9U93J			
8-azidoadenosine 5'-triphosphate	53696-59-6	8-Azidoadenosine 5'-triphosphate	53696-59-6		Affinity Labels	Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. (See all compounds classified as Affinity Labels.)	
8-azidoadenosine diphosphate	59432-65-4	8-Azidoadenosine diphosphate	59432-65-4	GSN94OF83M	Affinity Labels	Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. (See all compounds classified as Affinity Labels.)	
8-Bromo Cyclic Adenosine Monophosphate	23583-48-4	Bcamp	23583-48-4	5QO1UW05Q5			
8-bromo-7-methoxychrysin		8-bromo-7-methoxychrysin					
8-bromoadenosine-3',5'-cyclic monophosphorothioate		(2r,4ar,6r,7r,7as)-6-(6-Amino-8-Bromo-9h-Purin-9-Yl)tetrahydro-4h-Furo[3,2-D][1,3,2]dioxaphosphinine-2,7-Diol 2-Sulfide					
8-bromocyclic GMP	31356-94-2	8-bromo-cGMP	31356-94-2				
8-bromoguanosino-3',5'-cyclic monophosphorothioate	150418-07-8	(2R,5R)-2-(2-amino-8-bromopurin-9-yl)-5-(dihydroxyphosphinothioyloxymethyl)-2,5-dihydrofuran-3,4-diol	150418-07-8				
8-chloro-2'-deoxyguanosine		8-Chloro-2'-deoxyguanosine					
8-chloroadenosine		8-Chloroadenosine	34408-14-5	PA05MFH3I7			
8-chlorodeoxyadenosine		8-chlorodeoxyadenosine					
8-chloroguanosine	2104-68-9	8-Chloroguanosine	2104-68-9				
8-cyclopentyl-1,3-dimethylxanthine	35873-49-5	8-Cyclopentyl-1,3-dimethylxanthine	35873-49-5	U7PWT4CPL5	Purinergic P1 Receptor Antagonists	Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS. (See all compounds classified as Purinergic P1 Receptor Antagonists.)	
8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine	156547-56-7	Fscpx	156547-56-7				
8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one		8-(4-Dibenzothienyl)-2-(4-morpholinyl)-4H-1-benzopyran-4-one	503468-95-9	XF6ZJD5WGU			
8-epi-prostaglandin F2alpha	27415-26-5	8-Isoprostane	27415-26-5	W83YE66SBY	Vasoconstrictor Agents	Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)	
8-epidiosbulbin E acetate		CID 134715250					
8-ethoxy-2-(4-fluorophenyl)-3-nitro-2H-chromene		8-ethoxy-2-(4-fluorophenyl)-3-nitro-2H-chromene					
8-ethyl-4-methyl-2-phenyl-4,5,7,8-tetrahydro-1H-imidazo(2,1-i)purin-5-one		8-ethyl-4-methyl-2-phenyl-4,5,7,8-tetrahydro-1H-imidazo(2,1-i)purin-5-one					
8-fluoro-12-(4-methylpiperazin-1-yl)-6H-(1)benzothieno(2,3-b)(1,5)benzodiazepine		8-fluoro-12-(4-methylpiperazin-1-yl)-6H-(1)benzothieno(2,3-b)(1,5)benzodiazepine					
8-hydroxy-11,12-epoxyeicosa-5,9,14-trienoic acid	85589-24-8	8-Hydroxy-11,12-epoxyeicosa-5,9,14-trienoic acid	85589-24-8				
8-Hydroxy-2-(di-n-propylamino)tetralin	78950-78-4	8-OH-Dpat	78950-78-4	IWS1724PX6	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	
8-hydroxy-2-(N-n-propyl-N-(3'-iodo-2'-propenyl)amino)tetralin	159559-70-3	8-Hydroxy-pipat	159559-70-3	CI98RA0M97			
8-Hydroxy-2'-Deoxyguanosine	88847-89-6	8-Hydroxy-2'-deoxyguanosine	88847-89-6	4RGB38T3IB			
8-hydroxyeicosatetraenoic acid	73179-96-1	Eicosatetraenoic acid, 8-hydroxy-	73179-96-1				
8-hydroxyguanine	5614-64-2	8-Hydroxyguanine	5614-64-2	V5WDN6HY4L			
8-hydroxyguanosine	3868-31-3	8-Hydroxyguanosine	3868-31-3		Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
8-hydroxyloxapine	61443-77-4	8-Hydroxyloxapine	61443-77-4	0Q6HMM3XRC			
8-hydroxyoctanoic acid	764-89-6	8-Hydroxyoctanoic acid	764-89-6				
8-hydroxyquinoline glucuronide	14683-61-5	8-Hydroxyquinoline glucuronide	14683-61-5	AY3E5ZM43M			
8-hydroxywarfarin	17834-04-7	8-Hydroxywarfarin	17834-04-7	T1CK4E3S36			
8-isoprostaglandin A2		8-iso-prostaglandin A2	474391-66-7				
8-isoprostaglandin E2	27415-25-4	8-isoprostaglandin E2	27415-25-4	W1ANC8Q5NW	Vasoconstrictor Agents	Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)	
8-methoxymethyl-3-isobutyl-1-methylxanthine		8-Methoxymethyl-3-isobutyl-1-methylxanthine	78033-08-6	67FPZ87JKY			
8-methyl-1,3,8-trichlorodibenzofuran		8-methyl-1,3,8-trichlorodibenzofuran					
8-methylbenzanthracene		8-Methylbenz[a]anthracene	2381-31-9	LP9SKC568Q			
8-methylquinoline	611-32-5	8-Methylquinoline	611-32-5	K97B12J636			
8-oxo-7,8-dihydrodeoxyguanine	6957-76-2	8-Oxo-7,8-dihydrodeoxyguanine	6957-76-2				
8-oxoberberine		Oxyberberine	549-21-3	4A04YKB3FT			
8-oxodeoxyguanosine triphosphate	139307-94-1	8-Oxo-dgtp	139307-94-1		Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
8-phenyl-6a,7,8,9,9a,10-hexahydro-6H-isoindolo(5,6-g)quinoxaline-7,9-dione		8-phenyl-6a,7,8,9,9a,10-hexahydro-6H-isoindolo(5,6-g)quinoxaline-7,9-dione					
8-phenyltheophylline	961-45-5	8-Phenyltheophylline	961-45-5	E6M543P3BL			
8-prenylnaringenin		8-Prenylnaringenin	53846-50-7	5L872SZR8X	Phytoestrogens	Compounds derived from plants, primarily ISOFLAVONES that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS. (See all compounds classified as Phytoestrogens.)	
8-sulfocholecystokinin octapeptide		8-sulfocholecystokinin octapeptide					
8,11,14-Eicosatrienoic Acid	7324-41-6	8,11,14-Eicosatrienoic acid	7324-41-6				
8,12-iso-isoprostane F2alpha-VI		8,12-iso-isoprostane F2alpha-VI					
8,5'-cyclo-2'-deoxyadenosine	117182-88-4	2'-Deoxy-8,5'-cycloadenosine	117182-88-4				
8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino(1,2-a)quinoxalin-5(6H)-one		8,9-Dichloro-1,2,3,4,4a,6-hexahydropyrazino[1,2-a]quinoxalin-5-one	75704-24-4	SCG2HM6F3D			
8,9-dihydro-8-(S-glutathionyl)-9-hydroxyaflatoxin B1	68385-50-2	8,9-Dihydro-8-(S-glutathionyl)-9-hydroxyaflatoxin B1	68385-50-2				
8,9-epoxyeicosatrienoic acid	81246-85-7	7-[3-(Undeca-2,5-dien-1-yl)oxiran-2-yl]hept-5-enoic acid	81246-85-7		Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
9-((2-phosphonylmethoxy)ethyl)guanine	114088-58-3	9-((2-Phosphonylmethoxy)ethyl)guanine	114088-58-3	N9YOI96LPP			
9-(2-hydroxy-3-nonyl)adenine	59262-86-1	9-(2-Hydroxy-3-nonyl)adenine	59262-86-1		Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
9-(2,3-dihydroxypropyl)adenine	55904-02-4	9-(2,3-Dihydroxypropyl)adenine	55904-02-4		Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole		9-(4'-Aminophenyl)-9H-pyrido[3,4-b]indole	219959-86-1	NMC04J95OA			
9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo(h)(1,6)naphthyridin-2(1H)-one		9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo(h)(1,6)naphthyridin-2(1H)-one					
9-(8-azabicyclo(3.2.1)oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide		9-(8-azabicyclo(3.2.1)oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide	825649-28-3	99HYH9K6MZ			
9-(benzoyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho(2,1-c)pyran-7-carboxylic acid methyl ester		Herkinorin	862073-77-6	5XN29VGR24			
9-(S)-(3-hydroxy-2-(phosphonomethoxy)propyl)adenine		9-(S)-(3-hydroxy-2-(phosphonomethoxy)propyl)adenine					
9-(tetrahydro-2-furyl)-adenine	17318-31-9	9-(Tetrahydrofuran-2-yl)-9h-purin-6-amine	17318-31-9		Adenylyl Cyclase Inhibitors	Compounds that bind to and inhibit the action of ADENYLYL CYCLASES. (See all compounds classified as Adenylyl Cyclase Inhibitors.)	
9-amino-6-chloro-2-methoxyacridine	3548-09-2	9-Amino-6-chloro-2-methoxyacridine	3548-09-2	R9EB8YPL49	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
9-aminophenanthrene	947-73-9	9-Aminophenanthrene	947-73-9	7M9M5KM2XY			
9-anilinoacridine	3340-22-5	9-Anilinoacridine	3340-22-5				
9-anthraldehyde	642-31-9	9-Anthraldehyde	642-31-9	353S277YHY			
9-anthroic acid	723-62-6	9-Anthracenecarboxylic acid	723-62-6	7VK69492FV			
9-bromo-5-(4,5-dimethoxy-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-(1,3)-dioxolo(4,5-g)isoquinoline		9-bromo-5-(4,5-dimethoxy-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-(1,3)-dioxolo(4,5-g)isoquinoline					
9-chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine		9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine	104615-18-1	Y5A5D5E2AQ			
9-chloro-2-(2-furyl)-5-phenylacetylamino(1,2,4)triazolo(1,5-c)quinazoline		N-(9-chloro-2-(furan-2-yl)-[1,2,4]triazolo[1,5-c]quinazolin-5-yl)-2-phenylacetamide	183721-15-5		Adenosine A3 Receptor Antagonists	Compounds that selectively bind to and block the activation of ADENOSINE A3 RECEPTORS. (See all compounds classified as Adenosine A3 Receptor Antagonists.)	
9-cis-retinal	514-85-2	9-cis-Retinal	514-85-2				
9-cyanoanthracene		9-Anthracenecarbonitrile	1210-12-4	6D39005L8T			
9-deaza-9-(3-thienylmethyl)guanine	132138-76-2	9-Deaza-9-(3-thienylmethyl)guanine	132138-76-2	TK5264YUH3			
9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2	87893-54-7	delta-12-Prostaglandin J2	87893-54-7		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
9-deoxy-delta-9-prostaglandin D2	60203-57-8	prostaglandin J2	60203-57-8		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
9-ethyl-6,6-dimethyl-8-(4-oxetan-3-ylpiperazin-1-yl)-11-oxo-6,11-dihydro-5H-benzo(b)carbazole-3-carbonitrile		9-ethyl-6,6-dimethyl-8-(4-oxetan-3-ylpiperazin-1-yl)-11-oxo-6,11-dihydro-5H-benzo(b)carbazole-3-carbonitrile					
9-ethynylphenanthrene		9-Ethynylphenanthrene	32870-98-7				
9-fluorenone	486-25-9	9-Fluorenone	486-25-9	AZ9T83S2AQ			
9-hydroxy-10,12-octadecadienoic acid	15514-85-9	9-Hydroxy-10,12-octadecadienoic acid	15514-85-9	ZCJ7V6WHP4			
9-hydroxy-12-oxo-10(E)-dodecenoic acid		10-Dodecenoic acid, 9-hydroxy-12-oxo-, (10E)-	74886-18-3				
9-hydroxybenzo(a)pyrene	17573-21-6	9-Hydroxybenzo[a]pyrene	17573-21-6	VE62PY8U9F			
9-hydroxycanthin-6-one		9-Hydroxycanthin-6-one	138544-91-9				
9-hydroxyellipticine	51131-85-2	5,11-dimethyl-6H-pyrido[4,3-b]carbazol-9-ol	51131-85-2	9G4A3ET6XG	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	
9-hydroxyfraxinellone-9-O-glucoside		9-hydroxyfraxinellone-9-O-glucoside					
9-hydroxymethylanthracene	1468-95-7	9-Anthracenemethanol	1468-95-7	2N7UVX2HLM			
9-hydroxyoctadecadienoic acid		9-hydroxyoctadecadienoic acid					
9-hydroxystearic acid	3384-24-5	9-Hydroxyoctadecanoic acid	3384-24-5				
9-methoxy-2-methylellipticinium acetate		9-Methoxy-2-methylellipticinium acetate					
9-methoxycamptothecin	19685-10-0	10-Methoxycamptothecin	19685-10-0				
9-methyl-4-phenyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine		9-methyl-4-phenyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine					
9-methylanthracene	779-02-2	9-Methylanthracene	779-02-2	65NK4CIN03			
9-mono-N'-methylnorharman	17994-14-8	9-Mono-N'-methylnorharman	17994-14-8				
9-nitroanthracene	602-60-8	9-Nitroanthracene	602-60-8	JZ1TB3N57P			
9-nitrophenanthrene	954-46-1	9-Nitrophenanthrene	954-46-1	836BX38BU5			
9-oxo-10,11-dehydroagerophorone		Euptox A					
9-oxononanoic acid	2553-17-5	9-Oxononanoic acid	2553-17-5	YH3Q8RSX3Z			
9-phenanthrol		9-Phenanthrol	484-17-3	9FYU45OV9H	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
9,10-anthraquinone	84-65-1	Anthraquinone	84-65-1	030MS0JBDO			
9,10-dihydro-2,5-dimethoxyphenanthrene-1,7-diol		2,5-Dimethoxy-9,10-dihydrophenanthrene-1,7-diol					
9,10-dihydro-9,10-dihydroxybenzo(a)pyrene	24909-09-9	9,10-Dihydro-9,10-dihydroxybenzo(a)pyrene	24909-09-9				
9,10-dihydrobenzo(a)pyrene	17573-15-8	9,10-Dihydrobenzo[a]pyrene	17573-15-8	DK44UY8IG3			
9,10-dihydroxy-12-octadecenoic acid		9,10-Dihydroxy-12-octadecenoic acid					
9,10-dimethoxy-3,3-dimethyl-7,7a,13,13atetrahydro-3H-chromeno(3,4-b)pyrano(2,3-h)chromen-7-ol		9,10-dimethoxy-3,3-dimethyl-7,7a,13,13atetrahydro-3H-chromeno(3,4-b)pyrano(2,3-h)chromen-7-ol					
9,10-Dimethyl-1,2-benzanthracene	57-97-6	7,12-Dimethylbenz[a]anthracene	57-97-6	F05B6S0395	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
9,10-dimethylanthracene	781-43-1	9,10-Dimethylanthracene	781-43-1	DI986077VR			
9,10-epoxy-12-octadecenoic acid	65167-83-1	9,10-Epoxy-12-octadecenoic acid	65167-83-1				
9,10-epoxy-9,10-dihydrophenanthrene	585-08-0	9,10-Epoxy-9,10-dihydrophenanthrene	585-08-0				
9,10-methylenehexadecanoic acid	5618-00-8	9,10-Methylenehexadecanoic acid	5618-00-8				
9,10-phenanthrenequinone	84-11-7	9,10-Phenanthrenequinone	84-11-7	42L7BZ8H74	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
9,10,13-trihydroxy-11-octadecenoic acid	29907-57-1	9,10,13-Trihydroxy-11-octadecenoic acid	29907-57-1				
9,11-linoleic acid	1839-11-8	9,11-Octadecadienoic acid	1839-11-8	K3BO6AJ7F7			
9,12-dioxo-10-dodecenoic acid		9,12-Dioxo-10-dodecenoic acid					
9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-		9H-Purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-	873436-91-0	06IVK87M04	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
A 182086		A 182086					
A 192621		3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)-	195529-54-5	5XE882529E			
A 285222		A 285222					
A 419259		7-[trans-4-(4-Methylpiperazin-1-Yl)cyclohexyl]-5-(4-Phenoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-4-Amine	364042-47-7				
A 443654		(2s)-1-(1h-Indol-3-Yl)-3-{[5-(3-Methyl-1h-Indazol-5-Yl)pyridin-3-Yl]oxy}propan-2-Amine	552325-16-3	Q4UG565ZYH			
A 61603		N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulfonamide					
A 68930		5,6-Dihydroxy-3-phenyl-1-aminomethylisochroman	130465-45-1	B4NI77O5D4	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
A 69024	58939-37-0	1-(2-Bromo-4,5-dimethoxybenzyl)-7-hydroxy-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline	58939-37-0				
A 77636	145307-34-2	A 77636 hydrochloride	145307-34-2	WA6RGP1J4W	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	
A 78773	141579-67-1	N-Hydroxy-N-(4-(5-(4-fluorophenoxy)-2-furyl)-3-butyn-2-yl)urea	141579-67-1				
A 81988	141887-34-5	2-(N-Propyl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)amino)pyridine-3-carboxylic acid	141887-34-5		Angiotensin II Type 1 Receptor Blockers	Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)	
A 85380		(S)-3-(Azetidin-2-ylmethoxy)pyridine	161416-98-4				
A 86929		Benzo(f)thieno(2,3-c)quinoline-9,10-diol, 4,5,5a,6,7,11b-hexahydro-2-propyl-, hydrochloride, (5aR,11bS)-rel-	171961-95-8	S3ZIH99X6E			
A 967079		1-Penten-3-one, 1-(4-fluorophenyl)-2-methyl-, oxime, (1E,3E)-	1170613-55-4	S15N98QQ2K			
A-1155463		2-[8-(1,3-Benzothiazol-2-Ylcarbamoyl)-3,4-Dihydroisoquinolin-2(1h)-Yl]-5-(3-{4-[3-(Dimethylamino)prop-1-Yn-1-Yl]-2-Fluorophenoxy}propyl)-1,3-Thiazole-4-Carboxylic Acid					
A-1210477		7-(5-((4-(4-(N,N-Dimethylsulfamoyl)piperazin-1-yl)phenoxy)methyl)-1,3-dimethyl-1H-pyrazol-4-yl)-1-(2-morpholinoethyl)-3-(3-(naphthalen-1-yloxy)propyl)-1H-indole-2-carboxylic acid					
A-196 compound		A-196 compound					
A-317491		1,2,4-Benzenetricarboxylic acid, 5-((((3-phenoxyphenyl)methyl)((1S)-1,2,3,4-tetrahydro-1-naphthalenyl)amino)carbonyl)-	475205-49-3	H327N08IPV			
A-582941		2-Methyl-5-(6-phenylpyridazin-3-yl)octahydropyrrolo[3,4-c]pyrrole					
A-83-01		3-(6-methylpyridin-2-yl)-N-phenyl-4-(quinolin-4-yl)-1H-pyrazole-1-carbothioamide	909910-43-6	X3ZNM7QJ2Q			
A-836339		N-(3-(2-Methoxyethyl)-4,5-dimethylthiazol-2(3H)-ylidene)-2,2,3,3-tetramethylcyclopropanecarboxamide	959746-77-1	Z6Y1J258EG			
A119637		3-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-5-phenyl-1H-thieno[3,2-e]pyrimidine-2,4-dione					
A1443 compound		A1443 compound					
A2-E (N-retinylidene-N-retinylethanolamine)		(1E,3E,5E,7E,9Z,NE)-N-((2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ylidene)-N-(2-hydroxyethyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-2-en-1-ylidene)nona-1,3,5,7-tetraen-1-aminium	147427-87-0				
A357300		A357300					
AAD-2004		Benzoic acid, 2-hydroxy-5-((2-(4-(trifluoromethyl)phenyl)ethyl)amino)-	927685-43-6	11VWK61J69			
AAL 881		AAL 881					
AB-FUBINACA		AB-Fubinaca	1185282-01-2	I7PZF0KTFK			
abacavir		Abacavir	136470-78-5	WR2TIP26VS	Reverse Transcriptase Inhibitors	Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)	Abacavir is indicated in combination with other anti-retroviral agents for the treatment of HIV-1 infection. It is available in a combination product alongside [dolutegravir] and [lamivudine] for the treatment of adult and pediatric patients with HIV-1 who weigh 10 kg.
abamectin	71751-41-2	Abamectin	71751-41-2		Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	
abana	105863-96-5	abana					
abanoquil	118931-00-3	4-Amino-6,7-dimethoxy-2-(1,2,3,4-tetrahydro-6,7-dimethoxyisoquinol-2-yl)quinoline methanesulfonate	118931-00-3	MAX6HQS78D			
Abbott 29590	18504-81-9	1H-Pyrido[2,3-b][1,4]thiazin-2(3H)-one	18504-81-9	2PL1478Z1W			
ABBV-744		N-ethyl-4-[2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide	2138861-99-9	9MX546E2SF			
abemaciclib		Abemaciclib	1231929-97-7	60UAB198HK			* Indicated in combination with fulvestrant for the treatment of women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with disease progression following endocrine therapy.   * Inidicated as monotherapy for the treatment of adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy and prior chemotherapy in the metastatic setting.
abexinostat		Abexinostat	783355-60-2	IYO470654U	Histone Deacetylase Inhibitors	Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)	
abietic acid	514-10-3	Abietic acid	514-10-3	V3DHX33184	Free Radical Scavengers	Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. (See all compounds classified as Free Radical Scavengers.)	
abiraterone		Abiraterone	154229-19-3	G819A456D0			Abiraterone is indicated for the treatment of **metastatic castration-resistant prostate cancer (mCRPC)** in combination with [methylprednisolone] or [prednisone].   In Europe and Canada, it is also used in patients with mCRPC who are asymptomatic or mildly symptomatic after the failure of androgen deprivation therapy for whom chemotherapy is not yet clinically indicated. In Europe, it is used in patients whose disease has progressed on or after a docetaxel-based chemotherapy regimen. In Canada, it is used in patients who have received prior chemotherapy containing [docetaxel] after the failure of androgen deprivation therapy.  Abiraterone is indicated in combination with [prednisone] for the treatment of **metastatic high-risk castration-sensitive prostate cancer (CSPC)**. In Europe and Canada, it may also be used in combination with [prednisolone] and androgen deprivation therapy in newly diagnosed patients.  In Canada and the US, abiraterone is also available in a combination product with [niraparib], which is indicated with [prednisone] for the treatment of adults with deleterious or suspected deleterious BRCA-mutated (BRCAm) mCRPC. In Canada, this combination product is also used with [prednisolone] and is reserved for patients who are asymptomatic or mildly symptomatic, and in whom chemotherapy is not clinically indicated.
Abiraterone Acetate		Abiraterone Acetate	154229-18-2	EM5OCB9YJ6	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Abiraterone Mylan is indicated with prednisone or prednisolone for: the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT). the treatment of metastatic castration resistant prostate cancer (mCRPC) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mCRPC in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abrine		Abrine	526-31-8	P57TWL22IX			
Abscisic Acid	21293-29-8	Abscisic acid	21293-29-8	72S9A8J5GW	Plant Growth Regulators	Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins. (See all compounds classified as Plant Growth Regulators.)	
ABT-100		4-[(2S)-2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[4-(trifluoromethoxy)phenyl]benzonitrile	450839-40-4	QG74WR2HRE			
ABT-737		Abt-737	852808-04-9	Z5NFR173NV			
ABTL0812		alpha-Hydroxylinoleic acid	57818-44-7	0DE74TJ7EZ			
ABVD protocol		ABVD protocol					
AC 93253		3-Ethyl-2-[3-(1,3,3-trimethylindol-2-ylidene)prop-1-enyl]-1,3-benzothiazol-3-ium;iodide	108527-83-9				
AC3056		Ethyl 3-(5-ethyl-1,2,4-oxadiazol-3-YL)benzoate	1166756-76-8				For the treatment of atherosclerosis and other conditions related to the obstruction of blood vessels.
acacetin	480-44-4	Acacetin	480-44-4	KWI7J0A2CC			
acadesine	2627-69-2	Acadesine	2627-69-2	53IEF47846			Investigated for use/treatment in cardiac reperfusion injury, cardiovascular disorders, and coronary artery disease.
acalabrutinib		Acalabrutinib	1420477-60-6	I42748ELQW	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Acalabrutinib is currently indicated for the treatment of adult patients with Mantle Cell Lymphoma (MCL) who have received at least one prior therapy. It has also been recently approved for chronic lymphocytic leukemia and small lymphocytic lymphoma.
Acamprosate	77337-76-9	Acamprosate	77337-76-9	N4K14YGM3J	Alcohol Deterrents	Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism. (See all compounds classified as Alcohol Deterrents.)	Acamprosate is indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. It is also indicated for the maintenance of alcohol abstinence in patients who have undergone alcohol detoxification. This drug should be used with a psychosocial support program providing adequate support.
acamprosate, ribavirin drug combination		acamprosate, ribavirin drug combination					
acanthoic acid		(-)-Acanthoic acid	119290-87-8				
acanthoside B	7374-79-0	Acanthoside B	7374-79-0				
Acarbose	56180-94-0	Glucobay	56180-94-0		Glycoside Hydrolase Inhibitors	Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES. (See all compounds classified as Glycoside Hydrolase Inhibitors.)	Acarbose is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
aceanthrylene	202-03-9	Aceanthrylene	202-03-9	68U0ZN4H6L			
Acebutolol	37517-30-9	Acebutolol	37517-30-9	67P356D8GH	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the management of hypertension and ventricular premature beats in adults.
aceclidine	827-61-2	Aceclidine	827-61-2	0578K3ELIO	Miotics	Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here. (See all compounds classified as Miotics.)	
aceclofenac	89796-99-6	Aceclofenac	89796-99-6	RPK779R03H	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Aceclofenac is indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
acemetacin		Acemetacin	53164-05-9	5V141XK28X	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Acemetacin is not FDA, Canada or EMA approved, but in the countries where it is marketed it is indicated for the symptomatic treatment of pain and swelling in acute inflammation of the joints in rheumathoid arthritis, osteoarthritis, low back pain and post-surgical pain. It is also indicated for the treatment of chronic inflammation of the joints in presence of rheumatoid arthritis, treatment of ankylosing spondylitis, treatment of irritation in the joints and spinal column caused by degenerative disorders, treatment of inflammatory soft-tissue rheumatism syndrome and painful swelling and inflammation caused by injury.
acenaphthene	83-32-9	Acenaphthene	83-32-9	V8UT1GAC5Y			
acenaphthene-1-ol	6306-07-6	1-Acenaphthenol	6306-07-6				
acenaphthenequinone	82-86-0	Acenaphthenequinone	82-86-0	3950D6UEIQ			
Acenaphthenes		Acenaphthenes					
acenaphthylene	208-96-8	Acenaphthylene	208-96-8	1Z25C36811			
Acenocoumarol	152-72-7	Acenocoumarol	152-72-7	I6WP63U32H	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.
acephate	30560-19-1	Acephate	30560-19-1	3Y417O444D	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Acepromazine	61-00-7	Acepromazine	61-00-7	54EJ303F0R	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	Acepromazine was first used in humans in the 1950s as an antipsychotic agent. It is now rarely used in humans. Acepromazine is frequently used in animals as a sedative and antiemetic. Its principal value is in quietening and calming anxious animals.
Acetaldehyde	75-07-0	Acetaldehyde	75-07-0	GO1N1ZPR3B			
acetaldehyde oxime	107-29-9	Acetaldehyde oxime	107-29-9	G2YQ9T90UB			
acetamide	60-35-5	Acetamide	60-35-5	8XOE1JSO29			
Acetamides		Acetamides					
Acetaminophen	103-90-2	Acetaminophen	103-90-2	362O9ITL9D	Analgesics, Non-Narcotic	A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)	In general, acetaminophen is used for the treatment of mild to moderate pain and reduction of fever. It is available over the counter in various forms, the most common being oral forms.  Acetaminophen _injection_ is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever.  Because of its low risk of causing allergic reactions, this drug can be administered in patients who are intolerant to salicylates and those with allergic tendencies, including bronchial asthmatics. Specific dosing guidelines should be followed when administering acetaminophen to children.
acetaminophen cysteine	64014-06-8	Acetaminophen cysteine	64014-06-8				
acetaminophen glucuronide	16110-10-4	Acetaminophen glucuronide	16110-10-4	8BE7G9R76X			
acetaminophen sulfate ester	10066-90-7	Acetaminophen sulfate	10066-90-7	S6002H6J9F			
acetamiprid		Acetamiprid	160430-64-8	5HL5N372P0	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Acetanilides		Acetanilides					
Acetates		Phenyl acetate	122-79-2	355G9R500Y			
Acetazolamide	59-66-5	Acetazolamide	59-66-5	O3FX965V0I	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies; chronic simple (open-angle) glaucoma
Acetic Acid	64-19-7	Acetic Acid	64-19-7	Q40Q9N063P	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Used to treat infections in the ear canal.
acetic anhydride	108-24-7	Acetic Anhydride	108-24-7	2E48G1QI9Q			
acetoacetic acid	541-50-4	Acetoacetic acid	541-50-4	4ZI204Y1MC			
acetoacetyl CoA	1420-36-6	acetoacetyl-CoA	1420-36-6				
acetochlor	34256-82-1	Acetochlor	34256-82-1	8L08WMO94K	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Acetohexamide	968-81-0	Acetohexamide	968-81-0	QGC8W08I6I	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	Used in the management of diabetes mellitus type 2 (adult-onset).
acetohydroxamic acid		Acetohydroxamic Acid	546-88-3	4RZ82L2GY5	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Used, in addition to antibiotics or medical procedures, to treat chronic urea-splitting urinary infections.
Acetoin	513-86-0	Acetoin	513-86-0	BG4D34CO2H			
Acetone	67-64-1	Acetone	67-64-1	1364PS73AF	Solvents	Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant and Hackh&apos;s Chemical Dictionary, 5th ed) (See all compounds classified as Solvents.)	
acetone phenylhydrazone	103-02-6	Acetone phenylhydrazone	103-02-6	0PV0413LW9			
acetonitrile	75-05-8	Acetonitrile	75-05-8	Z072SB282N			
acetophenazine	2751-68-0	Acetophenazine	2751-68-0	8620H6K4QH			For the treatment of disorganized and psychotic thinking. Also used to help treat false perceptions (e.g. hallucinations or delusions.)
acetophenone	98-86-2	Acetophenone	98-86-2	RK493WHV10	Photosensitizing Agents	Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)	
Acetophenones		Acetophenones					
acetosulfame		Acesulfame	33665-90-6	MA3UYZ6K1H			
acetovanillone	498-02-2	Acetovanillone	498-02-2	B6J7B9UDTR	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
Acetoxyacetylaminofluorene	6098-44-8	Acetoxyacetylaminofluorene	6098-44-8		Alkylating Agents	Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)	
acetoxycycloheximide	3326-96-3	Cyclohexanecarboxylic acid, ethyl ester, cis-	33073-61-9				
acetyl acetonate	17272-66-1	Acetylacetonate	17272-66-1				
Acetyl Coenzyme A	72-89-9	Acetyl coenzyme A	72-89-9	76Q83YLO3O			
acetyl methyl tetramethyl tetralin	21145-77-7	Tonalid	21145-77-7	360Q8Z01IP	Perfume	A substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell, especially a fluid containing fragrant natural oils extracted from flowers, woods, etc., or similar synthetic oils. (Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Perfume.)	
acetyl phosphate	590-54-5	Acetylphosphate	590-54-5	54979W5TJB			
acetyl tert-butyl dimethylindan	13171-00-1	Celestolide	13171-00-1	E1HM68Q21P	Perfume	A substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell, especially a fluid containing fragrant natural oils extracted from flowers, woods, etc., or similar synthetic oils. (Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Perfume.)	
acetyl triethyl citrate		Acetyl triethyl citrate	77-89-4	5WBR36T90E			
acetyl-11-ketoboswellic acid		3-ACETYL-11-KETO-beta-BOSWELLIC ACID	67416-61-9	BS16QT99Q1			
acetyl-aspartyl-glutamyl-valyl-aspartal		Ac-DEVD-CHO	169332-60-9		Cysteine Proteinase Inhibitors	Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. (See all compounds classified as Cysteine Proteinase Inhibitors.)	
acetyl-aspartyl-glutamyl-valyl-aspartic acid p-nitroanilide		Acetyl-aspartyl-glutamyl-valyl-aspartic Acid P-nitroanilide					
acetyl-isoleucyl-glutamyl-threonyl-aspartyl-aldehyde		acetyl-isoleucyl-glutamyl-threonyl-aspartyl-aldehyde					
acetyl-leucyl-glutamyl-histidyl-aspartal		acetyl-leucyl-glutamyl-histidyl-aspartal					
acetyl-valyl-isoleucyl-aspartyl-aldehyde		acetyl-valyl-isoleucyl-aspartyl-aldehyde					
acetylalanine 4-nitroanilide	35978-75-7	Acetylalanine 4-nitroanilide	35978-75-7				
acetylaminophenylarsine oxide	129409-57-0	Acetylaminophenylarsine oxide	129409-57-0				
acetylbritannilatone		acetylbritannilatone					
Acetylcarnitine	14992-62-2	Acetyl-DL-carnitine	14992-62-2	07OP6H4V4A	Vitamin B Complex	A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)	Acetylcarnitine is not approved for any indication in the United states and Canada, but it is approved and indicated in Italy for cerebrovascular disorders, mental function disorders, peripheral nerve disorders, diabetic neuropathy, and nutritional supplementation; Portugal for mental function disorders; Argentina for cerebral vasculopathy, nutritional supplementation, and peripheral neuropathy; Chile for dementia; Philippines for cerebrovascular disorders and mental function disorders; Australia for nutritional supplementation; and India for nutritional supplementation to increase sperm count. Acetylcarnitine also has several potential therapeutic indications for which it is still being investigated: in Norway, acetylcarnitine is in a phase IV trial for prophylactic treatment of migraines; in Italy acetylcarnitine is in a phase II trial for use in patients with type 2 Diabetes Mellitus, a phase III trial for alleviating fatigue in patients with chronic hepatitis C, and for use in patients with Minimal Hepatic Encephalopathy; in the United States acetylcarnitine is in a phase II trial for the neurodegenerative disorder Progressive Supranuclear Palsy, a phase II and III trial for reducing peripheral neuropathy in cancer patients as an adjunct to chemotherapy, a phase I and II trial for treating patients in septic shock, a phase II trial for bipolar depression, a phase II trial to reduce oxidative stress in patients with Sickle Cell disease, a phase I and II trial for chronic fatigue syndrome, and a study for preventing nerve damage in HIV patients; in China acetylcarnitine is in a phase III trial for reducing peripheral neuropathy in cancer patients as an adjunct to chemotherapy; in the United Kingdom acetylcarnitine is being investigated for preventing nerve damage in HIV patients; and in Israel acetylcarnitine is being studied for the treatment of male infertility.
Acetylcholine	51-84-3	Acetylcholine	51-84-3	N9YNS0M02X	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	Used to obtain miosis of the iris in seconds after delivery of the lens in cataract surgery, in penetrating keratoplasty, iridectomy and other anterior segment surgery where rapid miosis may be required.
Acetylcysteine	616-91-1	Acetylcysteine	616-91-1	WYQ7N0BPYC	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	Acetylcysteine is indicated for mucolytic therapy and in the management of [acetaminophen] overdose.
acetyldiethylcholine	54378-00-6	Acetyldiethylcholine	54378-00-6				
acetylenedicarboxylic acid dimethyl ester	762-42-5	Dimethyl acetylenedicarboxylate	762-42-5	7HZA2PL15F			
acetyleugenol	93-28-7	Eugenol acetate	93-28-7	V9OSB376X8			
Acetylgalactosamine	31022-50-1	N-Acetyl-D-Galactosamine	1136-42-1	833755V695			
Acetylglucosamine	7512-17-6	N-Acetylglucosamine	7512-17-6	V956696549			For the treatment and prevention of osteoarthritis, by itself or in combination with chondroitin sulfate.
acetylhydrazine	1068-57-1	Acetohydrazide	1068-57-1	SK0DPC9098	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
acetylisoniazid		Acetylisoniazid	1078-38-2	J42942UVUN			
acetylleucyl-leucyl-norleucinal	110044-82-1	Acetylleucyl-leucyl-norleucinal	110044-82-1		Cysteine Proteinase Inhibitors	Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. (See all compounds classified as Cysteine Proteinase Inhibitors.)	
acetylmonoethylcholine	40792-85-6	Acetylethylcholine	40792-85-6				
Acetylmuramyl-Alanyl-Isoglutamine	53678-77-6	N-Acetylmuramyl-L-alanyl-D-isoglutamine	53678-77-6		Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
acetylsalicylic acid lysinate		Solusprin	37933-78-1	XAN4V337CI	Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
acetylspiramycin	24916-51-6	Acetylspiramycin	24916-51-6	05298J5WMU			
Acetylthiocholine	4468-05-7	Acetylthiocholine	4468-05-7	4V9VG6MX6E			
acetylthiocholine iodide		Acetylthiocholine iodide	1866-15-5	6SKH6P4YRN			
aciculatin	134044-97-6	8-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxychromen-4-one	134044-97-6				
acid chrome blue K		acid chrome blue K					
acid red 337		Acid red 337	67786-14-5	9H247YW69C			
Acids		Acids					
acifluorfen	50594-66-6	Acifluorfen	50594-66-6	OI60IB203A	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
acifluorfen-methyl	50594-67-7	Acifluorfen-methyl	50594-67-7	9261T4QE1K			
acifran		Acifran	72420-38-3	B1X701S0MV			
acipimox	51037-30-0	Acipimox	51037-30-0	K9AY9IR2SD	Hypolipidemic Agents	Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)	Used in the treatment of hyperlipidemias (abnormally elevated levels of any or all lipids and/or lipoproteins in the blood).
Acitretin	55079-83-9	Acitretin	55079-83-9	LCH760E9T7	Keratolytic Agents	Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases. (See all compounds classified as Keratolytic Agents.)	For the treatment of severe psoriasis in adults.
acivicin	52583-41-2	5-Isoxazoleacetic acid, alpha-amino-3-chloro-4,5-dihydro-	52583-41-2		Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
aclacinomycins		Aklavin	60504-57-6	T87WN25BNW	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
Aclarubicin	57576-44-0	Aclarubicin	57576-44-0	74KXF8I502	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	
aclonifen	74070-46-5	Aclonifen	74070-46-5	1762RDA835			
Aconitic Acid	499-12-7	cis-Aconitic acid	4023-65-8	OF5471ZHRR			
Aconitine	302-27-2	Aconitine	302-27-2	X8YN71D5WC	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
acridine mustard		Acridine mustard	146-59-8	0I3A3407T2	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
Acridine Orange	494-38-2	Acridine orange	494-38-2	F30N4O6XVV	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
Acridines		Acridine	260-94-6	42NI1P5Q1X			
Acriflavine	8048-52-0	Acriflavine neutral	8048-52-0		Intercalating Agents	Agents that are capable of inserting themselves between the successive bases in DNA, thus kinking, uncoiling or otherwise deforming it and therefore preventing its proper functioning. They are used in the study of DNA. (See all compounds classified as Intercalating Agents.)	
acriflavine chloride		2,8-Diamino-10-methylacridinium chloride mixture with 2,8-diaminoacridine					
acrinathrin	103833-18-7	Rufast	103833-18-7				
acrivastine		Acrivastine	87848-99-5	A20F9XAI7W	Histamine H1 Antagonists, Non-Sedating	A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. (See all compounds classified as Histamine H1 Antagonists, Non-Sedating.)	For the relief of symptoms associated with seasonal allergic rhinitis such as sneezing, rhinorrhea, pruritus, lacrimation, and nasal congestion.
Acrolein	107-02-8	Acrolein	107-02-8	7864XYD3JJ			
Acrylamide	79-06-1	Acrylamide	79-06-1	20R035KLCI			
Acrylamides		Acrylamides					
Acrylates		79-10-7					
acrylic acid	79-10-7	Acrylic acid	9003-01-4	J94PBK7X8S	Tissue Adhesives	Substances used to cause adherence of tissue to tissue or tissue to non-tissue surfaces, as for prostheses. (See all compounds classified as Tissue Adhesives.)	
acrylodan	86636-92-2	6-Acryloyl-2-dimethylaminonaphthalene	86636-92-2		Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
Acrylonitrile	107-13-1	Acrylonitrile	107-13-1	MP1U0D42PE	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
acryloyl-coenzyme A	5776-58-9	Acryloyl-CoA	5776-58-9	PV7BP6Q8B6			
actein	18642-44-9	Actein	18642-44-9	I14QO4LW9V			
acteoside	61276-17-3	Verbascoside	61276-17-3	3TGX09BD5B	Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	
actinidine	524-03-8	Actinidine	524-03-8	VWU976C78Y			
actinonin	13434-13-4	Actinonin	13434-13-4	P18SPA8N0K	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Active Hexose Correlated Compound		Active Hexose Correlated Compound					
Acyclovir	59277-89-3	Acyclovir	59277-89-3	X4HES1O11F	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	An acyclovir topical cream is indicated to treat recurrent herpes labialis in immunocompetent patients 12 years and older. Acyclovir oral tablets, capsules, and suspensions are indicated to treat herpes zoster, genital herpes, and chickenpox. An acyclovir topical ointment is indicated to treat initial genital herpes and limited non-life-threatening mucocutaneous herpes simplex in immunocompromised patients. An acyclovir cream with hydrocortisone is indicated to treat recurrent herpes labialis, and shortening lesion healing time in patients 6 years and older. An acyclovir buccal tablet is indicated for the treatment of recurrent herpes labialis. An acyclovir ophthalmic ointment is indicated to treat acute herpetic keratitis.
Acyl Coenzyme A		9029-97-4					
acylcarnitine		Ademetionine	29908-03-0	7LP2MPO46S			S-Adenosylmethionine (SAMe) is used as a drug in Europe for the treatment of depression, liver disorders, fibromyalgia, and osteoarthritis. It has also been introduced into the United States market as a dietary supplement for the support of bone and joint health, as well as mood and emotional well being.
acylfulvene		Acylfulvene	125392-76-9	G4T2FA57Q6			
acyline		Acyline	170157-13-8	S3439D3B35	Hormone Antagonists	Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)	
Adapalene		Adapalene	106685-40-9	1L4806J2QF	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Adapalene is indicated for the topical treatment of acne vulgaris in patients aged 12 and over. It is also indicated for acne vulgaris in combination with [benzoyl peroxide] and in a triple combination therapy with benzoyl peroxide and [clindamycin].
adavosertib		Adavosertib	955365-80-7	K2T6HJX3I3	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Treatment of malignant endometrial neoplasms, Treatment of pancreatic cancer
ADB-FUBINACA		Adb-fubinaca	1445583-51-6				
adefovir	106941-25-7	Adefovir	106941-25-7	6GQP90I798	Reverse Transcriptase Inhibitors	Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)	
adefovir dipivoxil	142340-99-6	Adefovir Dipivoxil	142340-99-6	U6Q8Z01514	Reverse Transcriptase Inhibitors	Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)	Indicated for the treatment of chronic hepatitis B in adult patients with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease; this is based on histological, virological, biochemical, and serological responses in adult patients with HBeAg+ and HBeAg- chronic hepatitis B with compensated liver function, and in adult patients with clinical evidence of lamivudine-resistant hepatitis B virus with either compensated or decompensated liver function.
adelmidrol		Adelmidrol	1675-66-7	1BUC3685QU			
Adenine	73-24-5	Adenine	73-24-5	JAC85A2161			For nutritional supplementation, also for treating dietary shortage or imbalance
Adenine Nucleotides		Adenine Nucleotides					
adenophostin A	149091-92-9	Adenophostin a	149091-92-9	2S7AR5SVD7	Calcium Channel Agonists	Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in VASCULAR SMOOTH MUSCLE and/or CARDIAC MUSCLE cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture. (See all compounds classified as Calcium Channel Agonists.)	
Adenosine	58-61-7	Adenosine	58-61-7	K72T3FS567	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	Adenosine is indicated as an adjunct to thallium-201 in myocardial perfusion scintigraphy in patients unable to adequately exercise. It is also indicated to convert sinus rhythm of paroxysmal supraventricular tachycardia.
adenosine 3'-phosphate-5'-phosphate		Adenosine-3'-5'-diphosphate	1053-73-2	C65F80D52U			
adenosine 5'-O-(3-thiotriphosphate)	35094-46-3	Phosphothiophosphoric acid-adenylate ester	35094-46-3		Affinity Labels	Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. (See all compounds classified as Affinity Labels.)	
adenosine 5'-pentaphosphate	14535-90-1	Adenosine 5'-pentaphosphate	14535-90-1				
adenosine 5'-tetraphosphate	1062-98-2	Adenosine tetraphosphate	1062-98-2				
Adenosine Diphosphate	58-64-0	Adenosine-5'-diphosphate	58-64-0	61D2G4IYVH			
Adenosine Diphosphate Ribose	20762-30-5	Adenosine diphosphate ribose	20762-30-5				
adenosine diphosphate-ferric chelate		adenosine diphosphate-ferric chelate					
Adenosine Monophosphate	61-19-8	Adenosine Phosphate	61-19-8	415SHH325A			For nutritional supplementation, also for treating dietary shortage or imbalance
Adenosine Triphosphate	56-65-5	Adenosine-5'-triphosphate	56-65-5	8L70Q75FXE			
adenosine-3',5'-cyclic phosphorothioate	23645-17-2	Sp-Camps	23645-17-2		Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
Adenosine-5'-(N-ethylcarboxamide)	35920-39-9	5'-N-Ethylcarboxamidoadenosine	35920-39-9	3WC8SJ5ZLJ	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
adenosine-N(6)-methyl-propylthioether-N-pyridoxamine	125162-97-2	Adenosine-N(6)-methyl-propylthioether-N-pyridoxamine	125162-97-2				
Adenovirus E1 Proteins		Adenovirus E1 Proteins					
Adenovirus E1A Proteins		Adenovirus E1A Proteins					
Adenylate Cyclase Toxin		Adenylate Cyclase Toxin					
Adenylyl Cyclase Inhibitors		Adenylyl Cyclase Inhibitors					
Adenylyl Imidodiphosphate	25612-73-1	Phosphoaminophosphonic acid-adenylate ester	25612-73-1				
adenylyl(3'-5')cytidine-3'-phosphate	2348-33-6	Adenylyl(3'-5')cytidine-3'-phosphate	2348-33-6				
adhumulone	31769-65-0	3,5,6-Trihydroxy-2-(2-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one	31769-65-0				
ADI PEG20		ADI PEG20					
adinazolam	37115-32-5	Adinazolam	37115-32-5	KN08449444	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	For the treatment of anxiety and status epilepticus.
Adipates		Adipates					
adiphenine	64-95-9	Adiphenine	64-95-9	YKG6OR043Q			
adipic acid	124-04-9	Adipic Acid	124-04-9	76A0JE0FKJ			
Adiponectin		Adiponectin					
Adjuvants, Immunologic		Adjuvants, Immunologic					
Ado-Trastuzumab Emtansine		Trastuzumab emtansine [USAN:INN]					
adolapin	79029-92-8	adolapin					
ADP-ribosylarginine		ADP-Ribosylarginine	103960-56-1	D5024CP23U			
Adrenal Cortex Hormones		Adrenal Cortex Hormones					
Adrenergic beta-Antagonists		Adrenergic beta-Antagonists					
adrenic acid	2091-25-0	7,10,13,16-Docosatetraenoic acid	2091-25-0	8BAV9DA2XJ			
Adrenocorticotropic Hormone	9002-60-2	Acthargel	9002-60-2		Hormones	Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. (See all compounds classified as Hormones.)	
adrenocorticotropin zinc	53468-06-7	Adrenocorticotropin zinc	53468-06-7		Hormones	Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. (See all compounds classified as Hormones.)	
adrenosterone	382-45-6	Adrenosterone	382-45-6	AE4E9102GY			
adriamycinol	141434-67-5	7-[(4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-9-(1,2-dihydroxyethyl)-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione	141434-67-5				
adrogolide hydrochloride		Adrogolide hydrochloride	166591-11-3	69MG3OZA0H			
AEE 788		(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine	497839-62-0	F9JLR95I3I			
AEG 35156		AEG 35156					
aegeline		Aegeline	456-12-2	60T59LN3SG			
AEOL 10150		AEOL 10150					
aeroplysinin I	28656-91-9	Aeroplysinin I	28656-91-9				
Aerosols		Aerosols					
Afatinib	850140-72-6	Afatinib	850140-72-6	41UD74L59M	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Afatinib is a kinase inhibitor indicated as monotherapy for the first-line treatment of (a) Epidermal Growth Factor Receptor (EGFR) TKI (tyrosine kinase inhibitor)-naive adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumours have non-resistant EGFR mutations as detected by an FDA-approved test, and (b) adult patients with locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum-based chemotherapy.  Recently, as of January 2018, the US FDA approved a supplemental New Drug Application for Boehringer Ingelheim's Gilotrif (afatinib) for the first line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations as detected by an FDA-approved test. The new label includes data on three additional EGFR mutations: L861Q, G719X and S768I.
AFDX 384	118290-27-0	N-[2-[2-[(dipropylamino)methyl]piperidin-1-yl]ethyl]-6-oxo-5H-pyrido[2,3-b][1,4]benzodiazepine-11-carboxamide	118290-26-9	KFR8EX22KX	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	
afimoxifene	68392-35-8	Afimoxifene	68047-06-3	95K54647BZ	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For the potential treatment of menstrual-cycle related mastalgia, fibrocystic breast disease, breast disease, gynecomastia and Keloid scarring.
aflatoxicol	29611-03-8	Aflatoxicol	29611-03-8	45I1K5482V	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Aflatoxin B1	1162-65-8	Aflatoxin B1	1162-65-8	9N2N2Y55MH	Poisons	Substances which, when ingested, inhaled, or absorbed, or when applied to, injected into, or developed within the body in relatively small amounts may, by their chemical action, cause damage to structure or disturbance of function. (From Dorland, 27th ed) (See all compounds classified as Poisons.)	
aflatoxin B1-2,3-oxide	42583-46-0	2,3-Epoxyaflatoxin B1	42583-46-0		Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
aflatoxin B1-bovine serum albumin		aflatoxin B1-bovine serum albumin					
aflatoxin B1-DNA adduct		aflatoxin B1-DNA adduct					
aflatoxin B2	22040-96-6	Aflatoxin B2 alpha	22040-96-6				
aflatoxin G1	1165-39-5	Aflatoxin G1	1402-68-2				
aflatoxin G2	7241-98-7	Aflatoxin G2	7241-98-7	2MS0D8WA29			
Aflatoxin M1	6795-23-9	Aflatoxin M1	6795-23-9	I3020O28I3	Poisons	Substances which, when ingested, inhaled, or absorbed, or when applied to, injected into, or developed within the body in relatively small amounts may, by their chemical action, cause damage to structure or disturbance of function. (From Dorland, 27th ed) (See all compounds classified as Poisons.)	
aflatoxin Q1	52819-96-2	Aflatoxin Q1	52819-96-2				
aflatoxin-albumin adduct		aflatoxin-albumin adduct					
Aflatoxins		5-(methyloxy)-3,4,7a,10a-tetrahydro-1H,12H-furo[3',2':4,5]furo[2,3-h]pyrano[3,4-c]chromene-1,12-dione					
afloqualone	56287-74-2	Afloqualone	56287-74-2	CO4U2C8ORZ	Muscle Relaxants, Central	A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)	
afromosin	550-79-8	Afrormosin	550-79-8	89P1SB9FYW			
afuresertib		Afuresertib	1047634-63-8	8739X25QI3			
afzelin		Afzelin	482-39-3	5M86W1YH7O			
AG 127	118409-62-4	Tyrphostin AG 126	118409-62-4	7YA4AMD1JC	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
AG 1879		1-tert-butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	172889-27-9	PK8JPC58XB			
AG 2034		L-Glutamic acid, N-((5-(2-((6S)-2-amino-4,6,7,8-tetrahydro-4-oxo-1H-pyrimido(5,4-b)(1,4)thiazin-6-yl)ethyl)-2-thienyl)carbonyl)-	177575-17-6	IC32U30905			
AG 494	139087-53-9	Tyrphostin B48	133550-35-3				
AG 538		Tyrphostin AG 538	133550-18-2	974K3CXM9B			
AG-012986		4-((4-Amino-5-(2,6-difluorobenzoyl)thiazol-2-yl)amino)-N-((R)-2-dimethylamino-1-methylethyl)benzamide	486414-35-1	SPQ325890Y			
AG-041R		2-[(3R)-1-(2,2-diethoxyethyl)-3-[(4-methylphenyl)carbamoylamino]-2-oxoindol-3-yl]-N-(4-methylphenyl)acetamide	159883-95-1				
AG-879		Tyrphostin AG 879	148741-30-4				
AG205		methyl 2-{[(1H-benzimidazol-2-ylsulfanyl)acetyl]amino}-1,3-benzothiazole-6-carboxylate					
agathic acid	640-28-8	Agathic acid	640-28-8				
agathisflavone	28441-98-7	Agathisflavone	28441-98-7				
Ageladine A		Ageladine A	643020-13-7				
Agent Orange	39277-47-9	Agent orange	39277-47-9	KQW750JQE5	Defoliants, Chemical	Herbicides that remove leaves from trees and growing plants. They may be either organic or inorganic. Several of the more persistent types have been used in military operations and many are toxic. (From Hawley&apos;s Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Defoliants, Chemical.)	
Agglutinins		Agglutinins					
Aggrecans		Aggrecans					
AGI-5198		N-cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-methyl-1H-imidazol-1-yl)acetamido)-2-(o-tolyl)acetamide	1355326-35-0				
AGI-6780		N-cyclopropyl-4-(thiophen-3-yl)-3-(3-(3-(trifluoromethyl)phenyl)ureido)benzenesulfonamide	1432660-47-3				
Agkistrodon venoms		Agkistrodon venoms					
aglepristone	124478-60-0	Aglepristone	124478-60-0	0UT4JLE1CM			
Agmatine	306-60-5	Agmatine	306-60-5	70J407ZL5Q			Agmatine is being studied experimentally for several indications such as cardioprotection, diabetes, decreased kidney function, neuroprotection (stroke, severe CNS injuries, epilepsy, glaucoma, and neuropathic pain), and psychiatric conditions (depression, anxiety, schizophrenia, and cognition). As an investigational drug, agamatine is being studied in a non-blinded prospective case study in the United States looking at patients who have been diagnosed with small fiber peripheral neuropathy.
AGN 190299	118292-41-4	Tazarotenic acid	118292-41-4	85FDJ14553			
AGN 193109		4-[2-[5,5-dimethyl-8-(4-methylphenyl)-6H-naphthalen-2-yl]ethynyl]benzoic acid	171746-21-7	ZC6062V1O9			
AGN 194204		2,4-Pentadienoic acid, 3-methyl-5-((1S,2S)-2-methyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)cyclopropyl)-, (2E,4E)-	220619-73-8	877M97Z38Y			
AGN 195183		4-(4-Chloro-3-hydroxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-carboxamido)-2,6-difluorobenzoic acid	367273-07-2	RC87L028HU			Investigated for use/treatment in adverse effects (chemotherapy) and blood (blood forming organ disorders, unspecified).
agomelatine		Agomelatine	138112-76-2	137R1N49AD	Hypnotics and Sedatives	Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)	Agomelatine is indicated to treat major depressive episodes in adults.
agrimoniin	82203-01-8	Agrimoniin					
Agrochemicals		Agrochemicals					
AH 13205	148436-63-9	trans-2-(4-(1-Hydroxyhexyl)phenyl)-5-oxocyclopentaneheptanoic acid	148436-63-9				
AH 23848	81443-73-4	(4Z)-7-[(1S,2S,5R)-5-[([1,1'-biphenyl]-4-yl)methoxy]-2-(morpholin-4-yl)-3-oxocyclopentyl]hept-4-enoic acid	81443-73-4	9NEV21ZEL6	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
AICA ribonucleotide	3031-94-5	AICA ribonucleotide	3031-94-5	F0X88YW0YK	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	
Air Pollutants		Air Pollutants					
Air Pollutants, Occupational		Air Pollutants, Occupational					
Ajmaline	4360-12-7	Ajmaline	4360-12-7	1PON08459R	Voltage-Gated Sodium Channel Blockers	A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)	For use as an antiarrhythmic agent.
ajoene	92285-01-3	Ajoene	92284-99-6	W36UK64JYA	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
ajugasterone C		Ajugasterone C	23044-80-6				
AK-1 compound		AK-1 compound					
AKT activator SC79		AKT activator SC79					
Akt-I-1 compound		N1-(7-cyclobutyl-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-N3,N3,2,2-tetramethylpropane-1,3-diamine	473382-39-7				
Akt-I-1,2 compound		Akt inhibitor VIII	612847-09-3	YX4CPQ6V6X			
AL 8810		(Z)-7-[(1R,2R,3S,5S)-2-[(E,3R)-3-(2,3-dihydro-1H-inden-2-yl)-3-hydroxyprop-1-enyl]-3-fluoro-5-hydroxycyclopentyl]hept-5-enoic acid	246246-19-5	12QE8J6004	Prostaglandin Antagonists	Compounds that inhibit the action of prostaglandins. (See all compounds classified as Prostaglandin Antagonists.)	
AL-10 compound		AL-10 compound					
alachlor	15972-60-8	Alachlor	15972-60-8	24S2S61PXL	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Alamethicin	27061-78-5	Ac-Aib-Pro-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Aib-Glu-Gln-D-Phe-ol	27061-78-5		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Alanine	56-41-7	Alanine	56-41-7	OF5P57N2ZX			Used for protein synthesis.
alantolactone	546-43-0	Alantolactone	546-43-0	M7GSN5Q1M6			
alanyl-4-methoxy-2-naphthylamide		alanyl-4-methoxy-2-naphthylamide					
alanyl-tyrosyl-prolyl-glycyl-lysyl-phenylalanine		alanyl-tyrosyl-prolyl-glycyl-lysyl-phenylalanine					
alanylglutamine	39537-23-0	l-Alanyl-l-glutamine	39537-23-0	U5JDO2770Z			
alanylproline-4-nitroanilide	60189-44-8	Appna	60189-44-8				
alanylpyrrolidine-boronic acid		alanylpyrrolidine-boronic acid					
alaproclate	60719-82-6	Alaproclate	60719-82-6	C4R42570ZO	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	
alatrofloxacin	157605-25-9	Alatrofloxacin mesylate	146961-77-5		Topoisomerase II Inhibitors	Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)	
Albendazole	54965-21-8	Albendazole	54965-21-8	F4216019LN	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	For the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium and for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.
albendazole sulfoxide	54029-12-8	Albendazole oxide	54029-12-8	J39B52TV34	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	
albicanol	54632-04-1	Albicanol	54632-04-1				
albiflorin	39011-90-0	Albiflorin	39011-90-0				
alborixin	57760-36-8	Alborixin	57760-36-8	0I21L1W8NY			
Albumin-Bound Paclitaxel		ABI-007					
Albuterol	18559-94-9	Albuterol	18559-94-9	QF8SVZ843E	Adrenergic beta-2 Receptor Agonists	Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)	Salbutamol is indicated for (i) the symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, reversible obstructive airway disease, and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor, and/or (ii) the acute prophylaxis against exercise-induced bronchospasm and other stimuli known to induce bronchospasm.
alclofenac	22131-79-9	Alclofenac	22131-79-9	M9CP5H21N8	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Alclofenac is indicated in rheumatology, in particular for the treatment of rheumatoid arthritis, ankylosing spondylitis and, as an analgesic, in painful arthritic pathologies.
alclometasone dipropionate		Alclometasone Dipropionate	66734-13-2	S56PQL4N1V	Glucocorticoids	A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)	
Alcohols		64-17-5					
Alcuronium	23214-96-2	Alcuronium	23214-96-2	S8U3J5W06N	Adjuvants, Anesthesia	Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)	
Aldehydes		aldehyde					
Aldicarb	116-06-3	Aldicarb	116-06-3		Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
aldophosphamide		Aldophosphamide	35144-64-0	7AM2ILM9FI			
Aldosterone	52-39-1	Aldosterone	52-39-1	4964P6T9RB			
aldosterone 18-glucuronide	3604-86-2	Aldosterone 18-glucuronide	3604-86-2				
Aldrin	309-00-2	Aldrex	309-00-2	OZE3CLY605	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
alectinib		Alectinib	1256580-46-7	LIJ4CT1Z3Y	Tyrosine Kinase Inhibitors	Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES. (See all compounds classified as Tyrosine Kinase Inhibitors.)	Alectinib is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
Alendronate	66376-36-1	Alendronic Acid	66376-36-1	X1J18R4W8P	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Alendronic acid is indicated for the treatment and prevention of osteoporosis in men and postmenopausal women, treatment of glucocorticoid-induced osteoporosis, and Paget's disease of bone. However, alendronic acid is not indicated for use in pediatric populations or patients with a creatinine clearance <35mL/min.
aleppo tannin		aleppo tannin					
alexidine	22573-93-9	Alexidine	22573-93-9	GVN71CAL3G			
alfacalcidol	41294-56-8	Alfacalcidol	41294-56-8	URQ2517572	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Alfacalcidol is indicated in adult patients with chronic renal failure for the management of hypocalcemia, secondary hyperparathyroidism, or osteodystrophy.  Alfacalcidol is indicated in the management of nutritional and malabsorptive rickets and osteomalacia, vitamin D-dependent rickets and osteomalacia, and hypophosphataemic vitamin D resistant rickets and osteomalacia.
alfatradiol		17alpha-Estradiol	57-91-0	3VQ38D63M7	5-alpha Reductase Inhibitors	Drugs that inhibit 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE. They are commonly used to reduce the production of DIHYDROTESTOSTERONE. (See all compounds classified as 5-alpha Reductase Inhibitors.)	Investigated for use/treatment in alzheimer's disease, neurologic disorders, parkinson's disease, and retinal disorders (unspecified).
Alfentanil	71195-58-9	Alfentanil	71195-58-9	1N74HM2BS7	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	For the management of postoperative pain and the maintenance of general anesthesia.
alfuzosin		Alfuzosin	81403-80-7	90347YTW5F	Adrenergic alpha-1 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)	Alfuzosin is used to treat the signs and symptoms of benign prostatic hyperplasia (BPH).
Alginic Acid		Alginic Acid					
alinidine	33178-86-8	Alinidine	33178-86-8	E7IDJ8DS1D	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
aliskiren		Aliskiren	173334-57-1	502FWN4Q32	Renin Inhibitors	Agents that inhibit the activity of RENIN and cause VASODILATION. (See all compounds classified as Renin Inhibitors.)	Aliskiren is used for the treatment of hypertension in children above 6 years and adults. This drug may also be used in conjunction with antihypertensives such as calcium channel blockers and thiazides in products form to provide additional blood pressure control.
alismol	87827-55-2	Alismol	87827-55-2				
alisol A	19885-10-0	Alisol A	19885-10-0				
alisol A 24-acetate		alisol A 24-acetate					
alisol B	18649-93-9	Alisol B	18649-93-9				
alisol B 23-acetate		alisol B 23-acetate	26575-95-1	72Y3NE3ZV8			
alisol B monoacetate		Alisol B monoacetate	25637-96-1				
alisol C 23-acetate		alisol C 23-acetate	26575-93-9	TF3DV2XK24			
alisol F		alisol F	155521-45-2	YQC8D2QG5Y			
alisol F 24-acetate		Alisol F 24-acetate					
Alitretinoin	5300-03-8	Alitretinoin	5300-03-8	1UA8E65KDZ	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma.
alizapride	59338-93-1	Alizapride	59338-93-1	P55703ZRZY	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	
alizarin	72-48-0	Alizarin	72-48-0	60MEW57T9G			
alizarin 1-methyl ether	6170-06-5	Alizarin 1-methyl ether	6170-06-5				
Alizarin Red S	83-61-4	3,4-Dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid	83-61-4	9A6LXA99ML			
Alkalies		Alkalies					
Alkaloids		Alkaloids					
Alkanes		Alkanes					
alkannin	23444-65-7	Alkannin	517-88-4	075CRZ9995			
Alkylating Agents		Alkylating Agents					
Allantoin	97-59-6	Allantoin	97-59-6	344S277G0Z	Dermatologic Agents	Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)	Allantoin is commonly applied in a variety of topical vehicles or applications such as cosmetic creams, toothpastes, mouthwashes, shampoos, lipsticks, anti-acne products, and lotions for the purpose of moisturizing skin, enhancing the smoothness of skin, stimulating the healing of wounds, and soothing irritated skin.
Allergens		Allergens					
allergovit		allergovit					
Allethrins		Allethrin	28434-00-6	0X03II877M	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
allicin	539-86-6	Allicin	539-86-6	3C39BY17Y6	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
alliin		3-(Allylsulphinyl)-L-alanine	17795-26-5		Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	
allocryptopine	485-91-6	Allocryptopine	24240-04-8	EK27J8ROYB			
alloin	8015-61-0	Barbaloin	8015-61-0		Cathartics	Agents that are used to stimulate evacuation of the bowels. (See all compounds classified as Cathartics.)	
allopregnan-20 alpha-ol-3-one	516-59-6	Allopregnan-20alpha-ol-3-one	516-59-6	K215Y6L2TC			
allopregnane-3,20-diol	4479-11-2	Allopregnane-3,20-diol	4479-11-2				
Allopurinol	315-30-0	Allopurinol	315-30-0	63CZ7GJN5I	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	Allopurinol is indicated in:  1) the management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy).  2) the management of patients with leukemia, lymphoma and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Treatment with allopurinol should be discontinued when the potential for overproduction of uric acid is no longer present.  3) the management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.
allosamidin	103782-08-7	Allosamidin	103782-08-7	5UDJ46528K	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
allose	6038-51-3	D-Allose	2595-97-3	SV1ATP0KYY			
Alloxan	50-71-5	Alloxan	50-71-5	6SW5YHA5NG			
Alloys		Alloys					
Allura Red AC Dye	25956-17-6	Allura Red AC	25956-17-6	WZB9127XOA	Food Coloring Agents	Natural or synthetic dyes used as coloring agents in processed foods. (See all compounds classified as Food Coloring Agents.)	
allyl 2,4,6-tribromophenyl ether		Allyl 2,4,6-tribromophenyl ether	3278-89-5	2QB5393K07			
allyl alcohol	107-18-6	Allyl alcohol	107-18-6	3W678R12M0			
allyl chloride	107-05-1	Allyl chloride	107-05-1	V2RFT0R50S			
Allyl Compounds		Allyl Compounds					
allyl cyanide	109-75-1	3-Butenenitrile	109-75-1	527U1WJJ18			
allyl formate	1838-59-1	Allyl formate	1838-59-1	A9WY6Q0U9C			
allyl isothiocyanate	57-06-7	Allyl isothiocyanate	57-06-7	BN34FX42G3	Food Preservatives	Substances capable of inhibiting, retarding or arresting the process of fermentation, acidification or other deterioration of foods. (See all compounds classified as Food Preservatives.)	
allyl methyl disulfide	2179-58-0	Allyl methyl disulfide	2179-58-0	OXW45UTR7B			
allyl methyl sulfide	10152-76-8	Allyl methyl sulfide	10152-76-8	V7QI1R316C			
allyl sulfide	592-88-1	Diallyl sulfide	592-88-1	60G7CF7CWZ	Cytochrome P-450 Enzyme Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES. (See all compounds classified as Cytochrome P-450 Enzyme Inhibitors.)	
Allylamine	107-11-9	Allylamine	107-11-9	48G762T011			
allylbenzene	300-57-2	Allylbenzene	300-57-2	3VT7C9MEQ9			
Allylestrenol	432-60-0	Allylestrenol	432-60-0	I47VB5DZ8O	Progestins	Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. (See all compounds classified as Progestins.)	Allylestrenol was designed to be used for miscarriage prevention, prevention of premature labour and has been investigated for possible use in men for treatment for benign prostatic hyperplasia.
Allylglycine	1069-48-3	DL-Allylglycine	7685-44-1		GABA Antagonists	Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS. (See all compounds classified as GABA Antagonists.)	
Allylisopropylacetamide	299-78-5	Allylisopropylacetamide	299-78-5	ZOF4719QS5			
allylpyrocatechol		Allylpyrocatechol	1125-74-2				
allysine	1962-83-0	2-Amino-6-oxohexanoic acid	1962-83-0				
almond oil		Almond Oil					
almotriptan	154323-57-6	Almotriptan	154323-57-6	1O4XL5SN61	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	For the treatment of acute migraine headache in adults
alniditan	155428-00-5	Alniditan dihydrochloride	155428-00-5	54PE58MGKB			
aloe emodin		Aloe emodin	481-72-1	C8IYT9CR7C			
Aloe vera gel		8001-97-6					
alogliptin		Alogliptin	850649-61-5	JHC049LO86	Dipeptidyl-Peptidase IV Inhibitors	Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release. (See all compounds classified as Dipeptidyl-Peptidase IV Inhibitors.)	Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
aloperine	56293-29-9	Aloperine	56293-29-9				
alopestatin		alopestatin					
alosetron	122852-42-0	Alosetron	122852-42-0	13Z9HTH115	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	Only for the treatment of symptoms of severe diarrhea-predominant irritable bowel syndrome (IBS) in women with chronic symptoms (generally lasting greater than 6 months) who does not present with anatomic or biochemical GI abnormalities and have not responded to conventional therapy.
aloxistatin	88321-09-9	Aloxistatin	88321-09-9	L5W337AOUR	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
alpha 1-Antitrypsin		Alpha-1-proteinase inhibitor					
alpha helical corticotropin-releasing hormone		alpha helical corticotropin-releasing hormone					
alpha phellandrene	99-83-2	alpha-PHELLANDRENE	4221-98-1	49JV13XE39			
alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol	105565-56-8	alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol	105565-56-8	A5NB5G07JO	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	
alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone		alpha-(4-Pyridyl-1-oxide)-N-tert-butylnitrone	66893-81-0	2140SM8Q5O			
Alpha-Amanitin		alpha-Amanitin	23109-05-9		Nucleic Acid Synthesis Inhibitors	Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)	
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	77521-29-0	alpha-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID	77521-29-0	J090588E6X	Excitatory Amino Acid Agonists	Drugs that bind to and activate excitatory amino acid receptors. (See all compounds classified as Excitatory Amino Acid Agonists.)	
alpha-amino-3-hydroxy-5-tert-butyl-4-isoxazolepropionate	140158-50-5	2-Amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl)propionic acid	140158-50-5				
alpha-amyrin		alpha-Amyrin	638-95-9	30ZAG40J8N			
alpha-benzoylamino-1,4-naphthoquinone		alpha-benzoylamino-1,4-naphthoquinone					
alpha-benzyl-N-methylphenethylamine	53660-20-1	alpha-Benzyl-N-methylphenethylamine	53660-20-1				
alpha-boswellic acid		alpha-Boswellic acid	471-66-9				
alpha-carotene	432-70-2	all-trans-alpha-Carotene	432-70-2				
alpha-chaconine	20562-03-2	alpha-Chaconine	20562-03-2	5QOL0LIM81			
alpha-Chlorohydrin	96-24-2	3-Chloro-1,2-propanediol	96-24-2	QGS78A3T6P	Chemosterilants	Compounds that cause reproductive sterility in organisms. They are sometimes used to control pest populations by sterilizing males within the population. (See all compounds classified as Chemosterilants.)	
alpha-cobratoxin	69344-74-7	alpha-Cobratoxin					
alpha-conotoxin ImI	156467-85-5	alpha-Conotoxin imi	156467-85-5				
alpha-conotoxin MII		Alpha-Conotoxin MII					
alpha-conotoxin PnIA		alpha-conotoxin PnIA	705300-84-1				
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide		Tyrphostin B42	133550-30-8	C4UD8F8XJY	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
alpha-cyano-4-hydroxycinnamate	28166-41-8	alpha-Cyano-4-hydroxycinnamic acid	122520-77-8				
alpha-damascone		alpha-Damascone	24720-09-0	MDD00FOW8J			
alpha-farnesene	502-61-4	Alpha-Farnesene	502-61-4	7E1785CZ0H			
alpha-Fetoproteins		alpha-Fetoproteins					
alpha-fluoromethylhistamine	69672-40-8	(S)-1-Fluoro-3-(1H-imidazol-4-yl)propan-2-amine	69672-40-8				
alpha-fluoromethylhistidine	70050-43-0	alpha-Monofluoromethylhistidine	70050-43-0	5PI41O6ETI	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	
alpha-galactosylceramide		alpha-GalCer	158021-47-7	WX671898JF	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
alpha-glycerophosphoric acid	57-03-4	Glycerophosphoric acid	57-03-4	9NTI6P3O4X			
alpha-hexachlorocyclohexane	319-84-6	Hexachlorocyclohexane	319-86-8	IVM9A2N49K			Used as a pancreatic enzyme replacement in pancreatic insufficiency.  It is intended to mimic naturally produced human pepsin.  Pepsin powder is prepared from the gastric mucosa of pigs, cattle or sheep. In the laboratory, it is primarily used for the unspecific hydrolysis of proteins and peptides in acidic media. In addition, it provides limited hydrolysis of native immunoglobulins, yielding biologically active fragments.  In certain supplements, pepsin may be combined with betaine and HCl (hydrochloric acid) to aid in digestion in various gastrointestinal conditions,.
alpha-hydroxy-gamma-methylmercaptobutyric acid	583-91-5	2-Hydroxy-4-(methylthio)butyric acid	583-91-5	Z94465H1Y7			
alpha-hydroxyalprazolam	37115-43-8	alpha-Hydroxyalprazolam	37115-43-8	V7J2Z5Y50U			
alpha-hydroxybenzoylglycine	16555-77-4	alpha-Hydroxyhippuric acid	16555-77-4				
alpha-hydroxyglutarate	2889-31-8	2-Hydroxyglutaric acid	2889-31-8	RS4M3UYS95			
alpha-hydroxyisocaproic acid	498-36-2	2-Hydroxy-4-methylvaleric acid	498-36-2	8RN4NSX3TY			
alpha-ionone	6901-97-9	alpha-IONONE	127-41-3	I9V075M61R			
alpha-iso-cubebenol		alpha-iso-cubebenol					
alpha-isomethylionone	127-51-5	3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one	127-51-5	9XP4LC555B			
alpha-keto-beta-methylvaleric acid	1460-34-0	3-Methyl-2-oxovaleric acid	1460-34-0	787T50HCIV			
alpha-ketoadipic acid	3184-35-8	2-Oxoadipic acid	3184-35-8	BB72FKL1M2			
alpha-ketobutyric acid	600-18-0	2-Oxobutanoic acid	600-18-0	B92RB6HY1A			
alpha-ketoisocaproic acid	816-66-0	4-Methyl-2-oxopentanoic acid	816-66-0	4GUJ8AH400			
alpha-ketoisovalerate	759-05-7	3-Methyl-2-oxobutanoic acid	759-05-7	34P71D50E0			
alpha-latrotoxin	65988-34-3	alpha-Latrotoxin					
alpha-Linolenic Acid	463-40-1	Linolenic Acid	463-40-1	0RBV727H71			For nutritional supplementation and for treating dietary shortage or imbalance.
alpha-methyl-3,4-methylene-dioxyhydrocinnamic aldehyde		Helional	1205-17-0	L65EG8H6PA			
alpha-methyl-4-carboxyphenylglycine	146669-29-6	alpha-Methyl-4-carboxyphenylglycine	146669-29-6	7HJ67IIE31	Excitatory Amino Acid Antagonists	Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)	
alpha-methylbenzylaminobenzotriazole	105026-61-7	alpha-Methylbenzylaminobenzotriazole	105026-61-7				
alpha-methylcinnamic acid		alpha-Methylcinnamic acid	1199-77-5	52D2H37MVU			
alpha-methyldopamine	555-64-6	alpha-Methyldopamine	555-64-6	XQ9A7WCY2L			
alpha-methylepinine	15398-87-5	3,4-Dihydroxymethamphetamine	15398-87-5	VFV03WN1VN			
alpha-methylhistamine	6986-90-9	alpha-Methylhistamine	6986-90-9		Histamine Agonists	Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. (See all compounds classified as Histamine Agonists.)	
alpha-methylserotonin	22965-81-7	1H-Indol-5-ol, 3-(2-amino-1-methylethyl)-	22965-81-7	65WGJ98AVS	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	
alpha-methylstyrol	98-83-9	alpha-Methylstyrene	98-83-9	D46R9753IK			
alpha-MSH	581-05-5	Intermedine	581-05-5	OVF025LA77	Hormones	Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. (See all compounds classified as Hormones.)	
alpha-naphthoflavone	604-59-1	alpha-Naphthoflavone	604-59-1	FML65D8PY5			
alpha-naphthyl acetate	830-81-9	1-Naphthyl acetate	830-81-9				
alpha-naphthyl isocyanate	86-84-0	1-Naphthyl isocyanate	30135-65-0	5LH2P0691E			
alpha-naphthyl thiourea	86-88-4	1-(1-Naphthyl)-2-thiourea	86-88-4	UKY0H6XJ4J	Rodenticides	Substances used to destroy or inhibit the action of rats, mice, or other rodents. (See all compounds classified as Rodenticides.)	
alpha-neoendorphin	69671-17-6	alpha-Neoendorphin	69671-17-6				
alpha-nicotyrine	487-19-4	Nicotyrine	487-19-4	XN4R1LH79Y			
alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol	101910-24-1	alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol	101910-24-1	WNW5RYD8MG	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
alpha-phenyl-1-(2-phenylethyl)-4-piperidinemethanol	107703-78-6	Glemanserin	107703-78-6	X96LS7MC5Z			
alpha-pinene	80-56-8	alpha-PINENE	25766-18-1	JPF3YI7O34			
alpha-pyrrolidinononanophenone		alpha-Pyrrolidinononanophenone	13415-58-2	S3FKL8RY1D			Investigated for use/treatment in actinic keratosis, breast cancer, liver cancer, melanoma, psoriasis and psoriatic disorders, and solid tumors.
alpha-pyrrolidinovalerophenone		alpha-Pyrrolidinovalerophenone	14530-33-7	767K3AWA4R			
alpha-resorcylic acid	99-10-5	3,5-Dihydroxybenzoic acid	99-10-5	2WC5LMO6L1			
alpha-solamargine	20318-30-3	alpha-Solamarine	20318-30-3	5YG8GM566A			
alpha-solanine		alpha-Solanine	20562-02-1				
alpha-terpineol	98-55-5	Alpha-Terpineol	8000-41-7	21334LVV8W			
alpha-terthienyl	1081-34-1	2,2':5',2''-Terthiophene	1081-34-1	0P77RAU2RR	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
alpha-terthienylmethanol		alpha-Terthienylmethanol	13059-93-3				
alpha-Tocopherol	59-02-9	Alpha-Tocopherol	59-02-9	H4N855PNZ1	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	Vitamin E supplementation is indicated for treatment of vitamin E deficiency which can occur in cystic fibrosis, cholestasis and severe liver disease, abetalipoproteinemia or simply poor diet.
alpha-viniferin	62218-13-7	alpha-Viniferin	62218-13-7	53XER6FHLX			
alpha,alpha-dimethoxytoluene	1125-88-8	Benzaldehyde dimethyl acetal	1125-88-8	W6T83K35CA			
alpha,beta-methyleneadenosine 5'-diphosphate		Phosphomethylphosphonic acid adenosyl ester	3768-14-7	0T2A5439OE	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
alpha,beta-methyleneadenosine 5'-triphosphate	7292-42-4	Diphosphomethylphosphonic acid adenosyl ester	7292-42-4	NYX13NT29D	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
alphaxalone	23930-19-0	Alfaxalone	23930-19-0	BD07M97B2A	Anesthetics	Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)	
alpidem	82626-01-5	Alpidem	82626-01-5	I93SC245QZ	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	
alpinetin		Alpinetin	36052-37-6	SX3EL59QD8			
Alpinia oxyphylla fruit extract		Alpinia oxyphylla fruit extract					
alpinumisoflavone	34086-50-5	Alpinumisoflavone	34086-50-5	6Q33HOF94Z			
Alprazolam	28981-97-7	Alprazolam	28981-97-7	YU55MQ3IZY	GABA Modulators	Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)	Alprazolam is indicated for the acute treatment of generalized anxiety disorder in adults. Alprazolam is also indicated, either as a standard or extended-release formulation, for the treatment of panic disorder with or without agoraphobia in adults.  Alprazolam may also be prescribed off-label for insomnia, premenstrual syndrome, and depression.
Alprenolol	13655-52-2	Alprenolol	13655-52-2	877K5MQ27W	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the treatment of hypertension, angina, and arrhythmia
Alprostadil	745-65-3	Alprostadil	745-65-3	F5TD010360	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	Alprostadil is indicated for palliative, not definitive, therapy to temporarily maintain the patency of the ductus arteriosus until corrective or palliative surgery can be performed in neonates who have congenital heart defects and who depend upon the patent ductus for survival. It is also indicated for the treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic, or mixed etiology, and as an adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.
alrestatin	51411-04-2	Alrestatin	51411-04-2	515DHK15LG	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	
alsterpaullone		Alsterpaullone	237430-03-4				
altenusin	31186-12-6	Altenusin	31186-12-6	WM31322YA1			
alternaramide		Alternaramide					
alternariol	641-38-3	Alternariol	641-38-3	KN9L4260JW	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
alternariol monomethyl ether		Alternariol monomethyl ether	23452-05-3	Y79STA800H			
alterperylenol		Alteichin	88899-62-1	GRK18WHV7F			
altertoxin I	56258-32-3	Altertoxin I	56258-32-3				
altertoxin II	56257-59-1	Altertoxin II	56257-59-1				
Altretamine	645-05-6	Altretamine	645-05-6	Q8BIH59O7H	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	For use as a single agent in the palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent-based combination.
Alum Compounds		Alum Compounds					
Aluminum	7429-90-5	Aluminum	7429-90-5	CPD4NFA903			
aluminum acetate		Aluminum Acetate	139-12-8	80EHD8I43D			
aluminum ammonium sulfate	7784-25-0	Aluminum ammonium sulfate	7784-25-0	DPU64XYB1D			
aluminum chlorhydrate	12042-91-0	Aluminum chlorohydrate [USAN]					
Aluminum Chloride		Aluminum Chloride	7446-70-0	LIF1N9568Y	Antiperspirants	Agents that are put on the SKIN to reduce SWEATING or prevent excess sweating (HYPERHIDROSIS). (See all compounds classified as Antiperspirants.)	- Indicated for the control of minor hemorrhage during dental restorative procedures. - Indicated to reduce underarm perspiration.
aluminum citrate	31142-56-0	Aluminum citrate	813-92-3	IJ623779BA			
Aluminum Compounds		Aluminum compounds					
aluminum fluoride	7784-18-1	Aluminum fluoride	7784-18-1	Z77H3IKW94			
Aluminum Hydroxide	21645-51-2	Aluminum Hydroxide	21645-51-2	5QB0T2IUN0	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	For relief of heartburn and acid indigestion.
aluminum lactate	99874-23-4	2-Hydroxypropanoic acid aluminium salt	18917-91-4	V797H4GG0Z			
aluminum maltolate	23058-19-7	Aluminum maltolate	103616-17-7				
aluminum nitrate	13473-90-0	Aluminum nitrate	13473-90-0	HUO854648Y			
Aluminum Oxide	1344-28-1	Aluminum Oxide	1344-28-1	LMI26O6933			
aluminum oxide hydroxide	63957-70-0	Versal 150	1318-23-6	NZO8Q0FP2E			
aluminum phosphate	13765-93-0	2,4,5-Trioxa-1lambda5-phospha-3-aluminabicyclo[1.1.1]pentane 1-oxide					
aluminum phosphide	20859-73-8	Aluminum phosphide	20859-73-8		Pesticides	Chemicals used to destroy pests of any sort. The concept includes fungicides (FUNGICIDES, INDUSTRIAL); INSECTICIDES; RODENTICIDES; etc. (See all compounds classified as Pesticides.)	
Aluminum Silicates		Aluminum Silicates					
aluminum sulfate	10043-01-3	Aluminum Sulfate	10043-01-3	I7T908772F	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	Solutions containing 5 to 10% aluminum sulfate have been used as local applications to ulcers and to arrest foul discharges from mucous surfaces. Aluminum sulfate is also used in the preparation of aluminum acetate ear drops.  It is often purchased over the counter and is available in solid stick or powder form for minor cuts and abrasions after shaving,. Aluminum sulfate is also used as an adjuvant in vaccines.
alverine	150-59-4	Alverine	150-59-4	46TIR1560O	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	Used to relieve cramps or spasms of the stomach and intestines. It is also useful in treating irritable bowel syndrome (IBS) and similar conditions. It can also be used to help relieve period pain. Alverine citrate is also under investigation to increase the cytotoxic effects of the proteasome inhibitor MG132 on breast cancer cells.
alvimopan		Alvimopan	156053-89-3	Q153V49P3Z	Gastrointestinal Agents	Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)	Used to accelerate the time to upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis. Also investigated for use in the treatment of pain (acute or chronic).
alvocidib		Alvocidib	146426-40-6	45AD6X575G	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Investigated for use/treatment in esophageal cancer, leukemia (lymphoid), lung cancer, liver cancer, and lymphoma (unspecified).
alyssin		Alyssin	646-23-1	0929AF184M			
AM 1241		(2-iodo-5-nitrophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)methanone	444912-48-5	DLM851L3RD			
AM 251		1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide	183232-66-8	3I4FA44MAI			
AM 281		1-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-4-morpholinyl-1H-pyrazole-3-carboxamide	202463-68-1	SBP4A4DYH2			
AM 3506		AM 3506					
Am 580	102121-60-8	4-{[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid	102121-60-8	VZ5S5G9ZFZ	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
AM 6527		AM 6527					
AM 694		1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole	335161-03-0	6RK7KN7L1O	Cannabinoid Receptor Agonists	Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)	
AM11542		(6aR,10aR)-3-(8-bromo-2-methyloctan-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol		QJ6GC7UX8D			
AM4113		5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide	614726-85-1	BBW5X7964A			
AM6538		4-[4-[2-(2,4-Dichlorophenyl)-4-methyl-5-(piperidin-1-ylcarbamoyl)pyrazol-3-yl]phenyl]but-3-ynyl nitrate					
AM6545		5-[4-(4-Cyanobut-1-yn-1-yl)phenyl]-1-(2,4-dichlorophenyl)-N-(1,1-dioxo-1lambda~6~,4-thiazinan-4-yl)-4-methyl-1H-pyrazole-3-carboxamide	1245626-05-4				
Amantadine	768-94-5	Amantadine	768-94-5	BF4C9Z1J53	Dopamine Agents	Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. (See all compounds classified as Dopamine Agents.)	For the chemoprophylaxis, prophylaxis, and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Also for the treatment of parkinsonism and drug-induced extrapyramidal reactions.
Amaranth Dye	915-67-3	Amaranth	915-67-3	37RBV3X49K	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
amarogentin	21018-84-8	Amarogentin	21018-84-8	5L82GT5I0W			
amastatin	67655-94-1	Amastatin	67655-94-1		Protease Inhibitors	Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)	
Amb a I protein, Ambrosia artemisiifolia		Amb a I protein, Ambrosia artemisiifolia					
Ambenonium Chloride	115-79-7	Ambenonium Chloride	115-79-7	51FOB87G3I	Parasympathomimetics	Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. (See all compounds classified as Parasympathomimetics.)	
ambrisentan		Ambrisentan	177036-94-1	HW6NV07QEC	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	Ambrisentan is indicated for treatment of idiopathic (primary) pulmonary arterial hypertension (IPAH) and pulmonary arterial hypertension (PAH) associated with connective tissue disease in patients with WHO functional class II or III symptoms. In the United States of America, ambrisentan is also indicated in combination with tadalafil to reduce the risks of disease progression and hospitalization for worsening PAH, and to improve exercise ability.
Ambroxol	18683-91-5	Ambroxol	18683-91-5	QH6ZT6J071	Expectorants	Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here. (See all compounds classified as Expectorants.)	
AMD 6221		AMD 6221					
amentoflavone	1617-53-4	Amentoflavone	1617-53-4	9I1VC79L77	Cytochrome P-450 CYP3A Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A. (See all compounds classified as Cytochrome P-450 CYP3A Inhibitors.)	
ametryne	834-12-8	Ametryn	834-12-8	1SPQ95183Y	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
amfonelic acid	15180-02-6	Amfonelic acid	15180-02-6	RR302AR19Y			
AMG 009		Amg-009	1027847-67-1	83262TRK3S			
AMG 221		4(5H)-Thiazolone, 2-((1S,2S,4R)-bicyclo(2.2.1)hept-2-ylamino)-5-methyl-5-(1-methylethyl)-, (5S)-	1095565-81-3	2T929W7AG8			
AMG-837		(S)-3-(4-((4'-(Trifluoromethyl)-[1,1'-biphenyl]-3-yl)methoxy)phenyl)hex-4-ynoic acid	865231-46-5	NE6U6R66U4			
amibegron	121524-09-2	Amibegron hydrochloride	121524-09-2	N910CJ679E	Adrenergic beta-3 Receptor Agonists	Compounds that bind to and activate ADRENERGIC BETA-3 RECEPTORS. (See all compounds classified as Adrenergic beta-3 Receptor Agonists.)	
Amides		Amides					
Amidines		Amidines					
Amifostine	20537-88-6	Amifostine	20537-88-6	ILA426L95O	Radiation-Protective Agents	Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)	For reduction in the cumulative renal toxicity in patients with ovarian cancer (using cisplatin) and moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer.
amifuraline		Amifuraline					
Amikacin	37517-28-5	Amikacin	37517-28-5	84319SGC3C	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	The amikacin sulfate injection is indicated in the short-term treatment of serious bacterial infections due to susceptible strains of gram-negative bacteria, including Pseudomonas species, Escherichia coli, species of indole-positive and indole-negative Proteus, Providencia species, Klebsiella-Enterobacter-Serratia species, as well as Acinetobacter (Mima-Herellea) species.  Clinical studies have shown amikacin sulfate injection to be effective in bacterial septicemia (including neonatal sepsis); in serious infections of the respiratory tract, bones and joints, central nervous system (including meningitis) and skin and soft tissue; intra-abdominal infections (including peritonitis); and in burns and postoperative infections (including post-vascular surgery).  Clinical studies have shown amikacin also to be effective in serious, complicated, and recurrent urinary tract infections due to the above organisms. Aminoglycosides, including amikacin, are not indicated in uncomplicated first-time episodes of urinary tract infections unless the causative organisms are not susceptible to antibiotics which are less toxic.  In September 2018, a new indication with a new dosage route was approved for this drug. Amikacin liposome inhalation suspension was approved for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex (MAC) in a limited population of patients with the disease who do not respond to conventional treatment (refractory disease). This indication is approved under accelerated approval based on achieving sputum culture conversion (defined as 3 consecutive negative monthly sputum cultures) by Month 6 of treatment. Clinical benefit has not yet been established.  **Important notes regarding Staphylococcus and Sensitivity testing:**  Staphylococcus aureus, including methicillin-resistant strains, is the principal Gram-positive organism sensitive to amikacin. The use of amikacin in the treatment of staphylococcal infections should be restricted only to second-line therapy, and should be limited to only those patients suffering from severe infections caused by susceptible strains of staphylococcus species who have failed to show sensitivity to other available antibiotics.  Bacteriologic studies should be performed to identify causative organisms and their susceptibilities to amikacin. Amikacin may be used as initial therapy in suspected gram-negative infections and therapy may be initiated before obtaining the results of susceptibility testing.
Amiloride	2609-46-3	Amiloride	2609-46-3	7DZO8EB0Z3	Acid Sensing Ion Channel Blockers	A subclass of sodium channel blockers that are specific for ACID-SENSING SODIUM CHANNELS. (See all compounds classified as Acid Sensing Ion Channel Blockers.)	For use as adjunctive treatment with thiazide diuretics or other kaliuretic-diuretic agents in congestive heart failure or hypertension.
Aminacrine	90-45-9	9-Aminoacridine	90-45-9	78OY3Z0P7Z	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
Amines		Amines					
Amino Acids		Amino acid					
Amino Acids, Peptides, and Proteins		Amino Acids, Peptides, and Proteins					
aminoacetone	298-08-8	Aminoacetone	298-08-8	ZB4ES38S4R			
Aminoacetonitrile	540-61-4	Aminoacetonitrile	540-61-4	3739OQ10IJ			
Aminobenzoates		Aminobenzoates					
Aminobiphenyl Compounds		Aminobiphenyl Compounds					
Aminocaproic Acid	60-32-2	Aminocaproic acid	60-32-2	U6F3787206	Antifibrinolytic Agents	Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders. (See all compounds classified as Antifibrinolytic Agents.)	For use in the treatment of excessive postoperative bleeding.
aminocarb	2032-59-9	Aminocarb	2032-59-9	767M03K32Y	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
aminochrome 1	39984-17-3	Dopaminechrome	39984-17-3				
aminoflavone		5-amino-2-(4-amino-3-fluorophenyl)-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one	165179-35-1	2EXS38428U			
Aminoglutethimide	125-84-8	Aminoglutethimide	125-84-8	0O54ZQ14I9	Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	For the suppression of adrenal function in selected patients with Cushing's syndrome, malignant neoplasm of the female breast, and carcinoma in situ of the breast.
Aminoglycosides		Aminoglycosides					
Aminoimidazole Carboxamide	360-97-4	5-Aminoimidazole-4-carboxamide	360-97-4	3V0Y2PDE6K			Investigated for use/treatment in allergic rhinitis and pediatric indications.
aminoindanol		Aminoindanol	74165-73-4				
Aminoisobutyric Acids		Aminoisobutyric Acids					
Aminolevulinic Acid	106-60-5	Aminolevulinic Acid	106-60-5	88755TAZ87	Photosensitizing Agents	Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)	As a topical gel, aminolevulinic acid (ALA) is indicated for lesion-directed and field-directed treatment of actinic keratoses (AKs) of mild-to-moderate severity on the face and scalp in combination with photodynamic therapy (PDT) using BF-RhodoLED lamp, a narrowband, red light illumination source. As a topical solution, ALA can also be used for the same indication mentioned previously in addition to AKs of the upper extremities, but in conjunction with blue light illumination using the BLU-U Blue Light Photodynamic Therapy Illuminator. Finally, ALA is also available as an oral solution to be used as an adjunct for the visualization of glioma during surgery.
aminomalonic acid	1068-84-4	Aminomalonic acid	1068-84-4				
aminomethylphosphonic acid (AMPA)		(Aminomethyl)phosphonic acid	1066-51-9	90825O5C1U			
Aminooxyacetic Acid	645-88-5	Aminooxyacetic acid	645-88-5	14I68GI3OQ	GABA Agents	Substances used for their pharmacological actions on GABAergic systems. GABAergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as GABA Agents.)	
aminophenyl fluorescein		aminophenyl fluorescein					
Aminophylline	317-34-0	Aminophylline	317-34-0	27Y3KJK423	Bronchodilator Agents	Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)	For the treatment of bronchospasm due to asthma, emphysema and chronic bronchitis.
aminopotentidine	140873-27-4	Aminopotentidine oxalate	140873-27-4				
Aminopropionitrile	151-18-8	3-Aminopropanenitrile	151-18-8	38D5LJ4KH2			
Aminopterin	54-62-6	Aminopterin	54-62-6	JYB41CTM2Q	Folic Acid Antagonists	Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Folic Acid Antagonists.)	Prior to its withdrawal, aminopterin was initially used in the treatment of childhood leukemia; specifically to induce remissions. Later, aminopterin was used off-label in the United States to treat psoriasis, yielding dramatic lesion clearing. Aminopterin was later supplanted by methotrexate for treating cancer because of its better therapeutic index. Aminopterin (as well as methotrexate) has also been explored for use as an abortifacient. However, their association with severe congenital malformations and teratogenic effects have become known as fetal aminopterin syndrome.
Aminopyrine	58-15-1	Aminopyrine	58-15-1	01704YP3MO			Formerly widely used as an antipyretic and analgesic in rheumatism, neuritis, and common colds. Currently used to measure total body water.
Aminoquinolines		Aminoquinolines					
Aminorex	2207-50-3	Aminorex	2207-50-3	2SH16612I9			
Aminosalicylic Acid	65-49-6	4-Aminosalicylic acid	65-49-6	5B2658E0N2	Antitubercular Agents	Drugs used in the treatment of tuberculosis. They are divided into two main classes: &quot;first-line&quot; agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and &quot;second-line&quot; drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. (See all compounds classified as Antitubercular Agents.)	For the treatment of tuberculosis
Aminosalicylic Acids		Aminosalicylic Acids					
Amiodarone	1951-25-3	Amiodarone	1951-25-3	N3RQ532IUT	Cytochrome P-450 CYP2C9 Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C9. (See all compounds classified as Cytochrome P-450 CYP2C9 Inhibitors.)	The FDA approved indications for amiodarone are recurrent ventricular fibrillation (VF) and recurrent hemodynamically unstable ventricular tachycardia (VT). The FDA emphasizes that this drug should only be given in these conditions when they are clinically documented and have not responded to normal therapeutic doses of other antiarrhythmic agents, or when other drugs are not tolerated by the patient.  Off-label indications include atrial fibrillation and supraventricular tachycardia.
amiprophos methyl	36001-88-4	Amiprofos-methyl	36001-88-4	D130E8V1ON			
amiridine	62732-44-9	Ipidacrine	62732-44-9	CV71VTP0VN			
Amisulpride		Amisulpride	71675-85-9	8110R61I4U	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	Intravenous amisulpride is indicated in adults for the prevention of postoperative nausea and vomiting, either alone or in combination with an antiemetic of a different class. It is also indicated for the treatment of postoperative nausea and vomiting in patients who have received anti-emetic prophylaxis with an agent of a different class or have not received prophylaxis.  Oral amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, characterized by positive symptoms with delusions, hallucinations, thought disorders, hostility and suspicious behavior; or primarily negative symptoms (deficit syndrome) with blunted affect, emotional and social withdrawal. Amisulpride also controls secondary negative symptoms in productive conditions as well as affective disorders such as depressive mood or retardation.
amitraz	33089-61-1	Amitraz	33089-61-1		Insect Repellents	Substances causing insects to turn away from them or reject them as food. (See all compounds classified as Insect Repellents.)	
Amitriptyline	50-48-6	Amitriptyline	50-48-6	1806D8D52K	Analgesics, Non-Narcotic	A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)	This drug in indicated for the following conditions:  Major depressive disorder in adults  Management of neuropathic pain in adults  Prophylactic treatment of chronic tension-type headache (CTTH) in adults  Prophylactic treatment of migraine in adults  Treatment of nocturnal enuresis in children aged 6 years and above when organic pathology, including spina bifida and related disorders, have been excluded and no response has been achieved to all other non-drug and drug treatments, including antispasmodics and vasopressin-related products. This product should only be prescribed by a healthcare professional with expertise in the management of persistent enuresis  Off-label uses: irritable bowel syndrome, sleep disorders, diabetic neuropathy, agitation, fibromyalgia, and insomnia
amitriptyline N-oxide	4317-14-0	Amitriptylinoxide	4317-14-0	TYR2U59WMA			
Amitrole	61-82-5	Amitrole	61-82-5	ZF80H5GXUF	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
amlexanox		Amlexanox	68302-57-8	BRL1C2459K	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	Used as a paste in the mouth to treat aphthous ulcers (canker sores).
Amlodipine	88150-42-9	Amlodipine	88150-42-9	1J444QC288	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	Amlodipine may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of the following conditions:   Hypertension    Coronary artery disease   Chronic stable angina   Vasospastic angina (Prinzmetals or Variant angina)    Angiographically documented coronary artery disease in patients without heart failure or an ejection fraction < 40%
amlodipine, atorvastatin drug combination		Amlodipine, atorvastatin drug combination	930274-47-8		Anticholesteremic Agents	Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)	
ammodytin L	130958-63-3	Ammodytin L					
ammodytoxin A	97089-72-0	Ammodytoxin A					
Ammonia	7664-41-7	Ammonia	7664-41-7	5138Q19F1X			- Indicated for use as a smelling salt to treat or prevent fainting.  - (when radiolabelled) Indicated for diagnostic PET imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease.
ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate		ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate					
ammonium 4,8-dioxa-3H-perfluorononanoate		Ammonium 4,8-dioxa-3H-perfluorononanoate	958445-44-8				
ammonium acetate	631-61-8	Ammonium Acetate	631-61-8	RRE756S6Q2			
Ammonium Chloride	12125-02-9	Ammonium Chloride	12125-02-9	01Q9PC255D			1. Expectorant in cough syrups. 2. The ammonium ion (NH4+) in the body plays an important role in the maintenance of acid-base balance. The kidney uses ammonium (NH4+) in place of sodium (Na+) to combine with fixed anions in maintaining acid-base balance, especially as a homeostatic compensatory mechanism in metabolic acidosis. The therapeutic effects of Ammonium Chloride depend upon the ability of the kidney to utilize ammonia in the excretion of an excess of fixed anions and the conversion of ammonia to urea by the liver, thereby liberating hydrogen (H+) and chloride (Cl) ions into the extracellular fluid. Ammonium Chloride Injection, USP, after dilution in isotonic sodium chloride injection, may be indicated in the treatment of patients with:  (1) hypochloremic states and (2) metabolic alkalosis.
Ammonium Compounds		Ammonium cation					
ammonium ferric sulfate	7783-83-7	Ferric ammonium sulfate dodecahydrate	7783-83-7	65390568Z5			
ammonium ferrous sulfate	19864-63-2	Azane; iron; sulfuric acid	10045-89-3				
ammonium hexachloroplatinate	16919-58-7	Ammonium chloroplatinate	16919-58-7				
Ammonium Hydroxide		Ammonium Hydroxide	1336-21-6				
ammonium metavanadate	7803-55-6	Ammonium metavanadate	7803-55-6	FL85PX638G			
ammonium molybdate		Ammonium molybdate	13106-76-8		Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
ammonium nitrate	6484-52-2	Ammonium nitrate	6484-52-2	T8YA51M7Y6	Fertilizers	Substances or mixtures that are added to the soil to supply nutrients or to make available nutrients already present in the soil, in order to increase plant growth and productivity. (See all compounds classified as Fertilizers.)	
ammonium perchlorate	7790-98-9	Ammonium perchlorate	7790-98-9	Z3DQ8VD57X			
Ammonium Sulfate	7783-20-2	Ammonium Sulfate	7783-20-2	SU46BAM238			
ammonium trichloro(dioxoethylene-O,O'-)tellurate		ammonium trichloro(dioxoethylene-O,O'-)tellurate			Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
Amobarbital	57-43-2	Amobarbital	57-43-2	GWH6IJ239E	GABA Modulators	Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)	
Amodiaquine	86-42-0	Amodiaquine	86-42-0	220236ED28	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	For treatment of acute malarial attacks in non-immune subjects.
amodiaquine quinoneimine		Amodiaquine quinoneimine					
amorolfine		Amorolfine	78613-35-1		Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
amorphigenin	4208-09-7	Amorphigenin	4208-09-7				
amosulalol	70958-86-0	Amosulalol hydrochloride	70958-86-0	4O4S698PEE	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	
Amoxapine	14028-44-5	Amoxapine	14028-44-5	R63VQ857OT	Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	For the relief of symptoms of depression in patients with neurotic or reactive depressive disorders as well as endogenous and psychotic depressions. May also be used to treat depression accompanied by anxiety or agitation.
Amoxicillin	26787-78-0	Amoxicillin	61336-70-7	9EM05410Q9	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Amoxicillin alone is indicated to treat susceptible bacterial infections of the ear, nose, throat, genitourinary tract, skin, skin structure, and lower respiratory tract. Amoxicillin is given with calvulanic acid to treat acute bacterial sinusitis, community acquired pneumonia, lower respiratory tract infections, acute bacterial otitis media, skin and skin structure infections, and urinary tract infections. Amoxicillin is given with omeprazole in the treatment of _Helicobacter pylori_ (_H. pylori_) infection.  Amoxicillin is used in combination with [vonoprazan] and [clarithromycin] as co-packaged triple therapy or in combination with [vonoprazan] as co-packaged dual therapy to treat _H. pylori_ infection in adults.
Amoxicillin-Potassium Clavulanate Combination	74469-00-4	Augmentin	74469-00-4		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
ampelopsin	27200-12-0	Dihydromyricetin	27200-12-0	KD8QND6427			
amperozide	75558-90-6	Amperozide	75558-90-6	0M2W3TAG39	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
Amphetamine	300-62-9	Amphetamine	300-62-9	CK833KGX7E	Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	Amphetamine is indicated for the treatment of attention-deficit/hyperactivity disorders (ADHD) as well as for the treatment of central nervous system disorders such as narcolepsy.   ADHD is a complex disorder associated with the substantial heterogeneity in etiology, clinical presentation, and treatment outcome. ADHD comes from a complex interplay between interdependent genetic and non-genetic factors which cause complex mental disorders in children and teenagers.  On the other hand, narcolepsy is a chronic sleep disorder typically resenting during adolescence and characterized by excessive daytime sleepiness.  Amphetamine is also being used nowadays off-label for the treatment of obesity, depression and chronic pain.
Amphetamines		Amphetamines					
Amphibian Venoms		Amphibian Venoms					
Amphotericin B	1397-89-3	Amphotericin B	1397-89-3	7XU7A7DROE	Antiprotozoal Agents	Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)	Used to treat potentially life threatening fungal infections.
amphotericin B, deoxycholate drug combination	87687-70-5	Amphotericin b deoxycholate	58501-21-6	44WG8E9MTU	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
Ampicillin	69-53-4	Ampicillin	69-53-4	7C782967RD	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc
amprenavir		Amprenavir	161814-49-9	5S0W860XNR	Anti-HIV Agents	Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)	For the treatment of HIV-1 infection in combination with other antiretroviral agents.
Amprolium		1-((4-Amino-2-propyl-5-pyrimidinyl)methyl)-2-picolinium chloride	121-25-5	71M75T660B	Coccidiostats	Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals. (See all compounds classified as Coccidiostats.)	
Amrinone	60719-84-8	Amrinone	60719-84-8	JUT23379TN	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	Used in the treatment of congestive heart failure.
Amsacrine		Amsacrine	51264-14-3	00DPD30SOY	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For treatment of acute myeloid leukaemia.
amthamine	142437-67-0	Amthamine	142437-67-0	N4ZJ2D98HM			
amurensin G		Amurensin G					
amuvatinib		Amuvatinib	850879-09-3	SO9S6QZB4R			Amuvatinib is a selective multi-targeted tyrosine kinase inhibitor that suppresses c-MET, c-RET and the mutant forms of c-KIT, PDGFR and FLT3. Amuvatinib also suppresses Rad51 protein, a critical component of double-stranded DNA repair in cancer cells.
Amygdalin	29883-15-6	Amygdalin	29883-15-6	214UUQ9N0H	Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	
amyloid beta-protein (1-40)		AMyloid beta-Protein (1-40)					
amyloid beta-protein (1-42)		amyloid beta-protein (1-42)					
amyloid beta-protein (25-35)		amyloid beta-protein (25-35)					
amyloid beta-protein (31-35)		amyloid beta-protein (31-35)					
amyrone		amyrone					
AN 204	175795-76-3	2-Pyrrolino-dox	175795-76-3				
AN 215		AN 215					
AN 238		AN 238					
ANA 12 compound		ANA 12 compound					
anabaseine		Anabaseine	3471-05-4	DYE103K23I	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Anabasine	494-52-0	Anabasine	494-52-0	LMS11II2LO	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Anabolic Agents		Anabolic Agents					
anacardic acid	18654-18-7	2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid	18654-18-7				
Anacardic Acids		Anacardic Acids					
anacetrapib		Anacetrapib	875446-37-0	P7T269PR6S	Anticholesteremic Agents	Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)	Investigated for use/treatment in hyperlipidemia.
anagliptin		Anagliptin	739366-20-2	K726J96838	Dipeptidyl-Peptidase IV Inhibitors	Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release. (See all compounds classified as Dipeptidyl-Peptidase IV Inhibitors.)	
anagrelide		Anagrelide	68475-42-3	K9X45X0051	Fibrinolytic Agents	Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)	Anagrelide is indicated for the treatment of thrombocythemia, secondary to malignant neoplasms, to reduce platelet count and the associated risk of thrombosis. It is also beneficial in the amelioration of thrombocythemia symptoms including thrombo-hemorrhagic events.
Analgesics		Analgesics					
Analgesics, Opioid		Opioid					
anandamide	94421-68-8	Anandamide	94421-68-8	UR5G69TJKH	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
Anastrozole	120511-73-1	Anastrozole	120511-73-1	2Z07MYW1AZ	Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	Anastrozole is indicated as adjunct therapy in the treatment of hormone receptor-positive early breast cancer in postmenopausal women, and as a first-line treatment for hormone receptor-positive (or hormone receptor-unknown) locally advanced or metastatic breast cancer in postmenopausal women. It may also be used in the treatment of advanced breast cancer in postmenopausal women who experience disease progression despite treatment with [tamoxifen].
anatoxin a		Anatoxin A	64285-06-9	80023A73NK			
Ancitabine	31698-14-3	Ancitabine	31698-14-3	DO2D32W0VC	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	
Ancriviroc		[4-[4-[(E)-C-(4-bromophenyl)-N-ethoxycarbonimidoyl]piperidin-1-yl]-4-methylpiperidin-1-yl]-(2,4-dimethyl-1-oxidopyridin-1-ium-3-yl)methanone			CCR5 Receptor Antagonists	Compounds and drugs that inhibit or block the activity of CCR5 RECEPTORS. (See all compounds classified as CCR5 Receptor Antagonists.)	
andrastin A		Andrastin A	174232-42-9	VL8DJU4GFD			
Androgen Antagonists		Androgen Antagonists					
Androgens		Androgens					
Andrographis paniculata extract		Andrographis Paniculata extract					
andrographolide	5508-58-7	Andrographolide	5508-58-7	410105JHGR	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Investigated for use/treatment in ulcerative colitis.
androst-16-en-3-ol	1153-51-1	Androstenol	1153-51-1	48K9VAM062			
androst-5-en-3-ol	1476-64-8	Androst-5-en-3beta-ol	1476-64-8	498C13Y7JP			
androsta-5,16-dien-3 beta-ol	1224-94-8	5,16-Androstadien-3beta-ol	1224-94-8				
androstan-17-ol	1225-43-0	5alpha-Androstan-17beta-ol	1225-43-0	I5JL49BERK			
androstan-3-ol		5alpha-Androstan-3beta-ol	1224-92-6	1394KPE67H			
Androstane-3,17-diol	25126-76-5	Androstane-3,17-diol	25126-76-5		Anabolic Agents	These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. (See all compounds classified as Anabolic Agents.)	
androstane-3,17-diol dipropionate	4350-14-5	Androstane-3,17-diol dipropionate	4350-14-5	S1GK360608			
androstane-3,17-diol glucuronide	27195-25-1	3,17-Androstanediol glucuronide	27195-25-1				
androstane-3,17-dione	5982-99-0	Androstane-3,17-dione	5982-99-0				
Androstanols		Androstanols					
Androstenediol	521-17-5	Androstenediol	521-17-5	95PS51EMXY	Anabolic Agents	These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. (See all compounds classified as Anabolic Agents.)	
Androstenedione	63-05-8	Androstenedione	63-05-8	409J2J96VR			
Androstenes		Androstenes					
Androstenols		Androstenols					
Androsterone	53-41-8	Androsterone	53-41-8	C24W7J5D5R			
androsterone glucuronide	1852-43-3	Androsterone glucuronide	1852-43-3	IMD4XD0W3U			
anemonin	508-44-1	Pulsatilla camphor	508-44-1	G99XG5B674			
anemoside A3		Anemoside A3	129724-84-1				
anemoside B4		Anemoside B4					
Anesthetics, Combined		Anesthetics, Combined					
anethole	104-46-1	Anethole	4180-23-8	Q3JEK5DO4K	Flavoring Agents	Substances added to foods and medicine to improve the taste. (See all compounds classified as Flavoring Agents.)	
Anethole Trithione	532-11-6	Anethole trithione	532-11-6	QUY32964DJ			The most typical uses for which anethol trithione is currently indicated for includes increasing salivary secretion in patients experiencing dry mouth or being used as an adjunctive therapy for cholecystitis, gallstone, indigestion, and acute/chronic hepatitis.  In addition, although some studies have suggested that anethol trithione also possesses a certain capacity to inhibit tumorigenesis as a potential cancer therapy medication, the specific mechanism of action for this effect remains to be elucidated with certain national cancer institutes listing the agent as 'a substance that is being studied in the treatment of cancer'.
ANFT	38514-71-5	2-Amino-4-(5-nitro-2-furyl)thiazole	38514-71-5	Q45KV2AN7K	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
angelica lactone	1333-38-6	5-Methyl-2(5H)-furanone	591-11-7	1AX0NCS144			
angelicae sinensis extract		angelicae sinensis extract					
angelicin	523-50-2	Angelicin	523-50-2	CZZ080D7BD	Tranquilizing Agents	A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes. (See all compounds classified as Tranquilizing Agents.)	
Angiotensin I	9041-90-1	Angiotensin I	484-42-4				
angiotensin I (1-7)		Angiotensin (1-7)	39386-80-6		Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
angiotensin I (1-9)		Angiotensin (1-9)					
Angiotensin II	11128-99-7	3-amino-4-[[1-[[1-[[1-[[1-[[1-[2-[(1-carboxy-2-phenylethyl)carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid			Vasoconstrictor Agents	Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)	
Angiotensin II Type 1 Receptor Blockers		Angiotensin II Type 1 Receptor Blockers					
angiotensin II, des-Asp(1)-des-Arg(2)-Ile(5)-	23025-68-5	Angiotensin IV	23025-68-5				
angiotensin III, Ile(7)-	52498-25-6	7-Isoleucine-aiii	52498-25-6				
Angiotensin Receptor Antagonists		Angiotensin Receptor Antagonists					
Angiotensin-Converting Enzyme Inhibitors		Angiotensin-Converting Enzyme Inhibitors					
Angiotensins		Angiotensins					
angoline	21080-31-9	Angoline	21080-31-9				
Angong Niuhuang Pill		Angong Niuhuang Pill					
anhydrocyprinol	3692-27-1	Anhydrocyprinol	3692-27-1				
anhydroecgonine methyl ester	43021-26-7	Methylecgonidine	43021-26-7	58C337KP3E			
anhydroicaritin		Anhydroicaritin	38226-86-7				
anhydrotetrodotoxin	13072-89-4	Anhydrotetrodotoxin	13072-89-4				
aniline	62-53-3	Aniline	62-53-3	SIR7XX2F1K	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Aniline Compounds		Aniline Compounds					
Aniline Mustard	553-27-5	N,N-Bis(2-chloroethyl)aniline	553-27-5	CUJ6745Z9J	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	
anilofos		Anilofos	64249-01-0	71W48U40S6	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Anions		Anions					
aniracetam		Aniracetam	72432-10-1	5L16LKN964	Nootropic Agents	Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)	
anisodamine	55869-99-3	Anisodamine	55869-99-3	01343Q8EL8	Adrenergic alpha-Agonists	Drugs that selectively bind to and activate alpha adrenergic receptors. (See all compounds classified as Adrenergic alpha-Agonists.)	
anisole		Anisole	100-66-3	B3W693GAZH			
Anisoles		Anisoles					
Anisomycin	22862-76-6	Anisomycin	22862-76-6	6C74YM2NGI	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
ankaflavin		Ankaflavin					
annomontine		Annomontine	82504-00-5				
annonacin		Annonacin	111035-65-5	40372ET6TM			
anpirtoline	98330-05-3	Anpirtoline	98330-05-3	32K9S228IK			
Anserine	584-85-0	Anserine	584-85-0	HDQ4N37UGV			
Antagomirs		Antagomirs					
antalarmin		Antalarmin	157284-96-3	G3DNT7X7YL			
Antazoline	91-75-8	Antazoline	91-75-8	DHA8014SS1	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	Used to relieve nasal congestion and in eye drops, usually in combination with naphazoline, to relieve the symptoms of allergic conjunctivitis.
anthanthrene	191-26-4	Anthanthrene	191-26-4	L65OZG189H			
Anthelmintics		Anthelmintics					
Anthocyanins		Anthocyanins					
anthracene	120-12-7	Anthracene	120-12-7	EH46A1TLD7			
Anthracenes		Anthracenes					
anthraceno(1,2-c)(1,2,5)selenadiazolo-6,11-dione		anthraceno(1,2-c)(1,2,5)selenadiazolo-6,11-dione					
anthracenylmethyl homospermidine		anthracenylmethyl homospermidine					
Anthracyclines		Anthracyclines					
Anthralin	480-22-8	1,8,9-Trihydroxyanthracene	480-22-8		Dermatologic Agents	Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)	
anthranilic acid	118-92-3	Anthranilic acid	118-92-3	0YS975XI6W	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
Anthraquinones		Anthraquinones					
anthrarobin	577-33-3	Anthrarobin	577-33-3	E0T985Y674			
anthrax toxin		anthrax toxin					
Anti-Asthmatic Agents		Anti-Asthmatic Agents					
Anti-Bacterial Agents		Anti-Bacterial Agents					
Anti-HIV Agents		Anti-HIV Agents					
Anti-Inflammatory Agents		Anti-Inflammatory Agents					
Anti-Inflammatory Agents, Non-Steroidal		Anti-Inflammatory Agents, Non-Steroidal					
Anti-Retroviral Agents		Anti-Retroviral Agents					
antibiotic G 418	49863-47-0	Geneticin	49863-47-0	A08F5XTI6G	Coccidiostats	Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals. (See all compounds classified as Coccidiostats.)	
Antibiotics, Antineoplastic		Antibiotics, Antineoplastic					
Antibodies, Antineutrophil Cytoplasmic		Antibodies, Antineutrophil Cytoplasmic					
Anticholesteremic Agents		Anticholesteremic Agents					
Anticoagulants		Anticoagulants					
anticoagulation factor II, Agkistrodon acutus		anticoagulation factor II, Agkistrodon acutus					
Anticonvulsants		Anticonvulsants					
Antidepressive Agents		Antidepressive Agents					
Antidepressive Agents, Tricyclic		Antidepressive Agents, Tricyclic					
Antifungal Agents		Antifungal Agents					
Antigen-Antibody Complex		Antigen-Antibody Complex					
Antigens		Antigens					
Antigens, Bacterial		Antigens, Bacterial					
Antigens, Dermatophagoides		Antigens, Dermatophagoides					
Antigens, Plant		Antigens, Plant					
Antigens, Polyomavirus Transforming		Antigens, Polyomavirus Transforming					
Antigens, Viral		Antigens, Viral					
Antihypertensive Agents		Antihypertensive Agents					
antileukinate		antileukinate					
Antimicrobial Cationic Peptides		Antimicrobial Cationic Peptides					
antimonite	39349-74-1	Antimony hydroxide	39349-74-1				
Antimony	7440-36-0	Antimony	7440-36-0	9IT35J3UV3			
antimony oxide	1332-81-6	1332-81-6					
Antimony Potassium Tartrate	28300-74-5	Antimony Potassium Tartrate	28300-74-5	Z8830U53UE	Schistosomicides	Agents that act systemically to kill adult schistosomes. (See all compounds classified as Schistosomicides.)	
Antimony Sodium Gluconate		Sodium stibogluconate	16037-91-5		Antiprotozoal Agents	Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)	For the treatment of various types of a protozoal infection called leishmaniasis, which may result from sandfly bites in tropical and temperate parts of the world. Also investigated for use/treatment in cancer/tumors (unspecified) and solid tumors.
antimony trichloride	10025-91-9	Antimony trichloride	10025-91-9				
antimony trioxide	1309-64-4	Antimony trioxide	1309-64-4	P217481X5E			
antimycin	11118-72-2	8-Hydroxy-3,4,5-trimethyl-6-oxo-4,6-dihydro-3H-isochromene-7-carboxylic acid	11118-72-2				
Antimycin A	642-15-9	antimycin A1	1397-94-0		Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
Antineoplastic Agents		Antineoplastic Agents					
Antineoplastic Agents, Alkylating		Antineoplastic Agents, Alkylating					
Antineoplastic Agents, Immunological		Antineoplastic Agents, Immunological					
Antioxidants		Antioxidants					
Antipain	37691-11-5	Antipain	37691-11-5	47V479BE6L	Protease Inhibitors	Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)	
Antiparkinson Agents		Antiparkinson Agents					
Antipsychotic Agents		Antipsychotic Agents					
Antipyrine	60-80-0	Antipyrine	60-80-0	T3CHA1B51H	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Antipyrine is an analgesic often used to test effects of other drugs on liver enzymes.  In combination with benzocaine in otic solutions, antipyrine is indicated for the symptomatic relief of acute otitis media arising from various etiologies.
Antirheumatic Agents		Antirheumatic Agents					
Antithrombins		Antithrombins					
Antithyroid Agents		Antithyroid Agents					
Antivenins		Antivenins					
Antiviral Agents		Antiviral Agents					
antofine		(13aR)-2,3,6-trimethoxy-9,11,12,13,13a,14-hexahydrophenanthro[9,10-f]indolizine	32671-82-2				
antrocin		Antrocin					
antroquinonol		Antroquinonol	1010081-09-0	AX9P92T7JZ			
AP 21967		AP 21967					
AP20187		B/B Homodimerizer	195514-80-8				
apabetalone		Apabetalone	1044870-39-4	8R4A7GDZ1D			
apalutamide		Apalutamide	956104-40-8	4T36H88UA7			Apalutamide is indicated for the treatment of patients with metastatic castration-sensitive prostate cancer and non-metastatic castration-resistant prostate cancer.
Apamin	24345-16-2	Apamin	24345-16-2				
apatinib		N-(4-(1-Cyanocyclopentyl)phenyl)-2-((pyridin-4-ylmethyl)amino)nicotinamide	811803-05-1	5S371K6132	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
apaziquone		Apaziquone	114560-48-4	H464ZO600O	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
Apazone	13539-59-8	Azapropazone	13539-59-8	K2VOT966ZI	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
APEKTx1 peptide, Anthopleura elegantissima		APEKTx1 peptide, Anthopleura elegantissima					
apelin-13 peptide		Apelin-13					
APETx1, Anthopleura elegantissima		APETx1, Anthopleura elegantissima					
APETx2 protein, Anthopleura elegantissima		APETx2 protein, Anthopleura elegantissima					
aphantoxin	77238-17-6	Aphantoxin					
Aphidicolin	38966-21-1	Aphidicolin	38966-21-1	6B3F8QW8TU	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
aphidicolin glycinate	92803-82-2	AphiG	92803-82-2				
apicidin		Apicidin	183506-66-3		Histone Deacetylase Inhibitors	Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)	
apicularen A		apicularen A	220757-04-0				
Apigenin	520-36-5	Apigenin	8002-66-2	7V515PI7F6			
apigenin-6-C-(2''-O-rhamnopyranosyl)-fucopyranoside		apigenin-6-C-(2''-O-rhamnopyranosyl)-fucopyranoside					
apigenin-6,8-di-C-glycopyranoside		Vicenin 2	23666-13-9				
apigetrin		Apigetrin	578-74-5	7OF2S66PCH			
apilimod		Apilimod	541550-19-0	GFW2K84S4L			Investigated for use/treatment in crohn's disease and psoriasis and psoriatic disorders.
aplaviroc		Aplaviroc	461443-59-4	98B425P30V	HIV Fusion Inhibitors	Inhibitors of the fusion of HIV to host cells, preventing viral entry. This includes compounds that block attachment of HIV ENVELOPE PROTEIN GP120 to CD4 RECEPTORS. (See all compounds classified as HIV Fusion Inhibitors.)	Investigated for use/treatment in HIV infection.
apo-12'-carotenoic acid		apo-12'-carotenoic acid					
apo-14'-carotenoic acid		apo-14'-carotenoic acid					
apocarotenal	1107-26-2	Apocarotenal	1107-26-2	V22N3E2U32			
apomine		Apomine	126411-13-0	JQ95208805			
Apomorphine	58-00-4	Apomorphine	58-00-4	N21FAR7B4S	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	Apomorphine is indicated to treat acute, intermittent treatment of hypomobility, off episodes associated with advanced Parkinson's disease.
Aporphines		Aporphines					
APP-CHMINACA		App-chminaca	1185887-14-2	3877T06H05			
apple polyphenol extract		apple polyphenol extract					
apraclonidine	66711-21-5	Apraclonidine	66711-21-5	843CEN85DI	Adrenergic alpha-2 Receptor Agonists	Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)	For prevention or reduction of intraoperative and postoperative increases in intraocular pressure (IOP) before and after ocular laser surgery when used prophylactically. Also used as a short-term adjunctive therapy in patients with open-angle glaucoma who are on maximally tolerated medical therapy requiring additional IOP reduction.
apratastat		Apratastat	287405-51-0	C6BZ5263BJ			
apratoxin A		Apratoxin A					
apremilast		Apremilast	608141-41-9	UP7QBP99PN	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Apremilast is indicated for the treatment of adults with active psoriatic arthritis and adults with oral ulcers associated with Behcet's Disease. In addition, apremilast is indicated for the treatment of plaque psoriasis, of any severity, in adult patients who are candidates for phototherapy or systemic therapy.
Aprepitant		Aprepitant	170729-80-3	1NF15YR6UY	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	For the prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including high-dose cisplatin (in combination with other antiemetic agents).
Aprindine	37640-71-4	Aprindine	37640-71-4	5Y48085P9Q	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
aprofen	3563-01-7	Aprofene	3563-01-7	PL791XXJ7B	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	
APS-2-79		6,7-Dimethoxy-~{n}-(2-Methyl-4-Phenoxy-Phenyl)quinazolin-4-Amine					
Aptamers, Nucleotide		Aptamers, Nucleotide					
APY0201		(E)-4-(5-(2-(3-methylbenzylidene)hydrazinyl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)morpholine					
AQ28A compound		AQ28A compound					
AQ4N		Banoxantrone	136470-65-0	W5H7E45YT3	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For the treatment of various forms of cancer.
aqua(edetic acid)chromium(III)		aqua(edetic acid)chromium(III)					
AR C155858		(S)-6-((3,5-dimethyl-1H-pyrazol-4-yl)methyl)-5-(4-hydroxyisoxazolidine-2-carbonyl)-1-isobutyl-3-methylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione	496791-37-8				
AR-C239	67339-62-2	Arc 239 dihydrochloride	67339-62-2				
AR-R 17779		(5S)-spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one	178419-47-1	C3VZ57BN3M			
ar-turmerone	532-65-0	ar-Turmerone	532-65-0	1944T899NO			
arabinoxylan	9040-27-1	9040-27-1					
arabitol	2152-56-9	D-Arabinitol	488-82-4	BOA443XF1X			
arachidin-1		Arachidin I	98391-38-9	48JFB58T4V			
Arachidonic Acid		Arachidonic Acid	506-32-1	27YG812J1I			
Arachidonic Acids		Arachidonic Acids					
arachidonoylserotonin		Arachidonoyl Serotonin	187947-37-1				
arachidonyl dopamine		N-Arachidonoyl dopamine	199875-69-9	Q8NX2KL2YP			
arachidonyl-2-chloroethylamide		Arachidonyl-2-chloroethylamide	220556-69-4				
arachidonyl-coenzyme A	17046-56-9	Arachidonyl-coa	17046-56-9				
arachidonylcyclopropylamide		Arachidonylcyclopropylamide	229021-64-1				
arachidonyltrifluoromethane		Aacocf3	149301-79-1	00XIW1CR0F	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
arachidoyl-coenzyme A	15895-27-9	Arachidoyl-coa	15895-27-9				
araldite	37226-48-5	Araldite	37226-48-5		Bronchoconstrictor Agents	Agents causing the narrowing of the lumen of a bronchus or bronchiole. (See all compounds classified as Bronchoconstrictor Agents.)	
araloside A	7518-22-1	Araloside A	7518-22-1	32BF7Y358G			
aranidipine	86780-90-7	Aranidipine	86780-90-7	4Y7UR6X2PO			Aranidipine has been used for many years to treat angina pectoris and hypertension.
arbutamine	130783-37-8	1,2-Benzenediol, 4-(1-hydroxy-2-((4-(4-hydroxyphenyl)butyl)amino)ethyl)-	130783-37-8				
Arbutin	497-76-7	Arbutin	497-76-7	C5INA23HXF			Indicated for over-the-counter use for epidermal hyperpigmentation in various skin conditions, such as melasma, freckles, and senile lentigines.
archazolid B		archazolid B	632335-03-6				
arctigenin		Arctigenin	7770-78-7	2FD8L150E7			
arctiin	20362-31-6	Arctiin	20362-31-6	TM5RQ949K7			
arecaidine	499-04-7	Arecaidine	499-04-7	0S8YEV0D4O			
arecaidine esters		arecaidine esters					
Arecoline	63-75-2	Arecoline	63-75-2	4ALN5933BH	Cholinergic Agonists	Drugs that bind to and activate cholinergic receptors. (See all compounds classified as Cholinergic Agonists.)	
arecoline hydrobromide		Arecoline hydrobromide	300-08-3	24S79B9CX7			
argan oil		Lipofructyl argan					
argatroban		Argatroban	74863-84-6	OCY3U280Y3	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	Argatroban is indicated for prevention and treatment of thrombosis caused by heparin-induced thrombocytopenia (HIT). It is also indicated for use in patients with, or at risk for, HIT who are undergoing percutaneous coronary intervention.
argemone oil		argemone oil					
Arginine	74-79-3	Arginine	74-79-3	94ZLA3W45F			Used for nutritional supplementation, also for treating dietary shortage or imbalance.
Arginine Vasopressin	113-79-1	Argipressin	113-79-1	Y4907O6MFD	Vasoconstrictor Agents	Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)	
Argininosuccinic Acid	2387-71-5	L-Argininosuccinic acid	2387-71-5	T67NZ5MU4H			
arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide		Elamipretide	736992-21-5	87GWG91S09			
arginyl-glycyl-aspartic acid	99896-85-2	Arginyl-glycyl-aspartic acid	99896-85-2	78VO7F77PN	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
arginyl-glycyl-aspartyl-tryptophan	144161-76-2	Arginyl-glycyl-aspartyl-tryptophan	144161-76-2				
Aripiprazole		Aripiprazole	129722-12-9	82VFR53I78	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Aripiprazole is indicated for the treatment of acute manic and mixed episodes associated with bipolar I disorder, irritability associated with autism spectrum disorder, schizophrenia, and Tourette's disorder. It is also used as an adjunctive treatment of major depressive disorder.[L45859 An injectable formulation of aripiprazole is indicated for agitation associated with schizophrenia or bipolar mania. Finally, an extended-release, bimonthly injection formulation of aripiprazole is indicated for the treatment of adult schizophrenia and maintenance therapy for adult bipolar I disorder.
aristolactam I	13395-02-3	Aristololactam	13395-02-3	3G8CFM4T9A			
aristolochic acid I	313-67-7	Aristolochic acid	313-67-7	94218WFP5T	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
aristolochic acid II	475-80-9	Aristolochic acid II	475-80-9	BB72D5PU2Y			
Aristolochic Acids		Aristolochic acids					
arjunolic acid	465-00-9	Arjunolic acid	465-00-9				
Armin	546-71-4	Ethyl 4-nitrophenyl ethylphosphonate	546-71-4	H39MRI1X2O	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
Aroclor 1016	12674-11-2	3,3',5-Trichlorobiphenyl	12674-11-2	D998089L9E			
aroclor 1221	11104-28-2	3-Chlorobiphenyl	11104-28-2	WLQ4633SJY			
aroclor 1242	53469-21-9	53469-21-9					
aroclor 1248	12672-29-6	3,3',5,5'-Tetrachlorobiphenyl	12672-29-6	M8CJF43Q12			
aroclor 1260	11096-82-5	2,2',3,3',4,4'-Hexachlorobiphenyl	11096-82-5	PJ11O9J71Y			
Aroclors		1,1'-Biphenyl, chloro derivs					
arodyn		arodyn					
aromadedrin		Aromadendrin	480-20-6	7YA4640575			
aromadendrin 3-O-beta-D-glucopyranoside		aromadendrin 3-O-beta-D-glucopyranoside					
Aromatase Inhibitors		Aromatase Inhibitors					
arotinolol	52560-77-7	Arotinolol	68377-92-4	394E3P3B99	Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	Artinolol was introduced to be used as an antihypertensive agent since 1986. It has been studied for other functions like tremor control for patients with Parkinson disease and it is currently in clinical trials for its use in the control of blood pressure and heart rate.
ARS-1620		(S)-1-(4-(6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)prop-2-en-1-one					
Arsanilic Acid		Arsanilic acid	98-50-0	UDX9AKS7GM			
Arsenates		Arsenates					
Arsenic	7440-38-2	Arsenic	7440-38-2	N712M78A8G			
arsenic acid	7778-39-4	Arsenic acid	7778-39-4	N7CIZ75ZPN	Teratogens	An agent that causes the production of physical defects in the developing embryo. (See all compounds classified as Teratogens.)	
arsenic disulfide	56320-22-0	CID 15241817					
arsenic pentoxide	1303-28-2	Arsenic pentoxide	1303-28-2	4GWL8T475I			
arsenic trichloride	7784-34-1	Arsenic trichloride	7784-34-1	5XW39M1300			
arsenic triiodide		Arsenic triiodide	7784-45-4	3029988O2T			
Arsenic Trioxide	1327-53-3	Arsenic oxide (As2O3)	1327-53-3		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For induction of remission and consolidation in patients with acute promyelocytic leukemia (APL), and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression
arsenic trisulfide	1303-33-9	Arsenic trisulfide	1303-33-9	44SIJ800OX			
Arsenicals		Arsenic	7440-38-2	N712M78A8G			
arsenite	15502-74-6	Arsenite ion	15502-74-6	N5509X556J	Teratogens	An agent that causes the production of physical defects in the developing embryo. (See all compounds classified as Teratogens.)	
Arsenites		Arsenites					
arsenotriglutathione		arsenotriglutathione					
arsenous acid	13464-58-9	Arsenous acid	13464-58-9	935XD1L5K2			
Artemether	71963-77-4	Artemether	71963-77-4		Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	Artemether and lumefantrine combination therapy is indicated for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum, including malaria acquired in chloroquine-resistant areas. May also be used to treat uncomplicated malaria when the Plasmodium species has not been identified. Indicated for use in adults and children greater than 5 kg.
Artemether, Lumefantrine Drug Combination		Artemether and lumefantrine	141204-94-6		Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	
artemetin	479-90-3	Artemetin	479-90-3	73KMT7R64H			
artemisic acid	80286-58-4	Artemisinic acid	80286-58-4	53N99527G7			
artemisin	481-05-0	Artemisin	481-05-0	Y1R67R7XWU			
artemisinin		Artemisinin	63968-64-9	9RMU91N5K2	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
Artemisinins		Artemisinins					
artemotil		Artemotil	75887-54-6	XGL7GFB9YI	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	
artenimol		Dihydroartemisinin	71939-50-9	6A9O50735X	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	For the treatment of uncomplicated *Plasmodium falciparum* infection in adults, children, and infants aged 6 months and up weighing over 5 kg. Used in combination with [DB13941].
Artesunate		Artesunate	88495-63-0	60W3249T9M	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	Artesunate is indicated for the initial treatment of severe malaria in adult and pediatric patients.
ARV-771		Arv-771					
ARV-825		2-((S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-(2-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)ethoxy)ethoxy)phenyl)acetamide					
arvanil		Arvanil	128007-31-8				
arvelexin		2-(4-methoxy-1H-indol-3-yl)acetonitrile	4837-74-5				
arzanol		Arzanol					
AS 19 compound		AS 19 compound					
AS602868		1-(5-methoxy-2-(thiophen-2-yl)quinazolin-4-ylamino)-3-methyl-1H-pyrrole-2,5-dione	219773-55-4	Y1FZ8P93E0			
asaronaldehyde		2,4,5-Trimethoxybenzaldehyde	4460-86-0	NDU8J2Q00D			
asarone	494-40-6	alpha-Asarone	2883-98-9	DQY9PNE5FK	Fibrinolytic Agents	Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)	
asarum oil	8016-69-1	Asarum oil					
Asbestos	1332-21-4	1332-21-4					
Asbestos, Amosite	12172-73-5	[Dioxido-[oxo(trioxidosilyloxy)silyl]oxysilyl]oxy-[[dioxido-[oxo(trioxidosilyloxy)silyl]oxysilyl]oxy-oxosilyl]oxy-dioxidosilane;iron(2+);dihydroxide					
Asbestos, Amphibole		Asbestos, Amphibole					
Asbestos, Crocidolite	12001-28-4	Crocidolite Asbestos	12001-28-4	CK28D16OLZ			
Asbestos, Serpentine		Asbestos, Serpentine					
ascaridole	512-85-6	Ascaridole	512-85-6	1718D0GEVJ			
ascladiol	32013-85-7	Ascladiol	32013-85-7	2R4H5L9HF9			
ascorbate-2-phosphate	23313-12-4	L-Ascorbic acid 2-phosphate	23313-12-4	VKX4PM7299	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
Ascorbic Acid	50-81-7	Ascorbic Acid	50-81-7	PQ6CK8PD0R	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	Used to treat vitamin C deficiency, scurvy, delayed wound and bone healing, urine acidification, and in general as an antioxidant. It has also been suggested to be an effective antiviral agent.
aseanostatin P5	5502-94-3	12-Methyltetradecanoic acid	5502-94-3	TP0OL0Z8US			
asenapine		(R,R)-asenapine	65576-45-6		Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Used for treatment in psychosis, schizophrenia and schizoaffective disorders, manic disorders, and bipolar disorders as monotherapy or in combination.
Ashwagandha		withaferin A					
Asian ginseng		Ginseng, Panax quinquefolium coreense, ext.					
asiatic acid	464-92-6	Asiatic Acid	464-92-6	9PA5A687X5			
asiaticoside	16830-15-2	Asiaticoside	16830-15-2	PKO39VY215	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
asolectin	69279-91-0	asolectin					
asoxime chloride		1-[[2-(Hydroxyiminomethyl)pyridin-1-ium-1-yl]methoxymethyl]pyridin-1-ium-4-carboxamide;dichloride	34433-31-3		Antidotes	Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)	
ASP8477		Pyridin-3-yl 4-(phenylcarbamoyl)piperidine-1-carboxylate	906737-25-5	W22BL56T55	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
aspalathin		Aspalathin	6027-43-6				
Asparagine	7006-34-0	DL-Asparagine	3130-87-8				
asparanin A		Asparanin A	84633-33-0				
Aspartame	22839-47-0	Aspartame	22839-47-0	Z0H242BBR1	Sweetening Agents	Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)	Used as a diet supplement and sugar substitute.
Aspartic Acid	56-84-8	Aspartic Acid	56-84-8	30KYC7MIAI			There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.
aspartyl-alanyl-histidyl-lysine		aspartyl-alanyl-histidyl-lysine					
aspartyl-glutamyl-valyl-aspartal		aspartyl-glutamyl-valyl-aspartal					
aspartyl-glutamyl-valyl-aspartyl-7-amino-4-trifluoromethylcoumarin		aspartyl-glutamyl-valyl-aspartyl-7-amino-4-trifluoromethylcoumarin					
aspartyl-glutamyl-valyl-aspartyl-p-nitroanilide		aspartyl-glutamyl-valyl-aspartyl-p-nitroanilide					
asperphenamate	63631-36-7	Asperphenamate	63631-36-7	2H4MD59YVT			
asperuloside	14259-45-1	Asperuloside	14259-45-1	V3CFI02X39			
asperulosidic acid		Asperulosidic acid	25368-11-0	39LA4NOT5K			
asphalt	8052-42-4	8052-42-4					
aspidin BB	584-28-1	Aspidin	584-28-1	N21SD2R570			
Aspirin	50-78-2	Aspirin	50-78-2	R16CO5Y76E	Antipyretics	Drugs that are used to reduce body temperature in fever. (See all compounds classified as Antipyretics.)	**Pain, fever, and inflammation**  Acetylsalicylic acid (ASA), in the regular tablet form (immediate-release), is indicated to relieve pain, fever, and inflammation associated with many conditions, including the flu, the common cold, neck and back pain, dysmenorrhea, headache, tooth pain, sprains, fractures, myositis, neuralgia, synovitis, arthritis, bursitis, burns, and various injuries. It is also used for symptomatic pain relief after surgical and dental procedures.   The _extra strength_ formulation of acetylsalicylic acid is also indicated for the management migraine pain with photophobia (sensitivity to light) and phonophobia (sensitivity to sound).  **Other indications**  ASA is also indicated for various other purposes, due to its ability to inhibit platelet aggregation. These include:   Reducing the risk of cardiovascular death in suspected cases of myocardial infarction (MI).   Reducing the risk of a first non-fatal myocardial infarction in patients, and for reducing the risk of morbidity and mortality in cases of unstable angina and in those who have had a prior myocardial infarction.  For reducing the risk of transient ischemic attacks (TIA) and to prevent atherothrombotic cerebral infarction (in conjunction with other treatments).  For the prevention of thromboembolism after hip replacement surgery.   For decreasing platelet to platelet adhesion following carotid endarterectomy, aiding in the prevention of transient ischemic attacks (TIA).  Used for patients undergoing hemodialysis with a silicone rubber arteriovenous cannula inserted to prevent thrombosis at the insertion site.   **Important note regarding use of the extended-release formulation**  In the setting of acute myocardial infarction, or before percutaneous interventions, the extended-release form of acetylsalicylic acid should not be used. Use immediate-release formulations in scenarios requiring rapid onset of action. The extended-release form is taken to decrease the incidence of mortality and myocardial infarction (MI) for individuals diagnosed with chronic coronary artery disease (CAD), including patients with previous myocardial infarction (MI) or unstable angina or with chronic stable angina. Additionally, the extended-release form is used to decrease the risk of death and recurrent episodes of stroke in patients with a history of stroke or TIA.
aspirin eugenol ester		Aspirin eugenol ester	201052-80-4				
Aspirin, Dipyridamole Drug Combination		Aggrenox			Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
AST 120	90597-58-3	Carbon	7440-44-0				
Astatine-211		Astatine-211					
astaxanthine	472-61-7	Astaxanthin	472-61-7	8XPW32PR7I			Investigated for use/treatment in eye disorders/infections, cancer/tumors (unspecified), and asthma.
Astemizole	68844-77-9	Astemizole	68844-77-9	7HU6337315	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	Astemizole was indicated for use in the relieving allergy symptoms, particularly rhinitis and conjunctivitis. It has been withdrawn from the market however due to concerns of arrhythmias.
astilbin	29838-67-3	Astilbin	29838-67-3				
astin B		astin B					
ASTM F-75 implant alloy		ASTM F-75 implant alloy					
Astragali compound		Astragali compound					
astragalin	480-10-4	Astragalin	480-10-4	APM8UQ3Z9O			
astragaloside A		Astragaloside A	83207-58-3	3A592W8XKE			
astragaloside VI		Astragaloside VI					
astressin	170809-51-5	Astressin			Neuroprotective Agents	Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)	
astressin B		astressin B					
astressin-2B		Astressin 2B	681260-70-8				
astringin		Astringin	29884-49-9	4ER6YKM4YL			
Atazanavir Sulfate		Atazanavir Sulfate	229975-97-7	4MT4VIE29P	HIV Protease Inhibitors	Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. (See all compounds classified as HIV Protease Inhibitors.)	Reyataz capsules, co-administered with low dose ritonavir, are indicated for the treatment of HIV-1 infected adults and paediatric patients 6 years of age and older in combination with other antiretroviral medicinal products (see section 4. 2). Based on available virological and clinical data from adult patients, no benefit is expected in patients with strains resistant to multiple protease inhibitors ( 4 PI mutations). The choice of Reyataz in treatment experienced adult and paediatric patients should be based on individual viral resistance testing and the patient's treatment history (see sections 4. 4 and 5. 1). Reyataz oral powder, co-administered with low dose ritonavir, is indicated in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected paediatric patients at least 3 months of age and weighing at least 5 kg (see section 4. 2). Based on available virological and clinical data from adult patients, no benefit is expected in patients with strains resistant to multiple protease inhibitors ( 4 PI mutations). The choice of Reyataz in treatment experienced adult and paediatric patients should be based on individual viral resistance testing and the patient's treatment history (see sections 4. 4 and 5. 1).
Atenolol	29122-68-7	Atenolol	29122-68-7	50VV3VW0TI	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	**Indicated** for:  1) Management of hypertension alone and in combination with other antihypertensives.  2) Management of angina pectoris associated with coronary atherosclerosis.  3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg.  **Off-label** uses include:  1) Secondary prevention of myocardial infarction.  2) Management of heart failure.  3) Management of atrial fibrillation.  4) Management of supraventricular tachycardia.  5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy.  6) Management of symptomatic thyrotoxicosis in combination with [methimazole].  7) Prophylaxis of migraine headaches.  8) Management of alcohol withdrawal.
atheronal-A		Secosterol-A					
atipamezole		Atipamezole	104054-27-5	03N9U5JAF6	Adrenergic alpha-2 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Antagonists.)	For the reversal of the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs.
ATL 146e		Apadenoson	250386-15-3	BTS1Y6777M			Investigated for use/treatment in cardiovascular disorders and inflammatory disorders (unspecified).
Atomoxetine Hydrochloride		Atomoxetine Hydrochloride	82248-59-7	57WVB6I2W0	Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	Treatment of Attention Deficit Hyperactivity Disorder (ADHD)
Atorvastatin		Atorvastatin	134523-00-5	A0JWA85V8F	Hydroxymethylglutaryl-CoA Reductase Inhibitors	Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)	Atorvastatin is indicated for the treatment of several types of dyslipidemias, including primary hyperlipidemia and mixed dyslipidemia in adults, hypertriglyceridemia, primary dysbetalipoproteinemia, homozygous familial hypercholesterolemia, and heterozygous familial hypercholesterolemia in adolescent patients with failed dietary modifications.  Dyslipidemia describes an elevation of plasma cholesterol, triglycerides or both as well as to the presence of low levels of high-density lipoprotein. This condition represents an increased risk for the development of atherosclerosis.   Atorvastatin is indicated, in combination with dietary modifications, to prevent cardiovascular events in patients with cardiac risk factors and/or abnormal lipid profiles.  Atorvastatin can be used as a preventive agent for myocardial infarction, stroke, revascularization, and angina, in patients without coronary heart disease but with multiple risk factors and in patients with type 2 diabetes without coronary heart disease but multiple risk factors.  Atorvastatin may be used as a preventive agent for non-fatal myocardial infarction, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure and angina in patients with coronary heart disease.  Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.
atosiban		Atosiban	90779-69-4	081D12SI0Z	Hormone Antagonists	Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)	Atosiban is indicated for use in delaying imminent pre-term birth in pregnant adult women with:   - regular uterine contractions of at least 30 s duration at a rate of at least 4 per 30 min - a cervical dilation of 1-3cm (0-3cm for nulliparas) and effacement of  at least 50% - a gestational age of 24-33 weeks - a normal fetal heart rate
Atovaquone	94015-53-9	Atovaquone	137732-39-9	F1W7QUV0KI	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	
ATP-biotin		ATP-biotin					
atpenin A5	119509-24-9	Atpenin A5	119509-24-9				
atractylenolide I		Atractylenolide I	73069-13-3				
atractylenolide II		Atractylenolide II	73069-14-4				
atractylodin	55290-63-6	Atractylodin	55290-63-6	V73E8B6UAC			
atractylon	6989-21-5	Atractylon	6989-21-5				
Atractyloside	17754-44-8	Atractyloside	17754-44-8	H6WC6L09RM	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Atracurium		Atracurium	64228-79-1	2GQ1IRY63P	Nicotinic Antagonists	Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)	
atranorin	479-20-9	Atranorin	479-20-9	450U2VJ2VG			
atraric acid		Methyl 2,4-dihydroxy-3,6-dimethylbenzoate	4707-47-5	12YH9T04QE			
Atrasentan		Atrasentan	173937-91-2	V6D7VK2215	Endothelin A Receptor Antagonists	Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN A RECECPTORS. (See all compounds classified as Endothelin A Receptor Antagonists.)	Investigated for use/treatment in prostate cancer and cancer/tumors (unspecified).
Atrazine	1912-24-9	Atrazine	1912-24-9	QJA9M5H4IM	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Atropine	51-55-8	Atropine	51-55-8		Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	As a drug that is not FDA approved, hyscyamine has no official indications. Intravenous hysocyamine has been used to reduce gastric motility, reduce pancreatic pain and secretions, to facilitate imaging of the gastrointestinal tract, treat anticholinesterase toxicity, treat certain cases of partial heart block, improve visualization of the kidneys, and for symptomatic relief of biliary and renal colic. Intravenous hyoscyamine is also used pre-operatively to reduce secretions of the mouth and respiratory tract to facilitate intubation. Oral hyoscyamine is used to treat functional intestinal disorders, for symptomatic relief of biliary and renal colic, and symptomatic relief of acute rhinitis.
aucubin	479-98-1	Aucubin	479-98-1	2G52GS8UML			
augustic acid		Augustic acid	26707-60-8				
Auranofin	34031-32-8	CID 24199313	34031-32-8		Antirheumatic Agents	Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)	Used in the treatment of active, progressive or destructive forms of inflammatory arthritis, such as adult rheumatoid arthritis.
aurantiamide		Aurantiamide	58115-31-4				
aurantio-obtusin		Aurantio-obtusin	67979-25-3				
aurapten		Auraptene	495-02-3	F79I1ZEL2E			
aureusidin	38216-54-5	Aureusidin	38216-54-5	U8B4XHN2DX			
auriculasin		Auriculasin	60297-37-2				
aurin	603-45-2	Aurin	603-45-2	85N4AK3JAU			
Aurintricarboxylic Acid	4431-00-9	Aurintricarboxylic acid	4431-00-9	NP9O8E29QW			
aurofusarin		Aurofusarin	13191-64-5	EYG3R23SI1			
Aurothioglucose	12192-57-3	Aurothioglucose	12192-57-3		Antirheumatic Agents	Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)	Aurothioglucose is indicated for the adjunctive treatment of early active adult and juvenile type rheumatoid arthritis that is not adequately controlled by other anti-inflammatory agents and conservative measures like salicylate, glucocorticoids, etc.. In chronic, advanced cases of rheumatoid arthritis, such gold therapy is not demonstrated to be as valuable.  Antirheumatic measures such as salicylate and other anti-inflammatory drugs (both steroidal and non steroidal) may be continued after initiation of gold therapy. After improvement commences, these measures may be discontinued slowly as symptoms permit.
austenitic steel		austenitic steel					
avarol	55303-98-5	Avarol	55303-98-5	KZX416VN2B	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
avasimibe	166518-60-1	Avasimibe	166518-60-1	28LQ20T5RC	Cytochrome P-450 CYP3A Inducers	Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP3A. (See all compounds classified as Cytochrome P-450 CYP3A Inducers.)	Investigated for use/treatment in peripheral vascular disease.
AVE 0991		2-Thiophenesulfonamide, N-((ethylamino)carbonyl)-3-(4-((5-formyl-4-methoxy-2-phenyl-1H-imidazol-1-yl)methyl)phenyl)-5-(2-methylpropyl)-	304462-19-9	68JR6NCI7I			
avermectin	73989-17-0	Avermectin	73989-17-0		Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
avobenzone		Avobenzone	70356-09-1	G63QQF2NOX	Sunscreening Agents	Chemical or physical agents that protect the skin from sunburn and erythema by absorbing or blocking ultraviolet radiation. (See all compounds classified as Sunscreening Agents.)	Sun protection factor, added in the sunscreen products for its wide spectrum ultraviolet absorption properties.
Avosentan		Avosentan	290815-26-8	L94KSX715K			Investigated for use/treatment in cardiovascular disorders and neuropathy (diabetic).
AWD 12-281		N-(3,5-dichloropyrid-4-yl)-(1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl)glyoxylic acid amide	257892-33-4	550671J24D			
Axitinib		Axitinib	319460-85-0	C9LVQ0YUXG	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Used in kidney cell cancer and investigated for use/treatment in pancreatic and thyroid cancer.
ayanin		Ayanin	572-32-7	YA465UF3LK			
AZ 002		AZ 002					
AZ 11645373		3-[1-[[(3'-Nitro[1,1'-biphenyl]-4-YL)oxy]methyl]-3-(4-pyridinyl)propyl]-2,4-thiazolidinedione	227088-94-0	XY4SZP4C72	Purinergic P2X Receptor Antagonists	Compounds that bind to and block the stimulation of PURINERGIC P2X RECEPTORS. Included under this heading are antagonists for specific P2X receptor subtypes. (See all compounds classified as Purinergic P2X Receptor Antagonists.)	
AZ 505		N-cyclohexyl-3-[2-(3,4-dichlorophenyl)ethylamino]-N-[2-[2-(5-hydroxy-3-oxo-4H-1,4-benzoxazin-8-yl)ethylamino]ethyl]propanamide					
AZ-628		3-(2-Cyanopropan-2-yl)-N-(4-methyl-3-((3-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)amino)phenyl)benzamide	878739-06-1	560S6B5D79			
AZ10606120		2-(1-adamantyl)-N-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide					
Aza Compounds		Aza Compounds					
aza-(6)-gingerol		aza-(6)-gingerol					
Azacitidine	320-67-2	Azacitidine	320-67-2	M801H13NRU	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Azacitidine (for subcutaneous or intravenous use) is indicated for the treatment of adult patients with the following French-American-British (FAB) myelodysplastic syndrome (MDS) subtypes: refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL). Azacitidine is also indicated for the treatment of pediatric patients aged 1 month and older with newly diagnosed Juvenile Myelomonocytic Leukemia (JMML).  Azacitidine (for oral use) is indicated for continued treatment of adult patients with acute myeloid leukemia (AML) who achieved first complete remission or complete remission with incomplete blood count recovery following intensive induction chemotherapy and are not able to complete intensive curative therapy.
azacyclonol	115-46-8	Azacyclonol	115-46-8	2MMR990PEM			
azadirachtin	11141-17-6	Azadirachtin	11141-17-6	O4U1SAF85H	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
azadiradione		Azadiradione	26241-51-0				
Azaguanine	134-58-7	8-Azaguanine	134-58-7	Q150359I72	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	
azalanstat	143393-27-5	Azalanstat	143393-27-5	2NL79NI1WS			
azamethiphos		Azamethiphos	35575-96-3	9440R8149U	Antiparasitic Agents	Drugs used to treat or prevent parasitic infections. (See all compounds classified as Antiparasitic Agents.)	
azamulin		Azamulin	76530-44-4	875AQ866X1			
Azaperone	1649-18-9	Azaperone	1649-18-9	19BV78AK7W	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	
azaribine	2169-64-4	Azaribine	2169-64-4	K1U80DO9EB	Dermatologic Agents	Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)	
azasetron	123039-99-6	Azasetron	123040-69-7	77HC7URR9Z	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	
azaspiracid		Azaspiracid	214899-21-5				
azaspiracid-2		Azaspiracid-2					
azaspirane	123018-47-3	Atiprimod	123018-47-3	MG7D3QD743			Investigated for use/treatment in cancer/tumors (unspecified), multiple myeloma, and rheumatoid arthritis.
azastene	13074-00-5	Azastene	13074-00-5	1XA84ITL1H			
azatadine	3964-81-6	Azatadine	3964-81-6	94Z39NID6C	Cholinergic Antagonists	Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists. (See all compounds classified as Cholinergic Antagonists.)	For the relief of the symptoms of upper respiratory mucosal congestion in perennial and allergic rhinitis, and for the relief of nasal congestion and eustachian t.b. congestion.
Azathioprine	446-86-6	Azathioprine	446-86-6	MRK240IY2L	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	Azathioprine is indicated to treat rheumatoid arthritis and prevent renal transplant rejection.
AZD 1152-HQPA		AZD 1152-HQPA					
AZD 1480		(S)-5-chloro-N2-(1-(5-fluoropyrimidin-2-yl)ethyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine	935666-88-9	KL2Z2TLF01			
AZD 6244		Selumetinib	606143-52-6	6UH91I579U			Selumetinib is indicated for the treatment of neurofibromatosis type 1 (NF1) in patients two years and older who have symptomatic, inoperable plexiform neurofibromas (PN).
AZD 7545		4-[(3-Chloro-4-{[(2r)-3,3,3-Trifluoro-2-Hydroxy-2-Methylpropanoyl]amino}phenyl)sulfonyl]-N,N-Dimethylbenzamide					
AZD 8931		AZD 8931					
AZD3965		(S)-5-(4-Hydroxy-4-methylisoxazolidine-2-carbonyl)-1-isopropyl-3-methyl-6-((5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)methyl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione	1448671-31-5	39OM5Y4K2F			
AZD4547		Azd-4547	1035270-39-3	2167OG1EKJ			
AZD5991		Unii-E3T5xxy9HX	2143061-82-7	E3T5XXY9HX	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
AZD8186		(R)-8-(1-((3,5-difluorophenyl)amino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide	1627494-13-6	AIQ4OWD0RA			
AZD8848		Methyl 2-(3-(((3-(6-amino-2-butoxy-8-oxo-7H-purin-9(8H)-yl)propyl)(3-morpholinopropyl)amino)methyl)phenyl)acetate	866269-28-5	322ZMR6920			
AZD9496		(E)-3-(3,5-difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic acid	1639042-08-2	DA9P7LN909			
azelaic acid		Azelaic Acid	123-99-9	F2VW3D43YT	Dermatologic Agents	Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)	For the topical treatment of mild-to-moderate inflammatory acne vulgaris.
azelastine	58581-89-8	Azelastine	58581-89-8	ZQI909440X	Bronchodilator Agents	Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)	Intranasal azelastine is indicated for the symptomatic treatment of seasonal allergic rhinitis in patients 5 years and older and for the symptomatic treatment of vasomotor rhinitis in patients 12 years and older. Ophthalmic azelastine solution is indicated for the treatment of itchy eyes associated with allergic conjunctivitis.  As a 0.15% nasal spray, azelastine hydrochloride is also indicated for over-the-counter treatment of allergies in patients aged six years and older.
azelnidipine	123524-52-7	Azelnidipine	123524-52-7	PV23P19YUG			For the treatment of hypertension.
Azepines		Azepines					
azetidine		Azetidine	503-29-7	37S883XDWR			
azetidine-2,4-dicarboxylic acid	127310-57-0	Azetidine-2,4-dicarboxylic acid	127310-57-0				
Azetidinecarboxylic Acid	2517-04-6	Azetidine-2-carboxylic acid	2517-04-6	775261TI36			
Azides		Azide ion	14343-69-2	88BIA49L8P			
azidopine	90523-31-2	Azidopine	90523-31-2	63XR70204A	Affinity Labels	Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. (See all compounds classified as Affinity Labels.)	
azidoprazosin	90990-97-9	Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(4-azido-3-iodobenzoyl)-	90990-97-9				
azilsartan		Azilsartan	147403-03-0	F9NUX55P23			
azimilide	149888-94-8	Azimilide hydrochloride	149888-94-8	6E6VJP68KR	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
azinphos ethyl	2642-71-9	Azinphos-ethyl	2642-71-9	EA96NYT5J5			
Azinphosmethyl	86-50-0	Azinphos-methyl	86-50-0	265842EWUV	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
azinphosmethyl oxon	961-22-8	Azinphosmethyl oxon	961-22-8				
Aziridines		Aziridines					
Azithromycin	83905-01-5	Azithromycin	83905-01-5	F94OW58Y8V	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	"Azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria in order to prevent the development antimicrobial resistance and maintain the efficacy of azithromycin.  Azithromycin is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the microorganisms listed in the specific conditions below. Recommended dosages, duration of therapy and considerations for various patient populations may vary among these infections. Refer to the FDA label and ""Indications"" section of this drug entry for detailed information.   **Adults**:  Acute bacterial exacerbations of chronic obstructive pulmonary disease due to _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_  Acute bacterial sinusitis due to _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_  Community-acquired pneumonia due to _Chlamydophila pneumoniae_, _Haemophilus influenzae_, _Mycoplasma pneumoniae_ or _Streptococcus pneumoniae_ in patients appropriate for oral therapy  Pharyngitis/tonsillitis caused by _Streptococcus pyogenes_ as an alternative to first-line therapy in individuals who cannot use first-line therapy. Uncomplicated skin and skin structure infections due to _Staphylococcus aureus_, _Streptococcus pyogenes_, or _Streptococcus agalactiae_. Abscesses usually require surgical drainage.  Urethritis and cervicitis due to _Chlamydia trachomatis_ or _Neisseria gonorrhoeae_.  Genital ulcer disease in men due to _Haemophilus ducreyi_ (chancroid). Due to the small number of women included in clinical trials, the efficacy of azithromycin in the treatment of chancroid in women has not been established.  **Pediatric Patients**  Acute otitis media caused by _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_  Community-acquired pneumonia due to _Chlamydophila pneumoniae_, _Haemophilus influenzae_, _Mycoplasma pneumoniae_ or _Streptococcus pneumoniae_ in patients appropriate for oral therapy.  Pharyngitis/tonsillitis caused by _Streptococcus pyogenes_ as an alternative to first-line therapy in individuals who cannot use first-line therapy."
AZM551248		AZM551248					
azo rubin S	13613-55-3	Azo rubin S	13613-55-3	83344C2N7U			
azobenzene	103-33-3	Azobenzene	103-33-3	F0U1H6UG5C			
Azoles		5-(4-Fluorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole	421581-70-6				
azomethane	503-28-6	Azomethane	503-28-6	MMG2EML2S5			
azosemide		Azosemide	27589-33-9	MR40VT1L8Z	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	
azoximer bromide		Azoximer bromide [INN]					
Azoxymethane	25843-45-2	Azoxymethane	25843-45-2	MO0N1J0SEN	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
azoxystrobin	131860-33-8	Azoxystrobin	131860-33-8	NYH7Y08IPM			
Aztreonam	78110-38-0	Aztreonam	78110-38-0	G2B4VE5GH8	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of the following infections caused by susceptible gram-negative microorganisms: urinary tract infections, lower respiratory tract infections, septicemia, skin and skin-structure infections, intra-abdominal infections, and gynecologic infections.
azumolene	64748-79-4	Azumolene	64748-79-4	5U7IO9CV80			
Azure A	531-53-3	Azure A	531-53-3	M731V243EF			
Azure B	531-55-5	Azure B	531-55-5	7C8BEL8WQV			
B 24-76	104970-08-3	1-(2,4-Dichlorophenoxy)-3-((2-(3,4-dimethoxyphenyl)ethyl)amino)-2-propanol	104970-08-3	2486GZ5YJL			
B 3824	111317-75-0	Aaphg-tfa	111317-75-0				
B 4146	103433-42-7	[2-[[(2S,4R)-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl] (2R)-2-[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-2-[[(2S)-2-amino-3,3-dithiophen-2-ylpropanoyl]-[(2R)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoate	103433-42-7				
B 4162	103412-42-6	L-Arginine, N2-(N-(N-(N-(N-(N-(1-(1-(N2-D-arginyl-L-arginyl)-L-prolyl)-trans-4-hydroxy-L-prolyl)glycyl)-3-(2-thienyl)-L-alanyl)-L-seryl)-D-phenylalanyl)-3-(2-thienyl)-L-alanyl)-	103412-42-6		Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
B 581	149759-96-6	FTase Inhibitor I	149759-96-6				
B 823-08	86604-69-5	2-((4-Methoxy-3-methyl-2-pyridylmethyl)sulfo)-5-trifluoromethyl-1H-benzimidazole	86604-69-5				
B3(Fv)-PE38KDEL recombinant immunotoxin		B3(Fv)-PE38KDEL recombinant immunotoxin					
baccharin		CID 45114377					
Bacitracin	1405-87-4	1405-87-4					
Baclofen	1134-47-0	Baclofen	1134-47-0	H789N3FKE8	GABA-B Receptor Agonists	Endogenous compounds and drugs that bind to and activate GABA-B RECEPTORS. (See all compounds classified as GABA-B Receptor Agonists.)	Oral baclofen is indicated for the treatment of spasticity resulting from multiple sclerosis and is particularly useful for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. It may also be used to treat patients with spinal cord injuries and other spinal cord diseases. Baclofen should not be used to treat skeletal muscle spasms resulting from rheumatic disorders.  Intrathecal baclofen is also indicated for the management of severe spasticity of the cerebral or spinal original in patients 4 years of age and older. It is reserved for patients unresponsive to oral baclofen therapy, or those who experience intolerable central nervous system side effects at effective doses. For use in spasticity due to traumatic brain injury, baclofen should be considered after at least one year of injury.
bacoside A		Bacoside A	11028-00-5				
Bacterial Toxins		Bacterial Toxins					
BAEC protocol		BAEC protocol					
bafetinib		Bafetinib	859212-16-1	NVW4Z03I9B	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
bafilomycin A	116764-51-3	Bafilomycin A	88899-55-2		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
bafilomycin A1	88899-55-2	bafilomycin A1	88899-55-2		Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
bafilomycin B1	88899-56-3	CID 74030053	88899-56-3				
BAG956		BAG956					
baicalein	491-67-8	Baicalein	491-67-8	49QAH60606	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
baicalein 5,6,7-trimethyl ether		5,6,7-Trimethoxyflavone	973-67-1				
baicalein-7-O-diglucoside		114482-86-9					
baicalin	21967-41-9	Baicalin	21967-41-9	347Q89U4M5	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
Baizhu		ATRACTYLODES MACROCEPHALA ROOT					
bakuchiol	10309-37-2	Bakuchiol	10309-37-2	OT12HJU3AR			
balanophonin		Balanophonin					
balofloxacin	127294-70-6	Balofloxacin	127294-70-6	Q022B63JPM	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
balsalazide	82101-18-6	Balsalazide Disodium	82101-18-6		Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
bambuterol	81732-65-2	Bambuterol	81732-65-2	Y1850G1OVC	Bronchodilator Agents	Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)	For the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema.
bamifylline	2016-63-9	Bamifylline	2016-63-9	ZTY15D026H	Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
Bandrowski's base	20048-27-5	Bandrowski's base	20048-27-5	63ZRE89T3Q			
banxia xiexin decoction		banxia xiexin decoction					
baohuoside I	113558-15-9	Baohuoside I	113558-15-9				
barban	101-27-9	Barban	101-27-9	33306K781F			
Barbital	57-44-3	Barbital	57-44-3	5WZ53ENE2P	GABA Modulators	Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)	
Barbiturates		Barbiturates					
barbituric acid	67-52-7	Barbituric acid	67-52-7	WQ92Y2793G			
bardoxolone methyl		Bardoxolone methyl	218600-53-4	CEG1Q6OGU1			Investigated for use/treatment in lymphoma (unspecified), multiple myeloma, and solid tumors.
baricitinib		Baricitinib	1187594-09-7	ISP4442I3Y			In the US and Europe, baricitinib is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more TNF blockers. Baricitinib may be used as monotherapy or in combination with [methotrexate] or other DMARDs.  In Europe, baricitinib is indicated for the treatment of moderate to severe atopic dermatitis in adult patients who are candidates for systemic therapy.  In the US, baricitinib is also indicated for the treatment of coronavirus disease 2019 (COVID-19) in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation. Recently, it is also approved as the treatment for severe alopecia areata in adults.
Barium	7440-39-3	Barium	7440-39-3	24GP945V5T			
barium chloride	10361-37-2	Barium chloride	10361-37-2	0VK51DA1T2			
Barium Sulfate	7727-43-7	Barium Sulfate	13462-86-7	25BB7EKE2E	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	Barium sulfate is a radiographic contrast agent indicated for use in computed tomography (CT) of the abdomen to delineate the gastrointestinal (GI) tract in adult and pediatric patients.
basic fuchsin		12418 Red					
Basic Red 51		Basic Red 51	77061-58-6	A7A946JJ6I			
basil oil	8015-73-4	Basil oil					
bastadin 12	134981-78-5	Bastadin 12	134981-78-5				
bathocuproine	4733-39-5	2,9-Dimethyl-4,7-diphenyl-1,10-phenanthroline	4733-39-5	9THP2V94FX	Free Radical Scavengers	Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. (See all compounds classified as Free Radical Scavengers.)	
bathocuproine sulfonate	73348-75-1	Bathocuproine disulfonate	166301-18-4		Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
bathophenanthroline	1662-01-7	4,7-Diphenyl-1,10-phenanthroline	1662-01-7	4A2B091F0G	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
bathophenanthroline disulfonic acid	28061-20-3	Bathophenanthroline disulfonic acid	28061-20-3		Chromogenic Compounds	Colorless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into colored compounds; used in biochemical assays and in diagnosis as indicators, especially in the form of enzyme substrates. Synonym: chromogens (not to be confused with pigment-synthesizing bacteria also called chromogens). (See all compounds classified as Chromogenic Compounds.)	
batimastat		Batimastat	130370-60-4	BK349F52C9	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
Batrachotoxins		Batrachotoxins					
batracylin	67199-66-0	Daniquidone	67199-66-0	E780TX33D2			
Batroxase, Bothrops atrox		Batroxase, Bothrops atrox					
Batroxobin		Batroxobin					
bavachalcone		Bavachalcone	28448-85-3				
bavachin		Bavachin	19879-32-4				
bavachinin		Bavachinin	19879-30-2	VL3EV483SZ			
BAY 11-7085		(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile	196309-76-9				
BAY 58-2667	329773-35-5	Cinaciguat	329773-35-5	59K0Y58UAD			
BAY 60-6583		2-({6-Amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-yl}sulfanyl)acetamide	910487-58-0	UAT5472LHH	Adenosine A2 Receptor Agonists	Compounds that selectively bind to and activate ADENOSINE A2 RECEPTORS. (See all compounds classified as Adenosine A2 Receptor Agonists.)	
BAY 73-6691		4H-Pyrazolo(3,4-d)pyrimidin-4-one, 1-(2-chlorophenyl)-1,5-dihydro-6-((2R)-3,3,3-trifluoro-2-methylpropyl)-	794568-92-6	80ZTV3INTW			
BAY u9773		4-{[(4S,5R,6E,8E,10Z,13Z)-1-carboxy-4-hydroxynonadeca-6,8,10,13-tetraen-5-yl]sulfanyl}benzoic acid	154978-38-8				
Bay W1807		BAY U6751 hydrate	114290-51-6				
BAY-876		N4-[1-[(4-cyanophenyl)methyl]-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoro-2,4-Quinolinedicarboxamide	1799753-84-6				
baysilon	63148-62-9	Octamethyltrisiloxane	63148-62-9	9G1ZW13R0G			
bazedoxifene		Bazedoxifene	198481-32-2	Q16TT9C5BK	Selective Estrogen Receptor Modulators	A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63) (See all compounds classified as Selective Estrogen Receptor Modulators.)	Indicated for following conditions alone or in combination with conjugated estrogens in women with a uterus:  - Treatment of moderate to severe vasomotor symptoms associated with menopause  - Prevention of postmenopausal osteoporosis
BBR 3464		Triplatin tetranitrate [INN:BAN]					
BBR3610		BBR3610					
BC 264		(3S)-3-[[(2S)-2-[[(2S)-2-[(3-amino-3-oxopropanoyl)amino]-3-(1H-indol-3-yl)propanoyl]-methylamino]hexanoyl]amino]-4-[[(2S)-1-[[(1S)-1-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(4-sulfooxyphenyl)propanoyl]amino]pentyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid					
BCG lipopolysaccharide		BCG lipopolysaccharide					
BCG Vaccine		BCG Vaccine					
BCH 1393		((5-(6-(N,N-dimethylamino)purin-9-yl)pentoxy)carbonyl)-D-arginine	175072-12-5	X9C2X476ZX			
BCH 2763		L-Leucine, D-phenylalanyl-L-prolyl-5-aminopentanoyl-5-aminopentanoyl-L-alpha-aspartyl-L-phenylalanyl-L-alpha-glutamyl-L-prolyl-L-isoleucyl-L-prolyl-	204641-27-0	2Y77S7IT1P			
BCI-210		BCI-210					
BD 1008	138356-08-8	N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine	138356-08-8	JCY43QE7FQ			
BDMC-A		BDMC-A					
BE 2254	40077-13-2	2-[[2-(4-hydroxyphenyl)ethylamino]methyl]-3,4-dihydro-2H-naphthalen-1-one	40077-13-2		Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	
BEACOPP protocol		Beacopp					
beauvericin	26048-05-5	(3S,6R,9S,12R,15S,18R)-3,9,15-tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone	26048-05-5	26S048LS2R			
Beclomethasone	4419-39-0	Beclomethasone	4419-39-0	KGZ1SLC28Z	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
beclomethasone 17-monopropionate	5534-18-9	Beclomethasone 17-Monopropionate	5534-18-9	5BGA9FD55H			
Bee Venoms		Bee Venoms					
befiradol		Befiradol	208110-64-9	RAT9OHA1YH	Serotonin 5-HT1 Receptor Agonists	Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes. (See all compounds classified as Serotonin 5-HT1 Receptor Agonists.)	
befloxatone	134564-82-2	Befloxatone	134564-82-2	4H75PAD8M3			
befunolol	39552-01-7	Befunolol	39552-01-7	418546MT3A	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	Used in the management of open angle glaucoma. PMID: 12480285.
BeKm-1 toxin		BeKm-1 toxin					
belinostat		Belinostat	866323-14-0	F4H96P17NZ	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Belinostat is indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) with manageable safety profile. It is a potential alternative therapy for patients who did not experience adequate response to first-line drugs for PTCL. It can be used in patients with baseline thrombocytopenia.
bellidifolin	2798-25-6	Bellidifolin	2798-25-6	X522Q6XJR9			
belnacasan		Belnacasan	273404-37-8	00OLE78529			Investigated for use/treatment in inflammatory disorders (unspecified) and psoriasis and psoriatic disorders.
bemcentinib		Bemcentinib	1037624-75-1	0ICW2LX8AS			
Bemegride	64-65-3	Bemegride	64-65-3	57DQA39DO2	Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	
bemesetron	40796-97-2	Bemesetron	40796-97-2	O98T3677PA	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
bemitradine	88133-11-3	Bemitradine	88133-11-3	LT9004D9N0			
Benactyzine	302-40-9	Benactyzine	302-40-9	595EG71R3F	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	
benazepril	86541-75-5	Benazepril	86541-75-5	PX47FSF9B3	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	Benazepril is indicated for the treatment of hypertension. It may be used alone or in combination with thiazide diuretics.
benazol P	2440-22-4	Drometrizole	2440-22-4	5X93W9OFZL			
Bendamustine Hydrochloride		Bendamustine Hydrochloride	3543-75-7	981Y8SX18M	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	
bendiocarb	22781-23-3	Bendiocarb	22781-23-3	QFH0ZU0A5U	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Bendroflumethiazide	73-48-3	Bendroflumethiazide	73-48-3	5Q52X6ICJI	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the treatment of high blood pressure and management of edema related to heart failure.
benefin		Benfluralin	1861-40-1	28224BUY6R			
benfluorex	23602-78-0	Benfluorex	23602-78-0	403FO0NQG3	Appetite Depressants	Agents that are used to suppress appetite. (See all compounds classified as Appetite Depressants.)	
benfuracarb	82560-54-1	Benfuracarb	82560-54-1	807671FRZY			
benfuresate	68505-69-1	Benfuresate	68505-69-1	5E3V59Y698			
benidipine	105979-17-7	Benidipine	105979-17-7	4G9T91JS7E	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	Benidipine is a potent and long-lasting drug indicated for the treatment of cardiovascular diseases such as hypertension, renoparenchymal hypertension and angina pectoris.
Benomyl	17804-35-2	Benomyl	17804-35-2	TLW21058F5	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
benoxacor		Benoxacor	98730-04-2	UAI2652GEV			
benoxaprofen		Benoxaprofen	51234-28-7	17SZX404IM	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
benoxaprofen glucuronide	67472-42-8	Benoxaprofen glucuronide	67472-42-8				
benoxinate	99-43-4	Oxybuprocaine	99-43-4	AXQ0JYM303	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	Used to temporarily numb the front surface of the eye so that the eye pressure can be measured or a foreign body removed.
Benperidol	2062-84-2	Benperidol	2062-84-2	97O6X78C53	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
benphothiamine	22457-89-2	S-(2-(N-((4-Amino-2-methylpyrimidin-5-yl)methyl)formamido)-5-(phosphonooxy)pent-2-en-3-yl) benzothioate	22457-89-2		Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
Benserazide	322-35-0	Benserazide	322-35-0	762OS3ZEJU	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	The primary therapeutic use for which benserazide is currently indicated for is as a combination therapy with levadopa for the treatment of Parkinson's disease in adults > 25 years of age, with the exception of drug-induced parkinsonism.  At certain doses, the combination product of levodopa and benserazide may also be used to treat restless legs syndrome, which is sometimes associated with Parkinson's disease.  There have also been some studies that have prompted the European Medicines Agency to confer orphan designation upon benserazide  hydrochloride as a potential therapy for beta thalassaemia. Although studies are ongoing, no evidence has been formally elucidated as of yet.
benserazide, levodopa drug combination		Modopar	37270-69-2		Dopamine Agents	Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. (See all compounds classified as Dopamine Agents.)	
bensulide	741-58-2	Bensulide	741-58-2	9882BW2Q2S			
bentazone	25057-89-0	Bentazone	25057-89-0	R4S7ZGZ9CT	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
benthiocarb	28249-77-6	Thiobencarb	28249-77-6	90LN6Y7I7H	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Bentonite	1302-78-9	Bentonite	1302-78-9		Dermatologic Agents	Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)	
benz(a)acridine	225-11-6	Benz[a]acridine	225-11-6	D4Q8MR98LU			
benz(a)anthracene	56-55-3	Benz(a)anthracene	56-55-3	C5PLF6152K			
benz(a)anthracene-3,4-dione		Benz(a)anthracene-3,4-dione	74877-25-1	7991ICW2Q8			
Benz(a)Anthracenes		Benz(a)Anthracenes					
benz(c)acridine	225-51-4	Benz[c]acridine	225-51-4	BV4376Y90X			
benz(j)aceanthrylene	202-33-5	Benz(j)aceanthrylene	202-33-5	844QXH8PK1			
benzaldehyde	100-52-7	Benzaldehyde	100-52-7	TA269SD04T			
Benzaldehydes		Benzaldehydes					
Benzalkonium Compounds		Benzalkonium Compounds					
benzamide	27208-38-4	Benzamide	55-21-0	6X80438640			
benzamide adenine nucleotide	156724-91-3	Benzamide adenine nucleotide	156724-91-3				
Benzamides		Benzamides					
benzamidine	618-39-3	Benzamidine	618-39-3	KUE3ZY3J1F	Serine Proteinase Inhibitors	Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)	
benzamidoxime	613-92-3	Benzamidoxime	613-92-3				
benzamil	2898-76-2	Benzamil	2898-76-2	04659UUJ94			
benzanthracene-3,4-dihydrodiol	60839-18-1	3,4-Dihydrobenz(a)anthracene-3,4-diol	60839-18-1				
benzanthrone	82-05-3	Benzanthrone	82-05-3	LP5P3RR8QN			
benzarone	1477-19-6	Benzarone	1477-19-6	23ZW4BG89C	Fibrinolytic Agents	Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)	
Benzbromarone	3562-84-3	Benzbromarone	3562-84-3	4POG0RL69O	Uricosuric Agents	Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma. (See all compounds classified as Uricosuric Agents.)	
benzcoprine	63805-80-1	N-(1-Ethoxycyclopropyl)benzamide	63805-80-1				
Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide	402-40-4	1,5-Bis(4-allyldimethylammoniumphenyl)pentan-3-one dibromide	402-40-4				
Benzene	71-43-2	Benzene	71-43-2	J64922108F			
benzene 1,2,4-trisphosphate	147527-30-8	Benzene 1,2,4-trisphosphate	147527-30-8				
Benzene Derivatives		Benzene Derivatives					
benzene oxide	1488-25-1	Benzene oxide	1488-25-1				
benzenearsonic acid	98-05-5	Phenylarsonic acid	98-05-5	57F9KU116M			
benzeneseleninic acid	6996-92-5	Benzeneseleninic acid	6996-92-5				
Benzenesulfonates		Benzenesulfonates					
Benzethonium	121-54-0	Benzethonium Chloride	121-54-0	PH41D05744	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
Benzhydryl Compounds		Benzhydryl Compounds					
benzidine	92-87-5	Benzidine	92-87-5	2X02101HVF			
benzil	134-81-6	Benzil	134-81-6	S85X61172J			
benzimidazole	51-17-2	Benzimidazole	51-17-2	E24GX49LD8	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	
Benzimidazoles		Benzimidazoles					
benzimidazolone	20662-53-7	4-(2-Keto-1-benzimidazolinyl)piperidine	20662-53-7	4RP0AED2PC			
benziodarone		Benziodarone	68-90-6	75CL65GTYR	Uricosuric Agents	Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma. (See all compounds classified as Uricosuric Agents.)	
benzo-1,2,3-thiadiazole	273-77-8	1,2,3-Benzothiadiazole	273-77-8	R3PA3EL3RP			
benzo(a)fluorene	238-84-6	11H-Benzo[a]fluorene	238-84-6	65EP6ZT62K			
Benzo(a)pyrene	50-32-8	Benzo[a]pyrene	50-32-8	3417WMA06D			
benzo(a)pyrene 7,8-dihydrodiol	13345-25-0	Benzo(a)pyrene-7,8-dihydrodiol	13345-25-0				
benzo(a)pyrene 7,8-oxide	36504-65-1	Benzo[a]pyrene-7,8-oxide	36504-65-1				
benzo(a)pyrene diolepoxide I	60268-85-1	trans-Anti-benzo(A)pyrene-7,8-diol-9,10-oxide					
benzo(a)pyrene-1,6-quinone	3067-13-8	Benzo[a]pyrene-1,6-dione	3067-13-8	MS3758O6C7			
benzo(a)pyrene-3,6-quinol	63148-10-7	Benzo[a]pyrene-3,6-diol	63148-10-7				
benzo(a)pyrene-3,6-quinone		Benzo[a]pyrene-3,6-dione	3067-14-9	CT61YDG18C			
benzo(a)pyrene-6,12-quinone	3067-12-7	Benzo(A)pyrene-6,12-dione	3067-12-7	QWW9F0H8TO			
benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide-DNA		benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide-DNA					
benzo(a)pyrene-7,8-dione	65199-11-3	Benzo[a]pyrene-7,8-dione	65199-11-3	8V4WNR6N7H			
benzo(a)pyrene-7,8,9,10-tetrol	73891-82-4	Benzo[a]pyrene-7,8,9,10-tetrol	73891-82-4				
benzo(a)pyrene-DNA adduct		benzo(a)pyrene-DNA adduct					
benzo(b)fluoranthene	205-99-2	Benzo[b]fluoranthene	205-99-2	FJO154KG1X			
benzo(b)fluorene	243-17-4	2,3-Benzofluorene	243-17-4	GMO75RUY0L			
benzo(c)chrysene	194-69-4	Benzo[c]chrysene	194-69-4	0I8Z8V58Z4			
benzo(c)phenanthrene	195-19-7	Benzo[c]phenanthrene	195-19-7	H22XVR3V8A	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
benzo(c)phenanthrene 3,4-dihydrodiol	73093-19-3	Benzo(c)phenanthrene-3,4-diol, 3,4-dihydro-, trans-(+-)-	73093-19-3				
benzo(e)pyrene	192-97-2	Benzo[e]pyrene	192-97-2	63APT6398R			
benzo(f)quinoline	85-02-9	Benzo[f]quinoline	85-02-9	525476DTML			
benzo(g)chrysene	196-78-1	Benzo[G]chrysene	196-78-1	E7MQ64XU75			
benzo(g)chrysene-11,12-dihydrodiol-13,14-epoxide	132832-27-0	Benzo(g)chrysene-11,12-dihydrodiol-13,14-epoxide	119441-69-9				
benzo(h)quinoline-5,6-dione	65938-98-9	Benzo[h]quinoline-5,6-dione	65938-98-9				
benzo(j)fluoranthene	205-82-3	7,8-Benzfluoranthene	205-82-3	P63HLW88W8			
benzo(k)fluoranthene	207-08-9	Benzo[k]fluoranthene	207-08-9	U0P6LY48VF			
Benzoates		Benzoates					
Benzocaine		Benzocaine	94-09-7	U3RSY48JW5	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	Benzocaine is indicated for local anesthesia in dentistry, minor trauma, and as preparation for infiltrative anesthesia. Benzocaine products are indicated for topical anesthesia in a wide variety of conditions including skin irritation, oral pain, and hemorrhoids.
Benzodiazepines	12794-10-4	Benzodiazepine	12794-10-4	M0Q7802G2B			
Benzoflavones		Benzoflavones					
benzofuran	271-89-6	Benzofuran	271-89-6	LK6946W774			
Benzofurans		2,3-Diphenylbenzofuran	13054-95-0				
benzohydrol	91-01-0	Diphenylmethanol	91-01-0	S4HQ1H8OWD			
benzohydroxamic acid		N-Hydroxybenzamide	495-18-1	K8YW73872D			
Benzoic Acid		Benzoic Acid	65-85-0	8SKN0B0MIM	Food Preservatives	Substances capable of inhibiting, retarding or arresting the process of fermentation, acidification or other deterioration of foods. (See all compounds classified as Food Preservatives.)	
Benzolamide	3368-13-6	Benzolamide	3368-13-6	FC5AAH89R5	Carbonic Anhydrase Inhibitors	A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES. (See all compounds classified as Carbonic Anhydrase Inhibitors.)	
benzonaphthyridone	28907-44-0	Benzonaphthyridone	28907-44-0				
benzonidazole		Benznidazole	22994-85-0	YC42NRJ1ZD	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	For use in the treatment of Chagas disease in children 2-12 years of age.
benzoperylene	11057-45-7	Benzo(a)perylene	191-85-5				
Benzophenanthridines		Benzophenanthridines					
benzophenone	119-61-9	Benzophenone	119-61-9	701M4TTV9O	Photosensitizing Agents	Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)	
Benzophenoneidum	2465-27-2	Auramine O	2465-27-2	DL992L7W39	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
Benzophenones		Benzophenones					
Benzopyrans		Benzopyrans					
Benzopyrenes		Benzopyrenes					
Benzoquinones		Benzoquinones					
benzothiazole	95-16-9	Benzothiazole	95-16-9	G5BW2593EP			
Benzothiazoles		Benzothiazoles					
benzothiophene	11095-43-5	Benzothiophene	95-15-8	073790YQ2G			
benzotriazole	27556-51-0	1H-Benzotriazole	95-14-7	86110UXM5Y			
benzotrichloride	98-07-7	Benzotrichloride	98-07-7	U62VHG99AM			
benzotriphenylene	215-58-7	Dibenz[a,c]anthracene	215-58-7	6OC62KCV5A			
Benzoxazines		Benzoxazines					
Benzoxazoles		Benzoxazole	273-53-0	J233Y1I55I			
benzoxazolone	59-49-4	2-Benzoxazolinone	59-49-4	3X996Q809V			
benzoyl chloride	98-88-4	Benzoyl chloride	98-88-4	VTY8706W36			
Benzoyl Peroxide	94-36-0	Benzoyl Peroxide	94-36-0	W9WZN9A0GM	Dermatologic Agents	Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)	Benzoyl peroxide is formulated with antibiotics such as [erythromycin] and [clindamycin] for the treatment of acne vulgaris. Benzoyl peroxide is formulated as a number of topical products for the treatment of acne. Benzoyl peroxide is also indicated in combination with [tretinoin] for the treatment of acne vulgaris in patients aged nine years and older. A triple-combination therapy including both clindamycin and [adapalene] is also available and indicated for the treatment of acne vulgaris in patients 12 years of age.  Topical benzoyl peroxide is also indicated for the treatment of inflammatory lesions of rosacea in adults.
benzoylacetone	93-91-4	Benzoylacetone	93-91-4	I3RUV8U115			
benzoylaconine	466-24-0	Benzoylaconine					
benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone		benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone					
benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone		benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone					
Benzoylcholine	2208-04-0	Benzoylcholine	2208-04-0	AE4LP5VL2P			
benzoylecgonine	519-09-5	Benzoylecgonine	519-09-5	5353I8I6YS			
benzoylhydrazine	613-94-5	Benzohydrazide	613-94-5	LLW11ZWZ20			
benzoylhypaconine		CID 78358535					
benzoylmesaconine		Benzoylmesaconine					
benzoylpaeoniflorin	38642-49-8	Benzoylpaeoniflorin	38642-49-8				
benzoylthiocholine		Benzoylthiocholine					
Benzphetamine	156-08-1	Benzphetamine	156-08-1	0M3S43XK27	Dopamine Agents	Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. (See all compounds classified as Dopamine Agents.)	For the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction
Benztropine	86-13-5	Benztropine			Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	
Benzydamine	642-72-8	Benzydamine	642-72-8	4O21U048EF	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	Available predominantly as a liquid mouthwash, oromucosal spray, or topical cream, benzydamine is most frequently employed as a locally acting analgesic and anti-inflammatory treatment for the relief of painful inflammatory conditions.   When formulated as a mouthwash or spray, benzydamine may be used to treat traumatic conditions like pharyngitis following tonsillectomy or the use of a naso-gastric tube, inflammatory conditions like pharyngitis, aphthous ulcers and oral ulceration due to radiation therapy, dentistry operations and procedures, or more general conditions like sore throat, sore tongue, sore gums, mouth ulcers, or discomfort caused by dentures.   When used as a topical cream, benzydamine may be employed to relieve symptoms associated with painful inflammatory conditions of the muscolo-skeletal system including acute inflammatory disorders such as myalgia and bursitis or traumatic conditions like sprains, strains, bruises, sore muscles, stiff joints, or even the after-effects of fractures.
benzydamine N-oxide	36504-71-9	Benzydamine N-oxide	36504-71-9	8PC48R5K78			
benzyl 2-naphthyl ether	613-62-7	Benzyl 2-naphthyl ether	613-62-7	TT5AWE5U2C			
benzyl acetate	140-11-4	Benzyl acetate	140-11-4	0ECG3V79ZJ			
Benzyl Alcohol	100-51-6	Benzyl Alcohol	100-51-6	LKG8494WBH	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	Ulesfia (benzyl alcohol) lotion is indicated for the topical treatment of head lice infestation in patients 6 months of age and older. Ulesfia Lotion does not have ovicidal activity.
Benzyl Alcohols		Benzyl Alcohols					
benzyl benzoate	120-51-4	Benzyl Benzoate	120-51-4	N863NB338G	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	Used to kill lice and the mites responsible for the skin condition scabies.
benzyl bromide	100-39-0	Benzyl bromide	100-39-0	XR75BS721D			
benzyl cinnamate		Benzyl cinnamate	103-41-3	V67O3RO97U			
benzyl isothiocyanate	622-78-6	Benzyl Isothiocyanate	622-78-6	871J6YOR8Q			
benzyl salicylate	118-58-1	Benzyl salicylate	118-58-1	WAO5MNK9TU			
benzyl selenocyanate	4671-93-6	Benzyl selenocyanate	4671-93-6	09ZBE12LSD			
Benzyl Viologen	13096-46-3	Benzyl Viologen	13096-46-3	9EC4TXL7J4			
benzyl-alpha-N-acetylgalactosamine	3554-93-6	Benzyl-alpha-galnac	3554-93-6				
benzylamine	100-46-9	Benzylamine	100-46-9	A1O31ROR09			
Benzylamines		Benzylamines					
benzylamphetamine	57378-23-1	1-Phenyl-2-benzylaminopropane	1085-42-3	1OV1CK7BED			
benzylhydrazine	555-96-4	Benzylhydrazine	555-96-4	9VP7PK6UMV			
benzylideneacetone	122-57-6	Benzylideneacetone	122-57-6	B03X40BMT5			
benzyloxyaspartate		Benzyloxyaspartate					
benzyloxycarbonyl-alanyl-glutamyl-valyl-aspartic acid fluoromethyl ketone		benzyloxycarbonyl-alanyl-glutamyl-valyl-aspartic acid fluoromethyl ketone					
benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone		benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone					
benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal		Z-Ile-Glu(O-t-butyl)-Ala-Leucinal	158442-41-2		Cysteine Proteinase Inhibitors	Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. (See all compounds classified as Cysteine Proteinase Inhibitors.)	
benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone		Z-LEHD-fmk					
benzyloxycarbonyl-leucyl-leucyl-norleucinal		benzyloxycarbonyl-leucyl-leucyl-norleucinal					
benzyloxycarbonyl-phenylalanylarginine-4-methylcoumaryl-7-amide	65147-22-0	Z-Phe-Arg-Amc HCl			Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
benzyloxycarbonyl-valyl-alanyl-aspartic acid		benzyloxycarbonyl-valyl-alanyl-aspartic acid					
benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane		benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane					
benzyloxycarbonylleucyl-leucyl-leucine aldehyde		Z-Leu-leu-leu-al	133407-82-6	RF1P63GW3K	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
benzyloxycarbonyltyrosyl-valyl-alanyl-aspartic acid fluoromethyl ketone		Caspase-1 Inhibitor VI					
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone		Benzyloxycarbonylvalyl-alanyl-aspartyl Fluoromethyl Ketone			Caspase Inhibitors	Endogenous and exogenous compounds and that either inhibit CASPASES or prevent their activation. (See all compounds classified as Caspase Inhibitors.)	
benzyloxyresorufin	87687-02-3	Benzyloxyresorufin	87687-02-3				
benzylparaben	94-18-8	Benzyl 4-hydroxybenzoate	94-18-8	8Y41DYV4VG			Benzylparaben is used in allergenic testing.
benzylphosphonic acid	6881-57-8	Benzylphosphonic acid	6881-57-8				
benzylsulfonylargininyl-proline-(4-amidinobenzyl)amide		benzylsulfonylargininyl-proline-(4-amidinobenzyl)amide					
BEP protocol		BCE protocol					
bepafant	114776-28-2	Bepafant	114776-28-2	CKS724B66O	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
Bepridil	64706-54-3	Bepridil	64706-54-3	755BO701MA	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	For the treatment of hypertension, and chronic stable angina (classic effort-associated angina).
beraprost	88430-50-6	1H-Cyclopenta(b)benzofuran-5-butanoic acid, 2,3,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-ynyl)-	88430-50-6		Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	For the treatment of pulmonary hypertension.
berbamine	478-61-5	Berbamine	478-61-5	V5KM4XJ0WM	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
Berberine	2086-83-1	Berberine	2086-83-1	0I8Y3P32UF			
Berberine Alkaloids		Berberine Alkaloids					
berberrubine	15401-69-1	Berberrubine chloride	15401-69-1				
bergamottin		Bergamottin	7380-40-7	JMU611YFRB			
bergaptol		Bergaptol	486-60-2	KTC8ANI30F			
bergenin	477-90-7	Bergenin	477-90-7	L84RBE4IDC			
Beryllium	7440-41-7	Beryllium	7440-41-7	OW5102UV6N			
beryllium chloride	7787-47-5	Beryllium Chloride	7787-47-5	58B7024067			
beryllium fluoride	7787-49-7	Beryllium Fluoride	7787-49-7	499FU9DQ5C			
beryllium nitrate	13597-99-4	Beryllium nitrate	13597-99-4 (anhydrous)	3VT1AXZ5LO			
beryllium sulfate	13510-49-1	Beryllium sulfate	13510-49-1	01UQ1KPC7E			
beryllium trifluoride	19181-26-1	Beryllium trifluoride	19181-26-1				
berzosertib		Berzosertib	1232416-25-9	L423PRV3V3			
BESEB CDRI-08		BESEB CDRI-08					
besonprodil		Besonprodil	253450-09-8	5K3N2D15WW			
beta Carotene	7235-40-7	Beta-Carotene	7235-40-7	01YAE03M7J	Provitamins	Precursor forms of vitamins. (See all compounds classified as Provitamins.)	"Beta-carotene is FDA approved to be used as a nutrient supplement and to be even added in infant formula as a source of vitamin A. It is also approved to be used as a color additive for food products, drugs (with the label of ""only as a color additive"") and cosmetics.  It is used commonly for the reduction of photosensitivity in patients with erythropoietic protoporphyria and other photosensitivity diseases."
beta-1,3-glucan	9051-97-2	(2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5S)-3,5-dihydroxy-2-(hydroxymethyl)oxan-4-yl]oxy-4-[(2S,3R,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-3,5-diol	9012-72-0		Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
beta-2-himachalen-6-ol		beta-2-himachalen-6-ol					
beta-Aminoethyl Isothiourea	151-16-6	2-Aminoethyl carbamimidothioate	151-16-6	2GIH68G0MX	Radiation-Protective Agents	Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)	
beta-amyrin		Beta-Amyrin	559-70-6	KM8353IPSO			
beta-apo-8'-carotenal		Apocarotenal	1107-26-2	V22N3E2U32			
beta-apocarotenoid-14',13'-dioxygenase		beta-apocarotenoid-14',13'-dioxygenase					
beta-carboline-3-carboxylic acid methyl ester	69954-48-9	beta-Carboline-3-carboxylic acid methyl ester	69954-48-9	I2A008F6YL	Convulsants	Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)	
beta-conglycinin protein, Glycine max		beta-conglycinin protein, Glycine max					
beta-cyclocitral		beta-Cyclocitral	432-25-7	77Y0U2X29G			
beta-Cyclodextrins		Betadex	7585-39-9	JV039JZZ3A	Sequestering Agents	Compounds that bind to and reduce the biological availability of a chemical or pharmaceutical agent. (See all compounds classified as Sequestering Agents.)	
beta-damascenone	23696-85-7	Damascenone	23696-85-7	U66V25TBO0			
beta-elemene		Beta-Elemene	33880-83-0	2QG8CX6LXD			
beta-elemonic acid		(2S)-6-methyl-2-[(5S,10S,13S,14S,17R)-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,7,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]hept-5-enoic acid	28282-25-9				
beta-Endorphin	60617-12-1	beta-ENDORPHIN	60617-12-1		Neurotransmitter Agents	Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as Neurotransmitter Agents.)	
beta-erythroidine	466-81-9	beta-ERYTHROIDINE	466-81-9	7334EOU8K5			
beta-eudesmol	473-15-4	beta-EUDESMOL	473-15-4	6R61524P48			
beta-funaltrexamine	72782-05-9	beta-Funaltrexamine	72782-05-9	9YX958J3X9	Narcotic Antagonists	Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)	
beta-Glucans		beta-Glucan	9041-22-9				
beta-glycerophosphoric acid	17181-54-3	beta-Glycerophosphoric acid	17181-54-3	WWH06G87W6			
beta-hexachlorocyclohexane		Hexachlorocyclohexane	319-86-8	IVM9A2N49K			Used as a pancreatic enzyme replacement in pancreatic insufficiency.  It is intended to mimic naturally produced human pepsin.  Pepsin powder is prepared from the gastric mucosa of pigs, cattle or sheep. In the laboratory, it is primarily used for the unspecific hydrolysis of proteins and peptides in acidic media. In addition, it provides limited hydrolysis of native immunoglobulins, yielding biologically active fragments.  In certain supplements, pepsin may be combined with betaine and HCl (hydrochloric acid) to aid in digestion in various gastrointestinal conditions,.
beta-hydroxy simvastatin acid		beta-hydroxy simvastatin acid					
beta-hydroxyisovaleric acid	625-08-1	beta-Hydroxyisovaleric acid	625-08-1	3F752311CD			
beta-hydroxyisovalerylshikonin		beta-hydroxyisovalerylshikonin					
beta-ionone	14901-07-6	beta-Ionone	79-77-6	A7NRR1HLH6			
beta-Lactams		2-Azetidinone	930-21-2				
beta-lactotensin		beta-lactotensin					
beta-lapachone		beta-Lapachone	4707-32-8	6N4FA2QQ6A	Reverse Transcriptase Inhibitors	Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)	
beta-methylcholine	7562-87-0	2-Methylcholine	7562-87-0	842Q90137O			
beta-myrcene	123-35-3	Myrcene	123-35-3	3M39CZS25B			
beta-N-methylamino-L-alanine		beta-N-Methylamino-L-alanine	15920-93-1	108SA6URTV	Excitatory Amino Acid Agonists	Drugs that bind to and activate excitatory amino acid receptors. (See all compounds classified as Excitatory Amino Acid Agonists.)	
beta-naltrexamine	67025-97-2	beta-Naltrexamine	67025-97-2				
beta-Naphthoflavone	6051-87-2	beta-Naphthoflavone	6051-87-2	1BT0256Y8O	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
beta-nitrostyrene	102-96-5	trans-beta-Nitrostyrene	102-96-5	5287E3OUAV			
beta-patchoulene		beta-Patchoulene	514-51-2				
beta-pinene	127-91-3	beta-Pinene	18172-67-3	4MS8VHZ1HJ			
beta-solamarine	3671-38-3	beta-Solamarine	3671-38-3				
beta-thujaplicin	499-44-5	Hinokitiol	499-44-5	U5335D6EBI	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
beta-thujone	471-15-8	beta-Thujone	471-15-8	8ZI5R3T54Q			
beta-Tocopherol		beta-Tocopherol	16698-35-4	8K9365K9PX	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
beta-tricalcium phosphate		Calcium Phosphate	10103-46-5	K4C08XP666			For use as an over the counter calcium and phosphate supplement, antacid, or a source of calcium and phosphate in toothpaste.
betadex	7585-39-9	Betadex	7585-39-9	JV039JZZ3A	Sequestering Agents	Compounds that bind to and reduce the biological availability of a chemical or pharmaceutical agent. (See all compounds classified as Sequestering Agents.)	
Betahistine	5638-76-6	Betahistine	5638-76-6	X32KK4201D	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	Investigated for use/treatment in adverse effects (drug), hyperlipidemia, and obesity.
Betaine	107-43-7	Betaine	107-43-7	3SCV180C9W	Gastrointestinal Agents	Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)	Betaine is indicated for the treatment of homocystinuria in pediatric and adult patients to decrease elevated homocysteine blood levels. Included within the category of homocystinuria are deficiencies or defects in cystathionine beta-synthase (CBS), 5,10-methylenetetrahydrofolate reductase (MTHFR), and cobalamin cofactor metabolism (cbl).
Betalains	37279-84-8	Betalains	37279-84-8		Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
Betamethasone	378-44-9	Betamethasone	378-44-9	9842X06Q6M	Anti-Asthmatic Agents	Drugs that are used to treat asthma. (See all compounds classified as Anti-Asthmatic Agents.)	As a member of the corticosteroid family, betamethasone is indicated for the treatment of several inflammatory conditions. As topical monotherapy, betamethasone is indicated to relieve pruritic and inflammatory symptoms of corticosteroid-responsive-dermatoses. Betamethasone can be used topically in combination with a vitamin D analog such as calcipotriene to treat plaque psoriasis. The corticosteroid is also available as an injectable suspension and can be used to manage a range of inflammatory conditions including endocrine disorders, gastrointestinal disorders, and rheumatic disorders among other conditions.
Betamethasone Valerate	2152-44-5	Betamethasone Valerate	2152-44-5	9IFA5XM7R2	Glucocorticoids	A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)	
betamethasone-17,21-dipropionate		Betamethasone Dipropionate	5593-20-4	826Y60901U	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
betanin	7659-95-2	Betanin					
Betaxolol	63659-18-7	Betaxolol	63659-18-7	O0ZR1R6RZ2	Sympatholytics	Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)	For the management of hypertension.
Bethanechol	674-38-4	Bethanechol	674-38-4	004F72P8F4	Parasympathomimetics	Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. (See all compounds classified as Parasympathomimetics.)	Bethanechol is indicated for the treatment of acute, functional postpartum and postoperative urinary retention. It is also indicated for the treatment of neurogenic atony of the bladder with retention.
betulin	473-98-3	Betulin	473-98-3	6W70HN7X7O			
Betulinic Acid		Betulinic Acid	472-15-1	4G6A18707N			
bevantolol	59170-23-9	Bevantolol	59170-23-9	34ZXW6ZV21	Adrenergic beta-1 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Antagonists.)	For the treatment of angina pectoris and hypertension.
bexagliflozin		Bexagliflozin	1118567-05-7	EY00JF42FV	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	Bexagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Bexarotene		Bexarotene	153559-49-0	A61RXM4375	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Used orally for the treatment of skin manifestations of cutaneous T-cell lymphoma (CTCL) in patients who are refractory to at least one prior systemic therapy. Also used topically for the treatment of skin lesions in early (stage IA and IB) CTCL in patients who experience refractory or persistent disease with the use of other therapies or are intolerant of other therapies.
Bezafibrate	41859-67-0	Bezafibrate	41859-67-0	Y9449Q51XH	Hypolipidemic Agents	Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)	For the treatment of primary hyperlipidaemia types IIa, IIb, III, IV and V (Fredrickson classification) corresponding to groups I, II and III of the European Atherosclerosis Society guidelines - when diet alone or improvements in lifestyle such as increased exercise or weight reduction do not lead to an adequate response. Also for the treatment of secondary hyperlipidaemias, e.g. severe hypertriglyceridemias, when sufficient improvement does not occur after correction of the underlying disorder (e.g. diabetes mellitus).
BGC638		D-Glutamic acid, N-(4-(2-propyn-1-yl((6S)-4,6,7,8-tetrahydro-2-methyl-4-oxo-3H-cyclopenta(g)quinazolin-6-yl)amino)benzoyl)-L-gamma-glutamyl-	416852-27-2	84ST9XJQ8K			
BGC945		N-(4-{[(6s)-2-(Hydroxymethyl)-4-Oxo-4,6,7,8-Tetrahydro-1h-Cyclopenta[g]quinazolin-6-Yl](Prop-2-Yn-1-Yl)amino}benzoyl)-L-Gamma-Glutamyl-D-Glutamic Acid	501332-69-0	Q718FS1C7X			
BGP 15		3-Pyridinecarboximidamide, N-(2-hydroxy-3-(1-piperidinyl)propoxy)-, hydrochloride (1:2)	66611-37-8	RLN2GTG4YS	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
BH30sucMan		BH30sucMan					
BHTOH-QM		BHTOH-QM					
BI 2536		4-{[(7r)-8-Cyclopentyl-7-Ethyl-5-Methyl-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxy-N-(1-Methylpiperidin-4-Yl)benzamide	755038-02-9	4LJG22T9C6			
BI 6		BI 6					
BI D1870		2-((3,5-difluoro-4-hydroxyphenyl)amino)-8-isopentyl-5,7-dimethyl-7,8-dihydropteridin-6(5H)-one	501437-28-1	WLN44M8WHJ			
BI-2852		(3~{S})-3-[2-[[[1-[(1-methylimidazol-4-yl)methyl]indol-6-yl]methylamino]methyl]-1~{H}-indol-3-yl]-5-oxidanyl-2,3-dihydroisoindol-1-one					
BI605906		3-Amino-4-(1,1-difluoropropyl)-6-(4-methylsulfonylpiperidin-1-yl)thieno[2,3-b]pyridine-2-carboxamide					
BIA 3-335		1-Propanone, 1-(3,4-dihydroxy-5-nitrophenyl)-3-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)-, dihydrochloride	359783-06-5	4M39AXR39C			
Bibenzyls		Bibenzyls					
BIBO 3304		Bibo 3304 trifluoroacetate	191868-14-1	O35HK034KO			
BIBP 3226		(2R)-5-(diaminomethylideneamino)-2-[(2,2-diphenylacetyl)amino]-N-[(4-hydroxyphenyl)methyl]pentanamide	159013-54-4	RG9766UGZ8	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	
BIBR 1532		(E)-2-(3-(naphthalen-2-yl)but-2-enamido)benzoic acid	321674-73-1				
BIBX 1382BS		Falnidamol	196612-93-8	0MU316797D			
bicalutamide		Bicalutamide	90357-06-5	A0Z3NAU9DP	Androgen Antagonists	Compounds which inhibit or antagonize the biosynthesis or actions of androgens. (See all compounds classified as Androgen Antagonists.)	Bicalutamide is indicated in combination with a luteinizing hormone-releasing hormone (LHRH) agonist for the treatment of Stage D2 metastatic carcinoma of the prostate.
Bicarbonates		Bicarbonate Ion	71-52-3	HN1ZRA3Q20	Buffers	A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer. (See all compounds classified as Buffers.)	
bicinchoninic acid	1245-13-2	[2,2'-Biquinoline]-4,4'-dicarboxylic acid	1245-13-2	CX56TX9Y1I	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
bictegravir		Bictegravir	1611493-60-7	8GB79LOJ07			Bictegravir is indicated in the management of HIV-1 infection in patients not previously treated with antiretroviral therapy.  Additionally, Bictegravir is indicated in the management of HIV-1 infection in patients who are virologically suppressed (HIV-1 RNA <50 c/mL) on a regular antiretroviral regimen for a minimum of three months without a history of failure in treatment and no known factors associated with the resistance to the individual components of the medication. It is used in combination with tenofovir and emtricitabine.
Bicuculline	485-49-4	Bicuculline	485-49-4	Y37615DVKC	GABA-A Receptor Antagonists	Drugs that bind to but do not activate GABA-A RECEPTORS thereby blocking the actions of endogenous or exogenous GABA-A RECEPTOR AGONISTS. (See all compounds classified as GABA-A Receptor Antagonists.)	
bicuculline methiodide	40709-69-1	Bicuculline methiodide	40709-69-1				
bicuculline methobromide	66016-70-4	Bicuculline methobromide	66016-70-4				
bicyclo(6.1.0)nonyne		Bicyclo[6.1.0]non-2-yne, cis-					
bicyclol		Bicyclol	118159-48-1	9734122TH2			
bifemelane	90293-01-9	Bifemelane	90293-01-9	Z4501GN13G	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	
bifenazate		Bifenazate	149877-41-8	24Z9QW0505			
bifendate		Bifendate	73536-69-3	0G32E321W1	Cytochrome P-450 Enzyme Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES. (See all compounds classified as Cytochrome P-450 Enzyme Inhibitors.)	
bifenox	42576-02-3	Bifenox	42576-02-3	KSB85XT26Y			
bifenthrin	82657-04-3	Bifenthrin	82657-04-3	6B66JED0KN			
bifeprunox		Bifeprunox	350992-10-8	AP69E83Z79			Bifeprunox is being evaluated for the treatment of schizophrenia, psychosis, and Parkinson's disease.
Biflavonoids		Biflavonoids					
biflorin		Biflorin	89701-85-9	YJ3TYM754D			
bifonazole	60628-96-8	Bifonazole	60628-96-8	QYJ305Z91O	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	Used for the treatment of various topical fungal infections, including athlete's foot (tinea pedis).
Biguanides		Biguanide	56-03-1	FB4Q52I9K2	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	
BIIB 513		Benzamide, N-(aminoiminomethyl)-4-(4-(2-furanylcarbonyl)-1-piperazinyl)-3-(methylsulfonyl)-, methanesulfonate (1:1)	265986-98-9	Q6418LHE3S	Sodium Channel Blockers	A class of drugs that act by inhibition of sodium influx through cell membranes. Blockade of sodium channels slows the rate and amplitude of initial rapid depolarization, reduces cell excitability, and reduces conduction velocity. (See all compounds classified as Sodium Channel Blockers.)	
BIIE 0246		Cyclopentaneacetamide, N-((1S)-4-((aminoiminomethyl)amino)-1-(((2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazolidin-4-yl)ethyl)amino)carbonyl)butyl)-1-(2-(4-(6,11-dihydro-6-oxo-5H-dibenz(b,E)azepin-11-yl)-1-piperazinyl)-2-oxoethyl)-	246146-55-4	N3Z657H81X			
BIII 890 CL		Crobenetine	221019-25-6	Q72DWI2G4C			
Bile Acids and Salts		Bile Acids and Salts					
Bilirubin	635-65-4	Bilirubin	635-65-4	RFM9X3LJ49	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
bilirubin ditaurine	89771-93-7	Bilirubin ditaurine	89771-93-7				
bilirubin glucuronate	27071-67-6	bilirubin glucuronate					
Biliverdine	114-25-0	Biliverdin	114-25-0	O9MIA842K9			
bilobalide		Bilobalide	33570-04-6	M81D2O8H7U			
BIM 23120		BIM 23120					
BIM 23127		N-(1-Amino-3-naphthalen-2-yl-1-oxopropan-2-yl)-19-[(2-amino-3-naphthalen-2-ylpropanoyl)amino]-10-(3-aminopropyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide					
BIM 23206		BIM 23206					
bimoclomol		Bimoclomol	130493-03-7	9IYF14814M			Investigated for use/treatment in neuropathy (diabetic) and wounds.
binimetinib		Binimetinib	606143-89-9	181R97MR71			Binimetinib, in conjunction with encorafenib, is indicated for the treatment of unresectable or metastatic melanoma with BRAF V600E or V600K mutation and metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation.
binospirone mesylate	124756-23-6	Binospirone mesylate	124756-23-6	155R3B9K8H	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	
bioallethrin	28434-00-6	S-Bioallethrin	28434-00-6	GFF4AL7FRM	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
biochanin A	491-80-5	Biochanin A	491-80-5	U13J6U390T	Phytoestrogens	Compounds derived from plants, primarily ISOFLAVONES that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS. (See all compounds classified as Phytoestrogens.)	
Biofuels		Biofuels					
Biogenic Monoamines		Biogenic Monoamines					
Biological Factors		Biological Factors					
Biological Products		Biological Products					
Biomarkers		Biomarkers					
Biopterins		Biopterins					
bioresmethrin	28434-01-7	Bioresmethrin	28434-01-7	8535H601Y7	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Biotin	58-85-5	Biotin	58-85-5	6SO6U10H04	Vitamin B Complex	A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)	For nutritional supplementation, also for treating dietary shortage or imbalance.
biotinylated linoleoylglycerylphosphatidylcholine		biotinylated linoleoylglycerylphosphatidylcholine					
Biperiden	514-65-8	Biperiden	514-65-8	0FRP6G56LD	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	For use as an adjunct in the therapy of all forms of parkinsonism and control of extrapyramidal disorders secondary to neuroleptic drug therapy.
biphenyl		Biphenyl	92-52-4	2L9GJK6MGN	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
biphenyl 2,3',4,5',6-pentakisphosphate		Biphenyl 2,3',4,5',6-Pentakisphosphate					
Biphenyl Compounds		Biphenyl Compounds					
biphenyl-indanone A		Biphenylindanone A	866823-73-6				
biphenylylacetic acid	51317-25-0	51317-25-0					
biphosphinic palladacycle complex		biphosphinic palladacycle complex					
bis-N,N-dimethylamino-2-(N-methylpyrrolyl)methyl cyclopentadienyl titanium (IV)		bis-N,N-dimethylamino-2-(N-methylpyrrolyl)methyl cyclopentadienyl titanium (IV)					
bis((2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N,N')copper(II)		bis((2-oxindol-3-ylimino)-2-(2-aminoethyl)pyridine-N,N')copper(II)					
bis(1-chloro-2-propyl)phosphate		bis(1-chloro-2-propyl)phosphate					
bis(1-piperidylthiocarbonyl)disulfide	94-37-1	Dipentamethylenethiuram disulfide	94-37-1	CR113982E5			
bis(1,3-dichloropropyl)phosphate		bis(1,3-dichloropropyl)phosphate					
bis(12)-hupyridone		bis(12)-hupyridone					
bis(2-chloroethoxy)methane		Bis(2-chloroethoxy)methane	111-91-1	5288KK0810			
bis(2-chloroethyl)ethylamine	538-07-8	Bis(2-chloroethyl)ethylamine	538-07-8	B75ZZA7WIG			
bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate		Bis(2-ethylhexyl) tetrabromophthalate	26040-51-7	413M0N3V1G			
bis(2-guanidinoethyl)disulfide	1072-13-5	Guanidinoethyl disulfide	1072-13-5	ON58WN42P2			
bis(2-hydroxy-2-ethylbutanoato)oxochromate(V)	70132-29-5	Bis(2-hydroxy-2-ethylbutanoato)oxochromate(V)					
bis(2-hydroxybenzylidene)acetone		bis(2-hydroxybenzylidene)acetone					
bis(2-propylheptyl)phthalate		Bis(2-propylheptyl) phthalate	53306-54-0				
bis(2,3,3,3-tetrachloropropyl) ether	127-90-2	Bis(2,3,3,3-tetrachloropropyl) ether	127-90-2				
bis(2,9-dimethyl-1,10-phenanthroline)copper(II)		bis(2,9-dimethyl-1,10-phenanthroline)copper(II)					
bis(3-hydroxyphenyl) diselenide		bis(3-hydroxyphenyl) diselenide					
bis(3',5')-cyclic diguanylic acid	61093-23-0	9,9'-[(2r,3r,3as,5s,7ar,9r,10r,10as,12s,14ar)-3,5,10,12-Tetrahydroxy-5,12-Dioxidooctahydro-2h,7h-Difuro[3,2-D:3',2'-J][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-Diyl]bis(2-Amino-1,9-Dihydro-6h-Purin-6-One)	61093-23-0				
bis(3)-cognitin		Bis(3)-cognitin					
bis(4-acetamidophenyl) 1-prolylpyrrolidine-2-phosphonate		bis(4-acetamidophenyl) 1-prolylpyrrolidine-2-phosphonate					
Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide	26087-98-9	Bis((hexahydro-4-methyl-1H-1,4-diazepin-1-yl)thiocarbonyl)disulfide	26087-98-9	6XX8M7P9DC			
bis(4-nitrophenyl)phosphate	645-15-8	Bis(4-nitrophenyl) hydrogen phosphate	645-15-8	1MF77LEI63	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
bis(4-oxyphenyl)sulfide	2664-63-3	4,4'-Thiodiphenol	2664-63-3	NGN288M6MM			
bis(8-quinolinolato)copper(II)	10380-28-6	Copper 8-hydroxyquinolinate	10380-28-6				
bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV)		bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV)					
bis(allixinato)oxovanadium(IV)		bis(allixinato)oxovanadium(IV)					
bis(alpha-furancarboxylato)oxovanadium(IV)		bis(alpha-furancarboxylato)oxovanadium(IV)					
bis(cysteinato)zincate(lI)		bis(cysteinato)zincate(lI)					
bis(isopropyl methyl)phosphonate		bis(isopropyl methyl)phosphonate					
bis(maleimido)ethane		bis(maleimido)ethane					
bis(maltolato)oxovanadium(IV)	38213-69-3	bis(maltolato)oxovanadium(IV)	38213-69-3	HA933D78YW			
bis(maltolato)zinc(II)		bis(maltolato)zinc(II)					
bis(monoacylglyceryl)phosphate		bis(monoacylglyceryl)phosphate					
bis(N,N-diethyldithiocarbamate)Cu (II) complex	13681-87-3	Cupric diethyldithiocarbamate	13681-87-3				
bis(phenylimidazoselenazolyl) diselenide		bis(phenylimidazoselenazolyl) diselenide					
bis(quercetinato)oxovanadium(IV)		bis(quercetinato)oxovanadium(IV)					
bis(sulfosuccinimidyl)suberate		Bis(sulfosuccinimidyl)suberate	82436-77-9	E647932J7Z	Cross-Linking Reagents	Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)	
bis(tri-n-butyltin)oxide		Bis(tributyltin) oxide	56-35-9	3353Q84MKM	Disinfectants	Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley&apos;s Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Disinfectants.)	
bisabolol	515-69-5	Bisabolol	515-69-5	105S6I733Z			
bisacurone		Bisacurone	120681-81-4	SA836UFA35			
bisbenzimide ethoxide trihydrochloride		Bisbenzimide ethoxide trihydrochloride	875756-97-1	P976261J69	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
bisdemethoxycurcumin	24939-16-0	Bisdemethoxycurcumin	33171-05-0	2EFO1BP34R			
bisdequalinium	16776-40-2	Bisdequalinium	16776-40-2	N848P5O593			
bisdesmethoxycurcumin		Bisdemethoxycurcumin	33171-05-0	2EFO1BP34R			
Bisecurin I	8056-92-6	Bisecurin I	8056-92-6		Contraceptives, Oral, Hormonal	Oral contraceptives which owe their effectiveness to hormonal preparations. (See all compounds classified as Contraceptives, Oral, Hormonal.)	
bisindolylmaleimide	119139-23-0	Bisindolylmaleimide IV	119139-23-0	MBK3OO5K8T			
bisindolylmaleimide I		Bisindolylmaleimide i	133052-90-1	L79H6N0V6C	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
bisindolylmaleimide II		Bisindolylmaleimide II	137592-45-1				
bisindolylmaleimide IX		bisindolylmaleimide IX	125314-64-9	W9A0B5E78O	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Bismuth	7440-69-9	Bismuth	7440-69-9	U015TT5I8H	Antacids	Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT. (See all compounds classified as Antacids.)	
bismuth nitrate	10361-44-1	Bismuth nitrate	10361-44-1	4R459R54N0			
bismuth tripotassium dicitrate	57644-54-9	Bismuth subcitrate	57644-54-9	HS813P8QPX	Antacids	Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT. (See all compounds classified as Antacids.)	For the treatment of peptic ulcer and gastro-oesophageal reflux disease (GORD). Treatment of inflammatory and erosive-ulcerous diseases of gastric and duodenal mucosa:  gastritis, ulcer disease of the stomach and duodenum, functional non-ulcerous dyspepsia, erosive duodenitis, post-operative inflammatory and erosive changes  anastomositis, peptic ulcer of anastomosis
bisnaphthalimidopropylspermidine		bisnaphthalimidopropylspermidine					
Bisoprolol	66722-44-9	Bisoprolol	66722-44-9	Y41JS2NL6U	Adrenergic beta-1 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Antagonists.)	Bisoprolol is indicated for the treatment of mild to moderate hypertension. It may be used off-label to treat heart failure, atrial fibrillation, and angina pectoris.
bisoxatin acetate	14008-48-1	Bisoxatin acetate	14008-48-1	79W5LFS83K			
bisperoxo(1,10-phenanthroline)oxovanadate(1-)	68832-78-0	Bpv(phen)					
bisperoxovanadium		bisperoxovanadium					
bisphenol A	80-05-7	Bisphenol A	80-05-7	MLT3645I99	Estrogens, Non-Steroidal	Non-steroidal compounds with estrogenic activity. (See all compounds classified as Estrogens, Non-Steroidal.)	
bisphenol A glucuronide		(2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-(4-(2-(4-hydroxyphenyl)propan-2-yl)phenoxy)tetrahydro-2H-pyran-2-carboxylic acid	267244-08-6				
Bisphenol A-Glycidyl Methacrylate	1565-94-2	Silux	1565-94-2	454I75YXY0			
bisphenol B		Bisphenol B	77-40-7	1RC731TJJA			
bisphenol E		1,1-Bis(4-hydroxyphenyl)ethane	2081-08-5	9U3NFM6ULF			
bisphenol F		4,4'-Methylenediphenol	620-92-8	QD2C19044Z			
bisphenol F diglycidyl ether		Bisphenol F diglycidyl ether	2095-03-6	V3625OQU1K			
bisphenol S	80-09-1	4,4'-Sulfonyldiphenol	80-09-1	3OX4RR782R			
bispyribac		Bispyribac	125401-75-4	9W20BD966G	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
bistratene A	115566-02-4	2,17,28-Trioxa-13,26-diazatricyclo(14.7.4.16,9)octacosane-14,25-dione, 6-hydroxy-18-(6-hydroxy-3,5-dimethyl-4-heptenyl)-8,15,23-trimethyl-3-(2-oxo-3-pentenyl)-	115566-02-4				
bitertanol		Bitertanol	55179-31-2		Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Bithionol	97-18-7	Bithionol	97-18-7	AMT77LS62O	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
bitolterol	30392-40-6	Bitolterol	30392-40-6	9KY0QXD6LI	Adrenergic beta-2 Receptor Agonists	Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)	Used to dilate air passages in the lungs that have become narrowed as a result of disease or inflammation. It is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
bivalirudin	128270-60-0	Bivalirudin	128270-60-0	TN9BEX005G	Antithrombins	Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. (See all compounds classified as Antithrombins.)	For treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivalirudin is indicated for use in patients undergoing percutaneous coronary intervention (PCI), in patients at moderate to high risk acute coronary syndromes due to unstable angina or non-ST segment elevation in whom a PCI is planned.
BIX 01294		BIX 01294 Trihydrochloride	1392399-03-9	57HBY4AC4W			
BIX 02188		(Z)-3-(((3-((dimethylamino)methyl)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxamide	1094614-84-2	4Y3VYY2X83			
BIX 02189		(Z)-3-((3-((dimethylamino)methyl)phenylamino)(phenyl)methylene)-N,N-dimethyl-2-oxoindoline-6-carboxamide	1265916-41-3				
bixin	6983-79-5	Bixin	6983-79-5	9L7T4VB66G			
BL 11282		BL 11282					
BL1521		2,4,6-Heptatrienamide, N-hydroxy-7-phenyl-, (2E,4E,6E)-	463329-07-9	028K52V859	Histone Deacetylase Inhibitors	Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)	
black widow spider venom		Venom, spider, Latrodectus indistinctus					
blasticidin S	2079-00-7	Blasticidin S	2079-00-7		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Bleaching Agents		Bleaching Agents					
blebbistatin		Blebbistatin	674289-55-5	20WC4J7CQ6			
bleomycetin	11116-32-8	Bleomycetin	11116-32-8		Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	
Bleomycin	11056-06-7	Bleomycin	11056-06-7	40S1VHN69B	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	For palliative treatment in the management malignant neoplasm (trachea, bronchus, lung), squamous cell carcinoma, and lymphomas.
Blood Glucose		Blood Glucose					
BLX 1002		BLX 1002					
BM 13677	129393-59-5	2-((3-Phenylpropoxy)imino)butanoic acid	129393-59-5				
BM 15766	86621-92-3	4-(2-(1-(4-Chlorocinnamyl)piperazin-4-yl)ethyl)benzoic acid	86621-92-3	FE9XN4NVW4	Anticholesteremic Agents	Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)	
BM 42304	88333-74-8	2-[3-(3-Methylphenyl)prop-2-enylhydrazinylidene]propanoate					
BM 910228		BM 910228					
BmK IT2 scorpion toxin		BmK IT2 scorpion toxin					
Bmk NT1 toxin, Buthus martensii Karsch		Bmk NT1 toxin, Buthus martensii Karsch					
BMS 181101		1H-Indole, 5-fluoro-3-(3-(4-(5-methoxy-4-pyrimidinyl)-1-piperazinyl)propyl)-, dihydrochloride	146479-45-0	K6PLZ2RJU5			
BMS 189453		Benzoic acid, 4-(2-(5,6-dihydro-5,5-dimethyl-8-phenyl-2-naphthalenyl)ethenyl)-, (E)-	166977-43-1	M531IV9E0V			
BMS 191095		(3R,4S)-4-[4-chloro-N-(1H-imidazol-2-ylmethyl)anilino]-3-hydroxy-2,2-dimethyl-3,4-dihydrochromene-6-carbonitrile	166095-21-2	K6V527OYN8			
BMS 310705		21-Aminoepothilone B	280578-49-6	J3SLJ7D1EH			
BMS 536924		4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone	468740-43-4	40E3AZG1MX			
BMS 649		Benzoic acid, 4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1,3-dioxolan-2-yl]-	146670-40-8				
BMS 708163		Avagacestat	1146699-66-2	TQ44WWY45Q	Gamma Secretase Inhibitors and Modulators	Agents that suppress GAMMA-SECRETASE by inhibiting or modulating its activities. Targeted enzymatic activities include its involvement in accumulation of toxic AMYLOID BETA-PEPTIDES (e.g., A&#x3B2;42) in ALZHEIMER DISEASE and activation of NOTCH RECEPTOR mediated SIGNAL PATHWAYS in certain cancer types. (See all compounds classified as Gamma Secretase Inhibitors and Modulators.)	
BMS 754807		Bms-754807	1001350-96-4	W9E3353E8J			
BMS 961		3-Fluoro-4-[[2-hydroxy-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)acetyl]amino]benzoic acid	185629-22-5				
BMS-764459		2-Pyrazinecarbonitrile,4-[(1S)-1-cyclopropyl-2-methoxyethyl]-6-[[6-(difluoromethoxy)-2,5-dimethyl-3-pyridinyl]amino]-4,5-dihydro-5-oxo-					
BMS-906024		Bms-906024	1401066-79-2	DRL23N424R			
BMS-986094		L-Alanine, N-(2'-C-methyl-6-O-methyl-P-1-naphthalenyl-5'-guanylyl)-, 2,2-dimethylpropyl ester	1234490-83-5	62F4AD749Y			
BMS201038		Lomitapide	182431-12-5	82KUB0583F			Used in homozygous familial hypercholesterolemia (HoFH) patients to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B), and non-high-density lipoprotein cholesterol (non-HDL-C).
BMS225975		BMS225975					
BMS453		Benzoic acid, 4-(2-(5,6-dihydro-5,5-dimethyl-8-phenyl-2-naphthalenyl)ethenyl)-, (E)-	166977-43-1	M531IV9E0V			
BMY 7378	21102-94-3	8-(2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl)-8-azaspiro[4.5]decane-7,9-dione	21102-94-3	08EI0K81OL	Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	
BN 50730	132579-32-9	Rocepafant	132579-32-9	4KGX1STY2N	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
BN 50739	128672-07-1	4H-Pyrido(4',3':4,5)thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 6-(2-chlorophenyl)-9-(2-((3,4-dimethoxyphenyl)thio)-1-thioxoethyl)-7,8,9,10-tetrahydro-1-methyl-	128672-07-1		Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
BnSO(2)-D-Arg-Gly-Arg-ketothiazole		BnSO(2)-D-Arg-Gly-Arg-ketothiazole					
BO-1012		BO-1012					
BO-1051		BO-1051					
Boc-D-FMK		Boc-D-FMK	187389-53-3				
BODIPY-FL prazosin		BODIPY-FL prazosin					
bohemine		Bohemine	189232-42-6				
boldenone		Boldenone	846-48-0	5H7I2IP58X	Anabolic Agents	These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. (See all compounds classified as Anabolic Agents.)	
boldenone undecylenate	13103-34-9	Boldenone Undecylenate	13103-34-9	ZS6D2ITA30			
boldine	476-70-0	Boldine	476-70-0	8I91GE2769	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
boldine methine		boldine methine					
bolinaquinone		Bolinaquinone	216498-95-2	HQ9RW9S9S5			
Bolton Hunter-cholecystokinin nonapeptide	117829-67-1	Bolton hunter-cholecystokinin nonapeptide	117829-67-1				
Bombesin	31362-50-2	Alytesin, 2-L-glutamine-6-L-asparagine-	31362-50-2	PX9AZU7QPK	Neurotransmitter Agents	Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as Neurotransmitter Agents.)	
bombesin (6-14), Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)-	138147-78-1	(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[1-[(1-amino-4-methyl-1-oxopentan-2-yl)amino]-4-methylpentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carbonylamino)pentanediamide;2,2,2-trifluoroacetic acid			Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	
bombesin (7-14)		bombesin (7-14)					
bombesin, Tyr(4)-	67338-70-9	4-Tyr-bombesin	67338-70-9				
Bongkrekic Acid	11076-19-0	Bongkrekic acid	11076-19-0	L7V4I673D2	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
bopindolol	69010-88-4	Bopindolol	62658-63-3	KT304VZO57	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	For the management of hypertension, edema, ventricular tachycardias, and atrial fibrillation.
boric acid	11113-50-1	Boric Acid	10043-35-3	R57ZHV85D4	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	No FDA- or EMA-approved therapeutic indications on its own.
Boric Acids		Boric Acids					
bornyl caffeate		Bornyl caffeate					
Boron	7440-42-8	Boron	7440-42-8	N9E3X5056Q	Trace Elements	A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)	
Boron Compounds		Boron compounds					
boron nitride		Boron nitride	10043-11-5	2U4T60A6YD			
Boronic Acids		CHEBI:38269					
borrelidin	7184-60-3	Borrelidin	7184-60-3	PWC22KGM2P			
Bortezomib		Bortezomib	179324-69-7	69G8BD63PP	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Bortezomib is indicated for the treatment of adults with multiple myeloma or mantle cell lymphoma.
Bosentan	147536-97-8	Bosentan	147536-97-8	XUL93R30K2	Endothelin Receptor Antagonists	Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN RECECPTORS. (See all compounds classified as Endothelin Receptor Antagonists.)	Used in the treatment of pulmonary arterial hypertension (PAH), to improve exercise ability and to decrease the rate of clinical worsening (in patients with WHO Class III or IV symptoms).
bosutinib		Bosutinib	380843-75-4	5018V4AEZ0	Tyrosine Kinase Inhibitors	Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES. (See all compounds classified as Tyrosine Kinase Inhibitors.)	Bosutinib is indicated for the treatment of adult and pediatric patients 1 year of age and older with chronic phase Philadelphia chromosome-positive chronic myelogenous leukemia that is newly diagnosed or resistant or intolerant to prior therapy. It is also indicated for the treatment of adult patients with accelerated or blast phase Philadelphia chromosome-positive chronic myelogenous leukemia that is newly diagnosed or resistant or intolerant to prior therapy.
boswellic acid	631-69-6	beta-Boswellic acid	631-69-6	B252M1YO2V	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
bothrojaracin	150633-76-4	Bothrojaracin					
botulinum toxin type C		botulinum toxin type C					
botulinum toxin type D		botulinum toxin type D					
botulinum toxin type E		botulinum toxin type E					
botulinum toxin type F		botulinum toxin type F					
botulinum toxin type G		botulinum toxin type G					
Botulinum Toxins		Botulinum Toxins					
Botulinum Toxins, Type A		Botulinum Toxins, Type A					
bourgeonal	18127-01-0	3-(4-Tert-butylphenyl)propanal	18127-01-0	H3XVS6E70V			
bovine serum albumin-corticosterone conjugate		bovine serum albumin-corticosterone conjugate					
BP 2-94	139191-80-3	2-((N-(1-(1H-Imidazol-4-yl)-2-propyl)imino)phenylmethyl)phenol	139191-80-3				
BP 897		2-Naphthalenecarboxamide, N-(4-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)-	192384-87-5	2FVL90IM8I	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
BP-1-102		4-(N-(4-cyclohexylbenzyl)-2-(2,3,4,5,6-pentafluoro-N-methylphenylsulfonamido)acetamido)-2-hydroxybenzoic acid	1334493-07-0				
BP-PM6		BP-PM6					
BPC96 peptide		BPC96 peptide					
BPDE-II	60268-86-2	trans-syn-Benzo(a)pyrene-7,8-diol-9,10-oxide					
BPMC	3766-81-2	Fenobucarb	3766-81-2	5MS2P7M0CF			
BQ 22-708	39715-02-1	Endralazine	39715-02-1	L44741F05P	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
BQ 485	141594-26-5	Perhydroazepino-N-carbonyl-L-Leu-D-Trp-D-Trp	141594-26-5				
BQ 610	141595-53-1	(2R)-2-[[(2R)-2-[[(2S)-2-(azepane-1-carbonylamino)-4-methylpentanoyl]amino]-3-(1-formylindol-3-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoic acid	141595-53-1				
BQ 788		BQ-788	156161-89-6	44OLL8XEJ4	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
Bradykinin	58-82-2	Bradykinin	58-82-2		Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
bradykinin, des-Arg(9)-	15958-92-6	[Des-Arg9]-BRADYKININ	15958-92-6	58QE2VVE3Q			
bradykinin, Leu(8)-des-Arg(9)-	64695-06-3	[Leu8,des-Arg9]bradykinin	64695-06-3				
bradykinin, Lys-Leu(8)-desArg(9)-		bradykinin, Lys-Leu(8)-desArg(9)-					
bradykinin, Sar-(D-Phe(8))des-Arg(9)	126959-88-4	(2R)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-1-[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid	126959-88-4				
brassinin	105748-59-2	Brassinin	105748-59-2	J2IBO1B8VH			
brassinolide	72962-43-7	Brassinolide	72962-43-7	Y9IQ1L53OX	Plant Growth Regulators	Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins. (See all compounds classified as Plant Growth Regulators.)	
brazilein	600-76-0	Brazilein	600-76-0				
brazilin	474-07-7	Brazilin	474-07-7	FZ39SW1K10			
BRD4770		Methyl 2-benzamido-1-(3-phenylpropyl)-1H-benzo[d]imidazole-5-carboxylate	1374601-40-7				
Brefeldin A	20350-15-6	brefeldin A	20350-15-6	XG0D35F9K6	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
bremazocine	75684-07-0	Bremazocine	75684-07-0	ISF76M2DBE	Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
brequinar	96187-53-0	Brequinar	96187-53-0	5XL19F49H6	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	
Bresol		Bresol					
bretazenil	84379-13-5	Bretazenil	84379-13-5	OSZ0E9DGOJ	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
Bretylium Tosylate	61-75-6	Bretylium Tosylate	61-75-6	78ZP3YR353	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
brevetoxin	98225-48-0	Brevetoxin	98225-48-0				
brevetoxin 2		Brevetoxin B	79580-28-2	8WBN7K7T6Z			
brevetoxin 3		Brevetoxin 3	85079-48-7				
brevetoxin B	79580-28-2	Brevetoxin B	79580-28-2	8WBN7K7T6Z			
brevianamide A	23402-09-7	Brevianamide A	23402-09-7	L2S5E3NBIH			
breviscapine	116122-36-2	Scutellarin	27740-01-8	16IGP0ML9A			
brexpiprazole		Brexpiprazole	913611-97-9	2J3YBM1K8C	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	Brexpiprazole is indicated as adjunctive therapy to antidepressants for the treatment of major depressive disorder in adults. It is also indicated for the treatment of schizophrenia in patients 13 years of age and older.  Brexpiprazole is also indicated for the treatment of agitation associated with dementia due to Alzheimers disease; however, it is not indicated as an as-needed (prn) treatment for this condition.
Bridged Bicyclo Compounds, Heterocyclic		Bridged Bicyclo Compounds, Heterocyclic					
brilliant blue		Brilliant Blue FCF	3844-45-9	PPQ093M8HR	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
brilliant green	633-03-4	Brilliant green	633-03-4	G0L543D370	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
Brimonidine Tartrate		Brimonidine Tartrate	70359-46-5	4S9CL2DY2H	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	Mirvaso is indicated for the symptomatic treatment of facial erythema of rosacea in adult patients.
brinzolamide		Brinzolamide	138890-62-7	9451Z89515	Carbonic Anhydrase Inhibitors	A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES. (See all compounds classified as Carbonic Anhydrase Inhibitors.)	Brinzolamide, either as a standalone agent or in combination with brimonidine, is approved by the FDA for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Brinzolamide is also approved in Europe to be used in combination with timolol to treat the same conditions.
brivaracetam		Brivaracetam	357336-20-0	U863JGG2IA	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	Used as adjunctive therapy for partial-onset seizures in patients 16 years of age or older.
brivudine		Brivudine	69304-47-8	2M3055079H	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
BRL 15572		3-[4-(3-Chlorophenyl)piperazin-1-yl]-1,1-diphenylpropan-2-ol	734517-40-9	LY8CZE6XUD	Serotonin 5-HT1 Receptor Antagonists	Drugs that bind to but do not activate SEROTONIN 5-HT1 RECEPTORS, thereby blocking the actions of SEROTONIN 5-HT1 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more of the specific 5-HT1 receptor subtypes. (See all compounds classified as Serotonin 5-HT1 Receptor Antagonists.)	
BRL 26830A	87857-42-9	Methyl 4-(2-((2-hydroxy-2-phenethyl)amino)propyl)benzoate-2-butanedioate	87857-42-9		Adrenergic beta-Agonists	Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)	
BRL 35135	91097-81-3	Methyl 4-(2-(2-hydroxy-2-(3-chlorophenyl)ethylamino)propyl)phenoxyacetate	91097-81-3		Adrenergic beta-Agonists	Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)	
BRL 37344		2-(4-((2R)-2-(((2R)-2-(3-Chlorophenyl)-2-hydroxyethyl)amino)propyl)phenoxy)acetic acid	116049-78-6	5DZZ1926YW	Adrenergic beta-Agonists	Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)	
BRL 39924A	131221-62-0	CID 196844	131221-62-0				
BRL 41992	124097-52-5	1,2-Dimethyl-2,3,9,13b-tetrahydro-1Hdibenzo(c,f)imidazo(1,5-a)azepine	124097-52-5				
BRL 44408		2-((4,5-Dihydro-1H-imidazol-2-yl)methyl)-2,3-dihydro-1-methyl-1H-isoindole	118343-19-4	ZET7B198W2	Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	
brofaromine	63638-91-5	Brofaromine	63638-91-5	6WV4B8Q07H	Monoamine Oxidase Inhibitors	A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed, p414) (See all compounds classified as Monoamine Oxidase Inhibitors.)	
bromacil	314-40-9	Bromacil	314-40-9	I048FFR2J0	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
bromadiolone	28772-56-7	Bromadiolone	28772-56-7		Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	
bromadoline	67579-24-2	Bromadoline	67579-24-2	R8DWN01P1M			
Bromates		Bromate	15541-45-4				
Bromazepam	1812-30-2	Bromazepam	1812-30-2	X015L14V0O	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	For the short-term treatment of insomnia, short-term treatment of anxiety or panic attacks, if a benzodiazepine is required, and the alleviation of the symptoms of alcohol- and opiate-withdrawal.
brombuterol	41937-02-4	Brombuterol	41937-02-4				
Bromcresol Green	76-60-8	Bromocresol green	76-60-8	8YGN0Y942M	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
Bromcresol Purple	115-40-2	Bromocresol purple	115-40-2	201C22C3EC	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
bromerguride	83455-48-5	Bromerguride	83455-48-5	HX58M2377W			
bromfenac	91714-94-2	Bromfenac	91714-94-2	864P0921DW	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	For the treatment of postoperative inflammation in patients who have undergone cataract extraction.
bromfenacoum	56073-10-0	Brodifacoum	56073-10-0	A25P3CP5S7	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	
bromfenvinphos	33399-00-7	Bromfenvinphos	33399-00-7				
Bromhexine	3572-43-8	Bromhexine	3572-43-8	Q1J152VB1P	Expectorants	Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here. (See all compounds classified as Expectorants.)	Bromohexine is used alone or with other ingredients such as [diphenhydramine], [dextromethorphan], and [guaifenesin] to reduce mucus viscosity and clear mucus in conditions associated with mucus hypersecretion, including the common cold, influenza, respiratory tract infections, or other conditions.
Bromides		Bromides					
bromindione	1146-98-1	Bromindione	1146-98-1	OQZ7BND2QN			
Bromine	7726-95-6	Bromine	7726-95-6	SBV4XY874G			
Bromkal 70	60371-14-4	Bromkal 70					
bromoacetanilide	103373-69-9	Bromoacetanilide	103373-69-9				
bromoacetate	68-10-0	Bromoacetate	68-10-0				
bromoacetonitrile		Bromoacetonitrile	590-17-0	07K08J16VK			
bromobenzene	108-86-1	Bromobenzene	108-86-1	CO4D5J547L			
Bromobenzoates		Bromobenzoates					
bromochloroacetic acid		Bromochloroacetic acid	68238-35-7	AL8MZ37Y51			
bromochloroacetonitrile	83463-62-1	Bromochloroacetonitrile	83463-62-1	SHY3J1BBQ6			
Bromocriptine	25614-03-3	Bromocriptine	25614-03-3	3A64E3G5ZO	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	For the treatment of galactorrhea due to hyperprolactinemia, prolactin-dependent menstrual disorders and infertility, prolactin-secreting adenomas, prolactin-dependent male hypogonadism, as adjunct therapy to surgery or radiotherapy for acromegaly or as monotherapy is special cases, as monotherapy in early Parksinsonian Syndrome or as an adjunct with levodopa in advanced cases with motor complications. Bromocriptine has also been used off-label to treat restless legs syndrome and neuroleptic malignant syndrome.
bromocyclen	1715-40-8	Bromociclen	1715-40-8				
Bromodeoxyuridine	59-14-3	5-Bromo-2'-deoxyuridine	59-14-3	G34N38R2N1	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	
bromodichloromethane	75-27-4	Bromodichloromethane	75-27-4	7LN464CH2O	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
bromoethane	74-96-4	Bromoethane	74-96-4	LI8384T9PH			
bromoform	75-25-2	Bromoform	75-25-2	TUT9J99IMU	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
bromophos		Bromofos	2104-96-3	74A4TNE8C3			
bromopride	4093-35-0	Bromopride	4093-35-0	75473V2YZK	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	Bromopride in indicated in the treatment of nausea and vomiting, including PONV (post-operative nausea and vomiting), gastroesophageal reflux disease (GERD/GORD), as well as endoscopy preparation and radiographic studies of the GI tract.
bromopyruvate	1113-59-3	Bromopyruvic acid	1113-59-3	63JMV04GRK	Affinity Labels	Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. (See all compounds classified as Affinity Labels.)	
Bromosuccinimide	39660-53-2	3-Bromopyrrolidine-2,5-dione	39660-53-2				
bromotetrandrine		Bromotetrandrine	62067-29-2	V3ORV27YJY			
bromotriethylstannane	2767-54-6	Triethyltin bromide	2767-54-6	UOP17166KC			
bromovanin		bromovanin					
bromoxynil	1689-84-5	Bromoxynil	1689-84-5	J46EK95K0P			
bromoxynil octanoate	1689-99-2	Bromoxynil octanoate	1689-99-2	9HL5XAW9SK			
bromperidol	10457-90-6	Bromperidol	10457-90-6	LYH6F7I22E	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
Brompheniramine	86-22-6	Brompheniramine	86-22-6	H57G17P2FN	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	For the treatment of the symptoms of the common cold and allergic rhinitis, such as runny nose, itchy eyes, watery eyes, and sneezing.
Bromphenol Blue	115-39-9	Bromophenol Blue	115-39-9	0R2969YC90	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
Bromthymol Blue	76-59-5	Bromothymol blue	76-59-5	VGU4LM0H96	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
bromuconazole		Bromuconazole	116255-48-2	PHS29ZMZ81			
bropirimine	56741-95-8	Bropirimine	56741-95-8	J57CTF25XJ	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
brorphine		Brorphine	2244737-98-0	38H2BE6LU4	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	
brotizolam		Brotizolam	57801-81-7	5XZM1R3DKF	Hypnotics and Sedatives	Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)	Brotizolam is indicated for 2-4 weeks in the treatment of severe or debilitating insomnia.
broussochalcone A	99217-68-2	Broussochalcone A	99217-68-2	8991DSI89V			
broxaterol	76596-57-1	Broxaterol	76596-57-1	ZE4IRB4DUC	Adrenergic beta-Agonists	Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)	
bruceine D	21499-66-1	Brucein D	21499-66-1				
brucine	357-57-3	Brucine	357-57-3	6NG17YCK6H	Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
brucine N-oxide	17301-81-4	Brucine N-oxide	17301-81-4				
brusatol	14907-98-3	Brusatol	14907-98-3	3ATY6SZ64B			
bryostatin 1	83314-01-6	Bryostatin 1	83314-01-6	37O2X55Y9E	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
bryostatin 2	87745-28-6	Bryostatin 2	87745-28-6				
BSF 302146		BSF 302146					
BTSA1 compound		BTSA1 compound					
BU 224		2-(4,5-dihydro-1H-imidazol-2-yl)quinoline	187173-05-3				
Bu-Fei-Yi-Shen		Bu-Fei-Yi-Shen					
bu-zhong-yi-qi-tang		bu-zhong-yi-qi-tang					
bucillamine	65002-17-7	Bucillamine	65002-17-7	R80LRA5WTF	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
bucindolol	70369-47-0	Bucindolol hydrochloride	70369-47-0	SH683G4QII	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	
Bucladesine	362-74-3	Bucladesine	362-74-3	63X7MBT2LQ			
buclizine	82-95-1	Buclizine	82-95-1	UFN4445AF2	Histamine Antagonists	Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)	For prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness and vertigo (dizziness caused by other medical problems).
bucolome	841-73-6	Bucolome	841-73-6	9T08RAL174			
Budesonide	51333-22-3	Budesonide	51333-22-3	Q3OKS62Q6X	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	Budesonide extended-release capsules are indicated for the treatment and maintenance of mild to moderate Crohns disease. Various inhaled budesonide products are indicated for prophylactic therapy in asthma and to reduce exacerbations of COPD. A budesonide nasal spray is available over the counter for symptoms of hay fever and upper respiratory allergies. Extended-release capsules are indicated to induce remission of mild to moderate ulcerative colitis and a rectal foam is used for mild to moderate distal ulcerative colitis. In addition, a delayed-release capsule formulation of budesonide is indicated to reduce proteinuria in adults with IgA nephropathy at risk of rapid disease progression. Budesonide is indicated to treat eosinophilic esophagitis (EoE): For this indication, it is only approved for use in adults in Europe while it is approved for short-term use (12 weeks) in patients 11 years of age and older in the US.
budlein A		Budlein A	59481-48-0				
bufalin	465-21-4	Bufalin	465-21-4	U549S98QLW	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
buflomedil	55837-25-7	Buflomedil	55837-25-7	V7I71DQ432	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
bufogenin	465-39-4	Resibufogenin	465-39-4	3K654P2M4J	Cardiotonic Agents	Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)	
bufuralol	54340-62-4	Bufuralol	54340-62-4	891H89GFT4	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	
bullatacin	102989-24-2	Bullatacin	102989-24-2		Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	
Bumetanide	28395-03-1	Bumetanide	28395-03-1	0Y2S3XUQ5H	Sodium Potassium Chloride Symporter Inhibitors	Agents that inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS which are concentrated in the thick ascending limb at the junction of the LOOP OF HENLE and KIDNEY TUBULES, DISTAL. They act as DIURETICS. Excess use is associated with HYPOKALEMIA and HYPERGLYCEMIA. (See all compounds classified as Sodium Potassium Chloride Symporter Inhibitors.)	For the treatment of edema associated with congestive heart failure, hepatic and renal disease including the nephrotic syndrome.
bunamidine	3748-77-4	Bunamidine	3748-77-4	A9IW1G3P6C	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	
Bungarotoxins		Bungarotoxins					
bunitrolol		Bunitrolol	34915-68-9	F2613LO055			
bupirimate	41483-43-6	Bupirimate	41483-43-6	MCJ121RIOI			
Bupivacaine	2180-92-9	Bupivacaine	38396-39-3	Y8335394RO	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	As an implant, bupivacaine is indicated in adults for placement into the surgical site to produce postsurgical analgesia for up to 24 hours following open inguinal hernia repair.  Bupivacaine, in liposome suspension, is indicated in patients aged 6 years and older for single-dose infiltration to produce postsurgical local analgesia. In adults, it is also indicated as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia.    Bupivacaine, in combination with [meloxicam], is indicated for postsurgical analgesia in adult patients for up to 72 hours following foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures.  Bupivacaine, alone or in combination with [epinephrine], is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations are recommended for each type of block indicated to produce local or regional anesthesia or analgesia. Finally, its use is not indicated in all blocks given clinically significant risks associated with use.
Bupleuran 2IIc	138726-08-6	Bupleuran 2IIc					
Bupranolol	23284-25-5	Bupranolol	14556-46-8	858YGI5PIT	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	Used to manage hypertension and tachycardia. Also used to treat glaucoma.
Buprenorphine	52485-79-7	Buprenorphine	52485-79-7	40D3SCR4GZ	Narcotic Antagonists	Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)	Buprenorphine is available in different formulations, such as sublingual tablets, buccal films, transdermal films, and injections, alone or in combination with [naloxone].  The buccal film, intramuscular or intravenous injection, and transdermal formulation are indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate.  The extended-release subcutaneous injections of buprenorphine are indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine. Injections are part of a complete treatment plan that includes counselling and psychosocial support.  Sublingual tablets and buccal films, in combination with naloxone, are indicated for the maintenance treatment of opioid dependence as part of a complete treatment plan that includes counselling and psychosocial support.
buprofezin		Buprofezin	69327-76-0	3B8KGI239I	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Bupropion	34841-39-9	Bupropion	34911-55-2	01ZG3TPX31	Smoking Cessation Agents	Substances that facilitate the cessation of tobacco smoking. (See all compounds classified as Smoking Cessation Agents.)	Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation.   When used in combination with [naltrexone] as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia).  Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.
Burimamide	34970-69-9	Burimamide	34970-69-9	TN5A4OD2TV	Histamine H2 Antagonists	Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (See all compounds classified as Histamine H2 Antagonists.)	
bursehernin	40456-51-7	Bursehernin	40456-51-7				
bursicon	9041-06-9	Bursicon					
Buserelin	57982-77-1	Buserelin	57982-77-1	PXW8U3YXDV	Fertility Agents, Female	Compounds which increase the capacity to conceive in females. (See all compounds classified as Fertility Agents, Female.)	Buserelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction.
bushen huoxue		bushen huoxue					
Buspirone	36505-84-7	Buspirone	36505-84-7	TK65WKS8HL	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	Indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety.
Busulfan	55-98-1	Busulfan	55-98-1	G1LN9045DK	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	For use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous  (myeloid, myelocytic, granulocytic) leukemia (FDA has designated busulfan as an orphan drug for this use). It is also used as a component of pretransplant conditioning regimens in patients undergoing bone marrow transplantation for acute myeloid leukemia and nonmalignant diseases.
butachlor	23184-66-9	Butachlor	23184-66-9	94NU90OO5K	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Butaclamol	36504-93-5	(+)-Butaclamol	36504-93-5	A7A2802VNL	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
Butadienes		Butadienes					
butafenacil		Butafenacil	134605-64-4	7Z141CCP2R			
butamben		Butyl 4-aminobenzoate	94-25-7	EFW857872Q	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	Butamben was indicated for the treatment of chronic pain due to its long-duration effect. It is also indicated as a surface anesthetic for skin a mucous membrane and for the relief of pain and pruritus associated with anorectal disorders.
butamifos		Butamifos	36335-67-8	KHP91X76U4			
butane	106-97-8	Butane	106-97-8	6LV4FOR43R			
butane-2,3-dione thiosemicarbazone oxime		butane-2,3-dione thiosemicarbazone oxime					
Butanes							
Butanols		1-Butanol	71-36-3	8PJ61P6TS3			
butaprost	69648-38-0	Butaprost	69648-38-0	HP16WVP23Y			
butein	487-52-5	Butein	487-52-5	4WVS5M0LGF			
butenafine	101828-21-1	Butenafine	101828-21-1	91Y494NL0X	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	For the topical treatment of the following dermatologic infections: tinea (pityriasis) versicolor due to M. furfur, interdigital tinea pedis (athletes foot), tinea corporis (ringworm) and tinea cruris (jock itch) due to E. floccosum, T. mentagrophytes, T. rubrum, and T. tonsurans.
butenolide	497-23-4	2(5H)-Furanone	497-23-4	8KXK25H388	Appetite Depressants	Agents that are used to suppress appetite. (See all compounds classified as Appetite Depressants.)	
buthionine	4378-14-7	D,L-Buthionine	4378-14-7				
Buthionine Sulfoximine	5072-26-4	Buthionine sulfoximine	5072-26-4	LW4108Q0BV	Radiation-Protective Agents	Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)	
buthionine sulfoximine ethyl ester	131202-22-7	Buthionine sulfoximine ethyl ester	131202-22-7				
butin	492-14-8	Butin	492-14-8	S23T8BI9DD			
butoconazole	67085-13-6	Butoconazole	64872-76-0	0Q771797PH	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	For the local treatment of vulvovaginal candidiasis (infections caused by Candida)
Butorphanol	42408-82-2	Butorphanol	42408-82-2	QV897JC36D	Antitussive Agents	Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)	For the relief of moderate to severe pain.
Butoxamine	2922-20-5	Butaxamine	2922-20-5		Hypolipidemic Agents	Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)	
butralin	33629-47-9	Butralin	33629-47-9	5CZK3K1YPB			
Butter	8029-34-3	Butter					
butyl bromide	109-65-9	1-Bromobutane	109-65-9	SAV6Y78U3D			
butyl caprylate	626-82-4	Butyl hexanoate	626-82-4	EBK588Q27T			
butyl diglycol acetate	124-17-4	2-(2-Butoxyethoxy)ethyl acetate	124-17-4	U6UTS77LXB			
butyl phosphorotrithioate		Tribufos	78-48-8	53075G8GRF	Defoliants, Chemical	Herbicides that remove leaves from trees and growing plants. They may be either organic or inorganic. Several of the more persistent types have been used in military operations and many are toxic. (From Hawley&apos;s Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Defoliants, Chemical.)	
Butylated Hydroxyanisole	25013-16-5	2-tert-Butyl-4-methoxyphenol	25013-16-5	62RAC24292			
Butylated Hydroxytoluene	128-37-0	Butylated Hydroxytoluene	128-37-0	1P9D0Z171K	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
butylbenzyl phthalate	85-68-7	Benzyl butyl phthalate	85-68-7	YPC4PJX59M	Teratogens	An agent that causes the production of physical defects in the developing embryo. (See all compounds classified as Teratogens.)	
butylcyclohexane	1678-93-9	Butylcyclohexane	1678-93-9				
butylene	25167-67-3	1-Butene	9003-28-5	LY001N554L			
Butylhydroxybutylnitrosamine	3817-11-6	N-Butyl-N-(4-hydroxybutyl)nitrosamine	3817-11-6	R2748J2P6S			
butylidenephthalide	551-08-6	3-Butylidenephthalide	551-08-6	6GM611H175			
butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine	66556-73-8	Butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine	66556-73-8				
butylparaben	94-26-8	Butylparaben	94-26-8	3QPI1U3FV8			
butylphen	98-54-4	4-tert-Butylphenol	98-54-4	O81VMW36CV			
Butylscopolammonium Bromide	149-64-4	Scopolamine butylbromide	149-64-4	0GH9JX37C8	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	
butyraldehyde	123-72-8	Butyraldehyde	123-72-8	H21352682A			
Butyrates		Butyrates					
Butyric Acid	107-92-6	Butyric Acid	107-92-6	40UIR9Q29H	Histamine Antagonists	Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)	
Butyrophenones		Butyrophenones					
butyryl-coenzyme A	2140-48-9	butyryl-CoA	2140-48-9				
butyrylcarnitine	25576-40-3	Butyrylcarnitine	25576-40-3				
butyrylcholine	3922-86-9	Butyrylcholine	3922-86-9	BCD8KEA5TE			
Butyrylthiocholine	4555-00-4	Butyrylthiocholine	4555-00-4	K8D83KI04M			
BV6 peptide		BV6 peptide					
BVT116429		BVT116429					
BW 175	120716-81-6	(2S)-N-[(2S,3R,4S)-1-cyclohexyl-3,4-dihydroxy-5-morpholin-4-ylpentan-2-yl]-2-[[(2S)-2-(ethylsulfonylmethyl)-3-naphthalen-1-ylpropanoyl]amino]hexanamide					
BW 245C	75693-75-3	7-[3-(3-Cyclohexyl-3-hydroxypropyl)-2,5-dioxoimidazolidin-4-yl]heptanoic acid	75693-75-3				
BW 373U86	150428-54-9	4-[(R)-[(2S,5R)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-hydroxyphenyl)methyl]-N,N-diethylbenzamide	150428-54-9	RR2QFN29K7			
BW A868C	118675-50-6	3-Benzyl-5-(6-carboxyhexyl)-1-(2-cyclohexyl-2-hydroxyethylamino)hydantoin	118675-50-6		Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
BW B70C	134470-38-5	(E)-N-(3-(3-(4-Fluorophenoxy)phenyl)-1-(R,S)-methylprop-2-enyl)-N-hydroxyurea	134470-38-5				
BX 471		BX-471 free base	217645-70-0	76K17ZG4ZN			
BX795		N-[3-[[5-Iodo-4-[[3-[(2-thienylcarbonyl)amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide	702675-74-9				
BXL628		Elocalcitol	199798-84-0	2WDS5F2V6Q			Investigated for use/treatment in benign prostatic hyperplasia, urinary incontinence, prostate disorders, and infertility.
BYI 06830		BYI 06830					
BZD9L1		BZD9L1					
C 021 compound		C 021 compound					
C 1305		C 1305					
C-Peptide		C-Peptide	33017-11-7	O2J76Y002M			
C.I. Acid Red 114	25317-45-7	8-((3,3'-Dimethyl-4'-((4-(((p-tolyl)sulphonyl)oxy)phenyl)azo)(1,1'-biphenyl)-4-yl)azo)-7-hydroxynaphthalene-1,3-disulphonic acid	25317-45-7				
C186 65		C186 65					
C188-9 compound		C188-9 compound					
C60-bis(N,N-dimethylpyrrolidinium)		C60-bis(N,N-dimethylpyrrolidinium)					
CA 074 methyl ester		Methyl N-({(2s,3s)-3-[(Propylamino)carbonyl]oxiran-2-Yl}carbonyl)-L-Isoleucyl-L-Prolinate	147859-80-1				
cabazitaxel		Cabazitaxel	183133-96-2	51F690397J			Cabazitaxel is indicated, in combination with [prednisone], for the treatment of patients with metastatic castration-resistant prostate cancer previously treated with a [docetaxel]-containing treatment regimen. In Europe and Canada, it can also be used in combination with [prednisolone].
Cabergoline	81409-90-7	Cabergoline	81409-90-7	LL60K9J05T	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	For the treatment of hyperprolactinemic disorders, either idiopathic or due to prolactinoma (prolactin-secreting adenomas). May also be used to manage symptoms of Parkinsonian Syndrome as monotherapy during initial symptomatic management or as an adjunct to levodopa therapy during advanced stages of disease.
cabozantinib		Cabozantinib	849217-68-1	1C39JW444G			Cabozantinib is indicated for the treatment of progressive, metastatic medullary thyroid cancer. It is also indicated for the treatment of advanced renal cell carcinoma and for hepatocellular carcinoma in patients previously treated with sorafenib.
cacalol		Cacalol	24393-79-1				
Cacodylic Acid	75-60-5	Cacodylic acid	75-60-5	AJ2HL7EU8K	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
cacospongionolide B		cacospongionolide B					
Cadaverine	462-94-2	Cadaverine	462-94-2	L90BEN6OLL			
Cadmium	7440-43-9	Cadmium	7440-43-9	00BH33GNGH			
cadmium acetate	543-90-8	Cadmium acetate	543-90-8	95KC50Z1L0			
Cadmium Chloride	10108-64-2	Cadmium Chloride	10108-64-2	J6K4F9V3BA			
Cadmium Compounds		C I 77180					
cadmium nitrate	10325-94-7	Cadmium nitrate	10325-94-7	VF9RQV8VXV			
cadmium oxide	1306-19-0	Cadmium oxide	1306-19-0				
cadmium selenide	1306-24-7	1306-24-7					
cadmium sulfate	10124-36-4	Cadmium Sulfate	10124-36-4	947UNF3Z6O			
cadmium sulfide	1306-23-6	Cadmium sulfide	68859-25-6				
cadmium telluride	1306-25-8	Cadmium telluride	1306-25-8	STG188WO13			
CAF protocol		CAF protocol					
cafenstrole	125306-83-4	Cafenstrole	125306-83-4	II8JP4LY7A			
cafestol	469-83-0	Cafestol	469-83-0	AC465T6Q6W			
caffeic acid	331-39-5	Caffeic Acid	331-39-5	U2S3A33KVM	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
caffeic acid phenethyl ester	104594-70-9	Caffeic acid phenethyl ester	115610-29-2	G960R9S5SK			
Caffeine	58-08-2	Caffeine	58-08-2	3G6A5W338E	Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	Caffeine is indicated for the short term treatment of apnea of prematurity in infants and off label for the prevention and treatment of bronchopulmonary dysplasia caused by premature birth. In addition, it is indicated in combination with sodium benzoate to treat respiratory depression resulting from an overdose with CNS depressant drugs. Caffeine has a broad range of over the counter uses, and is found in energy supplements, athletic enhancement products, pain relief products, as well as cosmetic products.
caffeine, sodium benzoate drug combination		Caffeine benzoate	5743-17-9	C2154V12SE	Analgesics, Non-Narcotic	A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)	
caffeoylquinic acid		caffeoylquinic acid					
cagA protein, Helicobacter pylori		cagA protein, Helicobacter pylori					
caged sphingosine 1-phosphate		caged sphingosine 1-phosphate					
cajanol	61020-70-0	Cajanol	61020-70-0	U192S21MNA			
Cajanus cajan extract		Cajanus cajan extract					
calcein AM	148504-34-1	Calcein AM	148504-34-1		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
Calcifediol	19356-17-3	Calcifediol	19356-17-3	T0WXW8F54E	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis.
Calcimycin	52665-69-7	Calcimycin	52665-69-7	37H9VM9WZL	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
calcipotriene		Calcipotriene	112965-21-6	143NQ3779B	Dermatologic Agents	Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)	For the treatment of moderate plaque psoriasis in adults.
calcitonin gene-related peptide (8-37)	119911-68-1	calcitonin gene-related peptide (8-37)					
Calcitriol	32222-06-3	Calcitriol	32222-06-3	FXC9231JVH	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis.
Calcium	7440-70-2	Calcium	7440-70-2	SY7Q814VUP	Calcium-Regulating Hormones and Agents	Hormones and molecules with calcium-regulating hormone-like actions that modulate OSTEOLYSIS and other extra-skeletal activities to maintain calcium homeostasis. (See all compounds classified as Calcium-Regulating Hormones and Agents.)	Calcium plays a vital role in the anatomy, physiology and biochemistry of organisms and of the cell, particularly in signal transduction pathways. It is vital in cell signaling, muscular contractions, bone health, and signalling cascades.
calcium arsenate	7778-44-1	Calcium arsenate	7778-44-1	95OX15I8ZU			
calcium bicarbonate	3983-19-5	Calcium bicarbonate	3983-19-5	7PRA4BLM2L			
Calcium Carbonate	471-34-1	Calcium Carbonate	471-34-1	H0G9379FGK	Antacids	Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT. (See all compounds classified as Antacids.)	For relief of heartburn and acid indigestion. May also be used as a nutritional supplement or to treat hypocalcemia.
Calcium Channel Blockers		Calcium Channel Blockers					
Calcium Chloride	10043-52-4	Calcium Chloride	10043-52-4	M4I0D6VV5M			For the treatment of hypocalcemia in those conditions requiring a prompt increase in blood plasma calcium levels, for the treatment of magnesium intoxication due to overdosage of magnesium sulfate, and used to combat the deleterious effects of hyperkalemia as measured by electrocardiographic (ECG), pending correction of the increased potassium level in the extracellular fluid.
calcium fructoborate		Borate(1-), bis(beta-D-fructofuranosato(2-)-kappaO2,kappaO3)-, calcium (2:1), (T-4)-	250141-42-5				
Calcium Gluconate	299-28-5	Calcium Gluconate	299-28-5	SQE6VB453K			Oral calcium salts are used as dietary supplemental therapy for person who may not get enough calcium in their regular diet. Calcium gluconate is used as a cardioprotective agent in high blood potassium. Calcium gluconate is the antidote for magnesium sulfate toxicity.
calcium heparin	37270-89-6	4-(Ethoxymethoxy)-1-methylidene-2-(2-methylpropylidene)cyclohexane;4-ethoxy-1-methylidene-2-(2-methylpropylidene)cyclohexane;3-(2-hydroxyethylidene)-4-methylidenecyclohexan-1-ol;1-methylidene-4-(2-methylidenebutyl)-2-(2-methylpropylidene)cyclohexane;[4-methylidene-3-(2-methylpropylidene)cyclohexyl] propanoate;[4-methylidene-3-(2-methylpropylidene)cyclohexyl] prop-2-enoate	37270-89-6		Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	
Calcium Hydroxide	1305-62-0	Calcium Hydroxide	1305-62-0	PF5DZW74VN	Bone Cements	Adhesives used to fix prosthetic devices to bones and to cement bone to bone in difficult fractures. Synthetic resins are commonly used as cements. A mixture of monocalcium phosphate, monohydrate, alpha-tricalcium phosphate, and calcium carbonate with a sodium phosphate solution is also a useful bone paste. (See all compounds classified as Bone Cements.)	
Calcium Ionophores		Calcium Ionophores					
calcium magnesium carbonate		Dolomite	16389-88-1	UG9H2002BF			
Calcium Oxalate	25454-23-3	Calcium oxalate	563-72-4	2612HC57YE			
calcium peroxide	1305-79-9	Calcium peroxide	1305-79-9				
calcium phosphate	10103-46-5	Calcium Phosphate	10103-46-5	K4C08XP666			For use as an over the counter calcium and phosphate supplement, antacid, or a source of calcium and phosphate in toothpaste.
calcium propionate		Calcium propionate	4075-81-4	8AI80040KW			
calcium silicate	1344-95-2	Calcium Silicate	1344-95-2	S4255P4G5M			
Calcium, Dietary		Calcium, Dietary					
calfactant		Calfactant					
calix(6)arene		Calix[6]arene	96107-95-8				
calmidazolium		Calmidazolium	95013-41-5	4R9H38JAWL	Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
caloxin 1b1		Caloxin 1b1					
calpain inhibitor 2	110115-07-6	N-acetylleucyl-leucyl-methioninal	110115-07-6	1D8SBU367Z	Cysteine Proteinase Inhibitors	Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. (See all compounds classified as Cysteine Proteinase Inhibitors.)	
calpain inhibitor III		Calpain Inhibitor III	88191-84-8	WCJ9LQ197S	Cysteine Proteinase Inhibitors	Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. (See all compounds classified as Cysteine Proteinase Inhibitors.)	
calpeptin		Calpeptin	117591-20-5	18X9FR245W	Cysteine Proteinase Inhibitors	Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. (See all compounds classified as Cysteine Proteinase Inhibitors.)	
calphostin C	121263-19-2	calphostin C	121263-19-2		Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	
calphostin complex		calphostin complex					
calycopterin		Calycopterin	481-52-7	8794DO3YB5			
calycosin-7-O-beta-D-glucoside		CALYCOSIN 7-O-beta-D-GLUCOSIDE	20633-67-4	247AW3A88C			
calyculin A	101932-71-2	calyculin A	101932-71-2	7D07U14TK3	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
camalexin		Camalexin	135531-86-1	QY3Z69LA99	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
cambinol		Cambinol	14513-15-6	8S2PHY4FNC			
camostat		Camostat	59721-28-7	0FD207WKDU	Protease Inhibitors	Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)	Camostat mesylate is indicated in Japan to treat chronic pancreatitis and drug induced lung injury. It is also being investigated as a potential treatment for COVID-19.
camphene	79-92-5	Camphene	79-92-5	G3VG94Z26E			
Camphor	76-22-2	Camphor	464-48-2		Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
camphoroquinone	465-29-2	Camphorquinone	10373-78-1				
camphorquinone	2767-84-2	(1S,4R)-1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione	2767-84-2				
Camptothecin	7689-03-4	Camptothecin	7689-03-4	XT3Z54Z28A	Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	Investigated for the treatment of cancer.
camylofine	54-30-8	Camylofin	54-30-8	340B6Q764V	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	
canadine	522-97-4	Canadine	522-97-4	V2SSH085X8	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
Canagliflozin		Canagliflozin	842133-18-0	6S49DGR869	Sodium-Glucose Transporter 2 Inhibitors	Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS. (See all compounds classified as Sodium-Glucose Transporter 2 Inhibitors.)	This drug is used in conjunction with diet and exercise to increase glycemic control in adults diagnosed with type 2 diabetes mellitus.  Another indication for canagliflozin is the prevention of major cardiovascular events (myocardial infarction, stroke, or death due to a cardiovascular cause) in patients with type 2 diabetes, as well as hospitalization for heart failure in patients with type 2 diabetes[L5897,.  In addition to the above, canagliflozin can be used to lower the risk of end-stage kidney disease and major increases in serum creatinine and cardiovascular death for patients with a combination of type 2 diabetes mellitus, diabetic nephropathy, and albuminuria.  It is important to note that this drug is **not** indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
Cancer Vaccines		Cancer Vaccines					
candesartan	139481-59-7	Candesartan	139481-59-7	S8Q36MD2XX	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
candesartan cilexetil	145040-37-5	Candesartan Cilexetil	145040-37-5	R85M2X0D68	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	May be used as a first line agent to treat uncomplicated hypertension, isolated systolic hypertension and left ventricular hypertrophy. May be used as a first line agent to delay progression of diabetic nephropathy. Candesartan may be also used as a second line agent in the treatment of congestive heart failure, systolic dysfunction, myocardial infarction and coronary artery disease in those intolerant of ACE inhibitors.
candoxatril		Candoxatril	123122-55-4	ACP75508EE	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
candoxatrilat	123898-42-0	4-((2-Carboxy-3-(2-methoxyethoxy)propyl)-1-cyclopentanecarbonylamino)-1-cyclohexanecarboxylic acid	123898-42-0		Protease Inhibitors	Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)	
candoxin		candoxin					
Canertinib	289499-45-2	Canertinib dihydrochloride	289499-45-2	ICJ93X8X90	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
cang er zi wan		cang er zi wan					
cangrelor		Cangrelor	163706-06-7	6AQ1Y404U7	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	For use as an adjunct to percutaneous coronary intervention (PCI) for reducing the risk of periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST) in patients in who have not been treated with a P2Y12 platelet inhibitor and are not being given a glycoprotein IIb/IIIa inhibitor.
cannabichromene	20675-51-8	Cannabichromene	20675-51-8	K4497H250W			
Cannabidiol	13956-29-1	Cannabidiol	13956-29-1	19GBJ60SN5	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	When used in combination with delta-9-tetrahydrocannabinol as the product Sativex, cannabidiol was given a standard marketing authorization (ie. a Notice of Compliance (NOC)) by Health Canada for the following indications:  1) as adjunctive treatment for symptomatic relief of spasticity in adult patients with multiple sclerosis (MS) who have not responded adequately to other therapy and who demonstrate meaningful improvement during an initial trial of therapy;  Due to the need for confirmatory studies to verify the clinical benefit coupled with the promising nature of the clinical evidence, Sativex was also given a Notice of Compliance with Conditions (NOC/c) by Health Canada for the following indications:  1) as adjunctive treatment for the symptomatic relief of neuropathic pain in adult patients with multiple sclerosis;  2) as adjunctive analgesic treatment in adult patients with advanced cancer who experience moderate to severe pain during the highest tolerated dose of strong opioid therapy for persistent background pain.
cannabidiol dimethyl ether	1242-67-7	Cannabidiol dimethyl ether	1242-67-7	MK7IHZ7MIM			
cannabidiol hydroxyquinone	137252-25-6	Cannabidiol hydroxyquinone	137252-25-6	I7Q196L4AU			
cannabidiolic acid	1244-58-2	Cannabidiolic acid	1244-58-2	FJX8O3OJCD			
cannabidivarin		Cannabidivarin	24274-48-4	I198VBV98I			Cannabidivarin does not currently have any FDA or Health Canada approved indications, however in October 2017 CBDV was given orphan designation by the European Medicines Agency for use in Rett Syndrome and again in February 2018 for treatment of Fragile X Syndrome.
cannabigerol	25654-31-3	Cannabigerol	25654-31-3	J1K406072N			
cannabigerolic acid	25555-57-1	Cannabigerolic acid	25555-57-1	80I4ZM847Y			
cannabinoid CB2 receptor agonist ABK5		cannabinoid CB2 receptor agonist ABK5					
Cannabinoid Receptor Agonists		Cannabinoid Receptor Agonists					
Cannabinoid Receptor Antagonists		Cannabinoid Receptor Antagonists					
Cannabinoids		Nabiximols	56575-23-6		Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	In Canada, Sativex has received a Notice of Compliance (NOC) for use as an as adjunctive treatment for symptomatic relief of spasticity in patients with multiple sclerosis (MS) who have not responded adequately to other therapy and who demonstrate meaningful improvement during an initial trial of therapy.   Sativex has also received a Notice of Compliance with Conditions (NOC/c) for use as an adjunctive treatment for the symptomatic relief of neuropathic pain in adult patients with multiple sclerosis (MS) and as adjunctive analgesic treatment in adult patients with advanced cancer who experience moderate to severe pain during the highest tolerated dose of strong opioid therapy for persistent background pain.   Marketing authorisations with conditions reflect the promising nature of the clinical evidence and the need for confirmatory studies to verify the clinical benefit. Patients should be advised of the conditional nature of the authorizations with conditions.
Cannabinol	521-35-7	Cannabinol	521-35-7	7UYP6MC9GH			
cannogenin thevetoside		Peruvoside	1182-87-2	CT36KGC6A6	Cardiotonic Agents	Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)	
Canrenoic Acid	4138-96-9	Canrenoic acid	4138-96-9	87UG89VA9K	Mineralocorticoid Receptor Antagonists	Drugs that bind to and block the activation of MINERALOCORTICOID RECEPTORS by MINERALOCORTICOIDS such as ALDOSTERONE. (See all compounds classified as Mineralocorticoid Receptor Antagonists.)	
cantharidic acid		Cantharidic acid	28874-45-5				
Cantharidin	56-25-7	Cantharidin	56-25-7	IGL471WQ8P	Irritants	Drugs that act locally on cutaneous or mucosal surfaces to produce inflammation; those that cause redness due to hyperemia are rubefacients; those that raise blisters are vesicants and those that penetrate sebaceous glands and cause abscesses are pustulants; tear gases and mustard gases are also irritants. (See all compounds classified as Irritants.)	Cantharidin is approved by the FDA for the topical treatment of molluscum contagiosum in adult and pediatric patients 2 years of age and older. It has also been approved by Health Canada for the treatment of common warts (verruca vulgaris), periungual warts, and molluscum contagiosum as a standalone product and resistant and heavily keratinized plantar warts as a combination product with [salicylic acid] and [podophyllin].   At the same time, such topical cantharidin applications have also been used for a number of off-label indications like callus removal, cutaneous leishmaniasis, herpes zoster, and acquired perforating dermatosis. Furthermore, since most topical cantharidin applications are most commonly available in a 0.7% formulation or a more potent 1% mixture, the 0.7% formulation is most commonly indicated for the treatment of common warts, periungual warts, and molluscum contagiosum while the more potent 1% mixture is typically limited only for use by healthcare professionals in a clinical setting for treating plantar warts and other more specialized off-label conditions.  Moreover, there have also been studies into whether or not cantharidin could be effective at being used as an inflammatory model or in cancer treatment - either of which has yet to elucidate any results formally.
Canthaxanthin	514-78-3	Canthaxanthin	514-78-3	4C3C6403MU	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
Canvaxin		Canvaxin					
Capecitabine		Capecitabine	154361-50-9	6804DJ8Z9U	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	Capecitabine is indicated as treatment for a variety of cancer types. For colorectal cancer, capecitabine is indicated as a single agent or a component of a combination chemotherapy regiment for the adjuvant treatment of stage III colon cancer and treatment unresectable or metastatic colorectal cancer. It can also be used as a part of a combination chemotherapy perioperative treatment of adult locally advanced rectal cancer. For breast cancer, capecitabine is indicated for advanced or metastatic breast cancer as a single agent if an anthracycline- or taxane-containing chemotherapy is not indicated or as a regimen with docetaxel after disease progression on prior anthracycline-containing chemotherapy. For gastric, esophageal, or gastroesophageal junction (GEJ) cancer, capecitabine is indicated as a component of a combination chemotherapy treatment for the treatment of adult unresectable or metastatic gastric, esophageal, or GEJ cancer or adult HER2-overexpressing metastatic gastric or GEJ adenocarcinoma who have not received prior treatment for metastatic disease. Finally, for pancreatic cancer, capecitabine is indicated as adjuvant treatment for adult pancreatic adenocarcinoma as a component of a combination chemotherapy regimen.
capillarisin	56365-38-9	Capillarisin	56365-38-9				
capivasertib		Capivasertib	1143532-39-1	WFR23M21IE			Capivasertib, in combination with fulvestrant, is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer with one or more PIK3CA/AKT1/PTEN-alteration as detected by an FDA-approved test following progression on at least one endocrine-based regimen in the metastatic setting or recurrence on or within 12 months of completing adjuvant therapy.
capmatinib		Capmatinib	1029712-80-8	TY34L4F9OZ			In the US, capmatinib is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping as detected by an FDA-approved test.  Capmatinib is approved to treat adults with locally advanced unresectable or metastatic non-small cell lung cancer (NSCLC) with MET exon 14 skipping alterations in Canada.
capoamycin	97937-29-6	Capoamycin	97937-29-6				
caprylic aldehyde	124-13-0	Octanal	124-13-0	XGE9999H19			
capryol propylene glycol monocaprylate		capryol propylene glycol monocaprylate					
Capsaicin	404-86-4	Capsaicin	404-86-4	S07O44R1ZM	Antipruritics	Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)	The capsaicin 8% patch is indicated in the treatment of neuropathic pain associated with post-herpetic neuralgia. There are multiple topical capsaicin formulations available, including creams and solutions, indicated for temporary analgesia in muscle and join pain as well as neuropathic pain.
capsanthin	465-42-9	Capsanthin	465-42-9	420NY1J57N			
capsazepine		Capsazepine	138977-28-3	LFW48MY844			
capseal I		capseal I					
capseal II		capseal II					
capsiate		Capsiate	205687-01-0	PX8I7HG5I3			
capsinolol		Capsinolol					
captafol	2425-06-1	Captafol	2425-06-1		Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Captan	133-06-2	Captan	133-06-2		Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
captax	149-30-4	2-Mercaptobenzothiazole	155-04-4	5RLR54Z22K	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
Captopril	62571-86-2	Captopril	62571-86-2	9G64RSX1XD	Angiotensin-Converting Enzyme Inhibitors	A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)	For the treatment of essential or renovascular hypertension (usually administered with other drugs, particularly thiazide diuretics). May be used to treat congestive heart failure in combination with other drugs (e.g. cardiac glycosides, diuretics, -adrenergic blockers). May improve survival in patients with left ventricular dysfunction following myocardial infarction. May be used to treat nephropathy, including diabetic nephropathy.
caracurine	466-85-3	Wieland-gumlich aldehyde	466-85-3	X3Q09D1K96			
caramiphen	125-85-9	Caramiphen hydrochloride	125-85-9	4858SN190E			
caraway oil		CCRIS 7119					
carazolol		Carazolol	57775-29-8	29PW75S82A	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	
Carbachol		Carbachol	51-83-2	8Y164V895Y	Miotics	Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here. (See all compounds classified as Miotics.)	
Carbadox	6804-07-5	N-[(E)-(1-hydroxy-4-oxido-quinoxalin-4-ium-2-ylidene)methyl]iminocarbamic acid methyl ester	6804-07-5		Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
Carbamates		Carbamate	302-11-4				
Carbamazepine	298-46-4	Carbamazepine	298-46-4	33CM23913M	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia. In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures. Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder. Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome.
carbamazepine epoxide	36507-30-9	Carbamazepine-10,11-epoxide	36507-30-9	QC9505F279			
carbamic acid	463-77-4	Carbamic acid	463-77-4	O0UC6XOS4H			
carbamothioic acid, S,S'-(2-(dimethylamino)-1,3-propanediyl) ester	15263-53-3	Cartap	15263-53-3	Z45YUY784H			
Carbamoyl Phosphate Synthetase I Activators		Carbamoyl Phosphate Synthetase I Activators					
Carbamyl Phosphate	590-55-6	Carbamoyl phosphate	590-55-6	GC5KZW01Q3			
carbamylhydrazine	57-56-7	Semicarbazide	57-56-7	37QUC23K2X	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Carbanilides		Carbanilides					
Carbapenems		7-Oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid	83200-96-8				
Carbaryl	63-25-2	Carbaryl	63-25-2	R890C8J3N1	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
carbazeran	70724-25-3	Carbazeran	70724-25-3	0N4I6K95P2			
carbazole	86-74-8	Carbazole	86-74-8	0P2197HHHN	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Carbazoles		Carbazoles					
carbendazim	10605-21-7	Carbendazim	10605-21-7	H75J14AA89	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	
Carbenoxolone	5697-56-3	Carbenoxolone	5697-56-3	MM6384NG73	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	
carbetapentane	77-23-6	Carbetapentane	77-23-6	32C726X12W	Antitussive Agents	Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)	Indicated as a cough suppressant to relieve cough caused by the common cold, flu, bronchitis, and sinusitis.
Carbidopa	38821-49-7	Lodosyn	38821-49-7	MNX7R8C5VO	Dopamine Agents	Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. (See all compounds classified as Dopamine Agents.)	Carbidopa is indicated with [levodopa] for the treatment of symptoms of idiopathic Parkinson disease, postencephalitic parkinsonism and symptomatic parkinsonism followed by carbon monoxide or manganese intoxication.  The combination therapy is administered for the reduction of [levodopa]-driven nausea and vomiting.  The product of carbidopa should be used in patients where the combination therapy of carbidopa/[levodopa] provide less than the adequate daily dosage.  As well carbidopa can be used in patients where the dosages of carbidopa and [levodopa] require individual titration.
carbidopa, levodopa drug combination		Nacom	57308-51-7		Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
Carbimazole	22232-54-8	Carbimazole	22232-54-8	8KQ660G60G	Antithyroid Agents	Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones. (See all compounds classified as Antithyroid Agents.)	For the treatment of hyperthyroidism and thyrotoxicosis. It is also used to prepare patients for thyroidectomy.
carbinoxamine	486-16-8	Carbinoxamine	486-16-8	982A7M02H5	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	For symptomatic relief of seasonal and perennial allergic rhinitis and vasomotor rhinitis, as well as allergic conjunctivitis caused by foods and inhaled allergens. Also for the relief of allergic reactions to blood or plasma, and the symptomatic management of mild, uncomplicated allergic skin manifestations of urticaria and angioedema.
carbitol	111-90-0	Diethylene Glycol Monoethyl Ether	111-90-0	A1A1I8X02B			
carbobenzoxy-leucyl-leucyl-leucine		carbobenzoxy-leucyl-leucyl-leucine					
carbobenzoxy-leucyl-leucyl-norvalinal		Z-LL-Nva-CHO	133407-86-0		Protease Inhibitors	Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)	
Carbocysteine	2387-59-9	S-Carboxymethylcysteine	638-23-3	4252LRM78Q	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
Carbofuran	1563-66-2	Carbofuran	1563-66-2	SKF77S6Y67	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Carbohydrates		Carbohydrates					
carbohydrazide	497-18-7	Carbohydrazide	497-18-7	W8V7FYY4WH			
Carbolines		Carbolines					
Carbon	7440-44-0	Carbon	7440-44-0				
Carbon Dioxide	124-38-9	Carbon Dioxide	124-38-9	142M471B3J			Carbon dioxide is commonly used as an insufflation gas for minimal invasive surgery (laparoscopy, endoscopy, and arthroscopy) to enlarge and stabilize body cavities to provide better visibility of the surgical area. It has been used also in cryotherapy and as respiratory stimulant before and after anesthesia.  It could be used also in expansion of blood vessels if required, to increase carbon dioxide level after rapid breathing, and to stimulate breathing after a period of nonbreathing.
Carbon Disulfide	75-15-0	Carbon Disulfide	75-15-0	S54S8B99E8			
Carbon Fiber		Methane	74-82-8	OP0UW79H66			
Carbon Monoxide	630-08-0	Carbon Monoxide	630-08-0	7U1EE4V452	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	Used as a marker of respiratory status in spirometry tests,.  Food additive for pigment fixation in meat.
Carbon Tetrachloride	56-23-5	Carbon Tetrachloride	56-23-5	CL2T97X0V0			
Carbonates		Carbonate Ion	3812-32-6	7UJQ5OPE7D			
Carbonic Acid	463-79-6	Carbonic Acid	463-79-6				
Carbonyl Cyanide m-Chlorophenyl Hydrazone	555-60-2	(3-Chlorophenyl)hydrazonomalononitrile	555-60-2	4D4NW27CG5	Proton Ionophores	Chemical agents that increase the permeability of CELL MEMBRANES to PROTONS. (See all compounds classified as Proton Ionophores.)	
Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone	370-86-5	Carbonyl cyanide p-trifluoromethoxyphenylhydrazone	370-86-5	SQR3W2FLV5	Proton Ionophores	Chemical agents that increase the permeability of CELL MEMBRANES to PROTONS. (See all compounds classified as Proton Ionophores.)	
carbonyl sulfide	463-58-1	Carbonyl sulfide	463-58-1	871UI0ET21			
carbophenothion	786-19-6	Carbophenothion	786-19-6	998NGA2Q61			
Carboplatin	41575-94-4	Paraplatin			Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
carboprostacyclin	69552-46-1	Carboprostacyclin	69552-46-1		Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
carbosulfan	39995-74-9	(2,2-dimethyl-3H-1-benzofuran-7-yl) N-[[(2,2-dimethyl-3H-1-benzofuran-7-yl)oxycarbonyl-methylamino]disulfanyl]-N-methylcarbamate	39995-74-9				
Carboxin	5234-68-4	Carboxin	5234-68-4	5A8K850HDE	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
carboxyamido-triazole		Carboxyamidotriazole	99519-84-3	6ST3ZF52WB	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
carboxyatractyloside		Carboxyatractyloside	33286-30-5	SNP1XL23E6			
carboxycinnamic acid bishydroxamide		m-Carboxycinnamic acid bishydroxamide	174664-65-4		Histone Deacetylase Inhibitors	Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)	
Carboxylic Acids		Carboxylic Acids					
carboxymethyl-chitosan		Carboxymethyl chitosan	61240-62-8				
Carboxymethylcellulose Sodium		CID 131698544					
Carcinogens		Carcinogens					
cardamonin		Cardamonin	19309-14-9	H8KP1OJ8JX			
cardanol		Cardanol	79353-39-2	9H1349HESU			
Cardenolides		Cardenolides					
Cardiac Glycosides		Cardiac Glycosides					
Cardiolipins		cardiolipin					
Cardiotonic Agents		Cardiotonic Agents					
Cardiotoxins		Cardiotoxins					
carebastine	90729-42-3	Carebastine	90729-42-3	75DLN707DO	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	
carexinol A		carexinol A					
carfentanil	59708-52-0	Carfentanil	59708-52-0	LA9DTA2L8F	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	Carfentanil is similar (but more potent) to the opioid analgesic fentanyl. It is used as a tranquilizer for large animals.
carfilzomib		Carfilzomib	868540-17-4	72X6E3J5AR			Carfilzomib is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy in combination with lenalidomide and dexamethasone; or dexamethasone; or daratumumab and dexamethasone; or daratumumab and hyaluronidase-fihj and dexamethasone; or isatuximab and dexamethasone. It is also indicated as a single agent for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy.
cariporide		Cariporide	159138-80-4	7E3392891K	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	Investigated for use/treatment in cardiac surgery.
cariprazine		Cariprazine			Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Reagila is indicated for the treatment of schizophrenia in adult patients.
Carisoprodol	78-44-4	Carisoprodol	78-44-4	21925K482H	Muscle Relaxants, Central	A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)	Carisoprodol is indicated for the relief of discomfort related to acute, painful musculoskeletal conditions.   **Important limitations of use**:   Should only be used for acute treatment periods up to two or three weeks    Adequate evidence of effectiveness for more prolonged use has not been established    Not recommended in pediatric patients less than 16 years of age
Carmine	1260-17-9	Carminic acid	1260-17-9	CID8Z8N95N	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
carmofur	61422-45-5	Carmofur	61422-45-5	HA82M3RAB2	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
carmoxirole	98323-83-2	Carmoxirole	98323-83-2	MRP4P457ZA			
Carmustine	154-93-8	Carmustine	154-93-8	U68WG3173Y	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	For the treatment of brain tumors, multiple myeloma, Hodgkin's disease and Non-Hodgkin's lymphomas.
carnegine		Carnegine	490-53-9	EOW70A27WK			
Carnitine		Carnitine	406-76-8	S7UI8SM58A			
Carnosine	305-84-0	Carnosine	305-84-0	8HO6PVN24W			Peptic ulcer disease, dyspepsia.
carnosol		Carnosol	5957-80-2	483O455CKD			
Carotenoids	36-88-4	Carotenoids					
carprofen	52263-47-5	Carprofen	53716-49-7	FFL0D546HO	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	For use as a pain reliever in the treatment of joint pain and post-surgical pain.
Carrageenan	9000-07-1	CID 71597331	9000-07-1				
Carteolol	51781-06-7	Carteolol	51781-06-7	8NF31401XG	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	For the treatment of intraocular hypertension and chronic open-angle glaucoma
Carthamus yellow		Carthamus yellow					
Carticaine	23964-58-1	Articaine	23964-58-1	D3SQ406G9X	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	
carvacrol	499-75-2	Carvacrol	499-75-2	9B1J4V995Q			
carvacryl acetate		Carvacryl acetate	6380-28-5	2A2BR75B36			
Carvedilol	72956-09-3	Carvedilol	72956-09-3	0K47UL67F2	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	Carvedilol is indicated to treat mild to severe heart failure, left ventricular dysfunction after myocardial infarction with ventricular ejection fraction 40%, or hypertension.
carveol	99-48-9	Carveol	99-48-9				
carvone		Carvone, (+/-)-	99-49-0	75GK9XIA8I	Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	
caryophyllene	13877-93-5	(4Z)-4,11,11-trimethyl-8-methylidenebicyclo[7.2.0]undec-4-ene	87-44-5		Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
caryophyllene oxide		beta-CARYOPHYLLENE OXIDE	1139-30-6	S2XU9K448U			
Cascade Blue	1325-87-7	[4-[Bis[4-(diethylamino)phenyl]methylidene]naphthalen-1-ylidene]-ethylazanium	1325-87-7				
caseargrewiin F		caseargrewiin F					
casiopeina II		casiopeina II					
casiopeina II-glycine		casiopeina II-glycine					
casopitant		Casopitant	414910-27-3	3B03KPM27L	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	Investigated for use/treatment in urinary incontinence and adverse effects (chemotherapy).
Caspase Inhibitors		Caspase Inhibitors					
Caspofungin		Caspofungin	162808-62-0	F0XDI6ZL63	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	For the treatment of esophageal candidiasis and invasive aspergillosis in patients who are refractory to or intolerant of other therapies.
cassine	5227-24-7	Cassine	5227-24-7				
casticin	479-91-4	Casticin	479-91-4	753GT729OU			
Castor Oil	8001-79-4	Optase	8001-79-4		Cathartics	Agents that are used to stimulate evacuation of the bowels. (See all compounds classified as Cathartics.)	
casuarictin	79786-00-8	Casuarictin	96292-46-5				
catalase-polyethylene glycol		catalase-polyethylene glycol					
catalpol	2415-24-9	Catalpol	2415-24-9	JCX5L7JIC2			
Catechin	154-23-4	Cianidanol	8001-48-7	8R1V1STN48			
catechol	120-80-9	Catechol	120-80-9	LF3AJ089DQ			
Catecholamines		Catecholamines					
Catechols		Catechols					
Cathelicidins		Cathelicidins					
cathinone	5265-18-9	2-Aminopropiophenone	5265-18-9	CX1Z9618HE	Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	
cationic amphipathic peptide RT2		cationic amphipathic peptide RT2					
cavidine	32728-75-9	Cavidine	32728-75-9				
CAY 10499		CAY 10499					
CAY 10580		7-[2-(3-Hydroxyoctyl)-5-oxopyrrolidin-1-YL]heptanoic acid	64054-40-6				
CAY10415		Mitoglitazone	146062-49-9	29I7RP18RG			
CAY10506		N-[2-[4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy]ethyl]-5-(dithiolan-3-yl)pentanamide	292615-75-9				
CAY10591		2-amino-N-cyclopentyl-1-(3-methoxypropyl)-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide			Enzyme Activators	Compounds or factors that act on a specific enzyme to increase its activity. (See all compounds classified as Enzyme Activators.)	
CB 1093		CB 1093					
CB 3717	76849-19-9	10-Propargyl-5,8-dideazafolic acid	76849-19-9		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
CB 403		2-Propenal, 3-(2-((2-methylphenyl)methoxy)phenyl)-	302356-18-9	4V9Q0C88UK			
CB-5083		CB-5083	1542705-92-9	591IV6UL6J			
CB-839		Telaglenastat	1439399-58-2	U6CL98GLP4			
CB65		7-chloro-N-cyclohexyl-1-(2-morpholinoethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide			Cannabinoid Receptor Agonists	Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)	
CBB2001		CBB2001					
CBLB502		CBLB-502					
CBLC137		CBL0137 hydrochloride					
CBP30 compound		CBP30 compound					
CBV protocol		CBV protocol					
CC 3052		2H-Isoindole-2-propanoic acid, beta-(3,4-dimethoxyphenyl)-1,3-dihydro-1-oxo-, methyl ester	216884-02-5				
CC 401		CC-401	395104-30-0	NOE38VQA1W			
CC-8490		CC-8490					
CCG 1423		n-(2-(4-Chloroanilino)-1-methyl-2-oxoethoxy)-3,5-bis(trifluoromethyl)benzamide	285986-88-1				
CCG215022		4-(4-fluoro-3-((pyridin-2-ylmethyl)carbamoyl)phenyl)-N-(1H-indazol-5-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide					
CD 2425		3-Thiophenecarboxylic acid, 5-(2-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-1-propenyl)-, (E)-	156691-84-8				
CD 2608		Benzoic acid, 3-(2-oxo-2-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethyl)-	201536-08-5				
CD 3254		3-[4-Hydroxy-3-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)phenyl]-2-propenoic acid					
CD 437		6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic Acid	125316-60-1		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
CD 666		4-[(E)-3-hydroxy-3-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzoic Acid					
CD2665		4-[7-(1-Adamantyl)-6-(2-methoxyethoxymethoxy)naphthalen-2-yl]benzoic acid	170355-78-9				
CD4528		(3e,5e)-6-(3-{2-[3,4-Bis(Hydroxymethyl)phenyl]ethyl}phenyl)-1,1,1-Trifluoro-2-(Trifluoromethyl)octa-3,5-Dien-2-Ol	476412-32-5				
CDN1163		4-isopropoxy-N-(2-methylquinolin-8-yl)benzamide					
CDP 840	162542-90-7	4-(2-(3-(Cyclopentyloxy)-4-methoxyphenyl)-2-phenylethyl)pyridine	162542-90-7	OK8OFX8K7F			
CDRI 85-287	130064-18-5	1-(2-(4-(3-Phenyl-2H-1-benzopyran-2-yl)phenoxy)ethyl)piperidine	130064-18-5				
CDRI-97-78		CDRI-97-78					
CDTA	482-54-2	Glycine, N,N'-1,2-cyclohexanediylbis[N-(carboxymethyl)-	482-54-2		Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	
CE 224,535		2-(4-Chloro-3-(3-(1-hydroxycycloheptyl)propanoyl)phenyl)-4-((2R)-2-hydroxy-3-methoxy-propyl)-1,2,4-triazine-3,5-dione	724424-43-5	T8B02RAU3C			
cedrelone		Cedrelone	1254-85-9				
cedrol	77-53-2	Cedrol	77-53-2	63ZM9703BO			
CEF regimen		CEF regimen					
Cefaclor	53994-73-3	Cefaclor	53994-73-3	3Z6FS3IK0K	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections.
Cefadroxil	50370-12-2	Cefadroxil	50370-12-2	Q525PA8JJB	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes
cefathiamidine	33075-00-2	Cefathiamidine	33075-00-2	8M7CAS5T8L			
Cefazolin	25953-19-9	Cefazolin	25953-19-9	IHS69L0Y4T	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Mainly used to treat bacterial infections of the skin. It can also be used to treat moderately severe bacterial infections involving the lung, bone, joint, stomach, blood, heart valve, and urinary tract. It is clinically effective against infections caused by staphylococci and streptococci species of Gram positive bacteria. May be used for surgical prophylaxis; if required metronidazole may be added to cover B. fragilis.
Cefdinir	91832-40-5	Cefdinir	91832-40-5	CI0FAO63WC	Third Generation Cephalosporins	Agents that are structurally similar to other CEPHALOSPORINS but have a broader spectrum of activity against bacteria than the first and second generation cephalosporins. These agents cover more resistant STREPTOCOCCUS, STAPHYLOCOCCUS, gram-positive anaerobes, and more resistant strains of HAEMOPHILUS, NEISSERIA, PROTEUS, ESCHERICHIA COLI, and KLEBSIELLA (HNPEK). (See all compounds classified as Third Generation Cephalosporins.)	Cefdinir is indicated to treat acute bacterial otitis media, acute maxillary sinusitis, community-acquired (CA) pneumonia, acute bacterial exacerbations of chronic bronchitis, pharyngitis/tonsillitis, and uncomplicated skin and skin structure infections in children and adults.  The organisms susceptible to cefdinir have been listed below in addition to their associated clinical condition that may be treated with cefdinir. Various beta-lactamase producing organisms may be treated, as indicated in certain sections below.  **Respiratory** Acute bacterial exacerbations of chronic bronchitis caused by Haemophilus influenzae, Haemophilus parainfluenzae, Streptococcus pneumoniae (penicillin-susceptible only), and Moraxella catarrhalis  Community-acquired pneumonia caused by Haemophilus influenzae, Haemophilus parainfluenzae, Streptococcus pneumoniae (penicillin-susceptible only), and Moraxella catarrhalis  **Ear, nose, and throat**  Acute bacterial otitis media caused by Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae (penicillin-susceptible only)  Tonsillitis caused by Streptococcus pyogenes  Pharyngitis caused by Streptococcus pyogenes  Acute maxillary sinusitis caused by Haemophilus pneumoniae and Streptococcus pneumoniae (penicillin-susceptible only), and Moraxella catarrhalis  **Skin and skin structure infections**  Uncomplicated skin and skin structure infections caused by Staphylococcus aureus and Streptococcus pyogenes
Cefepime	88040-23-7	Cefepime	88040-23-7	807PW4VQE3	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Cefepime is indicated for the treatment of pneumonia caused by susceptible bacteria, and for empiric therapy for febrile neutropenic patients. Cefepime is also indicated for the treatment of uncomplicated and complicated urinary tract infections (cUTI) including pyelonephritis, uncomplicated skin and skin structure infections, and complicated intra-abdominal infections (used in combination with [metronidazole]) in adults caused by susceptible bacteria.  Cefepime is also used in combination with [enmetazobactam] to treat cUTI.
cefetamet		Cefetamet	65052-63-3	4R5TV783X3	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Cefixime	79350-37-1	Cefixime	79350-37-1	97I1C92E55	Third Generation Cephalosporins	Agents that are structurally similar to other CEPHALOSPORINS but have a broader spectrum of activity against bacteria than the first and second generation cephalosporins. These agents cover more resistant STREPTOCOCCUS, STAPHYLOCOCCUS, gram-positive anaerobes, and more resistant strains of HAEMOPHILUS, NEISSERIA, PROTEUS, ESCHERICHIA COLI, and KLEBSIELLA (HNPEK). (See all compounds classified as Third Generation Cephalosporins.)	Cefixime is indicated for the treatment of uncomplicated urinary tract infections caused by _Escherichia coli_ and _Proteus mirabilis_, otitis media caused by _Haemophilus influenzae_, _Moraxella catarrhalis_, and _Streptococcus pyogenes_, pharyngitis and tonsillitis caused by _Streptococcus pyogenes_,  acute exacerbations of chronic bronchitis caused by _Streptococcus pneumoniae_ and _Haemophilus influenzae_, and uncomplicated gonorrhea (cervical/urethral) caused by _Neisseria gonorrhoeae_ (penicillinase-and non-penicillinase-producing isolates).
Cefmenoxime	65085-01-0	Cefmenoxime	65085-01-0	KBZ4844CXN	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Used to treat female gynecologic and obstetric infections caused by susceptible aerobic (including the gonococcus) and anaerobic bacteria.
Cefmetazole	56796-20-4	Cefmetazole	56796-20-4	3J962UJT8H	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of infections caused by susceptible organisms.
cefminox	84305-41-9	Cefminox	84305-41-9	PW08Y13465	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Cefonicid	61270-58-4	Cefonicid	61270-58-4	6532B86WFG	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of bacterial infections caused by susceptible microorganisms.
Cefoperazone	62893-19-0	Cefoperazone	62893-19-0	7U75I1278D	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Indicated for the treatment of following infections caused by susceptible bacteria:  1) Respiratory tract infections caused by _S. pneumoniae_, _H. influenzae_, _S. aureus_ (penicillinase and non-penicillinase producing strains), _S. pyogenes_ (Group A beta-hemolytic streptococci), _P. aeruginosa_, _Klebsiella pneumoniae_, _E. coli_, _Proteus mirabilis_, and Enterobacter species.  2) Peritonitis and other intra-abdominal infections caused by _E. coli_, _P. aeruginosa_, and anaerobic gram-negative bacilli (including _Bacteroides fragilis_).  3) Bacterial septicemia caused by _S. pneumoniae_, _S. agalactiae_, _S. aureus_, _Pseudomonas aeruginosa_, _E. coli_, _Klebsiella_ spp., _Klebsiella pneumoniae_, Proteus species (indole-positive and indole-negative), _Clostridium_ spp. and anaerobic gram-positive cocci.  4) Infections of the skin and skin structures caused by S. aureus (penicillinase and non-penicillinase producing strains), S. pyogenes, and P. aeruginosa.  5) Pelvic Inflammatory Disease, Endometritis, and Other Infections of the Female Genital Tract caused by N. gonorrhoeae, S. epidermidis, S. agalactiae, E. coli, Clostridium spp., Bacteroides species (including Bacteroides fragilis), and anaerobic gram-positive cocci.  6) Urinary tract infections caused by Escherichia coli and Pseudomonas aeruginosa.  7) Enterococcal Infections. Although cefoperazone has been shown to be clinically effective in the treatment of infections caused by enterococci in cases of peritonitis and other intra-abdominal infections, infections of the skin and skin structures, pelvic inflammatory disease, endometritis and other infections of the female genital tract, and urinary tract infections, the majority of clinical isolates of enterococci tested are not susceptible to cefoperazone but fall just at or in the intermediate zone of susceptibility, and are moderately resistant to cefoperazone. However, _in vitro_ susceptibility testing may not correlate directly with _in vivo_ results. Despite this, cefoperazone therapy has resulted in clinical cures of enterococcal infections, chiefly in polymicrobial infections. Cefoperazone should be used in enterococcal infections with care and at doses that achieve satisfactory serum levels of cefoperazone.
cefoselis	122841-12-7	Cefoselis sulfate	122841-12-7	6EY42207VS	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Cefotaxime	63527-52-6	Cefotaxime	63527-52-6	N2GI8B1GK7	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Used to treat gonorrhoea, meningitis, and severe infections including infections of the kidney (pyelonephritis) and urinary system. Also used before an operation to prevent infection after surgery.
Cefotetan	69712-56-7	Cefotetan	69712-56-7		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Cefotiam	61622-34-2	Cefotiam	61622-34-2	91W6Z2N718	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For treatment of severe infections caused by susceptible bacteria.
Cefoxitin	35607-66-0	Cefoxitin	35607-66-0	6OEV9DX57Y	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of serious infections caused by susceptible strains microorganisms.
Cefpirome		Cefpirome	84957-29-9	S72Q2F09HY	beta Lactam Antibiotics	Bactericidal agents that contain a beta-lactam ring in their chemical structure. They inhibit bacterial cell wall synthesis by binding to PENICILLIN-BINDING PROTEINS, preventing the synthesis of peptidoglycan in bacterial cell walls. (See all compounds classified as beta Lactam Antibiotics.)	
Cefpodoxime		Cefpodoxime	80210-62-4	7R4F94TVGY	beta Lactam Antibiotics	Bactericidal agents that contain a beta-lactam ring in their chemical structure. They inhibit bacterial cell wall synthesis by binding to PENICILLIN-BINDING PROTEINS, preventing the synthesis of peptidoglycan in bacterial cell walls. (See all compounds classified as beta Lactam Antibiotics.)	Indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms.
cefquinome	84957-30-2	Cefquinome	84957-30-2	Z74S078CWP			
Ceftaroline		Ceftaroline Fosamil	229016-73-3	7P6FQA5D21	beta Lactam Antibiotics	Bactericidal agents that contain a beta-lactam ring in their chemical structure. They inhibit bacterial cell wall synthesis by binding to PENICILLIN-BINDING PROTEINS, preventing the synthesis of peptidoglycan in bacterial cell walls. (See all compounds classified as beta Lactam Antibiotics.)	Ceftaroline fosamil is indicated for the treatment of patients with the following infections caused by susceptible isolates of the designated microorganisms.
Ceftazidime	78439-06-2	Ceftazidime pentahydrate	78439-06-2		Third Generation Cephalosporins	Agents that are structurally similar to other CEPHALOSPORINS but have a broader spectrum of activity against bacteria than the first and second generation cephalosporins. These agents cover more resistant STREPTOCOCCUS, STAPHYLOCOCCUS, gram-positive anaerobes, and more resistant strains of HAEMOPHILUS, NEISSERIA, PROTEUS, ESCHERICHIA COLI, and KLEBSIELLA (HNPEK). (See all compounds classified as Third Generation Cephalosporins.)	
ceftazidime monobactam	80904-83-2	Ceftazidim monobaktam	80904-83-2		Third Generation Cephalosporins	Agents that are structurally similar to other CEPHALOSPORINS but have a broader spectrum of activity against bacteria than the first and second generation cephalosporins. These agents cover more resistant STREPTOCOCCUS, STAPHYLOCOCCUS, gram-positive anaerobes, and more resistant strains of HAEMOPHILUS, NEISSERIA, PROTEUS, ESCHERICHIA COLI, and KLEBSIELLA (HNPEK). (See all compounds classified as Third Generation Cephalosporins.)	
Ceftibuten	97519-39-6	Ceftibuten	97519-39-6	IW71N46B4Y	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Indicated for the treatment of acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsilitis.
Ceftizoxime	68401-81-0	Ceftizoxime	68401-81-0	C43C467DPE	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Cetizoxime was previously indicated for the treatment of infections due to susceptible strains of bacteria.
Ceftriaxone	73384-59-5	Ceftriaxone	73384-59-5	75J73V1629	Third Generation Cephalosporins	Agents that are structurally similar to other CEPHALOSPORINS but have a broader spectrum of activity against bacteria than the first and second generation cephalosporins. These agents cover more resistant STREPTOCOCCUS, STAPHYLOCOCCUS, gram-positive anaerobes, and more resistant strains of HAEMOPHILUS, NEISSERIA, PROTEUS, ESCHERICHIA COLI, and KLEBSIELLA (HNPEK). (See all compounds classified as Third Generation Cephalosporins.)	Ceftriaxone is used for the treatment of the infections (respiratory, skin, soft tissue, UTI, ENT) caused by susceptible organisms. Organisms that are generally susceptible to ceftriaxone include S. pneumoniae, S. pyogenes (group A beta-hemolytic streptococci), coagulase-negative staphylococci, Some Enterobacter spp, H. influenzae, N. gonorrhoeae, P. mirabilis, E. coli, Klebsiella spp, M. catarrhalis, B. burgdorferi, and some oral anaerobes.
Cefuroxime	55268-75-2	Cefuroxime	55268-75-2	O1R9FJ93ED	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of many different types of bacterial infections such as bronchitis, sinusitis, tonsillitis, ear infections, skin infections, gonorrhea, and urinary tract infections.
celastrol		Celastrol	34157-83-0	L8GG98663L			
celastrol methyl ester		Pristimerin	1258-84-0	28ZK7PR57S			
Celecoxib		Celecoxib	169590-42-5	JCX84Q7J1L	Cyclooxygenase 2 Inhibitors	A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2. (See all compounds classified as Cyclooxygenase 2 Inhibitors.)	Celecoxib is indicated for symptomatic treatment of adult osteoarthritis (OA) and adult rheumatoid arthritis (RA). Celecoxib is not a substitute for aspirin for cardiovascular event prophylaxis.   It may be also be used to treat acute pain from various sources, juvenile rheumatoid arthritis in children over 2, ankylosing spondylitis, and primary dysmenorrhea.  Celecoxib, in combination with [tramadol], is indicated for the management of acute pain in adults severe enough to require an opioid analgesic and in whom alternative treatments are inadequate.
Celiprolol	56980-93-9	Celiprolol	56980-93-9	DRB57K47QC	Sympathomimetics	Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)	Celiprolol is indicated for the management of mild to moderate hypertension and effort-induced angina pectoris.
Cell-Penetrating Peptides		Cell-Penetrating Peptides					
Cellfood		Cellfood					
Cellulose	9004-34-6	Cellulose	9004-34-6				
Celsior		Celsior					
cenicriviroc		Cenicriviroc	497223-25-3	15C116UA4Y	CCR5 Receptor Antagonists	Compounds and drugs that inhibit or block the activity of CCR5 RECEPTORS. (See all compounds classified as CCR5 Receptor Antagonists.)	Treatment of non-alcoholic steatohepatitis (NASH)
Centchroman	31477-60-8	Centchroman	31477-60-8	V994WJY688	Estrogen Antagonists	Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)	
Centella asiatica extract		Centella asiatica extract					
centipedic acid		Centipedic acid					
Central Nervous System Agents		Central Nervous System Agents					
CEP 33779		N-(3-(4-methylpiperazin-1-yl)phenyl)-8-(4-(methylsulfonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine	1257704-57-6	TE2YU6E6YP			
CEP 8983		1H-Cyclopenta(a)pyrrolo(3,4-c)carbazole-1,3(2H)-dione, 4,5,6,7-tetrahydro-11-methoxy-	374071-46-2	E5YA7GMH0H			
CEP-11004		methyl (15S,16S,18R)-16-hydroxy-15-methyl-3-oxo-10,23-bis(propan-2-ylsulfanylmethyl)-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8(13),9,11,20(25),21,23,26-nonaene-16-carboxylate	178404-52-9				
cephaelin	483-17-0	Cephaeline	483-17-0	QA971541A1			
Cephalexin	15686-71-2	Cephalexin	15686-71-2	5SFF1W6677	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Cephalexin is indicated for the treatment of certain infections caused by susceptible bacteria. These infections include respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections.
Cephaloglycin	3577-01-3	Cephaloglycin	3577-01-3	HD2D469W6U	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For treatment of severe infections caused by susceptible bacteria.
Cephaloridine	50-59-9	Cephaloridine	50-59-9	LVZ1VC61HB	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
cephalosporin C	61-24-5	cephalosporin C	61-24-5	3XIY7HJT5L			
Cephalosporins		cephalosporin C	61-24-5	3XIY7HJT5L			
Cephalothin	153-61-7	Cephalothin	153-61-7	R72LW146E6	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Used to prevent infection during surgery and to treat many kinds of infections of the blood, bone or joints, respiratory tract, skin, and urinary tract.
cepharanthine	481-49-2	Cepharanthine	481-49-2	7592YJ0J6T	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
Cephradine		Cephradine	38821-53-3	9YA6SX5S4D	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
ceramide 1-phosphate		CerP(d18:1/18:0)	128543-23-7				
Ceramides		CERAMIDES					
cerebrolysin	12656-61-0	Cerebrolysin					
cereulide		Cereulide	157232-64-9				
ceric oxide	1306-38-3	Ceric oxide	1306-38-3	619G5K328Y			
ceritinib		Ceritinib	1032900-25-6	K418KG2GET	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Ceritinib is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under accelerated approval based on tumor response rate and duration of response. An improvement in survival or disease-related symptoms has not been established. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
Cerium	7440-45-1	Cerium	7440-45-1	30K4522N6T			
cerivastatin		Cerivastatin	145599-86-6	AM91H2KS67	Hydroxymethylglutaryl-CoA Reductase Inhibitors	Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)	Used as an adjunct to diet for the reduction of elevated total and LDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia (Fredrickson Types IIa and IIb) when the response to dietary restriction of saturated fat and cholesterol and other non-pharmacological measures alone has been inadequate.
ceronapril		Ceronapril	111223-26-8	X3MM60SOVP	Angiotensin-Converting Enzyme Inhibitors	A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)	
cerous chloride	7790-86-5	Cerium trichloride	7790-86-5				
certoparin		Lovenox	9005-49-6				
Cerulenin	17397-89-6	Cerulenin	17397-89-6	MF286Y830Q	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	For use as a biochemical tool, Cerulenin is shown to cause dramatic weight loss in animals
Ceruletide		Ceruletide	17650-98-5	888Y08971B			Caerulein is used in the treatment of paralytic ileus and as diagnostic aid in pancreatic malfunction.
Cesium	7440-46-2	Cesium	7440-46-2	1KSV9V4Y4I			
cesium chloride	7647-17-8	Cesium Chloride	7647-17-8	GNR9HML8BA			
Cesium-137		Cesium-137	10045-97-3				
cetaben		Cetaben	55986-43-1	DTL5W0113X			
cetalkonium chloride	122-18-9	Cetalkonium chloride	122-18-9	85474O1N9D	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
cetilistat		Cetilistat	282526-98-1	LC5G1JUA39	Anti-Obesity Agents	Agents that increase energy expenditure and weight loss by neural and metabolic regulation. (See all compounds classified as Anti-Obesity Agents.)	Investigated for use/treatment in obesity.
Cetirizine	83881-51-0	Cetirizine	83881-51-0	YO7261ME24	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	**Seasonal Allergic Rhinitis**: Indicated for the relief of symptoms associated with seasonal allergic rhinitis caused by allergens such as ragweed, grass and tree pollens in adults and children 2 years of age and above. Symptoms treated effectively include sneezing, rhinorrhea, nasal pruritus, ocular pruritus, tearing, and redness of the eyes.   **Perennial allergic rhinitis**: This drug is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens including dust mites, animal dander, and molds in adults and children 6 months of age and older. Symptoms treated effectively include sneezing, rhinorrhea, postnasal discharge, nasal pruritus, ocular pruritus, and tearing.   **Chronic urticaria**: Cetirizine is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. It markedly reduces the occurrence, severity, and duration of hives and significantly reduces pruritus.
Cetrimonium	6899-10-1	Cetrimonium	6899-10-1	Z7FF1XKL7A	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
cetrorelix	120287-85-6	Cetrorelix	120287-85-6	OON1HFZ4BA	Fertility Agents, Female	Compounds which increase the capacity to conceive in females. (See all compounds classified as Fertility Agents, Female.)	For the inhibition of premature LH surges in women undergoing controlled ovarian stimulation
cetyl sulfate	143-02-2	Cetyl sulfate	143-02-2	588KRC8J32			
cetyldimethylethylammonium		Mecetronium	10328-33-3	17T62WR2KI			
Cetylpyridinium	7773-52-6	Cetylpyridinium	7773-52-6	CUB7JI0JV3	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	Typically employed as the cetylpyridinium chloride salt, this compound is commonly used as an active ingredient in various over-the-counter mouthwashes, toothpastes, lozenges, and mouth sprays where it is generally indicated for antiseptic actions, gingivitis and plaque prevention, as well as action or prevention against some other oropharyngeal bacterial infections.
cevimeline	107233-08-9	Cevimeline	107233-08-9	K9V0CDQ56E	Parasympathomimetics	Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. (See all compounds classified as Parasympathomimetics.)	For the treatment of symptoms of dry mouth in patients with Sjgren's Syndrome.
CF 25397	57935-49-6	Tiomergine	57935-49-6	85J22V47HN			
CF regimen		CF regimen					
CF101		IB-Meca	152918-18-8	30679UMI0N			Investigated for use/treatment in cancer/tumors (unspecified), eye disorders/infections, psoriasis and psoriatic disorders, and rheumatoid arthritis. Can-Fite BioPharma has reported that by targeting the adenosine A3-receptor, CF101 may also be used to treat Crohn's disease, a serious gastrointestinal disorder.
CFM 1		CFM 1					
CGC 11093		N-Ethyl-N'-[[2-[[4-(ethylamino)butylamino]methyl]cyclopropyl]methyl]butane-1,4-diamine;tetrahydrochloride	306292-64-8				
CGK 733		Diphenyl acetamidotrichloroethyl fluoronitrophenyl thiourea	905973-89-9	L3DGZ99QYM			
CGP 12177	81047-99-6	4-(3-tert-Butylamino-2-hydroxypropoxy)benzimidazol-2-one	81047-99-6	R89UMZ82MJ	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	
CGP 20712A		CGP 20712A methanesulfonate	105737-62-0	CNU8DA2K9J	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	
CGP 42112A	127060-75-7	L-Isoleucine, N-(1-(N-(N6-(N2-((phenylmethoxy)carbonyl)-L-arginyl)-N2-(N-(3-pyridinylcarbonyl)-L-tyrosyl)-L-lysyl)-L-histidyl)-L-prolyl)-	127060-75-7	9Q3V7W3XDD			
CGP 48369	135689-23-5	2,6-Dibutyl-5-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)pyrimidin-4-ol	135689-23-5				
CGP 52608	87958-67-6	1-methyl-3-[(E)-(4-oxo-3-prop-2-enyl-1,3-thiazolidin-2-ylidene)amino]thiourea	87958-67-6	QS3ABF85TR			
CGP 55845A	148056-42-2	(3-((1-(3,4-Dichlorophenyl)ethyl)amino)-2-hydroxypropyl)(P-benzyl)-phosphinic acid	148056-42-2		GABA Antagonists	Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS. (See all compounds classified as GABA Antagonists.)	
CGP 56999A		3-[(1R)-1-[[(2S)-3-(cyclohexylmethyl-hydroxyphosphoryl)-2-hydroxypropyl]amino]ethyl]benzoic acid					
CGP 57380		N3-(4-fluorophenyl)-1h-pyrazolo[3,4-d]pyrimidine-3,4-diamine	522629-08-9				
CGP 57698		Butanoic acid, 2,2-diethyl-4-((3-((7-fluoro-2-quinolinyl)methoxy)phenyl)amino)-4-oxo-	168082-74-4				
CGP 71872		3-[(1R)-1-[[(2S)-3-[5-[(4-azido-2-hydroxy-5-iodobenzoyl)amino]pentyl-hydroxyphosphoryl]-2-hydroxypropyl]amino]ethyl]benzoic acid			GABA-B Receptor Antagonists	Drugs that bind to but do not activate GABA-B RECEPTORS thereby blocking the actions of endogenous or exogenous GABA-B RECEPTOR AGONISTS. (See all compounds classified as GABA-B Receptor Antagonists.)	
CGP 77675		1-(4-(4-amino-5-(3-methoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)phenethyl)piperidin-4-ol	234772-64-6	EQH27E0WRV	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
CGP049090		Cercosporin, pure	35082-49-6				
CGS 12066B	109028-10-6	CGS 12066B dimaleate	109028-10-6	VJ9I4R0C0C	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	
CGS 15855A	107320-86-5	Isomolpan	107320-86-5	I06LXQ54TY			
CGS 24592		CGS 24592					
CGS 26303	154116-31-1	(S)-2-Biphenyl-4-yl-1-(1H-tetrazol-5-yl)ethylaminomethyl phosphonic acid	154116-31-1				
CGS 27023A		N-Hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](3-picolyl)amino]-3-methylbutanamide hydrochloride	161314-70-1	80AXY59IT2			
CGS 34043		CGS 34043					
CGS 35066		3-Dibenzofuran-3-yl-2-(phosphonomethylamino)propionic acid	261619-50-5				
CGS 35601		L-Tryptophan, N-((1-(((2S)-2-mercapto-4-methyl-1-oxopentyl)amino)cyclopentyl)carbonyl)-	849066-09-7	7D7KS7Y7JY			
CH 5138514		CH 5138514					
CH 5166623		CH 5166623					
Ch 80	95906-68-6	4-[3-Oxo-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-YL)-propenyl]-benzoic acid	95906-68-6	C9FL8WH6S4			
CH4933468		1-Imidazolidinepropanesulfonamide, 3-(3-chloro-4-cyanophenyl)-5,5-dimethyl-4-oxo-2-thioxo-	875055-92-8	626ZE9ZBKU			
chaetocin	28097-03-2	Chetocin	28097-03-2	DF939M63W4			
chaetoglobosins	50335-03-0	Chaetoglobosin A	50335-03-0				
chaetomugilin D		chaetomugilin D	1098081-38-9				
Chalcone	94-41-7	Chalcone	94-41-7	5S5A2Q39HX			
chalcone epoxide	5411-12-1	1,3-Diphenyl-2,3-epoxy-1-propanone	5411-12-1				
Chalcones		Chalcones					
chan su		chan su					
chan-yu-bao-yuan-tang		chan-yu-bao-yuan-tang					
Changkil		Changkil					
Charcoal	16291-96-6	Carbon	7440-44-0				
Charybdotoxin	115422-61-2	Charybdotoxin	95751-30-7		Neurotoxins	Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept. (See all compounds classified as Neurotoxins.)	
chebulagic acid	23094-71-5	CID 250397	23094-71-5		Lipoxygenase Inhibitors	Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)	
chebulic acid		Chebulic acid	23725-05-5	G66Q7V3DPP			
chebulinic acid	18942-26-2	2-[(4R,5S,7R,8R,11S,12S,13S,21S)-13,17,18-trihydroxy-2,10,14-trioxo-5,21-bis[(3,4,5-trihydroxybenzoyl)oxy]-7-[(3,4,5-trihydroxybenzoyl)oxymethyl]-3,6,9,15-tetraoxatetracyclo[10.7.1.14,8.016,20]henicosa-1(19),16(20),17-trien-11-yl]acetic acid					
Chelating Agents		Chelating Agents					
chelerythrine	34316-15-9	Chelerythrine	34316-15-9	E3B045W6X0	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
chelex	80208-96-4	Chelex					
chelidonine	476-32-4	Chelidonine	20267-87-2	8K7EK8446J			
Chenodeoxycholic Acid	474-25-9	Chenodiol	474-25-9	0GEI24LG0J	Gastrointestinal Agents	Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)	Chenodiol is indicated for patients with radiolucent stones in well-opacifying gallbladders, in whom selective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age. Chenodiol will not dissolve calcified (radiopaque) or radiolucent bile pigment stones.
chetomin	1403-36-7	Chetomin	1403-36-7	BKU7CX6USX			
CHF 4056		3-phenyl-4-((4-(2-(1-piperidinyl)ethoxy)phenyl)methyl)-2H-1-benzopyran-7-ol	437756-52-0				
CHF 5022		Cyclopropanecarboxylic acid, 1-(2-fluoro-4'-(trifluoromethyl)(1,1'-biphenyl)-4-yl)-	749269-77-0	JO8EVV007Q			
chicoric acid		Chicoric acid	70831-56-0	S4YY3V8YHD	HIV Integrase Inhibitors	Inhibitors of HIV INTEGRASE, an enzyme required for integration of viral DNA into cellular DNA. (See all compounds classified as HIV Integrase Inhibitors.)	
chiglitazar		Chiglitazar	743438-45-1	E6EJV1J6Y0			
chikusetsusaponin V		Ginsenoside Ro	34367-04-9	OF1PLT74Q8			
chimaphilin	482-70-2	Chimaphilin	482-70-2	U8Z086618U			
Chir 98014		N2-(2-((4-(2,4-Dichlorophenyl)-5-(1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)-5-nitropyridine-2,6-diamine	556813-39-9				
Chir 99021		6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile	252917-06-9	234CMT4GK4			
CHIR-124		4-[(3s)-1-Azabicyclo[2.2.2]oct-3-Ylamino]-3-(1h-Benzimidazol-2-Yl)-6-Chloroquinolin-2(1h)-One	405168-58-3	5K64W8EU3E			
Chitin	1398-61-4	N-[(2R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide	1398-61-4				
chitobiose	577-76-4	beta-D-glucosaminyl-(1->4)-aldehydo-D-glucosamine	577-76-4				
Chitosan	9012-76-4	Chitosan	9012-76-4		Hemostatics	Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)	
chlamydocin	53342-16-8	Chlamydocin	53342-16-8				
Chloral Hydrate	302-17-0	Chloral Hydrate	302-17-0	418M5916WG	Hypnotics and Sedatives	Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)	Mainly used as a hypnotic in the treatment of insomnia; however, it is only effective as a hypnotic for short-term use. May be used as a routine sedative preoperatively to decrease anxiety and cause sedation and/or sleep with respiration depression or cough reflex.
Chloralose	15879-93-3	Chloralose	15879-93-3	238BZ29MUE	Anesthetics, Intravenous	Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) (See all compounds classified as Anesthetics, Intravenous.)	
Chlorambucil	305-03-3	Chlorambucil	305-03-3	18D0SL7309	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	For treatment of chronic lymphatic (lymphocytic) leukemia,  childhood minimal-change nephrotic syndrome, and malignant lymphomas including lymphosarcoma, giant follicular lymphoma, Hodgkin's disease,  non-Hodgkin's lymphomas, and Waldenstrms Macroglobulinemia.
chloramine	10599-90-3	Chloramine	10599-90-3	KW8K411A1P			
chloramine-T	127-65-1	chloramine-t anhydrous	127-65-1	328AS34YM6	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
Chloramphenicol	56-75-7	Chloramphenicol	56-75-7	66974FR9Q1	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Used in treatment of cholera, as it destroys the vibrios and decreases the diarrhea. It is effective against tetracycline-resistant vibrios. It is also used in eye drops or ointment to treat bacterial conjunctivitis.
chloramphenicol palmitate	530-43-8	Chloramphenicol Palmitate	530-43-8	43VU4207NW			
Chloranil	118-75-2	Chloranil	118-75-2	01W5X7N5XV	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
chlorantranilipole		Chlorantraniliprole	500008-45-7	622AK9DH9G	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Chlorates		Chlorate ion	14866-68-3	08Z8093742			
chlorbenzuron		Chlorobenzuron	57160-47-1				
chlorcyclizine	82-93-9	Chlorcyclizine	82-93-9	M26C4IP44P			
Chlordan	12789-03-6	Chlordane	12789-03-6		Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Chlordecone	143-50-0	Chlordecone	143-50-0	RG5XJ88UDF	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Chlordiazepoxide	58-25-3	Chlordiazepoxide	58-25-3	6RZ6XEZ3CR	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	Chlordiazepoxide is indicated for the management of anxiety disorders or for the short-term relief of symptoms of anxiety, withdrawal symptoms of acute alcoholism, and preoperative apprehension and anxiety.   In combination with amitriptyline, chlordiazepoxide is indicated for the treatment of moderate to severe depression. In combination with clidinium, chlordiazepoxide is indicated to control emotional and somatic factors in gastrointestinal disorders, and is used as adjunctive therapy in the treatment of peptic ulcer, irritable bowel syndrome and acute enterocolitis.
chlorendic acid	115-28-6	Chlorendic acid	115-28-6				
chlorethylclonidine	98086-36-3	N-(2,6-Dichloro-4-(2-chloroethyl)phenyl)-4,5-dihydro-1H-imidazol-2-amine dihydrochloride					
Chlorfenvinphos	470-90-6	Chlorfenvinphos	470-90-6	WO4EMF0QD6	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
chlorfluazuron	71422-67-8	Chlorfluazuron	71422-67-8	Q42JG8449K			
Chlorhexidine	55-56-1	Chlorhexidine	55-56-1	R4KO0DY52L	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	"Chlorhexidine is available over-the-counter in various formulations (e.g. solution, sponge, cloth, swab) as a topical antiseptic to sanitize prior to surgeries and/or medical procedures. Dental formulations, available by prescription only, include an oral rinse indicated for the treatment of gingivitis and a slow-release ""chip"" which is inserted into periodontal pockets and is indicated for the reduction of pocket depth in adult patients with periodontitis as an adjunct therapy to dental scaling and root planing procedures."
chlorhexidine gluconate	18472-51-0	Chlorhexidine Gluconate	18472-51-0	MOR84MUD8E	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	"Chlorhexidine is available over-the-counter in various formulations (e.g. solution, sponge, cloth, swab) as a topical antiseptic to sanitize prior to surgeries and/or medical procedures. Dental formulations, available by prescription only, include an oral rinse indicated for the treatment of gingivitis and a slow-release ""chip"" which is inserted into periodontal pockets and is indicated for the reduction of pocket depth in adult patients with periodontitis as an adjunct therapy to dental scaling and root planing procedures."
chloric acid	7790-93-4	Chloric acid	7790-93-4	Z0V9L75H3K			
Chlorides		Chloride Ion	16887-00-6	Q32ZN48698			
Chlorine	7782-50-5	Chlorine	7782-50-5	4R7X1O2820	Chemical Warfare Agents	Chemicals that are used to cause the disturbance, disease, or death of humans during WARFARE. (See all compounds classified as Chemical Warfare Agents.)	
Chlorisondamine	7701-62-4	Chlorisondamine	7701-62-4	JD3M24F66I	Ganglionic Blockers	Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. They may still be used in the control of blood pressure in patients with acute dissecting aortic aneurysm and for the induction of hypotension in surgery. (See all compounds classified as Ganglionic Blockers.)	
chlorite	1318-59-8	Chlorite	14998-27-7	Z63H374SB6			
Chlormadinone Acetate	302-22-7	Chlormadinone acetate	302-22-7	0SY050L61N	Contraceptives, Oral, Hormonal	Oral contraceptives which owe their effectiveness to hormonal preparations. (See all compounds classified as Contraceptives, Oral, Hormonal.)	
Chlormequat	999-81-5	Chlormequat chloride	999-81-5	PPL2215L82	Plant Growth Regulators	Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins. (See all compounds classified as Plant Growth Regulators.)	
Chlormethiazole	533-45-9	Clomethiazole	533-45-9	0C5DBZ19HV	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	Investigated for use/treatment in strokes.
chlormethoxynil	32861-85-1	Chlomethoxyfen	32861-85-1	VO5437P1A2			
chlormidazole	3689-76-7	Chlormidazole	3689-76-7	8IKK64FJVX			
chlornaltrexamine	67025-94-9	Chlornaltrexamine	67025-94-9		Narcotic Antagonists	Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)	
chloro(2,2'-6',2''-terpyridine)(2,2'-bipyridine)ruthenium		chloro(2,2'-6',2''-terpyridine)(2,2'-bipyridine)ruthenium					
chloroacetaldehyde	107-20-0	Chloroacetaldehyde	107-20-0	CF069F5D9C			
chloroacetamide	79-07-2	2-Chloroacetamide	79-07-2	2R97846T1L			
chloroacetic acid	79-11-8	Chloroacetic acid	79-11-8	5GD84Y125G			
chloroacetonitrile	107-14-2	Chloroacetonitrile	107-14-2	CN524K9DXD			
chlorobenzene	108-90-7	Chlorobenzene	108-90-7	K18102WN1G			
Chlorobenzenes		Chlorobenzenes					
chlorobenzilate	510-15-6	Chlorobenzilate	510-15-6	H850P004CZ			
Chlorobenzoates		Chlorobenzoates					
Chlorobutanol	57-15-8	Chlorobutanol	57-15-8	HM4YQM8WRC	Preservatives, Pharmaceutical	Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include ANTI-BACTERIAL AGENTS and antioxidants. (See all compounds classified as Preservatives, Pharmaceutical.)	No approved therapeutic indications on its own.
chlorocresol	59-50-7	4-Chloro-3-methylphenol	59-50-7	36W53O7109	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
chlorodibromomethane	124-48-1	Chlorodibromomethane	124-48-1	3T4AJR1H24			
chlorodifluoroacetaldehyde	811-96-1	Chlorodifluoroacetaldehyde	811-96-1				
chlorodimedone	7298-89-7	Chlorodimedone	7298-89-7				
Chlorodiphenyl (54% Chlorine)	11097-69-1	2,2',3,3',4-Pentachlorobiphenyl	52663-62-4	88Z0CKE07W	Antithyroid Agents	Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones. (See all compounds classified as Antithyroid Agents.)	
chlorofluoroacetic acid	471-44-3	Chlorofluoroacetic acid	471-44-3				
Chloroform	67-66-3	Chloroform	67-66-3	7V31YC746X	Solvents	Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant and Hackh&apos;s Chemical Dictionary, 5th ed) (See all compounds classified as Solvents.)	
Chlorogenic Acid	327-97-9	Chlorogenic Acid	327-97-9	318ADP12RI			
chloromethyl methyl ether	107-30-2	Chloromethyl methyl ether	107-30-2	334G5B96VG			
chlorophacinone	3691-35-8	Chlorophacinone	3691-35-8	34Y6E0063Y	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
Chlorophenols		2,3,4,6-Tetrachlorophenol	58-90-2	2442S914FX			
chlorophenyl isocyanate		52500-91-1					
Chlorophyll	1406-65-1	Chlorophyll	1406-65-1				
Chlorophyllides		Chlorophyllides					
chlorophyllin	15611-43-5	Chlorophyllin A	15611-43-5		Antimutagenic Agents	Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved. (See all compounds classified as Antimutagenic Agents.)	
chloropicrin	76-06-2	Chloropicrin	76-06-2	I4JTX7Z7U2	Chemical Warfare Agents	Chemicals that are used to cause the disturbance, disease, or death of humans during WARFARE. (See all compounds classified as Chemical Warfare Agents.)	
chloroplatinic acid	16941-12-1	16941-12-1					
Chloroprene	126-99-8	Chloroprene	9010-98-4	42L93DWV3A			
chloroprocaine	133-16-4	Chloroprocaine	133-16-4	5YVB0POT2H	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	Chloroprocaine for intrathecal injection is indicated for the production of subarachnoid block (spinal anesthesia) in adults. It is also indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, and a preservative-free form can also be used for lumbar and caudal epidural blocks. Topical chloroprocaine for ophthalmic use is indicated for ocular surface anesthesia.
chloropropylate	5836-10-2	Chloropropylate	5836-10-2	GI03ROM7HQ			
Chloroquine	54-05-7	Chloroquine	54-05-7	886U3H6UFF	Amebicides	Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal. (See all compounds classified as Amebicides.)	Chloroquine is indicated to treat infections of _P. vivax_, _P. malariae_, _P. ovale_, and susceptible strains of _P. falciparum_. It is also used to treat extraintestinal amebiasis.  Chloroquine is also used off label for the treatment of rheumatic diseases, as well as treatment and prophylaxis of Zika virus. Chloroquine is currently undergoing clinical trials for the treatment of COVID-19.
chloroquine diphosphate	50-63-5	Chloroquine Phosphate	50-63-5	6E17K3343P	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
Chlorotrianisene	569-57-3	Chlorotrianisene	569-57-3	6V5034L121	Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	Used to treat symptoms of menopause, deficiencies in ovary function (including underdevelopment of female sexual characteristics and some types of infertility), and in rare cases, prostate cancer. Chlorotrianisene may also be used to prevent breast engorgement following childbirth.
chlorotrifluoroethylene	79-38-9	Chlorotrifluoroethylene	9002-83-9	AF215GW34G			
chlorotriphenylsilane	76-86-8	Chlorotriphenylsilane	76-86-8				
chlorowax 500C	56509-64-9	chlorowax 500C					
chloroxine	773-76-2	Chloroxine	773-76-2	2I8BD50I8B	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	Used in the treatment of dandruff and mild to moderately severe seborrheic dermatitis of the scalp.
chloroxoquinoline		7-Chloro-4-hydroxyquinoline	86-99-7	23FWH4CH0U			
chloroxylenol	88-04-0	Chloroxylenol	88-04-0	0F32U78V2Q	Schistosomicides	Agents that act systemically to kill adult schistosomes. (See all compounds classified as Schistosomicides.)	The predominant medical applications for which chloroxylenol is formally indicated for therapeutic use is as an application to the skin for use in cuts, bites, stings, abrasions, and for use as antiseptic hand cleaner.
chlorphenesin carbamate	886-74-8	Chlorphenesin Carbamate	886-74-8	57U5YI11WP			
Chlorpheniramine	132-22-9	Chlorpheniramine	25523-97-1	3U6IO1965U	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	For the treatment of rhinitis, urticaria, allergy, common cold, asthma and hay fever.
chlorproethazine	84-01-5	Chlorproethazine	84-01-5	960NX27Z07	Muscle Relaxants, Central	A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)	
Chlorpromazine	50-53-3	Chlorpromazine	50-53-3	U42B7VYA4P	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	For the treatment of schizophrenia; to control nausea and vomiting; for relief of restlessness and apprehension before surgery; for acute intermittent porphyria; as an adjunct in the treatment of tetanus; to control the manifestations of the manic type of manic-depressive illness; for relief of intractable hiccups; for the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance.
Chlorpropamide	94-20-2	Chlorpropamide	94-20-2	WTM2C3IL2X	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	For treatment of NIDDM in conjunction with diet and exercise.
Chlorpropham	101-21-3	Chlorpropham	101-21-3	0HBU04R8B0	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Chlorprothixene	113-59-7	Chlorprothixene	113-59-7	9S7OD60EWP	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	For treatment of psychotic disorders (e.g. schizophrenia) and of acute mania occuring as part of bipolar disorders.
Chlorpyrifos	2921-88-2	Chlorpyrifos	2921-88-2	JCS58I644W	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
chlorpyrifos-methyl	5598-13-0	Chlorpyrifos-methyl	5598-13-0	O49S38267J			
Chlorquinaldol	72-80-0	Chlorquinaldol	72-80-0	D6VHC87LLS	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	Chlorquinaldol was used historically as a topical antiseptic agent for skin infections. It maintains use in European countries as a combination vaginal tablet with promestriene for use in the treatment of vaginal infections.
Chlortetracycline	57-62-5	Chlortetracycline	57-62-5		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Chlorthalidone	77-36-1	Chlorthalidone	77-36-1	Q0MQD1073Q	Sodium Chloride Symporter Inhibitors	Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA. (See all compounds classified as Sodium Chloride Symporter Inhibitors.)	Chlorthalidone is indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension.  Chlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy.  Chlorthalidone has also been found useful in edema due to various forms of renal dysfunction, such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure.
chlortoluron	15545-48-9	Chlorotoluron	15545-48-9	SUW8L8G38A	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Chlorzoxazone	95-25-0	Chlorzoxazone	95-25-0	H0DE420U8G	Muscle Relaxants, Central	A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)	For the relief of discomfort associated with acute painful musculoskeletal conditions.
cholan-2,3,24-tryl-2,3,24-trisulfate		cholan-2,3,24-tryl-2,3,24-trisulfate					
cholanic acid	25312-65-6	Cholanic acid	25312-65-6	NS0L7RS7DA			
Cholates		Cholates					
Cholecalciferol	67-97-0	Cholecalciferol	1406-16-2	1C6V77QF41	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Cholecalciferol use is indicated for the treatment of specific medical conditions like refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia.  Concurrently, as one of the most commonly utilized forms of vitamin D, cholecalciferol is also very frequently used as a supplement in individuals to maintain sufficient vitamin d levels in the body or to treat vitamin D deficiency, as well as various medical conditions that can be associated directly or indirectly with vitamin d insufficiency like osteoporosis and chronic kidney disease, among others.
Cholecystokinin	9011-97-6	Cholecystokinin	9011-97-6		Cholagogues and Choleretics	Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)	For use as a diagnostic aid for evaluation of gallbladder disorders.  It is also used in conjunction with secretin in pancreatic insufficiency.
cholecystokinin pentapeptide	18917-24-3	Cholecystokinin pentapeptide	18917-24-3				
Cholera Toxin	9012-63-9	Cholera Toxin					
cholest-4-en-3-one	601-57-0	Cholest-4-en-3-one	601-57-0	7T94NHD99C			
cholest-5-en-3 beta,7 alpha-diol	566-26-7	7alpha-Hydroxycholesterol	566-26-7	95D0I22I0V			
cholest-5-ene-3,4-diol	17320-10-4	4beta-Hydroxycholesterol	17320-10-4	3T705H20G7			
cholest-8(14)-en-3-ol-15-one	50673-97-7	Colestolone	50673-97-7	5P8396T5XF	Anticholesteremic Agents	Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)	
cholestane-3,5,6-triol	115510-05-9	Cholestane-3,5,6-triol			Hypolipidemic Agents	Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)	
Cholestanol	80-97-7	Dihydrocholesterol	80-97-7	8M308U816E			
Cholestanols		Cholestanols					
Cholesterol	57-88-5	Cholesterol	57-88-5	97C5T2UQ7J			
cholesterol alpha-oxide	1250-95-9	Epoxycholesterol	1250-95-9	3UQ9PF5XBD			
Cholesterol Esters		Cholesterol Esters					
cholesterol stearate	35602-69-8	Cholesteryl stearate	35602-69-8	I1Q82N9DYQ			
cholesterol-3-beta,5-alpha, 6-beta-triol		cholesterol-3-beta,5-alpha, 6-beta-triol					
Cholesterol, Dietary		Cholesterol, Dietary					
Cholesterol, HDL		Cholesterol, HDL					
Cholesterol, LDL		Cholesterol, LDL					
Cholesterol, VLDL		Cholesterol, VLDL					
cholesteryl arachidonate	604-34-2	Cholesteryl arachidonate	604-34-2	USB7VS82GH			
cholesteryl ester hydroperoxide	2058-59-5	Cholesteryl ester hydroperoxide	2058-59-5				
cholesteryl linoleate	604-33-1	Cholesteryl linoleate	604-33-1	75427237HI			
cholesteryl linolenate	2545-22-4	Cholesteryl linolenate	2545-22-4				
cholesteryl myristate	1989-52-2	Cholesteryl myristate	1989-52-2				
cholesteryl oleate	303-43-5	Cholesteryl oleate	303-43-5	3DPK9KFN2M			
cholesteryl oleyl ether	66106-91-0	Cholesteryl oleyl ether	66106-91-0				
cholesteryl palmitate	601-34-3	Cholesteryl palmitate	601-34-3	ZR4D53AD57			
cholesteryl sulfate	1256-86-6	Cholesterol sulfate	1256-86-6	KU576NT9O9	Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	
Cholic Acid	81-25-4	Cholic Acid	81-25-4	G1JO7801AE			Oral cholic acid is indicated for: treatment of bile acid synthesis disorders due to single enzyme defects; and as adjunctive treatment of peroxisomal disorders including Zellweger spectrum disorders in patients who exhibit manifestations of liver disease, steatorrhea or complications from decreased fat soluble vitamin absorption.
Cholic Acids		Cholic Acids					
Choline	62-49-7	Choline	62-49-7	N91BDP6H0X	Nootropic Agents	Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)	For nutritional supplementation, also for treating dietary shortage or imbalance
choline plasmalogens		choline plasmalogens					
Cholinesterase Inhibitors		Cholinesterase Inhibitors					
Cholinesterase Reactivators		Cholinesterase Reactivators					
cholix toxin, Vibrio cholerae		cholix toxin, Vibrio cholerae					
cholyl-lysylfluorescein		cholyl-lysylfluorescein					
chondroitin sulfate glycosaminoglycan		chondroitin sulfate glycosaminoglycan					
Chondroitin Sulfate Proteoglycans		Chondroitin Sulfate Proteoglycans					
Chondroitin Sulfates	9007-28-7	Chondroitin 4-sulfate	9007-28-7				
chong-myung-tang		chong-myung-tang					
CHOP protocol		CHOP regimen					
Chorionic Gonadotropin		Chorionic Gonadotropin					
Chromans		Chromans					
chromated copper arsenate	37337-13-6	37337-13-6					
Chromates		Chromate	13907-45-4	9S2Y101D6M			
chromic acid	13530-68-2	Dichromic acid	13530-68-2				
chromic chloride		Chromic Chloride	10025-73-7	Z310X5O5RP			For use as a supplement to intravenous solutions given for total parenteral nutrition (TPN).
chromic oxide	1308-38-9	Chromium(III) oxide	1308-38-9				
chromic phosphate	7789-04-0	Chromic phosphate	7789-04-0	AQ86ZJ9U98			
Chromium	7440-47-3	Chromium	7440-47-3	0R0008Q3JB	Trace Elements	A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)	Indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN), to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.
chromium (D-Phenylalanine)3		chromium (D-Phenylalanine)3					
chromium (III) beta,gamma-bidentate guanosine triphosphate	113903-19-8	Chromium (III) beta,gamma-bidentate guanosine triphosphate	113903-19-8				
chromium (III) bidentate guanosine 5'-(beta,gamma-imido)triphosphate	117604-44-1	Cr(III)-B-Gppnhp	117604-44-1				
Chromium Alloys		Chromium Alloys					
Chromium Compounds		CCRIS 159					
chromium dinicocysteinate		chromium dinicocysteinate					
chromium hexavalent ion	18540-29-9	Chromium(6+)	18540-29-9		Carcinogens, Environmental	Carcinogenic substances that are found in the environment. (See all compounds classified as Carcinogens, Environmental.)	
chromium histidinate		Chromium histidinate	18984-90-2	1BY3EP7D99			
chromium mesoporphyrin		chromium mesoporphyrin					
chromium nicotinic acid complex		Chromium nicotinate					
chromium nitrate	10103-47-6	Nitric acid, chromium salt	10103-47-6				
chromium protoporphyrin IX	84640-43-7	Cr-Protoporphyrin	84640-43-7				
chromium trioxide	1333-82-0	Chromium Trioxide	1333-82-0	8LV49809UC	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
chromium tripicolinate	14639-25-9	Chromium Picolinate	14639-25-9	S71T8B8Z6P			
Chromones		Chromones					
chromotrope 2R	4197-07-3	Chromotrope 2R	4197-07-3				
chromous chloride	10049-05-5	10049-05-5					
chromozym PL	71663-39-3	Chromozym PL					
chrysamine G	6472-91-9	Chrysamine	6472-91-9				
chrysarobin	491-59-8	3-Methyl-1,8,9-anthracenetriol	491-59-8	0433FJV3CI			
chrysene	218-01-9	Chrysene	218-01-9	084HCM49PT			
chrysene-5,6-oxide	15131-84-7	Chrysene-5,6-oxide	15131-84-7				
chrysene,2-diol-3,4-epoxide-1	67252-82-8	Anti-cde	67252-82-8				
Chrysenes		Chrysenes					
chrysin	480-40-0	Chrysin	480-40-0	3CN01F5ZJ5			
chrysoeriol		Chryseriol	491-71-4	Q813145M20			
chrysophanic acid	481-74-3	Chrysophanic acid	481-74-3	N1ST8V8RR2	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
chrysophenine	2870-32-8	Chrysophenine	2870-32-8	8Q5531T139			
chrysophsin		chrysophsin					
chrysosplenetin		Chrysosplenetin	603-56-5	9AA5Z8PMYE			
chuangxiong extract		chuangxiong extract					
chuanxiong rhizome preparation		chuanxiong rhizome preparation					
chymostatin	9076-44-2	Chymostatin	9076-44-2		Serine Proteinase Inhibitors	Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)	
CI 1044		CI-1044	197894-84-1	O4T475XIIY	Phosphodiesterase 4 Inhibitors	Compounds that specifically inhibit PHOSPHODIESTERASE 4. (See all compounds classified as Phosphodiesterase 4 Inhibitors.)	
CI 972	115787-68-3	4H-Pyrrolo(3,2-d)pyrimidin-4-one, 2,6-diamino-1,5-dihydro-7-(3-thienylmethyl)-, monohydrochloride	115787-68-3				
Cibacron Blue F 3GA	12236-82-7	12236-82-7					
cibinetide		Cibinetide	1208243-50-8	9W5677JKDA			Treatment of sarcoidosis
cicaprost	95722-07-9	Cicaprost	94079-80-8	NE94J8CAMD	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
ciclesonide	141845-82-1	Ciclesonide	126544-47-6	S59502J185	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	For the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in adults and adolescents 12 years of age and older.
ciclobendazole	31431-43-3	Ciclobendazole	31431-43-3	JF3KQ40J31			
Ciclopirox	29342-05-0	Ciclopirox	29342-05-0	19W019ZDRJ	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	Used as a topical treatment in immunocompetent patients with mild to moderate onychomycosis of fingernails and toenails without lunula involvement, due to Trichophyton rubrum.
cicloprofen		Cicloprofen	36950-96-6	325708J22C			
cicloprolol	63659-12-1	Cicloprolol	94651-09-9	1K2ACH4U3R			
CID2950007		CID2950007					
CID755673		7-Hydroxy-2,3,4,5-tetrahydro-1H-benzofuro[2,3-c]azepin-1-one	521937-07-5				
Cidofovir	113852-37-2	Cidofovir	113852-37-2	768M1V522C	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS)
cifenline	53267-01-9	Cibenzoline	53267-01-9	Z7489237QT	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
CIGB-552 peptide		CIGB-552 peptide					
ciglitazone	74772-77-3	Ciglitazone	74772-77-3	U8QXS1WU8G	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	
ciguatoxin 1B (CTX 1B)		ciguatoxin 1B (CTX 1B)					
ciguatoxin 3C		Ciguatoxin 3C	148471-85-6				
Ciguatoxins	11050-21-8	Pacific ciguatoxin 1	11050-21-8	2UKQ3B7696	Poisons	Substances which, when ingested, inhaled, or absorbed, or when applied to, injected into, or developed within the body in relatively small amounts may, by their chemical action, cause damage to structure or disturbance of function. (From Dorland, 27th ed) (See all compounds classified as Poisons.)	
ciji-hua'ai-baosheng		ciji-hua'ai-baosheng					
Cilastatin	82009-34-5	Cilastatin	82009-34-5	141A6AMN38	Protease Inhibitors	Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)	Cilastatin is indicated, in combination with [imipenem] with or without [relebactam], for the treatment of bacterial infections including respiratory, skin, bone, gynecologic, urinary tract, and intra-abdominal as well as septicemia and endocarditis.
Cilastatin, Imipenem Drug Combination	92309-29-0	Imipenem and cilastatin	92309-29-0		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Cilazapril	92077-78-6	Cilazapril monohydrate	92077-78-6	19KW7PI29F	Angiotensin-Converting Enzyme Inhibitors	A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)	
Cilengitide		Cilengitide	188968-51-6	4EDF46E4GI			Treatment of high-grade glioma
cilnidipine	132203-70-4	Cilnidipine	132203-70-4	97T5AZ1JIP	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	Cilnidipine is indicated for the management of hypertension for end-organ protection. It is reported to be useful in elderly patients and in those with diabetes and albuminuria. Cilnidipine has been increasingly used in patients with chronic kidney disease   Hypertension is the term used to describe the presence of high blood pressure. The blood pressure is generated by the force of the blood pumped from the heart against the blood vessels. Thus hypertension is caused when there is too much pressure on the blood vessels and this effect can damage the blood vessel.
Cilomilast		Cilomilast	153259-65-5	8ATB1C1R6X	Phosphodiesterase 4 Inhibitors	Compounds that specifically inhibit PHOSPHODIESTERASE 4. (See all compounds classified as Phosphodiesterase 4 Inhibitors.)	Investigated for use/treatment in chronic obstructive pulmonary disease (COPD).
cilostamide	68550-75-4	Cilostamide	68550-75-4	45S5605Q18	Phosphodiesterase Inhibitors	Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)	
Cilostazol	73963-72-1	Cilostazol	73963-72-1	N7Z035406B	Bronchodilator Agents	Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)	Indicated for the alleviation of symptoms of intermittent claudication (pain in the legs that occurs with walking and disappears with rest).
cimaterol	54239-37-1	Cimaterol	54239-37-1	ZPY8VRF0GB	Adrenergic beta-Agonists	Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)	
cimbuterol		Cimbuterol	54239-39-3				
Cimetidine	51481-61-9	Cimetidine	51481-61-9	80061L1WGD	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	Cimetidine is indicated to reduce gastric acid secretion and to treat the following disease states: duodenal ulcers, non-malignant gastric ulcers, gastroesophageal reflux disease, and pathological hypersecretion associated with Zollinger-Ellison Syndrome, systemic mastocytosis, and multiple endocrine adenomas. It is indicated for prophylaxis of recurrent gastric or duodenal ulcers, as adjunctive therapy in the management of cystic fibrosis in children, and to treat NSAID induced lesions and gastrointestinal symptoms.
Cimicifuga extract BNO 1055		Cimicifuga extract BNO 1055					
cimifugin		Cimifugin	37921-38-3				
cimoxatone	73815-11-9	Cimoxatone	73815-11-9	V6FT1QJ7VL	Monoamine Oxidase Inhibitors	A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed, p414) (See all compounds classified as Monoamine Oxidase Inhibitors.)	
Cinacalcet		Cinacalcet	226256-56-0	UAZ6V7728S	Calcimimetic Agents	Small organic molecules that act as allosteric activators of the calcium sensing receptor (CaSR) in the PARATHYROID GLANDS and other tissues. They lower the threshold for CaSR activation by extracellular calcium ions and diminish PARATHYROID HORMONE (PTH) release from parathyroid cells. (See all compounds classified as Calcimimetic Agents.)	For the treatment of secondary hyperparathyroidism in patients with Chronic Kidney Disease who are on hemodialysis or peritoneal dialysis. Also for the treatment of hypercalcemia in patients with parathyroid carcinoma.
Cinanserin	1166-34-3	Cinanserin	1166-34-3	KI6J9OY7A3	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
cinchonidine	485-71-2	(-)-Cinchonidine	118-10-5	1U622LRA8Z			
cinchonine	118-10-5	Cinchonine	118-10-5	V43X79NZCD	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	
cinerubine A	34044-10-5	Cinerubine A	34044-10-5				
cinerubine B	35906-51-5	Cinerubin B	35906-51-5				
cinitapride	66564-14-5	Cinitapride	66564-14-5	R8I97I2L24	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	It is indicated to treat gastrointestinal disorders associated with motility disturbances like gastroesophageal reflux disease (GERD), non-ulcer dyspepsia and delayed gastric emptying.
cinnabar	19122-79-3	Mercury(II) sulfide	1344-48-5				
cinnamaldehyde		Cinnamaldehyde	104-55-2	SR60A3XG0F	Antimutagenic Agents	Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved. (See all compounds classified as Antimutagenic Agents.)	Cinnamaldehyde is approved by the FDA for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.
cinnamic acid	140-10-3	Cinnamic Acid	140-10-3	U14A832J8D			
cinnamon oil, bark		cinnamon oil, bark					
cinnamyl alcohol	104-54-1	Cinnamyl alcohol	104-54-1	SS8YOP444F			Cinnamyl alcohol is approved by the FDA for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.
cinnamyl anthranilate	87-29-6	Cinnamyl anthranilate	87-29-6	LTW6QIC74B			
cinnamyl-3,4-dihydroxycyanocinnamate		cinnamyl-3,4-dihydroxycyanocinnamate					
Cinnarizine	298-57-7	Cinnarizine	298-57-7	3DI2E1X18L	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.
cinobufagin	470-37-1	Cinobufagin	470-37-1	T9PSN4R8IR			
cinobufotalin		Cinobufotalin	1108-68-5	L0QBZ37386			
Cinoxacin	28657-80-9	Cinoxacin	28657-80-9	LMK22VUH23	Topoisomerase II Inhibitors	Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)	For the treatment of initial and recurrent urinary tract infections in adults caused by the following susceptible microorganisms: Escherichia coli, Proteus mirabilis, Proteus vulgaris, Klebsiella species (including K. pneumoniae), and Enterobacter species.
ciprofibrate	52214-84-3	Ciprofibrate	52214-84-3	F8252JGO9S	Peroxisome Proliferators	A class of nongenotoxic CARCINOGENS that induce the production of hepatic PEROXISOMES and induce hepatic neoplasms after long-term administration. (See all compounds classified as Peroxisome Proliferators.)	
ciprofibrate-coenzyme A	111900-25-5	Ciprofibrate-coenzyme A	111900-25-5				
Ciprofloxacin	85721-33-1	Ciprofloxacin	85721-33-1	5E8K9I0O4U	Topoisomerase II Inhibitors	Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)	Ciprofloxacin is only indicated in infections caused by susceptible bacteria.  Ciprofloxacin immediate release tablets, oral suspensions, and intravenous injections are indicated for the treatment of skin and skin structure infections, bone and joint infections, complicated intra-abdominal infections, nosocomial pneumonia, febrile neutropenia, adults who have inhaled anthrax, plague, chronic bacterial prostatitis, lower respiratory tract infections including acute exacerbations of chronic bronchitis, urinary tract infections, complicated urinary tract infections in pediatrics, complicated pyelonephritis in pediatrics, and acute sinusitis.  A ciprofloxacin otic solution and otic suspension with hydrocortisone are indicated for acute otitis externa. Ciprofloxacin suspension with dexamethasone is indicated for acute otitis media in pediatric patients with tympanostomy tubes or acute otitis externa. A ciprofloxacin intratympanic injection is indicated for pediatric patients with bilateral otitis media with effusion who are having tympanostomy tubes placed or pediatric patients 6 months or older with acute otitis externa.  A ciprofloxacin eye drop is indicated for bacterial corneal ulcers and conjunctivitis. A ciprofloxacin eye ointment is indicated for bacterial conjunctivitis.  A ciprofloxacin extended release tablet is indicated for uncomplicated urinary tract infections, complicated urinary tract infections, and acute uncomplicated pyelonephritis.
ciproxifan		Ciproxifan	184025-18-1	5EVQ7IRG99	Histamine H3 Antagonists	Drugs that selectively bind to but do not activate HISTAMINE H3 RECEPTORS. They have been used to correct SLEEP WAKE DISORDERS and MEMORY DISORDERS. (See all compounds classified as Histamine H3 Antagonists.)	
cirazoline	59939-16-1	Cirazoline	59939-16-1	QK318GVY3Y	Nasal Decongestants	Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993) (See all compounds classified as Nasal Decongestants.)	
cirsilineol	41365-32-6	Fastigenin	41365-32-6	08DZZ529FE			
cirsiliol	34334-69-5	Cirsiliol	34334-69-5	8W4Y5JK3XE			
cirsimarin	13020-19-4	Cirsimarin	13020-19-4	72U3YNK7DV			
cis-1-methyl-7-((4-(2,6-dichlorophenyl)piperidin-1-yl)methyl)-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol		cis-1-methyl-7-((4-(2,6-dichlorophenyl)piperidin-1-yl)methyl)-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol					
cis-9, trans-11-conjugated linoleic acid		Bovinic acid	2540-56-9	46JZW3MR59			
cis-bis(3-aminoflavone)dichloroplatinum(II)		cis-bis(3-aminoflavone)dichloroplatinum(II)					
cis-diammine(pyridine)chloroplatinum(II)		cis-diammine(pyridine)chloroplatinum(II)					
Cisapride	81098-60-4	Cisapride	81098-60-4	UVL329170W	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	For the symptomatic treatment of adult patients with nocturnal heartburn due to gastroesophageal reflux disease.
cisatracurium		Cisatracurium	96946-41-7	SKE79AOA7L	Neuromuscular Blocking Agents	Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc. (See all compounds classified as Neuromuscular Blocking Agents.)	Cisatracurium is indicated as an adjunct to general anesthesia to facilitate tracheal intubation in adults and pediatric patients 1 month to 12 years of age. Cisatracurium is also indicated to provide skeletal muscle relaxation during surgery in adults and pediatric patients 2 to 12 years of age as a bolus or infusion maintenance and for mechanical ventilation in the ICU in adults.
cismethrin	35764-59-1	Cismethrin	35764-59-1	2VWB5PVB6A	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Cisplatin	15663-27-1	azane;dichloroplatinum	15663-27-1		Cross-Linking Reagents	Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)	
cisplatin-deoxy(guanosine monophosphate guanosine) adduct		cisplatin-deoxy(guanosine monophosphate guanosine) adduct					
cisplatin-DNA adduct		cisplatin-DNA adduct					
Citalopram	59729-33-8	Citalopram	59729-33-8	0DHU5B8D6V	Selective Serotonin Reuptake Inhibitors	Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Selective Serotonin Reuptake Inhibitors.)	Citalopram is approved by the FDA for treating adults with major depressive disorder. It has also been used off-label to treat various diseases, including but not limited to sexual dysfunction, ethanol abuse, psychiatric conditions such as obsessive-compulsive disorder (OCD), social anxiety disorder, panic disorder, and diabetic neuropathy.
citraconic acid	498-23-7	Citraconic acid	498-23-7	0RQ6CXO9KD	Dermatologic Agents	Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)	
Citraconic Anhydrides		Citraconic anhydride	616-02-4	105NP7PMXX			
citral	5392-40-5	Citral	5392-40-5	T7EU0O9VPP			
citral dimethyl acetal		Citral dimethyl acetal	7549-37-3	3B1N36AM3A			
Citrates		Citrates					
citreoviridin	25425-12-1	Citreoviridin	25425-12-1	OWX7Q6CF4F			
Citric Acid	77-92-9	Citric Acid	77-92-9	XF417D3PSL	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	
Citrinin	518-75-2	Citrinin	518-75-2	3S697X6SNZ	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
citronellal	106-23-0	Citronellal	106-23-0	QB99VZZ7GZ			
citronellol	106-22-9	beta-CITRONELLOL, (+/-)-	106-22-9	565OK72VNF			
citronellyl acetate	150-84-5	Citronellyl acetate	150-84-5	IZ420RT3OY			
Citrulline	372-75-8	Citrulline	372-75-8	29VT07BGDA			Used for nutritional supplementation, also for treating dietary shortage or imbalance.
CJ 13610		4-(3-((4-(2-Methyl-1H-imidazol-1-yl)phenyl)sulfanyl)phenyl)tetrahydro-2H-pyran-4-carboxamide	179420-17-8	5275PJ1C59			
CJX1, amlodipine derivative		CJX1, amlodipine derivative					
CJY compound		CJY compound					
CK0106023		Benzamide, 4-bromo-N-(1-(7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl)propyl)-N-(3-(dimethylamino)propyl)-	336115-72-1	S38NRK3X01			
CKD732		Beloranib hemioxalate	529511-79-3	4T7B8LC5I7	Angiogenesis Inhibitors	Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. (See all compounds classified as Angiogenesis Inhibitors.)	
CL 075		CL 075					
CL 218872	66548-69-4	3-Methyl-6-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazine	66548-69-4	O7GR5XL5B5	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	
CL 387785		N-(4-((3-bromophenyl)amino)quinazolin-6-yl)but-2-ynamide	194423-06-8	B4W27J1Z8B	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
CL097 compound		CL097 compound					
cladosporin		Cladosporin	35818-31-6	81PR0D5FI4	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Cladribine	4291-63-8	Cladribine	4291-63-8	47M74X9YT5	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For the treatment of active hairy cell leukemia (leukemic reticuloendotheliosis) as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms. Also used as an alternative agent for the treatment of chronic lymphocytic leukemia (CLL), low-grade non-Hodgkin's lymphoma, and cutaneous T-cell lymphoma.
cladribine monophosphate		cladribine monophosphate					
claramine		Claramine					
Clarithromycin	81103-11-9	Clarithromycin	81103-11-9	H1250JIK0A	Cytochrome P-450 CYP3A Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A. (See all compounds classified as Cytochrome P-450 CYP3A Inhibitors.)	An alternative medication for the treatment of acute otitis media caused by H. influenzae, M. catarrhalis, or S. pneumoniae in patients with a history of type I penicillin hypersensitivity. Also for the treatment of pharyngitis and tonsillitis caused by susceptible Streptococcus pyogenes, as well as respiratory tract infections including acute maxillary sinusitis, acute bacterial exacerbations of chronic bronchitis, mild to moderate community-acquired pneuomia, Legionnaires' disease, and pertussis. Other indications include treatment of uncomplicated skin or skin structure infections, helicobacter pylori infection, duodenal ulcer disease, bartonella infections, early Lyme disease, and encephalitis caused by Toxoplasma gondii (in HIV infected patients in conjunction with pyrimethamine). Clarithromycin may also decrease the incidence of cryptosporidiosis, prevent the occurence of -hemolytic (viridans group) streptococcal endocarditis, as well as serve as a primary prevention for Mycobacterium avium complex (MAC) bacteremia or disseminated infections (in adults, adolescents, and children with advanced HIV infection).  Clarithromycin is indicated in combination with [vonoprazan] and [amoxicillin] as co-packaged triple therapy to treat _Helicobacter pylori_ (_H. pylori_) infection in adults.
clasto-lactacystin beta-lactone	155975-72-7	(4s,5r)-1-(1-Hydroxy-2-methylpropyl)-4-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione	155975-72-7		Cysteine Proteinase Inhibitors	Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. (See all compounds classified as Cysteine Proteinase Inhibitors.)	
Clavulanic Acid	58001-44-8	Clavulanic Acid	58001-44-8	23521W1S24	beta-Lactamase Inhibitors	Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES. (See all compounds classified as beta-Lactamase Inhibitors.)	Clavulanic acid combined with other antibiotics is indicated to prevent the development of drug-resistant strains of bacteria and promotes their therapeutic antibacterial effects.  The following conditions, when they produced beta-lactamases, have been treated with a combination of amoxicillin and clavulanic acid or ticarcillin and clavulanic acid:  Acute otitis media caused by  H. influenzae and M. catarrhalis  Sinusitis due to H. influenzae and M. catarrhalis  Lower respiratory tract infections due to Haemophilus influenzae, S.aureus, Klebsiella species, and Moraxella catarrhalis   Skin and skin structure infections caused by Staphylococcus aureus, Escherichia coli, and Klebsiella species  Urinary Tract Infections due to E. coli, Klebsiella species of bacteria, and Enterobacter species of bacteria, S.marcescens, or S.aureus  Gynecologic infections due to a variety of bacteria, including P.melaninogenicus, Enterobacter species, E.Coli species, Klebsiella species, S. aureus, S.epidermidis  Septicemia due to a variety of bacteria, including Klebsiella species, E.Coli species, S.aureus, or Pseudomonas species  Bone and joint infections due to S.aureus  Intraabdominal infections due to E.Coli, K.pnemoniae, or B.fragilis group  **A note on susceptibility**  It should be noted that it is only to be administered in infections that are confirmed or highly likely to be caused by susceptible bacteria. Culture and susceptibility tests should be performed if possible and used in selecting whether this antibiotic is prescribed. When beta-lactamase enzyme production is not detected during microbiological testing, clavulanic acid should not be used. When these tests are not available patterns of local infection and susceptibility may be used to determine the appropriateness of using clavulanic acid. Ticarcillin with clavulanate has shown particular efficacy in mixed infections in addition to empiric therapy before determining the susceptibility of causative organisms. The ticarcillin-clavulanic acid combination may prove to be an effective single-agent antibiotic therapy to treat infections where a regimen of several drugs may normally be used.
clavulone II	85700-43-2	Clavulone II	85700-43-2				
Clay	1302-87-0	Aluminum oxide silicate	12141-46-7				
clazosentan	180384-56-9	Clazosentan	180384-56-9	3DRR0X4728			Investigated for use/treatment in strokes.
clebopride	55905-53-8	Clebopride	55905-53-8	I0A84520Y9	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	
Clemastine	15686-51-8	Clemastine	15686-51-8	95QN29S1ID	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	For the relief of symptoms associated with allergic rhinitis such as sneezing, rhinorrhea, pruritus and acrimation. Also for the management of mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Used as self-medication for temporary relief of symptoms associated with the common cold.
clemizole	442-52-4	Clemizole	442-52-4	T97CB3796L			
Clenbuterol	37148-27-9	Clenbuterol	37148-27-9	XTZ6AXU7KN	Adrenergic beta-Agonists	Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)	Used as a bronchodilator in the treatment of asthma patients.
clenproperol		Clenproperol	38339-11-6				
clerodermic acid		Clerodermic acid					
clethodim		Clethodim	99129-21-2	DLY40VJ33K	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
clevidipine		Clevidipine	167221-71-8	19O2GP3B7Q	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	For the reduction of blood pressure when when oral antihypertensive therapy is not feasible or not desirable.
clidinium	7020-55-5	Clidinium	7020-55-5	BO76JF850N	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	For the treatment of peptic ulcer disease and also to help relieve abdominal or stomach spasms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome. In combination with chlordiazepoxide, clidinium is indicated to control emotional and somatic factors in gastrointestinal disorders, and is used as adjunctive therapy in the treatment of peptic ulcer, irritable bowel syndrome and acute enterocolitis.
CLIK 148		CLIK 148					
climbazole	38083-17-9	Climbazole	38083-17-9	9N42CW7I54			
clinafloxacin	105956-97-6	Clinafloxacin	105956-97-6	8N86XTF9QD	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Clindamycin	18323-44-9	Clindamycin	18323-44-9	3U02EL437C	Protein Synthesis Inhibitors	Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)	In oral and parenteral formulations, clindamycin is indicated for the treatment of serious infections caused by susceptible anaerobic bacteria, as well as susceptible staphylococci, streptococci, and pneumococci. Used topically, it is indicated for the treatment of acne vulgaris and is available in combination with [benzoyl peroxide] or [tretinoin] for this purpose, or as a triple combination therapy with benzoyl peroxide and [adapalene]. Clindamycin is also indicated as a vaginal cream, suppository, or gel for the treatment of bacterial vaginosis in non-pregnant females.  Clindamycin is used for antimicrobial prophylaxis against _Viridans_ group streptococcal infections in susceptible patients undergoing oral, dental, or upper respiratory surgery, and may be used for prophylaxis against bacterial endocarditis in penicillin-allergic patients at high risk of these infections.
clindamycin phosphate		Clindamycin Phosphate	24729-96-2	EH6D7113I8	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
clinofibrate	30299-08-2	Clinofibrate	30299-08-2	0374EZJ8CU			
clinoptilolite	12173-10-3	CID 6336554					
Clioquinol	130-26-7	Clioquinol	130-26-7	7BHQ856EJ5			Used as a topical antifungal treatment.
clivorine		(1R,4Z,6S,7S)-7-acetyloxy-4-ethenyl-6,7,14-trimethyl-3,8-dioxo-2,9-dioxa-14-azoniatricyclo[9.5.1.014,17]heptadeca-4,11-dien-17-olate	33979-15-6				
Clobazam	22316-47-8	Clobazam	22316-47-8	2MRO291B4U	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	Clobazam is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.
clobenpropit		Clobenpropit	145231-45-4	RKU631JF4H	Histamine H3 Antagonists	Drugs that selectively bind to but do not activate HISTAMINE H3 RECEPTORS. They have been used to correct SLEEP WAKE DISORDERS and MEMORY DISORDERS. (See all compounds classified as Histamine H3 Antagonists.)	
Clobetasol	25122-41-2	Clobetasol	25122-41-2	ADN79D536H	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
clobutinol	14860-49-2	Clobutinol	14860-49-2	1NY2IX043A	Antitussive Agents	Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)	
clocinnamox	117332-69-1	Methoclocinnamox	117332-69-1		Narcotic Antagonists	Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)	
clodinafop-propargyl		Clodinafop-Propargyl	105512-06-9	QEH394TY6Y			
Clodronic Acid	10596-23-3	Clodronic Acid	10596-23-3	0813BZ6866	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Clodronic acid is indicated as an adjunct in the management of osteolysis from bone metastases of malignant tumors and for management of hypercalcemia of malignancy.
Clofarabine	123318-82-1	Clofarabine	123318-82-1	762RDY0Y2H	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	For the treatment of pediatric patients 1 to 21 years old with relapsed or refractory acute lymphocytic (lymphoblastic) leukemia after at least two prior regimens. It is designated as an orphan drug by the FDA for this use.
Clofazimine	2030-63-9	Clofazimine	2030-63-9		Leprostatic Agents	Substances that suppress Mycobacterium leprae, ameliorate the clinical manifestations of leprosy, and/or reduce the incidence and severity of leprous reactions. (See all compounds classified as Leprostatic Agents.)	
clofedanol	791-35-5	Clofedanol	791-35-5	42C50P12AP			Used in the treatment of dry cough.
Clofenapate	21340-68-1	Methyl clofenapate	21340-68-1	F54J2WV8PX	Hypolipidemic Agents	Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)	
clofexamide	1223-36-5	Clofexamide	1223-36-5	071P4J77HF			
Clofibrate	637-07-0	Clofibrate	637-07-0	HPN91K7FU3	Anticholesteremic Agents	Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)	For Primary Dysbetalipoproteinemia (Type III hyperlipidemia) that does not respond adequately to diet. This helps control high cholesterol and high triglyceride levels.
Clofibric Acid	882-09-7	Clofibric acid	882-09-7	53PF01Q249	Hypolipidemic Agents	Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)	
clofilium	68379-02-2	Clofilium	68379-02-2	847G178BMC	Potassium Channel Blockers	A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS. (See all compounds classified as Potassium Channel Blockers.)	
cloflucarban	369-77-7	Halocarban	369-77-7	I5ZZY3DC5G			
clofoctol	37693-01-9	Clofoctol	37693-01-9	704083NI0R			
clomacran	5310-55-4	Clomacran	5310-55-4	5B1UZF65WW			
Clomiphene	911-45-5	Zuclomiphene	15690-55-8	3JU1DU3652	Estrogen Antagonists	Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)	Used mainly in female infertility due to anovulation (e.g. due to polycystic ovary syndrome) to induce ovulation.
Clomipramine	303-49-1	Clomipramine	303-49-1	NUV44L116D	Selective Serotonin Reuptake Inhibitors	Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Selective Serotonin Reuptake Inhibitors.)	May be used to treat obsessive-compulsive disorder and disorders with an obsessive-compulsive component (e.g. depression, schizophrenia, Tourettes disorder). Unlabeled indications include: depression, panic disorder, chronic pain (e.g. central pain, idiopathic pain disorder, tension headache, diabetic peripheral neuropathy, neuropathic pain), cataplexy and associated narcolepsy (limited evidence), autistic disorder (limited evidence), trichotillomania (limited evidence), onchophagia (limited evidence), stuttering (limited evidence), premature ejaculation, and premenstrual syndrome.
Clonazepam	1622-61-3	Clonazepam	1622-61-3	5PE9FDE8GB	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	Clonazepam is indicated as monotherapy or as an adjunct in the treatment of Lennox-Gastaut syndrome (petit mal variant), akinetic, and myoclonic seizures. Furthermore, clonazepam may also be of some value in patients with absence spells (petit mal) who have failed to respond to succinimides. Additionally, clonazepam is also indicated for the treatment of panic disorder, with or without agoraphobia, as defined in the DSM-V.  Alternatively, some regional prescribing information note that clonazepam is indicated for all clinical forms of epileptic disease and seizures in adults, especially absence seizures (petit mal) including atypical absence; primary or secondarily generalised tonic-clonic (grand mal), tonic or clonic seizures; partial (focal) seizures with elementary or complex symptomatology; various forms of myoclonic seizures, myoclonus and associated abnormal movements. Such regional label data also has clonazepam indicated for most types of epilepsy in infants and children, especially absences (petit mal), myoclonic seizures and tonic-clonic fits, whether due to primary generalized epilepsy or to secondary generalization of partial epilepsy.
Clonidine	4205-90-7	Clonidine	4205-90-7	MN3L5RMN02	Adrenergic alpha-2 Receptor Agonists	Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)	Clonidine tablets and transdermal systems are indicated for the treatment of hypertension alone or in combination with other medications. A clonidine injection is indicated for use with opiates in the treatment of severe cancer pain where opiates alone are insufficient. An extended release tablet of clonidine is indicated for the treatment of ADHD either alone or in combination with other medications.  Clonidine is also used for the diagnosis of pheochromocytoma, treatment of nicotine dependance, and opiate withdrawal.
Clopamide	636-54-4	Clopamide	636-54-4	17S83WON0I	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	
Clopenthixol	982-24-1	Sordinol	53772-84-2	FLE878A8ZI	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
cloperastine	3703-76-2	Cloperastine	3703-76-2	69M5L7BXEK			
clophen A60	11096-99-4	clophen A60					
Clopidogrel		Clopidogrel	113665-84-2	A74586SNO7	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	Clopidogrel is indicated to reduce the risk of myocardial infarction for patients with non-ST elevated acute coronary syndrome (ACS), patients with ST-elevated myocardial infarction, and in recent MI, stroke, or established peripheral arterial disease,
clopidogrel carboxylic acid		(S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid	144457-28-3	1B9Z4634CD	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
Cloprostenol	40665-92-7	Cloprostenol	40665-92-7	52EJR3Y9IN	Luteolytic Agents	Chemical compounds that cause LUTEOLYSIS or degeneration of the CORPUS LUTEUM. (See all compounds classified as Luteolytic Agents.)	
Clorgyline	17780-72-2	Clorgiline	17780-72-2	LYJ16FZU9Q	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	
cloricromen		Cloricromen	68206-94-0	B9454PE93C	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
clorophene	120-32-1	2-Benzyl-4-chlorophenol	120-32-1	7560BB0BO3	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
clorprenaline	3811-25-4	Clorprenaline	3811-25-4	3W4327W76O	Bronchodilator Agents	Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)	
closantel	57808-65-8	Closantel	57808-65-8	EUL532EI54	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Clostridium difficile lethal toxin B		Clostridium difficile lethal toxin B					
clothianidin		Clothianidin	210880-92-5	2V9906ABKQ	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
clothiapine	2058-52-8	Clothiapine	2058-52-8	Z05HCY0X1T	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
Clotrimazole	23593-75-1	Clotrimazole	23593-75-1	G07GZ97H65	14-alpha Demethylase Inhibitors	Compounds that specifically inhibit STEROL 14-DEMETHYLASE. A variety of azole-derived ANTIFUNGAL AGENTS act through this mechanism. (See all compounds classified as 14-alpha Demethylase Inhibitors.)	**Topical preparations**  Clotrimazole topical cream is indicated for the topical treatment of the following dermal infections,:  Tinea pedis, tinea cruris, and tinea corporis due to _Trichophyton rubrum_, _Trichophyton mentagrophytes_, _Epidermophyton floccosum_  Candidiasis due to _Candida albicans_  Tinea versicolor due to _Malassezia furfur_  Diaper rash infected by _Candida albicans_   In some preparations, clotrimazole may be combined with betamethasone dipropionate, a corticosteroid.   **Oral preparations**  The oral troche preparation is indicated for the local treatment of oropharyngeal candidiasis.  It is also indicated as a prophylactic drug to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions such as chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation. Troche preparations are not indicated for the treatment of any systemic mycoses.
Clove Oil		8000-34-8					
Cloxacillin	61-72-3	Cloxacillin	61-72-3	O6X5QGC2VB	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Cloxacillin is indicated for the treatment of beta-hemolytic streptococcal, pneumococcal, and staphylococcal infections (including beta-lactamase producing organisms).
cloxazolam	24166-13-0	Cloxazolam	24166-13-0	GYL649Z0HY			Used primarily as an anti-anxiety agent. Typically used short term, and may be given as a single dose of up to 100mcg/kg to reduce anxiety and tension experienced prior to surgery.
Clozapine	5786-21-0	Clozapine	5786-21-0	J60AR2IKIC	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Clozapine is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment. Because of the risks of severe neutropenia and of seizure associated with its use, Clozapine should be used only in patients who have failed to respond adequately to standard antipsychotic treatment.  Clozapine is also indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. Suicidal behavior refers to actions by a patient that put him/herself at risk for death.
clozapine N-oxide		Clozapine N-oxide	34233-69-7	MZA8BK588J	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
CMF protocol		CMF protocol					
CMF regimen		CMF regimen					
CMI 392		Urea, N'-((2-(2-((4-chlorophenyl)thio)ethoxy)-3-methoxy-5-(tetrahydro-5-(3,4,5-trimethoxyphenyl)-2-furanyl)phenyl)methyl)-N-hydroxy-N-methyl-, trans-	193739-23-0	59G5JG906D	Lipoxygenase Inhibitors	Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)	
CNB 001		4,4'-(1E,1'E)-2,2'-(1-Phenyl-1H-pyrazole-3,5-diyl)bis(ethene-2,1-diyl)bis(2-methoxyphenol)	1019110-87-2	TS3085B7P8			
cnidiadin		CID5315980					
coagulin-L		Coagulin L	216164-64-6	42EZK9ND5H			
Coal		CoAl					
Coal Ash		Ash					
Coal Tar	8007-45-2	4-Tert-butyl-2-[[2-[(5-tert-butyl-2-hydroxy-3-pyridin-2-ylphenyl)methylideneamino]cyclohexyl]iminomethyl]-6-pyridin-2-ylphenol;copper	8007-45-2		Keratolytic Agents	Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases. (See all compounds classified as Keratolytic Agents.)	
Cobalt	7440-48-4	Cobalt	7440-48-4	3G0H8C9362	Trace Elements	A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)	
cobalt ferrite		cobalt ferrite					
cobalt mesoporphyrin	21158-51-0	Cobalt mesoporphyrin	21158-51-0				
cobalt oxide	11104-61-3	Cobalt(2+);oxygen(2-)	11104-61-3	V9X9644V7Q			
cobalt sulfate	10124-43-3	Cobalt sulfate	10124-43-3	H7965X29HX			
Cobalt-60		Cobalt-60	10198-40-0	5C8182XDPZ			
cobalt-ethylenediamine tetraacetic acid chelate	14931-83-0	Cobaltate(2-), [[N,N'-1,2-ethanediylbis[N-[(carboxy-kappaO)methyl]glycinato-kappaN,kappaO]](4-)]-, (OC-6-21)-	14931-83-0		Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	
cobalt-nickel-chromium-molybdenum alloy		cobalt-nickel-chromium-molybdenum alloy					
cobalt(II) acetate		Cobalt(II) acetate	71-48-7	3XC4P44U7E			
cobaltiprotoporphyrin	14325-03-2	Cobalt protoporphyrin	14325-03-2				
cobaltous chloride	7646-79-9	Cobalt chloride (CoCl2)	7646-79-9				
cobaltous nitrate	10141-05-6	Cobalt nitrate	10141-05-6	65W79BFD5V			
cobamamide	13870-90-1	Calomide	13870-90-1				
Cobicistat		Cobicistat	1004316-88-4	LW2E03M5PG	Anti-HIV Agents	Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)	Cobicistat is a CYP3A inhibitor indicated to increase systemic exposure of atazanavir or darunavir (once daily dosing regimen) in combination with other antiretroviral agents in the treatment of HIV-1 infection. It is not interchangeable with ritonavir to increase systemic exposure of darunavir 600 mg twice daily, fosamprenavir, saquinavir, or tipranavir due to lack of exposure data. The use of cobicistat is not recommended with darunavir 600 mg twice daily, fosamprenavir, saquinavir or tipranavir. Complex or unknown mechanisms of drug interactions preclude extrapolation of ritonavir drug interactions to certain cobicistat interactions. Cobicistat and ritonavir when administered with either atazanavir or darunavir may result in different drug interactions when used with concomitant medications.
cobimetinib		Cobimetinib	934660-93-2	ER29L26N1X			Cobimetinib is indicated in combination with [vemurafenib] for the treatment of unresectable or metastatic melanoma with a BRAF V600E or V600K mutation. As a single agent, cobimetinib is also indicated for the treatment of adult patients with histiocytic neoplasms.
cobinamide	13497-85-3	cobalt(3+);3-[(1R,2S,3S,5Z,7S,8S,10Z,13S,15Z,17R,18R,19R)-2,7,18-tris(2-amino-2-oxoethyl)-3,13-bis(3-amino-3-oxopropyl)-17-[3-[[(2R)-2-hydroxypropyl]amino]-3-oxopropyl]-1,2,5,7,12,12,15,17-octamethyl-8,13,18,19-tetrahydro-3H-corrin-24-id-8-yl]propanamide	13497-85-3	HP8A6YZX4S			
cobra venom factor		Cobra venom factor					
cocaethylene	529-38-4	Cocaethylene	529-38-4	FJO3071W5Y	Dopamine Uptake Inhibitors	Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. (See all compounds classified as Dopamine Uptake Inhibitors.)	
Cocaine	50-36-2	Cocaine	50-36-2	I5Y540LHVR	Vasoconstrictor Agents	Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)	For the introduction of local (topical) anesthesia of accessible mucous membranes of the oral, laryngeal and nasal cavities.
cochinchinenin		3-(2,4-Dihydroxy-5-(3-(4-hydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)propyl)phenyl)-1-(4-hydroxyphenyl)propan-1-one	400603-95-4				
coclaurine	486-39-5	Coclaurine	486-39-5	CW1576313Y			
cocoa butter	8002-31-1	27-Methyl-14-propan-2-yl-18-aza-8-azoniapentacyclo[13.12.0.02,12.03,8.019,24]heptacosa-1,3,5,7,12,14,19,21,23,25-decaene	8002-31-1				
Coconut Oil		8001-31-8					
Cod Liver Oil	8001-69-2	8001-69-2					
Codeine	76-57-3	Codeine	76-57-3	Q830PW7520	Antitussive Agents	Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)	Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate.  The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above,.
codonoposide		codonoposide					
Coenzyme A	85-61-0	coenzyme A	85-61-0	SAA04E81UX			
coenzyme Q10		Ubidecarenone	303-98-0	EJ27X76M46	Vitamins	Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body. (See all compounds classified as Vitamins.)	The diet supplements containing ubidecarenone are indicated, as stated in the product label, to assist individuals with cardiovascular complaints including congestive heart failure and systolic hypertension. In the product, ubidecarenone is used to increase the cardiac input as well as for the prevention of several other diseases like Parkinson, fibromyalgia, migraine, periodontal disease and diabetes, based on preclinical studies. It is important to highlight that these products are not FDA approved and it is recommended to use under discretion.
Coffee		Coffea dybowshii (alc. extract)					
Coformycin	11033-22-0	Coformycin	11033-22-0	E49510ZL0H	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	
cohumulone		Cohumulone	511-25-1	2Y34G4NIC8			
Coke		Cocaine	50-36-2	I5Y540LHVR	Vasoconstrictor Agents	Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)	For the introduction of local (topical) anesthesia of accessible mucous membranes of the oral, laryngeal and nasal cavities.
Colchicine	64-86-8	Colchicine	64-86-8	SML2Y3J35T	Gout Suppressants	Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout. (See all compounds classified as Gout Suppressants.)	Colchicine is indicated for the prophylaxis and treatment of gout flares. It is also indicated in Familial Mediterranean fever (FMF) in children and adults of four years of age and older. It is also indicated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple risk factors for cardiovascular disease.   Some off-label uses of colchicine include the treatment of the manifestations of Behcet's syndrome, pericarditis, and postpericardiotomy syndrome.
Colesevelam Hydrochloride		1-Hexaminium, N,N,N-trimethyl-6-(2-propenylamino)-, chloride, polymer with (chloromethyl)oxirane, 2-propen-4-amine and N-2-propenyl-1-decanamine, hydrochloride					
colestimide		Colestilan	95522-45-5				Treatment of hyperphosphataemia in adult patients with chronic kidney disease stage 5 receiving haemodialysis or peritoneal dialysis.
Colforsin	138605-00-2	Colforsin daropate hydrochloride	138605-00-2	C6P4R272GT	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
Colistin	1066-17-7	Colistin	1066-17-7		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli, particularly Pseudomonas aeruginosa.
colistinmethanesulfonic acid	12705-41-8	Colistinmethanesulfonic acid	8068-28-8				For the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli, particularly _Pseudomonas aeruginosa_.
Coloring Agents		Coloring Agents					
columbamine	3621-36-1	Columbamine	3621-36-1	7T4808FEJW			
columbin	546-97-4	(2S,4AR,6aR,7R,10R,10aS,10bS)-2-(furan-3-yl)-7-hydroxy-6a,10b-dimethyl-4a,5,6,6a,7,10,10a,10b-octahydro-1H-10,7-(epoxymethano)benzo[f]isochromene-4,12(2H)-dione	546-97-4				
Complex Mixtures		Complex Mixtures					
concanamycin A	80890-47-7	Concanamycin a	80890-47-7		Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
concanamycin B	81552-33-2	Concanamycin B	81552-33-2				
conduritol epoxide	6090-95-5	Conduritol b epoxide	6090-95-5	NHM754Q310	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Congo Red	573-58-0	Congo red	573-58-0	3U05FHG59S	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
coniferaldehyde	458-36-6	4-Hydroxy-3-methoxycinnamaldehyde	20649-42-7	06TPT01AD5			
connective tissue-activating peptide	69344-77-0	connective tissue-activating peptide					
conocarpan	30358-74-8	(4s,8r,9r)-8-[(1s)-1,2-Dihydroxyethyl]-9-hydroxy-4-(4-hydroxyphenyl)-1,7-dioxaspiro[4.4]nonane-2,6-dione					
conotoxin alpha-RgIA, Conus regius		conotoxin alpha-RgIA, Conus regius					
conotoxin AuIB		conotoxin AuIB					
conotoxin GIII	101484-15-5	Conotoxin giii					
conotoxin GV	93438-65-4	Conotoxin GV	93438-65-4		Excitatory Amino Acid Antagonists	Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)	
Conotoxins		Conotoxins					
Contact Lens Solutions		Contact Lens Solutions					
Contraceptives, Oral		Contraceptives, Oral					
Contraceptives, Oral, Combined		Contraceptives, Oral, Combined					
Contrast Media		Contrast Media					
convallatoxin	508-75-8	508-75-8					
convulxin	37206-04-5	Convulxin					
coomassie Brilliant Blue	6104-58-1	C.I. Acid Blue 90	6104-58-1	M1ZRX790SI	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	This drug is indicated for selectively staining the internal limiting membrane (ILM).
Coordination Complexes		Coordination Complexes					
copanlisib		Copanlisib	1032568-63-0				
COPP protocol		COPP regimen					
Copper	7440-50-8	Copper	7440-50-8	789U1901C5	Trace Elements	A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)	For use in the supplementation of total parenteral nutrition and in contraception with intrauterine devices.
copper (II) diacetyl-di(N(4)-methylthiosemicarbazone)		CID10064708					
copper (N-2-hydroxyacetophenone)glycinate		copper (N-2-hydroxyacetophenone)glycinate					
copper bis(3,5-diisopropylsalicylate)	21246-18-4	Copper bis-3,5-diisopropylsalicylate	21246-18-4		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
copper histidine		Copper Histidine	12561-67-0	9078K3MO9U			
copper methionate	13985-65-4	Bis(L-methioninato-N,O)copper	13985-65-4				
copper protoporphyrin IX		copper protoporphyrin IX					
copper pyruvaldehyde bis(N(4)-methylthiosemicarbazone) complex	19976-14-8	CU-Ptsm	53109-53-8				
Copper Sulfate	7758-98-7	Cupric Sulfate	7758-98-7	KUW2Q3U1VV	Emetics	Agents that cause vomiting. They may act directly on the gastrointestinal tract, bringing about emesis through local irritant effects, or indirectly, through their effects on the chemoreceptor trigger zone in the postremal area near the medulla. (See all compounds classified as Emetics.)	Elemental use in copper deficiency  Copper and copper containing compounds are broadly used in medical practice. Metallic copper is used already for many years in dental fillings and in copper intrauterine devices (IUD) for reversible contraception. Ointments containing copper, which release copper ions that are absorbed by the skin in the management of cramps, disturbances of renal function, peripheral, venous hypostatic circulatory disturbances, rheumatic disease and swelling associated with trauma. There are also cosmetic facial creams containing copper as their main active ingredient.
copper-1,10-phenanthroline		copper-1,10-phenanthroline					
copper-thiosemicarbazone complex	127913-88-6	3-Hydroxy-5-hydroxymethyl-2-methyl-4-formylpyridine thiosemicarbazonato-Cu(II)	127913-88-6				
copper(II) nitrate		Cupric nitrate	3251-23-8	9TC879S2ZV			
copper(II)(1,10-phenanthroline)3		copper(II)(1,10-phenanthroline)3					
coproporphyrinogen III	2624-63-7	coproporphyrinogen III	2624-63-7				
Coproporphyrinogens		Coproporphyrinogens					
Coproporphyrins		Coproporphyrins					
Coptidis rhizoma extract		Coptidis rhizoma extract					
coptisine	3486-66-6	Coptisine	3486-66-6	0GCL71VN14			
coralyne	6872-73-7	Coralyne chloride	38989-38-7				
corannulene		Corannulene	5821-51-2	KFD2X7NT86			
Cord Factors		Cord Factors	61512-20-7		Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
cordycepin	73-03-0	Cordycepin	73-03-0	GZ8VF4M2J8	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
corexit 9500		corexit 9500					
corexit 9527	60617-06-3	Corexit 9527					
coriander oil		Coriander absolute					
corianin	35481-77-7	Corianin	35481-77-7				
corilagin	23094-69-1	Corilagin	2088321-44-0				
Corn Oil	8001-30-7	8001-30-7					
cornin iridoid	548-37-8	Verbenalin	548-37-8	71B68181Z6			
coronarin D		CID 73073981					
coronene	191-07-1	Coronene	191-07-1	7YY0X5XT1W			
corosolic acid		Corosolic acid	4547-24-4	AMX2I57A98			
coroxon	321-54-0	Coroxon	321-54-0	FS49K9Q80B			
CORT118335		Miricorilant	1400902-13-7	311Y5GV21M			
corticosteroid methanetriol mixture		corticosteroid methanetriol mixture					
Corticosterone	50-22-6	Corticosterone	50-22-6	W980KJ009P	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
corticosterone acetate	1173-26-8	Corticosterone acetate	1173-26-8	KN17U0V6BL			
corticosterone-21-hemisuccinate	10215-77-7	Corticosterone-21-hemisuccinate	10215-77-7	IU50V885SP			
corticotropin releasing hormone (9-41)	96118-75-1	alpha-Corticotropin releasing factor	96118-75-1		Hormone Antagonists	Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)	
Corticotropin-Releasing Hormone	9015-71-8	L-threonyl-l-LYSYL-l-prolyl-l-arginine	9015-71-8	QF5336J16C	Immunologic Factors	Biologically active substances whose activities affect or play a role in the functioning of the immune system. (See all compounds classified as Immunologic Factors.)	
Cortisone	53-06-5	Cortisone	53-06-5	V27W9254FZ	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
cortivazol	1110-40-3	Cortivazol	1110-40-3	YM183K0H63	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
Cortodoxone	152-58-9	Cortodoxone	152-58-9	WDT5SLP0HQ			
corvitin		Quercetin	117-39-5	9IKM0I5T1E	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
corylin		Corylin	53947-92-5				
corynoline	18797-79-0	Corynoline	68035-45-0	ZQ9W3JU6N3			
corynoxine B		Corynoxine B					
Cosmetics		Cosmetics					
COSS-86 protocol		COSS-86 protocol					
costunolide	553-21-9	Costunolide	553-21-9		Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	
costus absolute	8023-88-9	3-(6-bromo-3-fluoropyridin-2-yl)-2-cyano-N-[1-[4-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]butyl]prop-2-enamide;3-(6-bromo-3-fluoropyridin-2-yl)-2-cyano-N-[1-[4-(2-piperidin-1-ylethoxy)phenyl]butyl]prop-2-enamide;3-(8-chloroquinolin-2-yl)-2-cyano-N-[1-[4-(2-piperidin-1-ylethoxy)phenyl]butyl]prop-2-enamide;2-cyano-3-(3,6-dichloropyridin-2-yl)-N-[4-methyl-1-[4-(2-piperidin-1-ylethoxy)phenyl]pentyl]prop-2-enamide;2-cyano-3-(3,6-dichloropyridin-2-yl)-N-[3-phenyl-1-[4-(2-piperidin-1-ylethoxy)phenyl]propyl]prop-2-enamide;2-cyano-3-(3,6-dichloropyridin-2-yl)-N-[1-[4-(2-piperidin-1-ylethoxy)phenyl]butyl]prop-2-enamide;2-cyano-3-(8-hydroxyquinolin-2-yl)-N-[1-[4-(2-piperidin-1-ylethoxy)phenyl]butyl]prop-2-enamide;2-cyano-3-(1,8-naphthyridin-2-yl)-N-(1-phenylbutyl)prop-2-enamide;2-cyano-N-[1-[4-(2-piperidin-1-ylethoxy)phenyl]butyl]-3-quinolin-2-ylprop-2-enamide	8023-88-9				
Cosyntropin	16960-16-0	Cosyntropin	16960-16-0	72YY86EA29	Hormones	Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. (See all compounds classified as Hormones.)	For use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency.
Cotinine	486-56-6	Cotinine	486-56-6	K5161X06LL	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
cotylenin A		Cotylenin A	12708-37-1	O6G9S48JRX			
coumachlor		Coumachlor	81-82-3	UCD8XZW42P	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	
Coumaphos	56-72-4	Coumaphos	56-72-4	L08SZ5Z5JC	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
coumaran	496-16-2	2,3-Dihydrobenzofuran	496-16-2	99E861415L			
Coumaric Acids		Coumaric Acids					
coumarin	91-64-5	Coumarin	91-64-5	A4VZ22K1WT			
Coumarins		Warfarin	81-81-2	5Q7ZVV76EI	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	**Indicated** for:  1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism.  2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation.  3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement.  4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction.  **Off-label** uses include:  1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.
coumatetralyl	5836-29-3	Coumatetralyl	5836-29-3	NWK4HW86A8			
coumermycin	4434-05-3	Coumermycin a1	4434-05-3	PCH9QZ1IIH	Topoisomerase II Inhibitors	Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)	
Coumestrol	479-13-0	Coumestrol	479-13-0	V7NW98OB34	Phytoestrogens	Compounds derived from plants, primarily ISOFLAVONES that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS. (See all compounds classified as Phytoestrogens.)	
CP 105696		1-(3-(4-Phenylbenzyl)-4-hydroxychroman-7-yl)cyclopentane-1-carboxylic acid	158081-99-3	Z7354TW4BM	Leukotriene Antagonists	A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level. (See all compounds classified as Leukotriene Antagonists.)	
CP 115953	136440-70-5	1-Cyclopropyl-6,8-difluoro-1,4-dihydro-7-(4-hydroxyphenyl)-4-oxo-3-quinolinecarboxylic acid	136440-70-5	QUJ5KNX7DW			
CP 154526		CP-154526 hydrochloride	257639-98-8				
CP 199330		Methanesulfonamide, N-(3-(((3R,4R)-6-((7-chloro-2-quinolinyl)methoxy)-3,4-dihydro-4-hydroxy-2H-1-benzopyran-3-yl)methyl)-4-methoxyphenyl)-1,1,1-trifluoro-	158102-92-2	V4WYK6T8QA			
CP 199331		CP 199331					
CP 265298		Methanesulfonamide, N-(3-((6-((5,6-difluoro-2-benzothiazolyl)methoxy)-3,4-dihydro-4-hydroxy-2,2-dimethyl-2H-1-benzopyran-3-yl)methyl)-4-methoxyphenyl)-1,1,1-trifluoro-, (3S-cis)-	158103-79-8				
CP 288886		Methanesulfonamide, N-(3-(((3S,4R)-6-((7-chloro-2-quinolinyl)methoxy)-3,4-dihydro-4-hydroxy-2,2-dimethyl-2H-1-benzopyran-3-yl)methyl)-4-methoxyphenyl)-1,1,1-trifluoro-	221332-74-7	A6P0F906YX			
CP 31398		Unii-IN3WH41H3A	259199-65-0	IN3WH41H3A			
CP 320626		1H-Indole-2-carboxamide, 5-chloro-N-((1S)-1-((4-fluorophenyl)methyl)-2-(4-hydroxy-1-piperidinyl)-2-oxoethyl)-	186430-23-9	FKX709RK3Q	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
CP 47497	70434-82-1	2-[(1r,3s)-3-Hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol	70434-82-1				
CP 55244	79678-32-3	(2S,4S,4aS,6R,8aR)-4-[4-(1,1-Dimethyl-heptyl)-2-hydroxy-phenyl]-6-hydroxymethyl-decahydro-naphthalen-2-ol	79678-32-3				
CP 80080	152247-02-4	3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-(4-methoxyphenyl)-4-oxo-	152247-02-4				
CP 94253		5-propoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-pyrrolo[3,2-b]pyridine	131084-35-0	FYC6YY5RYL			
CP 96345	132746-60-2	2-(Diphenylmethyl)-N-((2-methoxyphenyl)methyl)-1-azabicyclo(2.2.2)octan-3-amine	132746-60-2	W22ILA2I52	Hypnotics and Sedatives	Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)	
CP-470711		(R)-1-(4-{(3S,5R)-4-[2-((R)-1-Hydroxy-ethyl)-pyrimidin-4-yl]-3,5-dimethyl-piperazin-1-yl}-pyrimidin-2-yl)-ethanol					
CP-471,358		CP-471,358					
CP-654577		3-Azabicyclo(3.1.0)hexane-6-methanol, 3-((4-(4-((3-methoxy-4-phenoxyphenyl)amino)-6-quinazolinyl)phenyl)methyl)-, (1alpha,5alpha,6alpha)-	639087-64-2	W39547M0FP			
CP-673,451		1-(2-(5-(2-Methoxyethoxy)benzimidazol-1-yl)quinolin-8-yl)piperidin-4-ylamine	343787-29-1	0AM0WWD90A			
CP-809,101		CP-809,101					
CpG ODN 1826		CpG ODN 1826					
CpG ODN 2006		CpG ODN 2006					
CpG ODN 2216		CpG ODN 2216					
CpG ODN 2395		CpG ODN 2395					
CpG-ODN DSP30		CpG-ODN DSP30					
CPG-oligonucleotide		CPG-oligonucleotide					
CPI-0610		CPI-0610 anhydrous	1380087-89-7	U4017GUQ06			
CPI203		(s)-2-(4-(4-Chlorophenyl)-2,3,9-trimethyl-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetamide					
CPS 11		2-(1-(Hydroxymethyl)-2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione	145945-21-7	4A6C91XW54			
CPS 49		2-(2,4-difluorophenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione	352017-52-8				
CPU0213		5-[2,4-Bis[(4-chlorophenyl)methoxy]phenyl]-2-butylpyrazole-3-carboxylic acid	821780-32-9				
CPW 399		CPW 399					
CQA 206-291	93822-42-5	Sulfamide, N,N-diethyl-N'-((8alpha)-1-ethyl-6-methylergolin-8-yl)-	93822-42-5	9I4I0M95U7			
CR 2945		Itriglumide	201605-51-8	879A12466H			
CR 3294		CR 3294					
CR8 compound		CR8 compound					
CRA1000		2-Pyrimidinamine, N-ethyl-4-(4-(3-fluorophenyl)-3,6-dihydro-1(2H)-pyridinyl)-6-methyl-N-(4-(1-methylethyl)-2-(methylthio)phenyl)-	226948-11-4	3899V9A17F	Hormone Antagonists	Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)	
Crack Cocaine		Cocaine	50-36-2	I5Y540LHVR	Vasoconstrictor Agents	Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)	For the introduction of local (topical) anesthesia of accessible mucous membranes of the oral, laryngeal and nasal cavities.
Creatine	57-00-1	Creatine	57-00-1	MU72812GK0			For nutritional supplementation, also for treating dietary shortage or imbalance.
Creatinine	60-27-5	creatinine	60-27-5	AYI8EX34EU			
cremophor EL	63393-92-0	Cremophor EL			Surface-Active Agents	Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)	
crenatoside	145985-09-7	Crenatoside	61276-16-2				
crenigacestat		Crenigacestat	1421438-81-4	923X28214S			
creosol	93-51-6	2-Methoxy-4-methylphenol	93-51-6	W9GW1KZG6N			
Creosote	8021-39-4	Guaiacol	8001-58-9	6JKA7MAH9C			It is used medicinally as an expectorant, antiseptic, and local anesthetic. Guaiacol is used in traditional dental pulp sedation, and has the property of inducing cell proliferation; guaiacol is a potent scavenger of reactive oxygen radicals and its radical scavenging activity may be associated with its effect on cell proliferation.
cresidine	120-71-8	2-Methoxy-5-methylaniline	120-71-8	4C11L78UR3			
cresolphthalein	596-27-0	o-Cresolphthalein	596-27-0	XOU2D9049G			
Crizotinib		Crizotinib	877399-52-5	53AH36668S	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Crizotinib is a kinase inhibitor indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK) or ROS1-positive as detected by an FDA-approved test. Crizotinib is also indicated for the treatment of relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is ALK-positive in pediatric patients 1 year of age and older and young adults. The safety and efficacy of crizotinib have not been established in older adults with relapsed or refractory, systemic ALK-positive ALCL. Additionally, crizotinib is indicated for the treatment of adult and pediatric patients 1 year of age and older with unresectable, recurrent, or refractory inflammatory myofibroblastic tumor (IMT) that is ALK-positive.
crocin	42553-65-1	Crocin	42553-65-1	877GWI46C2			
crofelemer		N-[(2-methoxyphenyl)methyl]-5-phenyl-1,2-oxazole-3-carboxamide					
Cromakalim	94470-67-4	Cromakalim	94535-51-0		Bronchodilator Agents	Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)	
Cromolyn Sodium	15826-37-6	Cromolyn Sodium	15826-37-6	Q2WXR1I0PK	Mast Cell Stabilizers	Compounds that prevent the release of inflammatory mediators from MAST CELLS. (See all compounds classified as Mast Cell Stabilizers.)	
croneton	29973-13-5	Ethiofencarb	29973-13-5	FY0YB813XV			
Crotalid Venoms		Crotalid Venoms					
crotamiton	483-63-6	2-Butenamide, N-ethyl-N-(2-methylphenyl)-	483-63-6	2EEH27851Y	Pesticides	Chemicals used to destroy pests of any sort. The concept includes fungicides (FUNGICIDES, INDUSTRIAL); INSECTICIDES; RODENTICIDES; etc. (See all compounds classified as Pesticides.)	
Croton Oil	8001-28-3	N-Acetylhexosamine	8001-28-3		Dermatologic Agents	Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)	
crotonyl alcohol		Crotyl alcohol	6117-91-5	L585TY5908			
Crotoxin	9007-40-3	2-[(2-ethylhexyl)oxy]ethyl 2-methylprop-2-enoate					
crotoxyphos	7700-17-6	Crotoxyphos	7700-17-6	B05A48683J			
crotylsarin	138780-00-4	Crotylsarin	138780-00-4	Y98LED33GD			
Crown Compounds		Crown Compounds					
Crown Ethers		Crown Ethers					
CRT 0066101		CRT0066101 HCl					
cruentaren A		Cruentaren A					
crufomate	299-86-5	Crufomate	299-86-5	V82Q65924L			
cryptolepine	480-26-2	Cryptolepine	480-26-2	OF1UIT4RDH	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	
cryptotanshinone	35825-57-1	Cryptotanshinone	35825-57-1	5E9SXT166N			
Cryptoxanthins		Cryptoxanthin	472-70-8	6ZIB13GI33	Provitamins	Precursor forms of vitamins. (See all compounds classified as Provitamins.)	
crystal violet lactone	1552-42-7	Crystal violet lactone	1552-42-7	USS7CW0676			
CSC-3436		CSC-3436					
CT 50547		CT 50547					
CT52923		N-(1,3-benzodioxol-5-ylmethyl)-4-(6,7-dimethoxyquinazolin-4-yl)piperazine-1-carbothioamide					
CTAP octapeptide		CTAP octapeptide					
CTCE-9908		L-Lysinamide, N2,N6-bis(L-lysylglycyl-L-valyl-L-seryl-L-leucyl-L-seryl-L-tyrosyl-L-arginyl)-	1030384-98-5	NF0BX95A31			Investigated for use/treatment in cancer/tumors (unspecified), lung cancer, and sarcoma.
CU-CPT22		CU-Cpt22					
cucurbit(7)uril		Cucurbit[7]uril	259886-50-5				
cucurbitacin B	6199-67-3	Cucurbitacin B	6199-67-3	0115W5MABF			
cucurbitacin E		Cucurbitacin E	18444-66-1	V8A45XYI21			
cucurbitacin I	2222-07-3	Cucurbitacin I	2222-07-3	SHQ47990PH			
cucurbitacin IIa		Cucurbitacin IIa	58546-34-2				
cudraflavone B		cudraflavone B					
cudratricusxanthone A		cudratricusxanthone A	740810-42-8				
CuFe2O4		Copper iron oxide	37220-43-2				
Cullen corylifolium extract		Cullen corylifolium extract					
cumene	98-82-8	Cumene	98-82-8	8Q54S3XE7K			
cumene hydroperoxide	80-15-9	Cumene hydroperoxide	80-15-9	PG7JD54X4I	Oxidants	Electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION). (See all compounds classified as Oxidants.)	
cuminol		4-Isopropylbenzyl alcohol	536-60-7	V261W8XR62			
CUMYL-PEGACLONE		Cumyl-pegaclone	2160555-55-3	CUT2RV7EIQ			
cupressuflavone		Cupressuflavone	3952-18-9				
cupric acetate	142-71-2	Cupric acetate	142-71-2	39M11XPH03			
cupric chloride	7447-39-4	Cupric Chloride	1344-67-8	S2QG84156O			For use as a supplement to intravenous solutions given for total parenteral nutrition (TPN).
cupric oxide	1317-38-0	Copper oxide	1317-38-0		Trace Elements	A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)	
Cuprizone	370-81-0	Cuprizone	370-81-0	5N16U7E0AO	Monoamine Oxidase Inhibitors	A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed, p414) (See all compounds classified as Monoamine Oxidase Inhibitors.)	
cuprous chloride	7758-89-6	Copper(I) chloride	7758-89-6				
cuprous sulfide	1308-78-7	Dicopper sulfide	22205-45-4	349M3C1RS1			
Curcumin	458-37-7	Curcumin	8024-37-1	IT942ZTH98	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	No approved therapeutic indications.
curcumin III	33171-05-0	Bisdemethoxycurcumin	33171-05-0	2EFO1BP34R			
curcumol	4871-97-0	Curcumol	4871-97-0	9190RTN07X			
curdlan	54724-00-4	Curdlan Gum					
CV 6504	117574-40-0	2,3,5-Trimethyl-6-(3-pyridylmethyl)-1,4-benzoquinone	117574-40-0	8PK64M8UXC			
CVS 1123		CVS 1123					
CVT 313		Cvt-313	199986-75-9	T5490K8I7S			
CVT-10216		3-(((3-(4-((Methylsulfonyl)amino)phenyl)-4-oxo-4H-chromen-7-yl)oxy)methyl)benzoic acid	1005334-57-5	F9H432757X			
CX 3543		Quarfloxin [USAN]					
CX 5461		2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide	1138549-36-6	3R4C5YLB9I			
CX 659S		2H-1-Benzopyran-2-carboxamide, N-(6-amino-1,2,3,4-tetrahydro-3-methyl-2,4-dioxo-1-phenyl-5-pyrimidinyl)-3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-, (2S)-	204980-81-4	YG2F04AVMQ	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
CX157		Tyrima	205187-53-7	O6L62LZJ0Q			Anxiety Disorders I, Depression I
CXA-10		10-Nitrooleic acid	875685-46-4	1N19AGY57Y	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
CY 208-243	100999-26-6	Indolophenanthridine	100999-26-6	8GJ4UR780B	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	
cyadox	65884-46-0	Cyadox	65884-46-0				
cyamemazine	3546-03-0	Cyamemazine	3546-03-0	A2JGV5CNU4			
cyamemazine sulfoxide		Cyamemazine sulfoxide	13384-45-7				
Cyanamide	420-04-2	Cyanamide	420-04-2	21CP7826LC			
Cyanates		Cyanate	71000-82-3	YML51WA0FW			
cyanazine	21725-46-2	Cyanazine	21725-46-2	W34C4P18WD	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Cyanides		Cyanide ion	57-12-5	OXN4E7L11K			
cyanidin		Cyanidin	13306-05-3	7732ZHU564			
cyanidin 3-O-glucopyranoside		cyanidin 3-O-glucopyranoside					
cyanidin 3-sambubioside		Cyanidin 3-O-sambubioside chloride	33012-73-6	4BIT5WSL15			
cyanidin-3-O-beta-glucopyranoside		Cyanidin-3-o-beta-glucopyranoside					
cyanine 863	550-15-2	Quinolinium, 2-[(3,6-dimethyl-2-phenyl-4(3H)-pyrimidinylidene)methyl]-1-ethyl-, chloride	550-15-2				
Cyanobacteria Toxins		Cyanobacteria Toxins					
cyanoginosin LR		Microcystin-LR	101043-37-2	EQ8332842Y	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
cyanoginosin-LA	96180-79-9	Microcystin-LA	96180-79-9	3E7C54U3SY			
cyanophenphos		Cyanofenphos	13067-93-1	1X6JV2NE2N			
cyanophos	2636-26-2	Cyanophos	2636-26-2	2AB0Z99OXP			
cyanopindolol	81608-27-7	4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)-1H-indole-2-carbonitrile	81608-27-7	4K0SD5SNFS	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	
cyanuric acid	108-80-5	Cyanuric acid	108-80-5	H497R4QKTZ			
cyanuric chloride	108-77-0	Cyanuric chloride	108-77-0	5U4L4QHD6I	Cross-Linking Reagents	Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)	
cyazofamid		Cyazofamid	120116-88-3	QJC4S2YQ4B			
Cyclamates		Cyclamic acid	100-88-9	HN3OFO5036	Sweetening Agents	Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)	
cyclamen aldehyde	103-95-7	3-(4-Isopropylphenyl)-2-methylpropanal	103-95-7	4U37UX0E1E			
Cyclazocine	3572-80-3	Cyclazocine	3572-80-3	J5W1B1159C	Narcotic Antagonists	Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)	
cyclazosin	139953-73-4	Cyclazosin	139953-73-4	2FH26454WF	Adrenergic alpha-2 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Antagonists.)	
cyclic 3',5'-uridine monophosphate	4004-57-3	Cyclic 3',5'-uridine monophosphate	4004-57-3				
Cyclic ADP-Ribose	119340-53-3	cyclic ADP-ribose	119340-53-3	Q780BR06V8			
Cyclic AMP	60-92-4	Adenosine cyclic phosphate	60-92-4	E0399OZS9N			
Cyclic GMP	7665-99-8	Cyclic GMP	7665-99-8	H2D2X058MU			
cyclic guanosine monophosphate-adenosine monophosphate		cyclic GMP-AMP	1441190-66-4	552Y49K43E			
Cyclizine	82-92-8	Cyclizine	82-92-8	QRW9FCR9P2	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	For prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness, and vertigo (dizziness caused by other medical problems).
cyclo-L-glycyl-L-2-allylproline		Pyrrolo(1,2-a)pyrazine-1,4-dione, hexahydro-8a-(2-propenyl)-, (8aR)-	847952-38-9	2T1HU6069S			
cyclo(Gln-Trp-Phe-Gly-Leu-Met)	125989-12-0	3-[(2S,8S,14S,17S)-8-benzyl-5-(1H-indol-3-ylmethyl)-14-(2-methylpropyl)-17-(2-methylsulfanylethyl)-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]propanamide	125989-12-0				
cyclo(leucyl-prolyl)		(3S,8aS)-3-Isobutylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione	2873-36-1	KQV8MY059B			
cyclo(leucylglycine)	5815-67-8	3-(2-Methylpropyl)-2,5-piperazinedione	5815-67-8				
cyclo(Trp-Asp-Pro-Val-Leu)		Cyclo(D-trp-D-asp-pro-D-val-leu)	136553-81-6	S2A8YZM151	Endothelin Receptor Antagonists	Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN RECECPTORS. (See all compounds classified as Endothelin Receptor Antagonists.)	
cyclo(tyrosyl-arginyl-arginyl-3-(2-naphthyl)alanyl-glycyl)		cyclo(tyrosyl-arginyl-arginyl-3-(2-naphthyl)alanyl-glycyl)					
cycloadiphenine	1679-76-1	Drofenine	1679-76-1	4QWV355536			
cycloartenol	469-38-5	Cycloartenol	469-38-5	YU32VE82N3			
cycloartenyl ferulate		gamma-Oryzanol	11042-64-1	3PQR2YON9T			
cycloastragenol		Cycloastragenol	78574-94-4	X37D9F2L0V			
cyclobarbital	52-31-3	Cyclobarbital	52-31-3	0M8A98AD9H			
cyclobenzaprine	303-53-7	Cyclobenzaprine	303-53-7	69O5WQQ5TI	Muscle Relaxants, Central	A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)	Cyclobenzaprine is indicated as a short-term (2-3 weeks) adjunct therapy, along with rest and physical therapy, for relief of muscle spasm associated with acute, painful musculoskeletal conditions. It has not been found effective in the treatment of spasticity originating from cerebral or spinal cord disease, or spasticity in children with cerebral palsy. Cyclobenzaprine is also occasionally used off-label for reducing pain and sleep disturbances in patients with fibromyalgia.
Cyclobutanes		Cyclobutanes					
Cyclodecanes		Cyclodecanes					
Cyclodextrins		Cyclodextrins					
Cyclofenil	2624-43-3	Cyclofenil	2624-43-3	J468V64WZ1	Fertility Agents, Female	Compounds which increase the capacity to conceive in females. (See all compounds classified as Fertility Agents, Female.)	
Cyclohexane		Cyclohexane	110-82-7	48K5MKG32S			
cyclohexanecarboxylic acid (3-(2,5-dimethylbenzyloxy)-4-(methanesulfonylmethylamino)phenyl)amide		N-[3-[(2,5-dimethylphenyl)methoxy]-4-[methyl(methylsulfonyl)amino]phenyl]cyclohexanecarboxamide					
cyclohexanediol bis-ethylhexanoate		cyclohexanediol bis-ethylhexanoate					
Cyclohexanols		Cyclohexanol	108-93-0	8E7S519M3P			
cyclohexanone	108-94-1	Cyclohexanone	108-94-1	5QOR3YM052			
Cyclohexanones		Tiletamine Hydrochloride	14176-50-2	99TAQ2QWJI	Anesthetics, Dissociative	Intravenous anesthetics that induce a state of sedation, immobility, amnesia, and marked analgesia. Subjects may experience a strong feeling of dissociation from the environment. The condition produced is similar to NEUROLEPTANALGESIA, but is brought about by the administration of a single drug. (From Gilman et al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) (See all compounds classified as Anesthetics, Dissociative.)	
cyclohexene	110-83-8	Cyclohexene	110-83-8	12L0P8F7GN			
cyclohexene oxide	286-20-4	Cyclohexene oxide	286-20-4				
Cyclohexenes		Cyclohexenes					
Cycloheximide	66-81-9	Cycloheximide	66-81-9	98600C0908	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester		3'-Carbamoyl-[1,1'-biphenyl]-3-yl cyclohexylcarbamate	546141-08-6	PX47LB88FO			
cyclohexyl carbonic acid 3'-carbamoyl-3-yl ester		cyclohexyl carbonic acid 3'-carbamoyl-3-yl ester					
cyclohexyl methylphosphonic acid	1932-60-1	Cyclohexyl methylphosphonic acid	1932-60-1				
cyclohexyl methylphosphonofluoridate	329-99-7	Cyclosarin	329-99-7	VM36F9N236			
cyclohexyl-(2-(3,5-dimethylpyrazol-1-yl)-6-methylpyrimidin-4-yl)amine		cyclohexyl-(2-(3,5-dimethylpyrazol-1-yl)-6-methylpyrimidin-4-yl)amine					
Cyclohexylamines		BDBM81970					
cyclohexylcarbamic acid biphenyl-3-yl ester		biphenyl-N-cyclopentyl-carbamate					
cyclohexylisocyanate	3173-53-3	Cyclohexyl isocyanate	3173-53-3	T699595BLW			
cyclohexylphenylketone	712-50-5	Cyclohexyl phenyl ketone	712-50-5	0NU53987V8			
cyclonite	121-82-4	Cyclonite	121-82-4	W91SSV5831	Explosive Agents	Substances that are energetically unstable and can produce a sudden expansion of the material, called an explosion, which is accompanied by heat, pressure and noise. Other things which have been described as explosive that are not included here are explosive action of laser heating, human performance, sudden epidemiological outbreaks, or fast cell growth. (See all compounds classified as Explosive Agents.)	
cyclopamine	4449-51-8	Cyclopamine	4449-51-8	ZH658AJ192			
cyclopenta(c,d)pyrene	27208-37-3	Cyclopenta[cd]pyrene	27208-37-3	29XD62TN4D	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Cyclopentanes		Cyclopentane	287-92-3	T86PB90RNU			
cyclopentanol	96-41-3	Cyclopentanol	96-41-3	1L43Q07TBU			
cyclopentanone	120-92-3	Cyclopentanone	120-92-3	220W81TN3S			
cyclopentaphenanthrene	219-08-9	17H-cyclopenta[a]phenanthrene	219-08-9	54VYW7U2DE			
cyclopentenone	930-30-3	2-Cyclopenten-1-one	930-30-3	Q0U2IGF9CK	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	
Cyclophosphamide	50-18-0	Cyclophosphamide	50-18-0	8N3DW7272P	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	Cyclophosphamide is indicated for the treatment of malignant lymphomas, multiple myeloma, leukemias, mycosis fungoides (advanced disease), neuroblastoma (disseminated disease), adenocarcinoma of the ovary, retinoblastoma, and carcinoma of the breast. It is also indicated for the treatment of biopsy-proven minimal change nephrotic syndrome in pediatric patients.
cyclopiazonic acid	18172-33-3	18172-33-3					
cyclopropapyrroloindole		cyclopropapyrroloindole					
cycloprothrin		Cycloprothrin	63935-38-6	GJD87S7ZH6			
CycloProvera	71615-27-5	Cycloprovera	71615-27-5		Contraceptives, Oral, Hormonal	Oral contraceptives which owe their effectiveness to hormonal preparations. (See all compounds classified as Contraceptives, Oral, Hormonal.)	
cyclorphan	4163-15-9	Cyclorphan	4163-15-9	U6Z73N36V0			
Cycloserine	68-41-7	Cycloserine	68-41-7	95IK5KI84Z	Antibiotics, Antitubercular	Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. (See all compounds classified as Antibiotics, Antitubercular.)	Used in combination with up to 5 other drugs as a treatment for Mycobacterium avium complex (MAC) and is also used to treat tuberculosis (TB).
cyclosporin G	74436-00-3	Geclosporin	74436-00-3	UA3JNW70T9	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	
cyclosporin H	83602-39-5	Cyclosporin H	83602-39-5	FUO6O3NDNH			
Cyclosporine	59865-13-3	cyclosporin A	59865-13-3	83HN0GTJ6D	Dermatologic Agents	Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)	Cyclosporine is approved for a variety of conditions. Firstly, it is approved for the prophylaxis of organ rejection in allogeneic kidney, liver, and heart transplants. It is also used to prevent bone marrow transplant rejection. For the above indications, cyclosporine can be used in conjunction with azathioprine and corticosteroids. Finally, cyclosporine can be used in patients who have chronic transplant rejection and have received previous immunosuppressive therapy and to prevent or treat graft-versus-host disease (GVHD).  Secondly, cyclosporine is used for the treatment of patients with severe active rheumatoid arthritis (RA) when they no longer respond to methotrexate alone. It can be used for the treatment of adult non-immunocompromised patients with severe, recalcitrant, plaque psoriasis that have failed to respond to at least one systemic therapy or when systemic therapies are not tolerated or contraindicated. The ophthalmic solution of cyclosporine is indicated to increase tear production in patients suffering from keratoconjunctivitis sicca. In addition, cyclosporine is approved for the treatment of steroid dependent and steroid-resistant nephrotic syndrome due to glomerular diseases which may include minimal change nephropathy, focal and segmental glomerulosclerosis or membranous glomerulonephritis.  A cyclosporine ophthalmic emulsion is indicated in the treatment of vernal keratoconjunctivitis in adults and children.  Off-label, cyclosporine is commonly used for the treatment of various autoimmune and inflammatory conditions such as atopic dermatitis, blistering disorders, ulcerative colitis, juvenile rheumatoid arthritis, uveitis, connective tissue diseases, as well as idiopathic thrombocytopenic purpura.
Cyclosporins		Cyclosporins					
cyclothiazide	2259-96-3	Cyclothiazide	2259-96-3	P71U09G5BW	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	Cyclothiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. It is also indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.
cyclovirobuxine D	860-79-7	Cyclovirobuxine D	860-79-7	51GY352868			
cyflufenamid		Cyflufenamid	180409-60-3	79ID05OQ82	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
cyfluthrin	68359-37-5	Cyfluthrin	68359-37-5	SCM2QLZ6S0	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
cyhalofop-butyl		Cyhalofop-butyl	122008-85-9	18HGV9OC6G			
cyhalothrin	68085-85-8	Cyhalothrin	68085-85-8	V0V73PEB8M	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
cyhexatin	13121-70-5	Cyhexatin	13121-70-5	8YJV11QB4R	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
cylindrospermopsin	143545-90-8	cylindrospermopsin					
CYM-5520		1-[2-(1-Benzyl-2,5-dimethyl-1H-pyrrol-3-yl)-2-oxo-ethyl]-6-oxo-1,6-dihydro-pyridine-3-carbonitrile	1449747-00-5				
CYM51010		Ethyl 1-[4-(acetylamino)benzyl]-4-(2-phenylethyl)piperidine-4-carboxylate	1069498-96-9				
Cymarine	508-77-0	Cymarin	508-77-0	UK3LS8435E	Cardiotonic Agents	Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)	
CYN 154806		CID 16133842					
cynandione A		cynandione A					
cynaropicrin		Cynaropicrin	35730-78-0	M9233789I9	Cytotoxins	Substances that are toxic to cells; they may be involved in immunity or may be contained in venoms. These are distinguished from CYTOSTATIC AGENTS in degree of effect. Some of them are used as CYTOTOXIC ANTIBIOTICS. The mechanism of action of many of these are as ALKYLATING AGENTS or MITOSIS MODULATORS. (See all compounds classified as Cytotoxins.)	
cynatratoside-C		cynatratoside-C					
cypermethrin	52315-07-8	Cypermethrin	52315-07-8	1TR49121NP	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
cyperusphenol B		cyperusphenol B					
cyproconazole		Cyproconazole	94361-06-5	622B9C3E6T	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
cyprodime	118111-54-9	Cyprodime	118111-54-9	2C6F5L8S8X			
cyprodinil	121552-61-2	Cyprodinil	121552-61-2	42P6T6OFWZ			
Cyproheptadine	129-03-3	Cyproheptadine	129-03-3	2YHB6175DO	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	In the US, prescription cyproheptadine is indicated for the treatment of various allergic symptomatologies - including dermatographia, rhinitis, conjunctivitis, and urticaria - as well as adjunctive therapy in the management of anaphylaxis following treatment with epinephrine. In Canada, cyproheptadine is available over-the-counter and is indicated for the treatment of pruritus and for appetite stimulation. In Australia, cyproheptadine is additionally indicated for the treatment vascular headaches.  Cyproheptadine is also used off-label for the treatment of serotonin syndrome.
Cyproterone	2098-66-0	Cyproterone	2098-66-0	E61Q31EK2F	Androgen Antagonists	Compounds which inhibit or antagonize the biosynthesis or actions of androgens. (See all compounds classified as Androgen Antagonists.)	
Cyproterone Acetate	427-51-0	Cyproterone acetate	427-51-0	4KM2BN5JHF	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For the palliative treatment of patients with advanced prostatic carcinoma.
cyromazine		Cyromazine	66215-27-8	CA49Y29RA9	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Cys(11)-Cys(15)-endothelin-1 (11-21)	144602-02-8	Cys(11)-Cys(15)-endothelin-1 (11-21)	144602-02-8				
cysmethynil		Cysmethynil	851636-83-4	R5MT8HFQ9E			
Cystamine	51-85-4	Cystamine	51-85-4	R110LV8L02	Sulfhydryl Reagents	Chemical agents that react with SH groups. This is a chemically diverse group that is used for a variety of purposes. Among these are enzyme inhibition, enzyme reactivation or protection, and labelling. (See all compounds classified as Sulfhydryl Reagents.)	
Cystathionine	56-88-2	L-cystathionine	56-88-2	375YFJ481O			
Cysteamine	60-23-1	Cysteamine	60-23-1	5UX2SD1KE2	Cystine Depleting Agents	Compounds and drugs that react with CYSTINE and convert it into a compound that can be more easily metabolized or intracellularly transported. Drugs in this class have been used to treat CYSTINOSIS. (See all compounds classified as Cystine Depleting Agents.)	The bitartrate salt of cysteamine is used for the oral treatment of nephropathic cystinosis and cystinuria in adults and children 6 years old. The hydrochloride salt, used in eye drop preparations, is indicated for the treatment of corneal cystine crystal accumulation in patients with cystinosis.
Cysteine	52-90-4	Cysteine	52-90-4	K848JZ4886			For the prevention of liver damage and kidney damage associated with overdoses of acetaminophen
Cysteine Proteinase Inhibitors		Cysteine Proteinase Inhibitors					
cysteine sulfinic acid		3-Sulfinoalanine	2381-08-0	UZY4HYK4ZX			
cysteinyl-arginyl-tyrosyl-prolyl-glutamyl-valyl-glutamyl-isoleucyl-cysteine (1-9) disulfide		cysteinyl-arginyl-tyrosyl-prolyl-glutamyl-valyl-glutamyl-isoleucyl-cysteine (1-9) disulfide					
cysteinyl-leukotriene		cysteinyl-leukotriene					
Cysteinyldopa	19641-92-0	Cysteinyldopa	19641-92-0	6I8HV27IUT			
Cystine	56-89-3	Cystine	56-89-3	48TCX9A1VT			It has been claimed that L-cysteine has anti-inflammatory properties, that it can protect against various toxins, and that it might be helpful in osteoarthritis and rheumatoid arthritis. More research will have to be done before L-cysteine can be indicated for any of these conditions. Research to date has mostly been in animal models.
Cytarabine	147-94-4	Cytarabine	147-94-4	04079A1RDZ	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	For the treatment of acute non-lymphocytic leukemia, acute lymphocytic leukemia and blast phase of chronic myelocytic leukemia.  Cytarabine is indicated in combination with [daunorubicin] for the treatment of newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in adults and pediatric patients 1 year and older.
cythioate	115-93-5	Cythioate	115-93-5	3OOH7Q4333	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Cytidine	65-46-3	Cytidine	65-46-3	5CSZ8459RP			
Cytidine Diphosphate Choline	987-78-0	Citicoline	987-78-0		Nootropic Agents	Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)	
Cytidine Diphosphate Diglycerides		Cytidine Diphosphate Diglycerides					
Cytidine Monophosphate	63-37-6	5'-Cytidylic acid	63-37-6	F469818O25			
Cytidine Monophosphate N-Acetylneuraminic Acid	3063-71-6	cytidine monophosphate N-acetylneuraminic acid	3063-71-6	T8I6M8AXA0			
Cytidine Triphosphate	65-47-4	Cytidine-5'-triphosphate	65-47-4	K0118UX80T			
cytisine	485-35-8	Cytisine	485-35-8	53S5U404NU			Indicated for use in smoking cessation.
Cytochalasin B	14930-96-2	Cytochalasin B	14930-96-2	3CHI920QS7			
Cytochalasin D	22144-77-0	cytochalasin D	22144-77-0	SY9F0FZ3TO	Nucleic Acid Synthesis Inhibitors	Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)	
cytochalasin H	53760-19-3	Cytochalasin H (>90%)	53760-19-3				
Cytochrome P-450 Enzyme Inhibitors		Cytochrome P-450 Enzyme Inhibitors					
cytosterone		cytosterone					
cytotoxic necrotizing factor type 1	106803-33-2	Cytotoxic necrotizing factor type 1					
Cytotoxins		Cytotoxins					
D-161 compound		D-161 compound					
D-65476		PDGF Receptor Tyrosine Kinase Inhibitor II					
D-Ala(2),MePhe(4),Met(0)-ol-enkephalin	64854-64-4	D-Ala2,MePhe4,Met5(O))enkephalinol	64854-64-4		Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
D-Aspartic Acid	1783-96-6	D-Aspartic acid	1783-96-6	4SR0Q8YD1X			
D-Glucaric acid, 1,4-lactone		D-Glucaric acid, 1,4-lactone					
D-JNKI-1		D-Jnki-1	1198367-70-2	FU288768DP			Investigated for use/treatment in hearing loss.
d,d-T80-prallethrin	23031-36-9	Prallethrin	23031-36-9				
DAA 1097		N-(4-chloro-2-phenoxyphenyl)-N-(2-isopropoxybenzyl)acetamide	220551-79-1	TE4VJ6U6XS			
dabequin	56548-51-7	Dabequin	56548-51-7				
Dabigatran		Dabigatran	211914-51-1	I0VM4M70GC	Antithrombins	Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. (See all compounds classified as Antithrombins.)	
daboiatoxin		Daboia russelli siamensis toxin					
dabrafenib		Dabrafenib	1195765-45-7	QGP4HA4G1B	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	As monotherapy, dabrafenib is indicated to treat unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test.   In combination with [trametinib], dabrafenib is indicated to treat for:  - the treatment of unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test. - the adjuvant treatment of melanoma with BRAF V600E or V600K mutations and involvement of lymph node(s), following complete resection. - the treatment of metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation. - the treatment of locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation and with no satisfactory locoregional treatment options. - treatment of adult and pediatric patients six years and older with unresectable or metastatic solid tumours with BRAF V600E mutation who have progressed following prior treatment and have no satisfactory alternative treatment options. This indication is approved under accelerated approval based on the overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s). - the treatment of pediatric patients one year of age and older with low-grade glioma (LGG) with a BRAF V600E mutation who require systemic therapy.  Dabrafenib has limitations of use: it is neither indicated for treating patients with colorectal cancer because of known intrinsic resistance to BRAF inhibition nor wild-type BRAF solid tumours.
Dacarbazine	4342-03-4	Dacarbazine	4342-03-4	7GR28W0FJI	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	For the treatment of metastatic malignant melanoma. In addition, dacarbazine is also indicated for Hodgkin's disease as a secondary-line therapy when used in combination with other antineoplastic agents.
dacomitinib		Dacomitinib	1110813-31-4	2XJX250C20	Tyrosine Kinase Inhibitors	Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES. (See all compounds classified as Tyrosine Kinase Inhibitors.)	Dacomitinib is indicated as the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations as verified by an FDA-approved test.  Lung cancer is the leading cause of cancer death and NSCLC accounts for 85% of lung cancer cases. From the cases of NSCLC, approximately 75% of the patients present a late diagnosis with metastatic and advanced disease which produces a survival rate of 5%. The presence of a mutation in EGFR accounts for more than the 60% of the NSCLC cases and the overexpression of EGFR is associated with frequent lymph node metastasis and poor chemosensitivity.
Dactinomycin	50-76-0	Dactinomycin	50-76-0	1CC1JFE158	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of Wilms' tumor, childhood rhabdomyosarcoma, Ewing's sarcoma and metastatic, nonseminomatous testicular cancer as part of a combination chemotherapy and/or multi-modality treatment regimen
dactolisib		Dactolisib	915019-65-7	RUJ6Z9Y0DT	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
dafachronic acid		(5alpha)-3-Oxocholestan-26-oic acid					
Dahuang Zhechong pill		Dahuang Zhechong pill					
dai-kenchu-to		Dai-kenchu-to					
daidzein	486-66-8	Daidzein	486-66-8	6287WC5J2L	Phytoestrogens	Compounds derived from plants, primarily ISOFLAVONES that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS. (See all compounds classified as Phytoestrogens.)	
daidzin	552-66-9	Daidzin	552-66-9	4R2X91A5M5	Alcohol Deterrents	Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism. (See all compounds classified as Alcohol Deterrents.)	
dalcetrapib		Dalcetrapib	211513-37-0	3D050LIQ3H	Anticholesteremic Agents	Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)	Lipoprotein deficiency
Dalteparin		Lovenox	9005-49-6				
daltroban	105218-03-9	Daltroban	79094-20-5	S25VDY08ZC	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	
damascenone		Damascenone	23696-85-7	U66V25TBO0			
damnacanthal	477-84-9	Damnacanthal	477-84-9	WUC3CB63CD			
dan-shen root extract		2C18H14O3					
danaparoid	83513-48-8	danaparoid					
Danazol	17230-88-5	Danazol	17230-88-5	N29QWW3BUO	Estrogen Antagonists	Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)	For the treatment of endometriosis and fibrocystic breast disease (in patients unresponsive to simple measures). Also used for the prophylactic treatment of all types of hereditary angioedema in males and females.
danggui buxue decoction		danggui buxue decoction					
danggui-shaoyao-san		danggui-shaoyao-san					
danhong		danhong					
danofloxacin		Danofloxacin	112398-08-0	24CU1YS91D	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
danshen dripping pill		danshen dripping pill					
Danshen-Gegen		Danshen-Gegen					
danthron	117-10-2	Danthron	117-10-2	Z4XE6IBF3V	Cathartics	Agents that are used to stimulate evacuation of the bowels. (See all compounds classified as Cathartics.)	
Dantrolene	7261-97-4	Dantrolene	7261-97-4	F64QU97QCR	Muscle Relaxants, Central	A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)	For use, along with appropriate supportive measures, for the management of the fulminant hypermetabolism of skeletal muscle characteristic of malignant hyperthermia crises in patients of all ages. Also used preoperatively, and sometimes postoperatively, to prevent or attenuate the development of clinical and laboratory signs of malignant hyperthermia in individuals judged to be malignant hyperthermia susceptible.
danusertib		Danusertib	827318-97-8	M3X659D0FY			
dapagliflozin		Dapagliflozin	461432-26-8	1ULL0QJ8UC	Sodium-Glucose Transporter 2 Inhibitors	Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS. (See all compounds classified as Sodium-Glucose Transporter 2 Inhibitors.)	Dapagliflozin is indicated as an adjunct treatment to improve glycemic control in adult patients with type 2 diabetes mellitus along with diet and exercise.For patients with chronic kidney disease at risk of progression, dapagliflozin in used to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure. Dapagliflozin is also indicated to either reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either established cardiovascular disease or multiple cardiovascular risk factors. Combination products with dapagliflozin also exist, either as a dapagliflozin-saxagliptin or dapagliflozin-metformin hydrochloride formulation. Both are used as an adjunct treatment to diet and exercise to improve glycemic control in adults with type 2 diabetes.
daphnetin	486-35-1	Daphnetin	486-35-1	XC84571RD2			
DAPI	47165-04-8	4',6-Diamidino-2-phenylindole	47165-04-8	K9W25Z7ROH	Trypanocidal Agents	Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. (See all compounds classified as Trypanocidal Agents.)	
dapoxetine	119356-77-3	Dapoxetine	119356-77-3	GB2433A4M3			For the treatment of premature ejaculation.
Dapsone	80-08-0	Dapsone	80-08-0	8W5C518302	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	For the treatment and management of leprosy and dermatitis herpetiformis.
darapladib		Darapladib	356057-34-6	UI1U1MYH09	Phospholipase A2 Inhibitors	Compounds that inhibit or block the activity of a PHOSPHOLIPASE A2 enzyme. (See all compounds classified as Phospholipase A2 Inhibitors.)	Investigated for use/treatment in atherosclerosis.
darbufelone		Darbufelone	139226-28-1	72H8H6K34C			
darexaban		Darexaban	365462-23-3	KF322K101S	Factor Xa Inhibitors	Endogenous factors and drugs that inhibit or block the activity of FACTOR XA. (See all compounds classified as Factor Xa Inhibitors.)	
darexaban glucuronide		Darexaban glucuronide					
darglitazone	141200-24-0	Darglitazone	141200-24-0	AVP9C03Z3K			
darifenacin	133099-04-4	Darifenacin	133099-04-4	APG9819VLM	Muscarinic Antagonists	Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)	For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.
darinaparsin		Darinaparsin	69819-86-9	9XX54M675G			Investigated for use/treatment in blood (blood forming organ disorders, unspecified), cancer/tumors (unspecified), solid tumors, multiple myeloma, and liver cancer.
darusentan		Darusentan	171714-84-4	33JD57L6RW	Endothelin Receptor Antagonists	Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN RECECPTORS. (See all compounds classified as Endothelin Receptor Antagonists.)	For the treatment of congestive heart failure and hypertension.
Dasatinib		Dasatinib	302962-49-8	RBZ1571X5H	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Dasatinib is indicated for the treatment of newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase, as well as adults with chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib, and adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy. Dasatinib is also indicated for the treatment of pediatric patients 1 year of age and older with Ph+ CML in chronic phase or newly diagnosed Ph+ ALL in combination with chemotherapy.
Daunorubicin	20830-81-3	Daunorubicin	20830-81-3		Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	For remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.  Daunorubicin is indicated in combination with [cytarabine] for the treatment of newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in adults and pediatric patients 1 year and older.
daunorubicinol	28008-55-1	Daunorubicinol	28008-55-1	YDU8YIP30L			
dauricine	524-17-4	Dauricine	524-17-4	8QTO90G5W5	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
davunetide		Davunetide	211439-12-2				
dazomet	533-74-4	Dazomet	533-74-4	S7419CG4W5			
dazoxiben	78218-09-4	Dazoxiben	78218-09-4	09ZFC7974Q	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
DC_MO1		DC_MO1					
DCB-SLE1		DCB-SLE1					
DCC-2036		Rebastinib	1020172-07-9	75017Q6I97	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
DDMS		1-Chloro-2,2-bis(4'-chlorophenyl)ethane					
DDOH	2642-82-2	2,2-Bis(4-chlorophenyl)ethanol	2642-82-2	59856K2U1E			
DDT	50-29-3	Clofenotane	50-29-3	CIW5S16655			
deacetoxyvinzolidine		Deacetoxyvinzolidine	165659-77-8	6PBV11IO5E			
deacylcortivazol	4906-84-7	Deacylcortivazol	4906-84-7	3JO09QT49F			
deacylketoconazole	67914-61-8	Deacylketoconazole	67914-61-8	P7P4A1FD7Z			
Deamino Arginine Vasopressin	16679-58-6	Desmopressin	16679-58-6	ENR1LLB0FP	Antidiuretic Agents	Agents that reduce the excretion of URINE, most notably the octapeptide VASOPRESSINS. (See all compounds classified as Antidiuretic Agents.)	- Indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void (intranasal).   - Indicated as antidiuretic replacement therapy in the management of central cranial diabetes insipidus and for management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region (intranasal/parenteral).  - Indicated for patients with hemophilia A with factor VIII coagulant activity levels greater than 5% or mild to moderate classic von Willebrand's Disease (Type I) with factor VIII levels greater than 5% during surgical procedures and postoperatively to maintain hemostasis (parenteral).
Deanol	108-01-0	Deanol	108-01-0	2N6K9DRA24	Anti-Dyskinesia Agents	Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias. (See all compounds classified as Anti-Dyskinesia Agents.)	
DEAP-C16Y peptide		DEAP-C16Y peptide					
deapi-platycodin D		Deapioplatycodin D	78763-58-3				
Debrisoquin	1131-64-2	Debrisoquine	1131-64-2	X31CDK040E	Adrenergic Agents	Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)	For the treatment of moderate and severe hypertension, either alone or as an adjunct, and for the treatment of renal hypertension.
decabromobiphenyl ether	1163-19-5	Decabromodiphenyl oxide	1163-19-5	N80BQ29A0H			
decabromodiphenyl ethane		1,2-Bis(perbromophenyl)ethane	84852-53-9	WZ2532TA0A			
decahydro-2-naphthyl-N-n-butylcarbamate		decahydro-2-naphthyl-N-n-butylcarbamate					
decamethonium	156-74-1	Decamethonium	156-74-1	C1CG1S3T2W	Neuromuscular Depolarizing Agents	Drugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarization of the motor end plate. These agents are primarily used as adjuvants in surgical anesthesia to cause skeletal muscle relaxation. (See all compounds classified as Neuromuscular Depolarizing Agents.)	For use as a skeletal muscle relaxant
decamethrin	52820-00-5	Cyclopropanecarboxylic acid, 3-(2,2-dibromoethenyl)-2,2-dimethyl-, cyano(3-phenoxyphenyl)methyl ester	52918-63-5		Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
decamethylcyclopentasiloxane		Cyclomethicone 5	541-02-6	0THT5PCI0R			
decan-4-olide	706-14-9	gamma-Decalactone	706-14-9	7HLS05KP9O			
decanaldehyde	112-31-2	Decanal	112-31-2	31Z90Q7KQJ			
decane	124-18-5	Decane	124-18-5	NK85062OIY			
decanoic acid	334-48-5	Capric Acid	334-48-5	4G9EDB6V73	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
decanoyl-coenzyme A	1264-57-9	Decanoyl-coa	1264-57-9				
decaprenoic acid	459-80-3	Geranic acid	459-80-3	10797G3M5Y			
dechlorane 602		1,2,3,4,6,7,8,9,10,10,11,11-Dodecachloro-1,4,4a,5a,6,9,9a,9b-octahydro-1,4:6,9-dimethanodibenzofuran	31107-44-5				
dechlorane plus		Dechlorane plus	13560-89-9				
dechloroethylcyclophosphamide	36761-83-8	3-Dechloroethylifosfamide	36761-83-8	C6Q3UC3WP5			
dechloroethylifosfamide		2-Dechloroethylifosfamide	53459-55-5	IIB78D4DQA			
Decitabine	2353-33-5	Decitabine	2353-33-5	776B62CQ27	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	Decitabine is indicated for the treatment of patients with myelodysplastic syndromes (MDS) including all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia), as well as for MDS scored as belonging to the intermediate-1, intermediate-2, or high-risk group in the International Prognostic Scoring System.
declopramide	891-60-1	Declopramide	891-60-1	916GJF577D			Investigated for use/treatment in colorectal cancer and inflammatory bowel disease.
decominol	60812-35-3	Decominol	60812-35-3	4A3T9Z2TKX			
decursin	5928-25-6	Decursin	5928-25-6	E95RTO3YQR	Enzyme Activators	Compounds or factors that act on a specific enzyme to increase its activity. (See all compounds classified as Enzyme Activators.)	
DEET	134-62-3	Diethyltoluamide	134-62-3	FB0C1XZV4Y	Insect Repellents	Substances causing insects to turn away from them or reject them as food. (See all compounds classified as Insect Repellents.)	Diethyltoluamide, or DEET, is an active ingredient that is predominantly indicated for as an insect repellant used to repel biting pests like mosquitoes and ticks. Products containing DEET currently are available to the public in a variety of liquids, lotions, sprays, and impregnated materials like towelettes or roll-ons.
deethylatrazine		Deethylatrazine	6190-65-4	07PV14BK6X			
Deferasirox		Deferasirox	201530-41-8	V8G4MOF2V9	Iron Chelating Agents	Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. (See all compounds classified as Iron Chelating Agents.)	For the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older.
Deferiprone	30652-11-0	Deferiprone	30652-11-0	2BTY8KH53L	Iron Chelating Agents	Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. (See all compounds classified as Iron Chelating Agents.)	Deferiprone is indicated in thalassemia syndromes when first line chelation agents are not adequate to treat transfusional iron overload.
Deferoxamine	70-51-9	Deferoxamine	70-51-9	J06Y7MXW4D	Siderophores	Low-molecular-weight compounds produced by microorganisms that aid in the transport and sequestration of ferric iron. (The Encyclopedia of Molecular Biology, 1994) (See all compounds classified as Siderophores.)	Used to treat acute iron or aluminum toxicity (an excess of aluminum in the body) in certain patients. Also used in certain patients with anemia who must receive many blood transfusions.
defibrotide	83712-60-1	Defibrotide	83712-60-1	E1942E7K32	Fibrinolytic Agents	Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)	Indicated for the treatment of severe hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), with renal or pulmonary dysfunction following hematopoietic stem-cell transplantation (HSCT).
deflazacort	14484-47-0	Deflazacort	14484-47-0	KR5YZ6AE4B	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	Deflazacort is indicated for the treatment of Duchenne Muscular Dystrophy (DMD) in patients 2 years of age and older.
degrasyn		(S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylbutyl)acrylamide	856243-80-6				
deguelin	522-17-8	Deguelin	522-17-8	K5Z93K66IE			
dehydroabietylamine		Dehydroabietylamine	1446-61-3	33289O147P			
dehydroacetic acid	520-45-6	Dehydroacetic acid	520-45-6				
dehydroandrographolide		2(3H)-Furanone, 3-(2-((1S,4aS,5R,6R,8aS)-decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl)ethylidene)-, (3E)-	134418-28-3	010E4IV714			
Dehydroascorbic Acid	490-83-5	Dehydroascorbic acid	490-83-5	Y2Z3ZTP9UM	Vitamins	Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body. (See all compounds classified as Vitamins.)	There is no approved indication for dehydroascorbic acid, but it has potential therapeutic use in patients with certain viruses and ischemic stroke.
Dehydrocholic Acid	81-23-2	Dehydrocholic acid	81-23-2	NH5000009I	Cholagogues and Choleretics	Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)	No approved therapeutic indications.
dehydrocostus lactone	477-43-0	Dehydrocostus lactone, (-)-	477-43-0	71TRF5K040			
dehydrocrenatidine		Dehydrocrenatidine	65236-62-6				
dehydrodiisoeugenol		Dehydrodiisoeugenol	2680-81-1				
dehydroeburicoic acid		Dehydroeburicoic acid	6879-05-6				
dehydroeffusol		5-Ethenyl-1-methylphenanthrene-2,7-diol	137319-34-7				
Dehydroepiandrosterone	53-43-0	Prasterone	53-43-0	459AG36T1B	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	DHEA is taken as a supplement for a variety of unsubstantiated indications. The following indications have shown promise and are backed up by some scientific evidence: schizophrenia (DHEA may be more effective in women than men); improving the appearance of older peoples skin (taking DHEA by mouth seems to increase skin thickness and moisture, and decrease facial age spots in elderly men and women); improving ability to achieve an erection in men with sexual dysfunction. Additionally, DHEA has shown promise in improving symptoms of lupus (SLE). Taking DHEA by mouth along with conventional treatment may help reduce the number of times symptoms flare up and may allow a reduction in the dose of prescription drugs needed. DHEA may also help SLE symptoms such as muscle ache and mouth ulcers. DHEA also seems to strengthen bones in SLE patients being treated with high-dose steroids (corticosteroids). DHEA also shows promise in the treatment of osteoporosis. Taking DHEA by mouth daily seems to improve bone mineral density (BMD) in older women and men with osteoporosis or osteopenia (pre-osteoporosis). DHEA may also increase BMD in young women with the eating disorder called anorexia nervosa. DHEA is often prescribed in India for the induction of ovulation to improve chances of pregnancy.
Dehydroepiandrosterone Sulfate	651-48-9	Dehydroepiandrosterone sulfate	651-48-9	57B09Q7FJR			Investigated for use/treatment in asthma and burns and burn infections.
dehydroepiandrosterone-bovine serum albumin		dehydroepiandrosterone-bovine serum albumin					
dehydroevodiamine	67909-49-3	Dehydroevodiamine	67909-49-3	8NT3HW64V9			
dehydroglyasperin C		Dehydroglyasperin C	199331-35-6	80H8MSZ44I			
dehydroglyasperin D		Dehydroglyasperin D	517885-72-2	N265YUZ764			
dehydronifedipine		Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate	67035-22-7	OR3W8GT1C8			
dehydroretinal	472-87-7	Dehydroretinaldehyde	472-87-7	HV8T003XO1			
dehydroxymethylepoxyquinomicin		Dehydroxymethylepoxyquinomicin	287194-38-1				
delapril	83435-67-0	Delapril hydrochloride	83435-67-0	2SMM3M5ZMH	Angiotensin-Converting Enzyme Inhibitors	A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)	
Delavirdine	136817-59-9	Delavirdine	136817-59-9	DOL5F9JD3E	Anti-HIV Agents	Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)	For the treatment of HIV-1 infection in combination with appropriate antiretroviral agents when therapy is warranted
delphinidin	13270-61-6	3,3',4',5,5',7-Hexahydroxyflavylium	13270-61-6	031A4BN94T			
delphinidin 3-O-glucopyranoside		delphinidin 3-O-glucopyranoside					
delta-1-piperidine-6-carboxylic acid	3038-89-9	2,3,4,5-Tetrahydropyridine-2-carboxylic acid	3038-89-9				
delta-8-tetrahydrocannabinol	5957-75-5	DELTA8-Tetrahydrocannabinol	5957-75-5	B49D0HH807			
delta-aminolevulinic acid methyl ester		5-Aminolevulinic acid methyl ester					
delta-hexachlorocyclohexane	319-86-8	Hexachlorocyclohexane	319-86-8	IVM9A2N49K			Used as a pancreatic enzyme replacement in pancreatic insufficiency.  It is intended to mimic naturally produced human pepsin.  Pepsin powder is prepared from the gastric mucosa of pigs, cattle or sheep. In the laboratory, it is primarily used for the unspecific hydrolysis of proteins and peptides in acidic media. In addition, it provides limited hydrolysis of native immunoglobulins, yielding biologically active fragments.  In certain supplements, pepsin may be combined with betaine and HCl (hydrochloric acid) to aid in digestion in various gastrointestinal conditions,.
delta-tocopherol	119-13-1	delta-Tocopherol	119-13-1	JU84X1II0N			
delta-viniferin		delta-Viniferin	204076-78-8				
delta(12)-prostaglandin J(2)		delta(12)-prostaglandin J(2)					
delta(4)-tibolone		17-Ethynyl-17-hydroxy-7,13-dimethyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one	1162-60-3	LHZ8R2OW0M			
delta(6)-tetrahydrocannabinol-7-oic acid	39690-06-7	delta(8)-Thc-11-oic acid	39690-06-7	685ZU7K3SY			
delta(9)-tetrahydrocannabinolic acid	23978-85-0	delta9-Tetrahydrocannabinolic acid	23978-85-0	EJ6CZV0K5Y			
delta8-tetrahydrocannabivarin		delta8-tetrahydrocannabivarin					
deltanit	65907-30-4	Furathiocarb	65907-30-4	WZI2IZ80UY			
deltorphin II, Ala(2)-	122752-16-3	Deltorphin II					
demalonyl thyrsiflorin A		demalonyl thyrsiflorin A					
Demeclocycline	127-33-3	Demeclocycline	127-33-3		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Demecolcine	477-30-5	Demecolcine	477-30-5	Z01IVE25KI	Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	
demethoxycurcumin	24939-17-1	Demethoxycurcumin	22608-11-3	W2F8059T80			
demethoxyfumitremorgin C		demethoxyfumitremorgin C					
demethylbellidifolin		1,3,5,8-Tetrahydroxyxanthone	2980-32-7	G78B8Y1AI5			
demethylchlordimeform	21787-80-4	Demethylchlordimeform	21787-80-4				
demeton-S-methyl	919-86-8	Demeton-S-methyl	919-86-8	HU8BO5S9WK			
demycarosyl-3D-digitoxosylmithramycin SK		demycarosyl-3D-digitoxosylmithramycin SK					
denatonium		Denatonium	47324-98-1	4IK22DF4OU	Aversive Agents	Chemicals added to pharmacologic preparations, poisonous household goods, and other chemicals to discourage their abuse or consumption. (See all compounds classified as Aversive Agents.)	
denbufylline		Denbufylline	57076-71-8	04B949KO6F	Phosphodiesterase Inhibitors	Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)	
Dendroaspis natriuretic peptide		Dendroaspis natriuretic peptide					
dendrobine	2115-91-5	Dendrobine	2115-91-5	A9N9FB9DPG			
dendrochrysanene		Dendrochrysanene					
dendropanoxide		5957-66-4					
dendrophenol	108853-14-1	Dendrophenol	108853-14-1				
denopamine	71771-90-9	Denopamine	71771-90-9	V5F60UPD8P	Adrenergic beta-Agonists	Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)	
dentinol		dentinol					
denufosol tetrasodium		Denufosol tetrasodium	318250-11-2	82M942WZ4A			
Deoxyadenosines		Deoxyadenosines					
deoxycalyciphylline B		Deoxycalyciphylline B					
Deoxycholic Acid	83-44-3	Deoxycholic Acid	83-44-3	005990WHZZ	Cholagogues and Choleretics	Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)	For improvement in appearance of moderate to severe fullness associated with submental fat in adults.
Deoxycytidine	951-77-9	2'-Deoxycytidine	951-77-9	0W860991D6			
Deoxycytidine Monophosphate	1032-65-1	Deoxycytidine 5'-monophosphate	1032-65-1	W7A9174XQL			
deoxyelephantopin		Deoxyelephantopin					
Deoxyepinephrine	501-15-5	Deoxyepinephrine	501-15-5	R7339QLN1C			
Deoxyglucose	154-17-6	2-deoxy-D-glucose	154-17-6	9G2MP84A8W	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	
Deoxyguanosine	961-07-9	2'-Deoxyguanosine	961-07-9	G9481N71RO			
deoxyguanosine triphosphate	2564-35-4	2'-Deoxyguanosine-5'-triphosphate	2564-35-4	8C2O37Y44Q			
deoxymiroestrol		Deoxymiroestrol					
deoxynivalenol	51481-10-8	Deoxynivalenol	51481-10-8	JT37HYP23V			
deoxynivalenol-15-glucuronide		Deoxynivalenol 15-glucuronide	1372859-16-9	D2N6KOV3DR			
deoxynivalenol-3-glucoside		Deoxynivalenol 3-glucoside	131180-21-7	HKI01R84M9			
deoxynivalenol-3-glucuronide		Deoxynivalenol 3-glucuronide	1000000-13-4	I0I7J8KVP2			
deoxypodophyllotoxin	69222-20-4	Isodeoxypodophyllotoxin	69222-20-4		Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
Deoxyribose	533-67-5	2-Deoxy-D-ribose	533-67-5	LSW4H01241			
dephostatin	151606-30-3	Dephostatin	151606-30-3				
Depsipeptides		Depsipeptides					
Dequalinium	6707-58-0	Dequalinium	6707-58-0	E7QC7V26B8	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	Dequalinium is used in several OTC products to treat mouth infections and inflammation, such as tonsillitis, pharyngitis, and gingivitis. As vaginal tablets, dequalinium is indicated for the treatment of bacterial vaginosis in adult women under 55 years of age.
Dermatan Sulfate	24967-94-0	Dermatan sulfate	24967-94-0		Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	
Dermatophagoides pteronyssinus antigen p 1		Dermatophagoides pteronyssinus antigen p 1					
Dermatophagoides pteronyssinus antigen p 2		Dermatophagoides pteronyssinus antigen p 2					
dermorphin	77614-16-5	Dermorphin	77614-16-5	2SEC01B703	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	
Derp2 allergen, Dermatophagoides pteronyssinus		Derp2 allergen, Dermatophagoides pteronyssinus					
des-aspartate-angiotensin I		des-aspartate-angiotensin I					
desethylamiodarone	83409-32-9	Desethylamiodarone	83409-32-9	M31FU99E3Y			
desethylamodiaquine	79352-78-6	Desethylamodiaquine	79352-78-6	BY36SG7NP9			
desethylatrazine		Deethylatrazine	6190-65-4	07PV14BK6X			
desethylchloroquine		Desethylchloroquine	1476-52-4	ZC9Z9XX2PD			
Desflurane		Desflurane	57041-67-5	CRS35BZ94Q	Anesthetics, Inhalation	Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173) (See all compounds classified as Anesthetics, Inhalation.)	Desflurane is indicated for the induction and maintenance of anesthesia in adults, as well as the maintenance of anesthesia in pediatric patients.
desformylflustrabromine		Desformylflustrabromine	474657-72-2	24C2SY7KUV			
desglucoanagalloside B		desglucoanagalloside B					
Desipramine	50-47-5	Desipramine	50-47-5	TG537D343B	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	For relief of symptoms in various depressive syndromes, especially endogenous depression. It has also been used to manage chronic peripheral neuropathic pain, as a second line agent for the management of anxiety disorders (e.g. panic disorder, generalized anxiety disorder), and as a second or third line agent in the ADHD management.
desisobutyrylciclesonide		Desisobutyrylciclesonide	161115-59-9	8DL7FH77SF			
desloratadine		Desloratadine	100643-71-8	FVF865388R	Histamine H1 Antagonists, Non-Sedating	A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. (See all compounds classified as Histamine H1 Antagonists, Non-Sedating.)	For the relief of symptoms of seasonal allergic rhinitis, perennial (non-seasonal) allergic rhinitis. Desloratidine is also used for the sympomatic treatment of pruritus and urticaria (hives) associated with chronic idiopathic urticaria.
deslorelin	70235-53-9	Ovuplant	70235-53-9	48S2W73QPR	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
desmethoxyyangonin		Demethoxyyangonin	15345-89-8	F2MBQ8QRUN			
desmethylarzoxifene		desmethylarzoxifene					
desmethylastemizole	73736-50-2	Desmethylastemizole	73736-50-2	L460QHM1YN			
desmethylazelastine	47491-38-3	Desmethylazelastine	47491-38-3	8W9SOB28Q4			
desmethylcyproheptadine 10,11-epoxide	54191-03-6	Piperidine, 4-(1a,10b-dihydro-6H-dibenzo(3,4:6,7)cyclohept(1,2-b)oxiren-6-ylidene)-	54191-03-6	V7JNC2PZ2C			
desmethylicaritin		8-Prenylkaempferol	28610-31-3	0V5XK67Y0S			
desmethylmisonidazole	13551-92-3	Desmethylmisonidazole	13551-92-3	H3N358OVQW	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
desmethylnaproxen	60756-73-2	Desmethylnaproxen	60756-73-2				
Desmodium gangeticum extract		Desmodium gangeticum extract					
Desmosterol	313-04-2	Desmosterol	313-04-2	ANP93865R8			
desnitroimidacloprid		(2z)-1-[(6-Chloropyridin-3-Yl)methyl]imidazolidin-2-Imine	115970-17-7	WT3F2K5PF2			
Desogestrel	54024-22-5	Desogestrel	54024-22-5	81K9V7M3A3	Contraceptives, Oral, Synthetic	Oral contraceptives which owe their effectiveness to synthetic preparations. (See all compounds classified as Contraceptives, Oral, Synthetic.)	Oral desogestrel is used in combination with [ethinylestradiol] as a contraceptive agent for the prevention of pregnancy.  Desogestrel is part of the combined oral contraceptives that contain a mix of estrogen and progestin which inhibit ovulation.
Desoximetasone	382-67-2	Desoximetasone	140218-14-0	4E07GXB7AU	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Desoxycorticosterone	64-85-7	Desoxycortone	64-85-7	40GP35YQ49	Mineralocorticoids	A group of CORTICOSTEROIDS primarily associated with water and electrolyte balance. This is accomplished through the effect on ION TRANSPORT in renal tubules, resulting in retention of sodium and loss of potassium. Mineralocorticoid secretion is itself regulated by PLASMA VOLUME, serum potassium, and ANGIOTENSIN II. (See all compounds classified as Mineralocorticoids.)	
Desoxycorticosterone Acetate		Desoxycorticosterone Acetate	56-47-3	6E0A168OB8	Mineralocorticoids	A group of CORTICOSTEROIDS primarily associated with water and electrolyte balance. This is accomplished through the effect on ION TRANSPORT in renal tubules, resulting in retention of sodium and loss of potassium. Mineralocorticoid secretion is itself regulated by PLASMA VOLUME, serum potassium, and ANGIOTENSIN II. (See all compounds classified as Mineralocorticoids.)	
desoxypeganine 1		desoxypeganine 1					
desthiobiotin	15720-25-9	Dethiobiotin	15720-25-9		Mitogens	Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) (See all compounds classified as Mitogens.)	
destruxin B		Destruxin B	2503-26-6				
Desvenlafaxine Succinate		4-(2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol succinate			Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	
Detergents		Detergents					
Deuterium	7782-39-0	Deuterium	7782-39-0	AR09D82C7G			
Deuterium Oxide	7789-20-0	Deuterium Oxide	7789-20-0	J65BV539M3	Radiation-Protective Agents	Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)	
deuterohemin-alanyl-histidyl-threonyl-valyl-glutamyl-lysine		deuterohemin-alanyl-histidyl-threonyl-valyl-glutamyl-lysine					
Deuteroporphyrins		Deuteroporphyrins					
deutetrabenazine		(3R,11bR)-3-(2-methylpropyl)-9,10-bis(trideuteriomethoxy)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one	1392826-25-3				Deutetrabenazine is indicated in adults patients for the treatment of tardive dyskinesia and for chorea associated with Huntington's disease.
Devazepide	103420-77-5	Devazepide	103420-77-5	JE6P7QY7NH	Hormone Antagonists	Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)	
devrinol	15299-99-7	Napropamide	15299-99-7	B56M9401K6			
Dexamethasone	50-02-2	Dexamethasone	50-02-2	7S5I7G3JQL	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	Dexamethasone and [ciprofloxacin] otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa. Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Oral tablets are indicated for the treatment of multiple myeloma. An intravitreal implant is indicated for some forms of macular edema and non-infectious posterior uveitis affecting the posterior of the eye. Various ophthalmic formulations are indicated for inflammatory conditions of the eye.
dexamethasone 21-methanesulfonate	2265-22-7	Dexamethasone 21-methanesulfonate	2265-22-7	O9S11FMA79	Affinity Labels	Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. (See all compounds classified as Affinity Labels.)	
dexamethasone 21-phosphate	312-93-6	Dexamethasone phosphate	312-93-6	2BP70L44PR	Glucocorticoids	A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)	
dexamethasone 21-tributylacetate	78901-95-8	Dexamethasone 21-tributylacetate	78901-95-8				
dexamethasone acetate	1177-87-3	Dexamethasone acetate	987-24-6	K7V8P532WP	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
dexamethasone oxetanone	4089-36-5	CID 9885914	4089-36-5				
dexbrompheniramine	132-21-8	Dexbrompheniramine	132-21-8	75T64B71RP	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	For treatment and relief of symptoms of allergies, hay fever, and colds
dexchlorpheniramine	25523-97-1	Dexchlorpheniramine	25523-97-1	3Q9Q0B929N	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	
Dexetimide	21888-98-2	Dexetimide	21888-98-2	43477QYX3D	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	
Dexfenfluramine	3239-44-9	Dexfenfluramine	3239-44-9	E35R3G56OV	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	For the management of obesity including weight loss and maintenance of weight loss in patients on a reduced calorie diet
dexloxiglumide	119817-90-2	Dexloxiglumide	119817-90-2	69DY40RH9B			For the treatment of Irritable Bowel Syndrome (IBS) and Gastroesophageal Reflux Disease (GERD).
Dexmedetomidine	113775-47-6	Dexmedetomidine	113775-47-6	67VB76HONO	Hypnotics and Sedatives	Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)	Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
dexon (fungicide), sodium salt		dexon (fungicide), sodium salt					
dexpanthenol		Dexpanthenol	81-13-0	1O6C93RI7Z			Injection: Prophylactic use immediately after major abdominal surgery to minimize the possibility of paralytic ileus. Intestinal atony causing abdominal distention; postoperative or postpartum retention of flatus, or postoperative delay in resumption of intestinal motility; paralytic ileus.  Topical: This medication is used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations (e.g., diaper rash, skin burns from radiation therapy).
Dexrazoxane		Dexrazoxane	24584-09-6	048L81261F	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin hydrochloride dose of 300 mg/m^2 and would benefit from continued doxorubicin therapy. Also approved for the treatment of extravasation from intravenous anthracyclines.
dextrallorphan	5822-43-5	Dextrallorphan	5822-43-5				
Dextran Sulfate	9042-14-2	Dextran	9004-54-0		Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	Dextran is used as the restoration of blood mass during surgical interventions if there is hypovolemia due to trauma or dehydration. It is as well used after the presence of hemorrhage in cases of blood loss to a level inferior to 15% of the blood mass, if compatibility test cannot be completed or when blood lots need to be tested for pathogen detection. Dextran is also used for the prevention of profound postoperative venous thrombosis.  Dextran as well presents ophthalmic applications as solutions or ointments for the temporary relief of xerophthalmia or minor ocular irritations.
Dextrans	9004-54-0	Dextran	9004-54-0		Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	Dextran is used as the restoration of blood mass during surgical interventions if there is hypovolemia due to trauma or dehydration. It is as well used after the presence of hemorrhage in cases of blood loss to a level inferior to 15% of the blood mass, if compatibility test cannot be completed or when blood lots need to be tested for pathogen detection. Dextran is also used for the prevention of profound postoperative venous thrombosis.  Dextran as well presents ophthalmic applications as solutions or ointments for the temporary relief of xerophthalmia or minor ocular irritations.
Dextroamphetamine	51-64-9	Dextroamphetamine	51-64-9	TZ47U051FI	Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	Dextroamphetamine is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).
Dextromethorphan	125-71-3	Dextromethorphan	125-71-3	7355X3ROTS	Antitussive Agents	Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)	Dextromethorphan is indicated in combination with [brompheniramine] and [pseudoephedrine] in the treatment of coughs and upper respiratory symptoms associated with allergies or the common cold. Dextromethorphan is also used in combination with [guaifenesin] as an over-the-counter product to relieve a cough. Dextromethorphan in combination with [quinidine] is indicated in the treatment of pseudobulbar affect.
Dextropropoxyphene	469-62-5	Propoxyphene	469-62-5	II2G62OV6F	Narcotics	Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)	For the relief of mild to moderate pain.
Dextrorphan	125-73-5	Dextrorphan	125-73-5	04B7QNO9WS	Excitatory Amino Acid Antagonists	Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)	
di-(2-ethylhexyl) terephthalate	6422-86-2	Bis(2-ethylhexyl) terephthalate	6422-86-2	4VS908W98L			
di-(4-aminophenyl)ether	101-80-4	4,4'-Oxydianiline	101-80-4	28DLB4Z70T			
di-(5-methylhexyl)phthalate	41451-28-9	Diisoheptyl phthalate	71888-89-6	9JJP9B98FG			
di-2-(ethylhexyl)phosphoric acid	298-07-7	Bis(2-ethylhexyl) hydrogen phosphate	298-07-7	2Z4W0L3H06			
di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone		di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone					
di-n-butyl adipate	105-99-7	Dibutyl adipate	105-99-7	F4K100DXP3			
di-n-butyl-2,2-dichlorovinyl phosphate	18795-58-9	Dibutyl 2,2-dichlorovinyl phosphate	18795-58-9				
di-n-butylphosphoric acid	107-66-4	Dibutyl phosphate	107-66-4	0072NN74TN			
di-n-butyltin	1002-53-5	Dibutyltin	1002-53-5	KUM3SW5CW4			
di-n-hexyl phthalate	84-75-3	Dihexyl phthalate	84-75-3	42MAH1QFG5			
di-n-octyl phthalate	117-84-0	Dioctyl phthalate	117-84-0	8X3RJ0527W	Plasticizers	Materials incorporated mechanically in plastics (usually PVC) to increase flexibility, workability or distensibility; due to the non-chemical inclusion, plasticizers leach out from the plastic and are found in body fluids and the general environment. (See all compounds classified as Plasticizers.)	
di-n-pentyl phthalate	131-18-0	Dipentyl phthalate	131-18-0	5DC92K224X			
di-n-propyldithiocarbamate	25179-61-7	Di-n-propyldithiocarbamate	25179-61-7				
di-n-propylphthalate	131-16-8	Dipropyl phthalate	131-16-8	8USP5Y77SS			
di-tert-butyl peroxide	110-05-4	Di-tert-butyl peroxide	110-05-4	M7ZJ88F4R1			
di(2-picolyl)amine-3(bromoacetyl)coumarin		di(2-picolyl)amine-3(bromoacetyl)coumarin					
diacerein		Diacerein	13739-02-1	4HU6J11EL5	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	For the treatment of osteoarthritis affecting the hip or knee.
diacetolol	28197-69-5	Diacetolol	22568-64-5	4ER0CZ5G7C			
diacetoxyscirpenol		Diacetoxyscirpenol	2270-40-8	UYL28I099N	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
Diacetyl	431-03-8	2,3-Butanedione	431-03-8	K324J5K4HM			
diacetylbis(4-methylthiosemicarbazonato)copper(II)		diacetylbis(4-methylthiosemicarbazonato)copper(II)					
diacetylcurcumin		Diacetylcurcumin	19697-86-0	5PUQ5907YX			
diacetyldichlorofluorescein	2044-85-1	Diacetyldichlorofluorescein	2044-85-1				
diacetyldiphenylurea bisguanylhydrazone	13284-07-6	Diacetyldiphenylurea bisguanylhydrazone	13284-07-6				
diacetylfluorescein		Fluorescein diacetate	596-09-8	YL39R93PRE			
diacetylmonoxime	57-71-6	2,3-Butanedione monoxime	57-71-6	19SQ93LM6H	Chromogenic Compounds	Colorless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into colored compounds; used in biochemical assays and in diagnosis as indicators, especially in the form of enzyme substrates. Synonym: chromogens (not to be confused with pigment-synthesizing bacteria also called chromogens). (See all compounds classified as Chromogenic Compounds.)	
diadenosine 5',5''''-P1,P6-hexaphosphate	56983-23-4	Diadenosine hexaphosphate	56983-23-4		Vasoconstrictor Agents	Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)	
diadenosine tetraphosphate	5542-28-9	Diadenosine tetraphosphate	5542-28-9		Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
diafenthiuron	80060-09-9	Diafenthiuron	80060-09-9	22W5MDB01G			
dialifor	10311-84-9	Dialifor	10311-84-9	8480K0VB4E			
diallyl disulfide	2179-57-9	Diallyl disulfide	2179-57-9	5HI47O6OA7	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
diallyl phthalate	131-17-9	Diallyl phthalate	25053-15-0	F79L0UL6ST			
diallyl sulfone	16841-48-8	Diallyl sulfone	16841-48-8				
diallyl tetrasulfide	2444-49-7	Diallyl tetrasulfide	2444-49-7	WRP12IW1D7			
diallyl trisulfide	2050-87-5	Diallyl trisulfide	2050-87-5	0ZO1U5A3XX	Antiprotozoal Agents	Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)	
diallyldimethylammonium chloride		Diallyldimethylammonium chloride	7398-69-8	8MC08B895B			
Diamide	10465-78-8	Diamide	10465-78-8	86EQC90W32	Sulfhydryl Reagents	Chemical agents that react with SH groups. This is a chemically diverse group that is used for a variety of purposes. Among these are enzyme inhibition, enzyme reactivation or protection, and labelling. (See all compounds classified as Sulfhydryl Reagents.)	
Diamines		Diamines					
diaminobutene	18231-61-3	1,4-Diamino-2-butene	18231-61-3				
diaminochlorotriazine		Diaminochlorotriazine	1314910-56-9				
diamsar chelate	91002-72-1	Diamsar chelate	91002-72-1				
dianhydro-3,4-diacetylgalactitol	57230-48-5	Galactitol, 1,2:5,6-dianhydro-, diacetate	57230-48-5				
Dianhydrogalactitol	23261-20-3	Dianhydrogalactitol	23261-20-3	4S465RYF7M	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	
Dianisidine	119-90-4	3,3'-Dimethoxybenzidine	119-90-4	MJY508JZXV			
diaoxinxuekang		diaoxinxuekang					
diapocynin		Diapocynin	29799-22-2	A65KM2ZD49			
diaqua(disalicylaldehyde ethylenediamine)chromium(III)		diaqua(disalicylaldehyde ethylenediamine)chromium(III)					
diarctigenin		Diarctigenin	160433-41-0	HC1O9LXQ32			
Diarylheptanoids		Diarylheptanoids					
Diatrizoate	117-96-4	Diatrizoic Acid	117-96-4	5UVC90J1LK	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	Used, alone or in combination, for a wide variety of diagnostic imaging methods, including angiography, urography, cholangiography, computed tomography, hysterosalpingography, and retrograde pyelography. It can be used for imaging the gastrointestinal tract in patients allergic to barium.
Diatrizoate Meglumine		Diatrizoate Meglumine	131-49-7	3X9MR4N98U	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	
diazene	3618-05-1	Diazene	3618-05-1	LM321PYV3Y			
Diazepam	439-14-5	Diazepam	439-14-5	Q3JTX2Q7TU	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	"In general, diazepam is useful in the symptomatic management of mild to moderate degrees of anxiety in conditions dominated by tension, excitation, agitation, fear, or aggressiveness such as may occur in psychoneurosis, anxiety reactions due to stress conditions, and anxiety states with somatic expression.  Moreover, in acute alcoholic withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, and impending acute delirium tremens.  Furthermore, diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathologies, such as inflammation of the muscle and joints or secondary to trauma; spasticity caused by upper motor neuron disorders, such as cerebral palsy and paraplegia; athetosis and the rare ""stiff man syndrome"".  Particular label information from the United Kingdom also lists particular age-specific indications, including for adults: (1) The short-term relief (2-4 weeks) only, of anxiety which is severe, disabling, or subjecting the individual to unacceptable distress, occurring alone or in association with insomnia or short-term psychosomatic, organic or psychotic illness, (2) cerebral palsy, (3) muscle spasm, (4) as an adjunct to certain types of epilepsy (eg. myoclonus), (5) symptomatic treatment of acute alcohol withdrawal, (6) as oral premedication for the nervous dental patient, and (7) for premedication before surgery.  In the same UK label information, diazepam is indicated in children for: (1) control of tension and irritability in cerebral spasticity in selected cases, (2) as an adjunct to the control of muscle spasm in tetanus, and for (3) oral premedication.  A diazepam nasal spray is indicated in patients 6 years and older to treat intermittent, stereotypic episodes of frequent seizure activity that are different than the patient's usual seizure pattern."
diazepinone riboside	75421-11-3	Diazepinone riboside					
diazepinylbenzoic acid		Diazepinylbenzoic acid					
Diazinon	333-41-5	Diazinon	333-41-5	YUS1M1Q929	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
diaziquone		Diaziquone	57998-68-2	FQL5EUP13W	Cross-Linking Reagents	Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)	
diazoline	6153-33-9	Mebhydrolin napadisilate	6153-33-9	O5G04RB25M			
Diazooxonorleucine	764-17-0	6-Diazo-5-oxo-norleucine	764-17-0	LOS90IK8XH			
Diazoxide	364-98-7	Diazoxide	364-98-7	O5CB12L4FN	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	Oral diazoxide is indicated to manage hypoglycemia due to hyperinsulinism associated with conditions such as inoperable islet cell adenoma or carcinoma, and extrapancreatic malignancy in adults, or leucine sensitivity, islet cell hyperplasia, nesidioblastosis, extrapancreatic malignancy, islet cell adenoma, and adenomatosis in infants and children. In infants and children oral diazoxide may be used preoperatively as a temporary measure, and postoperatively, if hypoglycemia persists. Diazoxide may also be used parentally or intravenously to treat hypertensive emergencies.
diazoxon	962-58-3	Diazoxon	962-58-3	9FX08D2L1U			
DIBA-1		2,2'-Dithiobis-(N-(4-sulfamoylphenyl)-benzamide)	171744-39-1	K7254LUC92			
dibefurin		Dibefurin					
Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide	19395-87-0	N'-acetyl-3-chloro-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide	19395-87-0		Prostaglandin Antagonists	Compounds that inhibit the action of prostaglandins. (See all compounds classified as Prostaglandin Antagonists.)	
dibenz(c,h)acridine	224-53-3	Dibenz[c,h]acridine	224-53-3	5L5784WI2U			
dibenzacridine	224-42-0	Dibenz[a,j]acridine	224-42-0	088X9K64S8	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Dibenzazepines		Dibenzazepines					
dibenzheptropine	604-51-3	Dibenzheptropine	604-51-3	AY31301GKG	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	
dibenzo(1,4)dioxin	262-12-4	Dibenzo-P-dioxin	262-12-4	O1B5KJ235I			
dibenzo(a,e)pyrene	192-65-4	Dibenzo[a,e]pyrene	192-65-4	SAC8PEK62H			
dibenzo(a,h)pyrene	189-64-0	Dibenzo(A,H)pyrene	189-64-0	XR5R3V8BJK			
dibenzo(a,i)pyrene	189-55-9	Dibenzo(A,I)pyrene	189-55-9	7FMI112D18			
dibenzo(a,l)pyrene	191-30-0	Dibenzo[a,l]pyrene	191-30-0	G3X629VE4A	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
dibenzo(a,l)pyrene 11,12-dihydrodiol	88191-01-9	Dibenzo(a,l)pyrene-11,12-dihydrodiol	88191-01-9				
dibenzo(a,l)pyrene diol epoxide		Dibenzo[A,L]Pyrene Diol Epoxide					
dibenzo(aj)anthracene	224-41-9	Dibenz[a,j]anthracene	224-41-9	M477C74UCX			
dibenzoanthracene-1,2-dihydrodiol	1421-82-5	1,2-Dihydrobenzo[k]tetraphene-1,2-diol	1421-82-5				
dibenzoanthracene-3,4-dihydrodiol	1421-83-6	3,4-Dihydrodibenz(a,h)anthracene-3,4-diol	1421-83-6				
dibenzofuran	132-64-9	Dibenzofuran	132-64-9	8U54U639VI			
Dibenzofurans		Dibenzofuran	132-64-9	8U54U639VI			
Dibenzofurans, Polychlorinated		Dibenzofurans, Polychlorinated					
dibenzothiazyl disulfide	120-78-5	2,2'-Dithiobisbenzothiazole	120-78-5	6OK753033Z			2,2'-Dibenzothiazyl disulfide is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.
dibenzothiophene	132-65-0	Dibenzothiophene	132-65-0	Z3D4AJ1R48			
Dibenzoxazepines		Dibenzoxazepines					
dibenzoylmethane	120-46-7	Dibenzoylmethane	120-46-7	ANS7ME8OKC			
dibenzyl trisulfide		Benzyl trisulfide	6493-73-8	C8U5BEF9RN			
dibenzylfluorescein		O-Benzylfluorescein benzyl ester	97744-44-0				
dibromoacetic acid		Dibromoacetic acid	631-64-1	7FUW62YY5L	Alkylating Agents	Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)	
dibromoacetonitrile	3252-43-5	Dibromoacetonitrile	3252-43-5	VGJ91H57XU			
dibromodiphenyl ether		2,3-Dibromodiphenyl ether	53563-56-7	L921VU5R3L			
dibromosulphthalein	17199-35-8	Dibromosulphthalein	17199-35-8				
Dibucaine	85-79-0	Dibucaine	85-79-0	L6JW2TJG99	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.
dibutyl maleate	105-76-0	Dibutyl maleate	105-76-0	4X371TMK9K			
Dibutyl Phthalate	84-74-2	Dibutyl Phthalate	84-74-2	2286E5R2KE	Plasticizers	Materials incorporated mechanically in plastics (usually PVC) to increase flexibility, workability or distensibility; due to the non-chemical inclusion, plasticizers leach out from the plastic and are found in body fluids and the general environment. (See all compounds classified as Plasticizers.)	
dibutyldi(4-chlorobenzohydroxamato)tin(IV)		dibutyldi(4-chlorobenzohydroxamato)tin(IV)					
dibutyldichlorotin	683-18-1	Dibutyltin dichloride	683-18-1	J4AQN88R8P	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	
dibutylnitrosamine	924-16-3	N-Nitrosodibutylamine	924-16-3	8K8942WN31	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Dibutyryl Cyclic GMP	32266-35-6	CID 135488018	32266-35-6				
dibutyrylglycerol	32648-01-4	Butanoic acid, diester with 1,2,3-propanetriol	17364-00-0				
Dicamba	1918-00-9	Dicamba	1918-00-9	SJG3M6RY6H	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Dicarbethoxydihydrocollidine	632-93-9	3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,4,6-trimethyl-, diethyl ester	632-93-9				
dicarbine	17411-19-7	Dicarbine	17411-19-7	Y0EA50IJ3V	Antimutagenic Agents	Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved. (See all compounds classified as Antimutagenic Agents.)	
Dicarboxylic Acids		Dicarboxylic Acids					
dichlobanil	1194-65-6	2,6-Dichlorobenzonitrile	1194-65-6	N42NR4196R	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
dichlofenthion	97-17-6	Dichlofenthion	97-17-6	64234GT8TT			
dichlone	117-80-6	Dichlone	117-80-6	C28BKZ2J9A			
dichlorfop-methyl	51338-27-3	Diclofop-methyl	51338-27-3	9T8QCB25UO			
dichlorido-zinc(II)-4-(2-(5-methoxybenzylideneamino)ethyl)piperazin-1-iumphenolate		dichlorido-zinc(II)-4-(2-(5-methoxybenzylideneamino)ethyl)piperazin-1-iumphenolate					
dichloridobis(3-imino-2-ethoxyflavanone)ruthenium(II)		dichloridobis(3-imino-2-ethoxyflavanone)ruthenium(II)					
dichloridobis(3-imino-2-methoxyflavanone)ruthenium(II)		dichloridobis(3-imino-2-methoxyflavanone)ruthenium(II)					
dichloro(4-cymene)ruthenium(II)		dichloro(4-cymene)ruthenium(II)					
Dichloroacetic Acid	79-43-6	Dichloroacetic acid	79-43-6	9LSH52S3LQ			
dichloroacetonitrile	3018-12-0	Dichloroacetonitrile	3018-12-0	O0L64V63M9			
dichloroallyl lawsone	36417-16-0	Dichloroallyl lawsone	36417-16-0	ZE2BI297KA			
Dichlorodiphenyl Dichloroethylene	72-55-9	p,p'-DDE	72-55-9	4M7FS82U08	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Dichlorodiphenyldichloroethane	72-54-8	p,p'-DDD	72-54-8	V14159DF29	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Dichloroethylenes		Dichloroethylenes					
Dichlorophen	97-23-4	Dichlorophene	97-23-4	T1J0JOU64O	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
Dichlororibofuranosylbenzimidazole	53-85-0	Dichlororibofuranosylbenzimidazole	53-85-0	8153319T3Q	Nucleic Acid Synthesis Inhibitors	Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)	
Dichlorphenamide	120-97-8	Dichlorphenamide	120-97-8	VVJ6673MHY	Carbonic Anhydrase Inhibitors	A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES. (See all compounds classified as Carbonic Anhydrase Inhibitors.)	For adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure
Dichlorvos	62-73-7	Dichlorvos	62-73-7	7U370BPS14	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	
dichlozolinate		Chlozolinate	84332-86-5	6YW05QFN1Y			
dicholesteroyl diselenide		dicholesteroyl diselenide					
Diclofenac	15307-86-5	Diclofenac	15307-86-5	144O8QL0L1	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Diclofenac is indicated for use in the treatment of pain and inflammation from varying sources including inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as injury-related inflammation due to surgery and physical trauma. It is often used in combination with [misoprostol] as a gastro-protective agent in patients with high risk of developing NSAID-induced ulcers.
diclofensine	67165-56-4	Diclofensine	67165-56-4	09HKW863J6			
dicloran		2,6-Dichloro-4-nitroaniline	99-30-9	F0BE9UC5J7			
diclosulam	145701-21-9	Diclosulam	145701-21-9	6X5DO0I08Z			
Dicloxacillin	3116-76-5	Dicloxacillin	3116-76-5	COF19H7WBK	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Used to treat infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug.
Dicofol	115-32-2	Dicofol	115-32-2	W4WMM0WS91	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
dicrotophos	3735-78-2	3-Hydroxy-N,N-dimethylcrotonamide dimethyl phosphate	3735-78-2				
dictamnine	484-29-7	Dictamnine	484-29-7	HQZ3798D0A			
Dicumarol	66-76-2	Dicumarol	66-76-2	7QID3E7BG7	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	For decreasing blood clotting. Often used along with heparin for treatment of deep vein thrombosis.
dicumyl peroxide	80-43-3	Dicumyl peroxide	80-43-3	M51X2J0U9D			
dicyanocobinamide		27792-36-5					
dicyclanil		Dicyclanil	112636-83-6	DBC8O809S5	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
dicyclohexyl phthalate	84-61-7	Dicyclohexyl phthalate	84-61-7	CGD15M7H2N			
Dicyclohexylcarbodiimide	538-75-0	Dicyclohexylcarbodiimide	538-75-0	0T1427205E			
Dicyclomine	77-19-0	Dicyclomine	77-19-0	4KV4X8IF6V	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	Dicyclomine is indicated for the treatment of functional bowel disorder and irritable bowel syndrome.
Didanosine	69655-05-6	Didanosine	69655-05-6	K3GDH6OH08	Anti-HIV Agents	Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)	For use, in combination with other antiretroviral agents, in the treatment of HIV-1 infection in adults.
didecyl phthalate	84-77-5	Didecyl phthalate	84-77-5	FI5FBN947Z			
didecyldimethylammonium	20256-56-8	Didecyldimonium	20256-56-8	Z7F472XQPA			
didemnins		Didemnin A	77327-04-9	4LSZ9C5HOB	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
Dideoxyadenosine	4097-22-7	2',3'-Dideoxyadenosine	4097-22-7	4Q86AH641A	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	
dideoxypetrosynol A		dideoxypetrosynol A	206554-64-5				
didymin		Didymin	14259-47-3	02Q5OS3TU3			
dieckol		Dieckol	88095-77-6	ZU0ESU4399			
Dieldrin	60-57-1	Dieldrin	60-57-1	I0246D2ZS0			
Dienestrol	84-17-3	Dienestrol	84-17-3	RRW32X4U1F	Estrogens, Non-Steroidal	Non-steroidal compounds with estrogenic activity. (See all compounds classified as Estrogens, Non-Steroidal.)	For use in the treatment of atrophic vaginitis and kraurosis vulvae.
dienochlor	2227-17-0	Dienochlor	2227-17-0	243Z2SVZ40			
dienogest		Dienogest	65928-58-7	46M3EV8HHE	Contraceptive Agents, Male	Chemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading. (See all compounds classified as Contraceptive Agents, Male.)	Indicated for use as the treatment of endometriosis alone and as a contraceptive in combination with ethinylestradiol.
diepoxybutane		2,2'-Bioxirane	298-18-0		Cross-Linking Reagents	Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)	
Dietary Carbohydrates		Dietary Carbohydrates					
Dietary Fats		Dietary Fats					
Dietary Fats, Unsaturated		Dietary Fats, Unsaturated					
Dietary Sucrose		Dietary Sucrose					
Dietary Sugars		Dietary Sugars					
diethanolamine	111-42-2	Diethanolamine	111-42-2	AZE05TDV2V			
diethofencarb	87130-20-9	Diethofencarb	87130-20-9	421BLT77U4			
diethoxyphosphoryloxymethyl butanoate		Butanoic acid, [(diethoxyphosphinyl)oxy]methyl ester	213262-83-0				
diethyl 2-((3-dimethylcarbamoyl-4-((4'-trifluoromethylbiphenyl-2-carbonyl)amino)phenyl)acetyloxymethyl)-2-phenylmalonate		Granotapide	594842-13-4	PSZ2YGB0DK			
diethyl fumarate	623-91-6	Diethyl fumarate	623-91-6	5WBU5A3E8A			
diethyl malate	7554-12-3	Diethyl malate	7554-12-3	59W97T99HI			
diethyl maleate	141-05-9	Diethyl maleate	141-05-9	G81WQB56OL			
diethyl malonate	105-53-3	Diethyl malonate	105-53-3	53A58PA183			
diethyl phosphate	598-02-7	Diethyl hydrogen phosphate	598-02-7	W0QQU4CAB7			
diethyl phthalate	84-66-2	Diethyl Phthalate	84-66-2	UF064M00AF			
Diethyl Pyrocarbonate	1609-47-8	Diethyl pyrocarbonate	1609-47-8	LMR3LZG146			
diethyl sulfate	64-67-5	Diethyl sulfate	64-67-5	K0FO4VFA7I	Alkylating Agents	Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)	
diethyl-1,3,6,8-tetrahydro-1,3,6,8-tetraoxobenzo(lmn)(3,8)phenanthroline-2,7-diacetate		diethyl-1,3,6,8-tetrahydro-1,3,6,8-tetraoxobenzo(lmn)(3,8)phenanthroline-2,7-diacetate					
diethylamine	109-89-7	Diethylamine	109-89-7	B035PIS86W			
diethylamine dinitric oxide adduct	92818-79-6	Deano	92818-79-6		Nitric Oxide Donors	A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)	
Diethylcarbamazine	90-89-1	Diethylcarbamazine	90-89-1	V867Q8X3ZD	Lipoxygenase Inhibitors	Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)	Used for the treatment of certain filarial diseases, including tropical pulmonary eosinophilia, loiasis, and lymphatic filariasis caused by infection with Wuchereria bancrofti, Brugia malayi, or Brugia timori.
diethylene glycol	111-46-6	Diethylene glycol	111-46-6	61BR964293			
diethylene glycol dibenzoate		Diethylene glycol dibenzoate	120-55-8	YAI66YDY1C			
diethylene glycol dimethacrylate monomer	2358-84-1	Diethylene glycol dimethacrylate	2358-84-1	R42PUI926F			
diethylenetriamine	111-40-0	Diethylenetriamine	111-40-0	03K6SX4V2J	Nitric Oxide Donors	A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)	
diethylglyoxime	4437-52-9	Diethylglyoxime	4437-52-9				
Diethylhexyl Phthalate	117-81-7	Bis(2-ethylhexyl) phthalate	117-81-7	C42K0PH13C	Plasticizers	Materials incorporated mechanically in plastics (usually PVC) to increase flexibility, workability or distensibility; due to the non-chemical inclusion, plasticizers leach out from the plastic and are found in body fluids and the general environment. (See all compounds classified as Plasticizers.)	
Diethylnitrosamine	55-18-5	N-Nitrosodiethylamine	55-18-5	3IQ78TTX1A	Alkylating Agents	Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)	
Diethylstilbestrol	56-53-1	Diethylstilbestrol	56-53-1	731DCA35BT	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	Used in the treatment of prostate cancer. Previously used in the prevention of miscarriage or premature delivery in pregnant women prone to miscarriage or premature delivery.
diethylstilbestrol monophosphate	47341-71-9	Diethylstilbestrol monophosphate	47341-71-9				
diethylthiourea	26914-14-7	diethylthiourea					
difenacoum	56073-07-5	Difenacoum	56073-07-5	SBA3K9U26B	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	
difenoconazole		Difenoconazole	119446-68-3	D9612XCH4P	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
difenzoquat	49866-87-7	Difenzoquat	49866-87-7	54NE792QN5			
diferuloylputrescine		Bis-ferulamidobutane	42369-86-8	576NVQ5724			
difethialone	104653-34-1	Difethialone	104653-34-1				
diffractaic acid	436-32-8	Diffractaic acid	436-32-8	PD86RC383X			
diflorasone		Diflorasone	2557-49-5	T2DHJ9645W	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	For relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
difloxacin	98106-17-3	Difloxacin	98106-17-3	5Z7OO9FNFD			Chickens: for the treatment of chronic respiratory infections caused by sensitive strains of Escherichia coli and Mycoplasma gallisepticum. Turkeys: For the treatment of chronic respiratory infections caused by sensitive strains of Escherichia coli and Mycoplasma gallisepticum. Also for the treatment of infections caused by Pasteurella multocida. Dogs: For the treatment of acute uncomplicated urinary-tract infections caused by Escherichia coli or Staphylococcus spp. and superficial pyoderma caused by Staphylococcus intermedius. Cattle: For the treatment of bovine respiratory disease (shipping fever, calf pneumonia) caused by single or mixed infections with Pasteurella haemolytica, Pasteurella multocida and / or Mycoplasma spp.
Diflubenzuron	35367-38-5	Diflubenzuron	35367-38-5	J76U6ZSI8D			
diflufenican	83164-33-4	Diflufenican	83164-33-4	3T8D1VDO6K			
Diflunisal	22494-42-4	Diflunisal	22494-42-4	7C546U4DEN	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	For symptomatic treatment of mild to moderate pain accompanied by inflammation (e.g. musculoskeletal trauma, post-dental extraction, post-episiotomy), osteoarthritis, and rheumatoid arthritis.
difluoroacetic acid	381-73-7	Difluoroacetic acid	381-73-7	ZQK1C95K3N			
difructose anhydride III	81129-73-9	Difructose anhydride III	81129-73-9				
diftalone	21626-89-1	Diftalone	21626-89-1	142FG4G74X			
digallic acid	536-08-3	Digallic acid	536-08-3	404KO0584X	Nucleic Acid Synthesis Inhibitors	Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)	
digalloylresveratrol		Digalloylresveratrol					
digeranyl bisphosphonate		Digeranyl bisphosphonate					
Digitonin	11024-24-1	Digitonin	11024-24-1	KOO5CM684H	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
Digitoxigenin	143-62-4	Digitoxigenin	143-62-4	S63WOD4VOL			
Digitoxin	71-63-6	Digitoxin	71-63-6	E90NZP2L9U	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	For the treatment and management of congestive cardiac insufficiency, arrhythmias and heart failure.
Diglycerides		Diglycerides					
diglycolic acid		Diglycolic acid	110-99-6	S4651635E0			
diglycyl-histidine	7451-76-5	Diglycyl-histidine					
Digoxigenin	1672-46-4	Digoxigenin	1672-46-4	NQ1SX9LNAU			
Digoxin	20830-75-5	Digoxin	20830-75-5	73K4184T59	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	Digoxin is indicated in the following conditions: 1) For the treatment of mild to moderate heart failure in adult patients. 2) To increase myocardial contraction in children diagnosed with heart failure. 3) To maintain control ventricular rate in adult patients diagnosed with chronic atrial fibrillation.  In adults with heart failure, when it is clinically possible, digoxin should be administered in conjunction with a diuretic and an angiotensin-converting enzyme (ACE) inhibitor for optimum effects.
digoxin-like factors		digoxin-like factors					
diguanosine tetraphosphate	4130-19-2	Diguanosine tetraphosphate	4130-19-2				
Dihematoporphyrin Ether	97067-70-4	Dihematoporphyrin Ether					
diheptyl phthalate	3648-21-3	Diheptyl phthalate	68515-44-6	IE05VO8P8P			
Dihydralazine	484-23-1	Dihydralazine	484-23-1	PCU411F5L6	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
dihydrexidine	123039-93-0	Dihydrexidine	123039-93-0	32D64VH037	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
Dihydro-beta-Erythroidine	23255-54-1	Dihydro-beta-erythroidine	23255-54-1	RBN56W7U63			
dihydroactinidiolide	17092-92-1	Dihydroactinidiolide	17092-92-1	O3M4862R3R			
Dihydroalprenolol	60106-89-0	Dihydroalprenolol	60106-89-0	2ZT5710I4T	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	
dihydrocapsaicin	19408-84-5	Dihydrocapsaicin	19408-84-5	W9BV32M08A			
dihydroceramide		Dihydroceramide					
dihydrocytochalasin B	39156-67-7	dihydrocytochalasin B	39156-67-7	L9RT18CY85			
dihydroequilin	651-55-8	Estra-1,3,5(10),7-tetraene-3,17alpha-diol	651-55-8	48P73794OJ			
Dihydroergotamine	511-12-6	Dihydroergotamine	511-12-6	436O5HM03C	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	Dihydroergotamine (DHE) in all formulations is indicated for the acute treatment of migraine with or without aura in adults. As an injection, DHE is also indicated for the acute treatment of cluster headache episodes.  DHE is not indicated for migraine prevention or the management of hemiplegic or basilar migraine.
dihydroethidine		dihydroethidine					
dihydroethidium	104821-25-2	Dihydroethidium	104821-25-2				
dihydrofluorescein		dihydrofluorescein					
dihydrofolate	4033-27-6	Dihydrofolic acid	4033-27-6	KXP0KNM559			
dihydroguaiaretic acid	36469-60-0	Dihydroguaiaretic acid	36469-60-0				
dihydroisotanshinone I	20958-18-3	Phenanthro[3,2-b]furan-7,11-dione, 8,9-dihydro-4,8-dimethyl-	20958-18-3				
dihydrokainic acid	52497-36-6	Dihydrokainic acid	52497-36-6	MQ4LMC2HN5			
dihydrokavain	587-63-3	Dihydrokawain	587-63-3	NW8ZGW9XRZ			
dihydrokawain		Dihydrokawain	587-63-3	NW8ZGW9XRZ			
dihydrolipoamide	3884-47-7	Dihydrolipoamide	3884-47-7	8RF8AN4JFL			
dihydrolipoic acid	462-20-4	Dihydrolipoic acid	462-20-4	7NV2KHU5JA	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
dihydromyricetin		Dihydromyricetin	27200-12-0	KD8QND6427			
dihydroouabain	1183-35-3	Dihydroouabain	1183-35-3				
dihydroptychantol A		dihydroptychantol A					
dihydroresveratrol		Dihydroresveratrol	58436-28-5	CBY43AY0TT			
dihydrosanguinarine		Dihydrosanguinarine	3606-45-9	3H1ZKG80F7			
dihydrosphingosine 1-phosphate	19794-97-9	Sphinganine 1-phosphate	19794-97-9				
Dihydrostreptomycin Sulfate	5490-27-7	Dihydrostreptomycin Sulfate	5490-27-7	T7D4876IUE	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
dihydrotanshinone I		Dihydrotanshinone I	87205-99-0	562G9360V6			
Dihydrotestosterone	521-18-6	Androstanolone	521-18-6	08J2K08A3Y	Androgens	Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. (See all compounds classified as Androgens.)	
dihydrotetrabenazine	3466-75-9	Dihydrotetrabenazine	3466-75-9				
dihydroxy-vitamin D3		Calcitriol	32222-06-3	FXC9231JVH	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis.
Dihydroxyacetone	96-26-4	Dihydroxyacetone	96-26-4	O10DDW6JOO			
Dihydroxyacetone Phosphate	57-04-5	Dihydroxyacetone phosphate	57-04-5	T7KF2T6W95			
dihydroxyaluminum aminoacetate	13682-92-3	Dihydroxyaluminium glycinate	13682-92-3				
Dihydroxydihydrobenzopyrenes		Dihydroxydihydrobenzopyrenes					
dihydroxyethyldithiocarbamate	1528-72-9	Dihydroxyethyldithiocarbamate	1528-72-9	IP73T3KT1R	Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	
dihydroxyfumarate	133-38-0	Dihydroxyfumaric acid	133-38-0				
Dihydroxyphenylalanine	63-84-3	DL-Dopa	63-84-3	QI9C343R60	Dopamine Agents	Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. (See all compounds classified as Dopamine Agents.)	
diinosine pentaphosphate		Diinosine Pentaphosphate					
Diiodothyronines		Diiodothyronines					
diisobutyl phthalate	84-69-5	Diisobutyl phthalate	84-69-5	IZ67FTN290			
diisodecyl phthalate	26761-40-0	Diisodecyl phthalate	26761-40-0	WF93T741QI			
diisononyl 1,2-cyclohexanedicarboxylic acid		diisononyl 1,2-cyclohexanedicarboxylic acid					
diisononyl phthalate	28553-12-0	Diisononyl phthalate	68515-48-0	4010KIX4CK			
diisopropanolnitrosamine		N-Nitrosobis(2-hydroxypropyl)amine	53609-64-6	4J072HB2ND	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
diisopropyl 1,3-dithiol-2-ylidenemalonate	59937-28-9	Malotilate	59937-28-9	RV59PND975			
diisopropylnitrosamine	601-77-4	N-Nitrosodiisopropylamine	601-77-4	AFI1E104OF			
Diketopiperazines		CID11694412					
Dilazep	35898-87-4	Dilazep	35898-87-4	F8KLC2BD5Z	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
Diltiazem	42399-41-7	Diltiazem	42399-41-7	EE92BBP03H	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	**Oral**  Indicated for the management of hypertension, to lower blood pressure, alone or in combination with other antihypertensive agents.  Indicated for use to improve exercise tolerance in patients with chronic stable angina.  Indicated for the management of variant angina (Prinzmetal's angina).  **Intravenous**  Indicated for the short-term management of atrial fibrillation or atrial flutter for temporary control of rapid ventricular rate.  Indicated for the rapid conversion of paroxysmal supraventricular tachycardias (PSVT) to sinus rhythm. This includes AV nodal reentrant tachycardias and reciprocating tachycardias associated with an extranodal accessory pathway such as the WPW syndrome or short PR syndrome.  **Off-label**  Indicated for off-label uses in anal fissures (as topical formulation), migraine prophylaxis, cramps in lower leg related to rest, pulmonary hypertension, idiopathic dilated cardiomyopathy, and proteinuria associated with diabetic nephropathy.
Dimaprit	65119-89-3	Dimaprit	65119-89-3	ZZQ699148P	Histamine Agonists	Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. (See all compounds classified as Histamine Agonists.)	
dimedone	126-81-8	5,5-Dimethyl-1,3-cyclohexanedione	126-81-8	B2B5DSX2FC			
dimefox	115-26-4	Dimefox	115-26-4	N8RU9F1IQD			
dimemorfan	36304-82-2	Dimemorfan	36309-01-0	623OAC38YU	Antitussive Agents	Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)	
Dimenhydrinate	523-87-5	Dimenhydrinate	523-87-5	JB937PER5C	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	Dimenhydrinate is indicated for the prevention and treatment of nausea, vomiting, or vertigo of motion sickness.
Dimercaprol	59-52-9	Dimercaprol	59-52-9	0CPP32S55X	Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	For the treatment of arsenic, gold and mercury poisoning. Indicated in acute lead poisoning when used concomitantly with edetate calcium disodium (DB00974).
dimerumic acid		Dimerum acid	26912-16-3				
dimethachlon		N-(3,5-Dichlorophenyl)succinimide	24096-53-5	4GNU6A4VQ6	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Dimethadione	695-53-4	Dimethadione	695-53-4	ALU9NPM703	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
dimethametryn	22936-75-0	Dimethametryn	22936-75-0	044DE9GA31			
Dimethindene	5636-83-9	Dimethindene	5636-83-9	661FH77Z3P	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	Indicated as symptomatic treatment of allergic reactions: urticaria, allergies of the upper respiratory tract such as hey fever and perennial rhinitis, food and drug allergies; pruritus of various origins, except pruritus due to cholestasis; insect bites. Dimethindene is also indicated for pruritus in eruptive skin diseases such as chicken-pox. Dimethindene can also be used as an adjuvant in eczema and other pruriginous dermatoses of allergic origin.
dimethisoquin	86-80-6	Dimethisoquin	86-80-6	772EN3BH6I	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	
Dimethoate	60-51-5	Dimethoate	60-51-5	W6U08B045O	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
dimethocaine	94-15-5	Dimethocaine	94-15-5	R3L4A6GOWZ	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	
dimethomorph	110488-70-5	(E)-Dimethomorph	113210-97-2	NU7EH56J7K	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
dimethoxon	1113-02-6	Omethoate	1113-02-6	28U28EWE79			
dimethoxy-4-indophenyl-2-aminopropane		dimethoxy-4-indophenyl-2-aminopropane					
dimethoxycurcumin		Dimethoxycurcumin	160096-59-3	D60XLY608D			
dimethoxyethyl phthalate	117-82-8	Bis(2-methoxyethyl) phthalate	117-82-8	68W8XUO221			
dimethyl 2,3,5,6-tetrachloroterephthalate	1861-32-1	Chlorthal-dimethyl	1861-32-1	ZU3X5G2QLR			
dimethyl 4-phthalate	120-61-6	Dimethyl terephthalate	120-61-6	IKZ2470UNV	Soil Pollutants	Substances which pollute the soil. Use for soil pollutants in general or for which there is no specific heading. (See all compounds classified as Soil Pollutants.)	
dimethyl alpha-ketoglutarate		Dimethyl 2-oxoglutarate	13192-04-6				
Dimethyl Fumarate		Dimethyl Fumarate	624-49-7	FO2303MNI2	Radiation-Sensitizing Agents	Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. (See all compounds classified as Radiation-Sensitizing Agents.)	Dimethyl fumarate is indicated for the treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
dimethyl lithospermate B		Dimethyl lithospermate B					
dimethyl maleate	624-48-6	Dimethyl maleate	624-48-6	K39366X5N0			
dimethyl mercaptosuccinate	17660-57-0	Dimethyl 2,3-bis(sulfanyl)butanedioate	17660-57-0				
dimethyl mercury	593-74-8	Dimethylmercury	593-74-8	C60TQU15XY			
dimethyl phosphate	813-78-5	Dimethyl hydrogen phosphate	813-78-5	HI4K2C9UEI			
dimethyl phthalate	131-11-3	Dimethyl Phthalate	131-11-3	08X7F5UDJM	Insect Repellents	Substances causing insects to turn away from them or reject them as food. (See all compounds classified as Insect Repellents.)	
dimethyl succinate	106-65-0	Dimethyl succinate	106-65-0	914I2127JR			
dimethyl sulfate	77-78-1	Dimethyl Sulfate	77-78-1	JW5CW40Z50	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
dimethyl sulfone	67-71-0	Dimethyl sulfone	67-71-0	9H4PO4Z4FT	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
Dimethyl Sulfoxide	67-68-5	Dimethyl Sulfoxide	67-68-5	YOW8V9698H	Cryoprotective Agents	Substances that provide protection against the harmful effects of freezing temperatures. (See all compounds classified as Cryoprotective Agents.)	For the symptomatic relief of patients with interstitial cystitis.
dimethyl-4-toluidine	99-97-8	N,N-Dimethyl-p-toluidine	99-97-8	S8XC5939VU			
dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate		dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate					
dimethyl-N-acetylmuramyl-alanylglutamate	60355-79-5	N-Acetylmuramyl-L-alanyl-D-glutamic acid dimethyl ester	60355-79-5				
dimethyl-W84		dimethyl-W84					
dimethylacetamide	127-19-5	N,N-Dimethylacetamide	127-19-5	JCV5VDB3HY	Cryoprotective Agents	Substances that provide protection against the harmful effects of freezing temperatures. (See all compounds classified as Cryoprotective Agents.)	
dimethyladipate	627-93-0	Dimethyl adipate	627-93-0	BY71RX0R62			
dimethylamine	124-40-3	Dimethylamine	124-40-3	ARQ8157E0Q			
Dimethylamines		Dimethylamines					
dimethylaminomicheliolide		Dimethylaminomicheliolide	1403357-81-2				
dimethylarsine	593-57-7	Arsine, dimethyl-	593-57-7				
dimethylarsinous acid		Dimethylarsinous acid	55094-22-9				
dimethyldioctadecylammonium	14357-21-2	Dimethyldioctadecylammonium	14357-21-2	251IW5I21C	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
Dimethyldithiocarbamate		Dimethyldithiocarbamate	137-30-4				
Dimethylformamide	68-12-2	N,N-Dimethylformamide	68-12-2	8696NH0Y2X			
dimethylglycine	1118-68-9	N,N-Dimethylglycine	1118-68-9	7797M4CPPA			
dimethylhistaprodifen		Dimethylhistaprodifen					
Dimethylhydrazines		Dimethylhydrazines	30260-66-3		Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
dimethylmonothioarsinic acid		dimethylmonothioarsinic acid					
Dimethylnitrosamine	62-75-9	N-Nitrosodimethylamine	62-75-9	M43H21IO8R			
dimethyloxallyl glycine		Dimethyloxalylglycine	89464-63-1				
Dimethylphenylpiperazinium Iodide	54-77-3	1,1-Dimethyl-4-phenylpiperazinium iodide	54-77-3	X95H7DRX99	Nicotinic Agonists	Drugs that bind to and activate nicotinic cholinergic receptors (RECEPTORS, NICOTINIC). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission. (See all compounds classified as Nicotinic Agonists.)	
dimethylselenide	593-79-3	Dimethyl selenide	593-79-3	YK0R6JKT6H			
dimethylstilbestrol	13366-36-4	Dimethylstilbestrol	552-80-7	30L22Q8N9M			
dimethylthioarsinic acid		Dimethylthioarsinic acid	754217-65-7				
dimetilan	644-64-4	Dimetilan	644-64-4	S53KQ82I35			
Diminazene	536-71-0	Diminazene	536-71-0	Y5G36EEA5Z	Trypanocidal Agents	Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. (See all compounds classified as Trypanocidal Agents.)	
diminazene aceturate	908-54-3	Diminazene aceturate	908-54-3	JI8SAD85NO	Trypanocidal Agents	Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. (See all compounds classified as Trypanocidal Agents.)	
dimyristoylphosphatidic acid	30170-00-4	Dimyristoylphosphatidic acid	30170-00-4				
dinaciclib		Dinaciclib	779353-01-4	4V8ECV0NBQ			
dinapsoline		Dinapsoline	679433-68-2	GZ9XC6C5P9			
diniconazole	76714-88-0	Diniconazole	83657-24-3	X82HVO1N83			
dinitramine	29091-05-2	Dinitramine	29091-05-2	XHQ6D15979			
dinitrobenzenesulfonic acid	12379-41-8	2,4-Dinitrobenzenesulfonic acid	89-02-1	3WF0U675G6			
Dinitrochlorobenzene		1-Chloro-2,4-dinitrobenzene	97-00-7	GE3IBT7BMN	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
Dinitrofluorobenzene	70-34-8	1-Fluoro-2,4-dinitrobenzene	70-34-8	D241E059U6			
dinitrophenyl-bovine serum albumin		dinitrophenyl-bovine serum albumin					
dinitrophenyl-human serum albumin conjugate		dinitrophenyl-human serum albumin conjugate					
dinitrophenylhydrazine		dinitrophenylhydrazine					
dinitrosyl iron complex	68586-27-6	Iron nitrosyl	68586-27-6				
dinocap	39300-45-3	39300-45-3					
dinonylphthalate	84-76-4	Dinonyl phthalate	84-76-4	90UCU78V8R			
dinophysistoxin 1		Dinophysistoxin 1	81720-10-7	4Q51CVY9O2			
dinophysistoxin 2		Dinophysistoxin 2	139933-46-3	RH78DHY1JZ			
Dinoprost	551-11-1	Dinoprost	551-11-1	B7IN85G1HY	Abortifacient Agents, Nonsteroidal	Non-steroidal chemical compounds with abortifacient activity. (See all compounds classified as Abortifacient Agents, Nonsteroidal.)	
Dinoprostone	363-24-6	Dinoprostone	363-24-6	K7Q1JQR04M	Oxytocics	Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) (See all compounds classified as Oxytocics.)	"For the termination of pregnancy during the second trimester (from the 12th through the 20th gestational week as calculated from the first day of the last normal menstrual period), as well as for evacuation of the uterine contents in the management of missed abortion or intrauterine fetal death up to 28 weeks of gestational age as calculated from the first day of the last normal menstrual period. Also used in the management of nonmetastatic gestational trophoblastic disease (benign hydatidiform mole). Other indications include improving the cervical inducibility (cervical ""ripening"") in pregnant women at or near term with a medical or obstetrical need for labor induction, and the management of postpartum hemorrhage."
dinoseb	88-85-7	Dinoseb	88-85-7	YD44ZEM22M	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
dinotefuran		Dinotefuran	165252-70-0	1W509710WF	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
dioctanoyl-phosphatidylinositol 4,5-bisphosphate		dioctanoyl-phosphatidylinositol 4,5-bisphosphate					
dioctanoylphosphatidic acid	102731-57-7	1,2-Dioctanoyl-sn-glycero-3-phosphate	102731-57-7	637NLP8R7J			
dioctyl adipate	103-23-1	Bis(2-ethylhexyl) adipate	103-23-1	MBY1SL921L			
Dioctyl Sulfosuccinic Acid	10041-19-7	Docusate	10041-19-7	M7P27195AG	Surface-Active Agents	Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)	Indicated for the treatment of constipation associated with dry, hard stools or opioid induced constipation. Though recently, pressure has been building to end the use of docusate over concerns of efficacy.
diofenolan		Diofenolan	63837-33-2	4809GWT7HE			
diolein	25637-84-7	Glyceryl dioleate	25637-84-7				
dioleoyl ethylene glycol	928-24-5	Ethylene glycol dioleate	9005-07-6	E10S5M8KE4			
dioleoylphosphatidic acid	14268-17-8	1,2-Dioleoyl-sn-glycero-3-phosphate	14268-17-8				
diosbulbin B	20086-06-0	Diosbulbin B					
dioscin	19057-60-4	Dioscin	19057-60-4	3B95U4OLWV			
dioscorealide B		Dioscorealide B					
Diosgenin	512-04-9	Diosgenin	512-04-9	K49P2K8WLX			
diosmetin	520-34-3	Diosmetin	520-34-3	TWZ37241OT			
Diosmin	520-27-4	Diosmin	520-27-4	7QM776WJ5N			Diosmin is used over-the-counter alone or with ingredients such as [hesperidin] and [diosmetin] to support vein and capillary function.
diosquinone	50886-69-6	Diosquinone	50886-69-6				
dioxinodehydroeckol		Dioxinodehydroeckol	639514-05-9	N5P71K0GE3			
Dioxins		Dioxins					
Dioxolanes		Dioxolanes					
dioxybenzone	131-53-3	Dioxybenzone	131-53-3	B762XZ551X			Indicated for use as an active sunscreen agent.
dipalmitin	26657-95-4	Dipalmitin	26657-95-4				
dipalmitoylphosphatidic acid	19698-29-4	2,3-Bis(palmitoyloxy)propyl dihydrogen phosphate	19698-29-4				
Dipeptides		Dipeptides					
diphenadione	82-66-6	Diphacinone	82-66-6	54CA01C6JX			
diphenamid	957-51-7	Diphenamid	957-51-7	6Z3R6EGA2B			
Diphenhydramine	58-73-1	Diphenhydramine	58-73-1	8GTS82S83M	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	Diphenhydramine is a first-generation histamine H1 receptor antagonist (H1 antihistamine) that is widely available as a non-prescription, over-the-counter (OTC) medication. As an OTC medication, diphenhydramine is typically formulated as tablets and creams indicated for use in treating sneezing, runny nose, itchy/watery eyes, itching of nose or throat, insomnia, pruritis, urticaria, insect bites/stings, allergic rashes, and nausea.  Additionally, when the use of oral diphenhydramine is impractical, there are also prescription-only formulations such as diphenhydramine injection products that are effective in adults and pediatric patients (other than premature infants and neonates) for: i) the amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after acute allergic reaction symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated; ii) the active treatment of motion sickness; and iii) use in parkinsonism when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents; mild cases of parkinsonism in other age groups, and in other cases of parkinsonism in combination with centrally acting anticholinergic agents.
diphenidol	972-02-1	Diphenidol	972-02-1	NQO8R319LY	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	For use in the prevention and symptomatic treatment of peripheral (labyrinthine) vertigo and associated nausea and vomiting that occur in such conditions as Meniere's disease and surgery of the middle and inner ear. Also for the control of nausea and vomiting associated with postoperative states, malignant neoplasms, labyrinthine disturbances, antineoplastic agent therapy, radiation sickness, and infectious diseases.
diphenolic acid		Diphenolic acid	126-00-1	2SIZ2CO5L3			
diphenoquinone	494-72-4	Diphenoquinone	494-72-4				
Diphenoxylate	915-30-0	Diphenoxylate	915-30-0	73312P173G	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	For as adjunctive therapy in the management of diarrhea
diphenyl disulfide	882-33-7	Diphenyl disulfide	882-33-7	7P54H519IJ			
diphenyl methyl phosphate	115-89-9	Diphenyl methyl phosphate	115-89-9	8RU4VED06P			
diphenyl phosphite		Diphenyl phosphite	4712-55-4	5144JS6XUM			
diphenylacetic acid	117-34-0	Diphenylacetic acid	117-34-0	658NCZ0NKO			
Diphenylamine	122-39-4	Diphenylamine	122-39-4	9N3CBB0BIQ			
diphenylarsinic acid		Diphenylarsinic acid	4656-80-8	TJ4E9CH5GH			
diphenylcarboxylate	93-99-2	Phenyl benzoate	93-99-2	B8A3WVZ590			
diphenylcresyl phosphate	26444-49-5	Phosphoric acid, 2-methylphenyl diphenyl ester	26444-49-5	4P1854YU14			
diphenylcyclopropenone	886-38-4	Diphenylcyclopropenone	886-38-4	I7G14NW5EC			
diphenyldiselenide	1666-13-3	Diphenyl diselenide	1666-13-3	9ATU3Z459Q			
diphenylditelluride		Diphenyl ditelluride	32294-60-3				
diphenyleneiodonium	244-54-2	Diphenyleneiodonium	244-54-2	6HJ411TU98	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
diphenylguanidine	102-06-7	1,3-Diphenylguanidine	102-06-7	6MRZ85RNHQ			Diphenylguanidine is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.
diphenyliodonium	10182-84-0	Diphenyliodonium	10182-84-0		Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
diphenylmethyl selenocyanate		Diphenylmethyl selenocyanate	27805-30-7				
diphenylpyraline	147-20-6	Diphenylpyraline	147-20-6	33361OE3AV			For use in the treatment of allergic rhinitis, hay fever, and allergic skin disorders.
diphenylthiourea	102-08-9	Thiocarbanilide	102-08-9	9YCB5VR86Z			
diphenyltin	1011-95-6	Diphenylstannane	1011-95-6				
diphenyltin chloride	1135-99-5	Diphenyltin dichloride	1135-99-5	0Y7MZ4K0DR			
diphlorethohydroxycarmalol		Diphlorethohydroxycarmalol	138529-04-1				
Diphosphates		Diphosphate	14000-31-8	X3SSV2V6L3			
Diphosphonates		Diphosphonates					
diphosphoric acid	2466-09-3	Pyrophosphoric acid	2466-09-3	4E862E7GRQ			
Diphtheria Toxin		DIPHTHERIA TOXIN					
diphtheria toxin fragment A		diphtheria toxin fragment A					
Diphtheria-Tetanus-acellular Pertussis Vaccines		Diphtheria-Tetanus-acellular Pertussis Vaccines					
dipicolinic acid	499-83-2	2,6-Pyridinedicarboxylic acid	499-83-2	UE81S5CQ0G	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
dipin	738-99-8	Dipin	738-99-8	L16KNK08VM	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	
dipotassium trioxohydroxytetrafluorotriborate		dipotassium trioxohydroxytetrafluorotriborate					
dipropyl sulfide	111-47-7	Dipropyl sulfide	111-47-7	Q6J7GNX8F9			
dipropylacetamide		Valpromide	2430-27-5	RUA6CWU76G	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
dipropylenetriamine-NONOate		N-[bis(3-aminopropyl)amino]-N-hydroxynitrous amide	146724-95-0				
Dipyridamole	58-32-2	Dipyridamole	58-32-2	64ALC7F90C	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	For as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement and also used in prevention of angina.
dipyrido(3,2-a-2',3'-c)phenazine		dipyrido(3,2-a-2',3'-c)phenazine					
Dipyrone		Dipyrone	68-89-3	VSU62Z74ON	Antipyretics	Drugs that are used to reduce body temperature in fever. (See all compounds classified as Antipyretics.)	
diquafosol		Diquafosol	59985-21-6	7828VC80FJ			
Diquat	2764-72-9	Diquat	85-00-7	A9A615U4MP	Defoliants, Chemical	Herbicides that remove leaves from trees and growing plants. They may be either organic or inorganic. Several of the more persistent types have been used in military operations and many are toxic. (From Hawley&apos;s Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Defoliants, Chemical.)	
direct black 3		Direct Black 3	6227-04-9	88C0AB64K7	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Direct Red 81	2610-11-9	Direct red 81	2610-11-9	7E49Q56PNB			
dironyl	37686-84-3	Terguride	37686-84-3	21OJT43Q88	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
discretamine	605-34-5	Scoulerine	6451-72-5				
Disinfectants		Disinfectants					
disitamab vedotin		Disitamab vedotin [INN]					
disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate	138908-40-4	Disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate	138908-40-4	CF9MRO9QWW	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	
disodium hexachloroplatinate	16923-58-3	Disodium hexachloroplatinate	16923-58-3				
disodium quercetin-7,4'-disulfate		disodium quercetin-7,4'-disulfate					
Disopyramide	3737-09-5	Disopyramide	3737-09-5	GFO928U8MQ	Voltage-Gated Sodium Channel Blockers	A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)	For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, ventricular pre-excitation and cardiac dysrhythmias. It is a Class Ia antiarrhythmic drug.
disparlure	35898-62-5	Disparlure	35898-62-5				
Disperse Blue 1		Disperse Blue 1	2475-45-8	2429NAZ8WH	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
Disperse Orange 3		Disperse orange 3	730-40-5	B7J3O076OT	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	Investigated for use/treatment in inflammatory disorders  such as rheumatoid arthritis, inflammatory bowel disease and psoriasis.
disprocynium 24	149578-82-5	1,1'-Diisopropyl-2,4'-cyanine	149578-82-5				
Disulfiram	97-77-8	Disulfiram	97-77-8	TR3MLJ1UAI	Acetaldehyde Dehydrogenase Inhibitors	Compounds that bind to and inhibit the enzymatic activity of acetaldehyde dehydrogenases. (See all compounds classified as Acetaldehyde Dehydrogenase Inhibitors.)	For the treatment and management of chronic alcoholism
Disulfoton	298-04-4	Disulfoton	298-04-4	3CY5EKL6MT	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
ditekiren		Ditekiren	103336-05-6	5355S3W1IS	Protease Inhibitors	Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)	
Diterpenes		Diterpenes					
Diterpenes, Clerodane		CID434062					
dithiane		1,2-Dithiane	505-20-4	C4KJF9QFR3			
dithianone	3347-22-6	Dithianon	3347-22-6	3ESS44NI1F			
Dithiazanine	7187-55-5	Dithiazanine	7187-55-5	5L7E7IY5EH	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	
Dithioerythritol	6892-68-8	Dithioerythritol	6892-68-8	R4SVL81GQI	Sulfhydryl Reagents	Chemical agents that react with SH groups. This is a chemically diverse group that is used for a variety of purposes. Among these are enzyme inhibition, enzyme reactivation or protection, and labelling. (See all compounds classified as Sulfhydryl Reagents.)	
dithiol	496-74-2	Toluene-3,4-dithiol	496-74-2	U89B11P7SC			
Dithionite	14844-07-6	Dithionite	14844-07-6	17Q56Y5LKH			
Dithionitrobenzoic Acid	69-78-3	5,5'-Dithiobis(2-nitrobenzoic acid)	69-78-3	9BZQ3U62JX	Sulfhydryl Reagents	Chemical agents that react with SH groups. This is a chemically diverse group that is used for a variety of purposes. Among these are enzyme inhibition, enzyme reactivation or protection, and labelling. (See all compounds classified as Sulfhydryl Reagents.)	
dithiopyr	97886-45-8	Dithiopyr	97886-45-8	2TXF17HAV1			
Dithiothreitol	3483-12-3	(2S,3S)-1,4-Dimercaptobutane-2,3-diol	3483-12-3				
Ditiocarb	147-84-2	Diethyldithiocarbamic acid	147-84-2	99Z2744345	Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	
Diuretics		Diuretics					
Diuron	330-54-1	Diuron	330-54-1	9I3SDS92WY	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
divinyl sulfone	77-77-0	Divinyl sulfone	77-77-0	5PFN71LP8M	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
Dizocilpine Maleate	77086-22-7	Dizocilpine maleate	77086-22-7	6LR8C1B66Q	Excitatory Amino Acid Antagonists	Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)	
DLBS 1425		DLBS 1425					
DLJ14 compound		DLJ14 compound					
Dmt-NMe-Ala-Aba-Gly-NH2		Dmt-NMe-Ala-Aba-Gly-NH2					
DNA-(2-amino-3-methylimidazo(4,5-f)quinoline) adduct		DNA-(2-amino-3-methylimidazo(4,5-f)quinoline) adduct					
Dobutamine	34368-04-2	Dobutamine	34368-04-2	3S12J47372	Adrenergic beta-1 Receptor Agonists	Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Agonists.)	Indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures.
Docetaxel		Docetaxel	114977-28-5	15H5577CQD	Tubulin Modulators	Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)	Docetaxel is indicated as a single agent for the treatment of locally advanced or metastatic breast cancer after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC. It is also indicated as a single agent for locally advanced or metastatic non-small cell lung cancer (NSCLC) after platinum therapy failure; and with cisplatin for unresectable, locally advanced or metastatic untreated NSCLC. For the treatment of metastatic castration-resistant prostate cancer, docetaxel is indicated with prednisone. Docetaxel is also indicated with cisplatin and fluorouracil for untreated, advanced gastric adenocarcinoma, including the gastroesophageal junction, and with cisplatin and fluorouracil for induction treatment of locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Docosahexaenoic Acids	25167-62-8	Docosa-2,4,6,8,10,12-hexaenoic acid	93470-46-3				
docosahexaenoyl lysophosphatidylcholine		docosahexaenoyl lysophosphatidylcholine					
docosapentaenoic acid	25448-00-4	Osbond acid	25182-74-5	7S686LQT6T			
dodecaborate	12008-78-5	Dodecaborate	12008-78-5				
dodecanedioic acid	693-23-2	Dodecanedioic acid	693-23-2	978YU42Q6I			
Dodecanol	112-53-8	Lauryl Alcohol	112-53-8	178A96NLP2			
dodecyl sulfate	151-41-7	Lauryl sulfate	151-41-7	DIQ16UC154	Surface-Active Agents	Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)	
dodecylamine	124-22-1	Dodecylamine	68155-27-1	YWY9OD6A2K	Surface-Active Agents	Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)	
dodecylbenzene	123-01-3	Dodecylbenzene	123-01-3	A2AX003680			
dodecylbenzenesulfonic acid	27176-87-0	2-Dodecylbenzenesulfonic acid	27176-87-0	QMO4A07H35			
dodecyltrimethylammonium	10182-91-9	Dodecyltrimethylammonium	10182-91-9	GT3793XV5S	Surface-Active Agents	Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)	
dofequidar	158681-49-3	4-(Diphenylacetyl)-alpha-((5-quinolinyloxy)methyl)-1-piperazineethanol (E)-2-butenedioate (2:3) (salt)	158681-49-3	3DM793MFSE	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
dofetilide	115256-11-6	Dofetilide	115256-11-6	R4Z9X1N2ND	Potassium Channel Blockers	A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS. (See all compounds classified as Potassium Channel Blockers.)	For the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [AF/AFl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm
dolasetron		Dolasetron	115956-12-2		Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	For the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy, including initial and repeat courses of chemotherapy. Also used for the prevention of postoperative nausea and vomiting. This drug can be used intravenously for the treatment of postoperative nausea and vomiting.
dolichol monophosphate	12698-55-4	Dolichyl phosphate	12698-55-4				
dolutegravir		Dolutegravir	1051375-16-6	DKO1W9H7M1	HIV Integrase Inhibitors	Inhibitors of HIV INTEGRASE, an enzyme required for integration of viral DNA into cellular DNA. (See all compounds classified as HIV Integrase Inhibitors.)	Dolutegravir is indicated in combination with other antiretroviral agents for the treatment of patients with HIV-1 infection that comply with the characteristics of being adults or children aged 12 years and older and present at least a weight of 40 kg. The FDA combination therapy approval of dolutegravir and [rilpivirine] is indicated for adults with HIV-1 infections whose virus is currently suppressed (< 50 copies/ml) on a stable regimen for at least six months, without history of treatment failure and no known substitutions associated to resistance to any of the two components of the therapy.  Dolutegravir is also available in combination with [lamivudine] and [abacavir] for the treatment of adult and pediatric patients with HIV-1 who weigh 10kg.
domiphen	538-71-6	Domiphen bromide	538-71-6	R4CY19YS7C			
domoic acid	14277-97-5	Domoic acid	14277-97-5	M02525818H	Neuromuscular Depolarizing Agents	Drugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarization of the motor end plate. These agents are primarily used as adjuvants in surgical anesthesia to cause skeletal muscle relaxation. (See all compounds classified as Neuromuscular Depolarizing Agents.)	
Domperidone	57808-66-9	Domperidone	57808-66-9	5587267Z69	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	For management of dyspepsia, heartburn, epigastric pain, nausea, and vomiting.
Donepezil	120011-70-3	Donepezil Hydrochloride	120011-70-3	3O2T2PJ89D	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
donitriptan	170911-68-9	Donitriptan hydrochloride	170911-68-9	XTD13T14MR			
DOPA melanin	63194-25-2	Dopa melanin					
dopachrome	3571-34-4	Dopachrome	3571-34-4	DWA58A6ZW7			
Dopamine	51-61-6	Dopamine	51-61-6	VTD58H1Z2X	Dopamine Agents	Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. (See all compounds classified as Dopamine Agents.)	For the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failure
Dopamine Agonists		Dopamine Agonists					
Dopamine Antagonists		Dopamine Antagonists					
dopamine quinone	50673-96-6	Dopamine quinone	50673-96-6	CF3WT5K23D			
dopexamine		Dopexamine	86197-47-9	398E7Z7JB5	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
doramapimod		Doramapimod	285983-48-4	HO1A8B3YVV			
doramectin	117704-25-3	Doramectin	117704-25-3	KGD7A54H5P	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	
dorsomorphin		Dorsomorphin	866405-64-3	10K52CIC1Z	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
dorzolamide	130693-82-2	Dorzolamide Hydrochloride	130693-82-2	QZO5366EW7	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
Dothiepin	113-53-1	Dothiepin	25627-38-7	CZ377VWX9P	Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	Indicated in the treatment of symptoms of depressive illness, especially where an anti-anxiety effect is required.
Doxapram	309-29-5	Doxapram	309-29-5	94F3830Q73	Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	For use as a temporary measure in hospitalized patients with acute respiratory insufficiency superimposed on chronic obstructive pulmonary disease.
Doxazosin	74191-85-8	Doxazosin	74191-85-8	NW1291F1W8	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	Doxazosin is indicated to treat the symptoms of benign prostatic hypertrophy, which may include urinary frequency, urgency, and nocturia, among other symptoms. In addition, doxazosin is indicated alone or in combination with various antihypertensive agents for the management of hypertension. Off-label uses of doxazosin include the treatment of pediatric hypertension and the treatment of ureteric calculi.
Doxepin	1668-19-5	Doxepin	1668-19-5	5ASJ6HUZ7D	Antidepressive Agents, Tricyclic	Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. (See all compounds classified as Antidepressive Agents, Tricyclic.)	Oral doxepin is approved for the following indications:  - Treatment of depression and/or anxiety. - Treatment of depression and/or anxiety associated with different conditions, including alcoholism, organic disease and manic-depressive disorders. - Treatment of psychotic depressive disorders with associated anxiety. - Treatment of involutional depression.  - Treatment of manic-depressive disorder. - Treatment of insomnia characterized by difficulties with sleep maintenance.  Topical doxepin is also approved for short-term (up to 8 days) management of moderate pruritus in adult patients with atopic dermatitis, pruritus or lichen simplex chronicus.  Off-label, doxepin is used topically for the management of neuropathic pain.  Depression is a common medical illness that causes feelings of sadness and or loss of interest in prior enjoyable activities. This condition can lead to emotional and physical disturbances that can decrease the ability of a person to function in a regular environment.  Anxiety is a normal reaction of the body towards a normal danger. When the anxious state is exacerbated or appears on situations without danger, it is defined as an anxiety disorder. This disorders can appear in different forms such as phobias, panic, obsessive-compulsive disorder and post-traumatic stress disorder.  Insomnia is a sleep disorder that directly affects the quality of life of the individual. It is characterized by the complication either to fall asleep or to stay asleep. This condition can be occasional or chronic.  Pruritus is defined as an unpleasant skin reaction that provokes the urge to scratch. It can be localized or generalized and it can appear in an acute or chronic manner.  Neuropathic pain occurs due to the damage or dysfunction of the peripheral or central nervous system rather than stimulation of the pain receptors.
doxifluridine	3094-09-5	Doxifluridine	3094-09-5	V1JK16Y2JP	Appetite Stimulants	Agents that are used to stimulate appetite. These drugs are frequently used to treat anorexia associated with cancer and AIDS. (See all compounds classified as Appetite Stimulants.)	
Doxorubicin	23214-92-8	Doxorubicin	23214-92-8	80168379AG	Topoisomerase II Inhibitors	Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)	Doxorubicin is indicated for the treatment of neoplastic conditions like acute lymphoblastic leukemia, acute myeloblastic leukemia, Hodgkin and non-Hodgkin lymphoma, metastatic breast cancer, metastatic Wilms tumor, metastatic neuroblastoma, metastatic soft tissue and bone sarcomas, metastatic ovarian carcinoma, metastatic transitional cell bladder carcinoma, metastatic thyroid carcinoma, metastatic gastric carcinoma, and metastatic bronchogenic carcinoma. Doxorubicin is also indicated for use as a component of adjuvant therapy in women with evidence of axillary lymph node involvement following resection of primary breast cancer. For the liposomal formulation, doxorubicin is indicated for the treatment of ovarian cancer that has progressed or recurred after platinum-based chemotherapy, AIDS-Related Kaposi's Sarcoma after the failure of prior systemic chemotherapy or intolerance to such therapy, and multiple myeloma in combination with bortezomib in patients who have not previously received bortezomib and have received at least one prior therapy.
doxorubicin-transferrin conjugate		doxorubicin-transferrin conjugate					
doxorubicin(6-maleimidocaproyl)hydrazone	151038-96-9	Aldoxorubicin	1361644-26-9	C28MV4IM0B			Investigated for use/treatment in solid tumors.
Doxycycline	564-25-0	Doxycycline	564-25-0	334895S862	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Doxycycline is indicated for the treatment of various infections by gram-positive and gram-negative bacteria, aerobes and anaerobes, as well other types of bacteria, including:  - Early Lyme disease (as evidenced by erythema migraines) due to _Borrelia burgdorferi_ in adults and pediatric patients 8 years of age and older weighing 45 kg and above - Rickettsial infections, such as Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers - Sexually transmitted infections - Respiratory tract infections caused by _Mycoplasma pneumoniae_ and _Haemophilus influenzae_ - Specific bacterial infections after indicative bacteriologic testing. These include infections caused by _Escherichia coli_, _Enterobacter aerogenes_, _Shigella_ species, _Acinetobacter_ species, and _Klebsiella_ species - Ophthalmic infections, such as inclusion conjunctivitis caused by _Chlamydia trachomatis_ - Anthrax, including inhalational anthrax (post-exposure) - Alternative treatment for selected infections when [penicillin] is contraindicated - Adjunctive therapy in acute intestinal amebiasis and severe acne - Lymphogranuloma venereum caused by _Chlamydia trachomatis_ - Psittacosis (ornithosis) caused by _Chlamydophila psittaci_ - Trachoma caused by _Chlamydia trachomatis_, although the infectious agent is not always eliminated, as judged by immunofluorescence - Uncomplicated urethral, endocervical, or rectal infections in adults caused by _Chlamydia trachomatis_ - Nongonococcal urethritis caused by _Ureaplasma urealyticum_ - Relapsing fever due to _Borrelia recurrentis_ - Prophylaxis of malaria due to _Plasmodium falciparum_ in short-term travelers (<4 months) to areas with chloroquine and/or pyrimethamine-sulfadoxine resistant strains  It is also used to treat infections caused by the following gram-negative microorganisms:  - Chancroid caused by _Haemophilus ducreyi_ - Plague due to _Yersinia pestis_ - Tularemia due to _Francisella tularensis_ - Cholera caused by _Vibrio cholerae_ - Campylobacter fetus infections caused by _Campylobacter fetus_ - Brucellosis due to _Brucella_ species (in conjunction with [streptomycin]) - Bartonellosis due to _Bartonella bacilliformis_ - Granuloma inguinale caused by _Klebsiella granulomatis_
Doxylamine	469-21-6	Doxylamine	469-21-6	95QB77JKPL	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	Used alone as a short-term sleep aid, in combination with other drugs as a night-time cold and allergy relief drug. Also used in combination with Vitamin B6 (pyridoxine) to prevent morning sickness in pregnant women.
doxylamine succinate	562-10-7	Doxylamine Succinate	562-10-7	V9BI9B5YI2	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	
DP 155		DP 155					
dracorhodin	643-56-1	Dracorhodin	643-56-1	C4TSX5M53X			
draflazine		Draflazine	120770-34-5	0Y25DT968Y	Cardiotonic Agents	Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)	
dragon's blood		Dragon's blood					
DRF 2519		5-[[4-[2-(4-oxo-2H-1,3-benzoxazin-3-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione					
drimenol		Drimenol	468-68-8				
Drinking Water		Drinking Water					
droloxifene		Droloxifene	82413-20-5	0M67U6Z98F	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
Dronabinol		Dronabinol	1972-08-3	7J8897W37S	Hallucinogens	Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. (See all compounds classified as Hallucinogens.)	Dronabinol is indicated for the treatment of anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
Dronedarone		Dronedarone	141626-36-0	JQZ1L091Y2	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	Dronedarone is indicated for the management of atrial fibrillation (AF) in patients in sinus rhythm with a history of paroxysmal or persistent AF to reduce the risk of hospitalization.
Droperidol	548-73-2	Droperidol	548-73-2	O9U0F09D5X	Adjuvants, Anesthesia	Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)	Droperidol is used to produce tranquilization and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures.
drospirenone	67392-87-4	Drospirenone	67392-87-4	N295J34A25	Mineralocorticoid Receptor Antagonists	Drugs that bind to and block the activation of MINERALOCORTICOID RECEPTORS by MINERALOCORTICOIDS such as ALDOSTERONE. (See all compounds classified as Mineralocorticoid Receptor Antagonists.)	Drospirenone, in combination with ethinyl estradiol or estetrol, is indicated as an oral contraceptive for the prevention of pregnancy. In addition to its use for contraceptive effects, this combination is used to treat moderate acne vulgaris and the symptoms of premenstrual dysphoric disorder.  The drug has approved indications for combination with estrogens for the treatment of menopause-associated symptoms, such as vasomotor symptoms and vulvovaginal atrophy. Drospirenone combined with estrogen may also may aid in the prevention of osteoporosis in women who have been post-menopausal for at least a year and are not candidates for other therapies.   It can sometimes be found in preparations containing estrogen and folic acid for folic acid replenishment during oral contraception.  When used for the treatment of acne vulgaris, drospirenone-containing contraceptives should only be used in women 14 years of age who have experienced menarche, desire oral contraception, and do not have any contraindications to oral contraceptives. Off-label uses for this drug include the treatment of menstrual irregularities, dysmenorrhea, hirsutism, and endometriosis.
drospirenone and ethinyl estradiol combination		Gianvi	164017-31-6		Reproductive Control Agents	Substances used either in the prevention or facilitation of pregnancy. (See all compounds classified as Reproductive Control Agents.)	
drotaverin	14009-24-6	Drotaverine	14009-24-6	98QS4N58TW	Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	Drotaverine is used to alleviate gastrointestinal and genitourinary smooth muscle spasms, such as cholecystitis and gallbladder disorders.
Drugs, Chinese Herbal		Drugs, Chinese Herbal					
Drupanin		Drupanin	53755-58-1				
DSF-27 compound		DSF-27 compound					
duanbanhuain A		Duanbanhuain A					
duanbanhuain B		Duanbanhuain B					
dulaglutide		Dulaglutide [USAN:INN]					
dulcin	150-69-6	Dulcin	150-69-6	8U78KF577Z			
Duloxetine Hydrochloride	136434-34-9	Duloxetine Hydrochloride	136434-34-9	9044SC542W	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	Treatment of major depressive disorder; Treatment of diabetic peripheral neuropathic pain; Treatment of generalised anxiety disorder; Duloxetine Mylan is indicated in adults.
DuP 697	88149-94-4	Thiophene, 5-bromo-2-(4-fluorophenyl)-3-(4-(methylsulfonyl)phenyl)-	88149-94-4	MRWLZPOFPA	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
Durapatite	1306-06-5	Tribasic Calcium Phosphate	1306-06-5	91D9GV0Z28	Biocompatible Materials	Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function. (See all compounds classified as Biocompatible Materials.)	
duroquinone	527-17-3	Duroquinone	527-17-3	X0Q8791R69			
Dust		Phencyclidine	77-10-1	J1DOI7UV76	Hallucinogens	Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. (See all compounds classified as Hallucinogens.)	
Dutasteride		Dutasteride	164656-23-9	O0J6XJN02I	5-alpha Reductase Inhibitors	Drugs that inhibit 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE. They are commonly used to reduce the production of DIHYDROTESTOSTERONE. (See all compounds classified as 5-alpha Reductase Inhibitors.)	Indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate gland to improve symptoms, and reduce the risk of acute urinary retention and the need for BPH-related surgery alone or in combination with [tamsulosin].
duvelisib		Duvelisib	1201438-56-3	610V23S0JI			Duvelisib is indicated for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in adult patients who have trialed at least two prior therapies.
DX 619		3-Quinolinecarboxylic acid, 7-((3R)-3-(1-aminocyclopropyl)-1-pyrrolidinyl)-1-((1R,2S)-2-fluorocyclopropyl)-1,4-dihydro-8-methoxy-4-oxo-	431058-65-0	H012AL9PN0			
DX600 peptide		DX600 peptide					
dyclonine	586-60-7	Dyclonine	586-60-7	078A24Q30O	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	Used to provide topical anesthesia of accessible mucous membranes prior to examination, endoscopy or instrumentation, or other procedures involving the esophagus, larynx, mouth, pharynx or throat, respiratory tract or trachea, urinary tract, or vagina. Also used to suppress the gag reflex and/or other laryngeal and esophageal reflexes to facilitate dental examination or procedures (including oral surgery), endoscopy, or intubation. Also used for relief of canker sores, cold sores or fever blister.
Dydrogesterone	152-62-5	Dydrogesterone	152-62-5	90I02KLE8K	Progestins	Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. (See all compounds classified as Progestins.)	Used to treat irregular duration of cycles and irregular occurrence and duration of periods caused by progesterone deficiency. Also used to prevent natural abortion in patients who have a history of habitual abortions.
dynorphin (1-13)	72957-38-1	Dynorphin A (1-13)	72957-38-1	VFC23V742Z	Narcotics	Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)	
dynorphin A-(1-11)-NH2, Nalpha-benzylTyr(1)-cyclo(Asp(5)-Dap(8))-		dynorphin A-(1-11)-NH2, Nalpha-benzylTyr(1)-cyclo(Asp(5)-Dap(8))-					
Dynorphins	74913-18-1	Dynorphin	74913-18-1		Neurotransmitter Agents	Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as Neurotransmitter Agents.)	
dysidenin	65647-65-6	Dysidenine	65647-65-6				
E 2078	103613-84-9	N-Methyltyrosyl-glycyl-glycyl-phenylalanyl-leucyl-arginyl-N-methyl-arginyl-leucyl ethylamide	103613-84-9	X741EI11EL	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	
E 3040	145096-30-6	6-Hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole	145096-30-6	T4AB9WQ98U			
E 3330	136164-66-4	(2E)-2-[(4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methylidene]undecanoic acid	136164-66-4	11267UI968			
E 4021		E 4021					
E 4031	113558-89-7	N-[4-[1-[2-(6-methylpyridin-2-yl)ethyl]piperidine-4-carbonyl]phenyl]methanesulfonamide	113558-89-7	1L1K8X5DF9	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
E 5555		Atopaxar	751475-53-3	HTI275SD2D			
E 5842		Pyridine, 4-(4-fluorophenyl)-1,2,3,6-tetrahydro-1-(4-(1H-1,2,4-triazol-1-yl)butyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)	220120-14-9	RSQ93DYX4X			
E 6080	120164-49-0	Benzenesulfonamide, 4-(((6-hydroxy-4,5,7-trimethyl-2-benzothiazolyl)amino)methyl)-, monohydrochloride	120164-49-0				
E platinum		E platinum					
E-2-(4'-methoxybenzylidene)-benzusuberone		E-2-(4'-methoxybenzylidene)-benzusuberone					
EB-47		2-[4-[(2s,3s,4r,5r)-5-(6-Aminopurin-9-Yl)-3,4-Bis(Oxidanyl)oxolan-2-Yl]carbonylpiperazin-1-Yl]-N-(1-Oxidanylidene-2,3-Dihydroisoindol-4-Yl)ethanamide					
ebastine	90729-43-4	Ebastine	90729-43-4	TQD7Q784P1	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	
ebrotidine	100981-43-9	Ebrotidine	100981-43-9	TMZ3IBW2OW	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	
ebselen	60940-34-3	Ebselen	60940-34-3	40X2P7DPGH	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
eburnamonine	474-00-0	Eburnamenin-14(15H)-one	474-00-0	NPD9S131ZU	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
EBVP protocol		EBVP protocol					
Ecdysone	3604-87-3	Ecdysone	3604-87-3	RH692X7B7B			
Ecdysterone	5289-74-7	20-Hydroxyecdysone	5289-74-7	779A7KPL0Y			
ecgonine methyl ester	7143-09-1	Ecgonine methyl ester	7143-09-1	Y35FJB3QBJ	Narcotics	Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)	
echimidine		Echimidine	520-68-3	31NEL09379			
echinacoside		Echinacoside	82854-37-3	I04O1DT48T			
echinatin		Echinatin	34221-41-5	3816S4UA9R			
echinocystic acid	510-30-5	Echinocystic acid	510-30-5	L4DUW10YOF			
Echinomycin	512-64-1	Echinomycin	1403-88-9		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
echistatin	118337-11-4	Echistatin beta	118337-11-4		Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
Echothiophate Iodide	513-10-0	Echothiophate Iodide	513-10-0	BA9QH3P00T	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
eckol	88798-74-7	Eckol	88798-74-7	4A5E8354UB			
Econazole	27220-47-9	Econazole	27220-47-9	6Z1Y2V4A7M	14-alpha Demethylase Inhibitors	Compounds that specifically inhibit STEROL 14-DEMETHYLASE. A variety of azole-derived ANTIFUNGAL AGENTS act through this mechanism. (See all compounds classified as 14-alpha Demethylase Inhibitors.)	For topical application in the treatment of tinea pedis, tinea cruris, and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans, Microsporum canis, Microsporum audouini, Microsporum gypseum, and Epidermophyton floccosum, in the treatment of cutaneous candidiasis, and in the treatment of tinea versicolor.
ecopipam	112108-01-7	Ecopipam	112108-01-7	0X748O646K	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	
Edaravone	89-25-8	Edaravone	89-25-8	S798V6YJRP	Free Radical Scavengers	Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. (See all compounds classified as Free Radical Scavengers.)	Edaravone is indicated for the treatment of amyotrophic lateral sclerosis (ALS) in the US and Canada. It is also indicated to treat acute ischemic stroke in Japan.
edelfosine	65492-82-2	Edelfosine	70641-51-9	1Y6SNA8L5S	Phosphodiesterase Inhibitors	Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)	
Edetic Acid	60-00-4	Edetic Acid	139-33-3	9G34HU7RV0	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	For the reduction of blood levels and depot stores of lead in lead poisoning (acute and chronic) and lead encephalopathy, in both pediatric populations and adults.
edifenphos	17109-49-8	Edifenphos	17109-49-8	770M9U0F8Q			
Edotreotide		Edotreotide	204318-14-9	U194AS08HZ	Radiopharmaceuticals	Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)	This medicinal product is for diagnostic use only. After radiolabelling with gallium (68Ga) chloride solution, the solution of gallium (68Ga) edotreotide obtained is indicated for Positron Emission Tomography (PET) imaging of somatostatin receptor overexpression in adult patients with confirmed or suspected well-differentiated gastro-enteropancreatic neuroendocrine tumours (GEP-NET) for localizing primary tumours and their metastases.
Edrophonium	312-48-1	Edrophonium	312-48-1	70FP3JLY7N	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.
EEDQ	16357-59-8	2-Ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline	16357-59-8	60O971AN19	Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	
efaroxan	89197-32-0	Efaroxan	89197-32-0	G00490L21H	Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	
efatutazone		Inolitazone	223132-37-4	M17ILL71MC	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
efavirenz	154635-17-3	6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one	177530-93-7				
efletirizine		Efletirizine	150756-35-7	B6C301298G			
efonidipine	111011-53-1	Efonidipine hydrochloride	111011-53-1	3BR983K69O	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	
EG-018		Naphthalen-1-yl(9-pentyl-9h-carbazol-3-yl)methanone	2219320-91-7	5G2788GL5G	Cannabinoid Receptor Agonists	Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)	
EGFR tyrosine kinase inhibitor 324674		EGFR tyrosine kinase inhibitor 324674					
EGPI-1 compound		EGPI-1 compound					
EGTA acetoxymethyl ester	99590-86-0	EGTA acetoxymethyl ester	99590-86-0				
Egtazic Acid	67-42-5	Egtazic acid	67-42-5	526U7A2651	Antidotes	Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)	
EGYT 3615	107634-87-7	Trazium Esilate	97110-59-3	1PO9LWW5IN			
EHT 1864		5-(5-(7-(Trifluoromethyl)quinolin-4-ylthio)pentyloxy)-2-(morpholinomethyl)-4H-pyran-4-one dihydrochloride	754240-09-0				
eicosa-5,11,14-trienoic acid	15541-36-3	5,11,14-Eicosatrienoic acid	15541-36-3				
eicosa-8,11,14-trien-5-ynoic acid	58688-54-3	Eicosa-8,11,14-trien-5-ynoic acid	58688-54-3				
Eicosanoids		Eicosanoids					
Eicosapentaenoic Acid	1553-41-9	Eicosapentaenoic Acid	25378-27-2				
eicosapentaenoic acid ethyl ester		Icosapent Ethyl	73310-10-8	6GC8A4PAYH	Lipid Regulating Agents	Substances that alter the metabolism of LIPIDS. (See all compounds classified as Lipid Regulating Agents.)	Icosapent ethyl is indicated as an adjunct to maximally tolerated statin therapy to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina requiring hospitalizing in adult patients with elevated triglycerides (150 mg/dL) and established cardiovascular disease or who have diabetes mellitus and 2 other risk factors for cardiovascular disease. It is also indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe (500 mg/dL) hypertriglyceridemia.
EKB 569		Pelitinib	257933-82-7	X5DWL380Z6	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	Investigated for use/treatment in colorectal cancer and lung cancer.
Elacridar	143664-11-3	Elacridar	143664-11-3	N488540F94			For the treatment of solid tumors.
elagolix		Elagolix	834153-87-6	5B2546MB5Z			Elagolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the management of moderate to severe pain associated with endometriosis.
Elapid Venoms		Elapid Venoms					
eldecalcitol		Eldecalcitol	104121-92-8	I2JP8UE90H	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Investigated for use/treatment in osteoporosis.
Electrolytes		Electrolytes					
Elements, Radioactive		Elements, Radioactive					
elemicin	487-11-6	Elemicin	487-11-6	HSZ191AKAN			
eleostearic acid	13296-76-9	Octadeca-9,11,13-trienoic acid	13296-76-9				
elesclomol		Elesclomol	488832-69-5	6UK191M53P			Investigated for use/treatment in melanoma.
eletriptan		Eletriptan	143322-58-1	22QOO9B8KI	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	For the acute treatment of migraine with or without aura in adults.
eliglustat		Eliglustat	491833-29-5	DR40J4WA67	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Eliglustat is a glucosylceramide synthase inhibitor indicated for the long-term treatment of type 1 Gaucher disease in adult patients who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an FDA-cleared test. CYP2D6 ultra-rapid metabolizers may not achieve adequate eliglustat concentrations to achieve a therapeutic effect. A specific dosage cannot be recommended for CYP2D6 indeterminate metabolizers.
eliprodil	119431-25-3	Eliprodil	119431-25-3	YW62A6TW29	Neuroprotective Agents	Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)	
Ellagic Acid	476-66-4	Ellagic Acid	476-66-4	19YRN3ZS9P			Ellagic acid is being investigated for use in follicular lymphoma, brain injury in intrauterine growth restricted babies, obese adolescents, and solar lentigines.
ellipticine	519-23-3	Ellipticine	519-23-3	117VLW7484	Uncoupling Agents	Chemical agents that uncouple oxidation from phosphorylation in the metabolic cycle so that ATP synthesis does not occur. Included here are those IONOPHORES that disrupt electron transfer by short-circuiting the proton gradient across mitochondrial membranes. (See all compounds classified as Uncoupling Agents.)	
eltoprazine	98224-03-4	Eltoprazine hydrochloride	98206-09-8	5275JY4PKD	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	
eltrombopag		Eltrombopag					Revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (ITP) who are refractory to other treatments (e. g. corticosteroids, immunoglobulins) (see sections4. 2 and 5. 1). Revolade is indicated for the treatment of paediatric patients aged 1year and above with primary immune thrombocytopenia (ITP) lasting 6months or longer from diagnosis and who are refractory to other treatments (e. g. corticosteroids, immunoglobulins) (see sections4. 2 and 5. 1). Revolade is indicated in adult patients with chronic hepatitisC virus (HCV) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections4. 4 and5. 1). Revolade is indicated in adult patients with acquired severe aplastic anaemia (SAA) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section5. 1).
eluforsen		Eluforsen [INN]					
eluxadoline		Eluxadoline	864821-90-9	45TPJ4MBQ1	Gastrointestinal Agents	Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)	For the treatment of irritable bowel syndrome with diarrhea (IBS-D).
elvitegravir		Elvitegravir	697761-98-1	4GDQ854U53	Anti-HIV Agents	Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)	Elvitegravir in combination with an HIV protease inhibitor coadministered with ritonavir and with other antiretroviral drug(s) is indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults.
elzasonan		Elzasonan	361343-19-3	933PJL964R			
EM703		(2R,3S,6R,7S,8S,9R,10R)-3-[(2R,3R)-2,3-dihydroxypentan-2-yl]-7-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-9-[(2S,3R,4S,6R)-3-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-2,6,8,10,12-pentamethyl-4,13-dioxabicyclo[8.2.1]tridec-1(12)-en-5-one					
emamectin		emamectin B1a	119791-41-2		Antiparasitic Agents	Drugs used to treat or prevent parasitic infections. (See all compounds classified as Antiparasitic Agents.)	
emamectin benzoate		Emamectin benzoate	155569-91-8		Antiparasitic Agents	Drugs used to treat or prevent parasitic infections. (See all compounds classified as Antiparasitic Agents.)	
embelin	550-24-3	Embelin	550-24-3	SHC6U8F5ER			
EMD 392949		EMD 392949					
EMD 527040		EMD 527040					
EMD 534085		1-(2-(dimethylamino)ethyl)-3-(((2R,4aS,5R,10bS)-5-phenyl-9-(trifluoromethyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinolin-2-yl)methyl)urea	858668-07-2	AL67QX8036			
EMD 53998	120223-04-3	5-[1-(3,4-dimethoxybenzoyl)-3,4-dihydro-2H-quinolin-6-yl]-6-methyl-3,6-dihydro-1,3,4-thiadiazin-2-one	120223-04-3	3L67D8JK8X	Phosphodiesterase Inhibitors	Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)	
EMD 638683		EMD 638683					
EMD 95885		6-(3-(4-((4-Fluorophenyl)methyl)-1-piperidinyl)-1-oxopropyl)-2(3H)-benzoxazolone	178165-43-0				
emedastine	87233-61-2	Emedastine	87233-61-2	9J1H7Y9OJV	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	For the temporary relief of the signs and symptoms of allergic conjunctivitis.
emeriamine	98063-21-9	(3r)-3-Amino-4-(trimethylammonio)butanoate	98063-21-9		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Emetine	483-18-1	Emetine	483-18-1	X8D5EPO80M	Amebicides	Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal. (See all compounds classified as Amebicides.)	
emodepside		Emodepside	155030-63-0	YZ647Y5GC9	Antiparasitic Agents	Drugs used to treat or prevent parasitic infections. (See all compounds classified as Antiparasitic Agents.)	
Emodin	518-82-1	Emodin	518-82-1	KA46RNI6HN	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
emodin-6-O-glucoside		emodin-6-O-glucoside					
emodin-8-O-beta-D-glucoside		emodin-8-O-beta-D-glucoside					
empagliflozin		Empagliflozin	864070-44-0	HDC1R2M35U	Sodium-Glucose Transporter 2 Inhibitors	Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS. (See all compounds classified as Sodium-Glucose Transporter 2 Inhibitors.)	Empagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in patients aged 10 years and older with type 2 diabetes. It is used either alone or in combination with [metformin] or [linagliptin]. It is also indicated to reduce the risk of cardiovascular death in adult patients with both type 2 diabetes mellitus and established cardiovascular disease, either alone or as a combination product with metformin.  An extended-release combination product containing empagliflozin, metformin, and linagliptin was approved by the FDA in January 2020 for the improvement of glycemic control in adults with type 2 diabetes mellitus when used adjunctively with diet and exercise.  Empagliflozin is also approved to reduce the risk of cardiovascular mortality and hospitalization due to heart failure in adult patients with heart failure, either alone or in combination with metformin. It is also indicated in adults to reduce the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease at risk of progression.  Empagliflozin is not approved for use in patients with type 1 diabetes.
Emtricitabine		Emtricitabine	143491-57-0	G70B4ETF4S	Anti-HIV Agents	Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)	Emtricitabine is indicated in combination with other medications for the treatment of HIV-1 infections; treatment of HIV-1 infections in pediatric patients 25-35kg, treatment of HIV-1 infections in adult patients 35kg, for pre exposure prophylaxis of HIV-1 in adolescent and adult patients excluding those who have receptive vaginal sex; treatment of HIV-1 infections in pediatric and adult patients 17kg, pre exposure prophylaxis in adolescents and adults 35kg; treatment of HIV-1 in patients 12 years and 35kg; treatment of HIV-1 in patients weighing 35kg; treatment of HIV-1 in patients weighing 25kg; and treatment of HIV-1 in patients weighing 40kg.
emulphogene BC 720	24938-91-8	2-(Tridecyloxy)ethanol	24938-91-8	36KKG1IWMU			
Emulsions		Emulsions					
enadoline	107431-28-7	4-Benzofuranacetamide, N-methyl-N-(7-(1-pyrrolidinyl)-1-oxaspiro(4.5)dec-8-yl)-	107431-28-7		Neuroprotective Agents	Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)	
Enalapril	75847-73-3	Enalapril	75847-73-3	69PN84IO1A	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	Indicated for the management of essential or renovascular hypertension as monotherapy or in combination with other antihypertensive agents, such as thiazide diuretics, for an additive effect.  Indicated for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis.  Indicated for the management of asymptomatic left ventricular dysfunction in patients with an ejection fraction of  to 35 percent to decrease the rate of development of overt heart failure and the incidence of hospitalization for heart failure.
Enalaprilat	84680-54-6	Enalaprilat dihydrate	84680-54-6	GV0O7ES0R3	Angiotensin-Converting Enzyme Inhibitors	A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)	
enasidenib		Enasidenib	1446502-11-9	3T1SS4E7AG			Enasidenib is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA-approved test.
Endocannabinoids		Cannabinoid Receptor Modulators					
Endocrine Disruptors		Endocrine Disruptors					
endomorphin 1		Endomorphin-1	189388-22-5		Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	
endomorphin 2		Endomorphin 2	141801-26-5	3PH5M0466G	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	
Endosulfan	115-29-7	Endosulfan	33213-65-9	OKA6A6ZD4K	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
endosulfan sulfate		Endosulfan sulfate	1031-07-8				
endothall	145-73-3	Endothall	145-73-3				
endothelium-dependent hyperpolarization factor		endothelium-dependent hyperpolarization factor					
endotoxin, Escherichia coli	67924-63-4	endotoxin, Escherichia coli					
Endotoxins		Endotoxins					
Endrin	72-20-8	Hexadrin	72-20-8	OB9NVE7YCL	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
energostim		energostim					
Enflurane	13838-16-9	Enflurane	13838-16-9	91I69L5AY5	Anesthetics, Inhalation	Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173) (See all compounds classified as Anesthetics, Inhalation.)	Enflurane may be used for both the induction and maintenance of general anesthesia. It can also be used to induce analgesia for vaginal delivery. Low concentrations of enflurane can also be used as an adjunct to general anesthetic drugs during delivery by Cesarean section.
Enfuvirtide		Enfuvirtide	159519-65-0	19OWO1T3ZE	HIV Fusion Inhibitors	Inhibitors of the fusion of HIV to host cells, preventing viral entry. This includes compounds that block attachment of HIV ENVELOPE PROTEIN GP120 to CD4 RECEPTORS. (See all compounds classified as HIV Fusion Inhibitors.)	Enfuvirtide is an antiretroviral drug used in combination therapy for the treatment of HIV-1/AIDS.
englitazone	122228-35-7	5-[(2-benzyl-3,4-dihydro-2H-chromen-6-yl)methyl]-1,3-thiazolidine-2,4-dione	109229-58-5		Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	
enilconazole		Enilconazole	35554-44-0	6K0NOF3XQ6	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
eniluracil		Eniluracil	59989-18-3	2E2W0W5XIU	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	For the treatment of cancer in combination with 5-fluorouracil.
eniporide		Eniporide	176644-21-6	7IGF9182QU			
enkephalin-Leu, Ala(2)-Arg(6)-		Dalargin	81733-79-1	V13505565P	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
enkephalin-Leu, Ala(2)-melphalan methyl ester-	88457-22-1	Enkephalin-leu, ala(2)-melphalan methyl ester-	88457-22-1				
Enkephalin, Ala(2)-MePhe(4)-Gly(5)-	100929-53-1	L-Phenylalaninamide, L-tyrosyl-D-alanylglycyl-N-(2-hydroxyethyl)-Nalpha-methyl-, monoacetate (salt)	100929-53-1		Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
Enkephalin, D-Penicillamine (2,5)-	88373-73-3	Dpdpe	88373-73-3	HB4QD9GL6F	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	
Enkephalin, Leucine	58822-25-6	Leucine enkephalin	58822-25-6	RI01R707R6	Neurotransmitter Agents	Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as Neurotransmitter Agents.)	
Enkephalin, Leucine-2-Alanine	63631-40-3	Dadle	63631-40-3	CQK2YXW6EZ			
Enkephalin, Methionine	58569-55-4	MET-enkephalin	58569-55-4	9JEZ9OD3AS	Neurotransmitter Agents	Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as Neurotransmitter Agents.)	Metenkefalin is indicated in Bosnia for the treatment of relapsing-remitting multiple sclerosis.
enkephalin, Ser(2), Leu(5), Thr(6)-	75644-90-5	Dslet	75644-90-5		Convulsants	Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)	
Enkephalins		Leucine enkephalin	58822-25-6	RI01R707R6	Neurotransmitter Agents	Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as Neurotransmitter Agents.)	
ENNG	4245-77-6	N-Ethyl-N'-nitro-N-nitrosoguanidine	4245-77-6	M7K69H3QFH	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
enniatins		CID164754					
Enoxacin	74011-58-8	Enoxacin	74011-58-8	325OGW249P	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of adults (18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: (1) uncomplicated urethral or cervical gonorrhea due to Neisseria gonorrhoeae, (2) uncomplicated urinary tract infections (cystitis) due to Escherichia coli, Staphylococcus epidermidis, or Staphylococcus saprophyticus, and (3) complicated urinary tract infections due to Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus epidermidis, or Enterobacter cloacae.
Enoxaparin		Lovenox	9005-49-6				
enrasentan	167256-08-8	Enrasentan	167256-08-8	QG16H8A6ZH	Endothelin Receptor Antagonists	Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN RECECPTORS. (See all compounds classified as Endothelin Receptor Antagonists.)	Investigated for use/treatment in congestive heart failure, chronic obstructive pulmonary disease (COPD), and benign prostatic hyperplasia.
Enrofloxacin	93106-60-6	Enrofloxacin	93106-60-6	3DX3XEK1BN	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
ent-1,3,6,11-tetrahydroxykaur-16-ene-15-one 3,11-diacetate		ent-1,3,6,11-tetrahydroxykaur-16-ene-15-one 3,11-diacetate					
entacapone	116314-67-1	Entacapone	130929-57-6	4975G9NM6T	Catechol O-Methyltransferase Inhibitors	Compounds and drugs that inhibit or block the activity of CATECHOL O-METHYLTRANSFERASE enzymes. Drugs in this class are used in management of central nervous system disorders such as PARKINSON DISEASE. (See all compounds classified as Catechol O-Methyltransferase Inhibitors.)	"Used as an adjunct to levodopa / carbidopa in the symptomatic treatment of patients with idiopathic Parkinson's Disease who experience the signs and symptoms of end-of-dose ""wearing-off""."
entecavir		Entecavir	142217-69-4	5968Y6H45M	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	For the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
enterotoxin A, Staphylococcal	37337-57-8	enterotoxin A, Staphylococcal					
enterotoxin B, staphylococcal	39424-53-8	enterotoxin B, staphylococcal					
enterotoxin C, staphylococcal	39424-54-9	enterotoxin C, staphylococcal					
enterotoxin F, Staphylococcal		enterotoxin F, Staphylococcal					
Enterotoxins		Enterotoxins					
entinostat		Entinostat	209783-80-2	1ZNY4FKK9H	Histone Deacetylase Inhibitors	Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)	
ENV-2 compound		ENV-2 compound					
Environmental Pollutants		Environmental Pollutants					
enzacamene	38102-62-4	Enzacamene	36861-47-9				Indicated for use as an active sunscreen agent.
enzalutamide		Enzalutamide	915087-33-1	93T0T9GKNU			Enzalutamide is indicated for the treatment of castration-resistant prostate cancer, metastatic castration-sensitive prostate cancer (mCSPC), and non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis (high-risk BCR). It is also used in combination with [talazoparib] for the treatment of adult patients with HRR gene-mutated mCRPC.
enzastaurin		Enzastaurin	170364-57-5	UC96G28EQF			Investigated for use/treatment in brain cancer, lymphoma (non-hodgkin's), and lung cancer.
Enzyme Activators		Enzyme Activators					
Enzyme Inhibitors		Enzyme Inhibitors					
Enzymes and Coenzymes		Enzymes and Coenzymes					
Eosine I Bluish	18472-87-2	Acid red 92	18472-87-2		Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
Eosine Yellowish-(YS)	17372-87-1	Eosin	548-26-5	TDQ283MPCW	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
epacadostat		Epacadostat	1204669-58-8	71596A9R13			
epalrestat	82159-09-9	Epalrestat	82159-09-9	424DV0807X	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
eperisone	56839-43-1	Eperisone hydrochloride	56839-43-1	U38O8U7P6X	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
Ephedrine	299-42-3	Ephedrine	299-42-3	GN83C131XS	Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	Ephedrine intravenous injections are indicated to treat hypotension under anesthesia, ephedrine injections by multiple routes are indicated to treat allergic conditions such as bronchial asthma, ephedrine nasal spray is and OTC medication used as a decongestant.
EPI 001		Bisphenol A (3-chloro-2-hydroxypropyl) (2,3-dihydroxypropyl) ether	227947-06-0	A9PRH4DC8H			
epiallopregnanolone sulfate		epiallopregnanolone sulfate					
epibatidine	140111-52-0	(1R,2R,4S)-2-(6-Chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane	140111-52-0	M6K314F1XX	Analgesics, Non-Narcotic	A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)	
epiberberine	6873-09-2	Epiberberine	6873-09-2	VWP9N35AYS			
epicatechin gallate	863-03-6	Epicatechin-3-gallate	863-03-6		Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	
Epichlorohydrin	106-89-8	Epichlorohydrin	106-89-8	08OOR508C0			
epigallocatechin gallate	989-51-5	Epigallocatechin Gallate	989-51-5	BQM438CTEL	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
epigallocatechin-3-O-gallate epigallocatechin dimer		epigallocatechin-3-O-gallate epigallocatechin dimer					
epimedin B	110623-73-9	Epimedin B	110623-73-9				
epimedokoreanin B		Epimedokoreanin B					
epimuqubilin A		Epimuqubilin A					
epinastine	80012-43-7	Epinastine	80012-43-7	Q13WX941EF	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	For the prevention of itching associated with allergic conjunctivitis.
epinecidin-1, Epinephelus coioides		epinecidin-1, Epinephelus coioides					
Epinephrine	51-43-4	Epinephrine	51-43-4	YKH834O4BH	Adrenergic alpha-Agonists	Drugs that selectively bind to and activate alpha adrenergic receptors. (See all compounds classified as Adrenergic alpha-Agonists.)	Epinephrine injection is indicated in the emergency treatment of type I allergic reactions, including anaphylaxis. It is also used to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock.  Epinephrine's cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes but is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock.  Epinephrine is used as a hemostatic agent. It is also used in treating mucosal congestion of hay fever, rhinitis, and acute sinusitis; to relieve bronchial asthmatic paroxysms; in syncope due to complete heart block or carotid sinus hypersensitivity; for symptomatic relief of serum sickness, urticaria, angioneurotic edema; for resuscitation in cardiac arrest following anesthetic accidents; in simple (open angle) glaucoma; for relaxation of uterine musculature and to inhibit uterine contractions. Epinephrine injection can be utilized to prolong the action of local anesthetics.  In addition to the above, epinephrine is used as an over the counter (OTC) agent for the intermittent symptoms of asthma, such as wheezing, tightness of chest and shortness of breath.  It is also used for the maintenance of mydriasis during intraocular surgery.
Epirubicin	56420-45-2	Epirubicin	56420-45-2	3Z8479ZZ5X	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	For use as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer.
Epitestosterone	481-30-1	Epitestosterone	481-30-1	48L726977Z			
Eplerenone		Eplerenone	107724-20-9	6995V82D0B	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For improvement of survival of stable patients with left ventricular systolic dysfunction (ejection fraction <40%) and clinical evidence of congestive heart failure after an acute myocardial infarction.
EPN oxon	2012-00-2	Epn oxon	2012-00-2	JF5VG2G4AA			
epofenonane	57342-02-6	Epofenonane	57342-02-6	8I82W3V5ZY			
epolactaene		Epolactaene	167782-17-4	4S7A4HLA92			
epomediol	56084-15-2	Epomediol	56084-15-2		Cholagogues and Choleretics	Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)	
Epoprostenol	35121-78-9	Epoprostenol	35121-78-9	DCR9Z582X0	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the long-term intravenous treatment of primary pulmonary hypertension and pulmonary hypertension associated with the scleroderma spectrum of disease in NYHA Class III and Class IV patients who do not respond adequately to conventional therapy.
epostane	80471-63-2	Epostane	80471-63-2	6375T36951	Abortifacient Agents, Steroidal	Steroidal compounds with abortifacient activity. (See all compounds classified as Abortifacient Agents, Steroidal.)	
epothilone A		Epothilone A	152044-53-6	51E07YBX96	Tubulin Modulators	Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)	
epothilone B		Epothilone B	152044-54-7	UEC0H0URSE	Tubulin Modulators	Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)	Investigated for use/treatment in ovarian cancer, lung cancer, brain cancer, breast cancer, and gastric cancer.
Epothilones		Epothilone A	152044-53-6	51E07YBX96	Tubulin Modulators	Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)	
epoxiconazole		Epoxiconazole	133855-98-8	U80T84L776	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
epoxomicin		Epoxomicin	134381-21-8	Y0900I3U8U	Proteasome Inhibitors	Compounds that inhibit the function or proteolytic action of the PROTEASOME. (See all compounds classified as Proteasome Inhibitors.)	
Epoxy Compounds		Epoxy Compounds					
epoxy resin AH-26	55599-25-2	epoxy resin AH-26					
eprenetapopt		Prima-1met	5291-32-7	Z41TGB4080			
eprinomectin		CID6450531					
eprosartan		Eprosartan	133040-01-4	2KH13Z0S0Y	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the management of hypertension alone or in combination with other classes of antihypertensive agents. Also used as a first-line agent in the treatment of diabetic nephropathy, as well as a second-line agent in the treatment of congestive heart failure (only in those intolerant of ACE inhibitors).
epsilon-viniferin	62218-08-0	Epsilon-viniferin	62218-08-0	0K8Z2K6Y7O			
eptapirone		Eptapirone	179756-85-5	3M824XRO8N			
EPTC	759-94-4	S-Ethyl dipropylthiocarbamate	759-94-4	R7PI3287F4			
Eptifibatide		Eptifibatide	188627-80-7	NA8320J834	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	For treatment of myocardial infarction and acute coronary syndrome.
epyrifenacil		Epyrifenacil	353292-31-6	RAE3HFQ5BK			
EPZ004777		1-(3-((((2R,3S,4R,5R)-5-(4-Amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea	1338466-77-5				
equiguard		Dichlorvos	62-73-7	7U370BPS14	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	
Equilenin	517-09-9	Equilenin	517-09-9	W8FTJ17C4J			
Equilin	474-86-2	Equilin	474-86-2	08O86EX0J4			For the treatment of moderate to severe vasomotor symptoms associated with the menopause, atrophic vaginitis, osteoporosis, hypoestrogenism due to hypogonadism, castration, primary ovarian failure, breast cancer (for palliation only), and Advanced androgen-dependent carcinoma of the prostate (for palliation only)
Equol	531-95-3	Equol	531-95-3	2T6D2HPX7Q	Phytoestrogens	Compounds derived from plants, primarily ISOFLAVONES that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS. (See all compounds classified as Phytoestrogens.)	
er-xian decoction		er-xian decoction					
erastin		Erastin	571203-78-6	ZJA3NS42T9			
ERB 041		Prinaberel	524684-52-4	A9C8MNF7CA			
Erbium	7440-52-0	Erbium	13550-53-3	77B218D3YE			
erbstatin	100827-28-9	Erbstatin	100827-28-9	WDH83K6T5P	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
erdafitinib		Erdafitinib	1346242-81-6	890E37NHMV			Erdafitinib is a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor that is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma that has susceptible FGFR3 or FGFR2 genetic alterations and has progressed during or following at least one line of prior platinum-containing chemotherapy including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy.  The selection of patients for the treatment of locally advanced or metastatic urothelial carcinoma with erdafitinib should be based on the presence of susceptible FGFR genetic alterations in tumor specimens as detected by an FDA-approved companion diagnostic like the FDA-approved therascreen FGFR RGQ RT-PCR Kit as developed by QIAGEN.  This above indication is approved under accelerated approval by the FDA based on tumor response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
erdosteine	84611-23-4	Erdosteine	84611-23-4	76J0853EKA	Expectorants	Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here. (See all compounds classified as Expectorants.)	Fro the treatment of chronic bronchitis in adults.
eremanthin	37936-58-6	Eremanthin	37936-58-6				
Ergocalciferols		Ergocalciferol	50-14-6	VS041H42XC	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Ergocalciferol is indicated for the treatment of hypoparathyroidism, refractory rickets, and familial hypophosphatemia.  Hypoparathyroidism is the result of inadequate parathyroid hormone production that occurs due to the presence of damage or removal of the parathyroid glands. This condition produces decreased calcium and increased phosphorus levels.  Rickets is a condition produced due to a deficiency in vitamin D, calcium or phosphorus. However, this condition can also be related to renal diseases. It is characterized to present weak or soft bones.  Familial hypophosphatemia is characterized by the impaired transport of phosphate and an altered vitamin D metabolism in the kidneys. The presence of this condition can derive in the presence of osteomalacia, bone softening and rickets.
ergocristine	511-08-0	Ergocristine	511-08-0	3E58HO2T0U	Peripheral Nervous System Agents	Drugs that act principally at one or more sites within the peripheral neuroeffector systems, the autonomic system, and motor nerve-skeletal system. (From Smith and Reynard, Textbook of Pharmacology, 1991, p75) (See all compounds classified as Peripheral Nervous System Agents.)	
ergocryptine	511-09-1	alpha-Ergocryptine	511-09-1	6WFB60157B	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
ergosine	561-94-4	Ergosine	561-94-4	6WF908487H			
ergosta-4,6,8(14),22-tetraen-3-one		Ergosta-4,6,8(14),22-tetraen-3-one	19254-69-4	RI51Y55U8P			
ergosta-7,22-dien-5-hydroxy-3,6-dione		ergosta-7,22-dien-5-hydroxy-3,6-dione					
Ergosterol	57-87-4	Ergosterol	57-87-4	Z30RAY509F	Provitamins	Precursor forms of vitamins. (See all compounds classified as Provitamins.)	
ergosterol-5,8-peroxide	2061-64-5	Ergosterol peroxide	2061-64-5	UG9TN81TGH			
Ergot Alkaloids		Ergot Alkaloids					
Ergotamine	113-15-5	Ergotamine	379-79-3	PR834Q503T	Analgesics, Non-Narcotic	A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)	"For use as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants, or so called ""histaminic cephalalgia""."
Ergothioneine	497-30-3	Ergothioneine	497-30-3	BDZ3DQM98W	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
ergotoxin, Centruroides noxius		ergotoxin, Centruroides noxius					
Erhuang formula		Erhuang formula					
Erianin		Erianin	95041-90-0				
erigeroflavanone		Erigeroflavanone					
eriocitrin		Eriocitrin	13463-28-0	AS293HR5XQ			
eriodictyol	552-58-9	Eriodictyol	552-58-9	Q520486B8Y			
erionite	12510-42-8	Erionite	12510-42-8				
eritoran		Eritoran	185955-34-4	551541VI0Y			Investigated for use/treatment in sepsis and septicemia.
Erlotinib Hydrochloride		Erlotinib Hydrochloride	183319-69-9	DA87705X9K	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Non-small cell lung cancer (NSCLC)Tarceva is also indicated for switch maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer with EGFR activating mutations and stable disease after first-line chemotherapy. Tarceva is also indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen. In patients with tumours without EGFR activating mutations, Tarceva is indicated when other treatment options are not considered suitable. When prescribing Tarceva, factors associated with prolonged survival should be taken into account. No survival benefit or other clinically relevant effects of the treatment have been demonstrated in patients with Epidermal Growth Factor Receptor (EGFR)-IHC - negative tumours. Pancreatic cancer Tarceva in combination with gemcitabine is indicated for the treatment of patients with metastatic pancreatic cancer . When prescribing Tarceva, factors associated with prolonged survival should be taken into account.
ershiwuwei shanhu		ershiwuwei shanhu					
ertiprotafib		Ertiprotafib	251303-04-5	5TPM2EB426			Investigated for use/treatment in diabetes mellitus type 2.
ertugliflozin		Ertugliflozin	1210344-57-2	6C282481IP	Sodium-Glucose Transporter 2 Inhibitors	Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS. (See all compounds classified as Sodium-Glucose Transporter 2 Inhibitors.)	Ertugliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus (T2DM). It is also available in combination with either [metformin] or [sitagliptin].  Ertugliflozin is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus.
erucic acid	1072-39-5	13-Docosenoic acid	1072-39-5				
erucifoline		Erucifoline	40158-95-0				
erucin	4430-36-8	Erucin	4430-36-8	CTE370DL3U			
erucyl amide	112-84-5	Erucamide	112-84-5	0V89VY25BN			
erucylphospho-N,N,N-trimethylpropylammonium		Erufosine	202867-33-2	W52C2EKX3F			
erucylphosphocholine	143317-74-2	Erucylphosphocholine	143317-74-2				
erysodine	7290-03-1	Erysodine	7290-03-1	6WZ3T41Y11			
erysolin	504-84-7	Erysolin	504-84-7	RC3ZLS8P7M			
erythraline		Erythraline	466-77-3	J7P8WA50QO			
Erythromycin	114-07-8	Erythromycin	7704-67-8	63937KV33D	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Erythromycin is indicated in the treatment of infections caused by susceptible strains of various bacteria. The indications for erythromycin have been summarized by body system below:  **Respiratory infections**  Mild to moderate upper respiratory tract infections caused by Streptococcus pyogenes, Streptococcus pneumoniae, or Haemophilus influenzae (when used concomitantly with appropriate doses of sulfonamides) can be treated with erythromycin. Mild to moderate lower-respiratory tract infections due to susceptible strains of Streptococcus pneumoniae or Streptococcus pyogenes may also be treated. Erythromycin treats listeriosis caused by Listeria monocytogenes may also be treated with erythromycin. Erythromycin is indicated to treat pertussis (whooping cough) caused by Bordetella pertussis. It is effective in eliminating the causative organism from the nasopharynx of infected individuals, rendering them noninfectious. Clinical studies suggest that erythromycin may aid in the prevention of pertussis infection for individuals who have been exposed to the bacteria. Respiratory tract infections due to Mycoplasma pneumoniae may also be treated with erythromycin.  Despite the fact that no controlled clinical efficacy studies have been conducted to this date, in vitro and certain preliminary clinical study results indicate that erythromycin may be an effective treatment in  Legionnaires Disease. Finally, erythromycin is indicated to treat diphtheria and other infections due to Corynebacterium diphtheriae, as an adjunct to antitoxin, to prevent carrier status and to eradicate the organism in existing carriers. In addition to the prevention of diphtheria, erythromycin can be used to prevent rheumatic fever in penicillin intolerant patients.    **Skin infections**  Mild to moderate skin or skin structure infections caused by Streptococcus pyogenes or Staphylococcus aureus may be treated with erythromycin, however, resistant staphylococcal organisms may emerge. Erythromycin can also be used to treat erythrasma, an infectious condition caused by Corynebacterium minutissimum.   **Gastrointestinal infections**  Intestinal amebiasis caused by Entamoeba histolytica can be treated with oral erythromycin. Extraenteric amebiasis warrants treatment with other antimicrobial drugs.   **Genital infections/STIs**  Erythromycin can be used as an alternative drug in treating acute pelvic inflammatory disease caused by N. gonorrheae in female patients who have demonstrated hypersensitivity or intolerance to penicillin. Syphilis, caused by Treponema pallidum, can be treated with erythromycin.  It serves as an alternative treatment for primary syphilis in patients who have demonstrated penicillin hypersensitivity. Erythromycin can also be used in the primary stage of primary syphilis. Another approved indication of erythromycin is to treat chlamydial infections that cause conjunctivitis of the newborn, pneumonia of infancy, and urogenital infections occurring in pregnancy. It is indicated as an alternative option to tetracyclines for the treatment of uncomplicated rectal, urethral and endocervical infections in adults caused by Chlamydia trachomatis. Erythromycin can be used in nongonococcal urethritis can be used when tetracyclines cannot be administered. Finally, erythromycin is indicated to treat nongonococcal urethritis due to Ureaplasma urealyticum.
Erythromycin Estolate	3521-62-8	Erythromycin Estolate	3521-62-8	XRJ2P631HP	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Erythropoietin	11096-26-7	Losartan Potassium	124750-99-8	3ST302B24A	Angiotensin II Type 1 Receptor Blockers	Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)	Proteinuria, Treatment of heart failure, Treatment of hypertension
erythrose 4-phosphate	585-18-2	D-Erythrose 4-phosphate	585-18-2	2156QF7O8M			
Erythrosine	16423-68-0	Erythrosine	16423-68-0		Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
erzhi tiangui		erzhi tiangui					
Escin	6805-41-0	Escin	6805-41-0		Cardiovascular Agents	Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)	
esculentoside A	65497-07-6	65497-07-6					
esculentoside B		Phytolaccoside B	60820-94-2				
esculetin	305-01-1	Esculetin	305-01-1	SM2XD6V944	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
eseroline	469-22-7	Eseroline	469-22-7	Q22H41O18D	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	
Esketamine		Esketamine	33643-46-8	50LFG02TXD	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	Esketamine is indicated in combination with an oral antidepressant for the treatment of treatment-resistant depression in adults. It is also indicated for the treatment of depressive symptoms in adults with major depressive disorder experiencing acute suicidal ideation or behaviour.
esmolol	84057-94-3	Esmolol	81147-92-4	MDY902UXSR	Adrenergic beta-1 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Antagonists.)	For the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. Also used in noncompensatory sinus tachycardia where the rapid heart rate requires specific intervention.
Esomeprazole		Esomeprazole	119141-88-7	N3PA6559FT	Proton Pump Inhibitors	Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)	Esomeprazole is indicated for the treatment of acid-reflux disorders including healing and maintenance of erosive esophagitis, and symptomatic gastroesophageal reflux disease (GERD), peptic ulcer disease, H. pylori eradication, prevention of gastrointestinal bleeds with NSAID use, and for the long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison Syndrome.
essential 303 forte	11137-48-7	essential 303 forte					
Estazolam	29975-16-4	Estazolam	29975-16-4	36S3EQV54C	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	For the short-term management of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings.
Estradiol	50-28-2	Estradiol	50-28-2	4TI98Z838E	Estrogens	Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. (See all compounds classified as Estrogens.)	Estradiol is indicated in various preparations for the treatment of moderate to severe vasomotor symptoms and vulvar and vaginal atrophy due to menopause, for the treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure, and for the prevention of postmenopausal osteoporosis. It is also used for the treatment of breast cancer (only for palliation therapy) in certain men or women with metastatic disease, and for the treatment of androgen-dependent prostate cancer (only for palliation therapy). It is also used in combination with other hormones as a component of oral contraceptive pills for preventing pregnancy (most commonly as [DB00977], a synthetic form of estradiol).  **A note on duration of treatment**  Recommendations for treatment of menopausal symptoms changed drastically following the release of results and early termination of the Women's Health Initiative (WHI) studies in 2002 as concerns were raised regarding estrogen use. Specifically, the combined estrogenprogestin group was discontinued after about 5 years of follow up due to a statistically significant increase in invasive breast cancer and in cardiovascular events.   Following extensive critique of the WHI results, Hormone Replacement Therapy (HRT) is now recommended to be used only for a short period (for 3-5 years postmenopause) in low doses, and in women without a history of breast cancer or increased risk of cardiovascular or thromboembolic disease. Estrogen for postmenopausal symptoms should always be given with a progestin component due to estrogen's stimulatory effects on the endometrium; in women with an intact uterus, unopposed estrogen has been shown to promote the growth of the endometrium which can lead to endometrial hyperplasia and possibly cancer over the long-term.
estradiol 17 beta-cypionate		17beta-Estradiol 17-cyclopentylpropionate					
estradiol 3-benzoate	50-50-0	Estradiol Benzoate	50-50-0	1S4CJB5ZGN	Contraceptive Agents, Hormonal	Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)	Estradiol benzoate is not currently available in any FDA or Health Canada approved products.
estradiol 3,17-disulfate	3233-70-3	17-Beta-Estradiol-3,17-beta-sulfate	3233-70-3	SF3WLQ8DVX			
estradiol benzoate, testosterone propionate drug combination		estradiol benzoate, testosterone propionate drug combination					
Estradiol Congeners		Estradiol Congeners					
estradiol dipropionate	113-38-2	Estradiol dipropionate	113-38-2	NIG5418BXB			
estradiol sulfate	28814-94-0	Estra-1,3,5(10)-triene-3,17-diol (17beta)-, hydrogen sulfate	28814-94-0				
estradiol valerate-dienogest		Qlaira					
estradiol-16	1090-04-6	Estradiol-16	1090-04-6				
estradiol-17 beta-3-methyl ether	1035-77-4	Estradiol 3-methyl ether	1035-77-4	0BQ383G656			
estradiol-17 beta-benzoate	983-30-2	17beta-Estradiol benzoate	983-30-2	3GFX41Z289			
estradiol-17 beta-glucuronide	1806-98-0	Estradiol-17beta-glucuronide	1806-98-0				
estradiol-17-benzoate		estradiol-17-benzoate					
estradiol-3-glucuronide	15270-30-1	17beta-Estradiol 3-(beta-D-glucuronide)	15270-30-1	32835P5TLT			
estradiol-3,4-quinone		Estradiol-3,4-quinone	144082-88-2				
estradiol-bovine serum albumin		estradiol-bovine serum albumin					
estradiol, norethindrone drug combination		Mesigyna	99897-30-0				
estragole	140-67-0	Estragole	140-67-0	9NIW07V3ET			
Estramustine	2998-57-4	Estramustine	2998-57-4	35LT29625A	Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	For the palliative treatment of patients with metastatic and/or progressive carcinoma of the prostate
Estranes		Estranes					
Estrenes		Estrenes					
Estriol	50-27-1	Estriol	50-27-1	FB33469R8E			Used as a test to determine the general health of an unborn fetus.
estriol 17-glucuronide	7219-89-8	16alpha,17beta-Estriol 17-(beta-D-glucuronide)	7219-89-8				
estriol 3-glucuronide	2479-91-6	Estriol 3-glucuronide	2479-91-6				
estriol glucuronide	28808-07-3	Estriol glucuronide	28808-07-3				
estriol-16 alpha-(beta-D-glucuronide)	1852-50-2	16-Glucuronide-estriol	1852-50-2				
Estrogens		Cenestin	12126-59-9	7XY8FW3E68			
Estrogens, Catechol		Estrogens, Catechol					
Estrogens, Conjugated (USP)		Estrogens, Conjugated (USP)					
Estrone	53-16-7	Estrone	53-16-7	2DI9HA706A	Estrogens	Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. (See all compounds classified as Estrogens.)	For management of perimenopausal and postmenopausal symptoms.
estrone benzoate	2393-53-5	Estrone benzoate	2393-53-5	O636LYL5W8			
estrone sulfate	481-97-0	Estrone sulfate	481-97-0	QTL48N278K			Estropipate is used for the treatment of moderate to severe vasomotor symptoms associated with the monopause, and moderate to severe symptoms of vulval and vaginal atrophy associated with the menopause. It is also used to treat hypoestrogenism due to hypogonadism, castration or primary ovarian failure, and prevent postmenopausal osteoporosis.
estrone-3-glucuronide	2479-90-5	Estrone glucuronide	2479-90-5	933Q277TO2			
estrone-3-O-sulfamate	148672-09-7	Emate	148672-09-7		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
estropipate	7280-37-7	Estropipate	7280-37-7	SVI38UY019	Contraceptive Agents, Hormonal	Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)	
esuprone	91406-11-0	Esuprone	91406-11-0	K7EB9E48ZE			
etafenone	90-54-0	Etafenone	90-54-0	0I14K589E7	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
Etanidazole	22668-01-5	Etanidazole	22668-01-5	30DKA3Q1HL	Radiation-Sensitizing Agents	Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. (See all compounds classified as Radiation-Sensitizing Agents.)	
Etazolate	51022-77-6	Etazolate	51022-77-6	I89Y79062L	Phosphodiesterase Inhibitors	Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)	
eteplirsen		Eteplirsen [USAN:INN]					
ETH 615	133430-69-0	4-[[N-[(3-fluorophenyl)methyl]-4-(quinolin-2-ylmethoxy)anilino]methyl]benzoic acid	133430-69-0				
Ethacridine	442-16-0	Ethacridine	442-16-0	WIX85M1A6R	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
Ethacrynic Acid	58-54-8	Ethacrynic acid	58-54-8	M5DP350VZV	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	For the treatment of high blood pressure and edema caused by diseases like congestive heart failure, liver failure, and kidney failure.
ethafluralin	55283-68-6	Ethalfluralin	55283-68-6	51DKA727XQ			
Ethambutol	74-55-5	Ethambutol	74-55-5	8G167061QZ	Antitubercular Agents	Drugs used in the treatment of tuberculosis. They are divided into two main classes: &quot;first-line&quot; agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and &quot;second-line&quot; drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. (See all compounds classified as Antitubercular Agents.)	Ethambutol is indicated in combination with other anti-tuberculosis drugs in the treatment of pulmonary tuberculosis. Ethambutol is commonly used in combination with [isoniazid], [rifampin], and [pyrazinamide].
Ethane	74-84-0	Ethane	68527-16-2	L99N5N533T			
Ethanol	64-17-5	Ethanol	64-17-5	3K9958V90M	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	For therapeutic neurolysis of nerves or ganglia for the relief of intractable chronic pain in such conditions as inoperable cancer and trigeminal neuralgia (tic douloureux), in patients for whom neurosurgical procedures are contraindicated.
Ethanolamine	141-43-5	Monoethanolamine	141-43-5	5KV86114PT			
ethanolamine O-sulfate	926-39-6	2-Aminoethyl hydrogen sulfate	926-39-6	9C8F910HLK	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
ethaverine		Ethaverine	486-47-5	2H2HC19DYZ	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	
ethephon	16672-87-0	Ethephon	16672-87-0	XU5R5VQ87S	Plant Growth Regulators	Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins. (See all compounds classified as Plant Growth Regulators.)	
Ether		Diethyl Ether	69227-20-9	0F5N573A2Y	Solvents	Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant and Hackh&apos;s Chemical Dictionary, 5th ed) (See all compounds classified as Solvents.)	
Ethidium	3546-21-2	Ethidium	3546-21-2	EN464416SI	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
Ethinyl Estradiol	57-63-6	Ethinyl Estradiol	57-63-6	423D2T571U	Contraceptives, Oral, Hormonal	Oral contraceptives which owe their effectiveness to hormonal preparations. (See all compounds classified as Contraceptives, Oral, Hormonal.)	Ethinylestradiol is combined with other drugs for use as a contraceptive, premenstrual dysphoric disorder, moderate acne, moderate to severe vasomotor symptoms of menopause, prevention of postmenopausal osteoporosis.
ethinyl estradiol glucuronide		Ethinyl estradiol glucuronide	86571-05-3				
ethinyl estradiol-desogestrel combination		Desogestrel and ethinyl estradiol	71138-35-7				
Ethinyl Estradiol-Norgestrel Combination	8056-51-7	Ovral	39366-37-5				
ethinyl estradiol, levonorgestrel drug combination		Ovral	39366-37-5				
ethion	563-12-2	Ethion	563-12-2	2TI07NO12Y	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Ethionamide	536-33-4	Ethionamide	536-33-4	OAY8ORS3CQ	Antitubercular Agents	Drugs used in the treatment of tuberculosis. They are divided into two main classes: &quot;first-line&quot; agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and &quot;second-line&quot; drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. (See all compounds classified as Antitubercular Agents.)	For use in the treatment of pulmonary and extrapulmonary tuberculosis when other antitubercular drugs have failed.
Ethionine	13073-35-3	L-Ethionine	13073-35-3	WX1BN24WZT	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	
ethirimol	23947-60-6	Ethirimol	23947-60-6	ZFF86Y4NA6			
Ethisterone	434-03-7	Ethisterone	434-03-7	P201BVY1MJ			
ethofenprox	80844-07-1	Etofenprox	80844-07-1	0LD7P9153C			
ethofumesate		Ethofumesate	26225-79-6	3051U1Z8KV	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
ethohexadiol	94-96-2	2-Ethyl-1,3-hexanediol	94-96-2	M9JGK7U88V			
ethoprop	13194-48-4	Ethoprophos	13194-48-4	765Y5683OQ			
Ethosuximide	77-67-8	Ethosuximide	77-67-8	5SEH9X1D1D	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	For the treatment of petit mal epilepsy.
ethotoin		Ethotoin	86-35-1	46QG38NC4U	Voltage-Gated Sodium Channel Blockers	A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)	For the control of tonic-clonic (grand mal) and complex partial (psychomotor) seizures.
ethoxyacetic acid	627-03-2	Ethoxyacetic acid	627-03-2	467VW095BX			
Ethoxyquin	91-53-2	Ethoxyquin	91-53-2	9T1410R4OR			
Ethoxzolamide	452-35-7	Ethoxzolamide	452-35-7	Z52H4811WX	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	For use in the treatment of duodenal ulcers, as a diuretic, and in the treatment of glaucoma, and may also be useful in the treatment of seizures associated with epilepsy.
ethyl (5-(diethylglycyl)-10,11-dihydro-5H-dibenzo(b,f)azepin-3-yl)carbamate		ethyl (5-(diethylglycyl)-10,11-dihydro-5H-dibenzo(b,f)azepin-3-yl)carbamate					
ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate	4450-98-0	1-Benzyl-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylic acid ethyl ester	4450-98-0	MW8LQ9P85C			
ethyl 2-(4-chlorophenyl)-5-(2-furyl)-4-oxzoleacetate	88352-44-7	Ethyl 2-(4-chlorophenyl)-5-(2-furyl)oxazole-4-acetate	88352-44-7				
ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate		Ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate	65673-63-4				
ethyl 2-methyl-3-oxobutanoate	609-14-3	Ethyl 2-methylacetoacetate	609-14-3	NE9WOZ20JE			
ethyl 3-phenylglycidate	121-39-1	Ethyl 3-phenylglycidate	121-39-1	2VVS520ZWM			
ethyl 4-(4-((2-hydroxy-3-(4-hydroxy-3-((methylsulfonyl)amino)phenoxy)propyl)amino)cyclohexyl)benzoate		ethyl 4-(4-((2-hydroxy-3-(4-hydroxy-3-((methylsulfonyl)amino)phenoxy)propyl)amino)cyclohexyl)benzoate					
ethyl 4-methoxycinnamate		Ethyl p-methoxycinnamate	1929-30-2	SD418S06XD			
ethyl 4-nitrophenyl methylphosphonate	3735-98-6	Ethyl 4-nitrophenyl methylphosphonate	3735-98-6				
ethyl 5-(4,6-dimethoxypyrimidin-2-ylcarbamoylsulfamoyl)-1-methylpyrazole-4-carboxylate		Pyrazosulfuron-ethyl	93697-74-6	3K2T2626KI	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzo(1,8)naphthyridine-3-carboxylate		ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzo(1,8)naphthyridine-3-carboxylate					
ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate		ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate					
ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate		ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate					
ethyl acetate	141-78-6	Ethyl Acetate	141-78-6	76845O8NMZ			
ethyl acrylate	140-88-5	Ethyl acrylate	9003-32-1	71E6178C9T	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Ethyl Biscoumacetate	548-00-5	Ethyl biscoumacetate	548-00-5	08KL644731	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	
ethyl bromophos	4824-78-6	Bromophos-ethyl	4824-78-6	CVT4KYL79N			
ethyl caffeate	102-37-4	Ethyl caffeate	66648-50-8	76GBB1JU5Y			
ethyl cinnamate	103-36-6	Ethyl cinnamate	103-36-6	C023P3M5JJ			
ethyl ferulate	4046-02-0	Ethyl ferulate	4046-02-0	5B8915UELW			
ethyl hexanoate	123-66-0	Ethyl hexanoate	123-66-0	FLO6YR1SHT			
ethyl maltol	4940-11-8	Ethyl maltol	4940-11-8	L6Q8K29L05			
Ethyl Methanesulfonate	62-50-0	Ethyl methanesulfonate	62-50-0	9H154DI0UP	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	
ethyl methylphosphonic acid	1832-53-7	Ethyl methylphosphonate	1832-53-7	921S33S5Y5			
ethyl myristate	124-06-1	Ethyl tetradecanoate	124-06-1	6995S49749			
ethyl N-allyl-N-(2-methyl-3-(4-(4-amidinophenoxycarbonyl)phenyl)propenoyl)aminoacetate methanesulfonate		CID 6442224	181586-07-2				
ethyl octylphosphonofluoridate		Ethyl octylphosphonofluoridate	171741-11-0				
ethyl protocatechuate	3943-89-3	Ethyl 3,4-dihydroxybenzoate	3943-89-3	4YGJ96WTBG			
ethyl pyruvate	617-35-6	Ethyl pyruvate	617-35-6	03O98E01OB			Investigated for use/treatment in burns and burn infections, cardiac surgery, inflammatory disorders (unspecified), ischemic reperfusion injury, and sepsis and septicemia.
ethyl salicylate	118-61-6	Ethyl salicylate	118-61-6	555U6TZ2MV			
ethyl tert-butyl ether	637-92-3	tert-Butyl ethyl ether	637-92-3	3R9B16WR19			
ethyl vanillin	121-32-4	Ethyl vanillin	121-32-4	YC9ST449YJ			
ethyl-1-(4-(2*3*3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate		ethyl-1-(4-(2*3*3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate					
ethyl-3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate		ethyl-3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate					
ethyl-3-(N-n-butyl-N-acetyl)aminopropionate		Ethyl Butylacetylaminopropionate	52304-36-6	65GQA237EH			
ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid	71441-09-3	Ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoate	71441-09-3		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
ethyl-p-hydroxybenzoate	120-47-8	Ethylparaben	9001-05-2	14255EXE39			
ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate		ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate					
ethylamine	75-04-7	Ethylamine	75-04-7	YG6MGA6AT5			
ethylbenzene	100-41-4	Ethylbenzene	100-41-4	L5I45M5G0O			
ethylcholine aziridinium	63918-37-6	Ethylcholine aziridinium	63918-37-6	A668M9E227	Neuromuscular Blocking Agents	Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc. (See all compounds classified as Neuromuscular Blocking Agents.)	
ethylene	74-85-1	Ethylene	9002-88-4	91GW059KN7	Plant Growth Regulators	Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins. (See all compounds classified as Plant Growth Regulators.)	
ethylene bromohydrin	540-51-2	2-Bromoethanol	540-51-2	Z33995S34R			
Ethylene Chlorohydrin	107-07-3	2-Chloroethanol	107-07-3	753N66IHAN			
Ethylene Dibromide	106-93-4	1,2-Dibromoethane	106-93-4	1N41638RNO			
ethylene dichloride	107-06-2	1,2-Dichloroethane	107-06-2	55163IJI47			
ethylene dimethacrylate	97-90-5	Glycol Dimethacrylate	25721-76-0	7BK5G69305	Cross-Linking Reagents	Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)	
ethylene dimethanesulfonate		Ethylene dimethanesulfonate	4672-49-5	EW8V7BJ66Q			
Ethylene Glycol	107-21-1	Ethylene Glycol	37225-26-6	FC72KVT52F			
ethylene glycol monohexyl ether	112-25-4	2-(Hexyloxy)ethanol	112-25-4	7P0O8282NR			
ethylene glycol monopropyl ether	2807-30-9	2-Propoxyethanol	2807-30-9	TF513KWZ2Y			
Ethylene Glycols		Ethylene Glycols					
Ethylene Oxide	75-21-8	Ethylene Oxide	75-21-8	JJH7GNN18P	Disinfectants	Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley&apos;s Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Disinfectants.)	
Ethylenebis(dithiocarbamates)		Ethylenebis(dithiocarbamates)					
ethylenediamine		Ethylenediamine	107-15-3	60V9STC53F			Ethylenediamine is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.
Ethylenethiourea	96-45-7	Ethylene thiourea	96-45-7	24FOJ4N18S			
ethylenimine quinone	526-62-5	Ethylenimine quinone	526-62-5	H7BS8U72CE			
Ethylestrenol	965-90-2	Ethylestrenol	965-90-2	ADC79EK5Q8	Anabolic Agents	These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. (See all compounds classified as Anabolic Agents.)	
ethylhexyl methoxycinnamate		Octinoxate	5466-77-3	4Y5P7MUD51	Sunscreening Agents	Chemical or physical agents that protect the skin from sunburn and erythema by absorbing or blocking ultraviolet radiation. (See all compounds classified as Sunscreening Agents.)	As an active ingredient in sunscreens and lip balms. Used for protection against damaging effects of sun rays.
ethylidene glucose	13224-99-2	4,6-O-Ethylidene-alpha-D-glucose	13224-99-2				
ethylisopropylamiloride	1154-25-2	Ethylisopropylamiloride	1154-25-2	VW50CE070T	Epithelial Sodium Channel Blockers	A subclass of sodium channel blockers that are specific for EPITHELIAL SODIUM CHANNELS. (See all compounds classified as Epithelial Sodium Channel Blockers.)	
Ethylketocyclazocine	58640-84-9	3-Cyclopropylmethyl-5-ethyl-8-hydroxy-11-methyl-3,4,5,6-tetrahydro-2H-2,6-methano-benzo[d]azocin-1-one	58640-84-9		Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	
Ethylmaleimide	128-53-0	N-ethylmaleimide	128-53-0	O3C74ACM9V	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Ethylmercuric Chloride	107-27-7	Ethylmercury chloride	107-27-7		Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Ethylmercury Compounds		Ethylmercury Compounds					
Ethylnitrosourea	759-73-9	1-Ethyl-1-nitrosourea	759-73-9	P8M1T4190R	Alkylating Agents	Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)	
ethylparaoxon		ethylparaoxon					
ethylphenidate		Ethylphenidate	57413-43-1		Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	
ethylphenylepoxygeranyl ether	37571-83-8	Ethylphenylepoxygeranyl ether	32766-80-6				
ethylphenylpropiolate	2216-94-6	Ethyl phenylpropiolate	2216-94-6	09CYB3Z9MR			
Ethynodiol Diacetate	297-76-7	Ethynodiol diacetate	297-76-7	62H10A1236	Contraceptives, Oral, Hormonal	Oral contraceptives which owe their effectiveness to hormonal preparations. (See all compounds classified as Contraceptives, Oral, Hormonal.)	For the prevention of pregnancy in women who elect to use this product as a method of contraception.
eticlopride	84226-12-0	Eticlopride	84226-12-0	J8M468HBH4	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	
Etidronic Acid	2809-21-4	Etidronic Acid	2809-21-4	M2F465ROXU	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Etidronate is indicated to treat Paget's disease of bone, as well as the treatment and prevention of heterotropic ossification after total hip replacement of spinal cord injury.
Etilefrine	709-55-7	Etilefrine	709-55-7	ZB6F8MY53V	Sympathomimetics	Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)	
Etiocholanolone	53-42-9	Etiocholanolone	53-42-9	97CGB1M48I			
etiron		s-Ethylisothiourea	2986-20-1	236P47H4VR	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
etizolam	40054-69-1	Etizolam	40054-69-1	A76XI0HL37	Tranquilizing Agents	A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes. (See all compounds classified as Tranquilizing Agents.)	Indicated for the treatment of generalized anxiety disorder with depression, panic disorder and insomnia.
Etodolac	41340-25-4	Etodolac	41340-25-4	2M36281008	Cyclooxygenase 2 Inhibitors	A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2. (See all compounds classified as Cyclooxygenase 2 Inhibitors.)	For acute and long-term management of signs and symptoms of osteoarthritis and rheumatoid arthritis, as well as for the management of pain.
etofibrate	31637-97-5	Etofibrate	31637-97-5	23TF67G79M	Hypolipidemic Agents	Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)	
Etomidate	33125-97-2	Etomidate	33125-97-2	Z22628B598	Anesthetics, Intravenous	Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) (See all compounds classified as Anesthetics, Intravenous.)	Used in the induction of general anesthesia.
etomoxir	82258-36-4	Ethyl 2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylate	82258-36-4		Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	
etonitazene	911-65-9	Etonitazene	911-65-9	9U3GT3353T			
etonogestrel		Etonogestrel	54048-10-1	304GTH6RNH	Contraceptive Agents, Female	Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. (See all compounds classified as Contraceptive Agents, Female.)	Etonogestrel is administered in subdermal implants as long-acting reversible contraception. It is known to be effective in postpartum insertion including breastfeeding women.  Etonogestrel is part of the long-acting contraceptive implants that prevent pregnancy. The implant's effect can remain for 5 years.
etoperidone	52942-31-1	Etoperidone	52942-31-1	KAI6MVO39Z			Etoperidone has been studied for the treatment of depression, tremors in Parkinson, extrapyramidal symptoms and male impotence. It is not certain if it was ever approved and marketed but its current status is withdrawn.
Etoposide	33419-42-0	Etoposide	33419-42-0	6PLQ3CP4P3	Topoisomerase II Inhibitors	Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)	For use in combination with other chemotherapeutic agents in the treatment of refractory testicular tumors and as first line treatment in patients with small cell lung cancer. Also used to treat other malignancies such as lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme.
etoposide phosphate		Etoposide Phosphate	117091-64-2	528XYJ8L1N	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
Etoricoxib	202409-33-4	Etoricoxib	202409-33-4	WRX4NFY03R	Cyclooxygenase 2 Inhibitors	A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2. (See all compounds classified as Cyclooxygenase 2 Inhibitors.)	For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout.
Etorphine	14521-96-1	Etorphine	14521-96-1	42M2Y6NU9O	Narcotics	Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)	Etorphine is only available for its use in veterinary. This main usage is related to the immobilization of large mammals.
etoxazole		Etoxazole	153233-91-1	LBE5H21G6L	Acaricides	A pesticide or chemical agent that kills mites and ticks. This is a large class that includes carbamates, formamides, organochlorines, organophosphates, etc, that act as antibiotics or growth regulators. (See all compounds classified as Acaricides.)	
ETP-45299		6-[(4-Methoxybenzyl)amino]-7-methylimidazo[1,2-b]pyridazine-3-carboxylic acid phenylamide					
Eucalyptol	470-82-6	Eucalyptol	470-82-6	RV6J6604TK	Flavoring Agents	Substances added to foods and medicine to improve the taste. (See all compounds classified as Flavoring Agents.)	
Eucalyptus Oil		1,3,3-Trimethyl-2-oxabicyclo(2.2.2)octane					
eudesmin	526-06-7	Eudesmin	526-06-7				
Eudragit RSPO		Eudragit RSPO					
Eugenol	97-53-0	Eugenol	97-53-0	3T8H1794QW	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	Eugenol is not currently available in any FDA-approved drug products. There are a number of unapproved OTC products that advertise it for the use of toothache.  Eugenol is is also commonly used in combination with zinc oxide in dental procedures for the cementation of temporary prostheses and the temporary restoration of teeth and cavities.
eugenol, zinc oxide dental cavity lining		eugenol, zinc oxide dental cavity lining					
eugenosedin-A		1-Piperazineethanol, 4-(2-chlorophenyl)-alpha-((2-methoxy-4-(1-propenyl)phenoxy)methyl)-	737005-02-6				
EUK-134		Ethylbisiminomethylguaiacol manganese chloride	81065-76-1	SM5YJ88LTU			
EUK-172		EUK-172					
EUK-189		CID 137216275					
eumelanin	12627-86-0	12627-86-0					
eupafolin		Eupafolin	520-11-6	I3O7LF3GED			
eupatilin	22368-21-4	Eupatilin	22368-21-4	4D58O05490			
eupatorin	855-96-9	Eupatorin	855-96-9	3J474AV6MY			
eupatorin-5-methyl ether		3'-Hydroxy-5,6,7,4'-tetramethoxyflavone	21764-09-0				
eurycomanone		Eurycomanone	84633-29-4	X7F43HL2HB			
eutigoside C		eutigoside C					
euxanthone	529-61-3	Euxanthone	529-61-3	QN875WE9R7			
evernic acid	537-09-7	Evernic acid	537-09-7	2EQ5W5403J			
Everolimus		Everolimus	159351-69-6	9HW64Q8G6G	MTOR Inhibitors	Agents that inhibit the activity of TOR SERINE-THREONINE KINASES. (See all compounds classified as MTOR Inhibitors.)	Everolimus is indicated for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer (advanced HR+ BC) in combination with exemestane, after failure of treatment with letrozole or anastrozole. Indicated for the treatment of adult patients with progressive neuroendocrine tumors of pancreatic origin (PNET) with unresectable, locally advanced or metastatic disease. Indicated for the treatment of adult patients with advanced renal cell carcinoma (RCC) after failure of treatment with sunitinib or sorafenib. Indicated for the treatment of adult patients with renal angiomyolipoma and tuberous sclerosis complex (TSC), not requiring immediate surgery. Indicated in pediatric and adult patients with tuberous sclerosis complex (TSC) for the treatment of subependymal giant cell astrocytoma (SEGA) that requires therapeutic intervention but cannot be curatively resected.
evodiamine	5956-87-6	Isoevodiamine	5956-87-6				
EVP 4593		6-Amino-4-(4-phenoxyphenylethylamino)quinazoline	545380-34-5				
excavatolide B		excavatolide B					
Excitatory Amino Acid Agents		Excitatory Amino Acid Agents					
Excitatory Amino Acid Agonists		Excitatory Amino Acid Agonists					
Excitatory Amino Acid Antagonists		Excitatory Amino Acid Antagonists					
exemestane	107868-30-4	Exemestane	107868-30-4	NY22HMQ4BX	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.
Exenatide	141732-76-5	Bydureon	141758-74-9		Anti-Obesity Agents	Agents that increase energy expenditure and weight loss by neural and metabolic regulation. (See all compounds classified as Anti-Obesity Agents.)	Exenatide is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes. An extended-release formulation is available which is indicated in patients 10 years old, while the immediate-acting formulation is approved only for adult patients.
exochelins		exochelins					
exoenzyme C3, Clostridium botulinum		exoenzyme C3, Clostridium botulinum					
Ezetimibe		Ezetimibe	163222-33-1	EOR26LQQ24	Anticholesteremic Agents	Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)	Ezetimibe is indicated to reduce elevated total-C, LDL-C, Apo B, and non-HDL-C in patients with primary hyperlipidemia, alone or in combination with an HMG-CoA reductase inhibitor (statin). It is also indicated to reduce elevated total-C, LDL-C, Apo B, and non-HDL-C in patients with mixed hyperlipidemia in combination with fenofibrate, and to reduce elevated total-C and LDL-C in patients with homozygous familial hypercholesterolemia (HoFH), in combination with atorvastatin or simvastatin. Ezetimibe may also be used to reduce elevated sitosterol and campesterol in patients with homozygous sitosterolemia (phytosterolemia).
EZN 2968		EZN 2968					
ezogabine	150812-12-7	Retigabine	150812-12-7	12G01I6BBU	Membrane Transport Modulators	Agents that affect ION PUMPS; ION CHANNELS; ABC TRANSPORTERS; and other MEMBRANE TRANSPORT PROTEINS. (See all compounds classified as Membrane Transport Modulators.)	Adjuvant treatment of partial-onset seizures.
F 12509A		CID 9862964	191608-64-7				
F-180 vasoconstrictor peptide		F-180 vasoconstrictor peptide					
F-amidine		F-amidine					
F14512		F14512					
F2-Isoprostanes		F2-Isoprostanes					
Fadrozole	102676-47-1	Fadrozole	102676-47-1	H3988M64PU	Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	
falcarindiol	55297-87-5	1,9-Heptadecadiene-4,6-diyne-3,8-diol	55297-87-5	8G3AW3GYU8			
falcarinol	21852-80-2	Falcarinol	21852-80-2	8P1DJD416I			
famophos	52-85-7	Famphur	52-85-7	02UOP4Z0O0	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Famotidine	76824-35-6	Famotidine	76824-35-6	5QZO15J2Z8	Histamine H2 Antagonists	Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (See all compounds classified as Histamine H2 Antagonists.)	Famotidine is indicated in pediatric and adult patients (with the bodyweight of 40 kg and above) for the management of active duodenal ulcer (DU), active gastric ulcer, symptomatic non-erosive gastroesophageal reflux disease (GERD), and erosive esophagitis due to GERD, diagnosed by biopsy.  It is also indicated in adult patients for the treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison Syndrome, multiple endocrine neoplasias) and reduction of the risk of DU recurrence.  The intravenous formulation of famotidine is available for some hospitalized patients with pathological hypersecretory conditions or intractable ulcers or as an alternative to the oral dosage form for short-term use in patients who are unable to take oral medication.  Over-the-counter famotidine is used for the management and prevention of heartburn caused by gastroesophageal reflux in children and adults. Off-label uses of famotidine include the reduction of NSAIDs-associated gastrointestinal effects, treatment of refractory urticarial, prevention of stress ulcer in critically-ill patients, and symptomatic relief of gastritis.
famoxadone		Famoxadone	131807-57-3	V1C07OR6II			
fananserin		Fananserin	127625-29-0	38QJ762ET6	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
FANFT	24554-26-5	Fanft	24554-26-5	7N99PZG62O			
fangchinoline		Fangchinoline	436-77-1	953592C3ZB			
Fangfeng		Saposhnikovia divaricata (turcz.) schischk., root					
Fantagen-rubine	16889-10-4	Disperse Red 73	16889-10-4	74YM5L40XM			
fargesin		Fargesin	68296-27-5	GR9853GI71			
farglitazar		Farglitazar	196808-45-4	3433GY7132			
farnesal		Farnesal	502-67-0	G4E58106EW			
farnesoic acid		Farnesoic acid	462-11-3	98SID9VM1V			
Farnesol	4602-84-0	trans,trans-Farnesol	4602-84-0	X23PI60R17			
farnesyl pyrophosphate	13058-04-3	Farnesyl diphosphate	372-97-4	79W6B01D07			
farnesylthiosalicylic acid		Salirasib	162520-00-5	MZH0OM550M	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
farrerol	24211-30-1	5,7-Dihydroxy-2-(4-hydroxyphenyl)-6,8-dimethylchroman-4-one	24211-30-1				
fascaplysine	114719-57-2	Fascaplysine	114719-57-2				
fasciculin	86697-68-9	Fasciculin					
Fast Green FCF	2353-45-9	Fast Green FCF	2353-45-9	9J3VQ0Y6BV			
fasudil	103745-39-7	Fasudil	103745-39-7	Q0CH43PGXS	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
Fat Emulsions, Intravenous		Fat Emulsions, Intravenous					
Fat Substitutes		Fat Substitutes					
fatostatin		Fatostatin	125256-00-0				
Fats		Fats					
Fats, Unsaturated		Fats, Unsaturated					
Fatty Acids		Fatty Acids					
Fatty Acids, Essential		Fatty Acids, Essential					
Fatty Acids, Monounsaturated		Fatty Acids, Monounsaturated					
Fatty Acids, Nonesterified		Fatty Acids, Nonesterified					
Fatty Acids, Omega-3		Fatty Acids, Omega-3					
Fatty Acids, Omega-6		Fatty Acids, Omega-6					
Fatty Acids, Unsaturated		Fatty Acids, Unsaturated					
Fatty Acids, Volatile		Fatty Acids, Volatile					
favipiravir		2-Pyrazinecarboxamide, 6-fluoro-3-hydroxy-					
FCE 23884	107052-56-2	Romergoline	107052-56-2	I4880ZI08R			
FD137 nitrosourea		FD137 nitrosourea					
FDU-PB-22		Fdu-PB-22	1883284-94-3	85E88884ZQ			
FdUMP(10)		FdUMP(10)					
Fe(III)-EDTA		Iron(III)-edta	15275-07-7		Iron Chelating Agents	Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. (See all compounds classified as Iron Chelating Agents.)	
febantel	58306-30-2	Febantel	58306-30-2	S75C401OS1	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	
Febuxostat		Febuxostat	144060-53-7	101V0R1N2E	Gout Suppressants	Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout. (See all compounds classified as Gout Suppressants.)	Febuxostat is indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of [allopurinol], who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable. It is not recommended for the treatment of asymptomatic hyperuricemia or secondary hyperuricemia.
FEC protocol		CEF regimen					
FeCl tetrakis-2-(triethyleneglycolmonomethylether)pyridylporphyrin		FeCl tetrakis-2-(triethyleneglycolmonomethylether)pyridylporphyrin					
fedotozine	123618-00-8	Fedotozine	123618-00-8	F45VW2087W			
fedratinib		Fedratinib	936091-26-8	6L1XP550I6			Fedratinib is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis.
Feitai		Feitai					
Felbamate	25451-15-4	Felbamate	25451-15-4	X72RBB02N8	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	For use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use.
Felodipine	72509-76-3	Felodipine	72509-76-3	OL961R6O2C	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the treatment of mild to moderate essential hypertension.
fenamic acid	91-40-7	N-phenylanthranilic acid	91-40-7	952VN06WBB	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
fenamidone		Fenamidone	161326-34-7	DN24MG2Z5E	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
fenamiphos		Fenamiphos	22224-92-6	H4NO3L2HBE	Pesticides	Chemicals used to destroy pests of any sort. The concept includes fungicides (FUNGICIDES, INDUSTRIAL); INSECTICIDES; RODENTICIDES; etc. (See all compounds classified as Pesticides.)	
fenarimol	60168-88-9	Fenarimol	60168-88-9	O088GU930Q	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
fenazaquin	120928-09-8	Fenazaquin	120928-09-8	DK5Q534WEE			
Fenbendazole	43210-67-9	Fenbendazole	43210-67-9	621BVT9M36	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	For the treatment and control of gastro-intestinal nematodes in pigs infected with: Ascaris suum (adult, intestinal and migrating larval stages); Oesophagostomum spp. (adult stages); Trichuris suis (adult stages). For the treatment of gastro-intestinal nematodes in chickens infected with: Ascaridia galli (L5 and adult stages); Heterakis gallinarum (L5 and adult stages); Capillaria spp. (L5 and adult stages).
fenbuconazole		Fenbuconazole	114369-43-6	P9P3C2AL0Z	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
fenbufen	36330-85-5	Fenbufen	36330-85-5	9815R1WR9B	Cyclooxygenase Inhibitors	Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)	
fenchone	1195-79-5	Fenchone	1195-79-5				
Fendiline	13042-18-7	Fendiline	13042-18-7	S253D559A8	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
Fenfluramine	458-24-2	Fenfluramine	458-24-2	2DS058H2CF	Serotonin Agents	Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons. (See all compounds classified as Serotonin Agents.)	Fenfluramine is indicated for the treatment of seizures associated with Dravet syndrome and  Lennox-Gastaut syndrome in patients aged two years and older.
fenfluthrin	67640-14-6	2,3,4,5,6-Pentafluorobenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate	67640-14-6				
fenitrooxone	2255-17-6	Fenitrooxone	2255-17-6				
Fenitrothion	122-14-5	Fenitrothion	122-14-5	W8M4X3Y7ZY	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
fenobam		3-(3-chlorophenyl)-1-(1-methyl-4-oxo-5H-imidazol-2-yl)urea	57653-26-6				
Fenofibrate	49562-28-9	Fenofibrate	49562-28-9	U202363UOS	Hypolipidemic Agents	Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)	Fenofibrate is indicated as adjunctive therapy to diet to reduce elevated LDL-C, Total-C, Triglycerides, and Apo B, and to increase HDL-C adults with primary hypercholesterolemia or mixed dyslipidemia. Fenofibrate is also indicated to treat adults with severe hypertriglyceridemia.
fenofibric acid	26129-32-8	Clofop	26129-32-8	KIH4IO8Q8Z	Anticholesteremic Agents	Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)	
Fenoldopam	67227-56-9	Fenoldopam	67227-56-9	INU8H2KAWG	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	For the in-hospital, short-term (up to 48 hours) management of severe hypertension when rapid, but quickly reversible, emergency reduction of blood pressure is clinically indicated, including malignant hypertension with deteriorating end-organ function.
Fenoprofen	31879-05-7	Fenoprofen	29679-58-1	RA33EAC7KY	Cyclooxygenase Inhibitors	Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)	For relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Also for the relief of mild to moderate pain.
fenoprop	93-72-1	2-(2,4,5-Trichlorophenoxy)propionic acid	93-72-1	D2HZL58IS3			
Fenoterol	13392-18-2	Fenoterol	13392-18-2		Bronchodilator Agents	Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)	Fenoterol is used for the treatment of asthma.
fenoverine	37561-27-6	Fenoverine	37561-27-6	N274ZQ6PZJ	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	
fenoxycarb	72490-01-8	Fenoxycarb	72490-01-8	JEN0LSV1G9	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
fenpropathrin		Fenpropathrin	39515-41-8	87BH96P0MX			
fenpropidine	67306-00-7	Fenpropidin	67306-00-7	845XW54F31	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
fenpropimorph	67306-03-0	4-[3-(4-tert-Butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine	67306-03-0		Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
fenproporex	16397-28-7	Fenproporex	16397-28-7	W0194S5FOA			Fenproporex is used as an appetite suppressant, and anti-obesity agent [2]; however, due to substance abuse potential, it is an illicit substance in many countries. In some countries, such as Brazil, it is still prescribed -- often in the form of diet pills (ie. Brazilian Diet Pills) which combine amphetamines, benzodiazepines, antidepressants, diuretics and laxatives.   In the United States the sale of such diet pills has been banned due to concerns over side effects, and the risk of potentially fatal overdose. However, internet sales and illicit markets has lead to international availability. It has been found by primary care physicians that Brazilian immigrant women utilized imported diet pills at particularly high rates, and sometimes suffered from side effects requiring hospitalization or experienced a loss of employment. [3]
fenpyroximate	134098-61-6	Fenpyroximate	134098-61-6	9W557V4RYA			
Fenretinide	65646-68-6	Fenretinide	65646-68-6	187EJ7QEXL	Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	Investigated for use/treatment in macular degeneration.
fensulfothion	115-90-2	Fensulfothion	115-90-2	VB39B105PO			
Fentanyl	437-38-7	Fentanyl	437-38-7	UF599785JZ	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	Fentanyl intravenous or intramuscular injections are indicated for short term analgesia during induction, maintenance, and recovery from general or regional anesthesia. These injections are also used with a neuroleptic for premedication, induction, and as an adjunct to maintenance of anesthesia. Finally, fentanyl intravenous or intramuscular injections are used with oxygen for anesthesia in high risk patients.  Fentanyl sublingual tablets, transmucosal lozenges, buccal tablets, sublingual sprays, transdermal systems, and nasal sprays are indicated for the management of breakthrough pain in opioid tolerant cancer patients who require around the clock pain management.
Fenthion	55-38-9	Fenthion	55-38-9	BL0L45OVKT	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
fentichlor	97-24-5	Fenticlor	97-24-5	D61659OVD0			
Fenton's reagent		Fenton's reagent	36047-38-8				
fenugreek seed meal	68990-15-8	Extract of fenugreek					
fenvalerate	51630-58-1	Fenvalerate	51630-58-1	Z6MXZ39302	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
ferbam	14484-64-1	Ferbam	14484-64-1	SKM8W5154H			
Ferene-S	79551-14-7	Ferene	79551-14-7				
ferric 8-hydroxyquinoline		ferric 8-hydroxyquinoline					
ferric ammonium citrate	1185-57-5	Ammonium iron(III) citrate	1185-57-5				
ferric chloride	7705-08-0	Ferric Chloride	7705-08-0	U38V3ZVV3V	Noxae	Agents capable of exerting a harmful effect on the body. (See all compounds classified as Noxae.)	
ferric citrate	3522-50-7	Ferric citrate	2338-05-8	63G354M39Z			Fexeric is indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease (CKD).
Ferric Compounds		Ferric Compounds					
ferric nitrate	10421-48-4	Ferric nitrate	10421-48-4	N8H8402XOB			
ferric nitrilotriacetate	16448-54-7	Ferric nitrilotriacetate	16448-54-7	Z3U5ED15B9	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
ferric oxide	1309-37-1	1309-37-1					
Ferric Oxide, Saccharated	8047-67-4	Iron saccharate	8047-67-4		Hematinics	Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias. (See all compounds classified as Hematinics.)	
ferric pyrophosphate	10058-44-3	Ferric pyrophosphate	10402-25-2	QK8899250F			Ferric pyrophosphate is intended to be indicated for the treatment of iron loss or iron deficiency as a formulation with a milder gastrointestinal effect.   Iron deficiency appears when the dietary intake does not meet the body's requirement or when there is chronic external blood loss. During acute blood loss, body iron stores are sufficient for accelerated erythropoiesis and restoration of iron homeostasis. But when the altered homeostasis remains for weeks to months then some supplement is needed. Some causes of iron deficiency include ectoparasitism, endoparasitism, hematuria, epistaxis, hemorrhagic skin, coagulopathy, thrombocytopenia, thrombocytopathia and gastrointestinal hemorrhage.
ferric sulfate	10028-22-5	Ferric Sulfate	10028-22-5	3HWS7HF5XD			Ferric sulfate was first used in dermatology as part of the Monsel's solution. This solution is an antihemorrhagic agent used in skin and mucosal biopsies. The use of ferric sulfate in dermatology is under review as ferric sulfate is corrosive and injurious and it can cause degenerative changes that are not observed with other alternatives like collagen.  Ferric sulfate is also used as a coagulative and hemostatic agent. It is a mechanic hemostatic agent used directly on the damaged tissue.  In dentistry, ferric sulfate is used as a pulpotomy medicament to control pulpal bleeding, as an antibacterial agent and as a hemostatic reagent for restorative dentistry, for postextraction hemorrhage and for periradicular and endodontic surgery.
ferric-adenosine triphosphate complex	99125-17-4	[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate;iron	99125-17-4				
ferric-sorbitol-citrate		Ferric-sorbitol citrate					
Ferrichrome	15630-64-5	N-[3-[5,8-bis[3-[acetyl(hydroxy)amino]propyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]propyl]-N-hydroxyacetamide	15630-64-5				
ferrite	1317-54-0	Ferrite					
ferrocene	102-54-5	Iron, bis(eta5-2,4-cyclopentadien-1-yl)-	102-54-5	U96PKG90JQ			
Ferrosoferric Oxide		1317-61-9					
ferrostatin-1		Ethyl 3-amino-4-(cyclohexylamino)benzoate	347174-05-4				
ferrous chloride	7758-94-3	Ferrous Chloride	7758-94-3	S3Y25PHP1W			
ferrous citrate		Ferrous citrate	23383-11-1	33KM3X4QQW	Trace Elements	A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)	
Ferrous Compounds		Ferrous Compounds					
ferrous oxide	1345-25-1	Ferrous oxide	1345-25-1				
ferrous sulfate		Ferrous Sulfate	7720-78-7	2IDP3X9OUD			Ferrous sulfate is used for the prevention and treatment of iron deficiency anemia in adults and children.
Ferrozine	28048-33-1	Ferrozine	28048-33-1	29J2CIW9PK	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
ferruginol		Ferruginol	514-62-5	N2CMM6X37M			
ferulenol	6805-34-1	Ferulenol	6805-34-1	TG6L57MGV9			
ferulic acid	1135-24-6	Ferulic acid	1135-24-6	AVM951ZWST	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
ferulinolol		Ferulinolol					
feruloyltyramine	65646-26-6	N-Trans-feruloyltramine	66648-43-9	WC99S6JM5Y			
ferumoxides	119683-68-0	Ferumoxides	119683-68-0	XM0M87F357	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	
ferumoxtran-10		ferumoxtran-10					
fexaramine		Fexaramine	574013-66-4	WTG9GFA65U			
fexofenadine		Fexofenadine	83799-24-0	E6582LOH6V	Histamine H1 Antagonists, Non-Sedating	A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. (See all compounds classified as Histamine H1 Antagonists, Non-Sedating.)	In the United States, fexofenadine is indicated for the symptomatic treatment of allergic rhinitis in patients 2 years old and chronic idiopathic urticaria in patients 6 months old. In Canada, fexofenadine carries the same indications but is approved only for patients 12 years old. Fexofenadine is also available in combination with [pseudoephedrine] for the symptomatic treatment of season allergic rhinitis in patients 12 years old.
FG 0041		FG 0041					
FG 7142	78538-74-6	N-Methyl-beta-carboline-3-carboxamide	78538-74-6	60PO70N1BP	GABA Antagonists	Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS. (See all compounds classified as GABA Antagonists.)	
FG 9041	2379-57-9	6,7-Dinitro-1,4-dihydroquinoxaline-2,3-dione	2379-57-9	62T278S1MX	Excitatory Amino Acid Antagonists	Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)	
FH535		2,5-dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide	108409-83-2				
fialuridine	69123-98-4	Fialuridine	69123-98-4	53T7IN77LC	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
fibric acid	943-45-3	2-Methyl-2-phenoxypropanoic acid	943-45-3	6848ST447Q			
Fibric Acids		Fibric Acids					
Fibrinolytic Agents		Fibrinolytic Agents					
Fibroblast Growth Factor 2	103107-01-3	103107-01-3					
Ficusin	66-97-7	Psoralen	66-97-7	KTZ7ZCN2EX	Cross-Linking Reagents	Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)	
fidarestat	136087-85-9	Fidarestat	136087-85-9	8SH8T1164U			
Fidaxomicin	56645-60-4	Fidaxomicin	873857-62-6	Z5N076G8YQ	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Fidaxomicin is indicated for the treatment of _Clostridioides_ (formerly _Clostridium_) _difficile_-associated diarrhea in adult and pediatric patients 6 months of age and older.  Fidaxomicin should only be used in patients with proven or strongly suspected _C. difficile_ infection to reduce the risk of development of drug-resistant bacteria and maximize the therapeutic effectiveness of fidaxomicin and other antimicrobial agents.
filanesib		Filanesib	885060-09-3	8A49OSO368	Antimitotic Agents	Agents that arrest cells in MITOSIS, most notably TUBULIN MODULATORS. (See all compounds classified as Antimitotic Agents.)	Investigated for use/treatment in cancer/tumors (unspecified).
Filipin	480-49-9	Filipin III	480-49-9		Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
fimasartan	247257-48-3	Fimasartan	247257-48-3	P58222188P			Used for the treatment of hypertension and heart failure.
Finasteride	98319-26-7	Finasteride	98319-26-7	57GNO57U7G	Urological Agents	Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)	Finasteride is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to improve symptoms, reduce the risk of acute urinary retention, and reduce the risk of the need for surgery including transurethral resection of the prostate (TURP) and prostatectomy. A combination product with [tadalafil] is also used for the symptomatic treatment of BPH for up to 26 weeks.  Finasteride is also indicated for the treatment of male pattern hair loss (androgenetic alopecia, hereditary alopecia, or common male baldness) in male patients.
Fingolimod Hydrochloride		Fingolimod Hydrochloride	162359-56-0	G926EC510T	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	Gilenya is indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult patients and paediatric patients aged 10 years and older: Patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections4. 4 and 5. 1). orPatients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more Gadolinium enhancing lesions on brain MRI or a significant increase in T2 lesion load as compared to a previous recent MRI.
finrozole		Finrozole	160146-17-8	40028KHQ6B			
fipexide	34161-24-5	Fipexide	34161-24-5	TG44VME01D			
fipronil	120068-37-3	Fipronil	120068-37-3	QGH063955F	Antiparasitic Agents	Drugs used to treat or prevent parasitic infections. (See all compounds classified as Antiparasitic Agents.)	
fipronil sulfone		Fipronil sulfone	120068-36-2	KE7T0T1PQ7	GABA-A Receptor Antagonists	Drugs that bind to but do not activate GABA-A RECEPTORS thereby blocking the actions of endogenous or exogenous GABA-A RECEPTOR AGONISTS. (See all compounds classified as GABA-A Receptor Antagonists.)	
Fire Trol 934		Fire Trol 934					
Firemaster 550		Firemaster 550					
Firemaster BP-6	59536-65-1	2,3,3',4,4',5'-Hexabromobiphenyl	59536-65-1	1DFM7VA843			
fisetin	528-48-3	Fisetin	528-48-3	OO2ABO9578			
Fish Oils		EINECS 232-402-9					
FK 156	76490-22-7	D-Lactyl-L-alanyl-alpha-glutamyl-(L)-meso-diaminopimelyl-(L)-glycine	76490-22-7		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
FK 175		FK 175					
FK 409	92454-60-9	(E,2Z)-4-Ethyl-2-hydroxyimino-5-nitro-hex-3-enamide	92454-60-9		Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
FK 706		L-Prolinamide, N-(4-(((carboxymethyl)amino)carbonyl)benzoyl)-L-valyl-N-(3,3,3-trifluoro-1-(1-methylethyl)-2-oxopropyl)-, monosodium salt	144055-55-0				
FK 838	131185-37-0	6-Oxo-3-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)-1(6H)-pyridazinebutyric acid	131185-37-0				
FK 888	138449-07-7	L-Alaninamide, (4R)-4-hydroxy-1-[(1-methyl-1H-indol-3-yl)carbonyl]-L-prolyl-N-methyl-3-(2-naphthalenyl)-N-(phenylmethyl)-	138449-07-7	DZQ7B7BPD4			
FK3453		6-(2-Amino-4-phenylpyrimidin-5-yl)-2-isopropylpyridazin-3(2h)-one	560111-91-3	NB2H3PD83X			
FLA 365	67759-58-4	4-(2-aminopropyl)-3,5-dichloro-N,N-dimethylaniline	67759-58-4				
Flame Retardants		Flame Retardants					
flavangenol		Flavangenol					
flavanone	487-26-3	Flavanone	487-26-3	WX22P730FB			
Flavanones		Flavanones					
Flavin Mononucleotide	146-17-8	Flavin mononucleotide	146-17-8	7N464URE7E	Vitamin B Complex	A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)	
Flavin-Adenine Dinucleotide	146-14-5	Flavin adenine dinucleotide	146-14-5	ZC44YTI8KK			Used to treat eye diseases caused by vitamin B2 deficiency, such as keratitis and blepharitis.
Flavins		CHEBI:30527					
flavocoxid		Limbrel	1206488-21-2				
flavokawain A		Flavokawain A	37951-13-6	8OM2XZ2ZM3			
flavokawain B		Flavokawain B	1775-97-9	R9WC6SM4UQ			
flavomannin-6,6'-dimethylether		flavomannin-6,6'-dimethylether					
flavone	525-82-6	Flavone	525-82-6	S2V45N7G3B			
flavone acetic acid	87626-55-9	Mitoflaxone	87626-55-9	X230G6E63B	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
Flavones		Flavones					
Flavonoids		Flavonoids					
Flavonolignans		Flavonolignans					
Flavonols		3-Hydroxyflavone	577-85-5	ZTG9LSS5QH			
Flavoring Agents		Flavoring Agents					
flazolone		p-Fluorophenyl 4-(p-fluorophenyl)-4-hydroxy-1-methyl-3-piperidyl ketone hydrochloride	34039-01-5				
FLB 457	107188-66-9	5-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,3-dimethoxybenzamide	107188-66-9		Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	
Flecainide	54143-55-4	Flecainide	54143-55-4	K94FTS1806	Voltage-Gated Sodium Channel Blockers	A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)	In New Zealand and America, flecainide is indicated to prevent supraventricular arrhythmias and ventricular arrhythmias. In the United States, it is also indicated to prevent paroxysmal atrial fibrillation and flutter.
Fleroxacin	79660-72-3	Fleroxacin	79660-72-3	N804LDH51K	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	Fleroxacin is a broad-spectrum antimicrobial fluoroquinolone.
flesinoxan	98206-10-1	CID 9909776	98206-10-1		Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	
FLLL 31		FLLL 31					
FLLL 32		FLLL 32					
flocoumafen	90035-08-8	Flocoumafen	90035-08-8				
florfenicol		Florfenicol	73231-34-2	9J97307Y1H	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
flosulide	80937-31-1	Flosulide	80937-31-1	GVR41S4ZHJ	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
Floxacillin	5250-39-5	Flucloxacillin	5250-39-5	43B2M34G2V	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Used to treat bacterial infection by susceptible microorganisms.
Floxuridine	50-91-9	Floxuridine	50-91-9	039LU44I5M	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	For palliative management of gastrointestinal adenocarcinoma metastatic to the liver, when given by continuous regional intra-arterial infusion in carefully selected patients who are considered incurable by surgery or other means. Also for the palliative management of liver cancer (usually administered by hepatic intra-arterial infusion).
fluanisone	1480-19-9	Fluanisone	1480-19-9	1D0W98U1I4	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
fluazifop-butyl	69806-50-4	Fluazifop-butyl	69806-50-4	12O1Z35LQA	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
fluazinam	79622-59-6	Fluazinam	79622-59-6	0P91PCK33Q			
flubendazole	31430-15-6	Flubendazole	31430-15-6	R8M46911LR	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	
flubendiamide		Flubendiamide	272451-65-7	GEV84ZI4K6	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Fluconazole	86386-73-4	Fluconazole	86386-73-4	8VZV102JFY	Cytochrome P-450 CYP2C19 Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C19. (See all compounds classified as Cytochrome P-450 CYP2C19 Inhibitors.)	Fluconazole can be administered in the treatment of the following fungal infections:   1) Vaginal yeast infections caused by Candida  2) Systemic Candida infections  3) Both esophageal and oropharyngeal candidiasis   4) Cryptococcal meningitis  5) UTI (urinary tract infection) by Candida  6) Peritonitis (inflammation of the peritoneum) caused by Candida  **A note on fungal infection prophylaxis**  Patients receiving bone marrow transplantation who are treated with cytotoxic chemotherapy and/or radiation therapy may be predisposed to candida infections, and may receive fluconazole as prophylactic therapy.  **A note on laboratory testing**  Obtaining specimens for fungal culture and other important laboratory studies such as serology or pathology is advised before starting fluconazole therapy in order to isolate the organisms to be eliminated through treatment. It is permissible to start therapy before the results are available, however, adjusting the therapy once laboratory results confirm the causative organism may be necessary.
flucycloxuron		Flucycloxuron	94050-52-9	V8H544MV3H			
flucythrinate	70124-77-5	Flucythrinate	70124-77-5	57D0GAO3RX			
Flucytosine	2022-85-7	Flucytosine	2022-85-7	D83282DT06	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	For the treatment (in combination with amphotericin B) of serious infections caused by susceptible strains of Candida (septicemia, endocarditis and urinary system infections) and/or Cryptococcus (meningitis and pulmonary infections).
fludarabine	21679-14-1	Fludarabine	21679-14-1	P2K93U8740	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen
fludioxonil	131341-86-1	Fludioxonil	131341-86-1	ENS9J0YM16			
Fludrocortisone	127-31-1	Fludrocortisone	127-31-1	U0476M545B	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	Fludrocortisone is indicated as partial replacement therapy for primary or secondary adrenocortical insufficiency in Addison's disease. It is also indicated for the treatment of salt-losing androgenital syndrome.
fludrocortisone acetate	514-36-3	Fludrocortisone Acetate	514-36-3	V47IF0PVH4			
fluensulfone		Fluensulfone	318290-98-1	I7V6200877			
Flufenamic Acid	530-78-9	Flufenamic acid	530-78-9	60GCX7Y6BH	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
flufenoxuron	101463-69-8	Flufenoxuron	101463-69-8	OD068OSS0N			
fluindione	957-56-2	Fluindione	957-56-2	EQ35YMS20Q	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	
Flumazenil	78755-81-4	Flumazenil	78755-81-4	40P7XK9392	GABA Modulators	Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)	For the complete or partial reversal of the sedative effects of benzodiazepines in cases where general anesthesia has been induced and/or maintained with benzodiazepines, and where sedation has been produced with benzodiazepines for diagnostic and therapeutic procedures. Also for the management of benzodiazepine overdose as an adjunct for appropriate supportive and symptomatic measures.
flumequine	42835-25-6	Flumequine	42835-25-6	UVG8VSP2SJ	Anti-Infective Agents, Urinary	Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)	
Flumethasone	2135-17-3	Flumethasone	2135-17-3	LR3CD8SX89	Glucocorticoids	A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)	For the treatment of contact dermatitis, atopic dermatitis, exczema, psoriasis, diaper rash and other skin conditions
flumethrin	69770-45-2	Flumethrin	69770-45-2	2O051W13LH			
flumetralin		Flumetralin	62924-70-3	FF3TSN8UV2			
Flunarizine	52468-60-7	Flunarizine	52468-60-7	R7PLA2DM0J	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	Used in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.
flunisolide		Flunisolide	3385-03-3	78M02AA8KF	Anti-Asthmatic Agents	Drugs that are used to treat asthma. (See all compounds classified as Anti-Asthmatic Agents.)	For the maintenance treatment of asthma as a prophylactic therapy.
Flunitrazepam	1622-62-4	Flunitrazepam	1622-62-4	620X0222FQ	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	For short-term treatment of severe insomnias, that are not responsive to other hypnotics.
flunixin		Flunixin	38677-85-9	356IB1O400	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
flunixin meglumine		Flunixin Meglumine	42461-84-7	8Y3JK0JW3U	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
Fluo-3	121714-13-4	Fluo-3	123632-39-3	23D4W0B50Y	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
Fluocinolone Acetonide	67-73-2	Fluocinolone Acetonide	67-73-2	0CD5FD6S2M	Glucocorticoids	A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)	Fluocinolone acetonide has been used extensively in different medical areas.  -In dermatology, it is extensively used for the relief of inflammatory dermatosis, dermatitis, psoriasis, hypertrophic tissues, keloid tissues and atopic dermatitis.  -It has been used in shampoo products as a low to medium potency corticosteroid for the treatment of seborrheic dermatitis of the scalp.  -In ear drops, it is used as a low to medium potency corticosteroid for the treatment of chronic eczematous external otitis in adults and pediatric patients 2 years and older.  -As an intravitreal implant, it is indicated for the treatment of diabetic macular edema with patients that have been previously treated with a course of corticosteroids and no clinically significant rise in intraocular pressure.  -Fluocinolone acetonide was announced on October 15, 2018 to be FDA approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.  -Some reports have indicated the use of fluocinolone acetonide as a vasoprotective agent and for its use in the treatment of first-degree hemorrhoids.
Fluocinonide	356-12-7	Fluocinonide	356-12-7	2W4A77YPAN	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	A topical anti-inflammatory product for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
fluor-edenite		fluor-edenite					
fluor-folpet	719-96-0	Fluorofolpet	719-96-0	JLQ9WCA0M7			
fluoranthene	206-44-0	Fluoranthene	206-44-0	360UOL779Z	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
fluorene	86-73-7	Fluorene	86-73-7	3Q2UY0968A	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
fluorene-9-bisphenol		9,9-Bis(4-hydroxyphenyl)fluorene	3236-71-3				
Fluorescein		Fluorescein	2321-07-5	TPY09G7XIR	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	For diagnostic imaging. Primarily indicated in diagnostic fluorescein angiography or angioscopy of the fundus and of the iris vasculature.
fluorescein 5-maleimide	75350-46-8	Fluorescein 5-maleimide	75350-46-8		Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
fluorescein glucuronide	74804-84-5	Fluorescein glucuronide	74804-84-5				
fluorescein isothiocyanate bovine serum albumin		fluorescein isothiocyanate bovine serum albumin					
fluorescein isothiocyanate dextran		Fluorescein isothiocyanate dextran					
Fluorescein-5-isothiocyanate	3326-32-7	Fluorescein-5-isothiocyanate	3326-32-7	I223NX31W9	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
fluorescein-methotrexate		Fluorescein Methotrexate					
Fluorescent Dyes		Fluorescent Dyes					
fluorexon	1461-15-0	Calcein	1461-15-0	V0YM2B16TS	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
Fluorides		Fluoride Ion	16984-48-8	Q80VPU408O	Cariostatic Agents	Substances that inhibit or arrest DENTAL CARIES formation. (Boucher&apos;s Clinical Dental Terminology, 4th ed) (See all compounds classified as Cariostatic Agents.)	
Fluoroacetates		Fluoroacetates					
fluoroaluminum	21330-18-7	fluoroaluminum					
Fluorobenzenes		Fluorobenzene	462-06-6	G3TSZ68K12			
Fluorocarbons		Fluorocarbons					
fluorocitrate	357-89-1	Fluorocitric acid	357-89-1				
fluoroclebopride	154540-49-5	Fluoroclebopride	154540-49-5				
Fluorodeoxyglucose F18	63503-12-8	Fludeoxyglucose F-18	63503-12-8	0Z5B2CJX4D	Radiopharmaceuticals	Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)	
fluorodeoxyuridine triphosphate		Fluorodeoxyuridine triphosphate					
Fluorodeoxyuridylate	134-46-3	5-Fluoro-2'-deoxyuridine-5'-monophosphate	134-46-3	7CJ707H131			
Fluorometholone	426-13-1	Fluorometholone	426-13-1	SV0CSG527L	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	For the ophthalmic treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.
fluoroneplanocin A		fluoroneplanocin A					
fluorophene	4776-06-1	Fluorosalan	4776-06-1	80OFG3WPYD			
Fluoroquinolones		Fluoroquinolones					
fluorotelomer alcohols		fluorotelomer alcohols					
fluorotelomer sulfonic acids		fluorotelomer sulfonic acids					
Fluorouracil	51-21-8	Fluorouracil	51-21-8	U3P01618RT	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	For the topical treatment of multiple actinic or solar keratoses. In the 5% strength it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites. Fluorouracil injection is indicated in the palliative management of some types of cancer, including colon, esophageal, gastric, rectum, breast, biliary tract, stomach, head and neck, cervical, pancreas, renal cell, and carcinoid.
fluoxastrobin		Fluoxastrobin	361377-29-9	XQ43WY091Y	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Fluoxetine	54910-89-3	Fluoxetine	54910-89-3	01K63SUP8D	Cytochrome P-450 CYP2D6 Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2D6. (See all compounds classified as Cytochrome P-450 CYP2D6 Inhibitors.)	Fluoxetine is indicated for both acute and maintenance treatment of major depressive disorder, obsessive compulsive disorder, and bulimia nervosa; however, it is only indicated for acute treatment of panic disorder independent of whether agoraphobia is present. Fluoxetine may also be used in combination with olanzapine to treat depression related to Bipolar I Disorder, and treatment resistant depression. Fluoxetine is additionally indicated for the treatment of female patients with premenstrual dysphoric disorder (PMDD).
Fluoxymesterone	76-43-7	Fluoxymesterone	76-43-7	9JU12S4YFY	Anabolic Agents	These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. (See all compounds classified as Anabolic Agents.)	In males, used as replacement therapy in conditions associated with symptoms of deficiency or absence of endogenous testosterone. In females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal.
Flupenthixol	2709-56-0	trans-Flupentixol	2709-56-0	895OJP78MJ	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	Flupentixol is indicated for maintenance therapy of chronic schizophrenic patients whose main manifestations do not include excitement, agitation or hyperactivity.  It is indicated for the management of depression in adult patients who may, or may not, also be showing signs of anxiety.  Flupentixol in combination with [melitracen] is indicated to manage symptoms of anxiety, depression, and asthenia in adults.
fluphenacur	103055-07-8	Lufenuron	103055-07-8	4629851K7Q	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Fluphenazine	69-23-8	Fluphenazine	69-23-8	S79426A41Z	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	For management of manifestations of psychotic disorders.
fluphenazine-N-mustard	83016-35-7	10-[3-[4-(2-Chloroethyl)-1-piperazinyl]propyl]-2-(trifluoromethyl)phenothiazine	83016-35-7				
flupirtine	56995-20-1	Flupirtine	56995-20-1	MOH3ET196H	Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	Investigated for use/treatment in fibromyalgia.
fluprostenol		Fluprostenol	40666-16-8	358S7VUE5N	Contraceptive Agents, Hormonal	Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)	
flupyradifurone		Flupyradifurone	951659-40-8	8H7JT159D0			
Flurandrenolone	1524-88-5	Flurandrenolide	1524-88-5	8EUL29XUQT	Glucocorticoids	A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)	For relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, particularly dry, scaling localized lesions
Flurazepam	17617-23-1	Flurazepam	17617-23-1	IHP475989U	Hypnotics and Sedatives	Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)	For short-term and intermittent use in patients with recurring insomnia and poor sleeping habits
Flurbiprofen	5104-49-4	Flurbiprofen	5104-49-4	5GRO578KLP	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Flurbiprofen tablets are indicated for the acute or long-term symptomatic treatment of rheumatoid arthritis, osteorarthritis and anklosing spondylitis. It may also be used to treat pain associated with dysmenorrhea and mild to moderate pain accompanied by inflammation (e.g. bursitis, tendonitis, soft tissue trauma). Topical ophthalmic formulations may be used pre-operatively to prevent intraoperative miosis.
fluridone	59756-60-4	Fluridone	59756-60-4	3L0JQA61JX	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Flurothyl	333-36-8	Flurothyl	333-36-8	9Z467FG2YK	Convulsants	Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)	
flusilazole	85509-19-9	Flusilazole	85509-19-9	F3WG2VVD87	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Flutamide	13311-84-7	Flutamide	13311-84-7	76W6J0943E	Androgen Antagonists	Compounds which inhibit or antagonize the biosynthesis or actions of androgens. (See all compounds classified as Androgen Antagonists.)	For the management of locally confined Stage B2-C and Stage D2 metastatic carcinoma of the prostate
Fluticasone		Fluticasone	90566-53-3	CUT2W21N7U	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	Fluticasone's 2 esters are indicated as inhalers for the treatment and management of asthma by prophylaxisas well as inflammatory and pruritic dermatoses. A [DB00588] nasal spray is indicated for managing nonallergic rhinitis while the [DB08906] nasal spray is indicated for treating season and perennial allergic rhinitis.
flutolanil	66332-96-5	Flutolanil	66332-96-5	2USL6Y9JZ4			
flutriafol		Flutriafol	76674-21-0	83P8CT2Z3H	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
fluvalinate	79472-91-6	Fluvalinate	69409-94-5	364G5G03VC	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Fluvastatin	93957-54-1	Lescol	93957-54-1				To be used as an adjunct to dietary therapy to prevent cardiovascular events. May be used as secondary prevention in patients with coronary heart disease (CHD) to reduce the risk of requiring coronary revascularization procedures, for reducing progression of coronary atherosclerosis in hypercholesterolemic patients with CHD, and for the treatment of primary hypercholesterolemia and mixed dyslidipidemia.
Fluvoxamine	54739-18-3	Fluvoxamine	54739-18-3	O4L1XPO44W	Selective Serotonin Reuptake Inhibitors	Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Selective Serotonin Reuptake Inhibitors.)	Indicated predominantly for the management of depression and for Obsessive Compulsive Disorder (OCD). Has also been used in the management of bulimia nervosa.
fluxapyroxad		Fluxapyroxad	907204-31-3	7U8P4NAR2S			
FM1 43		N-(3-(triethylammonium)propyl)-4-(4-(dibutylamino)styryl)pyridinium	149838-22-2	83IGZ86I9D	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
FMRFamide	64190-70-1	Fmrfamide	64190-70-1	8953X1KZFL	Membrane Transport Modulators	Agents that affect ION PUMPS; ION CHANNELS; ABC TRANSPORTERS; and other MEMBRANE TRANSPORT PROTEINS. (See all compounds classified as Membrane Transport Modulators.)	
FND-4b		1-(3-Chloro-4-((trifluoromethyl)thio)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea					
FOE 5043	142459-58-3	Flufenacet	142459-58-3	OL44PP5145			
Foeniculum vulgare fruit							
Folfox protocol		Folfox					
Folic Acid	59-30-3	Folic Acid	59-30-3	935E97BOY8	Hematinics	Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias. (See all compounds classified as Hematinics.)	Folic acid is indicated for the treatment of folic acid deficiency, megaloblastic anemia, and in anemias of nutritional origins, pregnancy, infancy, or childhood.
Folic Acid Antagonists							
folpet	133-07-3	Folpet	133-07-3	X5NFK36917	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Fomepizole	7554-65-6	Fomepizole	7554-65-6	83LCM6L2BY	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Antizol is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning, or for use in suspected ethylene glycol or methanol ingestion, either alone or in combination with hemodialysis
fomesafen	72178-02-0	Fomesafen	72178-02-0	M0A3U4CDTF			
fomocain	17692-39-6	Fomocaine	17692-39-6	4XO7A09HQM			
Fondaparinux		Fondaparinux	104993-28-4	J177FOW5JL	Factor Xa Inhibitors	Endogenous factors and drugs that inhibit or block the activity of FACTOR XA. (See all compounds classified as Factor Xa Inhibitors.)	Approved for: (1) prophylaxis of VTE for up to one month post surgery in patients undergoing orthopedic surgery of the lower limbs such as hip fracture, hip replacement and knee surgery; (2) prophylaxis of VTE patients undergoing abdominal surgery who are at high risk of thromboembolic complications (e.g. patients undergoing abdominal cancer surgery); (3) treatment of acute DVT and PE; (4) management of UA and NSTEMI for the prevention of death and subsequent myocardial infarction (MI); and (5) management of STEMI for the prevention of death and myocardial reinfarction in patients who are managed with thrombolytics or who are initially to receive no form of reperfusion therapy. Fondaparinux should not be used as the sole anticoagulant during percutaneous coronary intervention (PCI) due to an increased risk of guiding catheter thrombosis.
Fonofos	944-22-9	Fonofos	944-22-9	P4VT8081QO	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Food Additives		Food Additives					
Food Coloring Agents		Food Coloring Agents					
Food Preservatives		Food Preservatives					
Formaldehyde	50-00-0	Formaldehyde	30525-89-4	1HG84L3525	Disinfectants	Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley&apos;s Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Disinfectants.)	Use for drying skin before or after surgical removal of warts or where dryness is required.
formamide	75-12-7	Formamide	75-12-7	4781T907ZS			
Formates		Formates					
formestane	566-48-3	Formestane	566-48-3	PUB9T8T355	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For the treatment of estrogen-receptor positive breast cancer in post-menopausal women.
formetanate	22259-30-9	Formetanate	22259-30-9	532HEC1KKM			
formic acid		Formic Acid	64-18-6	0YIW783RG1			
Formic Acid Esters		Formic Acid Esters					
formononetin	485-72-3	Formononetin	485-72-3	295DQC67BJ	Phytoestrogens	Compounds derived from plants, primarily ISOFLAVONES that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS. (See all compounds classified as Phytoestrogens.)	
formosanin C	50773-42-7	Diosgenin tetraglycoside	50773-42-7				
Formoterol Fumarate		Formoterol hemifumarate			Adrenergic beta-2 Receptor Agonists	Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)	
formycin	6742-12-7	formycin A	6742-12-7		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
formylchromone		Formylchromone					
formylmethionyl-leucyl-phenylalanine methyl ester	65929-03-5	Formylmethionyl-leucyl-phenylalanine methyl ester	65929-03-5				
forodesine		Forodesine	209799-67-7	426X066ELK			Investigated for use/treatment in lymphoma (non-hodgkin's) and leukemia (lymphoid).
Foropafant		Foropafant	136468-36-5	VWJ2QVH41J	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
forsterite		Forsterite					
forsythiaside		Forsythiaside	79916-77-1	OUH5BQ893P			
forsythoside B		Forsythoside B	81525-13-5				
fosbretabulin		Fosbretabulin	222030-63-9	I5590ES2QZ	Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	
Foscarnet	4428-95-9	Foscarnet	4428-95-9	364P9RVW4X	Reverse Transcriptase Inhibitors	Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)	For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) and for treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients.
fosetyl-Al	39148-24-8	Fosetyl-al	39148-24-8	3979UH4J7X			
Fosfomycin	23155-02-4	Fosfomycin	23155-02-4	2N81MY12TE	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Fosfomycin is indicated for the treatment of uncomplicated cases of cystitis caused by susceptible strains of _Escherichia coli_ and _Enterococcus faecalis_. Fosfomycin is not officially indicated for the treatment of pyelonephritis or perinephric abscess, although there have been reported cases of off-label usage in these situations.
fosfosal		Fosfosal	6064-83-1	124X2V25W4			
Fosinopril	98048-97-6	(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	98048-97-6	8B3FLG23GN	Angiotensin-Converting Enzyme Inhibitors	A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)	For treating mild to moderate hypertension, use as an adjunct in treating congestive heart failure, and may be used to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt nephropathy.
Fossil Fuels		Fossil Fuels					
fosthiazate		Fosthiazate	98886-44-3	96QJ4O095U	Pesticides	Chemicals used to destroy pests of any sort. The concept includes fungicides (FUNGICIDES, INDUSTRIAL); INSECTICIDES; RODENTICIDES; etc. (See all compounds classified as Pesticides.)	
fostriecin	87810-56-8	Fostriecin	87810-56-8	ZO1648L551	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
fotemustine		Fotemustine	92118-27-9	GQ7JL9P5I2	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
FPEPIR regimen		FPEPIR regimen					
FPL 55712		7-[3-(4-Acetyl-3-hydroxy-2-propylphenoxy)-2-hydroxypropoxy]-4-oxo-8-propylchromene-2-carboxylic acid	40785-97-5	8Q3M8GL2XV	Leukotriene Antagonists	A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level. (See all compounds classified as Leukotriene Antagonists.)	
FPL 64176	120934-96-5	Methyl 4-(2-benzylbenzoyl)-2,5-dimethyl-1H-pyrrole-3-carboxylate	120934-96-5	UU89L306PO	Calcium Channel Agonists	Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in VASCULAR SMOOTH MUSCLE and/or CARDIAC MUSCLE cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture. (See all compounds classified as Calcium Channel Agonists.)	
FPS-ZM1		N-benzyl-4-chloro-N-cyclohexylbenzamide	945714-67-0				
FR 118487		FR 118487					
FR 139317	142375-60-8	D-Alanine, N-((hexahydro-1H-azepin-1-yl)carbonyl)-L-leucyl-1-methyl-D-tryptophyl-3-(2-pyridinyl)-	142375-60-8				
FR 167653		1-(7-(4-Fluorophenyl)-8-(pyridin-4-yl)-3,4-dihydropyrazolo[5,1-c][1,2,4]triazin-2(1H)-yl)-2-phenylethane-1,2-dione sulfate	158876-66-5		Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
FR 173657		(E)-3-(6-acetamidopyridin-3-yl)-N-[2-[2,4-dichloro-N-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]prop-2-enamide	167838-64-4	262AL91J0Y	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
FR 180204		5-(2-Phenylpyrazolo[1,5-A]pyridin-3-YL)-1H-pyrazolo[3,4-C]pyridazin-3-amine	865362-74-9	4C7X7GV82C			
FR 190997		4-[(E)-3-[[2-[[2,4-dichloro-3-[[2-methyl-4-(pyridin-2-ylmethoxy)quinolin-8-yl]oxymethyl]phenyl]-methylamino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-N-methylbenzamide					
FR900359		[(1R)-1-[(3S,6S,9S,12S,18R,21S,22R)-21-acetamido-18-benzyl-3-[(1R)-1-methoxyethyl]-4,9,10,12,16-pentamethyl-15-methylidene-2,5,8,11,14,17,20-heptaoxo-22-propan-2-yl-1,19-dioxa-4,7,10,13,16-pentazacyclodocos-6-yl]-2-methylpropyl] (2S,3R)-3-hydroxy-4-methyl-2-(propanoylamino)pentanoate	107530-18-7	N7M4365U6Y			
Fra a 1 allergen, Fragaria ananassa		Fra a 1 allergen, Fragaria ananassa					
frangulin A		Frangulin A	521-62-0	HXU301W02A			
frangulin B	14101-04-3	Frangulin B	14101-04-3	8CIK094KBU			
Frankincense		Boswellia carterii resin					
fraxetin	574-84-5	Fraxetin	574-84-5	CD3GD44O3K			
fraxinellone	28808-62-0	Fraxinellone	28808-62-0	2HP328XN7C			
Free Radicals		Free Radicals					
frenolicin B	68930-68-7	Frenolicin B	68930-68-7	385375GE9Y			
frentizole	26130-02-9	Frentizole	26130-02-9	7EY946394I			
Freund's Adjuvant	9007-81-2	1-beta-D-Arabinofuranosyl-5-fluorocytosine	4298-10-6		Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
friedelin		Friedelin	559-74-0	AK21264UAD			
frovatriptan		Frovatriptan	158747-02-5	H82Q2D5WA7	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	For the acute treatment of migraine attacks with or without aura in adults.
fructooligosaccharide		Fructo-oligosaccharide DP12/GF11					
Fructosamine	4429-04-3	Fructosamine	106294-91-1				
Fructose	30237-26-4	D-(-)-Fructose	57-48-7	02T79V874P	Sweetening Agents	Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)	
fructose 2,6-diphosphate	79082-92-1	2,6-di-O-phosphono-beta-D-fructofuranose	79082-92-1	SE96VBE4LU			
fructose-1-phosphate	15978-08-2	Fructose-1-phosphate	15978-08-2	J82727ADC8			
fructose-1,6-diphosphate	488-69-7	D-fructofuranose 1,6-bisphosphate	488-69-7		Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
fructose-6-phosphate	6814-87-5	Fructose-6-phosphate	643-13-0	2012QM764Y			
fructus schizandrae, radix ginseng, radix ophiopogonis drug combination		fructus schizandrae, radix ginseng, radix ophiopogonis drug combination					
FSH-BI protein, human		FSH-BI protein, human					
FSL-1 lipoprotein, synthetic		FSL-1 lipoprotein, synthetic	322455-70-9				
FTI 277		FTI-277 trifluoroacetate salt			Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
FTY 720P		FTY 720P					
FUB-PB-22 compound		FUB-PB-22 compound					
fucoidan	9072-19-9	9072-19-9					
Fucose		L-Fucose	87-96-7	28RYY2IV3F			
fucosterol	17605-67-3	(24E)-24-N-Propylidenecholesterol	17605-67-3	504ZAM710C			
fucoxanthin	3351-86-8	Fucoxanthin	3351-86-8	06O0TC0VSM			
Fuel Oils		Fuel oils					
fujiflavone P40		fujiflavone P40					
fullerene C60	99685-96-8	Buckminsterfullerene	99685-96-8	NP9U26B839			
Fullerenes		Buckminsterfullerene	99685-96-8	NP9U26B839			
fullerol C60(OH)24		fullerol C60(OH)24					
Fulvestrant	129453-61-8	Fulvestrant	129453-61-8	22X328QOC4	Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	For the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy, as monotherapy or in combination with other antineoplastic agents.
fulvic acid	479-66-3	Fulvic acid	479-66-3	XII14C5FXV			
fumagillin	23110-15-8	Fumagillin	23110-15-8	7OW73204U1	Angiogenesis Inhibitors	Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. (See all compounds classified as Angiogenesis Inhibitors.)	
Fumarates		Fumarate	142-42-7				
fumaric acid	110-17-8	Fumaric Acid	110-17-8	88XHZ13131			
fumaronitrile	764-42-1	Fumaronitrile	764-42-1				
fumarylacetone		Fumaryl acetone	62966-21-6				
FuMi protocol		FuMi protocol					
fumigaclavine C		Fumigaclavine C	62867-47-4				
fumonisin B1	116355-83-0	Fumonisin b1	116355-83-0	3ZZM97XZ32	Carcinogens, Environmental	Carcinogenic substances that are found in the environment. (See all compounds classified as Carcinogens, Environmental.)	
fumonisin B2	116355-84-1	Fumonisin b2	116355-84-1	UX4WHT4MKB	Carcinogens, Environmental	Carcinogenic substances that are found in the environment. (See all compounds classified as Carcinogens, Environmental.)	
Fumonisins		Fumonisins					
fumosorinone		fumosorinone					
Fungal Polysaccharides		Fungal Polysaccharides					
Fungicides, Industrial		Fungicides, Industrial					
furafylline	80288-49-9	Furafylline	80288-49-9	C2087G0XX3	Cytochrome P-450 CYP1A2 Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP1A2. (See all compounds classified as Cytochrome P-450 CYP1A2 Inhibitors.)	
furaltadon		Furaltadone	139-91-3	5X4V82ZN30	Anti-Infective Agents, Urinary	Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)	
furan	110-00-9	Furan	110-00-9	UC0XV6A8N9			
Furans		Furans					
Furazolidone	67-45-8	Furoxone	67-45-8	5J9CPU3RE0	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	For the specific and symptomatic treatment of bacterial or protozoal diarrhea and enteritis caused by susceptible organisms.
furegrelate	85666-17-7	Furegrelate sodium	85666-17-7	4F11B27M90	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
furfuryl alcohol	98-00-0	Furfuryl alcohol	98-00-0	D582054MUH			
Furocoumarins		Furocoumarins					
Furosemide	54-31-9	Furosemide	54-31-9	7LXU5N7ZO5	Sodium Potassium Chloride Symporter Inhibitors	Agents that inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS which are concentrated in the thick ascending limb at the junction of the LOOP OF HENLE and KIDNEY TUBULES, DISTAL. They act as DIURETICS. Excess use is associated with HYPOKALEMIA and HYPERGLYCEMIA. (See all compounds classified as Sodium Potassium Chloride Symporter Inhibitors.)	Furosemide is indicated for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome, in adults and pediatric patients.   Oral furosemide is indicated alone for the management of mild to moderate hypertension or severe hypertension in combination with other antihypertensive medications.  Intravenous furosemide is indicated as adjunctive therapy in acute pulmonary edema when a rapid onset of diuresis is desired.  Subcutaneous furosemide is indicated for the treatment of congestion due to fluid overload in adults with NYHA Class II/III chronic heart failure. This drug formulation is not indicated for emergency situations or in patients with acute pulmonary edema.
Fursultiamin	804-30-8	Fursultiamine	804-30-8	05J61265PX	Vitamin B Complex	A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)	
furtrethonium	7618-86-2	Furtrethonium	7618-86-2	AIQ630U6XO	Cholinergic Agonists	Drugs that bind to and activate cholinergic receptors. (See all compounds classified as Cholinergic Agonists.)	
furylacryloylalanylarginine	76079-06-6	Furylacryloylalanylarginine	76079-06-6				
fusaproliferin		Proliferin	152469-17-5				
fusarenon-X	23255-69-8	Fusarenon X	23255-69-8	0CV8D1DR96			
Fusaric Acid	536-69-6	Fusaric acid	536-69-6	JWJ963070N	Nucleic Acid Synthesis Inhibitors	Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)	
fusarielin A		fusarielin A	162341-17-5				
Fusidic Acid	6990-06-3	Fusidic Acid	6990-06-3	59XE10C19C	Protein Synthesis Inhibitors	Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)	For the treatment of bacterial infections.
fuzheng huayu		Fuzhenghuayu					
fuzi drug herbal		fuzi drug herbal					
FV-429 compound		FV-429 compound					
FX1 thiazolidinedione compound		FX1 thiazolidinedione compound					
G 27550	2814-20-2	2-Isopropyl-6-methyl-4-pyrimidone	2814-20-2	0JET159MZQ			
G(M1) Ganglioside	37758-47-7	Ganglioside GM1	37758-47-7	562413257Z			
G(M2) Ganglioside	19600-01-2	Ganglioside GM2	104443-57-4				
G(M3) Ganglioside		G(M3) Ganglioside					
G226 compound		G226 compound					
G36 compound		G36 compound					
GABA Agents		GABA Agents					
GABA Modulators		GABA Modulators					
Gabapentin		Gabapentin	60142-96-3	6CW7F3G59X	Antimanic Agents	Agents that are used to treat bipolar disorders or mania associated with other affective disorders. (See all compounds classified as Antimanic Agents.)	In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older. In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older and as monotherapy in patients 12 years of age and older. It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.
gabazine	104104-50-9	Gabazine	104104-50-9	99460MG420	GABA Antagonists	Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS. (See all compounds classified as GABA Antagonists.)	
Gabexate	39492-01-8	Gabexate	39492-01-8	4V7M9137X9	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	No approved indication.
gaboxadol		Gaboxadol	64603-91-4	K1M5RVL18S	GABA Agonists	Endogenous compounds and drugs that bind to and activate GAMMA-AMINOBUTYRIC ACID receptors (RECEPTORS, GABA). (See all compounds classified as GABA Agonists.)	Investigated for use/treatment in sleep disorders and insomnia.
gadobutrol		Gadobutrol	770691-21-9	1BJ477IO2L	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	Gadobutrol is indicated for use with magnetic resonance imaging for the following diagnostic processes:  - To detect and visualize areas with disrupted blood-brain barrier and/or abnormal vascularity of the central nervous system in adult and pediatric patients, including term neonates. - To assess the presence and extent of malignant breast disease in adult patients - To evaluate known or suspected supra-aortic or renal artery disease in adult and pediatric patients, including term neonates - To assess myocardial perfusion (under stress and at rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease
gadodiamide		Gadodiamide	131410-48-5	84F6U3J2R6	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	Gadodiamide is indicated for the visualization of lesions with abnormal vascularity in the brain (intracranial lesions), spine, and associated tissues and the body (including  the thoracic (noncardiac), abdominal, pelvic cavities, and retroperitoneal space) by the FDA and Health Canada. Additionally, gadoliamide is approved by Health Canada to detect and localize tenosis in renal arteries and aorto-iliac arteries in magnetic resonance angiography (MRA).
Gadolinium	7440-54-2	Gadolinium	7440-54-2	AU0V1LM3JT			
gadolinium chloride	10138-52-0	Gadolinium chloride	10138-52-0		Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
Gadolinium DTPA	80529-93-7	Gadopentetate	80529-93-7		Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	For use with magnetic resonance imaging (MRI) in adults, and pediatric patients (2 years of age and older) to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues as well as lesions with abnormal vascularity in the head and neck. Also used to facilitate the visualization of lesions with abnormal vascularity in the body (excluding the heart).
galactaric acid	526-99-8	Galactaric acid	526-99-8	E149J5OTIF			
Galactolipids		Galactolipids					
Galactosamine	7535-00-4	(2R,3R,4R,5R)-2-amino-3,4,5,6-tetrahydroxyhexanal	7535-00-4				
Galactose	26566-61-0	(2R,3S,4S,5R)-2,3,4,5,6-pentahydroxyhexanal	59-23-4				
galactose-1-phosphate	2255-14-3	alpha-D-Galactose 1-phosphate	2255-14-3	4Z9Z6N3GH4			
galangin	548-83-4	Galangin	548-83-4	142FWE6ECS	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
Galanin	88813-36-9	Galanin					
Galantamine	357-70-0	Galantamine	357-70-0	0D3Q044KCA	Nootropic Agents	Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)	Galantamine is indicated for the treatment of mild to moderate dementia of the Alzheimers type.
galaxolide	1222-05-5	Galaxolide	1222-05-5	14170060AT			
galbanic acid	3566-55-0	Galbanic acid	3566-55-0	9OFS0HWC92			
galiellalactone		Galiellalactone					
Gallamine Triethiodide	65-29-2	Gallamine Triethiodide	65-29-2	Q3254X40X2	Neuromuscular Nondepolarizing Agents	Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. (See all compounds classified as Neuromuscular Nondepolarizing Agents.)	For use as adjuncts to anesthesia to induce skeletal muscle relaxation and to facilitate the management of patients undergoing mechanical ventilation
gallein	2103-64-2	Gallein	2103-64-2	8L0084U2QR			
Gallic Acid	149-91-7	Gallic Acid	149-91-7	632XD903SP			
Gallium	7440-55-3	Gallium	7440-55-3	CH46OC8YV4			
gallium arsenide	1303-00-0	Gallium arsenide	1303-00-0	27FC46GA44			
gallium chloride	13450-90-3	Gallium chloride	13450-90-3	4Y6GQD4915			
gallium nitrate	13494-90-1	Gallium nitrate	13494-90-1	Y2V2R4W9TQ	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Gallium nitrate does not currently have approved indications. It was previously used in the treatment of cancer-related hypercalcemia.
gallium phosphide		Gallium phosphide	12063-98-8	3J421F73DV			
gallium-transferrin complex		gallium-transferrin complex					
gallocatechin gallate		Gallocatechin gallate	5127-64-0	0C056HB16M			
gallocatechol	1617-55-6	Gallocatechin	970-73-0	HEJ6575V1X			
Gallopamil	16662-47-8	Gallopamil	16662-47-8	39WPC8JHR8	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
gamabufotalin		Gamabufotalin	465-11-2	5HH3KM165O			
gambierol		Gambierol	146763-62-4	844Q8WC5F6			
gambogic acid	2752-65-0	Gambogic acid	2752-65-0	8N585K83U2			
gamisopoonghwanghyul-tang		gamisopoonghwanghyul-tang					
gamma-Aminobutyric Acid	56-12-2	Gamma-Aminobutyric Acid	56-12-2	2ACZ6IPC6I	GABA Agents	Substances used for their pharmacological actions on GABAergic systems. GABAergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as GABA Agents.)	
gamma-butyrobetaine	407-64-7	4-(Trimethylammonio)butanoate	407-64-7	HD7GI3HY9Q			
gamma-Glu-S-BzCys-PhGly diethyl ester		Ezatiostat hydrochloride	286942-97-0	D59N834676			
gamma-glutamyl-glutathione	105644-04-0	gamma-Glutamyl-gamma-glutamylcysteinylglycine	105644-04-0				
gamma-glutamylcysteine	636-58-8	gamma-Glutamylcysteine	636-58-8	M984VJS48P			
gamma-glutamylcysteinylacetominophen		gamma-glutamylcysteinylacetominophen					
gamma-Linolenic Acid		gamma-Linolenic acid	506-26-3	78YC2MAX4O			Indicated as a dietary supplement for over-the-counter uses.
gamma-oryzanol	11042-64-1	gamma-Oryzanol	11042-64-1	3PQR2YON9T			
gamma-resorcylic acid		2,6-Dihydroxybenzoic acid	303-07-1	RSA5G6VRPV			
gamma-sitosterol		Clionasterol	83-46-5	5LI01C78DD	Hypolipidemic Agents	Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)	
gamma-terpinene	99-85-4	gamma-Terpinene	99-85-4	4YGF4PQP49			
gamma-Tocopherol		gamma-Tocopherol	54-28-4	8EF1Z1238F	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
gamma-valerolactone	108-29-2	gamma-Valerolactone	108-29-2	O7056XK37X			
Ganciclovir	82410-32-0	Ganciclovir	82410-32-0	P9G3CKZ4P5	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	For induction and maintenance in the treatment of cytomegalovirus (CMV) retinitis in immunocompromised patients, including patients with acquired immunodeficiency syndrome (AIDS). Also used in the treatment of severe cytomegalovirus (CMV) disease, including CMV pneumonia, CMV gastrointestinal disease, and disseminated CMV infections, in immunocompromised patients.
ganglioside, GD1a	12707-58-3	Ganglioside GD1	12707-58-3				
ganglioside, GD1b	19553-76-5	II(3)Neu5Ac2GgOse4Cer	19553-76-5				
ganglioside, GD3	62010-37-1	disialoganglioside GD3	62010-37-1				
Gangliosides		Gangliosides					
ganirelix		Ganirelix	124904-93-4	IX503L9WN0	Hormone Antagonists	Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)	Ganirelix is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation for assisted reproduction techniques (ART).
ganoderic acid		Ganoderic acid					
ganoderic acid A		Ganoderic acid A	81907-62-2	548G37DF65			
ganoderic acid C2		Ganoderic Acid C2					
ganoderic acid T		Ganoderic Acid T					
ganoderiol F		Ganoderiol F	114567-47-4				
ganoderol B		ganoderol B	104700-96-1	Z99BBB5WR6			
GANT 61		2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline	500579-04-4				
Gap 26 peptide		Gap 26 peptide					
gap 27 peptide		gap 27 peptide					
garcinielliptone FC		garcinielliptone FC					
garcinol		CID 5281560	78824-30-3				
gardenia yellow		Crocin	42553-65-1	877GWI46C2			
gardenin B		Gardenin B	2798-20-1	313E89KN5E			
gardiquimod		Gardiquimod	1020412-43-4	Y3W4QVW5BY	Toll-Like Receptor Agonists	Agents that stimulate TOLL-LIKE RECEPTOR signaling, and the activity of both the INNATE IMMUNE RESPONSE and ADAPTIVE IMMUNITY. (See all compounds classified as Toll-Like Receptor Agonists.)	
Gasoline		8006-61-9					
gastrin 17	60748-06-3	Little gastrin I	60748-06-3				
Gastrins		Gastrin human	9002-76-0		Hormones	Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. (See all compounds classified as Hormones.)	
gastrodin	62499-27-8	Gastrodin	62499-27-8	5YS9U2W3RQ			
Gatifloxacin	112811-59-3	Gatifloxacin	112811-59-3	81485Y3A9A	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of bronchitis, sinusitis, community-acquired pneumonia, and skin infections (abscesses, wounds) caused by S. pneumoniae, H. influenzae, S. aureus, M. pneumoniae, C. pneumoniae, L. pneumophila, S. pyogenes
GBR 13069	77862-93-2	CID 132474	77862-93-2				
GC 1 compound		Sobetirome	211110-63-3	XQ31741E9Q			
GCS-100		GCS-100					
GDC-0152		Gdc-0152	873652-48-3	4KW1M48SHS			
GDP 366		1-[4-(4-Aminothieno[2,3-d]pyrimidin-5-yl)phenyl]-3-(3-methylphenyl)urea					
gedatolisib		Gedatolisib	1197160-78-3	96265TNH2R	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
gedunin	2753-30-2	Gedunin	2753-30-2	VH4BN8F5Z5			
Gefitinib		Gefitinib	184475-35-2	S65743JHBS	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of either platinum-based or docetaxel chemotherapies.
geissoschizine methylether		geissoschizine methylether					
geldanamycin	30562-34-6	Geldanamycin	30562-34-6	Z3K3VJ16KU	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
gelsemine		Gelsemine	509-15-9	5Y13A78Z72			
gelsenicine		Gelsenicine	82354-38-9				
Gemcitabine		Gemcitabine	95058-81-4		Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	Gemcitabine is a chemotherapeutic agent used as monotherapy or in combination with other anticancer agents.   In combination with [carboplatin], it is indicated for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy.  Gemcitabine in combination with [paclitaxel] is indicated for the first-line treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated.  In combination with [cisplatin], gemcitabine is indicated for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB) or metastatic (Stage IV) non-small cell lung cancer (NSCLC). Dual therapy with cisplatin is also used to treat patients with Stage IV (locally advanced or metastatic) transitional cell carcinoma (TCC) of the bladder.  Gemcitabine is indicated as first-line treatment for patients with locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma of the pancreas. Gemcitabine is indicated for patients previously treated with [fluorouracil].
Gemfibrozil	25812-30-0	Gemfibrozil	25812-30-0	Q8X02027X3	Cytochrome P-450 CYP2C8 Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C8. (See all compounds classified as Cytochrome P-450 CYP2C8 Inhibitors.)	Gemfibrozil is indicated to treat patients with Types IV and V hyperlipidemia who have elevated serum triglycerides (usually above 2000mg/dL), elevated VLDL cholesterol, fasting chylomicrons, are at risk of developing pancreatitis, and do not adequately respond to dietary restrictions. Gemfibrozil is also indicated to reduce the risk of developing coronary heart disease in patients with Type IIb hyperlipidemia without history or symptoms of coronary heart disease; who do not adequately respond to weight loss, diet, exercise, and other medications; and have low HDL, raised LDL, and raised triglycerides.
gemfibrozil 1-O-acylglucuronide	91683-38-4	Gemfibrozil 1-O-beta-Glucuronide	91683-38-4	954F30WZ3Y			
genapol X 080	9043-30-5	Polidocanol	9043-30-5	0AWH8BFG9A			Polidocanol is a sclerosing agent indicated to treat uncomplicated spider veins and uncomplicated reticular veins in the lower extremity.
genipin	6902-77-8	Genipin	6902-77-8	A3V2NE52YG	Cholagogues and Choleretics	Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)	
geniposide	24512-63-8	Geniposide	24512-63-8	145295QLXY			
geniposidic acid	27741-01-1	Geniposidic acid	27741-01-1				
Genistein	446-72-0	Genistein	446-72-0	DH2M523P0H	Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	Currently Genistein is being studied in clinical trials as a treatment for prostate cancer.
genistin	529-59-9	Genistin	529-59-9	1POG3SCN5T			
genkwanin	437-64-9	Genkwanin	437-64-9	5K3I5D6B2B			
gentamicin C	11097-82-8	(2R,3S,4R,5R)-2-[(1S,2R,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol	11097-82-8				
Gentamicins		Gentamicin	1403-66-3	T6Z9V48IKG	Protein Synthesis Inhibitors	Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)	Treatment of infected diabetic foot ulcers
gentian root extract		Gentian extract					
Gentian Violet	548-62-9	Gentian Violet	548-62-9	J4Z741D6O5	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
gentiopicroside	20831-76-9	Gentiopicrin	20831-76-9	0WE09Z21RC			
gepirone	83928-76-1	Gepirone	83928-76-1	JW5Y7B8Z18	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	Gepirone is indicated for the treatment of major depressive disorder (MDD) in adults.
Geraniin	60976-49-0	Geraniin					
geraniol	624-15-7	Geraniol	624-15-7	L837108USY			Geraniol is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.
geranyl acetate	105-87-3	Geranyl acetate	105-87-3	3W81YG7P9R			
geranyl diphosphate		Geranyl diphosphate	763-10-0	7X7DBM66JG			
geranyl pyrophosphate	763-10-0	Geranyl diphosphate	763-10-0	7X7DBM66JG			
geranylacetone	689-67-8	Geranylacetone	3796-70-1	9B7RY79U9Z			
geranylgeranic acid	83807-40-3	Geranylgeranic acid	83807-40-3				
geranylgeraniol	7614-21-3	Geranylgeraniol	24034-73-9	AIA02AJA3A			
geranylgeranyl pyrophosphate	6699-20-3	Geranylgeranyl diphosphate	6699-20-3	N21T0D88LX			
geranylgeranylacetone		Teprenone	3796-63-2	57B67OXM8F	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	
geranylnaringenin		geranylnaringenin					
germacrone	6902-91-6	Germacrone	6902-91-6	E2WQ6N4FBP			
Gerovital H3	12663-50-2	p-Aminobenzoic acid diethylaminoethyl ester hydrochloride	51-05-8				
Gestodene	60282-87-3	Gestodene	60282-87-3	1664P6E6MI	Contraceptives, Oral, Hormonal	Oral contraceptives which owe their effectiveness to hormonal preparations. (See all compounds classified as Contraceptives, Oral, Hormonal.)	
Gestrinone	16320-04-0	Gestrinone	16320-04-0	1421533RCM	Progestins	Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. (See all compounds classified as Progestins.)	Endometriosis with or without accompanying sterility. Treatment is limited to a single course of 6 months duration per lifetime.
GFX 109203x		GFX 109203x					
GGTI 2147		4-[[N-(Imidazol-4-yl)methyleneamino]-2-(1-naphthyl)benzoyl]leucine methyl ester	191102-87-1				
GGTI 298		(S)-methyl 2-(4-(((R)-2-amino-3-mercaptopropyl)amino)-2-(naphthalen-1-yl)benzamido)-4-methylpentanoate	180977-44-0	ELA97V8Q7P			
GGTI-2133		GGTI-2133 free base	191102-79-1				
GH-RH(1-29), desaminotyrosyl(1)-ornithyl(12,21)-alpha-aminobutryic acid(15)-norleucyl(27)-aspartyl(28)-agmatine(29)-		GH-RH(1-29), desaminotyrosyl(1)-ornithyl(12,21)-alpha-aminobutryic acid(15)-norleucyl(27)-aspartyl(28)-agmatine(29)-					
Ghee		Dairy products, ghee					
Ghrelin		Ghrelin					
GHRP-6, Lys(3)-		GHRP-6, Lys(3)-					
gibberellic acid	77-06-5	Gibberellic acid	77-06-5	BU0A7MWB6L	Plant Growth Regulators	Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins. (See all compounds classified as Plant Growth Regulators.)	
GIF 0010		GIF 0010					
gigantol	67884-30-4	Gigantol	67884-30-4				
gimeracil	103766-25-2	Gimeracil	103766-25-2	UA8SE1325T			Gimeracil is used as an adjunct to antineoplastic therapy. When used within the product Teysuno, gimeracil is indicated for the treatment of adults with advanced gastric (stomach) cancer when given in combination with cisplatin.
ginger extract		CCRIS 7641					
gingerenone A		Gingerenone A	128700-97-0				
gingerol	1391-73-7	Gingerol	23513-14-6	925QK2Z900			
ginkgetin	481-46-9	Ginkgetin	481-46-9	HY5EZW8269			
Ginkgo biloba extract		90045-36-6					
ginkgolic acid	22910-60-7	Ginkgolic acid	22910-60-7				
ginkgolide A		9H-1,7a-(Epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione, 3-tert-butylhexahydro-4,7b-dihydroxy-8-methyl-	15291-75-5				
ginkgolide B	99796-69-7	Gingko lactone	15291-77-7		Fibrinolytic Agents	Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)	
ginkgolide C	15291-76-6	Ginkgolide C (>90%)	15291-76-6				
ginkgolide J		Ginkgolide J	107438-79-9	M5297RI2UE			
ginkgolide K		ginkgolide K					
Ginkgolides		Ginkgolides					
ginnalin A		Ginnalin A			Glycoside Hydrolase Inhibitors	Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES. (See all compounds classified as Glycoside Hydrolase Inhibitors.)	
ginsan		ginsan					
ginsenoside 20S-protopanaxatriol		ginsenoside 20S-protopanaxatriol					
ginsenoside F1	53963-43-2	Ginsenoside F1	53963-43-2				
ginsenoside F2		ginsenoside F2	62025-49-4				
ginsenoside M1		ginsenoside C-K	39262-14-1	G8D4792Q7K			
ginsenoside Rb1		Ginsenoside Rb1	41753-43-9	7413S0WMH6			
ginsenoside Rb2	11021-13-9	Ginsenoside C	11021-13-9	N219O0L31C	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
ginsenoside Rc		Ginsenoside Rc	11021-14-0	0K83B0L786			
ginsenoside Rd	52705-93-8	Ginsenoside Rd	52705-93-8	WB232T95AV			
ginsenoside Re	52286-59-6	Ginsenoside B2	52286-59-6	46F3R0BL3I			
ginsenoside Rf		Ginsenoside Rf	52286-58-5	JOS8BON5YW			
ginsenoside Rg1	22427-39-0	Ginsenoside Rg1	22427-39-0	PJ788634QY	Central Nervous System Agents	A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into &quot;specific&quot; agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and &quot;nonspecific&quot; agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed, p252) (See all compounds classified as Central Nervous System Agents.)	
ginsenoside Rg2	52286-74-5	Ginsenoside RG2	52286-74-5	5R89LAS235			
ginsenoside Rg3		Ginsenoside Rg3	14197-60-5	227D367Y57	Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	
ginsenoside Rg5		Ginsenoside Rg5	186763-78-0				
ginsenoside Rh1	63223-86-9	Ginsenoside Rh1	63223-86-9	XBR6F7G8FU			
ginsenoside Rh2	78214-33-2	Ginsenoside Rh2	78214-33-2	0JU44A5KWG			
ginsenoside Rh4		Ginsenoside Rh4	174721-08-5				
ginsenoside Rk1		ginsenoside Rk1					
ginsenoside Rk3		Ginsenoside Rk3					
ginsenoside Ro	34367-04-9	Ginsenoside Ro	34367-04-9	OF1PLT74Q8			
Ginsenosides		Ginsenosides	74749-74-9				
ginsenoslaloside-I		ginsenoslaloside-I					
glabridin	59870-68-7	Glabridin	59870-68-7	HOC5567T41			
Glafenine	3820-67-5	Glafenine	3820-67-5	46HL4I09AH	Analgesics, Non-Narcotic	A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)	
Glatiramer Acetate		CID 3081884	147245-92-9		Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
glaucine	5630-11-5	1,2,9,10-Tetramethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline	5630-11-5				
glaucocalyxin A	79498-31-0	Glaucocalyxin A	79498-31-0				
Gliclazide	21187-98-4	Gliclazide	21187-98-4		Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	For the treatment of NIDDM in conjunction with diet and exercise.
glimepiride		Glimepiride	261361-60-8	24T6XIR2MZ	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	
Gliotoxin	67-99-2	Gliotoxin	67-99-2	5L648PH06K	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	
Glipizide	29094-61-9	Glipizide	29094-61-9	X7WDT95N5C	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
gliquidone		Gliquidone	33342-05-1	C7C2QDD75P	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	Used in the treatment of diabetes mellitus type 2.
glisoflavone	125709-32-2	Glisoflavone	125709-32-2				
globotriaosylceramide	71965-57-6	alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:1/24:0)					
GLPG1837		N-(3-carbamoyl-5,5,7,7-tetramethyl-4,7-dihydro-5H-thieno[2,3-c]pyran-2-yl)-1H-pyrazole-3-carboxamide	1654725-02-6	MM4S7BD3DF			
Glu-P-2	67730-10-3	2-Aminodipyrido[1,2-a:3',2'-d]imidazole	67730-10-3	N79505HO3L	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Glucagon	9007-92-5	Glucagon	9007-92-5		Gastrointestinal Agents	Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)	Glucagon is indicated as a diagnostic aid in radiologic exams to temporarily inhibit the movement of the gastrointestinal tract and to treat severe hypoglycemia.
glucagon-like peptide 1 (7-36)amide	119637-73-9	Glucagon-like peptide 1 (7-36)amide	119637-73-9				
glucan phosphate		glucan phosphate					
Glucans		Glucans					
Glucaric Acid		Glucaric acid	25525-21-7	QLZ991V4A2			
glucobrassicin	4356-52-9	3-Indolylmethylglucosinolate	4356-52-9				
Glucocorticoids		Glucocorticoids					
glucoerucin	21973-56-8	Glucoerucin	21973-56-8				
glucogallin	58511-73-2	Glucogallin	58511-73-2				
gluconic acid	526-95-4	Gluconic Acid	526-95-4	R4R8J0Q44B			For use as part of electrolyte supplementation in total parenteral nutrition.
glucoraphanin		4-Methylsulfinylbutyl glucosinolate	21414-41-5				
Glucosamine	3416-24-8	D-Glucosamine	3416-24-8	N08U5BOQ1K			Glucosamine is generally used over the counter in the symptomatic treatment of osteoarthritis and joint pain, frequently combined with chondroitin sulfate and/or ibuprofen.
glucosamine 3-O-sulfate	76330-20-6	[(2R,3R,4R,5R)-2-amino-4,5,6-trihydroxy-1-oxohexan-3-yl] hydrogen sulfate	76330-20-6				
glucosamine 6-O-sulfate	91674-26-9	Glucosamine 6-sulfate	91674-26-9				
glucosamine 6-phosphate	3616-42-0	Glucosamine 6-phosphate	3616-42-0				
Glucose	50-99-7	D(+)-Glucose	8027-56-3	5SL0G7R0OK	Sweetening Agents	Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)	
glucose tolerance factor		glucose tolerance factor					
glucose-1-phosphate	59-56-3	alpha-D-glucose-1-phosphate	59-56-3	CIX3U01VAU			
Glucose-6-Phosphate	56-73-5	D-Glucose 6-phosphate	56-73-5	375AW34SQA			
Glucosides		beta-D-glucopyranose	9001-37-0	J4R00M814D			
Glucosinolates		Glucosinolates					
Glucosylceramides		Glucosylceramides					
Glucuronic Acid	576-37-4	(2S,3S,4S,5R)-2,3,4,5-tetrahydroxy-6-oxohexanoic acid	6556-12-3				
Glucuronides		Glucuronides					
glucuronolactone	32449-92-6	Glucuronolactone	32449-92-6	XE4Y3016M9			
glucuronoxylomannan	76082-65-0	glucuronoxylomannan					
glucuronyl glucosamine glycan sulfate		glucuronyl glucosamine glycan sulfate					
Glupearl 19S		Glupearl 19S					
Glutamic Acid	56-86-0	Glutamic Acid	56-86-0	61LJO5I15S			"Considered to be nature's ""Brain food"" by improving mental capacities; helps speed the healing of ulcers; gives a ""lift"" from fatigue; helps control alcoholism, schizophrenia and the craving for sugar."
Glutamine	56-85-9	Glutamine	56-85-9	0RH81L854J			Used for nutritional supplementation, also for treating dietary shortage or imbalance.  Used to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older.
glutamyl-(2-(((3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl)oxy)carbonyl)-3-((2-(1H-indol-3-yl)ethyl)amino)-3-oxopropyl)-cysteinyl-glycine sodium salt		glutamyl-(2-(((3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl)oxy)carbonyl)-3-((2-(1H-indol-3-yl)ethyl)amino)-3-oxopropyl)-cysteinyl-glycine sodium salt					
glutamyl-Se-methylselenocysteine		CID440760					
glutapyrone	125387-12-4	Glutapyrone	125387-12-4				
Glutaral	111-30-8	Glutaral	111-30-8	T3C89M417N	Disinfectants	Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley&apos;s Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Disinfectants.)	
Glutarates		Glutarates					
glutaric acid	110-94-1	Glutaric acid	110-94-1	H849F7N00B			
glutaryl-coenzyme A	3131-84-8	glutaryl-CoA	3131-84-8	UB84B82P7Y			
Glutathione	70-18-8	Glutathione	70-18-8	GAN16C9B8O			For nutritional supplementation, also for treating dietary shortage or imbalance
glutathione diethyl ester	97451-40-6	Glutathione diethyl ester	97451-40-6				
Glutathione Disulfide	27025-41-8	Oxiglutatione	27025-41-8	ULW86O013H			
glutathione glycylethyl ester	145356-41-8	Glutathione glycylethyl ester	145356-41-8				
glutathione persulfide		S-sulfanylglutathionate(1-)					
glutathione sulfinamide		Glutathione sulfinamide					
glutathione-BPDE conjugate		glutathione-BPDE conjugate					
glutathione-C4		glutathione-C4					
glutathionyl 4-hydroxy-2-nonenal conjugate		glutathionyl 4-hydroxy-2-nonenal conjugate					
glutathionylcobalamin	129128-04-7	Glutathionylcobalamin	129128-04-7				
Glutethimide	77-21-4	Glutethimide	77-21-4	C8I4BVN78E	Hypnotics and Sedatives	Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)	For the treatment of insomnia.
glutinol		Glutinol	545-24-4				
GLX351322		Ethyl 2-(2-(4-(furan-2-carbonyl)piperazin-1-yl)acetamido)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate					
Glyburide	10238-21-8	Glyburide	10238-21-8	SX6K58TVWC	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	Glyburide is indicated alone or as part of combination product with metformin, as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus.
Glycation End Products, Advanced		Glycation End Products, Advanced					
glyceollin	57103-57-8	Glyceollin	57103-57-8	6461TV6UCH			
Glyceraldehyde	367-47-5	Glyceraldehyde	56-82-6	DI19XSG16H			
Glyceraldehyde 3-Phosphate	142-10-9	3-Phosphoglyceraldehyde	591-59-3	7466PL1110			
glyceric acid	473-81-4	Glyceric acid	473-81-4	70KH64UX7G			
Glycerides		Glycerides					
Glycerol	56-81-5	Glycerin	25618-55-7	PDC6A3C0OX	Cryoprotective Agents	Substances that provide protection against the harmful effects of freezing temperatures. (See all compounds classified as Cryoprotective Agents.)	It is used as a solvent, emollient, pharmaceutical agent, and sweetening agent.
Glycerophospholipids		Glycerophospholipids					
glyceryl 2-arachidonate		2-Arachidonoylglycerol	53847-30-6	8D239QDW64	Cannabinoid Receptor Agonists	Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)	
glyceryl-isoeugenol		glyceryl-isoeugenol					
Glycerylphosphorylcholine	563-24-6	Glycerylphosphorylcholine	563-24-6				
glycidamide		Glycidamide	5694-00-8	6G5ELX5XYN			
glycidol	556-52-5	Glycidol	556-52-5	S54CF1DV9A	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
glycidyl methacrylate	106-91-2	Glycidyl methacrylate	106-91-2	R8WN29J8VF			
glycidyl stearate	7460-84-6	Glycidyl stearate	7460-84-6	Q7QG7S8K60			
Glycine	56-40-6	Glycine	56-40-6	TE7660XO1C	Glycine Agents	Substances used for their pharmacological actions on glycinergic systems. Glycinergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as Glycine Agents.)	Supplemental glycine may have antispastic activity. Very early findings suggest it may also have antipsychotic activity as well as antioxidant and anti-inflammatory activities.
Glycine Agents		Glycine Agents					
glycine linoleamide	2764-03-6	N-linoleoylglycine	2764-03-6				
glycine propionyl carnitine		GlycoCarn	423152-20-9				
glycine-extended gastrin 17		glycine-extended gastrin 17					
glycitein	40957-83-3	Glycitein	40957-83-3	92M5F28TVF	Phytoestrogens	Compounds derived from plants, primarily ISOFLAVONES that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS. (See all compounds classified as Phytoestrogens.)	
glycitin		Glycitin	40246-10-4	G2S44P62XC	Phytoestrogens	Compounds derived from plants, primarily ISOFLAVONES that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS. (See all compounds classified as Phytoestrogens.)	
Glycochenodeoxycholic Acid	640-79-9	Glycochenodeoxycholic acid	640-79-9	451ZNJ667Y	Detergents	Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)	
Glycocholic Acid	475-31-0	Glycocholic acid	475-31-0	G59NX3I3RT	Cholagogues and Choleretics	Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)	
Glycodeoxycholic Acid	360-65-6	Glycodeoxycholic acid	360-65-6	DS124M0828	Detergents	Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)	
Glycogen	9005-79-2	(2S,3R,4S,5S,6R)-2-[[(2R,3S,4R,5R,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol	9005-79-2				
glycohyodeoxycholic acid	13042-33-6	Glycohyodeoxycholic acid	13042-33-6				
glycolaldehyde	141-46-8	Glycolaldehyde	141-46-8	W0A0XPU08U			
glycolamide	598-42-5	2-Hydroxyacetamide	598-42-5	18EAK3UR7C			
Glycolates		Glycolates					
glycolic acid	79-14-1	Glycolic Acid	79-14-1	0WT12SX38S	Keratolytic Agents	Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases. (See all compounds classified as Keratolytic Agents.)	
Glycolipids		Sphingomyelins	85187-10-6				
glycolithocholic acid	474-74-8	Glycolithocholic acid	474-74-8	Q53GV75CJG			
Glycopeptides		Glycopeptides					
Glycosaminoglycans		Glycosaminoglycans					
Glycosides		Kombetin	630-60-4				
Glycosylphosphatidylinositols		Glycosylphosphatidylinositols					
glycoursodeoxycholic acid	64480-66-6	Glycoursodeoxycholic acid	64480-66-6	PF1G5J2X2A			
glycycoumarin		Glycycoumarin	94805-82-0	CWQ2B8G346			
glycyl-histidyl-lysine	49557-75-7	Glycyl-l-histidyl-l-lysine	49557-75-7	39TG2H631E			Commonly used in cosmetic products for the skin and hair.
glycylglutamine	13115-71-4	Glycyl-l-glutamine	13115-71-4	H7125Z98HT			
glycylphenylalanine 2-naphthylamide	21438-66-4	Glycyl-L-phenylalanine 2-naphthylamide	21438-66-4				
glycylproline 4-nitroanilide	60189-43-7	Glycylproline 4-nitroanilide	60189-43-7				
glycylsarcosine	29816-01-1	Glycylsarcosine	29816-01-1	2JE8SG6VDT			
glycyrin		Glycyrin	66056-18-6	994BQ9M3AV			
glycyrol		Glycyrol	23013-84-5	6C3DSA537F			
Glycyrrhetinic Acid	471-53-4	Enoxolone	471-53-4	P540XA09DR	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
Glycyrrhiza glabra extract		B2048					
Glycyrrhizic Acid	1405-86-3	Glycyrrhizin	1405-86-3	6FO62043WK	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	Glycyrrhizic acid is widely applied in foods as a natural sweetener. As a therapeutic agent, is has been used in a vast variety of formulations as it is reported to be anti-inflammatory, anti-ulcer, anti-allergic, antioxidant, anti-tumor, anti-diabetic and hepatoprotective. Due to this properties, its indications have been: treatment of premenstrual syndrome, treatment of viral infections, anti-lipidemic and antihyperglycemic. It is also known to be used as a remedy for peptic ulcer and other stomach diseases.
Glyoxal	107-22-2	Glyoxal	107-22-2	50NP6JJ975			
glyoxalbis(N(4)-methylthiosemicarbazonato)copper(II)		glyoxalbis(N(4)-methylthiosemicarbazonato)copper(II)					
glyoxylic acid	298-12-4	Glyoxylic acid	298-12-4	JQ39C92HH6			
Glyphosate		Glyphosate	1071-83-6	4632WW1X5A			
glyphosate, isopropyl amine salt		glyphosate, isopropyl amine salt					
GNE-617		N-{4-[(3,5-Difluorophenyl)sulfonyl]benzyl}imidazo[1,2-A]pyridine-6-Carboxamide					
GNE-618		N-(4-{[3-(Trifluoromethyl)phenyl]sulfonyl}benzyl)-2h-Pyrazolo[3,4-B]pyridine-5-Carboxamide					
GNE-629		GNE-629					
gnetin C		Gnetin C					
Go 6976	136194-77-9	Go-6976	136194-77-9	B9IQO7JZ16	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
goitrin	13190-34-6	DL-Goitrin	13190-34-6	O8KVD7J2P5	Antithyroid Agents	Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones. (See all compounds classified as Antithyroid Agents.)	
Gold	7440-57-5	Gold	7440-57-5	79Y1949PYO			
gold (III) porphyrin 1a		gold (III) porphyrin 1a					
Gold Alloys		Gold Alloys					
gold chloride	11118-27-7	Gold chloride					
Gold Compounds		Gold Compounds					
gold cyanide	506-65-0	Gold cyanide	506-65-0				
Gold Sodium Thiomalate	12244-57-4	Sodium aurothiomalate	12244-57-4		Antirheumatic Agents	Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)	A disease-modifying antirheumatic drug (DMARD) indicated for the symptomatic treatment of arthritis.
Gold Sodium Thiosulfate	15283-45-1	15283-45-1					
gold tetrachloride, acid	16903-35-8	Aurate(1-), tetrachloro-, hydrogen, (SP-4-1)-	16903-35-8	8H372EGX3V			
golodirsen		Golodirsen [USAN:INN]					
Gonadal Hormones		Gonadal Hormones					
Gonadal Steroid Hormones		Gonadal Steroid Hormones					
Gonadotropin-Releasing Hormone	33515-09-2	Gonadorelin	9034-40-6	9O7312W37G			For evaluating the functional capacity and response of the gonadotropes of the anterior pituitary also for evaluating residual gonadotropic function of the pituitary following removal of a pituitary tumor by surgery and/or irradiation.
Gonadotropins		Gonadotropins					
Gonadotropins, Equine		Gonadotropins, Equine					
goniothalamin	17303-67-2	Goniothalamin	17303-67-2	34W9GO6B2Z			
goralatide	120081-14-3	Goralatide	120081-14-3	H041538E9P	Growth Inhibitors	Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth (= PLANT GROWTH REGULATORS). (See all compounds classified as Growth Inhibitors.)	
Goserelin	65807-02-5	Goserelin	65807-02-5	0F65R8P09N	Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	Goserelin is indicated for:  - Use in combination with flutamide for the management of locally confined carcinoma of the prostate - Palliative treatment of advanced carcinoma of the prostate - The management of endometriosis - Use as an endometrial-thinning agent prior to endometrial ablation for dysfunctional uterine bleeding - Use in the palliative treatment of advanced breast cancer in pre- and perimenopausal women
gossypetin		Gossypetin	489-35-0	SET4M23ZTM			
gossypin	652-78-8	Gossypin	652-78-8	A3Q367XWX9			
Gossypol	303-45-7	Gossypol	20300-26-9	8DY2X8LXW4	Contraceptive Agents, Male	Chemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading. (See all compounds classified as Contraceptive Agents, Male.)	
gossypol acetic acid	12542-36-8	Gossypol acetic acid	12542-36-8	U9GNI6VT5N	Spermatocidal Agents	Chemical substances that are destructive to spermatozoa used as topically administered vaginal contraceptives. (See all compounds classified as Spermatocidal Agents.)	
govaniadine		Govaniadine					
gp120 protein, Human immunodeficiency virus 1		gp120 protein, Human immunodeficiency virus 1					
GQ1b ganglioside	68652-37-9	GQ1b-Ganglioside					
GR 103691		4'-Acetyl-N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-[1,1'-biphenyl]-4-carboxamide	162408-66-4	0Y0CM1A77L	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	
GR 113808		1H-Indole-3-carboxylic acid, 1-methyl-, (1-(2-((methylsulfonyl)amino)ethyl)-4-piperidinyl)methyl ester	144625-51-4	ZT350OYT3I	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
GR 127935		2'-Methyl-4'-(5-methyl-(1,2,4)-oxadiazol-3-yl)biphenyl-4-carboxylic acid (4-methoxy-3-(4-methylpiperazin-1-yl)phenyl)amide	148672-13-3	2LLH6CEB40	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
GR 159897		5-fluoro-3-[2-[4-methoxy-4-[[(R)-phenylsulfinyl]methyl]piperidin-1-yl]ethyl]-1H-indole	158848-32-9				
GR 218231		(2R)-6-[(4-methoxyphenyl)sulfonylmethyl]-N,N-dipropyl-1,2,3,4-tetrahydronaphthalen-2-amine	175442-95-2				
GR 46611		3-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-(4-methoxybenzyl)acrylamide	185259-85-2				
GR 65630	117186-80-8	3-(5-methyl-1H-imidazol-4-yl)-1-(1-methylindol-2-yl)propan-1-one	117186-80-8				
GR 73632	133156-06-6	L-Methioninamide, N-(5-amino-1-oxopentyl)-L-phenylalanyl-L-phenylalanyl-L-prolyl-N-methyl-L-leucyl-	133156-06-6				
GR 82334	129623-01-4	(3S)-4-[(2S)-2-[[(2S)-4-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[(5S)-7-[(2S)-1-[[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-6-oxo-1,7-diazaspiro[4.4]nonan-1-yl]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxohexan-2-yl]amino]-1,4-dioxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxo-3-[[(2S)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]amino]butanoic acid	129623-01-4				
GR 89696	126766-32-3	GR 89696 fumarate	126766-32-3	YDF52K5SDR			
Gramicidin	1405-97-6	Gramicidin	1405-97-6		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
gramine	87-52-5	Gramine	87-52-5	FGQ8A78L14			
Granisetron		Granisetron	109889-09-0		Serotonin 5-HT3 Receptor Antagonists	Drugs that bind to but do not activate SEROTONIN 5-HT3 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT3 RECEPTOR AGONISTS. (See all compounds classified as Serotonin 5-HT3 Receptor Antagonists.)	For the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy (including high dose cisplatin), postoperation, and radiation (including total body irradiation and daily fractionated abdominal radiation).
granite		Penoxsulam	219714-96-2	784ELC1SCZ			
Grape Seed Extract		Grape Seed Extract					
Grape Seed Proanthocyanidins		Grape Seed Proanthocyanidins					
graphene oxide		GRAPHENE OXIDE					
Graphite	7782-42-5	Carbon	7440-44-0				
green tea extract AR25		green tea extract AR25					
grepafloxacin	119914-60-2	Grepafloxacin	119914-60-2	L1M1U2HC31	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For treatment of adults with mild to moderate infections caused by susceptible strains of Haemophilus influenzae, Streptococcus pneumoniae, or Moraxella catarrhalis.
grifolin	6379-55-1	5,7,11-Tridecatriene-3,4-diol, 3,8,12-trimethyl-	6379-55-1				
Griseofulvin	126-07-8	Griseofulvin	126-07-8	32HRV3E3D5	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	For the treatment of ringworm infections of the skin, hair, and nails, namely: tinea corporis, tinea pedis, tinea cruris, tinea barbae, cradle cap or other conditions caused by Trichophyton or Microsporum fungi.
GS-441524		(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile	1191237-69-0	1BQK176DT6	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
GS-Succ-BP		GS-Succ-BP					
GSK 1070916		3-(4-(4-(2-(3-((dimethylamino)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl)phenyl)-1,1-dimethylurea	942918-07-2	8VLB51V7HO			
GSK 1363089		Foretinib	849217-64-7	81FH7VK1C4			
GSK 2324		6-(4-{[3-(2,6-Dichlorophenyl)-5-(1-Methylethyl)isoxazol-4-Yl]methoxy}phenyl)quinoline-2-Carboxylic Acid					
GSK 3987		1-Benzyl-3-(4-methoxyphenylamino)-4-phenylpyrrole-2,5-dione					
GSK 461364		(R)-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide	929095-18-1	8QO27TK6Q4			
GSK 461364A		GSK 461364A					
GSK 4716		4-hydroxy-N-[(E)-(4-propan-2-ylphenyl)methylideneamino]benzamide	101574-65-6				
GSK 8470		(3as,6ar)-5-[(4e)-Oct-4-En-4-Yl]-N,4-Diphenyl-2,3,6,6a-Tetrahydropentalen-3a(1h)-Amine					
GSK-2816126		(S)-1-(sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide	1346574-57-9	W4OGW9QZ97			
GSK-J4		Ethyl 3-((6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoate	1373423-53-0				
GSK0660		Methyl 3-[(4-anilino-2-methoxyphenyl)sulfamoyl]thiophene-2-carboxylate	1014691-61-2	NLW7Q75SNS			
GSK1210151A		7-(3,5-Dimethylisoxazol-4-yl)-8-methoxy-1-((R)-1-(pyridin-2-yl)ethyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one	1300031-49-5				
GSK2110183		1047634-63-8					
GSK2141795		Uprosertib	1047634-65-0	ZXM835LQ5E			
GSK2193874		7-bromo-N-(1-phenylcyclopropyl)-3-[(4-piperidin-1-ylpiperidin-1-yl) methyl]-2-[3-(trifluoromethyl)phenyl]quinoline-4-carboxamide	1336960-13-4				
GSK2656157		1-(5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-4-fluoroindolin-1-yl)-2-(6-methylpyridin-2-yl)ethanone	1337532-29-2				
GSK2795039		N-(1-Isopropyl-3-(1-methylindolin-6-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-methyl-1H-pyrazole-3-sulfonamide					
GSK2837808A		3-[[3-[(Cyclopropylamino)sulfonyl]-7-(2,4-dimethoxy-5-pyrimidinyl)-4-quinolinyl]amino]-5-(3,5-difluorophenoxy)-benzoic acid					
GSK2879552		4-((4-((((1R,2S)-2-Phenylcyclopropyl)amino)methyl)piperidin-1-yl)methyl)benzoic acid	1401966-69-5	GT77Z6Y09Z			
GSK3235025		(S)-N-(3-(3,4-Dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-6-(oxetan-3-ylamino)pyrimidine-4-carboxamide					
GSK343		1-isopropyl-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(2-(4-methylpiperazin-1-yl)pyridin-4-yl)-1H-indazole-4-carboxamide	1346704-33-3				
GSK5182		(Z)-4-(1-{4-[2-(Dimethylamino)ethoxy]phenyl}-5-hydroxy-2-phenylpent-1-enyl)phenol					
GSK690693		(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol	937174-76-0	GWH480321B			
GSK872		N-(6-(isopropylsulfonyl)quinolin-4-yl)benzo[d]thiazol-5-amine					
GSK876008		GSK 876008					
GSK923295		3-Chloro-N-((S)-1-(2-(dimethylamino)acetamido)-3-(4-(8-((S)-1-hydroxyethyl)imidazo[1,2-a]pyridin-2-yl)phenyl)propan-2-yl)-4-isopropoxybenzamide	1088965-37-0	072702W9QD			Investigated for use/treatment in cancer/tumors (unspecified) and solid tumors.
Gu-Ben-Fang-Xiao decoction		Gu-Ben-Fang-Xiao decoction					
Guaiacol	90-05-1	Guaiacol	8001-58-9	6JKA7MAH9C			It is used medicinally as an expectorant, antiseptic, and local anesthetic. Guaiacol is used in traditional dental pulp sedation, and has the property of inducing cell proliferation; guaiacol is a potent scavenger of reactive oxygen radicals and its radical scavenging activity may be associated with its effect on cell proliferation.
guaiazulene	489-84-9	Guaiazulene	489-84-9	2OZ1K9JKQC			
Guanabenz	5051-62-7	Guanabenz	60329-03-5	GGD30112WC	Adrenergic alpha-2 Receptor Agonists	Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)	For management of High blood pressure
Guanethidine	55-65-2	Guanethidine	55-65-2	ZTI6C33Q2Q	Sympatholytics	Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)	For the treatment of moderate and severe hypertension, either alone or as an adjunct, and for the treatment of renal hypertension.
Guanfacine	29110-47-2	Guanfacine	29110-47-2	30OMY4G3MK	Adrenergic alpha-2 Receptor Agonists	Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)	Guanfacine is indicated alone or as an adjunct with stimulants to treat ADHD.
Guanidine	113-00-8	Guanidine	113-00-8	JU58VJ6Y3B			For the reduction of the symptoms of muscle weakness and easy fatigability associated with the myasthenic syndrome of Eaton-Lambert. It is not indicated for treating myasthenia gravis.
Guanidines		Guanidines					
guanidinopropionic acid		3-Guanidinopropionic acid	353-09-3	UL1984YRKA			
Guanine	73-40-5	Guanine	73-40-5	5Z93L87A1R			
Guanine Nucleotides		Guanine Nucleotides					
Guanosine	118-00-3	Guanosine	118-00-3	12133JR80S			
guanosine 5'-O-(2-thiodiphosphate)	71376-97-1	Guanosine 5'-O-(2-thiodiphosphate)	71376-97-1				
Guanosine 5'-O-(3-Thiotriphosphate)	37589-80-3	5'-Guanosine-diphosphate-monothiophosphate	37589-80-3	EJ7Q9D2M9D			
Guanosine Diphosphate	146-91-8	Guanosine-5'-diphosphate	146-91-8				
guanosine diphosphate glucose	5750-57-2	GDP-glucose	5750-57-2				
Guanosine Monophosphate	85-32-5	Guanosine-5'-monophosphate	85-32-5	16597955EP			
Guanosine Triphosphate	86-01-1	Guanosine-5'-triphosphate	86-01-1	01WV7J708X			
guanylin	140653-38-9	Guanylin	140653-38-9		Guanylyl Cyclase C Agonists	Compunds that bind to and activate GUANYLYL CYCLASE-C RECEPTORS. (See all compounds classified as Guanylyl Cyclase C Agonists.)	
Guanylyl Imidodiphosphate	34273-04-6	Phosphoaminophosphonic acid-guanylate ester	34273-04-6	9L7GM5N7EG			
guggulu extract		guggulu extract					
guizhi-fuling		guizhi-fuling					
gulonic acid	20246-33-7	Gulonic acid	20246-53-1	1HB2H1463Q			
gulonolactone	3327-64-8	D-Gulono-1,4-lactone	6322-07-2				
Gum Arabic	9000-01-5	Arabic gum	9000-01-5				
GUM1 compound		GUM1 compound					
Gur		GLYCOLURIL					
gusperimus	84937-45-1	Deoxyspergualin trihydrochloride	84937-45-1	S0D7V00ZRX			
Gutta-Percha	9000-32-2	Geran-8-YL geran	9000-32-2				
GV 150013X		1-[(3R)-1-(1-adamantylmethyl)-2,4-dioxo-5-phenyl-1,5-benzodiazepin-3-yl]-3-phenylurea	167355-22-8	WSFVPEEMNO			
GW 1929		(S)-2-(2-benzoylphenylamino)-3-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)phenyl)propanoic acid	196808-24-9	X8S066WKF4			
GW 2331		Butanoic acid, 2-(4-(2-((((2,4-difluorophenyl)amino)carbonyl)heptylamino)ethyl)phenoxy)-2-methyl-	190844-95-2				
GW 2433		2-[4-[3-[2-(2-Chloro-6-fluorophenyl)ethyl-[(2,3-dichlorophenyl)carbamoyl]amino]propyl]phenoxy]-2-methylpropanoic acid					
GW 273629		GW 273629					
GW 274150		GW 274150					
GW 3965		3-(3-(N-(2-Chloro-3-trifluoromethylbenzyl)(2,2-diphenylethyl)amino)propoxy)phenylacetic acid	405911-09-3	6JI5YOG7RC			
GW 4064		(E)-3-(2-chloro-4-((3-(2,6-dichlorophenyl)-5-isopropylisoxazol-4-yl)methoxy)styryl)benzoic acid	278779-30-9	SR225WUZ0H			
GW 441756		1,3-Dihydro-3-[(1-methyl-1H-indol-3-yl)methylene]-2H-pyrrolo[3,2-b]pyridin-2-one	504433-24-3				
GW 4869		(E)-3-[4-[(E)-3-[4-(4,5-dihydro-1H-imidazol-2-yl)anilino]-3-oxo-prop-1-enyl]phenyl]-N-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]prop-2-enamide	6823-69-4				
GW 501516		Endurobol	317318-70-0	7I2HA1NU22			Investigated for use/treatment in hyperlipidemia.
GW 506033X		8-(1H-Imidazol-4-ylmethylene)-6,8-dihydro-thiazolo[5,4-E]indol-7-one	608512-97-6				
GW 583340		GW 583340 dihydrochloride					
GW 610742		{4-[({2-[3-Fluoro-4-(Trifluoromethyl)phenyl]-4-Methyl-1,3-Thiazol-5-Yl}methyl)sulfanyl]-2-Methylphenoxy}acetic Acid	317318-84-6	4PZK9FJC4Z			
GW 6471		GW 6471	880635-03-0				
GW 707		GW 707					
GW 7604		(E)-3-[4-[(E)-1-(4-hydroxyphenyl)-2-phenylbut-1-enyl]phenyl]prop-2-enoic acid	195611-82-6				
GW 7647		2-[(4-{2-[(4-Cyclohexylbutyl)(cyclohexylcarbamoyl)amino]ethyl}phenyl)sulfanyl]-2-methylpropanoic acid	265129-71-3	NTL2A9CAZ7			
GW 7845		N-(2-(Methoxycarbonyl)phenyl]-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl)-L-tyrosine	196809-22-0	23Y783RURX			
GW 876008		GW 876008					
GW 9578		2-[4-[2-[(2,4-Difluorophenyl)carbamoyl-heptylamino]ethyl]phenyl]sulfanyl-2-methylpropanoic acid	247923-29-1	H32ABL87X4			
GW0072		(+/-)(2S,5S)-3-(4-(4-Carboxyphenyl)butyl)-2-heptyl-4-oxo-5-thiazolidine					
GW280264X		benzyl N-[(5S)-5-[[(2R,3S)-3-[formyl(hydroxy)amino]-2-(2-methylpropyl)hexanoyl]amino]-6-oxo-6-(1,3-thiazol-2-ylamino)hexyl]carbamate					
GW2974		N6,N6-dimethyl-N4-[1-(phenylmethyl)-5-indazolyl]pyrido[3,4-d]pyrimidine-4,6-diamine	202272-68-2				
GW833972A		2-[(3-chlorophenyl)amino]-N-(4-pyridinylmethyl)-4-(trifluoromethyl)-5-Pyrimidinecarboxamide hydrochloride	1092502-33-4	S22C7PYU3Z			
GW8510		4-[(7-oxo-6H-pyrrolo[2,3-g][1,3]benzothiazol-8-ylidene)methylamino]-N-(2-pyridinyl)benzenesulfonamide	222036-17-1				
GW9508		3-(4-((3-Phenoxybenzyl)amino)phenyl)propanoic acid	885101-89-3	4T77GYP2CS			
GxTX-1E, Plesiophrictus guangxiensis		GxTX-1E, Plesiophrictus guangxiensis					
GYKI 52466	102771-26-6	4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine	102771-26-6	471V8NZ5X3	Neuroprotective Agents	Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)	
gymnodimine A		Gymnodimine	173792-58-0	7TV3J97IT8			
gypenoside		gypenoside					
gypenoside LXXV		Gypenoside LXXV					
GYPGKF-NH(2)		GYPGKF-NH(2)					
gyrophoric acid		Gyrophoric acid	548-89-0	BAQ44A6C6H			
GYY 4137		Morpholine (4-methoxyphenyl)(morpholino)phosphinodithioate	106740-09-4	UDZ9ARY4YG			
H 1356	147819-32-7	JB-1 peptide	147819-32-7				
H 2545		N-[3-(1,3-dioxoisoindol-2-yl)propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide	93799-37-2	P30K57LQLK			
H 35-25	13549-60-5	alpha-(1-(Isopropylamino)ethyl)-4-methylbenzyl alcohol	13549-60-5				
H-Arg-Pro-Arg-Nva-Tyr-Dap-Hol-NH2		H-Arg-Pro-Arg-Nva-Tyr-Dap-Hol-NH2					
hachimijiogan		D07031					
hainanolide	64761-48-4	(11s,12r,13s,19r)-8,19-Dimethyl-14,17-dioxahexacyclo[13.3.1.01,11.04,10.09,13.012,16]nonadeca-4,7,9-triene-6,18-dione	64761-48-4				
Hair Dyes		Hair Dyes					
Hair Preparations		Hair Preparations					
haizao yuhu		haizao yuhu					
halazone	80-13-7	Halazone	80-13-7	G359OL82VB			
Halcinonide	3093-35-4	Halcinonide	3093-35-4	SI86V6QNEG	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	Indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
halichondramide	113275-14-2	Halichondramide	113275-14-2				
halofantrine	36167-63-2	Halofantrine Hydrochloride	36167-63-2	2B7ENL644K	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	
Halofenate	26718-25-2	Halofenate	24136-24-1	K9TZK4MNO6	Uricosuric Agents	Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma. (See all compounds classified as Uricosuric Agents.)	
halofuginone		7-bromo-6-chloro-3-(3-((2S,3R)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one	55837-20-2	NVY6A324PU	Protein Synthesis Inhibitors	Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)	For the treatment of scleroderma, cancer, and restenosis.
Halogenated Diphenyl Ethers		Halogenated Diphenyl Ethers					
Halogens		Halogens					
Haloperidol	52-86-8	Haloperidol	52-86-8	J6292F8L3D	Anti-Dyskinesia Agents	Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias. (See all compounds classified as Anti-Dyskinesia Agents.)	Haloperidol is indicated for a number of conditions including for the treatment of schizophrenia, for the manifestations of psychotic disorders, for the control of tics and vocal utterances of Tourettes Disorder in children and adults, for treatment of severe behavior problems in children of combative, explosive hyperexcitability (which cannot be accounted for by immediate provocation). Haloperidol is also indicated in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance. Haloperidol should be reserved for these two groups of children only after failure to respond to psychotherapy or medications other than antipsychotics.
haloperidol decanoate	74050-97-8	Haloperidol Decanoate	74050-97-8	AC20PJ4101	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
Halothane	151-67-7	Halothane	151-67-7	UQT9G45D1P	Anesthetics, Inhalation	Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173) (See all compounds classified as Anesthetics, Inhalation.)	For the induction and maintenance of general anesthesia
halowax 1051		1,3,4,5,6,7,8-Octachloronaphthalene					
haloxon	321-55-1	Haloxon	321-55-1	T8KXA37068			
haloxyfop-p-methyl		Haloxyfop-P-methyl	72619-32-0	7VD796HHTS			
Haptens		Haptens					
hard metal		hard metal					
Harmaline	304-21-2	Harmaline	304-21-2	CN58I4TOET	Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	
harmalol	525-57-5	Harmalol	525-57-5	2NQN80556Q			
harman	486-84-0	Harman	486-84-0	82D6J0535P	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
Harmine	442-51-3	Harmine	442-51-3	4FHH5G48T7	Monoamine Oxidase Inhibitors	A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed, p414) (See all compounds classified as Monoamine Oxidase Inhibitors.)	
harmol	487-03-6	Harmol	487-03-6	7PQ075MCA6			
harpagide	6926-08-5	CID 10044294	6926-08-5				
Hazardous Substances		Hazardous Substances					
HB-19 peptide		HB-19 peptide					
HC toxin	83209-65-8	HC-Toxin	83209-65-8	17NL0QLS6P			
HC-067047		2-methyl-1-(3-morpholin-4-ylpropyl)-5-phenyl-N-[3-(trifluoromethyl)phenyl]pyrrole-3-carboxamide	883031-03-6				
HCV 796		Nesbuvir	691852-58-1	EYK815W3Z8			
HDL cholesteryl ester		HDL cholesteryl ester					
HDN-1 compound		HDN-1 compound					
heat stable toxin (E coli)		heat stable toxin (E coli)					
heclin		Heclin			Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
hecogenin	467-55-0	Hecogenin	467-55-0	3XP44JJ79F			
helenalin	6754-13-8	Helenalin	6754-13-8	4GUY9L896T	Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	
helicenes		helicenes					
heliotrine		Heliotrine	303-33-3	ZYB88Y4FUZ			
helioxanthin		Helioxanthin	18920-47-3				
hellebrigenin	465-90-7	Hellebrigenin	465-90-7				
helveticoside	630-64-8	Helveticoside	630-64-8	52OAE3C457			
Hemagglutinins		Hemagglutinins					
hematide		Peginesatide [USAN:INN]					
Hematoporphyrins		Hematoporphyrin	136752-88-0		Photosensitizing Agents	Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)	
Hematoxylin	517-28-2	Haematoxylin	8005-33-2	YKM8PY2Z55	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
Heme	14875-96-8	Protoheme	104244-10-2	42VZT0U6YR			Used in the management of porphyria attacks, particularly in acute intermittent porphyria.
heme arginate	100438-92-4	Normosang	100438-92-4				
heme lysinate		heme lysinate					
hemiasterlin		Hemiasterlin	157207-90-4	6S0T7U2I3F	Tubulin Modulators	Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)	
Hemicholinium 3	312-45-8	Hemicholinium-3	312-45-8	65NY3I7ZD0	Cholinergic Agents	Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of ACETYLCHOLINE, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of MUSCARINIC AGONISTS, although most modern texts discourage that usage. (See all compounds classified as Cholinergic Agents.)	
Hemin	16009-13-5	Hemin	16009-13-5				Used in the management of porphyria attacks, particularly in acute intermittent porphyria.
heminordihydroguaiaretic acid	54473-24-4	4-[(2r,3s)-4-(4-Hydroxy-3-methoxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol	54473-24-4				
hemistepsin		Hemistepsin					
Hemocyanins	9013-72-3	Keyhole limpet hemocyanin	9013-72-3				Investigated for use/treatment in bladder cancer and solid tumors.
Hempa	680-31-9	Hexamethylphosphoramide	680-31-9	M42TU5843Z	Chemosterilants	Compounds that cause reproductive sterility in organisms. They are sometimes used to control pest populations by sterilizing males within the population. (See all compounds classified as Chemosterilants.)	
hempseed oil		Cannabis sativa seed oil					
Heparan Sulfate Proteoglycans		Heparan Sulfate Proteoglycans					
Heparin	9005-49-6	Heparin					
heparin-sepharose		heparin-sepharose					
Heparin, Low-Molecular-Weight		Heparin, Low-Molecular-Weight					
heparin, O-desulfated		heparin, O-desulfated					
Heparitin Sulfate	9050-30-0	Heparitin, sulfate	9050-30-0				
Hepatitis B e Antigens		Hepatitis B e Antigens					
Hepatitis B Surface Antigens		Hepatitis B Surface Antigens					
HEPES	7365-45-9	4-(2-Hydroxyethyl)-1-piperazine ethanesulfonic acid	7365-45-9	RWW266YE9I	Buffers	A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer. (See all compounds classified as Buffers.)	
Heptachlor	76-44-8	Heptachlor	76-44-8		Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Heptachlor Epoxide	1024-57-3	Epoxyheptachlor	1024-57-3	055UWF6R6I	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Heptaminol	372-66-7	Heptaminol	372-66-7	3DQS188SY5			
heptanal	111-71-7	Heptanal	111-71-7	92N104S3HF			
heptane-1,7-bis-(dimethyl-3'-phthalimidopropyl)ammonium bromide		heptane-1,7-bis-(dimethyl-3'-phthalimidopropyl)ammonium bromide					
Heptanoic Acids		Heptanoic Acids					
Heptanol	111-70-6	1-Heptanol	111-70-6	8JQ5607IO5			
heptanoyl-gamma-D-glutamyl-L-meso-diaminopimelyl-D-alanine		N-(1-Oxoheptyl)-D-gamma-glutamyl-(6R)-6-carboxy-L-lysyl-D-alanine	79335-75-4	HD9KDE59ZR	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
heptelidic acid	57710-57-3	Heptelidic acid	57710-57-3	6H8EDV2NKQ			
heptenophos	34783-40-9	(3-Chloro-4-bicyclo[3.2.0]hepta-3,6-dienyl) dimethyl phosphate	34783-40-9				
heptylparaben		Heptyl 4-hydroxybenzoate	1085-12-7	K2CIJ448IX			
heraclenin	2880-49-1	Heraclenin	2880-49-1	G71S84CX12			
herbacetin		Herbacetin	527-95-7	736854V2KE			
herbal compound 861		herbal compound 861					
Herbicides		Herbicides					
herbimycin	70563-58-5	Herbimycin a	70563-58-5	815WDV2HST	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	
Heroin	561-27-3	Heroin	561-27-3	70D95007SX	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	Diamorphine, as a prescription medication in the United Kingdom, is indicated for use in the treatment of severe pain associated with surgical procedures, myocardial infarction or pain in the terminally ill and for the relief of dyspnoea in acute pulmonary edema.
hesperetin	520-33-2	Hesperetin	520-33-2	Q9Q3D557F1			For lowering cholesterol and, possibly, otherwise favorably affecting lipids. In vitro research also suggests the possibility that hesperetin might have some anticancer effects and that it might have some anti-aromatase activity, as well as activity again.
Hesperidin	520-26-3	Hesperidin	520-26-3	E750O06Y6O			
hesperidin methylchalcone	24292-52-2	Hesperidin methylchalcone	24292-52-2	4T2GVA922X			
HET0016		N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine	339068-25-6				
Heterocyclic Compounds		Heterocyclic Compounds					
Heterocyclic Compounds, 1-Ring		Heterocyclic Compounds, 1-Ring					
Heterocyclic Compounds, 3-Ring		Heterocyclic Compounds, 3-Ring					
heteronemin		Heteronemin	62008-04-2				
hexaarginine amide		hexaarginine amide					
hexabrominated diphenyl ether 153		hexabrominated diphenyl ether 153					
hexabromobenzene	87-82-1	Hexabromobenzene	87-82-1	T01859XWIR			
hexabromocyclododecane	25637-99-4	1,1,2,2,3,3-Hexabromocyclododecane	25637-99-4				
hexabromodiphenyl ether 154		2,2',4,4',5,6'-Hexabromodiphenyl ether	207122-15-4	OGY508QK5U			
Hexachlorobenzene	118-74-1	Hexachlorobenzene	118-74-1	4Z87H0LKUY	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
hexachlorobutadiene	87-68-3	Hexachloro-1,3-butadiene	87-68-3	CQ8AAO9MO1	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Hexachlorocyclohexane		Hexachlorocyclohexane	319-86-8	IVM9A2N49K			Used as a pancreatic enzyme replacement in pancreatic insufficiency.  It is intended to mimic naturally produced human pepsin.  Pepsin powder is prepared from the gastric mucosa of pigs, cattle or sheep. In the laboratory, it is primarily used for the unspecific hydrolysis of proteins and peptides in acidic media. In addition, it provides limited hydrolysis of native immunoglobulins, yielding biologically active fragments.  In certain supplements, pepsin may be combined with betaine and HCl (hydrochloric acid) to aid in digestion in various gastrointestinal conditions,.
hexachlorocyclopentadiene	77-47-4	Hexachlorocyclopentadiene	77-47-4	IP6ATU242I	Teratogens	An agent that causes the production of physical defects in the developing embryo. (See all compounds classified as Teratogens.)	
hexachlorocyclopentadienyl-dibromocyclooctane		Hexachlorocyclopentadienyl-dibromocyclooctane					
Hexachlorophene		Hexachlorophene	70-30-4	IWW5FV6NK2	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	For use as a surgical scrub and a bacteriostatic skin cleanser. It may also be used to control an outbreak of gram-positive infection where other infection control procedures have been unsuccessful.
hexaconazole		Hexaconazole	79983-71-4	SX9R3X1FQV			
hexacyanoferrate III	13408-62-3	Ferricyanide	13408-62-3				
hexadecafluoro-nonanoic acid	76-21-1	2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-Hexadecafluorononanoic acid	76-21-1	D634UW8QCQ			
hexadecyl-N-methylpiperidinium	71595-57-8	Hexadecyl-N-methylpiperidinium	71595-57-8				
Hexadimethrine Bromide	9011-04-5	Hexadimethrin bromide for protein			Heparin Antagonists	Coagulant substances inhibiting the anticoagulant action of heparin. (See all compounds classified as Heparin Antagonists.)	
hexafluoroisopropanol		1,1,1,3,3,3-Hexafluoro-2-propanol	920-66-1	3D632GYQ50			
hexafluoroisopropanol glucuronide		Hexafluoroisopropanol glucuronide	77769-20-1	F2F7B35D87			
hexafluoron		Hexaflumuron	86479-06-3	4GW50R449T	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
hexahydrosiladifenidol	98299-40-2	Hexahydrosiladifenidol	98299-40-2	LXZ2G00X0W	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	
Hexamethonium	60-26-4	Hexamethonium	60-26-4	3C9PSP36Z2	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
hexamethylcyclotrisiloxane	541-05-9	Hexamethylcyclotrisiloxane	541-05-9	EPV75L8O0R			
hexamethylene bisacetamide	3073-59-4	Hexamethylene bisacetamide	3073-59-4	LA133J59VU	Hematinics	Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias. (See all compounds classified as Hematinics.)	
hexamethylene glycol	629-11-8	Hexane-1,6-diol	629-11-8				
Hexanes		2-Methylpentane	64742-49-0	49IB0U6MLD			
hexanoic acid	142-62-1	Caproic Acid	142-62-1	1F8SN134MX			
Hexanols		1-Hexanol	111-27-3	6CP2QER8GS	Nicotinic Antagonists	Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)	
Hexanones		Hexanones					
hexanoyl-coenzyme A	5060-32-2	Hexanoyl-coenzyme a	5060-32-2				
hexarelin	140703-51-1	Examorelin	140703-51-1	09QF37C617			
hexazinone	51235-04-2	Hexazinone	51235-04-2	Y51727MR1Y	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Hexestrol	5635-50-7	Hexestrol	5635-50-7		Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	
hexestrol diazirine	153145-01-8	Hexestrol diazirine	153145-01-8				
Hexetidine	141-94-6	Hexetidine	141-94-6	852A84Y8LS	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
Hexobarbital	56-29-1	Hexobarbital	56-29-1	AL8Z8K3P6S	GABA Modulators	Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)	For the induction of anesthesia prior to the use of other general anesthetic agents and for induction of anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli.
Hexoses		2,3,4,5,6-Pentahydroxyhexanal	3458-28-4		Sweetening Agents	Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)	
Hexuronic Acids		Hexuronic Acids					
hexyl 2,5-dichlorophenylphosphoroamidate	109791-13-1	Hexyl 2,5-dichlorophenylphosphoroamidate	109791-13-1				
hexyl cinnamic aldehyde	101-86-0	alpha-Hexylcinnamaldehyde	101-86-0	E9947QRR9O			
hexyl salicylate		Hexyl salicylate	6259-76-3	8F78EY72YL			
hexylglutathione	24425-56-7	s-Hexylglutathione	24425-56-7	M73SNN908F	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Hexylresorcinol	136-77-6	Hexylresorcinol	136-77-6	R9QTB5E82N	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	Hexylresorcinol is predominantly employed as the active ingredient in lotions, sprays, or lozenges indicated as a (a) topical antiseptic to help prevent skin infection in minor cuts, scrapes, or burns, or (b) as an antiseptic and local anesthetic for the relief of a sore throat and its associated pain.  In addition, hexylresorcinol is used as an active ingredient in various commercial cosmetic skincare products as an anti-aging cream while other studies have looked into whether or not the compound could be used effectively as an anti-inflammatory agent or even as an anti-cancer therapy.
Heymann Nephritis Antigenic Complex		Heymann Nephritis Antigenic Complex					
heyneanol A		heyneanol A					
HFPO4 compound		HFPO4 compound					
HG-7-85-01 compound		HG-7-85-01 compound					
HhAntag691		Vismodegib	879085-55-9	25X868M3DS			Vismodegib is indicated for the treatment of adults with metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery and who are not candidates for radiation.
hibifolin	55366-56-8	Hibifolin	55366-56-8	JR6MS62GTB			
higenamine	5843-65-2	Higenamine	5843-65-2	TBV5O16GAP	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
High Fructose Corn Syrup		Corn syrup, high fructose					
hiiranlactone D		hiiranlactone D					
himbacine	6879-74-9	(+)-Himbacine	6879-74-9	M17C7V122D	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	
hinokiflavone	19202-36-9	Hinokiflavone	19202-36-9	GFF5VYC4NB			
hinokiresinol	17676-24-3	(-)-Hinokiresinol	17676-24-3				
hippuric acid	495-69-2	Hippuric Acid	495-69-2	TE0865N2ET			
hippuryl-histidyl-leucine	31373-65-6	Hippuryl-histidyl-leucine	31373-65-6				
hirsuteine	18904-54-6	Corynantheine	18904-54-6	ALO105K75L			
hirsutine	7729-23-9	Hirsutine	7729-23-9	W596OF93C7			
Hirudins		Hirudin	8001-27-2		Antithrombins	Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. (See all compounds classified as Antithrombins.)	
hirugen	121822-23-9	Asparaginyl-glycyl-aspartyl-phenylalanyl-glutamyl-glutamyl-isoleucyl-prolyl-glutamyl-glutamyl-O-sulfotyrosyl-leucine	121822-23-9				
hirulog-like peptide		hirulog-like peptide					
His-Asp-Ala-Pro-Ile-Gly-Tyr-Asp		His-Asp-Ala-Pro-Ile-Gly-Tyr-Asp					
hispanolone		Hispanolone	18676-07-8				
hispidin	555-55-5	Hispidin	555-55-5	SSJ18CG55E			
hispidulin		Hispidulin	1447-88-7	N7F61604C2			
hispolon		Hispolon	173933-40-9				
Histamine	51-45-6	Histamine	51-45-6	820484N8I3	Histamine Agonists	Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. (See all compounds classified as Histamine Agonists.)	Histamine phosphate is indicated as a diagnostic aid for the evaluation of gastric acid secretory function.
Histamine H3 Antagonists		Histamine H3 Antagonists					
histamine phosphate	51-74-1	Histamine Phosphate	51-74-1	QWB37T4WZZ	Histamine Agents	Drugs used for their actions on histaminergic systems. Included are drugs that act at histamine receptors, affect the life cycle of histamine, or affect the state of histaminergic cells. (See all compounds classified as Histamine Agents.)	
histamine trifluoromethyl-toluidide	103827-16-3	Htfmt	103827-16-3	Y89R9XVK5W			
histaprodifen		Histaprodifen					
Histidine	71-00-1	Histidine	71-00-1	4QD397987E			The actions of supplemental L-histidine are entirely unclear. It may have some immunomodulatory as well as antioxidant activity. L-histidine may be indicated for use in some with rheumatoid arthritis. It is not indicated for treatment of anemia or uremia or for lowering serum cholesterol.
histidine methyl ester	1499-46-3	Histidine methyl ester	1499-46-3	9IHZ1723UE			
histidyl-proline diketopiperazine	4257-92-5	Histidylproline diketopiperazine	4257-92-5		Neurotransmitter Uptake Inhibitors	Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects. (See all compounds classified as Neurotransmitter Uptake Inhibitors.)	
Histone Deacetylase Inhibitors		Histone Deacetylase Inhibitors					
HIV Envelope Protein gp120		HIV Envelope Protein gp120					
HLo 7	120103-35-7	[(Z)-[1-[(4-carbamoylpyridin-1-ium-1-yl)methoxymethyl]-2-[(Z)-hydroxyiminomethyl]-4-pyridylidene]methyl]-oxo-ammonium			Cholinesterase Reactivators	Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates. (See all compounds classified as Cholinesterase Reactivators.)	
HMR 1098		Unii-aau99uzb44	261717-22-0	AAU99UZB44			
HMR 1556		Methanesulfonamide, N-((3R,4S)-3,4-dihydro-3-hydroxy-2,2-dimethyl-6-(4,4,4-trifluorobutoxy)-2H-1-benzopyran-4-yl)-N-methyl-	223749-46-0	4IF4R31066			
HMR 3339		HMR 3339					
HNK-102		HNK-102					
HOE 140, desArg(10)-	138680-92-9	Hoe 140, desarg(10)-	138680-92-9				
Holmium	7440-60-0	Holmium	7440-60-0	W1XX32SQN1			
homatropine	87-00-3	Homatropine	87-00-3		Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	Indicated as an overdose-rescuing agent in combination with hydrocodone antitussive.  Indicated for the induction of mydriasis in ophthalmic solutions.
Homoarginine	156-86-5	L-Homoarginine	156-86-5	JF751CK38I			
homobrassinolide	74174-44-0	28-Homobrassinolide	82373-95-3	P301F2094N			
homocamptothecin		Homocamptothecin	186669-19-2	5B3LFU8GLM			
homocarnosine	3650-73-5	Homocarnosine	3650-73-5	M8L4BH36SC			
homocastasterone	83509-42-6	Homocastasterone	83509-42-6				
homochlorocyclizine	848-53-3	Homochlorcyclizine	848-53-3	N5MVC31W2N			
homocysteic acid	1001-13-4	DL-Homocysteic acid	504-33-6	HYA2G5T79L			
Homocysteine	454-28-4	DL-Homocysteine	454-29-5	S7IJP4A89K			
homocysteine thiolactone	10593-85-8	DL-Homocysteine thiolactone	10593-85-8	D5H88XF24X	Radiation-Protective Agents	Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)	
homoeriodictyol		Homoeriodictyol	446-71-9	EHE7H3705C			
Homoharringtonine	26833-87-4	Omacetaxine Mepesuccinate	26833-87-4	6FG8041S5B	Protein Synthesis Inhibitors	Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)	Used in patients who are intolerant and/or resistant to two or more tyrosine kinase inhibitors used to treat accelerated or chronic phase CML.
homoorientin		Isoorientin	4261-42-1	A37342TIX1			
homosalate		Homosalate	118-56-9	V06SV4M95S	Sunscreening Agents	Chemical or physical agents that protect the skin from sunburn and erythema by absorbing or blocking ultraviolet radiation. (See all compounds classified as Sunscreening Agents.)	As ingredient in many sunscreen for protection against sunburn, skin aging and skin cancer.
Homovanillic Acid	306-08-1	Homovanillic Acid	306-08-1	X77S6GMS36			
Honghua extract, Carthamus tinctorius		Honghua extract, Carthamus tinctorius					
honokiol	35354-74-6	Honokiol	35354-74-6	11513CCO0N	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
hopane	471-62-5	Hopane	471-62-5	W2H93796GT			
hopeahainol A		Hopeahainol A					
Hormones		Hormones					
Houttuynia cordata extract		Houttuynia cordata extract					
HR 325		Cch-mtpp	171197-16-3				
HR22C16		Justine					
HS 1030		methyl 2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetate	188529-17-1				
HS 1183		HS 1183					
HS 1200		HS 1200					
HS 142-1		HS 142-1					
HS 3	25487-36-9	2-((Hydroxyimino)methyl)-1-(((4-((hydroxyimino)methyl)pyridinio)methoxy)methyl)pyridinium dichloride	25487-36-9				
HS-1199		HS-1199					
HT-2 toxin		HT-2 Toxin	26934-87-2	NC6C26RM46			
HTH-01-015		1613724-42-7					
HTI-286		Taltobulin	228266-40-8	J6D6912BXS			
HTS 466284		4-(3-Pyridin-2-YL-1H-pyrazol-4-YL)quinoline	396129-53-6				
HU 211		Dexanabinol	112924-45-5	R6VT8U5372	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	Investigated for use/treatment in traumatic brain injuries and neurologic disorders.
HU 308		[(1S,4S,5S)-4-[2,6-Dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methanol	256934-39-1	8I5L034D55	Cannabinoid Receptor Agonists	Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)	
huachansu		Huachansu					
huai qi huang		huai qi huang					
Huang Qi		Huang Qi					
huang-lien-chieh-tu-tang		huang-lien-chieh-tu-tang					
huanglian		Huanglian					
huanglian-jie-du decoction		huanglian-jie-du decoction					
Huangqin-Tang		Huangqin-Tang					
HUF-101		HUF-101					
hugan qingzhi		hugan qingzhi					
Humic Substances		Humic Substances					
humulene	6753-98-6	Humulene	6753-98-6	54W56MD2WD			
huperzine A	102518-79-6	(-)-Selagine	102518-79-6		Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	Investigated for use/treatment in alzheimer's disease.
huwentoxin IV, Selenocosmia huwena		huwentoxin IV, Selenocosmia huwena					
hwanggunchungyitang		hwanggunchungyitang					
HX 600	172705-89-4	4-(5,7,7,10,10-Pentamethyl-8,9-dihydronaphtho[2,3-b][1,5]benzodiazepin-12-yl)benzoic acid	172705-89-4				
HX 630		Benzoic acid, 4-(7,8,9,10-tetrahydro-7,7,10,10-tetramethylbenzo(b)naphtho(2,3-f)(1,4)thiazepin-12-yl)-	188844-52-2	N564S742U1			
Hyaluronic Acid	9004-61-9	9004-61-9					
Hycanthone	3105-97-3	Hycanthone	3105-97-3	2BXX5EVN2A	Schistosomicides	Agents that act systemically to kill adult schistosomes. (See all compounds classified as Schistosomicides.)	
Hydantoins		Hydantoin	461-72-3	I6208298TA			
Hydralazine	86-54-4	Hydralazine	86-54-4	26NAK24LS8	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	Hydralazine is indicated alone or adjunct to standard therapy to treat essential hypertension. A combination product with isosorbide dinitrate is indicated as an adjunct therapy in the treatment of heart failure.
hydramethylnon	67485-29-4	Hydramethylnon	67485-29-4	J265GZ7MFJ	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
hydrastine	118-08-1	Hydrastine	118-08-1	8890V3217X			
hydratropic acid	492-37-5	2-Phenylpropionic acid	492-37-5	CH15E393A2			
hydratropic aldehyde	93-53-8	2-Phenylpropanal	93-53-8	8JKX55PKZQ			
hydrazine	302-01-2	Hydrazine	302-01-2	27RFH0GB4R	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Hydrazines		Hydrazine	302-01-2	27RFH0GB4R	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Hydrazones		Hydrazones					
hydrobupropion		hydrobupropion					
Hydrocarbons		Caswell No. 907					
Hydrocarbons, Aromatic		Hydrocarbons, Aromatic					
Hydrocarbons, Brominated		Hydrocarbons, Brominated					
Hydrocarbons, Chlorinated		Hydrocarbons, Chlorinated					
Hydrocarbons, Fluorinated		Hydrocarbons, Fluorinated					
Hydrocarbons, Halogenated		Hydrocarbons, Halogenated					
Hydrochloric Acid	7647-01-0	Hydrochloric Acid	7647-01-0	QTT17582CB			
Hydrochlorothiazide	58-93-5	Hydrochlorothiazide	58-93-5	0J48LPH2TH	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy. Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.
Hydrocodone	125-29-1	Hydrocodone	125-29-1	6YKS4Y3WQ7	Antitussive Agents	Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)	Hydrocodone is indicated for the management of acute pain, sometimes in combination with [acetaminophen] or [ibuprofen], as well as the symptomatic treatment of the common cold and allergic rhinitis in combination with decongestants, antihistamines, and expectorants.
Hydrocortisone	50-23-7	Hydrocortisone	50-23-7	WI4X0X7BPJ	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	Otic solutions are indicated for infections of the external auditory canal caused by susceptible organisms and with inflammation. Hydrocortisone tablets are indicated for certain endocrine, rheumatic, collagen, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, gastrointestinal, and other conditions. A hydrocortisone enema is indicated for ulcerative colitis, a topical ointment with antibiotics is indicated for corticosteroid responsive dermatoses with infections, and a topical cream with [acyclovir] is indicated to treat cold sores. Oral granules of hydrocortisone are used as a replacement therapy for Adrenocortical Insufficiency (AI) in children under 17 years of age.
hydrocortisone acetate		Hydrocortisone Acetate	50-03-3	3X7931PO74	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease.
hydrocortisone hemisuccinate		Hydrocortisone hemisuccinate	125-04-2	IHV1VP592V	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
Hydrogels		Hydrogels					
Hydrogen	1333-74-0	Hydrogen	1333-74-0	7YNJ3PO35Z			
Hydrogen Cyanide	74-90-8	Hydrogen Cyanide	74-90-8	2WTB3V159F	Chemical Warfare Agents	Chemicals that are used to cause the disturbance, disease, or death of humans during WARFARE. (See all compounds classified as Chemical Warfare Agents.)	
Hydrogen Peroxide	7722-84-1	Hydrogen Peroxide	7722-84-1	BBX060AN9V	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	Indicated to be used as a disinfectant and sterilizer.
Hydrogen Sulfide	7783-06-4	Hydrogen Sulfide	7783-06-4	YY9FVM7NSN	Gasotransmitters	Endogenously produced lipid-soluble gaseous molecules which function as neurotransmitters and signal mediators targeting ION CHANNELS and transporters. (See all compounds classified as Gasotransmitters.)	
Hydrolyzable Tannins		Hydrolyzable Tannins					
Hydromorphone	466-99-9	Hydromorphone	466-99-9	Q812464R06	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	Hydromorphone is indicated for the management of moderate to severe acute pain and severe chronic pain. Due to its addictive potential and overdose risk, hydromorphone is only prescribed when other first-line treatments have failed.  The WHO has proposed a three-step ladder for the management of pain in which it is suggested to start with a non-opioid medication followed by addition of weak opioids to the non-opioid treatment for moderate pain and finishing in the use of strong opioids such as hydromorphone along with the existing regimen for cases of severe pain.  Off-label, hydromorphone can be administered for the suppression of refractory cough.
hydroperoxyisophosphamide	39800-28-7	4-Hydroperoxyisophosphamide	39800-28-7				
hydroquinone	123-31-9	Hydroquinone	123-31-9	XV74C1N1AE	Radiation-Protective Agents	Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)	Hydroquinone is used as an OTC topical lightening agent for disorders of hyperpigmentation including melasma, post-inflammatory hyperpigmention, sunspots and freckles.
Hydroquinones		Hydroquinones					
Hydroxamic Acids		Hydroxamic Acids					
Hydroxocobalamin	13422-51-0	Hydroxocobalamin	13422-51-0	Q40X8H422O	Hematinics	Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias. (See all compounds classified as Hematinics.)	For treatment of pernicious anemia and the prevention and treatment of vitamin B12 deficiency arising from alcoholism, malabsorption, tapeworm infestation, celiac, hyperthyroidism, hepatic-biliary tract disease, persistent diarrhea, ileal resection, pancreatic cancer, renal disease, prolonged stress, vegan diets, macrobiotic diets or other restrictive diets. Also for the treatment of known or suspected cyanide poisoning.
hydroxopentaamminechromium(III)complex		hydroxopentaamminechromium(III)complex					
Hydroxy Acids		Hydroxy Acids					
hydroxy-2-naphthalenyl-methyl phosphonic acid trisacetoxymethylester		Hnmpa-(AM)3	120944-03-8				
Hydroxyacetylaminofluorene	53-95-2	N-Hydroxy-2-acetamidofluorene	53-95-2	6AGD02HUQC			
hydroxyapatite-beta tricalcium phosphate		hydroxyapatite-beta tricalcium phosphate					
Hydroxyapatites		Hydroxyapatites					
Hydroxybenzoates		Hydroxybenzoates					
hydroxybupropion		Hydroxybupropion	92264-81-8	V94F513635			
hydroxycamptothecinum		hydroxycamptothecinum					
Hydroxychloroquine	118-42-3	Hydroxychloroquine	118-42-3	4QWG6N8QKH	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Hydroxychloroquine is indicated for the prophylaxis of malaria where chloroquine resistance is not reported, treatment of uncomplicated malaria (caused by _P. falciparum_, _P. malariae_, _P. ovale_, or _P. vivax_), chronic discoid lupus erythematosus, systemic lupus erythematosus, acute rheumatoid arthritis, and chronic rheumatoid arthritis.
Hydroxycholesterols		Hydroxycholesterols					
hydroxycitronellal	107-75-5	Hydroxycitronellal	107-75-5	8SQ0VA4YUR			Hydroxycitronellal is approved by the FDA for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.
hydroxycobalamin(c-lactam)		hydroxycobalamin(c-lactam)					
hydroxycotinine	27323-64-4	Hydroxycotinine	34834-67-8	H7LH47Y29A			
Hydroxyeicosatetraenoic Acids		Hydroxyeicosatetraenoic Acids					
Hydroxyestrones		Estrone	53-16-7	2DI9HA706A	Estrogens	Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. (See all compounds classified as Estrogens.)	For management of perimenopausal and postmenopausal symptoms.
hydroxyethyl methacrylate	868-77-9	2-Hydroxyethyl Methacrylate	868-77-9	6E1I4IV47V			
Hydroxyethyl Starch Derivatives		Hydroxyethyl Starch Derivatives					
hydroxyfasudil		Hydroxyfasudil	105628-72-6	EYH4AU7P63			
hydroxyflutamide	52806-53-8	Hydroxyflutamide	52806-53-8	31D90UKP5Y	Androgen Antagonists	Compounds which inhibit or antagonize the biosynthesis or actions of androgens. (See all compounds classified as Androgen Antagonists.)	
hydroxygenkwanin	20243-59-8	7-O-Methylluteolin	20243-59-8	732GA1Z079			
hydroxyhexamide	3168-01-2	Hydroxyhexamide	3168-01-2	F3F26TZ9HN			
hydroxyhydroquinone	533-73-3	1,2,4-Benzenetriol	533-73-3	173O8B04RD			
hydroxyindoleacetaldehyde	1892-21-3	5-Hydroxyindole-3-acetaldehyde	1892-21-3	DAE26MT2UK			
Hydroxyindoleacetic Acid	54-16-0	5-Hydroxyindole-3-acetic acid	54-16-0	YHC763JY1P			
hydroxyitraconazole		Hydroxyitraconazole	112559-91-8		Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
Hydroxyl Radical	3352-57-6	Hydroxyl radical	3352-57-6		Oxidants	Electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION). (See all compounds classified as Oxidants.)	
Hydroxylamine	7803-49-8	Hydroxylamine	7803-49-8	2FP81O2L9Z			
hydroxymaprotilin	56433-44-4	Oxaprotiline	56433-44-4	3V3Z2HK4LS	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	Investigated for the treatment of depression.
Hydroxymercuribenzoates		Hydroxymercuribenzoates					
Hydroxymethylglutaryl-CoA Reductase Inhibitors		Hydroxymethylglutaryl-CoA Reductase Inhibitors					
hydroxymethyltolbutamide		4-Hydroxytolbutamide	5719-85-7	52K8J94779			
hydroxynefazodone		Hydroxynefazodone	98159-82-1	325402PVUU			
hydroxyoctadecadienoic acid		Hydroxyoctadecadienoic acid					
hydroxypentenal	16931-17-2	4-Hydroxypentenal	34424-65-2				
hydroxyphenytoin	2784-27-2	5-(4-Hydroxyphenyl)-5-phenylimidazolidine-2,4-dione	2784-27-2	L42OQX7ZQY			
Hydroxyprogesterones		Hydroxyprogesterones					
hydroxypyruvic acid	1113-60-6	3-Hydroxypyruvic acid	1113-60-6	934B2KHY0S			
hydroxysafflor yellow A	146087-19-6	Hydroxysafflor Yellow A	78281-02-4	HI7O919OYZ			
Hydroxysteroids		Hydroxysteroids					
Hydroxytestosterones		Hydroxytestosterones					
Hydroxytryptophol	154-02-9	5-Hydroxytryptophol	154-02-9	52MNE52QA1			
Hydroxyurea	127-07-1	Hydroxyurea	127-07-1	X6Q56QN5QC	Antisickling Agents	Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions. (See all compounds classified as Antisickling Agents.)	Hydroxyurea is indicated to reduce the frequency of painful crises and to reduce the need for blood transfusions in adult and pediatric patients, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises.
Hydroxyzine	68-88-2	Hydroxyzine	68-88-2	30S50YM8OG	Antipruritics	Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)	Hydroxyzine is indicated for the symptomatic relief of anxiety and tension associated with psychoneuroses, and as an adjunct in organic disease states in which anxiety is manifested. It is also indicated in the treatment of histamine-mediated pruritus and pruritus due to allergic conditions such as chronic urticaria.  Canadian labeling states that hydroxyzine is also indicated in adults and children as a premedication prior to medical procedures, such as dental surgery. It is also used in the control of nausea and vomiting, excluding nausea and vomiting of pregnancy.
Hymecromone	90-33-5	Hymecromone	90-33-5	3T5NG4Q468	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
hymenialdisine	95569-43-0	Hymenialdisine	82005-12-7	5WMS4GA67M			
hymexazol		Hymexazol	10004-44-1	20T2M875LO			
hyodeoxycholic acid	83-49-8	Hyodeoxycholic acid	83-49-8	7A33Y6EHYK			
Hyoscyamine	101-31-5	Hyoscyamine	101-31-5		Adjuvants, Anesthesia	Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)	As a drug that is not FDA approved, hyscyamine has no official indications. Intravenous hysocyamine has been used to reduce gastric motility, reduce pancreatic pain and secretions, to facilitate imaging of the gastrointestinal tract, treat anticholinesterase toxicity, treat certain cases of partial heart block, improve visualization of the kidneys, and for symptomatic relief of biliary and renal colic. Intravenous hyoscyamine is also used pre-operatively to reduce secretions of the mouth and respiratory tract to facilitate intubation. Oral hyoscyamine is used to treat functional intestinal disorders, for symptomatic relief of biliary and renal colic, and symptomatic relief of acute rhinitis.
hypaconitine	6900-87-4	Hypaconitine	6900-87-4				
hyperforin	11079-53-1	Hyperforin	11079-53-1	RM741E34FP			
hyperforin dicyclohexylammonium		hyperforin dicyclohexylammonium					
hypericin	548-04-9	Hypericin	548-04-9	7V2F1075HD	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	
hyperoside	482-36-0	Hyperoside	482-36-0	8O1CR18L82			
Hypochlorous Acid	7790-92-3	Hypochlorous Acid	7790-92-3	712K4CDC10	Oxidants	Electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION). (See all compounds classified as Oxidants.)	
Hypolipidemic Agents		Hypolipidemic Agents					
hypotaurine	300-84-5	Hypotaurine	300-84-5	5L08GE4332	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
Hypoxanthine	68-94-0	Hypoxanthine	68-94-0	2TN51YD919			
hypsiziprenol A9		Hypsiziprenol A9	181482-92-8				
HZ-6d compound		HZ-6d compound					
I-152 compound		I-152 compound					
I-C11 compound		I-C11 compound					
Ibandronic Acid	114084-78-5	Ibandronic Acid	114084-78-5	UMD7G2653W	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	For the treatment and prevention of osteoporosis in postmenopausal women.
iberin	505-44-2	Iberin	505-44-2	RZ680L4LP3			
iberiotoxin	129203-60-7	Iberiotoxin	129203-60-7				
iberogast		iberogast					
ibipinabant		Ibipinabant	464213-10-3	O5CSC6WH1T	Cannabinoid Receptor Antagonists	Compounds that inhibit or block the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Antagonists.)	Investigated for use/treatment in obesity.
Ibogaine	83-74-9	Ibogaine	83-74-9	3S814I130U	Hallucinogens	Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. (See all compounds classified as Hallucinogens.)	
Ibotenic Acid	2552-55-8	Ibotenic acid	2552-55-8	44AS82FRSI	Excitatory Amino Acid Agonists	Drugs that bind to and activate excitatory amino acid receptors. (See all compounds classified as Excitatory Amino Acid Agonists.)	
ibrutinib		Ibrutinib	936563-96-1	1X70OSD4VX	Tyrosine Kinase Inhibitors	Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES. (See all compounds classified as Tyrosine Kinase Inhibitors.)	Ibrutinib is indicated for the treatment of the following conditions.   **Chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)**  - In the US, it is used in adult patients with or without 17p deletion.  - In Europe and Canada, it is used as a single agent or combined with [rituximab], [obinutuzumab], or [venetoclax] in previously untreated CLL patients. In patients who have received at least one prior therapy, it is used as a single agent or in combination with [bendamustine] and [rituximab].  **Waldenstrm's macroglobulinemia**  - It is used alone or with [rituximab]. - In Europe, it is approved for patients who have received at least one prior therapy or in first-line treatment for patients unsuitable for chemoimmunotherapy.  **Chronic graft-versus-host disease (cGVHD)**  - In the US, it is approved in patients aged one year and older after the prior failure of one or more lines of systemic therapy. - In Canada, it is approved in adults with steroid-dependent or refractory cGVHD.  **Mantle cell lymphoma (MCL)**  - In Europe and Canada, ibrutinib is also indicated to treat relapsed or refractory MCL in adults.  **Marginal zone lymphoma (MZL)**  - In Canada, it is approved for adults who require systemic therapy and have received at least one prior anti-CD20-based therapy.
IBS008738		[3-(4-methylphenyl)-5-[(E)-morpholin-4-ylmethylideneamino]imidazol-4-yl]-phenylmethanone					
ibudilast	50847-11-5	Ibudilast	50847-11-5	M0TTH61XC5	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	For the treatment of multiple sclerosis, asthma, and cerebrovascular disease.
ibufenac		Ibufenac	1553-60-2	5V4WIX44VI			
Ibuprofen	15687-27-1	Ibuprofen	15687-27-1	WK2XYI10QM	Analgesics, Non-Narcotic	A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)	Ibuprofen is the most commonly used and prescribed NSAID. It is a very common over-the-counter medication widely used as an analgesic, anti-inflammatory and antipyretic.  The use of ibuprofen and its enantiomer [DB09213] in a racemic mix is common for the management of mild to moderate pain related to dysmenorrhea, headache, migraine, postoperative dental pain, spondylitis, osteoarthritis, rheumatoid arthritis, and soft tissue disorder.  Due to its activity against prostaglandin and thromboxane synthesis, ibuprofen has been attributed to alteration of platelet function and prolongation of gestation and labour.  As ibuprofen is a widely used medication, the main therapeutic indications are:  * Patent Ductus Arteriosus - it is a neonatal condition wherein the ductus arteriosus (blood vessel that connects the main pulmonary artery to the proximal descending aorta) fails to close after birth causing severe risk of heart failure. The prostaglandin inhibition of ibuprofen has been studied for the treatment of this condition as it is known that prostaglandin E2 is responsible for keeping the ductus arteriosus open.  * Rheumatoid- and osteo-arthritis - ibuprofen is very commonly used in the symptomatic treatment of inflammatory, musculoskeletal and rheumatic disorders.  * Cystic fibrosis - the use of high dosages of ibuprofen has been proven to decrease inflammation and decreasing polymorphonuclear cell influx in the lungs.  * Orthostatic hypotension - ibuprofen can induce sodium retention and antagonize the effect of diuretics which has been reported to be beneficial for patients with severe orthostatic hypotension.  * Dental pain - ibuprofen is used to manage acute and chronic orofacial pain.  * Pain - ibuprofen is widely used to reduce minor aches and pains as well as to reduce fever and manage dysmenorrhea. It is very commonly used for the relief of acute indications such as fever and tension headaches. It is also used to manage mild to moderate pain and moderate to severe pain as an adjunct to opioid analgesics.  * Investigational uses - efforts have been put into developing ibuprofen for the prophylaxis of Alzheimer's disease, Parkinson disease, and breast cancer.
ibuprofen acyl glucuronide	115075-59-7	1-(alpha-Methyl-4-(2-methylpropyl)benzeneacetate)-beta-D-Glucopyranuronic acid	115075-59-7	M8A4QU2JGT			
ibutilide	130350-52-6	Ibutilide	122647-31-8	2436VX1U9B	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	Indicated for the rapid conversion of atrial fibrillation or atrial flutter of recent onset to sinus rhythm.
IC 261		3-[(2,4,6-Trimethoxy-phenyl)-methylene]-indolin-2-one	186611-52-9				
IC 87114		2-((6-amino-9H-purin-9-yl)methyl)-5-methyl-3-o-tolylquinazolin-4(3H)-one	371242-69-2	9HC746B1KF			
IC486241		IC486241					
icajine	30864-63-2	(10S,22R,23R,24S)-4-Methyl-9-oxa-4,13-diazahexacyclo[11.6.5.01,24.06,22.010,23.014,19]tetracosa-6,14,16,18-tetraen-20-one	30864-63-2				
icariin	489-32-7	Icariin	489-32-7	VNM47R2QSQ			
icaritin		Icaritin	118525-40-9	UFE666UELY			
icatibant	130308-48-4	Icatibant	130308-48-4	7PG89G35Q7	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Icatibant is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
ICG 001		(6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxooctahydro-1H-pyrazino[1,2-a]pyrimidine-1-carboxamide	780757-88-2				
ICI 118551	72795-19-8	(2R,3S)-1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-(propan-2-ylamino)butan-2-ol	72795-20-1		Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	
ICI 154129	83420-94-4	(2S)-2-[[(2S)-2-[2-[[2-[[(2S)-2-[bis(prop-2-enyl)amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]ethylsulfanyl]-3-phenylpropanoyl]amino]-4-methylpentanoic acid	83420-94-4	97BUE7NR2M	Narcotic Antagonists	Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)	
ICI 164384	98007-99-9	N-n-Butyl-N-methyl-11-(3,17beta-dihydroxyestra-1,3,5(10)-trien-7alpha-yl)undecanamide	98007-99-9	84LT43726C	Estrogen Antagonists	Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)	
ICI 192605	117621-64-4	6-(2-(2-Chlorophenyl-4-hydroxyphenyl)-1,3-dioxan-5-yl)hexenoic acid	117621-64-4	FQ9418XA31			
ICI 198615	104448-53-5	(1-((2-Methoxy-4-(((phenylsulfonyl)amino)carbonyl)phenyl)methyl)-1H-indazol-6-yl)carbamic acid cyclopentyl ester	104448-53-5	E9XYB5543A			
ICI 199441	115199-84-3	2-(3,4-Dichlorophenyl)-N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]acetamide hydrochloride	115199-84-3	CT5E310AJL			
ICI 211965	129424-08-4	1-(3-(Naphth-2-ylmethoxy)phenyl)-1-(thiazol-2-yl)propyl methyl ether	129424-08-4				
ICI 89406		1-[2-[[3-(2-Cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-3-phenylurea	53671-71-9	C027IY98WE	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	
ICI D2138	140841-32-3	6-[[3-Fluoro-5-(4-methoxyoxan-4-yl)phenoxy]methyl]-1-methylquinolin-2-one	140841-32-3	B6G6OX1ZH5			
ICI D7114	129689-30-1	Acetamide, 2-(4-(2-((2-hydroxy-3-phenoxypropyl)amino)ethoxy)phenoxy)-N-(2-methoxyethyl)-, (S)-	129689-30-1	EF5S87KTK2	Adrenergic beta-Agonists	Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)	
icilin		Icilin	36945-98-9	CS70PZQ4QJ	Calcium Channel Agonists	Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in VASCULAR SMOOTH MUSCLE and/or CARDIAC MUSCLE cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture. (See all compounds classified as Calcium Channel Agonists.)	
icotinib		Icotinib	610798-31-7	9G6U5L461Q			Icotinib hydrochloride is a novel epidermal growth factor receptor (EGFR)tyrosine kinase inhibitor, exhibits encouraging efficacy and tolerability in patients with advanced non-small-cell lung cancer (NSCLC) who failed previous chemotherapy.
Idarubicin	58957-92-9	Idarubicin	58957-92-9	ZRP63D75JW	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	For the treatment of acute myeloid leukemia (AML) in adults. This includes French-American-British (FAB) classifications M1 through M7.
idarubicinol	86189-66-4	Idarubicinol	86189-66-4	Z3GYR877XQ	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
Idazoxan	79944-58-4	Idazoxan	79944-58-4	Y310PA316B	Adrenergic alpha-2 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Antagonists.)	
idebenone	58186-27-9	Idebenone	58186-27-9	HB6PN45W4J	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	Idebenone is indicated for use by the European Medicines Agency (EMA) for the treatment of visual impairment in adolescent and adult patients with Lebers Hereditary Optic Neuropathy (LHON). It is not currently approved for use by either the Food and Drug Administration (USA) or Health Canada.
idelalisib		Idelalisib	870281-82-6	YG57I8T5M0	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Idelalisib is indicated in the treatment of chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma (FL), and relapsed small lymphocytic lymphoma (SLL). For the treatment of relapsed CLL, it is currently indicated as a second-line agent in combination with rituximab in patients for whom rituximab alone would be considered appropriate therapy due to other co-morbidities, while in the treatment of FL and SLL it is intended to be used in patients who have received at least two prior systemic therapies.
IDN 5109		Ortataxel	186348-23-2	8H61Y4E29N	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
idobenzamide		idobenzamide					
idoxifene		Idoxifene	116057-75-1	456UXE9867	Estrogen Antagonists	Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)	
Idoxuridine	54-42-2	Idoxuridine	54-42-2	LGP81V5245	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	For use in keratoconjunctivitis and keratitis caused by herpes simplex virus.
idraparinux		Idraparinux	162610-17-5	6ADD3H8MFZ	Factor Xa Inhibitors	Endogenous factors and drugs that inhibit or block the activity of FACTOR XA. (See all compounds classified as Factor Xa Inhibitors.)	Investigated for use/treatment in thrombosis, venous thromboembolism, strokes, heart disease, and atrial fibrillation.
idrapril	127420-24-0	Idrapril	127420-24-0	176P5C4QU8			
IEM 1460		5-(1-Adamantylmethylamino)pentyl-trimethylazanium;bromide;hydrobromide	121034-89-7				
ifenprodil	23210-56-2	Ifenprodil	23210-56-2	R8OE3P6O5S	Excitatory Amino Acid Antagonists	Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)	
ifetroban		Ifetroban	143443-90-7	E833KT807K	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
IFNG protein, human		IFNG protein, human					
Ifosfamide	3778-73-2	Ifosfamide	3778-73-2	UM20QQM95Y	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	Used as a component of various chemotherapeutic regimens as third-line therapy for recurrent or refractory germ cell testicular cancer. Also used as a component of various chemotherapeutic regimens for the treatment of cervical cancer, as well as in conjunction with surgery and/or radiation therapy in the treatment of various soft tissue sarcomas. Other indications include treatment of osteosarcoma, bladder cancer, ovarian cancer. small cell lung cancer, and non-Hodgkin's lymphoma.
igmesine	130152-35-1	Igmesine hydrochloride	130152-35-1	JV6M14TY35			
IH 764-3		IH 764-3					
IkK-16 compound		IkK-16 compound					
IL13 protein, human		IL13 protein, human					
IL4 protein, human		IL4 protein, human					
ilimaquinone		Ilimaquinone	71678-03-0	5U0WAN3N8Q			
illite	12173-60-3	Ledikite	12173-60-3	D7BC5B0F46			
illudin S	1149-99-1	Illudin S	1149-99-1	EWJ0GY2H7X	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	
ilomastat	142880-36-2	Ilomastat	142880-36-2	I0403ML141			
iloperidone		Iloperidone	133454-47-4	VPO7KJ050N	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Treatment of acute schizophrenia.
Iloprost	78919-13-8	Iloprost	78919-13-8	JED5K35YGL	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	Iloprost is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve a composite endpoint consisting of exercise tolerance, symptoms (NYHA Class), and lack of deterioration. Studies establishing effectiveness included predominately patients with NYHA Functional Class IIIIV symptoms and etiologies of idiopathic or heritable PAH (65%) or PAH associated with connective tissue diseases (23%).  It is also indicated for the treatment of severe frostbite in adults to reduce the risk of digit amputations. Effectiveness was established in young, healthy adults who suffered frostbite at high altitudes.
Imatinib Mesylate		Imatinib Mesylate	220127-57-1	8A1O1M485B	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Glivec is indicated for the treatment of, , , adult and paediatric patients with newly diagnosed Philadelphia-chromosome (bcr-abl)-positive (Ph+) chronic myeloid leukaemia (CML) for whom bone-marrow transplantation is not considered as the first line of treatment; , adult and paediatric patients with Ph+ CML in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis; , adult and paediatric patients with newly diagnosed Philadelphia-chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL) integrated with chemotherapy; , adult patients with relapsed or refractory Ph+ ALL as monotherapy; , adult patients with myelodysplastic / myeloproliferative diseases (MDS / MPD) associated with platelet-derived growth factor receptor (PDGFR) gene re-arrangements; , adult patients with advanced hypereosinophilic syndrome (HES) and / or chronic eosinophilic leukaemia (CEL) with FIP1L1-PDGFRa rearrangement. , , , The effect of Glivec on the outcome of bone-marrow transplantation has not been determined. , , Glivec is indicated for: , , , the treatment of adult patients with Kit (CD 117)-positive unresectable and / or metastatic malignant gastrointestinal stromal tumours (GIST); , the adjuvant treatment of adult patients who are at significant risk of relapse following resection of Kit (CD117)-positive GIST. Patients who have a low or very low risk of recurrence should not receive adjuvant treatment; , the treatment of adult patients with unresectable dermatofibrosarcoma protuberans (DFSP) and adult patients with recurrent and / or metastatic DFSP who are not eligible for surgery. , , , In adult and paediatric patients, the effectiveness of Glivec is based on overall haematological and cytogenetic response rates and progression-free survival in CML, on haematological and cytogenetic response rates in Ph+ ALL, MDS / MPD, on haematological response rates in HES / CEL and on objective response rates in adult patients with unresectable and / or metastatic GIST and DFSP and on recurrence-free survival in adjuvant GIST. The experience with Glivec in patients with MDS / MPD associated with PDGFR gene re-arrangements is very limited (see section 5. 1). Except in newly diagnosed chronic phase CML, there are no controlled trials demonstrating a clinical benefit or increased survival for these diseases. ,
imazamox		Imazamox	114311-32-9	UG6793ON5F	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
imazapyr	81334-34-1	Imazapyr	81334-34-1	787MX0M5A6	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
imazethapyr	81335-77-5	Imazethapyr	81335-77-5	72T2IN94I4	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
imazodan	84243-58-3	Imazodan	84243-58-3	6PVQ5VQW24	Cardiotonic Agents	Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)	
imetelstat		Imetelstat	868169-64-6		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Treatment of acute myeloid leukemia, Treatment of myelodysplastic syndromes, including juvenile myelomonocytic leukemia
imetit		Imetit	102203-18-9	677MJ4VPZC	Histamine Agonists	Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. (See all compounds classified as Histamine Agonists.)	
imidacloprid	105827-78-9	N-[1-[(6-chloro-3-pyridinyl)methyl]-4,5-dihydroimidazol-2-yl]nitramide	138261-41-3				
imidapril	89371-37-9	Imidapril	89371-37-9	BW7H1TJS22	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
imidaprilat	120294-09-9	3-(2-(N-(1-Carboxy-3-phenylpropyl)amino)propionyl)-1-methyl-2-oxoimidazolidine-4-carboxylic acid	120294-09-9		Angiotensin-Converting Enzyme Inhibitors	A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)	
imidazenil		Imidazenil	151271-08-8	7N95V6864R	GABA Modulators	Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)	
imidazole	288-32-4	Imidazole	288-32-4	7GBN705NH1	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
imidazoleacetic acid	30581-89-6	Imidazoleacetic acid	645-65-8	IGZ30Z24EJ			
Imidazoles		Imidazoles					
imidazolidinyl urea	39236-46-9	Imidurea	39236-46-9	M629807ATL			
imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III)		imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III)					
imidazolone		Imidazolone	378750-35-7				
imidazopyrazole	251-80-9	1H-Imidazo[1,2-b]pyrazole	251-80-9				
imidocarb dipropionate	55750-06-6	Imidocarb Dipropionate	55750-06-6	ZSM1M03SHC	Antiprotozoal Agents	Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)	
Imiloxan	81167-16-0	Imiloxan	81167-16-0	ZJ56PS1DWK			
Imines		imine					
Imipenem	74431-23-5	Imipenem hydrate	74431-23-5	71OTZ9ZE0A	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Imipramine	50-49-7	Imipramine	50-49-7	OGG85SX4E4	Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	For the relief of symptoms of depression and as temporary adjunctive therapy in reducing enuresis in children aged 6 years and older.   May also be used off-label to manage panic disorders with or without agoraphobia, as a second line agent for ADHD in children and adolescents, to manage bulimia nervosa, for short-term management of acute depressive episodes in bipolar disorder and schizophrenia, for the treatment of acute stress disorder and posttraumatic stress disorder, and for symptomatic treatment of postherpetic neuralgia and painful diabetic neuropathy.
imipramine N-oxide	6829-98-7	Imipraminoxide	6829-98-7	8MKS280XJW			
imiprothrin		Imiprothrin	72963-72-5				
Imiquimod	99011-02-6	Imiquimod	9050-31-1	P1QW714R7M	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	For the topical treatment of clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses on the face or scalp in immunocompetent adults. Also indicated for the treatment of external genital and perianal warts/condyloma acuminata in individuals 12 years old and above.
imirestat		Imirestat	89391-50-4	0PM69S95UQ			
imisopasem manganese		Unii-2Q6R3259KS	218791-21-0	2Q6R3259KS			Intended for the treatment of pain and possibly various forms of cancer.
IMM 125		IMM 125					
IMMLG5521		IMMLG5521					
IMMU-110		IMMU-110					
Immune Checkpoint Inhibitors		Immune Checkpoint Inhibitors					
Immunoferon	87139-86-4	Immunoferon					
Immunologic Factors		Immunologic Factors					
immunomycin		Ascomycin	104987-12-4	AUF4U5NSJK	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	
Immunosuppressive Agents		Immunosuppressive Agents					
Immunotoxins		Immunotoxins					
IMOL S-140	1330-78-5	1330-78-5					
imoxin		imoxin					
imperatorin	482-44-0	Pentosalen	482-44-0	K713N25C78			
importazole		Importazole					
Impromidine	55273-05-7	Impromidine	55273-05-7	931L4X5WMM	Histamine Agonists	Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. (See all compounds classified as Histamine Agonists.)	
inauzhin		inauzhin					
INCB054329		(11S)-7-(3,5-dimethyl-1,2-oxazol-4-yl)-11-pyridin-2-yl-9-oxa-1,3-diazatricyclo[6.3.1.04,12]dodeca-4(12),5,7-trien-2-one	1628607-64-6		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
INCB057643		2,2,4-trimethyl-8-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)-6-methylsulfonyl-1,4-benzoxazin-3-one	1820889-23-3	87TZD0JEBS	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
inchinko-to		inchinko-to					
incobotulinumtoxinA		Botulinum toxin type A					
incomplete Freund's adjuvant		incomplete Freund's adjuvant					
Incretins		Incretin	54241-84-8				
indacaterol		Indacaterol	312753-06-3	8OR09251MQ			For the long term, once-daily-dosing maintenance of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
indacrinone		Indacrinone	56049-88-8	B926Y9U4QN	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	
indan	496-11-7	Indan	496-11-7	H9SCX043IG			
indanofan		Indanofan	133220-30-1	Z5WQ384U76			
Indans		Indans					
Indapamide	26807-65-8	Indapamide	26807-65-8	F089I0511L	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	Indapamide is a diuretic indicated for use as monotherapy or in combination with other blood pressure-lowering agents to treat hypertension. It may also be used to treat fluid and salt retention associated with congestive heart failure.
indapamide, perindopril drug combination		Biprel			Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
indatraline	86939-10-8	Indatraline	86939-10-8	4U40Y96J1Z			
Indazoles		Indazole	271-44-3	7C4VQE5C03			
indene	95-13-6	Indene	95-13-6	67H8Y6LB8A			
indenestrol	24643-97-8	3-Ethyl-2-(4-hydroxyphenyl)-1-methyl-1H-inden-6-ol	24643-97-8	4A464K3BSI			
indeno(1,2,3-cd)pyrene	193-39-5	Indeno[1,2,3-cd]pyrene	193-39-5	T4SWX8I0U2			
indenoindole	3254-91-9	5,10-Dihydroindeno[1,2-b]indole	3254-91-9				
Indican	487-94-5	Indoxyl sulfate	487-94-5	KT0QA88913			
indicine	480-82-0	Indicine	480-82-0	T82SFG1584			
Indigo Carmine	860-22-0	Indigo carmine	860-22-0		Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
indimitecan		Indimitecan	915360-05-3	V5T7S4HP8A			
Indinavir	150378-17-9	Indinavir	150378-17-9	9MG78X43ZT	HIV Protease Inhibitors	Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. (See all compounds classified as HIV Protease Inhibitors.)	Indinavir is an antiretroviral drug for the treatment of HIV infection.
indioside D		indioside D					
indirubin	479-41-4	Indirubin	479-41-4	1LXW6D3W2Z	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	
Indirubin E804		Indirubin E804					
indirubin-3'-monoxime		Indirubin-3'-monoxime	160807-49-8				
indium tin oxide	71243-84-0	Indium tin oxide (In1.69Sn0.15O2.85)	71243-84-0				
indium trichloride	10025-82-8	Indium trichloride	10025-82-8	31JB8MKF8Z			
Indocyanine Green	3599-32-4	Cardio-Green	3599-32-4		Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
indol-3-yl pyruvic acid	392-12-1	Indole-3-pyruvic acid	392-12-1	4QM0LT13A8	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
Indolapril	80876-01-3	Indolapril	80876-01-3	R07Y89H0HB			
indole	120-72-9	Indole	120-72-9	8724FJW4M5			
indole-3-acetaldehyde	2591-98-2	2-(1H-indol-3-yl)acetaldehyde	2591-98-2	A346H8E8WU			
indole-3-carbaldehyde	487-89-8	Indole-3-carboxaldehyde	487-89-8	7FN04C32UO			
indole-3-carbinol	700-06-1	Indole-3-carbinol	700-06-1	C11E72455F	Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	
indole-3-carboxylic acid		Indole-3-carboxylic acid	771-50-6	59711R38B0			
indole-3-guanylhydrazone hydrochloride		indole-3-guanylhydrazone hydrochloride					
indole-3-lactic acid	1821-52-9	Indole-3-lactic acid	1821-52-9	5SW11R7M7M			
indole-5-carboxamide		1H-Indole-5-carboxamide	1670-87-7				
indoleacetamide	879-37-8	Indole-3-acetamide	879-37-8	O9SEW65XW3			
indoleacetic acid	87-51-4	Indole-3-acetic acid	87-51-4	6U1S09C61L	Plant Growth Regulators	Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins. (See all compounds classified as Plant Growth Regulators.)	
indolebutyric acid	133-32-4	Indole-3-butyric acid	133-32-4	061SKE27JP			
indolepropionic acid	830-96-6	3-Indolepropionic acid	830-96-6	JF49U1Q7KN			
Indoles		Indoles					
indolidan		Indolidan	100643-96-7	0751ZOW7OR			
indoline		Indoline	496-15-1	6DPT9AB2NK			
Indolinone A		Indolinone A					
indolo(3,2-b)carbazole	241-55-4	Indolo[3,2-b]carbazole	241-55-4				
Indomethacin	53-86-1	Indomethacin	53-86-1	XXE1CET956	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Oral indometacin is indicated for symptomatic management of moderate to severe rheumatoid arthritis including acute flares of chronic disease, moderate to severe ankylosing spondylitis, moderate to severe osteoarthritis, acute painful shoulder (bursitis and/or tendinitis) and acute gouty arthritis.   Intravenous indometacin is indicated to induce closure of a hemodynamically significant patent ductus arteriosus in premature infants weighing between 500 and 1750 g when after 48 hours usual medical management (e.g., fluid restriction, diuretics, digitalis, respiratory support, etc.) is ineffective.
indomethacin morpholinylamide		2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-1-morpholinoethanone	2854-32-2				
indomethacin phenethylamide		N-(2-Phenylethyl)indomethacin Amide	261766-32-9				
indopan	299-26-3	alpha-Methyltryptamine	299-26-3	BIK35ACJ0Q			
indophenyl acetate	7761-80-0	2,5-Cyclohexadien-1-one, 4-[[4-(acetyloxy)phenyl]imino]-	7761-80-0	I0H60V4I6S			
Indoprofen	31842-01-0	Indoprofen	31842-01-0	CPE46ZU14N	Cyclooxygenase Inhibitors	Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)	
Indoramin	26844-12-2	Indoramin	26844-12-2	0Z802HMY7H	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
indoxacarb		Indoxacarb	173584-44-6	52H0D26MWR			Treatment and prevention of flea infestation. For dogs and cats: Treatment and prevention of flea infestation. The veterinary medicinal product can be used as part of a treatment strategy for flea-allergy dermatitis. Developing stages of fleas in the pet's immediate surroundings are killed following contact with Activyl-treated pets.
indoxam		Indoxam					
indoxyl acetate	608-08-2	3-Acetoxyindole	608-08-2	3AF7Z8794Q			
Industrial Waste		Industrial Waste					
inecalcitol		Inecalcitol	163217-09-2	05FZV98342			Investigated for use/treatment in prostate cancer, psoriasis and hyperparathyroidism.
inermin		Maackiain	2035-15-6	TF360D25IJ			
infigratinib		Infigratinib	872511-34-7	A4055ME1VK	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Infigratinib is indicated for the treatment of previously treated, unresectable locally advanced or metastatic cholangiocarcinoma in adults with a fibroblast growth factor receptor 2 (FGFR2) fusion or another rearrangement as detected by an FDA-approved test.
ingenol dibenzoate	59086-90-7	Ingenol 3,20-dibenzoate	59086-90-7				
iniparib		Iniparib	160003-66-7	2ZWI7KHK8F	Poly(ADP-ribose) Polymerase Inhibitors	Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. (See all compounds classified as Poly(ADP-ribose) Polymerase Inhibitors.)	
INO 1001		INO 1001					
Inorganic Chemicals		Inorganic Chemicals					
Inosine	58-63-9	Inosine	58-63-9	5A614L51CT			The primary popular claim made for inosine, that it enhances exercise and athletic performance, is refuted by the available research data. There is some preliminary evidence that inosine may have some neurorestorative, anti-inflammatory, immunomodulatory and cardioprotective effects.
Inosine Diphosphate	86-04-4	Inosine diphosphate	86-04-4	F15JU6D39T			
Inosine Monophosphate	131-99-7	Inosinic Acid	131-99-7	TAO7US05G5			
Inositol	6917-35-7	Inositol	87-89-8	8LQ63P85IC			Inositol may be used in food without any limitation. As a drug, inositol is used as a nutrient supplement in special dietary foods and infant formula. As it presents a relevant role in ensuring oocyte fertility, inositol has been studied for its use in the management of polycystic ovaries. Inositol is also being researched for the treatment of diabetes, prevention of metabolic syndrome, aid agent for weight loss, treatment of depression, psychiatric disorder and anxiety disorder and for prevention of cancer.
inositol 1-phosphate	15421-51-9	Inositol 1-phosphate	573-35-3	5G9I890092			
Inositol 1,4,5-Trisphosphate	85166-31-0	d-Myo-inositol-1,4,5-triphosphate	85166-31-0	MU34XVK5NR			
inositol pentaphosphate	25663-09-6	Inositol pentakisphosphate	25663-09-6				
Inositol Phosphates		Inositol Phosphates					
inositol-1,3,4,5-tetrakisphosphate	102850-29-3	Inositol 1,3,4,5-tetrakisphosphate	102850-29-3	XK67P86535			
inositol-1,3,4,5,6-pentakisphosphate		Inositol 1,3,4,5,6-pentakisphosphate	20298-95-7	8444PN9XUW			
inostamycin	129905-10-8	Inostamycin	129905-10-8				
insecticidal crystal protein, Bacillus Thuringiensis		insecticidal crystal protein, Bacillus Thuringiensis					
Insecticides		Insecticides					
Insulin		Insulin	9004-10-8		Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	
Insulin Glargine		Basaglar	160337-95-1		Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	
insulin, Asp(B10)-		insulin, Asp(B10)-					
INT 131		Benzenesulfonamide, 2,4-dichloro-N-(3,5-dichloro-4-(3-quinolinyloxy)phenyl)-	315224-26-1	E7ILQ6U50J			Investigated for use/treatment in diabetes mellitus type 2.
interferon alfa-n1		Interferon alfa-n1					
Interferon alpha-2		IFN-alpha2					
Interferon beta-1b	145155-23-3	145155-23-3					
Interferon-alpha		Interferon-alpha					
Interferons	9008-11-1	Interferons					
Interleukin 1 Receptor Antagonist Protein		Interleukin 1 Receptor Antagonist Protein					
Interleukin-6		IL-6					
intermedine		Intermedine, (+)-	10285-06-0	DLC9FEP81A			
Inulin	9005-80-5	9005-80-5					
inuviscolide		Inuviscolide	63109-30-8				
invasin, Yersinia	114073-91-5	Invasin, Yersinia					
Iodates		Iodates					
Iodides		Iodide Ion	100934-04-1	09G4I6V86Q			
Iodine	7553-56-2	Iodine	7553-56-2	9679TC07X4	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	Investigated for use/treatment in breast disorders (unspecified) and pain (acute or chronic).
Iodine-131		Iodine I-131	10043-66-0	I5X6L61HUT			
iodixanol	92339-11-2	Iodixanol	92339-11-2	HW8W27HTXX	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	Iodixanol is a contrast agent during coronary angiography.
iodo-alpha-bungarotoxin	77097-81-5	Iodo-alpha-bungarotoxin					
Iodoacetamide	144-48-9	Iodoacetamide	144-48-9	ZRH8M27S79	Alkylating Agents	Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)	
Iodoacetates		Iodoacetates					
Iodoacetic Acid	64-69-7	Iodoacetic acid	64-69-7	WF5188V710	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
iodobisphenol A		iodobisphenol A					
Iodocyanopindolol	83498-72-0	Iodocyanopindolol	83498-72-0	WP4LUA5RAK	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	
iodofenphos	18181-70-9	Iodofenphos	18181-70-9	SME6G1846X			
iodoform	75-47-8	Iodoform	75-47-8	KXI2J76489			No approved therapeutic indications.
iodopravadoline		(6-iodo-2-methyl-1-(2-morpholinoethyl)-1H-indol-3-yl)(4-methoxyphenyl)methanone	164178-33-0	U1LNJ6NBKA	Cannabinoid Receptor Agonists	Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)	
Iodoquinol	83-73-8	Iodoquinol	83-73-8	63W7IE88K8	Amebicides	Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal. (See all compounds classified as Amebicides.)	Used in the treatment of amoebiasis.
iodoresiniferatoxin		Iodoresiniferatoxin	535974-91-5				
iodosulfuron		Iodosulfuron	185119-76-0	SQJ52ZS2AB	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
iodosulpride	100038-54-8	Iodosulpride	100038-54-8				
Iofetamine	95896-48-3	Iofetamine	82691-33-6	C2A5X08042	Radiopharmaceuticals	Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)	
Iohexol	66108-95-0	Iohexol	66108-95-0	4419T9MX03	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	Iohexol ia used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures.
iomeprol	78649-41-9	Iomeprol	78649-41-9	17E17JBP8L	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	
Ionic Liquids		Ionic Liquids					
Ionomycin	56092-81-0	Ionomycin	56092-81-0	54V905V6AT	Calcium Ionophores	Chemical agents that increase the permeability of CELL MEMBRANES to CALCIUM ions. (See all compounds classified as Calcium Ionophores.)	
Ionophores		Ionophores					
Ions		Ions					
Iopamidol	62883-00-5	Bracco 15000	60208-45-9				
Iopanoic Acid	96-83-3	Iopanoic Acid	96-83-3	FE9794P71J	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	
iopromide		Iopromide	73334-07-3	712BAC33MZ	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	Iopromide, as the product IOVIST, is approved by the FDA for use as an intra-arterial or intravenous X-ray contrast agent. For intra-arterial administration, iopromide is indicated for cerebral arteriography, peripheral arteriography, coronary arteriography, left ventriculography, visceral angiography, and aortography in adults and radiographic evaluation of cardiac chambers and related arteries in pediatric patients aged 2 years and older. For intravenous administration, iopromide is indicated for excretory urography in adults and pediatric patients aged 2 years and older, contrast Computed Tomography (CT) of the head and body (intrathoracic, intra-abdominal, and retroperitoneal regions) for the evaluation of neoplastic and non-neoplastic lesions in adults and pediatric patients aged 2 years and older, and contrast mammography to visualize known or suspected lesions of the breast in adults, as an adjunct following mammography and/or ultrasound.  Iopromide is also approved by Health Canada as an intravascular contrasting agent, although the indications differ depending on the dosage. At 300 mg I/mL, iopromide is indicated for computed tomography (CT), excretory urography, pediatric excretory urography, renal arteriography, peripheral arteriography (bifemoral pelvis/leg), cerebral arteriography, phlebography of the extremities, and arthrography.
ioversol	87771-40-2	Ioversol	87771-40-2	N3RIB7X24K	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	As the product Optiray 300, the intra-arterial use of ioversol is indicated for cerebral arteriography and peripheral arteriography in adults, while its intravenous use is indicated for CT imaging of the head and body, venography, and intravenous excretory urography in adults.  As the product Optiray 320, the intra-arterial use of ioversol is indicated for cerebral arteriography, peripheral arteriography, visceral and renal arteriography, aortography, coronary arteriography, and left ventriculography in adults, and angiocardiography in pediatic patients. The intravenous use of this product is indicated for CT imaging of the head and body, venography, and intravenous excretory urography in adults and CT imaging of the head and body, and intravenous excretory urography in pediatric patients.  As the product Optiray 350, the intra-arterial use of ioversol is indicated for peripheral arteriography coronary arteriography, and left ventriculography in adults, and angiocardiography in pediatic patients. The intravenous use of this product is indicated for CT imaging of the head and body, venography, intravenous excretory urography, and intravenous digital subtraction angiography (IV-DSA) in adults and CT imaging of the head and body, and intravenous excretory urography in pediatric patients.
Ioxaglic Acid	59017-64-0	Ioxaglic acid	59017-64-0	Z40X7EI2AF	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	This medicinal product is for diagnostic use only in adults and children as a low-osmolality medium,.
ioxitalamic acid	28179-44-4	Ioxitalamic acid	28179-44-4	967RDI7Z6K	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	Ioxitalamate in both of its available forms is indicated for exploration of the digestive tract by tomodensitometry or by regular gastroduodenal radiography. Its use is restrained to the cases in which the administration of barium sulfate is not recommended or contraindicated. The intravascular administration of ioxitalamate is contraindicated as it may present significant side effects.
ioxynil	1689-83-4	Ioxynil	1689-83-4	8Y734M4V9E			
IPA-3 compound		IPA-3 compound					
ipatasertib		Ipatasertib	1001264-89-6	524Y3IB4HQ	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Treatment of breast cancer , Treatment of prostate cancer
Ipodate	5587-89-3	Ipodate	5587-89-3	F604ZKI910	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	Iopodic acid is available as a cholecystographic agent. This denomination indicates the iopodic acid is a radiopaque substance that can be used to visualize the gallbladder and biliary channels in abdominal X-ray. An abdominal X-ray uses a minimal amount of ionizing radiation to produce pictures of the inside of the abdominal cavity. It is commonly used to evaluate the stomach, liver, intestines, and spleen.  Iopodic acid has also been indicated for the treatment of hyperthyroidism such as Graves disease. Hyperthyroidism refers to any condition where there is too much thyroid hormone produced in the body (overactive thyroid). When the overactivity involves the entire thyroid gland, it is known as Grave's disease.
Ipratropium	60205-81-4	Ipratropium	60205-81-4		Bronchodilator Agents	Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)	Inhaled ipratropium is indicated in combination with inhaled beta-agonist systemic corticosteroids for the management of severe exacerbations of asthma flares requiring treatment.  Asthma exacerbations are characterized by a progressive increase in one or more of asthma symptoms accompanied by a decrease in expiratory flow.  As a single agent, ipratropium was indicated for the symptomatic relief of rhinorrhea associated with the common cold or seasonal allergic rhinitis for patients 5 years or older. It does not alleviate nasal congestion nor sneezing.  Rhinorrhea refers to recurrent or chronic watery nasal discharge. This condition is debilitating and its pathogenesis and etiology is complex and not very well understood presenting very substantial cost burden.  Additionally, ipratropium is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and emphysema.  The chronic obstructive pulmonary disease includes a large number of conditions characterized by breathlessness. As this includes several conditions, the etiology, symptoms, and treatments are diverse.  Ipratropium has also been studied to be used for the treatment of sialorrhea.  Sialorrhea is a common symptom that accompanies different neurologic conditions and it is characterized by drooling or excessive salivation.
ipriflavone	35212-22-7	Ipriflavone	35212-22-7	80BJ7WN25Z			
iprodione	36734-19-7	Iprodione	36734-19-7	S3AYV2A6EU	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Iproniazid	54-92-2	Iproniazid	54-92-2	D892HFI3XA	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	For the treatment of depression (originally intended to treat tuberculosis).
iproplatin	83291-20-7	Platinum(4+) chloride hydroxide--propan-2-amine (1/2/2/2)	62928-11-4				
IPS 339	60979-28-4	9H-Fluoren-9-one, O-(3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)oxime, monohydrochloride	60979-28-4		Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	
ipsapirone	92589-98-5	Ipsapirone hydrochloride	92589-98-5	08R5U8PYVO	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	
iralukast	125617-94-9	Iralukast sodium	125617-94-9	NH3ZU6H7KE			
Irbesartan	138402-11-6	Irbesartan	138402-11-6	J0E2756Z7N	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	Irbesartan is indicated to treat hypertension and diabetic nephropathy in hypertensive patients with type 2 diabetes, elevated serum creatinine, and proteinuria. A combination product with hydrochlorothiazide is indicated for hypertension in patients with uncontrolled hypertension with monotherapy or first line in patients not expected to be well controlled with monotherapy.
ircinin-1		2(5H)-Furanone, 5-(9-(5-(3-furanylmethyl)-3-furanyl)-2,6-dimethyl-6-nonenylidene)-	35731-89-6				
Irganox 1010	6683-19-8	Pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate)	6683-19-8	255PIF62MS			
irgarol 1051	28159-98-0	Cybutryne	28159-98-0	E7B77O21GH			
Iridoid Glycosides		Iridoid Glycosides					
irigenin		Irigenin	548-76-5	6O4NX37350			
irilone		Irilone	41653-81-0	FB3FTT7LYK			
Irinotecan		Irinotecan	97682-44-5	7673326042	Topoisomerase I Inhibitors	Compounds that inhibit the activity of DNA TOPOISOMERASE I. (See all compounds classified as Topoisomerase I Inhibitors.)	For the treatment of metastatic colorectal cancer (first-line therapy when administered with 5-fluorouracil and leucovorin). Also used in combination with cisplatin for the treatment of extensive small cell lung cancer. Irinotecan is currently under investigation for the treatment of metastatic or recurrent cervical cancer. Also used in combination with fluorouracil and leucovorin for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy.
irisflorentin		Irisflorentin	41743-73-1	JHL5KQ3BWA			
irofulven		Irofulven	158440-71-2	6B799IH05A	Radiation-Sensitizing Agents	Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. (See all compounds classified as Radiation-Sensitizing Agents.)	Investigated for use/treatment in brain cancer, breast cancer, endometrial cancer, liver cancer, lung cancer, ovarian cancer, pancreatic cancer, pediatric indications, prostate cancer, and sarcoma.
Iron	7439-89-6	Iron	7439-89-6	E1UOL152H7			Used in preventing and treating iron-deficiency anemia.
Iron Carbonyl Compounds	13463-40-6	13463-40-6					
Iron Chelating Agents		Iron Chelating Agents					
Iron Compounds		Iron compounds					
iron pentacarbonyl		Iron pentacarbonyl	13463-40-6	6WQ62TAQ6Z			
iron protoporphyrin IX		Protoheme	104244-10-2	42VZT0U6YR			Used in the management of porphyria attacks, particularly in acute intermittent porphyria.
Iron-Dextran Complex	9004-66-4	Conferon	9004-66-4		Hematinics	Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias. (See all compounds classified as Hematinics.)	
Iron, Dietary		Iron, Dietary					
iron(II)-ascorbic acid complex		iron(II)-ascorbic acid complex					
iron(III) meso-tetramesitylporphyrin		iron(III) meso-tetramesitylporphyrin					
iron(III)-ascorbic acid complex	91260-12-7	Fe(3+)-Ascorbate	91260-12-7				
irosustat		Irosustat	288628-05-7	366037O6O7			
iroxanadine		Iroxanadine	276690-58-5	6K69EJ1DL1			Investigated for use/treatment in atherosclerosis and vascular diseases as a cardioprotective agent. Its use has also been suggested for the prevention of early restenosis following vascular surgery or balloon angioplasty.
irsogladine	57381-26-7	Irsogladine	57381-26-7	QBX79NZC1D	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	
isamoltane	99740-06-4	Isamoltane	99740-06-4	214SP5P1EX	Serotonin 5-HT1 Receptor Antagonists	Drugs that bind to but do not activate SEROTONIN 5-HT1 RECEPTORS, thereby blocking the actions of SEROTONIN 5-HT1 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more of the specific 5-HT1 receptor subtypes. (See all compounds classified as Serotonin 5-HT1 Receptor Antagonists.)	
Isatin	91-56-5	Isatin	91-56-5	82X95S7M06			
isazophos	42509-80-8	Isazofos	42509-80-8	CF67CG9STQ			
isepamicin		Isepamicin	58152-03-7	G7K224460P	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Isethionic Acid	107-36-8	2-Hydroxyethanesulfonic acid	107-36-8	97J3QN9884			
ISIS104838		ISIS 104838					
isoalantolactone		Isoalantolactone	470-17-7	BYH07P620U			
isoalloxazine	490-59-5	Alloxazine	490-59-5	880W3VF9YW			
isoamyl acetate	123-92-2	Isoamyl acetate	123-92-2	Z135787824			
isoangustone A		Isoangustone A	129280-34-8	58NM254N9T			
isoascorbic acid	89-65-6	Erythorbic acid	89-65-6	311332OII1	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
isobavachalcone	20784-50-3	Isobavachalcone	20784-50-3	ZWO2SC993A			
isobavachin	31524-62-6	Isobavachin	31524-62-6				
isoborneol	10385-78-1	1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ol	124-76-5				
isoborneol glucuronide	68296-69-5	Isoborneol glucuronide	68296-69-5				
isobutyl alcohol	78-83-1	Isobutanol	78-83-1	56F9Z98TEM			
isobutyl nitrite	542-56-3	Isobutyl nitrite	542-56-3	GW9WAB6QOM	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
isobutyl-4-hydroxybenzoate	4247-02-3	Isobutyl 4-hydroxybenzoate	4247-02-3	0QQJ25X58G			
isobutylparaben		Isobutyl 4-hydroxybenzoate	4247-02-3	0QQJ25X58G			
isobutyraldehyde	78-84-2	Isobutyraldehyde	78-84-2	C42E28168L			
isobutyric acid	79-31-2	Isobutyric acid	79-31-2	8LL210O1U0			
isobutyronitrile	78-82-0	Isobutyronitrile	78-82-0	699AWF2WV2			
isobutyryl-coenzyme A	15621-60-0	isobutyryl-CoA	15621-60-0				
isocaproaldehyde	1119-16-0	4-Methylpentanal	1119-16-0	T0AO9E93RH			
isocaproic acid	646-07-1	4-Methylpentanoic acid	646-07-1	4G4U8JA28T			
isocarbophos		Isocarbophos	24353-61-5	7741NPW06X	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Isocarboxazid	59-63-2	Isocarboxazid	59-63-2	34237V843T	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	Isocarboxazid is indicated for the treatment of the enduring and debilitating symptoms of depression that have not responded to other antidepressant drugs. Depression is a common but serious mood disorder. The patient will present changes in its feelings, thoughts, and ability to handle everyday activities. For a mood disorder to be considered as depression, the symptoms should be present for at least two weeks.
isoconazole	27523-40-6	Isoconazole	27523-40-6	GRI7WFR424	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
isocoproporphyrin	36548-09-1	Isocoproporphyrin	36548-09-1				
isocoumarin NM-3		2-(8-Hydroxy-6-methoxy-1-oxo-1H-isochromen-3-yl)propionic acid	181427-78-1	5797K23F95			
isocupressic acid	1909-91-7	Isocupressic acid	1909-91-7	6DV5EL78HE			
Isocyanates		Cyanate	71000-82-3	YML51WA0FW			
isocytisoside	4328-19-2	Isocytisoside	4328-19-2				
Isoetharine	530-08-5	Isoetharine	530-08-5		Bronchodilator Agents	Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)	For the treatment of asthma, wheezing, and chronic asthmatic bronchitis.
isoeugenol	97-54-1	Isoeugenol	97-54-1	28FSR1NAY4			Isoeugenol is approved by the FDA for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.
isofagomine		Afegostat	169105-89-9	G23AP190YS			
isofenphos	25311-71-1	Isofenphos	25311-71-1	0514MAW53A	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
isoflavanone	4737-27-3	Isoflavanone	4737-27-3				
Isoflavones		Isoflavones					
Isoflurane	26675-46-7	Isoflurane	26675-46-7	CYS9AKD70P	Anesthetics, Inhalation	Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173) (See all compounds classified as Anesthetics, Inhalation.)	For induction and maintenance of general anesthesia.
Isoflurophate	55-91-4	Isoflurophate	55-91-4	12UHW9R67N	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	For use in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia.
isohelenin		Isohelenin	470-17-7				
isoimperatorin		Isoimperatorin	482-45-1	0ZMV066080			
Isoindoles		Isoindoles					
isolariciresinol	548-29-8	Isolariciresinol, (+)-	548-29-8	FRJ46XRJ28			
Isoleucine	73-32-5	l-Isoleucine	73-32-5	5HX0BYT4E3			The branched-chain amino acids may have antihepatic encephalopathy activity in some. They may also have anticatabolic and antitardive dyskinesia activity.
isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone		isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone					
isolevin	54750-10-6	Isoproterenol tartrate, (-)-	54750-10-6	I172M2811Q			
isoliensinine		Isoliensinine	6817-41-0				
isoline		Isoline	30000-36-3	KGE82EDN24			
isoliquiritigenin	961-29-5	Trihydroxychalcone	961-29-5	B9CTI9GB8F	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
isoliquiritigenin 2'-methyl ether		isoliquiritigenin 2'-methyl ether					
isomalathion	3344-12-5	Isomalathion	3344-12-5	9XEP5P83AO			
isomenthol		Isomenthol	3623-52-7	Q3I568EO1X			
isomenthone		Isomenthone, (+/-)-	491-07-6	9WZ3E2G6CL			
isomethyleugenol	93-16-3	Methylisoeugenol	93-16-3	J6M6C71VVR			
Isoniazid	54-85-3	Isoniazid	54-85-3	V83O1VOZ8L	Antitubercular Agents	Drugs used in the treatment of tuberculosis. They are divided into two main classes: &quot;first-line&quot; agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and &quot;second-line&quot; drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. (See all compounds classified as Antitubercular Agents.)	Isoniazid is used for the treatment of all forms of tuberculosis in which organisms are susceptible. It is also used in combination with rifampin and pyrazinamide.
isoniazid, pyrazinamide, rifampin drug combination		Trifazid	161935-14-4		Antitubercular Agents	Drugs used in the treatment of tuberculosis. They are divided into two main classes: &quot;first-line&quot; agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and &quot;second-line&quot; drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. (See all compounds classified as Antitubercular Agents.)	
isonicotinamide	1453-82-3	Isonicotinamide	1453-82-3	4H3BH6YX9Q			
Isonicotinic Acids		Isonicotinic Acids					
isonicotinyl-NAD		isonicotinyl-NAD					
isonitrosoacetone		Isonitrosoacetone	306-44-5	U32V8CLT4W			
isooctyl acrylate	29590-42-9	Isooctyl acrylate	29590-42-9	GU1V16S82F			
isopentane	78-78-4	Isopentane	78-78-4	ZH67814I0O			
isopentenyl pyrophosphate	358-71-4	Isopentenyl pyrophosphate	358-71-4	LSC8849M7B			
isopentyl alcohol	123-51-3	Isoamyl alcohol	123-51-3	DEM9NIT1J4			
isopentyl ferulate		Isopentyl ferulate					
isophorone	78-59-1	Isophorone	78-59-1	2BR99VR6WA			
isophorone diisocyanate	4098-71-9	Isophorone diisocyanate	4098-71-9	43B0856528			
isophthalate	121-91-5	Isophthalic acid	121-91-5	X35216H9FJ			
isopimaric acid		Isopimaric acid	5835-26-7	1E37K85HHK	Ionophores	Chemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channels across membranes. Many are antibiotics, and many act as uncoupling agents by short-circuiting the proton gradient across mitochondrial membranes. (See all compounds classified as Ionophores.)	
isopimpinellin	482-27-9	Isopimpinellin	482-27-9	20GCF755G6			
isopraeroside IV		isopraeroside IV					
isoprene	78-79-5	Isoprene	9006-04-6	0A62964IBU			
isoprocarb		Isoprocarb	2631-40-5	714I55QH9K	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
isopropamide iodide	71-81-8	Isopropamide Iodide	71-81-8	E0KNA372SZ			
isopropyl 4-hydroxybenzoate	4191-73-5	Isopropyl 4-hydroxybenzoate	4191-73-5	A6EOX47QK0			
isopropyl 4,4'-dibromobenzilate	18181-80-1	Bromopropylate	18181-80-1	3U468ZM257			
isopropyl 5,12-hydroxypentadeca-8,10-dien-6,14-diynoate		Navamepent	1251537-11-7	Q7789B8MWM			
isopropyl methylphosphonic acid	1832-54-8	Isopropyl methylphosphonate	1832-54-8	30DEK38OFS			
isopropyl palmitate	142-91-6	Isopropyl Palmitate	142-91-6	8CRQ2TH63M			
Isopropyl Thiogalactoside	367-93-1	Isopropyl-beta-D-thiogalactopyranoside	367-93-1	X73VV2246B			
isopropyl thioxanthone		4-Isopropyl-thioxanthene-9-one					
isopropyl-9H-thioxanthen-9-one		4-Isopropylthioxanthone	83846-86-0	PAF3CW7TJ8			
isopropylmethanesulfonate	926-06-7	Isopropyl methanesulfonate	926-06-7	T0K2TXY26B	Alkylating Agents	Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)	
Isoprostanes		Isoprostanes					
Isoproterenol	7683-59-2	Isoproterenol	7683-59-2	L628TT009W	Adrenergic beta-Agonists	Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)	Isoprenaline is indicated to treat mild or transient episodes of heart block not requiring electric shock or pacemakers, serious episodes of heart block and Adams-Stokes attacks not caused by ventricular tachycardia or fibrillation, and bronchospasm during anesthesia. Isoprenaline is also indicated for cases of cardiac arrest until preferable treatments like electric shock and pacemakers are available. Isoprenaline is also indicated as an adjunct therapy to fluid and electrolyte replacement therapy in hypovolemic shock, septic shock, hypoperfusion, congestive heart failure, and cardiogenic shock.
isoprothiolane	50512-35-1	Isoprothiolane	50512-35-1	88HCS898G6			
isoproturon	34123-59-6	Isoproturon	34123-59-6	66066K098P	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
isoquercitrin	21637-25-2	Isoquercitrin	21637-25-2	0YX10VRV6J			
Isoquinolines		Isoquinolines					
isorhamnetin 3-O-glucoside		isorhamnetin 3-O-glucoside	5041-82-7	BI252A6EPL			
isorhapontigenin		Isorhapontigenin	32507-66-7	CZ49V3K5HS			
isosafrole	120-58-1	Isosafrole	120-58-1	94BY31ALL6			
isosakuranetin		Isosakuranetin	480-43-3	U02X7TF8UA			
isosalipurposide	4547-85-7	Isosalipurposide	4547-85-7				
isoschaftoside		Isoschaftoside	52012-29-0	H27X8715V3			
isoscutellarein		Isoscutellarein	41440-05-5	3WAC3UX5SC			
isosilybin	72581-71-6	CID 21723007	72581-71-6				
isosilybin A		Isosilybin A	142796-21-2	HHN3Q9H3DK			
Isosorbide	652-67-5	Isosorbide	652-67-5	WXR179L51S	Diuretics, Osmotic	Compounds that increase urine volume by increasing the amount of osmotically active solute in the urine. Osmotic diuretics also increase the osmolarity of plasma. (See all compounds classified as Diuretics, Osmotic.)	Isosorbide was previously indicated for temporary reduction of intraocular pressure and used to interrupt an acute glaucoma attack, however, this is not a currently approved indication. Refer to [isosorbide mononitrate] and [isosorbide dinitrate] drug entries for more isosorbide indications.
Isosorbide Dinitrate	87-33-2	Isosorbide Dinitrate	87-33-2	IA7306519N	Nitric Oxide Donors	A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)	For the prevention of angina pectoris due to coronary artery disease.
isosorbide-5-mononitrate	16051-77-7	Isosorbide Mononitrate	16051-77-7	LX1OH63030	Nitric Oxide Donors	A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)	Isosorbide mononitrate is indicated for the prevention and management of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid to be useful in aborting an acute anginal episode.
isospaglumic acid		Spaglumic acid	3106-85-2	1W8M12WXYL	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	Used in patients with allergic conjunctivitis.
isostearic acid	5638-12-0	2-Methylheptadecanoic acid	5638-12-0	USO2AQ1J3Z			
isostevic acid		isostevic acid					
isosteviol		Isosteviol	27975-19-5	091QB7QO95			
isothiazolidinone		isothiazolidinone					
Isothiocyanates		Isothiocyanates					
Isothiuronium	22584-04-9	Isothiuronium	22584-04-9	8XYH0MIG48			
isotocin	550-21-0	Isotocin	550-21-0				
isotonitazene		Isotonitazene	14188-81-9	ZFY1ZBQ8AV			
Isotretinoin	4759-48-2	Isotretinoin	4759-48-2	EH28UP18IF	Dermatologic Agents	Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)	Isotretinoin is indicated to treat severe recalcitrant nodular acne and patients 12 years enrolled in the iPLEDGE program.
isourolithin A		3,9-dihydroxy-6H-benzo[c]chromen-6-one					
isovaleric acid	503-74-2	Isovaleric acid	503-74-2	1BR7X184L5			
isovitexin	38953-85-4	Isovitexin	38953-85-4	KTQ9R9MS0Q			
isoxaben	82558-50-7	Isoxaben	82558-50-7	101V41EEA4			
isoxanthohumol		Isoxanthohumol	72247-79-1				
Isoxazoles		Isoxazole	288-14-2	00SRW0M6PW			
Isoxsuprine	395-28-8	Duvadilan	395-28-8		Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
ispinesib		Ispinesib	336113-53-2	BKT5F9C2NI			Investigated for use/treatment in breast cancer, lung cancer, solid tumors, renal cell carcinoma, pediatric indications, ovarian cancer, and head and neck cancer.
ispronicline		Ispronicline	252870-53-4	3E05NBH9V5			
Isradipine	75695-93-1	Isradipine	75695-93-1	YO1UK1S598	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the management of mild to moderate essential hypertension. It may be used alone or concurrently with thiazide-type diuretics.
istradefylline		Istradefylline	155270-99-8	2GZ0LIK7T4	Adenosine A2 Receptor Antagonists	Compounds that selectively bind to and block the activation of ADENOSINE A2 RECEPTORS. (See all compounds classified as Adenosine A2 Receptor Antagonists.)	Istradefylline is indicated in adjunct to levodopa and carbidopa in the treatment of Parkinson's disease.
itaconic acid	97-65-4	Itaconic acid	97-65-4	Q4516562YH			
itopride	122898-67-3	Itopride	122898-67-3	81BMQ80QRL			Investigated for use/treatment in gastrointestinal diseases and disorders (miscellaneous).
Itraconazole	84625-61-6	Itraconazole	84625-61-6	304NUG5GF4	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	Itraconazole is indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients:  - Blastomycosis, pulmonary and extrapulmonary - Histoplasmosis, including chronic cavitary pulmonary disease and disseminated, nonmeningeal histoplasmosis, and - Aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy  It is also indicated for the treatment of the following fungal infections in non-immunocompromised patients:  - Onychomycosis of the toenail, with or without fingernail involvement, due to dermatophytes (tinea unguium) - Onychomycosis of the fingernail due to dermatophytes (tinea unguium).  Itraconazole oral solution is indicated for the treatment of oropharyngeal and esophageal candidiasis.
iturelix	112568-12-4	Antide	112568-12-4	94055UOQ3Y	Hormone Antagonists	Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)	
ITX3 compound		ITX3 compound					
Ivabradine	155974-00-8	Ivabradine	155974-00-8	3H48L0LPZQ	Cardiovascular Agents	Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)	Ivabradine is indicated by the FDA to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction 35%, who are in sinus rhythm with resting heart rate 70 beats per minute and either are on maximally tolerated doses of beta-blockers or have a contraindication to beta-blocker use. It is also indicated for treatment of stable symptomatic heart failure as a result of dilated cardiomyopathy for pediatric patients 6 months of age or more.
ivacaftor		Ivacaftor	873054-44-5	1Y740ILL1Z	Chloride Channel Agonists	A class of drugs that stimulate chloride ion influx through cell membrane channels. (See all compounds classified as Chloride Channel Agonists.)	When used as monotherapy as the product Kalydeco, ivacaftor is indicated for the treatment of cystic fibrosis (CF) in patients aged one month and older who have one mutation in the CFTR gene that is responsive to ivacaftor potentiation based on clinical and/or _in vitro_ assay data.  When used in combination with the drug [lumacaftor] as the product Orkambi, ivacaftor is indicated for the management of CF in patients aged one year and older who are homozygous for the _F508del_ mutation in the CFTR gene. If the patients genotype is unknown, an FDA-cleared CF mutation test should be used to detect the presence of the _F508del_ mutation on both alleles of the CFTR gene.  When used in combination with [tezacaftor] in the product Symdeko, it is used to manage CF in patients 12 years and older who have at least one mutation in the CFTR gene or patients aged 12 or older who are shown to be homozygous for the F508del mutation.  When used in combination with tezacaftor and [elexacaftor] in the product Trikafta, it is indicated for the treatment of cystic fibrosis in patients 12 years of age and older who have at least one _F508del_ mutation in the CFTR gene.
Ivermectin	70288-86-7	Ivermectin B1a	71827-03-7	91Y2202OUW	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	Administered topically, ivermectin cream is indicated for the treatment of inflammatory lesions associated with rosacea. An over-the-counter ivermection lotion is commercially available and indicated for the topical treatment of head lice infestations in patients 6 months of age.  Orally administered ivermectin is indicated as a broad-spectrum anti-parasitic for the treatment of intestinal strongyloidiasis caused by _Strongyloides stercoralis_ and onchocerciasis caused by _Onchocerca volvulus_. Systemic ivermectin therapy is used internationally for the treatment of various tropical diseases, including filariasis, cutaneous larva migrans, and _Loa loa_ infection, amongst others.
IWR-1 compound		IWR-1 compound					
ixazomib		Ixazomib	1072833-77-2	71050168A2	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Ixazomib is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
J 104132		5H-Cyclopenta(b)pyridine-6-carboxylic acid, 5-(1,3-benzodioxol-5-yl)-2-butyl-7-(2-((2S)-2-carboxypropyl)-4-methoxyphenyl)-6,7-dihydro-, (5S,6R,7R)-	198279-45-7	N71Z6M3T0I	Endothelin Receptor Antagonists	Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN RECECPTORS. (See all compounds classified as Endothelin Receptor Antagonists.)	
J 113397		CompB	256640-45-6	00M5444DIY			
J2326 compound		J2326 compound					
jaceosidin	18085-97-7	Jaceosidin	18085-97-7	5U4Y68G678			
jacobine	6870-67-3	Jacobine	6870-67-3	GM32U80H1R			
JAI-51		JAI-51					
Janus Kinase Inhibitors		Janus Kinase Inhibitors					
japonicone A		japonicone A					
jasmine oil	8022-96-6	1-But-2-enyl-2-methylcyclopentene	8022-96-6				
jasplakinolide	102396-24-7	Jasplakinolide	102396-24-7		Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
jatrorrhizine	3621-38-3	Jatrorrhizine	3621-38-3	091S1F8V5Q			
JB-788		JB-788					
JBIR-99		CID 49817544					
JBP 485		Cyclo-trans-4-L-Hydroxyprolyl-L-serine	211868-63-2				
JBT-3002		CID 11707967					
JHW 015		(2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone	155471-08-2	W4FL204T10	Cannabinoid Receptor Agonists	Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)	
JI-38		1-29-Somatoliberin (1-desaminotyrosine,8-glutamine,12-ornithine,15-alpha-aminobutyric ACID,21-ornithine,27-norleucine,28-aspartic ACID,29-agmatine) (human)	164080-22-2				
JIB-04		(E)-5-chloro-2-(2-(phenyl(pyridin-2-yl)methylene)hydrazinyl)pyridine	909077-07-2				
jinfukang		jinfukang					
jinhong		jinhong					
JK 1624F2-1		JK 1624F2-1					
JK184		N-(4-ethoxyphenyl)-4-(2-methylimidazo[1,2-a]pyridin-3-yl)thiazol-2-amine	315703-52-7				
JNJ 10397049		Urea, N-(2,4-dibromophenyl)-N'-((4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl)-	708275-58-5	1B419P24AV			
JNJ-64619178		Onametostat	2086772-26-9	N8VKI8FPW0	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
JNK-IN-8		Jnk-IN-8	1410880-22-6		Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
Josamycin	16846-24-5	Josamycin	16846-24-5	HV13HFS217	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of bacterial infections.
JP-1302		N-(4-(4-Methyl-1-piperazinyl)phenyl)-9-acridinamine	80259-18-3				
JP5 jet fuel	8008-20-6	8008-20-6					
JP8 aviation fuel		JP8 aviation fuel					
JTE 013		1-(2,6-Dichloropyridin-4-yl)-3-[(1,3-dimethyl-4-propan-2-ylpyrazolo[3,4-b]pyridin-6-yl)amino]urea	383150-41-2				
JTE 607		JTE 607 dihydrochloride	188791-09-5	2B68H6BWCX			
JTE 907		3-Quinolinecarboxamide, N-(1,3-benzodioxol-5-ylmethyl)-1,2-dihydro-7-methoxy-2-oxo-8-(pentyloxy)-	282089-49-0	DAV3Q7SNOL			
JTP 4819		(S)-N-benzyl-2-((S)-2-(2-hydroxyacetyl)pyrrolidine-1-carbonyl)pyrrolidine-1-carboxamide	162203-65-8	ASG803L8RD			
juglone	481-39-0	Juglone	481-39-0	W6Q80SK9L6	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
juniper berry oil		8002-68-4					
juvenile hormone III	5255-04-9	Juvenate	24198-95-6				
juzentaihoto		D06981					
JW74 compound		JW74 compound					
JWH-073		1-Butyl-3-(1-naphthoyl)indole	208987-48-8	BBX3BP2772	Cannabinoid Receptor Agonists	Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)	
JYL 1421		3-[(4-Tert-butylphenyl)methyl]-1-[(3-fluoro-4-methanesulfonamidophenyl)methyl]thiourea	401907-26-4	Y6TH2I6W99			
JZL 184		4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate	1101854-58-3	7MZ1I2J68A			
JZL195		(4-Nitrophenyl) 4-[(3-phenoxyphenyl)methyl]piperazine-1-carboxylate	1210004-12-8	TP6P2HKJ54			
K 7174		1H-1,4-Diazepine, hexahydro-1,4-bis((4E)-5-(3,4,5-trimethoxyphenyl)-4-penten-1-yl)-	191089-59-5	36376CA57N			
K-12 lipopolysaccharide		K-12 lipopolysaccharide					
K-48 compound		K-48 compound					
K075 compound		K075 compound					
K117 compound		K117 compound					
K127 compound		K127 compound					
K201 compound		JTV-519 hydrochloride	1038410-88-6	0I621Y6R4Q			
K456 compound		K456 compound					
kabiramide C		Kabiramide C					
kadethrin	58769-20-3	Spray-tox	58769-20-3	N52O84U83Z			
kaempferide		Kaempferide	491-54-3	508XL61MPD			
kaempferol	520-18-3	Kaempferol	520-18-3	731P2LE49E			
kaempferol 3-O-sophoroside	19895-95-5	Kaempferol 3-O-sophoroside	19895-95-5	3C1196Z645			
kaempferol 7-O-glucoside		kaempferol 7-O-glucoside	16290-07-6	RZF1QN1Z8R			
kaempferol-3-O-galactoside	23627-87-4	Trifolin	23627-87-4	7CKD5ET5SP			
kaempferol-7-methyl ether		Kaempferol 7-methyl ether					
kahweol	6894-43-5	Kahweol	6894-43-5	KX95B6688Y			
kahweol acetate	81760-47-6	Kahweol acetate	81760-47-6				
kahweol palmitate	81760-45-4	CID 44134788					
Kai-Xin-San		Kai-Xin-San					
Kainic Acid	487-79-6	Kainic acid	487-79-6	SIV03811UC	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	
kalafungin	11048-15-0	Antibiotic U-19,718	29394-61-4				
Kallidin	342-10-9	Kallidin	342-10-9		Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
kallidin, des-Arg(10)-	71800-36-7	Lys-[Des-Arg9]Bradykinin	71800-36-7				
Kalpaamruthaa		Kalpaamruthaa					
kamebakaurin	73981-34-7	Kamebakaurin					
Kanamycin	59-01-8	Kanamycin	59-01-8	RUC37XUP2P	Protein Synthesis Inhibitors	Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)	For treatment of infections where one or more of the following are the known or suspected pathogens: E. coli, Proteus species (both indole-positive and indole-negative), E. aerogenes, K. pneumoniae, S. marcescens, and Acinetobacter species.
kang-lai-te		Kanglaite					
Kangen-karyu		Kangen-karyu					
kangshuai yizhi		kangshuai yizhi					
kansuinin A	57701-86-7	Kansuinine A	57701-86-7				
kansuinin B		Kansuinine B	57685-46-8				
Kaolin	1332-58-7	Kaolin	1340-68-7		Antidiarrheals	Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition. (See all compounds classified as Antidiarrheals.)	Used for upset stomach and diarrhea, a traditional medicine used in China, South America and Africa. Kaolin is also used to treat AIDs-related diarrhea. Kaolin based bandages are also under investigation.
kappa-casein glycomacropeptide		kappa-casein glycomacropeptide					
kappa-selenocarrageenan		kappa-selenocarrageenan					
Kathon 886	55965-84-9	Kathon 886	55965-84-9		Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
Kathon 930	64359-81-5	Kathon 930	64359-81-5	HCY9Q844W2			
kavain	1635-33-2	Neuronica	3155-48-4	5L1NI60TGB	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
KB 130015		2-Methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran	147030-48-6	9YA9HD8JR2			
KB 5-21		KB 5-21					
KB R7785		(4-(N-hydroxyamino)-2R-isobutyl-3S-methylsuccinyl)-L-phenylglycine-N-methylamide	168158-16-5				
KB R8301		CID 10047585	190383-65-4				
kb-NB142-70		3,4-Dihydro-9-hydroxy-[1]benzothieno[2,3-f]-1,4-thiazepin-5(2H)-one	1233533-04-4				
KC 400	12737-87-0	3,3',5,5'-Tetrachlorobiphenyl	12672-29-6	M8CJF43Q12			
KC 500		KC 500					
KC7F2 compound		KC7F2 compound					
KCC 009		benzyl N-[(2S)-1-[(3-bromo-4,5-dihydro-1,2-oxazol-5-yl)methylamino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]carbamate	744198-19-4				
kemptide	65189-71-1	H-Leu-Arg-Arg-Ala-Ser-Leu-Gly-OH					
kenpaullone		Kenpaullone	142273-20-9	T72H2BL53P			
Keratan Sulfate	9056-36-4	Keratan	69992-87-6				
Kerosene		64771-72-8					
Ketamine	6740-88-1	Ketamine	6740-88-1	690G0D6V8H	Anesthetics, Dissociative	Intravenous anesthetics that induce a state of sedation, immobility, amnesia, and marked analgesia. Subjects may experience a strong feeling of dissociation from the environment. The condition produced is similar to NEUROLEPTANALGESIA, but is brought about by the administration of a single drug. (From Gilman et al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) (See all compounds classified as Anesthetics, Dissociative.)	Ketamine is indicated as an anesthetic agent for recommended diagnostic and surgical procedures. If skeletal muscle relaxation is needed, it should be combined with a muscle relaxant. If the surgical procedure involves visceral pain, it should be supplemented with an agent that obtunds visceral pain. Ketamine can be used for induction of anesthesia prior other general anesthetic agents and as a supplement of low potency agents.  Reports have indicated a potential use of ketamine as a therapeutic tool for the management of depression when administered in lower doses. These reports have increased the interest for ketamine in this area and several clinical trials are launched for this indication.
Ketanserin	74050-98-9	Ketanserin	74050-98-9	97F9DE4CT4	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
ketazocine	36292-69-0	Ketazocine	36292-69-0	6IO4IG518S			
ketobemidone	469-79-4	Ketobemidone	469-79-4	PQS1L514CF	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	For the treatment of all types of severe pain, such as postoperative, cancer, kidney stones and fractures.
Ketocholesterols		Ketocholesterols					
Ketoconazole	65277-42-1	(+)-Ketoconazole	65277-42-1		14-alpha Demethylase Inhibitors	Compounds that specifically inhibit STEROL 14-DEMETHYLASE. A variety of azole-derived ANTIFUNGAL AGENTS act through this mechanism. (See all compounds classified as 14-alpha Demethylase Inhibitors.)	Ketoconazole is used in the treatment or prevention of fungal infections including blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. In Europe, it is also used in the treatment of endogenous Cushing's syndrome.
Ketoglutaric Acids		Oxoglurate [INN]					
Ketolides		Ketolides					
Ketone Bodies		Ketone Bodies					
Ketones		Ketones					
Ketoprofen	22071-15-4	Ketoprofen	22071-15-4	90Y4QC304K	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	For symptomatic treatment of acute and chronic rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, primary dysmenorrhea and mild to moderate pain associated with musculotendinous trauma (sprains and strains), postoperative (including dental surgery) or postpartum pain.
Ketorolac	66635-83-4	Ketorolac	74103-06-3	YZI5105V0L	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and has antipyretic, analgesic and anti-inflammatory properties.  It is indicated for short term management of acute pain that requires the calibre of pain management offered by opioids.  Clinicians may choose to initiate ketorolac to manage post-operative pain, spinal and soft tissue pain, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, menstrual disorders and headaches among other ailments. Regardless of the etiology of pain, patients should use the lowest possible dose, and avoid using ketorolac for an extended period of time (ideally  5 days). A benefit of choosing ketorolac over other analgesics with similar potency is that that there does not appear to be a risk of dependence or tolerance with ketorolac use.
Ketorolac Tromethamine	74103-07-4	Ketorolac Tromethamine	74103-07-4	4EVE5946BQ	Cyclooxygenase Inhibitors	Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)	Investigated for use/treatment in pain (acute or chronic).
Ketosteroids		Ketosteroids					
Ketotifen	34580-13-7	Ketotifen	34580-13-7	X49220T18G	Antipruritics	Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)	Administered orally, ketotifen is indicated as an add-on medication in the chronic treatment of mild atopic asthma in children. It is also available as an over-the-counter ophthalmic solution which is indicated for the temporary prevention of itching of the eye due to allergic conjunctivitis.
keyhole-limpet hemocyanin		Keyhole limpet hemocyanin	9013-72-3				Investigated for use/treatment in bladder cancer and solid tumors.
KF 17837	152881-18-0	8-(3,4-Dimethoxyphenyl)-7-methyl-1,3-dipropyl-1H-purine-2,6(3H,7H)-dione	152881-18-0				
KF 20274	143394-68-7	7,8-Dnipo	143394-68-7		Purinergic P1 Receptor Antagonists	Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS. (See all compounds classified as Purinergic P1 Receptor Antagonists.)	
KF58333		KF58333					
KH 1060	131875-08-6	Lexacalcitol	131875-08-6	9G3DCA3958	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	
kifunensine		Kifunensine	109944-15-2	0NI8960271	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
kinamycin F	50556-18-8	Kinamycin F	50556-18-8				
KIRA6		1-(4-(8-Amino-3-(tert-butyl)imidazo[1,5-a]pyrazin-1-yl)naphthalen-1-yl)-3-(3-(trifluoromethyl)phenyl)urea	1589527-65-0		Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
kirenol		Kirenol	52659-56-0				
KJM 429		KJM 429					
Klebsiella O3 lipopolysaccharide		Klebsiella O3 lipopolysaccharide					
KM-233		(6aR,10aR)-6,6,9-Trimethyl-3-(2-phenylpropan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol	628263-22-9	YMV7S3C3B7			
KMUP 1		1H-Purine-2,6-dione, 7-(2-(4-(2-chlorophenyl)-1-piperazinyl)ethyl)-3,7-dihydro-1,3-dimethyl-	81996-46-5	1X0H7WEC5D	Potassium Ionophores	Chemical agents that increase the permeability of CELL MEMBRANES to POTASSIUM ions. (See all compounds classified as Potassium Ionophores.)	
KMUP 880602		KMUP 880602					
KN 62	127191-97-3	(S)-4-(2-(N-methylisoquinoline-5-sulfonamido)-3-oxo-3-(4-phenylpiperazin-1-yl)propyl)phenyl isoquinoline-5-sulfonate	127191-97-3	63HM46XPOW	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
KN 93	139298-40-1	Methoxybenzene-sulfonamide	139298-40-1	2TW744QBU1	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
KNK 437		N-Formyl-3,4-methylenedioxy-benzylidine-gamma-butyrolactam	218924-25-5				
kojic acid	501-30-4	Kojic acid	501-30-4	6K23F1TT52	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
kokusaginine		Kokusaginine	484-08-2	JG1753DK5H			
kolaviron		Kolaflavanone	68705-66-8	VY4E467596			
koninginin A		2-Hexyloctahydro-2h-3,9a-epoxy-1-benzoxepine-6,9-diol					
KP372-1		6H-Indeno[1,2-e]tetrazolo[1,5-b][1,2,4]triazin-6-one	1374996-60-7				
KR-31612		KR-31612					
kresoxim-methyl		Kresoxim-Methyl	143390-89-0	0LXZ062TTB	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
KRN 7000	158021-47-7	alpha-GalCer	158021-47-7	WX671898JF	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
KT 5720	108068-98-0	KT5720	108068-98-0	58HV29I28S	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
KT 5823	126643-37-6	9,12-Epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid, 2,3,9,10,11,12-hexahydro-10-methoxy-2,9-dimethyl-1-oxo-, methyl ester, (9S,10R,12R)-	126643-37-6	WY40BAB02W	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
KT 5926	126643-38-7	9-Hydroxy-9-methoxycarbonyl-8-methyl-14-n-propoxy-2,3,9,10-tetrahydro-8,11-epoxy-1H,8H,11H-2,7b,11a-triazadibenzo(a,g)cycloocta(cde)trinden-1-one	126643-38-7		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Ku 0063794		Ku-0063794	938440-64-3	81HJG228AB	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
KU-32 compound		KU-32 compound					
kuguacin J		Kuguacin J					
kukoamine A		Kukoamine A	75288-96-9	9YM64FBW2R			
kukoamine B		Kukoamine B	164991-67-7	XZE94LC57W			
kuntai capsule		kuntai capsule					
kurarinol		Kurarinol	855746-98-4				
kurarinone		Kurarinone	34981-26-5				
kurtoxin		Kurtoxin					
kutkin	12708-05-3	Kutkin	12708-05-3		Antiprotozoal Agents	Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)	
kuwanon G	75629-19-5	Kuwanon G	75629-19-5	GQ6QVK8YZM			
kuwanon H	76472-87-2	Kuwanon H	76472-87-2	822Q5M4B5D			
kuwanon-L		Kuwanon L	88524-65-6	K7L2NL4ZQF			
KYA1797K		potassium (Z)-3-(5-((5-(4-nitrophenyl)furan-2-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)propanoate					
Kynuramine	363-36-0	Kynuramine	363-36-0	2WR44BV65E			
Kynurenic Acid	492-27-3	Kynurenic acid	492-27-3	H030S2S85J	Excitatory Amino Acid Antagonists	Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)	
Kynurenine	343-65-7	Kynurenine	343-65-7	298M20B2AU			
L 158809		2-Ethyl-5,7-dimethyl-3-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)imidazo(4,5-b)pyridine	133240-46-7		Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
L 245976		L 245976					
L 364373		CID 15614735					
L 365260	118101-09-0	N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea	118101-09-0	370JHF4586			
L 644698		L 644698					
L 655,708		L 655,708					
L 655238		L 655238					
L 657743	111466-41-2	Unii-UT87RB8I1V	111466-41-2	UT87RB8I1V	Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	
L 659989	129314-27-8	trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran	129314-27-8				
L 663581	122384-14-9	7-chloro-5-methyl-3-(5-propan-2-yl-1,2,4-oxadiazol-3-yl)-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one	122384-14-9	7V0I080855			
L 685458		L-Phenylalaninamide, N-[(2R,4R,5S)-5-[[(1,1-dimethylethoxy)carbonyl]amino]-4-hydroxy-1-oxo-6-phenyl-2-(phenylmethyl)hexyl]-L-leucyl-	292632-98-5		Gamma Secretase Inhibitors and Modulators	Agents that suppress GAMMA-SECRETASE by inhibiting or modulating its activities. Targeted enzymatic activities include its involvement in accumulation of toxic AMYLOID BETA-PEPTIDES (e.g., A&#x3B2;42) in ALZHEIMER DISEASE and activation of NOTCH RECEPTOR mediated SIGNAL PATHWAYS in certain cancer types. (See all compounds classified as Gamma Secretase Inhibitors and Modulators.)	
L 689065	146775-25-9	3-(1-(4-Chlorobenzyl)-4-methyl-6-(5-phenylpyridin-2-ylmethoxy)-4,5-dihydro-1H-thiopyrano(2,3,4-c,d)indol-2-yl)-2,2-dimethylpropanoic acid	146775-25-9				
L 694247	137403-12-4	N-(4-((5-(3-(2-Aminoethyl)-1H-indol-5-yl)-1,2,4-oxadiazol-3-yl)methyl)phenyl)methanesulfonamide	137403-12-4	PZ5DP5EN56			
L 703606	144425-84-3	2-(Diphenylmethyl)-N-((2-iodophenyl)methyl)-3-quinuclidinamine	144425-84-3				
L 706000	150481-98-4	OM3KJ27Ats	150481-98-4	8NWU765OLC			
L 708714		Benzoic acid, 2-(((1-((4-azido-3-iodophenyl)sulfonyl)-4,5-dihydro-4-methyl-6-((5-phenyl-2-pyridinyl)methoxy)-1H-thiopyrano(2,3,4-cd)indol-2-yl)methyl)thio)-	161447-83-2				
L 709049	143313-51-3	L 709049					
L 742694		2-((3,5-Bis(trifluoromethyl)benzyl)oxy)-3-phenyl-4-((3-oxo-1,2,4-triazol-5-yl)methyl)morpholine	159706-39-5				
L 744832		propan-2-yl (2S)-2-[[2-[(2S,3S)-2-[[(2R)-2-amino-3-sulfanylpropyl]amino]-3-methylpentoxy]-3-phenylpropanoyl]amino]-4-methylsulfonylbutanoate	160141-09-3				
L 745337		Thioflosulide	158205-05-1		Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
L 748,337		N-[[3-[(2S)-2-Hydroxy-3-[[2-[4-[(phenylsulfonyl)amino]phenyl]ethyl]amino]propoxy]phenyl]methyl]-acetamide	244192-94-7				
L 748706		L 748706					
L 750667		3-[[4-(4-iodophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine	158985-08-1				
L 754394		1-Piperazinepentanamide, N-((1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl)-2-(((1,1-dimethylethyl)amino)carbonyl)-4-(furo(2,3-b)pyridin-5-ylmethyl)-gamma-hydroxy-alpha-(phenylmethyl)-, (alphaR,gammaS,2S)-	160729-91-9				
L 759656		(6aR,10aR)-1-methoxy-6,6-dimethyl-9-methylidene-3-(2-methyloctan-2-yl)-7,8,10,10a-tetrahydro-6aH-benzo[c]chromene	174627-56-6				
L 779976		U5B58A46QX	214770-19-1	U5B58A46QX			
L 783281		Demethylasterriquinone B1	78860-34-1	F6582H6JQW			
L 817818		[(2S)-2-aminopropyl] (2S)-6-amino-2-[[2-(2-naphthalen-2-yl-1H-benzo[g]indol-3-yl)acetyl]amino]hexanoate					
L-161982		N-[2-[4-[[3-butyl-5-oxo-1-[2-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]methyl]phenyl]phenyl]sulfonyl-3-methyl-2-thiophenecarboxamide	147776-06-5				
L-335677		L-335677					
L-4F peptide		L-4F peptide					
L-826,141		Benzenemethanol, 4-(1-(3,4-bis(difluoromethoxy)phenyl)-2-(3-methyl-1-oxido-4-pyridinyl)ethyl)-alpha,alpha-bis(trifluoromethyl)-	491869-01-3	2JN104XMOK			
L-826266		(E)-N-(5-bromo-2-methoxyphenyl)sulfonyl-3-[5-chloro-2-(naphthalen-2-ylmethyl)phenyl]prop-2-enamide	244101-03-9				
L-N6-(1-iminoethyl)lysine-5-tetrazole-amide		L-N6-(1-iminoethyl)lysine-5-tetrazole-amide					
L-pyroglutamyl-L-histidyl-3,3-dimethylprolinamide	76820-40-1	5-Oxo-L-prolyl-L-histidyl-3,3-dimethyl-L-prolinamide	76820-40-1	PYAIKU1M4K			
L796778		methyl (2S)-6-amino-2-[[(2R)-2-[[(2S)-1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoylamino]hexanoyl]amino]hexanoate					
labdanolic acid methyl ester		labdanolic acid methyl ester					
labedipinedilol A		labedipinedilol A					
Labetalol	36894-69-6	Labetalol	36894-69-6	R5H8897N95	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	Labetalol injections are indicated to control blood pressure in severe hypertension. Labetalol tablets are indicated alone or in combination with antihypertensives like thiazides and loop diuretics to manage hypertension.
Labrasol		PEG-6 caprylic/capric glycerides					
lac dye	27597-77-9	Lac Dye	27597-77-9				
lacidipine		Lacidipine	103890-78-4	260080034N	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	Indicated for the treatment of hypertension either alone or in combination with other antihypertensive agents, including -adrenoceptor antagonists, diuretics, and ACE-inhibitors.
lactacystin	133343-34-7	Lactacystin	133343-34-7		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Lactates		Lactates					
Lactic Acid	50-21-5	Lactic Acid	50-21-5	3B8D35Y7S4			For use as an alkalinizing agent.
lactiflorin		(+)-Lactiflorin					
lactisole		Sodium 2-(4-methoxyphenoxy)propanoate	150436-68-3	ZU3D90W5GZ			
lactofen		Lactofen	77501-63-4	L44N8UV47O	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Lactones		Lactones					
Lactose		beta-Lactose	63-42-3	13Q3A43E0S	Sweetening Agents	Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)	
Lactosylceramides		beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-acylsphingosine					
Lactulose	4618-18-2	Lactulose	4618-18-2	9U7D5QH5AE	Gastrointestinal Agents	Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)	Lactulose is indicated for use as a laxative in the treatment of chronic constipation in adults and geriatric patients.  Additionally, lactulose is also employed as an adjunct to protein restriction and supportive therapy for the prevention and treatment of portal-systemic encephalopathy (PSE), including both the hepatic pre-coma and coma variations. In particular, lactulose solution has been effective at managing PSE resulting from surgical portacaval shunts or from chronic hepatic diseases like cirrhosis.  Moreover, there have also been studies demonstrating the capacity for lactulose to minimize the formation of gallstones and even some investigations regarding the experimental use of the agent in developing novel anticancer agents owing to its ability to bind galactin carbohydrates involved in various tumor progressions.
lafutidine	118288-08-7	Lafutidine	118288-08-7	49S4O7ADLC	Histamine H2 Antagonists	Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (See all compounds classified as Histamine H2 Antagonists.)	
lalistat 2		4-(Piperidin-1-yl)-1,2,5-thiadiazol-3-yl piperidine-1-carboxylate					
lamellarin D		Lamellarin D	97614-65-8	YEF6XD93VE			
lamellarin L		Lamellarin L					
lamellarin N		Lamellarin N	149379-26-0				
laminaran	9008-22-4	Laminaran	9008-22-4		Hypolipidemic Agents	Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)	
Lamivudine	134678-17-4	Lamivudine	134678-17-4	2T8Q726O95	Anti-HIV Agents	Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)	For the treatment of HIV infection and chronic hepatitis B (HBV).
Lamotrigine	84057-84-1	Lamotrigine	84057-84-1	U3H27498KS	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Lamotrigine is indicated as adjunctive therapy for the following seizure types in patients 2 years of age: partial seizures, primary generalized tonic-clonic seizures, and generalized seizures due to Lennox-Gastaut syndrome.  It is also indicated for the process of conversion to drug monotherapy for those at least 16 years of age or older with partial seizures and currently are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug (AED).  In addition to the above, lamotrigine is also indicated for the maintenance treatment of bipolar I disorder, delaying the time to mood episodes (which may include mania, hypomania, depression, mixed episodes) in adults at least 18 years or older, who have been treated for acute mood symptoms with standard therapy.  Limitations of use  It is important to note that lamotirigine should not be used in the treatment of acute mood episodes, as efficacy has not been established in this context.
lanatoside C	17575-22-3	lanatoside C	17575-22-3	5RR3JFZ771			
lancemaside A		lancemaside A					
lanifibranor		Lanifibranor	927961-18-0	28Q8AG0PYL			
lanosten-3-ol-32-al	59200-40-7	3beta-Hydroxylanost-8-en-32-al	59200-40-7				
lanostenol	79-62-9	24,25-Dihydrolanosterol	79-62-9	9H273A8B2X			
Lanosterol	79-63-0	Lanosterol	79-63-0	1J05Z83K3M			
lanreotide	118992-92-0	Lanreotide	108736-35-2	0G3DE8943Y	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Lanreotide is indicated for the long-term treatment of patients with acromegaly who have had an inadequate response to, or cannot be treated with, surgery and/or radiotherapy. It is also indicated in the treatment of adult patients with unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) to improve progression-free survival.  Lanreotide is additionally indicated for the treatment of adults with carcinoid syndrome - when used, it reduces the frequency of short-acting somatostatin analog rescue therapy.
Lansoprazole		Lansoprazole	103577-45-3	0K5C5T2QPG	Proton Pump Inhibitors	Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)	Lansoprazole is used to reduce gastric acid secretion and is approved for short term treatment of active gastric ulcers, active duodenal ulcers, erosive reflux oesophagitis, symptomatic gastroesophageal reflux disease, and non-steroidal anti-inflammatory drug (NSAID) induced gastric and duodenal ulcers.  It may be used in the maintenance and healing of several gastric conditions including duodenal ulcers, NSAID related gastric ulcers, and erosive esophagitis. Lansoprazole prevents recurrence of gastric ulcers in patients who have a documented history of gastric ulcers who also use NSAIDs chronically.  Predictably, it is also useful in the management of hypersecretory conditions including Zollinger-Ellison syndrome.  Lansoprazole is effective at eradicating H. pylori when used in conjunction with amoxicillin and clarithromycin (triple therapy) or with amoxicillin alone (dual therapy).
lanthanide nitrate	10099-59-9	Lanthanide nitrate	10099-59-9				
Lanthanoid Series Elements		Lanthanoid Series Elements					
Lanthanum	7439-91-0	Lanthanum	7439-91-0	6I3K30563S			
lanthanum chloride	10099-58-8	Lanthanum trichloride	10099-58-8				
lanthanum oxide	1312-81-8	Lanthanum(III) oxide	1312-81-8	4QI5EL790W			
lanthionine	3183-08-2	Lanthionine	922-55-4	9N5M8Q1P1C			
lapachol	84-79-7	Lapachol	84-79-7	B221938VB6	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	
Lapatinib		Lapatinib	231277-92-2	0VUA21238F	Tyrosine Kinase Inhibitors	Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES. (See all compounds classified as Tyrosine Kinase Inhibitors.)	Indicated in combination with capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress the human epidermal receptor type 2 (HER2) protein and who have received prior therapy including an anthracycline, a taxane, and trastuzumab.
lappaconitine	32854-75-4	(+)-Lappaconitine			Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
LAQ824		Dacinostat	404951-53-7	V10P524501			
laquinimod		Laquinimod	248281-84-7	908SY76S4G			Investigated for use/treatment in multiple sclerosis.
lard	61789-99-9	Lard (JP17)					
largazole		Largazole	1009815-87-5				
lariciresinol		Lariciresinol	27003-73-2	73XCE5OZB0			
laromustine		Laromustine	173424-77-6	14J2G0U3NQ			Investigated for use/treatment in brain cancer, cancer/tumors (unspecified), colorectal cancer, leukemia (lymphoid), leukemia (myeloid), lung cancer, myelodysplastic syndrome, pediatric indications, and solid tumors.
Lasalocid	25999-31-9	Lasalocid	25999-20-6	W7V2ZZ2FWB	Ionophores	Chemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channels across membranes. Many are antibiotics, and many act as uncoupling agents by short-circuiting the proton gradient across mitochondrial membranes. (See all compounds classified as Ionophores.)	
lasiocarpine	303-34-4	Lasiocarpine	303-34-4	S770100Q96			
Lasofoxifene		Lasofoxifene	180916-16-9	337G83N988			Investigated for use/treatment in postmenopausal osteoporosis to reduce the risk of both vertebral and novertebral fractures, as well as address other postmenopausal conditions, including reduction in risk of breast cancer and treatment of vulvar and vaginal atrophy (VVA)
Latanoprost	130209-82-4	Latanoprost	130209-82-4	6Z5B6HVF6O	Ophthalmic Solutions	Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. (See all compounds classified as Ophthalmic Solutions.)	Latanoprost is indicated for the reduction of elevated intraocular pressure in patients who have been diagnosed with open-angle glaucoma or ocular hypertension. It is available as monotherapy or in a combination product with [netarsudil] or [timolol].  In Canada, latanoprost is also indicated to treat elevated intraocular pressure due to angle-closure glaucoma that has been treated with peripheral iridotomy or laser iridoplasty.
Latex		(C8-H8)x-					
lathosterol	80-99-9	Lathosterol	80-99-9				
latoconazole	126509-69-1	Lanoconazole	101530-10-3	4E7858311F			
latrunculin A	76343-93-6	Latrunculin a	76343-93-6	SRQ9WWM084			
latrunculin B	76343-94-7	latrunculin B	76343-94-7	LW7U308U7U			
Laurates		Laurates					
lauric acid	143-07-7	Lauric Acid	143-07-7	1160N9NU9U			
lauric acid methyl ester	111-82-0	Methyl dodecanoate	111-82-0	8IPS6BI6KW			
laurolactam		Laurolactam	25038-74-8	UB8VFC953G			
lauroyl-coenzyme A	6244-92-4	Lauroyl-coa	6244-92-4				
lauryl gallate	1166-52-5	Dodecyl gallate	1166-52-5	45612DY463			
lavender oil	8000-28-0	8000-28-0					
lavendustin A		Lavendustin A	125697-92-9	3Y0G32G2RV	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
lawsone	83-72-7	2-Hydroxy-1,4-naphthoquinone	83-72-7	TLH4A6LV1W	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
laxogenin	1177-71-5	Laxogenin	1177-71-5	HT7W184YG4			
lazabemide	103878-84-8	Lazabemide	103878-84-8	420HD787N9	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	
LBQ657		Sacubitrilat	149709-44-4	SPI5PBF81S			
LBT 613		LBT 613					
LCL161		(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide	1005342-46-0	6TNS415Y3P			
LCS101		LCS101					
LCS1269		LCS1269					
LDN 193189		4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline	1062368-24-4	W69H5YQU9O			
LDN 57444		[(E)-[5-chloro-1-[(2,5-dichlorophenyl)methyl]-2-oxoindol-3-ylidene]amino] acetate	668467-91-2				
LE 135		4-(5,7,7,10,10-Pentamethyl-8,9-dihydronaphtho[2,3-b][1,4]benzodiazepin-13-yl)benzoic acid	155877-83-1				
LE 540		LE 540					
LE-Cl2MDP		LE-Cl2MDP					
Lead	7439-92-1	Lead	7439-92-1	7Y62STE4M2			
lead acetate	301-04-2	lead acetate anhydrous	301-04-2	KL498O6790			
lead chloride	7758-95-4	Lead chloride	7758-95-4	4IL61GN3YI			
lead chromate	11119-70-3	Lead chromate	7758-97-6	AA3229AOUS	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
lead nitrate	18256-98-9	Dinitrooxylead			Hazardous Substances	Elements, compounds, mixtures, or solutions that are considered severely harmful to human health and the environment. They include substances that are toxic, corrosive, flammable, or explosive. (See all compounds classified as Hazardous Substances.)	
lead oxide	1317-36-8	Lead monoxide	1317-36-8				
lead tetraacetate	546-67-8	Lead tetraacetate	546-67-8				
lead titanate zirconate	12626-81-2	Lead titanium zirconium oxide	12626-81-2				
Lecithins		Lecithins					
ledipasvir		Ledipasvir	1256388-51-8	013TE6E4WV	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	When used in combination with the antiviral medication [sofosbuvir], ledipasvir is indicated for the treatment of treatment of chronic hepatitis C virus (HCV) in adults and pediatric patients 3 years of age and older with the following conditions:   - Genotype 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis. - Genotype 1 infection with decompensated cirrhosis, in combination with [ribavirin]. - Genotype 1 or 4 infection who are liver transplant recipients without cirrhosis or with compensated cirrhosis, in combination with [ribavirin].  Its use has also proven successful in the treatment of HCV in patients co-infected with HIV.
Leflunomide	75706-12-6	Leflunomide	75706-12-6	G162GK9U4W	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	For the management of the signs and symptoms of active rheumatoid arthritis (RA) to improve physical function and to slow the progression of structural damage associated with the disease. Has also been used for the prevention of acute and chronic rejection in recipients of solid organ trasnplants and is designated by the FDA as an orphan drug for this use.
lei gong teng		lei gong teng					
LEI121		LEI121					
leiurotoxin I	116235-63-3	Leiurotoxin I	142948-19-4				
LEK 8829	145204-78-0	CID 44212056					
lemon oil		Cedro oil					
lemongrass oil	8007-02-1	CID 6850743	8007-02-1				
lenabasum		Ajulemic acid	137945-48-3	OGN7X90BT8	Cannabinoid Receptor Agonists	Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)	
Lenalidomide	191732-72-6	Lenalidomide	191732-72-6	F0P408N6V4	Immunologic Factors	Biologically active substances whose activities affect or play a role in the functioning of the immune system. (See all compounds classified as Immunologic Factors.)	Lenalidomide is indicated for the treatment of adult patients with multiple myeloma (MM) in combination with dexamethasone. It is also indicated as maintenance therapy in multiple myeloma following autologous hematopoietic stem cell transplantation (auto-HSCT).  It is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.  Lenalidomide is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.  In combination with a rituximab product, lenalidomide is indicated for the treatment of adult patients with previously treated follicular lymphoma (FL) or previously treated marginal zone lymphoma (MZL).
lenperone		Lenperone	24678-13-5	13P4GX22ES			
Lentinan	37339-90-5	Glc(b1-3)[Glc(b1-6)]Glc(b1-3)Glc(b1-3)Glc(b1-3)[Glc(b1-6)]b-Glc			Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
lenvatinib		Lenvatinib	417716-92-8	EE083865G2	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Lenvatinib is indicated for the treatment of the following cancerous conditions:  **Differentiated Thyroid Cancer (DTC)**  - Treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer  **Renal Cell Carcinoma (RCC)**  - First-line treatment, in combination with [pembrolizumab], in adult patients with advanced renal cell carcinoma (RCC)  - Treatment of advanced renal cell carcinoma, in combination with [everolimus], in adult patients who have previously tried 1 anti-angiogenic therapy  **Hepatocellular Carcinoma (HCC)**  - First-line treatment of patients with unresectable hepatocellular carcinoma  **Endometrial Carcinoma**  - Treatment of advanced endometrial carcinoma that is not microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR), in combination with [pembrolizumab], in patients who have experienced disease progression following prior systemic therapy and are not candidates for curative surgery or radiation
leonurine	24697-74-3	Leonurine	24697-74-3	09Q5W34QDA			
lephetamine	7262-75-1	Lefetamine	7262-75-1	4J9726V5Y9			
lepirudin		Lepirudin	138068-37-8		Antithrombins	Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. (See all compounds classified as Antithrombins.)	Lepirudin is indicated for anticoagulation in adult patients with acute coronary syndromes (ACS) such as unstable angina and acute myocardial infarction without ST elevation. In patients with ACS, lepirudin is intended for use with [aspirin]. Lepirudin is also indicated for anticoagulation in patients with heparin-induced thrombocytopenia (HIT) and associated thromboembolic disease in order to prevent further thromboembolic complications.
leptin (116-130)		leptin (116-130)					
leptocarpin	73522-63-1	CID 6438714	73522-63-1				
leptomycin B	87081-35-4	Leptomycin B	87081-35-4	Y031I2N1EO	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	
Leptophos	21609-90-5	Leptophos	21609-90-5	C45E8FUG3Z	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
leptophos oxon	25006-32-0	Leptophos oxon	25006-32-0	83S10ESQ22			
lercanidipine	100427-26-7	Lercanidipine	100427-26-7	V7XTJ4R0BH	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the treatment of Hypertension, management of angina pectoris and Raynaud's syndrome
Letrozole	112809-51-5	Letrozole	112809-51-5	7LKK855W8I	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Letrozole is indicated to treat postmenopausal women with hormone receptor (HR) positive early breast cancer, postmenopausal women with early breast cancer who have periviously been treated with tamoxifen, and postmenopausal women with HR+ or unknown advanced breast cancer. Letrozole, given with ribociclib, is indicated to treat pre, peri, and postmenopausal women with HR+ and human epidermal growth factor 2 (HER2) negative advanced or metastatic breast cancer.
Leu-Ser-Lys-Leu peptide		LSKL, Inhibitor of Thrombospondin (TSP-1)	283609-79-0				
Leucine	61-90-5	Leucine	61-90-5	GMW67QNF9C			Indicated to assist in the prevention of the breakdown of muscle proteins that sometimes occur after trauma or severe stress.
leucine methyl ester	2666-93-5	Methyl L-leucinate	2666-93-5	G3M3TO108Y			
leucine sarcolysine	3577-89-7	Leucine sarcolysine	3577-89-7				
leucinostatin A	76600-38-9	Leucinostatin A	76600-38-9				
leucisterol		Leucisterol					
leucomalachite green	129-73-7	Leucomalachite green	129-73-7	8U61G37Z20			
leucoselect phytosome		leucoselect phytosome					
Leucovorin	58-05-9	Leucovorin	1492-18-8	Q573I9DVLP	Antidotes	Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)	For the treatment of osteosarcoma (after high dose methotrexate therapy). Used to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosages of folic acid antagonists, and to treat megaloblastic anemias due to folic acid deficiency. Also used in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer.
leucyl-leucine-methyl ester	13022-42-9	Leucylleucine methyl ester	13022-42-9	74SY3EEM9R	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	
leukadherin-1		Leukadherin-1	2055362-72-4	HF23I3UYO2			
leukotriene A methyl ester	75879-18-4	Leukotriene A methyl ester	75879-18-4				
Leukotriene A4		Leukotriene A4	72059-45-1	7Y7MPZ6563			
Leukotriene B4	71160-24-2	Leukotriene B4	71160-24-2	1HGW4DR56D			
leukotriene B5	80445-66-5	leukotriene B5	80445-66-5				
Leukotriene C4	72025-60-6	leukotriene C4	72025-60-6	2CU6TT9V48			
Leukotriene D4	73836-78-9	leukotriene D4	73836-78-9	5FNY4416UE			
Leukotriene E4	75715-89-8	leukotriene E4	75715-89-8	8EYT8ATL7G			
Leukotrienes		Leukotrienes					
leupeptin	24365-47-7	L-Leucinamide, N-acetyl-L-leucyl-N-[4-[(aminoiminomethyl)amino]-1-formylbutyl]-	24365-47-7		Cysteine Proteinase Inhibitors	Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. (See all compounds classified as Cysteine Proteinase Inhibitors.)	
Leuprolide	53714-56-0	Leuprolide	53714-56-0	EFY6W0M8TG	Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	Leuprolide is indicated for the treatment of advanced prostate cancer and as palliative treatment of advanced prostate cancer.   It is also used for the treatment of pediatric patients with central precocious puberty (CPP).   In combination with oral [norethisterone] (also known as norethindrone), leuprolide is also indicated for the initial treatment of the symptoms of endometriosis. Finally, in combination with iron supplementation, leuprolide is indicated for the preoperative hematological improvement of anemic patients with uterine leiomyomata (uterine fibroids).
Levallorphan	152-02-3	Levallorphan	152-02-3	353613BU4U	Narcotic Antagonists	Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)	For the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids.
Levamisole	14769-73-4	Levamisole	14769-73-4	2880D3468G	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	For adjuvant treatment in combination with fluorouracil after surgical resection in patients with Dukes' stage C colon cancer. Also used to treat malignant melanoma and head/neck cancer.
Levetiracetam		Levetiracetam	102767-28-2	44YRR34555	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	Levetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.  Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.
levistolide A		Levistolide A	88182-33-6	29MRT0H4CE			
Levobunolol	47141-42-4	Levobunolol	47141-42-4	G6317AOI7K	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	For lowering intraocular pressure (IOP) and may be used in patients with chronic open-angle glaucoma or ocular hypertension.
Levobupivacaine		Levobupivacaine	27262-47-1	A5H73K9U3W	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	For the production of local or regional anesthesia for surgery and obstetrics, and for post-operative pain management
levocabastine	79516-68-0	Levocabastine	79449-98-2	COU3RRH769	Histamine H1 Antagonists, Non-Sedating	A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. (See all compounds classified as Histamine H1 Antagonists, Non-Sedating.)	As an ophthalmic for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis. Also used as a nasal spray for allergic rhinitis.
Levodopa		Levodopa	59-92-7	46627O600J	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	Levodopa on its own is formulated as an oral inhalation powder indicated for intermittent treatment of off episodes in Parkinson's patients who are already being treated with carbidopa and levodopa. Levodopa is most commonly formulated as an oral tablet with a peripheral dopa decarboxylase inhibitor indicated for treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism following carbon monoxide intoxication or manganese intoxication.
levodopa methyl ester	7101-51-1	Melevodopa	7101-51-1	M30686U4X4	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	
Levofloxacin	100986-85-4	Levofloxacin	100986-85-4	6GNT3Y5LMF	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	In oral and intravenous formulations, levofloxacin is indicated in adults for the treatment of various infections caused by susceptible bacteria, including infections of the upper respiratory tract, lower respiratory tract, skin, skin structures, urinary tract, and prostate. The oral formulation is also indicated in both adults and children 6 months of age and older for the post-exposure management of inhalational anthrax caused by _Bacillus anthracis_ and for the treatment and/or prophylaxis of plague caused by _Yersinia pestis_.  In its ophthalmic formulation, levofloxacin is indicated for the treatment of bacterial conjunctivitis caused by susceptible organisms. An inhalational solution available in Canada is indicated for the management of cystic fibrosis patients aged 18 years or older with chronic pulmonary _Pseudomonas aeruginosa_ infections.
levomepromazine maleate	7104-38-3	Levomepromazine maleate	7104-38-3	5KN5Y9V01K			
Levonorgestrel	797-63-7	Norgestrel	797-63-7	3J8Q1747Z2	Contraceptive Agents, Female	Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. (See all compounds classified as Contraceptive Agents, Female.)	Norgestrel in combination with ethinyl estradiol is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.
levormeloxifene	78994-23-7	Levormeloxifene	78994-23-7	44AXY5VE90			
Levorphanol	77-07-6	Levorphanol	297-90-5	27618J1N2X	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	For the management of moderate to severe pain or as a preoperative medication where an opioid analgesic is appropriate.
lewisite	541-25-3	Lewisite	541-25-3	1HMJ948W6A	Chemical Warfare Agents	Chemicals that are used to cause the disturbance, disease, or death of humans during WARFARE. (See all compounds classified as Chemical Warfare Agents.)	
LF 16-0687		Anatibant	209733-45-9	CLO4JRD21F	Bradykinin Receptor Antagonists	Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ RECEPTORS. (See all compounds classified as Bradykinin Receptor Antagonists.)	Investigated for use/treatment in traumatic brain injuries.
LF 16.0335		LF 16.0335					
LFM A13		2-Butenamide, 2-cyano-N-(2,5-dibromophenyl)-3-hydroxy-	62004-35-7				
LG 100268		6-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)nicotinic acid	153559-76-3	UVU4X1103P			
LG 100754		(2e,4e,6z)-3-Methyl-7-(5,5,8,8-Tetramethyl-3-Propoxy-5,6,7,8-Tetrahydronaphthalen-2-Yl)octa-2,4,6-Trienoic Acid	180713-37-5				
LG 100815		LG 100815					
LG 268		6-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)nicotinic acid	153559-76-3	UVU4X1103P			
LGK974		2-(2',3-Dimethyl-[2,4'-bipyridin]-5-yl)-N-(5-(pyrazin-2-yl)pyridin-2-yl)acetamide	1243244-14-5	U27F40013Q	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
LGM2605		CID 134694972					
LHRH, acetyl-2-(2-naphthyl)-Ala(1)-4-F-Phe(2)-Trp(3)-Arg(6)-	86855-16-5	LHRH, acetyl-2-(2-naphthyl)-ala(1)-4-F-phe(2)-trp(3)-arg(6)-	86855-16-5				
LHRH, Ala(6)-Gly(10)-ethylamide-	79561-22-1	Alarelin acetate	79561-22-1	288L2XKV2J			
LHRH, Leu(6)-des-Et-GlyNH2(10)-		LHRH, Leu(6)-des-Et-GlyNH2(10)-					
LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-	83539-08-6	Aptaa-lhrh	83539-08-6	D0NOF0ET2C	Hormone Antagonists	Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)	
liarozole	115575-11-6	Liarozole	115575-11-6	17NYD2210B	Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	
licarin A		Licarin A					
licochalcone A		Licochalcone a	58749-22-7	JTV5467968			
licochalcone B		Licochalcone B	58749-23-8	G7383L14F6			
licochalcone E		Licochalcone E					
licocoumarone		Licocoumarone	118524-14-4	EFB3Z7MN3P			
licofelone		Licofelone	156897-06-2	P5T6BYS22Y	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	For the management of osteoarthritis.
licoisoflavone B		Licoisoflavone B	66056-30-2	LR156FQ2XS			
licopyranocoumarin	117038-80-9	Licopyranocoumarin	117038-80-9	4X8VZO798F			
licoricidin		Licoricidin	30508-27-1	929XTD20VK			
Lidocaine	137-58-6	Lidocaine	137-58-6	98PI200987	Voltage-Gated Sodium Channel Blockers	A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)	Lidocaine is an anesthetic of the amide group indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.
Lidoflazine	3416-26-0	Lidoflazine	1338-51-8	J4ZHN3HBTE	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
liensinine	2586-96-1	Liensinine	2586-96-1				
lifibrate	22204-91-7	Lifibrate	22204-91-7	Y4X961F8Z1			
Lignans		Lignans					
Lignin	9005-53-2	Lignin	9005-53-2				
lignoceric acid	557-59-5	Tetracosanoic acid	557-59-5	RK3VCW5Y1L			
ligustilide	4431-01-0	Ligustilide	4431-01-0	10HE68JD06			
lilial	80-54-6	Lilial	80-54-6	T7540GJV69			
lime-piper betel quid		lime-piper betel quid					
Limonene		Limonene, (+/-)-	8016-20-4	9MC3I34447			
limonin	1180-71-8	Limonin	1180-71-8	L0F260866S			
Linagliptin		Linagliptin	668270-12-0	3X29ZEJ4R2	Dipeptidyl-Peptidase IV Inhibitors	Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release. (See all compounds classified as Dipeptidyl-Peptidase IV Inhibitors.)	Linagliptin is indicated for the treatment of type II diabetes in addition to diet and exercise. It should not be used to treat type I diabetes or in diabetic ketoacidosis. An extended-release combination product containing empagliflozin, linagliptin, and metformin was approved by the FDA in January 2020 for the improvement of glycemic control in adults with type 2 diabetes mellitus when used adjunctively with diet and exercise.
linalool	78-70-6	Linalool, (+/-)-	78-70-6	D81QY6I88E	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
linalyl acetate	115-95-7	Linalyl acetate	115-95-7	5K47SSQ51G			
linarin	480-36-4	Linarin	480-36-4	HBH2I685IU			
Lincomycin	154-21-2	Lincomycin	154-21-2	BOD072YW0F	Protein Synthesis Inhibitors	Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)	Lincomycin is indicated for the treatment of serious bacterial infections by susceptible strains of streptococci, pneumococci, and staphylococci in patients who are allergic to penicillins or for situations in which a penicillin is deemed inappropriate. As with all antibacterial agents, lincomycin should only be used to treat infections proven or strongly suspected to be caused by susceptible bacteria.
Linezolid		Linezolid	165800-03-3	ISQ9I6J12J	Protein Synthesis Inhibitors	Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)	Linezolid is indicated in adults and children for the treatment of infections caused by susceptible Gram-positive bacteria, including nosocomial pneumonia, community-acquired pneumonia, skin and skin structure infections, and vancomycin-resistant _Enterococcus faecium_ infections. Examples of susceptible bacteria include _Staphylococcus aureus_, _Streptococcus pneumoniae_, _Streptococcus pyogenes_, and _Streptococcus agalactiae_.  Linezolid is not indicated for the treatment of Gram-negative infections, nor has it been evaluated for use longer than 28 days.
linoleamide	3999-01-7	Linoleamide	3999-01-7	5340S2UXSP			
Linoleic Acid	2197-37-7	9,12-Octadecadienoic acid	8016-21-5				
linoleic acid hydroperoxide	25657-09-4	Peroxylinoleic acid	7722-17-0	W11BR4K13S			
Linoleic Acids, Conjugated		Linoleic Acids, Conjugated					
Linolenic Acids		Linolenic Acids					
linoleoyl-coenzyme A	40757-80-0	Linoleoyl-coenzyme A	40780-14-1				
linoleylanilide	19878-10-5	Linoleylanilide	19878-10-5				
linopirdine		Linopirdine	105431-72-9	I5TB3NZ94T	Potassium Channel Blockers	A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS. (See all compounds classified as Potassium Channel Blockers.)	
Linseed Oil	8001-26-1	8001-26-1					
linsidomine		Linsidomine	33876-97-0	5O5U71P6VQ	Nitric Oxide Donors	A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)	
Linuron	330-55-2	Linuron	330-55-2	01XP1SU59O	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Lipid A		lipid A					
lipid A precursors, bacterial		CID10329124					
lipid mobilizing substance		lipid mobilizing substance					
Lipid Peroxides		Lipid Peroxides					
lipid-linked oligosaccharides		lipid-linked oligosaccharides					
Lipids		Lipids					
lipoamide	940-69-2	Lipoamide	940-69-2	Q1GT04827L			
lipoarabinomannan		lipoarabinomannan					
Lipofundin	11096-66-5	Lipofundin					
Lipofuscin		Lipofuscin					
lipopeptidophosphoglycan		lipopeptidophosphoglycan					
lipophosphonoglycan		C05677					
lipopolysaccharide A		lipopolysaccharide A					
lipopolysaccharide, E coli O55-B5		lipopolysaccharide, E coli O55-B5					
lipopolysaccharide, E. coli O26-B6		lipopolysaccharide, E. coli O26-B6					
lipopolysaccharide, Escherichia coli O111 B4		lipopolysaccharide, Escherichia coli O111 B4					
lipopolysaccharide, Helicobacter pylori		lipopolysaccharide, Helicobacter pylori					
Lipopolysaccharides		Lipopolysaccharides					
liposomal amphotericin B		Amphotericin B	1397-89-3	7XU7A7DROE	Antiprotozoal Agents	Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)	Used to treat potentially life threatening fungal infections.
liposomal doxorubicin		liposomal doxorubicin					
lipostabil	11096-62-1	lipostabil					
lipoteichoic acid	56411-57-5	Lipoteichoic acid	56411-57-5				
lipoxin A4		lipoxin A4	89663-86-5	F7C6J3D79J	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
lipoxin A4 methyl ester		Lipoxin A4 methyl ester					
liproxstatin-1		Liproxstatin-1					
lipstatin	96829-59-3	Lipstatin	96829-59-3	UBD38W8LEW			
liquiritigenin		Liquiritigenin	578-86-9	T194LKP9W6			Investigated for use/treatment in hormone replacement therapy: menopause and menopause.
liquiritin		Liquiritin	551-15-5	T0O79T74CD			
liquorice decocta		liquorice decocta					
Liraglutide		Liraglutide	204656-20-2		Glucagon-Like Peptide-1 Receptor Agonists	Compounds that stimulate the activity of GLUCAGON-LIKE PEPTIDE-1 RECEPTOR. Glucagon-like peptide-1 receptor agonists are used to treat TYPE 2 DIABETES and OBESITY. (See all compounds classified as Glucagon-Like Peptide-1 Receptor Agonists.)	Saxenda, a formulation of liraglutide intended for weight loss, is indicated as an adjunct to diet and exercise for chronic weight management in adult patients who are obese (BMI30 kg/m2), or who are overweight (BMI27 kg/m2) and have at least one weight-related comorbidity. It is also indicated for chronic weight management in pediatric patients 12 years old who weigh 60 kg and have an initial BMI corresponding to obesity based on international cut-offs.  Victoza, a formulation of liraglutide used in diabetes, is indicated as an adjunct to diet and exercise to improve glycemic control in patients 10 years old with type 2 diabetes mellitus. It is also indicated to reduce the risk of major adverse cardiovascular events in adult patients with type 2 diabetes and established cardiovascular disease.  Liraglutide is also available in combination with [insulin degludec] as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus.
liranaftate	88678-31-3	Liranaftate	88678-31-3	5253IGO5X3			
Lisdexamfetamine Dimesylate		Lisdexamfetamine Dimesylate	608137-33-3	SJT761GEGS	Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	Treatment of Attention Deficit Hyperactivity Disorder (ADHD)
Lisinopril	83915-83-7	Lisinopril dihydrate	83915-83-7		Angiotensin-Converting Enzyme Inhibitors	A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)	
Lisuride	18016-80-3	Lisuride	18016-80-3	E0QN3D755O	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	For the management of Parkinson's Disease
Lithium	7439-93-2	Lithium	7439-93-2	9FN79X2M3F			
Lithium Carbonate	554-13-2	Lithium Carbonate	554-13-2	2BMD2GNA4V	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	Lithium carbonate is indicated as a monotherapy for the treatment of acute manic and mixed episodes associated with bipolar 1 disorder in patients 7 years of age. It is also indicated as a maintenance treatment for bipolar 1 disorder in patients 7 years of age.
Lithium Chloride	7447-41-8	Lithium Chloride	7447-41-8	G4962QA067	Antimanic Agents	Agents that are used to treat bipolar disorders or mania associated with other affective disorders. (See all compounds classified as Antimanic Agents.)	
lithium sulfate	10377-48-7	Lithium sulfate	10377-48-7	919XA137JK			
Lithocholic Acid	434-13-9	Lithocholic acid	434-13-9	5QU0I8393U	Detergents	Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)	
lithocholic acid acetate		(3beta,5beta,9beta)-3-(Acetyloxy)cholan-24-Oic Acid					
lithol rubine BCA		D&C Red No. 6	5858-81-1	481744AI4O			
lithospermate B	122021-74-3	Lithospermate B			Free Radical Scavengers	Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. (See all compounds classified as Free Radical Scavengers.)	
lithospermic acid	28831-65-4	Lithospermic acid	28831-65-4	100IP83JAC			
Liuwei Dihuang Decoction		Liuwei Dihuang Decoction					
Liver Glycogen		Liver Glycogen					
lixisenatide		Lixisenatide	320367-13-3	74O62BB01U			Lixisenatide is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type II diabetes mellitus. It is also available in combination with [insulin glargine] for the same indication.
LL Z1640-2		(5Z)-7-Oxozeaenol	253863-19-3				
LL202 flavonoid		LL202 flavonoid					
LLL12 compound		LLL12 compound					
lly-283		(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-[(R)-hydroxy(phenyl)methyl]oxolane-3,4-diol					
LLY-507		5-Cyano-2'-{4-[2-(3-Methyl-1h-Indol-1-Yl)ethyl]piperazin-1-Yl}-N-[3-(Pyrrolidin-1-Yl)propyl]biphenyl-3-Carboxamide					
LM-1685		COX-2 Inhibitor I	416901-58-1				
LM11 compound		LM11 compound					
LM11A-31		(2S,3S)-2-Amino-3-methyl-N-(2-morpholinoethyl)pentanamide	1243259-19-9	Y9GUF3B7Q7			
LMK-235		N-((6-(hydroxyamino)-6-oxohexyl)oxy)-3,5-dimethylbenzamide	1418033-25-6		Histone Deacetylase Inhibitors	Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)	
LMT-28		(4S)-3-[(2S,3S)-3-Hydroxy-2-methyl-4-methylene-1-oxononyl]-4-(1-methylethyl)-2-oxazolidinone					
LMWH-DOCA conjugate		LMWH-DOCA conjugate					
Lobeline	90-69-7	Lobeline	90-69-7	D0P25S3P81	Ganglionic Stimulants	Agents that mimic neural transmission by stimulation of the nicotinic receptors on postganglionic autonomic neurons. Drugs that indirectly augment ganglionic transmission by increasing the release or slowing the breakdown of acetylcholine or by non-nicotinic effects on postganglionic neurons are not included here nor are the nonspecific cholinergic agonists. (See all compounds classified as Ganglionic Stimulants.)	Investigated for use/treatment in addictions.
locostatin		(S)-4-Benzyl-3-(but-2-enoyl)oxazolidin-2-one	90719-30-5				
Lofepramine	23047-25-8	Lofepramine	23047-25-8	OCA4JT7PAW	Antidepressive Agents, Tricyclic	Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. (See all compounds classified as Antidepressive Agents, Tricyclic.)	
loganin		Loganin	18524-94-2	H7WJ16Q93C			
loliolide	5989-02-6	Loliolide	5989-02-6	U3BB4IM281			
lomatin		Lomatin	1147-25-7				
lomefloxacin	98079-51-7	Lomefloxacin	98079-51-7	L6BR2WJD8V	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of bacterial infections of the respiratory tract (chronic bronchitis) and urinary tract, and as a pre-operative prophylactic to prevent urinary tract infection caused by: S.pneumoniae, H.influenzae, S.aureus, P.aeruginosa, E. cloacae, P. mirabilis, C. civersus, S. asprphyticus, E.coli, and K.pneumoniae.
lomeguatrib	192441-08-0	Lomeguatrib	192441-08-0	S79265T71M			
lomerizine		Lomerizine	101477-55-8	DEE37CY4VO	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
lometrexol	95693-76-8	5,10-Dideazatetrahydrofolic acid	95693-76-8		Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	
Lomustine	13010-47-4	Lomustine	13010-47-4	7BRF0Z81KG	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	For the treatment of primary and metastatic brain tumors as a component of combination chemotherapy in addition to appropriate surgical and/or radiotherapeutic procedures. Also used in combination with other agents as secondary therapy for the treatment of refractory or relapsed Hodgkin's disease.
lonafarnib		Lonafarnib	193275-84-2	IOW153004F	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Lonafarnib is a farnesyltransferase inhibitor indicated in patients aged 12 months and older with a body surface area of at least 0.39 m2 to reduce the risk of mortality associated with Hutchinson-Gilford progeria syndrome (HGPS). It is also indicated in this same population for the treatment of processing-deficient progeroid laminopathies that either involve a heterozygous _LMNA_ mutation resulting in the accumulation of a progerin-like protein or homozygous/compound heterozygous mutations in _ZMPSTE24_.
lonchocarpine		Lonchocarpin	31501-55-0				
longikaurin A		Longikaurin A	75207-67-9				
lonidamine	50264-69-2	Lonidamine	50264-69-2	U78804BIDR	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Investigated for use/treatment in benign prostatic hyperplasia, prostate disorders, and cancer/tumors (unspecified).
Loperamide	53179-11-6	Loperamide	53179-11-6	6X9OC3H4II	Antidiarrheals	Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition. (See all compounds classified as Antidiarrheals.)	Loperamide is indicated for the relief of diarrhea, including Travelers Diarrhea. As an off-label use, it is often used to manage chemotherapy-related diarrhea.
lophirone B		lophirone B					
lophirone C		lophirone C					
Lopinavir		Lopinavir	192725-17-0	2494G1JF75	HIV Protease Inhibitors	Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. (See all compounds classified as HIV Protease Inhibitors.)	The combination product lopinavir/ritonavir, marketed under the brand name Kaletra, is indicated in combination with other antiretrovirals for the treatment of HIV-1 infection in adults and pediatric patients 14 days old.
lopinavir-ritonavir drug combination		lopinavir-ritonavir drug combination					
Loratadine	79794-75-5	Loratadine	79794-75-5	7AJO3BO7QN	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	Loratadine is a 2nd generation antihistamine and is used to manage symptoms of allergic rhinitis, wheal formation, urticaria, and other allergic dermatologic conditions.
Lorazepam	846-49-1	Lorazepam	846-49-1	O26FZP769L	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	Lorazepam is FDA-approved for the short-term relief of anxiety symptoms related to anxiety disorders and anxiety associated with depressive symptoms such as anxiety-associated insomnia. It is as well used as an anesthesia premedication in adults to relieve anxiety or to produce sedation/amnesia and for the treatment of status epilepticus.  Some off-label indications of lorazepam include rapid tranquilization of an agitated patient, alcohol withdrawal delirium, alcohol withdrawal syndrome, muscle spasms, insomnia, panic disorder, delirium, chemotherapy-associated anticipatory nausea and vomiting, and psychogenic catatonia.
lorcaserin		Lorcaserin	616202-92-7	637E494O0Z			For the treatment of obesity, as an adjunct to a reduced-calorie diet and increased physical activity.
loreclezole	117857-45-1	Loreclezole	117857-45-1	6DJ32STZ5W	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
lorlatinib		Lorlatinib	1454846-35-5	OSP71S83EU			Lorlatinib is indicated for the treatment of adult patients with ALK-positive metastatic non-small cell lung cancer (NSCLC). In the EU, it is indicated for the treatment of adult patients with ALK-positive advanced NSCLC not previously treated with an ALK inhibitor, or whose disease has progressed after using either [alectinib] or [ceritinib], or [crizotinib] and at least one other ALK inhibitor.
lornoxicam	70374-39-9	Lornoxicam	70374-39-9	ER09126G7A	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	For the treatment of acute mild to moderate pain, as well as pain and inflammation of the joints caused by certain types of rheumatic diseases.
Losartan	114798-26-4	Losartan	114798-26-4	JMS50MPO89	Angiotensin II Type 1 Receptor Blockers	Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)	Losartan is indicated to treat hypertension in patients older than 6 years, reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage), and to treat diabetic nephropathy with elevated serum creatinine and proteinuria in patients with type 2 diabetes and hypertension. Losartan with hydrochlorothiazide is indicated to treat hypertension and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage).
losartan carboxylic acid		Losartan carboxylic acid	124750-92-1	GD76OCH73X	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
losigame	112856-44-7	Losigamona	112856-44-7	84R8O3QM2G			
losoxantrone		Losoxantrone	88303-60-0	47KPH00809	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
Loteprednol Etabonate		Loteprednol Etabonate	82034-46-6	YEH1EZ96K6	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	A number of prescription loteprednol etabonate ophthalmic products are specifically indicated for the treatment of post-operative inflammation and pain following ocular surgery.
Lovastatin	75330-75-5	Lovastatin	75330-75-5	9LHU78OQFD	Anticholesteremic Agents	Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)	Lovastatin is indicated to reduce the risk of myocardial infarction, unstable angina, and the need for coronary revascularization procedures in individuals without symptomatic cardiovascular disease, average to moderately elevated total-C and LDL-C, and below average HDL-C. It is indicated as an intervention alternative in individuals presenting dyslipidemia at risk of developing atherosclerotic vascular disease. The administration of this agent should be accompanied by the implementation of a fat and cholesterol-restricted diet.  Therapy with lipid-altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Lovastatin is indicated as an adjunct to diet for the reduction of elevated total-C and LDL-C levels in patients with primary hypercholesterolemia (Types IIa and IIb2), when the response to diet restricted in saturated fat and cholesterol and to other nonpharmacological measures alone has been inadequate.  Lovastatin is also indicated to slow the progression of coronary atherosclerosis in patients with coronary heart disease as part of a treatment strategy to lower total-C and LDL-C to target levels.  Lovastatin is indicated as an adjunct to diet to reduce total-C, LDL-C and apolipoprotein B levels in adolescent boys and girls with Heterozygous Familial Hypercholesterolemia (HeFH) who are at least one year post-menarche, 10 to 17 years of age, with HeFH if after an adequate trial of diet therapy the following findings are present: LDL-C remains greater than 189 mg/dL or LDL-C remains greater than 160 mg/dL and there is a positive family history of premature cardiovascular disease or two or more other CVD risk factors are present in the adolescent patient.  Before administering lovastatin, it is important to rule out the presence of secondary causes of hypercholesterolemia and a lipid profile should be performed.  Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.
lovastatin-niacin combination		lovastatin-niacin combination					
Loxapine	1977-10-2	Loxapine	1977-10-2	LER583670J	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	For the management of the manifestations of psychotic disorders such as schizophrenia
loxoprofen	68767-14-6	Loxoprofen	68767-14-6	3583H0GZAP	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Loxoprofen is non-steroidal anti-inflammatory medication (NSAID) indicated for pain and inflammation related to musculoskeletal and joint disorders. In addition to its effects on pain, it is an antipyretic and anti-inflammatory medication.
loxoribine	121288-39-9	Loxoribine	121288-39-9	9CAS0V66OI			
loxtidine	76956-02-0	Lavoltidine	76956-02-0	X16K5179V5	Histamine H2 Antagonists	Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (See all compounds classified as Histamine H2 Antagonists.)	
LPM4870108		(7S)-10-fluorospiro[5,14-dioxa-2,12,17,21,22,25-hexazapentacyclo[17.5.2.02,7.08,13.022,26]hexacosa-1(25),8(13),9,11,19(26),20,23-heptaene-16,1'-cyclopropane]-18-one			Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
LQFM030		1-[4-[[1-(4-Chlorophenyl)pyrazol-4-yl]methyl]piperazin-1-yl]ethanone					
LQFM166		LQFM166					
LR-90		2,2'-(4,4'-(4,4'-methylenebis(2-chloro-4,1-phenylene))bis(azanediyl)bis(oxomethylene)bis(azanediyl)bis(4,1-phenylene))bis(oxy)bis(2-Methylpropanoic acid)	245075-84-7	PJ8V885848			
LRRK2-IN1		Lrrk2-IN-1	1234480-84-2				
LU 224332		Feloprentan	204267-33-4	6RW6H4951Z	Endothelin Receptor Antagonists	Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN RECECPTORS. (See all compounds classified as Endothelin Receptor Antagonists.)	
Lu 28-179		Siramesine Fumarate Salt					
lubazodone hydrochloride		Lubazodone hydrochloride	161178-10-5	2KT2C544LR			
lubeluzole	144665-07-6	Lubeluzole	144665-07-6	V2SIB71583	Neuroprotective Agents	Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)	
Lubiprostone		Lubiprostone	333963-40-9	7662KG2R6K	Chloride Channel Agonists	A class of drugs that stimulate chloride ion influx through cell membrane channels. (See all compounds classified as Chloride Channel Agonists.)	Lubiprostone is indicated for the treatment of adult patients with chronic idiopathic constipation, or opioid-induced constipation in patients with chronic non-cancer pain. It is also indicated for the treatment of irritable bowel syndrome with constipation (IBS-C) in female patients 18 years old.
Lucanthone	479-50-5	Lucanthone	479-50-5	FC6D57000M	Schistosomicides	Agents that act systemically to kill adult schistosomes. (See all compounds classified as Schistosomicides.)	Intended for use as a radiation sensitizer in the treatment of brain cancer.
lucidenic acid N		Lucidenic acid N	364622-33-3				
lucidenic acid P		Lucidenic acid P					
lucidenic acid Q		Methyl lucidenate Q					
lucidin 3-O-beta-primveroside	29706-59-0	Lucidin primeveroside	29706-59-0				
lucidone		Lucidone	19956-53-7				
lucifer yellow	77944-88-8	Lucifer yellow	77944-88-8	9654F8OVKE	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
Lugol's solution	12298-68-9	Potassium triiodide	12298-68-9	T66M6Y3KSA	Hemostatics	Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)	
luliconazole		Luliconazole	187164-19-8	RE91AN4S8G	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	Luliconazole is indicated for the treatment of interdigital tinea pedis, tinea cruris, or tinea corporis infections caused by Trichophyton rubrum and Epidermophyton floccosum.
lumacaftor		Lumacaftor	936727-05-8	EGP8L81APK			When used in combination with the drug [lumacaftor] as the product Orkambi, ivacaftor is indicated for the management of CF in patients aged one year and older who are homozygous for the _F508del_ mutation in the CFTR gene. If the patients genotype is unknown, an FDA-cleared CF mutation test should be used to detect the presence of the _F508del_ mutation on both alleles of the CFTR gene.
Lumefantrine	82186-77-4	Lumefantrine	82186-77-4	F38R0JR742	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	Lumefantrine and artemether combination therapy is indicated for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum, including malaria acquired in chloroquine-resistant areas. May also be used to treat uncomplicated malaria when the Plasmodium species has not been identified. Indicated for use in adults and children greater than 5 kg.
lumiflavin	1088-56-8	Lumiflavin	1088-56-8	4M2669414M			
lumiracoxib		Lumiracoxib	220991-20-8	V91T9204HU	Cyclooxygenase 2 Inhibitors	A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2. (See all compounds classified as Cyclooxygenase 2 Inhibitors.)	For the acute and chronic treatment of the signs and symptoms of osteoarthritis of the knee in adults.
lupalbigenin		Lupalbigenin	76754-24-0	0RZW2IS86C			
lupane	464-99-3	Lupane	464-99-3				
lupeol	545-47-1	Lupeol	545-47-1	O268W13H3O	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
lupeol linoleate		Lupeol linoleate					
lupiwighteone		Lupiwighteone	104691-86-3	S5W46B3BUM			
Lurasidone Hydrochloride		Lurasidone Hydrochloride	367514-88-3	O0P4I5851I	Adrenergic alpha-2 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Antagonists.)	Treatment of schizophrenia in adults aged 18 years and over.
Lutein	127-40-2	Lutein	127-40-2	X72A60C9MT			Xanthophylls are taken for nutritional supplementation, and also for treating dietary shortage or imbalance.
Luteolin	491-70-3	Luteolin	491-70-3	KUX1ZNC9J2			
luteolin 3'-glucuronide		Luteolin 3'-o-glucuronide	53527-42-7	1T6AU6J856			
luteolin 4'-O-glucoside		Luteolin-4'-o-glucoside	6920-38-3				
luteolin 5-O-glucopyranoside		luteolin 5-O-glucopyranoside					
luteolin-7-glucoside		Luteolin 7-O-glucoside	5373-11-5	98J6XDS46I			
luteolin-7-O-glucuronide		Luteolin-7-o-glucuronide					
luteolinidin		Luteolinidin	16975-93-2	935OS7WHP6			
luzindole	117946-91-5	Luzindole	117946-91-5	B31Y10A9UR			
LW 50020		LW 50020					
LY 117018	63676-25-5	Lilly 117018	63676-25-5	9FQT7VSR3V	Estrogen Antagonists	Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)	
LY 134046	71274-97-0	8,9-dichloro-2,3,4,5-tetrahydro-1H-2-benzazepine	71274-97-0	2K2UE2I8AY			
LY 171883	88107-10-2	Tomelukast	88107-10-2	59762X5CLS	Leukotriene Antagonists	A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level. (See all compounds classified as Leukotriene Antagonists.)	
LY 215840	137328-52-0	LY 215840	137328-52-0	D2G5U4P5B3			
LY 231617	93811-58-6	p-Cresol, 2,6-di-tert-butyl-alpha-(ethylamino)-	93811-58-6				
LY 255283		1-[5-Ethyl-2-hydroxy-4-[[6-methyl-6-(1H-tetrazol-5-YL)heptyl]oxy]phenyl]ethanone	117690-79-6	H037W1I5AL	Leukotriene Antagonists	A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level. (See all compounds classified as Leukotriene Antagonists.)	
LY 290042		LY 290042					
LY 293111		Etalocib	161172-51-6	THY6RIW44R			
LY 303511	154447-38-8	2-Piperazinyl-8-phenyl-4H-1-benzopyran-4-one	154447-38-8				
LY 306740		N-[(R)-1-{[Acetyl-(2-methoxy-benzyl)-amino]-methyl}-2-(1H-indol-3-yl)-ethyl]-2-(4-cyclohexyl-piperazin-1-yl)-acetamide	170567-08-5		Neurokinin-1 Receptor Antagonists	Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS. (See all compounds classified as Neurokinin-1 Receptor Antagonists.)	
LY 311727		(3-{[3-(2-Amino-2-Oxoethyl)-1-Benzyl-2-Ethyl-1h-Indol-5-Yl]oxy}propyl)phosphonic Acid	164083-84-5				
LY 320135		4-(6-Methoxy-2-(4-methoxyphenyl)benzofuran-3-carbonyl)benzonitrile	176977-56-3	CJY03984CT	Cannabinoid Receptor Antagonists	Compounds that inhibit or block the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Antagonists.)	
LY 341495		2-[(1s,2s)-2-Carboxycyclopropyl]-3-(9h-Xanthen-9-Yl)-D-Alanine	201943-63-7	AQ73SP6QSF	Excitatory Amino Acid Antagonists	Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)	
LY 344864		N-[(6R)-6-(dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide	186544-26-3	L4WN6HH63L			
LY 353381		Arzoxifene	182133-25-1	E569WG6E60			Investigated for use/treatment in breast cancer, osteoporosis, and endometrial cancer.
LY 367265		SS58Uxz8ZU	210751-39-6	SS58UXZ8ZU	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
LY 379268		(1R,4R,5S,6R)-4-Amino-2-oxabicyclo[3.1.0]hexane-4,6-dicarboxylic acid	191471-52-0	S96JF4J697			
LY 465608		2-Methyl-2-[4-[2-[5-methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]phenoxy]propanoic acid					
LY 518674		2-Methyl-2-[4-[3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl]phenoxy]propanoic acid	425671-29-0	U8I57RC739			
LY-2157299	700874-72-2	Galunisertib	700874-72-2	3OKH1W5LZE			
LY2066948		6-(4-(Methanesulfonyl)phenyl)-5-(4-(2-(piperidin-1-yl)ethoxy)phenoxy)naphthalen-2-ol	648904-56-7	BJK5U4XT4B			
LY2109761		4-(2-((4-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl)oxy)ethyl)morpholine	700874-71-1	DV3HD37UBK			
LY2112688		LY2112688					
LY2603618		Rabusertib	911222-45-2	3S9L1NU6U7			
LY2784544		Gandotinib	1229236-86-5	ANC71R916O			
LY382884		(3S,4aR,6S,8aR)-6-[(4-carboxyphenyl)methyl]-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid	211566-75-5				
LY686017		Tradipitant	622370-35-8	NY0COC51FI			
lycium barbarum polysaccharide		lycium barbarum polysaccharide					
Lycopene	502-65-8	Lycopene	502-65-8	SB0N2N0WV6	Radiation-Protective Agents	Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)	
lycorine	476-28-8	Lycorine	476-28-8	I9Q105R5BU			
Lynestrenol	52-76-6	Lynestrenol	52-76-6	N2Z8ALG4U5	Contraceptives, Oral, Hormonal	Oral contraceptives which owe their effectiveness to hormonal preparations. (See all compounds classified as Contraceptives, Oral, Hormonal.)	
LYR 71		LYR 71					
Lys01		N1-(7-Chloroquinolin-4-yl)-N2-(2-((7-chloroquinolin-4-yl)amino)ethyl)-N2-methylethane-1,2-diamine					
Lysergic Acid Diethylamide	50-37-3	Lysergide	50-37-3	8NA5SWF92O	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	
lysergol	602-85-7	Lysergol	602-85-7	NTR684Z1AZ	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
Lysine	56-87-1	Lysine	56-87-1	K3Z4F929H6			Supplemental lysine has putative anti-herpes simplex virus activity. There is preliminary research suggesting that it may have some anti-osteoporotic activity.
lysine tyrosylquinone		Lysine tyrosylquinone	178989-72-5	047HO35WM6			
lysionotin		Nevadensin	10176-66-6				
lysocellin	55898-33-4	Lysocellin	55898-33-4				
lysomustine	137573-87-6	lysomustine					
lysophosphatidic acid		Lysophosphatidic acid	22002-87-5	PG6M3969SG			
Lysophosphatidylcholines		Lysophosphatidylcholine	9008-30-4				
lysophosphatidylethanolamine		Lysophosphatidylethanolamine					
lysophosphatidylglycerol		Lysophosphatidylglycerol					
lysophosphatidylinositol		Lysophosphatidylinositol					
Lysophospholipids		Lysophospholipids					
M 50367		1H-Benzimidazole-4-propanoic acid, beta-hydroxy-2-(2-phenylethyl)-, ethyl ester	201411-46-3				
m-(N,N,N-trimethylammonio)trifluoroacetophenone		N,N,N-trimethyl-3-(2,2,2-trifluoroacetyl)benzenaminium	156781-80-5	Z3M6Q7J3MZ			
m-trifluoromethyl-diphenyl diselenide		m-Trifluoromethyl-diphenyl diselenide					
M-VAC protocol		M-VAC protocol					
M50354		1H-Benzimidazole-4-propanoic acid, beta-hydroxy-2-(2-phenylethyl)-	201411-47-4				
M8OI compound		M8OI compound					
MAB-CHMINACA		N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indole-3-carboxamide	1185887-13-1	SL4C60689M			
mabuterol	56341-08-3	Mabuterol	56341-08-3	R4K19W6S7Q	Adrenergic beta-Agonists	Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)	
macitentan		Macitentan	441798-33-0	Z9K9Y9WMVL	Endothelin A Receptor Antagonists	Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN A RECECPTORS. (See all compounds classified as Endothelin A Receptor Antagonists.)	Investigated for use/treatment in cardiovascular disorders, hypertension, and pulmonary hypertension.
macluraxanthone C		Macluraxanthone C					
Macrolides		Macrolides					
Macrophage Colony-Stimulating Factor	81627-83-0	81627-83-0					
macrophage stimulatory lipopeptide 2		macrophage stimulatory lipopeptide 2					
macrosphelide A		Macrosphelide A					
macrosphelide B		Macrosphelide B					
macrosphelide J		Macrosphelide J					
macrosporin	22225-67-8	Macrosporin	22225-67-8				
maculosin	4549-02-4	Maculosin	4549-02-4				
madecassoside		[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (1S,2R,4aS,6aR,6aR,6bR,8R,8aR,9R,10R,11R,12aR,14bS)-8,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylate	34540-22-2				
maduramicin		Maduramicin	61991-54-6		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
mafosfamide	88859-04-5	Mafosfamide	88859-04-5		Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
Magnesium	7439-95-4	Magnesium	7439-95-4	I38ZP9992A			Healthy levels of magnesium can be achieved through a well balanced diet, but if food sources are insufficient, magnesium supplements can be used to prevent and treat magnesium deficiencies.  In medicine, various magnesium salts may be used in laxative and antacid products. For example, [magnesium citrate] is available over-the-counter and may be used to manage occasional constipation. [Magnesium sulfate] may be used on its own or with total parenteral nutrition to treat hypomagnesemia. [Magnesium sulfate] is also indicated to prevent seizures in pregnant women with pre-eclampsia, and to manage seizures associated with eclampsia.
Magnesium Chloride	7786-30-3	Magnesium Chloride	7786-30-3	59XN63C8VM			Magnesium chloride  is used in several medical and topical (skin related) applications. Magnesium chloride usp, anhydrous uses as electrolyte replenisher, pharmaceutic necessity for hemodialysis and peritoneal dialysis fluids.
Magnesium Hydroxide	1309-42-8	Magnesium Hydroxide	1309-42-8	NBZ3QY004S	Antacids	Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT. (See all compounds classified as Antacids.)	Magnesium hydroxide can be used as an antacid or a laxative depending on the administered dose.  As an antacid, it is used for the temporary relief of heartburn, upset stomach, sour stomach or acid indigestion.  As a laxative, it is used for the relief of occasional constipation by promoting bowel movements for 30 minutes and up to 6 hours.
Magnesium Oxide	1309-48-4	Magnesium oxide (JP17/USP)					
Magnesium Sulfate	7487-88-9	Magnesium Sulfate	7487-88-9	ML30MJ2U7I	Anesthetics	Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)	Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant.
magnesium tanshinoate B		Magnesium lithospermate B	122021-74-3	8V4R1E4C5Y	Free Radical Scavengers	Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. (See all compounds classified as Free Radical Scavengers.)	
Magnetite Nanoparticles		Magnetite Nanoparticles					
magnoflorine	2141-09-5	Magnoflorine	2141-09-5	NI8K6962K4			
magnolialide		Magnolialide	72145-13-2				
magnolin	31008-18-1	Medioresinol dimethyl ether	31008-18-1	95DA2NWV8P			
magnolol	528-43-8	Magnolol	528-43-8	001E35HGVF	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
mahanine		Mahanine	28360-49-8	KBJ2W7E9BH			
Maharishi Amrit Kalash		Maharishi Amrit Kalash					
makatoxin I		makatoxin I					
malabaricone B	63335-24-0	Malabaricone B	63335-24-0				
malabaricone C	63335-25-1	Malabaricone C	63335-25-1	C9K53R3PRN			
malachite green	10309-95-2	Malachite green cation	10309-95-2	AWT9R95TV1	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
malaoxon		Malaoxon	1634-78-2	2439JYF84Q	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
malassezin		malassezin					
Malathion	121-75-5	Malathion	121-75-5	U5N7SU872W	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	For patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair.
malealdehyde	2363-83-9	Fumaraldehyde	2363-83-9				
Maleates		Maleates					
maleic acid	110-16-7	Maleic Acid	10237-70-4	91XW058U2C	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Maleic Anhydrides		Maleic Anhydride	108-31-6	V5877ZJZ25			
Maleic Hydrazide	123-33-1	Maleic hydrazide	123-33-1	TQ7L3FCV66	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
maleimide	541-59-3	Maleimide	541-59-3	2519R1UGP8			
Maleimides		Maleimides					
maleylacetone		Maleylacetone					
malic acid	6915-15-7	Malic Acid	6915-15-7	817L1N4CKP			
Malondialdehyde	542-78-9	Malonaldehyde	542-78-9	4Y8F71G49Q			
malondialdehyde-low density lipoprotein, human		malondialdehyde-low density lipoprotein, human					
malonic acid	141-82-2	Malonic acid	141-82-2	9KX7ZMG0MK			
malononitrilamide 279		malononitrilamide 279					
Malonyl Coenzyme A	524-14-1	malonyl-CoA	524-14-1	LNB9YCJ9F9			
maltodextrin	9050-36-6	maltodextrin					
maltol	118-71-8	Maltol	118-71-8	3A9RD92BS4			
maltolyl p-coumarate		maltolyl p-coumarate					
Maltose	69-79-4	Maltose	69-79-4	R4B6462NGR	Sweetening Agents	Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)	
maltotetraose	34612-38-9	alpha-Maltotetraose	34612-38-9		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
malvidin	10463-84-0	Malvidin	10463-84-0				
malvidin-3-glucoside	7228-78-6	Malvidin 3-Glucoside	7228-78-6	B34F52D7NB			
malvidin-3-O-glucoside-4 vinyl		malvidin-3-O-glucoside-4 vinyl					
malvin		3,5-Bis(beta-D-glucopyranosyloxy)-7-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-1-benzopyrylium chloride	16727-30-3				
mancozeb	8018-01-7	zinc;manganese(2+);N-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate	8018-01-7		Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
mandelic acid	90-64-2	Mandelic Acid	90-64-2	NH496X0UJX			
Maneb	12427-38-2	Maneb	8018-01-7	K221E12G7T	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Manganese	7439-96-5	Manganese	7439-96-5	42Z2K6ZL8P	Trace Elements	A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)	Indicated for use as a supplement to intravenous solutions given for Total Parenteral Nutrition (TPN). Administration helps to maintain plasma levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.
manganese (III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin		manganese (III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin					
manganese chloride	7773-01-5	Manganese Chloride	13446-34-9	6YB4901Y90			
Manganese Compounds		CCRIS 1579					
manganese dioxide	1313-13-9	Manganese dioxide	197667-28-0	TF219GU161			
manganese ferrite		manganese ferrite					
manganese phosphate		Manganese phosphate, dibasic					
manganese protoporphyrin	21393-64-6	Manganese protoporphyrin IX	21393-64-6				
manganese sulfate	7785-87-7	Manganese Sulfate	7785-87-7	W00LYS4T26			
manganese tetrakis-(N-ethyl-2 pyridyl) porphyrin		manganese tetrakis-(N-ethyl-2 pyridyl) porphyrin					
manganese tetrakis-(N-methyl-2 pyridyl) porphyrin		manganese tetrakis-(N-methyl-2 pyridyl) porphyrin					
manganese(III) acetate dihydrate		ONJSLAKTVIZUQS-UHFFFAOYSA-K					
manganese(III) tetrakis(5,10,15,20-benzoic acid)porphyrin		manganese(III) tetrakis(5,10,15,20-benzoic acid)porphyrin					
manganese(III)-tetrakis(4-benzoic acid)porphyrin		manganese(III)-tetrakis(4-benzoic acid)porphyrin					
Mangifera indica extract		Mangifera indica extract					
mangiferin	4773-96-0	Mangiferin	4773-96-0	1M84LD0UMD			
mangiferin heptasulfate		Mangiferin heptasulfate					
mangostin	6147-11-1	Mangostin	6147-11-1	U6RIV93RU1			
manidipine	89226-50-6	Manidipine	89226-50-6	6O4754US88	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the treatment of hypertension.
Mannans		Mannan	9036-88-8				
Mannitol	69-65-8	Mannitol	87-78-5	3OWL53L36A	Sweetening Agents	Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)	Used for the promotion of diuresis before irreversible renal failure becomes established, the reduction of intracranial pressure, the treatment of cerebral edema, and the promotion of urinary excretion of toxic substances.  Mannitol is also indicated as add-on maintenance therapy for improving pulmonary function in cystic fibrosis patients aged 18 and over who have passed the BRONCHITOL tolerance test (BTT). It is recommended that patients take an orally inhaled short-acting bronchodilator 5-15 minutes prior to every inhaled mannitol dose.
Mannoheptulose	654-29-5	D-manno-2-Heptulose	3615-44-9	W19YH62373			
mannosamine	2636-92-2	2-Amino-2-deoxymannose	14307-02-9				
Mannose	31103-86-3	(2S,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal	3458-28-4				
mannose-6-phosphate	3672-15-9	Mannose-6-phosphate					
mannuronic acid	6814-36-4	(2S,3S,4S,5S)-2,3,4,5-tetrahydroxy-6-oxohexanoic acid	1986-14-7	980IT47Y34			
manoalide	75088-80-1	Manoalide	75088-80-1	E1DK0157K9	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
mansonone G		1,2-Naphthalenedione, 6-hydroxy-3,8-dimethyl-5-(1-methylethyl)-					
manumycin	52665-74-4	Manumycin A	52665-74-4	OIQ298X4XD	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Manure		Manure					
manzamine A	104196-68-1	Manzamine A	104196-68-1				
mapenterol		1-[4-Amino-3-chloro-5-(trifluoromethyl)phenyl]-2-(2-methylbutan-2-ylamino)ethanol	95656-68-1				
maphosphamide		maphosphamide					
Maprotiline	10262-69-8	Maprotiline	10262-69-8	2U1W68TROF	Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	For treatment of depression, including the depressed phase of bipolar depression, psychotic depression, and involutional melancholia, and may also be helpful in treating certain patients suffering severe depressive neurosis.
Maraviroc		Maraviroc	2414315-81-2	A3C7SRV8DV	HIV Fusion Inhibitors	Inhibitors of the fusion of HIV to host cells, preventing viral entry. This includes compounds that block attachment of HIV ENVELOPE PROTEIN GP120 to CD4 RECEPTORS. (See all compounds classified as HIV Fusion Inhibitors.)	
marbofloxacin		Marbofloxacin	115550-35-1	8X09WU898T	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
marbostat-100		Marbostat-100			Histone Deacetylase Inhibitors	Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)	
margaric acid	506-12-7	Heptadecanoic acid	506-12-7	V987Y9OZ8L			
Margarine	8029-82-1	Margarine					
margatoxin		Margatoxin	145808-47-5		Potassium Channel Blockers	A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS. (See all compounds classified as Potassium Channel Blockers.)	
marimastat		Marimastat	154039-60-8	D5EQV23TDS	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	For the treatment of various cancers
marinobufagenin		Marinobufagenin	470-42-8	3KBT25GV2B	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
marinopyrrole A		Marinopyrrole A					
marliolide		Marliolide			Enzyme Activators	Compounds or factors that act on a specific enzyme to increase its activity. (See all compounds classified as Enzyme Activators.)	
maropitant		Maropitant	147116-67-4	4XE2T9H4DH	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	Dogs: For the treatment and prevention of nausea induced by chemotherapyFor the prevention of vomiting except that induced by motion sicknessFor the treatment of vomiting, in combination with other supportive measuresFor the prevention of perioperative nausea and vomiting and improvement in recovery from general anaesthesia after use of the -opiate receptor agonist morphineCats: For the prevention of vomiting and the reduction of nausea, except that induced by motion sicknessFor the treatment of vomiting, in combination with other supportive measures.
marrubiin	465-92-9	Marrubiin	465-92-9	AP086P88M4			
martentoxin, Buthus martensi		martentoxin, Buthus martensi					
masitinib		Masitinib	790299-79-5	M59NC4E26P			Treatment of amyotrophic lateral sclerosis.
maslinic acid		Maslinic Acid	4373-41-5	E233J88OHQ			
Masoprocol		Masoprocol	27686-84-6	7BO8G1BYQU	Cyclooxygenase Inhibitors	Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)	Used for the treatment of actinic keratoses (precancerous skin growths that can become malignant if left untreated).
Mastic Resin		Mastic Resin					
mastoparan	72093-21-1	Mastoparan	72093-21-1				
matairesinol	580-72-3	Matairesinol	580-72-3	XLW63P8WUA			
Matrines		Matrines					
Matrix Metalloproteinase Inhibitors		Matrix Metalloproteinase Inhibitors					
maxacalcitol	103909-75-7	Maxacalcitol	103909-75-7	N2UJM5NBF6	Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	
Maxepa		Promega	308064-99-5				
maytenonic acid	33600-93-0	Maytenonic acid	33600-93-0				
Mazindol	22232-71-9	Mazindol	22232-71-9	C56709M5NH	Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	Used in short-term (a few weeks) treatment of exogenous obesity in conjunction with a regimen of weight reduction based on caloric restriction, exercise, and behavior modification in patients with a body mass index of 30 kg of body weight per height in meters squared (kg/m2) or in patients with a body mass index of 27 kg/m2 in the presence of risk factors such as hypertension, diabetes, or hyperlipidemia.
MB327		1,1'-(Propane-1,3-diyl)bis(4-tert-butylpyridin-1-ium) diiodide	61368-98-7				
MC1568		MC 1568					
MCC-257		Coleneuramide	204200-47-5	G2D52T65LR			
MCI 154	98326-33-1	Senazodan hydrochloride	98326-33-1	8AQJ5MIM3P	Cardiotonic Agents	Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)	
MCI 826	140646-80-6	Butanoic acid, 2,2-diethyl-4-((3-(2-(4-(1-methylethyl)-2-thiazolyl)ethenyl)phenyl)amino)-4-oxo-, (E)-	140646-80-6				
MCS-18		MCS-18					
MDL 100,151		MDL 100,151					
MDL 201053		Z-FA-Fmk	96922-64-4		Cysteine Proteinase Inhibitors	Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. (See all compounds classified as Cysteine Proteinase Inhibitors.)	
MDL 75608A		MDL 75608A					
MDMB-4en-PINACA		Unii-K2dzn2tdd6	2504100-70-1	K2DZN2TDD6			
ME 3229		ME 3229					
ME 3277		Kxx3WL2K5P	165948-72-1	KXX3WL2K5P			
ME-143		3,4-bis(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-7-ol					
ME-344		2H-1-Benzopyran-7-ol, 3,4-dihydro-3,4-bis(4-hydroxyphenyl)-8-methyl-, (3R,4S)-	1374524-68-1	843G0TDV51			
mead acid	2751-14-6	5,8,11-Eicosatrienoic acid	2751-14-6				
Measles-Mumps-Rubella Vaccine		Measles-Mumps-Rubella Vaccine					
Mebendazole	31431-39-7	Mebendazole	31431-39-7	81G6I5V05I	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	For the treatment of Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American hookworm) in single or mixed infections.
mebeverine	3625-06-7	Mebeverine	3625-06-7	7F80CC3NNV	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
Mecamylamine	60-40-2	Mecamylamine	60-40-2	6EE945D3OK	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the treatment of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension
mecarbam	2595-54-2	Mecarbam	2595-54-2	U6N6869C7Z			
Mechlorethamine		Mechlorethamine	51-75-2	50D9XSG0VR	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	For the palliative treatment of Hodgkin's disease (Stages III and IV), lymphosarcoma, chronic myelocytic or chronic lymphocytic leukemia, polycythemia vera, mycosis fungoides, and bronchogenic carcinoma. Also for the palliative treatment of metastatic carcinoma resulting in effusion.
Meclizine	569-65-3	Meclizine	569-65-3	3L5TQ84570	Cholinergic Antagonists	Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists. (See all compounds classified as Cholinergic Antagonists.)	Indicated for the symptomatic treatment of nausea, vomiting, and dizziness associated with motion sickness, and management of vertigo due to various causes, including radiation sickness, Menieres syndrome, labyrinthitis and other vestibular disturbances.
meclocycline	2013-58-3	Meclocycline	2013-58-3	23Q8M2HE6S	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Currently under investigation for the topical treatment of ulcerative oral mucositis
Meclofenamic Acid	644-62-2	Meclofenamic Acid	644-62-2	48I5LU4ZWD	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	For the relief of mild to moderate pain, for the treatment of primary dysmenorrhea and for the treatment of idiopathic heavy menstrual blood loss. Also for relief of the signs and symptoms of acute and chronic rheumatoid arthritis and osteoarthritis.
Meclofenoxate	3685-84-5	Meclofenoxate hydrochloride	3685-84-5	5BK3070BDY	Nootropic Agents	Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)	
mecobalamin	13422-55-4	Methyl vitamin B12	13422-55-4				
mecoprop	93-65-2	Mecoprop	93-65-2	74N8TKR9P8	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Medazepam	2898-12-6	Medazepam	2898-12-6	P0J3387W3S	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
medermycin	60227-09-0	Medermycin	60227-09-0				
Medetomidine	86347-14-0	Medetomidine	86347-14-0	MR15E85MQM	Adrenergic alpha-2 Receptor Agonists	Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)	
Medroxyprogesterone	520-85-4	Medroxyprogesterone	520-85-4	HSU1C9YRES	Contraceptives, Oral, Synthetic	Oral contraceptives which owe their effectiveness to synthetic preparations. (See all compounds classified as Contraceptives, Oral, Synthetic.)	
Medroxyprogesterone Acetate	71-58-9	Medroxyprogesterone acetate	71-58-9	C2QI4IOI2G	Contraceptive Agents, Female	Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. (See all compounds classified as Contraceptive Agents, Female.)	Medroxyprogesterone acetate (MPA) oral tablets are indicated to treat secondary amenorrhea, reduce the incidence of endometrial hyperplasia in postmenopausal women, and to treat abnormal uterine bleeding due to hormonal imbalance, not organic pathology. Oral tablets containing MPA and conjugated estrogens are indicated to prevent postmenopausal osteoporosis and to treat moderate to severe menopausal symptoms such as vasomotor symptoms, vulvar atrophy, and vaginal atrophy. Subcutaneous MPA is indicated to prevent pregnancy and manage pain associated with endometriosis. Intramuscular MPA is indicated to prevent pregnancy, and at higher concentrations for palliative treatment of endometrial or renal carcinoma.
mefenacet		Mefenacet	73250-68-7	QI0QTA02DG			
Mefenamic Acid	61-68-7	Mefenamic Acid	61-68-7	367589PJ2C	Cyclooxygenase Inhibitors	Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)	For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever.
mefenoxam		Metalaxyl-M	70630-17-0	F1Q54ONN4H			
mefentrifluconazole		Mefentrifluconazole	1417782-03-6	D9EYN9N7UI			
Mefloquine	53230-10-7	Mefloquine	51742-87-1	TML814419R	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	Mefloquine is indicated for the treatment of mild to moderate cases of malaria caused by Plasmodium falciparum and Plasmodium vivax.  It is effective against chloroquine-resistant forms of Plasmodium falciparum.  Mefloquine is also indicated for the prophylaxis of malaria caused by Plasmodium falciparum and Plasmodium vivax, including chloroquine-resistant forms of Plasmodium falciparum.
Megestrol	3562-63-8	Megestrol	3562-63-8	EA6LD1M70M	Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	
Megestrol Acetate	51154-23-5	Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl-, (9beta,10alpha)-	51154-23-5				
Meglumine	6284-40-8	Meglumine	6284-40-8	6HG8UB2MUY	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	
Meglumine Antimoniate	133-51-7	Glucantime	133-51-7	75G4TW236W	Antiprotozoal Agents	Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)	
melagatran	159776-70-2	Melagatran	159776-70-2	2A9QP32MD4	Antithrombins	Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. (See all compounds classified as Antithrombins.)	
melamine	108-78-1	Melamine	108-78-1	N3GP2YSD88			
Melanins		Melanins					
Melanocyte-Stimulating Hormones	9002-79-3	Melanotropin					
melarsen oxide	21840-08-4	Melarsen oxide	21840-08-4	2XH88IXE7W			
melarsomine	128470-15-5	Melarsomine	128470-15-5	374GJ0S41A			
Melarsoprol	494-79-1	Melarsoprol	494-79-1	ZF3786Q2E8	Trypanocidal Agents	Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. (See all compounds classified as Trypanocidal Agents.)	
Melatonin	73-31-4	Melatonin	73-31-4	JL5DK93RCL	Central Nervous System Depressants	A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics and antianxiety agents). (See all compounds classified as Central Nervous System Depressants.)	Used orally for jet lag, insomnia, shift-work disorder, circadian rhythm disorders in the blind (evidence for efficacy), and benzodiazepine and nicotine withdrawal. Evidence indicates that melatonin is likely effective for treating circadian rhythm sleep disorders in blind children and adults. It has received FDA orphan drug status as an oral medication for this use. A number of studies have shown that melatonin may be effective for treating sleep-wake cycle disturbances in children and adolescents with mental retardation, autism, and other central nervous system disorders. It appears to decrease the time to fall asleep in children with developmental disabilities, such as cerebral palsy, autism, and mental retardation. It may also improve secondary insomnia associated with various sleep-wake cycle disturbances. Other possible uses for which there is some evidence for include: benzodiazepine withdrawal, cluster headache, delayed sleep phase syndrome (DSPS), primary insomnia, jet lag, nicotine withdrawal, preoperative anxiety and sedation, prostate cancer, solid tumors (when combined with IL-2 therapy in certain cancers), sunburn prevention (topical use), tardive dyskinesia, thrombocytopenia associated with cancer, chemotherapy and other disorders.
Meldola blue	7057-57-0	Basic blue 6	966-62-1	CP2ST8ED1O			
Melengestrol Acetate	2919-66-6	Melengestrol Acetate	2919-66-6	4W5HDS3936	Glucocorticoids	A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)	
Melibiose	585-99-9	6-O-beta-D-Galactopyranosyl-D-galactose	13299-21-3				
Melitten	20449-79-0	Forapin	37231-28-0				
Meloxicam	71125-38-7	Meloxicam	71125-38-7	VG2QF83CGL	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Meloxicam is indicated for the symptomatic treatment of arthritis and osteoarthritis.  In addition, it is indicated for the pauciarticular and polyarticular course of Juvenile Rheumatoid Arthritis (JRA) in patients aged 2 years old or above. Off-label uses include the treatment of dental or post-surgical pain. In addition to the above, meloxicam has also been studied in the treatment of neuropathic pain.  Meloxicam, in combination with [bupivacaine], is indicated for postsurgical analgesia in adult patients for up to 72 hours following foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures.
Melphalan	148-82-3	Melphalan	148-82-3	Q41OR9510P	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	Melphalan is indicated for use as a high-dose conditioning treatment prior to hematopoietic stem cell transplantation in patients with multiple myeloma. It is also indicated for the palliative treatment of multiple myeloma and for the palliation of non-resectable epithelial carcinoma of the ovary.  Melphalan is a component of HEPZATO KIT, a liver-directed therapy indicated for the treatment of adults with uveal melanoma with unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic disease or extrahepatic disease limited to the bone, lymph nodes, subcutaneous tissues, or lung that is amenable to resection or radiation.
Memantine	19982-08-2	Memantine	19982-08-2	W8O17SJF3T	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	Memantine is used to manage moderate to severe Alzheimer's dementia.   A more recent systemic review and meta-analysis indicates that memantine is beneficial as a first line drug for the treatment of Alzheimer's dementia.  Cholinesterase inhibitors may be added to memantine for further beneficial effects on behavioral symptoms and other symptoms of dementia.
Membrane Transport Modulators		Membrane Transport Modulators					
memoquin		Memoquin					
MEN 11270		H-D-Arg-Arg-Pro-Hyp-Gly-D-2Thi-Dab(1)-D-Tic-Oic(3axi,7axi)-Arg-(1)	235082-52-7		Bradykinin Receptor Antagonists	Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ RECEPTORS. (See all compounds classified as Bradykinin Receptor Antagonists.)	
MEN 11420		Nepadutant	183747-35-5	XW59TYL1XH	Bronchodilator Agents	Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)	
MEN91507		4H-1-Benzopyran-4-one, 8-(2-(4-(4-(4-fluorophenyl)butoxy)phenyl)ethenyl)-2-(1H-tetrazol-5-yl)-, (E)-	197506-04-0	A444JV3EJ0			
menadiol	481-85-6	Menadiol	481-85-6	VQ093653DO			
menadione epoxide	15448-59-6	Menadione epoxide	15448-59-6				
menadione semiquinone	34524-96-4	Menadione	58-27-5	723JX6CXY5	Vitamins	Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body. (See all compounds classified as Vitamins.)	The primary known function of vitamin K is to assist in the normal clotting of blood, but it may also play a role in normal bone calcification.
menaquinone 7		Menaquinone-7	2124-57-4	8427BML8NY	Hemostatics	Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)	
menatetrenone	863-61-6	Menatetrenone	863-61-6	27Y876D139	Hemostatics	Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)	
Menhaden oil	8002-50-4	6-(2,6-Dichloro-3,5-dimethoxyphenyl)-8-[1-[3-[5-(dimethylamino)-2-oxopent-3-enyl]phenyl]ethyl]-2-[(1-methylpyrazol-3-yl)amino]pyrido[2,3-d]pyrimidin-7-one;6-(2,6-dichloro-3,5-dimethoxyphenyl)-8-[1-[3-[5-(dimethylamino)-2-oxopent-3-enyl]phenyl]ethyl]-2-(4-morpholin-4-ylanilino)pyrido[2,3-d]pyrimidin-7-one;6-(2,6-dichloro-3,5-dimethoxyphenyl)-8-[1-[3-[5-(dimethylamino)-2-oxopent-3-enyl]phenyl]ethyl]-2-[(5-morpholin-4-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one;6-(2,6-dichloro-3,5-dimethoxyphenyl)-8-[1-[3-[5-(dimethylamino)-2-oxopent-3-enyl]phenyl]ethyl]-2-(pyrimidin-4-ylamino)pyrido[2,3-d]pyrimidin-7-one	8002-50-4				
menthofuran	494-90-6	Menthofuran	494-90-6	LK024V9U3C			
Menthol	1490-04-6	Menthol	1490-04-6		Antipruritics	Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)	
menthol glucuronide	79466-08-3	l-Menthol Glucuronide	79466-08-3	WW64GZ6LQY			
menthone	89-80-5	Menthone	14073-97-3	5F709W4OG4			
menthyl anthranilate		Menthyl anthranilate	134-09-8	J9QGD60OUZ			Meradimate is used as an active ingredient in sunscreens or as a sunblock factor in different products. It fits under the category of broad-spectrum absorbent agent. These characteristics are important to consider due to the fact that this kind of ingredients can either absorb or reflect UV radiation. It is also important to know the type of rays that cover. UVA rays are the responsible of causing sun damage and reaching deeper layers of the skin while UVB can only cause sunburn in the outer layer of the skin. When an agent is of broad spectrum, this means that this agent is capable of acting in both UVA and UVB rays.
mepanipyrim	110235-47-7	Mepanipyrim	110235-47-7	B150X76OJY			
mepazine	60-89-9	Pecazine	60-89-9	PH34873A38			
mepenzolic acid	25990-43-6	Mepenzolate	25990-43-6	ONW3LB39P7			For use as adjunctive therapy in the treatment of peptic ulcer. It has not been  shown to be effective in contributing to the healing of peptic ulcer, decreasing the rate of recurrence, or preventing complications.
Meperidine	57-42-1	Meperidine	57-42-1	9E338QE28F	Adjuvants, Anesthesia	Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)	Used to control moderate to severe pain.
mephedrone		Mephedrone	1189805-46-6	8BA8T27317			
Mephenytoin	50-12-4	Mephenytoin	50-12-4	R420KW629U	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	For the treatment of refractory partial epilepsy.
Mephobarbital	115-38-8	Mephobarbital	115-38-8	5NC67NU76B	GABA Modulators	Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)	For the relief of anxiety, tension, and apprehension, also used as an anticonvulsant for the treatment of epilepsy.
mepifiline	57383-74-1	Mepifiline	57383-74-1	20HD67185N			
mepiquat	15302-91-7	Mepiquat	15302-91-7	S2SFZ0Z4TW			
mepirodipine	104713-75-9	Barnidipine	104713-75-9	2VBY96ASWJ	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	Indicated for the treatment of mild to moderate essential hypertension and management of chronic stable angina.
Mepivacaine	96-88-8	Mepivacaine	96-88-8	B6E06QE59J	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	For production of local or regional analgesia and anesthesia by local infiltration, peripheral nerve block techniques, and central neural techniques including epidural and caudal blocks.
meprednisone		Meprednisone	1247-42-3	67U96J8P35			
Meprobamate	57-53-4	Meprobamate	57-53-4	9I7LNY769Q	Hypnotics and Sedatives	Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)	For the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.
Meptazinol	54340-58-8	Meptazinol	54340-58-8	18Y7S5JKZD	Narcotics	Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)	
Mequindox		Mequindox	13297-17-1				
mequinol		Mequinol	150-76-5	6HT8U7K3AM	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Mequinol is currently primarily available only as an active ingredient in combination products combined with tretinoin that are indicated for the treatment of solar lentigines and related hyperpigmented lesions resulting from chronic sun exposure.
mequitazine	29216-28-2	Mequitazine	29216-28-2	Y463242LY2	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	For the treatment of Hay fever, urticaria (hives) and allergic rhinitis
merbarone		Merbarone	97534-21-9	YWB9IF596V	Topoisomerase II Inhibitors	Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)	
Merbromin	129-16-8	Merbromin	129-16-8				
Mercaptoethanol	60-24-2	Beta-Mercaptoethanol	60-24-2	14R9K67URN			
Mercaptopurine		Mercaptopurine	50-44-2	E7WED276I5	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	For remission induction and maintenance therapy of acute lymphatic leukemia.
mercaptosteroid 4		mercaptosteroid 4					
mercaptosteroid 6		mercaptosteroid 6					
mercuric acetate	1600-27-7	1600-27-7					
mercuric bromide	7789-47-1	Mercuric bromide	7789-47-1				
Mercuric Chloride	7487-94-7	Mercuric Chloride	7487-94-7	53GH7MZT1R	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
mercuric oxide	21908-53-2	Mercuric oxide	21908-53-2	IY191986AO			
mercuric perchlorate	7616-83-3	Mercuric perchlorate	7616-83-3				
Mercury	7439-97-6	Mercury	7439-97-6	FXS1BY2PGL			
Mercury Compounds		Mercury compounds					
mercury nitrate	24670-15-3	Nitric acid, mercury(1+) salt (1:1)	10045-94-0				
Meropenem	96036-03-2	Meropenem	96036-03-2	FV9J3JU8B1	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For use as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms: complicated skin and skin structure infections due to Staphylococcus aureus (b-lactamase and non-b-lactamase producing, methicillin-susceptible isolates only), Streptococcus pyogenes, Streptococcus agalactiae, viridans group streptococci, Enterococcus faecalis (excluding vancomycin-resistant isolates), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis and Peptostreptococcus species; complicated appendicitis and peritonitis caused by viridans group streptococci, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacteroides fragilis, B. thetaiotaomicron, and Peptostreptococcus species. Also for use in the treatment of bacterial meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (b-lactamase and non-b-lactamase-producing isolates), and Neisseria meningitidis.
Mersalyl	492-18-2	Mersalyl	492-18-2		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Elevated blood pressure, edema.
mesaconitine	2752-64-9	Mesaconitine	2752-64-9				
Mesalamine	89-57-6	Mesalamine	89-57-6	4Q81I59GXC	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Mesalazine is indicated for the treatment of mildly to moderately active ulcerative colitis in adults and patients 5 years or older.. Mesalazine is also indicated for the maintenance of remission of ulcerative colitis in adults and maintenance of remission of Crohn's ileocolitis.
Mescaline	54-04-6	Mescaline	54-04-6	RHO99102VC	Hallucinogens	Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. (See all compounds classified as Hallucinogens.)	
mesityl oxide	141-79-7	Mesityl oxide	141-79-7	77LAC84669			
mesitylene	108-67-8	Mesitylene	108-67-8	887L18KQ6X			
Mesna	19767-45-4	Mesna	19767-45-4	NR7O1405Q9	Protective Agents	Synthetic or natural substances which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent. (See all compounds classified as Protective Agents.)	
mesoporphyrin IX	493-90-3	Mesoporphyrin IX	493-90-3				
Mesoporphyrins		Mesoporphyrins					
Mesoridazine	5588-33-0	Mesoridazine	5588-33-0	5XE4NWM740	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Used in the treatment of schizophrenia, organic brain disorders, alcoholism and psychoneuroses.
mesosulfuron-methyl		Mesosulfuron-methyl	208465-21-8	22L00R79A6			
mesotrione		Mesotrione	104206-82-8	48TR68G21T			
mesoxalonitrile	1115-12-4	Mesoxalonitrile	1115-12-4				
mestanolone	521-11-9	Mestanolone	521-11-9	S712YZ168E			
Mestranol	72-33-3	Mestranol	72-33-3	B2V233XGE7	Contraceptives, Oral, Hormonal	Oral contraceptives which owe their effectiveness to hormonal preparations. (See all compounds classified as Contraceptives, Oral, Hormonal.)	Mestranol was used as one of the first oral contraceptives.
mesulergine		Mesulergine	64795-35-3	SML95FK06I	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	
Mesylates		Mesylates					
metacept-1		metacept-1					
metaflumizone		Metaflumizone	139970-56-2	298TMI336S			Treatment and prevention of flea infestations (Ctenocephalides canis and C. felis) in cats. The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
metalaxyl	57837-19-1	Metalaxyl	57837-19-1	16K4M187IF	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
metaldehyde	9002-91-9	Metaldehyde	9002-91-9	4CI033VJYG	Molluscacides	Agents destructive to snails and other mollusks. (See all compounds classified as Molluscacides.)	
Metalloids		Metalloids					
Metalloporphyrins		Metalloporphyrins					
Metals		Metals					
Metals, Heavy		Metals, Heavy					
Metanephrine	5001-33-2	Metanephrine	5001-33-2	1ZE0530JEJ			
metanicotine	538-79-4	Rivanicline	15585-43-0	6H35LF645A			Investigated for use/treatment in ulcerative colitis.
metanil yellow	4005-68-9	4-(Phenylamino)-3'-sulfoazobenzene	4005-68-9				
Metaproterenol	586-06-1	Metaproterenol	586-06-1	53QOG569E0	Tocolytic Agents	Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)	For the treatment of bronchospasm, chronic bronchitis, asthma, and emphysema.
metarrestin		Metarrestin	1443414-10-5	Q6A9F9DSX5			
metaxalone	1665-48-1	Metaxalone	1665-48-1	1NMA9J598Y	Neuromuscular Agents	Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (NEUROMUSCULAR BLOCKING AGENTS), and drugs that act centrally as skeletal muscle relaxants (MUSCLE RELAXANTS, CENTRAL). Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS. (See all compounds classified as Neuromuscular Agents.)	For the treatment of painful peripheral musculoskeletal conditions and spasticity from upper motor neuron syndromes.
metazachlor		Metazachlor	67129-08-2	TPY2K437O4			
metazocine	3734-52-9	Metazocine	3734-52-9				
metconazole		Metconazole	125116-23-6				
Metergoline	17692-51-2	Metergoline	17692-51-2	1501393LY5	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
Metformin	657-24-9	Metformin	657-24-9	9100L32L2N	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	**Metformin immediate-release formulations**   Metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years old with type 2 diabetes mellitus.  **Metformin extended-release tablet (XR)**  The extended-release formulation of metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Safety in children has not been determined to this date.  **Metformin combination products**  Metformin is a component of a variety of combination products with other anti-diabetic agents. It is indicated, along with diet and exercise, to improve glycemic control in adult patients with type 2 diabetes mellitus in combination with DPP-4 inhibitors ([sitagliptin], [linagliptin], [alogliptin], or [saxagliptin]), in combination with SGLT2 inhibitors ([canagliflozin], [empagliflozin], [ertugliflozin], or [dapagliflozin]), or in combination with [pioglitazone].
methabenzthiazuron	18691-97-9	Methabenzthiazuron	18691-97-9	82NPF43P0X			
Methacholine Chloride	62-51-1	Methacholine Chloride	62-51-1	0W5ETF9M2K	Miotics	Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here. (See all compounds classified as Miotics.)	Diagnosis of asthma
Methacholine Compounds		Methacholine Compounds					
methacrylaldehyde	78-85-3	Methacrolein	78-85-3	9HRB24892H			
methacrylonitrile	126-98-7	Methacrylonitrile	126-98-7	04S4K38612			
methacrylyl-coenzyme A	6008-91-9	methacrylyl-CoA	6008-91-9	FZ43RKZ3NL			
Methadone	76-99-3	Methadone	76-99-3	UC6VBE7V1Z	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	Methadone is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatment options are inadequate. It's recommended that use is reserved for use in patients for whom alternative treatment options (eg, nonopioid analgesics, opioid combination products) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.  Methadone is also indicated for detoxification treatment of opioid addiction (heroin or other morphine-like drugs), and for maintenance substitution treatment for opioid dependence in adults in conjunction with appropriate social and medical services.
Methadyl Acetate	509-74-0	Methadyl acetate	509-74-0	L59OC40KWJ	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	Used mainly in the treatment of narcotic dependence.
methamidophos	10265-92-6	Methamidophos	10265-92-6	8Z083FM94W	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Methamphetamine	537-46-2	Methamphetamine	537-46-2	44RAL3456C	Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	For the treatment of Attention Deficit Disorder with Hyperactivity (ADHD) and exogenous obesity.
methamphetamine hydroxylamine		Methamphetamine hydroxylamine					
methanandamide	150314-39-9	(R)-methanandamide	150314-39-9	63WDT9CZ3Y			
Methandrostenolone	72-63-9	Methandrostenolone	72-63-9	COZ1R7EOCC	Anabolic Agents	These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. (See all compounds classified as Anabolic Agents.)	
methaneselenol	60343-91-1	Methyl selenol	60343-91-1				
methanesulfonyl fluoride	558-25-8	Methanesulfonyl fluoride	558-25-8	9H250YYY0R	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
methanethiosulfonate	44059-82-7	Methanethiosulfonate	44059-82-7		Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
methanethiosulfonate ethylammonium		methanethiosulfonate ethylammonium					
Methanol	67-56-1	Methanol	67-56-1	Y4S76JWI15	Solvents	Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant and Hackh&apos;s Chemical Dictionary, 5th ed) (See all compounds classified as Solvents.)	
Methapyrilene	91-80-5	Methapyrilene	91-80-5	A01LX40298	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	
Methazolamide	554-57-4	Methazolamide	554-57-4	DA43GW06P1	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	
methdilazine	1982-37-2	Methdilazine	1982-37-2	4Q13LY9Z8X			Used for the symptomatic relief of hypersensitivity reactions and particularly for the control of pruritic skin disorders
Methenamine	100-97-0	Methenamine	100-97-0	J50OIX95QV	Anti-Infective Agents, Urinary	Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)	For prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary.  This drug is not used to treat  infection and should only be used after appropriate eradication of infection with antimicrobial agents.
methenolone enanthate		Methenolone enanthate	303-42-4	0SPD480WFH			
methidathion	950-37-8	Methidathion	950-37-8	Y2P145U7KK	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Methimazole	60-56-0	Methimazole	60-56-0	554Z48XN5E	Antithyroid Agents	Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones. (See all compounds classified as Antithyroid Agents.)	In the United States, methimazole is indicated for the treatment of hyperthyroidism in patients with Graves' disease or toxic multinodular goiter for whom thyroidectomy or radioactive iodine therapy are not appropriate treatment options. Methimazole is also indicated for the amelioration of hyperthyroid symptoms in preparation for thyroidectomy or radioactive iodine therapy.  In Canada, methimazole carries the above indications and is also indicated for the medical treatment of hyperthyroidism regardless of other available treatment options.
Methiocarb	2032-65-7	Methiocarb	2032-65-7	JI9431OS31	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
methiocarb sulfoxide		Methiocarb sulfoxide	2635-10-1	S9303L7A4D			
methional	3268-49-3	3-(Methylthio)propionaldehyde	3268-49-3	0AAO8V0F1R	Prostaglandin Antagonists	Compounds that inhibit the action of prostaglandins. (See all compounds classified as Prostaglandin Antagonists.)	
Methionine	63-68-3	Methionine	63-68-3	AE28F7PNPL			Used for protein synthesis including the formation of SAMe, L-homocysteine, L-cysteine, taurine, and sulfate.
methionine selenoxide		methionine selenoxide					
methionine sulfoxide	454-41-1	Methionine sulfoxide	62697-73-8	O74B4F6OYL			
Methionine Sulfoximine	1982-67-8	Methionine sulfoximine	1982-67-8				
Methiothepin	20229-30-5	Methiothepin	20229-30-5	55D94103HL	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
methixene	4969-02-2	Metixene	4969-02-2	32VY6L26ZW			Used for the symptomatic treatment of parkinsonism.
methoctramine	104807-46-7	Methoctramine	104807-46-7	RLO2T99XT3	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	
Methohexital	18652-93-2	Methohexital	151-83-7	E5B8ND5IPE	Anesthetics, Intravenous	Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) (See all compounds classified as Anesthetics, Intravenous.)	Methohexital is indicated for use as an intravenous anaesthetic. It has also been commonly used to induce deep sedation.
Methomyl	16752-77-5	Methomyl	16752-77-5		Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
Methoprene	40596-69-8	Methoprene	40596-69-8	8B830OJ2UX			
Methotrexate	59-05-2	Methotrexate	59-05-2	YL5FZ2Y5U1	Abortifacient Agents, Nonsteroidal	Non-steroidal chemical compounds with abortifacient activity. (See all compounds classified as Abortifacient Agents, Nonsteroidal.)	Methotrexate oral solution is indicated for pediatric acute lymphoblastic leukemia and pediatric polyarticular juvenile idiopathic arthritis. Methotrexate injections for subcutaneous use are indicated for severe active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and severe, recalcitrant, disabling psoriasis. It has also been approved by the EMA for the treatment of adult patients requiring systemic therapy for moderate-to-severe plaque psoriasis.  Other formulations are indicated to treat gestational choriocarcinoma, chorioadenoma destruens, hydatiform mole, breast cancer, epidermoid cancer of the head and neck, advanced mycosis fungoides, lung cancer, and advanced non-Hodgkin's lymphoma. It is also used in the maintenance of acute lymphocytic leukemia. Methotrexate is also given before treatment with leucovorin to prolong relapse-free survival following surgical removal of a tumour in non-metastatic osteosarcoma.
methotrexate polyglutamate	82334-40-5	82334-40-5					
methotrexate-alpha glutamate	71074-49-2	L-Glutamic acid, N-(N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-alpha-glutamyl)-	71074-49-2				
Methotrimeprazine	60-99-1	Levomepromazine	60-99-1	9G0LAW7ATQ	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	For the treatment of psychosis, particular those of schizophrenia, and manic phases of bipolar disorder.
Methoxamine	390-28-3	Methoxamine	390-28-3		Adrenergic alpha-1 Receptor Agonists	Compounds that bind to and activate ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Agonists.)	Indicated for the treatment and management of hypotension.
Methoxsalen	298-81-7	Methoxsalen	298-81-7	U4VJ29L7BQ	Photosensitizing Agents	Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)	For the treatment of psoriasis and vitiligo
methoxy poly(ethylene glycol-co-epsilon-caprolactone)		methoxy poly(ethylene glycol-co-epsilon-caprolactone)					
methoxy-morpholinyl-doxorubicin	108852-90-0	Nemorubicin	108852-90-0	7618O47BQM			
methoxyacetic acid	625-45-6	Methoxyacetic acid	625-45-6	F11T1H7Q7W	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	
methoxyamine	67-62-9	O-Methylhydroxylamine	67-62-9	9TZH4WY30J			Investigated for use/treatment in cancer/tumors (unspecified).
Methoxychlor	72-43-5	Methoxychlor	72-43-5	RIA79UD69L	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Methoxydimethyltryptamines		Methoxydimethyltryptamines					
methoxyfenozide		Methoxyfenozide	161050-58-4	62A22651ZX	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Methoxyflurane	76-38-0	Methoxyflurane	76-38-0	30905R8O7B	Anesthetics, Inhalation	Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173) (See all compounds classified as Anesthetics, Inhalation.)	For use in the induction and maintenance of general anesthesia
methoxytryptophol	712-09-4	5-Methoxytryptophol	712-09-4		Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	
methyl (1-(5-fluoropentyl)-1H-indazole-3-carbonyl)valinate		methyl (1-(5-fluoropentyl)-1H-indazole-3-carbonyl)valinate					
methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate		methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate					
methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamide)-3,3-dimethylbutanoate		methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamide)-3,3-dimethylbutanoate					
methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate		Mdmb-chmica, (+/-)-	1863065-84-2	0C9W96YPI1			
methyl 2-(2-acetoxy-6,7-dihydrothieno(3,2-c)pyridin-5(4H)-yl)-2-(2-chlorophenyl)acetate		Methyl 2-(2-acetoxy-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-2-(2-chlorophenyl)acetate	178688-44-3				
methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate		methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate					
methyl 2-(3-ethyl-9-fluoro-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate		methyl 2-(3-ethyl-9-fluoro-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate					
methyl 2-(7-hydroxy-2-oxonaphtho(1,2-b)furan-3(2H)-yliden)acetate		methyl 2-(7-hydroxy-2-oxonaphtho(1,2-b)furan-3(2H)-yliden)acetate					
methyl 2-benzoylbenzoate		Methyl 2-benzoylbenzoate	606-28-0	XUP7S9NT59			
methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate		Bardoxolone methyl	218600-53-4	CEG1Q6OGU1			Investigated for use/treatment in lymphoma (unspecified), multiple myeloma, and solid tumors.
methyl 2,5-dihydroxycinnamate	63177-57-1	Methyl 2,5-dihydroxycinnamate	63177-57-1	6LF2DGK4XM	Cross-Linking Reagents	Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)	
methyl 3-hydroxyimino-11-oxoolean-12-en-28-oate		methyl 3-hydroxyimino-11-oxoolean-12-en-28-oate					
methyl 3, 5-O-dicaffeoylquinate		methyl 3, 5-O-dicaffeoylquinate					
methyl 4-tolylsulfide		methyl 4-tolylsulfide					
methyl 5-((tert-butylcarbamothioylhydrazinylidene)methyl)-1-(2,4-difluorophenyl)pyrazole-4-carboxylate		methyl 5-((tert-butylcarbamothioylhydrazinylidene)methyl)-1-(2,4-difluorophenyl)pyrazole-4-carboxylate					
methyl 5-chloro-4,5-didehydrojasmonate		methyl 5-chloro-4,5-didehydrojasmonate					
methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate		Methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate	82499-00-1	1309288N1J	Convulsants	Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)	
methyl antcinate A		Methyl 4alpha-methylergost-8,24(28)-diene-3,11-dion-26-oate	169477-80-9				
methyl arachidonylfluorophosphonate		Methoxy arachidonyl fluorophosphonate					
methyl bensulfuron	83055-99-6	Bensulfuron-methyl	83055-99-6	QWL4I737BL			
methyl bromide	74-83-9	Bromomethane	74-83-9	9V42E1Z7B6	Noxae	Agents capable of exerting a harmful effect on the body. (See all compounds classified as Noxae.)	
methyl caffeate	3843-74-1	Caffeic acid methyl ester	3843-74-1	N79173B9HF			
methyl caproate		Methyl hexanoate	106-70-7	246364VPJS			
methyl carbamate	598-55-0	Methyl carbamate	598-55-0	9WFX634X2T			
methyl cellosolve	109-86-4	2-Methoxyethanol	109-86-4	EK1L6XWI56	Teratogens	An agent that causes the production of physical defects in the developing embryo. (See all compounds classified as Teratogens.)	
Methyl Chloride	74-87-3	Chloromethane	74-87-3	A6R43525YO			
methyl demeton		Methyl demeton	8022-00-2		Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
methyl farnesoate	10485-70-8	Methyl farnesoate	10485-70-8				
methyl ferulate		Methyl ferulate	22329-76-6	Y98BUA66RX			
methyl gallate	99-24-1	Methyl gallate	99-24-1	623D3XG80C			
Methyl Green	82-94-0	Double green	82-94-0	6P7U4T9BXA	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
methyl heptine carbonate	111-12-6	Methyl 2-octynoate	111-12-6	0TTP6YT2T3			
methyl iodide	74-88-4	Iodomethane	74-88-4	DAT010ZJSR			
methyl isobutyl ketone	108-10-1	Methyl isobutyl ketone	108-10-1	U5T7B88CNP			
methyl isocyanate	624-83-9	Methyl Isocyanate	624-83-9	C588JJ4BV9	Antisickling Agents	Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions. (See all compounds classified as Antisickling Agents.)	
methyl isothiocyanate	556-61-6	Methyl isothiocyanate	556-61-6	RWE2M5YDW1	Disinfectants	Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley&apos;s Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Disinfectants.)	
methyl jasmonate	1211-29-6	Methyl jasmonate	1211-29-6	900N171A0F	Plant Growth Regulators	Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins. (See all compounds classified as Plant Growth Regulators.)	
methyl linoleate	112-63-0	Methyl linoleate	68605-14-1	24N6726DE5			
Methyl Methanesulfonate	66-27-3	Methyl methanesulfonate	66-27-3	AT5C31J09G	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
methyl methanethiosulfonate	2949-92-0	Methyl methanethiosulfonate	2949-92-0	0906Z2356U			
Methyl n-Butyl Ketone	591-78-6	2-Hexanone	591-78-6	6QDY60NH6N			
methyl oleate	112-62-9	Methyl oleate	112-62-9	39736AJ06R			
methyl palmitate	112-39-0	Methyl palmitate	112-39-0	DPY8VCM98I			
Methyl Parathion	298-00-0	Methyl parathion	298-00-0	41BCL2O91D	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
methyl phenylphosphonate	10088-45-6	Methoxy(phenyl)phosphinic acid	10088-45-6				
methyl protodioscin		Methylprotodioscin	54522-52-0	1VJB6VV6IA			
methyl pyruvate	600-22-6	Methyl pyruvate	600-22-6	3KJM65G5XL			
methyl salicylate	119-36-8	Methyl Salicylate	68917-50-0	LAV5U5022Y	Antirheumatic Agents	Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)	Ointments or liniments containing methyl salicylate are applied topically as counter irritant for relief of acute pain associated with lumbago,sciatica and rheumatic conditions. Local analgesics for human and veterinary medicine.
methyl tert-butyl ether	1634-04-4	Methyl tert-butyl ether	1634-04-4	29I4YB3S89	Air Pollutants	Any substance in the air which could, if present in high enough concentration, harm humans, animals, vegetation or materials. Substances include GASES; PARTICULATE MATTER; and volatile ORGANIC CHEMICALS. (See all compounds classified as Air Pollutants.)	
methyl triclosan		Methyl triclosan	4640-01-1	5174UR1DP5			
methyl vanillate		Methyl vanillate	3943-74-6	2HXG8QSO3D			
methyl-(4-carboxyphenyl)glycine		methyl-(4-carboxyphenyl)glycine					
methyl-beta-cyclodextrin		methyl-beta-cyclodextrin					
methyl(acetoxymethyl)nitrosamine	56856-83-8	Methyl(acetoxymethyl)nitrosamine	56856-83-8		Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
methylamine	74-89-5	Methylamine	74-89-5	BSF23SJ79E			
Methylamines		Methylamines					
methylamphotericin B	36148-89-7	Amphotericin B methyl ester	36148-89-7	074Z98YIW3	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
methylarsenic diglutathione		Methylarsenic diglutathione	91919-81-2				
methylarsine		Methylarsine	83636-33-3				
methylarsine oxide	593-58-8	Methyloxoarsine	593-58-8				
methylarsonite		Methylarsonous acid	25400-23-1				
methylatropine	31610-87-4	Methylatropine	31610-87-4	80719I460H	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	
methylazoxymethanol	590-96-5	Methylazoxymethanol	590-96-5	JGG19N3YDQ	Alkylating Agents	Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)	
Methylazoxymethanol Acetate	592-62-1	Methylazoxymethyl acetate	592-62-1	4C7R36N7Q7	Neurotoxins	Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept. (See all compounds classified as Neurotoxins.)	
methylbenzethonium chloride		Methylbenzethonium chloride	25155-18-4	NN7590IUQX	Antiprotozoal Agents	Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)	
methylbromfenvinphos	13104-21-7	[2-Bromo-1-(2,4-dichlorophenyl)ethenyl] dimethyl phosphate	13104-21-7		Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Methylcholanthrene	56-49-5	3-Methylcholanthrene	56-49-5	214U33M1RL			
methylcholine		methylcholine					
methyldihydrojasmonate		METHYL DIHYDROJASMONATE (SYNTHETIC)					
Methyldimethylaminoazobenzene	55-80-1	3'-Methyl-4-dimethylaminoazobenzene	55-80-1	SXK3ZE3U4Q			
methyldithiocarbamate	144-54-7	Metam	144-54-7	OA1I97689K	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	
Methyldopa	555-30-6	Methyldopa	555-30-6	M4R0H12F6M	Sympatholytics	Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)	Methyldopa is indicated for the management of hypertension as monotherapy or in combination with hydrochlorothiazide. Methyldopa injection is used to manage hypertensive crises.
methylene bis(4-cyclohexylisocyanate)		Bis(4-isocyanatocyclohexyl)methane	5124-30-1	6Y80AJA84R			
methylene bis(thiocyanate)	6317-18-6	Methylene dithiocyanate	6317-18-6	K1QS9QOS1J			
Methylene Blue	61-73-4	Methylene Blue	61-73-4	T42P99266K	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia.   Other clinical applications of methylene blue include improvement of hypotension associated with various clinical states, an antiseptic in urinary tract infections, treatment of hypoxia and hyperdynamic circulation in cirrhosis of liver and severe hepatopulmonary syndrome, and treatment of ifofosamide induced neurotoxicity.
methylene bromide	74-95-3	Dibromomethane	74-95-3	V69B659W01	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
Methylene Chloride	75-09-2	Methylene Chloride	75-09-2	588X2YUY0A			
methylene diisocyanate	4747-90-4	Methylene isocyanate	4747-90-4	3K6QR7JP6V			
methylene violet	2516-05-4	Methylene violet	2516-05-4	Y3G6PD8NRB			
Methylenebis(chloroaniline)	101-14-4	4,4'-Methylenebis(2-chloroaniline)	101-14-4	3L2W5VTT2A			
Methylergonovine	113-42-8	Methylergonovine	113-42-8	W53L6FE61V	Oxytocics	Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) (See all compounds classified as Oxytocics.)	For the prevention and control of excessive bleeding following vaginal childbirth
methylethyl ketone	78-93-3	Methyl Ethyl Ketone	78-93-3	6PT9KLV9IO			
methylethylnitrosamine	10595-95-6	N-Nitrosomethylethylamine	10595-95-6	00RLM29Y3A			
methyleugenol	93-15-2	Methyleugenol	93-15-2	29T9VA6R7M	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
methyleugenol-2',3'-epoxide		methyleugenol-2',3'-epoxide					
methylformamide	123-39-7	N-Methylformamide	123-39-7	XPE4G7Y986	Radiation-Sensitizing Agents	Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. (See all compounds classified as Radiation-Sensitizing Agents.)	
methylgerambullin		Methylgerambullin					
methylglucoside	25360-07-0	Methylglucoside	25360-07-0				
Methylhistamines		Methylhistamines					
methylhistaprodifen		Methylhistaprodifen					
methyllycaconitine	21019-30-7	Methyllycaconitine			Nicotinic Antagonists	Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)	
Methylmalonic Acid	516-05-2	Methylmalonic acid	516-05-2	8LL8S712J7			
methylmalonyl-coenzyme A	1264-45-5	methylmalonyl-CoA	1264-45-5				
methylmercaptan	74-93-1	Methanethiol	74-93-1	2X8406WW9I			
methylmercuric chloride	115-09-3	Methylmercury chloride	115-09-3				
Methylmercury Compounds		Methylmercury Compounds					
methylmercury cysteine	12628-19-2	Methylmercury cysteine	12628-19-2				
methylmercury glutathione	78505-11-0	Glycine, N-(N-L-gamma-glutamyl-3-(methylmercurio)-L-alanyl)-	78505-11-0				
methylmercury hydroxide	1184-57-2	Hydroxymethylmercury	1184-57-2	EZ74BDI0HB			
methylmercury II	22967-92-6	Methylmercury II	22967-92-6				
methylmercury sulfide	54277-95-1	Mercaptomethylmercury	54277-95-1				
Methylmethacrylate	80-62-6	Methyl methacrylate	9011-14-7	196OC77688	Antimutagenic Agents	Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved. (See all compounds classified as Antimutagenic Agents.)	
methylmethacrylate-methacrylic acid copolymer	25086-15-1	Polymethacrylate	25086-15-1				
methylnaltrexone	83387-25-1	Methylnaltrexone	83387-25-1	0RK7M7IABE	Narcotic Antagonists	Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)	Treatment of opioids induced constipation in palliative patients that are inadequately responding to laxative therapy.
Methylnitronitrosoguanidine	70-25-7	1-Methyl-3-nitro-1-nitrosoguanidine	70-25-7	12H3O2UGSF			
Methylnitrosourea	684-93-5	N-Nitroso-N-methylurea	684-93-5	W8KW4E3XSU	Alkylating Agents	Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)	
methylone		Methylone	186028-79-5	L4I4B1R01F			
methylparaben	99-76-3	Methylparaben	99-76-3	A2I8C7HI9T	Preservatives, Pharmaceutical	Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include ANTI-BACTERIAL AGENTS and antioxidants. (See all compounds classified as Preservatives, Pharmaceutical.)	
methylparaoxon	950-35-6	Methyl paraoxon	950-35-6	UE1A2XL95H			
Methylphenazonium Methosulfate	299-11-6	Phenazine methosulfate	299-11-6	J3GYQ3401Y			
Methylphenidate	113-45-1	Methylphenidate	113-45-1	207ZZ9QZ49	Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	Methylphenidate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older and for the treatment of narcolepsy.
methylphenyl carbinol	98-85-1	1-Phenylethanol	98-85-1	E6O895DQ52			
methylphosphate	812-00-0	Methyl dihydrogen phosphate	812-00-0	7C7GH393JL			
methylphosphonfluoridate	1511-67-7	Methylphosphonfluoridate	1511-67-7				
methylphosphonic difluoride	676-99-3	Methylphosphonic difluoride	676-99-3	Z7V517240K			
Methylprednisolone	83-43-2	Methylprednisolone	83-43-2	X4W7ZR7023	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	Oral and intramuscular methylprednisolone are indicated for a number of endocrine,  rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, gastrointestinal, nervous system, and other disorders. Intra-articular and soft tissue injections are indicated for short term treatment of acute gouty arthritis, acute and subactute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, and synovitis of osteoarthritis. Intralesional injections are indicated for alopecia areata, discoid lupus erythematosus, keloids, lichen planus, lichen simplex chronicus and psoriatic plaques, necrobiosis lipoidica diabeticorum, and localized hypertrophic infiltrated inflammatory lesions of granuloma annulare.
methylprednisolone aceponate		Methylprednisolone aceponate	86401-95-8	ET54W9J4U2	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
Methylprednisolone Acetate	53-36-1	Methylprednisolone Acetate	53-36-1	43502P7F0P	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
Methylprednisolone Hemisuccinate	2921-57-5	Methylprednisolone hemisuccinate	2921-57-5	5GMR90S4KN	Glucocorticoids	A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)	
methylselenic acid		Methylselenic acid	28274-57-9	9900C6V162			
methylsulfonyl benzothiazole		Benzothiazole, 2-(methylsulfonyl)-	7144-49-2				
methylswertianin		1,8-Dihydroxy-2,6-dimethoxy-9H-xanthen-9-one	22172-17-4				
Methyltestosterone	58-18-4	Methyltestosterone	58-18-4	V9EFU16ZIF	Anabolic Agents	These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. (See all compounds classified as Anabolic Agents.)	Methyltestosterone is an anabolic steroid hormone used to treat men with a testosterone deficiency. It is also used in women to treat breast cancer, breast pain, swelling due to pregnancy, and with the addition of estrogen it can treat symptoms of menopause.
methylthio-ADP	34983-48-7	2-Methylthio-adenosine-5'-diphosphate	34983-48-7				
Methylthioinosine	342-69-8	6-Methylmercaptopurine riboside	342-69-8	Y5G39SHR0V			
Methylthiouracil	56-04-2	Methylthiouracil	56-04-2	QW24888U5F	Antithyroid Agents	Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones. (See all compounds classified as Antithyroid Agents.)	
methyltin	16408-15-4	Methyltin(3+)	16408-15-4	U64V227YY6			
methylumbelliferyl-alpha-D-mannopyranoside	28541-83-5	4-METHYLUMBELLIFERYL-alpha-D-MANNOPYRANOSIDE	28541-83-5				
methylurea		Methylurea	598-50-5	VZ89YBW3P8			
Methylurea Compounds		Methylurea Compounds					
methylxanthine	28109-92-4	Hydroxyl methyl purine-one					
Methysergide	361-37-5	Methysergide	361-37-5	XZA9HY6Z98	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	For the treatment of vascular headache
methysticin	495-85-2	Methysticin	495-85-2	M832AIJ6HX			
Metiamide	34839-70-8	Metiamide	34839-70-8	3K7670861M	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	Potential in the treatment and the management of acid-reflux disorders (GERD), peptic ulcer disease, heartburn, and acid indigestion.
Metipranolol	22664-55-7	Metipranolol	22664-55-7	X39AL81KEB	Sympatholytics	Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)	Indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open angle glaucoma.
metiprenaline	1212-03-9	Metiprenaline	1212-03-9	1WBF92D66N			
metkephamid	66960-34-7	Metkephamid	66960-34-7	MNL20FXH9Y			
Metoclopramide	364-62-5	Metoclopramide	364-62-5	L4YEB44I46	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	Metoclopramide in the oral tablet form is used for symptomatic treatment of both acute and recurrent diabetic gastroparesis, in addition to the treatment of gastroesophageal reflux disease (GERD) in patients who have failed to respond to traditional therapy. A nasal spray formulation is also indicated to treat adults with acute, recurrent diabetic gastroparesis.  In the intravenous injection form, it is indicated for the above conditions as well as for the prevention of vomiting that may follow emetogenic chemotherapy or nausea and vomiting after surgery. Intravenous metoclopramide facilitates intubation of the small bowel and stimulates gastric emptying and barium flow in patients who require radiological examination of the stomach or small intestine.  In some cases, the delay of gastrointestinal emptying interferes with the radiographic visualization of the gastrointestinal tract, and metoclopramide is used to facilitate emptying in these cases, allowing for adequate diagnostic visualization.  Some off-label uses of metoclopramide include the management of radiation-induced nausea and vomiting, gastric bezoars, intractable hiccups, and migraine pain.
metolachlor	51218-45-2	Metolachlor	51218-45-2	X0I01K05X2	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Metolazone	17560-51-9	Metolazone	17560-51-9	NM7V2Y3G0U	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	For the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class.
metolcarb		Metolcarb	1129-41-5	4N7OMZ879V			
metoprine		Metoprine	7761-45-7	2L9RKX796Q	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Metoprolol	37350-58-6	Metoprolol	51384-51-1	GEB06NHM23	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension.  Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm.  All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.
metrafenone		Metrafenone	220899-03-6	S04CWW41HM			
Metribolone	965-93-5	Methyltrienolone	965-93-5	2C323EGI97			
metribuzin	21087-64-9	Metribuzin	21087-64-9	QO836138OV	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Metronidazole	443-48-1	Metronidazole	443-48-1	140QMO216E	Antiprotozoal Agents	Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)	Metronidazole is indicated for the treatment of confirmed trichomoniasis caused by Trichomonas vaginalis (except for in the first trimester of pregnancy) and the patient's sexual partners, bacterial vaginosis, certain types of amebiasis, and various anaerobic infections. The above anaerobic infections may occur on the skin and skin structures, the abdomen, the heart, reproductive organs, central nervous system, and the respiratory system. Some may also be present in the bloodstream in cases of septicemia. Common infections treated by metronidazole are Bacteroides species infections, Clostridium infections, and Fusobacterium infections, as well as Peptococcus and Peptostreptococcus infections. Topical formulations of metronidazole are indicated for the treatment of inflammatory lesions of rosacea.  It is also used off-label in the treatment of Crohn's disease, as a prophylactic agent after surgery, and in the treatment of Helicobacter pylori infection. It has also been studied in the prevention of preterm births and to treat periodontal disease.
metsulfuron methyl	74223-64-6	Metsulfuron-methyl	74223-64-6	2589ET7417			
Metyrapone	54-36-4	Metyrapone	54-36-4	ZS9KD92H6V	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	Used as a diagnostic drug for testing hypothalamic-pituitary ACTH function. Occasionally used in Cushing's syndrome.
Mevalonic Acid	150-97-0	3,5-Dihydroxy-3-methylpentanoic acid	150-97-0	S5UOB36OCZ			
mevalonolactone	503-48-0	4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one	674-26-0	1RJ06DC41B			
mevastatin		Mevastatin	73573-88-3	1UQM1K0W9X	Anticholesteremic Agents	Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)	Not used therapeutically due to its many side effects.
Mevinphos	7786-34-7	Mevinphos	7786-34-7	Q6VSZ656WV	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Mexiletine	31828-71-4	Mexiletine	31828-71-4	1U511HHV4Z	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	For the treatment of ventricular tachycardia and symptomatic premature ventricular beats, and prevention of ventricular fibrillation.
mezerein	34807-41-5	Daphnetoxin, 12-[(1-oxo-5-phenyl-2,4-pentadienyl)oxy]-, [12beta(E,E)]-	34807-41-5		Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	
MF 592		MF 592					
MF-310		MF-310					
MF101 extract		MF101 extract					
MF59 oil emulsion		MF59 oil emulsion					
MF63 compound		2-(9-Chloro-1h-Phenanthro[9,10-D]imidazol-2-Yl)benzene-1,3-Dicarbonitrile	892549-43-8	7TU641M876			
MG 262		PS-III	179324-22-2	549V4DP94W			
mHA11		mHA11					
MHY966		MHY966					
MI-219		Unii-2FJ6Y9S5AK	908027-55-4	2FJ6Y9S5AK			
Mianserin	24219-97-4	Mianserin	24219-97-4	250PJI13LM	Antidepressive Agents, Second-Generation	A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)	For the treatment of depression.
Mibefradil	116644-53-2	Mibefradil	116644-53-2	27B90X776A	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the treatment of angina and high blood pressure.
mibolerone		Mibolerone	3704-09-4	9OGY4BOR8D			
Miconazole	22916-47-8	Miconazole	22916-47-8	7NNO0D7S5M	Cytochrome P-450 CYP3A Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A. (See all compounds classified as Cytochrome P-450 CYP3A Inhibitors.)	Miconazole is indicated for the local treatment of oropharyngeal candidiasis in adult patients and for the adjunctive treatment of diaper dermatitis complicated by candidiasis in immunocompetent patients aged four weeks and older. Miconazole is available as both a suppository and cream for the treatment of vaginal yeast infections and the relief of associated vulvar itching and irritation. Lastly, miconazole cream is effective in treating athlete's foot (tinea pedis), jock itch (tinea cruris), ringworm infections (tinea corporis), pityriasis (formerly tinea) versicolor, and cutaneous candidiasis.
microcrystalline cellulose		9004-34-6					
microcystin	77238-39-2	Microcystin	77238-39-2		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
microcystin RR		microcystin RR	111755-37-4	CZ021GH33H			
microcystin-LF		Microcystin LF	154037-70-4				
Microcystins		Microcystins					
microorganism fermentation extract		microorganism fermentation extract					
micrurus venom		micrurus venom					
Midazolam	59467-70-8	Midazolam	59467-70-8	R60L0SM5BC	Anesthetics, Intravenous	Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) (See all compounds classified as Anesthetics, Intravenous.)	Midazolam has different indications depending on its formulation by the FDA.   **Nasal**   For the nasal spray formulation, midazolam is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patients usual seizure pattern in patients with epilepsy 12 years of age and older.   **Intravenous**   For the intravenous injection formulation, midazolam is indicated as an agent for sedation/anxiolysis/amnesia and prior to or during diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography, cardiac catheterization, oncology procedures, radiologic procedures, suture of lacerations and other procedures either alone or in combination with other CNS depressants. The sedative, anxiolytic and amnestic use of midazolam can also be employed pre-operatively. It can also be indicated for induction of general anesthesia, before administration of other anesthetic agents or as a component of intravenous supplementation of nitrous oxide and oxygen for a balanced anesthesia. A relatively narrower dose range of midazolam and a shorter period of induction can be achieved if midazolam is combined with narcotic premedication. Finally, midazolam can be indicated as a continous intravenous infusion for sedation of intubated and mechanically ventilated patients as a component of anesthesia or during treatment in a critical care setting.  **Intramuscular**   For the intramusuclar injection formulation, midazolam is indicated for preoperative sedation/anxiolysis/amnesia or for treatment of status epilepticus in adults.  **Oral**  Midazolam syrup is indicated for use in pediatric patients for sedation, anxiolysis and amnesia prior to diagnostic, therapeutic or endoscopic procedures or before induction of anesthesia. It is only approved in monitored settings only and not for chronic or home use.  In Europe, a buccal formulation of midazolam is also approved for the treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). For infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.
midecamycin		Midecamycin	35457-80-8	N34Z0Y5UH7	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Midecamycin was used for the treatment of infections in the oral cavity, upper and lower respiratory tracts and skin and soft tissue infections. The alone use of midecamycin was mainly used in Europe or Japan.
Midodrine	42794-76-3	Midodrine	42794-76-3	6YE7PBM15H	Vasoconstrictor Agents	Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)	For the treatment of symptomatic orthostatic hypotension (OH).
midostaurin		Midostaurin	120685-11-2	ID912S5VON	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Investigated for use/treatment in adult patients with high-risk acute myeloid leukemia (AML) who are FLT3 mutation-positive, agressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).
mifamurtide		Mifamurtide	83461-56-7	EQD2NNX741	Immunologic Factors	Biologically active substances whose activities affect or play a role in the functioning of the immune system. (See all compounds classified as Immunologic Factors.)	
Mifepristone	84371-65-3	Mifepristone	84371-65-3	320T6RNW1F	Contraceptives, Postcoital, Synthetic	Postcoital contraceptives which owe their effectiveness to synthetic preparations. (See all compounds classified as Contraceptives, Postcoital, Synthetic.)	For the medical termination of intrauterine pregnancy through 49 days' pregnancy. Also indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and are not candidates for surgery or have had unsuccessful surgery.
mifobate	76541-72-5	Mifobate	76541-72-5	ZKA4OVV12E			
migalastat		Migalastat	108147-54-2	C4XNY919FW			Migalastat is approved by the FDA for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene (GLA) variant based on in vitro assay data.   This indication is approved under accelerated approval based on a reduction in kidney interstitial capillary cell globotriaosylceramide (KIC GL-3) substrate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.  Migalastat is also approved by the EMA and Health Canada to treat the same disease, although it is approved for both adults and adolescents aged 16 years and older in Europe.
miglitol		Miglitol	72432-03-2	0V5436JAQW	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	For use as an adjunct to diet to improve glycemic control in patients with non-insulin-dependent diabetes mellitus (NIDDM) whose hyperglycemia cannot be managed with diet alone.
miglustat		Miglustat	72599-27-0	ADN3S497AZ	Anti-HIV Agents	Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)	For the treatment of adult patients with mild to moderate type 1 (nonneuropathic) Gaucher's disease for whom enzyme replacement therapy is not a therapeutic option (e.g. due to constraints such as allergy, hypersensitivity, or poor venous access). Now approved in some countries for the treatment of progressive neurological symptoms in adult and pediatric patients with Niemann-Pick disease type C (NP-C).
Milnacipran		Milnacipran	96847-55-1	ES1O38J3C4	Analgesics, Non-Narcotic	A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)	Milnacipran is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the management of fibromyalgia in patients that are 18 years old or above.   While milnacipran may be used for the treatment of major depressive disorder (MDD), it is only recommended in adult patients who are 18 years old or above due to an increased risk for suicidal ideation, thinking, and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder (MDD) and other psychiatric disorders. Some regional prescribing information notes that the use of the medication is specifically for the short-term symptomatic relief of MDD. Nevertheless, it is important to note that the regulatory approval of and/or indications listed here for milnacipran may or may not exist and/or vary greatly between regions and nations.
Milrinone	78415-72-2	Milrinone	78415-72-2	JU9YAX04C7	Phosphodiesterase 3 Inhibitors	Compounds that specifically inhibit PHOSPHODIESTERASE 3. (See all compounds classified as Phosphodiesterase 3 Inhibitors.)	Milrinone is indicated for the short-term (48 hours or less) treatment of patients with acute decompensated heart failure. Milrinone administration should occur together with close monitoring using appropriate electrocardiographic equipment and should occur in a facility equipped for the immediate treatment of potential cardiac events, including ventricular arrhythmias.
miltefosine		Miltefosine	58066-85-6	53EY29W7EC	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	For the treatment of mucosal (caused by Leishmania braziliensis), cutaneous (caused by L. braziliensis, L. guyanensis, and L. panamensis), and visceral leishmaniasis (caused by L. donovani). In comparing Leishmania drug susceptibility, it has been found that L. donovani is the most susceptible to miltefosine while L. major is the least susceptible.  Off-label use includes treatment of free-living amebae (FLA) infections (unlabeled use; CDC, 2013).
miltirone	27210-57-7	Miltirone	27210-57-7				
Mimosine	500-44-7	Mimosine	500-44-7	Z46B1LUI5N			
minalrestat	129688-50-2	Minalrestat	129688-50-2	G44PE6QB31			
mineral acids, trace elements, water, drug combination		mineral acids, trace elements, water, drug combination					
Mineral Fibers		Mineral Fibers					
Mineral Oil	8020-83-5	CID 139291139	8020-83-5		Emollients	Oleagenous substances used topically to soothe, soften or protect skin or mucous membranes. They are used also as vehicles for other dermatologic agents. (See all compounds classified as Emollients.)	
mineral trioxide aggregate		mineral trioxide aggregate					
Mineral Waters		Mineral Waters					
Mineralocorticoid Receptor Antagonists		Mineralocorticoid Receptor Antagonists					
Mineralocorticoids		Mineralocorticoids					
Minerals		Minerals					
Minocycline	10118-90-8	Minocycline	10118-90-8		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Minoxidil	38304-91-5	Minoxidil	38304-91-5		Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
mipafox	371-86-8	Mipafox	371-86-8	24MJP5H3YN			
mipomersen		Mipomersen	1000120-98-8				Used in patients with homozygous familial hypercholesterolemia as an adjunct to diet and other lipid-lowering medications.
mirabegron		Mirabegron	223673-61-8	MVR3JL3B2V	Adrenergic beta-3 Receptor Agonists	Compounds that bind to and activate ADRENERGIC BETA-3 RECEPTORS. (See all compounds classified as Adrenergic beta-3 Receptor Agonists.)	Mirabegron is indicated for the treatment of overactive bladder (OAB) - with symptoms of urge urinary incontinence, urgency, and urinary frequency - either alone or in combination with [solifenacin]. It is also indicated for the treatment of neurogenic detrusor overactivity (NDO) in pediatric patients 3 years of age and older and weighing 35kg or more.
mirabijalone E		mirabijalone E					
Miransertib		Miransertib	1313881-70-7	T1DQI1B52Y			
mirdametinib		N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide	391210-10-9	86K0J5AK6M			
Mirex	2385-85-5	Mirex	2385-85-5	Z917AN264P			
Mirtazapine		Mirtazapine	85650-52-8	A051Q2099Q	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	This drug is indicated for the treatment of major depressive disorder and its associated symptoms.  Mirtazapine has been used off-label for a variety of conditions including panic disorder, generalized anxiety disorder, dysthymia, tension headaches, hot flushes, post-traumatic stress disorder (PTSD), sleep disorders, substance abuse disorders, and sexual disorders, among others.
Misonidazole	13551-87-6	Misonidazole	13551-87-6	8FE7LTN8XE	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
Misoprostol	59122-46-2	Misoprostol	59122-46-2	0E43V0BB57	Oxytocics	Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) (See all compounds classified as Oxytocics.)	Misoprostol is indicated as a tablet to reduce the risk of NSAID induced gastric ulcers but not duodenal ulcers in high risk patients. Misoprostol is also formulated in combination with diclofenac to treat symptoms of osteoarthritis or rheumatoid arthritis in patients with a high risk of developing gastric ulcers. Misoprostol is used off label for the management of miscarriages, prevention of post partum hemorrhage, and is also used alone or in combination with mifepristone in other countries for first trimester abortions.
mitemcinal		Mitemcinal	154738-42-8	6X5NRJ664L			Investigated for use/treatment in gastroparesis and irritable bowel syndrome (IBS).
mithramycin A	97666-60-9	Plicamycin	18378-89-7	NIJ123W41V	Calcium-Regulating Hormones and Agents	Hormones and molecules with calcium-regulating hormone-like actions that modulate OSTEOLYSIS and other extra-skeletal activities to maintain calcium homeostasis. (See all compounds classified as Calcium-Regulating Hormones and Agents.)	For the treatment of testicular cancer, as well as hypercalcemia and hypercalciuria associated with a variety of advanced forms of cancer.
mithramycin SK		mithramycin SK					
mitiglinide		Mitiglinide	145375-43-5	D86I0XLB13	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	For the treatment of type 2 diabetes.
mito-carboxy proxyl		mito-carboxy proxyl					
mitochondrial uncoupler BAM15		mitochondrial uncoupler BAM15					
Mitogens		Mitogens					
Mitomycin	50-07-7	Mitomycin	50-07-7	50SG953SK6	Alkylating Agents	Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)	For treatment of malignant neoplasm of lip, oral cavity, pharynx, digestive organs, peritoneum, female breast, and urinary bladder. Also used as an adjunct to ab externo glaucoma surgery. Mitomycin is also indicated as a pyelocalyceal solution for the treatment of adults with low-grade upper tract urothelial cancer (LG-UTUC).
mitonafide	54824-17-8	Mitonafide	54824-17-8	06Q0V17SI9	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
mitoquinol		Mitoquinol	747398-82-9	65M41NIO61			
mitoquinone		Mitoquinone	444890-41-9	47BYS17IY0			Investigated for use/treatment in hepatitis (viral, C) and parkinson's disease.
Mitotane	53-19-0	Mitotane	53-19-0	78E4J5IB5J	Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	Mitotane is indicated for the treatment of inoperable, functional or nonfunctional, adrenocortical carcinoma.
MitoTEMPO		MitoTEMPO					
mitotracker green FM		mitoTracker Green FM	201860-17-5				
Mitoxantrone	65271-80-9	Mitoxantrone	65271-80-9	BZ114NVM5P	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For the treatment of secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis
mitozolomide	85622-95-3	Mitozolomide	85622-95-3	E3U7286V3W	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
mitragynine	4098-40-2	Mitragynine	4098-40-2	EP479K822J			
mitragynine pseudoindoxyl		Mitragynine pseudoindoxyl	2035457-43-1	BKA67VHE3B			
Mivacurium	106791-40-6	Mivacurium	133814-19-4		Neuromuscular Nondepolarizing Agents	Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. (See all compounds classified as Neuromuscular Nondepolarizing Agents.)	For inpatients and outpatients, as an adjunct to general anesthesia, to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
mivebresib		Mivebresib	1445993-26-9	VR86R11J7J			
mizolastine		Mizolastine	108612-45-9	244O1F90NA	Histamine H1 Antagonists, Non-Sedating	A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. (See all compounds classified as Histamine H1 Antagonists, Non-Sedating.)	
mizoribine	50924-49-7	Mizoribine	50924-49-7	4JR41A10VP	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	
MJN110		2,5-Dioxopyrrolidin-1-yl 4-(bis(4-chlorophenyl)methyl)piperazine-1-carboxylate	1438416-21-7				
MK 0591	136668-42-3	Quiflapon	136668-42-3	9295C885I4	5-Lipoxygenase-Activating Protein Inhibitors	Compounds that bind to and inhibit the action of 5-LIPOXYGENASE-ACTIVATING PROTEINS. (See all compounds classified as 5-Lipoxygenase-Activating Protein Inhibitors.)	
MK 2206		MK-2206	1032349-93-1	51HZG6MP1K			
MK 287	135947-75-0	2-[3-methoxy-2-propoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]sulfonylethanol	135947-75-0	FEE1BH3VXV			
MK 473	54197-05-6	[(6,7-Dichloro-2-cyclopentyl-2-methyl-1-oxo-2,3-dihydro-1h-inden-5-yl)oxy]acetic acid	53108-00-2		Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	
MK 6892		1-Cyclohexene-1-carboxylic acid, 2-((3-(3-(5-hydroxy-2-pyridinyl)-1,2,4-oxadiazol-5-yl)-2,2-dimethyl-1-oxopropyl)amino)-	917910-45-3	PH9ZB6IRW0			
MK-0249		2-Methyl-3-[4-(3-pyrrolidin-1-ylpropoxy)phenyl]-5-(trifluoromethyl)quinazolin-4-one	1167574-41-5	KF50235Q04			
MK-0524		Laropiprant	571170-77-9	G7N11T8O78			
MK-8722		(3R,3aR,6R,6aR)-6-[[6-chloro-5-(4-phenylphenyl)-1H-imidazo[4,5-b]pyridin-2-yl]oxy]-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-ol	1394371-71-1	RW3ZG69SHT			
MK-8776		6-bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(piperidin-3-yl)pyrazolo[1,5-a]pyrimidin-7-amine	891494-63-6				
MK-8825		2-((R)-8-(3,5-Difluorophenyl)-8-methyl-10-oxo-6,9-diazaspiro[4.5]decan-9-yl)-N-((S)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-3-yl)acetamide	1380887-60-4				
MK-886	118414-82-7	3-[3-Tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-propan-2-ylindol-2-yl]-2,2-dimethylpropanoic acid	118414-82-7	080626SQ8C	Lipoxygenase Inhibitors	Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)	
MK0626		MK0626					
MK2i peptide		MK2i peptide					
MK615 extract		MK615 extract					
MKC8866		7-hydroxy-6-methoxy-4-methyl-3-(2-morpholino-2-oxoethyl)-2-oxo-2H-chromene-8-carbaldehyde	1338934-59-0	1NZ0YBP9HB			
MKC9989		CID 89542001					
MKT 077		Pyridinium, 1-ethyl-2-[[3-ethyl-5-(3-methyl-2(3H)-benzothiazolylidene)-4-oxo-2-thiazolidinylidene]methyl]-, chloride (1:1)	147366-41-4	8PF5ZXI0JE			
ML 204		4-Methyl-2-(piperidin-1-yl)quinoline	5465-86-1				
ML 7	109376-83-2	1H-1,4-Diazepine, hexahydro-1-((5-iodo-1-naphthalenyl)sulfonyl)-	109376-83-2	E2C2LB77BF	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
ML 9	105637-50-1	1-((5-Chloronaphthalen-1-yl)sulfonyl)-1,4-diazepane hydrochloride	105637-50-1	BZ2L6JK93I	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
ML-792		{(1R,2S,4R)-4-[(5-{[1-(3-Bromobenzyl)-1H-pyrazol-3-yl]carbonyl}pyrimidin-4-yl)amino]-2-hydroxycyclopentyl}methyl sulfamate					
ML-SA1 compound		ML-SA1 compound					
ML240 compound		ML240 compound					
ML241 compound		ML241 compound					
ML324		N-(3-(Dimethylamino)propyl)-4-(8-hydroxyquinolin-6-yl)benzamide	1222800-79-4				
MLN 8237		Alisertib	1028486-01-2	T66ES73M18			For the treatment of various forms of cancer.
MLN8054		4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid	869363-13-3	BX854EHD63			
MM-589		N-{(3r,6s,9s,12r)-6-Ethyl-12-Methyl-9-[3-(N'-Methylcarbamimidamido)propyl]-2,5,8,11-Tetraoxo-3-Phenyl-1,4,7,10-Tetraazacyclotetradecan-12-Yl}-2-Methylpropanamide					
Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin		Mntmpyp	72924-08-4				
Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin		Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin					
mocetinostat		Mocetinostat	9003-99-0	A6GWB8T96J	Histone Deacetylase Inhibitors	Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)	
Moclobemide	71320-77-9	Moclobemide	71320-77-9	PJ0Y7AZB63	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	For the treatment of major depressive disorder and bipolar disorder.
Modafinil	68693-11-8	Modafinil	68693-11-8	R3UK8X3U3D	Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	To improve wakefulness in patients with excessive daytime sleepiness (EDS) associated with narcolepsy.
moexipril	103775-10-6	Moexipril	103775-10-6	WT87C52TJZ	Angiotensin-Converting Enzyme Inhibitors	A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)	For the treatment of hypertension.
mofegiline	119386-96-8	Mofegiline	119386-96-8	1FMJ6D8Y1B	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	
mofezolac	78967-07-4	Mofezolac	78967-07-4	RVJ0BV3H3Y	Cyclooxygenase Inhibitors	Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)	
mogroside V	88901-36-4	Mogroside V	88901-36-4	ZFF6Z51TUR			
molibresib		2-[(4s)-6-(4-Chlorophenyl)-8-Methoxy-1-Methyl-4h-[1,2,4]triazolo[4,3-A][1,4]benzodiazepin-4-Yl]-N-Ethylacetamide	1260907-17-2	5QIO6SRZ2R			Treatment of breast cancer
molinate	2212-67-1	Molinate	2212-67-1	68N5G08DJQ	Antispermatogenic Agents	Agents, either mechanical or chemical, which destroy spermatozoa in the male genitalia and block spermatogenesis. (See all compounds classified as Antispermatogenic Agents.)	
molinate sulfoxide		Molinate sulfoxide	52236-29-0	CK1Y8WEV19			
Molindone	7416-34-4	Molindone	7416-34-4	RT3Y3QMF8N	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Molindone is used for the management of the manifestations of psychotic disorders.
Molsidomine	25717-80-0	Molsidomine	25717-80-0	D46583G77X	Nitric Oxide Donors	A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)	The indications for use of molsidomine include ischemic heart disease, angina, chronic heart failure, and pulmonary hypertension.
moluodan		moluodan					
molybdate	14259-85-9	Molybdate	11116-47-5	O0L10E6352			
Molybdenum	7439-98-7	Molybdenum	7439-98-7	81AH48963U	Trace Elements	A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)	
molybdenum chloride		Molybdenum chloride	11119-46-3	779I95MPQK			
molybdenum trioxide	1313-27-5	Molybdenum trioxide	1313-27-5	22FQ3F03YS			
molybdopterin		Molybdopterin	220399-50-8	ATN6EG42UQ			
Mometasone Furoate		Mometasone Furoate	83919-23-7	04201GDN4R	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	Inhaled mometasone furoate is indicated for prophylaxis of asthma in patients 4 years. Applied topically as an ointment, mometasone furoate is indicated for symptomatic treatment of dermatitis and pruritis in patients 2 years.  Mometasone furoate nasal spray is available both over-the-counter (OTC) and by prescription. The OTC nasal spray formulation of mometasone furoate is indicated for the treatment of upper respiratory allergic symptoms (e.g. rhinorrhea, sneezing) in patients 2 years of age. The prescription formulation is indicated for the treatment of chronic rhinosinusitis with nasal polyps in patients 18 year old and for the and prophylaxis of seasonal allergic rhinitis in patients 12 years old. It is also approved in combination with [olopatadine] for the symptomatic treatment of seasonal allergic rhinitis in patients 12 years.
momfluorothrin		Momfluorothrin	609346-29-4	3782I29Z4G			
momordin I (Oleanolic Acid)		momordin I (Oleanolic Acid)					
momordin II (Oleanolic Acid)	95851-41-5	Momordin Ii (oleanolic Acid)	95851-41-5				
monascin		Monascin	21516-68-7	W74D2M37FX			
monascusic acid A		monascusic acid A					
monastrol		Monastrol	329689-23-8		Antimitotic Agents	Agents that arrest cells in MITOSIS, most notably TUBULIN MODULATORS. (See all compounds classified as Antimitotic Agents.)	
Monensin	17090-79-8	Monensin	17090-79-8	906O0YJ6ZP	Proton Ionophores	Chemical agents that increase the permeability of CELL MEMBRANES to PROTONS. (See all compounds classified as Proton Ionophores.)	For the reduction in the incidence of ketosis in the peri-parturient dairy cow/heifer which is expected to develop ketosis.
monepantel		Monepantel	887148-69-8	82MA79VJ33			Zolvix oral solution is a broad spectrum anthelmintic for the treatment and control of gastro-intestinal nematode infections and associated diseases in sheep including lambs, hoggets, breeding rams and ewes. , , Spectrum of activity includes fourth larvae and adults of: , , , Haemonchus contortus*; , Teladorsagia circumcincta*; , Teladorsagia trifurcata*; , Teladorsagia davtiani*; , Trichostrongylus axei*; , Trichostrongylus colubriformis; , Trichostrongylus vitrinus; , Cooperia curticei; , Cooperia oncophora; , Nematodirus battus; , Nematodirus filicollis; , Nematodirus spathiger; , Chabertia ovina; , Oesophagostomum venulosum. , , , * including inhibited larvae. , , The veterinary medicinal product is effective against strains of these parasites resistant to (pro)benzimidazoles, levamisole, morantel, macrocyclic lactones and H. contortus strains resistant to salicylanilides. ,
monepantel sulfone		Monepantel sulfone	851976-52-8	HXC5RGC2GW			
mono-(2-ethylhexyl)phthalate	4376-20-9	2-(((2-Ethylhexyl)oxy)carbonyl)benzoic acid	4376-20-9	FU2EWB60RT			
mono-benzyl phthalate	2528-16-7	Monobenzyl phthalate	2528-16-7	27NM8BNV1K			
mono-isobutyl phthalate		mono-isobutyl phthalate					
mono-n-butyltin		Monobutyltin	78763-54-9				
mono-N-demethyladinazolam	37115-33-6	Mono-N-demethyladinazolam	37115-33-6	NYA2I3DDW4			
mono-N-desethylamiodarone		Desethylamiodarone	83409-32-9	M31FU99E3Y			
mono-n-hexyl phthalate	24539-57-9	Monohexyl Phthalate	24539-57-9				
mono-n-octyl phthalate	5393-19-1	Octyl hydrogen phthalate	5393-19-1	9KSH93UAM4			
mono(2-ethyl-5-hydroxyhexyl) phthalate		Mono(2-ethyl-5-hydroxyhexyl) phthalate	40321-99-1				
mono(2-ethyl-5-oxohexyl)phthalate	40321-98-0	Mono(2-ethyl-5-oxohexyl)phthalate	40321-98-0	7J8J8977X9			
mono(carboxy-isooctyl)phthalate		mono(carboxy-isooctyl)phthalate					
monoacetin	26446-35-5	2,3-Dihydroxypropyl acetate	26446-35-5	1NA86SF2H2			
Monobactams		Monobactams					
monobenzone		Monobenzone	103-16-2	9L2KA76MG5			Used topically to treat the loss of skin color (vitiligo).
monobromobimane	71418-44-5	Monobromobimane	71418-44-5	V23UK0CYXL	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
monobutyl phthalate	131-70-4	Monobutyl phthalate	131-70-4	ZI46LWZ45G			
monobutyryl cyclic AMP	13117-60-7	Monobutyryl cyclic AMP	13117-60-7				
monochlorobimane	76421-73-3	Monochlorobimane	76421-73-3		Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
monochloropropanediol		162077-EP2284146A2					
Monocrotaline	315-22-0	Monocrotaline	315-22-0	73077K8HYV			
monocrotaline pyrrole	23291-96-5	Dehydromonocrotaline	23291-96-5	1HW8C6SVG7	Alkylating Agents	Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)	
Monocrotophos	6923-22-4	Monocrotophos	6923-22-4	5Q3PE07Z18	Monoamine Oxidase Inhibitors	A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed, p414) (See all compounds classified as Monoamine Oxidase Inhibitors.)	
monocrystalline iron oxide nanoparticle		monocrystalline iron oxide nanoparticle					
monocyte locomotion inhibitory factor		monocyte locomotion inhibitory factor					
monodansylcadaverine	10121-91-2	Dansylcadaverine	10121-91-2	I9N81SC5HD	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
monoethyl phosphate	1623-14-9	Ethyl dihydrogen phosphate	1623-14-9	BMH1WT204A			
monoethyl phthalate		Monoethyl phthalate	2306-33-4	NKH4WF48DS			
monoethylglycinexylidide	7728-40-7	Monoethylglycinexylidide	7728-40-7	D8Q99HC770			
Monoglycerides		68990-53-4					
Monoiodotyrosine	29592-76-5	3-Iodo-L-tyrosine	70-78-0	FRQ98U4U27			
monoisoamyl-2,3-dimercaptosuccinate		Monoisoamyl-2,3-dimercaptosuccinate	142609-62-9	9O8B0VBE22			
monoisononylphthalate		monoisononylphthalate					
monomethyl phthalate		2-(Methoxycarbonyl)benzoic acid	4376-18-5	2STT6D18JR			
monomethyl succinate	3878-55-5	Monomethyl succinate	3878-55-5	YA2V724S0A			
monomethylarsonic acid	124-58-3	Methylarsonic acid	124-58-3	J37VJ5709S	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
monomethylarsonous acid		Methylarsonous acid	25400-23-1				
Monomethylhydrazine	60-34-4	Methylhydrazine	60-34-4	UWA30B5Z1J			
monomethylmonothioarsonic acid		Monomethylmonothioarsonic acid					
monomethylpropion	5650-44-2	Methcathinone	5650-44-2	386QA522QG			
monoolein	25496-72-4	Glyceryl monooleate	25496-72-4	D3AEF6S35P			
monophosphoryl lipid A		monophosphoryl lipid A					
monorden	12772-57-5	Radicicol	12772-57-5	I60EH8GECX	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	
Monoterpenes		3-Carene	13466-78-9	H2M15SNR6N			
monotributyltin trichloride	1118-46-3	Butyltin trichloride	1118-46-3				
monotropein		Monotropein	5945-50-6	0Y61M84O2T			
montelukast	158966-92-8	Montelukast	158966-92-8	MHM278SD3E	Cytochrome P-450 CYP1A2 Inducers	Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP1A2. (See all compounds classified as Cytochrome P-450 CYP1A2 Inducers.)	Montelukast is indicated for:  (a) the prophylaxis and chronic treatment of asthma in adults and pediatric patients who are 12 months of age and older, although other regional health authorities specifically note this indication for adults and adolescents who are 15 years and older and also include indications for preventing day and night-time symptoms, and the treatment of acetylsalicylic acid-sensitive asthma;  (b) the prevention of exercise-induced bronchoconstriction (EIB) in patients who are 6 years of age and older, although other regional health authorities specifically note this indication for adults and adolescents who are 15 years and older; and  (c) the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older, although other regional health authorities specifically note the relief of seasonal allergic rhinitis symptoms for adults and adolescents who are 15 years and older.  Furthermore, some formulations like chewable montelukast tablets may also be specifically indicated by particular regulatory bodies for the prophylaxis and chronic treatment of asthma, including the prevention of day and night-time symptoms, the treatment of acetylsalicylic acid based asthma, and the prevention of exercise-induced bronchoconstriction in adult and pediatric patients aged 2 and older, between the ages 2 and 5, or between the ages of 6 and 14 years.  Moreover, when employed for such indications montelukast is considered effective as monotherapy or when combined with other medications indicated for the maintenance treatment of chronic asthma. For instance, montelukast and inhaled corticosteroids can be used concomitantly to demonstrate additive effects to control asthma or to decrease the necessary inhaled corticosteroid dose while still maintaining clinical stability.  Additionally, in patients who continue to experience asthma symptoms, montelukast can also be combined with an 'as required' short-acting beta-agonist, an inhaled corticosteroid, or inhaled corticosteroid paired with a long-acting beta-agonist.
monuron	150-68-5	Monuron	150-68-5	I99GAK5X1D			
MOPP protocol		MOPP protocol					
moracin M		Moracin M	56317-21-6	L9FI83128D			
morelloflavone	16851-21-1	8-[(2S,3R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydrochromen-3-yl]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one	16851-21-1	XH2KXX2C5D			
Moricizine	31883-05-3	Moricizine	31883-05-3	2GT1D0TMX1	Voltage-Gated Sodium Channel Blockers	A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)	Used to treat irregular heartbeats (arrhythmias) and maintain a normal heart rate.
morin	480-16-0	Morin	480-16-0	8NFQ3F76WR	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
moringin		Moringin	73255-40-0				
morniflumate	65847-85-0	Morniflumate	65847-85-0	R133MWH7X1			Morniflumate is indicated for the treatment of inflammatory conditions affecting the airways, ENT system, urogenital tract and bone and joint systems in adults. In Italy, morniflumate is also indicated for the treatment of pain associated with ear, nose, throat (ENT) and gastrointestinal inflammatory conditions in children.  Morniflumate is a well established NSAID that has been in use for over three decades in Italy (particularly for the treatment of upper respiratory tract infections in children), France, Belgium, Austria, Switzerland, Spain and Portugal; it has a generally favorable tolerability profile.
morphiceptin	74135-04-9	Morphiceptin	74135-04-9	97TZA8ANPC	Convulsants	Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)	
Morphine	57-27-2	Morphine	57-27-2	76I7G6D29C	Narcotics	Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)	Morphine is used for the management of chronic, moderate to severe pain.  Opiods, including morphine, are effective for the short term management of pain. Patients taking opioids long term may need to be monitored for the development of physical dependence, addiction disorder, and drug abuse.
morphine-3-glucuronide	20290-09-9	Morphine-3-glucuronide	20290-09-9	O27Z9CH39A	Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	
morphinone	467-02-7	Morphinone	467-02-7	28MBK63MAW			
Morpholines		Morpholines					
Morpholinos		Morpholinos					
morroniside		Morroniside	25406-64-8				
morusin	62596-29-6	Morusin	62596-29-6	T4VGD5NP9B			
mosapride	112885-42-4	Mosapride citrate	112885-42-4	MF497J489P	Gastrointestinal Agents	Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)	
motexafin gadolinium		Motexafin gadolinium	246252-06-2	0BG5NE3APZ	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	Investigated for use/treatment in brain cancer, cancer/tumors (unspecified), lung cancer, and lymphoma (non-hodgkin's).
moutan cortex		moutan cortex					
Moxalactam	64952-97-2	Latamoxef	64952-97-2	VUF6C936Z3	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Latamoxef is an oxacephem antibiotic usually grouped with the cephalosporins. It is used to treat bacterial infections. Latamoxef  is primarily indicated in conditions like Bone and joint infection, GI infections, Gynecological infections, Meningitis, Respiratory tract infections, Septicaemia, Skin infections, Soft tissue infections, UTI.
moxestrol		Moxestrol	34816-55-2	6923NT44OW	Estrogen Antagonists	Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)	
moxidectin		Moxidectin	113507-06-5	NGU5H31YO9	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	Moxidectin is indicated for the treatment of river blindness, also called onchocerciasis, in patients aged 12 years and older. River blindness is caused by a parasitic worm _Onchocerca volvulus_ and it is manifested as severe itching, disfiguring skin conditions and visual impairment caused by the worm's larvae.   The transmission of _Onchocerca volvulus_ is performed person to person by black flies that breed in fast-flowing rivers in sub-Saharan Africa, Yemen and South and Central America. The larvae released by the adult parasite invade skin and eyes where they can produce the severe disease manifestations.
Moxifloxacin		Moxifloxacin	151096-09-2	U188XYD42P	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of sinus and lung infections such as sinusitis, pneumonia, and secondary infections in chronic bronchitis. Also for the treatment of bacterial conjunctivitis (pinkeye).
Moxisylyte	54-32-0	Moxisylyte	54-32-0	PW8QYA7KI0	Miotics	Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here. (See all compounds classified as Miotics.)	By the WHO, moxisylyte is indicated for the symptomatic management of sequelae of cerebral infarction or hemorrhage. The cerebral infarction is characterized by the blockage of the artery either by the formation of a thrombus or an embolus.   On the other hand, the FDA classified moxisylyte for the reversal of phenylephrine-induced mydriasis in patients who have narrow anterior angles and are at risk of developing an acute attack of angle-closure glaucoma.  Closed-angle glaucoma is caused by the contact between the iris and the trabecular meshwork. This contact will damage the aqueous outflow by the meshwork thus, increasing eye pressure and producing the symptoms of glaucoma. Mydriasis is referred to the dilatation of the pupils and this standard body function is known to be a trigger factor for the development of acute closed-angle glaucoma.This risk is explained by the generation of a pupillary block, which is the contact between the pupillary margins and the lens, thus preventing flow from the aqueous humor to the anterior chamber and followed by an increased pressure gradient.   Moxisylyte is also approved in France as the first drug for the treatment of impotence.
moxonidine		Moxonidine	75438-57-2	CC6X0L40GW	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the treatment of mild to moderate essential or primary hypertension. Effective as most first-line antihypertensives when used as monotherapy.
mozavaptan		Mozavaptan	137975-06-5	17OJ42922Y	Antidiuretic Hormone Receptor Antagonists	Endogenous compounds and drugs that inhibit or block the activity of ANTIDUIRETIC HORMONE RECEPTORS. (See all compounds classified as Antidiuretic Hormone Receptor Antagonists.)	
MR 2266	56649-76-4	Mrz 2266 BS	56649-76-4		Narcotic Antagonists	Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)	
MRE 3008-F20		Mcp-neca			Purinergic P1 Receptor Antagonists	Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS. (See all compounds classified as Purinergic P1 Receptor Antagonists.)	
MRI-1867		(4S)-N-(1-aminoethylidene)-5-(4-chlorophenyl)-N'-(4-chlorophenyl)sulfonyl-4-phenyl-3,4-dihydropyrazole-2-carboximidamide					
MRK 003		(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide	623165-93-5	DJ2AZE88DE	Gamma Secretase Inhibitors and Modulators	Agents that suppress GAMMA-SECRETASE by inhibiting or modulating its activities. Targeted enzymatic activities include its involvement in accumulation of toxic AMYLOID BETA-PEPTIDES (e.g., A&#x3B2;42) in ALZHEIMER DISEASE and activation of NOTCH RECEPTOR mediated SIGNAL PATHWAYS in certain cancer types. (See all compounds classified as Gamma Secretase Inhibitors and Modulators.)	
MRS 1191		3-Benzyl 5-ethyl 6-methyl-2-phenyl-4-(2-phenylethynyl)-1,4-dihydropyridine-3,5-dicarboxylate	185222-90-6				
MRS 1845		N-Propargylnitrendipene	544478-19-5				
MRS 2211		2-[(2-Chloro-5-nitrophenyl)azo]-5-hydroxy-6-methyl-3-[(phosphonooxy)methyl]-4-pyridinecarboxaldehyde disodium salt					
MRT67307		N-{3-[(5-Cyclopropyl-2-{[3-(Morpholin-4-Ylmethyl)phenyl]amino}pyrimidin-4-Yl)amino]propyl}cyclobutanecarboxamide	1190378-57-4	MEY37JZ4XR			
MS 857	107189-96-8	4-Acetyl-1-methyl-7-(4-pyridyl)-5,6,7,8-tetrahydro-3(2H)-isoquinolinone	107189-96-8				
MSH, 4-Nle-7-Phe-alpha-	75921-69-6	Scenesse			Affinity Labels	Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. (See all compounds classified as Affinity Labels.)	Prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).
MST 312		MST 312					
MSX 3 compound		MSX 3 compound					
MT19c compound		MT19c compound					
MTDZ compound		MTDZ compound					
mu-conotoxin KIIIA, Conus kinoshitai		mu-conotoxin KIIIA, Conus kinoshitai					
mu-conotoxin PIIIA		mu-conotoxin PIIIA					
mucochloric acid	87-56-9	Mucochloric acid	87-56-9	5I5877JHIW			
muconaldehyde	3249-28-3	Hexa-2,4-dienedial	18409-46-6		Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
muconic acid	505-70-4	trans,trans-Muconic acid	3588-17-8	3KD92ZL2KH			
muconomycin A		Verrucarin A	3148-09-2	OL62X66O4I	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Mulberrin		Mulberrin	62949-79-5		Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
mulberrofuran C		Mulberrofuran C	77996-04-4				
mulberroside A		Mulberroside A	102841-42-9	OJU5SVA08B			
multi-kinase inhibitor 108600		multi-kinase inhibitor 108600					
mumbaistatin		Mumbaistatin	252961-22-1				
muraglitazar		Muraglitazar	331741-94-7	W1MKM70WQI			Investigated for use/treatment in diabetes mellitus type 2.
muricholic acid	39016-49-4	Muricholic acid	39016-49-4				
muristerone A	38778-30-2	Muristerone a	38778-30-2				
Muscarine	300-54-9	Muscarine	300-54-9	7T101UWZ5W	Muscarinic Agonists	Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate. (See all compounds classified as Muscarinic Agonists.)	
Muscarinic Agonists		Muscarinic Agonists					
Muscarinic Antagonists		Muscarinic Antagonists					
muscarinic toxin 7		Unii-9S0OA6A3HZ	946507-08-0	9S0OA6A3HZ			
Muscimol	2763-96-4	Muscimol	2763-96-4	D5M179TY2E	GABA-A Receptor Agonists	Endogenous compounds and drugs that bind to and activate GABA-A RECEPTORS. (See all compounds classified as GABA-A Receptor Agonists.)	
muscone		3-Methylcyclopentadecanone	541-91-3	5JO79R7S9R			
musk ketone	81-14-1	Musk ketone	81-14-1	483V3E1L6J	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
musk xylene	81-15-2	Musk xylene	81-15-2	1ZAO16GU5K			
Mustard Compounds		Mustard Compounds					
Mustard Gas	505-60-2	Mustard gas	505-60-2	T8KEC9FH9P	Chemical Warfare Agents	Chemicals that are used to cause the disturbance, disease, or death of humans during WARFARE. (See all compounds classified as Chemical Warfare Agents.)	
mustard oil	8007-40-7	Allyl isothiocyanate	57-06-7	BN34FX42G3	Food Preservatives	Substances capable of inhibiting, retarding or arresting the process of fermentation, acidification or other deterioration of foods. (See all compounds classified as Food Preservatives.)	
Mutagens		Mutagens					
MV026630		MV026630					
MW167		MW167					
MY 5445	78351-75-4	1-Phthalazinamine, N-(3-chlorophenyl)-4-phenyl-	78351-75-4	F8CSS73B6A			
Mycophenolic Acid	24280-93-1	Mycophenolic Acid	24280-93-1	HU9DX48N0T	Antibiotics, Antitubercular	Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. (See all compounds classified as Antibiotics, Antitubercular.)	Mycophenolic acid is an antimetabolite immunosuppressant indicated for prophylaxis of organ rejection in adult patients receiving kidney transplants and in pediatric patients at least 5 years of age and older who are at least 6 months post kidney transplant. Mycophenolic acid is used in combination with cyclosporine and corticosteroids.
mycophenolic acid glucuronide		Mycophenolic acid glucuronide	31528-44-6	54TS5J9T0K			
Mycoplasma arthritidis mitogen		Mycoplasma arthritidis mitogen					
Mycotoxins		Mycotoxins					
mycotrienin I	82189-03-5	Ansatrienin A	82189-03-5				
mycotrienin II	82189-04-6	CID 78393265					
myelin oligodendrocyte glycoprotein (35-55)		Myelin Oligodendrocyte Glycoprotein (35-55)					
myelin proteolipid protein (139-151)		myelin proteolipid protein (139-151)					
Myelophil		Myelophil					
MYK-461		Mavacamten	1642288-47-8	QX45B99R3J			Mavacamten is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms by the FDA, Health Canada, and the EMA.
myricetin	529-44-2	Myricetin	529-44-2	76XC01FTOJ			
myricitrin	17912-87-7	Myricitrin	17912-87-7	5Z0ZO61WPJ			
Myristic Acid	544-63-8	Myristic Acid	544-63-8	0I3V7S25AW			
myristicin	607-91-0	Myristicin	607-91-0	04PD6CT78W			
myristoylated autocamtide-2-related inhibitory peptide		myristoylated autocamtide-2-related inhibitory peptide					
myrrh resin	9000-45-7	9000-45-7					
myrsinoic acid B		Myrsinoic acid B					
myrtecaine	7712-50-7	Myrtecaine	7712-50-7				
myrtenal	564-94-3	Myrtenal	564-94-3				
myrtenol		Myrtenol	515-00-4				
myrtucommulone A		Myrtucommulone A	54247-21-1				
mytilan	78769-14-9	Mytilan					
myxothiazol		Myxothiazol	76706-55-3	6VY98BQ7NB	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
MZ-J-7-118		MZ-J-7-118					
N-(-4-(N-(biphenyl-2-ylmethyl)-N-2-methylpropylamino)- 1-(2-(2,4-difluorobenzoyl)benzoyl)pyrrolidin- 2-yl)methyl-3-(4-(2,4-dioxothiazolidin-5-ylidenemethyl) phenyl)acrylamide		N-(-4-(N-(biphenyl-2-ylmethyl)-N-2-methylpropylamino)- 1-(2-(2,4-difluorobenzoyl)benzoyl)pyrrolidin- 2-yl)methyl-3-(4-(2,4-dioxothiazolidin-5-ylidenemethyl) phenyl)acrylamide					
N-((1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl)octanamide		N-((1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl)octanamide					
N-((2-(hydroxyaminocarbonyl)methyl)-4-methylpentanoyl)-3-(2'-naphthyl)alanylalanine, 2-aminoethylamide		N-[(2S)-1-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-N'-hydroxy-2-(2-methylpropyl)butanediamide	143457-40-3				
N-((2,2-dimethyl-2,3-dihydrobenzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)benzylamine		N-((2,2-dimethyl-2,3-dihydrobenzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)benzylamine					
N-((2'-(((4,5-dimethyl-3-isoxazolyl)amino)sulfonyl)-4-(2-oxazolyl)(1,1'-biphenyl)-2-yl)methyl)-N,3,3-trimethylbutanamide		Edonentan	210891-04-6	S5016F5ZH4	Endothelin Receptor Antagonists	Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN RECECPTORS. (See all compounds classified as Endothelin Receptor Antagonists.)	
N-((3-(aminomethyl)phenyl)methyl)ethanimidamide		N-(3-(Aminomethyl)benzyl)acetamidine	180001-34-7	M1VB8VP8OH	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
N-((3,5-difluorophenyl)acetyl)alanyl-2-phenylglycine-1,1-dimethylethyl ester		N-((3,5-difluorophenyl)acetyl)alanyl-2-phenylglycine-1,1-dimethylethyl ester					
N-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-1H-indazole-3-carboxamide hydrochloride		Facinicline hydrochloride	677305-02-1	O6J463N18M			
N-((4-(((3-(6-((2-amino-1,3-benzothiazol-4-yl)oxy)pyrimidin-4-yl)) -6-(trifluoromethyl)pyridin-2-yl)amino)methyl)-2-fluorophenyl)methanesulfonamide		N-((4-(((3-(6-((2-amino-1,3-benzothiazol-4-yl)oxy)pyrimidin-4-yl)) -6-(trifluoromethyl)pyridin-2-yl)amino)methyl)-2-fluorophenyl)methanesulfonamide					
N-((4-(4-methylpiperazin-1-yl)phenyl)methyl)-1,2-oxazole-5-carboxamide		N-((4-(4-methylpiperazin-1-yl)phenyl)methyl)-1,2-oxazole-5-carboxamide					
N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide		N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide					
N-((4-dimethylaminophenyl)methyl)-N-(4-isopropylphenyl)-7-methoxy-1,2,3,4-tetrahydronaphthalen-1-carboxamide		N-((4-dimethylaminophenyl)methyl)-N-(4-isopropylphenyl)-7-methoxy-1,2,3,4-tetrahydronaphthalen-1-carboxamide					
N-((5-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)propyl)thiophen-2-yl)carbonyl)glutamic acid		N-((5-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)propyl)thiophen-2-yl)carbonyl)glutamic acid					
N-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine		N-[[5-[3-(1-benzylpiperidin-4-yl)propoxy]-1-methylindol-2-yl]methyl]-N-methylprop-2-yn-1-amine					
N-((5-(3-(4,6-difluoro-1H-benzimidazol-2-yl)-1H-indazol-5-yl)-4-methylpyridin-3-yl)methyl)ethanamine		N-((5-(3-(4,6-difluoro-1H-benzimidazol-2-yl)-1H-indazol-5-yl)-4-methylpyridin-3-yl)methyl)ethanamine					
N-(1-((4-(2-(((2,4-dichlorophenyl)sulfonyl)amino)-3-hydroxypropanoyl)-1-piperazinyl)carbonyl)-3-methylbutyl)-1-benzothiophene-2-carboxamide		N-(1-((4-(2-(((2,4-dichlorophenyl)sulfonyl)amino)-3-hydroxypropanoyl)-1-piperazinyl)carbonyl)-3-methylbutyl)-1-benzothiophene-2-carboxamide					
N-(1-((4-(3-carbamoylphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-2-methylpropyl)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide		N-(1-((4-(3-carbamoylphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-2-methylpropyl)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide					
N-(1-(2,3-dihydro(1,4)dioxin-5-yl)piperidi-4-yl)indan-2-ylamine		N-(1-(2,3-dihydro(1,4)dioxin-5-yl)piperidi-4-yl)indan-2-ylamine					
N-(1-(2,3-dimethoxyphenyl)-4-methyl-3-penten-1-yl)-1-(5-bromofurfuryl)-1-piperidyl-4-amine		N-(1-(2,3-dimethoxyphenyl)-4-methyl-3-penten-1-yl)-1-(5-bromofurfuryl)-1-piperidyl-4-amine					
N-(1-(3-chloro-4-hydroxyphenyl)-3-(1,1-dimethylethyl)-1H-pyrazol-5-yl)-N'-((2-((3-(2-((2-hydroxyethyl)thio)phenyl)-1,2,4-triazolo(4,3-a)pyridin-6-yl)thio)phenyl)methyl)-urea		N-(1-(3-chloro-4-hydroxyphenyl)-3-(1,1-dimethylethyl)-1H-pyrazol-5-yl)-N'-((2-((3-(2-((2-hydroxyethyl)thio)phenyl)-1,2,4-triazolo(4,3-a)pyridin-6-yl)thio)phenyl)methyl)-urea					
N-(1-(3-morpholin-4-ylphenyl)ethyl)-3-phenylacrylamide		N-(1-(3-morpholin-4-ylphenyl)ethyl)-3-phenylacrylamide					
N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine		3-Pyridazinamine, N-(1-((3,4-difluorophenyl)methyl)-4-piperidinyl)-6-(trifluoromethyl)-, hydrochloride (1:2)	2108806-02-4	Y3XCP46PA8	Dopamine D2 Receptor Antagonists	Compounds and drugs that bind to and inhibit or block the activation of DOPAMINE D2 RECEPTORS. (See all compounds classified as Dopamine D2 Receptor Antagonists.)	
N-(1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)-2-(1H-indol-3-yl)ethyl)-2-aminoacetamide		N-(1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)-2-(1H-indol-3-yl)ethyl)-2-aminoacetamide					
N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl)piperidin-1-yl)propan-2-yl)-2-naphthamide		N-(1-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl)piperidin-1-yl)propan-2-yl)-2-naphthamide					
N-(1-(4-cyclopropylmethyl-3,4-dihydro-2H-benzo(1,4)oxazin-6-yl)ethyl)-3-(2-fluorophenyl)acrylamide		N-(1-(4-cyclopropylmethyl-3,4-dihydro-2H-benzo(1,4)oxazin-6-yl)ethyl)-3-(2-fluorophenyl)acrylamide					
N-(1-(4-fluoro-3-morpholin-4-ylphenyl)ethyl)-3-(4-fluorophenyl)acrylamide		N-(1-(4-fluoro-3-morpholin-4-ylphenyl)ethyl)-3-(4-fluorophenyl)acrylamide					
N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine		N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine					
N-(1-(aminocarbonyl)-2-methylpropyl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide		N-(1-(aminocarbonyl)-2-methylpropyl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide					
N-(1-(cyclohexylmethyl)piperidin-4-yl)-2-(4-isopropyl-1,4-diazepan-1-yl)-6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-amine		N-(1-(cyclohexylmethyl)piperidin-4-yl)-2-(4-isopropyl-1,4-diazepan-1-yl)-6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-amine					
N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-(1-(2-cyclopentyl-ethyl)-piperidin-4yl)acrylamide		trans-N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyanophenyl)-N-(1-(2-cyclopentylethyl)piperidin-4-yl)acrylamide	683746-68-1	OW44B6FA0Y			
N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide		N-(1-Adamantyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide	1400742-13-3	TX64ZY5P0R			
N-(1-adamantyl)-1-pentylindazole-3-carboxamide		Apinaca	1345973-53-6	MHR0400Y84			
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide		N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide	1863065-99-9	8FST4IAG3N			
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide		N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide	1445583-20-9	3KIP69YNQK			
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide		Adb-pinaca	1633766-73-0	U1Q4F41C9U			
N-(1-azabicyclo(2.2.2)oct-3-yl)furo(2,3-c)pyridine-5-carboxamide		N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide	478149-53-0	R36R9KVD6Y			
N-(1-cyclohexylpiperidin-4-yl)-2-(4-isopropyl-1,4-diazepan-1-yl)-6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-amine		N-(1-cyclohexylpiperidin-4-yl)-2-(4-isopropyl-1,4-diazepan-1-yl)-6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-amine	1320288-17-2	Z5F4D95Y7J			
N-(1-ethyl-1-(4-methylphenyl)propyl)-7,7-dimethyl-5-phenyl-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide		N-(1-ethyl-1-(4-methylphenyl)propyl)-7,7-dimethyl-5-phenyl-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide					
N-(1-ethylpropyl)-(3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl)amine		N-(1-ethylpropyl)-(3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl)amine					
N-(1-fluoro-3-phenylpropan-2-yl)-N-methylprop-2-yn-1-amine		N-(1-fluoro-3-phenylpropan-2-yl)-N-methylprop-2-yn-1-amine					
N-(1-methyl-2-oxo-1,2,3,4-tetrahydro-7-quinolyl)-2-((2-methylpyrrolidin-1-yl)methyl)biphenyl-4-carboxamide		N-(1-methyl-2-oxo-1,2,3,4-tetrahydro-7-quinolyl)-2-((2-methylpyrrolidin-1-yl)methyl)biphenyl-4-carboxamide					
N-(1-methyl-2-phenylethyl)adenosine	20125-40-0	N-(1-Methyl-2-phenylethyl)adenosine	20125-40-0		Neuroprotective Agents	Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)	
N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea		1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea	152239-46-8	9VHM49MS42			
N-(1-methylethyl)-1,1,2-trimethylpropylamine		Iptakalim	642407-44-1	O0A6DQ769T			
N-(1-naphthyl)ethylenediamine	551-09-7	N-(1-Naphthyl)ethylenediamine	551-09-7	02X37521XE			
N-(1-phenylcyclohexyl)-3-ethoxypropanamine		Pcepa	836627-78-2	X1YWK0A61T			
N-(1-pyrenyl)iodoacetamide	76936-87-3	N-(1-pyrenyl)iodoacetamide	76936-87-3	D39CEY9MDL	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
N-(1,2,3,4-tetrahydro-1-naphthyl)-4-nitroaniline		N-(4-nitrophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine					
N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide		N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide					
N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide		N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide	349438-38-6				
N-(1,3-dimethylbutyl)-N'-phenyl-1,4-phenylenediamine	793-24-8	N-(1,3-Dimethylbutyl)-N'-phenyl-p-phenylenediamine	793-24-8	HJD0U67PS1			
N-(1,3-dimethylbutyl)-N'-phenyl-p-phenylenediamine quinone		N-(1,3-dimethylbutyl)-N'-phenyl-p-phenylenediamine quinone					
N-(2-(1-azabicyclo(3.3.0)octan-5-yl)ethyl)-2-nitroaniline		N-(2-(1-azabicyclo(3.3.0)octan-5-yl)ethyl)-2-nitroaniline	167889-18-1				
N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide		Sedaxane	874967-67-6	UHZ33J8Z9F			
N-(2-(2-(2-aminoethoxy)ethoxy)ethyl)-N-butyl-6-decyl-1,3,5-triazine-2,4-diamine		N-(2-(2-(2-aminoethoxy)ethoxy)ethyl)-N-butyl-6-decyl-1,3,5-triazine-2,4-diamine					
N-(2-(2-(4-(4-(2-hydroxypropyl)piperazin-1-yl)-2-methoxyphenylamino)pyrrolo(2,1-f)(1,2,4)triazin-7-yl)phenyl)-N-methylmethanesulfonamide		N-(2-(2-(4-(4-(2-hydroxypropyl)piperazin-1-yl)-2-methoxyphenylamino)pyrrolo(2,1-f)(1,2,4)triazin-7-yl)phenyl)-N-methylmethanesulfonamide					
N-(2-(2-ethyl-8,9-dihydrofuro(3,2-c)pyrazolo(1,5-a)pyridin-1-yl)ethyl)acetamide		N-(2-(2-ethyl-8,9-dihydrofuro(3,2-c)pyrazolo(1,5-a)pyridin-1-yl)ethyl)acetamide					
N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide		N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide					
N-(2-(3-(3,5-bis(trifluoromethyl)phenyl)ureido)ethyl)glycyrrhetinamide		N-(2-(3-(3,5-bis(trifluoromethyl)phenyl)ureido)ethyl)glycyrrhetinamide					
N-(2-(3-chloro-5-(trifluoromethyl)-2-pyridyl)ethyl)-alpha,alpha,alpha-trifluoro-o-toluamide		N-(2-(3-chloro-5-(trifluoromethyl)-2-pyridyl)ethyl)-alpha,alpha,alpha-trifluoro-o-toluamide					
N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin		N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(dimethylamino)ethylamine	138356-20-4	1S3X75QGDO			
N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine		N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine					
N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo(3,2-d)pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide		Tak-285	871026-44-7	70CCB438L6			
N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide	162760-96-5	Cyclohexanecarboxamide, n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-n-2-pyridinyl-	162760-96-5	71IH826FEG	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide	127243-85-0	N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide	127243-85-0	M876330O56	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
N-(2-(4-hydroxyphenyl)ethyl)-2-(2,5-dimethoxyphenyl)-3-(3-methoxy-4-hydroxyphenyl)acrylamide		N-(2-(4-hydroxyphenyl)ethyl)-2-(2,5-dimethoxyphenyl)-3-(3-methoxy-4-hydroxyphenyl)acrylamide					
N-(2-(7-(cyclohexylmethyl)-1,6-dihydro-2H-indeno(5,4-b)furan-8-yl)ethyl)acetamide		N-(2-(7-(cyclohexylmethyl)-1,6-dihydro-2H-indeno(5,4-b)furan-8-yl)ethyl)acetamide					
N-(2-(dimethylamino)ethyl)-2-aminothiazonaphthalimide		N-(2-(dimethylamino)ethyl)-2-aminothiazonaphthalimide					
N-(2-(m-methoxyphenyl)ethyl)-N-ethyl-2-(1-pyrrolidinyl)ethylamine		N-(2-(m-methoxyphenyl)ethyl)-N-ethyl-2-(1-pyrrolidinyl)ethylamine					
N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide	84478-11-5	N-(2-(Methylamino)ethyl)-5-isoquinolinesulfonamide	84478-11-5	TX277E49WT	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
N-(2-(o-methoxyphenyl)ethyl)-N-ethyl-2-(1-pyrrolidinyl)ethylamine		N-(2-(o-methoxyphenyl)ethyl)-N-ethyl-2-(1-pyrrolidinyl)ethylamine					
N-(2-(p-methoxyphenyl)ethyl)-N-ethyl-2-(1-pyrrolidinyl)ethylamine		N-(2-(p-methoxyphenyl)ethyl)-N-ethyl-2-(1-pyrrolidinyl)ethylamine					
N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide		N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide	349453-49-2	BDP0YZR82B	Endothelin A Receptor Antagonists	Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN A RECECPTORS. (See all compounds classified as Endothelin A Receptor Antagonists.)	Investigated for use/treatment in congestive heart failure, hypertension, and pulmonary hypertension.
N-(2-amino-3-methyl-n-butyl)-3-((bis-4-fluorophenyl)methoxy)tropane		N-(2-amino-3-methyl-n-butyl)-3-((bis-4-fluorophenyl)methoxy)tropane					
N-(2-aminoethyl)-4-(5-(4-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide		N-(2-aminoethyl)-4-(5-(4-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide					
N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide	120615-25-0	N-(2-Aminoethyl)-5-chloroisoquinoline-8-sulfonamide	120615-25-0	3IE84W82O5			
N-(2-aminoethyl)-5-isoquinolinesulfonamide	84468-17-7	N-(2-aminoethyl)isoquinoline-5-sulfonamide	84468-17-7		Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
N-(2-chloro-4-pyridyl)-N'-phenylurea		Forchlorfenuron	68157-60-8	K62IP7463J	Plant Growth Regulators	Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins. (See all compounds classified as Plant Growth Regulators.)	
N-(2-chloroethyl)-4-piperidinyl diphenylacetate	130817-71-9	N-(2-Chloroethyl)-4-piperidinyl diphenylacetate	130817-71-9				
N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine		Tecalcet hydrochloride	177172-49-5	3HP28R98LC			
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	123653-11-2	N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamide	123653-11-2	9SP55KM2KS	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
N-(2-ethylhexyl)-5-norbornene-2,3-dicarboxamide		5-Norbornene-2,3-dicarboximide, N-(2-ethylhexyl)-	113-48-4	1B9RV7L76C			
N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide		N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide					
N-(2-hydroxy-3-(2-cyano-3-chlorophenoxy)propyl)-1,1-dimethyl-2-(2-nephthyl)ethylamine		N-(2-hydroxy-3-(2-cyano-3-chlorophenoxy)propyl)-1,1-dimethyl-2-(2-nephthyl)ethylamine					
N-(2-hydroxybenzoyl)tyramine		N-(2-hydroxybenzoyl)tyramine					
N-(2-hydroxybenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-aminium		N-(2-hydroxybenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-aminium					
N-(2-hydroxybenzyl)glycine		N-(2-hydroxybenzyl)glycine					
N-(2-hydroxyethyl)retinamide	33631-47-9	N-(2-Hydroxyethyl)retinamide	33631-47-9	ZBJ8HC23XW			
N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugate	171714-74-2	N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugate					
N-(2-mercaptoethyl)-1,3-diaminopropane		2-((3-Aminopropyl)amino)ethanethiol	31098-42-7	05P3K9I49L	Radiation-Protective Agents	Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)	
N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide		N-[2-methyl-3-[[4-[4-[[4-(trifluoromethoxy)phenyl]methoxy]piperidin-1-yl]-1,3,5-triazin-2-yl]amino]phenyl]acetamide					
N-(2-methyl-3-hydroxyphenyl)-5,8,11,14-eicosatetraenamide		N-(2-methyl-3-hydroxyphenyl)-5,8,11,14-eicosatetraenamide					
N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine		N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine					
N-(2-naphthalenyl)-((3,5-dibromo-2,4-dihydroxyphenyl)methylene)glycine hydrazide		CFTR Inhibitor II, GlyH-101					
N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine		N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine					
N-(2-pyridone-6-yl)-N',N'-di-n-propylformamidine	111757-17-6	N'-(1,6-Dihydro-6-oxo-2-pyridinyl)-N,N-dipropylmethanimidamide	111757-17-6	DXF3D37XR3			
N-(2-thiolethyl)-2-(2-(N'-(2,6-dichlorophenyl)amino) phenyl)acetamide		N-(2-thiolethyl)-2-(2-(N'-(2,6-dichlorophenyl)amino) phenyl)acetamide					
N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide		Fenhexamid	126833-17-8	Q68C3C9P1U			
N-(2,4-dichloro-5-(4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl)phenyl)methanesulfonamide		Sulfentrazone	122836-35-5	7TY7WT1599			
N-(2'-(dimethylamino)ethyl)acridine-4-carboxamide	89459-25-6	Acridine carboxamide	89459-25-6	0N3V8R4E13	Topoisomerase II Inhibitors	Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)	
N-(2'-deoxyguanosin-8-yl)-3-aminobenzanthrone		n-(2'-Deoxyguanosin-8-yl)-3-aminobenzanthrone					
N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide		N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide					
N-(3-((2-ethyl-4-methyl-1H-imidazol-5-yl)methylene)-2-oxoindolin-5-yl)propiolamide		N-(3-((2-ethyl-4-methyl-1H-imidazol-5-yl)methylene)-2-oxoindolin-5-yl)propiolamide					
N-(3-((2-hydroxynaphthalen-1-ylmethylene)amino)phenyl)-2-phenylpropionamide		N-(3-((2-hydroxynaphthalen-1-ylmethylene)amino)phenyl)-2-phenylpropionamide					
N-(3-((5-cyano-6-methylpyridin-2-yl)oxy)-2,2,4,4-tetramethylcyclobutyl)imidazo(1,2-a)pyrimidine-3-carboxamide		N-(3-((5-cyano-6-methylpyridin-2-yl)oxy)-2,2,4,4-tetramethylcyclobutyl)imidazo(1,2-a)pyrimidine-3-carboxamide					
N-(3-(2-dimethylamino)ethoxy-4-methoxyphenyl)-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-(1,1'-biphenyl)-4-carboxamide		N-(3-(2-dimethylamino)ethoxy-4-methoxyphenyl)-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-(1,1'-biphenyl)-4-carboxamide					
N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide		Taranabant	701977-09-5	X9U622S114	Cannabinoid Receptor Agonists	Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)	Investigated for use/treatment in obesity.
N-(3-(aminomethyl)benzyl)acetamidine		N-(3-(Aminomethyl)benzyl)acetamidine	180001-34-7	M1VB8VP8OH	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
N-(3-(aminosulfonyl)-4-chloro-2-hydroxyphenyl)-N'-(2,3-dichlorophenyl)urea		N-(3-(aminosulfonyl)-4-chloro-2-hydroxyphenyl)-N'-(2,3-dichlorophenyl)urea					
N-(3-aminopropyl)-2-(((3-methylphenyl) methyl)oxy)-N-(2-thienylmethyl)benzamide hydrochloride salt		N-(3-aminopropyl)-2-(((3-methylphenyl) methyl)oxy)-N-(2-thienylmethyl)benzamide hydrochloride salt					
N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide		N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide					
N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide		N-(3-Chloro-4-morpholinophenyl)-N'-hydroxyformimidamide	339071-18-0	FP24MFJ1RM			
N-(3-chloro-5-trifluoromethylpyridin-2-ylmethyl-2,3,5,6-tetrafluoro-4-methoxybenzamide		N-(3-chloro-5-trifluoromethylpyridin-2-ylmethyl-2,3,5,6-tetrafluoro-4-methoxybenzamide					
N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide		Indisulam	165668-41-7	WJ98J3NM90	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Investigated for use/treatment in lung cancer.
N-(3-chlorophenyl)-2-(4-((2,4-dioxothiazolidin-5-ylidene)methyl)phenoxy)acetamide		N-(3-chlorophenyl)-2-(4-((2,4-dioxothiazolidin-5-ylidene)methyl)phenoxy)acetamide					
N-(3-fluoro-4-nitronaphthyl)-5-norbornene-2,3-dicarboxylic imide		N-(3-fluoro-4-nitronaphthyl)-5-norbornene-2,3-dicarboxylic imide					
N-(3-fluorophenyl)-1-((4-(((3S)-3-methyl-1-piperazinyl)methyl)phenyl)acetyl)-4-piperidinamine		Camicinal	923565-21-3	3C8348951H			
N-(3-furylmethyl)eicosa-5,8,11,14-tetraenamide		N-(3-furylmethyl)eicosa-5,8,11,14-tetraenamide					
N-(3-hydroxy-1-(naphthalen-1-yl)-1,8,11-trioxa-5-azatridecan-13-yl)-6-(2-(2-(4,4-difluoro-4,4a-dihydro-5-(thiophen-2-yl)-4-bora-3a,4a-diaza-s-indacene-3-yl)vinyl)phenoxyacetamido)hexanamide		N-(3-hydroxy-1-(naphthalen-1-yl)-1,8,11-trioxa-5-azatridecan-13-yl)-6-(2-(2-(4,4-difluoro-4,4a-dihydro-5-(thiophen-2-yl)-4-bora-3a,4a-diaza-s-indacene-3-yl)vinyl)phenoxyacetamido)hexanamide					
N-(3-iodoprop-(2)-enyl)		N-(3-iodoprop-(2)-enyl)					
N-(3-methoxyphenyl)-4-chlorocinnamanilide		N-(3-methoxyphenyl)-4-chlorocinnamanilide	472981-92-3	E8EY4M2N4H			
N-(3-nitratopivaloyl)cysteine ethyl ester	130432-17-6	N-(3-Nitratopivaloyl)cysteine ethyl ester	130432-17-6				
N-(3-oxo-3-(4-(pyridin-4-yl)piperazin-1-yl)propyl)benzo(c)(1,2,5)thiadiazole-4-sulfonamide		N-(3-oxo-3-(4-(pyridin-4-yl)piperazin-1-yl)propyl)benzo(c)(1,2,5)thiadiazole-4-sulfonamide					
N-(3-oxododecanoyl)homoserine lactone		N-(3-Oxododecanoyl)homoserine lactone	152833-54-0				
N-(3-phenoxy-4-pyridinyl)trifluoromethanesulfonamide		N-(3-phenoxy-4-pyridinyl)trifluoromethanesulfonamide					
N-(3-phenoxycinnamyl)acetohydroxamic acid	106328-57-8	N-(3-phenoxycinnamyl)acetohydroxamic acid	106328-57-8	ZK4N9HRN7L	Lipoxygenase Inhibitors	Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)	
N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline	134448-10-5	Cathepsin B Inhibitor III			Cysteine Proteinase Inhibitors	Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. (See all compounds classified as Cysteine Proteinase Inhibitors.)	
N-(3,3-diphenylpropyl)-N'-(1-(3,4-bis(butoxyphenyl))ethyl)propylenediamine		N-(3,3-diphenylpropyl)-N'-(1-(3,4-bis(butoxyphenyl))ethyl)propylenediamine					
N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide		Bay 869766;rdea119					
N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide		N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide	978-62-1	76145IS906			
N-(3,5-dichlorophenyl)succinimide	24096-53-5	N-(3,5-Dichlorophenyl)succinimide	24096-53-5	4GNU6A4VQ6	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine		N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine	945595-80-2	9R2G075611			
N-(4-((4,5-dichloro-2-fluorophenyl)amino)quinazolin-6-yl)acrylamide		N-(4-((4,5-dichloro-2-fluorophenyl)amino)quinazolin-6-yl)acrylamide					
N-(4-((5-(((cyclopentyloxy)carbonyl)amino)benzo(b)thien-3-yl)methyl)-3-methoxybenzoyl)benzenesulfonamide	107786-74-3	N-(4-((5-(((Cyclopentyloxy)carbonyl)amino)benzo(b)thien-3-yl)methyl)-3-methoxybenzoyl)benzenesulfonamide	107786-74-3				
N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide		Daporinad	658084-64-1	V71TF6V9M7			
N-(4-(2-((2-hydroxy-2-(3-pyridinyl)ethyl)amino)ethyl)phenyl)-4-(4-(4-(trifluoromethyl)phenyl)thiazol-2-yl)benzenesulfonamide		N-(4-(2-((2-hydroxy-2-(3-pyridinyl)ethyl)amino)ethyl)phenyl)-4-(4-(4-(trifluoromethyl)phenyl)thiazol-2-yl)benzenesulfonamide					
N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide		N-(4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenyl)methanesulfonamide					
N-(4-(2-(4-(3-cyano-5-trifluoromethylphenyl)piperazin-1-yl)ethyl)cyclohexyl)-3-pyridinesulfonic amide		N-(4-(2-(4-(3-cyano-5-trifluoromethylphenyl)piperazin-1-yl)ethyl)cyclohexyl)-3-pyridinesulfonic amide					
N-(4-(2-(8-cyano-1,3a,4,9b-tetrahydro(1)benzopyrano(3,4-c)pyrrol-2(3H)-yl)ethyl)phenyl)acetamide		N-(4-(2-(8-cyano-1,3a,4,9b-tetrahydro(1)benzopyrano(3,4-c)pyrrol-2(3H)-yl)ethyl)phenyl)acetamide					
N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide		N-(4-((2-amino-3-chloropyridin-4-yl)oxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide	1025720-94-8	A3MMS6HDO1			
N-(4-(2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl)-2-pyridyl)benzamide		Benzamide, N-[4-[2-ethyl-4-(3-methylphenyl)-5-thiazolyl]-2-pyridinyl]-	303162-79-0	WE92U03C5Z			
N-(4-(2-hydroxy-3-(2-methoxy-1-oxyethylaminobenzene)propoxy))benzaldehyde		N-(4-(2-hydroxy-3-(2-methoxy-1-oxyethylaminobenzene)propoxy))benzaldehyde					
N-(4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl)acrylamide		N-(4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl)acrylamide					
N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)but-2-enyl)-4-pyridine-2-ylbenzamide		N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)but-2-enyl)-4-pyridine-2-ylbenzamide					
N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide		N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide					
N-(4-(4-(3-aminocarbonyl-phenyl)-piperazin-1-yl)-butyl)-4-bromo-benzamide		N-(4-(4-(3-aminocarbonyl-phenyl)-piperazin-1-yl)-butyl)-4-bromo-benzamide					
N-(4-(4-amino-2-ethyl-1H-imidazo(4,5c)quinolin-1-yl)butyl)methanesulfonamide		N-(4-(4-amino-2-ethyl-1H-imidazo(4,5c)quinolin-1-yl)butyl)methanesulfonamide					
N-(4-(4-chlorobenzyloxy)pyridin-2-yl)-2-(2,6-difluorophenyl)acetamide		N-(4-(4-chlorobenzyloxy)pyridin-2-yl)-2-(2,6-difluorophenyl)acetamide					
N-(4-(6-(4-(1-(4-fluorophenyl)ethyl)piperazin-1-yl)pyrimidin-4-yloxy)benzo(d)thiazol-2-yl)acetamide		N-(4-(6-(4-(1-(4-fluorophenyl)ethyl)piperazin-1-yl)pyrimidin-4-yloxy)benzo(d)thiazol-2-yl)acetamide					
N-(4-(N-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(5-nitrothiophene-2-yl)acrylamide		Necrosulfonamide	432531-71-0				
N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide	81705-04-6	N-(4-aminobutyl)-5-chloronaphthalene-2-sulfonamide	81705-04-6				
N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide		Cppha	693288-97-0				
N-(4-chloro-3-methoxyphenyl)-2-picolinamide		N-(4-chloro-3-methoxyphenyl)-2-picolinamide					
N-(4-chlorobenzoyl)melatonin		N-(4-chlorobenzoyl)melatonin					
N-(4-chlorophenyl)-1-((3-(furan-2-yl)phenyl)carbonyl)piperidine-3-carboxamide		N-(4-chlorophenyl)-1-((3-(furan-2-yl)phenyl)carbonyl)piperidine-3-carboxamide					
N-(4-cyano-benzo(b)thiophene-2-carbonyl)guanidine		N-(4-cyano-benzo(b)thiophene-2-carbonyl)guanidine	861218-37-3	FX7EF8AXC3			
N-(4-cyanophenyl)-2-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-phenoxy)acetamide		N-(4-cyanophenyl)-2-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-phenoxy)acetamide					
N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal		Calpain Inhibitor VI	190274-53-4				
N-(4-hydroxy-3-methoxybenzyl)-7-hydroxy-8-methyl-5-nonenamide		Capsaicinol	137493-36-8				
N-(4-hydroxyphenyl)arachidonylamide		(5Z,8Z,11Z,14Z)-N-(4-hydroxyphenyl)icosa-5,8,11,14-tetraenamide	183718-77-6	XVJ94H0U21			
N-(4-methoxy-3-(4-methylpiperazin-1-yl)phenyl)-3-methyl-4-(4-pyridyl)benzamide		N-(4-methoxy-3-(4-methylpiperazin-1-yl)phenyl)-3-methyl-4-(4-pyridyl)benzamide					
N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea		N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-YL)urea	487021-52-3	87KSH90Q6D			
N-(4-methoxyphenyl)-4-menthone-3-carboxamide		N-(4-methoxyphenyl)-4-menthone-3-carboxamide					
N-(4-methoxyphenyl)retinamide	79965-10-9	N-(4-Methoxyphenyl)-all-trans-retinamide					
N-(4-O-(2-methoxy,phenoxyethylaminobutyl)-3-methoxybenzyl)nonamide		N-(4-O-(2-methoxy,phenoxyethylaminobutyl)-3-methoxybenzyl)nonamide					
N-(4-O-glycerol-3-methoxybenzyl)nonivamide	147465-43-8	Glyceryl nonivamide	147465-43-8				
N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide		Bctc	393514-24-4	3HW474Y8YZ			
N-(4((6-(((cyclopentyloxy)carbonyl)amino)benzimidazol-1-yl)methyl)-3-methoxybenzoyl)benzenesulfonamide	107786-78-7	N-(4((6-(((Cyclopentyloxy)carbonyl)amino)benzimidazol-1-yl)methyl)-3-methoxybenzoyl)benzenesulfonamide	107786-78-7				
N-(5-(((5-(1,1-dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide		N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide	345627-80-7	9979I93686			Investigated for use/treatment in cancer/tumors (unspecified), leukemia (unspecified), lymphoma (unspecified), multiple myeloma, and solid tumors.
N-(5-(3-dimethylaminobenzamido)-2-methylphenyl)-4-hydroxybenzamide		3-(dimethylamino)-N-(3-(4-hydroxybenzamido)-4-methylphenyl)benzamide	208260-29-1				
N-(5-amino-2-pyridinyl)-4-trifluoromethylbenzamide		N-(5-aminopyridin-2-yl)-4-(trifluoromethyl)benzamide					
N-(5-azido-6-chloropyridin-3-ylmethyl)-N'-methyl-N''-nitroguanidine		N-(5-azido-6-chloropyridin-3-ylmethyl)-N'-methyl-N''-nitroguanidine					
N-(5-methylisoxazol-3-yl)-2-(4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidin-2-ylthio)acetamide		N-(5-methylisoxazol-3-yl)-2-(4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidin-2-ylthio)acetamide					
N-(6-(6-chloro-5-(4-fluorophenylsulfonamido)pyridin-3-yl)benzo(d)thiazol-2-yl)acetamide		N-(6-(6-chloro-5-(4-fluorophenylsulfonamido)pyridin-3-yl)benzo(d)thiazol-2-yl)acetamide					
N-(6-chlorophenoxyhexyl)-N''-cyano-N''-4-pyridylguanidine		N-(6-chlorophenoxyhexyl)-N''-cyano-N''-4-pyridylguanidine					
N-(6-methylamino-3-nitrophenyl)-3-(3-indolyl)acrylamide		N-(6-methylamino-3-nitrophenyl)-3-(3-indolyl)acrylamide					
N-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine	86701-10-2	Hexanamide, N-(2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl)-6-((7-nitro-4-benzofurazanyl)amino)-	86701-10-2		Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)-3-(2-(piperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl)acrylamide		2-Propenamide, 3-(2-(1-piperidinyl)-6-(trifluoromethyl)-3-pyridinyl)-N-(5,6,7,8-tetrahydro-7-hydroxy-1-naphthalenyl)-, (2E)-	946615-43-6	CD7L9290QR			
N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide	103771-14-8	N-(8-Aminooctyl)-5-iodonaphthalene-1-sulfonamide	103771-14-8				
N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide		N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide	1354631-26-7	E6917946XH			
N-(adamantan-1-yl)-8-methoxy-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxamide		4-Quinolone-3-Carboxamide CB2 Ligand	1314230-69-7				
N-(adamtan-1-yl)-1-pentyl-1H-indole-3-carboxamide		Apica	1345973-50-3	HKU510FH74			
N-(benzyloxycarbonyl)-phenylalanyl-tyrosinal		N-(benzyloxycarbonyl)-phenylalanyl-tyrosinal					
N-(carboxyheptyl)maleimide	57079-00-2	N-(Carboxyheptyl)maleimide	57079-00-2				
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide		Momelotinib	1056634-68-4	6O01GMS00P	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	Momelotinib is indicated for the treatment of intermediate or high-risk myelofibrosis (MF), including primary MF or secondary MF [postpolycythemia vera (PV) and post-essential thrombocythemia (ET)], in adults with anemia.
N-(deoxyguanosin-8-yl)-1-aminopyrene	85989-43-1	N-(Deoxyguanosin-8-yl)-1-aminopyrene	85989-43-1				
N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	142784-25-6	N-(Deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-beta]pyridine	142784-25-6				
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester		Dapt	208255-80-5		Gamma Secretase Inhibitors and Modulators	Agents that suppress GAMMA-SECRETASE by inhibiting or modulating its activities. Targeted enzymatic activities include its involvement in accumulation of toxic AMYLOID BETA-PEPTIDES (e.g., A&#x3B2;42) in ALZHEIMER DISEASE and activation of NOTCH RECEPTOR mediated SIGNAL PATHWAYS in certain cancer types. (See all compounds classified as Gamma Secretase Inhibitors and Modulators.)	
N-(n-butyl)-(bis-fluorophenyl)methoxytropane		N-(n-butyl)-(bis-fluorophenyl)methoxytropane					
n-(n-nonyl)-deoxygalactonojirimycin		n-(n-nonyl)-deoxygalactonojirimycin					
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride		N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride					
N-(p-methylphenylsulfonyl)phenoxazine		55476-47-6					
N-(piperidin-1-yl)-1-(2,4-dichlorophenyl)-1,4-dihydro-6-methylindeno(1,2-c)pyrazole-3-carboxamide		N-(piperidin-1-yl)-1-(2,4-dichlorophenyl)-1,4-dihydro-6-methylindeno(1,2-c)pyrazole-3-carboxamide					
N-1-naphthalenyl-1-pentyl-1H-indazole-3-carboxamide		N-1-Naphthalenyl-1-pentyl-1H-indazole-3-carboxamide	1391484-80-2				
N-2-(4-bromophenyl) ethyl caffeamide		N-2-(4-bromophenyl) ethyl caffeamide					
N-2-diazo-3,3,3-trifluoropropionyl-3,5,3'-triiodothyronine	83093-58-7	L-T3 Pal	83093-58-7				
N-3-benzylnirvanol		(+/-)-N-3-Benzylnirvanol					
N-3-benzylphenobarbital		N-3-benzylphenobarbital					
N-4-chlorobenzoyl-N'-benzoyl-N'-tert-butylhydrazine		Halofenozide	112226-61-6	C81K20PELV	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
N-7-(2-(nitrophenyldithio)ethyl)mitomycin C	95056-36-3	N-7-(2-(Nitrophenyldithio)ethyl)mitomycin C	95056-36-3	27O4QKT84G			
N-acetyl glycine cysteine amide		N-acetyl glycine cysteine amide					
N-acetyl-4-benzoquinoneimine	50700-49-7	Acetimidoquinone	50700-49-7	G6S9BN13TI			
N-acetyl-Cys-Gly-Pro-Cys-amide		Ac-Cys-Gly-Pro-Cys-amide					
N-acetyl-N-formyl-5-methoxykynurenamine	52450-38-1	N-Acetyl-N-formyl-5-methoxykynurenamine	52450-38-1	S82P8JZ4YJ			
N-acetyl-S--(1,2,3,4,4-pentachlorobutadienyl)cysteine sulfoxide		N-acetyl-S--(1,2,3,4,4-pentachlorobutadienyl)cysteine sulfoxide					
N-acetyl-S-(2-carbamoylethyl)cysteine		N-acetyl-S-(2-carbamoylethyl)cysteine					
N-acetyl-S-(2-cyanoethyl)cysteine	74514-75-3	N-Acetyl-S-(2-cyanoethyl)-L-cysteine	74514-75-3	Q710T40465			
N-acetyl-S-(alpha-methyl-4-(2-methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl ester		N-acetyl-S-(alpha-methyl-4-(2-methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl ester					
N-acetyl-S-geranylgeranyl-cysteine		N-Acetyl-S-geranylgeranyl-L-cysteine	139332-94-8				
N-acetyl-S-pentachloro-1,3-butadienylcysteine	89784-39-4	S-Pentachlorobutadienyl-N-acetylcysteine	89784-39-4	CC5RL57PPV			
N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketone		Ac-YVAD-CMK			Cysteine Proteinase Inhibitors	Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. (See all compounds classified as Cysteine Proteinase Inhibitors.)	
N-Acetylcysteinamide	10061-64-0	N-Acetylcysteinamide	10061-64-0				
N-acetylcysteine lysinate		Nacystelyn	89344-48-9	8G1KV0RT1P			
N-acetyldopamine	2494-12-4	N-Acetyldopamine	2494-12-4	AYU97G37EM			
N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime	132489-69-1	Pugnac	132489-69-1	AWZ7VE64B6			
N-acetylglutamic acid		N-Acetyl-L-glutamic acid	1188-37-0	MA61H539YZ			
N-acetylleucyl-leucyl-norleucine		N-acetylleucyl-leucyl-norleucine					
N-acetylmannosamine	4773-29-9	N-Acetyl-D-Mannosamine	4773-29-9	X80PR7P73R			
N-acetylmethionine	65-82-7	N-Acetyl-L-methionine	65-82-7	9J12WX5B6A			
N-Acetylneuraminic Acid	131-48-6	N-acetyl-beta-neuraminic acid	131-48-6	TIP79W5HPN			
N-acetylpropargylglycine	23234-80-2	2-Acetamidopent-4-ynoic acid	23234-80-2				
N-acetylserotonin	1210-83-9	N-Acetyl-5-hydroxytryptamine	1210-83-9	P4TO3C82WV			
N-acetylsphingosine		N-acetylsphingosine	3102-57-6	8YTC7R47CW	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
N-acetyltryptophan	1218-34-4	N-Acetyl-L-tryptophan	1218-34-4	U9264T8OAE	Protease Inhibitors	Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)	
N-alpha-(2-carboxyl)benzoyl-N5-(2-chloro-1-iminoethyl)ornithine amide		N-alpha-(2-carboxyl)benzoyl-N5-(2-chloro-1-iminoethyl)ornithine amide					
N-alpha-(2-carboxyl)benzoyl-N5-(2-fluoro-1-iminoethyl)ornithine amide		N-alpha-(2-carboxyl)benzoyl-N5-(2-fluoro-1-iminoethyl)ornithine amide					
N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide		N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide					
N-arachidonoylalanine		N-Arachidonoyl-L-Alanine					
N-benzoyl-12-nitrodehydroabietylamine-7-one		N-benzoyl-12-nitrodehydroabietylamine-7-one					
N-benzoylalanine	2198-64-3	N-Benzoyl-L-alanine	2198-64-3				
N-benzoylphenylalanylphenylalinol acetate	56121-42-7	Asperglaucide	56121-42-7	2Z6NA534YE			
N-benzyl-N-ethyl-2-(7,8-dihydro-7-methyl-8-oxo-2-phenyl-9H-purin-9-yl)acetamide		N-benzyl-N-ethyl-2-(7,8-dihydro-7-methyl-8-oxo-2-phenyl-9H-purin-9-yl)acetamide					
N-benzyl-N-hydroxy-5-phenylpentamide	158999-12-3	N-benzyl-N-hydroxy-5-phenylpentanamide	158999-12-3				
N-benzyl-N-methyl-2-(7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide		N-benzyl-N-methyl-2-(7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide					
N-benzyladriamycin-14-valerate	98983-21-2	N-Benzyladriamycin-14-valerate	98983-21-2				
N-benzyloxycarbonyl-valyl-leucyl-leucinal		N-benzyloxycarbonyl-valyl-leucyl-leucinal					
N-benzyloxycarbonylprolylprolinal	86925-97-5	Z-Pro-prolinal	88795-32-8	4YM8D0GKX6			
N-benzylpiperazine		1-Benzylpiperazine	2759-28-6	3UG152ZU0E			
N-biotinylaminoethyl methanethiosulfonate		N-biotinylaminoethyl methanethiosulfonate	162758-04-5				
N-bromoacetamide	79-15-2	n-Bromoacetamide	79-15-2	0AQ6MWH7ZB	Molluscacides	Agents destructive to snails and other mollusks. (See all compounds classified as Molluscacides.)	
N-bromotaurine	52316-57-1	N-Bromotaurine	52316-57-1				
N-butanoylsphingosine		N-butanoylsphingosine					
n-butoxyacetaldehyde	29043-89-8	Butoxyacetaldehyde	29043-89-8				
n-butoxyacetic acid	2516-93-0	Butoxyacetic acid	2516-93-0				
n-butoxyethanol	111-76-2	2-Butoxyethanol	111-76-2	I0P9XEZ9WV			
n-butyl glycidyl ether	2426-08-6	Butyl glycidyl ether	2426-08-6	M03777A62S			
n-butyl mercaptan	109-79-5	1-Butanethiol	109-79-5	77OY909F30			
N-butyl-N'-nitro-N-nitrosoguanidine	13010-08-7	1-butyl-3-nitro-1-nitrosoguanidine					
n-butylamine	109-73-9	Butylamine	109-73-9	N2QV60B4WR			
n-butylbenzene	104-51-8	Butylbenzene	104-51-8	S8XZ2901RZ			
N-butylbenzenesulfonamide		N-Butylbenzenesulfonamide	3622-84-2	YO7UAW6717	Neurotoxins	Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept. (See all compounds classified as Neurotoxins.)	
N-butyloxycarbonyl-methionyl-aspartyl-glycyl-cysteinyl-glutamyl-leucine		N-butyloxycarbonyl-methionyl-aspartyl-glycyl-cysteinyl-glutamyl-leucine					
N-butyrylglucosamine		N-butyrylglucosamine					
N-butyrylhomoserine lactone		N-Butyrylhomoserine lactone					
N-caffeoyldopamine		N-Caffeoyldopamine	103188-49-4	HEM1G2VY70			
N-caffeoyltyramine		N-Caffeoyltyramine	103188-48-3	3LZ974DQ9J			
N-caproylsphingosine		N-hexanoylsphingosine	124753-97-5	038753E78J			
N-carbamylglutamate	1188-38-1	Carglumic Acid	1188-38-1	5L0HB4V1EW			For the treatment of acute and chronic hyperammonaemia in patients with N-acetylglutamate synthase (NAGS) deficiency. This enzyme is an important component of the urea cycle to prevent build up of neurotoxic ammonium in the blood.
N-chloromethylbrucine		N-chloromethyl-brucine					
N-chlorophenylalanine		N-Chlorophenylalanine	106984-40-1				
N-chlorotaurine	51036-13-6	N-Chlorotaurine	51036-13-6		Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	Investigated for use/treatment in eye disorders/infections.
N-cinnamoyl-5,6-dehydro-4-hydroxyindolidin-2,7-dione		N-cinnamoyl-5,6-dehydro-4-hydroxyindolidin-2,7-dione					
N-coumaroyltyramine		Paprazine	36417-86-4	5WQM3PJ2UK			
N-cyano-1-((3,4-dimethoxyphenyl)methyl)-3,4-dihydro-6,7-dimethoxy-N'-octyl-2(1H)-isoquinoline-carboximidamide		N-cyano-1-((3,4-dimethoxyphenyl)methyl)-3,4-dihydro-6,7-dimethoxy-N'-octyl-2(1H)-isoquinoline-carboximidamide					
N-decarbomethoxyllated JW062		N-decarbomethoxyllated JW062					
n-decyl alcohol	112-30-1	1-Decanol	112-30-1	89V4LX791F			
N-desbutyldronedarone		N-desbutyldronedarone					
N-desisopropylpropranolol	20862-11-7	N-Desisopropylpropranolol	20862-11-7	23EJC6KS1X			
N-desmethylclobazam	22316-55-8	Norclobazam	22316-55-8	MZ4L647O2H	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
N-desmethyldauricine	146763-55-5	N-Desmethyldauricine	146763-55-5				
N-desmethyltamoxifen	31750-48-8	N-Desmethyltamoxifen	31750-48-8	OOJ759O35C			
N-desmethylvenlafaxine		N-Desmethylvenlafaxine	149289-30-5	19V5EX4E8B			
N-dichlorofluoromethylthio-N',N'-dimethyl-N-p-tolylsulfamide	731-27-1	Tolylfluanid	731-27-1	382277YXSG			
n-dodecane	112-40-3	Dodecane	93924-07-3	11A386X1QH	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
N-dodecylmorpholine	1541-81-7	4-Dodecylmorpholine	1541-81-7	WRS8493T84			
N-ethoxymethyl-3-amino-1,2,4-benzotriazine-1,4-dioxide		N-ethoxymethyl-3-amino-1,2,4-benzotriazine-1,4-dioxide					
N-ethyl-1,2-diphenylethylamine		Ephenidine	60951-19-1	NG69VG2948			
N-ethyl-3-fluoro-3-(3-fluoro-4-(pyrrolidinylmethyl)phenyl)cyclobutanecarboxamide		N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutane-1-carboxamide	935840-31-6	G3QE979K1X			
N-ethyl-3-toluamide		N-ethyl-3-toluamide					
N-ethyl-N-(4-hydroxybutyl)nitrosamine	54897-62-0	N-Ethyl-N-(4-hydroxybutyl)nitrosamine	54897-62-0	1BL5T2E6YF			
N-ethyl-N-hydroxyethylnitrosamine	13147-25-6	N-Ethyl-N-(2-hydroxyethyl)nitrosamine	13147-25-6	CB5Z268XDH	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
N-ethylmaleimide-S-glutathione	97908-43-5	N-(S-(2-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)ethyl)-N-L-gamma-glutamyl-L-cysteinyl)glycine	97908-43-5				
N-ethylmercapto-3-4-dihydroxy-2-hydroxymethylpyrrolidine		N-ethylmercapto-3-4-dihydroxy-2-hydroxymethylpyrrolidine					
N-ethylpentylone		N-Ethylpentylone	727641-67-0	D3H9D57JV9			
N-formyl-isoleucine-1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester		Isoleucine orlistat, L-	1072902-75-0	9P192EY8ZT			
N-Formylmethionine Leucyl-Phenylalanine	59880-97-6	N-Formyl-Met-Leu-Phe	59880-97-6	LO6AVJ8RCE			
n-hexadecane	544-76-3	Hexadecane	544-76-3	F8Z00SHP6Q			
n-hexanal	66-25-1	Hexanal	66-25-1	9DC2K31JJQ	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
n-hexane	110-54-3	n-HEXANE	110-54-3	2DDG612ED8			
N-hydroxy-2-aminofluorene	53-94-1	N-Hydroxy-2-aminofluorene	53-94-1	61M94X4V24	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
N-hydroxy-3-(1-(phenylthio)methyl-1H-1,2,3-triazol-4-yl)benzamide		N-hydroxy-3-(1-(phenylthio)methyl-1H-1,2,3-triazol-4-yl)benzamide					
N-hydroxy-3-aminobenzanthrone		n-Hydroxy-3-aminobenzanthrone					
N-hydroxy-4-acetylaminobiphenyl	4463-22-3	N-Hydroxy-4-acetylaminobiphenyl	4463-22-3				
N-hydroxy-4-aminobiphenyl	6810-26-0	N-Hydroxy-4-aminobiphenyl	6810-26-0	KJC7V247MG			
N-hydroxyphenacetin	19315-64-1	N-Hydroxyphenacetin	19315-64-1	BX808PYL73			
N-hydroxyurethane	589-41-3	N-Hydroxyurethane	589-41-3	QWI3C4ASI7			
N-isobutyl-N-(4-methoxyphenylsulfonyl)glycylhydroxamic acid		N-isobutyl-N-(4-methoxyphenylsulfonyl)glycylhydroxamic acid					
N-isopropyl-1,2-diphenylethylamine		N-isopropyl-1,2-diphenylethylamine					
N-isopropyl-N-phenyl-4-phenylenediamine		1,4-Benzenediamine, N-(1-methylethyl)-N-phenyl-	3085-82-3	E0FUI016V7	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
N-isopropylbenzylamine	102-97-6	N-Isopropylbenzylamine	102-97-6	67SYC92FNS			
N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine	103818-46-8	N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine	135795-90-3	E8HMQ4F9JQ			
N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)-1H-pyrazol-3-yl)propanamide		N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)-1H-pyrazol-3-yl)propanamide					
N-methyl-3-(bis(4'-fluorophenyl)methoxy)tropane		N-methyl-3-(bis(4'-fluorophenyl)methoxy)tropane	156428-89-6				
N-Methyl-3,4-methylenedioxyamphetamine	42542-10-9	3,4-Methylenedioxymethamphetamine	42542-10-9	KE1SEN21RM	Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	Clinical trials are now testing the therapeutic potential of MDMA for post-traumatic stress disorder (PTSD) and anxiety associated with terminal cancer. MDMA is one of the four most widely used illicit drugs in the U.S.
N-methyl-4-aminophenol		4-(Methylamino)phenol	150-75-4	11W1883EFB			
N-methyl-7H-dibenzo(c,g)carbazole	27093-62-5	N-Methyl-7H-dibenzo(c,g)carbazole	27093-62-5	CW2LR35YB3			
N-methyl-delta-3,3-dihydroindole-2,2 diketone		N-methyl-delta-3,3-dihydroindole-2,2 diketone					
N-methyl-N-(6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethyl)aminomethylcarboxylic acid		N-methyl-N-(6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethyl)aminomethylcarboxylic acid					
N-methyl-N-2-(methylsulfinyl)ethylpropionic acid amide	137915-12-9	N-Methyl-N-2-(methylsulfinyl)ethylpropionic acid amide	137915-12-9				
N-methyl-N-benzylnitrosamine		N-methyl-n-benzylnitrosamine	937-40-6	H81CGI9K6Z	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
N-methyl-N-nitrosoaniline	614-00-6	N-Nitroso-N-methylaniline	614-00-6	9SM68I29WQ			
N-methyladenosine		N6-Methyladenosine	1867-73-8	CLE6G00625	Antiprotozoal Agents	Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)	
N-methylaminoethanol	109-83-1	2-(Methylamino)ethanol	109-83-1	ZMQ4G4V497			
N-Methylaspartate	6384-92-5	N-methyl-D-aspartic acid	6384-92-5	1903B9Q6PI	Excitatory Amino Acid Agonists	Drugs that bind to and activate excitatory amino acid receptors. (See all compounds classified as Excitatory Amino Acid Agonists.)	
N-methylcarbamylcholine	14721-69-8	N-methylcarbamylcholine	14721-69-8				
N-methylhistamine	673-50-7	1H-Imidazole-4-ethanamine, N-methyl-	673-50-7	Y7QR253130			
N-methylisoindigotin	97207-47-1	Meisoindigo	97207-47-1	92UIP6405R			
N-methylmaleimide		N-Methylmaleimide	930-88-1	P0TFZ8R21Y			
N-methylnaloxone	73232-50-5	Methylnaloxonium	73232-50-5	R4755TU8QX			
N-methylnicotinamide	114-33-0	N-Methylnicotinamide	114-33-0	X3I82S5L8I			N-methylnicotinamide is an experimental drug with no approved indication.
N-methylolacrylamide		N-(Hydroxymethyl)acrylamide	924-42-5	W8W68JL80Q			
N-methylprotoporphyrin IX	79236-56-9	N-Methylprotoporphyrin	79236-56-9				
N-methylpyrrolidone	26138-58-9	Methylpyrrolidone	872-50-4	JR9CE63FPM	Teratogens	An agent that causes the production of physical defects in the developing embryo. (See all compounds classified as Teratogens.)	
N-methylquipazine		N-methylquipazine	28614-26-8	0YV1ZIR6S0			
N-Methylscopolamine	13265-10-6	Methscopolamine	155-41-9		Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	
N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide		MS-Ppoh	206052-02-0				
N-methylthiourea	598-52-7	N-Methylthiourea	598-52-7	HRK3DMO87X			
N-methyltropan-3-yl 2-(4-bromophenyl)propionate	156143-26-9	(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-(4-bromophenyl)propanoate	156143-26-9				
N-n-decylnicotinium		N-n-decylnicotinium					
N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride	67383-44-2	Phenol, 3-(2-((2-phenylethyl)propylamino)ethyl)-, hydrochloride	67383-44-2		Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
N-n-propylnorapomorphine	58479-52-0	N-n-Propylnorapomorphine	57559-68-9	AZ9L8ZYZ3A	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	
N-nitroso-tris-chloroethylurea		Urea, 1-nitroso-1,3,3-tris(2-chloroethyl)-	69113-01-5				
N-nitroso(di-n-propyl)amine	621-64-7	N-Nitrosodipropylamine	621-64-7	2920IH58NC	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
N-nitrosodiethanolamine	1116-54-7	N-Nitrosodiethanolamine	1116-54-7	30YI1289VY	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
N-nitrosoguvacoline	55557-02-3	N-Nitrosoguvacoline	55557-02-3	DT8D8H2TX8			
N-nitrosoheptamethyleneimine	20917-49-1	N-Nitrosoheptamethyleneimine	20917-49-1	0VCF90A5FP			
N-nitrosomorpholine	59-89-2	N-Nitrosomorpholine	59-89-2	3L25FO7FN7	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
N-nitrosopiperidine	100-75-4	N-Nitrosopiperidine	100-75-4	6N066XUL4L	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
N-Nitrosopyrrolidine	930-55-2	1-Nitrosopyrrolidine	930-55-2	SZ4J5WK201			
N-nonyl-1-deoxynojirimycin		(2R,3R,4R,5S)-2-(hydroxymethyl)-1-nonylpiperidine-3,4,5-triol	81117-35-3		Glycoside Hydrolase Inhibitors	Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES. (See all compounds classified as Glycoside Hydrolase Inhibitors.)	
n-octylbenzene	2189-60-8	Octylbenzene	2189-60-8	P5EAX722SI			
N-oleoyldopamine		N-Oleoyldopamine	105955-11-1	T87P7X9XSZ			
N-oleoylethanolamine	111-58-0	n-Oleoylethanolamine	111-58-0	1HI5J9N8E6	Cannabinoid Receptor Agonists	Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)	
N-palmitoyl dopamine		N-[2-(3,4-Dihydroxyphenyl)ethyl]hexadecanamide	136181-87-8				
N-palmitoyl-vanillamide		N-palmitoyl-vanillamide					
N-palmitoylserine phosphoric acid		N-palmitoylserine phosphoric acid					
N-palmitoylsphingosine	4201-58-5	C16-0(Palmitoyl)ceramide	4201-58-5				
n-pentanoic acid	109-52-4	Valeric acid	109-52-4	GZK92PJM7B			
n-pentanol	71-41-0	1-Pentanol	71-41-0	M9L931X26Y			
N-phenyl-1-naphthylamine	90-30-2	N-Phenyl-1-naphthylamine	90-30-2	5I112077IN	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
N-phenyl-4-(quinolin-2-ylmethyl)piperazine-1-carboxamide		N-phenyl-4-(quinolin-2-ylmethyl)piperazine-1-carboxamide	898235-65-9				
N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide		N-phenyl-4-(quinolin-3-ylmethyl)piperidine-1-carboxamide	959151-50-9	7756CPP14K			
N-phenyl-7-(hydroxyimino)cyclopropa(b)chromen-1a-carboxamide		N-phenyl-7-(hydroxyimino)cyclopropa(b)chromen-1a-carboxamide					
N-phenylmaleimide	941-69-5	N-Phenylmaleimide	941-69-5	9U9KT462VW			
N-pip-phenylalanine-homophenylalanine-vinyl sulfone phenyl		N-pip-phenylalanine-homophenylalanine-vinyl sulfone phenyl					
N-piperidinyl-(8-chloro-1-(2,4-dichlorophenyl)-1,4,5,6-tetrahydrobenzo(6,7)cyclohepta(1,2-c)pyrazole-3-carboxamide)		N-piperidinyl-(8-chloro-1-(2,4-dichlorophenyl)-1,4,5,6-tetrahydrobenzo(6,7)cyclohepta(1,2-c)pyrazole-3-carboxamide)					
N-propargyl		N-propargyl					
n-propyl disulfide	629-19-6	Dipropyl disulfide	629-19-6	I7K169J70F			
n-propylbenzene	103-65-1	Propylbenzene	103-65-1	0WR86ZHG2Z			
N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate		N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate					
N-pyridazin-3-yl-4-(3-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzylidene)piperidine-1-carboxamide		N-pyridazin-3-yl-4-(3-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzylidene)piperidine-1-carboxamide					
N-retinoylglucosamine		N-retinoylglucosamine					
N-stearoylsphingomyelin		N-(octadecanoyl)-sphing-4-enine-1-phosphocholine	85187-10-6	05UG6280NI			
N-substituted Glycines		N-substituted Glycines					
N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine		N-t-butyl-N'-tetradecyl-3-tetradecylaminopropionamidine					
N-tert-butyl-alpha-(4-nitrophenyl)nitrone	3585-88-4	N-Tert-butyl-alpha-(4-nitrophenyl)nitrone	3585-88-4				
N-tert-butylisoquine		N-tert-butyl isoquine	459133-38-1	NSC8QP4B6Z			
n-tetradecane	629-59-4	Tetradecane	629-59-4	03LY784Y58			
N-vinyl-2-pyrrolidinone	88-12-0	N-Vinyl-2-pyrrolidone	9003-39-8	76H9G81541	Biocompatible Materials	Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function. (See all compounds classified as Biocompatible Materials.)	
N,N-bis(3,4-dimethoxyphenethyl)-N-methylamine	33978-72-2	2-(3,4-Dimethoxyphenyl)-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylethanamine	33978-72-2				
N,N-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide	142720-24-9	N,N-Dihexyl-2-(4-fluorophenyl)indole-3-acetamide	142720-24-9				
N,N-diacetylcystine	5545-17-5	N,N'-Diacetyl-L-cystine	5545-17-5	5H6NA7JU5E			
N,N-diallyl-5-methoxytryptamine		N,N-Diallyl-5-methoxytryptamine	928822-98-4	V25VK0QTAA			
N,N-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine	89352-67-0	N,N-diallyl-Tyr-Aib-Aib-Phe-Leu	92535-15-4				
N,N-didesmethyl-4-hydroxytamoxifen		N,N-didesmethyl-4-hydroxytamoxifen					
N,N-didesmethyltamoxifen		Desdimethyltamoxifen	80234-20-4	LHP6JE56UZ			
N,N-diethyl 4-phenylenediamine	93-05-0	N,N-Diethyl-P-phenylenediamine	93-05-0	0QQA4DFV2J			
N,N-diethyl-3-hydroxymethylbenzamide		N,N-diethyl-3-(hydroxymethyl)benzamide	72236-22-7	9K0BU4F1UC			
N,N-diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide		N,N-diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide					
N,N-diisopropyltryptamine	14780-24-6	N,N-Diisopropyltryptamine	14780-24-6	E352B01VMH			
N,N-dimethyl-2-(2-amino-4-cyanophenylthio)benzylamine		DASB hydrochloride	371971-10-7	6JUA5M5RFV			
N,N-dimethyl-2-(2-amino-4-fluorophenylthio)benzylamine		2-[[2-[(Dimethylamino)methyl]phenyl]thio]-5-fluoroaniline					
N,N-dimethyl-4-(6-benzothiazolylazo)aniline	18463-85-9	N,N-Dimethyl-4-(6-benzothiazolylazo)aniline	18463-85-9				
N,N-dimethylaniline	121-69-7	N,N-Dimethylaniline	121-69-7	7426719369			
N,N-dimethylarginine	30315-93-6	N,N-Dimethylarginine	30315-93-6	63CV1GEK3Y	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
N,N-dimethylethylamine	598-56-1	N,N-Dimethylethylamine	598-56-1	9N5384XVEM			
N,N-dimethylhistamine	673-46-1	N,N-Dimethylhistamine	673-46-1				
N,N-dimethylphenylethylamine	1126-71-2	N,N-Dimethylphenethylamine	1126-71-2	I4C10U12C8			
N,N-dimethylphytosphingosine		N,N-dimethylphytosphingosine					
N,N-dimethylsphingosine		N,N-dimethylsphingosine	119567-63-4		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
N,N-Dimethyltryptamine	61-50-7	Dimethyltryptamine	61-50-7	WUB601BHAA	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	Some people use this compound as a psychedelic inducing agent.
N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride	149409-57-4	4-Methoxy-3-(2-phenylethoxy)-N,N-dipropylbenzeneethanamine hydrochloride	149409-57-4	T6QLY532R9	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
N,N-dipropylcarboxamidotryptamine	74885-25-9	Dipropyl-5-CT	74885-25-9				
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	16858-02-9	N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine	16858-02-9	R9PTU1U29I	Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	
N,N'-((5-(2-amino-5-(2-methylpropyl)-4-thiazolyl)-2-furanyl)phosphinylidene)bis(alanine) diethyl ester		Managlinat dialanetil	280782-97-0	3W93F83K7S			Investigated for use/treatment in diabetes mellitus type 2.
N,N'-bis(2-1(piperidino)-ethyl)-3,4,9,10-perylene-tetracarboxylic diimide		N,N'-bis(2-1(piperidino)-ethyl)-3,4,9,10-perylene-tetracarboxylic diimide					
N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid	35998-29-9	N,N'-Bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid	35998-29-9	5B9PRC5C53	Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	
N,N'-Bis(2-mercaptoethyl)isophthalamide		Emeramide	351994-94-0	4U7K5X4ANS	Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	
N,N'-bis(dichloroacetyl)-1,8-octamethylenediamine	1477-57-2	Fertilysin	1477-57-2	3F56RA64JN			
N,N'-bis(salicylideneamino)ethane-manganese(II)	53177-12-1	N,N'-Bis(salicylideneamino)ethane-manganese(II)	53177-12-1				
N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride		Amn082 dihydrochloride	97075-46-2				
N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine		N4,N6-dicyclopentyl-2-(methylthio)-5-nitropyrimidine-4,6-diamine	39069-52-8	HD3T22A5DM			
N,N'-diphenyl-4-phenylenediamine	74-31-7	N,N'-Diphenyl-p-phenylenediamine	74-31-7	DD517SCM92	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
N,N'-monomethylenebis(pyridiniumaldoxime)	61444-84-6	N,N'-Monomethylenebis(pyridiniumaldoxime)	61444-84-6		Cholinesterase Reactivators	Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates. (See all compounds classified as Cholinesterase Reactivators.)	
N,N'-p-xylene-bis-((2,2'-hydroxyiminomethyl)pyridinium) dibromide		N,N'-p-xylene-bis-((2,2'-hydroxyiminomethyl)pyridinium) dibromide					
N,N''-1,4-butanediylbis(N'-(3-isothiocyanatophenyl))thiourea		N,N''-1,4-butanediylbis(N'-(3-isothiocyanatophenyl))thiourea					
N,O-didesmethylvenlafaxine		N,O-Didesmethylvenlafaxine	135308-74-6	DYW3W9739Y			
N'-((1E)-(4-(diethylamino)phenyl)methylene)-4-hydroxybenzohydrazide		Benzoic acid, p-hydroxy-, (p-(diethylamino)benzylidene)hydrazide	95167-41-2	5VWV92039E			
N'-((2-hydroxyphenyl)carbonothioyl)pyridine-2-carbohydrazide		N'-((2-hydroxyphenyl)carbonothioyl)pyridine-2-carbohydrazide					
N'-((3Z)-1-(1-hexyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide		N'-((3Z)-1-(1-hexyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide					
N'-(10H-indolo(3,2-b)quinolin-11-yl)-N,N-dimethylpropane-1,3-diamine		Syuiq-5	188630-47-9				
N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine		N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine					
N'-(2-chloroethyl)-N-(2-(methylsulfonyl)ethyl)-N'-nitrosourea	79955-36-5	Cystemustine	79955-36-5	07G51A6FMA	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
N'-(2-phenylallyl)hydrazine		N'-(2-phenylallyl)hydrazine					
N'-(3-bromo-4-hydroxybenzylidene)-2-(9-oxo-10(9H)-acridinyl)acetohydrazide		N'-(3-bromo-4-hydroxybenzylidene)-2-(9-oxo-10(9H)-acridinyl)acetohydrazide	331749-88-3				
N'-(3,4-dihydroxybenzylidene)-3-hydroxy-2-naphthahydrazide		N'-(3,4-dihydroxybenzylidene)-3-hydroxy-2-naphthahydrazide					
N'-(7-fluoroH-pyrrolo(1,2-a)quinoxalin-4-yl)pyrazine-2-carbohydrazide		N'-(7-fluoroH-pyrrolo(1,2-a)quinoxalin-4-yl)pyrazine-2-carbohydrazide					
N'-ethyl-2-(hydroxyimino)-N,N-dimethylacetimidamide		N'-ethyl-2-(hydroxyimino)-N,N-dimethylacetimidamide					
N'-methyl-2-pyridone-5-carboxamide	701-44-0	1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxamide	701-44-0	68139USC7W			
N'-nitrosoanabasine	37620-20-5	N'-Nitrosoanabasine	37620-20-5	Y7VU5E9XAT			
N'-nitrosoanatabine	71267-22-6	N'-Nitrosoanatabine	71267-22-6	7V3JJ391AU			
N'-nitrosonornicotine	80508-23-2	3-(1-Nitrosopyrrolidin-2-yl)pyridine	80508-23-2		Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
N''-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine		N''-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine	335381-68-5				
N(1)-methyl-4-pyridone-5-carboxamide	3128-29-8	N-Methyl-4-oxo-1,4-dihydropyridine-3-carboxamide	3128-29-8				
N(1)-methylnicotinamide		1-Methylnicotinamide	3106-60-3	UM47085BXC			
N(1), N(12)-diethylspermine	61345-84-4	N(1), N(12)-diethylspermine	61345-84-4	3XXE6ARW3H	Growth Inhibitors	Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth (= PLANT GROWTH REGULATORS). (See all compounds classified as Growth Inhibitors.)	
N(1),N(11)-diethylnorspermine	121749-39-1	N1,N11-Bis(ethyl)norspermine	121749-39-1	HLI827Z1ST	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	Investigated for use/treatment in renal cell carcinoma, pancreatic cancer, melanoma, and lung cancer.
N(2)-(2-aminocyclohexyl)-N(6)-(3-chlorophenyl)-9-ethyl-9H-purine-2,6-diamine		N(2)-(2-aminocyclohexyl)-N(6)-(3-chlorophenyl)-9-ethyl-9H-purine-2,6-diamine					
N(2)-furfuryl-deoxyguanosine		N(2)-furfuryl-deoxyguanosine					
N(4)-hydroxycytidine		N(4)-Hydroxycytidine	3258-02-4	C3D11PV2O4			N4-hydroxycytidine and its prodrug [EIDD-2801] is being studied for its activity against a number of viral infections including influenza, MERS-CoV, and SARS-CoV-2.
N(4)-hydroxycytosine	20555-88-8	N(4)-Hydroxycytosine	20555-88-8				
N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine	152918-18-8	IB-Meca	152918-18-8	30679UMI0N			Investigated for use/treatment in cancer/tumors (unspecified), eye disorders/infections, psoriasis and psoriatic disorders, and rheumatoid arthritis. Can-Fite BioPharma has reported that by targeting the adenosine A3-receptor, CF101 may also be used to treat Crohn's disease, a serious gastrointestinal disorder.
N(6)-(delta(2)-isopentenyl)adenine	2365-40-4	N-(3-Methylbut-2-EN-1-YL)-9H-purin-6-amine	2365-40-4	V500BB256Z			
N(6)-2-(4-aminophenyl)ethyladenosine		N(6)-2-(4-aminophenyl)ethyladenosine					
N(6)-benzoyl-cyclic AMP	30275-80-0	Bz-Camp	30275-80-0				
N(6)-benzyl-5'-N-ethylcarboxamidoadenosine		N(6)-benzyl-5'-N-ethylcarboxamidoadenosine					
N(6)-benzyl-cyclic adenosine 5'-monophosphate	32115-08-5	N(6)-Benzyl cyclic amp	32115-08-5				
N(6)-cyclohexyladenosine	36396-99-3	N6-Cyclohexyladenosine					
N(6)-cyclopentyladenosine	41552-82-3	N6-Cyclopentyladenosine	41552-82-3	7LG47VG1ID	Purinergic P1 Receptor Agonists	Compounds that bind to and stimulate PURINERGIC P1 RECEPTORS. (See all compounds classified as Purinergic P1 Receptor Agonists.)	
N(6)-cyclopropyl-9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine		N(6)-cyclopropyl-9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine					
N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate		N(6)-methyl-2'-deoxyadenosine 3',5'-diphosphate					
N(6)-phenyl-cAMP		N(6)-phenyl-cAMP	34051-30-4				
N(6),N(6)-dimethyladenine		6-Dimethylaminopurine	938-55-6	649SA4S2CV	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
N(6),N(6)-dimethyladenosine	2620-62-4	N6,N6-Dimethyladenosine	2620-62-4	0L9766EW9W			
N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine	113857-87-7	Talotrexin	113857-87-7	A8E516A20K			Investigated for use/treatment in solid tumors, lung cancer, leukemia (unspecified), and leukemia (lymphoid).
N(G)-nitroarginine-4-nitroanilide	85697-89-8	N(omega)-Nitro-L-arginine p-nitroanilide	85697-89-8				
N1-(2-aminophenyl)-N8-phenyloctanediamide		N1-(2-aminophenyl)-N8-phenyloctanediamide	537034-17-6		Histone Deacetylase Inhibitors	Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)	
N1-(4-bis(pivaloyloxymethyl)phosphinylbuten-2-yl)thymine		N1-(4-bis(pivaloyloxymethyl)phosphinylbuten-2-yl)thymine					
N1-(n-butyl)-7-azaisoindigo		N1-(n-butyl)-7-azaisoindigo					
N1-benzyl-4-methylbenzene-1,2-diamine		N-Benzyl-4-methyl-o-phenylenediamine	39235-93-3	1JB5C96T8S			
N2 Dental Cement	8068-83-5	Kalzinol	8068-83-5				
N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide		N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide					
N2-(1H-indazole-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine		Kribb11					
N2,N4-dibenzylquinazoline-2,4-diamine		N2,N4-dibenzylquinazoline-2,4-diamine	177355-84-9				
N3-(4-(4-morpholinocyclohexyl)phenyl)-1-(pyridin-2-yl)-1H-1,2,4-triazole-3,5-diamine		N3-(4-(4-morpholinocyclohexyl)phenyl)-1-(pyridin-2-yl)-1H-1,2,4-triazole-3,5-diamine					
N3-cyclopropyl-7-((4-(1-methylethyl)phenyl)methyl)-7H-pyrrolo(3, 2-f)quinazoline-1,3-diamine		N3-cyclopropyl-7-[(4-propan-2-ylphenyl)methyl]pyrrolo[3,2-f]quinazoline-1,3-diamine	245520-69-8				
N4-(2,2-dimethyl-3-oxo-4H-pyrid(1,4)oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine		R406 Benzenesulfonate	841290-81-1				
N4-(9-ethyl-9H-carbazol-3-yl)-N2-(3-morpholin-4-ylpropyl)-pyrimidine-2,4-diamine		N4-(9-ethyl-9H-carbazol-3-yl)-N2-(3-morpholin-4-ylpropyl)-pyrimidine-2,4-diamine					
N6-(((4-(4-(acetylamino)benzyl)phenyl)amino)carbonyl)lysine		N6-(((4-(4-(acetylamino)benzyl)phenyl)amino)carbonyl)lysine					
N6-(((4-(4-aminobenzyl)phenyl)amino)carbonyl)lysine		N6-(((4-(4-aminobenzyl)phenyl)amino)carbonyl)lysine					
N6-(2-hydroxy-3-buten-1-yl)-2'-deoxyadenosine		N6-(2-hydroxy-3-buten-1-yl)-2'-deoxyadenosine					
N6-(2-hydroxyethyl)adenosine		n6-(2-Hydroxyethyl)adenosine					
N6L peptide		N6L peptide					
NAADP	5502-96-5	Nicotinic acid adenine dinucleotide phosphate	5502-96-5				
nabilone		Nabilone	51022-71-0	2N4O9L084N	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	Nabilone is indicated for the treatment of the nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. This restriction is required because a substantial proportion of any group of patients treated with Nabilone can be expected to experience disturbing psychotomimetic reactions not observed with other antiemetic agents.
nabiximols		Sativex	56575-23-6		Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	In Canada, Sativex has received a Notice of Compliance (NOC) for use as an as adjunctive treatment for symptomatic relief of spasticity in patients with multiple sclerosis (MS) who have not responded adequately to other therapy and who demonstrate meaningful improvement during an initial trial of therapy.   Sativex has also received a Notice of Compliance with Conditions (NOC/c) for use as an adjunctive treatment for the symptomatic relief of neuropathic pain in adult patients with multiple sclerosis (MS) and as adjunctive analgesic treatment in adult patients with advanced cancer who experience moderate to severe pain during the highest tolerated dose of strong opioid therapy for persistent background pain.   Marketing authorisations with conditions reflect the promising nature of the clinical evidence and the need for confirmatory studies to verify the clinical benefit. Patients should be advised of the conditional nature of the authorizations with conditions.
Nabumetone	42924-53-8	Nabumetone	42924-53-8	LW0TIW155Z	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	**Indicated** for:  1) Symptomatic relief in rheumatoid arthritis.  2) Symptomatic relief in osteoarthritis.
NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt		Abt-510	251579-55-2	CRR8E37XOB			Investigated for use/treatment in lymphoma (unspecified), melanoma, and solid tumors.
NAD	53-84-9	Nadide	53-84-9	0U46U6E8UK			
nadifloxacin		Nadifloxacin	124858-35-1	6CL9Y5YZEQ	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Nadolol	42200-33-9	Nadolol	220045-89-6	FEN504330V	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	Nadolol is indicated to treat angina pectoris and hypertension. Another product formulated with [bendroflumethiazide] is indicated to treat hypertension.
NADP	53-59-8	Triphosphopyridine nucleotide	53-59-8	BY8P107XEP			
nafadotride		Nafadotride	149649-22-9		Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	
nafamostat	81525-10-2	Nafamostat	81525-10-2	Y25LQ0H97D	Complement Inactivating Agents	Compounds that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host. (See all compounds classified as Complement Inactivating Agents.)	Used as an anticoagulant in patients with disseminative blood vessel coagulation, hemorrhagic lesions, and hemorrhagic tendencies. It prevents blood clot formation during extracorporeal circulation in patients undergoing continuous renal replacement therapy and extra corporeal membrane oxygenation.
nafazatrom		Nafazatrom	59040-30-1		Lipoxygenase Inhibitors	Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)	
Nafcillin	147-52-4	Nafcillin	147-52-4	4CNZ27M7RV	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug.
Nafenopin	3771-19-5	Nafenopin	3771-19-5	093W78U96W	Hypolipidemic Agents	Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)	
nafenopin-coenzyme A	112195-81-0	Nafenopin-coenzyme A	112195-81-0				
Nafoxidine	1845-11-0	Nafoxidine	1845-11-0	4RIY10WM82	Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	
Nafronyl	31329-57-4	Naftidrofuryl	31329-57-4	42H8PQ0NMJ	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
naftalofos		Naftalofos	1491-41-4	H5IT2P8H5I			
naftifine	65472-88-0	Naftifine	65472-88-0	4FB1TON47A	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	For the topical treatment of tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans and Epidermophyton floccosum.
naftopidil	57149-07-2	Naftopidil	57149-07-2	R9PHW59SFN	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
Nalbuphine	20594-83-6	Nalbuphine	20594-83-6	L2T84IQI2K	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	For the relief of moderate to severe pain.
Naled	300-76-5	Naled	300-76-5	PAM1AI9KU1	Acaricides	A pesticide or chemical agent that kills mites and ticks. This is a large class that includes carbamates, formamides, organochlorines, organophosphates, etc, that act as antibiotics or growth regulators. (See all compounds classified as Acaricides.)	
Nalidixic Acid	389-08-2	Nalidixic Acid	389-08-2	3B91HWA56M	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of urinary tract infections caused by susceptible gram-negative microorganisms, including the majority of E. Coli, Enterobacter species, Klebsiella species, and Proteus species.
nalmefene	55096-26-9	Nalmefene	55096-26-9	TOV02TDP9I	Narcotic Antagonists	Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)	Nalmefene oral tablet is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking risk level (DRL), without physical withdrawal symptoms and who do not require immediate detoxification. Nalmefene should only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption. Nalmefene should be initiated only in patients who continue to have a high DRL two weeks after the initial assessment.  Nalmefene injection and nasal spray are indicated for the complete or partial reversal of opioid drug effects, including respiratory depression, induced by either natural or synthetic opioids. They are also indicated in the management of known or suspected opioid overdose. Nalmefene injection can be used for postoperative opioid overdose reversal.
Nalorphine	62-67-9	Nalorphine	62-67-9	U59WB2WRY2	Narcotic Antagonists	Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)	Used to reverse opioid overdose.
naloxonazine	82824-01-9	7-[(4a,9-Dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ylidene)hydrazinylidene]-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol	82824-01-9				
Naloxone	465-65-6	Naloxone	465-65-6	36B82AMQ7N	Narcotic Antagonists	Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)	Naloxone nasal sprays are indicated for the reversal of an opioid overdose or suspected opioid overdose: it is intended for immediate administration as emergency therapy in settings where opioids may be present. Intramuscular, intravenous, and subcutaneous injections are indicated for complete or partial reversal of opioid depression, diagnosis of known or suspected opioid overdose, and as an adjunct therapy in the treatment of septic shock.  Sublingual tablets and films are formulated with [buprenorphine] for the treatment of opioid dependence. Naloxone is also formulated with [pentazocine] as an oral tablet for severe pain.  Intramuscular or subcutaneous naloxone autoinjectors are used for the emergency treatment of people 12 years of age and older where the use of high-potency opioids such as fentanyl analogues as a chemical weapon, is suspected.  Naloxone has been used off-label for the treatment of neuraxial opioid-induced pruritus.
naloxone benzoylhydrazone	119630-94-3	Naloxone benzoylhydrazone	119630-94-3	0W13ZI072Q			
Naltrexone	16590-41-3	Naltrexone	16590-41-3	5S6W795CQM	Alcohol Deterrents	Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism. (See all compounds classified as Alcohol Deterrents.)	Used as an adjunct to a medically supervised behaviour modification program in the maintenance of opiate cessation in individuals who were formerly physically dependent on opiates and who have successfully undergone detoxification. Also used for the management of alcohol dependence in conjunction with a behavioural modification program.
naltrindole	111555-53-4	Naltrindole	111555-53-4	G167Z38QA4	Narcotic Antagonists	Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)	
naltrindole benzofuran	111555-58-9	Naltriben	111555-58-9	RXG719F189	Narcotic Antagonists	Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)	
Nandrolone	434-22-0	Nandrolone	434-22-0	6PG9VR430D	Anabolic Agents	These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. (See all compounds classified as Anabolic Agents.)	
Nandrolone Decanoate	360-70-3	Nandrolone Decanoate	360-70-3	H45187T098	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Nandrolone decanoate is indicated in the management of anemia of renal insufficiency. In Canada, it is also indicated as an adjunct therapy in the treatment of senile and postmenopausal osteoporosis.
nandrolone phenpropionate	62-90-8	Nandrolone phenpropionate	62-90-8	KF7Z9K2T3W	Anabolic Agents	These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. (See all compounds classified as Anabolic Agents.)	For the treatment of refractory deficient red cell production anemias, breast carcinoma, hereditary angioedema, antithrombin III deficiency, fibrinogen excess, growth failure and Turner's syndrome. It is also indicated in the prophylaxis of hereditary angioedema.
nannocystin Ax		nannocystin Ax					
nano-diamino-tetrac		nano-diamino-tetrac					
Nanodiamonds		Nanodiamonds					
Nanotubes, Carbon		Methane	74-82-8	OP0UW79H66			
naoxintong		Naoxintong					
napabucasin		Napabucasin	83280-65-3	Z1HHM49K7O			
Naphazoline	835-31-4	Naphazoline	835-31-4	H231GF11BV	Nasal Decongestants	Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993) (See all compounds classified as Nasal Decongestants.)	Naphazoline is indicated for use as OTC eyedrops for ocular vasoconstriction or as a nasal preparation for nasal congestion.
napht-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate		napht-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate					
naphthacene		Naphthacene	92-24-0	QYJ5Z6712R			
naphthalene	91-20-3	Naphthalene	91-20-3	2166IN72UN			
naphthalene 1,2-oxide	277-50-9	Naphth(1,2-b)oxirene	277-50-9				
naphthalenediimide	22291-04-9	Naphthalenediimide	22291-04-9				
Naphthalenes		Naphthalenes					
Naphthalimides		1,8-Naphthalimide	81-83-4	GI0TV19GBN			
naphthazarin	475-38-7	5,8-Dihydroxy-1,4-naphthoquinone	475-38-7	S9IX5I5C0K	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
naphthenic acid	1338-24-5	1338-24-5					
naphtho(1,2-a)pyrene		38115-48-9					
naphtho(1,2-b)fluoranthene	111189-32-3	Naphtho(1,2-b)fluoranthene	111189-32-3	OFL7ZNF6AC			
naphtho(1,2-b)furan-4,5-dione	32358-83-1	NF-4,5-Dione	32358-83-1				
naphtho(1,2-d)thiazol-2-ylamine		naphtho(1,2-d)thiazol-2-ylamine					
naphtho(2,3-a)pyrene		Naphtho[2,3-a]pyrene	196-42-9				
naphthol AS-E phosphate		N-(4-Chlorophenyl)-3-(phosphonooxy)naphthalene-2-carboxamide	18228-17-6	H6R6B93QFC			
naphtholphthalein	596-01-0	alpha-Naphtholphthalein	596-01-0	2QEG1706NN			
Naphthols		2-Naphthol	135-19-3	P2Z71CIK5H			
Naphthoquinones		Acetamide, N-[1,4-dihydro-3-(methylamino)-1,4-dioxo-2-naphthalenyl]-	1676-56-8				
naphthoresorcinol	132-86-5	1,3-Naphthalenediol	132-86-5	5X457YEW8Y			
naphthyl glucuronide	27710-10-7	Naphthyl glucuronide	27710-10-7				
naphthyl sulfate	3197-94-2	1-Naphthyl sulfate	3197-94-2	20A00650AX			
naphthylene-2,7-diyl-bis(2-hydroxyiminomethylpyridinium)		naphthylene-2,7-diyl-bis(2-hydroxyiminomethylpyridinium)					
Naphthyridines		Naphthyridines					
Naproxen	22204-53-1	Naproxen	22204-53-1	57Y76R9ATQ	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Naproxen is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain. Further, it is first-line therapy for osteoarthritis, acute gouty arthritis, dysmenorrhea, and musculoskeletal inflammation and pain.
naratriptan		Naratriptan	121679-13-8	QX3KXL1ZA2	Serotonin 5-HT1 Receptor Agonists	Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes. (See all compounds classified as Serotonin 5-HT1 Receptor Agonists.)	For the acute treatment of migraine attacks with or without aura in adults.
narciclasine	29477-83-6	Narciclasine	29477-83-6				
nardosinone	23720-80-1	Nardosinone	23720-80-1	5VA93HYL8U			
naringenin	480-41-1	Naringenin	480-41-1	HN5425SBF2	Estrogen Antagonists	Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)	
naringenin chalcone	73692-50-9	Naringenin chalcone	25515-46-2	YCF6Z24AS2			
naringenin-6-C-glucoside	3682-03-9	Hemiphloin	3682-03-9	SXB3TK6ELL			
naringenin-7-O-glucoside		Prunin	529-55-5	LSB8HDX4E5			
naringin	10236-47-2	Naringin	10236-47-2	N7TD9J649B			
natakalim		natakalim					
Natamycin	7681-93-8	Natamycin	52882-37-8	8O0C852CPO	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	For the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including Fusarium solani keratitis.
Nateglinide	105816-04-4	Nateglinide	105816-06-6	XTM4DQP5S5	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	
naveglitazar		Naveglitazar	476436-68-7	Y995M7GM0G			
navitoclax		Navitoclax	923564-51-6	XKJ5VVK2WD	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Treatment of myelofibrosis
naxagolide	88058-88-2	Naxagolide	88058-88-2	22Z7E0X6OF	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
NBD peptide, mouse		NBD peptide, mouse					
NBI 77860		Verucerfont	885220-61-1	X60608B091			
NC 1153		N-[2-[1-[2-(4-methylphenoxy)ethyl]benzimidazol-2-yl]ethyl]cyclohexanecarboxamide					
NC 174	138460-25-0	N-(P-Cyanophenyl)-N'-diphenylmethyl-guanidine-acetic acid	138460-25-0	MW7J9SU4JQ			
NC 1900		NC 1900					
NCGC 00229600		NCGC 00229600					
NCP-2454		NCP-2454					
NCQ 298		3-Iodo-N-((1-ethyl-2-pyrrolidinyl)methyl)-5,6-dimethoxysalicylamide	131062-31-2	Y762GLD7US	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
NCQ 344		NCQ 344					
NCQ 436	148460-80-4	Benzamide, 3-bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-5,6-dihydroxy-2-methoxy-, (S)-	148460-80-4				
NCS 382	131733-92-1	Acetic acid, (5,7,8,9-tetrahydro-5-hydroxy-6H-benzocyclohepten-6-ylidene)-, monosodium salt	131733-92-1		Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
NCX 4040		NO-aspirin	287118-97-2				
NCX 6560		NCX 6560					
ND 322		ND 322					
NE-52-qq57		NE-52-qq57					
nebicapone		Nebicapone	274925-86-9	NM2KXJ990T			
Nebivolol		Nebivolol	99200-09-6	030Y90569U	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	Nebivolol is indicated to treat hypertension.
nebularine	550-33-4	Nebularine	550-33-4	B8B604PS4P	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
necrostatin-1		5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-4-Imidazolidinone	4311-88-0				
nectandrin-B		nectandrin-B	74683-16-2				
Nedocromil	69049-73-6	Nedocromil	69049-73-6	0B535E0BN0	Mast Cell Stabilizers	Compounds that prevent the release of inflammatory mediators from MAST CELLS. (See all compounds classified as Mast Cell Stabilizers.)	For the treatment of mild to moderate asthma
neem oil		EPA Pesticide Chemical Code 025006					
nefazodone	83366-66-9	Nefazodone	83366-66-9	59H4FCV1TF	Serotonin 5-HT2 Receptor Antagonists	Drugs that bind to but do not activate SEROTONIN 5-HT2 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT2 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more specific 5-HT2 receptor subtypes. (See all compounds classified as Serotonin 5-HT2 Receptor Antagonists.)	For the treatment of depression.
neferine	2292-16-2	Neferine	2292-16-2				
nefiracetam	77191-36-7	Nefiracetam	77191-36-7	1JK12GX30N	Neuroprotective Agents	Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)	
Nefopam	13669-70-0	Nefopam	13669-70-0	4UP8060B7J	Analgesics, Non-Narcotic	A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)	
Nelfinavir	159989-64-7	Nelfinavir	159989-64-7	HO3OGH5D7I	HIV Protease Inhibitors	Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. (See all compounds classified as HIV Protease Inhibitors.)	Used in combination with other antiviral drugs in the treatment of HIV in both adults and children.
nemadectin	102130-84-7	Nemadectin	102130-84-7	1Y8VJ1G3TY			
nemonapride		Nemonapride	187139-87-3	Q88T5P3444	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
nemorubicin		Nemorubicin	108852-90-0	7618O47BQM			
neo-gambogic acid	93772-31-7	Neogambogic acid	93772-31-7				
neoandrographolide		Neoandrographolide	27215-14-1	XBY0Z806J2			
neobavaisoflavone		Neobavaisoflavone	41060-15-5				
neocuproine	484-11-7	Neocuproine	484-11-7	8E7D2SH3BV	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
Neodymium	7440-00-8	Neodymium	7440-00-8	2I87U3734A			
neodymium oxide		Neodymium oxide	1313-97-9	AYT3H319PN			
neoechinulin	25644-25-1	Neoechinulin	25644-25-1				
neoechinulin A		neoechinulin A					
neoeriocitrin		Neoeriocitrin	13241-32-2				
neohesperidin dihydrochalcone	20702-77-6	Neohesperidin dihydrochalcone	20702-77-6	3X476D83QV			
Neomycin	1404-04-2	Framycetin	119-04-0	4BOC774388	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of bacterial blepharitis, bacterial bonjunctivitis, corneal injuries, corneal ulcers and meibomianitis. For the prophylaxis of ocular infections following foreign body removal
Neonicotinoids		Neonicotinoids					
Neopterin	670-65-5	2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone	670-65-5				
neosaxitoxin		Neosaxitoxin	64296-20-4	6YRL8BWD9H	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
neosolaniol	65041-92-1	8-Acetylneosolaniol	65041-92-1				
Neostigmine	59-99-4	Neostigmine	59-99-4	3982TWQ96G	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	Neostigmine is used for the symptomatic treatment of myasthenia gravis by improving muscle tone.
neotame		Neotame	165450-17-9	VJ597D52EX			
neoxanthin	14660-91-4	Neoxanthin	14660-91-4	KK8M5T48AI			
nepicastat		Nepicastat	173997-05-2	VPG12K4540			
neplanocin A	72877-50-0	Neplanocin A	72877-50-0		Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	
NEPP11 compound		NEPP11 compound					
neratinib		Neratinib	698387-09-6	JJH94R3PWB	Tyrosine Kinase Inhibitors	Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES. (See all compounds classified as Tyrosine Kinase Inhibitors.)	For use as an extended adjuvant treatment in adult patients with early stage HER2-overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy.
nereistoxin	1631-58-9	Nereistoxin	1631-58-9	ZU7BQ8TC6K			
nerodilol		NEROLIDOL					
nerolidol	7212-44-4	trans-Nerolidol	7212-44-4	FG5V0N8P2H			
Nerve Agents		Nerve Agents					
Nerve Growth Factors		Nerve Growth Factors					
nervonic acid	506-37-6	Nervonic Acid	506-37-6	91OQS788BE			
neticonazole	130726-68-0	Neticonazole	130726-68-0	KVL61ZF9UO			
Netilmicin	56391-56-1	Netilmicin	56391-56-1	4O5J85GJJB	Protein Synthesis Inhibitors	Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)	For the treatment of bacteremia, septicaemia, respiratory tract infections, skin and soft-tissue infection, burns, wounds, and peri-operative infections caused by susceptible strains.
netoglitazone		Netoglitazone	161600-01-7	QOV2JZ647A			
Neurokinin A	86933-74-6	Neurokinin A	86933-74-6	94168F9W1D	Neurotransmitter Agents	Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as Neurotransmitter Agents.)	
neurokinin A (4-10), beta-Ala(8)-	122063-01-8	[bAla8]-Neurokinin A(4-10)					
Neurokinin-1 Receptor Antagonists		Neurokinin-1 Receptor Antagonists					
Neuromuscular Agents		Neuromuscular Agents					
neuropeptide Y (13-36)		neuropeptide Y (13-36)					
neuropeptide Y (18-36)	114495-97-5	Neuropeptide Y (18-36)	114495-97-5				
neuropeptide Y, Leu(31)-Pro(34)-	125580-28-1	(Leu31,pro34)-neuropeptide Y (porcine)	125580-28-1				
neurostatin		Neurostatin					
Neurotensin	39379-15-2	Neurotensin	39379-15-2	XHB61LG5QS			
neurotensin 69L		neurotensin 69L					
neurotensin NT79		neurotensin NT79					
Neurotoxins		Neurotoxins					
Neurotransmitter Agents		Neurotransmitter Agents					
neurotropin	57657-35-9	57657-35-9					
nevadensin	10176-66-6	Nevadensin	10176-66-6				
Nevirapine	129618-40-2	Nevirapine	129618-40-2	99DK7FVK1H	Anti-HIV Agents	Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)	For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.
NF023		NF023					
NF157 compound		NF157 compound					
NG-Nitroarginine Methyl Ester	50903-99-6	L-Name	50903-99-6	V55S2QJN2X	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
NGB 2904		N-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]-9H-fluorene-2-carboxamide	189060-98-8				
NGD-61338		NGD-61338					
Niacin		Nicotinic acid	59-67-6	2679MF687A	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	Niacin is indicated to prevent vitamin deficiencies in pediatric and adult patients receiving parenteral nutrition as part of multivitamin intravenous injections. Niacin oral tablets are indicated as a monotherapy or in combination with simvastatin or lovastatin to treat primary hyperlipidemia and mixed dyslipidemia. It can also be used to reduce the risk of nonfatal myocardial infarctions in patients with a history of myocardial infarction and hyperlipidemia. Niacin is also indicated with bile acid binding resins to treat atherosclerosis in patients with coronary artery disease and hyperlipidemia or to treat primary hyperlipidemia. Finally niacin is indicated to treat severe hypertriglyceridemia.
Niacinamide	98-92-0	Niacinamide	98-92-0	25X51I8RD4	Vitamin B Complex	A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)	
Nialamide	51-12-7	Nialamide	51-12-7	T2Q0RYM725	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	
Nicardipine	55985-32-5	Nicardipine	55985-32-5	CZ5312222S	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	Used for the management of patients with chronic stable angina and for the treatment of hypertension.
Nickel	7440-02-0	Nickel	7440-02-0	7OV03QG267	Trace Elements	A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)	
nickel acetate		Nickel acetate	373-02-4	99QP4ELX96			
nickel carbonate	3333-67-3	Nickel carbonate	3333-67-3	WM50SQU829			
nickel carbonyl	13463-39-3	13463-39-3					
nickel chloride	7718-54-9	Nickel Chloride	7718-54-9	696BNE976J			
nickel ferrite		Nickel ferrite	12168-54-6				
nickel hydroxide	12054-48-7	Nickel hydroxide	11113-74-9	L8UW92NW6J			
nickel monoxide	1313-99-1	Nickel oxide	1313-99-1				
nickel nitrate	13138-45-9	Nickel nitrate	13138-45-9	50L0S38I2D			
nickel nitrilotriacetic acid	34831-03-3	Nickel nitrilotriacetate	34831-03-3	810W6QZ3QT			
nickel subsulfide		12035-72-2					
nickel sulfate	7786-81-4	Nickel Sulfate	7786-81-4	4FLT4T3WUN	Irritants	Drugs that act locally on cutaneous or mucosal surfaces to produce inflammation; those that cause redness due to hyperemia are rubefacients; those that raise blisters are vesicants and those that penetrate sebaceous glands and cause abscesses are pustulants; tear gases and mustard gases are also irritants. (See all compounds classified as Irritants.)	
nickel sulfide	16812-54-7	Nickel sulfide	12137-12-1				
Niclosamide	50-65-7	Niclosamide	50-65-7	8KK8CQ2K8G	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	For the treatment of tapeworm and intestinal fluke infections: Taenia saginata (Beef Tapeworm), Taenia solium (Pork Tapeworm), Diphyllobothrium latum (Fish Tapeworm), Fasciolopsis buski (large intestinal fluke). Niclosamide is also used as a molluscicide in the control of schistosomiasis.
Nicorandil	65141-46-0	Nicorandil	65141-46-0	260456HAM0	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	Indicated for the prevention and treatment of chronic stable angina pectoris and reduction in the risk of acute coronary syndromes.
nicosulfuron		Nicosulfuron	111991-09-4	CG297D9264			
nicotianamine	34441-14-0	Nicotianamine	34441-14-0	2OGX6YHQ1F			
Nicotinamide Mononucleotide	1094-61-7	Nicotinamide mononucleotide	1094-61-7	2KG6QX4W0V			
nicotinamide N-oxide	1986-81-8	Nicotinamide N-oxide	1986-81-8	6UY6QXJ2DP			
nicotinamide-beta-riboside		Nicotinamide riboside	1341-23-7	0I8H2M0L7N			
nicotinate mononucleotide	321-02-8	1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]pyridin-1-ium-3-carboxylate	321-02-8				
Nicotine		Nicotine	54-11-5	6M3C89ZY6R	Ganglionic Stimulants	Agents that mimic neural transmission by stimulation of the nicotinic receptors on postganglionic autonomic neurons. Drugs that indirectly augment ganglionic transmission by increasing the release or slowing the breakdown of acetylcholine or by non-nicotinic effects on postganglionic neurons are not included here nor are the nonspecific cholinergic agonists. (See all compounds classified as Ganglionic Stimulants.)	For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.
nicotine imine	74710-78-4	Nicotine imine	72344-33-3				
nicotinic acid adenine dinucleotide	6450-77-7	Deamidonicotinamide adenine dinucleoetide	6450-77-7	4Y1TS06J4H			
Nicotinic Acids		Nicotinic Acids					
Nicotinic Antagonists		Nicotinic Antagonists					
Nicotinyl Alcohol	100-55-0	3-Pyridinemethanol	100-55-0	9TF312056Y	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
Nifedipine	21829-25-4	Nifedipine	21829-25-4	I9ZF7L6G2L	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	Nifedipine capsules are indicated to treat vasospastic angina and chronic stable angina. Extended release tablets are indicated to treat vasospastic angina, chronic stable angina, and hypertension.
nifekalant		Nifekalant	130636-43-0	5VZ7GZM43E	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
Niflumic Acid	4394-00-7	Niflumic acid	4394-00-7	4U5MP5IUD8	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Used in the treatment of rheumatoid arthritis.
nifuroxazide	965-52-6	Nifuroxazide	965-52-6	PM5LI0P38J	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
Nifurtimox	23256-30-6	Nifurtimox	23256-30-6	M84I3K7C2O	Trypanocidal Agents	Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. (See all compounds classified as Trypanocidal Agents.)	Nifurtimox is indicated in pediatric patients under 18 weighing at least 2.5 kg. Continued approval of this drug for this indication is dependent upon confirmatory clinical trial results.
Nigella sativa oil		Nigella sativa oil					
Nigericin	28380-24-7	Nigericin	28380-24-7	RRU6GY95IS	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
niguldipine	102993-22-6	Niguldipine	102993-22-6	6Q39TPF0GL	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
nilotinib		Nilotinib	641571-10-0	F41401512X	Tyrosine Kinase Inhibitors	Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES. (See all compounds classified as Tyrosine Kinase Inhibitors.)	For the potential treatment of various leukemias, including chronic myeloid leukemia (CML).
nilutamide		Nilutamide	63612-50-0	51G6I8B902	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For use in combination with surgical castration for the treatment of metastatic prostate cancer involving distant lymph nodes, bone, or visceral organs (Stage D2).
nilvadipine		Nilvadipine	75530-68-6	0214FUT37J	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	For the management of vasospastic angina, chronic stable angina and hypertension.
nimbidiol		Nimbidiol	113332-25-5				
nimbin	5945-86-8	Nimbin	5945-86-8	N4CTG7K9IU			
nimbolide	25990-37-8	Nimbolide	25990-37-8	N993G4LGD6			
nimesulide	51803-78-2	Nimesulide	51803-78-2	V4TKW1454M	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	For the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old.
nimetazepam	2011-67-8	Nimetazepam	2011-67-8	4532264KW6	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
Nimodipine	66085-59-4	Nimodipine	66085-59-4	57WA9QZ5WH	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For use as an adjunct to improve neurologic outcome following subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms by reducing the incidence and severity of ischemic deficits.
Nimustine	42471-28-3	Nimustine	42471-28-3	0S726V972K	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
Ninhydrin	485-47-2	Ninhydrin	485-47-2	HCL6S9K23A	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
nintedanib		Nintedanib	928326-83-4		Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	Ofev is indicated in adults for the treatment of Idiopathic Pulmonary Fibrosis (IPF).
NIP142		N-[4-(cyclopropylamino)-3-hydroxy-2,2-dimethyl-7-nitro-3,4-dihydrochromen-6-yl]-2-(4-methoxyphenyl)acetamide					
niraparib		Niraparib	1038915-60-4	HMC2H89N35	Poly(ADP-ribose) Polymerase Inhibitors	Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. (See all compounds classified as Poly(ADP-ribose) Polymerase Inhibitors.)	Niraparib is indicated for the maintenance treatment of adult patients with advanced or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to first-line platinum-based chemotherapy.  In Canada and the US, niraparib is also available in a combination product with [abiraterone], which is indicated with [prednisone] for the treatment of adults with deleterious or suspected deleterious BRCA-mutated (BRCAm) metastatic castration-resistant prostate cancer (mCRPC). In Canada, this combination product is also used with [prednisolone] and is reserved for patients who are asymptomatic or mildly symptomatic, and in whom chemotherapy is not clinically indicated.
nirogacestat		Nirogacestat	1290543-63-3	QZ62892OFJ	Gamma Secretase Inhibitors and Modulators	Agents that suppress GAMMA-SECRETASE by inhibiting or modulating its activities. Targeted enzymatic activities include its involvement in accumulation of toxic AMYLOID BETA-PEPTIDES (e.g., A&#x3B2;42) in ALZHEIMER DISEASE and activation of NOTCH RECEPTOR mediated SIGNAL PATHWAYS in certain cancer types. (See all compounds classified as Gamma Secretase Inhibitors and Modulators.)	Nirogacestat is indicated for adult patients with progressing desmoid tumors who require systemic treatment.
Nisin	1414-45-5	1414-45-5					
Nisoldipine	63675-72-9	Nisoldipine	63675-72-9	4I8HAB65SZ	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.
nisoxetine	57226-61-6	Nisoxetine	53179-07-0	17NV064B2D			
nitazoxanide	55981-09-4	Nitazoxanide	55981-09-4	SOA12P041N	Antiparasitic Agents	Drugs used to treat or prevent parasitic infections. (See all compounds classified as Antiparasitic Agents.)	For the treatment of diarrhea in adults and children caused by the protozoa Giardia lamblia,  and for the treatment of diarrhea in children caused by the protozoan,  Cryptosporidium parvum.  Nitazoxanide has not been shown to be superior to placebo medication for the management of diarrhea caused by Cryptosporidium parvum in patients with HIV/immunodeficiency.
nitecapone	116313-94-1	Nitecapone	116313-94-1	98BS722498	Catechol O-Methyltransferase Inhibitors	Compounds and drugs that inhibit or block the activity of CATECHOL O-METHYLTRANSFERASE enzymes. Drugs in this class are used in management of central nervous system disorders such as PARKINSON DISEASE. (See all compounds classified as Catechol O-Methyltransferase Inhibitors.)	
nitenpyram		Nitenpyram	150824-47-8	3A837VZ81Y	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
nithiazine		4H-1,3-Thiazine, 5,6-dihydro-2-(aci-nitromethyl)-	58842-20-9		Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
nitidine	6872-57-7	Nitidine	6872-57-7	933301178Z			
nitisinone		Nitisinone	104206-65-7	K5BN214699	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Used as an adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of hereditary tyrosinemia type 1.
nitrapyrin	1929-82-4	Nitrapyrin	1929-82-4	8PCE86U01W			
Nitrates		Nitrate	14797-55-8	T93E9Y2844			
Nitrazepam	146-22-5	Nitrazepam	146-22-5	9CLV70W7HS	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	Used to treat short-term sleeping problems (insomnia), such as difficulty falling asleep, frequent awakenings during the night, and early-morning awakening.
Nitrendipine	39562-70-4	Nitrendipine	39562-70-4	9B627AW319	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the treatment of mild to moderate hypertension
Nitric Acid	7697-37-2	Nitric Acid	7697-37-2	411VRN1TV4	Explosive Agents	Substances that are energetically unstable and can produce a sudden expansion of the material, called an explosion, which is accompanied by heat, pressure and noise. Other things which have been described as explosive that are not included here are explosive action of laser heating, human performance, sudden epidemiological outbreaks, or fast cell growth. (See all compounds classified as Explosive Agents.)	
Nitric Oxide	10102-43-9	Nitric Oxide	10102-43-9	31C4KY9ESH	Bronchodilator Agents	Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)	For the treatment of term and near-term (>34 weeks) neonates with hypoxic respiratory failure
Nitric Oxide Donors		Nitric Oxide Donors					
Nitriles		Nitriles					
Nitrites		Nitrite Ion	14797-65-0	J39976L608			
nitroaniline	29757-24-2	Nitroaniline	645-55-6				
Nitroarginine	2149-70-4	Nitroarginine	2149-70-4	7O8V7H6P2J	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
nitroaspirin		Nitroaspirin	175033-36-0	EH04H13L6B	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
nitrobenzene	98-95-3	Nitrobenzene	98-95-3	E57JCN6SSY			
Nitrobenzenes		Nitrobenzenes					
Nitrobenzoates		Nitrobenzoates					
Nitroblue Tetrazolium	298-83-9	Nitroblue tetrazolium chloride	298-83-9	X44P41F7ZK	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
nitrocatechol		3-Nitrobenzene-1,2-diol	6665-98-1				
nitrofen		Nitrofen	1836-75-5	N71UYG034A	Pesticides	Chemicals used to destroy pests of any sort. The concept includes fungicides (FUNGICIDES, INDUSTRIAL); INSECTICIDES; RODENTICIDES; etc. (See all compounds classified as Pesticides.)	
nitroflurbiprofen	158836-71-6	Nitroflurbiprofen	158836-71-6	Q8ERI3E76F			
Nitrofurans		Nitrofurans					
Nitrofurantoin	67-20-9	Nitrofurantoin	67-20-9	927AH8112L	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Nitrofurantoin is indicated to treat acute uncomplicated urinary tract infections.
Nitrofurazone	59-87-0	Nitrofurazone	59-87-0	X8XI70B5Z6	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	For the treatment of bacterial skin infections including pyodermas, infected dermatoses and infections of cuts, wounds, burns and ulcers due to susceptible organisms.
Nitrogen	7727-37-9	Nitrogen	7727-37-9	N762921K75			Liquid nitrogen is used mainly as a cryogenic agent for the treatment of various benign and malignant skin lesions.
Nitrogen Compounds		Nitrogen Compounds					
Nitrogen Dioxide	10102-44-0	Nitrogen Dioxide	10102-44-0	S7G510RUBH	Oxidants, Photochemical	Compounds that accept electrons in an oxidation-reduction reaction. The reaction is induced by or accelerated by exposure to electromagnetic radiation in the spectrum of visible or ultraviolet light. (See all compounds classified as Oxidants, Photochemical.)	
Nitrogen Mustard Compounds		Nitrogen Mustard Compounds					
Nitrogen Oxides		Nitrogen Oxides					
Nitroglycerin	55-63-0	Nitroglycerin	55-63-0	G59M7S0WS3	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	Sublingual nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease. Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease.  Intravenous nitroglycerin is indicated for the treatment of peri-operative hypertension; for control of congestive heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and beta ()-blockers; and for induction of intraoperative hypotension.   Topical nitroglycerin ointment is used to treat moderate to severe pain associated with chronic anal fissure.
Nitroimidazoles		2-Nitroimidazole	527-73-1	K8E96XL55D			
Nitrophenols		Nitrophenols	25154-55-6				
nitrophenylphosphate	330-13-2	4-Nitrophenyl phosphate	330-13-2	59NF9TE3BA	Chromogenic Compounds	Colorless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into colored compounds; used in biochemical assays and in diagnosis as indicators, especially in the form of enzyme substrates. Synonym: chromogens (not to be confused with pigment-synthesizing bacteria also called chromogens). (See all compounds classified as Chromogenic Compounds.)	
Nitroprusside	15078-28-1	Pentacyano(nitroso)iron(2-)			Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
Nitrosamines		Nitrosamines					
nitrosobenzylmethylamine	937-40-6	N-methyl-n-benzylnitrosamine	937-40-6	H81CGI9K6Z	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
nitrosobis(2-oxopropyl)amine	60599-38-4	N-Nitrosobis(2-oxopropyl)amine	60599-38-4	H5C28SA7UB	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
Nitrosomethylurethane	615-53-2	N-Nitroso-N-methylurethane	615-53-2	741GDM4803	Alkylating Agents	Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)	
nitrosonium ion		Nitrilooxonium					
nitrosonium tetrafluoroborate	14635-75-7	Nitrosonium tetrafluoroborate	14635-75-7	B99S282SUJ			
Nitrosourea Compounds		Nitrosourea Compounds					
Nitrous Oxide	10024-97-2	Nitrous Oxide	10024-97-2	K50XQU1029	Analgesics, Non-Narcotic	A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)	Sedation
Nitrovin	804-36-4	Nitrovin	804-36-4		Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
nitroxoline	4008-48-4	Nitroxoline	4008-48-4	A8M33244M6	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	Nitroxoline is an antibiotic agent.
nitroxyl	14332-28-6	Nitroxyl	14332-28-6	GFQ4MMS07W	Neuroprotective Agents	Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)	
niuhuang		Oriental bezoar					
nivalenol	23282-20-4	12,13-Epoxy-3,4,7,15-tetrahydroxytrichothec-9-en-8-one	23282-20-4	5WOP02RM1U			
Nizatidine	76963-41-2	Nizax	76963-41-2		Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.
NKCT1 protein, Naja kaouthia		NKCT1 protein, Naja kaouthia					
NL-71-101		375854-09-4					
Nle(1)-AngIV		Nle(1)-AngIV					
NMS-873		3-(3-(Cyclopentylthio)-5-(((2-methyl-4'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)oxy)methyl)-4h-1,2,4-triazol-4-yl)pyridine	1418013-75-8				
NNC 112	125341-24-4	1H-3-Benzazepin-7-ol, 5-(7-benzofuranyl)-8-chloro-2,3,4,5-tetrahydro-3-methyl-, (S)-	125341-24-4	KH84I8R060			
NNC 711	145645-62-1	NO-711 hydrochloride	145645-62-1	500M0G931K	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
NO 756	123424-57-7	8-Chloro-5-(2,3-dihydrobenzofuran-7-yl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine	123424-57-7				
nobiletin	478-01-3	Nobiletin	478-01-3	D65ILJ7WLY	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
nobotanin B	104696-16-4	Nobotanin B	104696-16-4				
NOC 18		2,2'-(Hydroxynitrosohydrazono)bis-ethanimine	146724-94-9		Nitric Oxide Donors	A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)	
Nociceptin		Nociceptin	170713-75-4	7AYI9N34FF			
nociceptin (1-13) amide		Nociceptin (1-13), amide					
nociceptin (1-13)-NH2, Phe(1)-psi(CH2-NH)-Gly(2)-		nociceptin (1-13)-NH2, Phe(1)-psi(CH2-NH)-Gly(2)-					
nociceptin-amide, Nphe(1)-(pF)Phe(4)-Aib(7)-Arg(14)-Lys(15)-		nociceptin-amide, Nphe(1)-(pF)Phe(4)-Aib(7)-Arg(14)-Lys(15)-					
Nocodazole	31430-18-9	Nocodazole	31430-18-9	SH1WY3R615	Tubulin Modulators	Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)	
nodakenin		Nodakenin	495-31-8	S2KTH28M3N			
nodosin		Nodosin	10391-09-0				
nodularin		Nodularin R	118399-22-7	0979BIK2QU			
noladin ether		Noladin ether	222723-55-9	0D295FLV8W			
nolatrexed	152946-68-4	Nolatrexed dihydrochloride	152946-68-4	1XA69O733O	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	
nomegestrol	58691-88-6	Nomegestrol	58691-88-6	10F89177CO			
nomegestrol acetate		Nomegestrol acetate	58652-20-3	83J78V5W05			
Nomifensine	24526-64-5	Nomifensine	24526-64-5	1LGS5JRP31	Dopamine Uptake Inhibitors	Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. (See all compounds classified as Dopamine Uptake Inhibitors.)	
nomilin	1063-77-0	Nomilin	1063-77-0	DRM0753K4T			
Nonachlazine	49780-10-1	Azaclorzine hydrochloride	49780-10-1	7531I37BK3	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
nonachlor	3734-49-4	cis-Nonachlor	3734-49-4		Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
nonanal	124-19-6	Nonanal	124-19-6	2L2WBY9K6T			
nonane	111-84-2	Nonane	111-84-2	T9W3VH6G10			
Nonidet P-40	9036-19-5	2-[2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]ethoxy]ethanol					
nonivamide	618-92-8	CID 20057001					
Nonoxynol	26027-38-3	Nonoxinol	26027-38-3	ZMD36H3ESX	Spermatocidal Agents	Chemical substances that are destructive to spermatozoa used as topically administered vaginal contraceptives. (See all compounds classified as Spermatocidal Agents.)	
nonylphenol	25154-52-3	2-Nonylphenol	25154-52-3	24R8721A3S			
nootkatone	91416-23-8	Nookatone	91416-23-8				
norathyriol	3542-72-1	Norathyriol	3542-72-1				
norbinaltorphimine	105618-26-6	Norbinaltorphimine	105618-26-6	36OOQ86QM1	Narcotic Antagonists	Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)	
norbolethone		Norbolethone	1235-15-0	U3BZU2241A			
norbuprenorphine	78715-23-8	Norbuprenorphine	78715-23-8	7E53B4O073			
norcantharidin		Norcantharidin	5442-12-6		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
norcisapride	102671-04-5	2-O-Desmethyl Cisapride	102671-04-5				
norclozapine		N-Desmethylclozapine	6104-71-8	1I9001LWY8	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Investigated for use/treatment in schizophrenia and schizoaffective disorders.
norcodeine	467-15-2	Norcodeine	467-15-2	32W9P3T4ML			
Nordazepam	1088-11-5	Nordazepam	1088-11-5	67220MCM01	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	
Nordefrin	6539-57-7	Nordefrin	6539-57-7		Vasoconstrictor Agents	Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)	
nordihydrocapsaicin		Nordihydrocapsaicin	28789-35-7	RF657P8DA8			
nordy		nordy					
norelgestromin		Norelgestromin	53016-31-2		Contraceptive Agents, Hormonal	Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)	Norelgestromin is used for contraception and menopausal hormonal therapy. Norelgestromin may potentially be used in breast cancer treatment due to its inhibitory effect on estrone sulfatase . They convert sulfated steroid precursors to estrogen during pregnancy.
Norepinephrine	51-41-2	Norepinephrine	51-41-2	X4W3ENH1CV	Adrenergic alpha-Agonists	Drugs that selectively bind to and activate alpha adrenergic receptors. (See all compounds classified as Adrenergic alpha-Agonists.)	Mainly used to treat patients in vasodilatory shock states such as septic shock and neurogenic shock and has shown a survival benefit over dopamine. Also used as a vasopressor medication for patients with critical hypotension.
Norethindrone	68-22-4	Norethindrone	68-22-4	T18F433X4S	Contraceptives, Oral, Synthetic	Oral contraceptives which owe their effectiveness to synthetic preparations. (See all compounds classified as Contraceptives, Oral, Synthetic.)	Norethisterone is indicated as an oral contraceptive when given as monotherapy or in combination with an estrogen component, such as [ethinylestradiol] or [estradiol]. In combination with an estrogen component, oral norethisterone is also indicated as a hormone replacement therapy in the treatment of postmenopausal osteoporosis and moderate-to-severe vasomotor symptoms arising from menopause. When applied via transdermal patch, the combination of norethisterone and estradiol is indicated for the treatment of hypoestrogenism, vulvovaginal atrophy, and moderate-severe vasomotor symptoms.  Norethisterone, taken in combination with intramuscular [leuprolide], is also indicated for the symptomatic treatment of endometriosis-related pain.
Norethindrone Acetate	38673-38-0	Aygestin	51-98-9		Contraceptive Agents, Female	Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. (See all compounds classified as Contraceptive Agents, Female.)	
norethindrone enanthate	3836-23-5	Norethisterone enanthate	3836-23-5	HY3S2K0J0F	Contraceptive Agents, Female	Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. (See all compounds classified as Contraceptive Agents, Female.)	
Norethynodrel	68-23-5	Norethynodrel	68-23-5	88181ACA0M	Contraceptives, Oral, Synthetic	Oral contraceptives which owe their effectiveness to synthetic preparations. (See all compounds classified as Contraceptives, Oral, Synthetic.)	
norfenefrine	536-21-0	Norfenefrine	536-21-0	D2P3M6SRN5	Adrenergic alpha-Agonists	Drugs that selectively bind to and activate alpha adrenergic receptors. (See all compounds classified as Adrenergic alpha-Agonists.)	
Norfenfluramine	1886-26-6	Norfenfluramine	1886-26-6	037A9J3PSW	Serotonin Agents	Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons. (See all compounds classified as Serotonin Agents.)	
Norfloxacin	70458-96-7	Norfloxacin	70458-96-7	N0F8P22L1P	Cytochrome P-450 CYP1A2 Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP1A2. (See all compounds classified as Cytochrome P-450 CYP1A2 Inhibitors.)	For the treatment of urinary tract infection
norfluoxetine	56161-73-0	Norfluoxetine	83891-03-6	K8D70XE2F4			
norflurane		1,1,1,2-Tetrafluoroethane	811-97-2	DH9E53K1Y8	Anesthetics	Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)	
norflurazone	27314-13-2	Norflurazon	27314-13-2	KES1HB07E4	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
norgestimate	35189-28-7	Norgestimate	107382-52-5	NKX8DN6TY9	Contraceptive Agents, Hormonal	Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)	Norgestimate is formulated with [ethinylestradiol] as a combined oral contraceptive. It can also be given with low dose ethinylestradiol for contraception as well as the treatment of moderate acne vulgaris in women 15 years old.
norgestimate, ethinyl estradiol drug combination		Tri-sprintec	79871-54-8		Contraceptives, Oral, Combined	Fixed drug combinations administered orally for contraceptive purposes. (See all compounds classified as Contraceptives, Oral, Combined.)	
norgestomet		Norgestomet	25092-41-5	3L33UD42X4			
Norgestrel	6533-00-2	Norgestrel	797-63-7	3J8Q1747Z2	Contraceptive Agents, Female	Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. (See all compounds classified as Contraceptive Agents, Female.)	Norgestrel in combination with ethinyl estradiol is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.
norharman	244-63-3	9H-Pyrido[3,4-B]indole	244-63-3	94HMA1I78O	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
noribogaine		12-Hydroxyibogamine	481-88-9	87T5QTN9SK			
norisoboldine		Norisoboldine	23599-69-1	63J46T4EQ3			
norketamine		Norketamine	35211-10-0	XQY6JVF94X			
norkurarinol		2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-8-(5-hydroxy-5-methyl-2-prop-1-en-2-ylhexyl)-2,3-dihydrochromen-4-one					
norlevorphanol	1531-12-0	Norlevorphanol	1531-12-0	IL94262N7K			
Normetanephrine	97-31-4	Normetanephrine	97-31-4	0J45DE6B88			
normetazocine	16808-63-2	1,2,3,4,5,6-Hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol	16808-63-2				
nornicotine	5746-86-1	Nornicotine	5746-86-1		Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
noroxycodone		Noroxycodone	57664-96-7	95Q949779D			
Norpregnenes		Norpregnenes					
norswertianolin	54954-12-0	Norswertianolin	54954-12-0	8FEU38L6GD			
Nortriptyline	72-69-5	Nortriptyline	72-69-5	BL03SY4LXB	Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	Nortriptyline is indicated for the relief of the symptoms of major depressive disorder (MDD). Some off-label uses for this drug include treatment of chronic pain, myofascial pain, neuralgia, and irritable bowel syndrome.
norverapamil	67018-85-3	Norverapamil	67018-85-3	957Z3K3R56	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
norwogonin	4443-09-8	Norwogonin	4443-09-8	70U0WT21IB			
Noscapine	128-62-1	Noscapine	128-62-1	8V32U4AOQU	Antitussive Agents	Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)	Investigated for use/treatment in lymphoma (non-hodgkin's), leukemia (lymphoid), cancer/tumors (unspecified), and multiple myeloma.
notexin	37223-96-4	notexin					
nothofagin		Nothofagin	11023-94-2				
notoginsenoside R1		Notoginsenoside R1	80418-24-2	Z62692362Z			
notopterol	88206-46-6	Notopterol	88206-46-6				
novichok		novichok					
Novobiocin	303-81-1	Novobiocin	303-81-1	17EC19951N	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of infections due to staphylococci and other susceptible organisms
NP 40208		NP 40208					
NP00111		NP00111					
NP260		NP260					
NPC 15437	136449-85-9	2,6-Diamino-N-((1-(oxotridecyl)-2-piperidinyl)methyl)hexanamide	136449-85-9				
NPC 18884		NPC 18884					
NPLC 0393		NPLC 0393					
NPS R-467		CID 10199287	148717-56-0				
NRA 0045		NRA 0045					
NRA 0160		4-(4-Fluorophenyl)-5-[2-[4-[(3-fluorophenyl)methylidene]piperidin-1-yl]ethyl]-1,3-thiazole-2-carboxamide					
NS 004	54425-30-8	1-(5-Chloro-2-hydroxyphenyl)-5-trifluoromethyl-1,3-dihydro-2-benzimidazol-2-one	54425-30-8				
NS 1619	153587-01-0	1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-1H-benzo[d]imidazol-2(3H)-one	153587-01-0				
NS 1652		Anthranilic acid, N-((alpha,alpha,alpha-trifluoro-m-tolyl)carbamoyl)-	1566-81-0	9B8X1YC8U2			
NS-3728		Urea, N-(3,5-bis(trifluoromethyl)phenyl)-N'-(4-bromo-2-(1H-tetrazol-5-yl)phenyl)-	265646-85-3	9H4XH6M8MU			Investigated for use/treatment in anemia (sickle cell) and cancer/tumors (unspecified).
NSC 23766		NSC 23766 trihydrochloride	1177865-17-6				
NSC 303530		1,2-Bis(7-methyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethane	64762-53-4				
NSC 354646	80790-68-7	Morpholinyl doxorubicin	80790-68-7	X0N4EFN4AI			
NSC 366140		Pyrazoloacridine mesylate	99009-21-9	F152KXF5MA	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
NSC 401077		2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-3-(1H-indol-3-yl)-propionic acid	32675-71-1				
NSC 652287		[5-[5-[5-(Hydroxymethyl)thiophen-2-yl]furan-2-yl]thiophen-2-yl]methanol	213261-59-7				
NSC 663284		6-Chloro-7-(2-morpholin-4-yl-ethylamino)quinoline-5,8-dione	383907-43-5	CY8W2F69MW			
NSC 668036		Boc-(Ala-Hmb)2-OH					
NSC 674495		4-(1,3-Benzothiazol-2-yl)-2-methylaniline	178804-04-1				
NSC 680410		Adaphostin	241127-58-2				
NSC 689534		1,1-bis(2-pyridylmethyl)-3-[(E)-2-pyridylmethyleneamino]thiourea					
NSC 724998		NSC 724998					
NSC 74859		2-Hydroxy-4-(2-(tosyloxy)acetamido)benzoic acid	501919-59-1	JG1E8503OI			
NSC-87877		8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid	56990-57-9				
NSC305787		[2-(1-Adamantyl)-6,8-dichloroquinolin-4-yl]-piperidin-2-ylmethanol					
NSC606985		4-Ethyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl aminoacetate hydrochloride					
NSC668394		7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione					
NSC73306		G3GZ237Put	874650-89-2	G3GZ237PUT			
NSP 804	125068-43-1	4,5-Dihydro-6-(4-((2-methyl-3-oxo-1-cyclopentenyl)amino)phenyl)-3(2H)-pyridazinone	125068-43-1				
NSP 805	125068-54-4	4,5-Dihydro-5-methyl-6-(4-((2-methyl-3-oxo-1-cyclopentenyl)amino)phenyl)-3-(2H)-pyridazinone	125068-54-4				
NT020 formula		NT020 formula					
NT157 compound		NT157 compound					
NU 1025		8-Hydroxy-2-methylquinazolin-4(3H)-one	90417-38-2	X5ZL2C7V9B			
NU2058		6-(cyclohexylmethoxy)-9H-purin-2-amine	161058-83-9	884MN6AR44			
NU6102		O6-Cyclohexylmethoxy-2-(4'-sulphamoylanilino) purine	444722-95-6	X5J53DR704			
nuarimol	63284-71-9	Nuarimol	63284-71-9	ZU7K80U0CY	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Nucleic Acids, Nucleotides, and Nucleosides		Nucleic Acids, Nucleotides, and Nucleosides					
Nucleosides		Nucleosides					
Nucleotides		Nucleotides					
nutlin 2		Nutlin-2					
nutlin 3		Nutlin-3	548472-68-0				
NuvaRing		Nuvaring	131562-74-8		Contraceptive Agents, Hormonal	Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)	
NVP ABE171		NVP ABE171					
NVP ADW742		5-(3-Phenylmethoxyphenyl)-7-[3-(pyrrolidin-1-ylmethyl)cyclobutyl]pyrrolo[2,3-d]pyrimidin-4-amine	475488-23-4	MXS2N5862L			
NVP-AEW541		Nvp-aew541	475488-34-7	97QB5037VR			
NVP-BHG712		4-methyl-3-(1-methyl-6-(pyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)-N-(3-(trifluoromethyl)phenyl)benzamide	940310-85-0	N86NEM4R7Q			
NVP-BKM120		Buparlisib	944396-07-0	0ZM2Z182GD			
NVP-BSK805		4-(2,6-difluoro-4-(3-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)quinoxalin-5-yl)benzyl)morpholine					
NVP-TAE684		5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine	761439-42-3	EH1713MN4K			
NW 1029		NW 1029					
nylestriol		Nilestriol	39791-20-3	7JA3B3IALU	Estrogens	Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. (See all compounds classified as Estrogens.)	
Nylidrin	447-41-6	Nylidrin	447-41-6	695DKH33EI	Tocolytic Agents	Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)	Nylidrin is mainly indicated in conditions like arteriosclerosis, cerebrovascular disease, peripheral vascular disease, Raynaud's disease, thrombo-angitis obliterans, and thrombophlebitis. It may sometimes be used in the treatment of peripheral vascular disorders in addition premature labor (however, the drug is not approved for premature labor).
nymphayol		Nymphayol					
Nystatin	1400-61-9	Mycostatin	1400-61-9		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Nystatin is available in oral formulations for the treatment and/or prevention of oral candidiasis (a.k.a. thrush), intestinal candidiasis, and anal candidiasis. It is indicated topically for the treatment of vulvovaginal candidiasis and other cutaneous candida infections. A combination product containing nystatin alongside [neomycin], [gramicidin D], and [triamcinolone] (Viaderm K.C.) is indicated in the treatment of corticosteroid-responsive dermatoses caused by bacterial or candidal infections and for pruritus ani/vulvae. It is also available in combination with [metronidazole] for the treatment of mixed infections due to _Trichomonas vaginalis_ and _Candida albicans_.  Nystatin is also sometimes used off-label for the prevention of invasive candidiasis in low birth weight neonates, though it is generally reserved as a second-line option after [fluconazole].
O-(6)-methylguanine	20535-83-5	2-Amino-6-methoxypurine	20535-83-5	9B710FV2AE			
O-(Chloroacetylcarbamoyl)fumagillol		O-(chloroacetylcarbamoyl)fumagillol	129298-91-5	X47GR46481	Angiogenesis Inhibitors	Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. (See all compounds classified as Angiogenesis Inhibitors.)	
O-1602 compound	317321-41-8	5-Methyl-4-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-YL]-1,3-benzenediol	317321-41-8	59F4R2N5N5			
O-Acetyl-ADP-Ribose		2''-O-acetyl-ADP-D-ribose					
o-Aminoazotoluene	97-56-3	o-Aminoazotoluene	97-56-3	QHZ900P7ZA	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
O-demethyltramadol		O-Demethyltramadol	73986-53-5		Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	
O-desmethylangolensin		O-Desmethylangolensin	21255-69-6	SCY1S10OK4	Phytoestrogens	Compounds derived from plants, primarily ISOFLAVONES that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS. (See all compounds classified as Phytoestrogens.)	
O-methyltyramine	55-81-2	4-Methoxyphenethylamine	55-81-2	UCE8P23XWF			
o-Phthalaldehyde	643-79-8	o-Phthalaldehyde	643-79-8	4P8QP9768A	Disinfectants	Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley&apos;s Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Disinfectants.)	
O,O-diethyl dithiophosphate	298-06-6	O,O-Diethyl dithiophosphate	298-06-6	02C5XR639P			
O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate	5598-15-2	Chlorpyrifos oxon	5598-15-2	7RC6H1MPX6			
O,O-diethylphosphorylcholine iodide		O,O-diethylphosphorylcholine iodide					
O,O-diisopropyl-S-benzylthiophosphate	26087-47-8	Iprobenfos	26087-47-8	OV3YOE2895			
O,O-dimethyl phosphorodithioate	756-80-9	O,O-Dimethyl dithiophosphate	756-80-9	4K09JRW4Z6			
O,O-dimethyl phosphorothionate	1112-38-5	Dimethyl thiophosphate	1112-38-5	6KM8HRE9WB			
o,p'-DDT	789-02-6	O,P'-Ddt	789-02-6	D4K93Z1TBH	Estrogens, Non-Steroidal	Non-steroidal compounds with estrogenic activity. (See all compounds classified as Estrogens, Non-Steroidal.)	
O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate		O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate					
O(2)-(2,4-dinitrophenyl) 1-(4-(N,N-diethylcarboxamido)piperazin-1-yl)diazen-1-ium 1,2-diolate		O(2)-(2,4-dinitrophenyl) 1-(4-(N,N-diethylcarboxamido)piperazin-1-yl)diazen-1-ium 1,2-diolate					
O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate		O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate					
O(6)-(4-bromothenyl)guanine		Lomeguatrib	192441-08-0	S79265T71M			
O(6)-benzyl-2'-deoxyguanosine	129732-90-7	O(6)-Benzyl-2'-deoxyguanosine	129732-90-7				
O(6)-benzyl-N-acetylguanosine		O(6)-benzyl-N-acetylguanosine					
O(6)-benzylguanine		o6-Benzylguanine	19916-73-5	01KC87F8FE	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
obacunone	751-03-1	Obacunone	751-03-1				
obacunone glucoside		obacunone glucoside					
obatoclax		Obatoclax	803712-67-6	QN4128B52A	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
obeticholic acid		Obeticholic Acid	459789-99-2	0462Z4S4OZ			Obeticholic acid is indicated for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA. It is also used as a monotherapy in adults with PBC that are unable to tolerate UDCA.  Obeticholic acid is currently being considered for FDA approval to treat fibrosis caused by non-alcoholic liver steatohepatitis (NASH), and is likely to be approved for this indication in 2020.
Obidoxime Chloride	114-90-9	Obidoxime chloride	114-90-9	3HXR312Z9M	Cholinesterase Reactivators	Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates. (See all compounds classified as Cholinesterase Reactivators.)	
oblimersen		Oblimersen sodium	190977-41-4		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
obtusifolin		Obtusifolin	477-85-0				
obtusifoline-2-O-beta-D-6-di-O-acetylglucopyranoside		obtusifoline-2-O-beta-D-6-di-O-acetylglucopyranoside					
OC 144-093		Ontogen	216227-54-2	PK2WD2XC83			
ochratoxin A	303-47-9	Ochratoxin A	303-47-9	1779SX6LUY	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
ochratoxin B	4825-86-9	Ochratoxin B	4825-86-9	ECJ5WS94N2			
Ochratoxins		Ochratoxin					
octa-2,4,6-trienoic acid	5205-32-3	2,4,6-Octatrienoic acid	5205-32-3	702XZO95X4			
octabromobiphenyl	27858-07-7	Tetrabromo(tetrabromophenyl)benzene	27858-07-7	4E96M09888			
octabromodiphenyl ether DE-79		octabromodiphenyl ether DE-79					
octachlorostyrene	29082-74-4	Octachlorostyrene	29082-74-4	304368U4VH			
octamethylcyclotetrasiloxane	556-67-2	Octamethylcyclotetrasiloxane	556-67-2	CZ227117JE	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
octanedioic acid (1-(3-azido-5-azidomethylbenzyl)-1H-pyrazol-4-yl)amide hydroxyamide		octanedioic acid (1-(3-azido-5-azidomethylbenzyl)-1H-pyrazol-4-yl)amide hydroxyamide					
octanoic acid	124-07-2	Octanoic Acid	68937-74-6	OBL58JN025			
Octanols		Octanols					
octanoylcarnitine	3671-77-0	Octanoylcarnitine	3671-77-0	S1HB7P0O16			
octaphlorethol A		Octaphlorethol A					
octenidine	71251-02-0	Octenidine	71251-02-0	OZE0372S5A	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
octoclothepine	13448-22-1	Clorotepine	13448-22-1	E65W20MU7A			
octocrylene	6197-30-4	Octocrylene	6197-30-4	5A68WGF6WM			In the US, Octocrylene has been evaluated by the FDA and is considered safe for use up to 10% in the formula. Similarly, the EU allows its use up to 10% in a formula while Health Canada allows a maximum use level of 12%.
Octopamine	104-14-3	Octopamine	104-14-3	14O50WS8JD	Vasoconstrictor Agents	Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)	
Octoxynol	9002-93-1	Triton X-100	9002-93-1	20CAX7IO75	Detergents	Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)	
Octreotide	83150-76-9	Octreotide	83150-76-9	RWM8CCW8GP	Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	Octreotide by injection is used for the treatment of acromegaly and the reduction of flushing and diarrhea symptoms related to carcinoid tumors and/or vasoactive intestinal peptide (VIPoma) tumors. The delayed-release oral formulation is used for the long-term treatment of acromegaly in patients who tolerate and respond adequately to injectable octreotide and [lanreotide].
octyl dimethyl 4-aminobenzoic acid	58817-05-3	Octyl dimethyl 4-aminobenzoic acid	58817-05-3	3X64HWP88S			
octyl gallate	1034-01-1	Octyl gallate	1034-01-1	079IIA2811	Food Preservatives	Substances capable of inhibiting, retarding or arresting the process of fermentation, acidification or other deterioration of foods. (See all compounds classified as Food Preservatives.)	
octylmethoxycinnamate		Octinoxate	5466-77-3	4Y5P7MUD51	Sunscreening Agents	Chemical or physical agents that protect the skin from sunburn and erythema by absorbing or blocking ultraviolet radiation. (See all compounds classified as Sunscreening Agents.)	As an active ingredient in sunscreens and lip balms. Used for protection against damaging effects of sun rays.
octylphenol		octylphenol					
odapipam		Odapipam	131796-63-9	847PQF7ZN6			
ODN2006		ODN2006					
oenothein B	104987-36-2	Oenothein B	104987-36-2				
Ofloxacin	82419-36-1	Ofloxacin	82419-36-1	A4P49JAZ9H	Anti-Infective Agents, Urinary	Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)	For the treatment of infections (respiratory tract, kidney, skin, soft tissue, UTI), urethral and cervical gonorrhoea.
ogerin		Ogerin					
OICR464		OICR464					
OICR573		OICR573					
Oils, Volatile		Oils, Volatile					
Okadaic Acid	78111-17-8	Okadaic acid	78111-17-8	1W21G5Q4N2	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
okanin		Okanin	484-76-4	8R55YLB39F			
Olanzapine		Olanzapine	132539-06-1	N7U69T4SZR	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	Olanzapine was initially used orally and intramuscularly for the chronic treatment of schizophrenia in patients over 13 years old and other psychiatric disorders such as bipolar I disorder including mixed or manic episodes.   Olanzapine is also indicated, in combination with lithium or valproate for the short-term treatment of acute manic or mixed episodes associated with bipolar I disorder in adults.  As well, olanzapine is indicated, in combination with fluoxetine for the treatment of episodes of depression associated with bipolar disorder type 1 and treatment-resistant depression in patients over 10 years old.  Olanzapine is also approved for the management of psychomotor agitation associated with schizophrenia and bipolar I mania.  Schizophrenia is a complex biochemical brain disorder that affects the person's ability to differentiate reality. It is usually observed as the presence of delusions, hallucinations, social withdrawal and disturbed thinking.  Bipolar disorder is a mental health condition defined by periods of extreme mood disturbances. It is categorized in different types from which type 1 is known to involve episodes of severe mania and often depression while type 2 presents less severe forms of mania.  Olanzapine is also indicated in combination with [samidorphan] for the treatment of bipolar I disorder, either as an adjunct to lithium or valproate or as monotherapy for the acute treatment of manic or mixed episodes or as maintenance therapy, and for the treatment of schizophrenia in adults.
olaparib		Olaparib	763113-22-0	WOH1JD9AR8	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	**Ovarian cancer**  Olaparib is indicated for the maintenance treatment of adults with deleterious or suspected deleterious germline or somatic BRCA-mutated advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum-based chemotherapy.  Olaparib is indicated in combination with [bevacizumab] for the maintenance treatment of adults with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to first-line platinum-based chemotherapy and whose cancer is associated with homologous recombination deficiency (HRD)-positive status defined by either: a deleterious or suspected deleterious BRCA mutation, and/or genomic instability.  Olaparib is indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in complete or partial response to platinum-based chemotherapy.  **Breast cancer**  Olaparib is indicated for the adjuvant treatment of adult patients with deleterious or suspected deleterious g_BRCA_m human epidermal growth factor receptor 2 (HER2)-negative high risk early breast cancer who have been treated with neoadjuvant or adjuvant chemotherapy.  Olaparib is indicated for the treatment of adult patients with deleterious or suspected deleterious g_BRCA_m, HER2-negative metastatic breast cancer, who have been treated with chemotherapy in the neoadjuvant, adjuvant, or metastatic setting. Patients with hormone receptor (HR) positive breast cancer should have been treated with a prior endocrine therapy or be considered inappropriate for endocrine therapy.  **Pancreatic cancer**  Olaparib is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious gBRCAm metastatic pancreatic adenocarcinoma whose disease has not progressed on at least 16 weeks of a first-line platinum-based chemotherapy regimen.  **Prostate cancer**  Olaparib is indicated for the treatment of adult patients with deleterious or suspected deleterious germline or somatic homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC) who have progressed following prior treatment with a hormone agent, such as [enzalutamide] or [abiraterone].  It is also indicated in combination with [abiraterone] and [prednisone] or [prednisolone] for the treatment of adult patients with deleterious or suspected deleterious BRCA-mutated (BRCAm) metastatic castration-resistant prostate cancer (mCRPC).
olaquindox		Olaquindox	23696-28-8	G3LAW9U88T			
olcegepant		Olcegepant	204697-65-4	WOA5J8TX6M	Calcitonin Gene-Related Peptide Receptor Antagonists	Pharmacologic agents that block NOCICEPTIVE PAIN signaling from CALCITONIN GENE-RELATED PEPTIDE RECEPTORS. They may be useful for the treatment of pain associated with MIGRAINE DISORDERS and OSTEOARTHRITIS. (See all compounds classified as Calcitonin Gene-Related Peptide Receptor Antagonists.)	For the treatment of migraine headaches.
oleacein		Oleacein, 90%	149183-75-5				
oleandrin	465-16-7	Oleandrin	465-16-7	II95UDU7I4			
Oleanolic Acid	508-02-1	Oleanolic Acid	508-02-1	6SMK8R7TGJ			
oleanolic acid 3-acetate	4339-72-4	3-O-Acetyloleanolic acid	4339-72-4				
Oleic Acid	112-80-1	Oleic Acid	112-80-1	2UMI9U37CP			
oleocanthal		Oleocanthal	289030-99-5	AC7QO6038O			
oleoresins		oleoresins					
oleoyl-coenzyme A	1716-06-9	oleoyl-CoA	1716-06-9	SPV646A327			
oleoyl-estrone		Oleoyl-estrone	180003-17-2	64R56KMG1Z	Anti-Obesity Agents	Agents that increase energy expenditure and weight loss by neural and metabolic regulation. (See all compounds classified as Anti-Obesity Agents.)	For the treatment of obesity.
oleoylanilide	5429-85-6	Oleanilide	5429-85-6	6J8G54ZUQ5			
oleoylethanolamide		n-Oleoylethanolamine	111-58-0	1HI5J9N8E6	Cannabinoid Receptor Agonists	Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)	
olesoxime		Cholest-4-en-3-one, oxime	22033-87-0				Investigated for use/treatment in neurologic disorders.
oleuropein	32619-42-4	Oleuropein	32619-42-4	2O4553545L	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
oleylamide	301-02-0	Oleamide	301-02-0	7L25QK8BWO	Food Additives	Substances used in the processing or storage of foods or animal feed including ANTIOXIDANTS; FOOD PRESERVATIVES; FOOD COLORING AGENTS; FLAVORING AGENTS; ANTI-INFECTIVE AGENTS; EXCIPIENTS and other similarly used substances. Many of the same substances are used as PHARMACEUTIC AIDS. (See all compounds classified as Food Additives.)	
Oleylethanolamide		n-Oleoylethanolamine	111-58-0	1HI5J9N8E6	Cannabinoid Receptor Agonists	Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)	
Oligodeoxyribonucleotides		Oligodeoxyribonucleotides					
Oligodeoxyribonucleotides, Antisense		Oligodeoxyribonucleotides, Antisense					
oligofectamine		oligofectamine					
oligofructose		oligofructose					
oligomycin A	579-13-5	Oligomycin A	579-13-5	05HQS4AI99			
oligomycin B	11050-94-5	Oligomycin A, 28-oxo-	11050-94-5				
Oligomycins		Oligomycins	1404-19-9		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Oligonucleotides		5'-Acacccaattctgaaaatgg-3'	104053-06-7				
Oligopeptides		Oligopeptides					
Oligoribonucleotides		Oligoribonucleotides					
Oligoribonucleotides, Antisense		Oligoribonucleotides, Antisense					
Oligosaccharides		Oligosaccharides					
olivacine	484-49-1	Olivacine	484-49-1	5WSL5LL2C3			
Olive Oil		8001-25-0					
olivetol	500-66-3	Olivetol	500-66-3	65OP0NEZ1P			
olmesartan		Olmesartan	144689-24-7	8W1IQP3U10	Angiotensin II Type 1 Receptor Blockers	Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)	Olmesartan is indicated for the treatment of hypertension either alone or in combination with other antihypertensive agents.   Olmesartan is also used off-label for the management Type 2 Diabetes-associated nephropathy, heart failure, and post-myocardial infarction, particularly in patients who are unable to tolerate ACE inhibitors. ARBs such as olmesartan have been shown in a number of large-scale clinical outcomes trials to improve cardiovascular outcomes including reducing risk of myocardial infarction, stroke, the progression of heart failure, and hospitalization. Like other ARBs, olmesartan blockade of RAAS slows the progression of diabetic nephropathy due to its renoprotective effects.
Olmesartan Medoxomil		Olmesartan Medoxomil	144689-63-4	6M97XTV3HD	Angiotensin II Type 1 Receptor Blockers	Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)	
olodaterol		Olodaterol	868049-49-4	VD2YSN1AFD	Bronchodilator Agents	Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)	Olodaterol is indicated for use in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated for the treatment of acute exacerbations of COPD or for the treatment of asthma.
olomoucine		Olomoucine	101622-51-9	6A839B2HYS	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
olomoucine II		Olomoucine II	500735-47-7				
Olopatadine Hydrochloride		Olopatadine Hydrochloride	140462-76-6	2XG66W44KF	Histamine H1 Antagonists, Non-Sedating	A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. (See all compounds classified as Histamine H1 Antagonists, Non-Sedating.)	Treatment of ocular signs and symptoms of seasonal allergic conjunctivitis. ,
olprinone	119615-63-3	Olprinone hydrochloride	119615-63-3	F18B658J56	Cardiotonic Agents	Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)	
olsalazine	15722-48-2	Olsalazine	15722-48-2		Gastrointestinal Agents	Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)	
oltipraz	64224-21-1	Oltipraz	64224-21-1	6N510JUL1Y	Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	
olvanil	58493-49-5	Olvanil	58493-49-5	4P7KIU7003	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
OM99-2		EVNLPsiAAEF	314266-76-7	4ZNA144ZS0			
Omacor		Lovaza	861006-80-6				
omadacycline		Omadacycline					
omapatrilat		Omapatrilat	167305-00-2	36NLI90E7T	Angiotensin-Converting Enzyme Inhibitors	A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)	For the treatment of hypertension.
omaveloxolone		Omaveloxolone	1474034-05-3	G69Z98951Q			Omaveloxolone is indicated for the treatment of Friedreich's ataxia in adults and adolescents aged 16 years and older.
OMDM 169		Orlistat derivative, 17c	130193-44-1				
OMDM-1 cpd		(S)-N-oleoyltyrosinol	616884-62-9				
OMDM-2 cpd		(Z)-N-[(2R)-1-hydroxy-3-(4-hydroxyphenyl)propan-2-yl]octadec-9-enamide	616884-63-0	S8GQN2QT3H			
omega-Agatoxin IVA		omega-Agatoxin IVA	145017-83-0		Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
omega-agatoxin-Aa4b		omega-agatoxin IVB					
omega-Chloroacetophenone	532-27-4	2-Chloroacetophenone	8007-12-3	88B5039IQG	Irritants	Drugs that act locally on cutaneous or mucosal surfaces to produce inflammation; those that cause redness due to hyperemia are rubefacients; those that raise blisters are vesicants and those that penetrate sebaceous glands and cause abscesses are pustulants; tear gases and mustard gases are also irritants. (See all compounds classified as Irritants.)	
omega-Conotoxin GVIA	92078-76-7	omega-Conotoxin G VIA (reduced)	92078-76-7		Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
omega-conotoxin-MVIIC	147794-23-8	omega-Conotoxin-mviic	147794-23-8		Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
omega-N-Methylarginine	17035-90-4	Tilarginine	17035-90-4	27JT06E6GR	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Omeprazole	73590-58-6	Omeprazole	73590-58-6	KG60484QX9	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	Omeprazole, according to the FDA label is a proton pump inhibitor (PPI) used for the following purposes:   Treatment of active duodenal ulcer in adults    Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence in adults    Treatment of active benign gastric ulcer in adults    Reduction of risk of upper gastrointestinal (GI) bleeding in critically ill adult patients.   Treatment of symptomatic gastroesophageal reflux disease (GERD) in patients 1 year of age and older    Treatment of erosive esophagitis (EE) due to acid-mediated GERD in patients 1 month of age and older    Maintenance of healing of EE due to acid-mediated GERD in patients 1 year of age and older    Pathologic hypersecretory conditions in adults
omeprazole sulfide	73590-85-9	Ufiprazole	73590-85-9	6FFV1V867C			
omipalisib		Omipalisib	1086062-66-9	1X8F5A3NA0			
Omite	2312-35-8	Propargite	2312-35-8	30M429ANKL			
ON 01910		Rigosertib	592542-59-1	67DOW7F9GL	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
ON123300		8-Cyclopentyl-2-((4-(4-methylpiperazin-1-yl)phenyl)amino)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitrile	1357470-29-1	QJ8RO3296G			
onabotulinum toxin A		Botox					
onapristone		Onapristone	96346-61-1	H6H7G23O3N	Hormone Antagonists	Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)	
Oncostatin M	106956-32-5	Oncostatin M					
oncrasin-1		1-(4-chlorobenzyl)-1H-indole-3-carbaldehyde	75629-57-1				
Ondansetron	99614-02-5	Ondansetron	99614-02-5	4AF302ESOS	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	In the adult patient population: i) orally administered ondansetron tablets and orally disintegrating tablets (ODT) are indicated for: - the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy, including high dose (ie. greater than or equal to 50 mg/m2) cisplatin therapy, and radiotherapy, and - the prevention and treatment of postoperative nausea and vomiting  ii) intravenously administered ondansetron injection formulations are indicated for: - the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy, including high dose (ie. greater than or equal to 50 mg/m2) cisplatin therapy, and - the prevention and treatment of postoperative nausea and vomiting  In the pediatric (4-18 years of age) patient population: i) ondansetron was effective and well tolerated when given to children 4-12 years of age for the treatment of post-chemotherapy induced nausea and vomiting, ii) ondansetron tablets, ondansetron ODT, ondansetron injection are not indicated for the treatment of children 3 years of age or younger, iii) ondansetron tablets, ondansetron ODT, ondansetron injection are not indicated for use in any age group of the pediatric population for the treatment of post-radiotherapy induced nausea and vomiting, and iV) ondansetron tablets, ondansetron ODT, ondansetron injection are not indicated for use in any age group of the pediatric population for the treatment of postoperative nausea and vomiting  In the geriatric (>65 years of age) patient population: i) efficacy and tolerance of ondansetron were similar to that observed in younger adults for the treatment of post-chemotherapy and radiotherapy-induced nausea and vomiting, and ii) clinical experience in the use of ondansetron in the prevention and treatment of postoperative nausea and vomiting is limited and is not indicated for use in the geriatric patient population
ONO 1301	176391-41-6	2-[[5-[2-[(E)-[phenyl(pyridin-3-yl)methylidene]amino]oxyethyl]-7,8-dihydronaphthalen-1-yl]oxy]acetic acid					
ONO 3708	102191-05-9	Ono-3708	102191-05-9	88SI3G560K	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
ONO 8711		6-((2S,3S)-3-(4-chloro-2-methylphenysulfonylaminomethyl)-bicyclo(2.2.2)octan-2-yl)-5Z-hexenoic acid	216158-34-8				
ONO AE 248		Ono-AE-248	211230-67-0				
ONO-5334		Unii-9tdn93L9FN	868273-90-9	9TDN93L9FN			
ONO-8430506		4-[2-[8-[(4-Fluorophenyl)methyl]-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraen-5-yl]-2-oxoethyl]bicyclo[2.2.1]heptane-1-carboxylic acid					
ONO-AE1-329		Ono-AE1-329					
ONO-LB 457	134578-96-4	5-(2-(2-Carboxyethyl)-3-(6-(4-methoxyphenyl)-5E-hexenyl)oxyphenoxy)valeric acid	134578-96-4		Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	
ONO-NT 012		ONO-NT 012					
onvansertib		Onvansertib	1034616-18-6	67RM91WDHQ	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
OPC 3911	76470-87-6	Butanamide, N-cyclohexyl-N-(2-hydroxyethyl)-4-((1,2,3,4-tetrahydro-2-oxo-6-quinolinyl)oxy)-	76470-87-6				
ophiobolin A	4611-05-6	Ophiobolin A	4611-05-6				
ophiocordin	63590-19-2	Balanol	63590-19-2	O0N0E1MP23			
ophiopogonin D	41753-55-3	Ophiopogonin D	945619-74-9				
Opiate Alkaloids		Opiate Alkaloids					
opicapone		Opicapone	923287-50-7	Y5929UIJ5N	Catechol O-Methyltransferase Inhibitors	Compounds and drugs that inhibit or block the activity of CATECHOL O-METHYLTRANSFERASE enzymes. Drugs in this class are used in management of central nervous system disorders such as PARKINSON DISEASE. (See all compounds classified as Catechol O-Methyltransferase Inhibitors.)	Opicapone is indicated as adjunctive therapy in adults with Parkinsons disease and end-of-dose motor fluctuations or off episodes whose symptoms cannot be stabilized on the combination therapy of levodopa and DOPA decarboxylase inhibitor (e.g., carbidopa).
Opium	8008-60-4	Opium (USP)					
oprelvekin		Oprelvekin					
OR 1958		OR 1958					
OR486		3,5-Dinitrocatechol	7659-29-2	VK0VA22GY2	Catechol O-Methyltransferase Inhibitors	Compounds and drugs that inhibit or block the activity of CATECHOL O-METHYLTRANSFERASE enzymes. Drugs in this class are used in management of central nervous system disorders such as PARKINSON DISEASE. (See all compounds classified as Catechol O-Methyltransferase Inhibitors.)	
oracine	148317-76-4	Oracine	148317-76-4				
orange oil		orange oil					
orantinib	210644-62-5	Orantinib	210644-62-5	9RL37ZZ665	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
orazipone		Orazipone	137109-78-5	64R9Y5FE39			
orbifloxacin		Orbifloxacin	113617-63-3	660932TPY6			
orcinol	504-15-4	Orcinol	504-15-4	534PMB3438	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
oren gedoku to		oren gedoku to					
Org 31710	118968-41-5	11-(4-Dimethylaminophenyl)-6-methyl-4',5'-dihydro(estra-4,9-diene-17,2'-(3H)-furan)-3-one	118968-41-5	X2V3MG6PE8			
Org 34850		ORG 34850					
Org 41841		5-amino-N-tert-butyl-4-(3-methoxyphenyl)-2-(methylthio)-6-thieno[2,3-d]pyrimidinecarboxamide	301847-37-0	5J2KL52JYJ			
Organic Chemicals		Organic Chemicals					
Organogold Compounds		Organogold Compounds					
Organometallic Compounds		Organometallic Compounds					
Organophosphates		Organophosphates					
Organophosphonates		Hydrogenphosphite	15477-76-6				
Organophosphorus Compounds		Organophosphorus Compounds					
Organoplatinum Compounds		Organoplatinum Compounds					
Organoselenium Compounds		Organoselenium Compounds					
Organothiophosphates		Organothiophosphates					
Organotin Compounds		Organotin Compounds					
oridonin	28957-04-2	Oridonin	28957-04-2	0APJ98UCLQ			
orientin		Orientin	28608-75-5	IAX93XCW6C			
origamicin		origamicin					
Orlistat	96829-58-2	Orlistat	96829-58-2	95M8R751W8	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Orlistat is indicated for obesity management including weight loss and weight maintenance when used in combination with calorie reduction in overweight and obese adults; this indication applies to both the prescription formulation of 120 mg and the over-the-counter formulation of 60 mg. Orlistat in the 120 mg prescription formulation is also indicated to reduce the risk of weight regain following weight loss.
ormeloxifene		Centchroman	31477-60-8	V994WJY688	Estrogen Antagonists	Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)	
ormosil		ormosil					
Ornidazole	16773-42-5	Ornidazole	16773-42-5	62XCK0G93T	Antitrichomonal Agents	Agents used to treat trichomonas infections. (See all compounds classified as Antitrichomonal Agents.)	
Ornithine	7006-33-9	L-ornithine	70-26-8	E524N2IXA3			Used for nutritional supplementation, also for treating dietary shortage or imbalance. It has been claimed that ornithine improves athletic performance, has anabolic effects, has wound-healing effects, and is immuno-enhancing.
Ornithine Decarboxylase Inhibitors		Ornithine Decarboxylase Inhibitors					
Orotic Acid	65-86-1	Orotic acid	65-86-1	61H4T033E5			
Orphenadrine	83-98-7	Orphenadrine	83-98-7	AL805O9OG9	Muscarinic Antagonists	Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)	Indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculo skeletal conditions.
orteronel		Orteronel	566939-85-3	UE5K2FNS92			
Ortho Evra		Norelgestromin	53016-31-2		Contraceptive Agents, Hormonal	Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)	Norelgestromin is used for contraception and menopausal hormonal therapy. Norelgestromin may potentially be used in breast cancer treatment due to its inhibitory effect on estrone sulfatase . They convert sulfated steroid precursors to estrogen during pregnancy.
ortho-Aminobenzoates		ortho-Aminobenzoates					
oryzalin	19044-88-3	Oryzalin	19044-88-3	662E385DWH	Coccidiostats	Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals. (See all compounds classified as Coccidiostats.)	
osajin		Osajin	482-53-1	83R5N9X74B			
Oseltamivir		Oseltamivir	196618-13-0	20O93L6F9H	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	According to FDA prescribing information, oseltamivir is indicated for the treatment of acute, uncomplicated illness due to influenza A and B infection in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours. In particular, this agent is indicated in adults and children including full-term neonates who present with symptoms typical of influenza when influenza virus is circulating in the community. Efficacy has been demonstrated when treatment is initiated within two days of the first onset of symptoms.  Oseltamivir is also indicated for the prophylaxis of influenza in patients one year and older. Specifically, post-exposure prevention in individuals one year of age or older following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community qualifies for such prophylactic therapy. Oseltamivir would only be indicated for post-exposure prevention of influenza in infants less than 1 year of age during a pandemic influenza outbreak.
oseltamivir carboxylate		Oseltamivir Acid	187227-45-8	K6106LV5Q8			
osemozotan		Osemozotan	137275-81-1	M65825806Q			Investigated for use/treatment in anxiety disorders, depression, insomnia, and neurologic disorders.
OSI 027		Osi-027	936890-98-1	25MKH1SZ0M			
osimertinib		Osimertinib	1421373-65-0	3C06JJ0Z2O	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Osimertinib is indicated as adjuvant therapy after tumor resection in adult patients with non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations (as detected by an FDA-approved test), and as the first-line treatment of adult patients with metastatic NSCLC whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations (as detected by an FDA-approved test). Osimertinib is also indicated for the treatment of adult patients with metastatic EGFR T790M mutation-positive NSCLC, as detected by an FDA-approved test, whose disease has progressed on or after EGFR TKI therapy.
Ospemifene		Ospemifene	128607-22-7	B0P231ILBK			Ospemifene is indicated for the treatment of moderate to severe dyspareunia and vaginal dryness associated with menopause.
osteum	143-19-1	Sodium Oleate	143-19-1	399SL044HN			
osthol	484-12-8	Osthol	484-12-8	XH1TI1759C	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
OSU 03012		PDK1 inhibitor AR-12	742112-33-0	EX3O2Q61UV			
OSU 6162		Piperidine, 3-(3-(methylsulfonyl)phenyl)-1-propyl-, (S)-	146798-66-5	0D21EQAQQA			
OSU-HDAC42 compound		OSU-HDAC42 compound					
OSU03013		OSU03013					
OSW 1	145075-81-6	(3beta,16beta)-16-[[2-O-Acetyl-3-O-[2-O-(4-methoxybenzoyl)-beta-D-xylopyranosyl]-alpha-L-arabinopyranosyl]oxy]-3,17-dihydroxycholest-5-en-22-one					
otenzepad	102394-31-0	Otenzepad	102394-31-0	WW6A9TFL2C	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	
otosenine		Otosenine	16958-29-5	Z999A1E7I4			
ottelione A		ottelione A					
OTX015		Birabresib	202590-98-5	X40LKS49S3			
Ouabain	630-60-4	Ouabain	630-60-4	5ACL011P69	Cardiotonic Agents	Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)	For the treatment of atrial fibrillation and flutter and heart failure
Ovalbumin	9006-59-1	3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one	9006-59-1				
ovalbumin-alum		ovalbumin-alum					
ovatodiolide		Ovatodiolide	3484-37-5	641ILF0QGZ			
Oviol	71138-35-7	Desogestrel and ethinyl estradiol	71138-35-7				
oxabolone cypionate	1254-35-9	Oxabolone cipionate	1254-35-9	5RXY50Q01N			Used as a performance enhancing drug illicitly in athletes.
Oxadiazoles		Oxadiazoles					
oxadiazon	19666-30-9	Oxadiazon	19666-30-9	C6U0E0YTP6			
Oxalates		Oxalates					
Oxalic Acid	144-62-7	Oxalic Acid	144-62-7	9E7R5L6H31	Reducing Agents	Materials that add an electron to an element or compound, that is, decrease the positiveness of its valence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) (See all compounds classified as Reducing Agents.)	
Oxaliplatin		Oxalato(trans-l-1,2-cyclohexanediamine)platinum(II)	61825-94-3		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Oxaliplatin, in combination with infusional fluorouracil and leucovorin, is indicated for the treatment of advanced colorectal cancer and adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor.
Oxaloacetates		Oxaloacetic Acids					
Oxaloacetic Acid	328-42-7	Oxalacetic acid	328-42-7	2F399MM81J			
oxalomalic acid	3687-15-8	Oxalomalic acid	3687-15-8				
oxalyldiaminopropionic acid	7554-90-7	2-Amino-3-(carboxyformamido)propanoic acid	7554-90-7	1TG777QI25			
oxalylglycine		N-Oxalylglycine	5262-39-5	VVW38EB8YS			
oxamflatin		Oxamflatin	151720-43-3				
Oxamic Acid	471-47-6	Oxamic acid	471-47-6	QU60N5OPLG			
oxamyl	23135-22-0	N,N-Dimethyl-alpha-methylcarbamoyloxyimino-alpha-(methylthio)acetamide	23135-22-0				
Oxandrolone	53-39-4	Oxandrolone	53-39-4	7H6TM3CT4L	Anabolic Agents	These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. (See all compounds classified as Anabolic Agents.)	Use to promote weight gain after weight loss following extensive surgery.
oxantel pamoate	68813-55-8	Oxantel pamoate	68813-55-8	UPY1D732T0	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	
Oxaprozin	21256-18-8	Oxaprozin	21256-18-8	MHJ80W9LRB	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Used to relieve the inflammation, swelling, stiffness, and joint pain associated with rheumatoid arthritis and osteoarthritis.
oxatomide	60607-34-3	Oxatomide	60607-34-3	J31IL9Z2EE	Anti-Asthmatic Agents	Drugs that are used to treat asthma. (See all compounds classified as Anti-Asthmatic Agents.)	
Oxazepam	604-75-1	Oxazepam	604-75-1	6GOW6DWN2A	GABA Modulators	Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)	Oxazepam is indicated for the management of anxiety disorders and for the short-term relief of symptoms of anxiety. It may also be used in the management of alcohol withdrawal symptoms.
oxazepam glucuronide	6801-81-6	Oxazepam glucuronide	6801-81-6	26IK2C76NO			
Oxazines		Oxazines					
Oxazoles		Oxazole	288-42-6	FJZ20I1LPS			
oxazolinodaunorubicin		oxazolinodaunorubicin					
Oxazolone	15646-46-5	4-Ethoxymethylene-2-phenyl-2-oxazolin-5-one	15646-46-5	40RAK33386	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
oxcarbamazepine		Oxcarbazepine	28721-07-5	VZI5B1W380	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	In the United States, oxcarbazepine is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures.   In Canada, oxcarbazepine is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in patients 6 years of age and older.
Oxcarbazepine	28721-07-5	Oxcarbazepine	28721-07-5	VZI5B1W380	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	In the United States, oxcarbazepine is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures.   In Canada, oxcarbazepine is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in patients 6 years of age and older.
oxeladin	468-61-1	Oxeladin	468-61-1	SNC1080T5Y	Antitussive Agents	Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)	
oxfendazole	53716-50-0	Oxfendazole	53716-50-0	OMP2H17F9E	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	
oxibendazole	20559-55-1	Oxibendazole	20559-55-1	022N12KJ0X	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	Investigated for use/treatment in infectious and parasitic disease (unspecified) and pediatric indications.
oxiconazole	64211-45-6	Oxiconazole	64211-45-6	C668Q9I33J	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	For treatment of dermal fungal infection.
Oxidants		Oxidants					
oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine		oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine					
Oxidopamine	1199-18-4	Oxidopamine	1199-18-4	8HW4YBZ748	Adrenergic Agents	Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)	
oxilofrine		Oxilofrine	365-26-4	F49638UBDR			Used in combination with [DB11609] as an antitussive.
Oximes		CHEBI:25750					
oxodiperoxo(pyridine-2-carboxylate)vanadate(V)		oxodiperoxo(pyridine-2-carboxylate)vanadate(V)					
oxoline	30266-58-1	1,2,3,4-Naphthalenetetrone	30266-58-1	M9FIQ15Q9N			
Oxonic Acid	937-13-3	Oxonic Acid	937-13-3	5VT6420TIG			Oteracil is used as an adjunct to antineoplastic therapy. When used within the product Teysuno, oteracil is indicated for the treatment of adults with advanced gastric (stomach) cancer when given in combination with cisplatin.
oxophenylarsine	637-03-6	Phenylarsine oxide	637-03-6	0HUR2WY345	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Oxotremorine	70-22-4	Oxotremorine	70-22-4	5RY0UWH1JL	Muscarinic Agonists	Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate. (See all compounds classified as Muscarinic Agonists.)	
oxotremorine M	63939-65-1	Oxotremorine M	63939-65-1	VWS78J9ZUJ	Muscarinic Agonists	Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate. (See all compounds classified as Muscarinic Agonists.)	
oxovanadium IV	20644-97-7	Oxidovanadium(2+)	20644-97-7				
Oxprenolol	6452-71-7	Oxprenolol	6452-71-7	519MXN9YZR	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	Used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
OXT-328		4-diethoxyphosphoryloxybutyl 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetate					
oxybenzone	131-57-7	Oxybenzone	131-57-7	95OOS7VE0Y	Sunscreening Agents	Chemical or physical agents that protect the skin from sunburn and erythema by absorbing or blocking ultraviolet radiation. (See all compounds classified as Sunscreening Agents.)	Used as an ingredient in sunscreen and other cosmetics.
oxybutynin	5633-20-5	Oxybutynin	5633-20-5	K9P6MC7092	Muscarinic Antagonists	Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)	Oxybutynin is indicated for the symptomatic treatment of overactive bladder, which causes urge urinary incontinence and frequency, and urgency.  Oxybutynin may also be used for children aged 6 and above for the symptomatic management of detrusor muscle overactivity which has been found to be related to a neurological condition. Spina bifida is an example of a neurological condition in which oxybutynin may be used to control urinary symptoms. On occasion, oxybutynin may be used off-label to relieve bladder spasms associated with ureteral stents or urinary catheters.
oxycarboxin	5259-88-1	Oxycarboxin	5259-88-1	NPU5GBN17X			
oxychlordane	27304-13-8	Oxychlordane	26940-75-0				
Oxycodone	76-42-6	Oxycodone	76-42-6	CD35PMG570	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	Oxycodone is indicated for the treatment of moderate to severe pain. There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.
oxyfluorofen		Oxyfluorfen	42874-03-3	46GY4Y6567			
Oxygen	7782-44-7	Oxygen	7782-44-7	S88TT14065			Oxygen therapy in clinical settings is used across diverse specialties, including various types of anoxia, hypoxia or dyspnea and any other disease states and conditions that reduce the efficiency of gas exchange and oxygen consumption such as respiratory illnesses, trauma, poisonings and drug overdoses. Oxygen therapy tries to achieve hyperoxia to reduce the extent of hypoxia-induced tissue damage and malfunction.
oxyhyponitrite	18550-55-5	N-hydroxynitramide	18550-55-5				
oxymatrine	16837-52-8	Oxymatrine	16837-52-8		Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
Oxymetazoline	1491-59-4	Oxymetazoline	1491-59-4	8VLN5B44ZY	Adrenergic alpha-Agonists	Drugs that selectively bind to and activate alpha adrenergic receptors. (See all compounds classified as Adrenergic alpha-Agonists.)	Oxymetazoline is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults.  Ophthalmic oxymetazoline is indicated for the treatment of acquired blepharoptosis in adults.  When used in combination with tetracaine intranasally, oxymetazoline is indicated for regional anesthesia when performing a restorative procedure on Teeth 4-13 and A-J in adults and children who weigh 40 kg or more.  Oxymetazoline can be found in over-the-counter nasal products as a nasal decongestant.  For off-label uses, oxymetazoline has been used during nasal intubation and during ear, nose, and throat surgery to improve visualization of the airway and to minimize post-operative bleeding.
Oxymetholone	434-07-1	Oxymetholone	434-07-1	L76T0ZCA8K	Androgens	Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. (See all compounds classified as Androgens.)	Indicated in the treatment of anemias caused by deficient red cell production. Acquired aplastic anemia, congenital aplastic anemia, myelofibrosis and the hypoplastic anemias due to the administration of myelotoxic drugs often respond. Oxymetholone should not replace other supportive measures such as transfusion, correction of iron, folic acid, vitamin B12 or pyridoxine deficiency, antibacterial therapy and the appropriate use of corticosteroids.
Oxymorphone	76-41-5	Oxymorphone	76-41-5	9VXA968E0C	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	For the treatment of moderate-to-severe pain.
oxypertine	153-87-7	Oxypertine	153-87-7	5JGL4G25R7			
Oxyphenbutazone	129-20-4	Oxyphenbutazone	129-20-4	H806S4B3NS	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
oxyphencyclimine	125-53-1	Oxyphencyclimine	125-53-1	4V44H1O8XI			For the treatment of peptic ulcer disease and the relief of smooth muscle spasms in gastrointestinal disorders.
Oxyphenisatin Acetate	115-33-3	Oxyphenisatin acetate	115-33-3	U0Y1YAL65X	Cathartics	Agents that are used to stimulate evacuation of the bowels. (See all compounds classified as Cathartics.)	
Oxypurinol	2465-59-0	Oxypurinol	2465-59-0	G97OZE5068	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Intended for the treatment of congestive heart failure and hyperuricemia.
Oxyquinoline	148-24-3	Oxyquinoline	148-24-3	5UTX5635HP			Oxyquinoline is used as a biocidal component of several over the counter products. These products are marketed for the purposes of inhibiting abnormal biological growth in the vagina and restoring natural pH.
Oxytetracycline	79-57-2	Oxytetracycline	79-57-2	SLF0D9077S	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Oxytetracycline is indicated for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae (respiratory infections), and Diplococcus pneumoniae.
Oxytocin	50-56-6	Oxytocin	50-56-6	1JQS135EYN	Oxytocics	Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) (See all compounds classified as Oxytocics.)	Administration of exogenous oxytocin is indicated in the antepartum period to initiate or improve uterine contractions for vaginal delivery in situations where there is fetal or maternal concern. For example, It may be used to induce labor in cases of Rh sensitization, maternal diabetes, preeclampsia at or near term, and when delivery is indicated due to prematurely ruptured membranes. Importantly, oxytocin is not approved or indicated for elective induction of labor. Oxytocin may be used to reinforce labor in select cases of uterine inertia and as adjunctive therapy in the management of incomplete or inevitable abortion. In the postpartum period, oxytocin may be used to induced contractions in the 3rd stage of labor and to control postpartum bleeding or hemorrhage.
oxytocin, Pen(1)-(4-MePhe)(2)-Thr(4)-Orn(8)-	106128-84-1	Oxytocin, pen(1)-(4-mephe)(2)-thr(4)-orn(8)-	106128-84-1				
oxytocin, Thr(4)-Gly(7)-	60786-59-6	(2S)-N-[(2R)-1-[[2-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S)-2-[[(2R)-2-amino-3-sulfanylidenepropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]butanediamide	60786-59-6				
ozagrel	82571-53-7	Ozagrel	82571-53-7	L256JB984D	Fibrinolytic Agents	Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)	
Ozone	10028-15-6	Ozone	10028-15-6	66H7ZZK23N	Oxidants, Photochemical	Compounds that accept electrons in an oxidation-reduction reaction. The reaction is induced by or accelerated by exposure to electromagnetic radiation in the spectrum of visible or ultraviolet light. (See all compounds classified as Oxidants, Photochemical.)	
P 34081	148504-23-8	Morpholine urea-phenylalanyl-homophenylalanine methyl fluoride	148504-23-8				
p-271 peptide		p-271 peptide					
p-Aminohippuric Acid	61-78-9	Aminohippuric acid	61-78-9	Y79XT83BJ9	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	Used to measure effective renal plasma flow (ERPF) and to determine the functional capacity of the tubular excretory mechanism.
p-aminophenylarsine oxide		4-Aminophenylarsenoxide	1122-90-3	Q80F4IJC71			
p-carboxymethylphenyl 1,1-bis(3'-indolyl)-1-(p-carboxymethylphenyl)methane		p-carboxymethylphenyl 1,1-bis(3'-indolyl)-1-(p-carboxymethylphenyl)methane					
p-Chloroamphetamine	64-12-0	p-CHLOROAMPHETAMINE	64-12-0	897NVD4A52	Serotonin Agents	Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons. (See all compounds classified as Serotonin Agents.)	
p-Chloromercuribenzoic Acid	59-85-8	4-Chloromercuribenzoic acid	59-85-8		Sulfhydryl Reagents	Chemical agents that react with SH groups. This is a chemically diverse group that is used for a variety of purposes. Among these are enzyme inhibition, enzyme reactivation or protection, and labelling. (See all compounds classified as Sulfhydryl Reagents.)	
p-coumaric acid		p-Coumaric acid	501-98-4	IBS9D1EU3J	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
p-Dimethylaminoazobenzene	60-11-7	4-(Dimethylamino)azobenzene	60-11-7	A49L8E13FD	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
P-glycoprotein inducer and activator TX5		P-glycoprotein inducer and activator TX5					
p-hydroxycinnamaldehyde		(E)-3-(4-hydroxyphenyl)prop-2-enal					
p-Methoxy-N-methylphenethylamine	4091-50-3	4-Methoxy-N-methylbenzeneethanamine	4091-50-3	J18PF78JWQ			
p-nitrophenol glucuronide		p-nitrophenol glucuronide					
p-tert-amylphenol	80-46-6	4-tert-Amylphenol	80-46-6	6NP9LYK846			
p-tert-butyl catechol	98-29-3	4-tert-Butylcatechol	98-29-3	9A069144KR	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
P(1),P(5)-di(adenosine-5'-)pentaphosphate	50304-44-4	P(1),P(5)-bis(5'-adenosyl)pentaphosphate	50304-44-4		Vasoconstrictor Agents	Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)	
p38alpha inhibitor CMPD1		p38alpha inhibitor CMPD1					
P5091		1-(5-(2,3-Dichlorophenylthio)-4-nitrothiophen-2-yl)ethanone	882257-11-6				
P57 compound		P57 compound					
P61-E7 compound		P61-E7 compound					
P61A6 compound		P61A6 compound					
pachastrissamine		Pachastrissamine					
pachymic acid		Pachymic acid	29070-92-6	X2FCK16QAH	Phospholipase A2 Inhibitors	Compounds that inhibit or block the activity of a PHOSPHOLIPASE A2 enzyme. (See all compounds classified as Phospholipase A2 Inhibitors.)	
Paclitaxel		Paclitaxel	33069-62-4	P88XT4IS4D			Used in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast. Abraxane is specfically indicated for the treatment of metastatic breast cancer and locally advanced or metastatic non-small cell lung cancer.
paclobutrazol	76738-62-0	(2R,3R)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pentan-3-ol	76738-62-0				
padimate-O	21245-02-3	2-Ethylhexyl-p-dimethyl-aminobenzoate					
paederosidic acid		Paederosidic acid					
paeonol	552-41-0	Paeonol	552-41-0	3R834EPI82			
pafuramidine		Pafuramidine	186953-56-0	H1VG379J2X	Trypanocidal Agents	Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. (See all compounds classified as Trypanocidal Agents.)	Investigated for use/treatment in pneumonia, trypanosomiasis, malaria, HIV infection, and infectious and parasitic disease (unspecified).
PAK 104P	131356-86-0	2-(4-(Diphenylmethyl)-1-piperazinyl)ethyl 5-(4,6-dimethyl-1,3,2-dioxaphosphorinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate P-oxide	131356-86-0				
palbinone	139954-00-0	Palbinone	139954-00-0	TXG6F287LT			
palbociclib		Palbociclib	571190-30-2	G9ZF61LE7G	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Palbociclib is indicated in combination with [letrozole] as initial endocrine-based therapy for the treatment of human epidermal growth factor receptor type 2 (HER2)-negative and hormone receptor(HR)-positive tumors in adult patients with advanced/metastatic breast cancer. It is as well approved in combination with [fulvestrant] in patients with disease progression with prior endocrine therapy.  In the official labeling, the use of palbociclib should be accompanied with either an aromatase inhibition, no restricted to letrozole, as initial endocrine-based therapy in postmenopausal women or in man.  The breast cancer starts as a group of cancer cells that grow into and destroy the nearby breast tissue. This growth can spread into other parts of the body which is called metastasis. According to the location of the cancer cells, it can be categorized in ductal carcinoma and lobular carcinoma. However, other types of breast cancer include inflammatory breast cancer, Paget disease of the breast, triple negative breast cancer non-Hodgkin lymphoma and soft tissue sarcoma. In males, breast cancer is usually treated as the cases of postmenopausal women and almost all the cases are ductal carcinoma.
Paliperidone Palmitate		Paliperidone Palmitate	199739-10-1	R8P8USM8FR	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Xeplion is indicated for maintenance treatment of schizophrenia in adult patients stabilised with paliperidone or risperidone. In selected adult patients with schizophrenia and previous responsiveness to oral paliperidone or risperidone, Xeplion may be used without prior stabilisation with oral treatment if psychotic symptoms are mild to moderate and a long-acting injectable treatment is needed.
Palladium	7440-05-3	Palladium	7440-05-3	5TWQ1V240M			
palladium chloride	7647-10-1	Palladium(II) chloride	7647-10-1				
pallidol		Pallidol	1622292-61-8	QE5TL72TJ8			
Palm Oil		[2-[(1,3-Benzothiazol-2-ylhydrazinylidene)methyl]-4-(4-propylphenyl)phenyl] 4-[1,2-di(prop-2-enoyloxy)ethoxy]benzoate;(2,4-dimethylphenyl) 7-[(1,3-benzothiazol-2-ylhydrazinylidene)methyl]-6-[4-[3-(4-prop-2-enoyloxybutoxy)-2-(3-prop-2-enoyloxypropanoyloxy)propoxy]benzoyl]oxynaphthalene-2-carboxylate;(4-methoxy-2-methylphenyl) 3-[(1,3-benzothiazol-2-ylhydrazinylidene)methyl]-4-[4-[3-(4-prop-2-enoyloxybutoxy)-2-(3-prop-2-enoyloxypropanoyloxy)propoxy]benzoyl]oxybenzoate	8002-75-3				
palmatine	3486-67-7	Palmatine	3486-67-7	G50C034217			
palmidrol		Palmitoylethanolamide	544-31-0	6R8T1UDM3V	Cannabinoid Receptor Agonists	Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)	
Palmitates		Palmitates					
Palmitic Acid	57-10-3	Palmitic Acid	57-10-3	2V16EO95H1	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
palmitoleic acid	2091-29-4	9-Hexadecenoic acid	2091-29-4	65DJ825A3Z			
Palmitoyl Coenzyme A	1763-10-6	palmitoyl-CoA	1763-10-6				
palmitoyl glycerol	542-44-9	2,3-Dihydroxypropyl hexadecanoate	542-44-9	U9H9OM3S75			
palmitoyl trifluoromethyl ketone		Palmitoyl Trifluoromethyl Ketone					
Palmitoylcarnitine	1935-18-8	Palmitoylcarnitine	1935-18-8	U8K6DKA8V2	Vitamin B Complex	A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)	
palmitoylsphingomyelin		N-Palmitoylsphingomyelin	6254-89-3	804F5DLI9L			
palomid 529		Palomid 529	914913-88-5	XV9409EWG4			
Palonosetron	135729-61-2	Palonosetron	135729-61-2	5D06587D6R	Serotonin 5-HT3 Receptor Antagonists	Drugs that bind to but do not activate SEROTONIN 5-HT3 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT3 RECEPTOR AGONISTS. (See all compounds classified as Serotonin 5-HT3 Receptor Antagonists.)	For the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy, as well as prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy. Also used for the prevention of postoperative nausea and vomiting for up to 24 hours post operation.
palytoxin	11077-03-5	Palytoxin	77734-91-9	OQ17NC0MOV			
Pam(3)CSK(4) peptide		Pam(3)CSK(4) peptide					
PAM2-CSK4		PAM2-CSK4					
Pam2CSK4 lipopeptide		Pam2CSK4 lipopeptide					
pamabrom	606-04-2	Pamabrom	606-04-2	UA8U0KJM72			
Pamidronate	40391-99-9	Pamidronic Acid	40391-99-9	OYY3447OMC	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Pamidronate is indicated to treat moderate to severe hypercalcemia of malignancy, moderate to severe Paget's disease of bone, osteolytic bone metastases of breast cancer, and osteolytic lesions of multiple myeloma.
pamoic acid	130-85-8	Pamoic acid	130-85-8	7RRQ8QZ38N			
panamesine		Panamesine	139225-22-2	023D9E916L			
Panax notoginseng extract		Panax notoginseng extract					
panaxadiol	19666-76-3	Panaxadiol	19666-76-3	F84BLM3L74			
panaxatriol	32791-84-7	Panaxatriol	32791-84-7	9F5B25FDDG			
panaxydol	72800-72-7	(3r)-8-[(2r,3s)-3-Heptyloxiran-2-yl]oct-1-ene-4,6-diyn-3-ol	72800-72-7	P3VHC8ZL8G			
pancratistatin	96281-31-1	(1R,2S,3S,4S,4aR)-1,2,3,4,7-pentahydroxy-2,3,4,4a,5,11b-hexahydro-1H-[1,3]dioxolo[4,5-j]phenanthridin-6-one	96281-31-1				
Pancreatic Polypeptide	59763-91-6	CID 24868176			Gastrointestinal Agents	Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)	
Pancuronium		Pancuronium	16974-53-1	J76UF062FS	Nicotinic Antagonists	Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)	Used as a muscle relaxant during anesthesia and surgical procedures.
panduratin A		Panduratin A	89837-52-5	27N2BIM2CR			
Panobinostat		Panobinostat	404950-80-7	9647FM7Y3Z	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Panobinostat is indicated in the treatment of multiple myeloma in combination with dexamethasone and bortezomib in patients who have received 2 previous treatment regimens including bortezomib and an immunomodulatory agent. This indication is approved by accelerated approval based on progression free survival as of February 23, 2015.
pantogab	1977-33-9	4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid	1977-33-9		Nootropic Agents	Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)	
Pantoprazole	102625-70-7	Pantoprazole	102625-70-7	D8TST4O562	Proton Pump Inhibitors	Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)	**Pantoprazole Injection**:  **Treatment of gastroesophageal reflux disease associated with a history of erosive esophagitis**  Pantoprazole for injection is indicated for short-term treatment (7-10 days) of patients having gastroesophageal reflux disease (GERD) with a history of erosive esophagitis, as an alternative to oral medication in patients who are unable to continue taking pantoprazole delayed-release tablets. _Safety and efficacy of pantoprazole injection as the initial treatment of patients having GERD with a history of erosive esophagitis have not been demonstrated at this time_.  **Pathological Hypersecretion Associated with Zollinger-Ellison Syndrome**  Pantoprazole for injection is indicated for the treatment of pathological hypersecretory conditions associated with Zollinger-Ellison Syndrome or other neoplastic conditions.  **Pantoprazole delayed-release oral suspension**:  **Short-Term Treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD)**  Indicated in adults and pediatric patients five years of age and above for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis. For adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of pantoprazole may be considered. Safety of treatment beyond 8 weeks in pediatric patients has not been determined.  **Maintenance of healing of erosive esophagitis**  Indicated for maintenance of healing of erosive esophagitis and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with GERD.  **Pathological hypersecretory conditions including Zollinger-Ellison syndrome**  Indicated for the long-term treatment of the above conditions.
Pantothenic Acid	79-83-4	Pantothenic Acid	79-83-4	19F5HK2737	Vitamin B Complex	A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)	Studied for the treatment of many uses such as treatment of testicular torsion, diabetic ulceration, wound healing, acne, obesity, diabetic peripheral polyneuropathy. It has also been investigated for its hypolipidemic effects and as cholesterol lowering agent.
PAPA NONOate		PAPA NONOate	146672-58-4		Nitric Oxide Donors	A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)	
Papaverine	58-74-2	Papaverine	58-74-2	DAA13NKG2Q	Phosphodiesterase Inhibitors	Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)	For the treatment of impotence and vasospasms.
PAR-1-activating peptide		PAR-1-activating peptide					
para-methyl-4-methylaminorex		para-methyl-4-methylaminorex					
Parabens		Parabens					
paraform	30525-89-4	30525-89-4					
Paraldehyde	123-63-7	Paraldehyde	123-63-7	S6M3YBG8QA	Hypnotics and Sedatives	Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)	Paraldehyde was used historically as a sedative and hypnotic. It has been used in the treatment of seizures as an anticonvulsant.
Paraoxon	311-45-5	Paraoxon	311-45-5	Q9CX8P80JW	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Paraquat	4685-14-7	Paraquat	4685-14-7	PLG39H7695	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
pararosaniline	479-73-2	C.I. Basic Red 9	479-73-2	20N4C0M8NM	Fixatives	Agents employed in the preparation of histologic or pathologic specimens for the purpose of maintaining the existing form and structure of all of the constituent elements. Great numbers of different agents are used; some are also decalcifying and hardening agents. They must quickly kill and coagulate living tissue. (See all compounds classified as Fixatives.)	
parasporin		parasporin					
Parathion	56-38-2	Parathion	56-38-2	61G466064D	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
parbendazole	14255-87-9	Parbendazole	14255-87-9	N4X8WVX2UG	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	
pardoprunox	269718-83-4	Pardoprunox hydrochloride	269718-83-4	U40903X6V8			
parecoxib		Parecoxib	198470-84-7	9TUW81Y3CE	Cyclooxygenase 2 Inhibitors	A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2. (See all compounds classified as Cyclooxygenase 2 Inhibitors.)	Used for short term perioperative pain control.
Pargyline	555-57-7	Pargyline	555-57-7	9MV14S8G3E	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the treatment of moderate to severe hypertension.
paricalcitol		Paricalcitol	131918-61-1	6702D36OG5			For treatment of secondary hyperparathyroidism associated with chronic kidney disease (CKD) Stage 3 and 4
parinaroyl-coenzyme A		parinaroyl-coenzyme A					
Paromomycin	7542-37-2	Paromomycin	7542-37-2	61JJC8N5ZK	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of acute and chronic intestinal amebiasis (it is not effective in extraintestinal amebiasis). Also for the management of hepatic coma as adjunctive therapy.
Paroxetine	61869-08-7	Paroxetine	61869-08-7	41VRH5220H	Antidepressive Agents, Second-Generation	A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)	Paroxetine is indicated for the management of depression, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, posttraumatic stress disorder. One form of paroxetine, commercially known as Brisdelle, is used to manage mild to moderate vasomotor symptoms of menopause. Off-label, paroxetine may be used for the treatment of premature ejaculation or irritable bowel syndrome (IBS).
PARP-1 inhibitor DHC-1		PARP-1 inhibitor DHC-1					
parthenin	508-59-8	Parthenin	508-59-8	982DJP4W6A			
Parthenium hysterophorus extract		Parthenium hysterophorus extract					
parthenocissin A		(1Z)-2-(3,5-dihydroxyphenyl)-3-(4-hydroxyphenyl)-1-[(4-hydroxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol					
parthenolide	29552-41-8	(7Z)-4,8-Dimethyl-12-methylidene-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-13-one	29552-41-8		Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
Particulate Matter		Particulate Matter					
pasireotide		Pasireotide	396091-73-9	98H1T17066	Hormones	Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. (See all compounds classified as Hormones.)	For the treatment of Cushings disease, specifically for those patients whom pituitary surgery has not been curative or is not an option.
Pasteurella multocida toxin		Toxin (Pasteurella multocida multocida reduced)					
patchouli alcohol	5986-55-0	Patchouli alcohol	5986-55-0	HHH8CPR1M2			
pateamine A		pateamine A	139220-18-1				
Patulin	149-29-1	Patulin	149-29-1	95X2BV4W8R	Poisons	Substances which, when ingested, inhaled, or absorbed, or when applied to, injected into, or developed within the body in relatively small amounts may, by their chemical action, cause damage to structure or disturbance of function. (From Dorland, 27th ed) (See all compounds classified as Poisons.)	
paxilline	57186-25-1	Paxilline	57186-25-1	3T9U9Z96L7	Potassium Channel Blockers	A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS. (See all compounds classified as Potassium Channel Blockers.)	
paynantheine		Paynantheine	4697-66-9	YLG43M4U5V			
pazopanib		Pazopanib	444731-52-6	7RN5DR86CK			Treatment of advanced renal cell cancer and advanced soft tissue sarcoma (in patients previously treated with chemotherapy)
PB28 compound		PB28 compound					
PBOX-6		Carbamic acid, N,N-dimethyl-, 6-(1-naphthalenyl)pyrrolo(2,1-d)(1,5)benzoxazepin-7-yl ester	290814-68-5	IN93MQ497D	Tubulin Modulators	Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)	
PCB 180		2,2',3,4,4',5,5'-Heptachlorobiphenyl	35065-29-3	52I0CG8IQX	Environmental Pollutants	Substances or energies, for example heat or light, which when introduced into the air, water, or land threaten life or health of individuals or ECOSYSTEMS. (See all compounds classified as Environmental Pollutants.)	
PCC-0105002		PCC-0105002					
PCI 5002		bis[1-(hydroxy-kO)-5-{[2-(2-methoxyethoxy)ethoxy]methyl}-2-(sulfanyl-kS)pyridiniumato(2-)]zinc					
PCI-45227		Dihydrodiol Ibrutinib	1654820-87-7	29446230GA			
PD 0166285		PD 0166285					
PD 068235		PD 068235					
PD 117302	111728-01-9	(+)-2-(Benzothiophen-4-yl)-N-methyl-N-((1R,2R)-2-pyrrolidin-1-ylcyclohexyl)acetamide	111728-01-9	T1I84BQJ6E	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
PD 123319	130663-39-7	(6S)-1-[4-(dimethylamino)-3-methylbenzyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid	130663-39-7		Vasoconstrictor Agents	Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)	
PD 134308	130404-91-0	4-[[(1R)-2-[[(2R)-2-(2-Adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-1-phenylethyl]amino]-4-oxobutanoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol	130404-91-0	12A1R692BX	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	
PD 136450	139067-52-0	(E)-4-[[(1R)-2-[[(2R)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-1-phenylethyl]amino]-4-oxobut-2-enoic acid	139067-52-0				
PD 142893	143037-36-9	Acetyldiphenylalanyl-leucyl-aspartyl-isoleucyl-isoleucyl-tryptophan	143037-36-9				
PD 144795	148550-96-3	5-Methoxy-3-(1-methylethoxy)benzo(b)thiophene-2-carboxamide-1-oxide	148550-96-3				
PD 145065	153049-49-1	Ac-(5H-Dibenzyl(a,d)cycloheptene-10,11-dihydroglycine-leu-asp-ile-ile-trp)	153049-49-1				
PD 150606		3-(4-Iodophenyl)-2-mercapto-(Z)-2-propenoic acid	179528-45-1				
PD 151242	155561-67-4	N-((Hexahydro-1-azepinyl)carbonyl)-leucyl(1-methyl)-tryptophyl-tryptophan	155561-67-4				
PD 156252		(3S)-3-[[(2S)-2-[[(2R)-2-Acetamido-2-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyl)acetyl]amino]-4-methylpentanoyl]amino]-4-[[(2S,3S)-1-[[(2S,3S)-1-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-3-methyl-1-oxopentan-2-yl]-methylamino]-3-methyl-1-oxopentan-2-yl]amino]-4-oxobutanoic acid			Endothelin Receptor Antagonists	Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN RECECPTORS. (See all compounds classified as Endothelin Receptor Antagonists.)	
PD 156707		sodium (Z)-2-(1,3-benzodioxol-5-yl)-4-(4-methoxyphenyl)-4-oxo-3-[(3,4,5-trimethoxyphenyl)methyl]but-2-enoate	162412-70-6				
PD 161570		N-[6-(2,6-Dichlorophenyl)-2-[[4-(diethylamino)butyl]amino]pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)urea	192705-80-9				
PD 166285		PD0166285 (dihydrochloride)	212391-63-4				
PD 166866		1-[2-Amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea	192705-79-6	NA856793UT	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
PD 173074		1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea	219580-11-7	A4TLL8634Y			
PD 180988		Fandosentan potassium	221246-12-4	14U0D2SA4K			
PD 198306		Benzamide, N-(cyclopropylmethoxy)-3,4,5-trifluoro-2-((4-iodo-2-methylphenyl)amino)-	212631-61-3	WQ5121ZGT3			
PD 407824		9-Hydroxy-4-phenylpyrrolo[3,4-C]carbazole-1,3(2H,6H)-dione	622864-54-4				
PD 81723	132861-87-1	(2-Amino-4,5-dimethylthiophen-3-yl)(3-(trifluoromethyl)phenyl)methanone	132861-87-1				
PD 90780		7-Benzamido-4-methyl-9-oxopyrazolo[5,1-b]quinazoline-2-carboxylic acid					
PD-0200347		PD-0200347					
PD168393		4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline	194423-15-9	3R996Y9T0I			
Peanut Oil		8002-03-7					
pectenotoxin 2	97564-91-5	Pectenotoxin 2	97564-91-5				
Pectins		alpha-D-GALACTURONIC ACID	12672-40-1	CEP8I6411H			
pectolinarigenin		Pectolinarigenin	520-12-7	4U3UZ1K35N			
pedalitin		Pedalitin	22384-63-0	DS9S9Z36F2			
pedicularioside A	135010-61-6	Pedicularioside A	135010-61-6				
Pefloxacin	70458-92-3	Pefloxacin	70458-92-3	2H52Z9F2Q5	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of uncomplicated gonococcal urethritis in males and for gram-negative-bacterial infections in the gastrointestinal system and the genitourinary tract.
pegaspargase		2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(2,4-dimethylphenyl)-	9015-68-3		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
peginterferon alfa-2a		Peginterferon alfa-2a					
peginterferon alfa-2b		NSC-720033					
pegvisomant		Pegvisomant					
PEGylated soluble tumor necrosis factor receptor I		Pegsunercept [USAN:INN]					
peiminine	18059-10-4	Peiminine	18059-10-4	QUB07U6VTQ			
pekinenal		pekinenal					
pelargonic acid	112-05-0	Nonanoic acid	112-05-0	97SEH7577T	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
pelargonidin	7690-51-9	Pelargonidin	7690-51-9				
pelargonidin-3-glucoside		Pelargonidin 3-glucoside	18466-51-8	8H1WZY9R6P			
Pemetrexed		Pemetrexed	137281-23-3	04Q9AIZ7NO	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Pemetrexed is indicated for the treatment of the following conditions:  **Non-squamous non-small cell lung cancer (NSCLC)**  - in combination with [pembrolizumab] and platinum-based chemotherapy as initial treatment in metastatic disease where no EGFR or ALK genomic tumour aberrations exist - in combination with [cisplatin] as initial treatment for locally advanced or metastatic disease - as maintenance treatment for locally advanced or metastatic disease that has not progressed following four cycles of platinum-based chemotherapy - recurrent metastatic disease following prior chemotherapy - as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-squamous non-small cell lung cancer  **Malignant pleural mesothelioma**  - in combination with [cisplatin] for the initial treatment of patients with malignant pleural mesothelioma. In the US, it is reserved for patients whose disease is unresectable or otherwise not candidates for curative surgery.
pemirolast	69372-19-6	Pemirolast	69372-19-6	2C09NV773M	Histamine Antagonists	Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)	For the prevention of itching of the eyes caused by allergies such as hay fever, and allergic conjunctivitis
Penbutolol	36507-48-9	1-(Tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol	36507-48-9	3JET4HND2G			
penconazole		Penconazole	66246-88-6	3UN9F9ZJ43	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
pencycuron	66063-05-6	Pencycuron	66063-05-6	GCH2G449HP			
pendimethalin	40487-42-1	Pendimethalin	40487-42-1	VL6L14C06U	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
pendulone		Pendulone					
Penfluridol	26864-56-2	Penfluridol	26864-56-2	25TLU22Q8H	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
Penicillamine	52-67-5	Penicillamine	771431-20-0	GNN1DV99GX	Antirheumatic Agents	Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)	For treatment of Wilson's disease, cystinuria and active rheumatoid arthritis.
Penicillin G	61-33-6	Penicillin G	61-33-6	Q42T66VG0C	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For use in the treatment of severe infections caused by penicillin G-susceptible microorganisms when rapid and high penicillin levels are required such as in the treatment of septicemia, meningitis, pericarditis, endocarditis and severe pneumonia.
Penicillin V	87-08-1	Penicillin V	87-08-1	Z61I075U2W	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Indicated for the treatment of mild to moderately severe infections due to penicillin G-sensitive microorganisms, with the use of bacteriological studies (including sensitivity tests) and clinical response.   Phenoxymethylpenicillin may be used for the treatment of:   - mild to moderate infections of the upper respiratory tract, scarlet fever, and mild erysipelas caused by Streptococcus without bacteremia - mild to moderately severe infections of the respiratory tract caused by Pneumococcus - mild infections of the skin and soft tissues caused by penicillin G-sensitive Staphylococcus - mild to moderately severe infections of the oropharynx caused by Fusospirochetosis, including Vincents gingivitis and pharyngitis, usually respond to oral penicillin therapy  **Off-label**  Indicated for use as prophylaxis against bacterial endocarditis in patients with congenital heart disease or rheumatic or other acquired valvular heart disease when they undergo dental procedures and surgical procedures of the upper respiratory tract.
Penicillins		penicillin					
penoxsulam		Penoxsulam	219714-96-2	784ELC1SCZ			
PENTA		Pentachlorophenol	87-86-5	D9BSU0SE4T	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
pentaacetyl geniposide	49776-64-9	Pentaacetyl geniposide	49776-64-9				
pentabrominated diphenyl ether 100		pentabrominated diphenyl ether 100					
pentabromodiphenyl ether	32534-81-9	32534-81-9					
pentabromophenol	608-71-9	Pentabromophenol	608-71-9	V89A88NMMX			
pentacarboxylic porphyrin	28100-78-9	Pentacarboxylporphyrin I	28100-78-9				
pentacene		Pentacene	135-48-8	9FQU5HA0UY			
pentachloroanisole	1825-21-4	Pentachloroanisole	1825-21-4	14D125MH3W			
pentachlorobenzene	608-93-5	Pentachlorobenzene	608-93-5	D62GWO6832	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Pentachlorophenol	87-86-5	Pentachlorophenol	87-86-5	D9BSU0SE4T	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Pentaerythritol Tetranitrate	78-11-5	Pentaerythritol tetranitrate	78-11-5	10L39TRG1Z	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	Used for the treatment of angina pectoris.
pentagalloylglucose		Pentagalloylglucose	14937-32-7	3UI3K8W93I			
Pentagastrin	5534-95-2	Pentagastrin	5534-95-2	EF0NX91490			Used as a diagnostic aid for evaluation of gastric acid secretory function
Pentamidine	100-33-4	Pentamidine	100-33-4	673LC5J4LQ	Trypanocidal Agents	Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. (See all compounds classified as Trypanocidal Agents.)	For the treatment of pneumonia due to Pneumocystis carinii.
pentanal	110-62-3	Valeraldehyde	110-62-3	B975S3014W			
pentane	109-66-0	Pentane	109-66-0	4FEX897A91			
Pentanes		Pentane	109-66-0	4FEX897A91			
Pentanoic Acids		Pentanoic Acids					
Pentanols		1-Pentanol	71-41-0	M9L931X26Y			
Pentanones		Pentanones					
Pentazocine	359-83-1	Pentazocine	359-83-1	RP4A60D26L	Adjuvants, Anesthesia	Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)	For the relief of moderate to severe pain.
pentedrone		Pentedrone	879722-57-3	2ELU1B757Q			
Pentetic Acid	67-43-6	Pentetic Acid	67-43-6	7A314HQM0I	Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	DTPA is widely used in industry and medicine. As a medical agent, it is approved for its use in medical imaging and for the decorporation of internally deposited radionuclides. It is FDA approved for the treatment of individuals with known or suspected internal contamination with plutonium, americium or curium to increase the rates of elimination.  Due to the pharmacokinetic elimination by the kidneys, pentetic acid conjugated with technetium Tc-99m is being used clinically to estimate physiological parameters such as glomerular filtration rat and effective renal plasma flow.
penthiopyrad		Penthiopyrad	183675-82-3	FAT7900E5H			
Pentobarbital	76-74-4	Pentobarbital	76-74-4	I4744080IR	Adjuvants, Anesthesia	Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)	For the short-term treatment of insomnia.
Pentolinium Tartrate	52-62-0	Pentolinium Tartrate	52-62-0	953357GACY	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
Pentosan Sulfuric Polyester	37300-21-3	Pentosan Polysulfate	37300-21-3	F59P8B75R4	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	For the relief of bladder pain or discomfort associated with interstitial cystitis.
Pentostatin	53910-25-1	Pentostatin	53910-25-1	395575MZO7	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For the treatment of hairy cell leukaemia refractory to alpha interferon.
Pentoxifylline	6493-05-6	Pentoxifylline	6493-05-6	SD6QCT3TSU	Phosphodiesterase Inhibitors	Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)	Pentoxifylline is indicated for the treatment of intermittent claudication in patients with chronic occlusive arterial disease. Pentoxifylline may improve limb function and reduce symptoms but cannot replace other therapies such as surgical bypass or removal of vascular obstructions.
pentrinitrol		Pentrinitrol	1607-17-6	4SL9HWA66P			
Pentylenetetrazole	54-95-5	Pentetrazol	54-95-5	WM5Z385K7T	Convulsants	Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)	
peonidin	134-01-0	Peonidin chloride	134-01-0	D0O766G47B			
peonidin 3-glucoside		Peonidin 3-monoglucoside	6906-39-4	3419IIT8I0			
peoniflorin	23180-57-6	Peoniflorin	23180-57-6	21AIQ4EV64	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
Pep42 peptide		Pep42 peptide					
peppermint oil	8006-90-4	CID 6850741	8006-90-4				
pepstatin	39324-30-6	Pepstatin	26305-03-3	V6Y2T27Q1U	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	
peptide 5F		peptide 5F					
Peptide Nucleic Acids		Peptide Nucleic Acids					
Peptides		Peptides					
Peptides, Cyclic		CID10056749					
Peptidoglycan		2,3-Epoxypropyl nitrate	6659-62-7				
peracetylated N-azidoacetylmannosamine		peracetylated N-azidoacetylmannosamine					
perampanel		Perampanel	380917-97-5	H821664NPK			Perampanel is indicated for the treatment of partial-onset seizures with or without secondarily generalized seizures in epileptic patients four years of age and older. It is also indicated as an adjunct in the treatment of primary generalized tonic-clonic seizures in epileptic patients aged 12 years and older.
Perazine	84-97-9	Perazine	84-97-9	8915147A2B	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	
perchlorate		Perchlorate	14797-73-0	VLA4NZX2P4			
Perchlorates		Perchlorates					
Perfadex		Perfadex					
perflubron	423-55-2	Perflubron	423-55-2	Q1D0Q7R4D9	Anti-Obesity Agents	Agents that increase energy expenditure and weight loss by neural and metabolic regulation. (See all compounds classified as Anti-Obesity Agents.)	Investigated for use/treatment in cardiac surgery, hemorrhage, and ileus.
perfluoro-2-methoxyacetic acid		Acetic acid, difluoro(trifluoromethoxy)-	674-13-5				
perfluoro-n-heptanoic acid	375-85-9	Perfluoroheptanoic acid	375-85-9	4Q4V9K363Y			
perfluoro-n-nonanoic acid	375-95-1	Perfluorononanoic acid	375-95-1	5830Z6S63M	Environmental Pollutants	Substances or energies, for example heat or light, which when introduced into the air, water, or land threaten life or health of individuals or ECOSYSTEMS. (See all compounds classified as Environmental Pollutants.)	
perfluorobutane		Perflubutane	355-25-9	SE4TWR0K2C			Diagnostic evaluation of focal hepatic lesions
perfluorobutanesulfonic acid		Perfluorobutanesulfonic acid	375-73-5	1FV02N6NVO			
perfluorobutyric acid	375-22-4	Heptafluorobutyric acid	375-22-4	12VHZ8L29I	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
perfluorodecalin	306-94-5	Perfluorodecalin	306-94-5	54A06VV62N			
perfluorodecanesulfonic acid		Perfluorodecane sulfonic acid	335-77-3	HAI638LYMV			
perfluorodecanoic acid	335-76-2	Perfluorodecanoic acid	335-76-2	W5XW2B8Q9E			
perfluorododecanoic acid		Perfluorododecanoic acid	307-55-1	P6G1J7NM2D			
perfluoroheptanesulfonic acid		Perfluoroheptanesulfonic acid	375-92-8				
perfluorohexanesulfonic acid	355-46-4	Perfluorohexanesulfonic acid	355-46-4	ZU6Y1E592S			
perfluorohexanoic acid		Perfluorohexanoic acid	307-24-4	ZP34Q2220R			
perfluorooctane sulfonic acid	1763-23-1	Perfluorooctanesulfonic acid	1763-23-1	9H2MAI21CL			
perfluorooctanesulfonamide	754-91-6	Perfluorooctanesulfonamide	754-91-6	80AM718FML			
perfluorooctanoic acid	335-67-1	Perfluorooctanoic acid	335-67-1	947VD76D3L			
perfluoropentanoic acid		Perfluorovaleric acid	2706-90-3	LUW3UY784P			
perfluoropropionic acid	422-64-0	Pentafluoropropionic acid	422-64-0	QB53AX6MW4			
perfluorotetradecanoic acid		Perfluorotetradecanoic acid	376-06-7	CY7BGN3727			
perfluorotridecanoic acid		Perfluorotridecanoic acid	72629-94-8				
perfluoroundecanoic acid		Perfluoroundecanoic acid	2058-94-8	JPZ6FNL628			
perfosfamide	39800-16-3	4-Hydroperoxycyclophosphamide	39800-16-3				
Perfume		Perfume					
Pergolide	66104-22-1	Pergolide	66104-22-1	24MJ822NZ9	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	Indicated as adjunctive treatment to levodopa/carbidopa in the management of the signs and symptoms of Parkinson's disease. It was withdrawn from the US and Canadian markets in 2007 due to an increased risk of cardiac valvulopathy.
Perhexiline	6621-47-2	Perhexiline	39648-47-0	KU65374X44	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	For the management of severe angina pectoris.
perhexiline maleate	6724-53-4	Perhexiline maleate	6724-53-4	K7V8Y90G0H			
perhydroxyl radical	3170-83-0	Hydroperoxy radical	3170-83-0				
periciazine	2622-26-6	Periciazine	2622-26-6	3405M6FD73			For use as adjunctive medication in some psychotic patients. Propericiazine (Pericyazine)is used for the control of residual prevailing hostility, impulsiveness and aggressiveness.
perifosine		Perifosine	157716-52-4	2GWV496552			Investigated for use/treatment in solid tumors, multiple myeloma, leukemia (unspecified), lung cancer, and brain cancer.
perilla seed oil	68132-21-8	Water	84776-64-7	059QF0KO0R			For diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.
perillaldehyde	2111-75-3	Perillaldehyde	2111-75-3	6EQL0XA86G			
perillic acid	7694-45-3	Perillic acid	7694-45-3	PKS69DU4ZQ			
perillyl alcohol	536-59-4	Perillyl alcohol	536-59-4	319R5C7293	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
Perindopril	82834-16-0	Perindopril	82834-16-0	Y5GMK36KGY	Angiotensin-Converting Enzyme Inhibitors	A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)	For the treatment of mild to moderate essential hypertension, mild to moderate congestive heart failure, and to reduce the cardiovascular risk of individuals with hypertension or post-myocardial infarction and stable coronary disease.
periodate-oxidized adenosine	34240-05-6	Adenosine dialdehyde	34240-05-6				
periodate-oxidized adenosine 5'-triphosphate		periodate-oxidized adenosine 5'-triphosphate					
perlecan	143972-95-6	Perlecan					
Permethrin	52645-53-1	Permethrin	52645-53-1	509F88P9SZ	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	For the treatment of infestation with Sarcoptes scabiei (scabies).
peroben	78371-63-8	Peroben	78371-63-8				
perospirone	129273-38-7	Perospirone hydrochloride	129273-38-7	T884I76TMN	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
Peroxides		Peroxides					
Peroxisome Proliferators		Peroxisome Proliferators					
peroxovanadate		peroxovanadate					
peroxycarbonic acid		Carbonoperoxoic acid	563-69-9				
peroxynitric acid	26404-66-0	Peroxynitric acid	26404-66-0		Oxidants	Electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION). (See all compounds classified as Oxidants.)	
Peroxynitrous Acid	14691-52-2	Peroxynitrous acid	14691-52-2				
peroxyvanadate		peroxyvanadate					
Perphenazine	58-39-9	Perphenazine	58-39-9	FTA7XXY4EZ	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	For use in the management of the manifestations of psychotic disorders and for the control of severe nausea and vomiting in adults.
perphenazine GABA ester		Perphenazine 4-aminobutyrate	751477-01-7	K1WO7H97QZ			Investigated for use/treatment in schizophrenia and schizoaffective disorders.
perrhenate	14333-24-5	Perrhenate	1092105-66-2				
Persistent Organic Pollutants		Persistent Organic Pollutants					
persulfated 3,6-(O-glucopyranosyl)xanthone		persulfated 3,6-(O-glucopyranosyl)xanthone					
Pertussis Toxin		70323-44-3					
Pertussis Vaccine		D06514					
Peruvian balsam	8007-00-9	3-Butyl-4-hydroxy-5-methyl-5-(2-methylbuta-1,3-dienyl)thiophen-2-one;4-ethyl-2-methyl-2-(2-methylbuta-1,3-dienyl)-5-methylidenethiophen-3-ol;4-hydroxy-5-methyl-5-(2-methylbuta-1,3-dienyl)-3-[4-(4-methylphenyl)butyl]thiophen-2-one;4-hydroxy-5-methyl-5-(2-methylbuta-1,3-dienyl)-3-[2-(4-methylphenyl)ethyl]thiophen-2-one;4-hydroxy-5-methyl-5-(2-methylbuta-1,3-dienyl)-3-propylthiophen-2-one	8024-01-9				
pervanadate		Pervanadate			Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Perylene	198-55-0	Perylene	198-55-0	5QD5427UN7			
Pesticides		Pesticides					
Petroleum		8002-05-9					
petrosaspongiolide m		Petrosaspongiolide m					
petunidin-3-glucoside	6988-81-4	Petunidin 3-monoglucoside	6988-81-4	AA9G36JBHT			
pevonedistat		Pevonedistat	905579-51-3	S3AZD8D215	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Treatment of acute myeloid leukaemia, Treatment of myelodysplastic syndromes
pexacerfont	459856-18-9	Pexacerfont	459856-18-9	LF1VBG4ZUK			
pexidartinib		Pexidartinib	1029044-16-3	6783M2LV5X			Pexidartinib is indicated for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not amenable to improvement with surgery.
PF 00477736		PF-477736	952021-60-2	XO23PGZ0SM	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
PF 232798		PF-232798	849753-15-7	63P7W7886U	CCR5 Receptor Antagonists	Compounds and drugs that inhibit or block the activity of CCR5 RECEPTORS. (See all compounds classified as CCR5 Receptor Antagonists.)	
PF 3758309		Pyrrolo[3,4-c]pyrazole-5(1H)-carboxaMide, N-[(1S)-2-(diMethylaMino)-1-phenylethyl]-4,6-dihydro-6,6-diMethyl-3-[(2-Methylthieno[3,2-d]pyriMidin-4-yl)aMino]-					
PF 3845		N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide	1196109-52-0	Q3PW846TYN			
PF 5168899		PF 5168899					
PF 956980		{(3r,4r)-4-Methyl-3-[methyl(7h-Pyrrolo[2,3-D]pyrimidin-4-Yl)amino]piperidin-1-Yl}(Pyrrolidin-1-Yl)methanone	384335-57-3				
PF-04254644		6-{(1S)-1-[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]ethyl}quinoline	959584-91-9	UN4C7N5KVB			
PF-06687252		(E)-1-(2-hydroxyphenyl)-3-((1R,4R)-5-(pyridin-2-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)prop-2-en-1-one					
PF-429242		(R)-4-((Diethylamino)methyl)-N-(2-methoxyphenethyl)-N-(pyrrolidin-3-yl)benzamide	947303-87-9	49WB3OA7VN			
PF-4708671		2-{[4-(5-Ethylpyrimidin-4-Yl)piperazin-1-Yl]methyl}-5-(Trifluoromethyl)-1h-Benzimidazole	1255517-76-0				
PF-670462		PF-670462	950912-80-8	D68ANS5I8B	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
PFL protocol		PFL protocol					
PGW5 compound		PGW5 compound					
PH 163	163251-41-0	1-Hydroxy-3-(3-hydroxy-7-phenyl-1-hepten-1-yl)-1-cyclohexane acetate sodium salt	163251-41-0				
phaclofen	108351-35-5	Phaclofen	114012-12-3		GABA Antagonists	Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS. (See all compounds classified as GABA Antagonists.)	
phaeomelanin	12627-61-1	12627-61-1					
Phalloidine	17466-45-4	CID 4752	17466-45-4		Poisons	Substances which, when ingested, inhaled, or absorbed, or when applied to, injected into, or developed within the body in relatively small amounts may, by their chemical action, cause damage to structure or disturbance of function. (From Dorland, 27th ed) (See all compounds classified as Poisons.)	
phantolid	15323-35-0	Phantolide	15323-35-0	3KM1212J0Y			
Pharmaceutical Vehicles		Pharmaceutical Vehicles					
Phe-Leu boronic acid		Phe-Leu boronic acid					
Phellinus linteus extract		Phellinus linteus extract					
phellodendrine	6873-13-8	Phellodendrine	6873-13-8	AR68S526RB			
phellopterin	2543-94-4	Phellopterin	2543-94-4	M7UP6XJ2AA			
Phenacetin	62-44-2	Phenacetin	62-44-2	ER0CTH01H9	Analgesics, Non-Narcotic	A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)	Used principally as an analgesic.
phenacyl bromide	70-11-1	2-Bromoacetophenone	70-11-1	754Y0U325I			
phenalen-1-one	548-39-0	Phenalen-1-one	548-39-0	EVU6EX9G8H			
Phenalenes		Phenalenes					
phenanthrene	85-01-8	Phenanthrene	85-01-8	448J8E5BST			
Phenanthrenes		Phenanthrenes					
Phenanthridines		Phenanthridines					
phenanthridone		6(5H)-Phenanthridinone	1015-89-0	AVQ13AUB5J	Poly(ADP-ribose) Polymerase Inhibitors	Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. (See all compounds classified as Poly(ADP-ribose) Polymerase Inhibitors.)	
Phenanthrolines		1,7-Phenanthroline	230-46-6	5Y778HQU2S			
phenazepam	51753-57-2	Phenazepam	51753-57-2	3DSB43090Z	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
Phenazines		Phenazines					
Phenazopyridine	94-78-0	Phenazopyridine	94-78-0				
Phencyclidine	77-10-1	Phencyclidine	77-10-1	J1DOI7UV76	Hallucinogens	Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. (See all compounds classified as Hallucinogens.)	
Phenelzine	51-71-8	Phenelzine	51-71-8	O408N561GF	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	Phenelzine is indicated for the treatment of nonendogenous, neurotic or atypical depression for patients that do not tolerate other forms of therapy.   Atypical depression has a high prevalence rate, starts in early life, tends to last longer, is more likely to occur in people with bipolar disorder, has a high comorbidity with anxiety disorder and carries more risk of suicidal behavior. It is important to specify the atypical feature to predict the clinical course of depression and hence generate the best treatment and service. The featuring symptoms of the atypical feature include mood reactivity, two or more of this symptoms: 1) increased appetite, 2) increased sleep, 3) leaden paralysis and 4) interpersonal rejection sensitivity and should not have melancholic or catatonic features of depression.  Neurotic depression is a depression of an emotionally unstable person. It is a secondary condition to major personality disorder, neuroses and drug use disorders. Likewise, a primary depression with a family history of depression spectrum disease would fit in this category.  A nonendogenous depression is characterized by a disturbance in mood and general outlook. The physical symptoms tend to be less severe and it often occurs in response to stressful life events that keep occurring over a large period of time generating a continuous stress in the daily living.
phenethyl isothiocyanate	2257-09-2	Phenethyl isothiocyanate	2257-09-2	6U7TFK75KV	Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	
phenethyl salicylate		Phenethyl salicylate	87-22-9	6LDP0U8UB0			
phenethylamine	64-04-0	Phenethylamine	64-04-0	327C7L2BXQ	Psychotropic Drugs	A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)	
Phenethylamines		Phenethylamines					
phenethylcymserine		Phenethylcymserine					
Phenetidine	156-43-4	p-Phenetidine	156-43-4	9TSL224ZSE			
Phenformin	114-86-3	Phenformin	114-86-3	DD5K7529CE	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	For the reatment of type II diabetes mellitus.
phenidone	92-43-3	Phenidone	92-43-3	H0U5612P6K	Cyclooxygenase Inhibitors	Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)	
phenindamine	82-88-2	Phenindamine	82-88-2	772BQ8KSST	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	Used to treat sneezing, runny nose, itching, watery eyes, hives, rashes, itching, and other symptoms of allergies and the common cold.
Phenindione	83-12-5	Phenindione	83-12-5	5M7Y6274ZE	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	For the treatment of pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, mural thrombosis, and thrombophili. Also used for anticoagulant prophylaxis.
Pheniramine	86-21-5	Pheniramine	86-21-5	134FM9ZZ6M	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	Pheniramine is commonly used in over-the-counter products to treat seasonal allergies or cold and flu symptoms.
phenmedipham		Phenmedipham	13684-63-4	UJE31KXP78	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Phenobarbital	50-06-6	Phenobarbital	50-06-6	YQE403BP4D	GABA Modulators	Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)	For the treatment of all types of seizures except absence seizures.
phenobarbital quinidine	1400-48-2	Phenobarbital quinidine	1400-48-2				
Phenol	108-95-2	Phenol	108-95-2	339NCG44TV	Sclerosing Solutions	Chemical agents injected into blood vessels and lymphatic sinuses to shrink or cause localized THROMBOSIS; FIBROSIS, and obliteration of the vessels. This treatment is applied in a number of conditions such as VARICOSE VEINS; HEMORRHOIDS; GASTRIC VARICES; ESOPHAGEAL VARICES; PEPTIC ULCER HEMORRHAGE. (See all compounds classified as Sclerosing Solutions.)	Phenol is primarily indicated for minor sore throat pain, sore mouth, minor mouth irritation, and pain associated with canker sores. Additionally, phenol is indicated in the treatment of focal spasticity.
Phenolphthalein	77-09-8	Phenolphthalein	77-09-8	6QK969R2IF	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	Used for over a century as a laxative.
phenolphthalein diphosphate	2090-82-6	Phenolphthalein diphosphate	2090-82-6	YHR6QWU6MK			
phenolphthalein glucuronide	15265-26-6	Phenolphthalein glucuronide	15265-26-6	0S390I6642			
phenolphthalein monophosphate	13306-67-7	Phenolphthalein monophosphate	13306-67-7				
Phenols		Phenols					
Phenolsulfonphthalein	143-74-8	Phenol red	143-74-8	I6G9Y0J1OJ	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
phenothiazine	92-84-2	Phenothiazine	92-84-2	GS9EX7QNU6	Antiprotozoal Agents	Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)	
Phenothiazines		Phenothiazines					
phenothrin		Phenothrin	26002-80-2	707484X33X	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
phenoxodiol		Idronoxil	81267-65-4	995FT1W541			Intended for the treatment of various forms of cancer.
Phenoxyacetates		Phenoxyacetates					
phenoxyacetic acid		Phenoxyacetic acid	122-59-8	YRC253429Q			
Phenoxybenzamine	59-96-1	Phenoxybenzamine	59-96-1	0TTZ664R7Z	Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	For the treatment of phaeochromocytoma (malignant), benign prostatic hypertrophy and malignant essential hypertension.
phenoxyethanol	122-99-6	Phenoxyethanol	122-99-6	HIE492ZZ3T	Anesthetics	Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)	Antimicrobial agent used as a preservative in cosmetics,,.
Phenprocoumon	435-97-2	Phenprocoumon	435-97-2	Q08SIO485D	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	Used for the prevention and treatment of thromboembolic disease including venous thrombosis, thromboembolism, and pulmonary embolism as well as for the prevention of ischemic stroke in patients with atrial fibrillation (AF).
phenserine		Phenserine	101246-66-6	SUE285UG3S	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	For the treatment of Alzheimer's disease (AD).
Phentermine	122-09-8	Phentermine	122-09-8	C045TQL4WP	Adrenergic Agents	Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)	Phentermine is indicated, alone or in combination with topiramate, as a short-term adjunct, not pass a few weeks, in a regimen of weight reduction based on exercise, behavioral modifications and caloric restriction in the management of exogenous obesity for patients with an initial body mass index (BMI) greater than 30 kg/m2 or greater than 27 kg/m2 in presence of other risk factors such as controller hypertension, diabetes or hyperlipidemia.  Exogenous obesity is considered when the overweight is caused by consuming more food than the person activity level warrants. This condition commonly causes an increase in fat storage. It is an epidemic condition in the United States where over two-thirds of adults are overweight or obese and one in three Americans is obese. In the world, the incidence of obesity has nearly doubled.
phenthoate	2597-03-7	Phenthoate	2597-03-7	J96Q7F091K	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
phentin acetate	900-95-8	Fentin acetate	900-95-8		Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Phentolamine	50-60-2	Phentolamine	50-60-2	Z468598HBV	Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	When used intravenously or intramuscularly, phentolamine is used to prevent or control hypertensive episodes that may occur in a patient with pheochromocytoma due to stress or manipulation during preoperative preparation and surgical excision. It is also used to prevent or treat dermal necrosis and sloughing following intravenous administration or extravasation of norepinephrine. It may be used to diagnose pheochromocytoma by the phentolamine-blocking test.  Submucosal injection of phentolamine is indicated for the reversal of soft-tissue anesthesia (e.g. anesthesia of the lip and tongue) and the associated functional deficits resulting from an intraoral submucosal injection of a local anesthetic containing a vasoconstrictor in patients three years old and older.  Phentolamine ophthalmic solution is used to treat pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide) agents.
phenyl acetate		Phenyl acetate	122-79-2	355G9R500Y			
phenyl biguanide	102-02-3	1-Phenylbiguanide	102-02-3	W8PKA3T2I3	Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
phenyl di-n-pentylphosphinate	14656-17-8	Phenyl di-n-pentylphosphinate	14656-17-8				
phenyl ether	101-84-8	Diphenyl ether	101-84-8	3O695R5M1U			
phenyl isocyanate	103-71-9	Phenyl isocyanate	103-71-9	196GO6BSOH			
phenyl salicylate	118-55-8	Phenyl salicylate	118-55-8	28A37T47QO			Pain and fever.
phenyl valerate	20115-23-5	Phenyl valerate	20115-23-5				
phenyl-N-methyl-N-benzylcarbamate	29044-69-7	Phenyl-N-methyl-N-benzylcarbamate	29044-69-7				
phenyl-N-tert-butylnitrone	3376-24-7	n-Tert-butyl-alpha-phenylnitrone	3376-24-7	3I91332OPG	Neuroprotective Agents	Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)	
phenylacetaldehyde	122-78-1	Phenylacetaldehyde	122-78-1	U8J5PLW9MR			
Phenylacetates		Phenylacetates					
phenylacetic acid	103-82-2	Phenylacetic Acid	103-82-2	ER5I1W795A	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	For use as adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.
phenylacetyl-Phe-Ser-Arg-N-(2,4-dinitrophenyl)ethylenediamine		phenylacetyl-Phe-Ser-Arg-N-(2,4-dinitrophenyl)ethylenediamine					
phenylacetylglycine	500-98-1	Phenylacetylglycine	500-98-1	O134PDX2SP			
Phenylalanine	63-91-2	Phenylalanine	63-91-2	47E5O17Y3R			L-phenylalanine may be helpful in some with depression. It may also be useful in the treatment of vitiligo. There is some evidence that L-phenylalanine may exacerbate tardive dyskinesia in some schizophrenic patients and in some who have used neuroleptic drugs.
phenylalanyl corticotropin-releasing factor (12-41)		phenylalanyl corticotropin-releasing factor (12-41)					
phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide	103429-31-8	Ctopa	103429-31-8				
phenylalanyl-glycyl-NHO-Bz		phenylalanyl-glycyl-NHO-Bz					
phenylalanyl-prolyl-arginine chloromethyl ketone-thrombin		phenylalanyl-prolyl-arginine chloromethyl ketone-thrombin					
phenylalanyl-prolyl-arginine methyl chloride	71142-71-7	Ppack	71142-71-7	N62UL02WW4			
phenylalanyl-prolyl-arginine-chloromethyl ketone	65149-23-7	Phenylalanyl-prolyl-arginine-chloromethyl ketone	65149-23-7		Cysteine Proteinase Inhibitors	Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. (See all compounds classified as Cysteine Proteinase Inhibitors.)	
phenylalanylserine	16053-39-7	Phenylalanylserine	16053-39-7				
phenylamil	2038-35-9	Phenamil	2038-35-9				
phenylarsonous acid	25400-22-0	Phenylarsonous acid	25400-22-0				
phenylbenzoquinone	363-03-1	Phenyl-p-benzoquinone	363-03-1	KNB6553J7R			
Phenylbutazone	50-33-9	Phenylbutazone	50-33-9	GN5P7K3T8S	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	For the treatment of backache and ankylosing spondylitis
Phenylbutyrates		Phenylbutyrates					
phenylcyclohexane	827-52-1	Cyclohexylbenzene	827-52-1	TRJ2SXT894			
Phenylenediamines		Phenylenediamines					
Phenylephrine	59-42-7	Phenylephrine	59-42-7	1WS297W6MV	Mydriatics	Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. (See all compounds classified as Mydriatics.)	Phenylephrine is available in various drug formulations, which have different indications. Phenylephrine injections are indicated to treat hypotension caused by shock or anesthesia. The ophthalmic formulation is indicated to induce mydriasis and conjunctival vasoconstriction. The intranasal formulation is used to treat congestion, and a topical formulation is used to treat hemorrhoids. Off-label uses include priapism and induction of local vasoconstriction.
Phenylethyl Alcohol	60-12-8	Phenylethyl Alcohol	60-12-8	ML9LGA7468	Disinfectants	Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley&apos;s Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Disinfectants.)	
phenylglycidol		Phenylglycidol					
phenylglycidyl ether	122-60-1	Phenyl glycidyl ether	122-60-1	44KJQ1655I			
Phenylglyoxal	1074-12-0	Phenylglyoxal	1074-12-0	N45G3015PA	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
phenylglyoxylic acid	611-73-4	Benzoylformic acid	611-73-4	2PZL5A0W0M			
phenylhydrazine	100-63-0	Phenylhydrazine	100-63-0	064F424C9K	Oxidants	Electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION). (See all compounds classified as Oxidants.)	
Phenylhydrazines		Phenylhydrazines					
phenylhydrazonopyrazolone sulfonate 1		PTP Inhibitor V, PHPS1	314291-83-3				
phenylhydroquinone		Phenylhydroquinone	1079-21-6	GPT41T80FJ			
Phenylisopropyladenosine	29193-86-0	Isopropylphenyladenosine	29193-86-0				
Phenylmercuric Acetate	62-38-4	Phenylmercuric acetate	62-38-4		Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
phenylmercuric chloride	100-56-1	Phenylmercuric chloride	100-56-1				
Phenylmethylsulfonyl Fluoride	329-98-6	Phenylmethylsulfonyl fluoride	329-98-6	57KD15003I	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
phenylphosphonic acid	1571-33-1	Phenylphosphonic acid	1571-33-1	BYD76T2868			
Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester	2104-64-5	O-Ethyl O-(4-nitrophenyl) phenylphosphonothioate	2104-64-5	9Y6HP0HYA8	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
phenylpiperazine	92-54-6	1-Phenylpiperazine	92-54-6	J9225CBI7D	Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	
Phenylpropanolamine	14838-15-4	Phenylpropanolamine	14838-15-4	33RU150WUN	Nasal Decongestants	Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993) (See all compounds classified as Nasal Decongestants.)	For the treatment of nasal congestion, control of urinary incontinence, priapism and obesity.
Phenylpropionates		Phenylpropionates					
phenylpropylene oxide		(2,3-Epoxypropyl)benzene	4436-24-2	LKQ2758W1E			
phenylpyruvic acid	156-06-9	Phenylpyruvic acid	156-06-9	X7CO62M413			
Phenylpyruvic Acids		Phenylpyruvic Acids					
phenylsaligenin cyclic phosphate	4081-23-6	2-Phenoxy-4H-1,3,2-benzodioxaphosphorin 2-oxide	4081-23-6	7WWH5KNA35			
phenylsulfonylfluoride	368-43-4	Benzenesulfonyl fluoride	368-43-4				
Phenylthiourea	103-85-5	Phenylthiourea	103-85-5	6F82C6Q54C			
phenyltin	2406-68-0	Stannane, phenyl-	2406-68-0				
phenyltoloxamine	92-12-6	Phenyltoloxamine	92-12-6	K65LB6598J			The primary therapeutic use for which phenyltoloxamine is currently indicated is as an adjuvant therapy in various combination products containing an analgesic(s) (either narcotic or non-narcotic), where it is expected to potentiate the pain relieving, anti-tussive, etc. effect(s) of the analgesic component of the product.  In that regard, some of these aforementioned combination products are typically indicated for the temporary relief of minor aches and pains like headache, muscular aches, backaches, minor arthritis pain, common cold, toothaches, menstrual cramps, etc; or perhaps for the treatment of exhausting or non-productive cough, associated with cold or with upper respiratory allergic condition that does not respond to non-narcotic antitussives.
Phenylurea Compounds		Phenylurea Compounds					
Phenytoin	57-41-0	Phenytoin	57-41-0	6158TKW0C5	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	Phenytoin is indicated to treat grand mal seizures, complex partial seizures, and to prevent and treat seizures during or following neurosurgery. Injectable phenytoin and [Fosphenytoin], which is the phosphate ester prodrug formulation of phenytoin, are indicated to treat tonic-clonic status epilepticus, and for the prevention and treatment of seizures occurring during neurosurgery.
pheomelanin		pheomelanin					
pheophorbide a	15664-29-6	Pheophorbide a	15664-29-6	IA2WNI2HO2	Radiation-Sensitizing Agents	Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. (See all compounds classified as Radiation-Sensitizing Agents.)	
phillygenin		Sylvatesmin	487-39-8	886IAL08GN			
phloretic acid	501-97-3	3-(4-Hydroxyphenyl)propionic acid	501-97-3	6QNC6P18SR			
Phloretin	60-82-2	Phloretin	60-82-2	S5J5OE47MK			
phloretin isonicotinyl hydrazone		Phloretin isonicotinyl hydrazone					
Phlorhizin	60-81-1	Phlorizin	60-81-1	CU9S17279X			
phlorofucofuroeckol A	128129-56-6	Phlorofucofuroeckol A	128129-56-6				
Phloroglucinol	108-73-6	Phloroglucinol	108-73-6	DHD7FFG6YS	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
phloxine	6441-77-6	Phloxin	6441-77-6	QDW0T759T6			
phomenone	55785-58-5	Phomenone	55785-58-5				
Phorate	298-02-2	Phorate	298-02-2	3W54X3W9IV	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
phoratoxon	2600-69-3	Phoratoxon	2600-69-3	KSY09QD27V			
phorbol	17673-25-5	Phorbol	17673-25-5	XUZ76S9127			
phorbol 12-phenylacetate 13-acetate 20-homovanillate	175796-50-6	Ppahv	175796-50-6				
Phorbol 12,13-Dibutyrate	37558-16-0	Phorbol 12,13-dibutyrate	37558-16-0	67MX82CL58	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Phorbol Esters		Phorbol Esters					
phorbol-12-myristate	20839-06-9	Phorbol-12-myristate	20839-06-9	365F3KD8DE			
phorbol-12,13-didecanoate	24928-17-4	Phorbol-12,13-didecanoate	24928-17-4		Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
phorbolol myristate acetate	56937-68-9	Phorbolol myristate acetate	56937-68-9				
phorone	504-20-1	Phorone	504-20-1	8F20OEI0MV			
Phortress		Phortress	328087-38-3	AXR52N9SMF			
phosalone	2310-17-0	Phosalone	2310-17-0	448B85HT8M	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Phosgene	75-44-5	Phosgene	75-44-5	117K140075	Chemical Warfare Agents	Chemicals that are used to cause the disturbance, disease, or death of humans during WARFARE. (See all compounds classified as Chemical Warfare Agents.)	
Phosmet	732-11-6	Phosmet	732-11-6	VN04LI540Y	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Phosphamidon	13171-21-6	Phosphamidon	13171-21-6	HQ7958Q90Z	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
Phosphates		Phosphate Ion	14265-44-2	NK08V8K8HR			
Phosphatidic Acids		CHEBI:16337					
phosphatidylbutanol		Phosphatidylbutanol					
phosphatidylcholine hydroperoxide		phosphatidylcholine hydroperoxide					
Phosphatidylcholines		1,2-Diacyl-sn-glycero-3-phosphocholine					
phosphatidylethanol		Phosphatidylethanol					
phosphatidylethanolamine	39382-08-6	Phosphatidylethanolamine	1334474-30-4	7CMB6B4449			
Phosphatidylglycerols		CHEBI:17517					
phosphatidylinositol 3-phosphate		Phosphatidylinositol-3-phosphate					
phosphatidylinositol 3,4-diphosphate		phosphatidylinositol 3,4-diphosphate					
phosphatidylinositol 3,4,5-triphosphate		phosphatidylinositol 3,4,5-triphosphate					
phosphatidylinositol 3,5-diphosphate		phosphatidylinositol 3,5-diphosphate					
phosphatidylinositol 4-phosphate		Phosphatidylinositol 4-phosphate					
Phosphatidylinositol 4,5-Diphosphate		Phosphatidylinositol 4,5-diphosphate	94161-15-6				
phosphatidylinositol 5-phosphate		Phosphatidylinositol-5-phosphate					
phosphatidylinositol dimannoside		phosphatidylinositol dimannoside					
Phosphatidylinositol Phosphates		Phosphatidylinositol Phosphates					
Phosphatidylinositols		Phosphatidylinositols					
Phosphatidylserines		Phosphatidylserines					
phosphine	7803-51-2	Phosphine	7803-51-2	FW6947296I	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Phosphines		Phosphines					
phosphinothricin	51276-47-2	Glufosinate	51276-47-2	C8W4FP6BTY	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Phosphites		Phosphite	65996-94-3				
Phosphoadenosine Phosphosulfate	482-67-7	Phosphoadenosine phosphosulfate	482-67-7	5TH3ERG159			
phosphoaspirin		phosphoaspirin					
Phosphocreatine	67-07-2	Phosphocreatine	67-07-2	020IUV4N33	Cardiotonic Agents	Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)	Phosphocreatine is a naturally occuring substance that is found predominantly in the skeletal muscles of vertebrates. Its primary utility within the body is to serve in the maintanence and recycling of adenosine triphosphate (ATP) for muscular activity like contractions.  Given this utility of phosphocreatine to recycle ATP, the most plausible therapeutic potentials for its use involve conditions caused by energy shortage or by increased energy requirements - such as in ischemic stroke and other cerebrovascular diseases. It is important to note however that relatively little clinical research has been done to significantly further the evidence for any such indications, although it is administered intravenously for cardiovascular conditions in some countries.  Additionally, because phosphocreatine is not regulated as a controlled substance it is taken as a supplement by some professional athletes as a means to perhaps increase short bursts of muscle strength or energy for professional athletics.
Phosphodiesterase Inhibitors		Phosphodiesterase Inhibitors					
Phosphoenolpyruvate	73-89-2	2-(Phosphonooxy)acrylate	73-89-2				
phosphoinositide-3,4-bisphosphate		phosphoinositide-3,4-bisphosphate					
Phospholipase A2 Inhibitors		Phospholipase A2 Inhibitors					
Phospholipids		Phospholipids					
phosphomannopentaose sulfate		Phosphomannopentaose sulfate					
phosphomevalonic acid	1189-94-2	3-Hydroxy-3-methyl-5-phosphonooxypentanoic acid	1189-94-2				
phosphoramide mustard	10159-53-2	Phosphoramide mustard	10159-53-2	4K9ULD24RM			
phosphoramidon	36357-77-4	Phosphoramidon	36357-77-4	T3G94E2LB1	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
phosphoric acid	7664-38-2	Phosphoric Acid	7664-38-2	E4GA8884NN	Dental Materials	Materials used in the production of dental bases, restorations, impressions, prostheses, etc. (See all compounds classified as Dental Materials.)	Phosphoric acid is used in dentistry and orthodontics as an etching solution, to clean and roughen the surfaces of teeth where dental appliances or fillings will be placed.
phosphoric acid mono-(2-(4-(3,3-dimethylbutyrylamino)-3,5-difluorobenzoylimino)thiazol-3-ylmethyl) ester		phosphoric acid mono-(2-(4-(3,3-dimethylbutyrylamino)-3,5-difluorobenzoylimino)thiazol-3-ylmethyl) ester					
Phosphorothioate Oligonucleotides		Phosphorothioate Oligonucleotides					
Phosphorous Acids		Phosphorous Acids					
Phosphorus	7723-14-0	Phosphorus	7723-14-0	27YLU75U4W			
phosphorus chloride	37231-52-0	Chlorophosphorane	24567-53-1				
Phosphorus, Dietary		Phosphorus, Dietary					
phosphoryl chloride	10025-87-3	Phosphorus oxychloride	10025-87-3	9XM78OL22K			
Phosphorylcholine	107-73-3	Choline phosphate	107-73-3	96AN057F7A			
phostebupirim		Tebupirimfos	96182-53-5	P036T39NSI			
photomirex	39801-14-4	Photomirex	39801-14-4	G7C95QE27Q			
Photosensitizing Agents		Photosensitizing Agents					
phoxim		Phoxim	14816-18-3		Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
phthalazine	253-52-1	Phthalazine	253-52-1	91Y28DM24N			
phthalic acid	88-99-3	Phthalic acid	88-99-3	6O7F7IX66E			
Phthalic Acids		Phthalic Acids					
phthalic anhydride	85-44-9	Phthalic anhydride	85-44-9	UVL263I5BJ			
phthalimide	85-41-6	Phthalimide	85-41-6	1J6PQ7YI80			
phthalocyanine Pc 4		phthalocyanine Pc 4					
PHY 906		PHY 906					
Phycocyanin	11016-15-2	Phycocyanin					
Phycoerythrin	11016-17-4	R-Phycoerythrin	987-65-5				
phyllanthin		Phyllanthin	10351-88-9	75O1TFF47Z			
phyllodulcin	480-46-6	3,4-Dihydro-8-hydroxy-3-(3-hydroxy-4-methoxyphenyl) 1H-2-benzopyran-1-one	480-46-6				
physapubescin B		Physapubescin B					
physcione	521-61-9	Physcione	521-61-9	H6PT94IV61			
Physostigmine	57-47-6	Physostigmine	57-47-6	9U1VM840SP	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	For the treatment of glaucoma, and in the treatment of severe anticholinergic toxicity.
physostigmine heptyl	101246-68-8	Eptastigmine	101246-68-8	6PZZ52D76Q	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
physostigmine salicylate		Physostigmine Salicylate	57-64-7	2046ZRO9VU			
Phytanic Acid	14721-66-5	Phytanic acid	14721-66-5				
Phytic Acid	83-86-3	Phytic acid	83-86-3	7IGF0S7R8I			
Phytochelatins	98726-08-0	Phytochelatin	98726-08-0		Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	
Phytochemicals		Phytochemicals					
phytochlorin	19660-77-6	Chlorin e6	19660-77-6	5S2CCF3T1Z	Radiation-Sensitizing Agents	Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. (See all compounds classified as Radiation-Sensitizing Agents.)	
Phytoestrogens		Phytoestrogens					
phytofluene	540-05-6	Phytofluene	540-05-6	6NUO4W7YQ6			
Phytol	150-86-7	Phytol	150-86-7	MZQ4XE15TP			
phytomonic acid	503-06-0	Phytomonic acid	503-06-0				
phytosphingosine	554-62-1	Phytosphingosine	554-62-1	GIN46U9Q2Q			
Phytosterols		Phytosterols	68441-03-2				
PI 540		3-[6-[(4-Methylpiperazin-1-yl)methyl]-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl]phenol					
PI 620		PI 620					
PI-3065		4-(6-((4-(cyclopropylmethyl)piperazin-1-yl)methyl)-2-(5-fluoro-1H-indol-4-yl)thieno[3,2-d]pyrimidin-4-yl)morpholine					
PI103		PI-103	371935-74-9	YQX02F616F			
pibrentasvir		Pibrentasvir	1353900-92-1	2WU922TK3L			Indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A). MAVYRET is also indicated for the treatment of adult patients with HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor (PI), but not both.
picaridin		Icaridin	119515-38-7	N51GQX0837	Insect Repellents	Substances causing insects to turn away from them or reject them as food. (See all compounds classified as Insect Repellents.)	Icaridin is indicated for use to repel insects, such as mosquitoes, biting flies, ticks, chiggers, and fleas, via topical use or over clothing.
picene	213-46-7	Picene	213-46-7	F70R8ZBR7T			
pichtosin	125-12-2	Isobornyl acetate	125-12-2				
Picibanil	39325-01-4	Picibanil	54836-26-9		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
piclamilast		Piclamilast	144035-83-6	WM58D7C3ZT	Phosphodiesterase 4 Inhibitors	Compounds that specifically inhibit PHOSPHODIESTERASE 4. (See all compounds classified as Phosphodiesterase 4 Inhibitors.)	
Picloram	1918-02-1	Picloram	1918-02-1	O7437X49DW	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Piclozotan		Piclozotan	182415-09-4	FQE44HS7AH	Serotonin 5-HT1 Receptor Agonists	Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes. (See all compounds classified as Serotonin 5-HT1 Receptor Agonists.)	
Picolines		Picolines					
picolinic acid	98-98-6	Picolinic acid	98-98-6	QZV2W997JQ	Iron Chelating Agents	Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. (See all compounds classified as Iron Chelating Agents.)	Investigated for use/treatment in acne, herpes labialis infections (cold sores), and venereal disease.
picolog		picolog					
picoxystrobin		Picoxystrobin	117428-22-5	62DH7GEL1P	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
picrasidine I		Picrasidine I					
picrocrocin		Picrocrocin	138-55-6	ON5B022511			
picropodophyllin		Picropodophyllin	477-47-4	0F35AOI227			
picroside II	39012-20-9	CID 3081484	39012-20-9				
Picrotoxin		Picrotoxin	124-87-8		Central Nervous System Stimulants	A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)	Used internally for relieving respiratory distress. Also for use as an antidote in poisoning by CNS depressants, especially barbiturates.
picrotoxinin	17617-45-7	Picrotoxinin	17617-45-7	9K011NUF0R	GABA-A Receptor Antagonists	Drugs that bind to but do not activate GABA-A RECEPTORS thereby blocking the actions of endogenous or exogenous GABA-A RECEPTOR AGONISTS. (See all compounds classified as GABA-A Receptor Antagonists.)	
Picryl Chloride	88-88-0	Picryl chloride	88-88-0	Z4ZG7O5SZ9			
pien tze huang		pien tze huang					
piericidin A		Piericidin A	2738-64-9	8VT513UJ9R	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
pifithrin		Pifithrin					
pifithrin-beta		Pifithrin-Beta	60477-34-1	45I8QO7K37			
PIK 75		N'-((6-bromoimidazo[1,2-a]pyridin-3-yl)methylene)-N,2-dimethyl-5-nitrobenzenesulfonohydrazide	1201670-42-9	NT63XAU01R			
Pilocarpine	92-13-7	Pilocarpine	92-13-7	01MI4Q9DI3	Miotics	Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here. (See all compounds classified as Miotics.)	Pilocarpine oral tablets are indicated for the treatment of dry mouth caused by Sjogren's Syndrome or radiotherapy for cancer of the head and neck.  Pilocarpine ophthalmic formulations are used to treat presbyopia in adults, reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension, manage acute angle-closure glaucoma, prevent postoperative elevated IOP associated with laser surgery, and induce miosis.
pilsicainide	88069-49-2	Pilsicainide hydrochloride	88069-49-2	03C8I9296V	Sodium Channel Blockers	A class of drugs that act by inhibition of sodium influx through cell membranes. Blockade of sodium channels slows the rate and amplitude of initial rapid depolarization, reduces cell excitability, and reduces conduction velocity. (See all compounds classified as Sodium Channel Blockers.)	
pimagedine	79-17-4	Aminoguanidine	79-17-4	SCQ4EZQ113	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Investigated for use/treatment in diabetic kidney disease.
pimaric acid	127-27-5	Pimaric acid	127-27-5	88R98Z71NI			
pimavanserin		Pimavanserin	706779-91-1	JZ963P0DIK	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	Pimavanserin is indicated for the treatment of hallucinations and delusions associated with Parkinsons disease psychosis.
pimecrolimus		Pimecrolimus	137071-32-0	7KYV510875	Dermatologic Agents	Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)	For treatment of mild to moderate atopic dermatitis.
Pimelic Acids		Pimelic acid					
pimobendan	74150-27-9	Pimobendan	74150-27-9	34AP3BBP9T	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
Pimozide	2062-78-4	Pimozide	2062-78-4	1HIZ4DL86F	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Used for the suppression of motor and phonic tics in patients with Tourette's Disorder who have failed to respond satisfactorily to standard treatment.
Pinacidil	85371-64-8	Pinacidil monohydrate	85371-64-8		Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
Pindolol	13523-86-9	Pindolol	13523-86-9	BJ4HF6IU1D	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	Pindolol is indicated in the management of hypertension. In Canada, it is also indicated in the prophylaxis of angina.
pinitol	484-68-4	D-Pinitol	484-68-4	TF9HZN9T0M			
pinocembrin		Pinocembrin	480-39-7	8T7C8CH791			
pinoresinol	487-36-5	Pinoresinol	487-36-5	V4N1UDY811			
pinostilbene		3-Methoxy-4',5-dihydroxy-trans-stilbene	42438-89-1	4PAK325BEM			
pinostrobin		Pinostrobin	480-37-5	SZD9LZS694			
pinosylvin	102-61-4	Pinosylvin	22139-77-1	881R434AIB			
Pioglitazone	111025-46-8	Pioglitazone	111025-46-8	X4OV71U42S	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	Pioglitazone is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is also available in combination with [metformin], [glimepiride], or [alogliptin] for the same indication.
pipecolic acid	535-75-1	Pipecolic acid	535-75-1	H254GW7PVV			
Pipecuronium	68399-58-6	Pipecuronium	68399-58-6	1N3O74HM92	Nicotinic Antagonists	Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)	Used as a muscle relaxant during anesthesia and surgical procedures.
Pipemidic Acid	51940-44-4	Pipemidic acid	51940-44-4	LT12J5HVR8	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
piperacetazine	3819-00-9	Piperacetazine	3819-00-9	KL6248WNW4			
Piperacillin	61477-96-1	Piperacillin	61477-96-1	9I628532GX	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of polymicrobial infections.
Piperazine	110-85-0	Piperazine	110-85-0	1RTM4PAL0V	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	Used as alternative treatment for ascariasis caused by Ascaris lumbricoides (roundworm) and enterobiasis (oxyuriasis) caused by Enterobius vermicularis (pinworm). It is also used to treat partial intestinal obstruction by the common roundworm, a condition primarily occurring in children.
Piperazines		Piperazines					
piperidine	110-89-4	Piperidine	110-89-4	67I85E138Y	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
Piperidines		Piperidines					
piperidolate	82-98-4	Piperidolate	82-98-4	RJO31255V9			
Piperidones		2-Piperidone	675-20-7	WLN0GQQ6EK			
piperine	7780-20-3	Piperine	94-62-2	U71XL721QK	Cytochrome P-450 Enzyme Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES. (See all compounds classified as Cytochrome P-450 Enzyme Inhibitors.)	
piperlongumine		Piperlongumine	20069-09-4	SGD66V4SVJ			
pipermethystine	71627-22-0	Pipermethystine	71627-22-0	APX8C8S6AW			
piperonyl alcohol	495-76-1	Piperonyl alcohol	495-76-1	4163K563GS			
Piperonyl Butoxide	51-03-6	Piperonyl butoxide	51-03-6	LWK91TU9AH	Pesticide Synergists	Chemicals that, while not possessing inherent pesticidal activity, nonetheless promote or enhance the effectiveness of other pesticides when combined. (See all compounds classified as Pesticide Synergists.)	For the treatment of head, pubic (crab), and body lice.
piperonylidene acetone	3160-37-0	Piperonylidene acetone	3160-37-0	T43BYJ64EG			
piperophos	24151-93-7	Piperophos	24151-93-7	NZQ0DO501J			
Piperoxan	59-39-2	Piperoxan	59-39-2	9ZCS27634Y	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
pipoxolan	23744-24-3	Pipoxolan	23744-24-3	493GZJ5T6I			
Piracetam	7491-74-9	Piracetam	7491-74-9	ZH516LNZ10	Nootropic Agents	Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)	Indicated in adult patients suffering from myoclonus of cortical origin, irrespective of aetiology, and should be used in combination with other anti-myoclonic therapies.
pirarubicin		Pirarubicin	72496-41-4	D58G680W0G	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
pirbuterol	38677-81-5	Pirbuterol	38677-81-5	OG645J8RVW	Bronchodilator Agents	Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)	For the prevention and reversal of bronchospasm in patients 12 years of age and older with reversible bronchospasm including asthma.
pirenperone	75444-65-4	Pirenperone	75444-65-4	Y9FMC4513X	Tranquilizing Agents	A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes. (See all compounds classified as Tranquilizing Agents.)	
Pirenzepine	28797-61-7	Pirenzepine	28797-61-7	3G0285N20N	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	For the treatment of peptic ulcer, gastric ulcer, and duodenal ulcer.
piretanide		Piretanide	55837-27-9	DQ6KK6GV93	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	
pirfenidone	53179-13-8	Pirfenidone	53179-13-8	D7NLD2JX7U	Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	Pirfenidone is indicated for the treatment of idiopathic pulmonary fibrosis (IPF). In Canada and Europe, it is approved in adults only.
Piribedil	3605-01-4	Piribedil	3605-01-4	DO22K1PRDJ	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	
pirimicarb	23103-98-2	Pirimicarb	23103-98-2	1I93PS935T	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
pirimiphos methyl	29232-93-7	Pirimiphos-methyl	29232-93-7	2VQZ4PK548	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
pirimiphos-ethyl	23505-41-1	Pirimiphos-ethyl	23505-41-1	3L26N84757			
pirinixic acid	50892-23-4	Pirinixic acid	50892-23-4	86C4MRT55A	Anticholesteremic Agents	Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)	
pirinixil	65089-17-0	Pirinixil	65089-17-0	969LVT6GJ2			
pirlindole	60762-57-4	Pirlindole	60762-57-4	V39YPH45FZ	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	"For the treatment of major depression.  It is being studied in the treatment of fibromyalgia pain syndrome. One study determined that the effect of pirlindole on sensorimotor performance while driving a motor vehicle shows many similarities to that of placebo. The drug appears to stimulate the central nervous system, rather than exhibit a sedative effect, like many antidepressants.  Because of its selective, reversible inhibition of monoamine oxidase (MAO-A) and short half-life, unpleasant ""cheese effects"" are avoided. This refers to the effects of consuming tyramine-rich foods, such as cheese while medicated with monoamine oxidase inhibitors, leading to severe headaches and hypertension.  of The available evidence supports pirlindole as a safe and effective treatment option for the management of depression and fibromyalgia syndrome."
Piroxicam	36322-90-4	Piroxicam	36322-90-4	13T4O6VMAM	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	For treatment of osteoarthritis and rheumatoid arthritis.
pirprofen	31793-07-4	Pirprofen	31793-07-4	T7KN291890	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
pisosterol		Pisosterol					
pitavastatin	147511-69-1	Pitavastatin	147511-69-1	M5681Q5F9P	Hydroxymethylglutaryl-CoA Reductase Inhibitors	Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)	Pitavastatin is indicated for the treatment of adult patients with primary hyperlipidemia or mixed dyslipidemia to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C). It is also indicated for the treatment of pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH) to reduce elevated TC, LDL-C, and Apo B.  Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.
pitolisant		Pitolisant	362665-56-3	4BC83L4PIY			Pitolisant is indicated for the treatment of narcolepsy with or without cataplexy in adults in the US and patients aged six years and older. In the US, it is also indicated for the treatment of excessive daytime sleepiness in narcolepsy in adult patients.
Pituitary Adenylate Cyclase-Activating Polypeptide		PACAP 38					
pivaloylcarnitine	98299-38-8	Pivaloylcarnitine	98299-38-8				
pivalyloxymethyl butyrate	122110-53-6	Pivanex	122110-53-6	55VNK5440P			Investigated for use/treatment in liver cancer, lung cancer, melanoma, and leukemia (lymphoid).
PIXY321 fusion protein, recombinant		PIXY321 fusion protein, recombinant					
Pizotyline	15574-96-6	Pizotifen	15574-96-6	0BY8440V3N	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	Indicated for the prophylactic management of migraines.
PK 11195	85340-56-3	1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide	85532-75-8	YNF83VN1RL	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
PKF115-584		Carbonic acid, 2-(12-(2-(benzoyloxy)propyl)-3,10-dihydro-4,9-dihydroxy-2,6,7,11-tetramethoxy-3,10-dioxo-1-perylenyl)-1-methylethyl 4-hydroxyphenyl ester	121263-19-2	I271P23G24	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	
PKF118-310		Toxoflavin	84-82-2	5N5YI4IP1P			
PKI 166		Pki-166	187724-61-4	9RIE5HW38P	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
plant extract, Puerariae Radix		Plant extract, Puerariae Radix					
Plant Extracts		Plant Extracts					
Plant Oils		Plant Oils					
Plant Preparations		Plant Preparations					
plant stanol ester		plant stanol ester					
plantamajoside	104777-68-6	Plantamajoside	104777-68-6				
Plasticizers		Plasticizers					
plastochromanol 8	4382-43-8	Plastochromanol 8	4382-43-8				
Platelet Activating Factor		Platelet activating factor	74389-68-7	42EWD89I80			
Platelet Aggregation Inhibitors		Platelet Aggregation Inhibitors					
Platinum	7440-06-4	Platinum	7440-06-4	49DFR088MY			
platinum chloride	12648-47-4	Platinum;hydrochloride					
Platinum Compounds		Platinum Compounds					
platycodigenin 3-O-(glucopyranosyl-(1-3)-glucopyranosyl)-28-O-(apiofuranosyl-(1-3)-xylopyranosyl-(1-4)-rhamnopyranosyl-(1-2)-arabinopyranoside)		platycodigenin 3-O-(glucopyranosyl-(1-3)-glucopyranosyl)-28-O-(apiofuranosyl-(1-3)-xylopyranosyl-(1-4)-rhamnopyranosyl-(1-2)-arabinopyranoside)					
platycodin D	58479-68-8	Platycodin D	58479-68-8	CWJ06TA2GI			
platycodin D3		67884-03-1					
platyconic acid		platyconic acid					
platyphylline	480-78-4	Platyphylline	480-78-4	A91172AJBY			
plaunotol	64218-02-6	Plaunotol	64218-02-6	MV715X4634	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	
plerixafor		Plerixafor	110078-46-1	OD49913540	Anti-HIV Agents	Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)	Plerixafor is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkins lymphoma or multiple myeloma.
Plicamycin	18378-89-7	Plicamycin	18378-89-7	NIJ123W41V	Calcium-Regulating Hormones and Agents	Hormones and molecules with calcium-regulating hormone-like actions that modulate OSTEOLYSIS and other extra-skeletal activities to maintain calcium homeostasis. (See all compounds classified as Calcium-Regulating Hormones and Agents.)	For the treatment of testicular cancer, as well as hypercalcemia and hypercalciuria associated with a variety of advanced forms of cancer.
plitidepsin		Plitidepsin	137219-37-5	Y76ID234HW			Intended for the treatment of various forms of cancer.
plumbagin	481-42-5	Plumbagin	481-42-5	YAS4TBQ4OQ	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
pluronic block copolymer p85		pluronic block copolymer p85					
Plutonium	7440-07-5	Plutonium	7440-07-5	53023GN24M			
PLX 4720		N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide	918505-84-7	EQY31RO8HA			
plY protein, Streptococcus pneumoniae		plY protein, Streptococcus pneumoniae					
PM 00104		PM 00104					
PMSG-HCG		PMSG-HCG					
PNU 109291		(S)-3,4-Dihydro-1-[2-[4-(4-methoxyphenyl)-1-piperazinyl]ethyl]-N-methyl-1H-2-benzopyran-6-carboxamide	187665-60-7	6E4LJL8K38			
PNU-282987		Benzamide, N-(3R)-1-azabicyclo(2.2.2)oct-3-yl-4-chloro-, hydrochloride (1:1)	123464-89-1	810P1694K2			
pobilukast	107023-41-6	Pobilukast	107023-41-6	R2N8IH71HC	Leukotriene Antagonists	A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level. (See all compounds classified as Leukotriene Antagonists.)	
podocarpic acid	5947-49-9	Podocarpic acid	5947-49-9	7K80G5Z96Y			
Podophyllotoxin	518-28-5	Podofilox	518-28-5	L36H50F353	Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	For treatment of external genital warts (Condyloma acuminatum).
polaprezinc		Zinc L-carnosine	107667-60-7		Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	Peptic ulcer disease, dyspepsia.
polihexanide	28757-47-3	Vantocil	28757-47-3		Disinfectants	Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley&apos;s Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Disinfectants.)	
Poloxalene	9003-11-6	Poloxamer	9003-11-6		Surface-Active Agents	Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)	
Poloxamer	106392-12-5	Poloxamer	9003-11-6		Surface-Active Agents	Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)	
Poly A-U	24936-38-7	[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate			Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
Poly Adenosine Diphosphate Ribose	26656-46-2	Adenosine diphosphate ribose	20762-30-5				
Poly C	30811-80-4	Cytosine arabinoside monophosphate	30811-80-4				
poly d(I-C)	25853-45-6	CID 135618616	25853-45-6				
Poly dA-dT	26966-61-0	[(2R,3S,5R)-5-(6-aminopurin-9-yl)-2-(phosphonooxymethyl)oxolan-3-yl] [(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl hydrogen phosphate	26966-61-0				
Poly G	25191-14-4	[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-4-hydroxyoxolan-2-yl]methyl [(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxy-2-(phosphonooxymethyl)oxolan-3-yl] hydrogen phosphate					
Poly I-C		5'-Inosinic acid, homopolymer, complex with 5'-cytidylic acid homopolymer (1:1)					
poly-APS		poly-APS					
poly-N-4-vinylbenzyllactonamide	96910-25-7	poly-N-4-vinylbenzyllactonamide					
poly-N-acetyl glucosamine		poly-N-acetyl glucosamine					
poly-N-acetyllactosamine	82441-98-3	Pnala	32181-59-2	3Y5B2K5OOK			
poly-N-vinylcaprolactam	25189-83-7	N-Vinylcaprolactam	2235-00-9	KFC10CY9UP			
Poly(ADP-ribose) Polymerase Inhibitors		Poly(ADP-ribose) Polymerase Inhibitors					
Poly(amidoamine)		Poly(amidoamine)					
poly(hexamethylenebiguanidinium)		poly(hexamethylenebiguanidinium)					
poly(N-isopropylacrylamide-N-tert-butylacrylamide)copolymer	102667-59-4	N-tert-butylprop-2-enamide;N-propan-2-ylprop-2-enamide	102667-59-4				
poly(N-vinylpyrrolidine)		poly(N-vinylpyrrolidine)					
poly(propyleneimine)		poly(propyleneimine)					
Polyamines		Polyamines					
polyaspartate	26063-13-8	polyaspartate					
Polybrominated Biphenyls		59536-65-1					
Polychlorinated Biphenyls		Polychlorinated Biphenyls					
Polychlorinated Dibenzodioxins		2,3,7,8-Tetrachlorodibenzo-p-dioxin					
polychlorodibenzofuran		polychlorodibenzofuran					
Polycyclic Aromatic Hydrocarbons		Polycyclic Aromatic Hydrocarbons					
polycyclic aromatic hydrocarbons-DNA adduct		polycyclic aromatic hydrocarbons-DNA adduct					
polydatin	65914-17-2	Polydatin	27208-80-6	XM261C37CQ			
Polydeoxyribonucleotides		Polydeoxyribonucleotides					
Polyenes		Polyenes					
polyestradiol phosphate	28014-46-2	13-Methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol;phosphoric acid					
Polyethylene	9002-88-4	Ethylene	9002-88-4	91GW059KN7	Plant Growth Regulators	Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins. (See all compounds classified as Plant Growth Regulators.)	
polyethylene glycol 1000		25322-68-3					
polyethylene glycol 400		25322-68-3					
Polyethylene Glycol 6000		Polyethylene Glycol 6000					
polyethylene glycol loxenatide		polyethylene glycol loxenatide					
polyethylene glycol-superoxide dismutase		polyethylene glycol-superoxide dismutase					
Polyethylene Glycols		Polyethylene Glycols					
Polyethyleneimine	9002-98-6	Aziridine	151-56-4	54P5FEX9FH			
Polyethylenes		Polyethylenes					
Polyglutamic Acid	25513-46-6	Glutamic Acid	56-86-0	61LJO5I15S			"Considered to be nature's ""Brain food"" by improving mental capacities; helps speed the healing of ulcers; gives a ""lift"" from fatigue; helps control alcoholism, schizophrenia and the craving for sugar."
polyglutamine	26700-71-0	Glutamine	56-85-9	0RH81L854J			Used for nutritional supplementation, also for treating dietary shortage or imbalance.  Used to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older.
polygodial	6754-20-7	Tadeonal	6754-20-7	A00RAV0W57	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
polyhexamethyleneguanidine	31961-54-3	Guanidine, N,N'-dibutyl-	34331-58-3				
polyisohexylcyanoacrylate	107811-81-4	Isohexylcyanoacrylate	107811-80-3	P2896L2A9K			
Polylactic Acid-Polyglycolic Acid Copolymer		C043435					
polylactide-polyethylene glycol-polylactide		polylactide-polyethylene glycol-polylactide					
Polylysine	25104-18-1	Lysine	56-87-1	K3Z4F929H6			Supplemental lysine has putative anti-herpes simplex virus activity. There is preliminary research suggesting that it may have some anti-osteoporotic activity.
polymarcine	9006-42-2	Zineb	9006-42-2	X1FSB1OZPT			
Polymethyl Methacrylate	9011-14-7	Methyl methacrylate	9011-14-7	196OC77688	Antimutagenic Agents	Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved. (See all compounds classified as Antimutagenic Agents.)	
Polymyxin B	1404-26-8	Aerosporin	1404-26-8		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
polyoxyethyleneamine		polyoxyethyleneamine					
Polyphenols		C025299					
polyphenon E		Kunecatechins					
Polyphosphates		Polyphosphates					
polyphyllin I		50773-41-6					
polyphyllin VII		Polyphyllin VII					
polyporic acid		2,4-dione, 2,5-dihydroxy-3,6-diphenyl-					
Polyribonucleotides		Polyribonucleotides					
polysaccharide peptide		polysaccharide peptide					
polysaccharide-K		polysaccharide-K					
Polysaccharides		Polysaccharides					
polyserine	25821-52-7	(C3-H7-N-O3)x-					
polysorbate 40		Polysorbate 40 [USAN:INN:BAN:NF]					
Polysorbates		CHEBI:53422					
Polystyrenes		Polystyrenes					
Polyurethanes		CID3033451					
Polyvinyl Chloride	9002-86-2	Vinyl Chloride	9002-86-2	WD06X94M2D	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Polyynes	25067-58-7	(C2-H2)x-					
pomalidomide		Pomalidomide	19171-19-8	D2UX06XLB5	Immunologic Factors	Biologically active substances whose activities affect or play a role in the functioning of the immune system. (See all compounds classified as Immunologic Factors.)	Pomalidomide is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and have demonstrated disease progression on or within 60 days of completion of the last therapy. It is also indicated for the treatment of Kaposi's sarcoma (KS) in AIDS patients who have failed highly active antiretroviral therapy (HAART) and for the treatment of KS in HIV-negative patients.
pomegranate fruit rind		Granati pericarpium					
pomiferin		Pomiferin	572-03-2	74YIS40APM			
ponalrestat	72702-95-5	Ponalrestat	72702-95-5	2CV0A5G64E	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
ponasterone A	13408-56-5	Ponasterone A	13408-56-5	84986BG3NG			
ponatinib		Ponatinib	943319-70-8	4340891KFS	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Ponatinib is indicated for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy.
ponceau 4R		Ponceau 4R	2611-82-7	Z525CBK9PG	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
ponceau MX	7481-49-4	Ponceau MX	3761-53-3				
poncirin		Poncirin	14941-08-3	8MUY4P95B4			
ponkoranol		Ponkoranol					
poractant alfa	129069-19-8	poractant alfa					
Porfiromycin	801-52-5	Porfiromycin	801-52-5	H1WK901OA6	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	Investigated for use/treatment in head and neck cancer.
Porphobilinogen	487-90-1	Porphobilinogen	487-90-1	74KHC72QXK			
porphycene	100572-96-1	Porphycene	133730-20-8				
Porphyrins		Porphyrins					
posaconazole		Posaconazole	171228-49-2	6TK1G07BHZ	14-alpha Demethylase Inhibitors	Compounds that specifically inhibit STEROL 14-DEMETHYLASE. A variety of azole-derived ANTIFUNGAL AGENTS act through this mechanism. (See all compounds classified as 14-alpha Demethylase Inhibitors.)	For prophylaxis of invasive Aspergillus and Candida infections in patients, 13 years of age and older, who are at high risk of developing these infections due to being severely immunocompromised as a result of procedures such as hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD), or due to hematologic malignancies with prolonged neutropenia from chemotherapy. Also for the treatment of oropharyngeal candidiasis, including oropharyngeal candidiasis refractory to itraconazole and/or fluconazole. Posaconazole is used as an alternative treatment for invasive aspergillosis, Fusarium infections, and zygomycosis in patients who are intolerant of, or whose disease is refractory to, other antifungals.
Potassium	7440-09-7	Potassium	7440-09-7	RWP5GA015D			**General uses of potassium**  Potassium is indicated to treat a variety of conditions. Firstly, it used to replenish potassium that has been depleted by conditions including but not limited to malabsorption, decreased intake, or excess sodium intake.  The causes of potassium deficiency are numerous. The following indications for potassium are not comprehensive, but include the main indications for which this nutrient is used. Various products and preparations contain potassium.  **Potassium chloride**  Potassium chloride is one of the main preparations of potassium used in a clinical setting. The oral solution is indicated for the prevention and treatment of hypokalemia presenting with or without metabolic alkalosis, in patients who have failed conservative management with potassium-rich foods or diuretic dose titrations. The injection form of potassium chloride is indicated to replenish potassium in patients who are not feasible candidates for oral potassium. Highly concentrated potassium is intended for the treatment of potassium deficiency in fluid restricted individuals who cannot tolerate fluid volumes normally associated with injected potassium solutions that contain lower concentrations. Finally, the extended-release tablet preparation of potassium chloride is used to treat hypokalemia with or without metabolic alkalosis, to treat digitalis intoxication, and to manage patients with hypokalemic familial periodic paralysis. It is also used in the prevention of hypokalemia in those who are at a high risk of negative clinical outcomes if hypokalemia occurs; patients on digitalis or those with cardiac arrhythmias would be at particular risk of negative outcomes.   **Potassium chloride with dextrose and sodium chloride**   This liquid preparation is is indicated in a clinical setting as a source of water, calories and electrolytes. Potassium acetate solution is meant as an alternative to potassium chloride, replenishing potassium and added to large volume infusion fluids for intravenous injection.  **Potassium citrate**  The potassium citrate preparation is used for the management of renal tubular acidosis (RTA) with calcium stones (nephrolithiasis); calcium oxalate stones by any cause, and uric acid nephrolithiasis (with or without calcium stones). This regimen also includes adequate water intake (leading to a urine out put of 2 L/day or more) and sodium restriction.
potassium bromate	7758-01-2	Potassium bromate	7758-01-2	04MB35W6ZA	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Potassium Chloride	7447-40-7	Potassium Chloride	7447-40-7	660YQ98I10			For use as an electrolyte replenisher and in the treatment of hypokalemia.
potassium chromate(VI)	7789-00-6	Potassium Chromate	7789-00-6	5P0R38CN2X			
Potassium Citrate	6100-05-6	Potassium citrate monohydrate	6100-05-6		Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	
Potassium Cyanide	151-50-8	Potassium Cyanide	151-50-8	MQD255M2ZO	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
potassium diazoacetate		Potassium diazoacetate	189457-96-3				
Potassium Dichromate	7778-50-9	Potassium Dichromate	7778-50-9	T4423S18FM	Caustics	Strong alkaline chemicals that destroy soft body tissues resulting in a deep, penetrating type of burn, in contrast to corrosives, that result in a more superficial type of damage via chemical means or inflammation. Caustics are usually hydroxides of light metals. SODIUM HYDROXIDE and potassium hydroxide are the most widely used caustic agents in industry. Medically, they have been used externally to remove diseased or dead tissues and destroy warts and small tumors. The accidental ingestion of products (household and industrial) containing caustic ingredients results in thousands of injuries per year. (See all compounds classified as Caustics.)	
potassium ferricyanide	13746-66-2	Potassium ferricyanide	13746-66-2				
potassium ferrocyanide	13943-58-3	13943-58-3					
potassium fluoride	7789-23-3	Potassium fluoride	7789-23-3	9082WG1G3F			
potassium hexachloropalladate(IV)		Potassium hexachloropalladate(IV)	16919-73-6				
potassium hydroxide	1310-58-3	Potassium Hydroxide	1310-58-3	WZH3C48M4T	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	Medically, the microscopic examination of potassium hydroxide (KOH) preparations is utilized in the diagnosis of fungal hyphae or trichomonads.  Samples from hair, skin, or nail tissue are obtained by scraping with a scalpel, cotton-tipped applicator and are inoculated directly onto the KOH solution.  In addition to the above, potassium hydroxide is used as a softener for nail grooves.
potassium iodate	7758-05-6	Potassium Iodate	7758-05-6	I139E44NHL	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
Potassium Iodide	7681-11-0	Potassium Iodide	7681-11-0	1C4QK22F9J			Potassium Iodide is oral antithyroid agent used in the prevention of radioactive iodine uptake into the thyroid gland during a nuclear radiation emergency. Potassium Iodide may be used as an adjunct to other antithyroid agents in the treatment of hyperthyroidism and thyrotoxicosis and preoperatively to induce thyroid involution.
potassium mercuric thiocyanate	14099-12-8	Potassium mercuric thiocyanate	14099-12-8				
potassium nitrate	7757-79-1	Potassium Nitrate	7757-79-1	RU45X2JN0Z	Explosive Agents	Substances that are energetically unstable and can produce a sudden expansion of the material, called an explosion, which is accompanied by heat, pressure and noise. Other things which have been described as explosive that are not included here are explosive action of laser heating, human performance, sudden epidemiological outbreaks, or fast cell growth. (See all compounds classified as Explosive Agents.)	For the relief of tooth sensitivity, and is also used as a pesticide, insecticide, as a food additive, and a rodenticide.
potassium octatitanate	59766-31-3	Fybex	59766-31-3				
potassium oxonate		Potassium oxonate	2207-75-2	4R7FFA00RX			
potassium perchlorate		Potassium Perchlorate	7778-74-7	42255P5X4D			No current FDA- or EMA-approved therapeutic indications.
potassium periodate	7790-21-8	Potassium periodate	7790-21-8	Q3LOC6P66L			
potassium persulfate	7727-21-1	Potassium persulfate	7727-21-1	6B86K0MCZC			
potassium phosphate	16068-46-5	Potassium phosphate	7778-53-2	16D59922JU	Cariostatic Agents	Substances that inhibit or arrest DENTAL CARIES formation. (Boucher&apos;s Clinical Dental Terminology, 4th ed) (See all compounds classified as Cariostatic Agents.)	
potassium sulfate	7778-80-5	Potassium Sulfate	7778-80-5	1K573LC5TV			Potassium is used to regulate hypokalemia as a primary condition or secondary to other medical conditions.
potassium superoxide	12030-88-5	Potassium superoxide	12030-88-5	7YX56J6Q4W			
potassium tellurate(IV)	7790-58-1	Potassium tellurite	7790-58-1	71M41949N8			
potassium tetraperoxochromate	12331-76-9	12331-76-9					
Potassium, Dietary		Potassium, Dietary					
Povidone		N-Vinyl-2-pyrrolidone	9003-39-8	76H9G81541	Biocompatible Materials	Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function. (See all compounds classified as Biocompatible Materials.)	
pozanicline	161417-20-5	(R)-2-Methyl-3-(2-pyrrolidinylmethoxy)pyridine	161417-20-5				
PP242		2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol	1092351-67-1	H5669VNZ7V			
PQ 401		1-(5-Chloro-2-methoxyphenyl)-3-(2-methylquinolin-4-yl)urea	196868-63-0	2N3LV83S8J			
PQQ Cofactor	72909-34-3	Pyrroloquinoline quinone	72909-34-3	47819QGH5L			
PR 39	139637-11-9	CID 16198954	139637-11-9		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Practolol	6673-35-4	Practolol	6673-35-4	SUG9176GRW	Adrenergic beta-1 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Antagonists.)	Used in the emergency treatment of cardiac arrhythmias.
pradimicin-IRD		pradimicin-IRD					
praeruptorin A		Praeruptorin A	73069-25-7				
praeruptorin C	83382-71-2	Praeruptorin C	72463-77-5				
praeruptorin E	78478-28-1	Praeruptorin E	78478-28-1				
pralidoxime	6735-59-7	Pralidoxime	6735-59-7	P7MU9UTP52	Antidotes	Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)	For the treatment of poisoning due to those pesticides and chemicals of the organophosphate class which have anticholinesterase activity and in the control of overdosage by anticholinesterase drugs used in the treatment of myasthenia gravis.
Pralidoxime Compounds		Pralidoxime Compounds					
pramanicin		Pramanicin					
pramiconazole		Pramiconazole	219923-85-0	4SYH0R661F			Investigated for use/treatment in seborrhea, fungal infections, skin infections/disorders, and onychomycosis.
Pramipexole		Pramipexole	104632-26-0	83619PEU5T	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	This drug is indicated for the symptomatic treatment of Parkinsons disease.  This drug can be administered as monotherapy or in conjunction with levodopa. It is also indicated for symptomatic treatment of moderate to severe primary Restless Legs Syndrome (RLS).
pranlukast		Pranlukast	103177-37-3	TB8Z891092	Leukotriene Antagonists	A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level. (See all compounds classified as Leukotriene Antagonists.)	Used as an adjunct to the standard therapy of inhaled steroids with inhaled long- and/or short-acting beta-agonists.
Prasugrel Hydrochloride		Prasugrel Hydrochloride	389574-19-0	G89JQ59I13	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
Pravastatin	81093-37-0	Pravastatin	81093-37-0	KXO2KT9N0G	Anticholesteremic Agents	Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)	Pravastatin is indicated for primary prevention of coronary events hypercholesterolemic patients without clinical evidence of coronary heart disease. Its use includes the reduction of risk on myocardial infarction, undergoing myocardial revascularization procedures and cardiovascular mortality.  As well, pravastatin can be used as a secondary prevention agent for cardiovascular events in patients with clinically evident coronary heart disease. This indication includes the reduction of risk of total mortality by reducing coronary death, myocardial infarction, undergoing myocardial revascularization procedures, stroke, and stroke/transient ischemic attack as well as to slow the progression of coronary atherosclerosis.  The term cardiovascular events correspond to all the incidents that can produce damage to the heart muscle including the interruption of blood flow.  As adjunctive therapy to diet, pravastatin is used in:  - Patients with primary hypercholesterolemia and mixed dyslipidemias including hyperlipidemia type IIa and IIb. - Patients with elevated serum triglycerides including type IV hyperlipidemia. - Patients with heterozygous familial hypercholesterolemia in patients over 8 years of age with low-density lipoprotein (LDL) cholesterol higher than 190 mg/dl after diet modifications or LDL levels higher than 160 mg/dl and familial history of premature cardiovascular diseases or at least two cardiovascular risk factors.  In patients that do not respond adequately to diet, pravastatin is used to treat patients with primary dysbetalipoproteinemia (type III hyperlipidemia).   Dyslipidemia is defined as an elevation of plasma cholesterol, triglycerides or both as well as to the presence of low levels of high-density lipoprotein. This condition represents an increased risk for the development of atherosclerosis.
Praziquantel	55268-74-1	Praziquantel	55268-74-1	6490C9U457	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	Praziquantel is indicated in patients aged 1 year and older for the treatment of the schistosomiasis due to all species of Schistosoma (for example, Schistosoma mekongi, Schistosoma japonicum, Schistosoma mansoni and Schistosoma hematobium) and clonorchiasis and opisthorchiasis due to the liver flukes, Clonorchis sinensis/Opisthorchis viverrini (approval of this indication was based on studies in which the two species were not differentiated).
Prazosin	19216-56-9	Prazosin	19216-56-9	XM03YJ541D	Adrenergic alpha-1 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)	This drug is indicated for the treatment of hypertension (high blood pressure). Prazosin can be given alone or given with other blood pressure-lowering drugs, including diuretics or beta-adrenergic blocking agents.  Prazosin does not negatively impact lung function, and therefore may be used to manage hypertension in patients who are asthmatic or patients with chronic obstructive lung disease (COPD).
preclamol	75240-91-4	3-(1-Propyl-3-piperidinyl)phenol	75240-91-4	ND3NDM2EHM	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	
Prednisolone	50-24-8	Prednisolone	50-24-8	9PHQ9Y1OLM	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	Prednisolone is indicated to treat endocrine, rheumatic, and hematologic disorders; collagen, dermatologic, ophthalmic, respiratory, and gastrointestinal diseases; allergic and edematous states; and other conditions like tuberculous meningitis.
prednisolone acetate		Prednisolone Acetate	52-21-1	8B2807733D	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	Prednisolone acetate is indicated as an anti-inflammatory or immunosuppressive agent for allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, or infectious conditions. Prednisolone acetate is also indicated in organ transplant patients, as well as endocrine or neoplastic conditions.
Prednisone	53-03-2	Prednisone	53-03-2	VB0R961HZT	Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	Prednisone is indicated as an anti-inflammatory or immunosuppressive drug for allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, infectious, endocrine, or neoplastic conditions as well as in organ transplant.
prednylidene	599-33-7	Prednylidene	599-33-7	IF8PQP966U			
Pregabalin		Pregabalin	148553-50-8	55JG375S6M	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.
pregna-4,17-diene-3,16-dione	95975-55-6	Guggulsterone	39025-23-5	6CST3U34GN			
Pregnadienes		Pregnadienes					
pregnane glycoside		pregnane glycoside					
pregnanediol-3 alpha-glucuronide	1852-49-9	Pregnanediol-3-glucuronide	38055-17-3	488GK5DQ5X			
Pregnanediones		Pregnanediones					
Pregnanes		Pregnanes					
Pregnanolone	128-20-1	Pregnanolone	128-20-1	BXO86P3XXW	Anesthetics	Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)	Treatment of postpartum depression
Pregnenolone	145-13-1	Pregnenolone	145-13-1	73R90F7MQ8			
pregnenolone 16-acetonitrile	102812-95-3	Pgaan	102812-95-3				
Pregnenolone Carbonitrile	1434-54-4	Pregnenolone carbonitrile	1434-54-4	BA9WH84QAJ			
pregnenolone sulfate	1247-64-9	Pregnenolone sulfate	1247-64-9	04Y4D91RG0			
Prenalterol	57526-81-5	Prenalterol	57526-81-5	M4G34404CX	Adrenergic beta-1 Receptor Agonists	Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Agonists.)	
Prenylamine	390-64-7	Prenylamine	390-64-7	K2OH82Z000	Adrenergic Agents	Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)	
prenylamine lactate	69-43-2	Prenylamine lactate	69-43-2	6J3J6SXI7V			
pretilachlor	51218-49-6	Pretilachlor	51218-49-6	617K7LM10D			
previtamin D(3)		previtamin D3	1173-13-3	HDA46400N5			
prexasertib		Prexasertib	1234015-52-1	820NH671E6	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
pridinol	511-45-5	Pridinol	511-45-5	9E75Q6SUUB			
Prilocaine	721-50-6	Prilocaine	721-50-6	046O35D44R	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	Used as a local anaesthetic and is often used in dentistry.
prim-O-glucosylcimifugin		Prim-O-glucosylcimifugin	80681-45-4	NZ97LQV2BL			
Primaquine	90-34-6	Primaquine	90-34-6	MVR3634GX1	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	For the treatment of malaria.
Prime and Bond NT		Prime and Bond NT					
Primidone	125-33-7	Primidone	125-33-7	13AFD7670Q	GABA Modulators	Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)	Primidone is commonly indicated for the management of grand mal, psychomotor, and focal epileptic seizures. In addition, it has also been studied and utilized as an effective management of essential tremor.
primycin	30003-49-7	Ebrimycin	30003-49-7	V303FVN95C			
prinomastat		Prinomastat	192329-42-3	10T6626FRK	Matrix Metalloproteinase Inhibitors	Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES. (See all compounds classified as Matrix Metalloproteinase Inhibitors.)	Investigated for use/treatment in brain cancer, lung cancer, and prostate cancer.
pristane	1921-70-6	Pristane	1921-70-6	26HZV48DT1	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
pro-diazepam	65617-86-9	Avizafone	65617-86-9	65NK71K78P			
pro-thyrotropin releasing hormone	98616-54-7	Pyroglutamyl-histidyl-prolyl-glycyl-lysine	98616-54-7				
Proadifen	302-33-0	Proadifen	302-33-0	A510CA4CBT	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
proadrenomedullin (9-20)		proadrenomedullin (9-20)					
proanthocyanidin	18206-61-6	Proanthocyanidin	18206-61-6		Antiprotozoal Agents	Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)	
Proanthocyanidins		Procyanidin	20347-71-1		Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
Probenecid	57-66-9	Probenecid	57-66-9	PO572Z7917	Uricosuric Agents	Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma. (See all compounds classified as Uricosuric Agents.)	For the reduction of serum uric acid concentrations in chronic gouty arthritis and tophaceous gout in patients with frequent disabling gout attacks. Has also been effectively used to promote uric acid excretion in hyperuricemia secondary to the administration of thiazide and related diuretics.
Probucol	23288-49-5	Probucol	23288-49-5	P3CTH044XJ	Anticholesteremic Agents	Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)	Used to lower LDL and HDL cholesterol.
Procainamide	51-06-9	Procainamide	51-06-9	L39WTC366D	Voltage-Gated Sodium Channel Blockers	A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)	For the treatment of life-threatening ventricular arrhythmias.
Procaine	59-46-1	Procaine	59-46-1	4Z8Y51M438	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	Used as a local anesthetic primarily in oral surgery
Procarbazine	671-16-9	Procarbazine	671-16-9	35S93Y190K	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For use with other anticancer drugs for the treatment of stage III and stage IV Hodgkin's disease.
Procaterol	72332-33-3	Procaterol	60443-17-6		Adrenergic beta-2 Receptor Agonists	Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)	For the treatment of asthma and chronic obstructive pulmonary disease (COPD).
prochloraz	67747-09-5	Prochloraz	67747-09-5	99SFL01YCL	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Prochlorperazine	58-38-8	Prochlorperazine	58-38-8	YHP6YLT61T	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	Indicated for the symptomatic treatment of severe nausea and vomiting.  Indicated for the management of manifestations of psychotic disorders, such as schizophrenia and generalized non-psychotic anxiety. The use of prochlorperazine for the management of generalized non-psychotic anxiety is typically not a first-line therapy and should be limited to doses of less than 20 mg per day or for shorter than 12 weeks.  Off-label uses include use in emergency settings for adult and pediatric migraines. The American Headache Society recommends the use of prochlorperazine as the first-line medication in this setting. In pediatric migraines, a non-steroidal anti-inflammatory agent is often used in combination with dopamine antagonist.
procyanidin	4852-22-6	Procyanidin	20347-71-1		Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
procyanidin B1	20315-25-7	Procyanidin B1	20315-25-7	0566J48E7X			
procyanidin B2	29106-49-8	Procyanidin B2, (+)-	29106-49-8	L88HKE854X			
procyanidin B3		Procyanidin B3	23567-23-9	2TC1A0KEAQ			
Procyclidine	77-37-2	Procyclidine	77-37-2	C6QE1Q1TKR	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	For the treatment of all forms of Parkinson's Disease, as well as control of extrapyramidal reactions induced by antipsychotic agents.
procymidone	32809-16-8	Procymidone	32809-16-8		Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
prodan	70504-01-7	Prodan	70504-01-7	3KRL7R0ZB7	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
Prodigiosin	82-89-3	Prodigiosine			Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
profadol	428-37-5	Profadol	428-37-5	41GDG43FTT			
profenamine	522-00-9	Profenamine	522-00-9	7WI4P02YN1	Muscarinic Antagonists	Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)	Profenamine is indicated in the symptomatic treatment of drug-induced extrapyramidal reactions and of the manifestations (rigidity, akinesia, sialorrhea, oculogyric crisis, tremor, etc.) of Parkinson's disease of encephalitic, arteriosclerotic or idiopathic origin. It is also used to control severe reactions to certain medicines such as reserpine.
profenofos	41198-08-7	Profenofos	41198-08-7	7J04O7BS4W	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Proflavine	92-62-6	Proflavine	1811-28-5	CY3RNB3K4T	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	Topical antiseptic used mainly in wound dressings.
Progesterone	57-83-0	Progesterone	57-83-0	4G7DS2Q64Y	Progestins	Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. (See all compounds classified as Progestins.)	**Gelatinized capsules**  The gelatinized capsules are indicated for use in the prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea.   **Vaginal gel**  Progesterone gel (8%) is indicated as progesterone supplementation or replacement as part of an Assisted Reproductive Technology (ART) treatment for infertile women with progesterone deficiency.  The lower concentration progesterone gel (4%) is used in the treatment of secondary amenorrhea, with the use of the 8% concentration if there is no therapeutic response to the 4% gel.  **Vaginal insert**  This form is indicated to support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an Assisted Reproductive Technology (ART) treatment program for infertile women.  **Injection (intramuscular)**  This drug is indicated in amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer.   **Tablets, contraceptive**  The tablet form of progesterone in contraceptive formulations is indicated for the prevention of pregnancy.
Progesterone Congeners		Progesterone Congeners					
progesterone-11-bovine serum albumin		progesterone-11-bovine serum albumin					
Progestins		Progestins					
Proguanil	500-92-5	Proguanil	500-92-5	S61K3P7B2V	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	For the causal prevention and suppression of malaria caused by susceptible strains of P. falciparum and other species of Plasmodium found in some geographical areas of the world.
Proliferating Cell Nuclear Antigen		NM_002592					
prolinedithiocarbamate	135467-92-4	Prolinedithiocarbamate	135467-92-4		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
Prolyl-Hydroxylase Inhibitors		Prolyl-Hydroxylase Inhibitors					
Promazine	58-40-2	Promazine	58-40-2	O9M39HTM5W	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Used as an adjunct for short term treatment of moderate and severe psychomotor agitation. Also used to treat agitation or restlessness in the elderly.
promecarb	2631-37-0	Promecarb	2631-37-0	1QRP20775S			
Promegestone	34184-77-5	Promegestone	34184-77-5	9XE0V2SQYX			
promen		1-(6-Methoxy-2-naphthyl)propan-1-one	2700-47-2	MSH38VG69W			
Promensil		Promensil					
Promethazine	60-87-7	Promethazine	60-87-7	FF28EJQ494	Antipruritics	Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)	Promethazine tablets and suppositories are indicated to treat rhinitis, allergic conjunctivitis, allergic reactions to blood or plasma, dermographism, anaphylactic reactions, sedation, nausea, vomiting, pain, motion sickness, and allergic skin reactions. Promethazine cough syrup with phenylephrine and codeine is indicated to relieve cough and upper respiratory symptoms, and nasal congestion associated with allergy or the common cold.
prometone	1610-18-0	Prometon	1610-18-0	DY7SQ0399L			
Prometryne	7287-19-6	Prometryn	7287-19-6	1K20TB75IL	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
ProMune		Agatolimod	207623-20-9				
pronamide	23950-58-5	Propyzamide	23950-58-5	2EZ95375S0			
propacetamol	66532-86-3	Propacetamol hydrochloride	66532-86-3	SH41QYH8E5			
propachlor	1918-16-7	Propachlor	1918-16-7	015443A483	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Propafenone	54063-53-5	Propafenone	54063-53-5	68IQX3T69U	Voltage-Gated Sodium Channel Blockers	A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)	Used to prolong the time to recurrence of paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms in patients without structural heart disease. Also used for the treatment of life-threatening documented ventricular arrhythmias, such as sustained ventricular tachycardia.
propamocarb	24579-73-5	Propamocarb	24579-73-5	8HLL7N9UWO			
propanethiol	107-03-9	1-Propanethiol	107-03-9	4AB0N08V2H			
Propanil	709-98-8	Propanil	709-98-8	F57I4G0520	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Propanols		Propanols					
Propantheline	298-50-0	Propantheline	298-50-0	1306V2B0Q8	Muscarinic Antagonists	Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)	For the treatment of enuresis. It has also been used for hyperhidrosis, and cramps or spasms of the stomach, intestines or bladder.
propaphos	7292-16-2	Propaphos	7292-16-2	0U4CU57BYP			
propargyl alcohol	107-19-7	Propargyl alcohol	107-19-7	E920VF499L			
propargyl ether		Dipropargyl ether	6921-27-3				
propargylamine	2450-71-7	Propargylamine	2450-71-7				
propargylglycine	64165-64-6	DL-Propargylglycine	50428-03-0	FU67PLJ48R	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
propazine		Propazine	139-40-2	UYP5U99Q5T	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
propentofylline		Propentofylline	55242-55-2	5RTA398U4H	Neuroprotective Agents	Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)	Investigated for use/treatment in alzheimer's disease.
propetamphos	31218-83-4	Propetamphos	31218-83-4	G4A07F635U			
prophalan		prophalan					
propham	122-42-9	Propham	122-42-9	Y647G714RY			
propiconazole	60207-90-1	Propiconazole	60207-90-1	142KW8TBSR			
Propidium	36015-30-2	Propidium	36015-30-2	74NX23J96Y	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
propineb	12071-83-9	Antracol	12071-83-9	003VPM353K			
propioin		4-Hydroxyhexan-3-one	4984-85-4	RB7X233LSR			
Propiolactone	57-57-8	Propiolactone	57-57-8	6RC3ZT4HB0	Disinfectants	Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley&apos;s Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Disinfectants.)	Propiolactone was used for vaccines, tissue grafts, surgical instruments, and enzymes, as a sterilant of blood plasma, water, milk and nutrient broth as a vapor-phase disinfectant in enclosed spaces. Its sporicidal action is used against vegetative bacteria, pathologic fungi, and viruses. It is no longer used in medical procedures or in food.
propionaldehyde	123-38-6	Propionaldehyde	123-38-6	AMJ2B4M67V			
propionamide	79-05-0	Propionamide	79-05-0	QK07G0HP47			
Propionates		Propionates					
propionic acid	79-09-4	Propionic Acid	79-09-4	JHU490RVYR			Propanoic acid and various direct sodium or calcium salt formulations of the acid are currently most commonly approved and indicated by organizations like the FDA and EMA for use as an antibacterial food additive preservative in animal feed and food for human consumption.  Similarly, although the use of propanoic acid or any of its direct sodium or calcium salt formulations as excipient ingredients in pharmaceuticals is not necessarily a major role for the compound today, sodium propionate was used in some vaginal cream preparations indicated for cervicitis, cervical tears, and/or postcauterization, postcryosurgery, and postconization of the cervix. In such products, the sodium propionate was primarily used to elicit a preservative, bacteriostatic effect while other active ingredients combined in the formulation like urea, benzalkonium chloride, inositol, and methionine and cystine amino acids facilitated debridement, enhanced medication spread, epithelialization promotion, and wound healing, respectively.  Nevertheless, a great variety of propionic acid derivatives exist as separate pharmaceuticals, each with their own unique therapeutic categories, pharmacodynamics, and pharmacokinetics.
propionylcholine	5072-54-8	Propionylcholine	5072-54-8	RF1RI05V6M			
propionylthiocholine	24578-90-3	Propionylthiocholine	24578-90-3				
propiverine	60569-19-9	Propiverine	60569-19-9	468GE2241L	Muscarinic Antagonists	Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)	Indicated for symptomatic treatment of urinary incontinence and/or increased urinary frequency and urgency in patients with overactive bladder (OAB).  Propiverine may also be used in patients with neurogenic bladder as a result of spinal cord injury.
Propofol	2078-54-8	Propofol	2078-54-8	YI7VU623SF	Anesthetics, Intravenous	Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) (See all compounds classified as Anesthetics, Intravenous.)	Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Propolis	9009-62-5	Guaiacol	8001-58-9	6JKA7MAH9C			It is used medicinally as an expectorant, antiseptic, and local anesthetic. Guaiacol is used in traditional dental pulp sedation, and has the property of inducing cell proliferation; guaiacol is a potent scavenger of reactive oxygen radicals and its radical scavenging activity may be associated with its effect on cell proliferation.
Propoxur	114-26-1	Propoxur	114-26-1	BFH029TL73	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
Propranolol	525-66-6	Propranolol	525-66-6	9Y8NXQ24VQ	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	Propranolol is indicated to treat hypertension. Propranolol is also indicated to treat angina pectoris due to coronary atherosclerosis, atrial fibrillation, myocardial infarction, migraine, essential tremor, hypertrophic subaortic stenosis, pheochromocytoma, and proliferating infantile hemangioma.
propyl ether	111-43-3	Dipropyl ether	111-43-3	42Q250HS4G			
Propyl Gallate	121-79-9	Propyl gallate	121-79-9	8D4SNN7V92	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
Propylamines		Propylamines					
propylene	115-07-1	Propylene	115-07-1	AUG1H506LY			
propylene dichloride	78-87-5	1,2-Dichloropropane	78-87-5	RRZ023OFWL			
Propylene Glycol	57-55-6	Propylene Glycol	57-55-6	6DC9Q167V3	Solvents	Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant and Hackh&apos;s Chemical Dictionary, 5th ed) (See all compounds classified as Solvents.)	
propylene glycol mono-t-butyl ether	57018-52-7	1-Tert-butoxy-2-propanol	57018-52-7	03077MV85B			
propylene phenoxetol	770-35-4	1-Phenoxy-2-propanol	770-35-4	87CZY0NY1A			
propyleneimine	75-55-8	2-Methylaziridine	75-55-8	ULC972Q7TZ			
propylisopropylacetamide	6098-19-7	Propylisopropylacetamide	6098-19-7				
propylparaben	94-13-3	Propylparaben	94-13-3	Z8IX2SC1OH	Preservatives, Pharmaceutical	Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include ANTI-BACTERIAL AGENTS and antioxidants. (See all compounds classified as Preservatives, Pharmaceutical.)	Propylparaben is used in allergenic testing.
Propylthiouracil	51-52-5	Propylthiouracil	51-52-5	721M9407IY	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	Used to manage hyperthyroidism which is due to an overactive thyroid gland (Grave's disease).
proroxan	33743-96-3	Proroxan	33743-96-3	T5WT3QN49G	Psychotropic Drugs	A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)	
prosapogenin D methyl ester		prosapogenin D methyl ester					
Proscillaridin	466-06-8	Proscillaridin	466-06-8	KC6BL281EN	Cardiotonic Agents	Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)	
ProstaCaid		ProstaCaid					
prostaglandin A1	14152-28-4	prostaglandin A1	14152-28-4	VYR271N44P	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
prostaglandin A2		prostaglandin A2	13345-50-1	K6VT5BDY9E			
prostaglandin B1	13345-51-2	prostaglandin B1	13345-51-2	1TYI1PJ64T			
Prostaglandin D2	41598-07-6	prostaglandin D2	41598-07-6	RXY07S6CZ2			
prostaglandin D3	71902-47-1	Prostaglandin D3	71902-47-1	895XE61E0I			
prostaglandin E2 glyceryl ester		prostaglandin E2 glyceryl ester					
prostaglandin E3	802-31-3	prostaglandin E3	802-31-3	ZED6SBL53S			
prostaglandin F1	745-62-0	Prostaglandin f1alpha	745-62-0	WJ72O6860W			
prostaglandin F3alpha	745-64-2	Prostaglandin F3alpha	745-64-2				
prostaglandin G2	51982-36-6	prostaglandin G2	51982-36-6	AZ87DUD2Y8			
Prostaglandin H2	42935-17-1	Prostaglandin h2	42935-17-1	J670X3LRU2			
prostaglandin I3	68794-57-0	prostaglandin I3	68794-57-0				
Prostaglandins		Prostaglandins					
Prostaglandins E		CHEBI:26338					
Prostaglandins F		CHEBI:26340					
prostratin	60857-08-1	Prostratin	60857-08-1	KO94U6DIQ6			
prosultiamine	59-58-5	Prosultiamine	59-58-5				
protamine heparin aggregate		protamine heparin aggregate					
Protease Inhibitors		Protease Inhibitors					
Proteasome Inhibitors		Proteasome Inhibitors					
protectin D1		Neuroprotectin D1	660430-03-5	P3FX063KLI			
protein kinase inhibitor peptide	128022-93-5	Protein kinase inhibitor peptide	128022-93-5		Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
Protein Kinase Inhibitors		Protein Kinase Inhibitors					
Protein Synthesis Inhibitors		Protein Synthesis Inhibitors					
protein-bound polysaccharide K, Basidiomycetes		protein-bound polysaccharide K, Basidiomycetes					
Proteoglycans		Proteoglycans					
prothioconazole		Prothioconazole	178928-70-6	27B9FV58IY			
prothioconazole-desthio		2-(1-chlorocyclopropyl)-1-(2-chlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol	120983-64-4	Y3EX17303Q			
prothiophos	34643-46-4	Prothiofos	34643-46-4	H5232196GP			
protoapigenone		Protoapigenone	862884-32-0				
protoberberine	19716-69-9	5,6-Dihydrodibenzo(a,g)quinolizinium	19716-69-9				
protocatechualdehyde	139-85-5	Protocatechualdehyde	139-85-5	4PVP2HCH4T	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	
protocatechuic acid	99-50-3	3,4-Dihydroxybenzoic acid	99-50-3	36R5QJ8L4B	Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	
protocatechuic acid methyl ester		Protocatechuic acid, methyl ester	2150-43-8	G72J90268X			
protolichesterinic acid	1448-96-0	Protolichesterinic acid	1448-96-0				
Proton Pump Inhibitors		Proton Pump Inhibitors					
Protons		Protons					
protopanaxadiol	7755-01-3	Protopanaxadiol	7755-01-3	P6717R7BP8			
protopine	130-86-9	Protopine	130-86-9	UIW569HT35	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	
protoporphyrin IX	553-12-8	protoporphyrin IX	553-12-8	C2K325S808	Photosensitizing Agents	Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)	
protoporphyrinogen	7412-77-3	Protoporphyrinogen	7412-77-3				
Protoporphyrins		Protoporphyrins					
Protriptyline	438-60-8	Protriptyline	438-60-8	4NDU154T12	Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	For the treatment of depression.
proxyfan		Proxyfan	177708-09-7	2F2S8PT5HN	Histamine Antagonists	Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)	
proxymetacaine	499-67-2	Proparacaine	499-67-2	B4OB0JHI1X	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	Used as a local (ophthalmic) anesthetic.
prucalopride		Prucalopride	179474-81-8	0A09IUW5TP	Serotonin 5-HT4 Receptor Agonists	Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT4 RECEPTORS. (See all compounds classified as Serotonin 5-HT4 Receptor Agonists.)	Prucalopride is indicated for the treatment of chronic idiopathic constipation (CIC) in adults.  CIC is one of the most common chronic functional gastrointestinal disorders worldwide. The diagnosis of this agent is very hard and it can be confirmed if the patient experience at least two of the following:  -Straining during more than 25% of the bowel movements.  -Lumpy or hard stools in 25% of the bowel movements.  -Sensation of incomplete evacuation in more than 25% of all bowel movements.  -Sensation of anorectal blockage or obstruction in more than 25% of the bowel movements.  -Manual maneuvers required in more than 25% of the bowel movements.  -Fewer than 3 bowel movements per week.
prulifloxacin	123447-62-1	Prulifloxacin	123447-62-1	J42298IESW	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
prunetin	552-59-0	Prunetin	552-59-0	1TG4H5H11J			
prunin		Prunin	529-55-5	LSB8HDX4E5			
PS1145		PS1145					
PSB603		8-{4-[4-(4-chlorophenyl)piperazine-1-sulfonyl]phenyl}-1-propyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione	1092351-10-4				
pseudocumene	95-63-6	1,2,4-Trimethylbenzene	95-63-6	34X0W8052F			
pseudohypericin	55954-61-5	Pseudohypericin	55954-61-5	MQ0U4663ZO	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
pseudoisocyanine	20766-49-8	Pseudoisocyanine	20766-49-8				
pseudolaric acid B	82508-31-4	Pseudolaric acid B	82508-31-4				
pseurotin d		Pseurotin D					
psi-tectorigenin		psi-Tectorigenin	13111-57-4	8HXB4THX7F			
psicose	23140-52-5	(3R,4R,5R)-1,3,4,5,6-pentahydroxyhexan-2-one	551-68-8				
Psilocybin		Psilocybine	520-52-5	2RV7212BP0	Hallucinogens	Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. (See all compounds classified as Hallucinogens.)	
psilostachyin C		Psilostachyin C	6466-67-7				
psoralidin		Psoralidin	18642-23-4	G16ZUQ069L	Estrogen Receptor Modulators	Substances that possess antiestrogenic actions but can also produce estrogenic effects as well. They act as complete or partial agonist or as antagonist. They can be either steroidal or nonsteroidal in structure. (See all compounds classified as Estrogen Receptor Modulators.)	
psorospermin	74045-97-9	Psorospermin	74045-97-9				
Psychotropic Drugs		Psychotropic Drugs					
psymberin		Psymberin	714954-37-7	SAK6W44ZUP			
PT-100 dipeptide		PT-100 dipeptide					
Pt(O,O'-acac)(gamma-acac)(DMS)		Pt(O,O'-acac)(gamma-acac)(DMS)					
ptaquiloside	87625-62-5	Ptaquiloside	87625-62-5	F0MN9S5699	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
PTC-209		N-(2,6-dibromo-4-methoxyphenyl)-4-(2-methylimidazo[1,2-a]pyrimidin-3-yl)thiazol-2-amine	315704-66-6				
pterostilbene		Pterostilbene	537-42-8	26R60S6A5I			
Pteroylpolyglutamic Acids		Pteroylpolyglutamic Acids					
Ptychodiscus brevis T2 toxin		Ptychodiscus brevis T2 toxin					
puag-haad	4721-07-7	Oxyresveratrol	29700-22-9	6V071CP5CR			
puerarin	3681-99-0	Puerarin	3681-99-0	Z9W8997416	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
pulegone	15932-80-6	p-Menth-4(8)-en-3-one	15932-80-6	DES3HN9CU5			
Pulmonary Surfactants		Pulmonary Surfactants					
Pulsatilla saponin A		alpha-Hederin	27013-91-8	4H15F0GLV2			
punarnavine		punarnavine					
punicalagin	65995-63-3	65995-63-3					
punicic acid		Punicic Acid	544-72-9	VFQ03H211O			
Purine Nucleosides		Purine Nucleosides					
Purines		Purines					
purmorphamine		Purmorphamine	483367-10-8	PB12M2F8KY			
Puromycin	53-79-2	Puromycin	58-58-2	4A6ZS6Q2CL	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	
Puromycin Aminonucleoside	58-60-6	Puromycin aminonucleoside	58-60-6	0Q580U88V8	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	
purpurin anthraquinone		purpurin anthraquinone					
purpurogallin	569-77-7	purpurogallin					
putranjivain A		Putranjivain A	131959-62-1				
Putrescine	110-60-1	1,4-Diaminobutane	110-60-1	V10TVZ52E4			
PX-102		4-(2-(2-Chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)phenyl)cyclopropyl)benzoic acid	1268244-85-4	378SU5NO8S			
PX-866		Sonolisib	502632-66-8	987796874T			
pycnidione		Pycnidione					
pycnogenols		pycnogenols					
pyeongwee-san extract		pyeongwee-san extract					
pymetrozine	123312-89-0	Pymetrozine	123312-89-0	F0G3V7874J			
Pyocyanine	85-66-5	Pyocyanin	85-66-5	9OQM399341			
pyrachlostrobin		Pyraclostrobin	175013-18-0	DJW8M9OX1H	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
pyralene	62251-11-0	Pyralene	53025-30-2				
pyranine		Pyranine	6358-69-6	I2W85YOX9L	Food Additives	Substances used in the processing or storage of foods or animal feed including ANTIOXIDANTS; FOOD PRESERVATIVES; FOOD COLORING AGENTS; FLAVORING AGENTS; ANTI-INFECTIVE AGENTS; EXCIPIENTS and other similarly used substances. Many of the same substances are used as PHARMACEUTIC AIDS. (See all compounds classified as Food Additives.)	
pyranoprofen		Pranoprofen	52549-17-4	2R7O1ET613	Gout Suppressants	Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout. (See all compounds classified as Gout Suppressants.)	
Pyrantel	15686-83-6	Pyrantel	15686-83-6	4QIH0N49E7	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	For the treatment of enterobiasis including roundworm (ascariasis), pinworm (enterobius) and hookworm (strongyloides) and hookworm (ancylostoma) in the pyrantel pamoate form.  Pyrantel is available in various formulations for humans, dogs, and cats as the pamoate (US Pharmacopeia nomenclature) or embonate (European Pharmacopoeia nomenclature) salt, which contains 34.7% pyrantel base combined with pamoic acid.,.  Pyrantel pamoate (embonate) ingested orally is effective for removal and control of ascarid and hookworm infections in puppies and dogs (adult Toxocara canis, Toxascaris leonina, Ancylostoma tubaeforme, An. braziliense, Uncinaria stenocephala), cats (adult Toxocara cati, Toxa. leonina, An. caninum, An. braziliense, U. stenocephala), horses and ponies (adult and immature Parascaris equorum, adult Strongylus vulgaris, S. edentatus, S. equinus, Cyathostomes (Triodontophorus spp., Cyathostomum spp., Cylicodontophorus spp., Cylicocyclus spp., Cylicostephanus spp., Poteriostomum spp.), Oxyuris equi, Anoplocephala perfoliata), swine (adult Ascaris suum, Oesophagostomum dentatum), and humans (adult A. lumbricoides, Enterobius vermicularis, An. duodenale, Necator americanus).
Pyrantel Pamoate	22204-24-6	Pyrantel Pamoate	22204-24-6	81BK194Z5M	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	
pyrathiazine	84-08-2	Pyrathiazine	84-08-2	2305SQ56Z2			
Pyrazinamide	98-96-4	Pyrazinamide	98-96-4	2KNI5N06TI	Antitubercular Agents	Drugs used in the treatment of tuberculosis. They are divided into two main classes: &quot;first-line&quot; agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and &quot;second-line&quot; drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. (See all compounds classified as Antitubercular Agents.)	For the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents.
Pyrazines		Pyrazine	290-37-9	2JKE371789			
pyrazinoic acid	98-97-5	Pyrazine-2-carboxylic acid	98-97-5	2WB23298SP			
pyrazolanthrone		1,9-Pyrazoloanthrone	129-56-6	1TW30Y2766			
pyrazole	288-13-1	Pyrazole	288-13-1	3QD5KJZ7ZJ	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Pyrazoles		Pyrazoles					
pyrazolo(3,4-d)pyrimidine	271-80-7	1h-Pyrazolo[3,4-d]pyrimidine	271-80-7				
pyrazolone	39455-90-8	Pyrazolone	39455-90-8		Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
pyrazophos	13457-18-6	Pyrazophos	13457-18-6	BEG0A8I17D			
pyrene	129-00-0	Pyrene	129-00-0	9E0T7WFW93	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
pyrenophorol		Pyrenophorol	22248-41-5				
Pyrethrins		Pyrethrins	8003-34-7		Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
pyridaben	96489-71-3	Pyridaben	96489-71-3	2E4JBA5272			
pyridafenthion	119-12-0	Pyridaphenthion	119-12-0	98M0VDD56Z			
pyridate	55512-33-9	Pyridate	55512-33-9	JQH131LU0A			
Pyridazines		Pyridazines					
pyridine	110-86-1	Pyridine	110-86-1	NH9L3PP67S			
pyridine N-oxide	694-59-7	Pyridine-N-oxide	694-59-7	91F12JJJ4H			
pyridine-2-aldoxime	873-69-8	Pyridine-2-aldoxime	873-69-8	2WFO9N5MQE			
pyridine-4-aldoxime	696-54-8	Pyridine-4-aldoxime	696-54-8				
Pyridines		2-Amino-4-chloropyridine	19798-80-2				
Pyridinium Compounds		Pyridinium Compounds					
Pyridones		Pyridones					
Pyridostigmine Bromide	101-26-8	Pyridostigmine Bromide	101-26-8	KVI301NA53	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
Pyridoxal	66-72-8	Pyridoxal	66-72-8	3THM379K8A	Vitamin B Complex	A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)	Pyridoxal is one of the natural forms available of vitamin B6, therefore, it is used for nutritional supplementation and for treating dietary shortage or imbalances.
pyridoxal isonicotinoyl hydrazone	737-86-0	Pyridoxal isonicotinoyl hydrazone	737-86-0	9I5AA0JKH0	Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	
Pyridoxal Phosphate	54-47-7	Pyridoxal phosphate	54-47-7	F06SGE49M6	Vitamin B Complex	A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)	For nutritional supplementation and for treating dietary shortage or imbalance.
pyridoxal phosphate gamma-aminobutyric acid	63221-68-1	Pyridoxal phosphate gamma-aminobutyrate	63221-68-1				
pyridoxal phosphate gamma-glutamyl hydrazone	14520-50-4	Pyridoxal phosphate gamma-glutamyl hydrazone	14520-50-4				
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid	149017-66-3	Ppads	149017-66-3	L6K2LJ9BJK	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
pyridoxaloxime	708-08-7	Pyridoxaloxime	708-08-7				
Pyridoxamine	85-87-0	Pyridoxamine	85-87-0	6466NM3W93	Vitamin B Complex	A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)	
Pyridoxic Acid	82-82-6	4-Pyridoxic acid	82-82-6	5K18793O8D			
Pyridoxine		Pyridoxine	65-23-6	KV2JZ1BI6Z	Vitamin B Complex	A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)	Pyridoxine is indicated for the treatment of vitamin B6 deficiency and for the prophylaxis of [DB00951]-induced peripheral neuropathy. It is also approved by Health Canada for the treatment of nausea and vomiting in pregnancy in a combination product with [DB00366] (as the commercially available product Diclectin).
Pyrilamine	91-84-9	Pyrilamine	91-84-9	HPE317O9TL	Sleep Aids, Pharmaceutical	Drugs used to induce SLEEP, prevent SLEEPLESSNESS, or treat SLEEP INITIATION AND MAINTENANCE DISORDERS. (See all compounds classified as Sleep Aids, Pharmaceutical.)	Indicated for the treatment of allergic conditions, symptomatic relief of hypersensitivity reaction, and treatment of pruritic skin disorders.
Pyrimethamine	58-14-0	Pyrimethamine	58-14-0	Z3614QOX8W	Antiprotozoal Agents	Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)	For the treatment of toxoplasmosis and acute malaria; For the prevention of malaria in areas non-resistant to pyrimethamine
pyrimethanil	53112-28-0	Pyrimethanil	53112-28-0	6IA5HP6C8Z			
pyrimidifen		Pyrimidifen	105779-78-0	I21MX86B4X			
pyrimidin-2-one beta-ribofuranoside		Zebularine	3690-10-6	7A9Y5SX0GY			
pyrimidine	289-95-2	Pyrimidine	289-95-2	K8CXK5Q32L			
Pyrimidine Dimers		Cyclobutadithymine	3660-32-0				
Pyrimidines		Pyrimidines					
Pyrimidinones		Pyrimidinones	1335-05-3				
pyriminil	53558-25-1	Pyrinuron	53558-25-1	Q7BGS137YP	Rodenticides	Substances used to destroy or inhibit the action of rats, mice, or other rodents. (See all compounds classified as Rodenticides.)	
pyriproxyfen	95737-68-1	Pyriproxyfen	95737-68-1	3Q9VOR705O	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Pyrithiamine	534-64-5	Pyrithiamine	534-64-5	5JB3029BJ7	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	
pyrithione	1121-30-8	Pyrithione	1121-30-8	6GK82EC25D	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	Indicated for the treatment of dandruff and seborrheic dermatitis.
pyrithione zinc		Pyrithione Zinc	13463-41-7	R953O2RHZ5	Keratolytic Agents	Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases. (See all compounds classified as Keratolytic Agents.)	
Pyrogallol	87-66-1	Pyrogallol	87-66-1	01Y4A2QXY0	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
pyromellitic dianhydride	89-32-7	Pyromellitic dianhydride	89-32-7	2Z22T30QZQ			
Pyrones		Pyrones					
pyrrole-2,3,5-tricarboxylic acid	945-32-4	Pyrrole-2,3,5-tricarboxylic acid	945-32-4				
Pyrroles		Pyrrole	109-97-7	86S1ZD6L2C			
pyrrolidine	123-75-1	Pyrrolidine	123-75-1	LJU5627FYV			
pyrrolidine dithiocarbamic acid	25769-03-3	Pyrrolidine dithiocarbamic acid	5108-96-3	RG3HRQ45HY	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
Pyrrolidines		Pyrrolidines					
Pyrrolidonecarboxylic Acid	98-79-3	L-Pyroglutamic acid	98-79-3	SZB83O1W42			There is currently no clinically approved and/or marketed medicine that relies upon pidolic acid as an active ingredient for any formal therapeutic indication.  Although pidolic acid may be sold in a variety of non-prescription, over-the-counter dietary supplement products for cognitive or memory enhancement, there are many studies that suggest that such products or such supplementation do not elicit any kind of cognitive benefit to users. In fact, the general suggestion for any such pidolic acid product is to exercise caution in their recommendation as much more research is necessary.  Pidolic acid and sodium pidolic acid are, however, used to some extent in skin and hair conditioning agents owing to their humectant characteristics.
Pyrrolizidine Alkaloids		Pyrrolizidine alkaloids					
pyrrolo(2,1-c)(1,4)benzodiazepine		pyrrolo(2,1-c)(1,4)benzodiazepine					
Pyruvaldehyde	78-98-8	Methylglyoxal	78-98-8	722KLD7415			
pyruvamide	631-66-3	Pyruvamide	631-66-3	P4O9E1R444			
Pyruvates		Pyruvates					
Pyruvic Acid	127-17-3	Pyruvic Acid	127-17-3	8558G7RUTR			For nutritional supplementation, also for treating dietary shortage or imbalance
pyrvinium	7187-62-4	Pyrvinium	7187-62-4	6B9991FLU3	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	Pyrvinium was once used in the treatment of pinworm infestations.
PYX 2	146999-93-1	Ac-(3-(2,6-Dichlorobenzyl)tyr(27,36)-D-thr(32))-neuropeptide Y (27-36) amide	146999-93-1				
QB 102		QB 102					
qiangxin		qiangxin					
qidan		qidan					
Qilong		Qilong					
Qing Ye Dan		Qing Ye Dan					
Qingdai compound		Qingdai compound					
qingdu		qingdu					
qinghuang		qinghuang					
qingre zaoshi liangxue fang		qingre zaoshi liangxue fang					
qishen yiqi		qishen yiqi					
Quartz	14808-60-7	Silicon Dioxide	14808-60-7	ETJ7Z6XBU4			
Quassins		Quassins					
Quaternary Ammonium Compounds		Quaternary Ammonium Compounds					
quercetagetin		Quercetagetin	90-18-6	SV68G507VO	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Quercetin	117-39-5	Quercetin	117-39-5	9IKM0I5T1E	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
quercetin 3-acetyl-7,3',4'-trisulfate		quercetin 3-acetyl-7,3',4'-trisulfate					
quercetin 3-arabinopyranoside		quercetin 3-arabinopyranoside					
quercetin 3-O-(2''-galloyl)glucopyranoside		quercetin 3-O-(2''-galloyl)glucopyranoside					
quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside		quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside					
quercetin 3-O-glucopyranoside		Isoquercetin	482-35-9	6HN2PC637T			
quercetin 3-O-glucuronide		Querciturone	22688-79-5	RY36PD0CQ2			
quercetin 3,7,3',4'-tetrasulfate		quercetin 3,7,3',4'-tetrasulfate					
quercetin 3'-O-glucoside		4H-1-Benzopyran-4-one, 2-(3-(beta-D-glucopyranosyloxy)-4-hydroxyphenyl)-3,5,7-trihydroxy-	19254-30-9				
quercetin 3'-sulfate		Quercetin 3'-O-sulfate	62369-28-2				
quercetin 4'-O-glucopyranoside		quercetin 4'-O-glucopyranoside					
quercetin 7-O-glucopyranoside		quercetin 7-O-glucopyranoside					
quercetin pentaacetate		Quercetin pentaacetate	1064-06-8	G0B9KJ0VKI			
quercetin-3-O-rutinoside		Rutin	153-18-4	5G06TVY3R7			
quercitrin	522-12-3	Quercitrin	522-12-3	2Y8906LC5P			
Quetiapine Fumarate		Quetiapine Fumarate	111974-72-2	2S3PL1B6UJ	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	
quifenadine	10447-39-9	Quifenadine	10447-39-9	W9A18RJ49B	Histamine Antagonists	Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)	
Quil A	66594-14-7	Quil A	66594-14-7		Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
Quin2	83014-44-2	Glycine, N-(2-((8-(bis(carboxymethyl)amino)-6-methoxy-2-quinolinyl)methoxy)-4-methylphenyl)-N-(carboxymethyl)-	83014-44-2	P6R8CW67YD	Iron Chelating Agents	Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. (See all compounds classified as Iron Chelating Agents.)	
Quinacrine	83-89-6	Quinacrine	83-89-6	H0C805XYDE	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	For the treatment of giardiasis and cutaneous leishmaniasis and the management of malignant effusions.
quinagolide	87056-78-8	Quinagolide	87056-78-8		Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	Indicated for the treatment of hyperprolactinemia (idiopathic or originating from a prolactin-secreting pituitary microadenoma or macroadenoma).
quinalphos	13593-03-8	Quinalphos	13593-03-8	26S837727Y	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Quinapril	82586-55-8	Quinapril Hydrochloride	82586-55-8	33067B3N2M	Cardiovascular Agents	Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)	
quinaprilat	82768-85-2	Quinaprilat	82768-85-2	34SSX5LDE5	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
Quinazolines		Quinazoline	253-82-7	UB9QUR18NL			
Quinazolinones		Quinazolinones					
quinclorac		Quinclorac	84087-01-4	3J06V625EE	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
quinelorane	97466-90-5	Quinelorane	97466-90-5	Z0X4VT3Y1Q	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
Quinic Acid	77-95-2	Quinic acid	77-95-2	058C04BGYI			
Quinidine	56-54-2	Quinidine	56-54-2	ITX08688JL	Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	Quinidine is indicated for the management and prophylactic therapy of atrial fibrillation/flutter, as well as the suppression of recurrent documented ventricular arrhythmias. It is also used in the treatment of Brugada syndrome, short QT syndrome and idiopathic ventricular fibrillation..
quinidinium		quinidinium					
Quinine	130-95-0	Quinine	130-95-0	A7V27PHC7A	Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	For the treatment of malaria and leg cramps
quinocetone		Quinocetone	81810-66-4				
quinoline	91-22-5	Quinoline	91-22-5	E66400VT9R			
quinoline yellow		Quinoline Yellow	8003-22-3	44F3HYL954			
quinoline-val-asp(OMe)-CH2-OPH		quinoline-val-asp(OMe)-CH2-OPH					
Quinolines		Quinolines					
Quinolinic Acid	89-00-9	Quinolinic acid	89-00-9	F6F0HK1URN			
Quinolinium Compounds		Quinolinium Compounds					
Quinolones		2-Hydroxyquinoline	70254-42-1	803BHY7QWU			
quinomethionate		Chinomethionate	2439-01-2	888OQA249R	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
quinone	106-51-4	1,4-Benzoquinone	106-51-4	3T006GV98U	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
quinone methide	138230-21-4	(S)-5-Hydroxy-6-oxo-2,6-dihydro-1H-indole-2-carboxylic acid	138230-21-4				
Quinones		Quinones					
quinotrierixin		Quinotrierixin					
Quinoxalines		Quinoxaline	91-19-0	QM4AR6M6T8			
quinoxyfen		Quinoxyfen	124495-18-7	PPC78J1VCW			
Quinpirole	85760-74-3	Quinpirole	80373-22-4	20OP60125T	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
quintozene	82-68-8	Pentachloronitrobenzene	82-68-8	Q37G40S4S8	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Quinuclidinyl Benzilate	6581-06-2	3-Quinuclidinyl benzilate	6581-06-2		Muscarinic Antagonists	Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)	
quinupristin-dalfopristin	126602-89-9	Quinupristin and dalfopristin			Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Quipazine	4774-24-7	Quipazine	4774-24-7	4WCY05C0SJ	Antidepressive Agents, Second-Generation	A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)	
Quisqualic Acid	52809-07-1	Quisqualic acid	52809-07-1	8OC22C1B99	Excitatory Amino Acid Agonists	Drugs that bind to and activate excitatory amino acid receptors. (See all compounds classified as Excitatory Amino Acid Agonists.)	
quizalofop-ethyl	76578-14-8	Quizalofop-ethyl	76578-14-8	7280704RL4	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
quizartinib		Quizartinib	950769-58-1	7LA4O6Q0D3	Tyrosine Kinase Inhibitors	Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES. (See all compounds classified as Tyrosine Kinase Inhibitors.)	Quizartinib is indicated in combination with standard cytarabine and anthracycline induction and cytarabine consolidation, and as maintenance monotherapy following consolidation chemotherapy, for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) that is FLT3 internal tandem duplication (ITD)-positive as detected by an FDA-approved test.
R 115866		Talarozole	201410-53-9	XKD9N5CJ6W	Cytochrome P-450 Enzyme Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES. (See all compounds classified as Cytochrome P-450 Enzyme Inhibitors.)	
R 121919		3-(6-(Dimethylamino)-4-methylpyridin-3-yl)-2,5-dimethyl-N,N-dipropylpyrazolo[1,5-a]pyrimidin-7-amine	195055-03-9	G82N555U1N			
R 59949	120166-69-0	Diacylglycerol kinase inhibitor II	120166-69-0				
R-1,1,1-trifluoro-4-(5-fluoro-2,3-dihydrobenzofuran-7-yl)-4-methyl-2-(((2-methyl-5-quinolyl)amino)methyl)pentan-2-ol		R-1,1,1-trifluoro-4-(5-fluoro-2,3-dihydrobenzofuran-7-yl)-4-methyl-2-(((2-methyl-5-quinolyl)amino)methyl)pentan-2-ol					
r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene		r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene					
R116010		Nil6pst6V7	201410-54-0	NIL6PST6V7			
R116301		R116301					
RA190		1-(L-phenylalanyl)-3,5-bis(3,4-dichlorobenzylidene)piperidin-4-one hydrochloride					
Rabeprazole		Rabeprazole	117976-89-3	32828355LL	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, H. pylori eradication, and prevention of gastroinetestinal bleeds with NSAID use.
rabeprazole-thioether		Rabeprazole thioether	117977-21-6	304S7E320P			
racecadotril		Racecadotril	81110-73-8	76K53XP4TO	Antidiarrheals	Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition. (See all compounds classified as Antidiarrheals.)	
Raclopride	84225-95-6	Raclopride	84225-95-6	430K3SOZ7G	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
ractopamine	97825-25-7	Ractopamine	97825-25-7	57370OZ3P1	Adrenergic beta-Agonists	Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)	
radafaxine		Radafaxine	192374-14-4	Q47741214K			
radolmidine		Fadolmidine	189353-31-9	WLN5FGH1CY			
Radon	10043-92-2	Radon	10043-92-2	Q74S4N8N1G	Carcinogens, Environmental	Carcinogenic substances that are found in the environment. (See all compounds classified as Carcinogens, Environmental.)	
Raffinose	512-69-6	Raffinose	512-69-6	N5O3QU595M			
Rafoxanide	22662-39-1	Rafoxanide	22662-39-1	22F4FLA7DH	Antiplatyhelmintic Agents	Agents used to treat cestode, trematode, or other flatworm infestations in man or animals. (See all compounds classified as Antiplatyhelmintic Agents.)	
ragaglitazar		Ragaglitazar	222834-30-2				Investigated for use/treatment in diabetes mellitus type 2.
raiser		Flurochloridone	61213-25-0		Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
ralimetinib		Ralimetinib	862505-00-8	73I34XW4HD			
Raloxifene Hydrochloride		Raloxifene Hydrochloride	82640-04-8	4F86W47BR6	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Optruma is indicated for the treatment and prevention of osteoporosis in post-menopausal women. A significant reduction in the incidence of vertebral, but not hip fractures has been demonstrated. When determining the choice of Optruma or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefits (see section 5. 1).
raloxifene-4'-beta-glucuronide		raloxifene-4'-beta-glucuronide					
raloxifene-6-beta-glucuronide		raloxifene-6-beta-glucuronide					
Raltegravir Potassium		Raltegravir Potassium	871038-72-1	43Y000U234	Anti-HIV Agents	Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)	Isentressis indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (HIV 1) infection.
raltitrexed		Raltitrexed	112887-68-0	FCB9EGG971	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	For the treatment of malignant neoplasm of colon and rectum
ramatroban	116649-85-5	Ramatroban	116649-85-5	P1ALI72U6C	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
ramelteon		Ramelteon	196597-26-9	901AS54I69			For the treatment of insomnia characterized by difficulty with sleep onset.
Ramipril	87333-19-5	Ramipril	87333-19-5	L35JN3I7SJ	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the management of mild to severe hypertension. May be used to reduce cardiovascular mortality following myocardial infarction in hemodynamically stable individuals who develop clinical signs of congestive heart failure within a few days following myocardial infarction. To reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events. May be used to slow the progression of renal disease in individuals with hypertension, diabetes mellitus and microalubinuria or overt nephropathy.
ramiprilat	87269-97-4	Ramiprilat	87269-97-4	6N5U4QFC3G	Angiotensin-Converting Enzyme Inhibitors	A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)	
ramosetron	132907-72-3	Ramosetron hydrochloride	132907-72-3	9551LHD87E	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	
ranirestat		Ranirestat	147254-64-6	Z26P56GFTV	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Investigated for use/treatment in neuropathy (diabetic).
Ranitidine	66357-35-5	Zantac	66357-35-5		Histamine H2 Antagonists	Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (See all compounds classified as Histamine H2 Antagonists.)	This drug is used alone or with concomitant antacids for the following conditions: short-term treatment of active duodenal ulcer, treating gastric acid hypersecretion due to Zollinger-Ellison syndrome, systemic mastocytosis, and other conditions that may pathologically raise gastric acid levels. It also used in the short term treatment of active benign gastric ulcers and maintenance therapy of gastric ulcers at a reduced dose. In addition to the above, ranitidine can be used for the treatment of GERD symptoms, treatment of erosive esophagitis (endoscopically diagnosed) and the maintenance of gastric or duodenal ulcer healing.
ranitidine bismuth citrate		Tritec			Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	
RANK Ligand		RANK ligand					
Ranolazine		Ranolazine	95635-55-5	A6IEZ5M406	Cardiovascular Agents	Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)	Ranolazine is indicated for the treatment of chronic angina. It can be used alone or in conjunction with nitrates, beta-blockers, angiotensin receptor blockers, anti-platelet drugs, calcium channel blockers, lipid-lowering drugs, and ACE inhibitors.  Ranolazine has also been used off-label for the treatment of certain arrhythmias, including ventricular tachycardia, however, this use is not strongly  supported by scientific evidence. Ranolazine has also been studied for the treatment of acute coronary syndrome, microvascular coronary dysfunction, arrhythmia, and glycemic control, which are not yet approved indications.
rapacuronium		Rapacuronium	465499-11-0	GG1LBM463S	Neuromuscular Nondepolarizing Agents	Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. (See all compounds classified as Neuromuscular Nondepolarizing Agents.)	Used in anaesthesia, to aid and enable endotracheal intubation.
Rapeseed Oil		Brassica campestris oil					
RAPTA-T		RAPTA-T					
rasagiline	1875-50-9	N-(2-Propynyl)-2,3-dihydroinden-1-amine	1875-50-9	UZ2TR4YN26	Monoamine Oxidase Inhibitors	A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed, p414) (See all compounds classified as Monoamine Oxidase Inhibitors.)	
raspberry ketone	5471-51-2	4-(4-Hydroxyphenyl)-2-butanone	5471-51-2	7QY1MH15BG			
raubasine	483-04-5	Ajmalicine	483-04-5	4QJL8OX71Z	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
ravoxertinib		Ravoxertinib	1453848-26-4	R6AXV96CRH	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
razaxaban		Razaxaban	218298-21-6	3K2509846L			
Razoxane	21416-87-5	Razoxane	21416-67-1	5AR83PR647	Antimitotic Agents	Agents that arrest cells in MITOSIS, most notably TUBULIN MODULATORS. (See all compounds classified as Antimitotic Agents.)	
RB 006		Pegnivacogin sodium	959716-32-6				
RB 007		RB 007					
RB 101	135949-60-9	benzyl (2S)-2-[[2-[[[(2S)-2-amino-4-methylsulfanylbutyl]disulfanyl]methyl]-3-phenylpropanoyl]amino]-3-phenylpropanoate	135949-60-9	QN6UQ885QE	Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
RCF-1 fiber		RCF-1 fiber					
RD162 compound		RD162 compound					
Re 80	116193-60-3	4-(1-Hydroxy-3-oxo-3-(5,6,7,8-tetrahydro-3-hydroxy-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid	116193-60-3				
Reactive Nitrogen Species		Reactive Nitrogen Species					
Reactive Oxygen Species		Reactive Oxygen Species					
ReAsH-EDT2 compound		ReAsH-EDT2 compound					
rebamipide	111911-87-6	Rebamipide	90098-04-7	LR583V32ZR	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
rebaudioside A	58543-16-1	Rebaudioside A	58543-16-1	B3FUD0528F			
rebeccamycin	93908-02-2	Rebeccamycin	93908-02-2	Y96MQM21V9			
rebemide	1696-17-9	N,N-Diethylbenzamide	1696-17-9	3Y74433ZXI			
Reboxetine	98769-81-4	Reboxetine	71620-89-8	947S0YZ36I	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	For the treatment of clinical depression.
Rec 15-2739		Upidosin	152735-23-4	TXG28R7G4Y			
Recombivax HB		Recombivax HB					
reevesioside A		Reevesioside A					
reevesioside F		Reevesioside F					
regorafenib		Regorafenib	755037-03-7	24T2A1DOYB			Regorafenib is indicated for the treatment of patients with metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if KRAS wild type, an anti-EGFR therapy. Regorafenib is also indicated for the treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumour (GIST) who have been previously treated with imatinib mesylate and sunitinib malate. Regorafenib is also indicated for the treatment of patients with hepatocellular carcinoma (HCC) previously treated with sorafenib.
relcovaptan		Relcovaptan	150375-75-0	C1GL8G6G0O	Hormone Antagonists	Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)	
relugolix		Relugolix	737789-87-6	P76B05O5V6	Androgen Antagonists	Compounds which inhibit or antagonize the biosynthesis or actions of androgens. (See all compounds classified as Androgen Antagonists.)	Relugolix is indicated for the treatment of adult patients with advanced prostate cancer. In a combination product with [estradiol] and [norethindrone], relugolix is indicated for the once-daily treatment for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
remdesivir		Remdesivir	1809249-37-3	3QKI37EEHE	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	Remdesivir is indicated for the treatment of adult and pediatric patients 28 days of age and older and weighing at least 3 kg for coronavirus disease 2019 (COVID-19) infection requiring hospitalization. It is also indicated for the treatment of non-hospitalized patients with mild-to-moderate COVID-19, who are at high risk for progression to severe COVID-19, including hospitalization or death.  Remdesivir was originally granted FDA Emergency Use Authorization (EUA) on May 1, 2020, for use in adults and children with suspected or confirmed COVID-19 in a hospital setting with an SpO2 94%. Following the FDA approval, this EUA was revised to cover hospitalized pediatric patients between 3.5 and 40 kg, as well as those under 12 years of age that weigh at least 3.5 kg, with suspected or laboratory-confirmed COVID-19.  Under both the on-label and EUA indications, patients not needing invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO) should be treated for 5 days (including the loading dose on day 1) and may be extended up to 10 days if they do not show improvement. Patients requiring invasive mechanical ventilation or ECMO should be treated for 10 days.  In Europe, remdesivir is approved for the treatment of adults and adolescents weighing at least 40 kg with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment). It is also indicated for the treatment of COVID-19 in adults who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19.
Remifemin		Cimicifuga racemosa extract					
Remifentanil		Remifentanil	132875-61-7	P10582JYYK	Analgesics, Opioid	Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)	For use during the induction and maintenance of general anesthesia.
remikiren		Remikiren	126222-34-2	LC7FBL96A4	Protease Inhibitors	Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)	For the treatment of hypertension and heart failure
remimazolam		Remimazolam	308242-62-8	7V4A8U16MB			Remimazolam is indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.
remogliflozin etabonate		Remogliflozin etabonate	442201-24-3	TR0QT6QSUL	Sodium-Glucose Transporter 2 Inhibitors	Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS. (See all compounds classified as Sodium-Glucose Transporter 2 Inhibitors.)	
Remoxipride	80125-14-0	Remoxipride	80125-14-0	0223RD59PE	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Remoxipride is an atypical antipsychotic once used for the treatment of schizophrenia.
ReN 1869		ReN 1869					
repaglinide		Repaglinide	135062-02-1	668Z8C33LU	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
reparixin		Reparixin	266359-83-5	U604E1NB3K			Treatment of Coronavirus disease 2019 (COVID-19)
repinotan hydrochloride		Repinotan hydrochloride	144980-77-8	1KBQ63168A	Serotonin 5-HT1 Receptor Agonists	Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes. (See all compounds classified as Serotonin 5-HT1 Receptor Agonists.)	
reproterol	54063-54-6	Reproterol	54063-54-6	11941YC6RN	Adrenergic beta-Agonists	Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)	
RES 701-1	151308-34-8	N(1)Trp-His-Gly-Thr-Ala-Pro-Asp(2)-Trp-Phe-Phe-Asn-Tyr-Tyr-Trp-OH.N(2)Gly-DL-Asp(1)-NH2	151308-34-8		Endothelin Receptor Antagonists	Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN RECECPTORS. (See all compounds classified as Endothelin Receptor Antagonists.)	
resacetophenone		Resacetophenone	89-84-9	UC3V356VZC			
resazurin	550-82-3	Resazurin	550-82-3	1FN9YD6968	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
rescinnamine		Rescinnamine	24815-24-5	Q6W1F7DJ2D			For the treatment of hypertension.
reserpic acid	83-60-3	Reserpic acid	83-60-3	K6L9W0QP1W			
Reserpine	50-55-5	Reserpine	50-55-5	8B1QWR724A	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the treatment of hypertension
resiniferatoxin	57444-62-9	Benzeneacetic acid, 4-hydroxy-3-methoxy-, ((2S,3aR,3bS,6aR,9aR,9bR,10R,11aR)-3a,3b,6,6a,9a,10,11,11a-octahydro-6a-hydroxy-8,10-dimethyl-11a-(1-methylethenyl)-7-oxo-2-(phenylmethyl)-7H-2,9b-epoxyazuleno(5,4-e)-1,3-benzodioxol-5-yl)methyl ester	57444-62-9	A5O6P1UL4I			Investigated for use/treatment in interstitial cystitis and urinary incontinence.
Resins, Plant		Resins, Plant					
resiquimod		Resiquimod	144875-48-9	V3DMU7PVXF	Toll-Like Receptor Agonists	Agents that stimulate TOLL-LIKE RECEPTOR signaling, and the activity of both the INNATE IMMUNE RESPONSE and ADAPTIVE IMMUNITY. (See all compounds classified as Toll-Like Receptor Agonists.)	Investigated for use/treatment in genital herpes.
resmethrin		Resmethrin	10453-86-8		Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
resolvin D1		Resolvin D1					
resolvin D2		Resolvin D2	810668-37-2				
resorcinol	108-46-3	Resorcinol	108-46-3	YUL4LO94HK			Contemporary therapeutic uses for resorcinol primarily revolve around the use of the phenol derivative as an active ingredient in topical antiseptics or as topical antibacterial skin treatment products for conditions like acne, seborrheic dermatitis, eczema, and others.
resorcinolnaphthalein		Resorcinolnaphthalein	41307-63-5		Enzyme Activators	Compounds or factors that act on a specific enzyme to increase its activity. (See all compounds classified as Enzyme Activators.)	
Resveratrol		Resveratrol	501-36-0	Q369O8926L	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	Being investigated for the treatment of Herpes labialis infections (cold sores).
resveratrol-4'-O-glucuronide		trans-Resveratrol 4'-O-glucuronide	387372-20-5				
retene		Retene	483-65-8	0W2D2E1P9Q			
retigeric acid B		retigeric acid B	38327-77-4	5M66ARA2BR			
retinal dimer		Retinal dimer	193532-21-7				
Retinaldehyde	116-31-4	Retinal	116-31-4	RR725D715M			
Retinoids		Retinoids					
retinol acetate	127-47-9	Retinyl acetate	127-47-9	3LE3D9D6OY	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
retinol palmitate	79-81-2	Vitamin A Palmitate	79-81-2	1D1K0N0VVC	Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	
retinylamine	43219-27-8	Retinylamine	43219-27-8	3GE3QR8C45			
retrorsine	480-54-6	Retrorsine	480-54-6	XJ86XWL8IY	Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	
rEV576 protein, tick		rEV576 protein, tick					
Revalor	39450-18-5	Revalor	39450-18-5				
revefenacin		Revefenacin	864750-70-9	G2AE2VE07O			Revefenacin is indicated as an inhalation solution for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).  COPD is a growing disease being the third leading cause of death in the US. This disease is characterized by not fully reversible airflow limitation.
Reverse Transcriptase Inhibitors		Reverse Transcriptase Inhibitors					
reversin 205		Reversin 205	174630-05-8				
reviparin		Lovenox	9005-49-6				
RG108		N-Phthalyl-L-tryptophan	48208-26-0				
RG2833		N-(6-(2-Aminophenylamino)-6-oxohexyl)-4-methylbenzamide	1215493-56-3	17V14R89EU			
RG7112		((4S,5R)-2-(4-(tert-Butyl)-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazol-1-yl)(4-(3-(methylsulfonyl)propyl)piperazin-1-yl)methanone	939981-39-2	Q8MI0X869M			
RG7800		2-(4-ethyl-6-methylpyrazolo[1,5-a]pyrazin-2-yl)-9-methyl-7-(1-methylpiperidin-4-yl)-4H-pyrido[1,2-a]pyrimidin-4-one					
RGFP966		(E)-N-(2-amino-4-fluorophenyl)-3-(1-cinnamyl-1H-pyrazol-4-yl)acrylamide	1357389-11-7				
rhamnazin		Rhamnazin	552-54-5	276CK9GP9Y			
rhamnetin	90-19-7	Rhamnetin	90-19-7	71803L5F4S			
Rhamnose	10485-94-6	L-Rhamnose	73-34-7	QN34XC755A			
rhapontigenin		Rhapontigenin	500-65-2	22BG4NNH6W			
rhapontin	155-58-8	Rhapontin	155-58-8	K691M2Z08V			
rhein	478-43-3	Rhein	478-43-3	YM64C2P6UX	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	No approved indication.
Rhodamine 123	62669-70-9	Rhodamine 123	62669-70-9	1N3CZ14C5O	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
rhodamine 6G	989-38-8	Rhodamine 6G	989-38-8	037VRW83CF	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
rhodioloside		Salidroside	10338-51-9	M983H6N1S9			
Rhodium	7440-16-6	Rhodium	7440-16-6	DMK383DSAC			
rhodocytin protein, Calloselasma rhodostoma		rhodocytin protein, Calloselasma rhodostoma					
rhododendrol		Rhododendrol	501-96-2	97PTR2F3Z8			
rhodojaponin II		Rhodojaponin II	26116-89-2				
rhodojaponin III		Rhodojaponin III	26342-66-5	C7FEJ7QWQE			
rhodostomin	127829-86-1	Kistrin	127829-86-1		Fibrinolytic Agents	Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)	
rhodotorulic acid	18928-00-2	Rhodotorulic acid	18928-00-2	61F3VBQ4G5			
rhyncophylline	76-66-4	Rhynchophylline	76-66-4	46BQ79VJ8D			
Ribavirin	36791-04-5	Ribavirin	36791-04-5	49717AWG6K	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	Indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents with the intent to cure or achieve a sustained virologic response (SVR). Typically added to improve SVR and reduce relapse rates.  The addition of ribavirin in Technivie therapy indicated for treating HCV genotype 1a and 4 infections is recommended in patients with or without cirrhosis.   Resistance: viral genetic determinants resulting in variable response to ribavirin therapy has not been yet determined.
Ribitol	488-81-3	Xylitol	488-81-3	353ZQ9TVDA	Sweetening Agents	Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)	Treatment of limb-girdle muscular dystrophy
ribociclib		Ribociclib	1211441-98-3	TK8ERE8P56			Kisqali (ribociclib) is a selective cyclin-dependent kinase inhibitor, a class of drugs that help slow the progression of cancer by inhibiting two proteins called cyclin-dependent kinase 4 and 6 (CDK4/6). These proteins, when over-activated, can enable cancer cells to grow and divide too quickly. Targeting CDK4/6 with enhanced precision may play a role in ensuring that cancer cells do not continue to replicate uncontrollably.
Riboflavin	83-88-5	Riboflavin	83-88-5	TLM2976OFR	Vitamin B Complex	A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)	For the treatment of ariboflavinosis (vitamin B2 deficiency).
Ribomunyl		Ribomunyl					
Ribonucleosides		Ribonucleosides					
Ribonucleotides		Ribonucleotides					
Ribose	50-69-1	(2R,3R,4R)-2,3,4,5-tetrahydroxypentanal	50-69-1				
ribose-5-phosphate		Ribose-5-phosphate	4300-28-1	4B2428FLTO			
ribosome inactivating protein, Viscum		ribosome inactivating protein, Viscum					
riccardin D		Riccardin D					
ricinoleic acid	141-22-0	Ricinoleic acid	141-22-0	I2D0F69854			
ricolinostat		Ricolinostat	1316214-52-4	WKT909C62B	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
ridaforolimus		Ridaforolimus	572924-54-0	48Z35KB15K			Investigated for use/treatment in solid tumors, sarcoma, cancer/tumors (unspecified), endometrial cancer, prostate cancer, and bone metastases.
ridaifen-B		Ridaifen-B	886465-70-9				
riddelliine	23246-96-0	Riddelline	23246-96-0	81YO8GX9J8			
riddelliine N-oxide	75056-11-0	Riddelliine N-oxide	75056-11-0				
ridogrel		Ridogrel	110140-89-1	QTS5QOO42O	Gastrointestinal Agents	Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)	Used as an adjunctive therapy to induce thrombolysis in patients suffering acute myocardial infarction.
Rifabutin	72559-06-9	Rifabutin					
Rifampin	13292-46-1	Rifampin	13292-46-1	VJT6J7R4TR	Antibiotics, Antitubercular	Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. (See all compounds classified as Antibiotics, Antitubercular.)	Rifampin is indicated for the treatment of tuberculosis and tuberculosis-related mycobacterial infections. In combination with pyrazinamide and isoniazid, it is used in the initial phase of the short-course treatment of pulmonary tuberculosis.
rifamycin SV	6998-60-3	Rifamycin	6998-60-3	DU69T8ZZPA	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Rifamycin is indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of _E. coli_. The status of the disease should not be complicated by fever or blood in the stool. To prevent drug-resistant bacteria, it is important to mention that the use of rifamycin for this indication should be only done in cases where the infection is proven or strongly suspected to be caused by bacteria.  Travallers' diarrhea is very common problem affecting 20-60% of the travellers and it is defined as an increase in frequency of bowel movements to three or more loose stools per day during a trip abroad. This condition is rarely life threatening but in severe cases it can produce dehydration and sepsis. The most common cause of travellers' diarrhea is a pathogen and from the pathogens identified, bacteria is the most common cause followed by norovirus, rotavirus and similar viruses.
Rifamycins		Rifamycins	13553-79-2		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
rifapentine	61379-65-5	Rifapentine	61379-65-5	XJM390A33U	Antibiotics, Antitubercular	Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. (See all compounds classified as Antibiotics, Antitubercular.)	For the treatment of pulmonary tuberculosis.
Rifaximin		Rifaximin	80621-81-4	L36O5T016N	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Rifaximin has multiple indications by the FDA: for the treatment of patients (12 years of age) with traveller's diarrhea caused by noninvasive strains of Escherichia coli; for the reduction of overt hepatic encephalopathy recurrence in patients 18 years of age; and in May 2015 it was approved for irritable bowel syndrome with diarrhea (IBS-D) treatment in adult men and women.
Rilmenidine	54187-04-1	Rilmenidine	54187-04-1	P67IM25ID8	Adrenergic alpha-2 Receptor Agonists	Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)	
Riluzole	1744-22-5	Riluzole	1744-22-5	7LJ087RS6F	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	For the treatment of amyotrophic lateral sclerosis (ALS, Lou Gehrig's Disease)
rimabotulinumtoxinB		Botulinum Toxin Type B					
rimcazole		Rimcazole	75859-04-0	C3N1PS8CX1	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
rimexolone	49697-38-3	Rimexolone	49697-38-3	O7M2E4264D	Glucocorticoids	A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)	For the treatment of postoperative inflammation following ocular surgery and in the treatment of anterior uveitis.
Rimonabant	158681-13-1	Rimonabant hydrochloride	158681-13-1	HL0V2LQZ09	Anti-Obesity Agents	Agents that increase energy expenditure and weight loss by neural and metabolic regulation. (See all compounds classified as Anti-Obesity Agents.)	
rimorphin	83335-41-5	Dynorphin B	85006-82-2	K41YC3AEI8			
rimsulfuron		Rimsulfuron	122931-48-0	462J071RD7			
riociguat		Riociguat	625115-55-1	RU3FE2Y4XI	Enzyme Activators	Compounds or factors that act on a specific enzyme to increase its activity. (See all compounds classified as Enzyme Activators.)	Riociguat is indicated for the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH), (WHO Group 4) after surgical treatment, or inoperable CTEPH, to improve exercise capacity and WHO functional class. Riociguat is indicated for the treatment of adults with pulmonary arterial hypertension (PAH), (WHO Group 1), to improve exercise capacity, WHO functional class and to delay clinical worsening. Efficacy was shown in patients on Riociguat monotherapy or in combination with endothelin receptor antagonists or prostanoids. Studies establishing effectiveness included predominately patients with WHO functional class IIIII and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases (25%).
ripretinib		Ripretinib	1442472-39-0	9XW757O13D			Ripretinib is indicated to treat adults diagnosed with advanced gastrointestinal stromal tumor (GIST) who have had prior therapy with at least 3 kinase inhibitors, including with [imatinib].
Risdiplam		Risdiplam	1825352-65-5	76RS4S2ET1	Neuromuscular Agents	Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (NEUROMUSCULAR BLOCKING AGENTS), and drugs that act centrally as skeletal muscle relaxants (MUSCLE RELAXANTS, CENTRAL). Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS. (See all compounds classified as Neuromuscular Agents.)	Risdiplam is indicated for the treatment of spinal muscular atrophy (SMA).
Risedronic Acid		Risedronic Acid	105462-24-6	KM2Z91756Z	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Risedronic acid is indicated for the treatment of osteoperosis in men, treatment of Paget's disease, treatment and prevention of osteoperosis in postmenopausal women, and treatment and prevention of glucocorticoid-induced osteoperosis.
Risperidone	106266-06-2	Risperidone	106266-06-2	L6UH7ZF8HC	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Risperidone is indicated for the treatment of schizophrenia and irritability associated with autistic disorder. It is also indicated as monotherapy, or adjunctly with lithium or valproic acid, for the treatment of acute mania or mixed episodes associated with bipolar I disorder.  Risperidone is additionally indicated in Canada for the short-term symptomatic management of aggression or psychotic symptoms in patients with severe dementia of the Alzheimer type unresponsive to nonpharmacological approaches.  Risperidone is also used off-label for a number of conditions including as an adjunct to antidepressants in treatment-resistant depression.
risuteganib		Luminate	1307293-62-4	123DNA66IA			
ritalinic acid	19395-41-6	Ritalinic acid	19395-41-6				
Ritanserin	87051-43-2	Ritanserin	87051-43-2	145TFV465S	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
Ritodrine	26652-09-5	Ritodrina	26652-09-5	I0Q6O6740J	Adrenergic beta-2 Receptor Agonists	Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)	For the treatment and prophylaxis of premature labour
Ritonavir		Ritonavir	155213-67-5	O3J8G9O825	Cytochrome P-450 CYP3A Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A. (See all compounds classified as Cytochrome P-450 CYP3A Inhibitors.)	Ritonavir is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.  In the US, Europe, and Canada, ritonavir, in combination with [nirmatrelvir], is indicated for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults who are at high risk for progression to severe COVID-19, including hospitalization or death. In Europe, this therapeutic indication is approved under conditional marketing authorization.
Rivaroxaban		Rivaroxaban	366789-02-8	9NDF7JZ4M3	Factor Xa Inhibitors	Endogenous factors and drugs that inhibit or block the activity of FACTOR XA. (See all compounds classified as Factor Xa Inhibitors.)	Rivaroxaban is indicated for the prevention of venous thromboembolic events (VTE) in patients who have undergone total hips replacements and total knee replacement surgery; prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE); to reduce risk of recurrent DVT and/or PE. Rivaroxaban is also indicated, in combination with aspirin, for reducing the risk of major cardiovascular events in patients with chronic coronary artery disease or peripheral artery disease. Its use is also not recommended in those with severe renal impairment (<30mL/min).  Rivaroxaban is also indicated for the treatment and prevention of VTE in pediatric patients (from birth to 18 years of age) and for thromboprophylaxis in pediatric patients 2 years old with congenital heart disease following the Fontan procedure.
Rivastigmine		Rivastigmine	123441-03-2	PKI06M3IW0	Neuroprotective Agents	Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)	For the treatment of mild to moderate dementia associated with Parkinson's disease or of the Alzheimer's type.
rizatriptan	145202-66-0	Rizatriptan Benzoate	145202-66-0	WR978S7QHH	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	
RMI 12330A	82985-31-7	Azacyclotridec-1-en-2-amine, N-(2-phenylcyclopentyl)-, cis-	82985-31-7				
RMP 7	159768-75-9	Labradimil	159768-75-9	2MK663C346			Investigated for use/treatment in brain cancer and pediatric indications.
RN 1734		2,4-Dichloro-N-isopropyl-N-(2-isopropylaminoethyl)benzenesulfonamide	946387-07-1				
RNA Cap Analogs		RNA Cap Analogs					
RNA Caps		RNA Caps					
Ro 03-7410	57704-16-2	1'-Hydroxybufuralol	57704-16-2				
Ro 106-9920		6-(Benzenesulfinyl)tetrazolo[1,5-b]pyridazine	62645-28-7				
Ro 15-4513	91917-65-6	Ethyl-8-azido-5,6-dihydro-5-methyl-6-oxo-4H-imidazo-1,4-benzodiazepine-3-carboxylate	91917-65-6	S5XGL82O5Y	Affinity Labels	Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. (See all compounds classified as Affinity Labels.)	
Ro 16-6491	87235-61-8	N-(2-aminoethyl)-4-chlorobenzamide	87235-61-8				
Ro 16-9100		Ro 16-9100					
Ro 19-8022	104604-66-2	(R)-1-((10-Chloro-4-oxo-3-phenyl-4H-benzo(a)quinolizin-1-yl)carbonyl)-2-pyrrolidinemethanol	104604-66-2				
Ro 20683	1954-17-2	(2-Hydroxy-5-phenylbenzyl)trimethylammonium bromide	1954-17-2	FKT5WGE47Y			
Ro 21-5104	35853-50-0	2,8-Bis(trifluoromethyl)quinoline-4-carboxylic acid	35853-50-0	462L37KS1K			
Ro 23-7553	118694-43-2	1,25-Dihydroxy-16-ene-23-yne-vitamin D3	118694-43-2	O13QTC8612	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
Ro 24-4736	125030-71-9	5-(3-(4-(2-Chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-2-yl)-2-propynyl)phenanthridin-6(5H)-one	125030-71-9	I2MJ13SOFO			
Ro 24-5531		(23E)-26,26,26,27,27,27-hexafluoro-1alpha,25-dihydroxy-23,24-didehydrovitamin D3/(23E)-26,26,26,27,27,27-hexafluoro-1alpha,25-dihydroxy-23,24-didehydrocholecalciferol					
Ro 25-6603		2,4-Pentadienoic acid, 3-methyl-5-(2-(2-(2,6,6-trimethyl-1-cyclohexen-1-yl)ethenyl)-1-cyclohexen-1-yl)-, (E,E,E)-	173792-73-9				
Ro 25-6981		4-[(1R,2S)-3-(4-benzylpiperidin-1-yl)-1-hydroxy-2-methylpropyl]phenol	169274-78-6				
Ro 28-2653		5-[4-(4-Nitrophenyl)piperazin-1-yl]-5-(4-phenylphenyl)-1,3-diazinane-2,4,6-trione					
Ro 31-7549		3-[1-(3-Aminopropyl)-1H-indol-3-YL]-4-(1-methyl-1H-indol-3-YL)-1H-pyrrole-2,5-dione	125313-65-7	Y6197FQK8I	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Ro 31-8220	125314-64-9	bisindolylmaleimide IX	125314-64-9	W9A0B5E78O	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Ro 31-8425	131848-97-0	3-[8-(Aminomethyl)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione	131848-97-0		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Ro 32-0432	151342-35-7	(S)-3-(8-(Dimethylaminomethyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione hydrochloride	151342-35-7				
RO 3306		(5Z)-5-(quinolin-6-ylmethylidene)-2-[(thiophen-2-ylmethyl)amino]-1,3-thiazol-4(5H)-one					
Ro 363	74513-77-2	1-(3,4-Dimethoxyphenethylamino)-3-(3,4-dihydroxyphenoxy)-2-propanol	74513-77-2		Adrenergic beta-Agonists	Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)	
Ro 4-6790		4-amino-N-[2,6-bis(methylamino)pyrimidin-4-yl]benzenesulfonamide	202466-68-0	CU78RAR5ZH			
Ro 41-0960	125628-97-9	(3,4-Dihydroxy-5-nitrophenyl)(2-fluorophenyl)methanone	125628-97-9	SXV6U29ZOI			
Ro 41-1049		N-(2-Aminoethyl)-5-(3-fluorophenyl)thiazole-4-carboxamide	127500-84-9	40Y4916ZJ4	Monoamine Oxidase Inhibitors	A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed, p414) (See all compounds classified as Monoamine Oxidase Inhibitors.)	
Ro 41-5253	144092-31-9	4-[(E)-2-(7-heptoxy-4,4-dimethyl-1,1-dioxo-2,3-dihydrothiochromen-6-yl)prop-1-enyl]benzoic acid	144092-31-9				
Ro 47-8634		Desmethyl Bosentan	253688-61-8	N373R7N42R			
Ro 48-8071	161582-11-2	[4-({6-[Allyl(methyl)amino]hexyl}oxy)-2-fluorophenyl](4-bromophenyl)methanone	161582-11-2	YDR69X9Q9M			
Ro 60-0175		(S)-2-(6-Chloro-5-fluoro-indol-1-yl)-1-methyl-ethylamine	169675-09-6				
Ro 61-8048		3,4-dimethoxy-N-(4-(3-nitrophenyl)thiazol-2-yl)benzenesulfonamide	199666-03-0				
Ro 65-7199		4-amino-N-(6-bromo-1H-indol-4-yl)benzenesulfonamide	350800-83-8				
Ro 68-3400		Ro 68-3400					
RO-28-0450		RO-28-0450					
RO3280		4-[(9-Cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide	1062243-51-9				
Ro4368554		3-benzenesulfonyl-7-(4-methyl-piperazin-1-yl)-1H-indole	478082-99-4				
RO5126766		3-[[2-[(methylaminosulfonyl)amino]-3-fluoropyridin-4-yl]methyl]-4-methyl-7-[(pyrimidin-2-yl)oxy]-2H-1-benzopyran-2-one	946128-88-7	D0D4252V97			
RO5166017		(4S)-4-[(N-ethylanilino)methyl]-4,5-dihydro-1,3-oxazol-2-amine	1048346-74-2	YK98JFQ52U			
robalzotan		Robalzotan	169758-66-1	I18M56OGME			Investigated for use/treatment in anxiety disorders and depression.
Robenidine	25875-51-8	Robenidine	25875-51-8	4888ME6C4E	Coccidiostats	Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals. (See all compounds classified as Coccidiostats.)	
robinetin	490-31-3	Robinetin	490-31-3	KJ6DBC4U7E			
robinin	301-19-9	Robinin	301-19-9	75RT1VGM60			
rocaglamide	84573-16-0	Rocaglamide	84573-16-0	FRG4N852F7			
rocaglaol		Rocaglaol					
rociletinib		Rociletinib	1374640-70-6	72AH61702G			
Rocuronium		Rocuronium	143558-00-3	WRE554RFEZ	Neuromuscular Nondepolarizing Agents	Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. (See all compounds classified as Neuromuscular Nondepolarizing Agents.)	For inpatients and outpatients as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
Rodenticides		Rodenticides					
rofecoxib		Rofecoxib	162011-90-7	0QTW8Z7MCR	Cyclooxygenase 2 Inhibitors	A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2. (See all compounds classified as Cyclooxygenase 2 Inhibitors.)	For the treatment of osteoarthritis, rheumatoid arthritis, acute pain in adults, and primary dysmenorrhea, as well as acute treatment of migraine attacks with or without auras.
Roflumilast		Roflumilast	162401-32-3	0P6C6ZOP5U			Oral roflumilast is indicated to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.  Topical cream roflumilast is indicated to treat plaque psoriasis, including intertriginous areas, in patients 12 years of age and older, while topical foam roflumilast is indicated to treat seborrheic dermatitis in adult and pediatric patients 9 years of age and older..
roflumilast N-oxide		roflumilast N-oxide	292135-78-5	F08MQ6CZCS	Phosphodiesterase 4 Inhibitors	Compounds that specifically inhibit PHOSPHODIESTERASE 4. (See all compounds classified as Phosphodiesterase 4 Inhibitors.)	
roflupram		Roflupram			Phosphodiesterase 4 Inhibitors	Compounds that specifically inhibit PHOSPHODIESTERASE 4. (See all compounds classified as Phosphodiesterase 4 Inhibitors.)	
rogletimide	92788-10-8	Rogletimide	92788-10-8	14P4QR28QF			
rolafagrel	89781-55-5	Rolafagrel	89781-55-5	OAH71568Y4			
Rolipram	61413-54-5	Rolipram	61413-54-5	K676NL63N7	Phosphodiesterase 4 Inhibitors	Compounds that specifically inhibit PHOSPHODIESTERASE 4. (See all compounds classified as Phosphodiesterase 4 Inhibitors.)	
rolofylline		Rolofylline	136199-02-5		Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	Heart Failure
romidepsin		Romidepsin	128517-07-7	CX3T89XQBK	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	Romidepsin is indicated for the treatment of cutaneous T-cell lymphoma (CTCL) in adult patients who have received at least one prior systemic therapy.
romiplostim		267639-76-9					
ronnel		Fenchlorphos	299-84-3	89RAG7SB3B			
ronoxon	3983-45-7	Ronoxon	3983-45-7	CEW5P2E499			
ropinirole	91374-21-9	Ropinirole	91374-21-9	030PYR8953	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	For the treatment of the signs and symptoms of Parkinson's disease and for the treatment of primary moderate-severe restless legs syndrome.
Ropivacaine	84057-95-4	Ropivacaine	84057-95-4	7IO5LYA57N	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
roquefortine	58735-64-1	Roquefortine C	58735-64-1	4VW6U94XFK			
roquinimex		Roquinimex	84088-42-6	372T2944C0	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	Roquinimex is investigated to be used as a treatment of a number of cancers and autoimmune conditions.   As well, roquinimex is researched to be used as adjuvant therapy after bone marrow transplantation in cases of acute leukemia.
roridin A	14729-29-4	Roridin A	14729-29-4	U28899D1U2			
rosavin		Rosavin	84954-92-7	1R72C0ROME			
Roscovitine		Seliciclib	186692-46-6	0ES1C2KQ94	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Investigated for use/treatment in breast cancer, lung cancer, lymphoma (unspecified), multiple myeloma, leukemia (lymphoid), and cancer/tumors (unspecified).
Rose Bengal	11121-48-5	Bengal rose	11121-48-5	1ZPG1ELY14			
rosemary oil	8000-25-7	Oils, rosemary					
Rosiglitazone		Rosiglitazone	122320-73-4	05V02F2KDG	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	Rosiglitazone is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
rosiglitazone-metformin combination		Rosiglitazone/metformin	622402-70-4				
Rosmarinic Acid		Rosmarinic acid	20283-92-5	MQE6XG29YI			
rossicaside B		rossicaside B					
rostafuroxin		Rostafuroxin	156722-18-8	P848LCX62B			
Rosuvastatin Calcium		Rosuvastatin Calcium	147098-20-2	83MVU38M7Q	Hydroxymethylglutaryl-CoA Reductase Inhibitors	Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)	Homozygous Familial Hypercholesterolaemia, Prevention of cardiovascular events, Primary combined (mixed) dyslipidaemia, Primary hypercholesterolaemia
rotenoisin A		Rotenoisin A					
Rotenone	83-79-4	Rotenone	83-79-4	03L9OT429T	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
rotigotine		Rotigotine	99755-59-6	87T4T8BO2E	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	For use/treatment in neurologic disorders and parkinson's disease as well as moderate-to-severe primary Restless Legs Syndrome.
rottlerin	82-08-6	Rottlerin	82-08-6	E29LP3ZMUH	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
roxadustat		Roxadustat	808118-40-3	X3O30D9YMX			Roxadustat is indicated for the treatment of adult patients with symptomatic anemia associated with chronic kidney disease (CKD).
Roxarsone	121-19-7	Roxarsone	121-19-7	H5GU9YQL7L	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
roxatidine acetate	78628-28-1	Roxatidine acetate	78628-28-1	ZUP3LSD0DO	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	For the treatment of disorders of the upper gastro-intestinal region that are due to an excess of hydrochloric acid in the gastric juice, i.e. duodenal ulcers, benign gastric ulcers. Also for prophylaxis of recurrent gastric and duodenal ulcers
Roxithromycin	80214-83-1	Rulide	80214-83-1	21KOF230FA	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Used to treat respiratory tract, urinary and soft tissue infections.
royal jelly	8031-67-2	Water	84776-64-7	059QF0KO0R			For diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.
RP 60180		N-propyl-10-[(2S)-1-pyrrolidin-1-ylpropan-2-yl]phenothiazine-2-carboxamide					
RPR 100893	153438-49-4	Dapitant	153438-49-4	NRD5XF638P			
RPR 121056		7-Ethyl-10-(4-N-aminopentanoic acid)-1-piperidino)carbonyloxycamptothecin	181467-56-1	QZR6VT7SW5			
RPR260243		(3R,4R)-4-[3-(6-methoxyquinolin-4-yl)-3-oxo-propyl]-1-[3-(2,3,5-trifluoro-phenyl)-prop-2-ynyl]-piperidine-3-carboxylic acid	668463-35-2				
RS 100329		5-methyl-3-[3-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperazin-1-yl]propyl]-1H-pyrimidine-2,4-dione	232953-52-5		Adrenergic alpha-1 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)	
RS 102895		1'-[2-[4-(trifluoromethyl)phenyl]ethyl]spiro[1H-3,1-benzoxazine-4,4'-piperidine]-2-one					
RS 17053		RS 17053 hydrochloride	169505-93-5				
RS 39604		Methanesulfonamide, N-(2-(4-(3-(4-amino-5-chloro-2-((3,5-dimethoxyphenyl)methoxy)phenyl)-3-oxopropyl)-1-piperidinyl)ethyl)-	161362-65-8	0RP0I19CSC			
RS 43179	91431-42-4	Lonapalene	91431-42-4	WIF31Q54NJ			
RS 67333	160845-95-4	1-(4-Amino-5-chloro-2-methoxyphenyl)-3-(1-butyl-4-piperidinyl)-1-propanone	160845-95-4	39N8XG5C9A			
RS 8359		4-(7-hydroxy-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-ylamino)benzonitrile	105365-76-2	79U9T1HIX9	Monoamine Oxidase Inhibitors	A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed, p414) (See all compounds classified as Monoamine Oxidase Inhibitors.)	
RS194B		RS194B					
RS41A		RS41A					
RSL3 compound		RSL3 compound					
RSVA314		316130-82-2					
RSVA405		N'-(4-(diethylamino)-2-hydroxybenzylidene)isonicotinohydrazide					
RTI 121	146145-21-3	3beta-(4-Iodophenyl)tropan-2beta-carboxylic acid isopropyl ester	146145-21-3				
RTI-113		Unii-G6867rwn6N	146145-17-7	G6867RWN6N			
RTKI cpd	170449-18-0	N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride	170449-18-0	QP952C4RUW	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Ru 360		Ru 360					
RU 43044	136959-96-1	(8S,10R,13S,14S,17R)-17-hydroxy-13-methyl-10-[(4-methylphenyl)methyl]-17-prop-1-ynyl-2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one	136959-96-1				
RU 5135	78774-26-2	3-Hydroxy-16-imino-17-azaandrostan-11-one	78774-26-2	R1OGA081AP	GABA Antagonists	Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS. (See all compounds classified as GABA Antagonists.)	
RU 58668	151555-47-4	Estra-1,3,5(10)-triene-3,17-diol, 11-[4-[[5-[(4,4,5,5,5-pentafluoropentyl)sulfonyl]pentyl]oxy]phenyl]-, (11beta,17beta)-	151555-47-4				
RU.521		2-(4,5-dichloro-1H-benzimidazol-2-yl)-5-methyl-4-(3-oxo-1H-2-benzofuran-1-yl)-1H-pyrazol-3-one					
RU24782		RU24782					
RU24858		CID 9886429	194413-69-9				
rubiadin		Rubiadin	117-02-2	CY0UH3X06R			
rubiarbonone C		rubiarbonone C					
Rubidium	7440-17-7	Rubidium	7440-17-7	MLT4718TJW			
rubidium chloride	7791-11-9	Rubidium chloride	7791-11-9	N3SHC5273S			
rubimaillin	55481-88-4	Mollugin	55481-88-4	M98N6A8Z2F			
rubitecan		Rubitecan	91421-42-0	H19C446XXB	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Investigated for use/treatment in pancreatic cancer, leukemia (unspecified), melanoma, ovarian cancer, and cancer/tumors (unspecified).
ruboxistaurin	169939-94-0	Ruboxistaurin	169939-94-0	721809WQCP	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
rubratoxins		CID11969548					
rucaparib		Rucaparib	283173-50-2	8237F3U7EH	Poly(ADP-ribose) Polymerase Inhibitors	Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. (See all compounds classified as Poly(ADP-ribose) Polymerase Inhibitors.)	Rucaparib is indicated for the maintenance treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)- associated recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.  Under accelerated approval by the FDA, rucaparib is also indicated for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy.
rufinamide		Rufinamide	106308-44-5	WFW942PR79	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	Adjunct therapy for treatment of seizures associated with Lennox-Gastaut syndrome.
ruscogenin	472-11-7	Ruscogenin	472-11-7	BXI92R2VUJ			
rutacarpine		Rutaecarpine	84-26-4	8XZV289PRY	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
rutaevin	33237-37-5	Rutaevin	33237-37-5				
rutamarin	14882-94-1	Rutamarin	14882-94-1	2UKD4797WG			
rutecarpine	84-26-4	Rutaecarpine	84-26-4	8XZV289PRY	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
Ruthenium	7440-18-8	Ruthenium	7440-18-8	7UI0TKC3U5			
Ruthenium Compounds		Ruthenium Compounds					
Ruthenium Red	11103-72-3	11103-72-3					
ruthenocene	1287-13-4	1287-13-4					
Rutin	153-18-4	Rutin	153-18-4	5G06TVY3R7			
ruxolitinib		Ruxolitinib	941678-49-5	82S8X8XX8H			Ruxolitinib is indicated for the treatment of the following conditions:  - intermediate or high-risk myelofibrosis (MF), including prima1y MF, post-polycythemia vera MF and post-essential thrombocythemia MF in adults. It is also used to treat disease-related splenomegaly or symptoms in adult patients with these conditions.  - polycythemia vera (PV) in adults who have had an inadequate response to or are intolerant of hydroxyurea. - steroid-refracto1y acute graft-versus-host disease (GVHD) in adult and pediatric patients 12 years and older. - chronic GVHD in patients aged 12 years and older who have failed one or two lines of systemic therapy.  Topical ruxolitinib is indicated for:  - the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised patients patients 12 years of age and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. - the treatment of non-segmental vitiligo in adult and pediatric patients 12 years of age and older.
RV 538	73257-80-4	2-Decanoylamino-3-morpholino-1-phenylpropanol	73257-80-4		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
RV09 compound		RV09 compound					
RWJ-56110		(2S)-4-amino-2-[[(2S)-2-[[1-[(2,6-dichlorophenyl)methyl]-3-(pyrrolidin-1-ylmethyl)indol-6-yl]carbamoylamino]-3-(3,4-difluorophenyl)propanoyl]amino]-N-(phenylmethyl)butanamide					
RY 008		RY 008					
Ryanodine	15662-33-6	Ryanodine	15662-33-6				
ryodipine	71653-63-9	Riodipine	71653-63-9	W12VDB26LB	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
S 0859 compound		S 0859 compound					
S 1 (combination)	150863-82-4	S 1 (Combination)	150863-82-4		Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	
S 145	112966-96-8	Domitroban	112966-96-8	742F5K270Q	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
S 16118		S 16118					
S 17092-1		[(2S,3aS,7aS)-2-(1,3-thiazolidine-3-carbonyl)-2,3,3a,4,5,6,7,7a-octahydroindol-1-yl]-[(1R,2R)-2-phenylcyclopropyl]methanone	176797-26-5	8W5MLJ83KU			
S 18523		S 18523					
S 2238	64815-81-2	D-Phenylalanyl-L-2-piperidinecarbonyl-N-(4-nitro phenyl)-L-argininamide	64815-81-2		Chromogenic Compounds	Colorless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into colored compounds; used in biochemical assays and in diagnosis as indicators, especially in the form of enzyme substrates. Synonym: chromogens (not to be confused with pigment-synthesizing bacteria also called chromogens). (See all compounds classified as Chromogenic Compounds.)	
S 2366	72194-57-1	Pyroglutamyl-prolyl-arginine-4-nitroanilide	72194-57-1				
S 28463		Resiquimod	144875-48-9	V3DMU7PVXF	Toll-Like Receptor Agonists	Agents that stimulate TOLL-LIKE RECEPTOR signaling, and the activity of both the INNATE IMMUNE RESPONSE and ADAPTIVE IMMUNITY. (See all compounds classified as Toll-Like Receptor Agonists.)	Investigated for use/treatment in genital herpes.
S 3304		D-Tryptophan, N-[[5-[2-(4-methylphenyl)ethynyl]-2-thienyl]sulfonyl]-	203640-27-1	BK459F050X	Matrix Metalloproteinase Inhibitors	Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES. (See all compounds classified as Matrix Metalloproteinase Inhibitors.)	
S 33084		N-[4-[(3aR,9bS)-8-cyano-3,3a,4,9b-tetrahydro-1H-chromeno[3,4-c]pyrrol-2-yl]butyl]-4-phenylbenzamide	273203-30-8				
S 3483		S 3483					
S 4048		(1S,3R,4R,5R)-1-[[(1R,2S)-2-(4-chlorophenyl)cyclopropyl]methoxy]-3,4-dihydroxy-5-[(Z)-3-imidazo[4,5-b]pyridin-1-yl-3-phenylprop-2-enoyl]oxycyclohexane-1-carboxylic acid					
S Ht31		S Ht31					
S-(1,1,2,2-tetrafluoroethyl)cysteine	94840-66-1	S-(1,1,2,2-Tetrafluoroethyl)cysteine	94840-66-1				
S-(1,2-dichlorovinyl)-L-cysteine sulfoxide		S-(1,2-dichlorovinyl)-L-cysteine sulfoxide					
S-(1,2-dichlorovinyl)cysteine	627-72-5	S-(1,2-Dichlorovinyl)-L-cysteine	627-72-5	Q9M8NNK4D4			
S-(1,2-dichlorovinyl)glutathione	96614-59-4	S-(1,2-Dichlorovinyl)glutathione	96614-59-4				
S-(2-carboxyethyl)-N-acetylcysteine	51868-61-2	N-Acetyl-S-(2-carboxyethyl)-L-cysteine	51868-61-2	RFS74C5561			
S-(2-chloroethyl)glutathione		S-(2-Chloroethyl)glutathione	75607-61-3	O3NB7BB10J			
S-(2,4-dinitrophenyl)glutathione	26289-39-4	S-(2,4-dinitrophenyl)glutathione	26289-39-4	HL4G8D2C8T			
S-(3-hydroxypropyl)cysteine N-acetate	23127-40-4	N-Acetyl-S-(3-hydroxypropyl)cysteine	23127-40-4	BFU3149V95			
S-(4-nitrophenacyl)glutathione		L-Gamma-Glutamyl-S-[2-(4-Nitrophenyl)-2-Oxoethyl]-L-Cysteinylglycine					
S-(N,N-diethylaminoethyl) isobutyl methylphosphothiolate		S-(N,N-diethylaminoethyl) isobutyl methylphosphothiolate					
S-1,2-dichlorovinyl-N-acetylcysteine	104713-70-4	N-Acetyl-S-(1,2-dichlorovinyl)-L-cysteine	104713-70-4	V2JL8YYY25			
S-2-pentyl-4-pentynoic hydroxamic acid		S-2-pentyl-4-pentynoic hydroxamic acid					
S-4-bromobenzylglutathione cyclopentyl diester	166038-00-2	S-4-Bromobenzylglutathione cyclopentyl diester	166038-00-2				
S-8 fuel		S-8 fuel					
S-Adenosylhomocysteine	979-92-0	S-adenosyl-L-homocysteine	979-92-0	8K31Q2S66S			
S-Adenosylmethionine	29908-03-0	Ademetionine	29908-03-0	7LP2MPO46S			S-Adenosylmethionine (SAMe) is used as a drug in Europe for the treatment of depression, liver disorders, fibromyalgia, and osteoarthritis. It has also been introduced into the United States market as a dietary supplement for the support of bone and joint health, as well as mood and emotional well being.
S-allylcysteine	21593-77-1	S-Allylcysteine	21593-77-1	81R3X99M15	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
S-allylmercapto-N-acetylcysteine		S-allylmercapto-N-acetylcysteine					
S-decylglutathione		2-Amino-5-[[1-(carboxymethylamino)-3-decylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid	102814-04-0				
S-dimethylaminoarsino-thiosuccinic acid		S-dimethylaminoarsino-thiosuccinic acid					
S-ethyl glutathione	24425-52-3	S-Ethyl glutathione	24425-52-3	7W95D60F4J	Radiation-Protective Agents	Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)	
S-ethyl-N-acetyl-cysteine		S-ethyl-N-acetyl-cysteine					
S-hexylglutathione-sepharose	69772-83-4	S-hexylglutathione-sepharose					
S-hydroxymethylglutathione	32260-87-0	S-(Hydroxymethyl)glutathione	32260-87-0				
S-methyl benzo(1,2,3)thiadiazole-7-carbothioate		Acibenzolar-S-Methyl	135158-54-2	BCW6119347			
S-methyl glutathione	2922-56-7	S-Methylglutathione	2922-56-7	OOW3025SR1			
S-methyl N,N-diethylthiocarbamate sulfone		S-Methyl-N,N-diethylthiocarbamate Sulfone	155514-79-7				
S-methyl N,N-diethylthiolcarbamate sulfoxide	140703-15-7	N,N-diethyl-1-methylsulfinylformamide	140703-15-7	Z6937KA5QD			
S-methyl-N-butylthiocarbamate sulfoxide		S-methyl-N-butylthiocarbamate sulfoxide					
S-methylcysteine	7728-98-5	Methylcysteine	7728-98-5				
S-methylisothiopseudouronium		Carbamimidothioic acid, methyl ester	2986-19-8	ES8C3884JW	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
S-methylthiocitrulline		S-Methylthiocitrulline	156719-41-4	M790X706JV	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
S-nitro-N-acetylpenicillamine		N-Acetyl-3-(nitrosulfanyl)-L-valine	168207-37-2		Nitric Oxide Donors	A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)	
S-Nitroso-N-Acetylpenicillamine	79032-48-7	N-Acetyl-S-nitrosopenicillamine	79032-48-7		Nitric Oxide Donors	A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)	
S-nitrosocysteine		S-Nitrosocysteine	51209-75-7	926P2322P4	Nitric Oxide Donors	A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)	
S-Nitrosoglutathione	57564-91-7	S-nitrosoglutathione	57564-91-7	78RRI89ZTO	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
S-nitrosopenicillamine	73466-15-6	S-Nitrosopenicillamine	73466-15-6				
S-Nitrosothiols		S-Nitrosothiols					
S-pentachlorobuta-1,3-dien-yl-cysteine	87619-82-7	S-(1,2,3,4,4-Pentachloro-1,3-butadienyl)-L-cysteine	87619-82-7				
S-phenyl-N-acetylcysteine	4775-80-8	S-Phenyl-N-acetylcysteine	4775-80-8	74XI8247P0			
S-sulindac		(S)-Sulindac	149116-77-8	P969C405OM			
S-tetradecanoyl-coenzyme A	3130-72-1	Myristoyl-coenzyme A	3130-72-1				
S,S'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester	98968-92-4	Thiosultap	98968-92-4	RA4HCQ7UPE	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
S,S'-1,4-phenylene-bis(1,2-ethanediyl)bis-isothiourea		S,S'-(1,4-Phenylene-bis(1,2-ethanediyl))bis-isothiourea					
S,S'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea		S,S'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea					
S(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid	133304-99-1	S(alpha)-Methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid	123016-21-7	N7KE8K89UV	Lipoxygenase Inhibitors	Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)	
S110 compound		S110 compound					
S63845		(2~{r})-2-[5-[3-Chloranyl-2-Methyl-4-[2-(4-Methylpiperazin-1-Yl)ethoxy]phenyl]-6-(5-Fluoranylfuran-2-Yl)thieno[2,3-D]pyrimidin-4-Yl]oxy-3-[2-[[2-[2,2,2-Tris(Fluoranyl)ethyl]pyrazol-3-Yl]methoxy]phenyl]propanoic Acid					
SA 4503		1-(3,4-Dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride	165377-44-6	B66RO93FXQ	Nootropic Agents	Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)	
SA00025		NOT Receptor Modulator 1					
sabcomeline		Sabcomeline	159912-53-5	P8P92V596C			
sabeluzole		Sabeluzole	104383-17-7	A998504XY4			
Saccharin	81-07-2	Saccharin	128-44-9	FST467XS7D	Sweetening Agents	Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)	
sacran		sacran					
sacubitril		Sacubitril	149709-62-6	17ERJ0MKGI			Used in combination with valsartan to reduce the risk of cardiovascular events in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction.  It is usually administered in conjunction with other heart failure therapies, in place of an ACE inhibitor or other ARB.  It is also used in combination with [valsartan].
sacubitril and valsartan sodium hydrate drug combination		sacubitril and valsartan sodium hydrate drug combination					
SAD-128	40225-02-3	Pyridinium, 1,1'-oxydimethylenebis(4-tert-butyl-, dichloride	40225-02-3				
Safflower Oil	8001-23-8	8001-23-8					
safinamide	133865-89-1	Safinamide	133865-89-1	90ENL74SIG			Safinamide is indicated as an add-on treatment to levodopa with or without other medicines for Parkinsons disease
safranal	116-26-7	Safranal	116-26-7	4393FR07EA			
Safrole	94-59-7	Safrole	94-59-7	RSB34337V9			
SAG compound		SAG compound					
SAICAR	3031-95-6	Saicar	3031-95-6	K1PVR64RIF			
saiko-keishi-to	63364-01-2	saiko-keishi-to					
saikogenin A	5092-09-1	Saikogenin A	5092-09-1				
saikogenin F		Saikogenin F					
saikosaponin D		Saikosaponin D	20874-52-6	UR635J3F00	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
Saint John's wort extract		St. John's Wort [NF]					
sairei-to		sairei-to					
salecan		salecan					
salicin	138-52-3	Salicin	138-52-3	4649620TBZ	Cyclooxygenase Inhibitors	Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)	
salicyl alcohol	90-01-7	Salicyl alcohol	90-01-7	FA1N0842KB			
salicyl hydrazide	936-02-7	2-Hydroxybenzohydrazide	936-02-7	R5T5F3Q8HR			
salicylaldehyde isonicotinoyl hydrazone		Salicylaldehyde isonicotinoyl hydrazone	495-84-1				
salicylaldoxime	94-67-7	Salicylaldoxime	94-67-7	2QTV2A0T5Q			
salicylamide		Salicylamide	65-45-2	3A52O8YREJ	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
Salicylates		Salicylate	63-36-5		Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
salicylhydroxamic acid	89-73-6	Salicylhydroxamic acid	89-73-6	8Q07182D0T	Antiprotozoal Agents	Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)	
Salicylic Acid	69-72-7	Salicylic Acid	69-72-7	O414PZ4LPZ	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	Key additive in many skin-care products for the treatment of acne, psoriasis, callouses, corns, keratosis pilaris and warts.
salicylideneaniline		Salicylideneaniline	779-84-0				
salicylsalicylic acid		Salsalate	552-94-3	V9MO595C9I	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	For relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis and related rheumatic disorders.
salicylurate	487-54-7	Salicyluric acid	487-54-7	5BR3P7J05U			
salinomycin	53003-10-4	Salinomycin	53003-10-4	62UXS86T64	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Salmeterol Xinafoate		Salmeterol Xinafoate	94749-08-3	6EW8Q962A5	Bronchodilator Agents	Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)	
salmon calcitonin	47931-85-1	Calcitonin Salmon	9007-12-9	DF35I47HCM	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Used in the treatment of symptomatic Paget's disease for patients unresponsive to alternate treatments or intolerant to such treatments. In addition, it is used in emergency situations when serum calcium levels must be decreased quickly until the underlying condition is identified. It can also be added to existing therapeutic regimens for hypercalcemia such as intravenous fluids and furosemide, oral phosphate or corticosteroids, or other agents. Calcitonin can be used in patients with azotemia and cases where intravenous fluids would be contraindicated due to limited cardiac reserves. Also for the treatment of post-menopausal osteoporosis in women more than 5 years post-menopause.
Salmonella Vaccines		Salmonella Vaccines					
salsolidine	5784-74-7	6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline	5784-74-7		Catechol O-Methyltransferase Inhibitors	Compounds and drugs that inhibit or block the activity of CATECHOL O-METHYLTRANSFERASE enzymes. Drugs in this class are used in management of central nervous system disorders such as PARKINSON DISEASE. (See all compounds classified as Catechol O-Methyltransferase Inhibitors.)	
salsoline	89-31-6	(-)-Salsoline	89-31-6	T246JT0V8K	Neurotoxins	Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept. (See all compounds classified as Neurotoxins.)	
salsolinol	525-72-4	1-Methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol	525-72-4	51619CO22Q			
Salts		Salts					
salubrinal		Salubrinal	405060-95-9	J8PSF5Z8KJ			
salvianolic acid		Salvianolic acid A	96574-01-5	51622542XO	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
salvianolic acid A		Salvianolic acid A	96574-01-5	51622542XO	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
salvianolic acid B	115939-25-8	(R)-2-(((2R,3R)-4-((E)-3-((R)-1-Carboxy-2-(3,4-dihydroxyphenyl)ethoxy)-3-oxoprop-1-en-1-yl)-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydrobenzofuran-3-carbonyl)oxy)-3-(3,4-dihydroxyphenyl)propanoic acid					
salvianolic acid C		Salvianolic acid C	115841-09-3	I16H9Z53ZL			
salvigenin	19103-54-9	Salvigenin	19103-54-9	V522YCM28A			
salvin	3650-09-7	Carnosic acid	3650-09-7	LI791SXT24	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
salvinorin A		Salvinorin A	83729-01-5	T56W91NG6J	Hallucinogens	Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. (See all compounds classified as Hallucinogens.)	
SAM-531		Cerlapirdine	925448-93-7	EK40PJ0V49			
sampatrilat		Sampatrilat	129981-36-8	V7O29949TG	Protease Inhibitors	Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)	
SAN 58035	78934-83-5	Sandoz 58-035	78934-83-5	QZW7O5C9AG	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
San-Ao decoction		San-Ao decoction					
San-Huang-Xie-Xin-Tang		San-Huang-Xie-Xin-Tang					
Sand		Silicon Dioxide	14808-60-7	ETJ7Z6XBU4			
sandostatinLAR		sandostatinLAR					
sanggenon D		Sanggenon-C	81422-93-7				
sanggenon G		(2S)-6-[(1S,5R,6S)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-(4-methylpent-3-enyl)cyclohex-2-en-1-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydrochromen-4-one					
sanggenon O		sanggenon O					
sanggenone C	80651-76-9	Sanggenon C	80651-76-9				
sanglifehrin A		Sanglifehrin A	187148-13-6				
sangre de grado		sangre de grado					
sanguinarine	2447-54-3	Sanguinarium	2447-54-3	AV9VK043SS	Cardiotonic Agents	Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)	
sannoshashinto		sannoshashinto					
sanshool	504-97-2	alpha-Sanshool	504-97-2	YB7LBG97PX			
SANT-1 compound		SANT-1 compound					
SANT-2 compound		SANT-2 compound					
santicizer 148	96300-95-7	Isodecyl diphenyl phosphate mixt. with triphenyl phosphate	96300-95-7				
Santonin	481-06-1	Santonin	481-06-1	1VL8J38ERO	Antinematodal Agents	Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)	
Santowhite powder	85-60-9	Santowhite	85-60-9	IM86P8WF2S			
sapanisertib		Sapanisertib	1224844-38-5	JGH0DF1U03			
saponin QA-21V1		qs-21-apiose isomer	141256-04-4	3LHL0S9KBM	Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	Investigated for use/treatment in genital herpes, HIV infection, hepatitis (viral, B), influenza, malaria, melanoma, and viral infection.
saponin Rb1, Panax notoginsenoside		saponin Rb1, Panax notoginsenoside					
Saponins		Saponins	6805-41-0		Cardiovascular Agents	Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)	
sappanchalcone	94344-54-4	Sappanchalcone	94344-54-4				
sappanone A		Sappanone A	104778-14-5	659E9Z3J5X			
saprisartan potassium	146613-90-3	Saprisartan potassium	146613-90-3	T28707PG7T	Angiotensin II Type 1 Receptor Blockers	Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)	
sapropterin		Sapropterin	62989-33-7	EGX657432I			For the treatment of tetrahydrobiopterin (BH4) deficiency.
Saquinavir	127779-20-8	Saquinavir	127779-20-8	L3JE09KZ2F	Cytochrome P-450 CYP3A Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A. (See all compounds classified as Cytochrome P-450 CYP3A Inhibitors.)	Saquinavir is indicated, in combination with ritonavir and other antiretroviral agents, for the treatment of HIV-1 infection in patients 16 years of age and older.
SAR 020106		(R)-5-(8-Chloroisoquinolin-3-Ylamino)-3-(1-(Dimethylamino)propan-2-Yloxy)pyrazine-2-Carbonitrile					
SAR7334		4-(((1R,2R)-2-((R)-3-aminopiperidin-1-yl)-2,3-dihydro-1H-inden-1-yl)oxy)-3-chlorobenzonitrile					
saracatinib		Saracatinib	379231-04-6	9KD24QGH76	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
sarafloxacin	98105-99-8	Sarafloxacin	98105-99-8	RC3WJ907XY			
sarafotoxins s6		Sarafotoxin 6c	121695-87-2		Vasoconstrictor Agents	Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)	
Saralasin	34273-10-4	Saralasin	34273-10-4		Angiotensin II Type 1 Receptor Blockers	Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)	
sarcophine	55038-27-2	Sarcophine	55038-27-2				
sarcophytolide		Sarcophytolide					
sargachromanol G		Sargachromanol G	856414-56-7				
sargahydroquinoic acid		Sargahydroquinoic acid					
sargaquinoic acid		70363-87-0					
Sarin	107-44-8	Sarin	107-44-8	B4XG72QGFM	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
sarizotan	177975-08-5	N-((3,4-Dihydro-2H-1-benzopyran-2-yl)methyl)-5-(4-fluorophenyl)-3-pyridinemethanamine	177975-08-5				
saroglitazar		Saroglitazar	495399-09-2	E0YMX3S4JD			
sarpogrelate	86819-20-7	4-[1-Dimethylamino-3-[2-[2-(3-ethylphenyl)ethyl]phenoxy]propan-2-yl]ox y-4-oxo-butanoic acid hydrochloride	86819-20-7				
sarsasapogenin	82597-74-8	Spirostan-3-ol	82597-74-8				
satraplatin		Satraplatin					
satratoxin G	53126-63-9	CID 23305158					
satratoxin H	53126-64-0	CID 156023764	53126-64-0				
sauchinone		Sauchinone	177931-17-8				
sauvagine	74434-59-6	Sauvagine	74434-59-6				
saxagliptin		Saxagliptin	361442-04-8	8I7IO46IVQ	Dipeptidyl-Peptidase IV Inhibitors	Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release. (See all compounds classified as Dipeptidyl-Peptidase IV Inhibitors.)	Treatment of type 2 diabetes mellitus to improve glycemic control in combination with other agents or as monotherapy.
Saxitoxin	35523-89-8	Saxitoxin	35523-89-8	Q0638E899B	Poisons	Substances which, when ingested, inhaled, or absorbed, or when applied to, injected into, or developed within the body in relatively small amounts may, by their chemical action, cause damage to structure or disturbance of function. (From Dorland, 27th ed) (See all compounds classified as Poisons.)	
sazetidine-A		5-Hexyn-1-ol, 6-[5-[(2S)-2-azetidinylmethoxy]-3-pyridinyl]-	820231-95-6	LH23S35NSM			
SB 203347		SB 203347					
SB 203580		4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole	152121-47-6	OU13V1EYWQ	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
SB 206553		Benzo(1,2-b:4,5-b')dipyrrole-1(2H)-carboxamide, 3,5-dihydro-5-methyl-N-3-pyridinyl-	158942-04-2	AL4387525T	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
SB 210661		1-((3S)-6-((2,6-Difluorophenyl)methoxy)-2,3-dihydrobenzofuran-3-yl)-1-hydroxyurea	162750-10-9	W3M5XAJ8H5			
SB 215505		6-Chloro-5-methyl-N-(quinolin-5-yl)indoline-1-carboxamide	162100-15-4				
SB 216763		3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione	280744-09-4				
SB 218078		SB-218078	135897-06-2	S6U3J3UP11			
SB 222200		3-methyl-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide	174635-69-9				
SB 223412	174636-32-9	Talnetant	174636-32-9	CZ3T9T146K			Investigated for use/treatment in schizophrenia and schizoaffective disorders, irritable bowel syndrome (IBS), and chronic obstructive pulmonary disease (COPD).
SB 22489G		SB 22489G					
SB 225002		1-(2-Bromophenyl)-3-(2-hydroxy-4-nitrophenyl)urea	182498-32-4	SSX8FD4H24			
SB 228357		N-(3-(3-Pyridinyl)-5-fluorophenyl)-5-methoxy-6-(trifluoromethyl)indoline-1-carboxamide	181629-93-6	5RDN2E8E97			
SB 239063		Cyclohexanol, 4-(4-(4-fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl)-, trans-	193551-21-2	HII3DC8CPI	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
SB 243213		5-methyl-N-[6-(2-methylpyridin-3-yl)oxypyridin-3-yl]-6-(trifluoromethyl)-2,3-dihydroindole-1-carboxamide	200940-22-3	R6MR8DB4PZ			
SB 258585		Benzenesulfonamide, 4-iodo-N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-	209480-63-7	54BP69J53F			
SB 269970		(R)-3-((2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidin-1-yl)sulfonyl)phenol	201038-74-6	KC8KP5XU6F			
SB 271046		5-chloro-N-(4-methoxy-3-(piperazin-1-yl)phenyl)-3-methylbenzo[b]thiophene-2-sulfonamide	209481-20-9	L3SK5KX24S			
SB 273005		SB 273005					
SB 277011		N-[4-[2-(6-cyano-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]cyclohexyl]quinoline-4-carboxamide	215803-78-4	CHW57ND47C			
SB 290157		(2S)-5-(diaminomethylideneamino)-2-[[2-(2,2-diphenylethoxy)acetyl]amino]pentanoic acid					
SB 297006		(S)-Ethyl 2-benzamido-3-(4-nitrophenyl)propanoate	58816-69-6				
SB 399885		N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-(1-piperazinyl)benzenesulfonamide	402713-80-8	5BH7TN3FWY			
SB 3CT compound		2-[(4-Phenoxyphenyl)sulfonylmethyl]thiirane	292605-14-2				
SB 657510		2-Bromo-N-[4-chloro-3-[[(3R)-1-methyl-3-pyrrolidinyl]oxy]phenyl]-4,5-dimethoxybenzenesulfonamide	474960-44-6				
SB 743921		(R)-N-(3-aminopropyl)-N-(1-(3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methylpropyl)-4-methylbenzamide hydrochloride	940929-33-9	2YW6FB68GM			Investigated for use/treatment in cancer/tumors (unspecified) and lymphoma (non-hodgkin's).
SB-332235		1-(4-Chloro-2-hydroxy-3-sulfamoyl-phenyl)-3-(2,3-dichlorophenyl)urea	276702-15-9	5HLP8UVL8M			
SB219994		(2S)-3-[4-[2-(1,3-benzoxazol-2-yl-methylamino)ethoxy]phenyl]-2-(2,2,2-trifluoroethoxy)propanoic acid					
SB939 compound		SB939 compound					
SBA-15		SBA-15					
SBI-425		3-Pyridinecarboxamide, 5-[[(5-chloro-2-methoxyphenyl)sulfonyl]amino]-					
SBI-797812		1-(4-((8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)sulfonyl)phenyl)-3-(pyridin-4-ylmethyl)urea					
SC 299		SC 299					
SC 41930	120072-59-5	BioMed 101	120072-59-5	EVH7O0422T	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Investigated for use/treatment in adverse effects (chemotherapy) and renal cell carcinoma.
SC 45647		Glycine, N-(((4-cyanophenyl)amino)((1-phenylethyl)amino)methylene)-, (S)-	116869-20-6				
SC 514		4-Amino-[2,3'-bithiophene]-5-carboxamide	354812-17-2	EU3S753TY9			
SC 560		5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole	188817-13-2	6QX8U7AHB4	Cyclooxygenase Inhibitors	Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)	
SC 58560		SC 58560					
SC 791		COX-2 Inhibitor II	181696-33-3				
SC-203048		SC-203048					
SC-66 compound		SC-66 compound					
scalaradial	53527-28-9	Scalaradial	53527-28-9				
Scandium	7440-20-2	Scandium	7440-20-2	YUJ4U1EW7R			
Scarlet Red	85-83-6	Scarlet red	85-83-6	I35E9QU96C	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
SCH 14988		SCH 14988					
SCH 23390		(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol	87075-17-0	UGT5535REQ			
Sch 28080		2-Methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile	76081-98-6	00427X161I	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	
SCH 351591		N-(3,5-Dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide	444659-43-2	G6EF7V146S			
SCH 442416		2-(Furan-2-yl)-7-(3-(4-methoxyphenyl)propyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine	316173-57-6	ZMC4G1W59S	Adenosine A2 Receptor Antagonists	Compounds that selectively bind to and block the activation of ADENOSINE A2 RECEPTORS. (See all compounds classified as Adenosine A2 Receptor Antagonists.)	
SCH 51866		Cyclopent(4,5)imidazo(2,1-b)purin-4(1H)-one, 5,6a,7,8,9,9a-hexahydro-5-methyl-2-((4-(trifluoromethyl)phenyl)methyl)-, (6aR,9aS)-rel-	167298-74-0	F8GU4PSP29			
Sch 59228		Piperazine, 1-(3-bromo-8-chloro-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-yl)-4-((1-oxido-4-pyridinyl)acetyl)-	183482-17-9				
SCH-202676		Methanamine, N-(2,3-diphenyl-1,2,4-thiadiazol-5(2H)-ylidene)-					
SCH772984		(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide					
schaftoside		Schaftoside	51938-32-0				
Schiff Bases		CID10293439					
schisanhenol		Schisanhenol	69363-14-0	80Y5907NIW			
schizandrer A	82042-38-4	Schizandrer A	82042-38-4				
schizandrin A		schisandrin A	61281-38-7	74XQL5DO3S			
schizandrin B		gomisin N	61281-37-6	02XA4X3KZW	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
schizandrin C		Schisandrin C	61301-33-5	C8754W6B3G			
schizandrol B	58546-54-6	Gomisin A	58546-54-6		Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	
sciadopitysin	521-34-6	Sciadopitysin	521-34-6	WL44VY201L			
SCIO-469		Talmapimod	309913-83-5	B1E00KQ6NT			Investigated for use/treatment in pain (acute or chronic) and rheumatoid arthritis.
scirpusin B		Scirpusin B	69297-49-0				
sclareol	515-03-7	Sclareol	515-03-7	B607NP0Q8Y			
scolymoside		Scolymoside	25694-72-8	ALJ2FB4ZDM			
scoparone	120-08-1	Scoparone	120-08-1	H5841PDT4Y	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
Scopolamine		Scopolamine	114-49-8		Adjuvants, Anesthesia	Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)	Scopolamine is indicated in adult patients for the prevention of nausea and vomiting associated with motion sickness and for the prevention of postoperative nausea and vomiting (PONV) associated with anesthesia or opiate analgesia.
Scopolamine Derivatives		Scopolamine Derivatives					
Scopoletin	92-61-5	Scopoletin	92-61-5	KLF1HS0SXJ			
scopolin	531-44-2	Scopolin	531-44-2	1Y49270PY8			
Scorpion Venoms		Scorpion Venoms					
SCR007		SCR007					
scriptaid		Scriptaid	287383-59-9	EJQ8CD8BSV	Histone Deacetylase Inhibitors	Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)	
scutebarbatine A		Scutebarbatine A					
scutellarein		Scutellarein	529-53-3	P460GTI853			
scutellarein tetramethyl ether		Tetramethylscutellarein	1168-42-9	DWN851IYG6			
Scutellaria baicalensis extract		Scutellaria baicalensis extract					
Scutellaria barbata extract		Scutellaria barbata extract					
scutellarin		Scutellarin	27740-01-8	16IGP0ML9A			
scymnol sulfate ester	119068-78-9	Sodium scymnol sulfate	119068-78-9	FS43TYT77C			
SD 1029		SD 1029					
SD-208		2-(5-chloro-2-fluorophenyl)-N-(pyridin-4-yl)pteridin-4-amine	627536-09-8				
SDZ 51641	91456-99-4	2-(1,1-Dimethylethyl)-2-(4-methylphenyl)-1,3-dioxolane	91456-99-4				
SDZ CPI 975		Sdz-cpi-975	157244-53-6	H5ZBP81CU0			
SDZ EAA 494	137424-80-7	Sdz eaa 494	132014-88-1		Excitatory Amino Acid Antagonists	Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)	
SDZ FOX 988		CID5491458					
SDZ HDL 376		SDZ HDL 376					
SEA 0400		2-(4-((2,5-Difluorobenzyl)oxy)phenoxy)-5-ethoxyaniline	223104-29-8				
Sealapex	115055-59-9	Sealapex					
sebacic acid	111-20-6	Sebacic Acid	111-20-6	97AN39ICTC			
Secobarbital	76-73-3	Secobarbital	76-73-3	1P7H87IN75	GABA Modulators	Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)	For the Short-term treatment of intractable insomnia for patients habituated to barbiturates
secoboldine		Secoboldine					
secoisolariciresinol	29388-59-8	Secoisolariciresinol	29388-59-8	M8QRJ7JEJH	Phytoestrogens	Compounds derived from plants, primarily ISOFLAVONES that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS. (See all compounds classified as Phytoestrogens.)	
secoisolariciresinol diglucoside		Secoisolariciresinol diglucoside	158932-33-3	T9281L29MV			
secomilbemycin D		secomilbemycin D					
Secosteroids		Secosteroids					
secramine A		Secramine A					
secretoneurin	149146-12-3	secretoneurin					
securinine	5610-40-2	Securinine	5610-40-2	G4VS580P5E			
sedoheptulose 1,7-bisphosphate	815-91-8	Sedoheptulose 1,7-bisphosphate	815-91-8				
selamectin		Selamectin	220119-17-5	A2669OWX9N	Antiparasitic Agents	Drugs used to treat or prevent parasitic infections. (See all compounds classified as Antiparasitic Agents.)	Cats and dogs: Treatment and prevention of flea infestations caused by Ctenocephalides spp. for one month following a single administration. This is as a result of the adulticidal, larvicidal and ovicidal properties of the product. The product is ovicidal for 3 weeks after administration. Through a reduction in the flea population, monthly treatment of pregnant and lactating animals will also aid in the prevention of flea infestations in the litter up to seven weeks of age. The product can be used as part of a treatment strategy for flea allergy dermatitis and through its ovicidal and larvicidal action may aid in the control of existing environmental flea infestations in areas to which the animal has access. Prevention of heartworm disease caused by Dirofilaria immitis with monthly administration. The product may be safely administered to animals infected with adult heartworms, however, it is recommended, in accordance with good veterinary practice, that all animals 6 months of age or more living in countries where a vector exists should be tested for existing adult heartworm infections before beginning medication with the product. It is also recommended that dogs should be tested periodically for adult heartworm infections, as an integral part of a heartworm prevention strategy, even when the product has been administered monthly. This product is not effective against adult D. immitis. Treatment of ear mites (Otodectes cynotis). Cats: Treatment of biting lice infestations (Felicola subrostratus)Treatment of adult roundworms (Toxocara cati)Treatment of adult intestinal hookworms (Ancylostoma tubaeforme)Treatment of biting lice infestations (Trichodectes canis)Treatment of sarcoptic mange (caused by Sarcoptes scabiei)
Selective Estrogen Receptor Modulators		Selective Estrogen Receptor Modulators					
Selective Serotonin Reuptake Inhibitors		Selective Serotonin Reuptake Inhibitors					
Selegiline		Selegiline	14611-51-9	2K1V7GP655	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	Monotherapy for initial treatment of Parkinson's disease, as well as an adjunct therapy in patients with a decreased response to levodopa/carbadopa. Also used for the palliative treatment of mild to moderate Alzheimer's disease and at higher doses, for the treatment of depression.
selenaproline	63578-00-7	1,3-Selenazolidine-4-carboxylic acid	63578-00-7				
Selenic Acid		Selenic acid	7783-08-6	HV0Y51NC4J	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	Indicated for use as a nutritional supplement.
Selenious Acid	7783-00-8	Selenious Acid	7783-00-8	F6A27P4Q4R	Trace Elements	A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)	Selenium injection is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN). Administration of selenious acid in TPN formulas helps to maintain plasma selenium levels and also to maintain endogenous stores to prevent deficiency.  Selenium compounds, such as selenium sulfide, are used topically in anti-dandruff shampoos and in cases of seborrhea.    For the purpose of brevity, selenite will the focus of discussion, and more information about selenium can be obtained at [DB11135].
Selenium	7782-49-2	Selenium	7782-49-2	H6241UJ22B	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	For the supplementation of total parenteral nutrition to prevent hyposelenemia.
Selenium Compounds		C.I. 77805					
Selenium Oxides		Selenium oxide					
selenium tetrachloride	10026-03-6	Selenium tetrachloride	10026-03-6	4GB8868P5J			
selenium-cisplatin conjugate		selenium-cisplatin conjugate					
seleno-furanoside		seleno-furanoside					
selenobetaine	97507-71-6	Carboxymethyl(dimethyl)selanium	97507-71-6				
selenobiotin	57956-29-3	Selenobiotin	57956-29-3				
Selenocysteine	10236-58-5	Selenocysteine	10236-58-5	0CH9049VIS			
selenocystine	1464-43-3	Selenocystine	2897-21-4		Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
Selenomethionine	1464-42-2	Selenomethionine	1464-42-2	J9V40V4PKZ			
selenomethylselenocysteine	2574-71-2	Methylselenocysteine	2574-71-2		Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	
selenophosphate	12509-41-0	Phosphino, selenoxo-	12509-41-0				
seletinoid G		seletinoid G	637357-50-7				
selinexor		Selinexor	1393477-72-9	31TZ62FO8F			Selinexor is indicated in combination with [bortezomib] and [dexamethasone] for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. Selinexor is also indicated in combination with [dexamethasone] for the treatment of relapsed or refractory multiple myeloma in adult patients who have received at least four prior therapies and who are refractory to at least two proteasome inhibitors, two immunomodulatory agents, and an anti-CD38 monoclonal antibody.  Selinexor is also indicated under an accelerated approval scheme for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including that arising from follicular lymphoma, in adult patients who have received at least two prior lines of systemic therapy. Continued approval for this indication may be contingent on verification in confirmatory clinical trials.
selonsertib		Selonsertib	1448428-04-3	NS3988A2TC	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	Treatment of non-alcoholic steatohepatitis (NASH)
semapimod		Semapimod	352513-83-8	9SGW2H1K8P	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
Semaxinib		Semaxanib	194413-58-6	71IA9S35AJ	Angiogenesis Inhibitors	Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. (See all compounds classified as Angiogenesis Inhibitors.)	Investigated for use/treatment in colorectal cancer and lung cancer.
semiquinone radicals	3225-29-4	1,4-Benzoquinone	106-51-4	3T006GV98U	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
Semustine	13909-09-6	Semustine	13909-09-6	2281H4FBL9	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	
senecionine	130-01-8	Senecionine	130-01-8	BO6N1U5YG6	Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	
seneciphylline	480-81-9	Seneciphylline	480-81-9	0ZYZ9L5454			
senkirkine	2318-18-5	Senkirkine	2318-18-5	X65P7V4LVJ			
senktide	106128-89-6	Senktide	106128-89-6				
seocalcitol	134404-52-7	Seocalcitol	134404-52-7	Q0OZ0D9223	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	
sepantronium		Sepantronium	753440-91-4	UZ77T1VFBM			
sephadex	9014-76-0	sephadex					
sepiapterin		Sepiapterin	17094-01-8	CJQ26KO7HP			
septilin		Septilin					
Ser-Phe-Asn-Ser-Tyr-Glu-Leu-Gly-Glu-Ser-Leu		Ser-Phe-Asn-Ser-Tyr-Glu-Leu-Gly-Glu-Ser-Leu					
seratrodast		Seratrodast	112665-43-7	4U58JM421N	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
sergliflozin		Sergliflozin etabonate	408504-26-7	4HY3523466	Sodium-Glucose Transporter 2 Inhibitors	Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS. (See all compounds classified as Sodium-Glucose Transporter 2 Inhibitors.)	
Serine	56-45-1	Serine	56-45-1	452VLY9402			Used as a natural moisturizing agent in some cosmetics and skin care products.
Serine Proteinase Inhibitors		Proteinase inhibitor, serine					
Serotonin	50-67-9	Serotonin	50-67-9	333DO1RDJY	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	
Serotonin Agents		Serotonin Agents					
serpentine (alkaloid)	18786-24-8	Serpentine	18786-24-8				
sertaconazole	99592-32-2	Sertaconazole	99592-32-2	72W71I16EG	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	For the topical treatment of interdigital tinea pedis in immunocompetent patients 12 years of age and older, caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum.
sertindole		Sertindole	106516-24-9	GVV4Z879SP	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Used in the treatment of schizophrenia.
Sertraline	79617-96-2	Sertraline	79617-96-2	QUC7NX6WMB	Selective Serotonin Reuptake Inhibitors	Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Selective Serotonin Reuptake Inhibitors.)	Sertraline is indicated for the management of major depressive disorder (MDD), post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), panic disorder (PD), premenstrual dysphoric disorder (PMDD), and social anxiety disorder (SAD). Common off-label uses for sertraline include the prevention of post stroke depression, generalized anxiety disorder (GAD), fibromyalgia, premature ejaculation, migraine prophylaxis, diabetic neuropathy, and neurocardiogenic syncope.
seryl-arginyl-leucyl-leucyl-argininamide		seryl-arginyl-leucyl-leucyl-argininamide					
seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide		Sligrl-NH2					
Sesame Oil	8008-74-0	Sesame Oil					
sesamex	51-14-9	Sesamex	51-14-9	RKX68JE7G6			
sesamin	607-80-7	Sesamin	607-80-7	FY3S29JVC9	Anticholesteremic Agents	Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)	
sesamol	533-31-3	3,4-Methylenedioxyphenol	533-31-3	94IEA0NV89	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
Sesquiterpenes		Sesquiterpenes					
setanaxib		2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione	1218942-37-0	45II35329V			Treatment of primary biliary cholangitis
setmelanotide		Setmelanotide	920014-72-8	N7T15V1FUY			Setmelanotide is indicated for chronic weight management in patients 6 years and older with obesity due to pro-opiomelanocortin (POMC) deficiency, proprotein subtilisin/kexin type 1 (PCSK1) deficiency, or leptin receptor (LEPR) deficiency as determined by an approved test demonstrating variants in POMC, PCSK1, or LEPR genes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance. These conditions affect the MC4R signalling pathway.  Setmelanotide is also indicated for chronic weight management in patients 6 years and older with obesity due to Bardet-Biedl syndrome.  The drug is not reported to be effective in patients with POMC, PCSK1, or LEPR variants classified as benign or likely benign, as well as other types of obesity not listed above.
setoperone	86487-64-1	Setoperone	86487-64-1	BQ67CS3Q3E	Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	
Sevelamer		2-(Chloromethyl)oxirane; prop-2-en-1-amine	52757-95-6		Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	
Sevoflurane		Sevoflurane	28523-86-6	38LVP0K73A	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	Sevoflurane is used for the induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.
SEW2871		5-[4-Phenyl-5-(trifluoromethyl)-2-thienyl]-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole	256414-75-2		Sphingosine 1 Phosphate Receptor Modulators	Agents that affect the function of G-protein coupled SPHINGOSINE 1-PHOSPHATE RECEPTORS. Their binding to the receptors blocks lymphocyte migration and are often used as IMMUNOSUPPRESSANTS. (See all compounds classified as Sphingosine 1 Phosphate Receptor Modulators.)	
Sewage		Sewage					
Sex Attractants		Sex Attractants					
SF 2446A1	115834-23-6	Antibiotic SF 2446A1	115834-23-6				
SGA 360		SGA 360					
SGC707		1-(Isoquinolin-6-yl)-3-(2-oxo-2-(pyrrolidin-1-yl)ethyl)urea					
SGI-1027		N-(4-((2-amino-6-methylpyrimidin-4-yl)amino)phenyl)-4-(quinolin-4-ylamino)benzamide	1020149-73-8				
SH-053-2'F-R-CH3		SH-053-2'F-R-CH3					
SH-6 compound		SH-6 compound					
shenqui-wan		shenqui-wan					
shexiang baoxin		shexiang baoxin					
Shi-Bi-Lin herbal formula		Shi-Bi-Lin herbal formula					
Shiga Toxin	75757-64-1	Shiga Toxin					
Shiga Toxin 1		Shiga Toxin 1					
Shiga Toxin 2		Shiga Toxin 2					
Shiga toxin subunit A		Shiga toxin subunit A					
shigyaku-san		Shigyaku-san					
Shikimic Acid	138-59-0	Shikimic acid	138-59-0	29MS2WI2NU			
shikonin		Shikonin	517-89-5	3IK6592UBW	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
sho-saiko-to-kyo-shokyo-ka-oren-bukuryo		sho-saiko-to-kyo-shokyo-ka-oren-bukuryo					
sho-seiryu-to		sho-seiryu-to					
shogaol	555-66-8	Shogaol	555-66-8	83DNB5FIRF	Mutagens	Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)	
shosaiko-to		LS-145100					
SHP099		6-(4-Azanyl-4-Methyl-Piperidin-1-Yl)-3-[2,3-Bis(Chloranyl)phenyl]pyrazin-2-Amine					
SHU 9119	168482-23-3	CID 9898183					
shuang-huang-lian		shuang-huang-lian					
shuanghuang shengbai		shuanghuang shengbai					
Shuangling Fuzheng anticancer preparation		Shuangling Fuzheng anticancer preparation					
Shuangshen		Shuangshen					
SI 27		SI 27					
si-wu-tang		si-wu-tang					
Sialic Acids		NEURAMINIC ACID, N-ACETYL-MIXTURE WITH NEURAMINIC ACID					
sialogangliosides		sialogangliosides					
Sialoglycoproteins		Sialoglycoproteins					
Sialyl Lewis X Antigen		sialyl Lewis x antigen					
SIB 1757		6-Methyl-2-(phenylazo)-3-pyridinol	31993-01-8				
SIB 1893		2-Methyl-6-(2-phenylethenyl)pyridine	7370-21-0	4X2F5X24UK			
sibutramine	106650-56-0	Sibutramine	106650-56-0	WV5EC51866	Appetite Depressants	Agents that are used to suppress appetite. (See all compounds classified as Appetite Depressants.)	For the treatment of obesity.
sidnocarb	34262-84-5	Mesocarb	34262-84-5	UMT8MP2NDU	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
Sijunzi decoction		Sijunzi decoction					
Sildenafil Citrate		Sildenafil Citrate	171599-83-0	BW9B0ZE037	Phosphodiesterase 5 Inhibitors	Compounds that specifically inhibit PHOSPHODIESTERASE 5. (See all compounds classified as Phosphodiesterase 5 Inhibitors.)	AdultsTreatment of adult patients with pulmonary arterial hypertension classified as WHO functional class II and III, to improve exercise capacity. Efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease. Paediatric populationTreatment of paediatric patients aged 1 year to 17 years old with pulmonary arterial hypertension. Efficacy in terms of improvement of exercise capacity or pulmonary haemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease (see section 5. 1).
Silica Gel	60650-90-0	Silicon Dioxide	14808-60-7	ETJ7Z6XBU4			
silica-calcium phosphate nanocomposite		silica-calcium phosphate nanocomposite					
Silicates		Silicates					
Silicic Acid	1343-98-2	Silicic acid					
Silicon	7440-21-3	Silicon	7440-21-3	Z4152N8IUI	Trace Elements	A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)	
silicon carbide	409-21-2	Silicon carbide	409-21-2		Biocompatible Materials	Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function. (See all compounds classified as Biocompatible Materials.)	
Silicon Compounds		Silicon Compounds					
Silicon Dioxide	7631-86-9	Silicon Dioxide	14808-60-7	ETJ7Z6XBU4			
silicon titanium dioxide		silicon titanium dioxide					
silidianin		Silidianin	29782-68-1	7P89L7W179			
silmitasertib		Silmitasertib	1009820-21-6	C6RWP0N0L2			
silodosin		Silodosin	160970-54-7	CUZ39LUY82	Adrenergic alpha-1 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)	Silodosin is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). It is not indicated for the treatment of hypertension.
Silver	7440-22-4	Silver	7440-22-4	3M4G523W1G			Indicated for the treatment of acne for topical use or the management of dental caries for dental use.
silver acetate	563-63-3	Silver acetate	563-63-3	19PPS85F9H			
silver chloride	7783-90-6	Silver Chloride	7783-90-6	MWB0804EO7			
Silver Compounds		Silver compounds					
Silver Nitrate	7761-88-8	Silver Nitrate	7761-88-8	95IT3W8JZE	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
Silybin	22888-70-6	Silibinin	65666-07-1	33X338MNE4	Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	Currently being tested as a treatment of severe intoxications with hepatotoxic substances, such as death cap (Amanita phalloides) poisoning.
silybin-phytosome		silybin-phytosome					
silychristin	33889-69-9	Silicristin	33889-69-9	LK279ER14X			
Silymarin		Silymarin	65666-07-1		Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
Simazine	122-34-9	Simazine	122-34-9	SG0C34SMY3	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Simendan	131741-08-7	Simendan	131741-08-7	349552KRHK	Cardiotonic Agents	Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)	
simiaowan		simiaowan					
Simvastatin	79902-63-9	Simvastatin	79902-63-9	AGG2FN16EV	Hydroxymethylglutaryl-CoA Reductase Inhibitors	Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)	Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLC), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).  This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH).  Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease.  Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.
simvastatin acid	121009-77-6	Simvastatin acid	121009-77-6	9L6M5TH46B			
simvastatin hydroxyacid		simvastatin hydroxyacid					
sinapinic acid	530-59-6	Sinapinic acid	7362-37-0	P0I60993EC	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
Sincalide	25126-32-3	Sincalide	25126-32-3	M03GIQ7Z6P			As the product Kinevac (FDA), sincalide is used for the following indications: 1) to stimulate gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol, bile salts, phospholipids, and crystals; (2) to stimulate pancreatic secretion in combination with secretin prior to obtaining a duodenal aspirate for analysis of enzyme activity, composition, and cytology; (3) to accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract.
sinefungin	58944-73-3	Sinefungin	58944-73-3	W2U467CIIL	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
sinensetin	2306-27-6	Sinensetin	2306-27-6	240LNZ51AT			
single bond		single bond					
Singlet Oxygen	17778-80-2	Atomic oxygen	29407-84-9		Oxidants	Electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION). (See all compounds classified as Oxidants.)	
sinigrin	534-69-0	[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-N-sulfooxybut-3-enimidothioate	534-69-0				
sinomenine	115-53-7	Sinomenine	115-53-7	63LT81K70N	Antirheumatic Agents	Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)	
sinularin		Sinularin	65669-72-9				
siomycin A		Siomycin A	11017-43-9		Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	
siponimod		Siponimod	1230487-00-9	RR6P8L282I	Sphingosine 1 Phosphate Receptor Modulators	Agents that affect the function of G-protein coupled SPHINGOSINE 1-PHOSPHATE RECEPTORS. Their binding to the receptors blocks lymphocyte migration and are often used as IMMUNOSUPPRESSANTS. (See all compounds classified as Sphingosine 1 Phosphate Receptor Modulators.)	This drug is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.
Sirolimus	53123-88-9	Sirolimus	53123-88-9	W36ZG6FT64	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Sirolimus is indicated for the prophylaxis of organ rejection in patients aged 13 years or older receiving renal transplants. In patients at low-to moderate-immunologic risk, it is recommended that sirolimus be used initially in a regimen with [cyclosporine] and corticosteroids; cyclosporine should be withdrawn two to four months after transplantation. In patients at high-immunologic risk (defined as Black recipients and/or repeat renal transplant recipients who lost a previous allograft for immunologic reason and/or patients with high panel-reactive antibodies [PRA; peak PRA level > 80%]), it is recommended that sirolimus be used in combination with cyclosporine and corticosteroids for the first year following transplantation.  It is also used to treat lymphangioleiomyomatosis.   In the US, albumin-bound sirolimus for intravenous injection is indicated for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumour (PEComa).  In Europe, it is recommended that sirolimus for the prophylaxis of organ rejection in renal transplants is used in combination with cyclosporin microemulsion and corticosteroids for two to three months. Sirolimus may be continued as maintenance therapy with corticosteroids only if cyclosporin microemulsion can be progressively discontinued.  Topical sirolimus is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis in adults and pediatric patients six years of age and older.
sirtinol		Sirtinol	410536-97-9				
sitafloxacin	163253-35-8	Sitafloxacin hydrate	163253-37-0	45IP57B62B	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Sitagliptin Phosphate		Sitagliptin Phosphate	654671-78-0	TS63EW8X6F	Incretins	Peptides which stimulate INSULIN release from the PANCREATIC BETA CELLS following oral nutrient ingestion, or postprandially. (See all compounds classified as Incretins.)	
sitaxsentan		Sitaxentan	184036-34-8	J9QH779MEM	Endothelin Receptor Antagonists	Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN RECECPTORS. (See all compounds classified as Endothelin Receptor Antagonists.)	Investigated for use/treatment in pulmonary hypertension, connective tissue diseases, hypertension, and congestive heart failure.
Sitosterols		Sitosterols	12002-39-0				
sivelestat	127373-66-4	Sivelestat	127373-66-4	DWI62G0P59	Serine Proteinase Inhibitors	Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)	
Sizofiran		Schizophyllan	9050-67-3		Adjuvants, Immunologic	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)	
SJ 000311413		SJ 000311413					
SK-7041		4-(dimethylamino)-N-[[4-[(E)-3-(hydroxyamino)-3-oxoprop-1-enyl]phenyl]methyl]benzamide	617690-98-9				
SK&F 10047	7619-35-4	2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3-allyl-6,11-dimethyl-	825594-24-9		Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
SK&F 104078	110857-22-2	6-Chloro-3-methyl-9-(3-methylbut-2-enoxy)-1,2,4,5-tetrahydro-3-benzazepine	110857-22-2	22XBK6DY1E	Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	
SK&F 104856	138194-10-2	7-Chloro-2-ethenyl-3,4,5,6-tetrahydro-4-methylthieno(4,3,2-ef)(3)benzazepine	136427-58-2				
SK&F 106760	126053-71-2	2-[(4R,7S,13S,16R)-16-acetamido-4-carbamoyl-13-[3-(diaminomethylideneamino)propyl]-3,3,14-trimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetrazacycloheptadec-7-yl]acetic acid	126053-71-2				
SK&F 550	38776-87-3	N-(2-Chloroethyl)-N-methyl-9H-fluoren-9-amine	38776-87-3				
SK&F 77434		3-Allyl-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine	104422-04-0	XA99M7XZR5	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
SK&F 81297	71636-61-8	6-Chloro-2,3,4,5-tetrahydro-1-phenyl-1H-3-benzazepine-7,8-diol	71636-61-8	9GBP09E08K	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
SK&F 82958	80751-65-1	6-Chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine	80751-65-1	7W60FE897Q	Dopamine Agonists	Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)	
SK&F 83959	80751-85-5	3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine	80751-85-5	8CJ9F3C4Q0			
SK&F 91488	68643-23-2	4-(Dimethylamino)butyl carbamimidothioate	68643-23-2	1I4LVX494H	Histamine Agonists	Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. (See all compounds classified as Histamine Agonists.)	
Skatole	83-34-1	Skatole	83-34-1	9W945B5H7R			
skepinone-L		Skepinone-L	1221485-83-1				
SKF 105111		SKF 105111					
SKF 82957	74115-04-1	3-Methyl-6-chloro-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine	74115-04-1				
skullcapflavone II	55084-08-7	Skullcapflavone II	55084-08-7	BV62EAN2VM			
SL 327		alpha-[Amino[(4-aminophenyl)thio]methylene]-2-(trifluoromethyl)benzeneacetonitrile	305350-87-2				
SL0101		5,7-Dihydroxy-2-(4-Hydroxyphenyl)-4-Oxo-4h-Chromen-3-Yl 3,4-Di-O-Acetyl-6-Deoxy-Alpha-L-Mannopyranoside	77307-50-7				
SLC-0111		4-{[(4-Fluorophenyl)carbamoyl]amino}benzenesulfonamide	178606-66-1	ANM9DBL9JT			
SM 164		(3S,3'S,6S,6'S,10aS,10a'S)-N,N'-((1S,1'S)-((1,4-phenylenebis(butane-4,1-diyl))bis(1H-1,2,3-triazole-1,4-diyl))bis(phenylmethylene))bis(6-((S)-2-(methylamino)propanamido)-5-oxodecahydropyrrolo[1,2-a]azocine-3-carboxamide)	957135-43-2	G2VA4GC8KB			
SM 21	155156-22-2	3-alpha-Tropanyl-(2-Cl)-acid phenoxybutyrate	155156-22-2				
SM-1 compound		SM-1 compound					
SMe1EC2		SMe1EC2					
Smoke		Smoke					
SN50 peptide		SN50 peptide					
Snake Venoms		Snake Venoms					
SNX 2112		4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide	908112-43-6	10C9P3FFOW			
SNX 482		H-Gly-Val-Asp-Lys-Ala-Gly-Cys(1)-Arg-Tyr-Met-Phe-Gly-Gly-Cys(2)-Ser-Val-Asn-Asp-Asp-Cys(3)-Cys(1)-Pro-Arg-Leu-Gly-Cys(2)-His-Ser-Leu-Phe-Ser-Tyr-Cys(3)-Ala-Trp-Asp-Leu-Thr-Phe-Ser-Asp-OH	203460-30-4				
so-ochim-tang-gamibang		so-ochim-tang-gamibang					
Sodium	7440-23-5	Sodium	7440-23-5	9NEZ333N27			
Sodium Acetate	6131-90-4	Sodium acetate trihydrate	6131-90-4				
sodium arsenate		Arsenic acid (H3AsO4), trisodium salt					
sodium arsenite	13768-07-5	Arsenenous acid	13768-07-5				
Sodium Azide	26628-22-8	Sodium azide	26628-22-8	968JJ8C9DV	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
Sodium Benzoate	532-32-1	Sodium Benzoate	532-32-1	OJ245FE5EU	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
Sodium Bicarbonate	144-55-8	Sodium Bicarbonate	144-55-8	8MDF5V39QO			Sodium bicarbonate is used for the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturateprotein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of blood pigments.
sodium bichromate	10588-01-9	Sodium Dichromate	10588-01-9	C9G6VY6ZZ4			
sodium bisulfide	16721-80-5	Sodium hydrosulfide	16721-80-5	FWU2KQ177W			
sodium bisulfite	7631-90-5	Sodium Bisulfite	7631-90-5	TZX5469Z6I	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
sodium boranocarbonate		sodium boranocarbonate					
sodium borate	1330-43-4	Sodium Borate	12267-73-1	91MBZ8H3QO			No FDA- or EMA-approved therapeutic indications on its own.
sodium borohydride	16940-66-2	Sodium borohydride	16940-66-2	87L0B9CPPA			
sodium bromate	7789-38-0	Sodium bromate	7789-38-0	U54JK6453O			
sodium bromide	7647-15-6	Sodium Bromide	7647-15-6	LC1V549NOM			
sodium chlorate	7775-09-9	Sodium Chlorate	7775-09-9	T95DR77GMR	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Sodium Chloride		Sodium Chloride	7647-14-5	451W47IQ8X			This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives.
Sodium Chloride Symporter Inhibitors		Sodium Chloride Symporter Inhibitors					
Sodium Chloride, Dietary		Sodium Chloride, Dietary					
Sodium Cholate	361-09-1	Sodium cholate	361-09-1	NU3Y4CCH8Z			
sodium chromate(VI)	7775-11-3	Sodium chromate	7775-11-3	6A49BO6K4M			
Sodium Citrate		Sodium Citrate	68-04-2	RS7A450LGA	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	Used as an anticoagulant during plasmophoresis as well as a neutralizing agent in the treatment of upset stomach and acidic urine.
sodium cyanate	917-61-3	Sodium cyanate	917-61-3	8UFS3JRV8P			
Sodium Cyanide	143-33-9	Sodium Cyanide	143-33-9	O5DDB9Z95G	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
sodium cyanoborohydride	25895-60-7	Sodium cyanoborohydride	25895-60-7	C4I8C58P9T	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
Sodium Dodecyl Sulfate	151-21-3	Sodium dodecyl sulfate	151-21-3	368GB5141J	Surface-Active Agents	Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)	SLS is used as a surfactant in shampoos and toothpastes. SLS also has microbicidal activities against both enveloped (Herpes simplex viruses, HIV-1, Semliki Forest virus) and nonenveloped (papillomaviruses, reovirus, rotavirus and poliovirus) viruses, although it has not been approved for this use.
Sodium Fluoride	7681-49-4	Sodium Fluoride	7681-49-4	8ZYQ1474W7	Cariostatic Agents	Substances that inhibit or arrest DENTAL CARIES formation. (Boucher&apos;s Clinical Dental Terminology, 4th ed) (See all compounds classified as Cariostatic Agents.)	Sodium fluoride in the oral or topical form is indicated for the prevention and control of dental caries and for the maintenance of dental health.  Fluoride supplements in the form of tablets and other formulas may be prescribed to prevent tooth decay in high-risk children aged 6 months to 16 years old whose drinking water source contains low fluoride concentrations.
Sodium Glutamate	142-47-2	Monosodium Glutamate	142-47-2	W81N5U6R6U	Flavoring Agents	Substances added to foods and medicine to improve the taste. (See all compounds classified as Flavoring Agents.)	
sodium houttuyfonate		Sodium houttuyfonate	83766-73-8	L01U4RI8IJ			
Sodium Hydroxide	1310-73-2	Sodium Hydroxide	1310-73-2	55X04QC32I	Caustics	Strong alkaline chemicals that destroy soft body tissues resulting in a deep, penetrating type of burn, in contrast to corrosives, that result in a more superficial type of damage via chemical means or inflammation. Caustics are usually hydroxides of light metals. SODIUM HYDROXIDE and potassium hydroxide are the most widely used caustic agents in industry. Medically, they have been used externally to remove diseased or dead tissues and destroy warts and small tumors. The accidental ingestion of products (household and industrial) containing caustic ingredients results in thousands of injuries per year. (See all compounds classified as Caustics.)	Used to destroy or kill the nail matrix (matrixectomies).
Sodium Hypochlorite	7681-52-9	Sodium Hypochlorite	7681-52-9	DY38VHM5OD	Disinfectants	Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley&apos;s Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Disinfectants.)	
sodium iodate	7681-55-2	Sodium iodate	7681-55-2	U558PCS5Z9			
Sodium Iodide	7681-82-5	Sodium Iodide	7681-82-5	F5WR8N145C			Indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN).
Sodium Lactate	72-17-3	Sodium Lactate	72-17-3	TU7HW0W0QT			
sodium laureth sulfate	3088-31-1	Sodium 2-(2-dodecyloxyethoxy)ethyl sulphate	3088-31-1	ZZQ59TY3KG			
sodium metabisulfite	7681-57-4	Sodium Metabisulfite	7681-57-4	4VON5FNS3C	Bronchoconstrictor Agents	Agents causing the narrowing of the lumen of a bronchus or bronchiole. (See all compounds classified as Bronchoconstrictor Agents.)	
sodium metasilicate	6834-92-0	Sodium silicate	6834-92-0	052612U92L			
sodium molybdate(VI)	7631-95-0	Sodium molybdate	7631-95-0	948QAQ08I1			
sodium nitrate	7631-99-4	Sodium Nitrate	7631-99-4	8M4L3H2ZVZ	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Sodium Nitrite	7632-00-0	Sodium Nitrite	7632-00-0	M0KG633D4F	Food Preservatives	Substances capable of inhibiting, retarding or arresting the process of fermentation, acidification or other deterioration of foods. (See all compounds classified as Food Preservatives.)	
Sodium Oxybate		Sodium Oxybate	502-85-2	7G33012534	Adjuvants, Anesthesia	Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)	Sodium oxybate is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients with narcolepsy. In the US and in Europe, the drug is approved for use in patients 7 years of age and older while in Canada, it is not recommended in children under the age of 18, unless clearly needed.
sodium p-perfluorous nonenoxybenzene sulfonate		Sodium p-perfluorous nonenoxybenzene sulfonate	70829-87-7				
sodium pentaborate		Sodium Pentaborate					
sodium percarbonate	14455-47-1	Sodium peroxocarbonate	14455-47-1				
sodium perchlorate	7601-89-0	Sodium perchlorate	7601-89-0	97F4MTY3VA			
sodium persulfate	7775-27-1	Sodium persulfate	7775-27-1	J49FYF16JE			
Sodium Pertechnetate Tc 99m	23288-60-0	Technetium Tc-99m Sodium Pertechnetate	23288-60-0	A0730CX801	Radiopharmaceuticals	Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)	
sodium phosphate	7632-05-5	Monosodium phosphate	7632-05-5	KH7I04HPUU			Used to treat constipation or to clean the bowel before a colonoscopy.
sodium propionate		Sodium propionate	137-40-6	DK6Y9P42IN			
Sodium Salicylate	54-21-7	Sodium Salicylate	54-21-7	WIQ1H85SYP	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
sodium selenide	1313-85-5	Sodium selenide	1313-85-5	1FEK1K7WCE			
Sodium Selenite	10102-18-8	Sodium Selenite	10102-18-8	HIW548RQ3W	Trace Elements	A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)	
sodium silicate	1344-09-8	Sodium silicate	6834-92-0	052612U92L			
sodium sulfide	1313-82-2	Disodium sulfide	1313-82-2				
sodium sulfite		Sodium Sulfite	7757-83-7	VTK01UQK3G			
Sodium Tetradecyl Sulfate	1191-50-0	Sodium tetradecyl sulfate	1191-50-0	2X50FW96YS	Sclerosing Solutions	Chemical agents injected into blood vessels and lymphatic sinuses to shrink or cause localized THROMBOSIS; FIBROSIS, and obliteration of the vessels. This treatment is applied in a number of conditions such as VARICOSE VEINS; HEMORRHOIDS; GASTRIC VARICES; ESOPHAGEAL VARICES; PEPTIC ULCER HEMORRHAGE. (See all compounds classified as Sclerosing Solutions.)	For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.
sodium tetrasulfide		Sodium tetrasulfide					
sodium thiocyanate	540-72-7	Sodium thiocyanate	540-72-7	5W0K9HKA05			
sodium thiosulfate	10102-17-7	Thiosulfuric acid, disodium salt, pentahydrate	10102-17-7		Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
sodium tungstate(VI)	13472-45-2	Sodium tungstate	13472-45-2	64LRH4405G			
sodium-4,5-dihydroxy-1,3-benzene disulfonate		sodium-4,5-dihydroxy-1,3-benzene disulfonate					
Sodium, Dietary		Sodium, Dietary					
Soil Pollutants		Soil Pollutants					
solabegron		Solabegron	252920-94-8	55P6YH9O6N	Adrenergic beta-3 Receptor Agonists	Compounds that bind to and activate ADRENERGIC BETA-3 RECEPTORS. (See all compounds classified as Adrenergic beta-3 Receptor Agonists.)	Investigated for use/treatment in diabetes mellitus type 2, irritable bowel syndrome (IBS), and urinary incontinence.
solanesol	13190-97-1	Solanesol	13190-97-1	FF31XTR2N4			
solanidine	80-78-4	Solanidine	80-78-4	W7801OHM8B			
solasodine	126-17-0	Solasodine	126-17-0	L40Y453Y96			
Solifenacin Succinate		Solifenacin Succinate	242478-38-2	KKA5DLD701	Muscarinic Antagonists	Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)	Treatment of neurogenic detrusor overactivity
solithromycin		Solithromycin	760981-83-7	9U1ETH79CK	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Investigated for the treatment of community-acquired pneumonia (CAP).
soluble tachyzoite antigen, Toxoplasma gondii		soluble tachyzoite antigen, Toxoplasma gondii					
Solvents		Solvents					
Soman	96-64-0	Soman	96-64-0	3OF3WXB67Q	Chemical Warfare Agents	Chemicals that are used to cause the disturbance, disease, or death of humans during WARFARE. (See all compounds classified as Chemical Warfare Agents.)	
Somatostatin	51110-01-1	Somatostatin-14	51110-01-1		Hormones	Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. (See all compounds classified as Hormones.)	For the symptomatic treatment of acute bleeding from esophageal varices. Other treatment options for long-term management of the condition may be considered if necessary, once initial control has been established.
sonidegib		Sonidegib	956697-53-3	0RLU3VTK5M			Sonidegib is approved for use in the US and EU for treatment of adults with locally advanced basal cell carcinoma (BCC) that has recurred post surgery or radiation therapy.  It is also approved for adult patients with BCC who are not eligible for surgery or radiation therapy. (2)
Soot		Soot					
sophocarpine	6483-15-4	Sophocarpine	6483-15-4	X9X8U6P2NP			
sophoranone		Sophoranone	23057-55-8				
sophoricoside		Sophoricoside	152-95-4	J0407L5MGM			
Sorafenib		Sorafenib	284461-73-0	9ZOQ3TZI87	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Sorafenib is indicated for the treatment of unresectable hepatocellular carcinoma and advanced renal cell carcinoma.  In the US, it is also indicated for the treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma that is refractory to radioactive iodine treatment.
Sorbic Acid	110-44-1	Sorbic Acid	110-44-1	X045WJ989B	Food Preservatives	Substances capable of inhibiting, retarding or arresting the process of fermentation, acidification or other deterioration of foods. (See all compounds classified as Food Preservatives.)	
sorbinil		Sorbinil	68367-52-2	G4186B906P			
sorbitan monolaurate		Span(R) 20	1338-39-2				
sorbitan monooleate		Sorbitan Monooleate	1338-43-8	06XEA2VD56	Surface-Active Agents	Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)	
Sorbitol	50-70-4	Sorbitol	50-70-4	506T60A25R	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	Used as a non-stimulant laxative via an oral suspension or enema.
Sorbose	3615-39-2	D-sorbose	3615-56-3	JJ09461NJS			
Sotalol	3930-20-9	Sotalol	3930-20-9	A6D97U294I	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	Sotalol is indicated to treat life threatening ventricular arrhytmias and maintain normal sinus rhythm in patients with atrial fibrillation or flutter. There are also oral solutions and intravenous injections indicated for patients requiring sotalol, but for whom a tablet would not be appropriate.
soterenol	13642-52-9	Soterenol	13642-52-9	9364W7589B			
sotorasib		Sotorasib	2252403-56-6	2B2VM6UC8G	Immune Checkpoint Inhibitors	Drugs that block negative regulator IMMUNE CHECKPOINT proteins (e.g., PD-1 RECEPTOR and CTLA-4 ANTIGEN) thereby increasing suppressed immune activation in immunotherapies. (See all compounds classified as Immune Checkpoint Inhibitors.)	Sotorasib is indicated in the treatment of KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) in adults who have received at least one prior systemic therapy.
sotrastaurin		Sotrastaurin	425637-18-9	7I279E1NZ8			
sovateltide		sovateltide					
soyasaponin Ab		soyasaponin Ab	118194-13-1				
soyasaponin I	51330-27-9	Soyasaponin I	51330-27-9				
soyasaponin II	55319-36-3	Soyasaponin II	55319-36-3				
Soybean Oil	8001-22-7	Soybean oil (JP17/USP)					
soybean oil, phospholipid emulsion		soybean oil, phospholipid emulsion					
SP 5186		SP 5186					
SP2509		(E)-N'-(1-(5-chloro-2-hydroxyphenyl)ethylidene)-3-(morpholinosulfonyl)benzohydrazide					
spantide	91224-37-2	Spantide I			Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
spantide II	129176-97-2	Spantide II	129176-97-2		Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
sparfloxacin		Sparfloxacin	110871-86-8	Q90AGA787L	Antitubercular Agents	Drugs used in the treatment of tuberculosis. They are divided into two main classes: &quot;first-line&quot; agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and &quot;second-line&quot; drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. (See all compounds classified as Antitubercular Agents.)	For the treatment of adults with the following infections caused by susceptible strains microorganisms: community-acquired pneumonia (caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae, or Streptococcus pneumoniae) and acute bacterial exacerbations of chronic bronchitis (caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus, or Streptococcus pneumoniae).
sparfosic acid		Sparfosic acid	51321-79-0	78QVZ7RG8L	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	
sparstolonin B		sparstolonin B					
Sparteine	90-39-1	Sparteine	90-39-1	298897D62S	Oxytocics	Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) (See all compounds classified as Oxytocics.)	
spathulenol	6750-60-3	Spathulenol	6750-60-3	7XV9L96SJJ			
spautin-1		6-Fluoro-N-(4-fluorobenzyl)quinazolin-4-amine	1262888-28-7				
SPD-304		6,7-Dimethyl-3-[(methyl{2-[methyl({1-[3-(trifluoromethyl)phenyl]-1H-indol-3-YL}methyl)amino]ethyl}amino)methyl]-4H-chromen-4-one	869998-49-2				
speciogynine		Speciogynine	4697-67-0	BB185OF16A			
spectaline		Spectaline					
Spermidine	124-20-9	Spermidine	124-20-9	U87FK77H25			
Spermine	71-44-3	Spermine	68956-56-9	2FZ7Y3VOQX			For nutritional supplementation, also for treating dietary shortage or imbalance
spermine nitric oxide complex	136587-13-8	Spermine NONOate	136587-13-8		Nitric Oxide Donors	A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)	
Sphingolipids		Sphingolipids					
Sphingomyelins		Sphingomyelins	85187-10-6				
Sphingosine	123-78-4	Sphingosine	123-78-4	0Y6SVQ612Q			
sphingosine 1-phosphate	26993-30-6	Sphingosine 1-phosphate	26993-30-6	YVE187NJ1U			
sphingosine phosphorylcholine	10216-23-6	Sphingosine phosphorylcholine	10216-23-6				
Spider Venoms		Spider Venoms					
spinetoram		Spinetoram	935545-74-7		Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
spinorphin	137201-62-8	Spinorphin	137201-62-8				
spinosad		SPINOSAD					
spinosyn A		Spinosyn A	131929-60-7	OY0L59V61N			
Spiperone	749-02-0	Spiperone	749-02-0	4X6E73CJ0Q	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
spiradoline	87151-85-7	Spiradoline mesylate salt			Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
spiraeoside	20229-56-5	Spiraeoside	20229-56-5	K2B74751XI			
spirapril	83647-97-6	Spirapril	83647-97-6	96U2K78I3V	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	Spirapril is an ACE inhibitor class drug used to treat hypertension.
Spiro Compounds		Spiro Compounds					
spiro(cyclohexane-1,3'(1'H)-furo(3,4-C)pyridine)-4-carboxamide, N-(1-(2-fluorophenyl)-1h-pyrazol-3-yl)-1'-oxo-, trans-		spiro(cyclohexane-1,3'(1'H)-furo(3,4-C)pyridine)-4-carboxamide, N-(1-(2-fluorophenyl)-1h-pyrazol-3-yl)-1'-oxo-, trans-	328232-95-7	HVE36P8422			
spiro(imidazo-(1,2-a)pyridine-3,2-indan)-2(3H)-one		spiro(imidazo-(1,2-a)pyridine-3,2-indan)-2(3H)-one					
spirodiclofen		Spirodiclofen	148477-71-8	3X7G31F5MX			
spiromesifen		Spiromesifen	283594-90-1	N726NTQ5ZC			
Spironolactone	52-01-7	Spironolactone	52-01-7	27O7W4T232	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	Spironolactone is indicated for the treatment of the following conditions:  - NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and reduce the need for hospitalization for heart failure. Spironolactone is usually administered in conjunction with other heart failure therapies. - Hypertension, as add-on therapy, in patients not adequately controlled by other agents. - Edema associated with hepatic cirrhosis when edema is not responsive to fluid and sodium restriction. - Edema associated with nephrotic syndrome when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics produce an inadequate response. - Refractory edema associated with congestive cardiac failure, malignant ascites, hepatic cirrhosis with ascites, and essential hypertension. - Short-term preoperative treatment of patients with primary hyperaldosteronism. - Diagnosis of primary aldosteronism. - Long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are not candidates for surgery. - Long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism).  As spironolactone has antiandrogenic activity, its off-label uses include the treatment of hirsutism, female pattern hair loss, and adult acne vulgaris.
spiroquinazoline	157075-58-6	(1R-(1alpha,4alpha,13R*(S*)))-1',9'a-Dihydro-1-methylspiro(1,4-ethano-2H-pyrazino(2,1-b)quinazoline-13,9'-(9H)imidazo(1,2-a)indole)-3,3',6(1H,2'H,4H)-trione	157075-58-6				
spirotetramat		Spirotetramat	203313-25-1	4G7KR034OX	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
spiroxamine		Spiroxamine	118134-30-8	OUT5YHB7BO	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
spiruchostatin A		spiruchostatin A	328548-11-4	30Q3VS5HZ4			
spiruchostatin B		spiruchostatin B			Histone Deacetylase Inhibitors	Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)	
SPL-334		4-[[2-[(2-Cyanophenyl)methylsulfanyl]-4-oxothieno[3,2-d]pyrimidin-3-yl]methyl]benzoic acid					
splitomicin	4707-36-2	2,3-dihydro-1H-benzo[f]chromen-1-one	4707-36-2	R1JT1VV9Z3			
sporidesmin	1456-55-9	Sporidesmin	1456-55-9	H70LC3H0RW			
SQ 29548	98299-61-7	7-(3-((2-((Phenylamino)carbonyl)hydrazino)methyl)-7-oxabicyclo(2.2.1)hept-2-yl)-5-heptenoic acid	98299-61-7				
Squalene	111-02-4	Squalene	111-02-4	7QWM220FJH			
squalestatin 1		Zaragozic acid A	142561-96-4	1117HVX02L	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
squamosamide	142750-35-4	Squamosamide	142750-35-4				
squaramide		3,4-Diaminocyclobut-3-ene-1,2-dione	5231-89-0	3Q8TZB9ESJ			
SR 1078		N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-4-(trifluoromethyl)benzamide	1246525-60-9				
SR 11237	146670-40-8	Benzoic acid, 4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1,3-dioxolan-2-yl]-	146670-40-8				
SR 11238		SR 11238					
SR 11302		(2E,4E,6Z,8E)-3-Methyl-7-(p-tolyl)-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid					
SR 121566		SR 121566					
SR 12813		4-[2,2-Bis(diethoxyphosphoryl)ethenyl]-2,6-ditert-butylphenol	126411-39-0	6Q7MN2PVB9			
SR 13668		SR 13668					
SR 140333	153050-21-6	Nolpitantium chloride	153050-21-6	22O6XI63E0			Investigated for use/treatment in asthma and inflammatory bowel disease.
SR 142801		Acetamide, N-(1-(3-((3R)-1-benzoyl-3-(3,4-dichlorophenyl)-3-piperidinyl)propyl)-4-phenyl-4-piperidinyl)-N-methyl-, monohydrochloride	173050-51-6		Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
SR 142948		2-[[5-(2,6-Dimethoxyphenyl)-1-[4-[3-(dimethylamino)propyl-methylcarbamoyl]-2-propan-2-ylphenyl]pyrazole-3-carbonyl]amino]adamantane-2-carboxylic acid	184162-64-9	W59C8B2MZS			
SR 142948A		2-(5-(2,6-Dimethoxyphenyl)-1-(4-((3-(dimethylamino)propyl)(methyl)carbamoyl)-2-isopropylphenyl)-1H-pyrazole-3-carboxamido)adamantane-2-carboxylic acid hydrochloride					
SR 144190		3-[1-[2-[4-Benzoyl-2-(3,4-difluorophenyl)morpholin-2-yl]ethyl]-4-phenylpiperidin-4-yl]-1,1-dimethylurea					
SR 144528		(1S-endo)-5-(4-Chloro-3-methylphenyl)-1-((4-methylphenyl)methyl)-N-(1,3,3-trimethylbicyclo(2.2.1)hept-2-yl)-1H-pyrazole-3-carboxamide	192703-06-3				
SR 27897	136381-85-6	Lintitript	136381-85-6	3YFV00531K	Hormone Antagonists	Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)	For the treatment of pancreatic cancer and appetite disorders.
SR 46349B	130580-02-8	Eplivanserin fumarate	130580-02-8	BT8UYC46KA	Fibrinolytic Agents	Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)	Insomnia
SR 48692	146362-70-1	Meclinertant	146362-70-1	5JBP4SI96H			Investigated for use/treatment in colorectal cancer, prostate cancer, schizophrenia and schizoaffective disorders, psychosis, depression, and lung cancer.
SR 48968		Saredutant	142001-63-6	720U2QK8I5			Investigated for use/treatment in depression and anxiety disorders.
SR 59104A		SR 59104A					
SR 59119A		SR 59119A					
SR 90107A-ORG 31540		SR 90107A-ORG 31540					
SR 95191	94011-82-2	Bazinaprine	94011-82-2	NU8Y4C529J			
SR1001		N-[5-[[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]sulfamoyl]-4-methyl-1,3-thiazol-2-yl]acetamide	1335106-03-0				
SR140333B		Nolpitantium besilate	155418-06-7	SN2G80PK4I			
SR18292		1-((1H-indol-4-yl)oxy)-3-(tert-butyl(4-methylbenzyl)amino)propan-2-ol					
SR9009		Ethyl 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]pyrrolidine-1-carboxylate	1379686-30-2	X5DCA09N30			
SR9238		Ethyl 5-[[[4-(3-methylsulfonylphenyl)phenyl]methyl-(2,4,6-trimethylphenyl)sulfonylamino]methyl]furan-2-carboxylate					
SR9243		N-(3-Bromophenethyl)-2,4,6-trimethyl-N-((3'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)methyl)benzenesulfonamide					
SRM 1597		SRM 1597					
SRPIN340		Srpin340	218156-96-8	9QS4MR9N9D			
SRT1460		3,4,5-trimethoxy-N-(2-(3-(piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)benzamide	925432-73-1	FN6D3F3HTG			
SRT1720		SRT 1720 Hydrochloride	1001645-58-4				
SRT2183		(R)-N-(2-(3-((3-hydroxypyrrolidin-1-yl)methyl)imidazo[2,1-b]thiazol-6-yl)phenyl)-2-naphthamide	1001908-89-9	6FKU9G9CX6			
SRT3025		5-(3-methoxypropyl)-2-phenyl-N-[2-[6-(pyrrolidin-1-ylmethyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]-1,3-thiazole-4-carboxamide	1231952-55-8	L4WQ6846SR			
SSR 69071		6-Methoxy-1,1-dioxo-2-[[4-oxo-9-(2-piperidin-1-ylethoxy)pyrido[1,2-a]pyrimidin-2-yl]oxymethyl]-4-propan-2-yl-1,2-benzothiazol-3-one	344930-95-6	Z96REB2D8H			
SSR180575		2-(7-Chloro-5-methyl-4-oxo-3-phenyl-4,5-dihydro-3H-pyridazino[4,5-b]indol-1-yl)-N,N-dimethylacetamide	220448-02-2	4K8W47WK2L			
SSR180711		4-Bromophenyl 1,4-diazabicyclo(3.2.2)nonane-4-carboxylate	298198-52-4	QF4P1U1666			
SST-VEDI-1 compound		SST-VEDI-1 compound					
ST 1435	7759-35-5	Nestorone	7759-35-5	9AMX4Q13CC	Contraceptive Agents, Hormonal	Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)	Segesterone acetate in combination with ethinyl estradiol is indicated for use by females of reproductive potential to prevent pregnancy as a combination hormonal contraceptive (CHC). It induces contraception for thirteen 28-day cycles (1 year) following vaginal administration. The vaginal system must remain in place continuously for 3 weeks (21 days) followed by a 1-week (7-day) vaginal system-free interval. The use in females with a body mass index of >29 kg/m^2 has not been adequately evaluated.
ST 1481		Gimatecan	292618-32-7	7KKS9R192F			
St 587	15327-38-5	1H-Imidazol-2-amine, N-(2-chloro-5-(trifluoromethyl)phenyl)-4,5-dihydro-, mononitrate	15327-38-5				
ST 679	104076-16-6	Amtolmetin guacil	87344-06-7	323A00CRO9	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
St. Thomas' Hospital cardioplegic solution		St. Thomas' Hospital cardioplegic solution					
ST2825		894787-30-5					
STA 9090		Ganetespib	888216-25-9	2E8412Y946			
stachydrine	471-87-4	Stachydrine	471-87-4	S1L688345C			
stallimycin	636-47-5	Stallimycin	636-47-5	80O63P88IS	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
stannous chloride	7772-99-8	Stannous Chloride	7772-99-8	R30H55TN67			Stannous chloride is a component of technetium-99m agents indicated for imaging of the skeleton for areas of altered osteogenesis or in the detection of  infarcted heart tissue.
stannous mesoporphyrin		stannous mesoporphyrin					
stanolone benzoate	1057-07-4	Stanolone benzoate	1057-07-4	T74307G2D9			
Stanozolol	10418-03-8	Stanozolol	302-96-5	4R1VB9P8V3	Androgens	Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. (See all compounds classified as Androgens.)	Stanozolol is a synthetic anabolic steroid with therapeutic uses in treating C1-inhibitor deficient hereditary angioedema. C1-inhibitor is a protease that inhibits the complement system (part of the innate immune system), a biochemical chain of reactions which assists the body in removing pathogens from the body. Stanozolol may help control attacks of hereditary angioedema.  Stanozolol can be administered orally or intramuscularly.
staphylococcal alpha-toxin		LS-146648					
staphylococcal delta toxin		staphylococcal delta toxin					
Staphylococcal Protein A		Staphylococcal Protein A					
Starch	9005-25-8	Starch					
stattic		Stattic	19983-44-9				
Staurosporine	62996-74-1	Staurosporine	62996-74-1	H88EPA0A3N	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
staurosporine aglycone	97161-97-2	k-252a	97161-97-2		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Stavudine	3056-17-5	Stavudine	3056-17-5	BO9LE4QFZF	Anti-HIV Agents	Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)	For the treatment of human immunovirus (HIV) infections.
Stearates		Sodium Stearate	822-16-2	QU7E2XA9TG			
stearic acid	57-11-4	Stearic Acid	57-11-4	4ELV7Z65AP			
Stearic Acids		Stearic Acids					
stearoyl alpha-lysolecithin	5655-17-4	2-Lysophosphatidylcholine	17364-19-1				
stearoyl-coenzyme A	362-66-3	stearoyl-CoA	362-66-3	OBC49BV194			
stearoylarachidonylglycerol	75060-22-9	(2-hydroxy-3-octadecanoyloxypropyl) (5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoate	75060-22-9				
stejnulxin protein, Trimeresurus stejnegeri		stejnulxin protein, Trimeresurus stejnegeri					
stemphyltoxin III	102694-32-6	Stemphyltoxin III	102694-32-6				
StemRegenin 1		StemRegenin 1	1227633-49-9	RNE1V1F9O1			
stephanthraniline A		Stephanthraniline A					
stephenanthrine	22108-99-2	Phenanthro(3,4-d)-1,3-dioxole-5-ethanamine, N,N-dimethyl-	22108-99-2				
stepholidine		l-Stepholidine	16562-13-3	0UPX3E69W8	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
Sterigmatocystin	10048-13-2	Sterigmatocystin	10048-13-2	5F95211S5Z			
Steroids		Steroids					
Steroids, Fluorinated		Steroids, Fluorinated					
Sterols		Sterols					
steviol	471-80-7	Steviol	471-80-7	4741LYX6RT			
steviolbioside	41093-60-1	Steviolbioside	41093-60-1	07GV37SOFN	Sweetening Agents	Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)	
stevioside	57817-89-7	Stevioside	57817-89-7	0YON5MXJ9P	Sweetening Agents	Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)	
STF 083010		(E)-N-((2-hydroxynaphthalen-1-yl)methylene)thiophene-2-sulfonamide	307543-71-1				
STF-118804		4-(5-Methyl-4-(tosylmethyl)oxazol-2-yl)-N-(pyridin-3-ylmethyl)benzamide					
STF-31		4-({[(4-Tert-Butylphenyl)sulfonyl]amino}methyl)-N-(Pyridin-3-Yl)benzamide	724741-75-7				
Stigmasterol	83-48-7	Stigmasterol	83-48-7	99WUK5D0Y8			
stigmatellin	91682-96-1	Stigmatellin	91682-96-1		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
stilbene oxide	17619-97-5	Stilbene oxide	17619-97-5				
Stilbenes		trans-Stilbene	103-30-0	3FA7NW80A0			
stiripentol	49763-96-4	Stiripentol	49763-96-4	R02XOT8V8I	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	In the US, stiripentol is indicated for the treatment of seizures associated with Dravet syndrome in patients taking [clobazam] who are 6 months of age and older and weighing 7 kg or more. There are no clinical data to support the use of stiripentol as monotherapy in Dravet syndrome.  In Europe and Canada, stiripentol is indicated for use as adjunctive therapy with clobazam and [valproate] to refractory generalized tonic-clonic seizures in patients with Dravet syndrome in infancy whose seizures are not adequately controlled with clobazam and valproate alone.
STO 609		7-Oxo-7h-Benzimidazo[2,1-A]benz[de]isoquinoline-3-Carboxylic Acid	52029-86-4	CV7Q6X3C4Q			
streptolysin O		LS-147049					
Streptomycin	57-92-1	Streptomycin	57-92-1	Y45QSO73OB	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Although streptomycin was the first antibiotic available for the treatment of mycobacterium tuberculosis, it is now largely a second line option due to resistance and toxicity. Streptomycin may also be used to treat a variety of other infections caused by susceptible strains of aerobic bacteria where other less toxic agents are ineffective. Examples include: _Yersinia pestis_, _Francisella tularensis_, _Brucella_, _Calymmatobacterium granulomatis_ (donovanosis, granuloma inguinale), _H. ducreyi_ (chancroid), _H. influenzae_ (in respiratory, endocardial, and meningeal infections - concomitantly with another antibacterial agents). _K. pneumoniae_ pneumonia (concomitantly with another antibacterial agent), _E.coli_, _Proteus_, _A.aerogenes_, _K. pneumoniae_, and  _Enterococcus faecalis_ in urinary tract infections, _Streptococcus viridans_, _Enterococcus faecalis_ (in endocardial infections - concomitantly with penicillin), and Gram-negative bacillary bacteremia (concomitantly with another antibacterial agent).
Streptonigrin	3930-19-6	Streptonigrin	3930-19-6	261Q3JB310	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	
Streptozocin	18883-66-4	Streptozocin	18883-66-4	5W494URQ81	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	For the treatment of malignant neoplasms of pancreas (metastatic islet cell carcinoma).
Strontium	7440-24-6	Strontium	7440-24-6	YZS2RPE8LE			
strontium chloride	10476-85-4	Strontium chloride	10476-85-4	EKE8PS9J6Z			When employed as an ingredient in toothpaste formulations, strontium chloride is predominantly indicated for treating teeth hypersensitivity.
Strontium-90		Strontium-90	10098-97-2	5TZZ77Z4ER			
Strophanthidin	66-28-4	Strophanthidin	66-28-4	W5O632DN33			
Strophanthins		CID5321527					
Strychnine	57-24-9	Strychnine	57-24-9	H9Y79VD43J	Convulsants	Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)	
STX 213		STX 213					
Styrene	100-42-5	Styrene	100-42-5	44LJ2U959V			
styrene glycol	93-56-1	1-Phenyl-1,2-ethanediol	93-56-1	2ZAC511UK8			
styrene oxide	96-09-3	Styrene oxide	96-09-3	9QH06NGT6O	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Styrenes		Styrenes					
styrofoam	9003-53-6	Styrene	100-42-5	44LJ2U959V			
SU 11657		SU 11657					
SU 12662		SU 12662					
SU 1498		(E)-2-Cyano-3-(4-hydroxy-3,5-diisopropylphenyl)-N-(3-phenylpropyl)acrylamide	168835-82-3				
SU 5402		3-[(3-(2-Carboxyethyl)-4-methylpyrrol-2-YL)methylene]-2-indolinone	215543-92-3				
SU 5614		(Z)-5-Chloro-3-((3,5-dimethyl-1H-pyrrol-2-yl)methylene)indolin-2-one	186611-56-3				
SU 6656		(3z)-N,N-Dimethyl-2-Oxo-3-(4,5,6,7-Tetrahydro-1h-Indol-2-Ylmethylidene)-2,3-Dihydro-1h-Indole-5-Sulfonamide					
SU 9516		SU9516	377090-84-1	FD2SWT2SDI			
subecholine	3810-71-7	Subecholine	3810-71-7		Cholinergic Agents	Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of ACETYLCHOLINE, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of MUSCARINIC AGONISTS, although most modern texts discourage that usage. (See all compounds classified as Cholinergic Agents.)	
suberoyl bis-hydroxamic acid		n,n'-Dihydroxyoctanediamide					
substance P (6-11), Tyr(6)-D-Phe(7)-D-His(9)-		Vofopitant dihydrochloride	168266-51-1	53187BIJ00			
substance P-saporin		substance P-saporin					
substance P, Sar(9)-Met(O2)(11)-	110880-55-2	Bhsar-SP	110880-55-2				Investigated for use/treatment in acute respiratory distress syndrome (ARDS) and viral infection.
Succimer	304-55-2	Succimer	304-55-2	DX1U2629QE	Antidotes	Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)	For the treatment of lead poisoning in pediatric patients with blood lead levels above 45 g/dL. May also be used to treat mercury or arsenic poisoning.
Succinates		Succinates					
Succinic Acid	110-15-6	Succinic Acid	110-15-6	AB6MNQ6J6L			For nutritional supplementation, also for treating dietary shortage or imbalance
succinic semialdehyde	692-29-5	Succinic semialdehyde	692-29-5	M73BX3CPMU			
Succinimides		Succinimides					
succinyl-coenzyme A		Succinyl-coenzyme A	604-98-8	BSI27HW5EQ			
succinylacetone	51568-18-4	4,6-Dioxoheptanoic acid	51568-18-4	KZ0KV2Q190	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Succinylcholine	306-40-1	Succinylcholine	306-40-1	J2R869A8YF	Neuromuscular Depolarizing Agents	Drugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarization of the motor end plate. These agents are primarily used as adjuvants in surgical anesthesia to cause skeletal muscle relaxation. (See all compounds classified as Neuromuscular Depolarizing Agents.)	Succinylcholine is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
succinyldithiocholine	15196-10-8	Succinyldithiocholine	15196-10-8				
succinylmonocholine	5518-77-4	Succinylmonocholine	5518-77-4	FU8UCR633Q			
succinylsulfathiazole	116-43-8	Succinylsulfathiazole	116-43-8	RSS8647O4S			
Sucralfate	54182-58-0	Sucralfate			Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	
Sucrose	57-50-1	Sucrose	57-50-1	C151H8M554	Sweetening Agents	Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)	
sucrose octaacetate	126-14-7	Sucrose octaacetate	126-14-7	07V591057T			
sucrose octasulfate	57680-56-5	Sucrosofate	57680-56-5	P7V86EYZ5L	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	
sudan III	85-86-9	Sudan III	85-86-9	ND733RX3JN	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
sudan red	3118-97-6	Sudan II	3118-97-6	8C1M5O3ECT			
sudoxicam	34042-85-8	Sudoxicam	34042-85-8	X033PDI962			
Sufentanil	56030-54-7	Sufentanil	56030-54-7	AFE2YW0IIZ	Narcotics	Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)	The indications for this drug are as follows:  1. As an analgesic adjunct in the maintenance of balanced general anesthesia in patients who are intubated and ventilated.  2. As a primary anesthetic agent for the induction and maintenance of anesthesia with 100% oxygen in patients undergoing major surgical procedures, in patients who are intubated and ventilated, such as cardiovascular surgery or neurosurgical procedures in the sitting position, to provide favorable myocardial and cerebral oxygen balance or when extended postoperative ventilation is anticipated.  3. For epidural administration as an analgesic combined with low dose (usually 12.5 mg per administration) bupivacaine usually during labor and vaginal delivery   4. The sublingual form is indicated for the management of acute pain in adults that is severe to warrant the use of an opioid analgesic in certified medically supervised healthcare settings, including hospitals, surgical centers, and emergency departments.
Sugars		Sugars					
suillin	103538-03-0	Suillin	103538-03-0	V324RA58SA			
Sulbactam	68373-14-8	Sulbactam	68373-14-8	S4TF6I2330	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Sulbactam is used in combination with other antibacterial agents. With [ampicillin], it is used to treat skin and skin structure infections, intra-abdominal infections, and gynecological infections caused by susceptible bacteria.  In combination with [durlobactam], sulbactam is indicated in adults for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP), caused by susceptible isolates of _Acinetobacter baumannii-calcoaceticus_ complex.
sulbutiamine	3286-46-2	Bisibutiamine	3286-46-2				
sulconazole	61318-90-9	Sulconazole	61318-90-9	5D9HAA5Q5S	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	Sulconazole solution 1.0% is indicated for the treatment of tinea cruris and tinea corporis caused by _Trichophyton rubrum_, _Trichophyton mentagrophytes_, _Epidermophyton floccosum_, and _Microsporum canis_; and for the treatment of tinea versicolor. Effectiveness has not been proven in tinea pedis (athletes foot).
Sulfadiazine	68-35-9	Sulfadiazine	68-35-9	0N7609K889	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of rheumatic fever and meningococcal meningitis
Sulfadimethoxine	122-11-2	Sulfadimethoxine	122-11-2	30CPC5LDEX	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	For use in the treatment of infections.
Sulfamerazine	127-79-7	Sulfamerazine	127-79-7	UR1SAB295F	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	A sulfanilamide that is used as an antibacterial agent. It can be used to treat bronchitis, prostatitis and urinary tract infections.
Sulfamethazine	57-68-1	Sulfamethazine	57-68-1	48U51W007F	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	For the treatment bacterial infections causing bronchitis, prostatitis and urinary tract infections.
Sulfamethizole	144-82-1	Sulfamethizole	144-82-1	25W8454H16	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	For the treatment of urinary tract infection
Sulfamethoxazole	723-46-6	Sulfamethoxazole	723-46-6	JE42381TNV	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	Sulfamethoxazole is indicated in combination with trimethoprim, in various formulations, for the following infections caused by bacteria with documented susceptibility: urinary tract infections, acute otitis media in pediatric patients (when clinically indicated), acute exacerbations of chronic bronchitis in adults, enteritis caused by susceptible _Shigella_, prophylaxis and treatment of _Pneumocystis jiroveci_ pneumonia, and travelers' diarrhea caused by enterotoxigenic _E. coli_.  In Canada, additional indications include the adjunctive treatment of cholera, treatment of bacillary dysentery, nocardiosis, and second-line treatment of brucellosis in combination with [gentamicin] or [rifampicin].
sulfamethoxazole hydroxylamine	114438-33-4	Sulfamethoxazole hydroxylamine	114438-33-4	S4YF7G89MZ			
sulfamic acid	5329-14-6	Sulfamic acid	5329-14-6	9NFU33906Q	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
sulfamidochrysoidine	103-12-8	Prontosil	103-12-8	Q64Q9N6Q6O			
Sulfanilamides		Sulfanilamides					
sulfanitran	122-16-7	Sulfanitran	122-16-7	QT35T5T35Q			
Sulfaphenazole	526-08-9	Sulfaphenazole	526-08-9	0J8L4V3F81	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	For the treatment bacterial infections.
Sulfapyridine	144-83-2	Sulfapyridine	144-83-2	Y5V2N1KE8U	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	For the treatment of dermatitis herpetiformis, benign mucous membrane pemphigoid and pyoderma gangrenosum
Sulfasalazine	599-79-1	Sulfasalazine	599-79-1		Gastrointestinal Agents	Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)	
Sulfates		Sulfates					
Sulfenic Acids		Sulfenic Acids					
Sulfhydryl Compounds		Sulfhydryl Compounds					
Sulfides		Sulfides					
Sulfinic Acids		CHEBI:37783					
sulfinosine	124508-99-2	Sulfinosine	124508-99-2				
Sulfinpyrazone	57-96-5	Sulfinpyrazone	57-96-5	V6OFU47K3W	Uricosuric Agents	Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma. (See all compounds classified as Uricosuric Agents.)	For the treatment of gout and gouty arthritis.
Sulfisomidine	515-64-0	Sulfisomidine	515-64-0	W03L3ODK6E	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
Sulfisoxazole	127-69-5	Sulfisoxazole	127-69-5	740T4C525W	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	For the treatment of severe, repeated, or long-lasting urinary tract infections, meningococcal meningitis, acute otitis media, trachoma, inclusion conjunctivitis, nocardiosis, chancroid, toxoplasmosis, malaria and other bacterial infections.
Sulfites		Sulfite	14265-45-3	15744271E9			
sulfluramid	4151-50-2	Sulfluramid	4151-50-2	IPX089YR0A			
sulfo-N-succinimidyl oleate		1026037-20-6					
Sulfobromophthalein	297-83-6	Sulfobromophthalein	297-83-6	0C2P5QKL36	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
Sulfoglycosphingolipids		3'-Sulfogalactosylceramide	151122-71-3				
sulfolipid I	53580-08-8	2-Palmitoyl-3-phthioceranoyl-6,6'-bis hydroxyphthioceranoyl trehalose-2'-sulfate	53580-08-8				
sulfolithocholic acid	34669-57-3	Sulfolithocholic acid	34669-57-3	0ENK5NMI1I			
sulfolithocholylglycine	15324-64-8	Sulfoglycolithocholic acid	15324-64-8	ZH5HPJ9WHW			
sulfometuron methyl	74222-97-2	Sulfometuron-methyl	74222-97-2	JLY5D60J1A	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Sulfonamides		Sulfonamides					
Sulfonium Compounds		Sulfonium Compounds					
Sulfonylurea Compounds		Sulfonylurea Compounds					
sulfoquinovosyl diglyceride		Sulfoquinovosyl diglyceride	207976-87-2		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
sulforaphane		Sulforaphane	4478-93-7	41684WL1GL	Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	
sulfotepp	3689-24-5	Sulfotep	3689-24-5	V41BK2EE8X			
sulfoxaflor		Sulfoxaflor	946578-00-3	671W88OY8K			
Sulfur	7704-34-9	Sulfur	7704-34-9	70FD1KFU70			
Sulfur Compounds		Sulfur	7704-34-9	70FD1KFU70			
Sulfur Dioxide	7446-09-5	Sulfur Dioxide	7446-09-5	0UZA3422Q4	Air Pollutants	Any substance in the air which could, if present in high enough concentration, harm humans, animals, vegetation or materials. Substances include GASES; PARTICULATE MATTER; and volatile ORGANIC CHEMICALS. (See all compounds classified as Air Pollutants.)	
sulfuric acid	7664-93-9	Sulfuric Acid	7664-93-9	O40UQP6WCF			
sulfuryl fluoride	2699-79-8	Sulfuryl fluoride	2699-79-8	64B59K7U6Q			
sulglicotide	54182-59-1	sulglicotide					
Sulindac	38194-50-2	Sulindac	38194-50-2	184SNS8VUH	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	For acute or long-term use in the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute painful shoulder (acute subacromial bursitis/supraspinatus tendinitis), and acute gouty arthritis.
sulindac derivative IND 12		sulindac derivative IND 12					
sulindac sulfide	32004-67-4	2-[(3E)-6-fluoro-2-methyl-3-[(4-methylsulfanylphenyl)methylidene]inden-1-yl]acetic acid	32004-67-4				
sulindac sulfone	59864-04-9	(Z)-5-Fluoro-2-methyl-1-[p-(methylsulfonyl)benzylidene]indene-3-acetic acid					
sulisobenzone	4065-45-6	Sulisobenzone	4065-45-6	1W6L629B4K			Sunscreening agents are used to prevent sunburn, actinic keratosis, and premature skin aging and to reduce the incidence of skin cancer.
Suloctidil	54767-75-8	(1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol	54767-75-8		Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
sulotroban		Sulotroban	72131-33-0	74574CO5A6	Fibrinolytic Agents	Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)	
sulphoraphene		Sulforaphene	592-95-0				
Sulpiride	15676-16-1	Sulpiride	15676-16-1	7MNE9M8287	Antidepressive Agents, Second-Generation	A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)	Sulpiride is indicated for the treatment of acute and chronic schizophrenia.
sulprofos	35400-43-2	Sulprofos	35400-43-2	FUX2I5F01B			
sulprostone		Sulprostone	60325-46-4	501Q5EQ1GM	Contraceptive Agents, Hormonal	Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)	
Sumatriptan	103628-46-2	Sumatriptan	103628-46-2	8R78F6L9VO	Serotonin 5-HT1 Receptor Agonists	Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes. (See all compounds classified as Serotonin 5-HT1 Receptor Agonists.)	A combination sumatriptan and [naproxen] tablet is indicated for the treatment of migraines with or without auras in patients 12 years of age and older. Sumatriptan nasal powder, nasal spray, subcutaneous injection, and tablets are indicated to treat migraines with or without auras in adults. One of the subcutaneous formulations of sumatriptan is also indicated to treat cluster headaches in adults, while the other subcutaneous formulation is not.
Sunflower Oil		8001-21-6					
Sunitinib		Sunitinib	557795-19-4	V99T50803M	Angiogenesis Inhibitors	Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. (See all compounds classified as Angiogenesis Inhibitors.)	Sunitinib is indicated for the following conditions:  - Treatment of adult patients with gastrointestinal stromal tumor (GIST) following disease progression on (or intolerance to) [imatinib] mesylate - Treatment of adult patients with advanced renal cell carcinoma (RCC) - Adjuvant treatment of adult patients at high risk of recurrent RCC following nephrectomy - Treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in adult patients with unresectable locally advanced or metastatic disease
Sunphenon	131258-00-9	[Butoxy-(4-nitrobenzoyl)amino] acetate	131258-00-9				
Sunscreening Agents		Sunscreening Agents					
Superantigens		Superantigens					
Superoxides	11062-77-4	Superoxide	11062-77-4		Oxidants	Electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION). (See all compounds classified as Oxidants.)	
suplatast tosilate	94055-76-2	Suplatast Tosilate	94055-76-2	C9J89787U1	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	
Suppressor Factors, Immunologic		Suppressor Factors, Immunologic					
Suprofen	40828-46-4	Suprofen	40828-46-4	988GU2F9PE	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Used as eye drops to inhibit the miosis (pupil constriction) that may occur during ocular surgery.
Suramin	145-63-1	Suramin	145-63-1	6032D45BEM	Trypanocidal Agents	Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. (See all compounds classified as Trypanocidal Agents.)	For treatment of human sleeping sickness, onchocerciasis and other diseases caused by trypanosomes and worms.
Surface-Active Agents		Surface-Active Agents					
surfactin peptide	24730-31-2	Surfactin	24730-31-2	E6T3DJ8ZVE	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
surinabant		Surinabant	288104-79-0	SF8R9VCB0X	Cannabinoid Receptor Antagonists	Compounds that inhibit or block the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Antagonists.)	
suvorexant		Suvorexant	1030377-33-3	081L192FO9	Orexin Receptor Antagonists	Substances that bind to and inhibit the action of OREXIN RECEPTORS. Drugs in this class have been used as SLEEP AIDS, PHARMACEUTICAL. (See all compounds classified as Orexin Receptor Antagonists.)	Suvorexant is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.
suxibuzone	27470-51-5	Suxibuzone	27470-51-5	86TDZ5WP2B	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
Swainsonine	72741-87-8	Swainsonine	72741-87-8	RSY4RK37KQ	Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	
Sweetening Agents		Sweetening Agents					
sweroside	14215-86-2	Sweroside	14215-86-2	I3YG76417O			
swertiamarin	17388-39-5	Swertiamarin	17388-39-5	4038595T7Y			
swietenine		Swietenine	4801-97-2				
swinholide A	95927-67-6	CID 6436221	95927-67-6				
sym-trinitrobenzene	99-35-4	1,3,5-Trinitrobenzene	99-35-4	2H75703R1X			
synaptamide		Docosahexaenoyl Ethanolamide	162758-94-3				
Synephrine	94-07-5	Synephrine	94-07-5	PEG5DP7434	Adrenergic alpha-Agonists	Drugs that selectively bind to and activate alpha adrenergic receptors. (See all compounds classified as Adrenergic alpha-Agonists.)	
Synthetic Cathinone		Synthetic Cathinone					
SYP-5 compound		SYP-5 compound					
syringaresinol	21453-69-0	Syringaresinol, (+)-	21453-69-0	155K1084GO			
syringic acid	530-57-4	Syringic acid	530-57-4	E390O181H5	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
syringin	118-34-3	Eleutheroside B	118-34-3	I6F5B11C96			
syrosingopine	84-36-6	Syrosingopine	84-36-6	PPG46JF0EG			
systhane		Myclobutanil	88671-89-0	B6T1JTM6KZ	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
SZU-101		SZU-101					
T 0070907		2-Chloro-5-nitro-N-4-pyridinylbenzamide	313516-66-4	N2LK5944GW			
T 1095		[(2R,3S,4S,5R,6S)-6-{2-[3-(1-benzofuran-5-yl)propanoyl]-3-hydroxy-5-methylphenoxy}-3,4,5-trihydroxyoxan-2-yl]methyl methyl carbonate					
T 113242		T 113242					
T 614	123663-49-0	Iguratimod	123663-49-0	4IHY34Y2NV			
T-2 Toxin	21259-20-1	T-2 Toxin	21259-20-1	I3FL5NM3MO			
t-butyl acetylene		3,3-Dimethyl-1-Butyne	917-92-0	PX4NL23U52			
t-butyloxycarbonyl-methionyl-leucyl-phenylalanine	67247-12-5	Boc-Met-Leu-Phe-OH	67247-12-5				
T0901317		N-(2,2,2-Trifluoroethyl)-N-{4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl}benzenesulfonamide	293754-55-9	A07663A39I			
T16AInh-A01		T16AInh-A01	552309-42-9				
tablysin-15, Tabanus yao		tablysin-15, Tabanus yao					
tabun	77-81-6	Tabun	77-81-6	S45M750QSH	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
TAC 101		Amsilarotene	125973-56-0	Q1418F39MH			
tacedinaline		Tacedinaline	112522-64-2	UMF554N5FG	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
Tacrine	321-64-2	Tacrine	321-64-2	4VX7YNB537	Parasympathomimetics	Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. (See all compounds classified as Parasympathomimetics.)	For the palliative treatment of mild to moderate dementia of the Alzheimer's type.
Tacrolimus	109581-93-3	Tacrolimus monohydrate	109581-93-3		Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	
Tadalafil		Tadalafil	171596-29-5	742SXX0ICT	Urological Agents	Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)	Tadalafil is indicated for the treatment of erectile dysfunction (ED) and either alone or in combination with [finasteride] for the treatment of benign prostatic hypertrophy (BPH). It is also indicated for the treatment of pulmonary arterial hypertension (PAH) both alone and in combination with [macitentan] or other endothelin-1 antagonists.
tafamidis		Tafamidis	594839-88-0	8FG9H9D31J			Tafamidis is indicated to treat cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis in adults.
tagatose	17598-81-1	(3S,4S,5R)-1,3,4,5,6-pentahydroxyhexan-2-one	87-81-0	T7A20Y888Y	Iron Chelating Agents	Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. (See all compounds classified as Iron Chelating Agents.)	
taiwanin C		Taiwanin C	14944-34-4				
taiwanin E		Taiwanin E					
TAK 044	157380-72-8	Cyclo(D-alpha-aspartyl-3-((4-phenylpiperazin-1-yl)carbonyl)-L-alanyl-L-alpha-aspartyl-D-2-(2-thienyl)glycyl-L-leucyl-D-tryptophyl) disodium salt	157380-72-8				
TAK 147		Zanapezil fumarate	142852-51-5	7Y1T8FKO1V			
TAK 733		(R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione	1035555-63-5	5J61HSP0QJ			
TAK 779		N,N-Dimethyl-N-(4-(((2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl)carbonyl)amino)benzyl)tetrahydro-2H-pyran-4-aminium chloride	229005-80-5	BQW1Y9KIIP	CCR5 Receptor Antagonists	Compounds and drugs that inhibit or block the activity of CCR5 RECEPTORS. (See all compounds classified as CCR5 Receptor Antagonists.)	
TAK-165		Mubritinib	366017-09-6	V734AZP9BR			
TAK-243		Sulfamic acid, [(1R,2R,3S,4R)-2,3-dihydroxy-4-[[2-[3-[(trifluoromethyl)thio]phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]cyclopentyl]methyl ester	1450833-55-2	V9GGV0YCDI			
TAK-875		Fasiglifam	1000413-72-8	GLP1W4JXAH			
TAK1 inhibitor NG25		TAK1 inhibitor NG25					
takinib		Takinib	1111556-37-6	Z56NTB3YHJ			
talazoparib		Talazoparib	1207456-01-6	9QHX048FRV	Poly(ADP-ribose) Polymerase Inhibitors	Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. (See all compounds classified as Poly(ADP-ribose) Polymerase Inhibitors.)	Talazoparib is indicated for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) HER2-negative locally advanced or metastatic breast cancer. This indication is approved by the FDA, EMA, and Health Canada.  In the US, talazoparib is also indicated in combination with [enzalutamide] for the treatment of adult patients with HRR gene-mutated metastatic castration-resistant prostate cancer (mCRPC).
Talc	14807-96-6	Dioxosilane;oxomagnesium;hydrate	14807-96-6		Antiperspirants	Agents that are put on the SKIN to reduce SWEATING or prevent excess sweating (HYPERHIDROSIS). (See all compounds classified as Antiperspirants.)	
taleranol	42422-68-4	Taleranol	42422-68-4	HUN219N434			
talinolol	38649-73-9	Talinolol	57460-41-0	3S82268BKG	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
talipexole	36085-73-1	Talipexole dihydrochloride	36085-73-1	9R6E1D8H1O	Adrenergic alpha-Agonists	Drugs that selectively bind to and activate alpha adrenergic receptors. (See all compounds classified as Adrenergic alpha-Agonists.)	
tallow	61789-97-7	61789-97-7					
talsupram	21489-20-3	Talsupram	21489-20-3	C6Z73MW6CR			
tamarixetin		Tamarixetin	603-61-2	73WRA8Z8M8			
tamibarotene	94497-51-5	Tamibarotene	94497-51-5	08V52GZ3H9			Investigated for use/treatment in leukemia (unspecified).
Tamoxifen	10540-29-1	Tamoxifen	10540-29-1	094ZI81Y45	Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	Tamoxifen is indicated to treat estrogen receptor positive metastatic breast cancer in adults, as an adjuvant in the treatment of early stage estrogen receptor positive breast cancer in adults, to reduce the risk of invasive breast cancer after surgery and radiation in adult women with ductal carcinoma in situ.
Tamsulosin	106133-20-4	Tamsulosin	106133-20-4	G3P28OML5I	Adrenergic alpha-1 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)	Tamsulosin is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia.  Tamsulosin is also used off label for the treatment of ureteral stones, prostatitis, and female voiding dysfunction.
TAN 67		Unii-UY7TB22PB7	148545-09-9		Analgesics	Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)	
tandospirone	112457-95-1	Tandospirone citrate	112457-95-1	0R8E9BWM4J	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	
tanespimycin		Tanespimycin	75747-14-7	4GY0AVT3L4			Investigated for use/treatment in leukemia (myeloid) and solid tumors.
tangeretin	481-53-8	Tangeretin	481-53-8	I4TLA1DLX6			
Tanjin extract		Tanjin extract					
Tannic Acid		Gallotannin	1401-55-4				Tannic acid is indicated for cold sores, fever blisters, diaper rash, minor burn or sunburn and prickly heat. Vaginally, tannic acid is used as a douche for leukorrhea. It has been also indicated for sore throat, inflamed tonsils, spongy or receding gums, and acute dermatitis.
tanoproget		tanoproget					
tanshinone	568-73-0	Tanshinone I	568-73-0	03UUH3J385	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
tanshinone II A sodium sulfonate	69659-80-9	Sodium 1,6,6-trimethyl-10,11-dioxo-6,7,8,9,10,11-hexahydrophenanthro[1,2-b]furan-2-sulfonate	69659-80-9	IVJ88KQ4XN			
tantalum pentachloride		Tantalum pentachloride	7721-01-9				
Taohong Siwu decoction II		Taohong Siwu decoction II					
taoren-honghua		taoren-honghua					
Tapentadol		Tapentadol	175591-23-8	H8A007M585	Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	Tapentadol is indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Due to the risks of addiction, drug abuse, and drug misuse, tapentadol is reserved for patients for whom alternative treatment options are unavailable.  The immediate-release tapentadol oral tablets are approved for use in patients six years and older with a body weight of at least 40 kg. Tapentadol oral solution is used in patients aged six years and older with a body weight of at least 16 kg. These formulations are not intended for long-term use unless the pain remains severe enough to require an opioid analgesic, for which alternative treatment options remain inadequate.  The extended-release tablets of tapentadol are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. They are also indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. This formulation is not indicated as an as-needed (prn) analgesic.
TAPI-2		N-(R)-[2-(Hydroxyaminocarbonyl)methyl]-4-methylpentanoyl-L-t-butyl-alanyl-L-alanine, 2-aminoethyl Amide					
tapinarof		Tapinarof	79338-84-4	84HW7D0V04			Tapinarof is indicated for the topical treatment of plaque psoriasis in adults.
tapotoclax		Tapotoclax	1883727-34-1	97W7N9T08G			Treatment of acute myeloid leukaemia
taraxasterol	1059-14-9	Taraxasterol	1059-14-9	64SK2ERN9P			
taraxerone	514-07-8	Taraxerone	514-07-8	VC7U2M012Z			
tarazepide	141374-81-4	Tarazepide	141374-81-4	RK2972YZ2U			Investigated for use/treatment in gastrointestinal diseases and disorders (miscellaneous).
tariquidar	206873-63-4	Tariquidar	206873-63-4	J58862DTVD			Investigated for use/treatment in ovarian cancer, lung cancer, and breast cancer.
Tartrazine	1934-21-0	Tartrazine	1934-21-0		Food Coloring Agents	Natural or synthetic dyes used as coloring agents in processed foods. (See all compounds classified as Food Coloring Agents.)	
tasosartan		ANA-756					
tasquinimod	254964-60-8	Tasquinimod	254964-60-8	756U07KN1R			Investigated for use/treatment in prostate cancer.
Tat-JBD peptide		Tat-JBD peptide					
Taurine	107-35-7	Taurine	107-35-7	1EQV5MLY3D			The use of diet supplements containing taurine is indicated for the nutritional support of infants and young pediatric patients requiring total parenteral nutrition via central or peripheral routes. The usage of diet supplements containing taurine prevents nitrogen and weight loss or to treat negative nitrogen balance in pediatric patients where the alimentary tract cannot be done through oral, gastrostomy or jejunostomy administration, there is impaired gastrointestinal absorption or protein requirements are substantially increased.
taurine-ursodeoxycholate conjugate		taurine-ursodeoxycholate conjugate					
Taurochenodeoxycholic Acid	516-35-8	Taurochenodeoxycholic acid	516-35-8	651KU15938	Detergents	Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)	Taurochenodeoxycholic acid is likely indicated as a choleretic and cholagogue. It is also being investigated for its role in inflammation and cancer therapy.
Taurocholic Acid	81-24-3	Taurocholic acid	81-24-3	5E090O0G3Z	Detergents	Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)	
Taurodeoxycholic Acid	516-50-7	Taurodeoxycholic acid	516-50-7	20668G0RPI	Cholagogues and Choleretics	Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)	
taurohyodeoxycholic acid	2958-04-5	Taurohyodeoxycholic acid	2958-04-5	D6V086EMME			
Taurolithocholic Acid	516-90-5	Taurolithocholic acid	516-90-5		Cholagogues and Choleretics	Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)	
taurolithocholic acid 3-sulfate	15324-65-9	Taurolithocholic acid 3-sulfate	15324-65-9				
tauromuricholic acid	25696-60-0	Tauro-alpha-muricholic acid	25696-60-0				
tauropyrone		tauropyrone					
tautomycin	109946-35-2	CID 3034761	109946-35-2		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
taxane	1605-68-1	Taxane	1605-68-1		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
taxifolin	480-18-2	Taxifolin	480-18-2	9SOB9E3987	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
Taxoids		Taxoids					
tazarotene		Tazarotene	118292-40-3	81BDR9Y8PS	Keratolytic Agents	Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases. (See all compounds classified as Keratolytic Agents.)	Used to treat psoriasis, acne and sun damaged skin (photodamage).
Tazobactam	93528-38-2	Sodium;3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate					
TBC 3214		TBC 3214					
TBE 31		TBE 31					
TC 2559		3-Buten-1-amine, 4-(5-ethoxy-3-pyridinyl)-N-methyl-, (3E)-, galactarate (2:1)	326924-19-0				
tcdA protein, Clostridium difficile		tcdA protein, Clostridium difficile					
TDO inhibitor LM10		TDO inhibitor LM10					
TDP 521252		TDP 521252					
TDP 665759		(3S)-4-[(1R)-1-(2-amino-4-chlorophenyl)ethyl]-3-(4-chlorophenyl)-7-iodo-1-[3-(4-methylpiperazin-1-yl)propyl]-3H-1,4-benzodiazepine-2,5-dione	787632-66-0				
Tea		102-71-6					
Tea Tree Oil	68647-73-4	ZINC;diheptoxy-sulfanylidene-sulfido-lambda5-phosphane	68649-42-3		Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	
Teas, Herbal		Teas, Herbal					
tebuconazole		Tebuconazole	107534-96-3	401ATW8TRW	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
tebufenozide		Tebufenozide	112410-23-8	TNN5MI5EKF	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
tebuthiuron	34014-18-1	Tebuthiuron	34014-18-1	E5OX6GM11E			
tecastemizole		Tecastemizole	75970-99-9	W5DCO14M05			Investigated for use/treatment in allergic rhinitis.
Technetium	7440-26-8	Technetium	7440-26-8				
technetium 99m (HYNIC-3PRGD(2))(tricine)(TPPTS)		technetium 99m (HYNIC-3PRGD(2))(tricine)(TPPTS)					
technetium 99m tricarbonyl 4-((2-methoxyphenyl)piperazin-1-yl)dithioformate		technetium 99m tricarbonyl 4-((2-methoxyphenyl)piperazin-1-yl)dithioformate					
technetium Tc 99m mebrofenin		Technetium Tc 99m mebrofenin	1415247-71-0		Radiopharmaceuticals	Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)	Technetium Tc 99m Mebrofenin is indicated as a hepatobiliary imaging agent.
Technetium Tc 99m Sestamibi	109581-73-9	Technetium (99mTc) sestamibi	109581-73-9	971Z4W1S09	Radiopharmaceuticals	Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)	
technetium tc-99m tetrofosmin		Myoview	127455-27-0		Radiopharmaceuticals	Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)	Technetium-99m tetrofosmin is indicated for the diagnosis of heart abnormalities by exercise myocardial scintigraphy. The exercise myocardial scintigraphy is an established method for the diagnosis of the severity of coronary artery disease. This method allows distinguishing regions of reversible myocardial ischemia in the presence or absence of infarcted myocardium following rest and stress conditions. The use of technetium-99m tetrofosmin is mainly used to assess myocardial perfusion in ischemia and infarction.
tectochrysin		Tectochrysin	520-28-5	9UBO28W2AK			
tectoridin		Tectoridin	611-40-5	968X515NZH			
tectorigenin		Tectorigenin	548-77-6	855130H9CO			
teferrol	79173-09-4	Noripurum			Hematinics	Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias. (See all compounds classified as Hematinics.)	
teflubenzuron	83121-18-0	Teflubenzuron	83121-18-0	FS9P57VL74			
Tegafur	17902-23-7	Tegafur	17902-23-7	1548R74NSZ	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	Indicated for the treatment of cancer usually in combination with other biochemically modulating drugs.  Indicated in adults for the treatment of advanced gastric cancer when given in combination with [DB00515].   Indicated for the first-line treatment of metastatic colorectal cancer with [DB03419] and calcium folinate.
tegaserod	145158-71-0	Tegaserod	145158-71-0	458VC51857	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	Tegaserod is a serotonin-4 (5-HT4) receptor agonist indicated for the treatment of adult women less than 65 years of age with irritable bowel syndrome with constipation (IBS-C). The safety and effectiveness of tegaserod in men with IBS-C have not been established.
TEI 9647		(23S)-1alpha-hydroxy-25,27-didehydrovitamin D3 26,23-lactone	173388-20-0				
Teicoplanin	61036-62-2	2-[3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-amino-5,15-dichloro-64-[3-(decanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-26,31,44,49-tetrahydroxy-21,35,38,54,56,59-hexaoxo-47-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14,16,23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,62,65-henicosaene-52-carboxylic acid	61036-62-2		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
telaprevir		Telaprevir	402957-28-2	655M5O3W0U			Telaprevir, when used in combination with [DB00811], [DB00008], and [DB00022] is indicated for use in the treatment of chronic HCV genotype 1 infection in adults.
Telbivudine		Telbivudine	3424-98-4	2OC4HKD3SF	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	For the treatment of chronic hepatitis B in adult and adolescent patients 16 years of age with evidence of viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
telcagepant		Telcagepant	781649-09-0	D42O649ALL			Migraine with or without aura
tele-methylhistamine	501-75-7	1-Methylhistamine	501-75-7	KCB81T4EOF	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
telenzepine	80880-90-6	Telenzepine	80880-90-6	0990EG3K10	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	
telithromycin		Telithromycin	191114-48-4	KI8H7H19WL	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of Pneumococcal infection, acute sinusitis, acute bacterial tonsillitis, acute bronchitis and bronchiolitis, lower respiratory tract infection and lobar (pneumococcal) pneumonia.
tellimagrandin I	79786-08-6	Tellimagradin I	79786-08-6				
Tellurium	13494-80-9	Tellurium	13494-80-9	NQA0O090ZJ			
Telmisartan		Telmisartan	144701-48-4	U5SYW473RQ	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	Used alone or in combination with other classes of antihypertensives for the treatment of hypertension. Also used in the treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes mellitus, as well as the treatment of congestive heart failure (only in patients who cannot tolerate ACE inhibitors).
Temazepam	846-50-4	Temazepam	846-50-4	CHB1QD2QSS	GABA Modulators	Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)	Temazepam is specifically indicated only for the short-term management of insomnia,. Furthermore, such management is generally predominantly associated with the symptomatic relief of transient and short-term insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings and/or early morning awakenings. In particular, the official prescribing information for temazepam typically specifies that the instructions issued for dispensed prescriptions of the medication should indicate specifically that patients are only expected to use the therapy for short periods of time - usually 7-10 days in general. Subsequently, treatment with temazepam should usually not exceed 7 to 10 consecutive days and nor should it be prescribed in quantities exceeding a one-month supply.  Some regional prescribing information also notes that temazepam may be used for premedication prior to minor surgery or other related procedures.
tembotrione		Tembotrione	335104-84-2	WA5UZ202KS			
Temefos	3383-96-8	Temephos	3383-96-8	ONP3ME32DL	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
temocapril hydrochloride	110221-44-8	Temocapril hydrochloride	110221-44-8	8G820I95VP	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
temocaprilat		Temocaprilat	110221-53-9	2D6A12Q12R			
Temozolomide	85622-93-1	Temozolomide	85622-93-1	YF1K15M17Y	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	Temozolomide is indicated in adult patients for the treatment of newly diagnosed glioblastoma concomitantly with radiotherapy and for use as maintenance treatment thereafter. It is also indicated for the treatment of refractory anaplastic astrocytoma in adult patients or adjuvant therapy for adults with newly diagnosed anaplastic astrocytoma.
TEMPO	2564-83-2	Tempo	2564-83-2	VQN7359ICQ	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
tempo carboxylic acid	37149-18-1	Tempo carboxylic acid	37149-18-1				
tempol	2226-96-2	tempol					
TEMPOL-H		4-Piperidinol, 1-hydroxy-2,2,6,6-tetramethyl-	3637-10-3	V55XB6IT82	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
temsirolimus		Temsirolimus	162635-04-3	624KN6GM2T	MTOR Inhibitors	Agents that inhibit the activity of TOR SERINE-THREONINE KINASES. (See all compounds classified as MTOR Inhibitors.)	For the treatment of renal cell carcinoma (RCC). Also investigated for use/treatment in breast cancer, lymphoma (unspecified), rheumatoid arthritis, and multiple myeloma.
tenidap	120210-48-2	Tenidap	120210-48-2	9K7CJ74ONH	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	
Teniposide	29767-20-2	Teniposide	29767-20-2	957E6438QA	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Teniposide is used for the treatment of refractory acute lymphoblastic leukaemia
Tenofovir		Tenofovir	147127-20-6	99YXE507IL	Reverse Transcriptase Inhibitors	Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)	Tenofovir has been shown to be effective against HIV, herpes simplex virus-2, and hepatitis B virus.  To know more about the specific product indications, please visit the information in the orally available forms of tenofovir, [tenofovir alafenamide] and [tenofovir disoproxil].
tenovin-1		Tenovin-1	380315-80-0	BIQ6AID2B7			
tenoxicam	59804-37-4	Tenoxicam	59804-37-4	Z1R9N0A399	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	For the treatment of rheumatoid arthritis, osteoarthritis, backache, and pain.
tephrosin	76-80-2	Tephrosin	76-80-2	9C081V83CC			
tepoxalin		Tepoxalin	103475-41-8	TZ4OX61974	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Reduction of inflammation and relief of pain caused by acute and chronic musculoskeletal disorders.
terameprocol	5701-82-6	tetra-O-methyl nordihydroguaiaretic acid	5701-82-6				
Teratogens		Teratogens					
Terazosin	63590-64-7	Terazosin	63590-64-7	8L5014XET7	Adrenergic alpha-1 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)	Terazosin is indicated for use in treating symptomatic benign prostatic hyperplasia and hypertension.
terbacil	5902-51-2	Terbacil	5902-51-2	S0017J6E25			
Terbinafine	91161-71-6	Terbinafine	91161-71-6	G7RIW8S0XP	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	Terbinafine hydrochloride is indicated to treat fungal skin and nail infections caused by _Trichophyton_ species, _Microsporum canis_, _Epidermophyton floccosum_, and _Tinea_ species. Terbinafine hydrochloride also treats yeast infections of the skin caused by _Candida_ species and _Malassezia furfur_.
terbufos	13071-79-9	Terbufos	13071-79-9	M83BN0F8R9			
Terbutaline	23031-25-6	Terbutaline	23031-25-6	N8ONU3L3PG	Adrenergic beta-2 Receptor Agonists	Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)	Terbutaline is indicated for prevention and reversal of bronchospasm in patients at least 12 years old, with asthma and reversible bronchospasm associated with bronchitis and emphysema.
terbutryne	886-50-0	Terbutryn	886-50-0	ZXL474TLFP	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
terbutylazine	5915-41-3	Terbuthylazine	5915-41-3	M095B391J7	Pesticides	Chemicals used to destroy pests of any sort. The concept includes fungicides (FUNGICIDES, INDUSTRIAL); INSECTICIDES; RODENTICIDES; etc. (See all compounds classified as Pesticides.)	
terconazole		Terconazole	67915-31-5	0KJ2VE664U	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	For the treatment of candidiasis (a yeast-like fungal infection) of the vulva and vagina.
terephthalic acid	100-21-0	Terephthalic acid	100-21-0	6S7NKZ40BQ	Free Radical Scavengers	Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. (See all compounds classified as Free Radical Scavengers.)	
Terfenadine	50679-08-8	Terfenadine	50679-08-8	7BA5G9Y06Q	Histamine H1 Antagonists, Non-Sedating	A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. (See all compounds classified as Histamine H1 Antagonists, Non-Sedating.)	For the treatment of allergic rhinitis, hay fever, and allergic skin disorders.
terics	27986-36-3	2-(Nonylphenoxy)ethanol	51938-25-1	RN8NP35H6T	Detergents	Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)	
teriflunomide		Teriflunomide	163451-81-8	1C058IKG3B	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Used in the treatment of relapsing forms of multiple sclerosis (MS).
terodiline	15793-40-5	Terodiline	15793-40-5	70KG06964W	Parasympatholytics	Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)	
teroxirone		Teroxirone	59653-73-5	456V4159SL	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
terpendole E		Terpendole E					
Terpenes		Terpenes					
terpestacin	146436-22-8	(1R,3Z,5S,8Z,12Z,15S)-5,17-dihydroxy-18-[(2S)-1-hydroxypropan-2-yl]-4,8,12,15-tetramethylbicyclo[13.3.0]octadeca-3,8,12,17-tetraen-16-one	146436-22-8				
Terphenyl Compounds		Terphenyl Compounds					
terpin	80-53-5	Terpin	80-53-5	MPF495B08R	Expectorants	Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here. (See all compounds classified as Expectorants.)	
terpinenol-4	562-74-3	4-Terpineol, (+/-)-	562-74-3	L65MV77ZG6			
terpinolene	586-62-9	Terpinolene	586-62-9	N9830X5KSL			
terpinyl acetate	8007-35-0	alpha-Terpinyl acetate	80-26-2	9RXE0I9F2J			
territrem B	70407-20-4	Territrem B	70407-20-4				
territrem C	89020-33-7	Territrem C	89020-33-7				
tert-butyl 1-methyl-2-propynyl ether		Tert-butyl 1-methyl-2-propynyl ether	26826-40-4				
tert-Butyl Alcohol	75-65-0	tert-Butanol	75-65-0	MD83SFE959			
tert-butyl beta-carboline-3-carboxylate	93835-05-3	tert-butyl 9H-pyrido[3,4-b]indole-3-carboxylate	93835-05-3				
tert-butyl-2-(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester)		tert-butyl-2-(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester)					
tert-butyl-2-(6-((2-(acetylamino)-1,3-benzothiazol-4-yl)oxy)pyrimidin-4-yl)-5-(trifluoromethyl)phenylcarbamate		tert-butyl-2-(6-((2-(acetylamino)-1,3-benzothiazol-4-yl)oxy)pyrimidin-4-yl)-5-(trifluoromethyl)phenylcarbamate					
tert-butylbicyclo-2-benzoate	98774-24-4	tert-Butylbicyclo-2-benzoate	98774-24-4				
tert-butylbicyclophosphorothionate	70636-86-1	tert-Butylbicyclophosphorothionate	70636-86-1		Convulsants	Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)	
tert-butylcatechol	27213-78-1	3-(tert-Butyl)benzene-1,2-diol	27213-78-1	47F26P1WUE			
tert-Butylhydroperoxide	75-91-2	tert-Butyl Hydroperoxide	75-91-2	955VYL842B			
tert-butylphenyl diphenyl phosphate	56803-37-3	tert-Butylphenyl diphenyl phosphate	56803-37-3	49FH9AU0N9			
tertatolol	83688-84-0	Tertatolol	83688-84-0	9ZO341YQXP	Adrenergic beta-Antagonists	Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)	
tertiapin	58694-52-3	Tertiapin	58694-52-3		Potassium Channel Blockers	A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS. (See all compounds classified as Potassium Channel Blockers.)	
tertiary-amyl methyl ether	994-05-8	tert-Amyl methyl ether	994-05-8	94525J1AP8			
terutroban		Terutroban	165538-40-9	A6WX9391D8			
tesaglitazar		Tesaglitazar	251565-85-2	6734037O3L			Investigated for use/treatment in diabetes mellitus type 2.
tesmilifene		Tesmilifene	98774-23-3	I43T3ID6G2	Histamine Antagonists	Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)	Intended for the treatment of various forms of cancer.
Testicular Hormones		Testicular Hormones					
Testolactone	968-93-4	Testolactone	968-93-4	6J9BLA949Q	Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	For palliative treatment of advanced breast cancer in postmenopausal women.
Testosterone	58-22-0	Testosterone	58-22-0	3XMK78S47O	Androgens	Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. (See all compounds classified as Androgens.)	Testosterone is indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.
testosterone 17 beta-cypionate	58-20-8	Testosterone Cypionate	58-20-8	M0XW1UBI14	Anabolic Agents	These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. (See all compounds classified as Anabolic Agents.)	Testosterone cypionate is used in males that present conditions derived from a deficiency or absence of endogenous testosterone. These conditions are 1) primary hypogonadism, defined as the testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome or orchidectomy; and 2) hypogonadotropic hypogonadism characterized by idiopathic gonadotropin, LHRH deficiency or pituitary-hypothalamic injury from tumors, trauma or radiation.
testosterone enanthate		Testosterone Enanthate	315-37-7	7Z6522T8N9	Androgens	Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. (See all compounds classified as Androgens.)	Testosterone enanthate in males is indicated as a replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone. Some of the treated conditions are 1) primary hypogonadism, defined as testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome or orchidectomy; 2) hypogonadotropic hypogonadism due to an idiopathic gonadotropin or luteinizing hormone-releasing hormone deficiency or due to a pituitary-hypothalamic injury from tumors, trauma or radiation, in this case it is important to accompany the treatment with adrenal cortical and thyroid hormone replacement therapy; 3) to stimulate puberty in patients with delayed puberty not secondary to a pathological disorder. If the conditions 1 and 2 occur prior to puberty, the androgen replacement therapy will be needed during adolescent years for the development of secondary sexual characteristics and prolonged androgen treatment might be needed it to maintain sexual characteristics after puberty.  In females, testosterone enanthate is indicated to be used secondarily in presence of advanced inoperable metastatic mammary cancer in women who are from one to five years postmenopausal. It has also been used in premenopausal women with breast cancer who have benefited from oophorectomy and are considered to have a hormone-responsive tumor.  Testosterone enanthate injections that are currently formulated for subcutaneous use are specifically indicated only for primary hypogonadism and hypogonadotropic hypogonadism. The use of such formulations is limited because the safety and efficacy of these subcutaneous products in adult males with late-onset hypogonadism and males less than 18 years old have not yet been established. Moreover, subcutaneously administered testosterone enanthate is indicated only for the treatment of men with hypogonadal conditions associated with structural or genetic etiologies, considering the medication could cause blood pressure increases that can raise the risk of major adverse cardiovascular events like non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death.
testosterone glucuronate	1180-25-2	Testosterone glucuronide	1180-25-2				
Testosterone Propionate	57-85-2	Testosterone Propionate	57-85-2	WI93Z9138A			Testosterone propionate is used in veterinary practice in heifers in order to stimulate maximal growth.
testosterone undecanoate		Testosterone Undecanoate	5949-44-0	H16A5VCT9C	Androgens	Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. (See all compounds classified as Androgens.)	Testosterone undecanoate is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone. These conditions include:  - **Congenital or acquired primary hypogonadism**: testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelters syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone concentrations and gonadotropins (follicle-stimulating hormone [FSH], luteinizing hormone [LH]) above the normal range. - **Congenital or acquired hypogonadotropic hypogonadism**: gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation. These men have low testosterone serum concentrations but have gonadotropins in the normal or low range.  Testosterone undecanoate is not used to treat age-related hypogonadism.
testosterone-3-carboxymethyloxime-bovine serum albumin conjugate		testosterone-3-carboxymethyloxime-bovine serum albumin conjugate					
tetanospasmin	11032-48-7	tetanospasmin					
Tetanus Toxin		Toxin, bacterium clostridium tetani, tetanus					
Tetanus Toxoid		NSC-722666					
tetra(4-N-methylpyridyl)porphine	38673-65-3	meso-Tetrakis(2-N-methylpyridyl)porphine	38673-65-3		Angiogenesis Inhibitors	Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. (See all compounds classified as Angiogenesis Inhibitors.)	
tetraarsenic tetrasulfide		Tetraarsenic tetrasulfide	12044-79-0	ZIK02R2PSD			
Tetrabenazine	58-46-8	Tetrabenazine	718635-93-9	Z9O08YRN8O	Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	Treatment of hyperkinetic movement disorders like chorea in Huntington's disease, hemiballismus, senile chorea, Tourette syndrome and other tic disorders, and tardive dyskinesia
tetrabromobisphenol A	79-94-7	Tetrabromobisphenol A	79-94-7	FQI02RFC3A			
tetrabromobisphenol A-bisallylether		tetrabromobisphenol A-bisallylether					
tetrabromobisphenol S		4,4'-Sulphonylbis(2,6-dibromophenol)	39635-79-5		Flame Retardants	Materials applied to fabrics, bedding, furniture, plastics, etc. to retard their burning; many may leach out and cause allergies or other harm. (See all compounds classified as Flame Retardants.)	
tetrabromobisphenol-S-bis(2,3-dibromopropyl ether)		tetrabromobisphenol-S-bis(2,3-dibromopropyl ether)					
tetrabromocinnamic acid		tetrabromocinnamic acid					
tetrabromophthalic anhydride	632-79-1	Tetrabromophthalic anhydride	632-79-1	Q8E543QKMK			
tetrabutylammonium	10549-76-5	Tetrabutylammonium	10549-76-5	CBU2X6BBJR	Detergents	Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)	
tetrabutyltin	1461-25-2	Tetrabutyltin	1461-25-2	QJ7Y5V377V			
Tetracaine	94-24-6	Tetracaine	94-24-6	0619F35CGV	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	Ophthalmic tetracaine is indicated for the for procedures requiring a rapid and short- acting topical ophthalmic anesthetic.  The combination lidocaine and tetracaine patch is indicated for local dermal analgesia for superficial dermatological procedures and superficial venous access.  The combination lidocaine and tetracaine cream is intended to provide topical local analgesia for superficial dermatological procedures.
tetrachlorobenzoquinone		Chloranil	118-75-2	01W5X7N5XV	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
tetrachlorodian	79-95-8	Tetrachlorobisphenol A	79-95-8	FO0P9ET4BN			
Tetrachlorodibenzodioxin	1746-01-6	2,3,7,8-Tetrachlorodibenzo-P-dioxin	1746-01-6	DO80M48B6O	Environmental Pollutants	Substances or energies, for example heat or light, which when introduced into the air, water, or land threaten life or health of individuals or ECOSYSTEMS. (See all compounds classified as Environmental Pollutants.)	
tetrachloroethane		26061-EP2270113A1					
Tetrachloroethylene	127-18-4	Tetrachloroethylene	127-18-4	TJ904HH8SN	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
tetrachloroguaiacol		Tetrachloroguaiacol	2539-17-5	JIU326512E			
tetrachloroisophthalonitrile	1897-45-6	Chlorothalonil	1897-45-6	J718M71A7A	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
tetrachloropalladium	14349-67-8	Tetrachloropalladate ion (PdCl42-)	14349-67-8				
tetrachlorophenol	25167-83-3	2,3,4,5-Tetrachlorophenol	4901-51-3	D2UW5NHW9J			
tetrachloroplatinate	13965-91-8	Tetrachloroplatinate(II)	13965-91-8				
Tetrachlorvinphos	22248-79-9	Tetrachlorvinphos	22248-79-9	DM33MW89QU	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
tetraconazole		Tetraconazole	112281-77-3	8FGY868T0G	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Tetracycline	60-54-8	Tetracycline	60-54-8	F8VB5M810T	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Used to treat bacterial infections such as Rocky Mountain spotted fever, typhus fever, tick fevers, Q fever, rickettsialpox and Brill-Zinsser disease. May be used to treat infections caused by Chlamydiae spp., B. burgdorferi (Lyme disease), and upper respiratory infections caused by typical (S. pneumoniae, H. influenzae, and M. catarrhalis) and atypical organisms (C. pneumoniae, M. pneumoniae, L. pneumophila). May also be used to treat acne. Tetracycline may be an alternative drug for people who are allergic to penicillin.
tetracycline CMT-3		Incyclinide	15866-90-7	21G64WZQ4I			
tetracycline CMT-8		tetracycline CMT-8					
Tetracyclines		Tetracyclines					
tetradecabromodiphenoxybenzene		Tetradecabromo-1,4-diphenoxybenzene	58965-66-5	6O8X25I9YV			
Tetradecanoylphorbol Acetate	16561-29-8	Phorbol 12-myristate 13-acetate	16561-29-8	NI40JAQ945	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
tetradecylselenoacetic acid		tetradecylselenoacetic acid					
tetradecyltrimethylammonium	10182-92-0	Trimethyltetradecylammonium	8044-71-1	Y3IR7RCT6J	Surface-Active Agents	Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)	
tetradifon	116-29-0	Tetradifon	116-29-0	TIP8EA8VTS			
tetraethoxysilane	78-10-4	Tetraethyl orthosilicate	78-10-4	42064KRE49			
Tetraethyl Lead	78-00-2	Tetraethyllead	78-00-2	13426ZWT6A			
tetraethyl pyrophosphate	107-49-3	Tetraethyl pyrophosphate	107-49-3	28QKT80KX2			
Tetraethylammonium	66-40-0	Tetraethylammonium	66-40-0	5AV7G7EIEE	Potassium Channel Blockers	A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS. (See all compounds classified as Potassium Channel Blockers.)	Tetraethylammonium is an experimental drug with no approved indication.
tetraethylenepentamine	112-57-2	Tetraethylenepentamine	112-57-2	YZD1C9KQ28			
tetrafluoroaluminate	21340-02-3	Tetrafluoroaluminate Ion	21340-02-3				
tetrafluoroethylene	116-14-3	Tetrafluoroethylene	116-14-3	OMW63Z518S			
Tetragastrin	1947-37-1	Tetragastrin	1947-37-1	0OL293AV80			
tetrahydrocannabivarin 9	28172-17-0	Tetrahydrocannabivarol	28172-17-0				
tetrahydrocurcumin	36062-04-1	Tetrahydrocurcumin	36062-04-1	00U0645U03			
tetrahydrodaidzein		Tetrahydrodaidzein					
tetrahydrodeoxycorticosterone	567-03-3	Tetrahydrodeoxycorticosterone	567-03-3	4AB717DP4A	Anesthetics	Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)	
Tetrahydrofolates		Tetrahydrofolates					
tetrahydrofuran	109-99-9	Tetrahydrofuran	109-99-9	3N8FZZ6PY4			
tetrahydrogestrinone		Tetrahydrogestrinone	618903-56-3	643MR6L9LB	Androgens	Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. (See all compounds classified as Androgens.)	
Tetrahydroisoquinolines		Tetrahydroisoquinolines					
Tetrahydronaphthalenes		Tetrahydronaphthalenes					
tetrahydropalmatine	10097-84-4	DL-Tetrahydropalmatine	2934-97-6	78F8583LNQ	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
Tetrahydropapaveroline	4747-99-3	Tetrahydropapaveroline	4747-99-3	V1EWJ6B8KY			
tetrahydrophthalamic acid	2028-12-8	3-Cyclohexene-1-carboxylic acid, 6-(aminocarbonyl)-	2028-12-8				
tetrahydrothiophene		Tetrahydrothiophene	110-01-0	744EHT13FM			
Tetrahydrouridine	18771-50-1	Tetrahydrouridine	18771-50-1	0NIZ8H6OL8	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	
tetrahydroxy-5-cholan-24-oic acid		tetrahydroxy-5-cholan-24-oic acid					
tetrahydrozoline	84-22-0	Tetrahydrozoline	84-22-0	S9U025Y077	Ophthalmic Solutions	Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. (See all compounds classified as Ophthalmic Solutions.)	Tetryzoline is indicated for the temporary relief of discomfort and redness of the eye due to minor eye irritations as monotherapy or in combination with other eye lubricants and anti-irritants.  Tetryzoline is also indicated for decongestion of nasal and nasopharyngeal mucosa.
tetraiodothyroacetic acid	67-30-1	Tetrac	67-30-1	PA7UX1FFYQ			
Tetraisopropylpyrophosphamide	513-00-8	Diphosphoramide, N,N',N'',N'''-tetrakis(1-methylethyl)-	513-00-8		Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
tetrakis(4-benzoic acid)porphyrin		tetrakis(4-benzoic acid)porphyrin					
tetrakis(4-benzoic acid)porphyriniron(III)		tetrakis(4-benzoic acid)porphyriniron(III)					
tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex	70649-54-6	Mnt4MPyP	70649-54-6		Free Radical Scavengers	Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. (See all compounds classified as Free Radical Scavengers.)	
tetralin	119-64-2	1,2,3,4-Tetrahydronaphthalene	119-64-2	FT6XMI58YQ			
tetralol	530-91-6	1,2,3,4-Tetrahydro-2-naphthol	530-91-6	6AE2V413JI			
tetramethrin	7696-12-0	Tetramethrin	7696-12-0	Z72930Q46K	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
tetramethyl-1,4-benzoquinone		Duroquinone	527-17-3	X0Q8791R69			
tetramethylammonium	51-92-3	Tetramethylammonium	51-92-3	H0W55235FC	Ganglionic Stimulants	Agents that mimic neural transmission by stimulation of the nicotinic receptors on postganglionic autonomic neurons. Drugs that indirectly augment ganglionic transmission by increasing the release or slowing the breakdown of acetylcholine or by non-nicotinic effects on postganglionic neurons are not included here nor are the nonspecific cholinergic agonists. (See all compounds classified as Ganglionic Stimulants.)	
tetramethylenedisulfotetramine	80-12-6	Tetramethylenedisulfotetramine	80-12-6	F6TS3WME05			
Tetramethylphenylenediamine	27215-51-6	N,N,N',N'-Tetramethyl-P-phenylenediamine	100-22-1	P4P3AC32ZB			
tetramethylpyrazine	1124-11-4	2,3,5,6-Tetramethylpyrazine	1124-11-4	V80F4IA5XG	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	
tetramethylrosamine		C11622					
tetramethylthiourea	2782-91-4	Tetramethylthiourea	2782-91-4	J6T67A1P72			
tetramethylthiuram monosulfide	97-74-5	Tetramethylthiuram monosulfide	97-74-5	01W430XXSQ			
tetrandrine	518-34-3	Tetrandrine	518-34-3	29EX23D5AJ	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
Tetranitromethane	509-14-8	Tetranitromethane	509-14-8	K1G7CKU98F	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
tetraoctylammonium bromide		Tetraoctylammonium bromide	14866-33-2	52QW29OWOC			
tetrapentylammonium	15959-61-2	Tetrapentylammonium	15959-61-2	9IKH79PSWL			
tetrapropylammonium	13010-31-6	Tetrapropylammonium	13010-31-6				
tetrathiomolybdate	16330-92-0	Tetrathiomolybdate	16330-92-0	91U3TGV99T	Angiogenesis Inhibitors	Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. (See all compounds classified as Angiogenesis Inhibitors.)	Investigated for use/treatment in liver disease and pulmonary fibrosis.
Tetrazoles		Tetrazoles					
tetrazolium violet		Tetrazolium violet	1719-71-7				
Tetrodotoxin	4368-28-9	Tetrodotoxin	4368-28-9	3KUM2721U9	Anesthetics, Local	Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)	For the treatment of chronic and breakthrough pain in advanced cancer patients as well as for the treatment of opioid dependence.
texapon TH	139-96-8	Triethanolamine lauryl sulfate	139-96-8	E8458C1KAA			
Texas red	82354-19-6	Texas red	82354-19-6	734EQA7PWK	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
tezosentan		Tezosentan	180384-57-0	64J9J55263	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	Investigated for use/treatment in congestive heart failure, liver disease, and heart disease.
TG 003		(Z)-1-(3-Ethyl-5-methoxy-2,3-dihydrobenzothiazol-2-ylidene)propan-2-one	719277-26-6	KPC5K8BPP7			
TG101209		N-tert-butyl-3-[(5-methyl-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide	936091-14-4				
TGX 221		7-methyl-2-morpholino-9-(1-(phenylamino)ethyl)-4H-pyrido[1,2-a]pyrimidin-4-one	663619-89-4	6L28AW98TH			
TH 302		Evofosfamide	918633-87-1	8A9RZ3HN8W			Investigated for use/treatment in solid tumors.
TH1020		4-[[4-(Phenylmethyl)-5-(4-pyridinyl)-4H-1,2,4-triazol-3-yl]thio]-pyrido[3',2'					
TH5487		4-(4-bromo-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-N-(4-iodophenyl)piperidine-1-carboxamide					
Thalidomide	50-35-1	Thalidomide	50-35-1	4Z8R6ORS6L	Teratogens	An agent that causes the production of physical defects in the developing embryo. (See all compounds classified as Teratogens.)	Thalidomide is primarily used for the acute treatment and maintenance therapy to prevent and suppress the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL).
Thallium	7440-28-0	Thallium	7440-28-0	AD84R52XLF			
thallium acetate	563-68-8	Thallium(I) acetate	563-68-8	Q2901889VM			
thallium chloride	7791-12-0	Thallium chloride	7791-12-0				For use as a diagnostic radiopharmaceutical. It is indicated to help diagnose heart disease (eg, coronary artery disease, heart attack). It is also used for the diagnosis of parathyroid problems.
thallium nitrate	10102-45-1	Thallium nitrate	10102-45-1	LJQ38DSR12			
thallium sulfate	10031-59-1	Thallium sulfate	7446-18-6	U9F9QIR12T	Rodenticides	Substances used to destroy or inhibit the action of rats, mice, or other rodents. (See all compounds classified as Rodenticides.)	
thallium(III) hydroxide		Thallium(III) hydroxide					
thamira parpam		thamira parpam					
Thapsigargin	67526-95-8	Thapsigargin	67526-95-8	Z96BQ26RZD	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
theaflavin	4670-05-7	1,8-Bis((2R,3R)-3,5,7-trihydroxy-2H-1-benzopyran-2-yl)-3,4,6-trihydroxy-5H-benzocyclohepten-5-one	4670-05-7	1IA46M0D13	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
theaflavin digallate	33377-72-9	33377-72-9					
theaflavin-3,3'-digallate		Theaflavin-3,3'-digallate					
theaflavine gallate	31629-79-5	[3,5-dihydroxy-6-oxo-8-[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]-1-(3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl)benzo[7]annulen-4-yl] 3,4,5-trihydroxybenzoate					
theanine	3081-61-6	Theanine	3081-61-6	8021PR16QO			
thenalidine	86-12-4	Thenalidine	86-12-4	6U94N2D00F			
Thenoyltrifluoroacetone	326-91-0	2-Thenoyltrifluoroacetone	326-91-0	MYQ9MNW7NI	Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	
Theobromine	83-67-0	Theobromine	83-67-0	OBD445WZ5P	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	theobromine is used as a vasodilator, a diuretic, and heart stimulant. And similar to caffeine, it may be useful in management of fatigue and orthostatic hypotension.
theonyltrifluoroacetone		theonyltrifluoroacetone					
Theophylline	58-55-9	Theophylline	58-55-9	C137DTR5RG	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	For the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and chronic bronchitis.
thermozymocidin	35891-70-4	Myriocin	35891-70-4	YRM4E8R9ST	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	
Thiabendazole	148-79-8	Thiabendazole	148-79-8	N1Q45E87DT	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	For the treatment of strongyloidiasis (threadworm), cutaneous larva migrans (creeping eruption), visceral larva migrans, and trichinosis.
thiacloprid		Thiacloprid	111988-49-9	DSV3A944A4	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Thiadiazoles		Thiadiazoles					
thiamet G		Thiamet-G					
Thiamethoxam	153719-23-4	Thiamethoxam	153719-23-4	747IC8B487	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Thiamine	59-43-8	vitamin B1	59-43-8		Vitamin B Complex	A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)	
Thiamphenicol	15318-45-3	Thiamphenicol	15318-45-3	FLQ7571NPM	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Thiamylal	77-27-0	Thiamylal	77-27-0	01T23W89FR	Anesthetics, Intravenous	Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) (See all compounds classified as Anesthetics, Intravenous.)	Used for the production of complete anaesthesia of short duration, for the induction of general anaesthesia, and for inducing a hypnotic state.
thiaton	71731-58-3	Tiquizium bromide	71731-58-3	659K6049SF			
Thiazides		Thiazides					
Thiazoles		Thiazole	288-47-1	320RCW8PEF			
Thiazolidinediones		Thiazolidinediones					
Thiazolidines		Thiazolidine	504-78-9	I320806BKW			
thiazolyl blue	298-93-1	Thiazolyl blue	298-93-1	EUY85H477I	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
thiazopyr	117718-60-2	Thiazopyr	117718-60-2	AEQ9R142XI			
thiazovivin		N-benzyl-2-(pyrimidin-4-ylamino)thiazole-4-carboxamide	1226056-71-8	7268XHE3P7			
thieno(2,3-c)isoquinolin-5-one		thieno(2,3-c)isoquinolin-5-one					
Thienopyridines		Thienopyridines					
Thiethylperazine	1420-55-9	Thiethylperazine	1420-55-9	8ETK1WAF6R	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	For the treatment or relief of nausea and vomiting.
thifluzamide		Thifluzamide	130000-40-7	2J3TB6Z254			
Thimerosal	54-64-8	Thimerosal	54-64-8	2225PI3MOV	Preservatives, Pharmaceutical	Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include ANTI-BACTERIAL AGENTS and antioxidants. (See all compounds classified as Preservatives, Pharmaceutical.)	Used as preservative in some cosmetics, topical pharmaceuticals, and biological drug products, which includes vaccines.
thio-dimethylarsinate		thio-dimethylarsinate					
Thioacetamide	62-55-5	Thioacetamide	62-55-5	075T165X8M			
thioacetamide-S-oxide	2669-09-2	Thioacetamide-S-oxide	2669-09-2				
thioacridone	6540-78-9	9-Acridanthione	6540-78-9	QCJ587J6UO			
Thiobarbituric Acid Reactive Substances		Thiobarbituric Acid Reactive Substances					
Thiocarbamates		Thiocarbamates					
thiocarbohydrazide	2231-57-4	Thiocarbohydrazide	2231-57-4	1IZ2H82NWU	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
thiocholchicine	2730-71-4	Thiocolchicine	2730-71-4	47541468FI			
Thiocholine	625-00-3	Trimethyl(1-sulfanylethyl)azanium	625-00-3		Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
thiocitrulline		Thiocitrulline	156719-37-8		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
thiocoraline		Thiocoraline	173046-02-1				
Thioctic Acid	62-46-4	Thioctic acid	1077-28-7	73Y7P0K73Y	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
thiocyanate	302-04-5	Thiocyanate	302-04-5	O748SU14OM			
thiodicarb	59669-26-0	Thiodicarb	59669-26-0				
thiodipropionic acid	111-17-1	3,3'-Thiodipropionic acid	111-17-1	3BBK323ED8			
thioflavin T	2390-54-7	Thioflavin T	2390-54-7	CAX9SG0II0	Fluorescent Dyes	Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)	
thioglycerol	96-27-5	3-Mercapto-1,2-propanediol	96-27-5	AAO1P0WSXJ			
Thioglycolates		Thioglycolates					
Thioguanine	154-42-7	Thioguanine	154-42-7	WIX31ZPX66	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	For remission induction and remission consolidation treatment of acute nonlymphocytic leukemias.
thiohexam	95-33-0	N-Cyclohexyl-2-benzothiazolesulfenamide	95-33-0	UCA53G94EV			Thiohexam is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.
Thiohydantoins		2-Thiohydantoin	503-87-7	CP2PH1A61R			
Thioinosine	574-25-4	Thioinosine	574-25-4	46S541971T	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	
Thiomalates		Thiomalates					
Thiones		Thiones					
thionicotinamide adenine dinucleotide phosphate	19254-05-8	(2R,3R,4S,5R)-5-[[[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-2-(3-carbamothioylpyridin-1-ium-1-yl)-4-hydroxyoxolan-3-olate	19254-05-8				
Thiopental	76-75-5	Thiopental	76-75-5	JI8Z5M7NA3	Anesthetics, Intravenous	Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) (See all compounds classified as Anesthetics, Intravenous.)	For use as the sole anesthetic agent for brief (15 minute) procedures, for induction of anesthesia prior to administration of other anesthetic agents, to supplement regional anesthesia, to provide hypnosis during balanced anesthesia with other agents for analgesia or muscle relaxation, for the control of convulsive states during or following inhalation anesthesia or local anesthesia, in neurosurgical patients with increased intracranial pressure, and for narcoanalysis and narcosynthesis in psychiatric disorders.
thioperamide	106243-16-7	Thioperamide	106243-16-7	II4319BWUI	Histamine H3 Antagonists	Drugs that selectively bind to but do not activate HISTAMINE H3 RECEPTORS. They have been used to correct SLEEP WAKE DISORDERS and MEMORY DISORDERS. (See all compounds classified as Histamine H3 Antagonists.)	
Thiophanate	23564-05-8	Thiophanate-methyl	23564-05-8	K4N81R84L8	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	
Thiophenes		Thiophene	110-02-1	SMB37IQ40B			
thiophosphoric acid	13598-51-1	Phosphorothioic acid	192268-65-8	TYM4M7EWCW			
thiophosphoryl chloride	3982-91-0	Thiophosphoryl chloride	3982-91-0	II99F8594N			
Thioridazine	50-52-2	Thioridazine	50-52-2	N3D6TG58NI	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	For the treatment of schizophrenia and generalized anxiety disorder.
Thiorphan	76721-89-6	Thiorphan	76721-89-6	B79L7B5X3Z	Protease Inhibitors	Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)	
thiosalicylic acid		Thiosalicylic acid	147-93-3	CIP6LXN5XW			
thiosemicarbazide	79-19-6	Thiosemicarbazide	79-19-6	6056O8W6ET	Convulsants	Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)	
Thiosemicarbazones		thiosemicarbazone					
Thiostrepton	1393-48-2	Thiostrepton from Streptomyces azureus	1393-48-2		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
thiosulfinic acids		thiosulfinic acids					
Thiotepa	52-24-4	Thiotepa	52-24-4	905Z5W3GKH	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	ThioTEPA is used a as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients. Also, when high dose chemotherapy with HPCT support it is appropriate for the treatment of solid tumours in adult and paediatric patients.
Thiouracil	141-90-2	2-Thiouracil	141-90-2	59X161SCYL	Antithyroid Agents	Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones. (See all compounds classified as Antithyroid Agents.)	
Thiourea	62-56-6	Thiourea	62-56-6	GYV9AM2QAG	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
thioxanthone		Thioxanthen-9-one	492-22-8	EOK1SAC304			
thioxolone	4991-65-5	Tioxolone	4991-65-5	S0FAJ1R9CD			
thiphenamil	82-99-5	Thiphenamil	82-99-5	GX4D5197DT			
Thiram	137-26-8	Thiram	137-26-8	0D771IS0FH	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
THJ-018		Naphthalen-1-yl-(1-pentylindazol-3-yl)methanone	1364933-55-0	B39WNG6743			
THJ-2201		(1-(5-Fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone	1801552-01-1	D7P051IW0T	Cannabinoid Receptor Agonists	Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Agonists.)	
thonningianin A		thonningianin A	271579-11-4				
thonzonium bromide		Thonzonium bromide	553-08-2	JI2B19CR0R			
Thorium Compounds		Thorium compounds					
thorium nitrate	13823-29-5	Thorium nitrate	13823-29-5	IF944P467K			
threitol	7493-90-5	D-Threitol	7493-90-5	6DN82XBT5M			
threo-pentos-2-ulose	26188-06-7	D-threo-Pentos-2-ulose	26188-06-7				
threonic acid	3909-12-4	Threonic acid	20246-26-8	NTD0MI8XRT			
Threonine	72-19-5	Threonine	80-68-2	TFM6DU5S6A			L-Threonine makes up collagen, elastin, and enamel protein. It aids proper fat metabolism in the liver, helps the digestive and intestinal tracts function more smoothly, and assists in metabolism and assimilation.
Thrombin		635-76-7					
thrombin receptor-activating peptide SFLLRNPNDKY		thrombin receptor-activating peptide SFLLRNPNDKY					
Thromboxane A2	57576-52-0	thromboxane A2	57576-52-0	4C2A5G825S			
thromboxane A2, carbocyclic	73543-47-2	2beta-(Z),3alpha-(1E,3R)-3-(3-Hydroxy-(1-octenyl)bicyclo(3.1.1)hept-2-yl)-5-heptenoic acid	73543-47-2				
Thromboxane B2	54397-85-2	thromboxane B2	54397-85-2				
Thromboxanes		Thromboxane	66719-58-2	PLB95F606Q			
THRX 165724		THRX 165724					
thunberginol A	147666-80-6	Thunberginol A	147666-80-6	WK8ZG6DZL6			
thunberginol B	147666-81-7	Thunberginol B	147666-81-7	D2866L3MW5			
thyme oil		Caswell No. 618F					
thymeleatoxin	94482-56-1	CID 6437389	94482-56-1				
Thymic Factor, Circulating	78922-62-0	Thymic factor, circulating	78922-62-0				
Thymidine	50-89-5	Thymidine	50-89-5	VC2W18DGKR			
thymidine 5'-diphosphate	491-97-4	Thymidine-5'-diphosphate	491-97-4	QQ3K1P45DF	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
thymidine 5'-triphosphate	365-08-2	Thymidine-5'-triphosphate	365-08-2	QOP4K539MU			
thymidine glycol	32645-65-1	Thymidine glycol	32645-65-1				
Thymidine Monophosphate	365-07-1	Thymidine-5'-phosphate	365-07-1	43W3021X6C			
Thymine	65-71-4	Thymine	65-71-4	QR26YLT7LT			
thymiplatin		thymiplatin					
thymoglobulin		Antithymocyte immunoglobulin (rabbit)					
Thymol	89-83-8	Thymol	89-83-8	3J50XA376E	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
thymol blue	76-61-9	Thymol blue	76-61-9	8YB4804L4M			
Thymolphthalein	125-20-2	Thymolphthalein	125-20-2	YG5I28WSQP	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
thymoquinone	490-91-5	Thymoquinone	490-91-5	O60IE26NUF			
Thyroid Hormones		Thyroid hormones					
Thyronines		L-thyronine	1596-67-4	E4QN8G00CV			
Thyroxine	7488-70-2	DL-Thyroxine	300-30-1	QR0BV3BRIA			
thyroxine glucuronide	21462-56-6	Thyroxine glucuronide	21462-56-6				
THZ1 compound		THZ1 compound					
tiadenol		Tiadenol	6964-20-1	22251270CX	Hypolipidemic Agents	Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)	
Tiagabine	115103-54-3	Tiagabine	115103-54-3	Z80I64HMNP	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	For the treatment of partial seizures
tiamulin	55297-95-5	Tiamulin	55297-95-5	E38WZ4U54R	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
tianeptine		Tianeptine	72797-41-2	XV6773012I	Antidepressive Agents, Tricyclic	Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. (See all compounds classified as Antidepressive Agents, Tricyclic.)	Used primarily in the treatment of major depressive disorder and anxiety. It is currently being studied for fibromyalgia pain treatment.
tianhuang		tianhuang					
tianma gouteng yin		tianma gouteng yin					
Tiapamil Hydrochloride	57010-31-8	Tiapamil	57010-31-8	0ONY823T4J	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	
Tiapride Hydrochloride	51012-32-9	Tiapride	51012-32-9	LAH70H9JPH	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Tiapride is indicated for the treatment of a variety of neurological and psychiatric disorders including dyskinesia, alcohol withdrawal syndrome, negative symptoms of psychosis, and agitation and aggression in the elderly.
tiaprofenic acid		Tiaprofenic acid	33005-95-7	1LS1T6R34C	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Tiaprofenic acid is used to treat pain, especially arthritic pain.
tiazofurin	60084-10-8	Tiazofurin	60084-10-8	ULJ82834RE	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)	
tibolone		Tibolone	5630-53-5	FF9X0205V2	Androgen Antagonists	Compounds which inhibit or antagonize the biosynthesis or actions of androgens. (See all compounds classified as Androgen Antagonists.)	For the relief of post-menopausal symptoms and for the prevention of osteoporosis.
Ticagrelor		Ticagrelor	274693-27-5	GLH0314RVC	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	Ticagrelor is indicated to reduce the risk of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome or a history of myocardial infarction. Ticagrelor is also indicated to reduce the risk of a first myocardial infarction or stroke in high risk patients with coronary artery disease.
Ticlopidine	55142-85-3	Ticlopidine	55142-85-3	OM90ZUW7M1	Cytochrome P-450 CYP2C19 Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C19. (See all compounds classified as Cytochrome P-450 CYP2C19 Inhibitors.)	Used in patients, who have had a stroke or stroke precursors and who cannot take aspirin or aspirin has not worked, to try to prevent another thrombotic stroke.
Ticrynafen	40180-04-9	Tienilic acid	40180-04-9	HC95205SY4	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	For the treatment of hypertension.
tideglusib		Tideglusib	865854-05-3	Q747Y6TT42			Tideglusib was initially formulated for the treatment of Alzheimer and progressive supranuclear palsy. The raising interest for the use of tideglusib comes from the significant upregulation of GSK-3 in the brain in patients with Alzheimer disease. Its function as a degradant of -catenin, was also important, as it prevents the transcription of cell survival genes. All these factors have directed current research towards this kinase as a potential target. Alzheimer disease is the most prevalent form of dementia. The most accepted hypothesis to explain this disease is related to the presence of amyloid , which triggers a cascade that will alter the Tau protein and provoke synaptic dysfunction and neuronal death.   GSK-3 importance in the tissue repair pathway has also pointed out a novel application for tideglusib. Thus, it is also under the research for the natural repair treatment of deep caries lesions.
tifluadom	83386-35-0	Tifluadom	83386-35-0	TF8X866L0I	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	
Tigecycline		Tigecycline	1229002-07-6		Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Tiletamine	14176-49-9	Tiletamine	14176-49-9	2YFC543249	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
tiliroside	20316-62-5	Tiliroside	20316-62-5	15M04TXR9M			
tilmicosin	108050-54-0	Tilmicosin	108050-54-0	XL4103X2E3	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
Tilorone	27591-97-5	Tilorone	27591-97-5	O6W7VEW6KS	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	
Timolol	26839-75-8	Timolol	26839-75-8	5JKY92S7BR	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	Ophthalmic timolol is indicated for the treatment of increased intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The oral form of this drug is used to treat high blood pressure. In certain cases, timolol is used in the prevention of migraine headaches.
timosaponin AIII		Timosaponin A-III	41059-79-4				
timosaponin B-II		Melongoside N	98524-46-0				
timosaponin BIII		timosaponin BIII					
Tin	7440-31-5	Tin powder	7440-31-5	387GMG9FH5	Trace Elements	A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)	
Tin Fluorides		Tin Fluorides					
tin mesoporphyrin	106344-20-1	Stanate	106344-20-1	0KAE1U0G7Q	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Investigated for use/treatment in liver disease, metabolic disease, and pediatric indications.
tin protoporphyrin IX		Tin protoporphyrin IX	14325-05-4		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
tin sulfide	12738-87-3	Mosaic gold	1315-01-1	YVY89V9BUH			
tingenin B	50656-68-3	22-Hydroxytingenone	50656-68-3				
Tinidazole	19387-91-8	Tinidazole	19387-91-8	033KF7V46H	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of trichomoniasis caused by T. vaginalis in both female and male patients. Also for the treatment of giardiasis caused by G. duodenalis in both adults and pediatric patients older than three years of age and for the treatment of intestinal amebiasis and amebic liver abscess caused by E. histolytica in both adults and pediatric patients older than three years of age.
Tinopal CBS-X	38775-22-3	2,2'-([1,1'-Biphenyl]-4,4'-diyldivinylene)bis(benzenesulphonic) acid	334756-45-5				
tinuvin	3896-11-5	Bumetrizole	3896-11-5	7ZF18Q354W			
Tiopronin	1953-02-2	Tiopronin	1953-02-2	C5W04GO61S			Tiopronin is indicated for the prevention of kidney stone formation in patients with severe homozygous cystinuria consisting of a urinary cystine concentration greater than 500 mg/day, and who have failed treatment with non-pharmacological measures of increased fluid intake, decreased sodium and protein intake, and urine alkalinization.
tiotidine		Tiotidine	69014-14-8	EZU9AIZ69M	Histamine H2 Antagonists	Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (See all compounds classified as Histamine H2 Antagonists.)	
Tiotropium Bromide		Tiotropium bromide	136310-93-5	XX112XZP0J	Cholinergic Antagonists	Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists. (See all compounds classified as Cholinergic Antagonists.)	
tipepidine	5169-78-8	Tipepidine	5169-78-8	2260ZP67IT			
tipifarnib		Tipifarnib	192185-72-1	MAT637500A	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Investigated for use/treatment in colorectal cancer, leukemia (myeloid), pancreatic cancer, and solid tumors.
tiplaxtinin		Tiplasinin	393105-53-8	L396QIB983			
tipranavir		Tipranavir	174484-41-4	ZZT404XD09	Anti-HIV Agents	Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)	For combination antiretroviral treatment of HIV-1 infected adult patients with evidence of viral replication, who are highly treatment-experienced or have HIV-1 strains resistant to multiple protease inhibitors.
tiracizine	78816-67-8	Bonnecor	78816-67-8	GB5HGM31RA	Anti-Arrhythmia Agents	Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)	
Tirapazamine	27314-97-2	Tirapazamine	27314-97-2	1UD32YR59G	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For the treatment of head and neck cancer.
tirbanibulin		Tirbanibulin	897016-82-9	4V9848RS5G	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Tirbanibulin is indicated for the topical treatment of actinic keratosis on the face or scalp.
Titanium	7440-32-6	Titanium	7440-32-6	D1JT611TNE			
titanium alloy (TiAl6V4)	12743-70-3	Aluminum;titanium;vanadium	99906-66-8				
titanium citrate		Titanium citrate					
titanium dioxide	13463-67-7	Titanium Dioxide	1317-70-0	15FIX9V2JP	Photosensitizing Agents	Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)	Titanium dioxide is used in most sunscreens to block UVA and UVB rays, similar to [zinc oxide].
titanium nickelide	12035-60-8	12035-60-8					
titanium nitride	11116-16-8	Titanium nitride	11116-16-8				
titanium(IV) transferrin		titanium(IV) transferrin					
Titanocene Y		Titanocene Y					
tizanidine		Tizanidine	51322-75-9	6AI06C00GW	Muscle Relaxants, Central	A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)	Tizanidine is indicated for the relief of muscle spasticity, which can interfere with daily activities.  The general recommendation is to reserve tizanidine use for periods of time when there is a particular need for relief, as it has a short duration of action.
tizoxanide		Tizoxanide	173903-47-4	15KFG88UOJ	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)	
TMC 120A		TMC 120A					
TMVA protein, Trimeresurus mucrosquamatus		TMVA protein, Trimeresurus mucrosquamatus					
TN 16	33016-12-5	3-(1-Anilinoethylidene)-5-benzylpyrrolidine-2,4-dione	33016-12-5				
Tobacco Smoke Pollution		Tobacco Smoke Pollution					
tobacco tar		tobacco tar					
Tobramycin	32986-56-4	Tobramycin	32986-56-4	VZ8RRZ51VK	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Inhaled tobramycin is indicated for the management of cystic fibrosis patients with _Pseudomonas aeruginosa_, but is not recommended in patients under six years of age, those with forced expiratory volume in 1 second (FEV1) 80% predicted, or in those with _Burkholderia cepacia_.  Tobramycin applied topically to the eyes is indicated for the treatment of external eye (and adjoining structure) infections by susceptible bacteria.   Tobramycin injection is indicated in adult and pediatric patients for the treatment of serious bacterial infections, including septicemia (caused by _P. aeruginosa_, _Escherichia coli_, and _Klebsiella_ spp.), lower respiratory tract infections (caused by _P. aeruginosa_, _Klebsiella_ spp., _Enterobacter_ spp., _Serratia_ spp., _E. coli_, and _Staphylococcus aureus_, both penicillinase and non-penicillinase-producing strains), serious central-nervous-system infections (meningitis, caused by susceptible organisms), intra-abdominal infections including peritonitis (caused by _E. coli_, _Klebsiella_ spp., and _Enterobacter_ spp.), skin, bone, and skin structure infections (caused by _P. aeruginosa_, _Proteus_ spp., _E. coli_, _Klebsiella_ spp., _Enterobacter_ spp., _Serratia_ spp. and _S. aureus_), and complicated and recurrent urinary tract infections (caused by _P. aeruginosa_, _Proteus_ spp., _E. coli_, _Klebsiella_ spp., _Enterobacter_ spp., _Serratia_ spp., _S. aureus_, _Providencia_ spp., and _Citrobacter_ spp.). Aminoglycosides, including tobramycin, should generally not be used in uncomplicated urinary tract infections or staphylococcal infections unless less toxic antibiotics cannot be used and the bacteria in question are known to be sensitive to aminoglycosides.  As with all antibiotics, tobramycin use should be limited to cases where bacterial infections are known or strongly suspected to be caused by sensitive organisms, and the possible emergence of resistance should be monitored closely.
Tocopherols		2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)-	1406-66-2	ECY0XG64DO	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
tocophersolan	30999-06-5	Tocophersolan	30999-06-5				
tocopheryloxybutyric acid		tocopheryloxybutyric acid					
tocotrienol, alpha	1721-51-3	alpha-Tocotrienol	58864-81-6	B6LXL1832Y	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
tocotrienol, beta	490-23-3	beta-Tocotrienol	490-23-3	CHH810ZM8C			
tocotrienol, delta	25612-59-3	delta-Tocotrienol	25612-59-3	1SRB74OWSI			
Tocotrienols		Tocotrienol	6829-55-6	0867I0N41V	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
Todralazine	3778-76-5	Todralazine hydrochloride	3778-76-5	C59540FEXP	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
tofacitinib		Tofacitinib	477600-75-2	87LA6FU830	Janus Kinase Inhibitors	Agents that inhibit JANUS KINASES. (See all compounds classified as Janus Kinase Inhibitors.)	Tofacitinib is indicated for the treatment of adult patients with moderately-to-severely active rheumatoid arthritis (RA), active psoriatic arthritis, active ankylosing spondylitis, or moderately-to-severely active ulcerative colitis who have had an inadequate response or intolerance to one or more TNF blockers. It is also indicated as an oral solution in patients 2 years of age for the treatment of polyarticular course juvenile idiopathic arthritis who have had an inadequate response or intolerance to one or more TNF blockers.  Tofacitinib is not recommended to be used in combination with other biologic disease-modifying anti-rheumatic drugs (DMARDs) or potent immunosuppressive agents such as azathioprine or cyclosporine.
tokaku-joki-to		tokaku-joki-to					
Tolazamide	1156-19-0	Tolazamide	1156-19-0	9LT1BRO48Q	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	For use as an adjunct to diet to lower the blood glucose in patients with non-insulin dependent diabetes mellitus (Type II) whose hyperglycemia cannot be satisfactorily controlled by diet alone.
Tolazoline	59-98-3	Tolazoline	59-98-3	CHH9H12AQ3	Adrenergic alpha-Antagonists	Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)	For the treatment of pulmonary artery anomalies
Tolbutamide	64-77-7	Tolbutamide	64-77-7	982XCM1FOI	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	For treatment of NIDDM (non-insulin-dependent diabetes mellitus) in conjunction with diet and exercise.
Tolcapone	134308-13-7	Tolcapone	134308-13-7	CIF6334OLY	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	Used as an adjunct to levodopa/carbidopa therapy for the symptomatic treatment of Parkinson's Disease. This drug is generally reserved for patients with parkinsonian syndrome receiving levodopa/carbidopa who are experiencing symptom fluctuations and are not responding adequately to or are not candidates for other adjunctive therapies.
tolclofos-methyl		Tolclofos-methyl	57018-04-9	G42OQL6F5B			
tolfenamic acid		Tolfenamic acid	13710-19-5	3G943U18KM	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	In the information for tolfenamic acid, it is stated that this drug, being an NSAID, is effective in treating the pain associated with the acute attack of migraines in adults.
Tolmetin	26171-23-3	Tolmetin	26171-23-3	D8K2JPN18B	Cyclooxygenase Inhibitors	Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)	For the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, including the treatment of acute flares long-term management. Also for treatment of juvenile rheumatoid arthritis.
tolmetin glucuronide	71595-19-2	Tolmetin glucuronide	71595-19-2	GC783NL4J5			
Tolnaftate	2398-96-1	Tolnaftate	2398-96-1	06KB629TKV	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	Tolnaftate topical is used to treat skin infections such as athlete's foot, jock itch, and ringworm infections. Tolnaftate is also used, along with other antifungals, to treat infections of the nails, scalp, palms, and soles of the feet. The powder and powder aerosol may be used to prevent athlete's foot.
Tolonium Chloride	92-31-9	Tolonium chloride	92-31-9	15XUH0X66N	Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	Treatment of dental and oral soft tissue infections
toloxatone	29218-27-7	Toloxatone	29218-27-7	5T206015T5	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	For the treatment of major depressive disorder.
Tolperisone	728-88-1	Tolperisone	728-88-1	F5EOM0LD8E	Muscle Relaxants, Central	A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)	Investigated for use/treatment in neurologic disorders, spinal cord injuries, muscle spasm, back pain, and multiple sclerosis.
tolrestat		Tolrestat	82964-04-3	0T93LG5NMK	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	For the pharmacological control of certain diabetic complications.
tolserine		Tolserine					
Tolterodine Tartrate		Tolterodine Tartrate	209747-05-7	5T619TQR3R	Muscarinic Antagonists	Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)	
toltrazuril	69004-03-1	Toltrazuril	69004-03-1	QVZ3IAR3JS	Coccidiostats	Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals. (See all compounds classified as Coccidiostats.)	
Tolu balsam	9000-64-0	Balsam tolu					
Toluene	108-88-3	Toluene	108-88-3	3FPU23BG52	Solvents	Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant and Hackh&apos;s Chemical Dictionary, 5th ed) (See all compounds classified as Solvents.)	Used for the removal of ascarids (Toxocara canis and Toxascaris leonina) and hookworms (Ancylostoma caninum and Uncinaria stenocephala) and as an aid in removing tapeworms (Taenia pisiformis, Dipylidium caninum, and Echinococcus granulosus) from dogs and cats.
Toluene 2,4-Diisocyanate	584-84-9	2,4-Diisocyanato-1-methylbenzene	26006-20-2	17X7AFZ1GH			
Tolvaptan	150683-30-0	Tolvaptan	150683-30-0	21G72T1950	Antidiuretic Hormone Receptor Antagonists	Endogenous compounds and drugs that inhibit or block the activity of ANTIDUIRETIC HORMONE RECEPTORS. (See all compounds classified as Antidiuretic Hormone Receptor Antagonists.)	Treatment of symptomatic and resistant to fluid restriction euvolemic or hypervolemic hyponatremia associated with congestive heart failure, SIADH, and cirrhosis.
tomatidine	77-59-8	Tomatidine	77-59-8	2B73S48786			
tomentosin		Tomentosin	33649-15-9				
tongxinluo		tongxinluo					
toosendanin	79304-40-8	6-Amino-2-[(1s)-3-amino-1-({3-amino-2-[(tert-butoxycarbonyl)amino]-3-oxopropyl}amino)-3-oxopropyl]-5-methylpyrimidine-4-carboxylic acid	75452-30-1				
Topiramate	97240-79-4	Topiramate	97240-79-4	0H73WJJ391	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	Topiramate is indicated  for the following conditions: 1)Monotherapy for partial onset or primary generalized tonic-clonic seizures for patients 2 years of age and above 2)Adjunctive therapy for partial onset seizures or primary generalized tonic-clonic seizures for both adult and pediatric patients above 2 years old 3)Adjunctive therapy for seizures associated with Lennox-Gastaut syndrome in patients above 2 years of age 4)Prophylaxis of migraine in children 12 years of age and older and adults.  Topiramate is also used off-label as an adjunct therapy for weight management and for mood disorders.
Topotecan	123948-87-8	Topotecan	123948-87-8	7M7YKX2N15	Topoisomerase I Inhibitors	Compounds that inhibit the activity of DNA TOPOISOMERASE I. (See all compounds classified as Topoisomerase I Inhibitors.)	For the treatment of advanced ovarian cancer in patients with disease that has recurred or progressed following therapy with platinum-based regimens. Also used as a second-line therapy for treatment-sensitive small cell lung cancer, as well as in combination with cisplatin for the treatment of stage IV-B, recurrent, or persistent cervical cancer not amenable to curative treatment with surgery and/or radiation therapy.
torbafylline	105102-21-4	Torbafylline	105102-21-4	65O78F9T1W			
torcetrapib		Torcetrapib	262352-17-0	4N4457MV2U	Anticholesteremic Agents	Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)	Investigated for use/treatment in peripheral vascular disease and hyperlipidemia.
Toremifene	89778-26-7	Toremifene	89778-26-7	7NFE54O27T	Selective Estrogen Receptor Modulators	A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63) (See all compounds classified as Selective Estrogen Receptor Modulators.)	For the treatment of metastatic breast cancer in postmenopausal women with estrogen receptor-positive or receptor-unknown tumors. Toremifene is currently under investigation as a preventative agent for prostate cancer in men with high-grade prostatic intraepithelial neoplasia and no evidence of prostate cancer.
Torsemide	56211-40-6	Torsemide	56211-40-6	W31X2H97FB	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	Torasemide is indicated for the treatment of edema associated with congestive heart failure, renal or hepatic diseases. From this condition, it has been observed that torasemide is very effective in cases of kidney failure.  As well, torasemide is approved to be used as an antihypertensive agent either alone or in combination with other antihypertensives.
Tosyllysine Chloromethyl Ketone	2104-86-1	Tosyllysine chloromethyl ketone	2104-86-1		Serine Proteinase Inhibitors	Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)	
Tosylphenylalanyl Chloromethyl Ketone	402-71-1	Tosylphenylalanyl chloromethyl ketone	402-71-1	P598716LJT	Alkylating Agents	Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)	
tounongsan		tounongsan					
Toxaphene	8001-35-2	1,4,5,6,7,7-Hexachloro-2,2-bis(chloromethyl)-3-methylidenebicyclo[2.2.1]heptane	8001-35-2		Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
toxB protein, Clostridium difficile		toxB protein, Clostridium difficile					
Toxic Actions		Toxic Actions					
Toximul MP8	37341-79-0	Toximul MP8					
toxin II (Anemonia sulcata)	60748-45-0	Toxin II (anemonia sulcata)	60748-45-0		Cardiotonic Agents	Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)	
Toxins, Biological		Toxins, Biological					
Toyocamycin	606-58-6	Toyocamycin	606-58-6	L7995C4D7F	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	
tozasertib		Tozasertib	639089-54-6	234335M86K			
TP 7		L-threonyl-L-lysyl-L-prolyl-L-arginyl-L-prolylglycyl-L-Proline					
tPA stop		tPA stop					
TPD7 compound		TPD7 compound					
TR4161	21562-57-2	Prostaglandin E1 alcohol	21562-57-2				
Trabectedin	114899-77-3	Trabectedin	114899-77-3	ID0YZQ2TCP	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	Indicated for treatment of advanced soft tissue sarcoma in patients refractory to or unsuitable to receive anthracycline or ifosfamide chemotherapy in Europe, Russia and South Korea. Approved for orphan drug status by the U.S. FDA for treatment of soft tissue sarcomas and ovarian cancer. Investigated for use/treatment in cancer/tumors (unspecified), gastric cancer, ovarian cancer, pediatric indications, sarcoma, and solid tumors.
tracazolate	41094-88-6	Tracazolate	41094-88-6	NH0HPL3U1T			
Trace Elements		Aluminosilicate-containing Clay					
trachelogenin		Trachelogenin	34209-69-3	379VHZ3K1I			
tralomethrin	66841-25-6	Tralomethrin	66841-25-6				
TRAM 34		1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole	289905-88-0	X3BGE57NBF			
Tramadol	27203-92-5	Tramadol	123154-38-1	39J1LGJ30J	Narcotics	Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)	Tramadol is approved for the management of moderate to severe pain in adults.  Tramadol is also used off-label in the treatment of premature ejaculation.
trametinib		Trametinib	871700-17-3	33E86K87QN	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Trametinib is indicated as monotherapy for the treatment of BRAF-inhibitor treatment-nave patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations.  It is used in combination with [dabrafenib] for the:  - treatment of unresectable or metastatic melanoma with BRAF V600E or V600K mutations. - adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutations and involvement of lymph node(s), following complete resection. - treatment of patients with metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation. In Europe, it is indicated for the treatment of adults with advanced non-small cell lung cancer with a BRAF V600 mutation. - treatment of patients with locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation and with no satisfactory locoregional treatment options. - the treatment of adult and pediatric patients six years of age and older with unresectable or metastatic solid tumours with BRAF V600E mutation who have progressed following prior treatment and have no satisfactory alternative treatment options. In the US, this indication is approved under accelerated approval based on the overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s). - the treatment of pediatric patients one year of age and older with low-grade glioma (LGG) with a BRAF V600E mutation who require systemic therapy.  In the US, BRAF V600E or V600K mutations must be detected by an FDA-approved test. Trametinib is not indicated for the treatment of patients with colorectal cancer because of known intrinsic resistance to BRAF inhibition.
trandolapril		Trandolapril	87679-37-6	1T0N3G9CRC	Angiotensin-Converting Enzyme Inhibitors	A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)	For the treatment of mild to moderate hypertension, as an adjunct in the treatment of congestive heart failure (CHF), to improve survival following myocardial infarction (MI) in individuals who are hemodynamically stable and demonstrate symptoms of left ventricular systolic dysfunction or signs of CHF within a few days following acute MI, and to slow progression of renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy.
Tranexamic Acid	1197-18-8	Tranexamic acid	701-54-2	37YD696II6	Antifibrinolytic Agents	Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders. (See all compounds classified as Antifibrinolytic Agents.)	
tranilast	53902-12-8	Tranilast	53902-12-8	HVF50SMY6E	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	For the treatment of bronchial asthma, keloid and hypertrophic scar, and allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.
Trans Fatty Acids		Trans Fatty Acids					
trans-(PtCl2(NH3)(thiazole))		trans-(PtCl2(NH3)(thiazole))					
trans-1,2-dihydro-1,2-naphthalenediol		(1S,2S)-1,2-dihydronaphthalene-1,2-diol	771-16-4	S8A9YQL2YS			
trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride	366-93-8	1,4-Cyclohexanedimethanamine, N,N'-bis((2-chlorophenyl)methyl)-, dihydrochloride, trans-	366-93-8		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
trans-10,cis-12-conjugated linoleic acid		(10E,12Z)-octadeca-10,12-dienoic acid	2420-56-6	N151ZM4M27			
trans-2-(2-nitrovinyl)furan		trans-2-(2-nitrovinyl)furan					
trans-3,4'-dimethyl-3-hydroxyflavanone		Dimethylhydroxy dihydroflavone	179125-68-9	1I7CW0S81Z			
trans-3,5,4'-trihydroxystilbene-4'-O-beta-D-glucopyranoside		trans-3,5,4'-trihydroxystilbene-4'-O-beta-D-glucopyranoside					
trans-phytol		Phytol	150-86-7	MZQ4XE15TP			
trans-sodium crocetinate		Trans sodium crocetinate	591230-99-8	YP57637WMX	Anticarcinogenic Agents	Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)	
transfluthrin		Transfluthrin	118712-89-3	QWL3SKA6EG	Insecticides	Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)	
Transforming Growth Factor beta1		Transforming Growth Factor beta1					
transplatin	14913-33-8	azane;dichloroplatinum	15663-27-1		Cross-Linking Reagents	Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)	
trantinterol		2-(4-Amino-3-chloro-5-trifluoromethyl-phenyl)-2-tert-butylaminoethanol hydrochloride					
Tranylcypromine	155-09-9	Tranylcypromine	155-09-9	3E3V44J4Z9	Antidepressive Agents	Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)	For the treatment of major depressive episode without melancholia.
Trapidil	15421-84-8	Trapidil	15421-84-8	EYG5Y6355E	Phosphodiesterase Inhibitors	Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)	Used in the treatment of chronic stable angina.
trapoxin B	133155-90-5	(3S,6S,9S,12R)-3,6-dibenzyl-9-[2-[(2S)-oxiran-2-yl]-2-oxoethyl]-1,4,7-triazabicyclo[10.3.0]pentadecane-2,5,8,11-tetrone	133155-90-5				
traxoprodil mesylate		Traxoprodil mesylate	188591-67-5	I23V4CCC9V			
Trazodone	19794-93-5	Trazodone	19794-93-5	YBK48BXK30	Antidepressive Agents, Second-Generation	A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)	Trazodone is indicated for the treatment of major depressive disorder (MDD). It has been used off-label for adjunct therapy in alcohol dependence, and off-label to treat anxiety and insomnia. It may also be used off-label to treat symptoms of dementia, Alzheimers disease, schizophrenia, eating disorders, and fibromyalgia due to its effects on various neurotransmitter receptors.
Trehalose	99-20-7	Trehalose	99-20-7	B8WCK70T7I			
trelagliptin		Trelagliptin	865759-25-7	Q836OWG55H			
tremolite	14567-73-8	Dicalcium;pentamagnesium;[dioxido-[oxo(trioxidosilyloxy)silyl]oxysilyl]oxy-[[dioxido-[oxo(trioxidosilyloxy)silyl]oxysilyl]oxy-oxosilyl]oxy-dioxidosilane;dihydroxide	14567-73-8				
Trenbolone Acetate		Trenbolone Acetate	10161-34-9	RUD5Y4SV0S	Anabolic Agents	These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. (See all compounds classified as Anabolic Agents.)	
treprostinil		Treprostinil	81846-19-7	RUM6K67ESG	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	The FDA has indicated treprostinil for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease to improve exercise ability. It is also used to treat pulmonary arterial hypertension in patients requiring transition from epoprostenol. The Health Canada label specifies that treprostinil is indicated for the long-term treatment of pulmonary arterial hypertension in NYHA Class III and IV patients who did not respond adequately to conventional therapy.  L24244
trequinsin	79855-88-2	Trequinsin	79855-88-2	739I2958C1	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
trestolone	3764-87-2	Trestolone	3764-87-2	40P3287I94	Contraceptives, Postcoital, Hormonal	Postcoital contraceptives which owe their effectiveness to hormonal preparations. (See all compounds classified as Contraceptives, Postcoital, Hormonal.)	Investigated for use/treatment in contraception and male hormonal deficiencies/abnormalities.
trestolone acetate		Trestolone acetate	6157-87-5	52XDF4N1XL			
tretazicar		Tretazicar	21919-05-1	7865D5D01M	Radiation-Sensitizing Agents	Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. (See all compounds classified as Radiation-Sensitizing Agents.)	
Tretinoin	302-79-4	Tretinoin	302-79-4	5688UTC01R	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Oral tretinoin is indicated for induction of remission in adults and pediatric patients one year of age and older with acute promyelocytic leukemia (APL), characterized by the presence of t(15;17) translocation or presence of PML/RAR gene expression and who are refractory to or who have relapsed from anthracycline chemotherapy or for whom anthracycline-based chemotherapy is contraindicated.  Topical tretinoin is also indicated alone or in combination with [benzoyl peroxide] or [clindamycin] for the treatment of acne vulgaris. It is also used in prescription and over-the-counter for treating various skin conditions such as melasma, hyperpigmentation, and photoaging alone or in combination with other drugs.
tri-(2-chloroisopropyl)phosphate	13674-84-5	Tris(1-chloro-2-propyl) phosphate	13674-84-5	CRT22GFY70			
tri-(2-ethylhexyl)trimellitate	3319-31-1	Tris(2-ethylhexyl) trimellitate	3319-31-1	378539Q830			
tri-isobutylphosphate	126-71-6	Triisobutyl phosphate	126-71-6	6MKE1AR3GB			
tri-o-cresyl phosphate	78-30-8	Tri-O-cresyl phosphate	78-30-8	X8II18JD0A			
tri-xylenyl phosphate	25155-23-1	Trixylenyl phosphate	25155-23-1	5TL8H5QK8V			
Triacetin	102-76-1	Triacetin	102-76-1	XHX3C3X673	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
triacsin C	76896-80-5	Triacsin c	76896-80-5	6M6D4602I5	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
triadimefon	43121-43-3	Triadimefon	43121-43-3	1HW039CJF0	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Triallate	2303-17-5	Triallate	2303-17-5	A9S097HS99	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Triamcinolone	124-94-7	Triamcinolone	124-94-7	1ZK20VI6TY	Glucocorticoids	A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)	Triamcinolone hexacetonide injections are indicated for intralesional administration in alopecia areata, discoid lupus erythematosus, keloids, and necrobiosis lipoidica diabeticorum. This formulation can also be used for localized hypertrophic infiltrated inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus, and psoriatic plaques.  Triamcinolone acetonide spray and cream are indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. A triamcinolone acetonide 10mg/mL or 40mg/mL injection is indicated intra-articularly for acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, and synovitis of osteoarthritis. The same 10mg/mL injection is indicated by the intralesional route for the treatment of alopecia areata, discoid lupus erythematosus, keloids, necrobiosis lipoidica diabeticorum, and tumors of an aponeurosis or tendon. This formulation can also be used for localized hypertrophic infiltrated inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus, and psoriatic plaques. The 40mg/mL injection is indicated intramuscularly for controlling severe allergic conditions such as asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity, perennial or seasonal allergic rhinitis, serum sickness, and transfusion reactions; treatment of bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, Stevens-Johnson syndrome, congenital adrenal hyperplasia, hypercalcemia in cancer, nonsuppurative thyroiditis, autoimmune hemolytic anemia, Diamond-Blackfan anemia, pure red cell aplasia, secondary thrombocytopenia, trichinosis, tuberculous meningitis, acute exacerbations of multiple sclerosis or cerebral edema, sympathetic ophthalmia, temporal arteritis, uveitis, ocular inflammation, berylliosis, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis, dermatomyositis, polymyositis, and systemic lupus erythematosus; adjunct treatment of adrenocortical insufficiency, regional enteritis, ulcerative colitis, fulminating or disseminated pulmonary tuberculosis, acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis; palliative management of leukemia and lymphoma; induction of diuresis or remission of proteinuria in idiopathic nephrotic syndrome or lupus erythematosus. A triamcinolone intravitreal injection is indicated for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions. The intravitreal injection is also used for visualization during vitrectomy. An extended release suspension is indicated intra-articularly for management of pain in osteoarthritis of the knee.  A triamcinolone acetonide suspension for injection into the suprachoroidal space is indicated for the treatment of macular edema associated with uveitis.
Triamcinolone Acetonide	76-25-5	Triamcinolone Acetonide	76-25-5	F446C597KA	Anti-Inflammatory Agents	Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)	Visualisation during vitrectomy
Triamterene	396-01-0	Triamterene	396-01-0	WS821Z52LQ	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	Triamterene is indicated for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and the nephrotic syndrome; also in steroid-induced edema, idiopathic edema, and edema due to secondary hyperaldosteronism.  Triamterene in combination with hydrochlorothiazide is indicated for the managment of hypertension or treatment of edema in patients who develop hypokalemia following hydrochlorothiazide monotherapy, and in patients who require thiazide diuretic and in whom the development of hypokalemia cannot be risked. Triamterene allows the maintenance of potassium balance when given in combination with loop diuretics and thiazides.
triaquaoxohexakis(propionato)trichromium(III)		triaquaoxohexakis(propionato)trichromium(III)					
Triarachidonin	23314-57-0	Triarachidonin					
triazacyclononane		Triazacyclononane					
Triazenes		Triazenes					
triazinate	41191-04-2	Triazinate	41191-04-2	DD99Y262WC	Folic Acid Antagonists	Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Folic Acid Antagonists.)	
Triazines		Triazines					
Triazolam	28911-01-5	Triazolam	28911-01-5	1HM943223R	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	For the short-term treatment of insomnia.
Triazoles		1H-1,2,3-Triazole	288-35-7	EM7554254W			
triazolopyrimidinone	273-40-5	8-Azapurine	273-40-5	H49B4KW3PH			
triazophos	24017-47-8	Triazophos	24017-47-8	6099J8L0EE			
tribendimidine	115103-15-6	Tribendimidine	115103-15-6	YO6SOD6ZTJ			
tribromodiphenyl ether 28		2,4-Dibromo-1-(4-bromophenoxy)benzene	41318-75-6	3XQ4Q434KF			
tribromoethanol	1329-86-8	2,2,2-Tribromoethanol	75-80-9	149JI83A44	Anesthetics	Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)	
tribromsalan	87-10-5	Tribromsalan	87-10-5	6MCE3VTF0O			
tribulin	84788-92-1	Isatin	91-56-5	82X95S7M06			
Tribulus extract		Tribulus extract					
tributyl citrate	77-94-1	Tributyl citrate	77-94-1	827D5B1B6S			
tributyl phosphate	126-73-8	Tributyl phosphate	126-73-8	95UAS8YAF5	Radiation-Protective Agents	Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)	
tributylhexadecylphosphonium bromide		Tributylhexadecylphosphonium bromide	14937-45-2				
tributyltin	688-73-3	Tributyl tin	688-73-3	4XDX163P3D			
tributyltinisothiocyanate	5035-65-4	Tributyltinisothiocyanate	5035-65-4				
tributyrin	60-01-5	Tributyrin	60-01-5	S05LZ624MF			
tricaine	582-33-2	Tricaine	582-33-2	02591PHL19	Anesthetics	Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)	
tricalcium phosphate	7758-87-4	Calcium Phosphate	10103-46-5	K4C08XP666			For use as an over the counter calcium and phosphate supplement, antacid, or a source of calcium and phosphate in toothpaste.
tricaproin	621-70-5	Glycerol trihexanoate	621-70-5	EZ1Y9R895Y			
tricarbonylchloro(glycinato)ruthenium(II)		tricarbonylchloro(glycinato)ruthenium(II)					
tricarbonyldichlororuthenium (II) dimer		tricarbonyldichlororuthenium (II) dimer					
tricetin		Tricetin	520-31-0	5627PY99ZO			
tricetinidin		Tricetinidin	65618-21-5		Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
Trichlorfon	52-68-6	Trichlorfon	52-68-6	1MVY4KU98F	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
Trichlormethiazide	133-67-5	Trichlormethiazide	133-67-5	Q58C92TUN0	Sodium Chloride Symporter Inhibitors	Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA. (See all compounds classified as Sodium Chloride Symporter Inhibitors.)	Used in the treatment of oedema (including that associated with heart failure) and hypertension.
trichloroacetaldehyde	75-87-6	Chloral	75-87-6	FLI06WS32H			
Trichloroacetic Acid	76-03-9	Trichloroacetic Acid	76-03-9	5V2JDO056X	Caustics	Strong alkaline chemicals that destroy soft body tissues resulting in a deep, penetrating type of burn, in contrast to corrosives, that result in a more superficial type of damage via chemical means or inflammation. Caustics are usually hydroxides of light metals. SODIUM HYDROXIDE and potassium hydroxide are the most widely used caustic agents in industry. Medically, they have been used externally to remove diseased or dead tissues and destroy warts and small tumors. The accidental ingestion of products (household and industrial) containing caustic ingredients results in thousands of injuries per year. (See all compounds classified as Caustics.)	
trichloroacetonitrile	545-06-2	Trichloroacetonitrile	545-06-2	6397DL8869			
Trichloroepoxypropane	3083-23-6	1,2-Epoxy-3,3,3-trichloropropane	3083-23-6	IQ92Z3552X	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Trichloroethylene	79-01-6	Trichloroethylene	79-01-6	290YE8AR51	Anesthetics, Inhalation	Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173) (See all compounds classified as Anesthetics, Inhalation.)	
trichloromethyl free radical	3170-80-7	Trichloromethyl radical	3170-80-7				
trichloronitritodiammineplatinum(IV)		trichloronitritodiammineplatinum(IV)					
trichlorosucrose		Sucralose	56038-13-2	96K6UQ3ZD4	Sweetening Agents	Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)	
trichodesmine	548-90-3	Trichodesmine	548-90-3				
trichostatin A	58880-19-6	trichostatin A	58880-19-6	3X2S926L3Z	Histone Deacetylase Inhibitors	Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)	
Trichothecenes		trichothecene					
tricin	520-32-1	Tricin	520-32-1	D51JZL38TQ			
triciribine		Triciribine	35943-35-2	2421HMY9N6			
Triclabendazole	68786-66-3	Triclabendazole	68786-66-3	4784C8E03O	Antiplatyhelmintic Agents	Agents used to treat cestode, trematode, or other flatworm infestations in man or animals. (See all compounds classified as Antiplatyhelmintic Agents.)	This drug is indicated for the treatment of fascioliasis in patients aged 6 years old and above.
triclabendazole sulfoxide		Triclabendazole sulfoxide	100648-13-3	KY3O5E011U	Anthelmintics	Agents that kill parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal. (See all compounds classified as Anthelmintics.)	
triclocarban	101-20-2	Triclocarban	101-20-2	BGG1Y1ED0Y	Anti-Infective Agents, Local	Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)	Triclocarban (TCC), or 3,4,4'-trichlorocarbanilide, is an antibacterial agent used in bar and liquid soaps and body washes.
triclopyr	55335-06-3	Triclopyr	55335-06-3	MV06PHJ6I0	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Triclosan	3380-34-5	Triclosan	3380-34-5	4NM5039Y5X	Fatty Acid Synthesis Inhibitors	Compounds that interfere with FATTY ACID SYNTHASE resulting in a reduction of FATTY ACIDS. This is a target mechanism in humans of some ANTINEOPLASTIC AGENTS and ANTI-OBESITY AGENTS and of some ANTI-INFECTIVE AGENTS which interfere with CELL WALL and CELL MEMBRANE formation. (See all compounds classified as Fatty Acid Synthesis Inhibitors.)	Triclosan is used in a variety of common household products, including soaps, mouthwashes, dish detergents, toothpastes, deodorants, and hand sanitizers.  It is also used in health care settings in surgical scrubs and personnel hand washes.
tricyclodecane-9-yl-xanthogenate		Potassium O-(octahydro-4,7-methano-1H-inden-5-yl) dithiocarbonate	83373-60-8		Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
tridecane	629-50-5	Tridecane	629-50-5	A3LZF0L939			
tridemorph	24602-86-6	Tridemorph	24602-86-6				
tridiphane	58138-08-2	Tridiphane	58138-08-2	Z5677LQE6J			
trienomycin A	98873-83-7	Trienomycin A	98873-83-7				
Trientine	112-24-3	Trientine	112-24-3	SJ76Y07H5F	Chelating Agents	Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)	Triethylenetetramine is a copper chelator indicated for the treatment of adult patients with stable Wilsons disease who are de-coppered and tolerant to [penicillamine].
trierixin		Trierixin					
triethanolamine	102-71-6	Triethanolamine	102-71-6	9O3K93S3TK			Trolamine is used as an alkalizing agent, surfactant, and counter-ion in cosmetic and pharmaceutical formulations. It is not considered to be an active pharmacological ingredient and so has no official indication.
triethyl phosphate	78-40-0	Triethyl phosphate	78-40-0	QIH4K96K7J			
triethyl phosphine gold	15529-90-5	Chloro(triethylphosphine)gold(I)	15529-90-5				
triethyl-(beta-4-stilbenoxyethyl)ammonium	2551-76-0	Stilonium iodide	2551-76-0	19B3530KQ6	Nicotinic Antagonists	Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)	
triethylene glycol dimethacrylate	109-16-0	Triethylene glycol dimethacrylate	109-16-0	14I47YJ5EY			
triethylenediamine	280-57-9	1,4-Diazabicyclo[2.2.2]octane	280-57-9	X8M57R0JS5	Radiation-Protective Agents	Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)	
Triethylenephosphoramide	545-55-1	Triethylenephosphoramide	545-55-1	GL19M2KE52	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	
triethyllead	5224-23-7	Triethyllead	5224-23-7	660G77BZ3J			
triethyllead acetate	2587-81-7	Triethyllead acetate	2587-81-7	EQ8AH752IZ			
triethylmethylammonium	302-57-8	n,n-Diethyl-n-methylethanaminium	302-57-8	2945YYM5JQ			
triethyltin	997-50-2	Triethyltin	997-50-2	5XCT3EQJ85			
trifloxystrobin		Trifloxystrobin	141517-21-7		Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
triflumizol	68694-11-1	Triflumizole	68694-11-1	7J6Y4H9MV5			
triflumuron	64628-44-0	Triflumuron	64628-44-0	3FT64DYG8K	Chemosterilants	Compounds that cause reproductive sterility in organisms. They are sometimes used to control pest populations by sterilizing males within the population. (See all compounds classified as Chemosterilants.)	
Trifluoperazine	117-89-5	Trifluoperazine	117-89-5	214IZI85K3	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	For the treatment of anxiety disorders, depressive symptoms secondary to anxiety and agitation.
Trifluoroacetic Acid	76-05-1	Trifluoroacetic Acid	76-05-1	E5R8Z4G708			
Trifluoroethanol	75-89-8	2,2,2-Trifluoroethanol	75-89-8	8T8I76KYF1			
Trifluperidol	749-13-3	Trifluperidol	749-13-3	R8869Q7R8I	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
Triflupromazine	146-54-3	Triflupromazine	146-54-3	RO16TQF95Y	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	Used mainly in the management of psychoses. Also used to control nausea and vomiting.
Trifluralin	1582-09-8	Trifluralin	1582-09-8	C8BX46QL7K	Herbicides	Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)	
Trifluridine	70-00-8	Trifluridine	70-00-8	RMW9V5RW38	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	As a standalone product, trifluridine is used for the ophthalmic treatment of primay keratoconjunctivitis and recurrent epithelial keratitis due to herpes simplex virus, types 1 and 2.   Trifluridine is also available as a combination product with [tipiracil], which is indicated either alone or in combination with [bevacizumab] for the treatment of adult patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy. This combination product is also used for adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma and were previously treated with at least two prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane or irinotecan, and if appropriate, HER2/neu-targeted therapy.
triflusal	322-79-2	Triflusal	322-79-2	1Z0YFI05OO	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	Triflusal is indicated as prophylaxis of thromboembolic disorders. It has been registered in Spain and in other countries of Europe, South America and South Korea for the prevention of Stroke and myocardial infarction.
triflusulfuron-methyl		Triflusulfuron-methyl	126535-15-7	Y8AR13FYC0			
triforine	26644-46-2	Triforine	26644-46-2	N1A4W8U0HH			
Triglycerides		Triglycerides					
trigonelline	535-83-1	Trigonelline	535-83-1	3NQ9N60I00			
Trihalomethanes		Trihalomethanes					
Trihexyphenidyl	144-11-6	Trihexyphenidyl	144-11-6	6RC5V8B7PO	Antiparkinson Agents	Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)	Tihexyphenidyl is indicated as an adjunct in the treatment of parkinsonism, an adjuvant in the treatment of parkinsonism with levodopa, and in the control of extrapyramidal disorders caused by central nervous system drugs.
Triiodothyronine	6893-02-3	Liothyronine	6893-02-3	06LU7C9H1V			Liothyronine is officially approved for the following indications:  - Replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism.  - As an adjunct therapy to surgery and radioiodine in the management of thyroid cancer.  - As a diagnostic agent in suppression tests for mild hyperthyroidism or thyroid gland autonomy.  In general terms, exogenous liothyronine is used to replace insufficient hormonal production and restore T3 plasma levels.  The lack of liothyronine can be presented as a pale and puffy face, coarse,  brittle hair, dry skin, croaky voice and constipation as well as irregular periods, drowsiness, and lethargy.  Liothyronine should never be used in the suppression of benign nodules and nontoxic diffuse goiter in iodine-sufficient patients nor in the treatment of hyperthyroidism during the recovery phase of subacute thyroiditis.
Triiodothyronine, Reverse	5817-39-0	3,3',5'-Triiodo-L-thyronine	5817-39-0	8NZ4Y08T96			
triisopropyl phosphate	513-02-0	Triisopropyl phosphate	513-02-0	PPV29GU295			
trikatu		trikatu					
trilinolein	537-40-6	Trilinolein	537-40-6	V5LJ52OGS7	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
trilinolenin	14465-68-0	Trilinolenin	14465-68-0	OI7S0A9873			
trilobatin		Trilobatin	4192-90-9	23298I791N			
trilostane	13647-35-3	Trilostane	13647-35-3	L0FPV48Q5R	Abortifacient Agents, Steroidal	Steroidal compounds with abortifacient activity. (See all compounds classified as Abortifacient Agents, Steroidal.)	Used in the treatment of Cushing's syndrome. It is normally used in short-term treatment until permanent therapy is possible.
trimazosin	35795-16-5	Trimazosin	35795-16-5	31L760807H	Adrenergic alpha-1 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)	
Trimedoxime	56-97-3	Trimedoxime bromide	56-97-3	ED0GXI9825	Antidotes	Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)	
trimegestone		Trimegestone	74513-62-5	4658K0H08W			
trimellitic acid	528-44-9	1,2,4-Benzenetricarboxylic acid	528-44-9	7NVY29MQ5F			
trimellitic anhydride	552-30-7	Trimellitic anhydride	552-30-7	80T61EUU7H			
trimeprazine tartrate		Trimeprazine Tartrate	4330-99-8	362NW1LD6Z	Histamine H1 Antagonists	Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)	
Trimeresurus venoms		Trimeresurus venoms					
Trimetazidine	5011-34-7	Trimetazidine	5011-34-7	N9A0A0R9S8	Vasodilator Agents	Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)	Trimetazidine is indicated for the symptomatic treatment of stable angina pectoris in patients inadequately controlled or intolerant to first line therapies.
Trimethaphan	7187-66-8	Trimethaphan	7187-66-8	6G8X656T45	Adjuvants, Anesthesia	Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)	For the controlled reduction of blood pressure during surgery and in the treatment of hypertensive emergencies.
trimethobenzamide	138-56-7	Trimethobenzamide	138-56-7	W2X096QY97	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	For the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis.
Trimethoprim	738-70-5	Trimethoprim	738-70-5	AN164J8Y0X	Cytochrome P-450 CYP2C8 Inhibitors	Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C8. (See all compounds classified as Cytochrome P-450 CYP2C8 Inhibitors.)	As a monotherapy, trimethoprim is indicated for the treatment of acute episodes of uncomplicated urinary tract infections caused by susceptible bacteria, including _E. coli._, _K. pneumoniae_, _Enterobacter spp._, _P. mirabilis_, and coagulase-negative _Staphylococcus_ species. In various formulations in combination with [sulfamethoxazole], trimethoprim is indicated for the following infections caused by bacteria with documented susceptibility: urinary tract infections, acute otitis media in pediatric patients (when clinically indicated), acute exacerbations of chronic bronchitis in adults, enteritis caused by susceptible _Shigella_, prophylaxis and treatment of _Pneumocystis jiroveci_ pneumonia, and travelers' diarrhea caused by enterotoxigenic _E. coli_.  Trimethoprim is available as an ophthalmic solution in combination with [polymyxin B] for the treatment of acute bacterial conjunctivitis, blepharitis, and blepharoconjunctivitis caused by susceptible bacteria.
Trimethoprim, Sulfamethoxazole Drug Combination	8064-90-2	Sulfamethoxazole; Trimethoprim	8064-90-2		Antimalarials	Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)	
trimethoxybenzoylyohimbine		Trimethoxybenzoylyohimbine					
trimethyl phosphate	512-56-1	Trimethyl phosphate	512-56-1	Z1E45TMW1Z			
trimethylamine	75-50-3	Trimethylamine	75-50-3	LHH7G8O305			
trimethylarsine	593-88-4	Trimethylarsine	593-88-4	MQ83UQ8A1Q			
trimethylarsine oxide	4964-14-1	Trimethylarsine oxide	4964-14-1	2G9V8FPD5G			
trimethylene-bis(4-hydroxyiminomethylpyridinium)		trimethylene-bis(4-hydroxyiminomethylpyridinium)					
trimethylenediamine	109-76-2	1,3-Diaminopropane	109-76-2	CB3ISL56KG			
trimethyllead	7442-13-9	Trimethyllead	7442-13-9	D49DUD1V6C			
trimethyllead acetate	5711-19-3	Trimethyllead acetate	5711-19-3	CC2BHY6YVF			
trimethyloxamine	1184-78-7	Trimethylamine oxide	1184-78-7	FLD0K1SJ1A	Oxidants	Electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION). (See all compounds classified as Oxidants.)	
trimethyltin	1631-73-8	Trimethyltin	17272-57-0				
trimethyltin chloride	1066-45-1	Trimethyltin chloride	1066-45-1	9E3BCA3684			
trimethyltin hydroxide		Trimethyltin hydroxide	56-24-6	10ALT8DJ2V			
Trimetrexate	52128-35-5	Trimetrexate	52128-35-5	UPN4ITI8T4	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	For use, with concurrent leucovorin administration (leucovorin protection), as an alternative therapy for the treatment of moderate-to-severe Pneumocystis carinii pneumonia (PCP) in immunocompromised patients, including patients with the acquired immunodeficiency syndrome (AIDS). Also used to treat several types of cancer including colon cancer.
Trimipramine	739-71-9	Trimipramine	3564-75-8	QJ9MUH57H8	Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	For the treatment of depression and depression accompanied by anxiety, agitation or sleep disturbance
Trinitrobenzenesulfonic Acid	2508-19-2	2,4,6-Trinitrobenzenesulfonic acid	2508-19-2	8T3HQG2ZC4			
Trinitrotoluene	118-96-7	2,4,6-Trinitrotoluene	118-96-7	H43RF5TRM5	Explosive Agents	Substances that are energetically unstable and can produce a sudden expansion of the material, called an explosion, which is accompanied by heat, pressure and noise. Other things which have been described as explosive that are not included here are explosive action of laser heating, human performance, sudden epidemiological outbreaks, or fast cell growth. (See all compounds classified as Explosive Agents.)	
trioctylmethylammonium	5137-55-3	Methyltrioctylammonium chloride	5137-55-3	07Q8S2MJ6A			
Triolein	122-32-7	Glyceryl Trioleate	122-32-7	O05EC62663			
Trioxsalen	3902-71-4	Trioxsalen	3902-71-4	Y6UY8OV51T	Photosensitizing Agents	Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)	Trioxsalen is a pigmenting photosensitizing agent used in conjunction with ultraviolet light in the treatment of vitiligo.
triparacresyl phosphate		triparacresyl phosphate					
tripchlorolide	132368-08-2	Tripchlorolide	132368-08-2				
Tripelennamine	91-81-6	Tripelennamine	91-81-6	3C5ORO99TY	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	Used for the symptomatic relief of hypersensitivity reactions, coughs, and the common cold.
tripeptide tyroservatide		tripeptide tyroservatide					
triphenyl bismuth	603-33-8	Triphenylbismuth	603-33-8	R18732F41W			
triphenyl phosphate	115-86-6	Triphenyl phosphate	115-86-6	YZE19Z66EA			
triphenyl phosphite	101-02-0	Triphenyl phosphite	101-02-0	9P45GRD24X			
triphenyl(phenylethynyl)phosphonium		Triphenyl(phenylethynyl)phosphonium	34387-64-9				
triphenylarsine		Triphenylarsine	603-32-7	MN8EZ3FL74			
triphenylethylene	58-72-0	Triphenylethylene	58-72-0	S4ZLZ1K74B	Estrogen Antagonists	Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)	
triphenylmethane	519-73-3	Triphenylmethane	519-73-3	8O4UTW9E17			
triphenylphosphine gold chloride	14243-64-2	Chloro(triphenylphosphine)gold(I)	14243-64-2				
triphenylphosphine oxide		Triphenylphosphine oxide	791-28-6	Z69161FKI3			
triphenyltin		Triphenyltin	892-20-6	95T92AGN0V	Pesticides	Chemicals used to destroy pests of any sort. The concept includes fungicides (FUNGICIDES, INDUSTRIAL); INSECTICIDES; RODENTICIDES; etc. (See all compounds classified as Pesticides.)	
triphenyltin chloride	639-58-7	Triphenyltin chloride	639-58-7	I1L80IDY27			
triphenyltin fluoride	379-52-2	Triphenyltin fluoride	379-52-2	1YP2L952MD			
triphenyltin hydroxide	76-87-9	Triphenyltin hydroxide	76-87-9				
triphlorethol-A		Triphlorethol A					
triplet acetone		triplet acetone					
Triprolidine	486-12-4	Triprolidine	486-12-4	2L8T9S52QM	Anti-Allergic Agents	Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)	For the symptomatic relief of seasonal or perennial allergic rhinitis or nonallergic rhinitis; allergic conjunctivitis; and mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Also used in combination with other agents for the symptomatic relief of symptoms associated with the common cold.
triptolide	38748-32-2	Triptolide	38748-32-2	19ALD1S53J	Antineoplastic Agents, Alkylating	A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)	
triptonide	38647-11-9	Triptonide	38647-11-9				
triptophenolide	74285-86-2	Triptophenolide	74285-86-2				
Triptorelin Pamoate		Decapeptyl	124508-66-3		Antineoplastic Agents, Hormonal	Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)	
triptycene		Triptycene	477-75-8	CL32869MEP			
tris(1,10-phenanthroline)chromium(III) chloride		tris(1,10-phenanthroline)chromium(III) chloride					
tris(1,3-dichloro-2-propyl)phosphate	13674-87-8	Tris(1,3-dichloro-2-propyl)phosphate	13674-87-8	B1PRV4G0T0			
tris(2-butoxyethyl) phosphate	78-51-3	Tris(2-butoxyethyl) phosphate	78-51-3	RYA6940G86			
tris(2-carboxyethyl)phosphine	5961-85-3	Tris(2-carboxyethyl)phosphine	5961-85-3	22OAC2MO2S	Indicators and Reagents	Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)	
tris(2-ethylhexyl)phosphate	78-42-2	Tris(2-ethylhexyl) phosphate	78-42-2	BQC0BKB72S			
tris(2,3-dibromopropyl)isocyanurate	52434-90-9	1,3,5-Tris(2,3-dibromopropyl)-1,3,5-triazinane-2,4,6-trione	52434-90-9				
tris(2,3-dibromopropyl)phosphate	126-72-7	Tris(2,3-dibromopropyl) phosphate	126-72-7	X7O89N7ZY0			
tris(4-chlorophenyl)methane		Tris(4-chlorophenyl)methane	27575-78-6				
tris(4-chlorophenyl)methanol	3010-80-8	Tris(4-chlorophenyl)methanol	3010-80-8				
tris(4-methyl-1-pyrazolyl)borohydride		tris(4-methyl-1-pyrazolyl)borohydride					
tris(acetylacetonate) aluminum(III)	13963-57-0	Aluminum, tris(2,4-pentanedionato)-	13963-57-0	77S22ZW4U3			
tris(chloroethyl)phosphate		Tris(2-chloroethyl) phosphate	115-96-8	32IVO568B0	Flame Retardants	Materials applied to fabrics, bedding, furniture, plastics, etc. to retard their burning; many may leach out and cause allergies or other harm. (See all compounds classified as Flame Retardants.)	
tris(dicarboxymethylene)fullerene-C3		tris(dicarboxymethylene)fullerene-C3					
trisialoganglioside GT1	59247-13-1	Trisialoganglioside GT1b	59247-13-1				
Triterpenes		Triterpenes					
triticonazole		Triticonazole	131983-72-7	C2O101E6G4			
Tritolyl Phosphates		Tritolyl Phosphates					
trityl chloride	76-83-5	Triphenylmethyl chloride	76-83-5	1D9GZ8QQXN			
Trityl Compounds		Trityl Compounds					
TRK 820		Nalfurafine	152657-84-6	XC41AVD567			
troclosene	2782-57-2	Dichloroisocyanuric acid	2893-78-9	PHR838Y52L	Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
Troglitazone	97322-87-7	Troglitazone	97322-87-7	I66ZZ0ZN0E	Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	For the treatment of Type II diabetes mellitus. It is used alone or in combination with a sulfonylurea, metformin, or insulin as an adjunct to diet and exercise.
troglitazone sulfate		Troglitazone sulfate		E6SH3NO0FM			
Troleandomycin	2751-09-9	Troleandomycin	2751-09-9	C4DZ64560D	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	For the treatment of bacterial infection.
Tromethamine	77-86-1	Tromethamine	77-86-1	023C2WHX2V	Buffers	A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer. (See all compounds classified as Buffers.)	For the prevention and correction of metabolic acidosis.
tropacocaine	537-26-8	Tropacocaine	537-26-8	1I92X32F6H			
Tropicamide	1508-75-4	Tropicamide	1508-75-4	N0A3Z5XTC6	Mydriatics	Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. (See all compounds classified as Mydriatics.)	Tropicamide is indicated to induce mydriasis (dilation of the pupil) for diagnostic procedures and in conditions where short-term pupil dilation is desired, either as monotherapy or in combination with [hydroxyamphetamine] or [phenylephrine]. It provides clinically significant mydriasis with partial cycloplegia.
Tropisetron	89565-68-4	Tropisetron	89565-68-4	6I819NIK1W	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	For the prevention of nausea and vomiting induced by cytotoxic therapy and postoperative.
Tropolone	533-75-5	Tropolone	533-75-5	7L6DL16P1T			
trospium chloride	10405-02-4	Trospium chloride	10405-02-4		Muscarinic Antagonists	Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)	
trovafloxacin	146836-84-2	7-[(1R,5S)-6-azaniumyl-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylate	147059-72-1				
troxacitabine		Troxacitabine	145918-75-8	60KQZ0388Y	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Investigated for use/treatment in leukemia (myeloid).
troxerutin	7085-55-4	Troxerutin	7085-55-4	7Y4N11PXO8	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	
Trp-Lys-Tyr-Met-Val-Met		Trp-Lys-Tyr-Met-Val-Met	496068-62-3				
trypanothione	96304-42-6	Trypanothione	96304-42-6				
Trypsin Inhibitors		Trypsin Inhibitors					
tryptamine	61-54-1	Tryptamine	61-54-1	422ZU9N5TV			
tryptamine-4,5-dione	108560-71-0	Tryptamine-4,5-dione	108560-71-0				
Tryptamines		Tryptamines					
tryptanthrine	13220-57-0	Tryptanthrin	13220-57-0	4Y6E3F2U66			
Tryptophan	73-22-3	Tryptophan	54-12-6	8DUH1N11BX	Antidepressive Agents, Second-Generation	A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)	Tryptophan may be useful in increasing serotonin production, promoting healthy sleep, managing depression by enhancing mental and emotional well-being, managing pain tolerance, and managing weight.
tryptophol	526-55-6	Tryptophol	526-55-6	5809LZ7G1U			
tryptophyl-arginyl-tryptophyl-tryptophyl-tryptophyl-tryptophanamide		tryptophyl-arginyl-tryptophyl-tryptophyl-tryptophyl-tryptophanamide					
tryptoquivaline	55387-45-6	Tryptoquivaline	55387-45-6	CW5S8OP3VO			
TS 108		Tas-108	229634-98-4	9B29N23K7E			Investigated for use/treatment in breast cancer.
tubacin		Tubacin	537049-40-4	02C2G1D30D	Histone Deacetylase Inhibitors	Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)	
tubastatin A		Tubastatin A	1252003-15-8	2XTSOX1NF8			
tubeimoside I	102040-03-9	102040-03-9					
tubeimoside II		Tubeimoside II					
tuberostemonine	6879-01-2	Tuberostemonine	6879-01-2				
tubocapsenolide A		Tubocapsenolide A					
Tubocurarine	57-95-4	Tubocurarine	57-95-4	W9YXS298BM	Nicotinic Antagonists	Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)	
tucatinib		Tucatinib	937263-43-9	234248D0HH	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Tucatinib is indicated with [trastuzumab] and [capecitabine] for the treatment of adults diagnosed with advanced unresectable or metastatic HER2-positive breast cancer. This includes patients with brain metastases and those who have received one or more prior anti-HER2-based regimens in the metastatic setting.   It is also indicated in combination with trastuzumab for the treatment of adult patients with RAS wild-type HER2-positive unresectable or metastatic colorectal cancer that has progressed following treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy. This indication is approved under accelerated approval; thus, it is contingent upon verification and description of clinical benefit in confirmatory trials.
TUG-469		3-(4-(((2'-Methyl-[1,1'-biphenyl]-3-yl)methyl)amino)phenyl)propanoic acid	1236109-67-3	GZP4K3I8PA			
tulobuterol	41570-61-0	Tulobuterol	41570-61-0	591I9SU0F7	Adrenergic beta-Agonists	Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)	Episodic wheeze, Asthma
tungstate	51682-10-1	Tungstate	12737-86-9	SW0Y0WQ46I			
Tungsten	7440-33-7	Tungsten	7440-33-7	V9306CXO6G			
tungsten carbide	11130-73-7	Tungsten monocarbide	12070-12-1				
Tungsten Compounds		Tungsten Compounds					
Tunicamycin	11089-65-9	11089-65-9					
turmeric extract		(1E,6E)-1,7-bis[4-hydroxy-3-(methyloxy)phenyl]hepta-1,6-diene-3,5-dione					
Turpentine		8006-64-2					
tussilagone		Tussilagone	104012-37-5	95N0GBB2SX			
tutin	2571-22-4	Tutin	2571-22-4	B69P754702			
TWS 119		3-[[6-(3-aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenol;2,2,2-trifluoroacetic acid					
tylophorine	482-20-2	Tylophorine	482-20-2	O41630Y8V3			
Tylosin	1401-69-0	Tylosin	1401-69-0	YEF4JXN031	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
tyloxapol	25301-02-4	Macrocyclon	25301-02-4		Detergents	Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)	Tyloxapol is an inhaled surfactant that assists in removing and liquefying and removing bronchopulmonary secretions with mucus and pus. Tyloxapol is administered either through nebulized solution or a stream of oxygen. Also investigated for use/treatment in cystic fibrosis and pediatric indications.
tynorphin		Tynorphin					
typhaneoside	104472-68-6	CID 44566503	104472-68-6				
Tyramine	51-67-2	Tyramine	51-67-2	X8ZC7V0OX3	Adrenergic Uptake Inhibitors	Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)	
Tyrosine	55520-40-6	Tyrosine	60-18-4	42HK56048U			Tyrosine is claimed to act as an effective antidepressant, however results are mixed. Tyrosine has also been claimed to reduce stress and combat narcolepsy and chronic fatigue, however these claims have been refuted by some studies.
tyrosyl-arginyl-phenylalanyl-glycinamide	100304-60-7	Tyrosyl-arginyl-phenylalanyl-glycinamide	100304-60-7				
tyrosyl-tetrahydroisoquinolinecarbonyl-psi(methylamino)phenylalanyl-phenylalanine		tyrosyl-tetrahydroisoquinolinecarbonyl-psi(methylamino)phenylalanyl-phenylalanine					
tyrosyl-valyl-alanyl-aspartal		tyrosyl-valyl-alanyl-aspartal					
tyrosyl-valyl-alanyl-aspartic acid fluoromethyl ketone		tyrosyl-valyl-alanyl-aspartic acid fluoromethyl ketone					
tyrphostin 25	118409-58-8	Tyrphostin A25	118409-58-8	C878BF87UY	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
tyrphostin 47	118409-60-2	Tyrphostin 47	122520-86-9	HKQ7UDF4J7	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
tyrphostin 51		Tyrphostin A51	122520-90-5				
tyrphostin A23		Tyrphostin A23	118409-57-7	RV0GCD31OJ	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
tyrphostin A9	10537-47-0	Malonoben	10537-47-0	87TE8MRS65			
tyrphostin AG 1024		Tyrphostin AG 1024	65678-07-1	NF4XN6A8V9			
tyrphostin AG825		Tyrphostin AG 825	149092-50-2				
tyrphostin B44		Tyrphostin B44, (-) enantiomer	133550-32-0				
Tyrphostins		Tyrphostins					
TZ2PA6 compound		TZ2PA6 compound					
U 0126		1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene	218601-62-8	8027P94HLL	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
U 0521	5466-89-7	1-Propanone, 1-(3,4-dihydroxyphenyl)-2-methyl-	5466-89-7				
U 40481	33089-74-6	N'-(2,4-Dimethylphenyl)-N-methylformamidine	33089-74-6	CTZ715OQFA			
U 69593	96744-75-1	n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide	96744-75-1	J5S4K6TKTG	Diuretics	Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)	
U 73343	142878-12-4	u-73343	142878-12-4	S2C4J8704C			
U 74389F	111668-89-4	Trilazad mesylate	111668-89-4		Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)	
U 75302	119477-85-9	6-(6-(3-Hydroxy-1,5-undecadien-1-yl)-2-pyridinyl)-1,5-hexanediol	119477-85-9				
U 78517F	133681-84-2	2-Methyl aminochroman	133681-84-2		Neuroprotective Agents	Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)	
U 95666E		U 95666E					
UA 0713		UA 0713					
UAB 30		UAB 30					
UAMC00039		N4-(4-chlorobenzyl)-2,4-diaminobutanoylpiperidine					
UAMC00132		UAMC00132					
Ubiquinone	1339-63-5	Ubiquinones	1339-63-5		Micronutrients	Essential dietary elements or organic compounds that are required in only small quantities for normal physiologic processes to occur. (See all compounds classified as Micronutrients.)	
ubiquinone 9	303-97-9	Coenzyme Q9	303-97-9	MGW7TYF2DQ	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	
Ubiquinone Q1	727-81-1	Ubiquinone-1	727-81-1	JR17826E4G			
Ubiquinone Q2	7704-04-3	Ubiquinone-2	606-06-4	I7T5V2W47R	Antidotes	Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)	
ubiquinone-O	605-94-7	2,3-Dimethoxy-5-methyl-1,4-benzoquinone	605-94-7				
UCF 101		High Temperature Requirement A2 Inhibitor I	313649-08-0				
UCF76-A		UCF76-A					
udenafil		Udenafil	268203-93-6	L5IB4XLY36	Phosphodiesterase 5 Inhibitors	Compounds that specifically inhibit PHOSPHODIESTERASE 5. (See all compounds classified as Phosphodiesterase 5 Inhibitors.)	Investigated for use/treatment in erectile dysfunction and hypertension.
UF010 compound		UF010 compound					
UFT(R) drug		Tegafur-Uracil	74578-38-4				Tegafur-uracil is indicated for the first line treatment of metastatic colorectal cancer with concomitant administration of calcium folinate. Colorectal cancer is the third most diagnosed cancer and 30% of the cases can present the metastatic state.
ugonin L		ugonin L					
UH 232	95999-11-4	cis-5-Methoxy-1-methyl-2-(di-n-propylamino)tetralin	95999-11-4		Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	
UH 301	127126-21-0	5-Fluoro-8-hydroxy-2-(dipropylamino)tetralin	127126-21-0	1G916IMD7L	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
ulapualide A	100045-73-6	CID 6438860	100045-73-6				
ulimorelin		Ulimorelin	842131-33-3	LGI67MCW2S			Prevention of post-operative ileus
ulipristal		Ulipristal	159811-51-5	6J5J15Q2X8			As the product Ella (available in Canada and the US), ulipristal is indicated for use as emergency contraception after unprotected intercourse or possible contraceptive failure when administered within 120 hours (5 days) after unprotected intercourse or a known or suspected contraceptive failure. As the product Fibristal (available in Canada), ulipristal is indicated for treatment of the signs and symptoms of uterine fibroids in adult women.
ultra-high molecular weight polyethylene		ultra-high molecular weight polyethylene					
Ultroser G		Ultroser G					
umbelliferone 6-carboxylic acid		umbelliferone 6-carboxylic acid					
UMI-77		2-[4-[(4-Bromophenyl)sulfonylamino]-1-hydroxynaphthalen-2-yl]sulfanylacetic acid					
UNC 0638		2-Cyclohexyl-N-(1-isopropylpiperidin-4-yl)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-amine	1255580-76-7	26A103L2FO			
UNC0642		2-(4,4-difluoropiperidin-1-yl)-6-methoxy-N-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine	1481677-78-4	3DG5AHY932			
UNC1215		(2-(Phenylamino)-1,4-phenylene)bis((4-(pyrrolidin-1-yl)piperidin-1-yl)methanone)	1415800-43-9				
UNC1999		N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-1-propan-2-yl-6-[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]indazole-4-carboxamide	1431612-23-5				
undecan-2-one		2-Undecanone	112-12-9	YV5DSO8CY9	Insect Repellents	Substances causing insects to turn away from them or reject them as food. (See all compounds classified as Insect Repellents.)	
undecanal	1337-83-3	2-Undecenal	2463-77-6	FNP3S9MG30			
undecane	1120-21-4	Undecane	1120-21-4	JV0QT00NUE			
undecanoic acid	112-37-8	Undecanoic acid	112-37-8	138ON3IIQG			
undecylenic acid		Undecylenic Acid	112-38-9	K3D86KJ24N			Indicated for the treatment of fungal infections as a salt form. No therapeutic indications on its own.
uniconazole		Uniconazole	83657-22-1	R4ATA06H50	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Unithiol	4076-02-2	Unithiol	4076-02-2	690VN2L7TK	Antidotes	Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)	
Uracil	66-22-8	Uracil	66-22-8	56HH86ZVCT			
Uranium	7440-61-1	Uranium	7440-61-1	4OC371KSTK			
Uranium Compounds		Uranium compounds					
uranyl acetate	541-09-3	Uranyl acetate	541-09-3		Coloring Agents	Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)	
Uranyl Nitrate	10102-06-4	10102-06-4					
urapidil		Urapidil	34661-75-1	A78GF17HJS	Serotonin Receptor Agonists	Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)	
URB602		Cyclohexyl biphenyl-3-ylcarbamate	565460-15-3	B8371SFA9K			
Urea	57-13-6	Urea	57-13-6	8W8T17847W			Urea is used topically for debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns and calluses, as well as damaged, devitalized and ingrown nails.
Urethane	51-79-6	Urethane	51-79-6	3IN71E75Z5	Anesthetics, Intravenous	Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) (See all compounds classified as Anesthetics, Intravenous.)	
Uric Acid	69-93-2	Uric Acid	69-93-2	268B43MJ25	Antioxidants	Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)	At present (August 2013), there is no approved indication for uric acid.  The potential therapeutic use for uric acid is as an adjunct in acute ischemic stroke.
Uridine	58-96-8	Uridine	58-96-8	WHI7HQ7H85			Investigated for use/treatment in bipolar disorders and manic disorders.
Uridine Diphosphate	58-98-0	Uridine-5'-diphosphate	58-98-0	5G0F599A1Y			
Uridine Diphosphate Galactose	2956-16-3	Galactose-uridine-5'-diphosphate	2956-16-3	O2HY4WY2W1			
Uridine Diphosphate Glucose	133-89-1	Uridine-5'-diphosphate-glucose	133-89-1	V50K1D7P4Y			
Uridine Diphosphate Glucuronic Acid	2616-64-0	Uridine diphosphate glucuronic acid	2616-64-0	04SZC4MEFQ			
Uridine Diphosphate N-Acetylgalactosamine	7277-98-7	Uridine-diphosphate-n-acetylgalactosamine	7277-98-7				
Uridine Diphosphate N-Acetylglucosamine	528-04-1	Uridine diphosphate-N-acetylglucosamine	528-04-1				
Uridine Diphosphate Xylose	3616-06-6	UDP-xylose	3616-06-6				
Uridine Monophosphate	58-97-9	Uridine Monophosphate	58-97-9	E2OU15WN0N			
Uridine Triphosphate	63-39-8	Uridine 5'-triphosphate	63-39-8	UT0S826Z60			
Urocanic Acid	104-98-3	Urocanic acid	104-98-3	G8D26XJJ3B			
Uroporphyrinogens		Uroporphyrinogen III	1976-85-8				
urovision	8064-12-8	Urovision	8064-12-8		Contrast Media	Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)	
Ursodeoxycholic Acid	128-13-2	Ursodiol	128-13-2	724L30Y2QR	Cholagogues and Choleretics	Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). (See all compounds classified as Cholagogues and Choleretics.)	Ursodeoxycholic acid is indicated for the treatment of patients with primary biliary cholangitis.   It is used for the short-term treatment of radiolucent, noncalcified gallbladder stones in patients selected for elective cholecystectomy. It is also used to prevent gallstone formation in obese patients experiencing rapid weight loss.
ursodoxicoltaurine		Tauroursodeoxycholic acid	14605-22-2	60EUX8MN5X	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	Tauroursodeoxycholic acid is used to prevent and treat gallstone formation.   Tauroursodeoxycholic acid is used in combination with [phenylbutyric acid] to treat amyotrophic lateral sclerosis (ALS) in adults.
Ursolic Acid		Ursolic Acid	77-52-1	P3M2575F3F	Cyclooxygenase Inhibitors	Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)	
ursonic acid		Ursonic acid	6246-46-4				
urushiol	53237-59-5	Urushiol	53237-59-5				
usnic acid	125-46-2	Usnic acid	125-46-2		Antifungal Agents	Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)	
uvariopsine		Uvariopsine					
UVI 3003		(2E)-3-{4-hydroxy-3-[5,5,8,8-tetramethyl-3-(pentyloxy)-5,6,7,8-tetrahydronaphthalen-2-yl]phenyl}prop-2-enoic acid	847239-17-2				
V 10367		V 10367					
Vaccines		Vaccines					
Vaccines, Virus-Like Particle		Vaccines, Virus-Like Particle					
vacuolin-1		Vacuolin-1	351986-85-1				
vadimezan	117570-53-3	Vadimezan	117570-53-3	0829J8133H	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Investigated for use/treatment in solid tumors, lung cancer, ovarian cancer, and prostate cancer.
Val-Pro-Met-Leu-Lys		Bax inhibitor peptide V5					
Valacyclovir	124832-27-5	Valacyclovir Hydrochloride	124832-27-5	G447S0T1VC	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
valbenazine		Valbenazine	1025504-45-3	54K37P50KH			Valbenazine is indicated for the treatment of adults with tardive dyskinesia and chorea associated with Huntingtons disease.
valdecoxib		Valdecoxib	181695-72-7	2919279Q3W	Cyclooxygenase 2 Inhibitors	A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2. (See all compounds classified as Cyclooxygenase 2 Inhibitors.)	For the treatment of osteoarthritis and dysmenorrhoea
Valerates		Valerate	10023-74-2				
valerophenone		Valerophenone	1009-14-9	F27Q043NT1			
valerylsalicylate		2-Valeryloxybenzoic acid	64206-54-8				
validamycin A	37248-47-8	Validamycin A	37248-47-8	313E9620QS			
valilactone	113276-96-3	Valilactone	113276-96-3				
Valine	7004-03-7	Valine	72-18-4	HG18B9YRS7			Promotes mental vigor, muscle coordination, and calm emotions. May also be of use in a minority of patients with hepatic encephalopathy and in some with phenylketonuria.
Valinomycin	2001-95-8	Valinomycin	2001-95-8	N561YS75MN	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	
valnemulin	101312-92-9	Valnemulin	101312-92-9	2AHC415BQG			PigsThe treatment and prevention of swine dysentery. The treatment of clinical signs of porcine proliferative enteropathy (ileitis). The prevention of clinical signs of porcine colonic spirochaetosis (colitis) when the disease has been diagnosed in the herd. Treatment and prevention of swine enzootic pneumonia. At the recommended dosage of 1012 mg/kg bodyweight lung lesions and weight loss are reduced, but infection with Mycoplasma hyopneumoniae is not eliminated. RabbitsReduction of mortality during an outbreak of epizootic rabbit enteropathy (ERE). Treatment should be started early in the outbreak, when the first rabbit has been diagnosed with the disease clinically.
valnoctamide	4171-13-5	Valnoctamide	4171-13-5	3O25NRX9YG			
Valproic Acid	99-66-1	Valproic Acid	99-66-1	614OI1Z5WI	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	**Indicated** for:   1) Use as monotherapy or adjunctive therapy in the management of complex partial seizures and simple or complex absence seizures.   2) Adjunctive therapy in the management of multiple seizure types that include absence seizures.   3) Prophylaxis of migraine headaches.  4) Acute management of mania associated with bipolar disorder.   **Off-label** uses include:   1) Maintenance therapy for bipolar disorder.  2) Treatment for acute bipolar depression.  3) Emergency treatment of status epilepticus.
valproic acid glucuronide	60113-83-9	Valproic acid glucuronide	60113-83-9	SB05J7266C			
valproyl-coenzyme A		valproyl-coenzyme A					
valproylcarnitine	95782-09-5	(3R)-3-(2-propylpentanoyloxy)-4-(trimethylazaniumyl)butanoate	95782-09-5	5Q9MQB3YZR			
valrubicin	56124-62-0	Valrubicin	56124-62-0	2C6NUM6878	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For the treatment of cancer of the bladder.
Valsartan		Valsartan	137862-53-4	80M03YXJ7I	Angiotensin II Type 1 Receptor Blockers	Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)	Valsartan is indicated for the treatment of hypertension to reduce the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. It is also indicated for the treatment of heart failure (NYHA class II-IV) and for left ventricular dysfunction or failure after myocardial infarction when the use of an angiotensin-converting enzyme inhibitor (ACEI) is not appropriate.  It is also used in combination with [sacubitril].
valspodar	121584-18-7	Valspodar	121584-18-7	Q7ZP55KF3X			
valyl-histidyl-threonyl-aspartamide		valyl-histidyl-threonyl-aspartamide					
valyl-prolyl-aspartyl-prolyl-arginine		valyl-prolyl-aspartyl-prolyl-arginine					
Vanadates		Vanadate(3-)					
Vanadium	7440-62-2	Vanadium	7440-62-2	00J9J9XKDE	Trace Elements	A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)	
Vanadium Compounds		Vanadium Compounds					
vanadium dioxide		Vanadium dioxide	12036-21-4				
vanadium pentoxide	1314-62-1	Vanadium pentoxide	1314-62-1				
vanadium trioxide		Vanadium trioxide	1314-34-7				
vanadyl sulfate	27774-13-6	Vanadyl sulfate	27774-13-6		Hypoglycemic Agents	Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)	
Vancomycin	1404-90-6	Vancomycin	1404-90-6	6Q205EH1VU	Anti-Bacterial Agents	Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)	Administered intravenously, vancomycin is indicated in adult and pediatric patients for the treatment of septicemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract infections. Administered orally, vancomycin is indicated in adult and pediatric patients for the treatment of _Clostridium difficile_-associated diarrhea and for enterocolitis caused by _Staphylococcus aureus_ (including methicillin-resistant strains).
vandetanib		Vandetanib	443913-73-3	YO460OQ37K			Vandetanib is currently approved as an alternative to local therapies for both unresectable and disseminated disease. Because Vandetanib can prolong the Q-T interval, it is contraindicated for use in patients with serious cardiac complications such as congenital long QT syndrome and uncompensated heart failure.
Vanillic Acid	121-34-6	Vanillic Acid	121-34-6	GM8Q3JM2Y8			
vanillin	121-33-5	Vanillin	121-33-5	CHI530446X	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	
vanillyl alcohol	498-00-0	Vanillyl alcohol	498-00-0	X7EA1JUA6M			
Vanilmandelic Acid	55-10-7	Vanillylmandelic acid	55-10-7	0DQI268449			
vaninolol		Vaninolol					
vanoxerine		Vanoxerine	67469-69-6	90X28IKH43	Dopamine Uptake Inhibitors	Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. (See all compounds classified as Dopamine Uptake Inhibitors.)	Vanoxerine has not been approved for therapeutic use.
vapiprost	85505-64-2	Vapiprost	85505-64-2	H84XT1COAU	Fibrinolytic Agents	Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)	
Vardenafil Dihydrochloride		Vardenafil dihydrochloride	224789-15-5	5O8R96XMH7	Phosphodiesterase 5 Inhibitors	Compounds that specifically inhibit PHOSPHODIESTERASE 5. (See all compounds classified as Phosphodiesterase 5 Inhibitors.)	
Varenicline		6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 7,8,9,10-tetrahydro-	249296-44-4		Nicotinic Agonists	Drugs that bind to and activate nicotinic cholinergic receptors (RECEPTORS, NICOTINIC). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission. (See all compounds classified as Nicotinic Agonists.)	For use as an aid in smoking cessation.  Varenicline as a nasal spray is indicated for the symptomatic treatment of dry eye disease.
varespladib		Varespladib	172732-68-2	2Q3P98DATH			
varespladib methyl		Varespladib methyl	172733-08-3	0NB98NBX3D	Phospholipase A2 Inhibitors	Compounds that inhibit or block the activity of a PHOSPHOLIPASE A2 enzyme. (See all compounds classified as Phospholipase A2 Inhibitors.)	Investigated for use/treatment in atherosclerosis and coronary artery disease.
variegin protein, Amblyomma variegatum		variegin protein, Amblyomma variegatum					
Vascular Endothelial Growth Factors		Vascular Endothelial Growth Factors					
vasoactive intestinal peptide, 4-chloro-Phe(6)-Leu(17)-	102805-45-8	Cpl-vip	102805-45-8		Hormone Antagonists	Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)	
Vasodilator Agents		Vasodilator Agents					
vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine-	73168-24-8	Vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(O-methyl-L-tyrosine)-8-L-arginine-	73168-24-8	FFM269698K	Hormone Antagonists	Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)	
vasopressin, beta mercapto(beta,beta)-cyclopentamethylenepropionic acid(1)-Phe(2)-Ile(4)-Arg(8)-Ala(9)-		vasopressin, beta mercapto(beta,beta)-cyclopentamethylenepropionic acid(1)-Phe(2)-Ile(4)-Arg(8)-Ala(9)-					
vasopressin, Phe(2)-Ile(3)-Hgn(4)-Orn(iPr)(8)-		vasopressin, Phe(2)-Ile(3)-Hgn(4)-Orn(iPr)(8)-					
Vasopressins	11000-17-2	Pituitrin	11000-17-2				
Vasotocin	9034-50-8	Vasotocin	9034-50-8		Oxytocics	Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) (See all compounds classified as Oxytocics.)	
vasotocin, (beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-O-methyl-Tyr(2)-Thr(4)-Orn(8)-Tyr(9)-NH2	114056-26-7	Ota-vasotocin	114056-26-7				
vatalanib		Vatalanib	212141-54-3	5DX9U76296	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	Used in combination with first- and second-line chemotherapy for the treatment of metastatic colorectal cancer and non-small cell lung cancer (NSCLC).
Vaticanol B		Vaticanol B					
vaticanol C		vaticanol C					
VBA protocol		VBA protocol					
VCE-003		2-[(2E)-3,7-dimethylocta-2,6-dienyl]-3-hydroxy-5-pentylcyclohexa-2,5-diene-1,4-dione					
Vecuronium Bromide	50700-72-6	Vecuronium Bromide	50700-72-6	7E4PHP5N1D	Neuromuscular Nondepolarizing Agents	Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. (See all compounds classified as Neuromuscular Nondepolarizing Agents.)	
Vehicle Emissions		Vehicle Emissions					
veliparib		Veliparib	912444-00-9	01O4K0631N	Poly(ADP-ribose) Polymerase Inhibitors	Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. (See all compounds classified as Poly(ADP-ribose) Polymerase Inhibitors.)	Treatment of high-grade glioma
velnacrine	104675-29-8	Velnacrine	124027-47-0	OQL6V4U301	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
Vemurafenib		Vemurafenib	918504-65-1	207SMY3FQT	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Vemurafenib is approved since 2011 for the treatment of metastatic melanoma with a mutation on BRAF in the valine located in the exon 15 at codon 600, this mutation is denominated as V600E. The V600E mutation, a substitution of glutamic acid for valine, accounts for 54% of the cases of cutaneous melanoma.  Vemurafenib approval was extended in 2017, for its use as a treatment of adult patients with Erdheim-Chester Disease whose cancer cells present BRAF V600 mutation. Erdheim-Chester disease is an extremely rare histiocyte cell disorder that affects large bones, large vessels, central nervous system, as well as, skin and lungs. It is reported an association of Erdheim-Chester disease and V600E mutation.
vendex	13356-08-6	Fenbutatin oxide	13356-08-6	ZSV4C2L4E7			
venetoclax		Venetoclax	1257044-40-8	N54AIC43PW	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Venetoclax is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It is also used in combination with azacitidine, or decitabine, or low-dose cytarabine for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.
venglustat		Venglustat	1401090-53-6	BLP1XA3FZA	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Treatment of autosomal dominant polycystic kidney disease
Venlafaxine Hydrochloride		Venlafaxine Hydrochloride	99300-78-4	7D7RX5A8MO	Antidepressive Agents, Second-Generation	A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)	
VER 155008		4-[[(2r,3s,4r,5r)-5-[6-Amino-8-[(3,4-Dichlorophenyl)methylamino]purin-9-Yl]-3,4-Dihydroxy-Oxolan-2-Yl]methoxymethyl]benzonitrile	1134156-31-2				
VER-246608		N-[4-(2-Chloro-5-Methylpyrimidin-4-Yl)phenyl]-N-(4-{[(Difluoroacetyl)amino]methyl}benzyl)-2,4-Dihydroxybenzamide					
veralipride	66644-81-3	Veralipride	66644-81-3	S7064109UD	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	
Verapamil	52-53-9	Verapamil	52-53-9	CJ0O37KU29	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	Verapamil is indicated in the treatment of vasopastic (i.e. Prinzmetal's) angina, unstable angina, and chronic stable angina. It is also indicated to treat hypertension, for the prophylaxis of repetitive paroxysmal supraventricular tachycardia, and in combination with digoxin to control ventricular rate in patients with atrial fibrillation or atrial flutter. Given intravenously, it is indicated for the treatment of various supraventricular tachyarrhythmias, including rapid conversion to sinus rhythm in patients with supraventricular tachycardia and for temporary control of ventricular rate in patients with atrial fibrillation or atrial flutter.  Verapamil is commonly used off-label for prophylaxis of cluster headaches.
Veratridine	71-62-5	Veratridine	71-62-5	M4BNP1KR7W			
verbascose	546-62-3	Verbascose	546-62-3	75493766S3			
verbenone	80-57-9	Verbenone	18309-32-5				
verlukast		Verlukast	120443-16-5	5Q9O54P0H7	Bronchodilator Agents	Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)	
vernakalant		Vernakalant	794466-70-9	9G468C8B13			Indicated for the rapid conversion of recent onset of atrial fibrillation to sinus rhythm in adults for non-surgery patients that lasts for less than 7 days of duration and post-cardiac surgery patients with atrial fibrillation lasting less than 3 days of duration.
vernodalin	21871-10-3	Vernodalin	21871-10-3				
versalide	88-29-9	Versalide	88-29-9	BM2DT9GHFQ			
versicolorin A		Versicolorin A	6807-96-1	DU1M9U6126			
versipelostatin		Versipelostatin					
Verteporfin	129497-78-5	129497-78-5					
very low density lipoprotein triglyceride		very low density lipoprotein triglyceride					
vesnarinone	81840-15-5	Vesnarinone	81840-15-5	5COW40EV8M	Phosphodiesterase Inhibitors	Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)	
vestipitant		Vestipitant	334476-46-9	S052TOI9BI	Neurokinin-1 Receptor Antagonists	Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS. (See all compounds classified as Neurokinin-1 Receptor Antagonists.)	
vestitol		Vestitol	56701-24-7	Z244UVZ669			
VH298		(2S,4R)-1-((S)-2-(1-cyanocyclopropane-1-carboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide			Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
VI-14 flavonoid		VI-14 flavonoid					
vicanicin		Vicanicin	33211-22-2	FHW4YP3B2Z			
vicriviroc		Vicriviroc	306296-47-9	TL515DW4QS			Investigated for use/treatment in HIV infection and viral infection.
Vidarabine	5536-17-4	Vidarabine	5536-17-4	3XQD2MEW34	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	For treatment of chickenpox - varicella, herpes zoster and herpes simplex
Vidarabine Phosphate	29984-33-6	Vidarabine phosphate	29984-33-6	106XV160TZ	Antiviral Agents	Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)	
Vigabatrin	60643-86-9	Vigabatrin	68506-86-5	GR120KRT6K	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	Vigabatrin is indicated as adjunctive therapy in the treatment of refractory complex partial seizures in patients 2 years of age and older who have had inadequate responses to multiple previous treatments (i.e. not to be used for first-line therapy). It is also indicated as monotherapy in the treatment of infantile spasms in patients between 1 month and 2 years of age for whom the potential benefits outweigh the risk of vision loss.
vilanterol		Vilanterol	503068-34-6	028LZY775B			Vilanterol is approved for use in several combination products such as with fluticasone furoate under the tradename Breo Ellipta, in combination with umeclidinium bromide as Anoro Ellipta, and in combination with both fluticasone furoate and umeclidinium under the tradename Trelegy Ellipta.   Approved by the FDA in 2013, the use of Breo Ellipta is indicated for the long-term, once-daily maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema, as well as the once-daily maintenance treatment of asthma in patients aged 18 or older with reversible obstructive airways disease. Anoro Ellipta is indicated for the maintenance treatment of patients with COPD, and Trelegy Ellipta is indicated for the maintenance treatment of patients with COPD as well as the maintenance treatment of asthma in patients aged 18 years and older.
Vildagliptin		Vildagliptin	274901-16-5	I6B4B2U96P	Dipeptidyl-Peptidase IV Inhibitors	Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release. (See all compounds classified as Dipeptidyl-Peptidase IV Inhibitors.)	Vildagliptin is indicated in the treatment of type II diabetes mellitus in adults. As monotherapy, vildagliptin is indicated in adults inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. It is also indicated as dual therapy in combination with metformin, a sulphonylurea, or a thiazolidinedione in adults patients with insufficient glycemic control despite maximal tolerated dose of monotherapy.   Vildagliptin is also marketed in a combination product with [metformin] for the treatment of adults with type II diabetes mellitus who inadequately respond to either monotherapy of vildagliptin or metformin. This fixed-dose formulation can be used in combination with a sulphonylurea or insulin (i.e., triple therapy) as an adjunct to diet and exercise in adults who do not achieve adequate glycemic control with monotherapy or dual therapy.
viltolarsen		CID 154562176					
Vinblastine	865-21-4	Vinblastine	865-21-4	5V9KLZ54CY	Tubulin Modulators	Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)	For treatment of breast cancer, testicular cancer, lymphomas, neuroblastoma, Hodgkin's and non-Hodgkin's lymphomas, mycosis fungoides, histiocytosis, and Kaposi's sarcoma.
Vinca Alkaloids		Vinca Alkaloids					
Vincamine	1617-90-9	Vincamine	1617-90-9	996XVD0JHT	Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
vinclozolin	50471-44-8	Vinclozolin	50471-44-8	JJ258EZN1I	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Vincristine		Vincristine	57-22-7	5J49Q6B70F	Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	Treatment of acute lymphocytic leukemia (ALL), Hodgkin lymphoma, non-Hodgkin lymphomas, Wilms' tumor, neuroblastoma, rhabdomyosarcoma. Liposomal vincristine is indicated for the treatment of relapsed Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL).
vindeburnol	68779-67-9	Vindeburnol					
Vindesine	53643-48-4	Vindesine	53643-48-4		Tubulin Modulators	Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)	For the treatment of acute leukaemia, malignant lymphoma, Hodgkin's disease, acute erythraemia and acute panmyelosis
Vinorelbine	71486-22-1	Vinorelbine	71486-22-1	Q6C979R91Y	Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	Vinorelbine tartrate is indicated for adults in the treatment of advanced non-small cell lung cancer (NSCLC), as a single therapy or in combination with other chemotherapeutic drugs.  Used in relapsed or refractory Hodgkin lymphoma, in combination with other chemotherapy agents.   For the treatment of desmoid tumor or aggressive fibromatosis, in combination with methotrexate.  For the treatment of recurrent or metastatic squamous cell head and neck cancer.  For the treatment of recurrent ovarian cancer.  For the treatment of metastatic breast cancer, in patients previously treated with anthracyline and/or taxane therapy.  For the treatment of HER2-positive, trastuzumab-resistant, advanced breast cancer in patients previously treated with a taxane, in combination with trastuzumab and everolimus.
vinpocetine	42971-12-0	Ethyl apovincaminate	42971-12-0		Neuroprotective Agents	Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)	
vinyl bromide	593-60-2	Vinyl bromide	593-60-2	83NRW59KFY			
vinyl carbamate	15805-73-9	Vinyl carbamate	15805-73-9	7Y2431GOM5			
Vinyl Chloride	75-01-4	Vinyl Chloride	9002-86-2	WD06X94M2D	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
Vinyl Compounds		Vinyl Compounds					
vinyl fluoride	75-02-5	Vinyl fluoride	75-02-5	2598465ICX	Carcinogens	Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)	
vinylidene chloride	75-35-4	Vinylidene chloride	75-35-4	21SK105J9D			
vinyltributylstannane		Tributyl(vinyl)tin	7486-35-3	2FA6XM467X			
violacein		Violacein	548-54-9	QJH0DSQ3SG			
Viper Venoms		Viperotoxin					
Viral Vaccines		Viral Vaccines					
virgatanol		virgatanol					
virodhamine		Virodhamine	287937-12-6		Cannabinoid Receptor Modulators	Compounds that interact with and modulate the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Modulators.)	
visnagin	82-57-5	Visnagin	82-57-5	P64438MLBW			
vistusertib		Vistusertib	1009298-59-2	0BSC3P4H5X			
Vitallium	12629-02-6	CID 9855813	105525-46-0				
Vitamin A	11103-57-4	Retinol	68-26-8	81G40H8B0T	Vitamins	Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body. (See all compounds classified as Vitamins.)	For the treatment of vitamin A deficiency.
vitamin A2	79-80-1	Vitamin A2	79-80-1	104621892X			
Vitamin B 12	68-19-9	vitamin B12	68-19-9		Vitamin B Complex	A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)	**Nasal spray**  The cyanocobalamin nasal spray is indicated for the maintenance of vitamin B12 concentrations after normalization with intramuscular vitamin B12 therapy in patients with deficiency of this vitamin who have no nervous system involvement.  Note:  CaloMist, the nasal spray form, has not been evaluated for the treatment of newly diagnosed vitamin B12 deficiency.  **Injection forms (subcutaneous, intramuscular)**  These forms are indicated for vitamin B12 deficiencies due to various causes, with or without neurologic manifestations.  Vitamin B12 deficiency is frequently caused by malabsorption, which is often associated with the following conditions:  Addisonian (pernicious) anemia  Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacterial overgrowth, total or partial gastrectomy  Fish tapeworm infestation  Malignancy of the pancreas or bowel  Folic acid deficiency   **Oral forms**  Vitamin B12 supplements are widely available and indicated in patients who require supplementation for various reasons.  Dose requirements for vitamin B12 which are higher than normal (caused by pregnancy, thyrotoxicosis, hemolytic anemia, hemorrhage, malignancy, hepatic and renal disease) can usually be achieved with oral supplementation.   Oral products of vitamin B12 are not recommended in patients with malabsorption, as these forms are primarily absorbed in the gastrointestinal tract.
Vitamin B 6	8059-24-3	(5-Hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate	8059-24-3		Vitamin B Complex	A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)	
Vitamin D	1406-16-2	Cholecalciferol	1406-16-2	1C6V77QF41	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Cholecalciferol use is indicated for the treatment of specific medical conditions like refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia.  Concurrently, as one of the most commonly utilized forms of vitamin D, cholecalciferol is also very frequently used as a supplement in individuals to maintain sufficient vitamin d levels in the body or to treat vitamin D deficiency, as well as various medical conditions that can be associated directly or indirectly with vitamin d insufficiency like osteoporosis and chronic kidney disease, among others.
Vitamin E	1406-18-4	DL-alpha-Tocopherol	10191-41-0	7QWA1RIO01			
Vitamin K	12001-79-5	Vitamin K	12001-79-5		Antifibrinolytic Agents	Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders. (See all compounds classified as Antifibrinolytic Agents.)	
Vitamin K 1	84-80-0	Phytonadione	12001-79-5	S5Z3U87QHF	Antifibrinolytic Agents	Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders. (See all compounds classified as Antifibrinolytic Agents.)	Oral phylloquinone is indicated to treat prothrombin deficiency caused by coumarin or indanedione derivatives; and hypoprothrombinemia secondary to antibacterial therapy, salicylates, or obstructive jaundice or biliary fistulas with concomitant bile salt administration.  Parenteral (intravenous, intramuscular, and subcutaneous) phylloquinone is indicated to treat coagulation disorders due to faulty formation of coagulation factors II, VII, IX, and X caused by vitamin K deficiency or some interference with vitamin K activity. These indications include the above indications as well as hypoprothrombinemia secondary to sprue, ulcerative colitis, celiac disease, intestinal resection, pancreatic cystic fibrosis, or regional enteritis; or hypoprothrombinemia caused by interference with vitamin k metabolism.
Vitamin K 2	11032-49-8	Menatetrenone	863-61-6	27Y876D139	Hemostatics	Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)	
Vitamin K 3	58-27-5	Menadione	58-27-5	723JX6CXY5	Vitamins	Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body. (See all compounds classified as Vitamins.)	The primary known function of vitamin K is to assist in the normal clotting of blood, but it may also play a role in normal bone calcification.
vitamin K1 oxide	25486-55-9	Phylloquinone oxide	25486-55-9				
vitamin k5	83-70-5	Vitamin k5	83-70-5	KKP97T7O0X			
Vitamin U		Methylmethionine sulfonium chloride	1115-84-0	G9CUR2204U	Anti-Ulcer Agents	Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)	
vitexin	521-33-5	Vitexin	3681-93-4	9VP70K75OK			
vitisin A	142449-89-6	Vitisin A	142449-89-6	832N5294M6			
VIVIT peptide		NFAT Inhibitor					
VL-0395		3-[[3-[(5-carbamimidoyl1H-indole-2-carbonyl)amino]benzoyl]amino]-3-phenylpropanoic acid					
VO-OHpic		VO-OHpic					
voacamine	3371-85-5	Voacamine	3371-85-5				For the treatment of malaria. Also under investigation for the modulation of multidrug resistance in cancer cells.
vofopitant	168266-90-8	Vofopitant	168266-90-8	K08BK043YS	Antiemetics	Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)	
voglibose		Voglibose	83480-29-9	S77P977AG8	Glycoside Hydrolase Inhibitors	Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES. (See all compounds classified as Glycoside Hydrolase Inhibitors.)	For the treatment of diabetes. It is specifically used for lowering post-prandial blood glucose levels thereby reducing the risk of macrovascular complications.
Volatile Organic Compounds		Volatile Organic Compounds					
volinanserin		Volinanserin	139290-65-6	EW71EE171J	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
vorapaxar		Vorapaxar	618385-01-6	ZCE93644N2	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	Vorapaxar is indicated for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or peripheral arterial disease (PAD). It is usually co-administered with acetylsalicylic acid (ASA) and/or clopidogrel, and should therefore be administered as an addition to these medications as it has not been studied alone.
Voriconazole		Voriconazole	188416-29-7	JFU09I87TR	14-alpha Demethylase Inhibitors	Compounds that specifically inhibit STEROL 14-DEMETHYLASE. A variety of azole-derived ANTIFUNGAL AGENTS act through this mechanism. (See all compounds classified as 14-alpha Demethylase Inhibitors.)	For the treatment of esophageal candidiasis, cadidemia, invasive pulmonary aspergillosis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp.
Vorinostat		Vorinostat	149647-78-9	58IFB293JI	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	For the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma who have progressive, persistent or recurrent disease on or following two systemic therapies.
vorozole		Vorozole	129731-10-8	1E2S9YXV2A	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
Vortioxetine		Vortioxetine	508233-74-7	3O2K1S3WQV	Anti-Anxiety Agents	Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)	Vortioxetine is indicated for the treatment of major depressive disorder (MDD).
vosaroxin		Vosaroxin	175414-77-4	K6A90IIZ19			Treatment of acute myeloid leukaemia
voxelotor		Voxelotor	1446321-46-5	3ZO554A4Q8	Hematologic Agents	Drugs that act on blood and blood-forming organs and those that affect the hemostatic system. (See all compounds classified as Hematologic Agents.)	In the US, voxelotor is indicated to treat sickle cell disease in both adult and pediatric patients aged 4 years and older. In Europe, it is indicated for the treatment of hemolytic anemia due to sickle cell disease (SCD) in adults and pediatric patients 12 years of age and older as monotherapy or in combination with [hydroxyurea].
VPC23019		(R)-2-Amino-3-((3-octylphenyl)amino)-3-oxopropyl dihydrogen phosphate			Sphingosine 1 Phosphate Receptor Modulators	Agents that affect the function of G-protein coupled SPHINGOSINE 1-PHOSPHATE RECEPTORS. Their binding to the receptors blocks lymphocyte migration and are often used as IMMUNOSUPPRESSANTS. (See all compounds classified as Sphingosine 1 Phosphate Receptor Modulators.)	
VPC32183		[(2R)-2-[[(Z)-octadec-9-enoyl]amino]-3-[4-(pyridin-3-ylmethoxy)phenyl]propyl] dihydrogen phosphate					
VRT 532		4-Methyl-2-(5-phenyl-1H-pyrazol-3-yl)phenol	38214-71-0				
VRX0466617		5-((4-((4-bromophenyl)amino)phenyl)amino)-3-hydroxy-N-(1-hydroxypropan-2-yl)isothiazole-4-carboximidamide					
VS-5584		5-(9-Isopropyl-8-methyl-2-morpholino-9H-purin-6-yl)pyrimidin-2-amine	1246560-33-7	W71J4X250V			
VU 0155041		(1R,2S)-2-[(3,5-dichlorophenyl)carbamoyl]cyclohexane-1-carboxylic acid					
VUF 5455		4-methoxy-N-(7-methyl-3-(2-pyridinyl)-1-isoquinolinyl)benzamide	390817-85-3		Purinergic P1 Receptor Agonists	Compounds that bind to and stimulate PURINERGIC P1 RECEPTORS. (See all compounds classified as Purinergic P1 Receptor Agonists.)	
VULM 1457		N-[2,6-Bis(1-methylethyl)phenyl]-N'-[4-[(4-nitrophenyl)thio]phenyl]urea	228544-65-8				
VX		O-Ethyl S-(2-diisopropylaminoethyl) methylphosphonothioate	50782-69-9	9A4381183B	Chemical Warfare Agents	Chemicals that are used to cause the disturbance, disease, or death of humans during WARFARE. (See all compounds classified as Chemical Warfare Agents.)	
Vx-11e		4-{2-[(2-Chloro-4-Fluorophenyl)amino]-5-Methylpyrimidin-4-Yl}-N-[(1s)-1-(3-Chlorophenyl)-2-Hydroxyethyl]-1h-Pyrrole-2-Carboxamide	896720-20-0				
VX-745	209409-98-3	5-(2,6-dichlorophenyl)-2-(phenylthio)-6H-pyrimido[1,6-b]pyridazin-6-one	209409-98-3				
W 7	65595-90-6	N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide	65595-90-6		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
waixenicin A		waixenicin A					
walleminone		Walleminone	221536-63-6				
walrycin A		4-Methoxy-1-naphthol	84-85-5	7CC5CL28DK			
warangalone	4449-55-2	Warangalone	4449-55-2				
Warfarin	81-81-2	Warfarin	81-81-2	5Q7ZVV76EI	Anticoagulants	Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)	**Indicated** for:  1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism.  2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation.  3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement.  4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction.  **Off-label** uses include:  1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.
Wasp Venoms		Wasp Venoms					
Wastewater		Wastewater					
Water	7732-18-5	Water	84776-64-7	059QF0KO0R			For diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.
Water Pollutants		Water Pollutants					
Water Pollutants, Chemical		Water Pollutants, Chemical					
WAY 100135	133025-23-7	N-tert-Butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide	133025-23-7		Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
WAY-169916		4-(1-Allyl-7-(trifluoromethyl)-1H-indazol-3-yl)benzene-1,3-diol	669764-18-5				
WAY-262611		(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine					
WAY-362450		Turofexorate isopropyl	629664-81-9	S6KDM312I5			
WEB 2086	105219-56-5	Apafant	105219-56-5	J613NI05SV	Platelet Aggregation Inhibitors	Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)	
wedelolactone	524-12-9	Wedelolactone	524-12-9	0K6L725GNS			
WEHI-539		5-[3-[4-(Aminomethyl)phenoxy]propyl]-2-[(8e)-8-(1,3-Benzothiazol-2-Ylhydrazinylidene)-6,7-Dihydro-5h-Naphthalen-2-Yl]-1,3-Thiazole-4-Carboxylic Acid					
Weichang'an		Weichang'an					
weifuchun		weifuchun					
WeiJia		WeiJia					
Wen-pi-tang-Hab-Wu-ling-san		Wen-pi-tang-Hab-Wu-ling-san					
wendan		wendan					
WHI P131		Janex-1	202475-60-3	1J8Q49TR3I			
WHI P154		2-Bromo-4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol	211555-04-3	PG8BT6T9MB			
WHI P180		WHI P180					
wilforgine		Wilforgine	37239-47-7				
wilforine		Wilforine	11088-09-8				
WIN 51708		(3S,4S,7S,8R,11S,12R,15S)-8-ethynyl-3,7-dimethyl-18,20,27-triazaheptacyclo[15.11.0.0^{3,15}.0^{4,12}.0^{7,11}.0^{19,27}.0^{21,26}]octacosa-1(28),17,19,21,23,25-hexaen-8-ol	144177-30-0				
WIN 62577		WIN 62577					
WIN 64338	151039-63-3	((4-((2-((Bis(cyclohexylamino)methylene)amino)-3-(2-naphthyl)-1-oxopropyl)amino)phenyl)methyl)tributylphosphonium chloride monohydrochloride	151039-63-3				
withaferin A	5119-48-2	Withaferin A	5119-48-2	L6DO3QW4K5			
Withanolides		2-[1-hydroxy-1-(5,6,14,17-tetrahydroxy-10,13-dimethyl-1-oxo-6,7,8,9,11,12,15,16-octahydro-4H-cyclopenta[a]phenanthren-17-yl)ethyl]-4,5-dimethyl-2,3-dihydropyran-6-one	63139-16-2				
withanone		Withanone	27570-38-3	GY036XA633			
WJ1376-1		WJ1376-1					
WJ1398-1		WJ1398-1					
wogonin	632-85-9	Wogonin	632-85-9	POK93PO28W			
wogonoside		Oroxindin	51059-44-0	ETX4944Z3R			
Wortmannin	19545-26-7	Wortmannin	19545-26-7	XVA4O219QW	Insulin Antagonists	Compounds which inhibit or antagonize the biosynthesis or action of insulin. (See all compounds classified as Insulin Antagonists.)	
WP 631		CID3008895					
WP 744		Berubicin hydrochloride	293736-67-1	7BA3X03948			Investigated for use/treatment in brain cancer.
WP1066		(S,E)-3-(6-Bromopyridin-2-yl)-2-cyano-N-(1-phenylethyl)acrylamide	857064-38-1	63V8AIE65T			
WP9QY peptide		WP9QY peptide					
WR 33278		N,N''-(Dithiodi-2,1-ethanediyl)bis-1,3-propanediamine	58205-87-1	S8KC806H2T	Radiation-Protective Agents	Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)	
WT161		N'-hydroxy-N-[(E)-[4-(N-phenylanilino)phenyl]methylideneamino]octanediamide			Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	
wulingsan		wulingsan					
wuzi yanzong		wuzi yanzong					
WY-135		CID 134612705					
WYE 125132		N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea	1144068-46-1				
WZ35 compound		WZ35 compound					
WZ4002		N-{3-[(5-chloro-2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)oxy]phenyl}prop-2-enamide	1213269-23-8	6BQ432Z61M	Protein Kinase Inhibitors	Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)	
WZ4003		N-(3-((5-chloro-2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)oxy)phenyl)propionamide	1214265-58-3				
WZB117		3-Fluoro-1,2-phenylene bis(3-hydroxybenzoate)	1223397-11-2				
X 910279		Cyclopropanepropanamide, alpha-cyano-N-(4-cyanophenyl)-beta-oxo-	185915-32-6	2785QG4477			
xaliproden	135354-02-8	Xaliproden	135354-02-8	V8QL94KNQO	Serotonin 5-HT1 Receptor Agonists	Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes. (See all compounds classified as Serotonin 5-HT1 Receptor Agonists.)	Investigated for use/treatment in amyotrophic lateral sclerosis (ALS) and alzheimer's disease.
Xamoterol	81801-12-9	Xamoterol	81801-12-9	7HE0JQL703	Adrenergic beta-1 Receptor Agonists	Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Agonists.)	
xanomeline		Xanomeline	131986-45-3	9ORI6L73CJ	Muscarinic Agonists	Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate. (See all compounds classified as Muscarinic Agonists.)	
xanthatin	26791-73-1	Xanthatin	26791-73-1	298X1N12LS	Antineoplastic Agents, Phytogenic	Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)	
Xanthenes		9H-Xanthene	92-83-1	A762Z8101Y			
Xanthine	69-89-6	Xanthine	69-89-6	1AVZ07U9S7			
Xanthines		Xanthines					
xanthoangelol	62949-76-2	Xanthoangelol	62949-76-2	91D4GN26Z1	Proton Pump Inhibitors	Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)	
xanthoceraside		Xanthoceraside					
xanthohumol	6754-58-1	Xanthohumol	6754-58-1	T4467YT1NT	Angiogenesis Inhibitors	Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. (See all compounds classified as Angiogenesis Inhibitors.)	
xanthone	90-47-1	Xanthone	90-47-1	9749WEV0CA			
Xanthones		Xanthones					
xanthorrhizol		Xanthorrhizol	30199-26-9				
xanthosine	146-80-5	Xanthosine	146-80-5	BM66HT53C3			
xanthurenic acid	59-00-7	Xanthurenic acid	59-00-7	58LAB1BG8J	Hypolipidemic Agents	Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)	
XAV939		3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one	284028-89-3	G2MY39VR77			
XCT790		Xct790	796844-24-1	A4CE428LGJ			
XELOX		Xelox	930113-49-8				
Xenon	7440-63-3	Xenon	7440-63-3	3H3U766W84	Anesthetics, Inhalation	Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173) (See all compounds classified as Anesthetics, Inhalation.)	
xestospongin B	88840-01-1	Xestospongin B	88840-01-1				
xestospongin C		Xestospongin c	88903-69-9				
XI-006		Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide	58131-57-0	63J576F4C5			
Xiao-Ke-An		Xiao-Ke-An					
xiaoluowan		xiaoluowan					
xiaoyaosan		xiaoyaosan					
xibenolol	30187-90-7	Xibenolol	30187-90-7	0871JY946G			
ximelagatran		Ximelagatran	192939-46-1		Antithrombins	Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. (See all compounds classified as Antithrombins.)	For the treatment of acute deep vein thrombosis.
xinfeng		xinfeng					
xinmaitong		xinmaitong					
xiongshao		xiongshao					
XK 469		Sodium 2-(4-((7-chloro-2-quinoxalinyl)oxy)phenoxy)propionate	157434-99-6	G6S5600O0D			
XL019 compound		XL019 compound					
XL147		N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide	956958-53-5				
XL765		N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide					For the treatment of various forms of cancer.
XLF-III-43		XLF-III-43					
XLR-11		(1-(5-Fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone	1364933-54-9	L2M8B977ZE			
XMD 8-92		2-{[2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino}-5,11-dimethyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one	1234480-50-2				
XMU-MP-1		Xmu-MP-1					
XP 620		XP 620					
Xuebijing		Xuebijing					
Xylazine	7361-61-7	Xylazine	7361-61-7	2KFG9TP5V8	Adrenergic alpha-2 Receptor Agonists	Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)	
Xylenes		1330-20-7					
Xylitol	87-99-0	Xylitol	488-81-3	353ZQ9TVDA	Sweetening Agents	Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)	Treatment of limb-girdle muscular dystrophy
xyloglucan	37294-28-3	37294-28-3					
xyloidone	15297-92-4	Xyloidone	15297-92-4	305WY61CUF			
xylometazoline	526-36-3	Xylometazoline	526-36-3	WPY40FTH8K	Nasal Decongestants	Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993) (See all compounds classified as Nasal Decongestants.)	Xylometazoline is indicated for the temporary relief of nasal congestion due to cold, hay fever or other respiratory allergies.
Xylose		D-Xylose	10257-31-5	A1TA934AKO			The predominant everyday nutritional usage of xylose is as a parent sugar alcohol from which another sugar alcohol - xylitol- can be derived from and used as an extremely common food additive or sweetener to be used in place of regular sugars as a lower calorie alternative.  Alternatively, xylose was also involved in a procedure known as a D-xylose absorption test that used to be employed to evaluate how well an individual was capable of absorbing a simple sugar like D-xylose from the intestines. By measuring the amount of D-xylose in urine and blood samples after an individual ingested a certain amount of the simple sugar dissolved in some water, the test sought to determine if nutrients were being properly absorbed in the patient's gastrointestinal tract.
xylosides		xylosides					
Xylulose	5962-29-8	D-xylulose	551-84-8	9N4LZL67SA			
xylulose-5-phosphate	60802-29-1	(2,3,5-Trihydroxy-4-oxopentyl) dihydrogen phosphate	60802-29-1				
Y 27632	138381-45-0	N-(4-Pyridyl)-4-(1-aminoethyl)cyclohexanecarboxamide dihydrochloride	138381-45-0		Antihypertensive Agents	Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)	
Y 32885		Y 32885					
Y134 compound		[6-Hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(4-propan-2-ylpiperazin-1-yl)phenyl]methanone	849662-80-2				
yangonin	500-62-9	Yangonin	500-62-9	R970U49V3C			
yangzheng xiaoji		Yangzheng xiaoji					
YC137		[4-[(4,9-dioxobenzo[f][1,3]benzothiazol-2-yl)amino]phenyl] (2S)-2-(methoxycarbonylamino)-4-methylsulfanylbutanoate	810659-53-1				
yessotoxin		Yessotoxin	112514-54-2	P6M9FM2L2G			
YF 476		Sograzepide	155488-25-8	HOU4I0G29C			
YH 439		Mivotilate	130112-42-4	0789652QUL			
Yi-Gan San		Yi-Gan San					
yishen huoxue decoction		yishen huoxue decoction					
YM 16151-1	103434-30-6	3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(2-(4-((2-hydroxy-3-phenoxypropyl)amino)butoxy)-5-nitrophenyl)-2,6-dimethyl-, dimethyl ester	103434-30-6				
YM 430		YM 430					
YM 511		4-[(4-Bromophenyl)methyl-(1,2,4-triazol-4-yl)amino]benzonitrile	148869-05-0	TK6QEB6SVR			
YM 529	127657-42-5	Minodronic acid	180064-38-4	40SGR63TGL			Investigated for use/treatment in multiple myeloma, breast cancer, osteoporosis, and lung cancer.
YM 758		YM 758 Phosphate					
YM-254890		(2S,3R)-2-acetamido-3-hydroxy-4-methylpentanoate					
yoda-1		2-[(2,6-Dichlorophenyl)methylsulfanyl]-5-pyrazin-2-yl-1,3,4-thiadiazole	448947-81-7	TW6GF9RW6S			
Yohimbine	146-48-5	Yohimbine	37247-87-3	2Y49VWD90Q	Adrenergic alpha-2 Receptor Antagonists	Drugs that bind to and block the activation of ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Antagonists.)	Indicated as a sympatholytic and mydriatic. Impotence has been successfully treated with yohimbine in male patients with vascular or diabetic origins and psychogenic origins.
you-gui-wan		you-gui-wan					
YSNSG cyclopeptide		YSNSG cyclopeptide					
Ytterbium	7440-64-4	Ytterbium	32997-62-9	MNQ4O4WSI1			
Yttrium	7440-65-5	Yttrium	7440-65-5	58784XQC3Y			
yttrium chloride	10361-92-9	Yttrium chloride	10361-92-9	11521XLD38			
yu ping feng san		yu ping feng san					
YU101		YU101					
Yueju-Wan		Yueju-Wan					
yufengningxin		yufengningxin					
yupingfeng		yupingfeng					
YW3-56		YW3-56 (hydrochloride, technical grade)					
Z 335		Sodium 2-((((4-chlorophenyl)sulfonyl)amino)methyl)-2,3-dihydro-1H-indene-5-acetate	146731-14-8				
Z 338		Acotiamide hydrochloride	185104-11-4	510791NN30	Cholinesterase Inhibitors	Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)	
z-Val-Ala-Asp(Ome)-fluoromethylketone		Benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone	187389-52-2		Caspase Inhibitors	Endogenous and exogenous compounds and that either inhibit CASPASES or prevent their activation. (See all compounds classified as Caspase Inhibitors.)	
zacopride	90182-92-6	Zacopride	90182-92-6	9GN3OT4156	Serotonin Antagonists	Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)	
zafirlukast	107753-78-6	Zafirlukast	107753-78-6	XZ629S5L50	Anti-Asthmatic Agents	Drugs that are used to treat asthma. (See all compounds classified as Anti-Asthmatic Agents.)	For the prophylaxis and chronic treatment of asthma.
Zalcitabine	7481-89-2	Zalcitabine	7481-89-2	6L3XT8CB3I	Anti-HIV Agents	Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)	For the treatment of Human immunovirus (HIV) infections in conjunction with other antivirals.
zaleplon		Zaleplon	151319-34-5	S62U433RMH	Anticonvulsants	Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)	For the treatment of short-term treatment of insomnia in adults.
zankiren hydrochloride		Zankiren hydrochloride	138810-64-7	FB7RZ4HUHJ			
zaprinast	37762-06-4	Zaprinast	37762-06-4	GXT25D5DS0	Phosphodiesterase Inhibitors	Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)	
zardaverine	101975-10-4	Zardaverine	101975-10-4	TQ358GWH6Y	Bronchodilator Agents	Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)	
zAsp(Ome)-Arg-His-Asp(Ome)-fluoromethyl ketone		zAsp(Ome)-Arg-His-Asp(Ome)-fluoromethyl ketone					
zatebradine	85175-67-3	Zatebradine	85175-67-3	TV27RY5876	Cardiotonic Agents	Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)	
ZCL-082		ZCL-082					
ZD 2574		ZD 2574					
ZD 7155		ZD 7155 hydrochloride	146709-78-6		Angiotensin II Type 1 Receptor Blockers	Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS. (See all compounds classified as Angiotensin II Type 1 Receptor Blockers.)	
ZD 9331		Plevitrexed	153537-73-6	L9P2881C3H	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)	Investigated for use/treatment in pancreatic cancer, solid tumors, gastric cancer, lung cancer, and colorectal cancer.
ZD4054		Zibotentan	186497-07-4	8054MM4902			Investigated for use/treatment in prostate cancer.
zearalenol		Zearalenol	5916-52-9				
Zearalenone	17924-92-4	Zearalenone	17924-92-4	5W827M159J	Estrogens, Non-Steroidal	Non-steroidal compounds with estrogenic activity. (See all compounds classified as Estrogens, Non-Steroidal.)	
Zeaxanthins		Zeaxanthin	144-68-3	CV0IB81ORO			
Zeneca ZD 6169		(2S)-N-(4-benzoylphenyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide	147696-46-6	H6UIO70F5E			
Zeocin	181494-14-4	Phleomycin D1	11031-11-1	O0VC1NEK5M			
Zeranol	26538-44-3	Zeranol	26538-44-3	76LO2L2V39	Estrogens, Non-Steroidal	Non-steroidal compounds with estrogenic activity. (See all compounds classified as Estrogens, Non-Steroidal.)	
zerumbone	471-05-6	Zerumbone	471-05-6				
zeta-inhibitory peptide		zeta-inhibitory peptide					
ZH-2 compound		ZH-2 compound					
zhenwu decoction		zhenwu decoction					
zhi-mu saponin		Zhi-mu saponin	41059-79-4				
Zidovudine	30516-87-1	Zidovudine	30516-87-1	4B9XT59T7S	Antimetabolites	Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)	Used in combination with other antiretroviral agents for the treatment of human immunovirus (HIV) infections.
zidovudine triphosphate		Combivir	92586-35-1	6RGF96R053	Anti-HIV Agents	Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)	
zifrosilone	132236-18-1	Zifrosilone	132236-18-1	6275788O83			
zileuton	132880-11-6	1-[1-(1-Benzothiophen-2-yl)ethyl]-3-hydroxyurea	132880-11-6				
Zilpaterol		Zilpaterol	119520-05-7	S384A1Y12J			
Zimeldine	56775-88-3	Zimeldine	56775-88-3	3J928617DW	Selective Serotonin Reuptake Inhibitors	Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Selective Serotonin Reuptake Inhibitors.)	For the treatment of depression.
Zinc	7440-66-6	Zinc	7440-66-6	J41CSQ7QDS	Trace Elements	A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)	Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections.
Zinc Acetate	5970-45-6	Zinc acetate dihydrate	5970-45-6				
zinc bis(histidinate)	144071-79-4	Zinc bis(histidinate)	144071-79-4	IW6DB980J8			
zinc chloride	7646-85-7	Zinc Chloride	7646-85-7	86Q357L16B	Mouthwashes	Solutions for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. (From Boucher&apos;s Clinical Dental Terminology, 4th ed) (See all compounds classified as Mouthwashes.)	Zinc chloride injections are indicated for use total parenteral nutrition to maintain zinc serum levels and prevent deficiency syndromes.
zinc chromate	13530-65-9	ZINC chromate	13530-65-9	05F2837HUF			
Zinc Compounds		Zinc Compounds					
zinc deuteroporphyrin IX 2,4-bis(glycol)	119700-81-1	3-[(4Z,10Z,15Z,19Z)-18-(2-carboxyethyl)-7,12-bis(1,2-dihydroxyethyl)-3,8,13,17-tetramethyl-1,2,3,12,13,14-hexahydroporphyrin-21,22,23,24-tetraid-2-yl]propanoic acid;zinc					
zinc hematoporphyrin	13939-11-2	Zinc hematoporphyrin	13939-11-2				
zinc mesoporphyrin		zinc mesoporphyrin					
zinc methionine	40816-51-1	Zinc methionine	40816-51-1	764D511203			
zinc nitrate	7779-88-6	Zinc Nitrate	7779-88-6	EDO66F5U49			
Zinc Oxide	1314-13-2	Zinc White	1314-13-2		Sunscreening Agents	Chemical or physical agents that protect the skin from sunburn and erythema by absorbing or blocking ultraviolet radiation. (See all compounds classified as Sunscreening Agents.)	For adjunctive treatment of diaper dermatitis. Also, it can be used to treat minor skin irritations (eg, cuts, burns, and scrapes, poison ivy). Zinc oxide can be used in ointments, creams, and lotions to protect against sunburn and other damage to the skin caused by ultraviolet light.
zinc protoporphyrin	15442-64-5	Protoporphyrin IX containing ZN	15442-64-5		Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
Zinc Sulfate	7733-02-0	Zinc Sulfate	7733-02-0	0J6Z13X3WO	Astringents	Agents, usually topical, that cause the contraction of tissues for the control of bleeding or secretions. (See all compounds classified as Astringents.)	This medication is a mineral used to treat or prevent low levels of zinc alone and together with oral rehydration therapy (ORT). It is also used as a topical astringent. Zinc Sulfate Injection, USP is indicated for use as a supplement to intravenous solutions given for TPN.
zinc sulfide	1314-98-3	ZINC sulfide	1314-98-3				
zinc(II) dipicolylamine		zinc(II) dipicolylamine					
ZINC06472206		CID7984904					
ZINC08438472		2-[4-[(Z)-[5-(4-ethoxyanilino)-4-ethoxycarbonyl-3-oxothiophen-2-ylidene]methyl]-2-methoxyphenoxy]acetic acid					
ZINC09315614		ZINC09315614					
ZINC17167211		3-[5-[(Z)-[3-[2-(4-fluoroanilino)-2-oxoethyl]-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl]furan-2-yl]-2-methylbenzoic acid					
ZINC18192594		ZINC18192594					
ZINC2120735		ZINC2120735					
ZINC32101539		ZINC32101539					
ZINC33468944		ZINC33468944					
ZINC3954010		C2BL8C9Zwy	754142-38-6	C2BL8C9ZWY			
ZINC58368839		ZINC58368839					
ZINC69391		1-(4,6-Dimethylpyrimidin-2-yl)-3-(2-(trifluoromethyl)phenyl)guanidine					
Zineb	12122-67-7	Zineb	9006-42-2	X1FSB1OZPT			
zingerone	122-48-5	Zingerone	122-48-5	4MMW850892			
zingiberene		Zingiberene	495-60-3	8XOC63EI5F			
zingiberis rhizome carbonisata		zingiberis rhizome carbonisata					
Zinostatin	9014-02-2	Zinostatin	9014-02-2		Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	
ziprasidone	146939-27-7	Ziprasidone	146939-27-7	6UKA5VEJ6X	Dopamine Antagonists	Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)	In its oral form, ziprasidone is approved for the treatment of schizophrenia, as monotherapy for acute treatment of manic or mixed episodes related to bipolar I disorder, and as adjunctive therapy to lithium or valproate for maintenance treatment of bipolar I disorder. The injectable formulation is approved only for treatment of acute agitation in schizophrenia.
Ziram	137-30-4	Ziram	137-30-4	73D8UA974J	Fungicides, Industrial	Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)	
Zirconium	7440-67-7	Zirconium	7440-67-7	C6V6S92N3C			
zirconium oxide	1314-23-4	Zirconium oxide	1314-23-4	S38N85C5G0	Dental Materials	Materials used in the production of dental bases, restorations, impressions, prostheses, etc. (See all compounds classified as Dental Materials.)	
ziyuglycoside I		Ziyuglycoside I					
ziyuglycoside II		ziyuglycoside II	35286-59-0	8AXK3E8B87			
ZK 110841	105595-17-3	(Z)-7-[(1R,2R,3R,5R)-5-chloro-2-[(E,3S)-3-cyclohexyl-3-hydroxyprop-1-enyl]-3-hydroxycyclopentyl]hept-5-enoic acid	105595-17-3				
ZK 119010	127451-69-8	2-(4-Hydroxyphenyl)-3-methyl-1-(6-(1-pyrrolidinyl)hexyl)indol-5-ol	127451-69-8	80Z22M837F			
ZK 164015		2-(4-Hydroxyphenyl)-3-methyl-1-(10-pentylsulfonyldecyl)-5-indolol	177583-70-9				
ZK 168281		(5Z,7E,22E)-(1S,3R,24R)-25-(carboethoxy-methylene)-26,26-cyclo-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,24-triol					
ZK 216348		7-Benzofuranbutanamide, 2,3-dihydro-alpha-hydroxy-gamma,gamma-dimethyl-N-(4-methyl-1-oxo-1H-2,3-benzoxazin-6-yl)-alpha-(trifluoromethyl)-, (+)-	669073-68-1	8BY7XK862L			
ZK159222		butyl 1-[(E,1R,4R)-4-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-1-hydroxypent-2-enyl]cyclopropane-1-carboxylate	156965-15-0				
ZLN005		2-(4-(tert-butyl)phenyl)-1H-benzo[d]imidazole	49671-76-3	3WT26285WB			
ZM 230487	155944-23-3	1-Ethyl-6-((3-fluoro-5-(4-methoxy-3,4,5,6-tetrahydro-2H-pyran-4-yl)phenoxy)methyl)-2-quinolone	155944-23-3	W3YP2PF3E9			
ZM 241385		4-(2-((7-Amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino)ethyl)phenol	139180-30-6	5NIC36BO71			
ZM323881		5-((7-(Benzyloxy)quinazolin-4-yl)amino)-4-fluoro-2-methylphenol	193001-14-8				
zolantidine		Zolantidine	104076-38-2	M1108XAY01	Histamine H2 Antagonists	Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (See all compounds classified as Histamine H2 Antagonists.)	
Zoledronic Acid		Zoledronic acid	118072-93-8	70HZ18PH24	Bone Density Conservation Agents	Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)	Zoledronic acid is indicated to treat hypercalcemia of malignancy, multiple myeloma, bone metastases from solid tumors, osteoporosis in men and postmenopausal women, glucocorticoid induced osteoporosis, and Paget's disease of bone in men and women. Zoledronic acid is also indicated for the prevention of osteoporosis in post menopausal women and glucocorticoid induced osteoporosis.
zolmitriptan		Zolmitriptan	139264-17-8	2FS66TH3YW	Serotonin 5-HT1 Receptor Agonists	Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes. (See all compounds classified as Serotonin 5-HT1 Receptor Agonists.)	Zolmitriptan is indicated for the acute treatment of migraine with or without auras in patients aged 18 and over.
Zolpidem		Zolpidem	82626-48-0	7K383OQI23	GABA-A Receptor Agonists	Endogenous compounds and drugs that bind to and activate GABA-A RECEPTORS. (See all compounds classified as GABA-A Receptor Agonists.)	This drug is indicated for the short-term treatment of insomnia in adults characterized by difficulties with sleep initiation.
zomepirac	33369-31-2	Zomepirac	33369-31-2	822G987U9J	Anti-Inflammatory Agents, Non-Steroidal	Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)	Zomepirac was indicated for the management of mild to severe pain.
zomepirac glucuronide	75871-31-7	Zomepirac glucuronide	75871-31-7				
zoniporide		Zoniporide	241800-98-6	8841R2UJPG			
Zonisamide	68291-97-4	Zonisamide	68291-97-4	459384H98V	Calcium Channel Blockers	A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)	Zonisamide capsules are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy. Zonisamide oral suspension is indicated as adjunctive therapy for the treatment of partial-onset seizures in adults and pediatric patients 16 years of age and older.
zopiclone		Zopiclone	43200-80-2	03A5ORL08Q	Hypnotics and Sedatives	Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)	For the short-term treatment of insomnia.
zopiclone N-oxide	43200-96-0	Zopiclone N-oxide	43200-96-0	0XXQ8C2EK4			
zopolrestat	110703-94-1	Zopolrestat	110703-94-1	1PV3S9WP3D	Enzyme Inhibitors	Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)	
zorubicin	54083-22-6	Zorubicin	54083-22-6	V25F9362OP	Antibiotics, Antineoplastic	Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)	
zosterin	11113-95-4	Zosterin					
zosuquidar trihydrochloride		Zosuquidar Trihydrochloride	167465-36-3	813AGY3126			
zotarolimus		Zotarolimus	221877-54-9	H4GXR80IZE			
zotepine	26615-21-4	Zotepine	26615-21-4	U29O83JAZW	Antipsychotic Agents	Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)	Zotepine, like other atypical antipsychotics, is considered as the first-line treatment in newly diagnosed schizophrenia. It is usually thought to be an option of choice for managing acute schizophrenic episodes when discussion with the patient is not possible. Zotepine, as an atypical antipsychotic, is used in patients who are suffering unacceptable side effects from conventional antipsychotics or in relapse patients that were inadequately controlled.   It is important to consider that the indications stated above are related to atypical antipsychotics, that zotepine is not currently FDA, Canada or EMA approved and that studies have not shown any additional benefit when compared with other approved atypical antipsychotics.  Schizophrenia is a chronic and severe mental disorder that affects how a person thinks, feels and behaves. It is usually marked for a loose reality perspective delineated by hallucinations, delusions and thought and movement disorders.
zoxamide		Zoxamide	156052-68-5	F1XZW465PC			
Zoxazolamine	61-80-3	Zoxazolamine	61-80-3	9DOW362Q29	Uricosuric Agents	Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma. (See all compounds classified as Uricosuric Agents.)	
ZR 777	37882-31-8	Kinoprene	42588-37-4	6IW5NLQ04R			
ZSTK474		4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine	475110-96-4	K0068GK39A			
Zymosan	9010-72-4	beta-D-glucopyranose	9001-37-0	J4R00M814D			
zymosterol	128-33-6	Zymosterol	128-33-6	PU2755PT4O			
